PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Patel, MR; Shen, K				Patel, Maulik R.; Shen, Kang			RSY-1 Is a Local Inhibitor of Presynaptic Assembly in C. elegans	SCIENCE			English	Article							CORNEAL EPITHELIAL-CELLS; CAENORHABDITIS-ELEGANS; PROTEIN; SYNAPSES; GENE; DIFFERENTIATION; TRANSCRIPTION; BRUCHPILOT; MECHANISMS; COMPONENTS	As fundamental units of neuronal communication, chemical synapses are composed of presynaptic and postsynaptic specializations that form at specific locations with defined shape and size. Synaptic assembly must be tightly regulated to prevent overgrowth of the synapse size and number, but the molecular mechanisms that inhibit synapse assembly are poorly understood. We identified regulator of synaptogenesis-1 (RSY-1) as an evolutionarily conserved molecule that locally antagonized presynaptic assembly. The loss of RSY-1 in Caenorhabditis elegans led to formation of extra synapses and recruitment of excessive synaptic material to presynaptic sites. RSY-1 directly interacted with and negatively regulated SYD-2/liprin-alpha, a master assembly molecule that recruits numerous synaptic components to presynaptic sites. RSY-1 also bound and regulated SYD-1, a synaptic protein required for proper functioning of SYD-2. Thus, local inhibitory mechanisms govern synapse formation.	[Patel, Maulik R.; Shen, Kang] Stanford Univ, Neurosci Program, Herrin Labs, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Dept Biol, Herrin Labs, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Dept Pathol, Herrin Labs, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Shen, K (corresponding author), Stanford Univ, Neurosci Program, Herrin Labs, 385 Serra Mall,Room 144, Stanford, CA 94305 USA.	kangshen@stanford.edu			NIH [1R01NS048392, National Research Service Award predoctoral fellowship]; Human Frontier Science Foundation; Howard Hughes Medical Institute; W. M. Keck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Foundation(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the Caenorhabditis Genetics Center and the Japanese NBPR for strains; Y. Kohara (National Institute of Genetics, Japan) for Y53H1A.1 cDNAs; J. Audhya (University of California, San Diego) for C. elegans optimized mCherry cDNA; L. Luo (Stanford University) for vertebrate mCherry cDNA; T. Meyer (Stanford University) for eYFP-C3 plasmid; M. Park (Stanford University) for mCerulean-C1 plasmid; C. Gao for technical assistance; and members of the Shen lab, C. Bargmann, T. Clandinin, and L. Luo for critical comments on the manuscript. We would also like to thank B. Grill (Stanford University) for providing protocol and guidance for coimmunoprecipitation experiments. This work was funded by grants awarded to K.S. [from NIH (1R01NS048392), the Human Frontier Science Foundation, the Howard Hughes Medical Institute, and the W. M. Keck Foundation] and by a National Research Service Award predoctoral fellowship awarded to M.R.P. by NIH.	Alpatov R, 2004, MOL CELL BIOL, V24, P10223, DOI 10.1128/MCB.24.23.10223-10235.2004; Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; Blanchard D, 2006, MOL CELL PROTEOMICS, V5, P2175, DOI 10.1074/mcp.T600025-MCP200; Chang Q, 2000, NEURON, V26, P287, DOI 10.1016/S0896-6273(00)81161-7; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; DEKEN SL, 2005, CELL, P5975; DESAI C, 1989, GENETICS, V121, P703; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; FULGA TA, 2008, CAENORHABDITIS, P339; Fulga TA, 2008, NEURON, V57, P339, DOI 10.1016/j.neuron.2008.01.016; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Joo JH, 2005, MOL VIS, V11, P133; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; KO J, E KIM; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pin OY, 1999, BIOCHEM BIOPH RES CO, V263, P192, DOI 10.1006/bbrc.1999.1353; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang P, 2002, BIOCHEM BIOPH RES CO, V294, P448, DOI 10.1016/S0006-291X(02)00495-3; Zhen M, 2004, CURR OPIN NEUROBIOL, V14, P280, DOI 10.1016/j.conb.2004.05.013; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zimowska G, 2003, INVEST OPHTH VIS SCI, V44, P4715, DOI 10.1167/iovs.03-0240	31	35	40	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1500	1503		10.1126/science.1169025	http://dx.doi.org/10.1126/science.1169025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286562	Green Accepted			2022-12-24	WOS:000264101700047
J	Buckley, B; Grant, AM				Buckley, Brian; Grant, Adrian M.			Uncertainties Page What is the most effective management of neurogenic bladder dysfunction?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Grant, Adrian M.] Univ Aberdeen, Coll Life Sci & Med, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen		bsbuckley@iol.ie	Buckley, Brian/B-4080-2010	Buckley, Brian/0000-0002-6007-9238				Broome Barbara Ann Shelton, 2003, Health Qual Life Outcomes, V1, P35, DOI 10.1186/1477-7525-1-35; Buckley B., 2007, CONTINENCE UK, V1, P76; *CONS SPIN CORD ME, 2006, BLADD MAN AD SPIN CO; Fowler CJ, 2003, J NEUROL NEUROSUR PS, V74, P27; HERBISON GP, 2003, COCHRANE DB SYST REV; Jamison J, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004375.PUB2, 10.1002/14651858.CD004375.pub2]; Moore KN, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006008.pub2; NABI G, 2003, COCHRANE DB SYST REV; NIELWEISE BS, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004201.PUB2; *NIH CLIN EXC ROY, 2006, UR INC MAN UR INC WO; *SOCTT INT GUID NE, 2004, MAN UR INC PRIM CAR; Stohrer M, 2003, GUIDELINES NEUROGENI; *U AB HLTH SERV RE, 2007, OUTC TRANSP INT SEGM	13	4	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2009	338								b659	10.1136/bmj.b659	http://dx.doi.org/10.1136/bmj.b659			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FV	19282439				2022-12-24	WOS:000264205400004
J	Kuo, Y; Sharma, G; Freeman, JL; Goodwin, JS				Kuo, Yong-Fang; Sharma, Gulshan; Freeman, Jean L.; Goodwin, James S.			Growth in the Care of Older Patients by Hospitalists in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMBULATORY-CARE; MEDICINE; SERVICE; PHYSICIANS; OUTCOMES; QUALITY; CANCER; ASSOCIATION; IMPACT; BREAST	Background: National and population-based information on the increase in patient care by hospitalists in the United States is lacking. Methods: Using a 5% sample of Medicare beneficiaries in 1995, 1997, 1999, and the period from 2001 through 2006, we identified 120,226 physicians in general internal medicine who were providing care to older patients in 5800 U.S. hospitals. We defined hospitalists as general internists who derived 90% or more of their Medicare claims for evaluation-and-management services from the care of hospitalized patients. We then calculated the percentage of all inpatient Medicare services provided by hospitalists and identified patient and hospital characteristics associated with the receipt of hospitalist services. Results: The percentage of physicians in general internal medicine who were identified as hospitalists increased from 5.9% in 1995 to 19.0% in 2006, and the percentage of all claims for inpatient evaluation-and-management services by general internists that were attributed to hospitalists increased from 9.1% to 37.1% during this same period. Accompanying the increase in care by hospitalists was an increase in the percentage of all hospitalized Medicare patients who were treated by general internists (both hospitalists and traditional, non-hospital-based general internists), from 46.4% in 1995 to 61.0% in 2006. In a multilevel, multivariable analysis controlling for patient and hospital characteristics, the odds of receiving care from a hospitalist increased by 29.2% per year from 1997 through 2006. In 2006, there was marked geographic variation in the rates of care provided by hospitalists, with rates of more than 70% in some hospital-referral regions. Conclusions: These analyses of data from Medicare claims showed a substantial increase in the care of hospitalized patients by hospitalist physicians from 1995 to 2006. N Engl J Med 2009;360:1102-12.	[Kuo, Yong-Fang] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kuo, Y (corresponding author), Univ Texas Med Branch, Dept Internal Med, 301 Univ Blvd, Galveston, TX 77555 USA.	yokuo@utmb.edu			Americans Independence Center [5P30AG024832]; Center for Population Health and Health Disparities [5P50CA105631]; University of Texas Medical Branch; NATIONAL CANCER INSTITUTE [P50CA105631, K05CA134923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033134, P30AG024832] Funding Source: NIH RePORTER	Americans Independence Center; Center for Population Health and Health Disparities; University of Texas Medical Branch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the Claude D. Pepper Older Americans Independence Center (5P30AG024832) and the Center for Population Health and Health Disparities (5P50CA105631) at the University of Texas Medical Branch.	Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Baldwin LM, 2002, MED CARE, V40, P82; Coffman J, 2005, MED CARE RES REV, V62, P379, DOI 10.1177/1077558705277379; Freed David H, 2004, Health Care Manag (Frederick), V23, P238; Freed GL, 2007, PEDIATRICS, V120, P33, DOI 10.1542/peds.2007-0304; Glasheen JJ, 2007, ARCH INTERN MED, V167, P727, DOI 10.1001/archinte.167.7.727; Greer A L, 1988, Int J Technol Assess Health Care, V4, P5; Kearns PJ, 2001, ARCH INTERN MED, V161, P235, DOI 10.1001/archinte.161.2.235; Keating NL, 2005, J GEN INTERN MED, V20, P38, DOI 10.1111/j.1525-1497.2004.40079.x; Kralovec PD, 2006, J HOSP MED, V1, P75, DOI 10.1002/jhm.82; Lackan NA, 2004, MED CARE, V42, P116, DOI 10.1097/01.mlr.0000108765.86294.1b; Landrigan CP, 2006, PEDIATRICS, V117, P1736, DOI 10.1542/peds.2005-0609; Lindenauer PK, 2007, NEW ENGL J MED, V357, P2589, DOI 10.1056/NEJMsa067735; Lindenauer PK, 1999, ANN INTERN MED, V130, P343, DOI 10.7326/0003-4819-130-4-199902161-00003; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Palmer HC, 2001, AM J MED, V111, P627, DOI 10.1016/S0002-9343(01)00976-7; Saint S, 2000, Eff Clin Pract, V3, P35; *SHM, 2008, SOC HOSP MED REL RES; Snyder CF, 2008, J GEN INTERN MED, V23, P254, DOI 10.1007/s11606-007-0497-5; *SOC HOSP MED, 2007, HOSP MED SPEC SHOWS; The Dartmouth Atlas of Health Care, ZIP COD CROSSW FIL H; Vansaghi LM, 2008, AM J MED, V121, P349, DOI 10.1016/j.amjmed.2007.11.019; VASILEVSKIS EE, 2007, RISE HOSP CALIFORNIA; Wachter RM, 1998, JAMA-J AM MED ASSOC, V279, P1560, DOI 10.1001/jama.279.19.1560; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; Wachter RM, 2008, MED CLIN N AM, V92, P265, DOI 10.1016/j.mcna.2007.10.008	27	180	180	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1102	1112		10.1056/NEJMsa0802381	http://dx.doi.org/10.1056/NEJMsa0802381			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279342	Bronze, Green Accepted			2022-12-24	WOS:000264051000008
J	Mehta, R; Zhu, R				Mehta, Ravi; Zhu, Rui (Juliet)			Blue or Red? Exploring the Effect of Color on Cognitive Task Performances	SCIENCE			English	Article							REGULATORY FOCUS; CUES; PREVENTION; PROMOTION	Existing research reports inconsistent findings with regard to the effect of color on cognitive task performances. Some research suggests that blue or green leads to better performances than red; other studies record the opposite. Current work reconciles this discrepancy. We demonstrate that red (versus blue) color induces primarily an avoidance (versus approach) motivation (study 1, n = 69) and that red enhances performance on a detail-oriented task, whereas blue enhances performance on a creative task (studies 2 and 3, n = 208 and 118). Further, we replicate these results in the domains of product design (study 4, n = 42) and persuasive message evaluation (study 5, n = 161) and show that these effects occur outside of individuals' consciousness (study 6, n = 68). We also provide process evidence suggesting that the activation of alternative motivations mediates the effect of color on cognitive task performances.	[Mehta, Ravi; Zhu, Rui (Juliet)] Univ British Columbia, Sauder Sch Business, Vancouver, BC V6T 1Z2, Canada	University of British Columbia	Zhu, R (corresponding author), Univ British Columbia, Sauder Sch Business, 2053 Main Mall, Vancouver, BC V6T 1Z2, Canada.	juliet.zhu@sauder.ubc.ca			Social Sciences and Humanities Research Council	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work benefited from financial support from the Social Sciences and Humanities Research Council to R.J.Z. We thank J. Meyers-Levy and K. D. Vohs for very helpful comments on earlier drafts of this paper. Research assistance from P. Behmardi, S. Ho, and S. Park is greatly appreciated.	Aslam M. M., 2006, J MARK COMMUN, V12, P15, DOI DOI 10.1080/13527260500247827; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BRAUN CC, 1995, ERGONOMICS, V38, P2207, DOI 10.1080/00140139508925263; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; Crowe E, 1997, ORGAN BEHAV HUM DEC, V69, P117, DOI 10.1006/obhd.1996.2675; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Elliot AJ, 2007, J EXP PSYCHOL GEN, V136, P154, DOI 10.1037/0096-3445.136.1.154; Friedman RS, 2005, J PERS SOC PSYCHOL, V88, P263, DOI 10.1037/0022-3514.88.2.263; Friedman RS, 2002, J EXP SOC PSYCHOL, V38, P41, DOI 10.1006/jesp.2001.1488; Friedman RS, 2001, J PERS SOC PSYCHOL, V81, P1001, DOI 10.1037/0022-3514.81.6.1001; Griskevicius V, 2006, J PERS SOC PSYCHOL, V91, P63, DOI 10.1037/0022-3514.91.1.63; Higgins ET, 1998, ADV EXP SOC PSYCHOL, V30, P1, DOI 10.1016/S0065-2601(08)60381-0; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Higgins ET, 2003, J PERS SOC PSYCHOL, V84, P1140, DOI 10.1037/0022-3514.84.6.1140; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Koch S, 2008, COGNITION, V109, P133, DOI 10.1016/j.cognition.2008.07.014; KWALLEK N, 1990, APPL ERGON, V21, P275, DOI 10.1016/0003-6870(90)90197-6; Moreau CP, 2005, J CONSUM RES, V32, P13, DOI 10.1086/429597; Naz K., 2004, COLL STUDENT J, V38, P396; Schwarz N., 1990, MOTIVATION COGNITION, V2, P527, DOI [10.2307/, DOI 10.2307/2072281]; Soldat AS, 1997, SOC COGNITION, V15, P55, DOI 10.1521/soco.1997.15.1.55; Stone NJ, 2003, J ENVIRON PSYCHOL, V23, P63, DOI 10.1016/S0272-4944(02)00107-X; THOMPSON E, 1992, BEHAV BRAIN SCI, V15, P1, DOI 10.1017/S0140525X00067248; Williams DJ, 2007, THEOR ISS ERGON SCI, V8, P1, DOI 10.1080/14639220500484419; Zhu R, 2007, J CONSUM RES, V34, P89, DOI 10.1086/513049	25	395	410	11	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1226	1229		10.1126/science.1169144	http://dx.doi.org/10.1126/science.1169144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19197022				2022-12-24	WOS:000263687600042
J	Cech, TR				Cech, Thomas R.			Crawling Out of the RNA World	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; GROUP-II INTRON; RIBOSOMAL-SUBUNIT; TELOMERASE RNA; PROTEINS; EVOLUTION; CATALYSIS; RIBONUCLEOPROTEIN; RIBOZYME; ENZYME	Comparison of phylogenetically diverse ribonucleoprotein (RNP) enzymes and information about their biochemistry have stimulated hypotheses about their evolution. Instead of the canonical view, in which catalysis proceeds from ribozyme to RNP enzyme to protein enzyme, RNP enzymes and proteins are seen to share contemporary catalysis. Furthermore, the RNA components of RNP enzymes show no evidence of fading out but instead, in some cases, have elaborated new functions.	Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Campus Box 215, Boulder, CO 80309 USA.	thomas.cech@colorado.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Atsumi S, 2001, EMBO J, V20, P5453, DOI 10.1093/emboj/20.19.5453; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Cleaves HJ, 2008, ORIGINS LIFE EVOL B, V38, P105, DOI 10.1007/s11084-007-9120-3; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Helm M, 2005, J AM CHEM SOC, V127, P10492, DOI 10.1021/ja052886i; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; KASHIWAGI N, 2007, NUCL ACIDS S SER, V51, P387; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Miller MC, 2002, P NATL ACAD SCI USA, V99, P6585, DOI 10.1073/pnas.102024699; Noller HF, 2006, COLD SPRING HARB MON, V43, P287; Noller HF, 2004, RNA, V10, P1833, DOI 10.1261/rna.7142404; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Poole AM, 1998, J MOL EVOL, V46, P1, DOI 10.1007/PL00006275; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Qiao F, 2008, NAT STRUCT MOL BIOL, V15, P634, DOI 10.1038/nsmb.1420; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Villa T, 2002, CELL, V109, P149, DOI 10.1016/S0092-8674(02)00726-2; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101	24	78	80	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					599	602		10.1016/j.cell.2009.02.002	http://dx.doi.org/10.1016/j.cell.2009.02.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239881	Bronze, Green Published			2022-12-24	WOS:000263688200011
J	Winkelmayer, WC; Liu, J; Brookhart, MA				Winkelmayer, Wolfgang C.; Liu, Jun; Brookhart, M. Alan			Altitude and All-Cause Mortality in Incident Dialysis Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-DISEASE; HIF-1	Context Patients undergoing dialysis at higher altitude receive lower erythropoietin doses, yet achieve higher hemoglobin concentrations. Increased iron availability caused by activation of hypoxia- induced factors at higher altitude may explain this finding. Hypoxia- induced factors are also involved in other pathways that may affect morbidity and mortality. Objective To study whether mortality differed by altitude in patients initiating dialysis. Design, Setting, and Participants Retrospective cohort of patients initiating dialysis in the United States between 1995 and 2004. Patients were stratified by the average elevation of their residential zip code. Covariates included age, sex, race, Medicaid coverage, dialysis modality, comorbidities, and reported laboratory measurements. We constructed proportional hazards models of all- cause mortality, stratifying by year, and censoring patients at 5 years from first dialysis, at the end of the database ( December 31, 2004), or loss to follow- up. We also compared age- and sex- adjusted standardized mortality rates of US patients receiving dialysis with the general population. Main Outcome Measure Mortality from any cause. Results A total of 804 812 patients initiated dialysis and were followed up for a median of 1.78 years. Crude mortality rates per 1000 person- years were 220.1 at an altitude lower than 76 m ( <250 ft), 221.2 from 76 through 609 m ( 250- 1999 ft), 214.6 from 610 through 1218 m ( 2000- 3999 ft), 184.9 from 1219 through 1828 m ( 4000 to 5999 ft), and 177.2 at an altitude higher than 1828 m ( > 6000 ft). After multivariable adjustment, compared with patients living at an altitude of lower than 76 m, the relative mortality rates were 0.97 ( 95% confidence interval [ CI], 0.96- 0.98) for those living from 76 through 609 m; 0.93 ( 95% CI, 0.91- 0.95), from 610 through 1218 m; 0.88 ( 95% CI, 0.84- 0.91), from 1219 through 1828 m, and 0.85 ( 95% CI, 0.79-0.92) higher than 1828 m. Age- and sex- standardized mortality decreased more with altitude in patients receiving dialysis than in the general population. Conclusions Altitude was inversely associated with all- cause mortality among US patients receiving dialysis.	[Winkelmayer, Wolfgang C.; Liu, Jun; Brookhart, M. Alan] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA 02120 USA; [Winkelmayer, Wolfgang C.; Liu, Jun; Brookhart, M. Alan] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Winkelmayer, Wolfgang C.] Brigham & Womens Hosp, Div Renal, Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Winkelmayer, WC (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Ste 3-030, Boston, MA 02120 USA.	wwinkelmayer@partners.org			American Heart Association [0535232N]; National Institute on Aging [AG-027400]; NATIONAL INSTITUTE ON AGING [K25AG027400] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Winkelmayer is supported by Scientist Development Grant 0535232N from the American Heart Association. Dr Brookhart is supported by career development award AG-027400 from the National Institute on Aging.	Baibas N, 2005, J EPIDEMIOL COMMUN H, V59, P274, DOI 10.1136/jech.2004.025510; Brookhart MA, 2008, J AM SOC NEPHROL, V19, P1389, DOI 10.1681/ASN.2007111181; BUECHLEY RW, 1979, AM J EPIDEMIOL, V109, P663, DOI 10.1093/oxfordjournals.aje.a112729; *CDC WONDER, COMPR MORT FIL 1999; Dawn B, 2005, AM J PHYSIOL-HEART C, V289, pH522, DOI 10.1152/ajpheart.00274.2005; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Maxwell P, 2003, J AM SOC NEPHROL, V14, P2712, DOI 10.1097/01.ASN.0000092792.97122.E0; MORTIMER EA, 1977, NEW ENGL J MED, V296, P581, DOI 10.1056/NEJM197703172961101; REGENSTEINER JG, 1985, JAMA-J AM MED ASSOC, V253, P3124, DOI 10.1001/jama.253.21.3124; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; WEINBERG CR, 1987, RADIAT RES, V112, P381, DOI 10.2307/3577265	11	47	49	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					508	512		10.1001/jama.2009.84	http://dx.doi.org/10.1001/jama.2009.84			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402CS	19190315	Bronze			2022-12-24	WOS:000262992400020
J	Junker, JP; Ziegler, F; Rief, M				Junker, Jan Philipp; Ziegler, Fabian; Rief, Matthias			Ligand-Dependent Equilibrium Fluctuations of Single Calmodulin Molecules	SCIENCE			English	Article							FORCE SPECTROSCOPY; MECHANICAL STABILITY; APO-CALMODULIN; PROTEIN; BINDING; KINETICS; ADHESION; AFFINITY	Single- molecule force spectroscopy allows superb mechanical control of protein conformation. We used a custom- built low- drift atomic force microscope to observe mechanically induced conformational equilibrium fluctuations of single molecules of the eukaryotic calcium- dependent signal transducer calmodulin ( CaM). From this data, the ligand dependence of the full energy landscape can be reconstructed. We find that calcium ions affect the folding kinetics of the individual CaM domains, whereas target peptides stabilize the already folded structure. Single- molecule data of full length CaM reveal that a wasp venom peptide binds noncooperatively to CaM with 2: 1 stoichiometry, whereas a target enzyme peptide binds cooperatively with 1: 1 stoichiometry. If mechanical load is applied directly to the target peptide, real- time binding/ unbinding transitions can be observed.	[Rief, Matthias] Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Junker, Jan Philipp; Ziegler, Fabian; Rief, Matthias] Tech Univ Munich, Phys Dept E22, D-85748 Munich, Germany	University of Munich; Technical University of Munich	Rief, M (corresponding author), Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany.	mrief@ph.tum.de	Junker, Jan Philipp/A-9754-2010	Junker, Jan Philipp/0000-0002-2826-8290	Deutsche Forschungsgemeinschaft [RI 990/3-1]; International Graduate School "Materials Science of Complex Interfaces	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School "Materials Science of Complex Interfaces	We thank P. M. Bayley for inspiring discussions and A. Bausch, H. Gaub, M. Bertz, and M. Schlierf for helpful comments on the manuscript. This work was supported by Deutsche Forschungsgemeinschaft grant RI 990/3-1. J.P.J. was supported by the International Graduate School "Materials Science of Complex Interfaces."	Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Best RB, 2008, J AM CHEM SOC, V130, P3706, DOI 10.1021/ja0762691; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao Y, 2008, P NATL ACAD SCI USA, V105, P11152, DOI 10.1073/pnas.0803446105; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; LINSE S, 1986, FEBS LETT, V199, P28, DOI 10.1016/0014-5793(86)81217-0; MALENCIK DA, 1983, BIOCHEM BIOPH RES CO, V114, P50, DOI 10.1016/0006-291X(83)91592-9; Masino L, 2000, PROTEIN SCI, V9, P1519, DOI 10.1110/ps.9.8.1519; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Munoz V, 2007, ANNU REV BIOPH BIOM, V36, P395, DOI 10.1146/annurev.biophys.36.040306.132608; Ng SP, 2007, P NATL ACAD SCI USA, V104, P9633, DOI 10.1073/pnas.0609901104; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Rabl CR, 2002, BIOPHYS CHEM, V101, P553, DOI 10.1016/S0301-4622(02)00150-3; Schlierf M, 2007, BIOPHYS J, V93, P3989, DOI 10.1529/biophysj.107.114397; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	26	169	172	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					633	637		10.1126/science.1166191	http://dx.doi.org/10.1126/science.1166191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179531				2022-12-24	WOS:000262862800043
J	White, DB; Katz, MH; Luce, JM; Lo, B				White, Douglas B.; Katz, Mitchell H.; Luce, John M.; Lo, Bernard			Who Should Receive Life Support During a Public Health Emergency? Using Ethical Principles to Improve Allocation Decisions	ANNALS OF INTERNAL MEDICINE			English	Article							FAIR PROCESS; PANDEMIC INFLUENZA; CRITICALLY-ILL; CRITICAL-CARE; TRIAGE	A public health emergency, such as an influenza pandemic, will lead to shortages of mechanical ventilators, critical care beds, and other potentially life-saving treatments. Difficult decisions about who will and will not receive these scarce resources will have to be made. Existing recommendations reflect a narrow utilitarian perspective, in which allocation decisions are based primarily on patients' chances of survival to hospital discharge. Certain patient groups, such as the elderly and those with functional impairment, are denied access to potentially life-saving treatments on the basis of additional allocation criteria. We analyze the ethical principles that could guide allocation and propose an allocation strategy that incorporates and balances multiple morally relevant considerations, including saving the most lives, maximizing the number of "life-years" saved, and prioritizing patients who have had the least chance to live through life's stages. We also argue that these principles are relevant to all patients and therefore should be applied to all patients, rather than selectively to the elderly, those with functional impairment, and those with certain chronic conditions. We discuss strategies to engage the public in setting the priorities that will guide allocation of scarce life-sustaining treatments during a public health emergency.	[White, Douglas B.] Univ Calif San Francisco, Program Med Eth, Sch Med, San Francisco, CA 94143 USA; San Francisco Dept Publ Hlth, San Francisco, CA USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; San Francisco Department of Public Health; San Francisco General Hospital Medical Center	White, DB (corresponding author), Univ Calif San Francisco, Program Med Eth, Sch Med, 521 Parnassus Ave,Suite C-126,Box 0903, San Francisco, CA 94143 USA.	dwhite@medicine.ucsf.edu			National Center for Research Resources [KL2 RR024130]; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG032875] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By grant KL2 RR024130 from the National Center for Research Resources, a component of the NIH and NIH Roadmap for Medical Research and by the Greenwall Foundation.	Agency for Healthc.Res.Quality (AHRQ), 2005, AHRQ PUBL, V05-P022; Barnato AE, 2004, CRIT CARE CLIN, V20, P345, DOI 10.1016/j.ccc.2004.03.002; Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA, Vseventh; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Burkle FM, 2002, EMERG MED CLIN N AM, V20, P409, DOI 10.1016/S0733-8627(01)00008-6; Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x; Childress JF, 2003, TRIAGE RESPONSE BIOT; Childress JF., 1970, SOUNDINGS, V53, P339; Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Daniels N, 2005, LANCET, V366, P169, DOI 10.1016/S0140-6736(05)66518-X; Daniels N, 1997, PHILOS PUBLIC AFF, V26, P303, DOI 10.1111/j.1088-4963.1997.tb00082.x; Danis M, 1997, CRIT CARE MED, V25, P887; *DEP HLTH HUM SERV, 2007, DRAFT GUID IN PRESS; Devereaux AV, 2008, CHEST, V133, p51S, DOI 10.1378/chest.07-2693; Egan TM, 2005, CHEST, V128, P407, DOI 10.1378/chest.128.1.407; Emanuel EJ, 2006, SCIENCE, V312, P854, DOI 10.1126/science.1125347; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Gostin L, 2006, JAMA-J AM MED ASSOC, V295, P1700, DOI 10.1001/jama.295.14.1700; Gostin LO, 2006, JAMA-J AM MED ASSOC, V295, P554, DOI 10.1001/jama.295.5.554; Gostin LO, 2002, JAMA-J AM MED ASSOC, V288, P622, DOI 10.1001/jama.288.5.622; Harris J., 1985, VALUE LIFE; Hick JL, 2006, ACAD EMERG MED, V13, P223, DOI [10.1111/j.1553-2712.2006.tb01677.x, 10.1197/j.aem.2005.07.037]; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; LEVINSKY NG, 1984, NEW ENGL J MED, V311, P1573, DOI 10.1056/NEJM198412133112412; Neuberger J, 1998, BMJ-BRIT MED J, V317, P172, DOI 10.1136/bmj.317.7152.172; Pesik N, 2001, ANN EMERG MED, V37, P642, DOI 10.1067/mem.2001.114316; PHILLIPS SJ, 2006, AHRQ PUBLICATION; Powell T, 2008, DISASTER MED PUBLIC, V2, P20, DOI 10.1097/DMP.0b013e3181620794; *PUBL ENG PIL PROJ, 2005, CIT VOIC PAND FLU CH; Ramsey P., 1970, PATIENT PERSON; Repine TB, 2005, MIL MED, V170, P505, DOI 10.7205/MILMED.170.6.505; RESCHER N, 1969, ETHICS, V79, P173, DOI 10.1086/291723; Rubinson L, 2005, CRIT CARE MED, V33, P2393, DOI 10.1097/01.CCM.0000173411.06574.D5; SANDERS D, 1968, UCLA LAW REV, V15, P357; Shortt SED, 1999, CAN MED ASSOC J, V161, P823; TANNER L, 2008, WASHINGTON POST 0505; Toner E, 2006, BIOSECUR BIOTERROR, V4, P207, DOI 10.1089/bsp.2006.4.207; vandenBos K, 1997, J PERS SOC PSYCHOL, V72, P1034, DOI 10.1037/0022-3514.72.5.1034; Veatch RM, 1997, KENNEDY INST ETHIC J, V7, P391, DOI 10.1353/ken.1997.0041; Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B	41	183	196	1	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					132	U94		10.7326/0003-4819-150-2-200901200-00011	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397ID	19153413	Green Accepted			2022-12-24	WOS:000262655200008
J	Geuking, MB; Weber, J; Dewannieux, M; Gorelik, E; Heidmann, T; Hengartner, H; Zinkernagel, RM; Hangartner, L				Geuking, Markus B.; Weber, Jacqueline; Dewannieux, Marie; Gorelik, Elieser; Heidmann, Thierry; Hengartner, Hans; Zinkernagel, Rolf M.; Hangartner, Lars			Recombination of Retrotransposon and Exogenous RNA Virus Results in Nonretroviral cDNA Integration	SCIENCE			English	Article							GENE-EXPRESSION; GERM-LINE; CELLS; ACTIVATION; GENOME; IDENTIFICATION; SEQUENCES; ONCOGENE; LEUKEMIA; ELEMENTS	Retroviruses have the potential to acquire host cell-derived genetic material during reverse transcription and can integrate into the genomes of larger, more complex DNA viruses. In contrast, RNA viruses were believed not to integrate into the host's genome under any circumstances. We found that illegitimate recombination between an exogenous nonretroviral RNA virus, lymphocytic choriomeningitis virus, and the endogenous intracisternal A-type particle (IAP) retrotransposon occurred and led to reverse transcription of exogenous viral RNA. The resulting complementary DNA was integrated into the host's genome with an IAP element. Thus, RNA viruses should be closely scrutinized for any capacity to interact with endogenous retroviral elements before their approval for therapeutic use in humans.	[Geuking, Markus B.; Weber, Jacqueline; Hengartner, Hans; Zinkernagel, Rolf M.; Hangartner, Lars] Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Dewannieux, Marie; Heidmann, Thierry] Inst Gustave Roussy, CNRS, Unite Mixte Rech 8122, Unite Retrovirus Endogenes & Elements Retroides E, F-94805 Villejuif, France; [Dewannieux, Marie; Heidmann, Thierry] Univ Paris 11, F-91405 Orsay, France; [Gorelik, Elieser] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15232 USA	University of Zurich; University Zurich Hospital; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Geuking, MB (corresponding author), McMaster Univ, Dept Med, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	geuking@mcmaster.ca; rolf.zinkernagel@usz.ch; hangartner.lars@virology.uzh.ch	Hangartner, Lars/H-3503-2011; Hangartner, Lars/AAS-1320-2021	Hangartner, Lars/0000-0002-3165-2058; Dewannieux, Marie/0000-0003-3918-2414	Swiss National Science Foundation; Canton of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Zurich	We are very grateful to K. K. Lueders for providing plasmids and critically reading the manuscript. We thank A. Macpherson, K. McCoy, and D. Burton for their support. We would also like to thank K. McCoy for critically reading the manuscript and for helpful comments. This study was supported by the Swiss National Science Foundation and the Canton of Zurich. M. B. G. planned and performed the experiments and wrote the paper together with L. H.; J. W. performed experiments; M. D., E. G., and T. H. provided reagents, cell lines, or plasmids; H. H. and R. M. Z. were involved in the planning and discussions of experiments, helped to write the paper, and provided the infrastructure used for this study; and L. H. initiated and supervised the study, planned and conducted experiments, and wrote the paper together with M. B. G. Sequences depicted in Fig. 1 are available from GenBank under accession numbers FJ460582 (MC57.18) and FJ460583 (MC57.23).	Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Braun E, 2000, VIROLOGY, V277, P136, DOI 10.1006/viro.2000.0568; CANAANI E, 1983, P NATL ACAD SCI-BIOL, V80, P7118, DOI 10.1073/pnas.80.23.7118; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Dupressoir A, 1996, MOL CELL BIOL, V16, P4495; Ishihara H, 2004, J RADIAT RES, V45, P25, DOI 10.1269/jrr.45.25; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; KUFF EL, 1983, NATURE, V302, P547, DOI 10.1038/302547a0; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; KUFF EL, 1985, MOL CELL BIOL, V5, P474, DOI 10.1128/MCB.5.3.474; Lehmann- Grube F, 1971, VIROLOGY MONOGRAPHS; LESLIE KB, 1991, MOL CELL BIOL, V11, P5562, DOI 10.1128/MCB.11.11.5562; Li MF, 1996, J GEN VIROL, V77, P2757, DOI 10.1099/0022-1317-77-11-2757; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; ONO M, 1983, NUCLEIC ACIDS RES, V11, P7169, DOI 10.1093/nar/11.20.7169; Recher M, 2007, NAT MED, V13, P1316, DOI 10.1038/nm1670; Wang XY, 1997, CYTOKINES CELL MOL T, V3, P3	19	105	112	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2009	323	5912					393	396		10.1126/science.1167375	http://dx.doi.org/10.1126/science.1167375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150848				2022-12-24	WOS:000262481400042
J	Boulton, AJM; Jeffcoate, WJ; Jones, TLZ; Ulbrecht, JS				Boulton, Andrew J. M.; Jeffcoate, William J.; Jones, Teresa L. Z.; Ulbrecht, Jon S.			International collaborative research on Charcot's disease	LANCET			English	Editorial Material									[Jeffcoate, William J.] Nottingham Univ Hosp Trust, Foot Ulcer Trials Unit, Dept Diabet & Endocrinol, Nottingham NG5 1PB, England; [Boulton, Andrew J. M.] Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England; [Jones, Teresa L. Z.] NIDDK, DEM, NIH, Bethesda, MD USA; [Ulbrecht, Jon S.] Penn State Univ, Penn State Inst Diabet & Obes, University Pk, PA 16802 USA	Nottingham University Hospital NHS Trust; University of Nottingham; University of Manchester; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park	Jeffcoate, WJ (corresponding author), Nottingham Univ Hosp Trust, Foot Ulcer Trials Unit, Dept Diabet & Endocrinol, City Hosp Campus, Nottingham NG5 1PB, England.	william.jeffcoate@tiscali.co.uk						Jeffcoate WJ, 2005, LANCET, V366, P2058, DOI 10.1016/S0140-6736(05)67029-8	1	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2009	373	9658					105	106		10.1016/S0140-6736(09)60019-2	http://dx.doi.org/10.1016/S0140-6736(09)60019-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135599				2022-12-24	WOS:000262340900009
J	Davis, JM; Ramakrishnan, L				Davis, J. Muse; Ramakrishnan, Lalita			The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection	CELL			English	Article							MYCOBACTERIUM-MARINUM INFECTION; HUMAN MACROPHAGES; CELL-DEATH; CALMETTE-GUERIN; IN-VIVO; APOPTOSIS; IMMUNITY; ZEBRAFISH; PATHOGENESIS; VIRULENCE	Granulomas, organized aggregates of immune cells, form in response to persistent stimuli and are hallmarks of tuberculosis. Tuberculous granulomas have long been considered host-protective structures formed to contain infection. However, work in zebrafish infected with Mycobacterium marinum suggests that granulomas contribute to early bacterial growth. Here we use quantitative intravital microscopy to reveal distinct steps of granuloma formation and assess their consequence for infection. Intracellular mycobacteria use the ESX-1/RD1 virulence locus to induce recruitment of new macrophages to, and their rapid movement within, nascent granulomas. This motility enables multiple arriving macrophages to efficiently find and phagocytose infected macrophages undergoing apoptosis, leading to rapid, iterative expansion of infected macrophages and thereby bacterial numbers. The primary granuloma then seeds secondary granulomas via egress of infected macrophages. Our direct observations provide insight into how pathogenic mycobacteria exploit the granuloma during the innate immune phase for local expansion and systemic dissemination.	[Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Davis, J. Muse] Emory Univ, Immunol & Mol Pathogenesis Grad Program, Atlanta, GA 30322 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	lalitar@u.washington.edu		Davis, J. Muse/0000-0001-9959-6921; Ramakrishnan, Lalita/0000-0003-0692-5533	NIH [RO1 AI54503, RO1 AI36396]; Burroughs Wellcome Foundation; American Society for Engineering Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036396, R01AI054503, R37AI054503] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); American Society for Engineering Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Troll for mathematical modelling, K. Winglee for data analysis, G. MacDonald, G. Davis, and F. Peri for technical advice, O. Humbert for initial observations, and B. Cormack, P. Edelstein, K. Urdahl, J. Egen, E. Brown, D. Tobin, H. Clay, H. Volkman, R. Lesley, and C. Cosma for discussion and critical comments. J. M. D. is grateful to R. Ahmed and to the late H. K. Ziegler for guidance. This work was supported by NIH RO1 grants AI54503 and AI36396 and the Burroughs Wellcome Foundation (L.R.) and an American Society for Engineering Education predoctoral fellowship (J.M.D.).	ADAMS DO, 1976, AM J PATHOL, V84, P164; ADAMS DO, 1975, AM J PATHOL, V80, P101; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Andersen P, 1997, SCAND J IMMUNOL, V45, P115, DOI 10.1046/j.1365-3083.1997.d01-380.x; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; BALASUBRAMANIAN V, 1994, TUBERCLE LUNG DIS, V75, P168, DOI 10.1016/0962-8479(94)90002-7; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chan K, 2002, P NATL ACAD SCI USA, V99, P3920, DOI 10.1073/pnas.002024599; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Cosma C. L., 2006, CURRENT PROTOCOLS MI, DOI 10.1002/; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; CREE IA, 1987, J CLIN PATHOL, V40, P1314, DOI 10.1136/jcp.40.11.1314; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Dannenberg AM, 2003, TUBERCULOSIS, V83, P251, DOI 10.1016/S1472-9792(03)00048-9; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Ernst JD, 2007, J CLIN INVEST, V117, P1738, DOI 10.1172/JCI31810; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kahnert A, 2007, J INFECT DIS, V195, P46, DOI 10.1086/508894; KAUFMANN SHE, 1994, IMMUNOBIOLOGY, V191, P509, DOI 10.1016/S0171-2985(11)80457-2; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lesley R, 2008, CURR OPIN MICROBIOL, V11, P277, DOI 10.1016/j.mib.2008.05.013; Miller EA, 2008, IMMUNITY, V29, P175, DOI 10.1016/j.immuni.2008.07.003; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Oddo M, 1998, J IMMUNOL, V160, P5448; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Peters W, 2003, MICROBES INFECT, V5, P151, DOI 10.1016/S1286-4579(02)00082-5; Rich AR, 1946, PATHOGENESIS TUBERCU; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Sherman DR, 2004, J INFECT DIS, V190, P123, DOI 10.1086/421472; Stamm LA, 2004, MICROBES INFECT, V6, P1418, DOI 10.1016/j.micinf.2004.10.003; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; STANLEY SA, 2003, SCIENCE, V296, P1873; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Webb SE, 1996, J CELL SCI, V109, P793; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	62	584	608	2	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					37	49		10.1016/j.cell.2008.11.014	http://dx.doi.org/10.1016/j.cell.2008.11.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135887	Green Accepted, Bronze			2022-12-24	WOS:000262318400013
J	Fu, DL; Uauy, C; Distelfeld, A; Blechl, A; Epstein, L; Chen, XM; Sela, HA; Fahima, T; Dubcovsky, J				Fu, Daolin; Uauy, Cristobal; Distelfeld, Assaf; Blechl, Ann; Epstein, Lynn; Chen, Xianming; Sela, Hanan; Fahima, Tzion; Dubcovsky, Jorge			A Kinase-START Gene Confers Temperature-Dependent Resistance to Wheat Stripe Rust	SCIENCE			English	Article								Stripe rust is a devastating fungal disease that afflicts wheat in many regions of the world. New races of Puccinia striiformis, the pathogen responsible for this disease, have overcome most of the known race-specific resistance genes. We report the map-based cloning of the gene Yr36 (WKS1), which confers resistance to a broad spectrum of stripe rust races at relatively high temperatures (25 degrees to 35 degrees C). This gene includes a kinase and a putative START lipid-binding domain. Five independent mutations and transgenic complementation confirmed that both domains are necessary to confer resistance. Yr36 is present in wild wheat but is absent in modern pasta and bread wheat varieties, and therefore it can now be used to improve resistance to stripe rust in a broad set of varieties.	[Fu, Daolin; Uauy, Cristobal; Distelfeld, Assaf; Dubcovsky, Jorge] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Distelfeld, Assaf; Sela, Hanan; Fahima, Tzion] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31905 Haifa, Israel; [Blechl, Ann] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Epstein, Lynn] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Chen, Xianming] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Chen, Xianming] Washington State Univ, USDA ARS, Pullman, WA 99164 USA	University of California System; University of California Davis; University of Haifa; United States Department of Agriculture (USDA); University of California System; University of California Davis; Washington State University; United States Department of Agriculture (USDA); Washington State University	Dubcovsky, J (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jdubcovsky@ucdavis.edu	Uauy, Cristobal/B-3879-2011; Uauy, Cristobal/B-7912-2014; Uauy, Cristobal/T-4382-2019; Dubcovsky, Jorge/A-4969-2008; Epstein, Lynn/F-1251-2013; Dubcovsky, Jorge/T-5214-2019; Distelfeld, Assaf/D-4951-2014	Uauy, Cristobal/0000-0002-9814-1770; Uauy, Cristobal/0000-0002-9814-1770; Dubcovsky, Jorge/0000-0002-7571-4345; Distelfeld, Assaf/0000-0003-1777-3053; Fahima, Tzion/0000-0001-5555-0040; Sela, Hanan/0000-0002-4218-4376	USDA-CSREES [2005-00975, 2006-55606-16629]; U.S. and Israel BARD Fund [US-4024-07]; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0628] Funding Source: researchfish	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); U.S. and Israel BARD Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by USDA-CSREES grants 2005-00975 and 2006-55606-16629 and by U.S. and Israel BARD Fund grant US-4024-07. We thank C. Li, F. Paraiso, L. Penman, K. L. Richardson, S. Bassein, M.R. Paddy, Q. Lam, and M. Jindal for technical assistance and R. Thilmony and M. Whalen for critical reading of the manuscript. Gene sequences have been deposited in GenBank with accession numbers EU835198-EU835200, FJ154103-FJ154118, and FJ155069-FJ155070.	ALPY F, 2005, PLANT PHYSIOL, V2791, P129; Cenci A, 2003, THEOR APPL GENET, V107, P931, DOI 10.1007/s00122-003-1331-z; Chen XM, 2007, AUST J AGR RES, V58, P648, DOI 10.1071/AR07045; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Distelfeld Assaf, 2004, Functional & Integrative Genomics, V4, P59, DOI 10.1007/s10142-003-0097-3; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Line RF, 2002, ANNU REV PHYTOPATHOL, V40, P75, DOI 10.1146/annurev.phyto.40.020102.111645; Ma Q, 2004, J PLANT PATHOL, V86, P19; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; QAYOUM A, 1985, PHYTOPATHOLOGY, V75, P1121, DOI 10.1094/Phyto-75-1121; Shang HongSheng, 1998, Scientia Agricultura Sinica, V31, P46; Singh R.P., 2004, 4 INT CROP SCI C BRI; Tang DZ, 2005, PLANT J, V44, P245, DOI 10.1111/j.1365-313X.2005.02523.x; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Verica JA, 2002, PLANT PHYSIOL, V129, P455, DOI 10.1104/pp.011028; Vorwerk S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-35; Wan AM, 2007, AUST J AGR RES, V58, P605, DOI 10.1071/AR06142	17	462	509	5	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1357	1360		10.1126/science.1166289	http://dx.doi.org/10.1126/science.1166289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19228999	Green Accepted			2022-12-24	WOS:000263876700046
J	Torchinsky, MB; Garaude, J; Martin, AP; Blander, JM				Torchinsky, Miriam Beer; Garaude, Johan; Martin, Andrea P.; Blander, J. Magarian			Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation	NATURE			English	Article							ESCHERICHIA-COLI ESPF; T-HELPER-CELLS; TGF-BETA; INTERLEUKIN-22; IL-17; MITOCHONDRIA; INFLAMMATION; CYTOKINE	Adaptive immune responses rely on differentiation of CD4 Thelper cells into subsets with distinct effector functions best suited for host defence against the invading pathogen. Interleukin (IL)-17 producing T helper cells (T(H)17) are a recently identified subset, separate from the T helper type 1 (T(H)1) and T helper type 2 (T(H)2) subsets(1). Synergy between the cytokines transforming growth factor-beta and IL-6 in vitro induces development of TH17 cells in mouse(1-5) and human(6) systems, whereas IL-23 supports expansion of these cells(2,4,5). However, it is not known which conditions in vivo would induce this combination of cytokines. Furthermore, it is enigmatic that a combination of pro-inflammatory and anti-inflammatory cytokines would be required to generate an effector TH17 response. Here we show that the relevant physiological stimulus triggering this combination of cytokines is the recognition and phagocytosis of infected apoptotic cells by dendritic cells. Phagocytosis of infected apoptotic cells uniquely triggers the combination of IL-6 and transforming growth factor-beta through recognition of pathogen-associated molecular patterns(7) and phosphatidylserine exposed on apoptotic cells(8), respectively. Conversely, phagocytosis of apoptotic cells in the absence of microbial signals induces differentiation of the closely related regulatory T cells, which are important for controlling autoimmunity(9). Blocking apoptosis during infection of the mouse intestinal epithelium with the rodent pathogen Citrobacter rodentium(10), which models human infections with the attaching and effacing enteropathogenic and enterohaemorrhagic Escherichia coli, impairs the characteristic TH17 response in the lamina propria. Our results demonstrate that infected apoptotic cells are a critical component of the innate immune signals instructing TH17 differentiation, and point to pathogens particularly adept at triggering apoptosis that might preferentially induce T(H)17-mediated immunity. Because TH17 cells have been correlated with autoimmune diseases(1), investigation of the pathways of innate recognition of infected apoptotic cells might lead to improved understanding of the causative defects in autoimmunity.	[Torchinsky, Miriam Beer; Garaude, Johan; Martin, Andrea P.; Blander, J. Magarian] Mt Sinai Sch Med, Dept Med, Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Blander, JM (corresponding author), Mt Sinai Sch Med, Dept Med, Inst Immunol, 1425 Madison Ave, New York, NY 10029 USA.	julie.blander@mssm.edu		Blander, Julie Magarian/0000-0001-9207-1700; Garaude, Johan/0000-0001-7789-7715	NIH [AI073899]; Kinship Foundation Searle Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073899, R01AI123284, R56AI073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinship Foundation Searle Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to R. Medzhitov, L. Mayer and D. Amsen for advice and critical reading of the manuscript, S. Lira for use of cryostat and microscope, B. B. Finlay and W. Deng for Citrobacter mutants, former Blander laboratory members H. Peche and B. Trinite for technical assistance and discussions, S. Mehrotra for advice with caspase inhibitors, and I. George and M. Grisotto for cell sorting. We are indebted to B. Brown, H. Xiong, G. Frankel, C. Dong, K. Schluns, M. Kamanaka, S. Yu, P. Arnaboldi, M. Bogunovic, B. M. Baker, S. L. Fishman, M. Blander and S. J. Blander for technical advice, assistance and support. J. G. is supported by the Fondation pour la Recherche Medicale, and J. M. B. is supported by NIH grant AI073899 and the Kinship Foundation Searle Scholar Award.	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Betti M, 2006, ANN ONCOL, V17, P235; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Laurence A, 2008, NAT MED, V14, P247, DOI 10.1038/nm0308-247; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; O'Garra A, 2008, NAT IMMUNOL, V9, P588, DOI 10.1038/ni0608-588; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Viswanathan VK, 2008, AM J PHYSIOL-GASTR L, V294, pG1165, DOI 10.1152/ajpgi.00596.2007; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zitvogel L, 2008, CURR OPIN IMMUNOL, V20, P501, DOI 10.1016/j.coi.2008.07.009	30	262	270	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 5	2009	458	7234					78	82		10.1038/nature07781	http://dx.doi.org/10.1038/nature07781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262671				2022-12-24	WOS:000263836000036
J	Tillman, K; Burton, B; Jacques, LB; Phurrough, SE				Tillman, Katherine; Burton, Brijet; Jacques, Louis B.; Phurrough, Steve E.			Compendia and Anticancer Therapy Under Medicare	ANNALS OF INTERNAL MEDICINE			English	Article							INVESTIGATIONAL THERAPY	In 1993, Congress directed the Medicare program to refer to 3 existing published compendia, American Medical Association Drug Evaluations (AMA-DE), United States Pharmacopoeia Drug Information for the Health Professional (USP-DI), and American Hospital Formulary Service Drug Information (AHFS-DI), to identify unlabeled but medically accepted uses of drugs and biologicals in anticancer chemotherapy regimens. Public discussion during the preceding years had centered on whether to designate unlabeled uses of anticancer treatments as experimental and thus outside the scope of Medicare benefits. American Medical Association Drug Evaluations and USP-DI subsequently ceased publication, and the Medicare program faced increasing calls to revise the list of acceptable compendia, as authorized in the statute. In 2007, the Centers for Medicare & Medicaid Services used its regulatory authority to establish a publicly transparent process to revise the list. The Centers for Medicare & Medicaid Services considered 5 requests in 2008 and added National Comprehensive Cancer Network Drugs and Biologics Compendium, DRUGDEX, and Clinical Pharmacology to the list of compendia. DrugPoints was not added, and AMA-DE was removed. Because of the potential for conflicts of interest to lead to biased judgments, the 2008 Medicare Improvements for Patients and Providers Act has a provision that explicitly prohibits inclusion of compendia that do not have a publicly transparent process for evaluating therapies and identifying potential conflicts of interest.	[Tillman, Katherine; Burton, Brijet; Jacques, Louis B.; Phurrough, Steve E.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services	Tillman, K (corresponding author), Ctr Medicare & Medicaid Serv, Mailstop C1-09-06,7500 Secur Blvd, Baltimore, MD 21244 USA.	katherine.tillman@cms.hhs.gov						Abernethy AP, 2009, ANN INTERN MED, V150, P336, DOI 10.7326/0003-4819-150-5-200903030-00107; ARONSON FR, 1990, J NATL CANCER I, V82, P1434, DOI 10.1093/jnci/82.17.1434; *CLIN PHARM, ED POL SUMM; *CTR MED MED SERV, THOMS MICR DRUGPOINT; *CTR MED MED SERV, CLIN PHARM COMP REV; *CTR MED MED SERV, THOMS MICR DRUGDEX C; *CTR MED MED SERV, NCCN COMP REV REQ; *CTR MED MED SERV, AMA DE COMP REV REQ; MCINTOSH H, 1990, J NATL CANCER I, V82, P996, DOI 10.1093/jnci/82.12.996; *NAT COMP CANC NET, NCCN EXP DISCL POL; *THOMS REUT HEALTH, THOMS MICR CONFL INT	11	24	24	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					348	+		10.7326/0003-4819-150-5-200903030-00109	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00109			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19221368				2022-12-24	WOS:000264051700007
J	Luan, B; Zhao, J; Wu, HY; Duan, BY; Shu, GW; Wang, XY; Li, DS; Jia, WP; Kang, JH; Pei, G				Luan, Bing; Zhao, Jian; Wu, Haiya; Duan, Baoyu; Shu, Guangwen; Wang, Xiaoying; Li, Dangsheng; Jia, Weiping; Kang, Jiuhong; Pei, Gang			Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance	NATURE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; ACTIVATION; PROTEIN; KINASE; AKT; SRC; OBESITY; PHOSPHORYLATION; TRANSDUCTION; PATHWAYS	Insulin resistance, a hallmark of type 2 diabetes, is a defect of insulin in stimulating insulin receptor signalling(1,2), which has become one of the most serious public health threats. Upon stimulation by insulin, insulin receptor recruits and phosphorylates insulin receptor substrate proteins(3), leading to activation of the phosphatidylinositol-3-OH kinase (PI(3) K)-Akt pathway. Activated Akt phosphorylates downstream kinases and transcription factors, thus mediating most of the metabolic actions of insulin(4-6). beta-arrestins mediate biological functions of G-protein-coupled receptors by linking activated receptors with distinct sets of accessory and effecter proteins, thereby determining the specificity, efficiency and capacity of signals(7-11). Here we show that in diabetic mouse models, beta-arrestin-2 is severely downregulated. Knockdown of beta-arrestin-2 exacerbates insulin resistance, whereas administration of beta-arrestin-2 restores insulin sensitivity in mice. Further investigation reveals that insulin stimulates the formation of a new beta-arrestin-2 signal complex, in which beta-arrestin-2 scaffolds Akt and Src to insulin receptor. Loss or dysfunction of beta-arrestin-2 results in deficiency of this signal complex and disturbance of insulin signalling in vivo, thereby contributing to the development of insulin resistance and progression of type 2 diabetes. Our findings provide new insight into the molecular pathogenesis of insulin resistance, and implicate new preventive and therapeutic strategies against insulin resistance and type 2 diabetes.	[Luan, Bing; Zhao, Jian; Duan, Baoyu; Shu, Guangwen; Kang, Jiuhong; Pei, Gang] Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Luan, Bing; Zhao, Jian; Duan, Baoyu; Shu, Guangwen; Kang, Jiuhong; Pei, Gang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Li, Dangsheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China; [Wu, Haiya; Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai, Peoples R China; [Wu, Haiya; Jia, Weiping] Shanghai Diabet Inst, Shanghai, Peoples R China; [Wu, Haiya; Jia, Weiping] Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China; [Wang, Xiaoying] Fudan Univ, Affiliated Zhongshan Hosp, Shanghai 200032, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences; Shanghai Jiao Tong University; Fudan University; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn	Luan, Bing/B-5521-2014; Zhao, Jian/E-2008-2019	Zhao, Jian/0000-0002-8862-0591; Luan, Bing/0000-0002-0409-2964; Kang, Jiuhong/0000-0001-7538-1889	Ministry of Science and Technology [2005CB522406, 2006CB943900, 2007CB947904, 2007CB947100, 2007CB948000, 2009CB941100]; National Natural Science Foundation of China [30621091, 30625014, 30623003, 30871285, 90713047]; Shanghai Municipal Commission for Science and Technology [07PJ14099, 06DZ22032]; Chinese Academy of Sciences [KSCX2-YW-R-56, 2007KIP204]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Chinese Academy of Sciences(Chinese Academy of Sciences)	We are grateful to R. J. Lefkowitz for providing us with beta-arr2-KO mice. We thank J.-L. Guan for discussions and comments on the manuscripts. We thank all members of the laboratory for sharing reagents and advice. This research was supported by the Ministry of Science and Technology (2005CB522406, 2006CB943900, 2007CB947904, 2007CB947100, 2007CB948000 and 2009CB941100), National Natural Science Foundation of China (30621091, 30625014, 30623003, 30871285 and 90713047), Shanghai Municipal Commission for Science and Technology (07PJ14099 and 06DZ22032), Chinese Academy of Sciences (KSCX2-YW-R-56 and 2007KIP204).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Craxton A, 1999, J BIOL CHEM, V274, P30644, DOI 10.1074/jbc.274.43.30644; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Haluzik MM, 2006, ENDOCRINOLOGY, V147, P4517, DOI 10.1210/en.2005-1624; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Luan B, 2005, EMBO J, V24, P4237, DOI 10.1038/sj.emboj.7600882; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Shen HQ, 1999, METABOLISM, V48, P965, DOI 10.1016/S0026-0495(99)90191-9; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	26	181	202	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1146	U105		10.1038/nature07617	http://dx.doi.org/10.1038/nature07617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19122674				2022-12-24	WOS:000263680100044
J	Molyneux, DH				Molyneux, David H.			10 years of success in addressing lymphatic filariasis	LANCET			English	Editorial Material							DISEASES; ACHIEVE		[Molyneux, David H.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Molyneux, DH (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England.	david.molyneux@liv.ac.uk						Blackburn BG, 2006, AM J TROP MED HYG, V75, P650, DOI 10.4269/ajtmh.2006.75.650; Goldman AS, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000067; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Molyneux DH, 2008, T ROY SOC TROP MED H, V102, P509, DOI 10.1016/j.trstmh.2008.02.024; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Ramaiah KD, 2000, PARASITOL TODAY, V16, P251, DOI 10.1016/S0169-4758(00)01643-4; WHO, 2006, PREV CHEM HUM HELM; *WHO, 2008, 61 WORLD HLTH ASS MA; World Health Organization, 2008, Weekly Epidemiological Record, V83, P333	11	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					529	530		10.1016/S0140-6736(09)60181-1	http://dx.doi.org/10.1016/S0140-6736(09)60181-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19217976				2022-12-24	WOS:000263333600011
J	Blow, N				Blow, Nathan			Glycobiology: A spoonful of sugar	NATURE			English	Editorial Material																		Campbell MP, 2008, BIOINFORMATICS, V24, P1214, DOI 10.1093/bioinformatics/btn090; Hwang GM, 2008, IEEE SENS J, V8, P2074, DOI 10.1109/JSEN.2008.2007663; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Wang CC, 2007, NATURE, V446, P896, DOI 10.1038/nature05730	4	43	46	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 29	2009	457	7229					617	622		10.1038/457617a	http://dx.doi.org/10.1038/457617a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177129				2022-12-24	WOS:000262852200049
J	Allison, DB; Mattes, RD				Allison, David B.; Mattes, Richard D.			Nutritively Sweetened Beverage Consumption and Obesity The Need for Solid Evidence on a Fluid Issue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTING CHILDHOOD OBESITY; WEIGHT; CHILDREN; YOUNG; FOOD		[Allison, David B.] Univ Alabama, Sect Stat Genet, Dept Biostat, Birmingham, AL 35294 USA; [Allison, David B.] Univ Alabama, Clin Nutr Res Ctr, Birmingham, AL 35294 USA; [Mattes, Richard D.] Purdue Univ, Dept Foods & Nutr, W Lafayette, IN 47907 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Allison, DB (corresponding author), Univ Alabama, Sect Stat Genet, Dept Biostat, Ryals Publ Hlth Bldg,Ste 414,1665 Univ Blvd, Birmingham, AL 35294 USA.	dallison@uab.edu		Allison, David/0000-0003-3566-9399	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079913, P30DK056336] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK079913, P30 DK056336, P30DK056336, R01 DK079913-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albala C, 2008, AM J CLIN NUTR, V88, P605, DOI 10.1093/ajcn/88.3.605; Almiron-Roig E, 2004, PHYSIOL BEHAV, V82, P671, DOI 10.1016/j.physbeh.2004.06.003; [Anonymous], 1931, BIOMETRIKA, V23, P398; Belpoggi F, 2006, ANN NY ACAD SCI, V1076, P736, DOI 10.1196/annals.1371.078; BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; James J, 2007, BMJ-BRIT MED J, V335, P762, DOI 10.1136/bmj.39342.571806.55; Mourao DM, 2007, INT J OBESITY, V31, P1688, DOI 10.1038/sj.ijo.0803667; NAGOURNEY E, 2006, NY TIMES        0307; Newby PK, 2004, J AM DIET ASSOC, V104, P1086, DOI 10.1016/j.jada.2004.04.020; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sichieri R, 2009, PUBLIC HEALTH NUTR, V12, P197, DOI 10.1017/S1368980008002644; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782	14	48	49	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					318	320		10.1001/jama.2008.974	http://dx.doi.org/10.1001/jama.2008.974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395IV	19155459	Green Accepted			2022-12-24	WOS:000262518700023
J	Raftery, J				Raftery, James			NICE and the challenge of cancer drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-EXCELLENCE; NATIONAL-INSTITUTE		[Raftery, James] Univ Southampton, Southampton SO16 7PX, Hants, England	University of Southampton	Raftery, J (corresponding author), Univ Southampton, Southampton SO16 7PX, Hants, England.	j.p.raftery@soton.ac.uk						Miners AH, 2005, BMJ-BRIT MED J, V330, P65, DOI 10.1136/bmj.38285.482350.82; NICE, 2008, APPR LIF EXT END LIF; ODOWD A, 2008, BRIT MED J, V336, pA444; Raftery JP, 2008, MED J AUSTRALIA, V188, P26, DOI 10.5694/j.1326-5377.2008.tb01500.x; Richards M, 2008, IMPROVING ACCESS MED; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; Thompson Coon J, 2008, BEVACIZUMAB SORAFENI	7	34	34	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 13	2009	338								b67	10.1136/bmj.b67	http://dx.doi.org/10.1136/bmj.b67			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404ZY	19141502				2022-12-24	WOS:000263192900001
J	Xiu, XA; Puskar, NL; Shanata, JAP; Lester, HA; Dougherty, DA				Xiu, Xinan; Puskar, Nyssa L.; Shanata, Jai A. P.; Lester, Henry A.; Dougherty, Dennis A.			Nicotine binding to brain receptors requires a strong cation-pi interaction	NATURE			English	Article							ACETYLCHOLINE-RECEPTORS; ION CHANNELS; M2 DOMAIN; AGONISTS; ACHBP; SITE; ACTIVATION; TOLERANCE; COMPLEXES; CHEMISTRY	Nicotine addiction begins with high-affinity binding of nicotine to acetylcholine (ACh) receptors in the brain. The end result is over 4,000,000 smoking-related deaths annually worldwide and the largest source of preventable mortality in developed countries. Stress reduction, pleasure, improved cognition and other central nervous system effects are strongly associated with smoking. However, if nicotine activated ACh receptors found in muscle as potently as it does brain ACh receptors, smoking would cause intolerable and perhaps fatal muscle contractions. Despite extensive pharmacological, functional and structural studies of ACh receptors, the basis for the differential action of nicotine on brain compared with muscle ACh receptors has not been determined. Here we show that at the alpha 4 beta 2 brain receptors thought to underlie nicotine addiction, the high affinity for nicotine is the result of a strong cation-pi interaction to a specific aromatic amino acid of the receptor, TrpB. In contrast, the low affinity for nicotine at the muscle-type ACh receptor is largely due to the fact that this key interaction is absent, even though the immediate binding site residues, including the key amino acid TrpB, are identical in the brain and muscle receptors. At the same time a hydrogen bond from nicotine to the backbone carbonyl of TrpB is enhanced in the neuronal receptor relative to the muscle type. A point mutation near TrpB that differentiates alpha 4 beta 2 and muscle-type receptors seems to influence the shape of the binding site, allowing nicotine to interact more strongly with TrpB in the neuronal receptor. ACh receptors are established therapeutic targets for Alzheimer's disease, schizophrenia, Parkinson's disease, smoking cessation, pain, attention-deficit hyperactivity disorder, epilepsy, autism and depression(1). Along with solving a chemical mystery in nicotine addiction, our results provide guidance for efforts to develop drugs that target specific types of nicotinic receptors.	[Xiu, Xinan; Puskar, Nyssa L.; Shanata, Jai A. P.; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu		Shanata, Jai/0000-0003-3588-040X	NIH [NS 34407, NS 11756]; California Tobacco-Related Disease Research Program of the University of California [16RT-0160]; NRSA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756, R37NS034407, R01NS034407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Tobacco-Related Disease Research Program of the University of California(University of California System); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. N. Cohen for advice on single-channel recording and analysis. This work was supported by the NIH (NS 34407; NS 11756) and the California Tobacco-Related Disease Research Program of the University of California, grant number 16RT-0160. J.A.P.S. was partially supported by an NRSA training grant.	Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cashin AL, 2005, J AM CHEM SOC, V127, P350, DOI 10.1021/ja0461771; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Dougherty DA, 2008, J ORG CHEM, V73, P3667, DOI 10.1021/jo8001722; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Fonck C, 2005, J NEUROSCI, V25, P11396, DOI 10.1523/JNEUROSCI.3597-05.2005; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Kearney PC, 1996, MOL PHARMACOL, V50, P1401; Koh JT, 1997, BIOCHEMISTRY-US, V36, P11314, DOI 10.1021/bi9707685; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; MCMANUS OB, 1987, PFLUG ARCH EUR J PHY, V410, P530, DOI 10.1007/BF00586537; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; SINE SM, 1995, NEURON, V15, P229, DOI 10.1016/0896-6273(95)90080-2; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Talley TT, 2006, BIOCHEMISTRY-US, V45, P8894, DOI 10.1021/bi060534y; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	31	281	288	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					534	U10		10.1038/nature07768	http://dx.doi.org/10.1038/nature07768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19252481	Green Accepted			2022-12-24	WOS:000264532400050
J	Hugonnet, JE; Tremblay, LW; Boshoff, HI; Barry, CE; Blanchard, JS				Hugonnet, Jean-Emmanuel; Tremblay, Lee W.; Boshoff, Helena I.; Barry, Clifton E., III; Blanchard, John S.			Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis	SCIENCE			English	Article							BETA-LACTAM ANTIBIOTICS; PERSISTENCE; INHIBITION; ACID	beta-lactam antibiotics are ineffective against Mycobacterium tuberculosis, being rapidly hydrolyzed by the chromosomally encoded blaC gene product. The carbapenem class of beta-lactams are very poor substrates for BlaC, allowing us to determine the three-dimensional structure of the covalent BlaC-meropenem covalent complex at 1.8 angstrom resolution. When meropenem was combined with the beta-lactamase inhibitor clavulanate, potent activity against laboratory strains of M. tuberculosis was observed [minimum inhibitory concentration (MICmeropenem) less than 1 microgram per milliliter], and sterilization of aerobically grown cultures was observed within 14 days. In addition, this combination exhibited inhibitory activity against anaerobically grown cultures that mimic the "persistent" state and inhibited the growth of 13 extensively drug-resistant strains of M. tuberculosis at the same levels seen for drug-susceptible strains. Meropenem and clavulanate are Food and Drug Administration-approved drugs and could potentially be used to treat patients with currently untreatable disease.	[Hugonnet, Jean-Emmanuel; Tremblay, Lee W.; Blanchard, John S.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Boshoff, Helena I.; Barry, Clifton E., III] NIAID, TB Res Stn, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Blanchard, JS (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	blanchar@aecom.yu.edu	HUGONNET, Jean-Emmanuel/H-3581-2014; HUGONNET, Jean-Emmanuel/ABC-7914-2021; Barry, Clifton E/ABE-7992-2020; Barry, III, Clifton/H-3839-2012	HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X	NIH [AI33696]; National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783, R01AI033696, ZIAAI000693] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to thank J. Chan and E. Russel for help in the Wayne model studies and H. Xiao for assistance in mass spectrometry. This work was supported partially by the NIH (AI33696 to J.S.B.); in part by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases; and in part by a grant from the Bill and Melinda Gates Foundation and the Wellcome Trust through the Grand Challenges in Global Health Initiative. A provisional U.S. patent application was filed on 27 May 2008 related to this work. Structure coordinates have been deposited as Protein Data Bank identification code 3DWZ.	Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Bush K, 1998, ADV EXP MED BIOL, V456, P71; Chambers HF, 1998, CLIN INFECT DIS, V26, P874, DOI 10.1086/513945; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CYNAMON MH, 1983, ANTIMICROB AGENTS CH, V24, P429, DOI 10.1128/AAC.24.3.429; Dincer I, 2004, INT J ANTIMICROB AG, V23, P408, DOI 10.1016/j.ijantimicag.2003.09.023; EASTON CJ, 1982, BIOCHEMISTRY-US, V21, P2857, DOI 10.1021/bi00541a008; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hugonnet JE, 2007, BIOCHEMISTRY-US, V46, P11998, DOI 10.1021/bi701506h; Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Segura C, 1998, ANTIMICROB AGENTS CH, V42, P1524, DOI 10.1128/AAC.42.6.1524; Tremblay LW, 2008, BIOCHEMISTRY-US, V47, P5312, DOI 10.1021/bi8001055; Wang F, 2006, ANTIMICROB AGENTS CH, V50, P2762, DOI 10.1128/AAC.00320-06; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	19	367	381	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1215	1218		10.1126/science.1167498	http://dx.doi.org/10.1126/science.1167498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251630	Green Accepted			2022-12-24	WOS:000263687600039
J	Varagunam, M; Yaqoob, MM; Dohler, B; Opelz, G				Varagunam, Mira; Yaqoob, Muhammad M.; Doehler, Bernd; Opelz, Gerhard			C3 Polymorphisms and Allograft Outcome in Renal Transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLEMENT C3; MOLECULAR ANALYSIS; REJECTION; ALLOTYPES; COMPONENT	Background: Complement activation plays a role in the development of chronic allograft nephropathy, a common cause of late allograft loss. The role of two complement component 3 (C3) allotypes, called C3F (fast) and C3S (slow) on the basis of their electrophoretic motility, in the long-term outcome of renal allografts remains controversial. Methods: We selected a random sample of 1147 donor and recipient pairs from the Collaborative Transplant Study DNA bank, and their DNA specimens were genotyped for the C3F and C3S alleles. The genotyping results were analyzed according to allograft outcome. Transplants were divided into four groups, according to the recipient and donor genotypes: SS recipient and FS or FF donor (the standard for comparison, since this combination has been reported to have the best outcome), SS recipient and donor, FS or FF recipient and SS donor, and FS or FF recipient and donor. Results: Baseline characteristics of the four transplant groups were similar. The hazard ratios for allograft survival in the SS recipient and FS or FF donor group as compared with the other three groups (SS recipient and donor, FS or FF recipient and SS donor, and FS or FF recipient and donor) were not significant: 0.90 (95% confidence interval [CI], 0.7 to 1.14; P=0.33), 0.87 (95% CI, 0.65 to 1.16; P=0.33), and 0.89 (95% CI, 0.65 to 1.23; P=0.48), respectively. The four groups had similar patient-survival rates and similar cumulative rates of acute rejection and allograft dysfunction, as assessed by means of serum creatinine levels. Conclusions: Our results suggest that transplantation of FS or FF kidneys to SS recipients is not advantageous, possibly because chronic allograft nephropathy is a multifaceted disease involving the interplay of many biologic pathways. N Engl J Med 2009;360:874-80.	[Varagunam, Mira; Yaqoob, Muhammad M.] Barts & London Queen Marys Sch Med & Dent, London, England; [Varagunam, Mira; Yaqoob, Muhammad M.] Natl Hlth Serv Trust, London, England; [Doehler, Bernd; Opelz, Gerhard] Univ Heidelberg, Dept Transplantat Immunol, Heidelberg, Germany	University of London; Queen Mary University London; Ruprecht Karls University Heidelberg	Yaqoob, MM (corresponding author), Royal London Hosp, Dept Renal Med & Transplantat, London E1 1BB, England.	m.m.yaqoob@qmul.ac.uk			Renal Unit, Barts; London National Health Service Trust; Department of Transplantation Immunology, University of Heidelberg	Renal Unit, Barts; London National Health Service Trust; Department of Transplantation Immunology, University of Heidelberg	Supported by grants from the Renal Unit, Barts and the London National Health Service Trust, and the Department of Transplantation Immunology, University of Heidelberg.; No potential conflict of interest relevant to this article was reported.	ANDREWS PA, 1995, EUR J IMMUNOL, V25, P1087, DOI 10.1002/eji.1830250434; Andrews PA, 1995, TRANSPLANTATION, V60, P1342; ARVILOMMI H, 1974, NATURE, V251, P740, DOI 10.1038/251740a0; BARTOK I, 1995, J IMMUNOL, V154, P5367; BOTTO M, 1990, J EXP MED, V172, P1011, DOI 10.1084/jem.172.4.1011; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Feucht HE, 2003, AM J TRANSPLANT, V3, P646, DOI 10.1034/j.1600-6143.2003.00171.x; FINN JE, 1994, NEPHROL DIAL TRANSPL, V9, P1564; Heinold A, 2008, AM J TRANSPLANT, V8, P95, DOI 10.1111/j.1600-6143.2007.02042.x; POZNANSKY MC, 1989, J IMMUNOL, V143, P3860; POZNANSKY MC, 1989, J IMMUNOL, V143, P1254; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; RAMBAUSEK M, 1987, Nephrology Dialysis Transplantation, V2, P208; Sacks SH, 2003, CURR OPIN IMMUNOL, V15, P487, DOI 10.1016/S0952-7915(03)00100-6; Soulillou J, 2006, NEW ENGL J MED, V354, P2060, DOI 10.1056/NEJMe068066; Tang S, 1999, J IMMUNOL, V162, P4336; TEISBERG P, 1970, VOX SANG, V19, P47, DOI 10.1111/j.1423-0410.1970.tb01494.x; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yates PJ, 2006, TRANSPL IMMUNOL, V16, P148, DOI 10.1016/j.trim.2006.10.001	19	60	62	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					874	880		10.1056/NEJMoa0801861	http://dx.doi.org/10.1056/NEJMoa0801861			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246358	Bronze			2022-12-24	WOS:000263624700005
J	Sidebotham, P; Pearson, G				Sidebotham, Peter; Pearson, Gale			Responding to and learning from childhood deaths	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNEXPECTED DEATH; SUDDEN		[Sidebotham, Peter] Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Pearson, Gale] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England	University of Warwick; University of Birmingham	Sidebotham, P (corresponding author), Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England.	p.sidebotham@warwick.ac.uk	Sidebotham, Peter D/E-3011-2010	Sidebotham, Peter D/0000-0003-4891-6926				Axford N., 2005, CHILD DEATH SIGNIFIC; Bunting L., 2005, CHILD ABUSE REV, V14, P82, DOI DOI 10.1002/CAR.886; Dent A, 1996, ARCH DIS CHILD, V74, P522, DOI 10.1136/adc.74.6.522; *DEP ED SKILLS, 2006, WORK TOG SAF CHILDR; Durfee M, 2002, CHILD ABUSE NEGLECT, V26, P619, DOI 10.1016/S0145-2134(02)00337-X; Fleming P., 2000, SUDDEN UNEXPECTED DE; Livesey A, 2005, BRIT MED J, V330, P227, DOI 10.1136/bmj.38323.652523.F7; *OFF NAT STAT, 2007, MORT STAT CHILDH INF; Onwuachi-Saunders C, 1999, Inj Prev, V5, P276; PEARSON GEE, 2008, WHY CHILDREN DIE PIL; Reder P, 1999, LOST INNOCENTS FOLLO; Rimsza ME, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e11; *ROY COLL PATH ROY, 2004, SUDD UN DEATH INF MU; SIDEBOTHAM P, 2007, UNEXPECTED DEATH CHI, P97; SIDEBOTHAM P, 2007, UNEXPECTED DEATH CHI, P10; Sidebotham P., 2008, PREVENTING CHILDHOOD	16	15	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2009	338								b531	10.1136/bmj.b531	http://dx.doi.org/10.1136/bmj.b531			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417DP	19237412				2022-12-24	WOS:000264056000018
J	McKay, CP				McKay, Christopher P.			PLANETARY SCIENCE Biologically Reversible Exploration	SCIENCE			English	Editorial Material							MARS; EARTH		[McKay, Christopher P.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	McKay, CP (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	christopher.mckay@nasa.gov						Barengoltz J, 2005, AEROSP CONF PROC, P253; Boston P J, 2003, Gravit Space Biol Bull, V16, P121; *COSPAR, 2003, COSPAR INF B, V156, P24; Kminek G, 2003, RADIAT RES, V159, P722, DOI 10.1667/0033-7587(2003)159[0722:RLFTVO]2.0.CO;2; Marinova MM, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002306; McKay C.P., 2001, PLANET REP, V21, P4; MCKAY CP, 1991, NATURE, V352, P489, DOI 10.1038/352489a0; McKay CP, 2004, PLOS BIOL, V2, P1260, DOI 10.1371/journal.pbio.0020302; *NAT RES COUNC, 2006, PREV FORW CONT MARS, P362; Schuerger AC, 2003, ICARUS, V165, P253, DOI 10.1016/S0019-1035(03)00200-8; Sleep NH, 1998, J GEOPHYS RES-PLANET, V103, P28529, DOI 10.1029/98JE01809; Weiss BP, 2000, SCIENCE, V290, P791, DOI 10.1126/science.290.5492.791	12	16	18	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					718	718		10.1126/science.1167987	http://dx.doi.org/10.1126/science.1167987			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197043	Green Submitted			2022-12-24	WOS:000263066800024
J	Drazen, JM; Desai, NR; Green, P				Drazen, Jeffrey M.; Desai, Nihar R.; Green, Philip			Fighting On.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Desai, Nihar R.; Green, Philip] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital			Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890					0	9	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					444	445		10.1056/NEJMp0809496	http://dx.doi.org/10.1056/NEJMp0809496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179313				2022-12-24	WOS:000262812400003
J	Ray, WA; Chung, CP; Murray, KT; Hall, K; Stein, CM				Ray, Wayne A.; Chung, Cecilia P.; Murray, Katherine T.; Hall, Kathi; Stein, C. Michael			Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TORSADE-DE-POINTES; INTERVAL ABNORMALITIES; QT INTERVAL; MECHANISM; THERAPY; PROLONGATION; PATIENT	Background Users of typical antipsychotic drugs have an increased risk of serious ventricular arrhythmias and sudden cardiac death. However, less is known regarding the cardiac safety of the atypical antipsychotic drugs, which have largely replaced the older agents in clinical practice. Methods We calculated the adjusted incidence of sudden cardiac death among current users of antipsychotic drugs in a retrospective cohort study of Medicaid enrollees in Tennessee. The primary analysis included 44,218 and 46,089 baseline users of single typical and atypical drugs, respectively, and 186,600 matched nonusers of antipsychotic drugs. To assess residual confounding related to factors associated with the use of antipsychotic drugs, we performed a secondary analysis of users of antipsychotic drugs who had no baseline diagnosis of schizophrenia or related psychoses and with whom nonusers were matched according to propensity score ( i. e., the predicted probability that they would be users of antipsychotic drugs). Results Current users of typical and of atypical antipsychotic drugs had higher rates of sudden cardiac death than did nonusers of antipsychotic drugs, with adjusted incidence-rate ratios of 1.99 ( 95% confidence interval [ CI], 1.68 to 2.34) and 2.26 ( 95% CI, 1.88 to 2.72), respectively. The incidence- rate ratio for users of atypical antipsychotic drugs as compared with users of typical antipsychotic drugs was 1.14 ( 95% CI, 0.93 to 1.39). Former users of antipsychotic drugs had no significantly increased risk ( incidence-rate ratio, 1.13; 95% CI, 0.98 to 1.30). For both classes of drugs, the risk for current users increased significantly with an increasing dose. Among users of typical antipsychotic drugs, the incidence- rate ratios increased from 1.31 ( 95% CI, 0.97 to 1.77) for those taking low doses to 2.42 ( 95% CI, 1.91 to 3.06) for those taking high doses ( P< 0.001). Among users of atypical agents, the incidence- rate ratios increased from 1.59 ( 95% CI, 1.03 to 2.46) for those taking low doses to 2.86 ( 95% CI, 2.25 to 3.65) for those taking high doses ( P = 0.01). The findings were similar in the cohort that was matched for propensity score. Conclusions Current users of typical and of atypical antipsychotic drugs had a similar, dose- related increased risk of sudden cardiac death.	[Ray, Wayne A.; Hall, Kathi] Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA; [Chung, Cecilia P.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Div Rheumatol, Nashville, TN 37212 USA; [Murray, Katherine T.] Vanderbilt Univ, Sch Med, Div Cardiol, Nashville, TN 37212 USA; [Murray, Katherine T.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Ray, Wayne A.] Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ray, WA (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Village Vanderbilt,Suite 2600,1501 21st Ave S, Nashville, TN 37212 USA.	cindy.naron@vanderbilt.edu	Chung, Cecilia P/ABE-2177-2021	Chung, Cecilia P/0000-0001-5908-9423	National Heart, Lung, and Blood Institute [HL081707]; Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics [HS1-0384]; Pfizer; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081707] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics; Pfizer(Pfizer); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (HL081707) and the Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics (cooperative agreement, HS1-0384).; Dr. Ray reports receiving research support from Pfizer and consulting fees from plaintiffs' attorneys in litigation involving rofecoxib and zoledronic acid and from insurance companies regarding rofecoxib and hormone- replacement therapy; and Dr. Stein, consulting fees from insurance companies regarding antipsychotic drugs. No other potential conflict of interest relevant to this article was reported.; We thank the staff of the Tennessee Bureau of TennCare and the Department of Health, who gave us access to the study data.	Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; *AM MED ASS, 1995, DRUG EV ANN 1995; Aparasu Rajender R, 2005, Ann Clin Psychiatry, V17, P147, DOI 10.1080/10401230591002084; Arbogast PG, 2008, EPIDEMIOLOGY, V19, P30, DOI 10.1097/EDE.0b013e31815be000; Buckley NA, 2000, DRUG SAFETY, V23, P215, DOI 10.2165/00002018-200023030-00004; Darpo B, 2001, EUR HEART J SUPPL, V3, pK70, DOI 10.1016/S1520-765X(01)90009-4; Flockhart DA, 2000, J CLIN PSYCHOPHARM, V20, P317, DOI 10.1097/00004714-200006000-00005; Glassman AH, 2005, J CLIN PSYCHIAT, V66, P5; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Haddad PM, 2002, DRUGS, V62, P1649, DOI 10.2165/00003495-200262110-00006; Harrigan EP, 2004, J CLIN PSYCHOPHARM, V24, P62, DOI 10.1097/01.jcp.0000104913.75206.62; Heinrich TW, 2006, PSYCHOSOMATICS, V47, P264, DOI 10.1176/appi.psy.47.3.264; Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Kongsamut S, 2002, EUR J PHARMACOL, V450, P37, DOI 10.1016/S0014-2999(02)02074-5; LANDRY JA, 1988, GERONTOLOGIST, V28, P672, DOI 10.1093/geront/28.5.672; LIBERATORE MA, 1984, J CLIN PSYCHOPHARM, V4, P143; Liberthson RR, 1996, NEW ENGL J MED, V334, P1039, DOI 10.1056/NEJM199604183341607; MARCUS FI, 1988, AM J CARDIOL, V61, P8, DOI 10.1016/0002-9149(88)91295-7; Ray WA, 2004, CLIN PHARMACOL THER, V75, P234, DOI 10.1016/j.clpt.2003.09.019; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ray WA, 2003, NEW ENGL J MED, V349, P1592, DOI 10.1056/NEJMp038145; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Reilly JG, 2002, BRIT J PSYCHIAT, V180, P515, DOI 10.1192/bjp.180.6.515; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; SISCOVICK DS, 1994, NEW ENGL J MED, V330, P1852, DOI 10.1056/NEJM199406303302603; STRAUS SM, 2004, ARCH INTERN MED, V164, P1839; Straus SMJM, 2004, ARCH INTERN MED, V164, P1293, DOI 10.1001/archinte.164.12.1293; Tei Y, 2004, PSYCHOSOMATICS, V45, P450, DOI 10.1176/appi.psy.45.5.450; THOMAS SHL, 1994, ADVERSE DRUG REACT T, V13, P77; Vieweg WVR, 2005, ACTA PSYCHIAT SCAND, V112, P318, DOI 10.1111/j.1600-0447.2005.00592.x; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Zarate CA, 2001, ARCH GEN PSYCHIAT, V58, P1168, DOI 10.1001/archpsyc.58.12.1168	39	799	828	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					225	235		10.1056/NEJMoa0806994	http://dx.doi.org/10.1056/NEJMoa0806994			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144938	Green Accepted			2022-12-24	WOS:000262434500005
J	Lipworth, BJ; Williamson, PA				Lipworth, Brian J.; Williamson, Peter A.			beta blockers for asthma: a double-edged sword	LANCET			English	Editorial Material							INHALED CORTICOSTEROIDS; METAANALYSIS; BLOCKADE; MODEL		[Lipworth, Brian J.; Williamson, Peter A.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland	University of Dundee	Lipworth, BJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland.	b.j.lipworth@googlemail.com						Callaerts-Vegh Z, 2004, P NATL ACAD SCI USA, V101, P4948, DOI 10.1073/pnas.0400452101; Currie GP, 2003, QJM-INT J MED, V96, P435, DOI 10.1093/qjmed/hcg071; Currie GP, 2003, ANN ALLERG ASTHMA IM, V90, P194, DOI 10.1016/S1081-1206(10)62140-0; Hanania NA, 2008, PULM PHARMACOL THER, V21, P134, DOI 10.1016/j.pupt.2007.07.002; IND PW, 1989, AM REV RESPIR DIS, V139, P1390, DOI 10.1164/ajrccm/139.6.1390; Lin R, 2008, PULM PHARMACOL THER, V21, P115, DOI 10.1016/j.pupt.2007.06.003; LIPWORTH BJ, 1991, EUR J CLIN PHARMACOL, V40, P467, DOI 10.1007/BF00315224; Lipworth BJ, 2007, TRENDS PHARMACOL SCI, V28, P257, DOI 10.1016/j.tips.2007.04.003; Nguyen LP, 2008, AM J RESP CELL MOL, V38, P256, DOI 10.1165/rcmb.2007-0279RC; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Salpeter SR, 2002, ANN INTERN MED, V137, P715, DOI 10.7326/0003-4819-137-9-200211050-00035; WHEELDON NM, 1994, BRIT J CLIN PHARMACO, V38, P103, DOI 10.1111/j.1365-2125.1994.tb04332.x	12	18	22	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					104	105		10.1016/S0140-6736(09)60018-0	http://dx.doi.org/10.1016/S0140-6736(09)60018-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135598				2022-12-24	WOS:000262340900008
J	Serruys, PW; Ormiston, JA; Onuma, Y; Regar, E; Gonzalo, N; Garcia-Garcia, HM; Nieman, K; Bruining, N; Dorange, C; Miquel-Hebert, K; Veldhof, S; Webster, M; Thuesen, L; Dudek, D				Serruys, Patrick W.; Ormiston, John A.; Onuma, Yoshinobu; Regar, Evelyn; Gonzalo, Nieves; Garcia-Garcia, Hector M.; Nieman, Koen; Bruining, Nico; Dorange, Cecile; Miquel-Hebert, Karine; Veldhof, Susan; Webster, Mark; Thuesen, Leif; Dudek, Dariusz			A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods	LANCET			English	Article							ATHEROSCLEROTIC PLAQUE COMPOSITION; INTRAVASCULAR ULTRASOUND; ARTERY LESIONS; ANGIOPLASTY; TOMOGRAPHY; COVERAGE	Background Drug-eluting metallic coronary stents predispose to late stent thrombosis, prevent late lumen vessel enlargement, hinder surgical revascularisation, and impair imaging with multislice CT. We assessed the safety of the bioabsorbable everolimus-eluting stent (BVS). Methods 30 patients with a single de-novo coronary artery lesion were followed up for 2 years clinically and with multiple imaging methods: multislice CT, angiography, intravascular ultrasound, derived morphology parameters (virtual histology, palpography, and echogenicity), and optical coherence tomography (OCT). Findings Clinical data were obtained from 29 of 30 patients. At 2 years, the device was safe with no cardiac deaths, ischaemia-driven target lesion revascularisations, or stent thromboses recorded, and only one myocardial infarction (non-Q wave). 18-month multislice CT (assessed in 25 patients) showed a mean diameter stenosis of 19% (SD 9). At 2-year angiography, the in-stent late loss of 0.48 mm (SD 0.28) and the diameter stenosis of 27% (11) did not differ from the findings at 6 months. The luminal area enlargement on OCT and intravascular ultrasound between 6 months and 2 years was due to a decrease in plaque size without change in vessel size. At 2 years, 34.5% of strut locations presented no discernible features by OCT, confirming decreases in echogenicity and in radiofrequency backscattering; the remaining apparent struts were fully apposed. Additionally, vasomotion occurred at the stented site and adjacent coronary artery in response to vasoactive agents. Interpretation At 2 years after implantation the stent was bioabsorbed, had vasomotion restored and restenosis prevented, and was clinically safe, suggesting freedom from late thrombosis. Late luminal enlargement due to plaque reduction without vessel remodelling needs confirmation.	[Serruys, Patrick W.; Onuma, Yoshinobu; Regar, Evelyn; Gonzalo, Nieves; Nieman, Koen; Bruining, Nico] Erasmus MC, Ctr Thorax, Rotterdam, Netherlands; [Nieman, Koen] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Ormiston, John A.; Webster, Mark] Auckland City Hosp, Auckland, New Zealand; [Garcia-Garcia, Hector M.] Cardialysis BV, Rotterdam, Netherlands; [Dorange, Cecile; Miquel-Hebert, Karine; Veldhof, Susan] Abbott Vasc, Diegem, Belgium; [Thuesen, Leif] Aarhus Univ Hosp, Skejby Sygehus, Skejby, Denmark; [Dudek, Dariusz] Jagiellonian Univ, Krakow, Poland	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Auckland City Hospital; Cardialysis; Aarhus University; Jagiellonian University	Serruys, PW (corresponding author), SGravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	p.w.j.c.serruys@erasmusmc.nl	Regar, E/ABA-3301-2020; Garcia-Garcia, Hector Manuel/AAG-7471-2020; Onuma, Yoshinobu/AHB-6273-2022; Regar, Evelyn/AAD-8201-2019; Bruining, Nico/ABG-5155-2020	Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; Onuma, Yoshinobu/0000-0001-7702-0649; Bruining, Nico/0000-0002-0272-5617	Abbott Vascular (Santa Clara, CA, USA)	Abbott Vascular (Santa Clara, CA, USA)(Abbott Laboratories)	This study was sponsored by Abbott Vascular (Santa Clara, CA, USA). We thank Wai-Fung Cheong, Krishnankutty Sudhir, and Robert McGreevy for their intellectual input in writing the report.	American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Aoki J, 2005, J AM COLL CARDIOL, V46, P1670, DOI 10.1016/j.jacc.2005.06.076; Bruining N, 1998, CATHETER CARDIO DIAG, V43, P254, DOI 10.1002/(SICI)1097-0304(199803)43:3<254::AID-CCD3>3.0.CO;2-8; Bruining N, 1999, CATHETER CARDIO INTE, V48, P133, DOI 10.1002/(SICI)1522-726X(199910)48:2<133::AID-CCD3>3.0.CO;2-H; BRUINING N, 2008, EUROINTERVENTION, V4, P1; Bruining N, 2007, CATHETER CARDIO INTE, V70, P968, DOI 10.1002/ccd.21310; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; de Winter SA, 2003, COMPUT CARDIOL, V30, P73, DOI 10.1109/CIC.2003.1291093; Eggebrecht H, 2005, CIRCULATION, V112, pE303, DOI 10.1161/CIRCULATIONAHA.104.521641; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; FOLEY DP, 1994, PROG CARDIOVASC DIS, V36, P363, DOI 10.1016/S0033-0620(05)80027-1; Fujimoto J.G.S.J., 2007, OPTICAL COHERENCE TO, V1st, DOI [10.3109/9780203931561, DOI 10.3109/9780203931561]; Garcia-Garcia HM, 2009, EUROINTERVENTION, V4, P443, DOI 10.4244/EIJV4I4A77; HAASE J, 1995, EUR HEART J, V16, P112, DOI 10.1093/eurheartj/16.1.112; Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; KURNIK PB, 1984, CATHETER CARDIO DIAG, V10, P353, DOI 10.1002/ccd.1810100408; Lind A Y, 2005, Heart, V91, P1604, DOI 10.1136/hrt.2005.064113; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Nair A, 2001, ULTRASOUND MED BIOL, V27, P1319, DOI 10.1016/S0301-5629(01)00436-7; Nair Anuja, 2007, EuroIntervention, V3, P113; NISSEN SE, 1991, CIRCULATION, V84, P1087, DOI 10.1161/01.CIR.84.3.1087; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Sabate M, 1999, CIRCULATION, V100, P1623, DOI 10.1161/01.CIR.100.15.1623; Schaar JA, 2004, CIRCULATION, V109, P2716, DOI 10.1161/01.CIR.0000131887.65955.3B; Schaar JA, 2003, CIRCULATION, V108, P2636, DOI 10.1161/01.CIR.0000097067.96619.1F; Serruys P W, 1983, Z Kardiol, V72 Suppl 3, P116; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Tamai H, 2000, CIRCULATION, V102, P399; TAMAI H, 2004, BIODEGRADABLE STENTS; Tanigawa Jun, 2007, EuroIntervention, V3, P128; Tsuchida K, 2007, AM J CARDIOL, V99, P607, DOI 10.1016/j.amjcard.2006.09.107; Van Mieghem CAG, 2006, J AM COLL CARDIOL, V47, P1134, DOI 10.1016/j.jacc.2005.09.075; Verheye S, 2007, J AM COLL CARDIOL, V49, P706, DOI 10.1016/j.jacc.2006.09.047; vonBirgelen C, 1996, AM J CARDIOL, V78, P520, DOI 10.1016/S0002-9149(96)00356-6; vonBirgelen C, 1997, CIRCULATION, V96, P2944, DOI 10.1161/01.CIR.96.9.2944	41	632	681	3	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					897	910		10.1016/S0140-6736(09)60325-1	http://dx.doi.org/10.1016/S0140-6736(09)60325-1			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286089				2022-12-24	WOS:000264158700031
J	Pruneda-Paz, JL; Breton, G; Para, A; Kay, SA				Pruneda-Paz, Jose L.; Breton, Ghislain; Para, Alessia; Kay, Steve A.			A Functional Genomics Approach Reveals CHE as a Component of the Arabidopsis Circadian Clock	SCIENCE			English	Article							GENE-EXPRESSION; RHYTHMS; TOC1; PLANTS; REGULATOR; GROWTH	Transcriptional feedback loops constitute the molecular circuitry of the plant circadian clock. In Arabidopsis, a core loop is established between CCA1 and TOC1. Although CCA1 directly represses TOC1, the TOC1 protein has no DNA binding domains, which suggests that it cannot directly regulate CCA1. We established a functional genomic strategy that led to the identification of CHE, a TCP transcription factor that binds specifically to the CCA1 promoter. CHE is a clock component partially redundant with LHY in the repression of CCA1. The expression of CHE is regulated by CCA1, thus adding a CCA1/CHE feedback loop to the Arabidopsis circadian network. Because CHE and TOC1 interact, and CHE binds to the CCA1 promoter, a molecular linkage between TOC1 and CCA1 gene regulation is established.	[Pruneda-Paz, Jose L.; Breton, Ghislain; Para, Alessia; Kay, Steve A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kay, SA (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	skay@ucsd.edu	Kay, Steve A/F-6025-2011; Breton, Ghislain/F-7266-2016	Kay, Steve A/0000-0002-0402-2878; Breton, Ghislain/0000-0001-6400-3858	NIH [GM56006, GM67837]; Fundacion Antorchas [postdoctoral fellowships]; National Sciences and Engineering Research Council of Canada; Wenner-Gren Stiftelserna; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067837, R01GM056006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Antorchas; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wenner-Gren Stiftelserna; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Imaizumi, E. Hamilton, E. Farre, B. Chow, D. A. Nusinow, and M. Sawa for critical reading of the manuscript; K. Yamada for providing the YM187 yeast strain; Y. Zhao for microscopy assistance; and A. Schopke, R. Sawaya, and S. Asbaghi for technical assistance. This work was supported by NIH grants GM56006 and GM67837 to S.A.K. and partially by postdoctoral fellowships from Fundacion Antorchas to J.L.P.-P., the National Sciences and Engineering Research Council of Canada to G.B., and Wenner-Gren Stiftelserna to A.P.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Baudry A, 2008, ADV BOT RES, V48, P69, DOI 10.1016/S0065-2296(08)00402-3; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Dobi KC, 2007, MOL CELL BIOL, V27, P5575, DOI 10.1128/MCB.00459-07; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603	20	328	358	5	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1481	1485		10.1126/science.1167206	http://dx.doi.org/10.1126/science.1167206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286557	Green Accepted			2022-12-24	WOS:000264101700042
J	Curtiss, LK				Curtiss, Linda K.			Reversing Atherosclerosis?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Curtiss, LK (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.							Fan EG, 2008, J MED FOOD, V11, P610, DOI 10.1089/jmf.2007.0091; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Witztum JL, 2005, J CLIN INVEST, V115, P2072, DOI 10.1172/JCI26130	4	38	46	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1144	1146		10.1056/NEJMcibr0810383	http://dx.doi.org/10.1056/NEJMcibr0810383			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279347				2022-12-24	WOS:000264051000015
J	Anderson, TM; vonHoldt, BM; Candille, SI; Musiani, M; Greco, C; Stahler, DR; Smith, DW; Padhukasahasram, B; Randi, E; Leonard, JA; Bustamante, CD; Ostrander, EA; Tang, H; Wayne, RK; Barsh, GS				Anderson, Tovi M.; vonHoldt, Bridgett M.; Candille, Sophie I.; Musiani, Marco; Greco, Claudia; Stahler, Daniel R.; Smith, Douglas W.; Padhukasahasram, Badri; Randi, Ettore; Leonard, Jennifer A.; Bustamante, Carlos D.; Ostrander, Elaine A.; Tang, Hua; Wayne, Robert K.; Barsh, Gregory S.			Molecular and Evolutionary History of Melanism in North American Gray Wolves	SCIENCE			English	Article							COAT COLOR; GENETIC-BASIS; DIFFERENTIATION; INTROGRESSION; PATTERNS; SEQUENCE; GENOME; BLACK; WOLF; WILD	Morphological diversity within closely related species is an essential aspect of evolution and adaptation. Mutations in the Melanocortin 1 receptor (Mc1r) gene contribute to pigmentary diversity in natural populations of fish, birds, and many mammals. However, melanism in the gray wolf, Canis lupus, is caused by a different melanocortin pathway component, the K locus, that encodes a beta-defensin protein that acts as an alternative ligand for Mc1r. We show that the melanistic K locus mutation in North American wolves derives from past hybridization with domestic dogs, has risen to high frequency in forested habitats, and exhibits a molecular signature of positive selection. The same mutation also causes melanism in the coyote, Canis latrans, and in Italian gray wolves, and hence our results demonstrate how traits selected in domesticated species can influence the morphological diversity of their wild relatives.	[Anderson, Tovi M.; Candille, Sophie I.; Tang, Hua; Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Anderson, Tovi M.; Candille, Sophie I.; Tang, Hua; Barsh, Gregory S.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [vonHoldt, Bridgett M.; Stahler, Daniel R.; Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 91302 USA; [Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Greco, Claudia; Randi, Ettore] Ist Nazl Fauna Selvat, I-40064 Ozzano Dell Emilia, BO, Italy; [Stahler, Daniel R.; Smith, Douglas W.] Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Natl Pk, WY 82190 USA; [Padhukasahasram, Badri; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Leonard, Jennifer A.] Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden; [Ostrander, Elaine A.] NHGRI, Bethesda, MD 20892 USA	Stanford University; Stanford University; University of California System; University of California Los Angeles; University of Calgary; Italian Institute for Environmental Protection & Research (ISPRA); United States Department of the Interior; Cornell University; Uppsala University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Barsh, GS (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	gbarsh@stanford.edu	Musiani, Marco/ABB-9387-2021; Greco, Claudia/ABA-6030-2020; Leonard, Jennifer/A-7894-2010	Musiani, Marco/0000-0002-6097-5841; Leonard, Jennifer/0000-0003-0291-7819; Bustamante, Carlos D./0000-0002-4187-7920; Greco, Claudia/0000-0002-8678-0890; Ostrander, Elaine/0000-0001-6075-9738	NIH; NSF; Swedish Research Council; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325, T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK068384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068882] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from NIH (G.S.B.), NSF (R.K.W., D.R.S., and D.W.S.), and the Swedish Research Council (J. A.L.). We are grateful to H. Chen and S. Schmutz for advice, to H. Manuel for technical assistance, and to members of the U.S. Department of Agriculture Wildlife Services and private citizens for assistance with sample collection. Sequences generated in this study are deposited in GenBank under accession numbers FJ609634 to FJ609641.	Andersson L, 2003, ANN NY ACAD SCI, V994, P313, DOI 10.1111/j.1749-6632.2003.tb03195.x; Bangs EE, 1996, WILDLIFE SOC B, V24, P402; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Gipson PS, 2002, WILDLIFE SOC B, V30, P821; Halbert ND, 2007, J HERED, V98, P1, DOI 10.1093/jhered/esl051; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; JOLICOEUR P, 1959, EVOLUTION, V13, P283, DOI 10.1111/j.1558-5646.1959.tb03016.x; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Klungland H, 2003, ANN NY ACAD SCI, V994, P331, DOI 10.1111/j.1749-6632.2003.tb03197.x; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; Leonard JA, 2008, BIOL LETTERS, V4, P95, DOI 10.1098/rsbl.2007.0354; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Majerus M, 1998, MELANISM EVOLUTION A; Mech LD., 1998, WOLVES DENALI; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Peterson RO, 1984, WILDLIFE MONOGR, P3; Randi E, 2002, CONSERV GENET, V3, P31; ROY MS, 1994, MOL BIOL EVOL, V11, P553; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Tang H, 2002, GENETICS, V161, P447; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Woolley SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001913	29	294	308	1	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1339	1343		10.1126/science.1165448	http://dx.doi.org/10.1126/science.1165448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19197024	Green Accepted			2022-12-24	WOS:000263876700041
J	Jackson, M				Jackson, Mark			Dust	LANCET			English	Editorial Material												m.a.jackson@exeter.ac.uk							0	0	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 7	2009	373	9662					453	453		10.1016/S0140-6736(09)60156-2	http://dx.doi.org/10.1016/S0140-6736(09)60156-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404EF	19200905				2022-12-24	WOS:000263132800014
J	Lyle, K; Kumar, P; Wittmann, T				Lyle, Karen; Kumar, Praveen; Wittmann, Torsten			SnapShot: Microtubule Regulators II	CELL			English	Editorial Material							PROTEINS; FAMILY		[Lyle, Karen; Kumar, Praveen; Wittmann, Torsten] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lyle, K (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.		Wittmann, Torsten/F-9833-2013	Wittmann, Torsten/0000-0001-9134-691X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079139] Funding Source: NIH RePORTER; NIDCR NIH HHS [5T32DE007306, T32 DE007306] Funding Source: Medline; NIGMS NIH HHS [R01 GM079139, R01GM079139] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Amos LA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-229; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; Dehmelt L, 2005, GENOME BIOL, V6; DeWard AD, 2008, CURR BIOL, V18, pR605, DOI 10.1016/j.cub.2008.06.001; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005	10	12	12	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3							566.e1	10.1016/j.cell.2009.01.011	http://dx.doi.org/10.1016/j.cell.2009.01.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203588	Green Accepted, Bronze			2022-12-24	WOS:000263120600025
J	Kao, SC; Wu, H; Xie, JM; Chang, CP; Ranish, JA; Graef, IA; Crabtree, GR				Kao, Shih-Chu; Wu, Hai; Xie, Jianming; Chang, Ching-Pin; Ranish, Jeffrey A.; Graef, Isabella A.; Crabtree, Gerald R.			Calcineurin/NFAT Signaling Is Required for Neuregulin-Regulated Schwann Cell Differentiation	SCIENCE			English	Article							TRANSCRIPTION FACTOR SOX10; PERIPHERAL NERVOUS-SYSTEM; HEART DEVELOPMENT; AXONAL REGULATION; NUCLEAR FACTOR; MYELINATION; SURVIVAL; PROLIFERATION; NERVES; OCT-6	Schwann cells develop from multipotent neural crest cells and form myelin sheaths around axons that allow rapid transmission of action potentials. Neuregulin signaling through the ErbB receptor regulates Schwann cell development; however, the downstream pathways are not fully defined. We find that mice lacking calcineurin B1 in the neural crest have defects in Schwann cell differentiation and myelination. Neuregulin addition to Schwann cell precursors initiates an increase in cytoplasmic Ca2+, which activates calcineurin and the downstream transcription factors NFATc3 and c4. Purification of NFAT protein complexes shows that Sox10 is an NFAT nuclear partner and synergizes with NFATc4 to activate Krox20, which regulates genes necessary for myelination. Our studies demonstrate that calcineurin and NFAT are essential for neuregulin and ErbB signaling, neural crest diversification, and differentiation of Schwann cells.	[Kao, Shih-Chu; Wu, Hai; Chang, Ching-Pin; Graef, Isabella A.; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Kao, Shih-Chu; Wu, Hai; Chang, Ching-Pin; Graef, Isabella A.; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Kao, Shih-Chu; Wu, Hai; Xie, Jianming; Chang, Ching-Pin; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ranish, Jeffrey A.] Inst Syst Biol, Seattle, WA 98103 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Institute for Systems Biology (ISB)	Graef, IA (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	igraef@stanford.edu; crabtree@stanford.edu	Xie, Jianming/AAC-6359-2019; Xie, Jianming/G-6567-2012	Xie, Jianming/0000-0003-4112-650X; Kao, Shih-chu/0000-0002-6294-5494	NIH [NS046789, HD55391, AI60037]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789, R37NS046789, R21NS061702] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B.A. Borres for insightful comments; K.J. Liu, Q. Lin, and J. Perrino for technical assistance; and J. I. Wu for critically reading this manuscript. G.R.C is an Investigator of HHMI. These studies were supported by grants from NIH (NS046789, HD55391, and AI60037) to G. R. C.	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Friedrich RP, 2005, MOL CELL BIOL, V25, P1821, DOI 10.1128/MCB.25.5.1821-1829.2005; Ghislain J, 2002, DEVELOPMENT, V129, P155; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Paratore C, 2001, DEVELOPMENT, V128, P3949; Parkinson DB, 2002, MOL CELL NEUROSCI, V20, P154, DOI 10.1006/mcne.2002.1109; Rahmatullah M, 1998, MOL CELL BIOL, V18, P6245, DOI 10.1128/MCB.18.11.6245; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Srinivasan R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-117; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wu H, 2007, J BIOL CHEM, V282, P30673, DOI 10.1074/jbc.M703622200; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006	29	161	166	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					651	654		10.1126/science.1166562	http://dx.doi.org/10.1126/science.1166562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179536	Green Accepted			2022-12-24	WOS:000262862800048
J	Chen, J; Novick, RP				Chen, John; Novick, Richard P.			Phage-Mediated Intergeneric Transfer of Toxin Genes	SCIENCE			English	Article							PANTON-VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS-AUREUS; PATHOGENICITY ISLAND; BACTERIOPHAGE THERAPY; BOVINE MASTITIS; SHOCK; EVOLUTION; VIRULENCE	Because bacteriophages generally parasitize only closely related bacteria, it is assumed that phage- mediated genetic exchange occurs primarily within species. Here we report that staphylococcal pathogenenicity islands, containing superantigen genes, and other mobile elements transferred to Listeria monocytogenes at the same high frequencies as they transfer within Staphylococcus aureus. Several staphylococcal phages transduced L. monocytogenes but could not form plaques. In an experiment modeling phage therapy for bovine mastitis, we observed pathogenicity island transfer between S. aureus and L. monocytogenes in raw milk. Thus, phages may participate in a far more expansive network of genetic information exchange among bacteria of different species than originally thought, with important implications for the evolution of human pathogens.	[Chen, John; Novick, Richard P.] NYU, Med Ctr, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Novick, RP (corresponding author), NYU, Med Ctr, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA.	novick@saturn.med.nyu.edu		Novick, richard/0000-0003-4418-7893; Chen, John/0000-0002-2318-1823	Kimmel Center for Biology and Medicine; New York University Medical Center	Kimmel Center for Biology and Medicine; New York University Medical Center	We thank D. Portnoy, R. Calendar, M. Bowden, and M. Wiedmann for gifts of strains and for helpful discussions. The expert technical assistance of A. Subedi is gratefully acknowledged. This work was supported by grants-in-aid from the Kimmel Center for Biology and Medicine, from New York University Medical Center, and by personal funds (R.P.N.).	Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Brabban AD, 2005, FOODBORNE PATHOG DIS, V2, P287, DOI 10.1089/fpd.2005.2.287; CHEETHAM BF, 1995, MOL MICROBIOL, V18, P201, DOI 10.1111/j.1365-2958.1995.mmi_18020201.x; Fitzgerald JR, 2001, J BACTERIOL, V183, P63, DOI 10.1128/JB.183.1.63-70.2001; Garcia P, 2007, INT DAIRY J, V17, P1232, DOI 10.1016/j.idairyj.2007.03.014; Gill JJ, 2006, ANTIMICROB AGENTS CH, V50, P2912, DOI 10.1128/AAC.01630-05; Jensen NE, 1996, INT J FOOD MICROBIOL, V32, P209, DOI 10.1016/0168-1605(96)01105-1; KENNY K, 1993, J CLIN MICROBIOL, V31, P706, DOI 10.1128/JCM.31.3.706-707.1993; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Maiques E, 2007, J BACTERIOL, V189, P5608, DOI 10.1128/JB.00619-07; MAZODIER P, 1991, ANNU REV GENET, V25, P147, DOI 10.1146/annurev.ge.25.120191.001051; MILES H, 1992, J DAIRY SCI, V75, P596, DOI 10.3168/jds.S0022-0302(92)77797-2; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick Richard P, 2007, Chem Immunol Allergy, V93, P42, DOI 10.1159/000100857; O'Flaherty S, 2005, LETT APPL MICROBIOL, V41, P482, DOI 10.1111/j.1472-765X.2005.01781.x; SHIMADA K, 1972, J MOL BIOL, V63, P483, DOI 10.1016/0022-2836(72)90443-3; Stephenson J, 2007, JAMA-J AM MED ASSOC, V298, P1388, DOI 10.1001/jama.298.12.1388; Stone R, 2002, SCIENCE, V298, P728, DOI 10.1126/science.298.5594.728; Subedi A, 2007, MICROBIOL-SGM, V153, P3235, DOI 10.1099/mic.0.2007/006932-0; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; WATTS JL, 1988, VET MICROBIOL, V16, P41, DOI 10.1016/0378-1135(88)90126-5	24	212	225	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					139	141		10.1126/science.1164783	http://dx.doi.org/10.1126/science.1164783			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119236				2022-12-24	WOS:000262104100060
J	Quigley, DA; To, MD; Perez-Losada, J; Pelorosso, FG; Mao, JH; Nagase, H; Ginzinger, DG; Balmain, A				Quigley, David A.; To, Minh D.; Perez-Losada, Jesus; Pelorosso, Facundo G.; Mao, Jian-Hua; Nagase, Hiroki; Ginzinger, David G.; Balmain, Allan			Genetic architecture of mouse skin inflammation and tumour susceptibility	NATURE			English	Article							ATOPIC-DERMATITIS; LINKAGE ANALYSIS; INNATE IMMUNITY; STEM-CELLS; DISEASE; CANCER; IDENTIFICATION; EXPRESSION; PSORIASIS; NETWORKS	Germline polymorphisms in model organisms and humans influence susceptibility to complex trait diseases such as inflammation and cancer(1-4). Mice of the Mus spretus species are resistant to tumour development, and crosses between M. spretus and susceptible Mus musculus strains have been used to map locations of genetic variants that contribute to skin cancer susceptibility(4-6). We have integrated germline polymorphisms with gene expression in normal skin from a M. musculus 3 M. spretus backcross to generate a network view of the gene expression architecture of mouse skin. Here we demonstrate how this approach identifies expression motifs that contribute to tissue organization and biological functions related to inflammation, haematopoiesis, cell cycle control and tumour susceptibility. Motifs associated with inflammation, epidermal barrier function and proliferation are differentially regulated in backcross mice susceptible or resistant to tumour development. The intestinal stem cell marker Lgr5 is identified as a candidate master regulator of the hair follicle, and the vitamin D receptor (Vdr) is linked to coordinated control of epidermal barrier function, inflammation and tumour susceptibility.	[Quigley, David A.; To, Minh D.; Pelorosso, Facundo G.; Mao, Jian-Hua; Ginzinger, David G.; Balmain, Allan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [To, Minh D.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94115 USA; [Perez-Losada, Jesus] Univ Salamanca, Fac Med, Dept Med, Salamanca 37007, Spain; [Mao, Jian-Hua] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Nagase, Hiroki] Nihon Univ, Adv Res Inst Sci & Humanities, Tokyo, Japan; [Nagase, Hiroki] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Salamanca; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Nihon University; Roswell Park Cancer Institute	Balmain, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA.	abalmain@cc.ucsf.edu	Mao, Jian-Hua/EIZ-8595-2022; 2009, Secribsal/A-1266-2012; Pérez-Losada, Jesús/A-5883-2019	Mao, Jian-Hua/0000-0001-9320-6021; Pérez-Losada, Jesús/0000-0003-2400-624X	National Cancer Institute; Barbara Bass Bakar Chair of Cancer Genetics; Sandler Foundation; Spanish 'Ministerio de Educacion y Ciencia'; European Community; Fondo de Investigaciones Sanitarias; Junta de Castilla y Leon; NATIONAL CANCER INSTITUTE [U01CA141455, U01CA084244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR050440] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barbara Bass Bakar Chair of Cancer Genetics; Sandler Foundation; Spanish 'Ministerio de Educacion y Ciencia'(Spanish Government); European Community(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Junta de Castilla y Leon(Junta de Castilla y Leon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to R. Del Rosario for technical assistance with mouse breeding. We thank G. Hirst, R. Akhurst and H. Quigley for their comments. This work was supported by the National Cancer Institute. A. B. acknowledges support from the Barbara Bass Bakar Chair of Cancer Genetics. M. D. T. was supported in part by a Sandler Foundation postdoctoral research fellowship. J. P.-L. is an investigator of the 'Programa Ramon y Cajal' from the Spanish 'Ministerio de Educacion y Ciencia' partially supported by the European Community; his research is partially funded by the 'Fondo de Investigaciones Sanitarias' and Junta de Castilla y Leon.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bikle DD, 2002, J INVEST DERMATOL, V119, P1109, DOI 10.1046/j.1523-1747.2002.19508.x; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chen L, 2006, GENETICS, V173, P2371, DOI 10.1534/genetics.105.052506; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Giovannucci E, 2008, ADV EXP MED BIOL, V624, P31, DOI 10.1007/978-0-387-77574-6_3; Hoffjan S, 2007, BRIT J DERMATOL, V157, P441, DOI 10.1111/j.1365-2133.2007.07999.x; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahieu T, 2006, P NATL ACAD SCI USA, V103, P2292, DOI 10.1073/pnas.0510874103; Manenti G, 1996, NAT GENET, V12, P455, DOI 10.1038/ng0496-455; Murphy JE, 2003, J IMMUNOL, V170, P5697, DOI 10.4049/jimmunol.170.11.5697; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VIAJE A, 1977, CANCER RES, V37, P1530; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Zinser GM, 2002, CARCINOGENESIS, V23, P2103, DOI 10.1093/carcin/23.12.2103	29	100	101	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					505	508		10.1038/nature07683	http://dx.doi.org/10.1038/nature07683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19136944	Green Submitted, Green Accepted			2022-12-24	WOS:000264532400044
J	Teixeira, FK; Heredia, F; Sarazin, A; Roudier, F; Boccara, M; Ciaudo, C; Cruaud, C; Poulain, J; Berdasco, M; Fraga, MF; Voinnet, O; Wincker, P; Esteller, M; Colot, V				Teixeira, Felipe Karam; Heredia, Fabiana; Sarazin, Alexis; Roudier, Francois; Boccara, Martine; Ciaudo, Constance; Cruaud, Corinne; Poulain, Julie; Berdasco, Maria; Fraga, Mario F.; Voinnet, Olivier; Wincker, Patrick; Esteller, Manel; Colot, Vincent			A Role for RNAi in the Selective Correction of DNA Methylation Defects	SCIENCE			English	Article							EPIGENETIC INHERITANCE; ARABIDOPSIS; EPIGENOME; IV	DNA methylation is essential for silencing transposable elements and some genes in higher eukaryotes, which suggests that this modification must be tightly controlled. However, accidental changes in DNA methylation can be transmitted through mitosis (as in cancer) or meiosis, leading to epiallelic variation. We demonstrated the existence of an efficient mechanism that protects against transgenerational loss of DNA methylation in Arabidopsis. Remethylation is specific to the subset of heavily methylated repeats that are targeted by the RNA interference (RNAi) machinery. This process does not spread into flanking regions, is usually progressive over several generations, and faithfully restores wild-type methylation over target sequences in an RNAi-dependent manner. Our findings suggest an important role for RNAi in protecting genomes against long-term epigenetic defects.	[Teixeira, Felipe Karam; Heredia, Fabiana; Roudier, Francois; Boccara, Martine; Colot, Vincent] Univ Evry Val Essonne, Inst Natl Rech Agron UMR 1165, CNRS, UMR 8114,Unite Rech Genom Vegetale, F-91057 Evry, France; [Teixeira, Felipe Karam; Sarazin, Alexis; Roudier, Francois; Boccara, Martine; Colot, Vincent] Ecole Normale Super, CNRS, Dept Biol, UMR 8186, F-75230 Paris 05, France; [Ciaudo, Constance; Voinnet, Olivier] CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, F-67084 Strasbourg, France; [Ciaudo, Constance] Inst Curie, CNRS, UMR 218, F-75248 Paris 05, France; [Cruaud, Corinne; Poulain, Julie; Wincker, Patrick] CEA, Inst Genom, F-91057 Evry, France; [Berdasco, Maria; Fraga, Mario F.; Esteller, Manel] Ctr Nacl Invest Oncol, Lab Epigenet Canc, Madrid 28029, Spain	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay	Colot, V (corresponding author), Univ Evry Val Essonne, Inst Natl Rech Agron UMR 1165, CNRS, UMR 8114,Unite Rech Genom Vegetale, F-91057 Evry, France.	colot@biologie.ens.fr	Herédia, Fabiana/J-3999-2013; Fraga, Mario F/H-7824-2017; Ciaudo, Constance/A-2014-2012; Esteller, Manel/L-5956-2014	Herédia, Fabiana/0000-0002-6390-7545; Fraga, Mario F/0000-0001-8450-2603; Ciaudo, Constance/0000-0002-0857-4506; Esteller, Manel/0000-0003-4490-6093; Sarazin, Alexis/0000-0002-1869-5192; Cruaud, Corinne/0000-0002-4752-7278; Poulain, Julie/0000-0002-8744-3116; Voinnet, Olivier/0000-0001-6982-9544; Karam Teixeira, Felipe/0000-0001-7651-1657; Heredia, Fabiana/0000-0003-0057-7654	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil [Ph.D. studentship]; Network of Excellence (NoE) [postdoctoral fellowships]; Fondation pour la Recherche Medicale [postdoctoral fellowships]; Agence Nationale de la Recherche Programme Blanc (PolIV); Genoplante (EPIVAR); Genoscope; CNRS (PIME)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Network of Excellence (NoE); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche Programme Blanc (PolIV)(French National Research Agency (ANR)); Genoplante (EPIVAR); Genoscope; CNRS (PIME)(Centre National de la Recherche Scientifique (CNRS))	We thank P. Audigier for plant care, A. Bulski for DNA samples, R. Martienssen for sharing unpublished observations, and E. Heard for critical reading of the manuscript. F.K.T. was supported by a Ph.D. studentship (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil) and F.H. and C.C. by postdoctoral fellowships [Network of Excellence (NoE) "The Epigenome" and Fondation pour la Recherche Medicale, respectively]. Grant support was from Agence Nationale de la Recherche Programme Blanc (PolIV), NoE "The Epigenome," Genoplante (EPIVAR), Genoscope, and CNRS (PIME). The Gene Expression Omnibus accession number for sRNA sequences is GSE13419.	Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; Flintoft L, 2009, NAT REV GENET, V10, DOI 10.1038/nrg2565; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; KAKUTANI T, 1995, NUCLEIC ACIDS RES, V23, P130, DOI 10.1093/nar/23.1.130; Kakutani T, 1999, GENETICS, V151, P831; Kankel MW, 2003, GENETICS, V163, P1109; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	23	273	285	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1600	1604		10.1126/science.1165313	http://dx.doi.org/10.1126/science.1165313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19179494				2022-12-24	WOS:000264342300037
J	Sureshkumar, S; Todesco, M; Schneeberger, K; Harilal, R; Balasubramanian, S; Weigel, D				Sureshkumar, Sridevi; Todesco, Marco; Schneeberger, Korbinian; Harilal, Ramya; Balasubramanian, Sureshkumar; Weigel, Detlef			A Genetic Defect Caused by a Triplet Repeat Expansion in Arabidopsis thaliana	SCIENCE			English	Article							FRIEDREICH ATAXIA; SOMATIC INSTABILITY; EPIGENETIC CHANGES; IN-VIVO; TRANSCRIPTION; SEQUENCE; MECHANISMS; DELETION; BRAIN	Variation in the length of simple DNA triplet repeats has been linked to phenotypic variability in microbes and to several human disorders. Population- level forces driving triplet repeat contraction and expansion in multicellular organisms are, however, not well understood. We have identified a triplet repeat- associated genetic defect in an Arabidopsis thaliana variety collected from the wild. The Bur- 0 strain carries a dramatically expanded TTC/ GAA repeat in the intron of the ISOPROPYL MALATE ISOMERASE LARGE SUB UNIT1 ( IIL1; At4g13430) gene. The repeat expansion causes an environment-dependent reduction in IIL1 activity and severely impairs growth of this strain, whereas contraction of the expanded repeat can reverse the detrimental phenotype. The Bur- 0 IIL1 defect thus presents a genetically tractable model for triplet repeat expansions and their variability in natural populations.	[Sureshkumar, Sridevi; Todesco, Marco; Schneeberger, Korbinian; Harilal, Ramya; Balasubramanian, Sureshkumar; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Sureshkumar, Sridevi; Balasubramanian, Sureshkumar] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia	Max Planck Society; University of Queensland	Balasubramanian, S (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	mb.suresh@uq.edu.au; weigel@weigelworld.org	Schneeberger, Korbinian/U-6329-2019; Todesco, Marco/HCH-3494-2022; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Balasubramanian, Sureshkumar/AAS-6919-2020	Schneeberger, Korbinian/0000-0002-5512-0443; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Balasubramanian, Sureshkumar/0000-0002-1057-2606; Todesco, Marco/0000-0002-6227-4096	EMBO (European Molecular Biology Organization) Long-Term Fellowship; Marie Curie Research Training Network SY-STEM; European Research Area-Plant Genomics (ERA-PG) Deutsche Forschungsgemeinschaft ARelatives Consortium; European Union Sixth Framework Programme for Research and Technological Development Integrated Project [EU FP6 IP, LSHG-CT-2006-037704]; Leibniz Award; Max Planck Society	EMBO (European Molecular Biology Organization) Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Research Training Network SY-STEM(European Commission); European Research Area-Plant Genomics (ERA-PG) Deutsche Forschungsgemeinschaft ARelatives Consortium(German Research Foundation (DFG)); European Union Sixth Framework Programme for Research and Technological Development Integrated Project(European Commission); Leibniz Award; Max Planck Society(Max Planck SocietyFoundation CELLEX)	We are very grateful to T. Knill and S. Binder for sharing unpublished information. We acknowledge experimental support from our colleagues at the Max Planck Institute and University of Queensland. We also thank them as well as J. Carrington and D. Tautz for critical reading of the manuscript, and the European Arabidopsis Stock Centre and the French National Institute for Agricultural Research (INRA) at Versailles for seeds. Supported by an EMBO (European Molecular Biology Organization) Long-Term Fellowship (S.B.), Marie Curie Research Training Network SY-STEM, European Research Area-Plant Genomics (ERA-PG) Deutsche Forschungsgemeinschaft ARelatives Consortium, European Union Sixth Framework Programme for Research and Technological Development Integrated Project (EU FP6 IP) Agronomics (LSHG-CT-2006-037704), a Leibniz Award (DFG), and the Max Planck Society (D.W.). GenBank accession numbers are FJ665284 to FJ665378.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Baralle M, 2008, AM J HUM GENET, V83, P77, DOI 10.1016/j.ajhg.2008.06.018; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; Frisch R, 2001, MOL GENET METAB, V74, P281, DOI 10.1006/mgme.2001.3229; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Hashem VI, 2004, NUCLEIC ACIDS RES, V32, P6334, DOI 10.1093/nar/gkh976; Hashem VI, 2002, MUTAT RES-FUND MOL M, V508, P107, DOI 10.1016/S0027-5107(02)00190-2; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; KNILL T, COMMUNICATION; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Levdansky E, 2007, EUKARYOT CELL, V6, P1380, DOI 10.1128/EC.00229-06; Michael TP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000795; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sharma R, 2002, HUM MOL GENET, V11, P2175, DOI 10.1093/hmg/11.18.2175; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	26	55	57	7	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1060	1063		10.1126/science.1164014	http://dx.doi.org/10.1126/science.1164014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19150812				2022-12-24	WOS:000263478400042
J	Silvester, JA; Rashid, M				Silvester, Jocelyn Anne; Rashid, Mohsin			A Patient's Journey Coeliac disease and a gluten-free diet	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rashid, Mohsin] Dalhousie Univ, Fac Med, Dept Paediat, Div Gastroenterol,IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada	Dalhousie University	Rashid, M (corresponding author), Dalhousie Univ, Fac Med, Dept Paediat, Div Gastroenterol,IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada.	mohsin.rashid@iwk.nshealth.ca	Silvester, Jocelyn/T-2680-2019	Silvester, Jocelyn/0000-0002-3615-1666				GODLEE F, 2009, BRIT MED J, V338, pB821; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b491; Jones R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3058; Willis HWM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3066	4	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 19	2009	338								b380	10.1136/bmj.b380	http://dx.doi.org/10.1136/bmj.b380			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228765				2022-12-24	WOS:000264052200003
J	Songkhla, MN				Songkhla, Mongkol Na			Health before profits? Learning from Thailand's experience	LANCET			English	Editorial Material											Songkhla, MN (corresponding author), Ladprao 15, Bangkok 10900, Thailand.	mongkol@health.moph.go.th						ABBOTT F, 2007, ACCESS ESSENTIAL MED; Fidler DP, 2009, LANCET, V373, P325, DOI 10.1016/S0140-6736(08)61775-4; FINK C, 2003, IMPLEMENTING DOHA MA; Gerhardsen Tove, 2007, INTELLECTUAL PR 0216; Lee K, 2009, LANCET, V373, P416, DOI 10.1016/S0140-6736(08)61776-6; Tantivess S, 2008, INTRO GOVT USE PATEN; Tantivess S, 2008, HEALTH POLICY PLANN, V23, P328, DOI 10.1093/heapol/czn023; VELASQUEZ G, 2008, IMPROVING ACCESS MED; *WORLD TRAD ORG, 2001, MIN DECL WT MIN 01 D; World Trade Organization, UR ROUND AGR TRIPS 2	10	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					441	442		10.1016/S0140-6736(08)61737-7	http://dx.doi.org/10.1016/S0140-6736(08)61737-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19167059	Green Submitted			2022-12-24	WOS:000263132800008
J	Weinmann, L; Hock, J; Ivacevic, T; Ohrt, T; Mutze, J; Schwille, P; Kremmer, E; Benes, V; Urlaub, H; Meister, G				Weinmann, Lasse; Hoeck, Julia; Ivacevic, Tomi; Ohrt, Thomas; Muetze, Joerg; Schwille, Petra; Kremmer, Elisabeth; Benes, Vladimir; Urlaub, Henning; Meister, Gunter			Importin 8 Is a Gene Silencing Factor that Targets Argonaute Proteins to Distinct mRNAs	CELL			English	Article							MICRORNA-DEPENDENT LOCALIZATION; HUMAN-CELLS; TRANSLATION INITIATION; CAENORHABDITIS-ELEGANS; PASSENGER-STRAND; MAMMALIAN-CELLS; PIWI PROTEINS; IN-VITRO; MIRNAS; COMPLEXES	Small regulatory RNAs including small interfering RNAs (siRNAs) and microRNAs ( miRNAs) guide Argonaute ( Ago) proteins to specific target RNAs leading to mRNA destabilization or translational repression. Here, we report the identification of Importin 8 (Imp8) as a component of miRNA-guided regulatory pathways. We show that Imp8 interacts with Ago proteins and localizes to cytoplasmic processing bodies ( P bodies), structures involved in RNA metabolism. Furthermore, we detect Ago2 in the nucleus of HeLa cells, and knockdown of Imp8 reduces the nuclear Ago2 pool. Using immunoprecipitations of Ago2-associated mRNAs followed by microarray analysis, we further demonstrate that Imp8 is required for the recruitment of Ago protein complexes to a large set of Ago2-associated target mRNAs, allowing for efficient and specific gene silencing. Therefore, we provide evidence that Imp8 is required for cytoplasmic miRNA-guided gene silencing and affects nuclear localization of Ago proteins.	[Weinmann, Lasse; Hoeck, Julia; Meister, Gunter] Max Planck Inst Biochem, Lab RNA Biol, D-82152 Martinsried, Germany; [Weinmann, Lasse; Hoeck, Julia; Meister, Gunter] Max Planck Inst Biochem, Ctr Integrated Prot Sci Munich, D-82152 Martinsried, Germany; [Ohrt, Thomas; Muetze, Joerg; Schwille, Petra] Tech Univ Dresden, BIOTEC, D-01307 Dresden, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, D-81377 Munich, Germany; [Ivacevic, Tomi; Benes, Vladimir] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spect Grp, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; European Molecular Biology Laboratory (EMBL); Max Planck Society	Meister, G (corresponding author), Max Planck Inst Biochem, Lab RNA Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	meister@biochem.mpg.de	Weinmann, Lasse/B-9839-2008; Schwille, Petra/A-4983-2010	Benes, Vladimir/0000-0002-0352-2547	Max Planck Society; Deutsche Forschungsgemeinschaft [Me2064/2-1]; European Union [LSHG-CT-2006-037900]; Deutsche Volkswagenstiftung [I/79308]; Boehringer Ingelheim Fonds	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Deutsche Volkswagenstiftung(Volkswagen); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank Keiichi Ozono for pGEX-Imp4, Erich Nigg for pcDNA3.1- RanWT, - RanQ69L, and - RanT24N, Olaf Stemmann for pCS2, Simone Heubes for recombinant RanWT and RanQ69L, and Susanna Nagel for technical advice. Further, we thank Dirk Go " rlich, Witold Filipowicz, Michael Doyle, Laura Riolobos, Thomas Gu " ttler, Sabine Ru " del, Michaela Beitzinger, and Christine Ender for helpful discussions, Thomas Tuschl and Tobias Walther for critical reading of the manuscript, Sabine Rottmu " ller and Bernd Haas for technical assistance, and Stefan Jentsch for support. Our research is funded by the Max Planck Society. This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG, Me2064/2-1), the European Union (LSHG-CT-2006-037900), and the Max Planck Society. T. O. is funded by Deutsche Volkswagenstiftung I/79308. L. W. received a fellowship from the Boehringer Ingelheim Fonds.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	53	239	255	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					496	507		10.1016/j.cell.2008.12.023	http://dx.doi.org/10.1016/j.cell.2008.12.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19167051	Bronze			2022-12-24	WOS:000263120600019
J	Westall, F				Westall, Frances			GEOCHEMISTRY Life on an Anaerobic Planet	SCIENCE			English	Editorial Material							CARBON ISOTOPES; MICROBIAL MATS		[Westall, Frances] CNRS, Ctr Biophys Mol, F-45071 Orleans 2, France; [Westall, Frances] Univ Orleans, F-45071 Orleans 2, France	Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Westall, F (corresponding author), CNRS, Ctr Biophys Mol, Rue Charles Sadron, F-45071 Orleans 2, France.	Frances.Westall@cnrs-orleans.fr						Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Derenne S, 2008, EARTH PLANET SC LETT, V272, P476, DOI 10.1016/j.epsl.2008.05.014; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Gerdes G., 1987, Lecture Notes in Earth Sciences, V9, P1; LOWE DR, 1994, GEOLOGY, V22, P387, DOI 10.1130/0091-7613(1994)022<0387:AOODSO>2.3.CO;2; Mcloughlin N, 2008, GEOBIOLOGY, V6, P95, DOI 10.1111/j.1472-4669.2007.00141.x; Noffke N, 2006, GEOLOGY, V34, P253, DOI 10.1130/G22246.1; NOFFKE N, 2008, EARTH IN PRESS  0910, DOI DOI 10.1016/J.EARSCIREV.2008.08.002; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Schidlowski M, 2001, PRECAMBRIAN RES, V106, P117, DOI 10.1016/S0301-9268(00)00128-5; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Ueno Y, 2004, GEOCHIM COSMOCHIM AC, V68, P573, DOI 10.1016/S0016-7037(03)00462-9; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; Walsh M.M., 1999, GEOL S AM S, P329; Westall F, 2006, GEOL SOC AM SPEC PAP, P105; Westall F, 2006, GEOPHYS MONOGR SER, V164, P283; Westall F, 2006, PHILOS T R SOC B, V361, P1857, DOI 10.1098/rstb.2006.1896	20	10	10	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					471	472		10.1126/science.1167220	http://dx.doi.org/10.1126/science.1167220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164738				2022-12-24	WOS:000262587900031
J	Persson, A; Gross, E; Laurent, P; Busch, KE; Bretes, H; de Bono, M				Persson, Annelie; Gross, Einav; Laurent, Patrick; Busch, Karl Emanuel; Bretes, Hugo; de Bono, Mario			Natural variation in a neural globin tunes oxygen sensing in wild Caenorhabditis elegans	NATURE			English	Article							NUCLEOTIDE DISSOCIATION INHIBITOR; C-ELEGANS; HUMAN NEUROGLOBIN; BODY-FLUID; EXPRESSION; BEHAVIOR; NEURONS; FAMILY; AGGREGATION; ENVIRONMENT	Behaviours evolve by iterations of natural selection, but we have few insights into the molecular and neural mechanisms involved. Here we show that some Caenorhabditis elegans wild strains switch between two foraging behaviours in response to subtle changes in ambient oxygen. This finely tuned switch is conferred by a naturally variable hexacoordinated globin, GLB-5. GLB-5 acts with the atypical soluble guanylate cyclases(1-3), which are a different type of oxygen binding protein, to tune the dynamic range of oxygen-sensing neurons close to atmospheric (21%) concentrations. Calcium imaging indicates that one group of these neurons is activated when oxygen rises towards 21%, and is inhibited as oxygen drops below 21%. The soluble guanylate cyclase GCY-35 is required for high oxygen to activate the neurons; GLB-5 provides inhibitory input when oxygen decreases below 21%. Together, these oxygen binding proteins tune neuronal and behavioural responses to a narrow oxygen concentration range close to atmospheric levels. The effect of the glb-5 gene on oxygen sensing and foraging is modified by the naturally variable neuropeptide receptor npr-1 (refs 4, 5), providing insights into how polygenic variation reshapes neural circuit function.	[Persson, Annelie; Gross, Einav; Laurent, Patrick; Busch, Karl Emanuel; Bretes, Hugo; de Bono, Mario] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Persson, Annelie] Univ Gothenburg, Dept Cell & Mol Biol, S-40530 Gothenburg, Sweden	MRC Laboratory Molecular Biology; University of Gothenburg	de Bono, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	debono@mrc-lmb.cam.ac.uk	Gross, Einav/AAS-7417-2021; laurent, patrick/ABD-9373-2021	laurent, patrick/0000-0001-5360-5597; Busch, Karl Emanuel/0000-0001-7886-3226; de Bono, Mario/0000-0001-8347-0443	Medical Research Council; EU Marie Curie Actions; European Molecular Biology Organization; Fondation Wiener-Anspach; MRC [MC_U105178786] Funding Source: UKRI; Medical Research Council [MC_U105178786] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU Marie Curie Actions(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Fondation Wiener-Anspach; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Caenorhabditis Genetics Center, A. Chisholm, M.-A. Felix and E. Dolgin for C. elegans strains, A. Couto, B. Olofsson, I. Rabinovitch and K. Weber for comments on the manuscript, and I. Johnston and C. Tan for microfluidic devices. This work was supported by the Medical Research Council, a Human Frontier Science Program (HFSP) long-term fellowship (E. G.) and program grant (M. d. B.), the EU Marie Curie Actions (K. E. B.), the European Molecular Biology Organization (K. E. B. and P. L.) and the Fondation Wiener-Anspach (P. L.).	Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Antonini E, 1971, FRONTIERS BIOL; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAUMGARTL H, 1994, ACTA OECOL, V15, P781; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hodgkin J, 1997, GENETICS, V146, P149; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Kerr Rex A., 2006, V351, P253; Kitatsuji C, 2007, J MOL BIOL, V368, P150, DOI 10.1016/j.jmb.2007.02.002; Korol A, 2006, P NATL ACAD SCI USA, V103, P18184, DOI 10.1073/pnas.0608777103; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; OKKEMA PG, 1993, GENETICS, V135, P385; Ota M, 1997, FEBS LETT, V415, P129, DOI 10.1016/S0014-5793(97)01110-1; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sambrook J., 1989, MOL CLONING LAB MANU; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Trandafir F, 2007, GENE, V398, P103, DOI 10.1016/j.gene.2007.02.038; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	33	102	107	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1030	U106		10.1038/nature07820	http://dx.doi.org/10.1038/nature07820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262507				2022-12-24	WOS:000265412900043
J	Lim, DA; Huang, YC; Swigut, T; Mirick, AL; Garcia-Verdugo, JM; Wysocka, J; Ernst, P; Alvarez-Buylla, A				Lim, Daniel A.; Huang, Yin-Cheng; Swigut, Tomek; Mirick, Anika L.; Manuel Garcia-Verdugo, Jose; Wysocka, Joanna; Ernst, Patricia; Alvarez-Buylla, Arturo			Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells	NATURE			English	Article							ADULT MAMMALIAN BRAIN; SUBVENTRICULAR ZONE; NEURONAL MIGRATION; SELF-RENEWAL; PROGENITORS; MICE; OLIGODENDROCYTES; PROLIFERATION; EXPRESSION; POLYCOMB	Epigenetic mechanisms that maintain neurogenesis throughout adult life remain poorly understood(1). Trithorax group (trxG) and Polycomb group (PcG) gene products are part of an evolutionarily conserved chromatin remodelling system that activate or silence gene expression, respectively(2). Although PcG member Bmi1 has been shown to be required for postnatal neural stem cell self-renewal(3,4), the role of trxG genes remains unknown. Here we show that the trxG member Mll1 (mixed-lineage leukaemia 1) is required for neurogenesis in the mouse postnatal brain. Mll1-deficient subventricular zone neural stem cells survive, proliferate and efficiently differentiate into glial lineages; however, neuronal differentiation is severely impaired. In Mll1-deficient cells, early proneural Mash1 (also known as Ascl1) and gliogenic Olig2 expression are preserved, but Dlx2, a key downstream regulator of subventricular zone neurogenesis, is not expressed. Overexpression of Dlx2 can rescue neurogenesis in Mll1-deficient cells. Chromatin immunoprecipitation demonstrates that Dlx2 is a direct target of MLL in subventricular zone cells. In differentiating wild-type subventricular zone cells, Mash1, Olig2 and Dlx2 loci have high levels of histone 3 trimethylated at lysine 4 (H3K4me3), consistent with their transcription. In contrast, in Mll1-deficient subventricular zone cells, chromatin at Dlx2 is bivalently marked by both H3K4me3 and histone 3 trimethylated at lysine 27 (H3K27me3), and the Dlx2 gene fails to properly activate. These data support a model in which Mll1 is required to resolve key silenced bivalent loci in postnatal neural precursors to the actively transcribed state for the induction of neurogenesis, but not for gliogenesis.	[Lim, Daniel A.; Huang, Yin-Cheng; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Lim, Daniel A.; Huang, Yin-Cheng; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA; [Lim, Daniel A.] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Mirick, Anika L.; Ernst, Patricia] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cavanilles, Lab Neurobiol Comparada, Valencia 46012, Spain; [Manuel Garcia-Verdugo, Jose] CIBERNED, Ctr Invest Principe Felipe, Lab Morfol Celular, Valencia 46012, Spain	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University; Dartmouth College; University of Valencia; CIBERNED; Prince Felipe Research Center	Lim, DA (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus St M779, San Francisco, CA 94143 USA.	limd@neurosurg.ucsf.edu; abuylla@stemcell.ucsf.edu	García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Swigut, Tomek/0000-0002-7649-6781; Ernst, Patricia/0000-0001-7638-2939; Lim, Daniel/0000-0001-7221-3425; Alvarez-Buylla, Arturo/0000-0003-4426-8925	Neurosurgery Research and Education Foundation/American Association of Neurological Surgeons; Sandler Family Foundation; Northern California Institute for Research and Education; Clinical and Translational Research Institute at the University of California, San Francisco; California Institute for Regenerative Medicine New Faculty Award; Chicago Community Trust Searle Scholar Award; Goldhirsch Foundation; J. G. Bowes Research Fund; National Institutes of Health (NIH) [5R37-NS028478]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028478] Funding Source: NIH RePORTER	Neurosurgery Research and Education Foundation/American Association of Neurological Surgeons; Sandler Family Foundation; Northern California Institute for Research and Education; Clinical and Translational Research Institute at the University of California, San Francisco; California Institute for Regenerative Medicine New Faculty Award(California Institute for Regenerative Medicine); Chicago Community Trust Searle Scholar Award; Goldhirsch Foundation; J. G. Bowes Research Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Rubenstein for anti-DLX2 antibodies and the pCAG-Dlx2 plasmid, D. Rowitch for anti-OLIG2 antibodies, and Y. Dou and R. Roeder for anti-MLL1 antibodies. This work was supported by the Neurosurgery Research and Education Foundation/American Association of Neurological Surgeons, Sandler Family Foundation, Northern California Institute for Research and Education, and the Clinical and Translational Research Institute at the University of California, San Francisco (D. A. L.), California Institute for Regenerative Medicine New Faculty Award and The Chicago Community Trust Searle Scholar Award (J. W.), and the Goldhirsch Foundation, J. G. Bowes Research Fund, and National Institutes of Health (NIH) 5R37-NS028478 (A. A.-B.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Long JE, 2007, J NEUROSCI, V27, P3230, DOI 10.1523/JNEUROSCI.5265-06.2007; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	31	285	292	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					529	U9		10.1038/nature07726	http://dx.doi.org/10.1038/nature07726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19212323	Green Accepted			2022-12-24	WOS:000264532400049
J	Schwamborn, JC; Berezikov, E; Knoblich, JA				Schwamborn, Jens C.; Berezikov, Eugene; Knoblich, Juergen A.			The TRIM-NHL Protein TRIM32 Activates MicroRNAs and Prevents Self-Renewal in Mouse Neural Progenitors	CELL			English	Article							ASYMMETRIC CELL-DIVISION; EMBRYONIC STEM-CELLS; DYSTROPHY TYPE 2H; UBIQUITIN LIGASE; LET-7 MICRORNA; NEURONAL DIFFERENTIATION; PLASMA-MEMBRANE; PAR-COMPLEX; IN-VIVO; DROSOPHILA	In the mouse neocortex, neural progenitor cells generate both differentiating neurons and daughter cells that maintain progenitor fate. Here, we show that the TRIM-NHL protein TRIM32 regulates protein degradation and microRNA activity to control the balance between those two daughter cell types. In both horizontally and vertically dividing progenitors, TRIM32 becomes polarized in mitosis and is concentrated in one of the two daughter cells. TRIM32 overexpression induces neuronal differentiation while inhibition of TRIM32 causes both daughter cells to retain progenitor cell fate. TRIM32 ubiquitinates and degrades the transcription factor c-Myc but also binds Argonaute-1 and thereby increases the activity of specific microRNAs. We show that Let-7 is one of the TRIM32 targets and is required and sufficient for neuronal differentiation. TRIM32 is the mouse ortholog of Drosophila Brat and Mei-P26 and might be part of a protein family that regulates the balance between differentiation and proliferation in stem cell lineages.	[Schwamborn, Jens C.; Knoblich, Juergen A.] IMBA, Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Berezikov, Eugene] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Knoblich, JA (corresponding author), IMBA, Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Schwamborn, Jens C/F-9395-2011; Berezikov, Eugene/D-3363-2013; Knoblich, Juergen A/C-2974-2015	Schwamborn, Jens C/0000-0003-4496-0559; Berezikov, Eugene/0000-0002-1145-2884; Knoblich, Juergen A/0000-0002-6751-3404	Austrian Academy of Sciences, the Wiener Wissenschafts-, Forschungs und Technologiefonds (WWTF); Austrian Science Fund (FWF)	Austrian Academy of Sciences, the Wiener Wissenschafts-, Forschungs und Technologiefonds (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors would like to thank Andrea Ballabio (Milan), Stephen Hann (Nashville), Dirk Bohmann (Rochester), Judy Lieberman (Boston), and Witold Filipowicz ( Basel) for plasmids; Gunter Meister Munich) for the anti- Ago1 antibody; Xiao- Bing Yuan (Shanghai) for teaching the in utero electroporation,; Jo r rg Betschinger for initiating production of the anti- TRIM32 antibody; Maria Novatchkova for sequence analysis; Katrin Heindl for help with the RNA end-labeling; and Angela M. Peer for excellent technical assistance. J. C. S. was supported by EMBO and HFSP. Work in J. A. K.' s lab is supported by the Austrian Academy of Sciences, the Wiener Wissenschafts-, Forschungs und Technologiefonds (WWTF), the Austrian Science Fund (FWF), the EU FP6 network ONCASYM, and the EU FP7 network EUROSYSTEM.	Albor A, 2007, MOL CARCINOGEN, V46, P585, DOI 10.1002/mc.20344; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Butcher BA, 2000, MOL BIOCHEM PARASIT, V107, P207, DOI 10.1016/S0166-6851(00)00189-4; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Coskun Volkan, 2007, Sci STKE, V2007, ppe58, DOI 10.1126/stke.4102007pe58; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Frank DJ, 2002, DEVELOPMENT, V129, P399; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Fults D, 2002, NEOPLASIA, V4, P32, DOI 10.1038/sj.neo.7900200; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Lassman AB, 2004, NEURON GLIA BIOL, V1, P157, DOI 10.1017/S1740925X04000249; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Li L, 2000, GENE DEV, V14, P147; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Tabata H, 2002, J NEUROSCI RES, V69, P723, DOI 10.1002/jnr.10345; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844	74	322	331	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					913	925		10.1016/j.cell.2008.12.024	http://dx.doi.org/10.1016/j.cell.2008.12.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269368	Green Accepted, Bronze			2022-12-24	WOS:000263930900014
J	Weisswange, I; Newsome, TP; Schleich, S; Way, M				Weisswange, Ina; Newsome, Timothy P.; Schleich, Sibylle; Way, Michael			The rate of N-WASP exchange limits the extent of ARP2/3-complex-dependent actin-based motility	NATURE			English	Article							VACCINIA VIRUS; INHIBITION; MEMBRANES; PATHWAYS; KINASES; COMPLEX	Understanding cell motility will require detailed knowledge not only of the localization of signalling networks regulating actin polymerization, but also of their dynamics. Unfortunately, many signalling networks are not amenable to such analysis, as they are frequently transient and dispersed. By contrast, the signalling pathways used by pathogens undergoing actin-based motility are highly localized and operate in a constitutive fashion(1-5). Taking advantage of this, we have analysed the dynamics of neuronal Wiskott-Aldrich syndrome protein (N-WASP), WASP-interacting protein (WIP), GRB2 and NCK, which are required to stimulate actin-related protein (ARP) 2/3-complex-dependent actin-based motility of vaccinia virus(6-9), using fluorescence recovery after photobleaching. Here we show that all four proteins are rapidly exchanging, albeit at different rates, and that the turnover of N-WASP depends on its ability to stimulate ARP2/3-complex-mediated actin polymerization. Conversely, disruption of the interaction of N-WASP with GRB2 and/or the barbed ends of actin filaments increases its exchange rate and results in a faster rate of virus movement. We suggest that the exchange rate of N-WASP controls the rate of ARP2/3-complex-dependent actin-based motility by regulating the extent of actin polymerization by antagonizing filament capping.	[Weisswange, Ina; Newsome, Timothy P.; Schleich, Sibylle; Way, Michael] London Res Inst, Canc Res UK, Cell Motil Lab, London WC2A 3PX, England	Cancer Research UK	Way, M (corresponding author), London Res Inst, Canc Res UK, Cell Motil Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	michael.way@cancer.org.uk	Newsome, Timothy P/AAB-4033-2019	Newsome, Timothy P/0000-0002-2193-596X; Way, Michael/0000-0001-7207-2722	Human Frontier Science Program (HFSP); Cancer Research UK	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Cancer Research UK(Cancer Research UK)	We would like to thank T. Pawson and S. Snapper for NCK-and N-WASP-null cell lines and the FACS laboratory (Cancer Research UK, London) for help sorting stable cell lines. We are also very grateful to the members of the Way laboratory, J. Beaudouin, M.- F. Carlier, H. Gerhardt, B. Mayer, K. Rottner, M. Rosen and M. Welch for discussions and comments on the manuscript. T. P. N. was funded in part by a fellowship from the Human Frontier Science Program (HFSP). This work was funded by Cancer Research UK.	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006; Arakawa Y, 2007, CELL HOST MICROBE, V1, P213, DOI 10.1016/j.chom.2007.04.007; Backert S, 2008, TRENDS BIOCHEM SCI, V33, P80, DOI 10.1016/j.tibs.2007.10.006; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Delatour V, 2008, BIOPHYS J, V94, P4890, DOI 10.1529/biophysj.107.118653; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; HILLER G, 1985, J VIROL, V55, P651, DOI 10.1128/JVI.55.3.651-659.1985; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Munter S., 2006, SCI STKE, V2006, pre5, DOI DOI 10.1126/STKE.3352006RE5; Newsome TP, 2006, CELL MICROBIOL, V8, P233, DOI 10.1111/j.1462-5822.2005.00613.x; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Zettl M, 2002, CURR BIOL, V12, P1617, DOI 10.1016/S0960-9822(02)01112-0	24	104	104	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					87	U6		10.1038/nature07773	http://dx.doi.org/10.1038/nature07773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262673				2022-12-24	WOS:000263836000038
J	McCartney, M				McCartney, Margaret			Hospital Hygiene Are superbug fears turning patients into hospital cleaners?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Coombes R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b833	1	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 25	2009	338								b729	10.1136/bmj.b729	http://dx.doi.org/10.1136/bmj.b729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DR	19244305				2022-12-24	WOS:000264056200002
J	Erb, RM; Son, HS; Samanta, B; Rotello, VM; Yellen, BB				Erb, Randall M.; Son, Hui S.; Samanta, Bappaditya; Rotello, Vincent M.; Yellen, Benjamin B.			Magnetic assembly of colloidal superstructures with multipole symmetry	NATURE			English	Article							PARTICLES; CRYSTALS; CRYSTALLIZATION; CLUSTERS	The assembly of complex structures out of simple colloidal building blocks is of practical interest for building materials with unique optical properties ( for example photonic crystals(1) and DNA biosensors(2)) and is of fundamental importance in improving our understanding of self- assembly processes occurring on molecular to macroscopic length scales(3-5). Here we demonstrate a self-assembly principle that is capable of organizing a diverse set of colloidal particles into highly reproducible, rotationally symmetric arrangements. The structures are assembled using the magneto-static interaction between effectively diamagnetic and paramagnetic particles within a magnetized ferrofluid. The resulting multipolar geometries resemble electrostatic charge configurations such as axial quadrupoles ('Saturn rings'), axial octupoles ('flowers'), linear quadrupoles (poles) and mixed multipole arrangements ('two tone'), which represent just a few examples of the type of structure that can be built using this technique.	[Erb, Randall M.; Son, Hui S.; Yellen, Benjamin B.] Duke Univ, Dept Mech Engn & Mat Sci, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27708 USA; [Samanta, Bappaditya; Rotello, Vincent M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Duke University; University of Massachusetts System; University of Massachusetts Amherst	Yellen, BB (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Ctr Biol Inspired Mat & Mat Syst, Box 90300,Hudson Hall, Durham, NC 27708 USA.	yellen@duke.edu	Erb, Randall M/E-6337-2014; Erb, Randall M/O-1984-2018; Erb, Randall M/B-1986-2012	Erb, Randall M/0000-0002-6351-395X; 	US National Science Foundation [NSEC DMI-0531171, MRSEC DMR-0213695, CMMI-0608819, CMMI-0625480]	US National Science Foundation(National Science Foundation (NSF))	The authors would like to thank the US National Science Foundation (grants NSEC DMI-0531171 and MRSEC DMR-0213695 to V. M. R. and grants CMMI-0608819 and CMMI-0625480 to B.B.Y.) for supporting this work.	Biswal SL, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041406; Cho YS, 2005, J AM CHEM SOC, V127, P15968, DOI 10.1021/ja0550632; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Erb RM, 2008, J APPL PHYS, V103, DOI 10.1063/1.2831789; HALSEY TC, 1992, SCIENCE, V258, P761, DOI 10.1126/science.258.5083.761; HELGESEN G, 1990, PHYS REV A, V42, P7271, DOI 10.1103/PhysRevA.42.7271; Kim SH, 2008, LANGMUIR, V24, P2365, DOI 10.1021/la703037g; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; Ozin GA, 2001, ADV FUNCT MATER, V11, P95, DOI 10.1002/1616-3028(200104)11:2<95::AID-ADFM95>3.0.CO;2-O; PANOFSKY WKH, 1955, CLASSICAL ELECT MAGN, P84; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; SKJELTORP AT, 1983, PHYS REV LETT, V51, P2306, DOI 10.1103/PhysRevLett.51.2306; Velev OD, 2000, SCIENCE, V287, P2240, DOI 10.1126/science.287.5461.2240; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Xia YN, 2001, ADV MATER, V13, P409, DOI 10.1002/1521-4095(200103)13:6<409::AID-ADMA409>3.0.CO;2-C; Yellen BB, 2005, P NATL ACAD SCI USA, V102, P8860, DOI 10.1073/pnas.0500409102; Yin YD, 2001, J AM CHEM SOC, V123, P8718, DOI 10.1021/ja011048v; Zerrouki D, 2008, NATURE, V455, P380, DOI 10.1038/nature07237; Zhuang JQ, 2008, ANGEW CHEM INT EDIT, V47, P2208, DOI 10.1002/anie.200705049	23	358	371	7	341	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					999	1002		10.1038/nature07766	http://dx.doi.org/10.1038/nature07766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225522				2022-12-24	WOS:000263425400039
J	Bliuc, D; Nguyen, ND; Milch, VE; Nguyen, TV; Eisman, JA; Center, JR				Bliuc, Dana; Nguyen, D. Nguyen; Milch, Vivienne E.; Nguyen, Tuan V.; Eisman, John A.; Center, Jacqueline R.			Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIP FRACTURE; OLDER WOMEN; EXCESS MORTALITY; VERTEBRAL FRACTURE; CLINICAL FRACTURES; PREDICT MORTALITY; ELDERLY-WOMEN; FOLLOW-UP; SURVIVAL; HOSPITALIZATION	Context There are few data on long- term mortality following osteoporotic fracture and fewer following subsequent fracture. Objectives To examine long- term mortality risk in women and men following all osteoporotic fractures and to assess the association of subsequent fracture with that risk. Design, Setting, and Participants Prospective cohort from the Dubbo Osteoporosis Epidemiology Study of community- dwelling women and men aged 60 years and older from Dubbo, Australia, who sustained a fracture between April 1989 and May 2007. Main Outcome Measures Age- and sex- specific standardized mortality ratios ( SMRs) compared with the overallDubbopopulation for hip, vertebral, major, and minor fractures. Results In women, there were 952 low- trauma fractures followed by 461 deaths, and in men, 343 fractures were followed by 197 deaths. Age- adjusted SMRs were increased following hip fractures ( SMRs, 2.43 [ 95% confidence interval [ CI], 2.02-2.93] and 3.51 [ 95% CI, 2.65- 4.66]), vertebral fractures ( SMRs, 1.82 [ 95% CI, 1.52-2.17] and 2.12 [ 95% CI, 1.66- 2.72]), major fractures ( SMRs, 1.65 [ 95% CI, 1.31-2.08] and 1.70 [ 95% CI, 1.23- 2.36]), and minor fractures ( SMRs, 1.42 [ 95% CI, 1.19- 1.70] and 1.33 [ 95% CI, 0.99- 1.80]) for both women and men, respectively. Mortality was increased for all ages for all fractures except minor fractures for which increased mortality was only apparent for those older than 75 years. Increased mortality risk persisted for 5 years for all fractures and up to 10 years for hip fractures. Increases in absolute mortality that were above expected, for 5 years after fracture, ranged from 1.3 to 13.2 per 100 person- years in women and from 2.7 to 22.3 per 100 person- years in men, depending on fracture type. Subsequent fracture was associated with an increased mortality hazard ratio of 1.91 ( 95% CI, 1.54- 2.37) in women and 2.99 ( 95% CI, 2.11- 4.24) in men. Mortality risk following a subsequent fracture then declined but beyond 5 years still remained higher than in the general population ( SMR, 1.41 [ 95% CI, 1.01- 1.97] and SMR, 1.78 [ 95% CI, 0.96- 3.31] for women and men, respectively). Predictors of mortality after any fragility fracture for both men and women included age, quadriceps weakness, and subsequent fracture but not comorbidities. Low bone mineral density, having smoked, and sway were also predictors for women and less physical activity for men. Conclusions In a sample of older women and men, all low- trauma fractures were associated with increased mortality risk for 5 to 10 years. Subsequent fracture was associated with increased mortality risk for an additional 5 years.	[Bliuc, Dana; Nguyen, D. Nguyen; Milch, Vivienne E.; Nguyen, Tuan V.; Eisman, John A.; Center, Jacqueline R.] St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Res Program, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney	Center, JR (corresponding author), Garvan Inst Med Res, 384 Victoria St, Sydney, NSW 2010, Australia.	j.center@garvan.org.au	Nguyen, Tuan V/B-6147-2008; Eisman, John A/C-2886-2014; Nguyen, Nguyen/D-1480-2010; Center, Jacqueline/AAY-8712-2021; Nguyen, Thao/GWN-0419-2022; Bliuc, Dana/Y-7240-2018; Nguyen, Nguyen/GVT-4511-2022	Nguyen, Tuan V/0000-0002-3246-6281; Center, Jacqueline/0000-0002-5278-4527; Bliuc, Dana/0000-0001-9682-2313; Milch, Vivienne/0000-0001-8834-0349	National Health and Medical Research Council [276413]; MBF Living Well Foundation; Ernst Heine Foundation; Amgen; Merck Sharp Dohme; Sanofi-Aventis; Servier; Novartis	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MBF Living Well Foundation; Ernst Heine Foundation; Amgen(Amgen); Merck Sharp Dohme(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Servier(Servier); Novartis(Novartis)	This study was supported in part by National Health and Medical Research Council (NHMRC) grant 276413. This study also received support from the MBF Living Well Foundation, the Ernst Heine Foundation; and untied grants from Amgen, Merck Sharp & Dohme, Sanofi-Aventis, Servier, and Novartis.	Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; BROWNER WS, 1991, LANCET, V338, P355, DOI 10.1016/0140-6736(91)90489-C; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; Cawthon PM, 2007, J AM GERIATR SOC, V55, P1216, DOI 10.1111/j.1532-5415.2007.01259.x; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Cooper Cyrus, 1997, American Journal of Medicine, V103, p12S, DOI 10.1016/S0002-9343(97)90022-X; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Empana JP, 2004, J AM GERIATR SOC, V52, P685, DOI 10.1111/j.1532-5415.2004.52203.x; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Farahmand BY, 2005, OSTEOPOROSIS INT, V16, P1583, DOI 10.1007/s00198-005-2024-z; Forsen L, 1999, OSTEOPOROSIS INT, V10, P73, DOI 10.1007/s001980050197; Haentjens P, 2004, J BONE MINER RES, V19, P1933, DOI 10.1359/JBMR.040917; Hasserius R, 2005, CALCIFIED TISSUE INT, V76, P235, DOI 10.1007/s00223-004-2222-2; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; Kado DM, 2003, OSTEOPOROSIS INT, V14, P589, DOI 10.1007/s00198-003-1412-5; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P108, DOI 10.1007/s00198-003-1516-y; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; Karagiannis A, 2006, CALCIFIED TISSUE INT, V78, P72, DOI 10.1007/s00223-005-0169-6; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Nguyen ND, 2007, J BONE MINER RES, V22, P1147, DOI [10.1359/jbmr.070412, 10.1359/JBMR.070412]; *OST AUSTR ACC EC, 2001, BURD BRITTL BON COST; Pongchaiyakul C, 2005, J BONE MINER RES, V20, P1349, DOI 10.1359/JBMR.050317; Randell AG, 2000, OSTEOPOROSIS INT, V11, P460, DOI 10.1007/s001980070115; SIMONS LA, 1990, AUST NZ J MED, V20, P783, DOI 10.1111/j.1445-5994.1990.tb00423.x; Tosteson ANA, 2007, OSTEOPOROSIS INT, V18, P1463, DOI 10.1007/s00198-007-0429-6; Trombetti A, 2002, OSTEOPOROSIS INT, V13, P731, DOI 10.1007/s001980200100; Trone DW, 2007, AM J EPIDEMIOL, V166, P1191, DOI 10.1093/aje/kwm206; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P1583, DOI 10.1007/s00198-007-0403-3; Woodward M., 1992, STATISTICIAN, V41, P185; 2006, BASE SAS 9 1 3 PROCE	35	1011	1051	0	37	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					513	521		10.1001/jama.2009.50	http://dx.doi.org/10.1001/jama.2009.50			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402CS	19190316	Bronze			2022-12-24	WOS:000262992400021
J	He, LM; Xue, L; Xu, JH; McNeil, BD; Bai, L; Melicoff, E; Adachi, R; Wu, LG				He, Liming; Xue, Lei; Xu, Jianhua; McNeil, Benjamin D.; Bai, Li; Melicoff, Ernestina; Adachi, Roberto; Wu, Ling-Gang			Compound vesicle fusion increases quantal size and potentiates synaptic transmission	NATURE			English	Article							MULTIVESICULAR RELEASE; POSTTETANIC POTENTIATION; TRANSMITTER RELEASE; RAT CALYX; 2 MODES; EXOCYTOSIS; ENDOCYTOSIS; CAPACITANCE; MEMBRANE; CURRENTS	Exocytosis at synapses involves fusion between vesicles and the plasma membrane(1). Although compound fusion between vesicles(2,3) was proposed to occur at ribbon-type synapses(4,5), whether it exists, how it is mediated, and what role it plays at conventional synapses remain unclear. Here we report the existence of compound fusion, its underlying mechanism, and its role at a nerve terminal containing conventional active zones in rats and mice. We found that high potassium application and high frequency firing induced giant capacitance up-steps, reflecting exocytosis of vesicles larger than regular ones, followed by giant down-steps, reflecting bulk endocytosis. These intense stimuli also induced giant vesicle-like structures, as observed with electron microscopy, and giant miniature excitatory postsynaptic currents (mEPSCs), reflecting more transmitter release. Calcium and its sensor for vesicle fusion, synaptotagmin, were required for these giant events. After high frequency firing, calcium/synaptotagmin-dependent mEPSC size increase was paralleled by calcium/synaptotagmin-dependent post-tetanic potentiation. These results suggest a new route of exocytosis and endocytosis composed of three steps. First, calcium/synaptotagmin mediates compound fusion between vesicles. Second, exocytosis of compound vesicles increases quantal size, which increases synaptic strength and contributes to the generation of post-tetanic potentiation. Third, exocytosed compound vesicles are retrieved via bulk endocytosis. We suggest that this vesicle cycling route be included in models of synapses in which only vesicle fusion with the plasma membrane is considered(1).	[He, Liming; Xue, Lei; Xu, Jianhua; McNeil, Benjamin D.; Bai, Li; Wu, Ling-Gang] NINDS, Bethesda, MD 20892 USA; [Melicoff, Ernestina; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Texas System; UTMD Anderson Cancer Center	Wu, LG (corresponding author), NINDS, 35 Convent Dr,Bldg 35,Room 2B 1012, Bethesda, MD 20892 USA.	wul@ninds.nih.gov		Adachi, Roberto/0000-0002-0146-0768; McNeil, Benjamin/0000-0001-7545-3598; Melicoff, Ernestina/0000-0001-5696-7112; Xu, Jianhua/0000-0003-0084-8856	National Institute of Neurological Disorders and Stroke Intramural Research Program; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003009] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Diamond and K. Paradiso for comments on the manuscript, and S. Cheng, R. Azzam and V. Crocker for help in EM. This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Research Program (L.-G. W.) and the American Heart Association (R. A.).	ALVAREZ DT, 1990, J GEN PHYSIOL, V95, P397, DOI DOI 10.1085/JGP.95.3.397; Boraud T, 2002, PROG NEUROBIOL, V66, P265, DOI 10.1016/S0301-0082(01)00033-8; Coggins MR, 2007, J PHYSIOL-LONDON, V584, P853, DOI 10.1113/jphysiol.2007.140848; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Henze DA, 2002, J NEUROPHYSIOL, V87, P15, DOI 10.1152/jn.00394.2001; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HEUSER JE, 1974, J PHYSIOL-LONDON, V239, pP106, DOI 10.1113/jphysiol.1974.sp010593; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; Lindau M, 2003, BBA-MOL CELL RES, V1641, P167, DOI 10.1016/S0167-4889(03)00085-5; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Matthews G, 2008, J NEUROSCI, V28, P5403, DOI 10.1523/JNEUROSCI.0935-08.2008; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Paillart C, 2003, J NEUROSCI, V23, P4092; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Satzler K, 2002, J NEUROSCI, V22, P10567; SCEPEK S, 1993, EMBO J, V12, P1811, DOI 10.1002/j.1460-2075.1993.tb05829.x; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wall MJ, 1998, NAT NEUROSCI, V1, P675, DOI 10.1038/3677; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	33	91	92	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					93	U99		10.1038/nature07860	http://dx.doi.org/10.1038/nature07860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19279571	Green Accepted			2022-12-24	WOS:000265801300036
J	Ishii, M; Egen, JG; Klauschen, F; Meier-Schellersheim, M; Saeki, Y; Vacher, J; Proia, RL; Germain, RN				Ishii, Masaru; Egen, Jackson G.; Klauschen, Frederick; Meier-Schellersheim, Martin; Saeki, Yukihiko; Vacher, Jean; Proia, Richard L.; Germain, Ronald N.			Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE; CELL-MIGRATION; VASCULAR MATURATION; LYMPHOID ORGANS; TRANSGENIC MICE; T-CELLS; MARROW; EXPRESSION; COLLAGEN	Osteoclasts are the only somatic cells with bone-resorbing capacity and, as such, they have a critical role not only in normal bone homeostasis (called 'bone remodelling') but also in the pathogenesis of bone destructive disorders such as rheumatoid arthritis and osteoporosis(1). A major focus of research in the field has been on gene regulation by osteoclastogenic cytokines such as receptor activator of NF-kappa B-ligand (RANKL, also known as TNFSF11) and TNF-alpha, both of which have been well documented to contribute to osteoclast terminal differentiation(2,3). A crucial process that has been less well studied is the trafficking of osteoclast precursors to and from the bone surface, where they undergo cell fusion to form the fully differentiated multinucleated cells that mediate bone resorption. Here we report that sphingosine-1-phosphate (S1P), a lipid mediator enriched in blood(4,5), induces chemotaxis and regulates the migration of osteoclast precursors not only in culture but also in vivo, contributing to the dynamic control of bone mineral homeostasis. Cells with the properties of osteoclast precursors express functional S1P(1) receptors and exhibit positive chemotaxis along an S1P gradient in vitro. Intravital two-photon imaging of bone tissues showed that a potent S1P(1) agonist, SEW2871, stimulated motility of osteoclast precursor-containing monocytoid populations in vivo. Osteoclast/monocyte (CD11b, also known as ITGAM) lineage-specific conditional S1P(1) knockout mice showed osteoporotic changes due to increased osteoclast attachment to the bone surface. Furthermore, treatment with the S1P(1) agonist FTY720 relieved ovariectomy-induced osteoporosis in mice by reducing the number of mature osteoclasts attached to the bone surface. Together, these data provide evidence that S1P controls the migratory behaviour of osteoclast precursors, dynamically regulating bone mineral homeostasis, and identifies a critical control point in osteoclastogenesis that may have potential as a therapeutic target.	[Ishii, Masaru; Egen, Jackson G.; Germain, Ronald N.] NIDDK, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Klauschen, Frederick; Meier-Schellersheim, Martin; Germain, Ronald N.] NIDDK, Program Syst Immunol & Infect Dis Modeling, NIAID, NIH, Bethesda, MD 20892 USA; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Ishii, Masaru] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Biol Imaging, Suita, Osaka 5650871, Japan; [Ishii, Masaru; Saeki, Yukihiko] Natl Osaka Minami Med Ctr, Dept Clin Res, Osaka 5868521, Japan; [Vacher, Jean] Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Osaka University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Germain, RN (corresponding author), NIDDK, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.	rgermain@niaid.nih.gov	Proia, Richard L/A-7908-2012; Ishii, Masaru/D-2361-2009; Germain, Ronald/ABE-7090-2020; Klauschen, Frederick/C-5637-2015; Germain, Ronald N./Z-1945-2019	Klauschen, Frederick/0000-0002-9131-2389; Proia, Richard/0000-0003-0456-1270; Egen, Jackson/0000-0003-2053-0837	Intramural Research Program of the National Institute of Allergy and Infectious Diseases; NIH; US Department of Health and Human Services; International Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056014, ZIADK056015] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; International Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank U. H. von Andrian and I. B. Mazo for their help with the technique of intravital skull bone imaging. We also thank Y. Takuwa and N. Sugimoto for discussions, and P. M. Murphy and S. Venkatesan for their help in imaging in vitro chemotaxis using the EZ-Taxiscan. This work was supported in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH, US Department of Health and Human Services, and by a fellowship grant to M. I. from the International Human Frontier Science Program.	Akbar H, 2006, METHOD ENZYMOL, V406, P554, DOI 10.1016/S0076-6879(06)06043-5; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; BOKOCH GM, 1984, J BIOL CHEM, V259, P3560; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Filgueira L, 2004, J HISTOCHEM CYTOCHEM, V52, P411, DOI 10.1177/002215540405200312; Ishii M, 2006, J BONE MINER RES, V21, P965, DOI 10.1359/JBMR.060308; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7; Takuwa Y, 2002, BBA-MOL CELL BIOL L, V1582, P112, DOI 10.1016/S1388-1981(02)00145-2; Tedesco-Silva H, 2007, TRANSPLANTATION, V84, P885, DOI 10.1097/01.tp.0000281385.26500.3b; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404	29	382	403	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					524	U8		10.1038/nature07713	http://dx.doi.org/10.1038/nature07713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19204730	Green Accepted			2022-12-24	WOS:000264532400048
J	Wood, E; Werb, D; Marshall, BDL; Montaner, JSG; Kerr, T				Wood, Evan; Werb, Daniel; Marshall, Brandon D. L.; Montaner, Julio S. G.; Kerr, Thomas			The war on drugs: a devastating public-policy disaster	LANCET			English	Editorial Material							HIV		[Wood, Evan; Werb, Daniel; Marshall, Brandon D. L.; Montaner, Julio S. G.; Kerr, Thomas] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas] Univ British Columbia, Fac Med, Div Aids, Dept Med, Vancouver, BC, Canada; [Werb, Daniel; Marshall, Brandon D. L.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia	Wood, E (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	uhri-ew@cfenet.ubc.ca	Marshall, Brandon/B-4895-2010; Montaner, Julio/K-7621-2012	Marshall, Brandon/0000-0002-0134-7052; 				[Anonymous], 2003, INT J DRUG POLICY, DOI DOI 10.1016/S0955-3959(03)00005-7; Bluthenthal R. N., 1999, International Journal of Drug Policy, V10, P25, DOI 10.1016/S0955-3959(98)00076-0; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; *EUR MON CTR DRUGS, 2008, STAT B 2008; FAZEY C, 2003, INT J DRUG POLICY, V14, P159; FELLNER J, 2008, TARGETING BLACKS DRU; HANSON S, 2008, WASHINGTON POST 1125; JELSMA M, 2003, INT J DRUG POLICY, V14, P195; Jurgens R, 2009, LANCET INFECT DIS, V9, P57, DOI 10.1016/S1473-3099(08)70305-0; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; MORRIS SK, 2003, INT J DRUG POLICY, V14, P209; *UN OFF DRUGS CRIM, 2002, 2005 WORLD DRUG REP; Werb D, 2008, J PUBLIC HEALTH POL, V29, P440, DOI 10.1057/jphp.2008.29	13	39	39	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					989	990		10.1016/S0140-6736(09)60455-4	http://dx.doi.org/10.1016/S0140-6736(09)60455-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422AA	19282025				2022-12-24	WOS:000264398200009
J	Cooter, R				Cooter, Roger			Historical keyword Crisis	LANCET			English	Editorial Material									UCL, Wellcome Trust Ctr, London, England	University of London; University College London	Cooter, R (corresponding author), UCL, Wellcome Trust Ctr, London, England.	r.cooter@ucl.ac.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					887	887		10.1016/S0140-6736(09)60532-8	http://dx.doi.org/10.1016/S0140-6736(09)60532-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19286073				2022-12-24	WOS:000264158700013
J	Krum, H; Abraham, WT				Krum, Henry; Abraham, William T.			Heart failure	LANCET			English	Review							LEFT-VENTRICULAR DYSFUNCTION; CARDIAC-RESYNCHRONIZATION THERAPY; CONVERTING-ENZYME INHIBITORS; PRESERVED SYSTOLIC FUNCTION; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; DIASTOLIC DYSFUNCTION; EJECTION FRACTION; RANDOMIZED-TRIAL; ISOSORBIDE DINITRATE	Despite advances in management of heart failure, the condition remains a major public-health issue, with high prevalence, poor clinical outcomes, and large health-care costs. Risk factors are well known and, thus, preventive strategies should have a positive effect on disease burden. Treatment of established systolic chronic heart failure includes use of agents that block the renin-angiotensin-aldosterone and sympathetic nervous systems to prevent adverse remodelling, to reduce symptoms and prolong survival. Diuretics are used to achieve and maintain euvolaemia. Devices have a key role in management of advanced heart failure and include cardiac resynchronisation in patients with evidence of cardiac dyssynchrony and implantation of a cardioverter defibrillator in individuals with low ejection fraction. Approaches for treatment of acute heart failure and heart failure with preserved ejection fraction are supported by little clinical evidence. Emerging strategies for heart failure management include individualisation of treatment, novel approaches to diagnosis and tracking of therapeutic response, pharmacological agents aimed at new targets, and cell-based and gene-based methods for cardiac regeneration.	[Krum, Henry] Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Abraham, William T.] Ohio State Univ, Div Cardiovasc Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	Monash University; University System of Ohio; Ohio State University	Krum, H (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia.	henry.krum@med.monash.edu.au			National Health and Medical Research Council; National Institutes of Health; Medtronic; Paracor; St Jude Medical	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medtronic(Medtronic); Paracor; St Jude Medical(St. Jude Medical)	H K has received grant and research support within the past 12 months from National Health and Medical Research Council. Medtronic, Scios, BUPA. Pfizer, and GlaxoSmithKline, and consultancy and speaker honoraria from Amgen, AstraZeneca. Medtronic, St Jude Medical, Roche, Novartis, Sanofi-Aventis, Pfizer, Mesoblast, and Gilead. HK is a member of the following advisory boards: Biotronik. Novartis, Sanofi-Aventis, Pfizer, Mesoblast, Apollo Life Sciences, and Gilead. WTA has received grant and research support within the past 12 months from National Institutes of Health, Medtronic, Paracor, and St Jude Medical, and consultancy and speaker honoraria from Amgen, AstraZeneca. Medtronic. Novartis, Pfizer, Respironics, St Jude Medical, and GlaxoSmithKline. WTA is a member of the following advisory boards: BioEnergy, Biotronik, CardioKine, CardioKinetix, CardioMEMS, Department of Veterans Affairs Cooperative Studies Program, Edwards Lifesciences, Inovise, Medtronic, National Institutes of Health, Paracor, St Jude Medical, and Sunshine Heart.	Abraham WT, 2005, J AM COLL CARDIOL, V46, P57, DOI 10.1016/j.jacc.2005.03.051; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Abraham WT, 2000, J CARD FAIL, V6, P369, DOI 10.1054/jcaf.2000.20841; Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; *AIHW, 1999, AIHW HLTH WELF EXP S, V5; Anker SD, 2004, ANN MED, V36, P518, DOI 10.1080/07853890410017467; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Aronow WS, 2005, GERIATRICS, V60, P24; Athanasuleas CL, 2001, J AM COLL CARDIOL, V37, P1199, DOI 10.1016/S0735-1097(01)01119-6; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Belardinelli R, 2006, EUR HEART J, V27, P2675, DOI 10.1093/eurheartj/ehl158; Berg TJ, 1999, DIABETES CARE, V22, P1186, DOI 10.2337/diacare.22.7.1186; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; BOLLING SF, 1995, J THORAC CARDIOV SUR, V109, P676, DOI 10.1016/S0022-5223(95)70348-9; BRAUNWALD E, 1986, J AM COLL CARDIOL, V8, P1467, DOI 10.1016/S0735-1097(86)80325-4; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Bristow MR, 2000, J CARD FAIL, V6, P276, DOI 10.1054/jcaf.2000.9501; BYRNE J, 2004, CARING HEART FAILURE, P75; Carson P, 2005, J CARD FAIL, V11, P576, DOI 10.1016/j.cardfail.2005.06.432; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cleland JGF, 2001, EUR J HEART FAIL, V3, P481, DOI 10.1016/S1388-9842(01)00176-3; Cleland JGF, 2006, EUR J HEART FAIL, V8, P764, DOI 10.1016/j.ejheart.2006.10.001; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Clerico A, 2002, CLIN CHEM LAB MED, V40, P371, DOI 10.1515/CCLM.2002.060; *CLIN GOV, ALD ANT THER AD HEAR; *CLIN GOV, COMP OUTC PAT NYHA C; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; Cohn JN, 1997, CIRCULATION, V96, P856, DOI 10.1161/01.cir.96.3.856; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; Damasceno A, 2007, J AM COLL CARDIOL, V50, P1688, DOI 10.1016/j.jacc.2007.07.030; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Davie AP, 1996, BRIT MED J, V312, P222; Davie AP, 1997, QJM-MON J ASSOC PHYS, V90, P335, DOI 10.1093/qjmed/90.5.335; Domanski M, 2006, J CARD FAIL, V12, P327, DOI 10.1016/j.cardfail.2006.03.006; Enck R E, 1999, Am J Hosp Palliat Care, V16, P373, DOI 10.1177/104990919901600102; Erdmann E, 2007, DIABETES CARE, V30, P2773, DOI 10.2337/dc07-0717; Fischer M, 2003, EUR HEART J, V24, P320, DOI 10.1016/S0195-668X(02)00428-1; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724; Fukuta H, 2005, CIRCULATION, V112, P357, DOI 10.1161/CIRCULATIONAHA.104.519876; Giannuzzi P, 2003, CIRCULATION, V108, P554, DOI 10.1161/01.CIR.0000081780.38477.FA; Goodlin SJ, 1998, J PALLIAT CARE, V14, P30, DOI 10.1177/082585979801400106; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Gray A, 2008, NEW ENGL J MED, V359, P142, DOI 10.1056/NEJMoa0707992; Haas SJ, 2003, AM HEART J, V146, P848, DOI 10.1016/S0002-8703(03)00403-4; Higgins SL, 2003, J AM COLL CARDIOL, V42, P1454, DOI 10.1016/S0735-1097(03)01042-8; Hjalmarson A, 1999, LANCET, V353, P2001; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jougasaki M, 2003, PEPTIDES, V24, P889, DOI 10.1016/S0196-9781(03)00163-3; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; KILLIP T, 1985, CIRCULATION, V72, P102; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Krum H, 2003, LANCET, V362, P147, DOI 10.1016/S0140-6736(03)13869-X; Krum H, 2003, EXPERT OPIN INV DRUG, V12, P751, DOI 10.1517/13543784.12.5.751; Krum H, 2002, J AM COLL CARDIOL, V39, P1567, DOI 10.1016/S0735-1097(02)01827-2; Krum H, 2006, J CARD FAIL, V12, P333, DOI 10.1016/j.cardfail.2006.05.001; Krum H, 2006, MED J AUSTRALIA, V185, P549, DOI 10.5694/j.1326-5377.2006.tb00690.x; Lechat P, 1999, LANCET, V353, P9; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lyon AR, 2008, HEART, V94, P89, DOI 10.1136/hrt.2007.116483; MacDonald MR, 2008, EUR HEART J, V29, P1224, DOI 10.1093/eurheartj/ehn156; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Maisel AS, 2003, J AM COLL CARDIOL, V41, P2010, DOI 10.1016/S0735-1097(03)00405-4; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; Massad MG, 2004, CARDIOLOGY, V101, P79, DOI 10.1159/000075988; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McGregor E, 2006, CIRC RES, V98, P309, DOI 10.1161/01.RES.0000201280.20709.26; MCKELVIE RS, 1995, J AM COLL CARDIOL, V25, P789, DOI 10.1016/0735-1097(94)00428-S; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; McNamara DM, 2008, CURR OPIN CARDIOL, V23, P261, DOI 10.1097/HCO.0b013e3282fcd662; Menasche P, 2007, PROG CARDIOVASC DIS, V50, P7, DOI 10.1016/j.pcad.2007.02.002; Morgan JA, 2003, J THORAC CARDIOV SUR, V126, P1188, DOI 10.1016/S0022-5223(03)00935-8; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Nieminen MS, 2005, EUR HEART J, V26, P384; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 2003, CIRCULATION, V108, P2950, DOI 10.1161/01.CIR.0000109205.35813.8E; Packer M, 2006, J AM COLL CARDIOL, V47, P2245, DOI 10.1016/j.jacc.2005.12.071; Parissis JT, 2005, EXPERT OPIN INV DRUG, V14, P567, DOI 10.1517/13543784.14.5.567; Paterna S, 2008, CLIN SCI, V114, P221, DOI 10.1042/CS20070193; Perry G, 1997, NEW ENGL J MED, V336, P525; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Ritzema J, 2007, CIRCULATION, V116, P2952, DOI 10.1161/CIRCULATIONAHA.107.702191; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Rothenburger M, 2002, THORAC CARDIOV SURG, V50, P351, DOI 10.1055/s-2002-35746; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Rundqvist B, 1997, CIRCULATION, V95, P169, DOI 10.1161/01.CIR.95.1.169; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Schuleri K. H., 2007, V180, P195; See F, 2004, J AM COLL CARDIOL, V44, P1679, DOI 10.1016/j.jacc.2004.07.038; Senni M, 2001, J AM COLL CARDIOL, V38, P1277, DOI 10.1016/S0735-1097(01)01567-4; Solomon SD, 2007, LANCET, V369, P2079, DOI 10.1016/S0140-6736(07)60980-5; Starling E. H., 1918, LINACRE LECT LAW HEA; STEVENSON WG, 1993, CIRCULATION, V88, P2953, DOI 10.1161/01.CIR.88.6.2953; Stevenson WG, 1997, CURR OPIN CARDIOL, V12, P242, DOI 10.1097/00001573-199705000-00005; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Stewart S, 2001, EUR HEART J, V22, P209, DOI 10.1053/euhj.2000.2291; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Tavazzi L, 2004, EUR J HEART FAIL, V6, P635, DOI 10.1016/j.ejheart.2004.03.001; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Uretsky BF, 1997, J AM COLL CARDIOL, V30, P1589, DOI 10.1016/S0735-1097(97)00361-6; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Vitarelli A, 1998, AM J CARDIOL, V81, p115G, DOI 10.1016/S0002-9149(98)00067-8; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Wexler DJ, 2001, AM HEART J, V142, P350, DOI 10.1067/mhj.2001.116476; Whellan DJ, 2007, AM HEART J, V153, P201, DOI 10.1016/j.ahj.2006.11.007; White JA, 2007, CARDIOL CLIN, V25, P71, DOI 10.1016/j.ccl.2007.02.003; Willenheimer R, 2005, CIRCULATION, V112, P2426, DOI 10.1161/CIRCULATIONAHA.105.582320; Witte KKA, 2001, J AM COLL CARDIOL, V37, P1765, DOI 10.1016/S0735-1097(01)01227-X; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145	149	127	137	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					941	955		10.1016/S0140-6736(09)60236-1	http://dx.doi.org/10.1016/S0140-6736(09)60236-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286093				2022-12-24	WOS:000264158700035
J	Hutchins, DCJ; White, SM				Hutchins, David C. J.; White, Stuart M.			Coming round to recycling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NATIONAL-HEALTH-SERVICE; CLIMATE-CHANGE; CARE WASTE; CORNWALL; SINGLE; STRATEGIES; MANAGEMENT; DEVICES; NHS		[Hutchins, David C. J.; White, Stuart M.] Royal Sussex Cty Hosp, Brighton Anaesthesia Res Forum, Brighton BN2 5BE, E Sussex, England	University of Brighton	White, SM (corresponding author), Royal Sussex Cty Hosp, Brighton Anaesthesia Res Forum, Brighton BN2 5BE, E Sussex, England.	stuart.white@bsuh.nhs.uk		White, Stuart/0000-0002-0258-8210				BILITEWSKI B, 1996, WASTE MANAGE, P1; Blunt MC, 2003, BRIT J ANAESTH, V90, P1, DOI 10.1093/bja/aeg006; Bogner J, 2008, WASTE MANAGE RES, V26, P11, DOI 10.1177/0734242X07088433; *CARB TRUST, 2007, HOSP HLTH BUDG EN EF; Carey D, 2001, J Contemp Health Law Policy, V17, P657; Coote A, 2008, BRIT MED J, V336, P733, DOI 10.1136/bmj.39538.509456.80; *DEP ENV FOOD RUR, 2003, STUD EST DIS COSTS L; Department of Health, HLTH TECHN MEM 07 01; Elliott P, 2001, BRIT MED J, V323, P363, DOI 10.1136/bmj.323.7309.363; Gaiser RR, 2004, BRIT J ANAESTH, V92, P584, DOI 10.1093/bja/aeh103; Griffiths J, 2008, BRIT MED J, V336, P1507; *HOSP EP STAT, DAT 2003 4; Jacobs P, 2008, INFECT CONT HOSP EP, V29, P297, DOI 10.1086/529587; Laupau W, 2006, ANAESTHESIA, V61, P524, DOI 10.1111/j.1365-2044.2006.04642.x; Lee BK, 2002, WASTE MANAGE, V22, P461, DOI 10.1016/S0956-053X(02)00006-5; *MED HEALTHC PROD, 2006, SINGL US MED DEV IMP; *NHS SUST DEV UN, 2008, SAV CARB IMPR HLTH C; Rowley E, 2007, ANAESTHESIA, V62, P569, DOI 10.1111/j.1365-2044.2007.04995.x; Seidman PA, 1998, ANESTH ANALG, V87, P634, DOI 10.1097/00000539-199809000-00027; Tudor TL, 2008, WASTE MANAGE, V28, P1209, DOI 10.1016/j.wasman.2007.04.004; Tudor TL, 2007, WASTE MANAGE RES, V25, P510, DOI 10.1177/0734242X07082030; Tudor TL, 2005, WASTE MANAGE, V25, P606, DOI 10.1016/j.wasman.2004.10.004; Webster J, 2005, AM J INFECT CONTROL, V33, P348, DOI 10.1016/j.ajic.2004.11.010; [No title captured]	24	44	44	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2009	338								b609	10.1136/bmj.b609	http://dx.doi.org/10.1136/bmj.b609			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FU	19278971				2022-12-24	WOS:000264205300003
J	Klareskog, L; Catrina, AI; Paget, S				Klareskog, Lars; Catrina, Anca Irinel; Paget, Stephen			Rheumatoid arthritis	LANCET			English	Review							CYCLIC CITRULLINATED PEPTIDE; ANTITUMOR NECROSIS FACTOR; COLLEGE-OF-RHEUMATOLOGY; HLA-DRB1 SHARED EPITOPE; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; CIGARETTE-SMOKING; RISK-FACTORS; RADIOLOGICAL PROGRESSION; CARDIOVASCULAR-DISEASE	Rheumatoid arthritis is a systemic, inflammatory, autoimmune disorder. Enhanced understanding of molecular pathogenesis has enabled development of innovative biological agents that target specific parts of the immune system. These treatments have changed the course and face of rheumatoid arthritis and outcomes for patients and society New knowledge has emerged of how environmental factors interact with susceptibility genes and the immune system in the pathogenesis of a major subset of rheumatoid arthritis. Research undertaken on the longitudinal disease process and molecular pathology of joint inflammation has led to new therapeutic strategies that promote early use of disease-modifying drugs with tight disease control and distinct and quantifiable treatment goals. Today, such approaches can halt most cases of joint destruction but not all instances of joint inflammation and comorbidity Understanding the cause and pathogenesis of different rheumatoid arthritis subsets will lead not only to individualised treatments during early phases of the illness but also, possibly, to disease prevention.	[Paget, Stephen] Hosp Special Surg, Div Rheumatol, New York, NY 10021 USA; [Klareskog, Lars; Catrina, Anca Irinel] Karolinska Inst, Rheumatol Unit, Dept Med, Stockholm, Sweden; [Klareskog, Lars; Catrina, Anca Irinel] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Paget, S (corresponding author), Hosp Special Surg, Div Rheumatol, 535 E 70th St, New York, NY 10021 USA.	pagets@hss.edu		Klareskog, Lars/0000-0001-9601-6186	EU FP6 programme Autocure; Rheuminations; James and Linda Gosden Robinson Foundation	EU FP6 programme Autocure(European Commission); Rheuminations; James and Linda Gosden Robinson Foundation	For work that led to this Seminar, we acknowledge funding from the EU FP6 programme Autocure (to LK) and from Rheuminations and the James and Linda Gosden Robinson Foundation (to SP). We thank our colleagues for discussions and advice that led to the ideas described in this Seminar.	AHO K, 1993, ANN RHEUM DIS, V52, P897, DOI 10.1136/ard.52.12.897-b; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Askling J, 2005, ANN RHEUM DIS, V64, P1421, DOI 10.1136/ard.2004.033993; Askling J, 2008, CURR OPIN RHEUMATOL, V20, P334, DOI 10.1097/BOR.0b013e3282f7c706; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Bongartz T, 2007, RHEUMATOLOGY, V46, P70, DOI 10.1093/rheumatology/kel202; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Boonen A, 2005, RHEUM DIS CLIN N AM, V31, P681, DOI 10.1016/j.rdc.2005.07.004; BRENNAN FM, 1989, LANCET, V2, P244; BRENNAN FM, 1989, J AUTOIMMUN, V2, P177, DOI 10.1016/0896-8411(89)90129-7; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Bukhari M, 2002, ARTHRITIS RHEUM-US, V46, P906, DOI 10.1002/art.10167; Burger D, 2006, BEST PRACT RES CL RH, V20, P879, DOI 10.1016/j.berh.2006.06.004; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CAPLAN A, 1959, P ROY SOC MED, V52, P1111, DOI 10.1177/003591575905201225; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; Combe B, 2007, BEST PRACT RES CL RH, V21, P27, DOI 10.1016/j.berh.2006.08.011; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; DING B, ARTHRITIS R IN PRESS; Dougados M, 2005, J RHEUMATOL, V32, P1; Edwards JCW, 1999, IMMUNOLOGY, V97, P188; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Ek M, 2001, NATURE, V410, P430, DOI 10.1038/35068632; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; Erickson Alan R, 2007, Curr Rheumatol Rep, V9, P416, DOI 10.1007/s11926-007-0066-2; Farragher TM, 2008, ARTHRITIS RHEUM-US, V58, P359, DOI 10.1002/art.23149; Feitsma AL, 2007, P NATL ACAD SCI USA, V104, P19966, DOI 10.1073/pnas.0710260104; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Freeston JE, 2007, ANN RHEUM DIS, V66, P1538, DOI 10.1136/ard.2007.074708; Furst DE, 2007, ANN RHEUM DIS, V66, P2, DOI 10.1136/ard.2007.081430; Genovese MC, 2008, ANN RHEUM DIS, V67, P547, DOI 10.1136/ard.2007.074773; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Horwood NJ, 1999, BIOCHEM BIOPH RES CO, V265, P144, DOI 10.1006/bbrc.1999.1623; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Jacobsson LTH, 2003, BRIT MED J, V326, P1068, DOI 10.1136/bmj.326.7398.1068; Jarrett SJ, 2006, ARTHRITIS RHEUM-US, V54, P1410, DOI 10.1002/art.21824; Jonsson IM, 2007, P NATL ACAD SCI USA, V104, P258, DOI 10.1073/pnas.0608620104; Kallberg H, 2009, ANN RHEUM DIS, V68, P222, DOI 10.1136/ard.2007.086314; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Karlson EW, 1999, ARTHRITIS RHEUM-US, V42, P910, DOI 10.1002/1529-0131(199905)42:5<910::AID-ANR9>3.3.CO;2-4; Karlson EW, 2004, ARTHRITIS RHEUM-US, V50, P3458, DOI 10.1002/art.20621; Keystone E, 2007, ARTHRITIS RHEUM-US, V56, P3896, DOI 10.1002/art.23059; KLARESKOG L, 1982, P NATL ACAD SCI-BIOL, V79, P3632, DOI 10.1073/pnas.79.11.3632; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; KLOCKARS M, 1987, BMJ-BRIT MED J, V294, P997, DOI 10.1136/bmj.294.6578.997; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Kremer JM, 2008, CURR OPIN RHEUMATOL, V20, P123, DOI 10.1097/BOR.0b013e3282f50eb1; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Laiho K, 1999, CLIN RHEUMATOL, V18, P122, DOI 10.1007/s100670050068; Landewe RBM, 2002, ARTHRITIS RHEUM-US, V46, P347, DOI 10.1002/art.10083; Landewe R, 2006, ARTHRITIS RHEUM-US, V54, P3119, DOI 10.1002/art.22143; Lange F, 2005, ANN RHEUM DIS, V64, P599, DOI 10.1136/ard.2004.026120; Lee AT, 2005, GENES IMMUN, V6, P129, DOI 10.1038/sj.gene.6364159; Lee HS, 2008, MOL MED, V14, P293, DOI 10.2119/2007-00123.Lee; Lee HS, 2007, ARTHRITIS RHEUM-US, V56, P1745, DOI 10.1002/art.22703; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Lofdahl JM, 2006, CLIN EXP IMMUNOL, V145, P428, DOI 10.1111/j.1365-2249.2006.03154.x; Lorentzen JC, 2007, ARTHRITIS RHEUM-US, V56, P2620, DOI 10.1002/art.22813; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Makrygiannakis D, 2008, ANN RHEUM DIS, V67, P1488, DOI 10.1136/ard.2007.075192; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Michaud K, 2007, BEST PRACT RES CL RH, V21, P885, DOI 10.1016/j.berh.2007.06.002; Montesinos MC, 2007, ARTHRITIS RHEUM-US, V56, P1440, DOI 10.1002/art.22643; Moreland LW, 2006, ARTHRIT RHEUM-ARTHR, V55, P287, DOI 10.1002/art.21838; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; *NAT I HLTH CLIN E, 2008, AB TREATM RHEUM ARTH, V141; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; Oliver JE, 2006, SCAND J RHEUMATOL, V35, P169, DOI 10.1080/03009740600718080; Olsson AR, 2004, OCCUP ENVIRON MED, V61, P233, DOI 10.1136/oem.2003.007971; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Pedersen M, 2007, ARTHRITIS RHEUM-US, V56, P1446, DOI 10.1002/art.22597; Pedersen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2022; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; PINCUS T, 1986, J RHEUMATOL, V13, P841; Plant MJ, 1998, J RHEUMATOL, V25, P417; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rengel Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2304; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Roman MJ, 2005, HYPERTENSION, V46, P194, DOI 10.1161/01.HYP.0000168055.89955.db; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schepp PP, 2007, ADV ENG MATER, V9, P1; Sigurdsson S, 2007, ARTHRITIS RHEUM-US, V56, P2202, DOI 10.1002/art.22704; Silman AJ, 1996, ARTHRITIS RHEUM, V39, P732, DOI 10.1002/art.1780390504; Smolen JS, 2007, ANN RHEUM DIS, V66, P143, DOI 10.1136/ard.2006.061002; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; SPITZ P W, 1987, Clinical Rheumatology, V6, P105, DOI 10.1007/BF02203393; STASTNY P, 1976, J CLIN INVEST, V57, P1148, DOI 10.1172/JCI108382; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Svensson B, 2005, ARTHRITIS RHEUM-US, V52, P3360, DOI 10.1002/art.21298; Sverdrup B, 2005, ARTHRITIS RES THER, V7, pR1296, DOI 10.1186/ar1824; Symmons DPM, 1997, ARTHRITIS RHEUM, V40, P1955, DOI 10.1002/art.1780401106; Szkudlarek M, 2004, ARTHRITIS RHEUM-US, V50, P2103, DOI 10.1002/art.20333; Teng YKO, 2007, ARTHRITIS RHEUM-US, V56, P3909, DOI 10.1002/art.22967; Ulfgren AK, 2000, ANN RHEUM DIS, V59, P439, DOI 10.1136/ard.59.6.439; van der Helm-van Mil AHM, 2005, ARTHRITIS RHEUM-US, V52, P2637, DOI 10.1002/art.21272; van der Helm-van Mil AHM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2384; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; VANBOXEL JA, 1975, NEW ENGL J MED, V293, P517, DOI 10.1056/NEJM197509112931101; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Verpoort KN, 2005, ARTHRITIS RHEUM, V52, P3058, DOI 10.1002/art.21302; VESSEY MP, 1987, CONTRACEPTION, V35, P457, DOI 10.1016/0010-7824(87)90082-5; Vossenaar ER, 2004, ARTHRITIS RHEUM-US, V50, P3485, DOI 10.1002/art.20584; Wallberg-Jonsson S, 1999, J RHEUMATOL, V26, P2562; Watts RA, 2004, RHEUMATOLOGY, V43, P920, DOI 10.1093/rheumatology/keh210; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wessels JAM, 2008, RHEUMATOLOGY, V47, P249, DOI 10.1093/rheumatology/kem279; Wijbrandts CA, 2008, ANN RHEUM DIS, V67, P1139, DOI 10.1136/ard.2007.080440; Zendman AJW, 2006, RHEUMATOLOGY, V45, P20, DOI 10.1093/rheumatology/kei111; Zhang HG, 2002, J IMMUNOL, V168, P4164, DOI 10.4049/jimmunol.168.8.4164	135	656	712	1	132	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2009	373	9664					659	672		10.1016/S0140-6736(09)60008-8	http://dx.doi.org/10.1016/S0140-6736(09)60008-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19157532				2022-12-24	WOS:000263563500031
J	Cassidy, J				Cassidy, Jane			Medicine and the Media Jade, class, and cervical cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com						Brown J, 1997, Popul Trends, P40; Brown J, 1997, POPUL TRENDS, V90, P49; Harris V, 1998, CANC REGISTRATION ST, P182; *NHS CERV SCREEN P, ANN REV 2008	4	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 18	2009	338								b691	10.1136/bmj.b691	http://dx.doi.org/10.1136/bmj.b691			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CG	19224973				2022-12-24	WOS:000264052100009
J	Hill, AVS; Shirley, M; Greenwood, BM				Hill, Adrian V. S.; Shirley, Martin; Greenwood, Brian M.			Jenner reborn: a new vaccine institute	LANCET			English	Editorial Material									[Hill, Adrian V. S.] Univ Oxford, Jenner Inst Labs, Oxford OX3 78DQ, England; [Shirley, Martin] Inst Food Res, Inst Anim Hlth, Compton Lab, Newbury RG16 0NN, Berks, England; [Greenwood, Brian M.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Quadram Institute; University of London; London School of Hygiene & Tropical Medicine	Hill, AVS (corresponding author), Univ Oxford, Jenner Inst Labs, Oxford OX3 78DQ, England.	adrian.hill@ndm.ox.ac.uk			Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Brookes RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002921; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Fowler VL, 2008, VACCINE, V26, P1982, DOI 10.1016/j.vaccine.2008.02.012; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Nossal GJV, 2004, NAT IMMUNOL, V5, P457, DOI 10.1038/ni0504-457; POLLARD AJ, NAT REV IMM IN PRESS; Snape MD, 2008, JAMA-J AM MED ASSOC, V299, P173, DOI 10.1001/jama.2007.29-c; WILKINSON E, 2008, BBC NEWS        0905	11	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 7	2009	373	9662					445	446		10.1016/S0140-6736(09)60150-1	http://dx.doi.org/10.1016/S0140-6736(09)60150-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19200904				2022-12-24	WOS:000263132800010
J	Sridharan, R; Tchieu, J; Mason, MJ; Yachechko, R; Kuoy, E; Horvath, S; Zhou, Q; Plath, K				Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Horvath, Steve; Zhou, Qing; Plath, Kathrin			Role of the Murine Reprogramming Factors in the Induction of Pluripotency	CELL			English	Article							STEM-CELLS; TRANSCRIPTIONAL NETWORK; MOUSE; FIBROBLASTS; MYC; GENERATION; EXPRESSION; CIRCUITRY	Induced pluripotent stem (iPS) cells can be obtained from fibroblasts upon expression of Oct4, Sox2, Klf4, and c-Myc. To understand how these factors induce pluripotency, we carried out genome-wide analyses of their promoter binding and expression in iPS and partially reprogrammed cells. We find that target genes of the four factors strongly overlap in iPS and embryonic stem (ES) cells. In partially reprogrammed cells, many genes co-occupied by c-Myc and any of the other three factors already show an ES cell-like binding and expression pattern. In contrast, genes that are specifically co-bound by Oct4, Sox2, and Klf4 in ES cells and encode pluripotency regulators severely lack binding and transcriptional activation. Among the four factors, c-Myc promotes the most ES cell-like transcription pattern when expressed individually in fibroblasts. These data uncover temporal and separable contributions of the four factors during the reprogramming process and indicate that ectopic c-Myc predominantly acts before pluripotency regulators are activated.	[Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Horvath, Steve; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Plath, Kathrin] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Tchieu, Jason; Plath, Kathrin] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Plath, Kathrin] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Mason, Mike J.; Zhou, Qing] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu	Tchieu, Jason/AAG-1551-2020	Tchieu, Jason/0000-0002-9793-9836; Plath, Kathrin/0000-0001-7796-3372; Mason, Michael/0000-0002-5652-7739; Kuoy, Edward/0000-0003-4721-1254	California Institute of Regenerative Medicine (CIRM); NSF [DMS-0805491]; Kimmel Scholar Foundations; NIH Director's Young Innovator Award; CIRM Young Investigator Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); Kimmel Scholar Foundations; NIH Director's Young Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM Young Investigator Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Stephen Smale, Siavash Kurdistani, Bernadett Papp, Lars Dreier, Mark Chin, Bill Lowry, and Konrad Hochedlinger for critical reading of the manuscript. R. S. is supported by a training grant from the California Institute of Regenerative Medicine (CIRM), Q. Z. by a NSF grant (DMS-0805491), and K. P. by the V and Kimmel Scholar Foundations, the NIH Director's Young Innovator Award, and a CIRM Young Investigator Award.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	27	501	531	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					364	377		10.1016/j.cell.2009.01.001	http://dx.doi.org/10.1016/j.cell.2009.01.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167336	Green Accepted, Bronze			2022-12-24	WOS:000262648800023
J	Grewal, J; McCully, RB; Kane, GC; Lam, C; Pellikka, PA				Grewal, Jasmine; McCully, Robert B.; Kane, Garvan C.; Lam, Carolyn; Pellikka, Patricia A.			Left Ventricular Function and Exercise Capacity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIASTOLIC DYSFUNCTION; CARDIAC-FUNCTION; HEART-FAILURE; AGE; MEN; ECHOCARDIOGRAPHY; PERFORMANCE; TOLERANCE; GENDER; WOMEN	Context Limited information exists regarding the role of left ventricular function in predicting exercise capacity and impact on age- and sex- related differences. Objectives To determine the impact of measures of cardiac function assessed by echocardiography on exercise capacity and to determine if these associations are modified by sex or advancing age. Design Cross- sectional study of patients undergoing exercise echocardiography with routine measurements of left ventricular systolic and diastolic function by 2- dimensional and Doppler techniques. Analyses were conducted to determine the strongest correlates of exercise capacity and the age and sex interactions of these variables with exercise capacity. Setting Large tertiary referral center in Rochester, Minnesota, in 2006. Participants Patients undergoing exercise echocardiography using the Bruce protocol ( N= 2867). Patients with echocardiographic evidence of exercise- induced ischemia, ejection fractions lower than 50%, or significant valvular heart disease were excluded. Main Outcome Measure Exercise capacity in metabolic equivalents ( METs). Results Diastolic dysfunction was strongly and inversely associated with exercise capacity. Compared with normal function, after multivariate adjustment, those with moderate/ severe resting diastolic dysfunction (- 1.30 METs; 95% confidence interval [ CI], - 1.52 to - 0.99; P <. 001) and mild resting diastolic dysfunction (- 0.70 METs; 95% CI, - 0.88 to - 0.46; P <. 001) had substantially lower exercise capacity. Variation of left ventricular systolic function within the normal range was not associated with exercise capacity. Left ventricular filling pressures measured by resting E/ e' of 15 or greater (- 0.41 METs; 95% CI, - 0.70 to - 0.11; P=. 007) or postexercise E/ e' of 15 or greater (- 0.41 METs; 95% CI, - 0.71 to - 0.11; P=. 007) were similarly associated with a reduction in exercise capacity, each in separate multivariate analyses. Individuals with impaired relaxation ( mild dysfunction) or resting E/e' of 15 or greater had a progressive increase in the magnitude of reduction in exercise capacity with advancing age ( P <. 001 and P=. 02, respectively). Other independent correlates of exercise capacity were age ( unstandardized beta coefficient, - 0.85 METs; 95% CI, - 0.92 to - 0.77, per 10- year increment; P <. 001), female sex (- 1.98 METs; 95% CI, - 2.15 to - 1.84; P <. 001), and body mass index greater than 30 (- 1.24 METs; 95% CI, - 1.41 to - 1.10; P <. 001). Conclusion In this large cross- sectional study of those referred for exercise echocardiography and not limited by ischemia, abnormalities of left ventricular diastolic function were independently associated with exercise capacity.	[Grewal, Jasmine; McCully, Robert B.; Kane, Garvan C.; Lam, Carolyn; Pellikka, Patricia A.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Pellikka, PA (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	pellikka.patricia@mayo.edu	Lam, Carolyn SP/ABD-6810-2021; Pellikka, Patricia A/N-5387-2014	Lam, Carolyn SP/0000-0003-1903-0018; Pellikka, Patricia A/0000-0001-6800-3521	National Center for Research Resources [1 UL1 RR024150]; National Institutes of Health; NIH Roadmap for Medical Research; Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by grant No. 1 UL1 RR024150 (for biostatistical analysis) from the National Center for Research Resources, a component of the National Institutes of Health (NIH); the NIH Roadmap for Medical Research; and the Mayo Foundation (data management).	BRANDAO MUP, 1993, J APPL PHYSIOL, V75, P1989, DOI 10.1152/jappl.1993.75.5.1989; Brassard P, 2007, MED SCI SPORT EXER, V39, P1896, DOI 10.1249/mss.0b013e318145b642; Burgess MI, 2006, J AM COLL CARDIOL, V47, P1891, DOI 10.1016/j.jacc.2006.02.042; BUSKIRK ER, 1987, FASEB J, V46, P1824; COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71; ELLSTAD MH, 1996, STRESS TESTING PRINC, P75; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1; Gilman G, 2007, J AM SOC ECHOCARDIOG, V20, P199, DOI 10.1016/j.echo.2006.08.005; Ha JW, 2003, AM J CARDIOL, V91, P114, DOI 10.1016/S0002-9149(02)03016-3; HIGGINBOTHAM MB, 1983, AM J CARDIOL, V51, P52, DOI 10.1016/S0002-9149(83)80010-1; HIGGINBOTHAM MB, 1986, AM J CARDIOL, V57, P1374, DOI 10.1016/0002-9149(86)90221-3; HOSSACK KF, 1982, J APPL PHYSIOL, V53, P799, DOI 10.1152/jappl.1982.53.4.799; JULIUS S, 1967, CIRCULATION, V36, P222, DOI 10.1161/01.CIR.36.2.222; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEVY WC, 1993, CIRCULATION, V88, P116, DOI 10.1161/01.CIR.88.1.116; Little WC, 2006, AM J CARDIOL, V98, P383, DOI 10.1016/j.amjcard.2006.01.106; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Okura H, 2000, AM HEART J, V139, P716, DOI 10.1016/S0002-8703(00)90054-1; OLDERSHAW PJ, 1983, BRIT HEART J, V49, P568; Ommen SR, 2000, CIRCULATION, V102, P1788; PAINTAL AS, 1969, J PHYSIOL-LONDON, V203, P511, DOI 10.1113/jphysiol.1969.sp008877; Proctor DN, 1998, J APPL PHYSIOL, V84, P599, DOI 10.1152/jappl.1998.84.2.599; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; ROBERTS AM, 1986, CIRC RES, V58, P512, DOI 10.1161/01.RES.58.4.512; Shubair Mamdouh M, 2004, J Cardiopulm Rehabil, V24, P405, DOI 10.1097/00008483-200411000-00008; Skaluba SJ, 2004, CIRCULATION, V109, P972, DOI 10.1161/01.CIR.0000117405.74491.D2; Smart N, 2007, AM HEART J, V153, P530, DOI 10.1016/j.ahj.2007.01.004; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; VANOVERSCHELDE JLJ, 1993, J APPL PHYSIOL, V74, P2225, DOI 10.1152/jappl.1993.74.5.2225; Warner JG, 1999, J AM COLL CARDIOL, V33, P1567, DOI 10.1016/S0735-1097(99)00048-0; Weiss EP, 2006, J APPL PHYSIOL, V101, P938, DOI 10.1152/japplphysiol.01398.2005; Woo JS, 2006, J AM COLL CARDIOL, V47, P1049, DOI 10.1016/j.jacc.2005.09.066	36	174	178	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					286	294		10.1001/jama.2008.1022	http://dx.doi.org/10.1001/jama.2008.1022			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395IV	19155455	Bronze, Green Accepted			2022-12-24	WOS:000262518700019
J	Hsu, HE; Shutt, KA; Moore, MR; Beall, BW; Bennett, NM; Craig, AS; Farley, MM; Jorgensen, JH; Lexau, CA; Petit, S; Reingold, A; Schaffner, W; Thomas, A; Whitney, CG; Harrison, LH				Hsu, Heather E.; Shutt, Kathleen A.; Moore, Matthew R.; Beall, Bernard W.; Bennett, Nancy M.; Craig, Allen S.; Farley, Monica M.; Jorgensen, James H.; Lexau, Catherine A.; Petit, Susan; Reingold, Arthur; Schaffner, William; Thomas, Ann; Whitney, Cynthia G.; Harrison, Lee H.			Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STREPTOCOCCUS-PNEUMONIAE; BACTERIAL-MENINGITIS; UNITED-STATES; DISEASE; ERA; CHILDHOOD; SEROTYPES; CARRIAGE; ADULTS	Background Invasive pneumococcal disease declined among children and adults after the introduction of the pediatric heptavalent pneumococcal conjugate vaccine ( PCV7) in 2000, but its effect on pneumococcal meningitis is unclear. Methods We examined trends in pneumococcal meningitis from 1998 through 2005 using active, population- based surveillance data from eight sites in the United States. Isolates were grouped into PCV7 serotypes ( 4, 6B, 9V, 14, 18C, 19F, and 23F), PCV7- related serotypes ( 6A, 9A, 9L, 9N, 18A, 18B, 18F, 19B, 19C, 23A, and 23B), and non- PCV7 serotypes ( all others). Changes in the incidence of pneumococcal meningitis were assessed against baseline values from 1998- 1999. Results We identified 1379 cases of pneumococcal meningitis. The incidence declined from 1.13 cases to 0.79 case per 100,000 persons between 1998- 1999 and 2004- 2005 ( a 30.1% decline, P< 0.001). Among persons younger than 2 years of age and those 65 years of age or older, the incidence decreased during the study period by 64.0% and 54.0%, respectively ( P< 0.001 for both groups). Rates of PCV7- serotype meningitis declined from 0.66 case to 0.18 case ( a 73.3% decline, P< 0.001) among patients of all ages. Although rates of PCV7- related- serotype disease decreased by 32.1% ( P = 0.08), rates of non- PCV7- serotype disease increased from 0.32 to 0.51 ( an increase of 60.5%, P< 0.001). The percentages of cases from non- PCV7 serotypes 19A, 22F, and 35B each increased significantly during the study period. On average, 27.8% of isolates were nonsusceptible to penicillin, but fewer isolates were nonsusceptible to chloramphenicol ( 5.7%), meropenem ( 16.6%), and cefotaxime ( 11.8%). The proportion of penicillin-nonsusceptible isolates decreased between 1998 and 2003 ( from 32.0% to 19.4%, P = 0.01) but increased between 2003 and 2005 ( from 19.4% to 30.1%, P = 0.03). Conclusions Rates of pneumococcal meningitis have decreased among children and adults since PCV7 was introduced. Although the overall effect of the vaccine remains substantial, a recent increase in meningitis caused by non- PCV7 serotypes, including strains nonsusceptible to antibiotics, is a concern.	[Hsu, Heather E.; Shutt, Kathleen A.; Harrison, Lee H.] Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15261 USA; [Moore, Matthew R.; Beall, Bernard W.; Whitney, Cynthia G.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Farley, Monica M.] Emory Univ, Vet Affairs Med Ctr, Atlanta, GA 30322 USA; [Bennett, Nancy M.] Univ Rochester, Rochester, NY USA; [Craig, Allen S.] Tennessee Dept Hlth, Nashville, TN USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Jorgensen, James H.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Lexau, Catherine A.] Minnesota Dept Hlth, St Paul, MN USA; [Petit, Susan] Connecticut Dept Publ Hlth, Hartford, CT USA; [Reingold, Arthur] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Thomas, Ann] Oregon State Publ Hlth Div, Portland, OR USA; [Harrison, Lee H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Rochester; Tennessee Department Health; Vanderbilt University; University of Texas System; University of Texas Health San Antonio; Minnesota Department of Health (MHD); University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Harrison, LH (corresponding author), Univ Pittsburgh, Infect Dis Epidemiol Res Unit, 521 Parran Hall,130 Desoto St, Pittsburgh, PA 15261 USA.	lharriso@edc.pitt.edu		Hsu, Heather/0000-0002-5863-1804; Shutt, Kathleen/0000-0003-3376-6152	National Institute of Allergy and Infectious Diseases [K24 AI052788]; Sanofi-Pasteur; AstraZeneca; Wyeth; BD Diagnostics; bioMerieux; Astellis; Siemens MicroScan; Accelr8 Technology; Arpida; Johnson Johnson; Cubist; Merck; Pfizer; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI052788] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sanofi-Pasteur; AstraZeneca(AstraZeneca); Wyeth(Wyeth); BD Diagnostics; bioMerieux; Astellis; Siemens MicroScan; Accelr8 Technology; Arpida; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Cubist; Merck(Merck & Company); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the CDC and a career development award from the National Institute of Allergy and Infectious Diseases (K24 AI052788, to Dr. Harrison). Ms. Shutt reports receiving grant support from Sanofi-Pasteur and AstraZeneca; Dr. Bennett, honoraria and travel expenses from Wyeth for an advisory board meeting on an experimental pneumococcal vaccine and from Merck for participation on an advisory board on herpes zoster vaccine; Dr. Farley, travel expenses for lectures from Wyeth; Dr. Jorgensen, consulting, lecture, or advisory fees from BD Diagnostics, bioMerieux, Astellis, Siemens MicroScan, and Accelr8 Technology and grant support from bioMerieux, Arpida, Johnson & Johnson, Cubist, Merck, and Pfizer; Dr. Schaffner, honoraria from Wyeth for an advisory board meeting about an experimental vaccine and from Merck for participation on a data and safety monitoring board for experimental vaccines and advisory-board meetings on adult immunization and pneumococcal vaccine; and Dr. Harrison, consulting fees and honoraria from Wyeth, Merck, Sanofi-Pasteur, and GlaxoSmithKline and grant support from Sanofi-Pasteur. No other potential conflict of interest relevant to this article was reported.; We thank the personnel in the Active Bacterial Core surveillance sites of the Emerging Infections Program, especially Wendy Baughman and Paul Malpiedi of the Georgia Emerging Infections Program; Rosemary Hollick and Kim Holmes of the Johns Hopkins Bloomberg School of Public Health; Brenda G. Barnes of the Department of Preventive Medicine, Vanderbilt School of Medicine; Lori Triden, Ruth Lynfield, and Richard Danila of the Clinical Microbiology Section, Minnesota Public Health Laboratory; James L. Hadler and Zack Fraser of the Connecticut Department of Public Health; Karen Stefonek of the Oregon Public Health Division; Shelley M. Zansky of the Emerging Infections Program, New York State Department of Health; Glenda L. Smith of the Emerging Infections Program, Rochester, NY; and Susan Brooks and Pamala Daily of the California Emerging Infections Program, Oakland, CA; and also Delois Jackson and her team in the CDC Strep Laboratory for serotyping and data on minimal inhibitory concentrations; M. Leticia McElmeel, Letitia Fulcher, and Christa Trippy for assistance with the antimicrobial susceptibility testing; and Tamara Pilishvili and Elizabeth Zell for assistance with data management and programming.	Abramson JS, 2000, PEDIATRICS, V106, P362; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P893; Bingen E, 2008, EUR J CLIN MICROBIOL, V27, P191, DOI 10.1007/s10096-007-0417-y; Black S, 2007, PEDIATR INFECT DIS J, V26, P771, DOI 10.1097/INF.0b013e318124a494; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; *CDCP, 2007, ACT BACT COR SURV OV; *CDCP, 2007, METH SURV POP ACT BA; *CDCP, 2006, ABCS REP EM INF PROG; *CLIN LAB STAND I, 2007, M100S17 NCCLS, P126; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Dery Mark Alain, 2007, Curr Infect Dis Rep, V9, P301, DOI 10.1007/s11908-007-0047-7; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kyaw MH, 2006, NEW ENGL J MED, V355, P638; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Musher DM, 2006, NEW ENGL J MED, V354, P1522, DOI 10.1056/NEJMe068038; *NAT CTR HLTH STAT, 2007, DAT FIL DOC; *NAT CTR IMM RESP, 2007, IMM COV US COV IND V; Neuman HB, 2001, CLIN PEDIATR, V40, P595, DOI 10.1177/000992280104001102; *NIH, 2007, STUD EV 13 VAL PNEUM; *NIH, 2006, SAF IMM STUD 10 VAL; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Temime L, 2005, EPIDEMIOL INFECT, V133, P493, DOI 10.1017/S0950268804003565; THIGPEN MC, 2005, 43 ANN M INF DIS SOC; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Yu XH, 1999, J INFECT DIS, V180, P1569, DOI 10.1086/315096	35	330	356	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					244	256		10.1056/NEJMoa0800836	http://dx.doi.org/10.1056/NEJMoa0800836			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144940	Green Accepted			2022-12-24	WOS:000262434500007
J	Gray, A; Read, S; McGale, P; Darby, S				Gray, Alastair; Read, Simon; McGale, Paul; Darby, Sarah			Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLLABORATIVE ANALYSIS; RESIDENTIAL RADON; INDIVIDUAL DATA; REMEDIATION; HOMES	Objective To determine the number of deaths from lung cancer related to radon in the home and to explore the cost effectiveness of alternative policies to control indoor radon and their potential to reduce lung cancer mortality. Design Cost effectiveness analysis. Setting United Kingdom. Data sources Epidemiological data on risks from indoor radon and from smoking, vital statistics on deaths from lung cancer, survey information on effectiveness and costs of radon prevention and remediation. Main outcome measures Estimated number of deaths from lung cancer related to indoor radon, lifetime risks of death from lung cancer before and after various potential interventions to control radon, the cost per quality adjusted life year ( QALY) gained from different policies for control of radon, and the potential of those policies to reduce lung cancer mortality. Results The mean radon concentration in UK homes is 21 becquerels per cubic metre (Bq/m(3)). Each year around 1100 deaths from lung cancer ( 3.3% of all deaths from lung cancer) are related to radon in the home. Over 85% of these arise from radon concentrations below 100 Bq/m(3) and most are caused jointly by radon and active smoking. Current policy requiring basic measures to prevent radon in new homes in selected areas is highly cost effective, and such measures would remain cost effective if extended to the entire UK, with a cost per QALY gained of 11 400 ((euro) 12 200; $ 16 913). Current policy identifying and remediating existing homes with high radon levels is, however, neither cost effective ( cost per QALY gained 36 800) nor effective in reducing lung cancer mortality. Conclusions Policies requiring basic preventive measures against radon in all new homes throughout the UK would be cost effective and could complement existing policies to reduce smoking. Policies involving remedial work on existing homes with high radon levels cannot prevent most radon related deaths, as these are caused by moderate exposure in many homes. These conclusions are likely to apply to most developed countries, many with higher mean radon concentrations than the UK.	[Gray, Alastair] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England; [Read, Simon; McGale, Paul; Darby, Sarah] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Read, Simon; McGale, Paul; Darby, Sarah] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England	University of Oxford; University of Oxford; University of Oxford	Gray, A (corresponding author), Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England.	alastair.gray@dphpc.ox.ac.uk			Cancer Research UK [C500/A10573, A10293]; Medical Research Council [E270/4]; European Commission [516483 (FI6R)]; National Institute for Health Research; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Cancer Research UK [grant Nos C500/A10573, A10293], the Medical Research Council [grant No E270/4], the European Commission sixth framework programme ( project: alpha risk grant No 516483 (FI6R)), and the National Institute for Health Research. The funders had no role in the design of the study, carrying out the analysis, or the decision to submit for publication.	AKERBLOM G, 1999, 9918 SWED RAD PROT I; Bradley EJ, 1996, NRPBM707; Cancer Research UK, 2008, CANC STAT; Chilton S., 2004, VALUATION HLTH BENEF; *COMM BIOL EFF ION, 1999, HLTH EFF EXP IND RAD; Coskeran T, 2005, HEALTH POLICY, V71, P43, DOI 10.1016/j.healthpol.2004.05.003; Darby S, 2006, SCAND J WORK ENV HEA, V32, P1; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; *DEP HLTH, 2004, POL APPR HLTH GUID D; *DEP TRANSP, 2007, 1 DEP TRANSP; Department of the Environment Transport and the Regions, 2000, DETRRAS00004; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Ford ES, 1999, AM J PUBLIC HEALTH, V89, P351, DOI 10.2105/AJPH.89.3.351; Gold MR, 1996, COST EFFECTIVENESS H; *HLTH PROT AG, HPA ADV RAD PROT MEA; HUNTER N, 2005, 7 INT S NAT RAD ENV, P438; *IND ADV GROUP ION, 2009, RAD PUBL HL IN PRESS; Kennedy CA, 1999, BRIT J CANCER, V81, P1243, DOI 10.1038/sj.bjc.6690836; LOMAS PR, 1994, RADIAT PROT DOSIM, V56, P323; Naismith SP, 1998, HEALTH PHYS, V75, P410, DOI 10.1097/00004032-199810000-00008; *NAT I HLTH CLIN E, 2005, GUID NICE; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; *OFF NAT STAT, 2006, LIV BRIT 2004 GEN HO; *PARL OFF SCI TECH, RED RAD RISKS HOM; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Stigum H, 2003, HEALTH PHYS, V84, P227, DOI 10.1097/00004032-200302000-00011; Thun MJ, 2006, JNCI-J NATL CANCER I, V98, P691, DOI 10.1093/jnci/djj187; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, UNSCEAR 2000 REPORT; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, UNSCEAR 2006 REP GEN, V1; *WHO, WHO IND AIR QUAL GUI; Wrixon AD, 1988, NRPBR190	31	102	102	2	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2009	338								a3110	10.1136/bmj.a3110	http://dx.doi.org/10.1136/bmj.a3110			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PN	19129153	Green Published, hybrid			2022-12-24	WOS:000263165600003
J	Stiglitz, JE				Stiglitz, Joseph E.			Trade agreements and health in developing countries	LANCET			English	Editorial Material									[Stiglitz, Joseph E.] Columbia Univ, New York, NY 10027 USA	Columbia University	Stiglitz, JE (corresponding author), Columbia Univ, New York, NY 10027 USA.	jes322@columbia.edu						*EUR COMM, BIL TRAD REL, P2; Matthijs G, 2004, BRIT MED J, V329, P1358, DOI 10.1136/bmj.329.7479.1358; *MED SANS FRONT, 2006, PEOPL NOT GETT TREAT, P2; *OFF US TRAD REPR, TRAD AGR, P2; Smith RD, 2009, LANCET, V373, P684, DOI 10.1016/S0140-6736(08)61779-1; Smith RD, 2009, LANCET, V373, P768, DOI 10.1016/S0140-6736(08)61780-8; SOEKIRMAN KD, 2008, ASIA PACIFIC J CLI S, V10, P557; STIGLITZ JE, 2006, MAKING GLOBALIZATION, P2; *UN DEV PROGR, 2003, MAK GLOB TRAD WORK P, P2; 2007, MED NEWS TODAY  0207, P2	10	28	28	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					363	365		10.1016/S0140-6736(08)61772-9	http://dx.doi.org/10.1016/S0140-6736(08)61772-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401BC	19167055	Green Published			2022-12-24	WOS:000262912100009
J	Gertsman, I; Gan, L; Guttman, M; Lee, K; Speir, JA; Duda, RL; Hendrix, RW; Komives, EA; Johnson, JE				Gertsman, Ilya; Gan, Lu; Guttman, Miklos; Lee, Kelly; Speir, Jeffrey A.; Duda, Robert L.; Hendrix, Roger W.; Komives, Elizabeth A.; Johnson, John E.			An unexpected twist in viral capsid maturation	NATURE			English	Article							X-RAY CRYSTALLOGRAPHY; VIRUS MATURATION; COMMON ANCESTRY; COAT PROTEIN; BACTERIOPHAGES; TRANSITION; DYNAMICS; DOMAIN; MODEL; DNA	Lambda-like double-stranded (ds) DNA bacteriophage undergo massive conformational changes in their capsid shell during the packaging of their viral genomes. Capsid shells are complex organizations of hundreds of protein subunits that assemble into intricate quaternary complexes that ultimately are able to withstand over 50 atm of pressure during genome packaging(1). The extensive integration between subunits in capsids requires the formation of an intermediate complex, termed a procapsid, from which individual subunits can undergo the necessary refolding and structural rearrangements needed to transition to the more stable capsid. Although various mature capsids have been characterized at atomic resolution, no such procapsid structure is available for a dsDNA virus or bacteriophage. Here we present a procapsid X-ray structure at 3.65 angstrom resolution, termed prohead II, of the lambda-like bacteriophage HK97, the mature capsid structure of which was previously solved to 3.44 angstrom (ref. 2). A comparison of the two largely different capsid forms has unveiled an unprecedented expansion mechanism that describes the transition. Crystallographic and hydrogen/deuterium exchange data presented here demonstrate that the subunit tertiary structures are significantly different between the two states, with twisting and bending motions occurring in both helical and beta-sheet regions. We also identified subunit interactions at each three-fold axis of the capsid that are maintained throughout maturation. The interactions sustain capsid integrity during subunit refolding and provide a fixed hinge from which subunits undergo rotational and translational motions during maturation. Previously published calorimetric data of a closely related bacteriophage, P22, showed that capsid maturation was an exothermic process that resulted in a release of 90 kJ mol(-1) of energy(3). We propose that the major tertiary changes presented in this study reveal a structural basis for an exothermic maturation process probably present in many dsDNA bacteriophage and possibly viruses such as herpesvirus, which share the HK97 subunit fold(4).	[Gertsman, Ilya; Gan, Lu; Lee, Kelly; Speir, Jeffrey A.; Johnson, John E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Gertsman, Ilya; Guttman, Miklos; Komives, Elizabeth A.; Johnson, John E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92037 USA; [Duda, Robert L.; Hendrix, Roger W.] Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; [Duda, Robert L.; Hendrix, Roger W.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Scripps Research Institute; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Johnson, JE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jackj@scripps.edu	Gan, Lu/F-8317-2011; Johnson, Johnson/HDL-9124-2022	Gan, Lu/0000-0002-8685-4896; Duda, Robert/0000-0002-9517-2731	NIH [RO1 AI40101, RO1 GM47795]; NIH Training Grant [GM08326]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326, R01GM047795] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Reddy for assistance with crystallographic studies and for discussions. We thank R. Huang for providing HK97 capsomer samples and for discussions, and T. Matsui for help with X-ray data collection. We thank B. Firek and C. Moyer for mutagenesis of the HK97 constructs used in the study. We also thank B. Szymczyma for material used in the study. We also thank I. Wilson for discussions. Wethank the staffs at beamlines 14-BMC and 23-ID- D of the Advanced Photon Source for assistance in data collection. This work was supported by NIH grants RO1 AI40101 (to J.E.J), RO1 GM47795 ( to R. W. H) and NIH Training Grant GM08326.	Agirrezabala X, 2007, STRUCTURE, V15, P461, DOI 10.1016/j.str.2007.03.004; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Conway JF, 2007, J STRUCT BIOL, V158, P224, DOI 10.1016/j.jsb.2006.11.006; CONWAY JF, 1995, J MOL BIOL, V253, P86, DOI 10.1006/jmbi.1995.0538; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Croy CH, 2004, PROTEIN SCI, V13, P1767, DOI 10.1110/ps.04731004; DUDA RL, 1995, J MOL BIOL, V247, P636, DOI 10.1006/jmbi.1994.0169; DUDA RL, 1995, J MOL BIOL, V247, P618, DOI 10.1016/S0022-2836(05)80143-3; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Gan L, 2006, STRUCTURE, V14, P1655, DOI 10.1016/j.str.2006.09.006; Helgstrand Charlotte, 2003, Journal of Molecular Biology, V334, P885, DOI 10.1016/j.jmb.2003.09.035; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Kang SB, 2005, J MOL BIOL, V347, P935, DOI 10.1016/j.jmb.2005.02.021; Korostelev A, 2002, ACTA CRYSTALLOGR D, V58, P761, DOI 10.1107/S0907444902003402; Lata R, 2000, CELL, V100, P253, DOI 10.1016/S0092-8674(00)81563-9; Lee KK, 2008, STRUCTURE, V16, P1491, DOI 10.1016/j.str.2008.06.014; Lee KK, 2005, J MOL BIOL, V352, P723, DOI 10.1016/j.jmb.2005.07.024; Lee KK, 2004, J MOL BIOL, V340, P419, DOI 10.1016/j.jmb.2004.05.008; Mandell JG, 2001, J MOL BIOL, V306, P575, DOI 10.1006/jmbi.2000.4416; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; TONG L, 1990, ACTA CRYSTALLOGR A, V46, P783, DOI 10.1107/S0108767390005530; Tuma R, 1998, P NATL ACAD SCI USA, V95, P9885, DOI 10.1073/pnas.95.17.9885; Wikoff WR, 2006, J STRUCT BIOL, V153, P300, DOI 10.1016/j.jsb.2005.11.009; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; XIE ZH, 1995, J MOL BIOL, V253, P74, DOI 10.1006/jmbi.1995.0537	31	98	101	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					646	U114		10.1038/nature07686	http://dx.doi.org/10.1038/nature07686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19204733	Green Accepted, Green Submitted			2022-12-24	WOS:000264796200044
J	Kara, P; Boyd, JD				Kara, Prakash; Boyd, Jamie D.			A micro-architecture for binocular disparity and ocular dominance in visual cortex	NATURE			English	Article							POSTNATAL-DEVELOPMENT; HORIZONTAL DISPARITY; DEPTH DISCRIMINATION; STRIATE CORTEX; PRIMATE V1; SENSITIVITY; NEURONS; ORGANIZATION; MECHANISMS; STEREOPSIS	In invertebrate predators such as the praying mantis and vertebrate predators such as wild cats the ability to detect small differences in inter-ocular retinal disparities is a critical means for accurately determining the depth of moving objects such as prey(1). In mammals, the first neurons along the visual pathway that encode binocular disparities are found in the visual cortex. However, a precise functional architecture for binocular disparity has never been demonstrated in any species, and coarse maps for disparity have been found in only one primate species(2,3). Moreover, the dominant approach for assaying the developmental plasticity of binocular cortical neurons used monocular tests of ocular dominance to infer binocular function(4). The few studies that examined the relationship between ocular dominance and binocular disparity of individual cells used single-unit recordings and have provided conflicting results regarding whether ocular dominance can predict the selectivity or sensitivity to binocular disparity(5-9). We used two-photon calcium imaging to sample the response to monocular and binocular visual stimuli from nearly every adjacent neuron in a small region of the cat visual cortex, area 18. Here we show that local circuits for ocular dominance always have smooth and graded transitions from one apparently monocular functional domain to an adjacent binocular region. Most unexpectedly, we discovered a new map in the cat visual cortex that had a precise functional micro-architecture for binocular disparity selectivity. At the level of single cells, ocular dominance was unrelated to binocular disparity selectivity or sensitivity. When the local maps for ocular dominance and binocular disparity both had measurable gradients at a given cortical site, the two gradient directions were orthogonal to each other. Together, these results indicate that, from the perspective of the spiking activity of individual neurons, ocular dominance cannot predict binocular disparity tuning. However, the precise local arrangement of ocular dominance and binocular disparity maps provide new clues regarding how monocular and binocular depth cues may be combined and decoded.	[Kara, Prakash; Boyd, Jamie D.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina	Kara, P (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	kara@musc.edu			NIH; Whitehall; Dana Foundations; NATIONAL EYE INSTITUTE [R01EY017925] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall; Dana Foundations; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank B. Cumming and N. Swindale for discussions. We thank B. Shi, Z. Shen, Z. Lu and J. Schnellmann for comments on the manuscript. This work was supported by grants from the NIH, Whitehall and Dana Foundations to P. K.	Anzai A, 1997, P NATL ACAD SCI USA, V94, P5438, DOI 10.1073/pnas.94.10.5438; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BONHOEFFER T, 1995, EUR J NEUROSCI, V7, P1973, DOI 10.1111/j.1460-9568.1995.tb00720.x; Chen G, 2008, NEURON, V58, P442, DOI 10.1016/j.neuron.2008.02.032; Chino YM, 1997, J NEUROSCI, V17, P296, DOI 10.1523/JNEUROSCI.17-01-00296.1997; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; FREEMAN RD, 1992, J NEUROSCI, V12, P4721; GARDNER JC, 1986, EXP BRAIN RES, V64, P505, DOI 10.1007/BF00340488; Haefner RM, 2008, NEURON, V57, P147, DOI 10.1016/j.neuron.2007.10.042; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; Maruko I, 2008, J NEUROPHYSIOL, V100, P2486, DOI 10.1152/jn.90397.2008; MITCHELL DE, 2004, VISUAL NEUROSCIENCES, P189; OBERMAYER K, 1992, PHYS REV A, V45, P7568, DOI 10.1103/PhysRevA.45.7568; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Parker A., 2003, BLINK EYE VISION SPA; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; ROSSEL S, 1983, NATURE, V302, P821, DOI 10.1038/302821a0; SHIMOJO S, 1988, NATURE, V333, P265, DOI 10.1038/333265a0; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011	30	81	81	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 2	2009	458	7238					627	U93		10.1038/nature07721	http://dx.doi.org/10.1038/nature07721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19158677	Green Accepted			2022-12-24	WOS:000264796200040
J	Lee, P; Lee, DJ; Chan, C; Chen, SW; Ch'en, I; Jamora, C				Lee, Pedro; Lee, Dai-Jen; Chan, Carol; Chen, Shih-Wei; Ch'en, Irene; Jamora, Colin			Dynamic expression of epidermal caspase 8 simulates a wound healing response	NATURE			English	Article							INFLAMMATORY SKIN-DISEASE; NF-KAPPA-B; STEM-CELLS; INNATE IMMUNITY; CUTTING EDGE; INTERLEUKIN-1-ALPHA; KERATINOCYTES; HOMEOSTASIS; ACTIVATION; CONTRIBUTE	Tissue homeostasis and regeneration are regulated by an intricate balance of seemingly competing processes-proliferation versus differentiation, and cell death versus survival(1). Here we demonstrate that the loss of epidermal caspase 8, an important mediator of apoptosis(2), recapitulates several phases of a wound healing response in the mouse. The epidermal hyperplasia in the caspase 8 null skin is the culmination of signals exchanged between epidermal keratinocytes, dermal fibroblasts and leukocytic cells. This reciprocal interaction is initiated by the paracrine signalling of interleukin 1 alpha (IL1 alpha), which activates both skin stem cell proliferation and cutaneous inflammation. The non-canonical secretion of IL1a is induced by a p38-MAPK-mediated upregulation of NALP3 (also known as NLRP3), leading to inflammasome assembly and caspase 1 activation. Notably, the increased proliferation of basal keratinocytes is counterbalanced by the growth arrest of suprabasal keratinocytes in the stratified epidermis by IL1 alpha-dependent NF kappa B signalling. Altogether, our findings illustrate how the loss of caspase 8 can affect more than programmed cell death to alter the local microenvironment and elicit processes common to wound repair and many neoplastic skin disorders.	[Lee, Pedro; Lee, Dai-Jen; Chan, Carol; Chen, Shih-Wei; Jamora, Colin] Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Ch'en, Irene] Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Jamora, Colin] Dept Med Dermatol, La Jolla, CA 92093 USA		Jamora, C (corresponding author), Div Biol Sci, Sect Cell & Dev Biol, Nat Sci Bldg,Room 6311,9500 Gilman Dr,MC 0380, La Jolla, CA 92093 USA.	cjamora@ucsd.edu			National Institutes of Health (NIAMS) [5R01AR053185-03]; American Skin Association; Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053185] Funding Source: NIH RePORTER	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Skin Association; Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Hedrick, W. Havran, B. Yu, D. Witherden, A. Hoffmann, D. Stachura and members of the Jamora laboratory for providing reagents and helpful discussions. This work was supported by grants from the National Institutes of Health (NIAMS grant number 5R01AR053185-03) and the American Skin Association, and a Career Award from the Dermatology Foundation.	Al-Mashat HA, 2006, DIABETES, V55, P487, DOI 10.2337/diabetes.55.02.06.db05-1201; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Anderson JP, 2004, GENE, V338, P25, DOI 10.1016/j.gene.2004.05.002; Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Faustin B, 2008, TRENDS CELL BIOL, V18, P4, DOI 10.1016/j.tcb.2007.10.004; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; HAUSER C, 1986, J IMMUNOL, V136, P3317; Hobbs RM, 2003, J BIOL CHEM, V278, P19798, DOI 10.1074/jbc.M300513200; Hobbs RM, 2004, J INVEST DERMATOL, V123, P503, DOI 10.1111/j.0022-202X.2004.23225.x; HOHL D, 1991, J BIOL CHEM, V266, P6626; Ichinohe M, 2007, BIOCHEM BIOPH RES CO, V356, P912, DOI 10.1016/j.bbrc.2007.03.082; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Johansen C, 2007, J INVEST DERMATOL, V127, P2857, DOI 10.1038/sj.jid.5700922; Kaufman CK, 2000, J CELL BIOL, V149, P999, DOI 10.1083/jcb.149.5.999; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; Murphy JE, 2003, J IMMUNOL, V170, P5697, DOI 10.4049/jimmunol.170.11.5697; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Yamanaka K, 2000, J IMMUNOL, V165, P997, DOI 10.4049/jimmunol.165.2.997	30	115	124	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					519	U7		10.1038/nature07687	http://dx.doi.org/10.1038/nature07687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19204729	Green Accepted			2022-12-24	WOS:000264532400047
J	Montes-Hugo, M; Doney, SC; Ducklow, HW; Fraser, W; Martinson, D; Stammerjohn, SE; Schofield, O				Montes-Hugo, Martin; Doney, Scott C.; Ducklow, Hugh W.; Fraser, William; Martinson, Douglas; Stammerjohn, Sharon E.; Schofield, Oscar			Recent Changes in Phytoplankton Communities Associated with Rapid Regional Climate Change Along the Western Antarctic Peninsula	SCIENCE			English	Article							SEA-ICE EXTENT; DISTRIBUTIONS; CHLOROPHYLL; VARIABILITY; ECOSYSTEMS; SEDIMENTS; RETREAT; SHELF; OCEAN; KRILL	The climate of the western shelf of the Antarctic Peninsula (WAP) is undergoing a transition from a cold-dry polar-type climate to a warm-humid sub-Antarctic-type climate. Using three decades of satellite and field data, we document that ocean biological productivity, inferred from chlorophyll a concentration (Chl a), has significantly changed along the WAP shelf. Summertime surface Chl a (summer integrated Chl a similar to 63% of annually integrated Chl a) declined by 12% along the WAP over the past 30 years, with the largest decreases equatorward of 63 S and with substantial increases in Chl a occurring farther south. The latitudinal variation in Chl a trends reflects shifting patterns of ice cover, cloud formation, and windiness affecting water-column mixing. Regional changes in phytoplankton coincide with observed changes in krill (Euphausia superba) and penguin populations.	[Montes-Hugo, Martin; Schofield, Oscar] Rutgers State Univ, Sch Biol & Environm Sci, Inst Marine & Coastal Sci, Coastal Ocean Observat Lab, New Brunswick, NJ 08901 USA; [Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Ducklow, Hugh W.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Fraser, William] Polar Oceans Res Grp, Sheridan, MT 59749 USA; [Martinson, Douglas] Lamont Doherty Earth Inst, Palisades, NY 10964 USA; [Stammerjohn, Sharon E.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	Rutgers State University New Brunswick; Woods Hole Oceanographic Institution; Marine Biological Laboratory - Woods Hole; University of California System; University of California Santa Cruz	Montes-Hugo, M (corresponding author), Rutgers State Univ, Sch Biol & Environm Sci, Inst Marine & Coastal Sci, Coastal Ocean Observat Lab, New Brunswick, NJ 08901 USA.	montes@marine.rutgers.edu	Doney, Scott C/F-9247-2010; Schofield, Oscar/H-4169-2018	Doney, Scott C/0000-0002-3683-2437; STAMMERJOHN, SHARON/0000-0002-1697-8244; Schofield, Oscar/0000-0003-2359-4131	NSF Office of Polar Programs [0217282]; Virginia Institute of Marine Science [0823101]; Marine Biological Laboratory	NSF Office of Polar Programs(National Science Foundation (NSF)); Virginia Institute of Marine Science; Marine Biological Laboratory	This research is part of the Palmer Antarctica Long-Term Ecological Research (LTER) project (http://pal.lternet.edu). It was supported by NSF Office of Polar Programs grants 0217282 to H.W.D. and the Virginia Institute of Marine Science and 0823101 to H.W.D. at the Marine Biological Laboratory.	Barcena MA, 2002, DEEP-SEA RES PT II, V49, P935, DOI 10.1016/S0967-0645(01)00132-1; Bentley MJ, 2005, GEOLOGY, V33, P173, DOI 10.1130/G21203.1; BURKHOLDER PR, 1965, LIMNOL OCEANOGR, V57, P437; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; DOMACK EW, 1996, ANTARCTIC RES SERIES, V70; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Dunbar RB, 1998, J GEOPHYS RES-OCEANS, V103, P30741, DOI 10.1029/1998JC900001; Fabres J, 2000, HOLOCENE, V10, P703, DOI 10.1191/09596830094953; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Garibotti IA, 2003, MAR ECOL PROG SER, V261, P21, DOI 10.3354/meps261021; Gregg WW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014689; Jin X, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002532; Knox G.A., 2006, BIOL SO OCEAN, DOI 10.1201/9781420005134; Leventer A, 1996, GEOL SOC AM BULL, V108, P1626, DOI 10.1130/0016-7606(1996)108<1626:PCOYIT>2.3.CO;2; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Marrari M, 2008, DEEP-SEA RES PT II, V55, P377, DOI 10.1016/j.dsr2.2007.11.011; MITCHELL G, 1991, DEEP-SEA RES, V38, P981; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; Pritchard HD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000597; Pudsey CJ, 2001, GEOLOGY, V29, P787, DOI 10.1130/0091-7613(2001)029<0787:FSOASI>2.0.CO;2; Smith RC, 2008, DEEP-SEA RES PT II, V55, P1949, DOI 10.1016/j.dsr2.2008.04.027; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Smith RC, 2001, ANN GLACIOL-SER, V33, P493, DOI 10.3189/172756401781818662; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; THOMPSON LG, 1994, ANN GLACIOL, V20, P420, DOI 10.3189/172756494794587438; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Vernet M, 2008, DEEP-SEA RES PT II, V55, P2068, DOI 10.1016/j.dsr2.2008.05.021	28	475	486	7	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1470	1473		10.1126/science.1164533	http://dx.doi.org/10.1126/science.1164533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286554				2022-12-24	WOS:000264101700039
J	Schiff, GD; Galanter, WL				Schiff, Gordon D.; Galanter, William L.			Promoting More Conservative Prescribing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DRUG; TRIAL; CARE		[Schiff, Gordon D.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gen Med,Ctr Patient Safety Res & Practice, Boston, MA 02120 USA; [Galanter, William L.] Univ Illinois, Dept Med, Chicago, IL USA; [Galanter, William L.] Univ Illinois, Dept Pharm Practice, Chicago, IL USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Schiff, GD (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gen Med,Ctr Patient Safety Res & Practice, 1620 Tremont,3rd Floor, Boston, MA 02120 USA.	gschiff@partners.org	Callahan, Charles D/L-1641-2013	Galanter, William/0000-0001-7811-5391	AHRQ [5U18HS016973-03, 5U18HS016973-04] Funding Source: Federal RePORTER; AHRQ HHS [U18HS016973] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016973] Funding Source: NIH RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Association of American Medical Colleges, 2008, IND FUND MED ED REP; Association of American Medical Colleges, 2008, CONT ISS MED ED SAF; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Jones OAH, 2004, CRIT REV TOXICOL, V34, P335, DOI 10.1080/10408440490464697; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Macht D I, 1994, Osler Libr Newsl, P1; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Schiff GD, 2003, ARCH INTERN MED, V163, P893, DOI 10.1001/archinte.163.8.893; Sigurgceirsson B, 2002, ARCH DERMATOL, V138, P353, DOI 10.1001/archderm.138.3.353; Waxman HA, 2005, NEW ENGL J MED, V352, P2576, DOI 10.1056/NEJMp058136; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823	14	35	36	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					865	867		10.1001/jama.2009.195	http://dx.doi.org/10.1001/jama.2009.195			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244196				2022-12-24	WOS:000263609900030
J	Bonetta, L				Bonetta, Laura			RNA-Based Therapeutics: Ready for Delivery?	CELL			English	Editorial Material								Delivery of RNA-based therapeutics to specific tissues for treating a variety of diseases faces many hurdles. But with several clinical trials and a slew of studies in animal models underway, the future of RNA-based therapeutics seems bright.											0	46	50	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					581	584		10.1016/j.cell.2009.02.010	http://dx.doi.org/10.1016/j.cell.2009.02.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239878	Bronze			2022-12-24	WOS:000263688200008
J	Greenhalgh, T				Greenhalgh, Trisha			Patient and public involvement in chronic illness: beyond the expert patient	BRITISH MEDICAL JOURNAL			English	Editorial Material							SELF-MANAGEMENT; CHRONIC DISEASE; EDUCATION-PROGRAMS; HEALTH-CARE; PEOPLE		UCL, London N19 5LW, England	University of London; University College London	Greenhalgh, T (corresponding author), UCL, London N19 5LW, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				Bate P, 2004, QUAL SAF HEALTH CARE, V13, P62, DOI 10.1136/qshc.2003.006965; Baum F. E., 2007, NEW PUBLIC HLTH; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Clarke J, 2005, CRIT SOC POLICY, V25, P447, DOI 10.1177/0261018305057024; Dieterich A, 2007, PATIENT EDUC COUNS, V67, P279, DOI 10.1016/j.pec.2007.03.017; Donaldson L, 2003, BRIT MED J, V326, P1279, DOI 10.1136/bmj.326.7402.1279; Fisher EB, 2005, AM J PUBLIC HEALTH, V95, P1523, DOI 10.2105/AJPH.2005.066084; Friere P., 1974, ED CRITICAL CONSCIOU; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Greenhalgh T, 2005, BRIT MED J, V330, P628, DOI 10.1136/bmj.330.7492.628; Griffiths C, 2007, BMJ-BRIT MED J, V334, P1254, DOI 10.1136/bmj.39227.698785.47; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Kralik D, 2004, J CLIN NURS, V13, P259, DOI 10.1046/j.1365-2702.2003.00826.x; Levy Jennifer M, 2007, Anthropol Med, V14, P55, DOI 10.1080/13648470601106343; Mol Annemarie, 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Newbould J, 2006, CHRONIC ILLN, V2, P249, DOI 10.1179/174592006X157508; O'Donnell CA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-75; OMI S, 2007, PEOPLE CTR HLTH CARE; Osborne RH, 2008, NAT CLIN PRACT RHEUM, V4, P224, DOI 10.1038/ncprheum0765; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; St John of God Health Care, 2019, OUR VIS; WANLESS D, 2004, SECURING PUBLIC HLTH; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; WHO, 1997, JAK DECL LEAD HLTH P	24	85	85	1	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2009	338								b49	10.1136/bmj.b49	http://dx.doi.org/10.1136/bmj.b49			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417CE	19223339	Green Submitted			2022-12-24	WOS:000264051900027
J	McGirk, J				McGirk, Jan			Gaza's health and humanitarian situation remains fragile	LANCET			English	Editorial Material																			0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					531	531		10.1016/S0140-6736(09)60182-3	http://dx.doi.org/10.1016/S0140-6736(09)60182-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19230075				2022-12-24	WOS:000263333600012
J	Sanchez-Garcia, I				Sanchez-Garcia, Isidro			The Crossroads of Oncogenesis and Metastasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER		[Sanchez-Garcia, Isidro] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Sanchez-Garcia, I (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain.		SANCHEZ-GARCIA, ISIDRO/A-5631-2019; 2009, Secribsal/A-1266-2012	SANCHEZ-GARCIA, ISIDRO/0000-0001-6989-9905				Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2008, NATURE, V454, P794, DOI 10.1038/nature07196	6	43	44	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					297	299		10.1056/NEJMcibr0808031	http://dx.doi.org/10.1056/NEJMcibr0808031			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394GR	19144947				2022-12-24	WOS:000262434500016
J	Grocott, MPW; Martin, DS; Levett, DZH; McMorrow, R; Windsor, J; Montgomery, HE				Grocott, Michael P. W.; Martin, Daniel S.; Levett, Denny Z. H.; McMorrow, Roger; Windsor, Jeremy; Montgomery, Hugh E.		Caudwell Xtreme Everest Res Grp	Arterial Blood Gases and Oxygen Content in Climbers on Mount Everest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALTITUDE PULMONARY-EDEMA; SIMULATED ALTITUDE; EXTREME ALTITUDE; SUPPLEMENTAL OXYGEN; MT EVEREST; SEA-LEVEL; EXERCISE; EXCHANGE; HUMANS; HYPOXIA	Background The level of environmental hypobaric hypoxia that affects climbers at the summit of Mount Everest ( 8848 m [ 29,029 ft]) is close to the limit of tolerance by humans. We performed direct field measurements of arterial blood gases in climbers breathing ambient air on Mount Everest. Methods We obtained samples of arterial blood from 10 climbers during their ascent to and descent from the summit of Mount Everest. The partial pressures of arterial oxygen ( PaO2) and carbon dioxide ( PaCO2), pH, and hemoglobin and lactate concentrations were measured. The arterial oxygen saturation ( SaO(2)), bicarbonate concentration, base excess, and alveolar - arterial oxygen difference were calculated. Results PaO2 fell with increasing altitude, whereas SaO(2) was relatively stable. The hemoglobin concentration increased such that the oxygen content of arterial blood was maintained at or above sea- level values until the climbers reached an elevation of 7100 m ( 23,294 ft). In four samples taken at 8400 m ( 27,559 ft) - at which altitude the barometric pressure was 272 mm Hg ( 36.3 kPa) - the mean PaO2 in subjects breathing ambient air was 24.6 mm Hg ( 3.28 kPa), with a range of 19.1 to 29.5 mm Hg ( 2.55 to 3.93 kPa). The mean PaCO2 was 13.3 mm Hg ( 1.77 kPa), with a range of 10.3 to 15.7 mm Hg ( 1.37 to 2.09 kPa). At 8400 m, the mean arterial oxygen content was 26% lower than it was at 7100 m ( 145.8 ml per liter as compared with 197.1 ml per liter). The mean calculated alveolar - arterial oxygen difference was 5.4 mm Hg ( 0.72 kPa). Conclusions The elevated alveolar - arterial oxygen difference that is seen in subjects who are in conditions of extreme hypoxia may represent a degree of subclinical high- altitude pulmonary edema or a functional limitation in pulmonary diffusion.	[Grocott, Michael P. W.; Martin, Daniel S.; Levett, Denny Z. H.; McMorrow, Roger; Windsor, Jeremy; Montgomery, Hugh E.] UCL, Inst Human Hlth & Performance, Ctr Altitude Space & Extreme Environm Med, London N19 5LW, England	University of London; University College London	Grocott, MPW (corresponding author), UCL, Inst Human Hlth & Performance, Ctr Altitude Space & Extreme Environm Med, 1st Fl,Charterhouse Bldg,Archway Campus,Highgate, London N19 5LW, England.	mike.grocott@ucl.ac.uk	o'dwyer, michael/D-6561-2012; Levett, Denny/D-2239-2017; Levett, Denny Zelda Hope/AAY-4627-2021; Mythen, Michael G/G-8682-2011; Edwards, Lindsay M/B-3727-2010; Murray, Andrew/B-3130-2010; Cooke, Debbie/D-6605-2011; Levett, Denny/F-4474-2011; Grocott, Michael/C-4394-2008; Martin, Daniel S/F-7997-2010; Montgomery, Hugh/L-1229-2019; Montgomery, Hugh/C-2592-2008	Levett, Denny/0000-0002-8418-1675; Levett, Denny Zelda Hope/0000-0002-8418-1675; Murray, Andrew/0000-0002-0929-9315; Levett, Denny/0000-0002-8418-1675; Grocott, Michael/0000-0002-9484-7581; Montgomery, Hugh/0000-0001-8797-5019; Richardson, Alan/0000-0001-8931-2518; O'Dwyer, Michael J/0000-0003-4038-5745; Martin, Daniel/0000-0001-6220-8235	BOC Medical (now part of Linde Gas Therapeutics); Eli Lilly; London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland; United Kingdom Intensive Care Foundation; Sir Halley Stewart Trust; Fellow of the Association of Anaesthetists of Great Britain and Ireland; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres; Siemens	BOC Medical (now part of Linde Gas Therapeutics); Eli Lilly(Eli Lilly); London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland; United Kingdom Intensive Care Foundation; Sir Halley Stewart Trust; Fellow of the Association of Anaesthetists of Great Britain and Ireland; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); Siemens(Siemens AG)	Supported by Mr. John Caudwell, BOC Medical (now part of Linde Gas Therapeutics), Eli Lilly, the London Clinic, Smiths Medical, Deltex Medical, and the Rolex Foundation (unrestricted grants), the Association of Anaesthetists of Great Britain and Ireland, the United Kingdom Intensive Care Foundation, and the Sir Halley Stewart Trust. Dr. Martin is a Critical Care Scholar of the London Clinic, and Dr. Levett is a Fellow of the Association of Anaesthetists of Great Britain and Ireland. Some of this work was undertaken at University College London Hospital-University College London Comprehensive Biomedical Research Centre, which received a proportion of funding from the United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. Caudwell Xtreme Everest is a research project coordinated by the Centre for Altitude, Space, and Extreme Environment Medicine, University College London. Membership, roles, and responsibilities of the Caudwell Xtreme Everest Research Group can be found at www. caudwell-xtreme-everest.co.uk/team.; Dr. Grocott reports receiving lecture fees from Eli Lilly and BOC Medical and grant support from BOC Medical, Eli Lilly, and Smiths Medical; Dr. Martin, lecture fees from Siemens; and Dr. McMorrow, grant support from Smiths Medical. No other potential conflict of interest relevant to this article was reported.; We thank the staff of Siemens, in particular Robert Mayall and Steve Carey, for their continual support to us in carrying out these measurements; Pasang Tenzing Sherpa for carrying the samples from the Balcony to Camp 2 in less than 2 hours; the Caudwell Xtreme Everest volunteers who trekked to the Everest base camp; and Tom Hornbein, Erik Swenson, Monty Mythen, and Mervyn Singer for their advice during the preparation of the manuscript.	BARTSCH P, 1987, J APPL PHYSIOL, V63, P752, DOI 10.1152/jappl.1987.63.2.752; Catron Thomas F, 2006, BMC Physiol, V6, P3, DOI 10.1186/1472-6793-6-3; CERRETELLI P, 1976, J APPL PHYSIOL, V40, P658, DOI 10.1152/jappl.1976.40.5.658; Cerretelli P, 2003, EUR J APPL PHYSIOL, V90, P431, DOI 10.1007/s00421-003-0928-x; EHRMEYER S, 1997, C25A NCCLS, V12; ERNSTING J, 1988, AVIATION MED, P46; GARRIDO E, 1995, EUR J APPL PHYSIOL O, V70, P477, DOI 10.1007/BF00634375; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5142; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5921; HAMMOND MD, 1986, J APPL PHYSIOL, V61, P1749, DOI 10.1152/jappl.1986.61.5.1749; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; HORNBEIN TF, 1989, NEW ENGL J MED, V321, P1714, DOI 10.1056/NEJM198912213212505; HOUSTON CS, 1987, J APPL PHYSIOL, V63, P877, DOI 10.1152/jappl.1987.63.2.877; Huey RB, 2000, JAMA-J AM MED ASSOC, V284, P181, DOI 10.1001/jama.284.2.181-a; HUEY RB, 2000, JAMA-J AM MED ASSOC, V284, P2999; JACKSON RM, 1985, CHEST, V88, P900, DOI 10.1378/chest.88.6.900; KRONENBERG RS, 1971, J CLIN INVEST, V50, P827, DOI 10.1172/JCI106554; Lindholm P, 2006, UNDERSEA HYPERBAR M, V33, P463; Messner R., 1979, EVEREST EXPEDITION U, V1st Edn; Proffitt F, 2005, SCIENCE, V308, P1541, DOI 10.1126/science.308.5728.1541; REEVES JT, 1969, J APPL PHYSIOL, V27, P658, DOI 10.1152/jappl.1969.27.5.658; REGARD M, 1989, NEUROLOGY, V39, P210, DOI 10.1212/WNL.39.2.210; Richalet JP, 1999, ADV EXP MED BIOL, V474, P297; Scherrer U, 1996, NEW ENGL J MED, V334, P624, DOI 10.1056/NEJM199603073341003; SCHOENE RB, 1984, J APPL PHYSIOL, V56, P1478, DOI 10.1152/jappl.1984.56.6.1478; SMITH CA, 2001, HIGH ALTITUDE, P139; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; TORREBUENO JR, 1985, J APPL PHYSIOL, V58, P989, DOI 10.1152/jappl.1985.58.3.989; WAGNER PD, 1986, J APPL PHYSIOL, V61, P260, DOI 10.1152/jappl.1986.61.1.260; WAGNER PD, 1987, J APPL PHYSIOL, V63, P2348, DOI 10.1152/jappl.1987.63.6.2348; WEST JB, 1983, J APPL PHYSIOL, V55, P688, DOI 10.1152/jappl.1983.55.3.688; WEST JB, 1983, J APPL PHYSIOL, V55, P678, DOI 10.1152/jappl.1983.55.3.678; WEST JB, 1983, J APPL PHYSIOL, V54, P1188, DOI 10.1152/jappl.1983.54.5.1188; Windsor JS, 2007, AVIAT SPACE ENVIR MD, V78, P426	36	287	301	0	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					140	149		10.1056/NEJMoa0801581	http://dx.doi.org/10.1056/NEJMoa0801581			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391UG	19129527	Green Published			2022-12-24	WOS:000262258300007
J	Tateishi, K; Okada, Y; Kallin, EM; Zhang, Y				Tateishi, Keisuke; Okada, Yuki; Kallin, Eric M.; Zhang, Yi			Role of Jhdm2a in regulating metabolic gene expression and obesity resistance	NATURE			English	Article							ACTIVATED RECEPTOR-ALPHA; MITOCHONDRIAL UNCOUPLING PROTEIN; ENERGY-BALANCE; BETA; THERMOGENESIS; TRANSCRIPTION; METHYLATION; ELEMENTS; MUSCLE; MICE	Recent studies indicate that the methylation state of histones can be dynamically regulated by histone methyltransferases and demethylases(1,2). The H3K9-specific demethylase Jhdm2a (also known as Jmjd1a and Kdm3a) has an important role in nuclear hormone receptor-mediated gene activation and male germ cell development(3,4). Through disruption of the Jhdm2a gene in mice, here we demonstrate that Jhdm2a is critically important in regulating the expression of metabolic genes. The loss of Jhdm2a function results in obesity and hyperlipidemia in mice. We provide evidence that the loss of Jhdm2a function disrupts beta-adrenergic-stimulated glycerol release and oxygen consumption in brown fat, and decreases fat oxidation and glycerol release in skeletal muscles. We show that Jhdm2a expression is induced by beta-adrenergic stimulation, and that Jhdm2a directly regulates peroxisome proliferator-activated receptor alpha (Ppara) and Ucp1 expression. Furthermore, we demonstrate that beta-adrenergic activation-induced binding of Jhdm2a to the PPAR responsive element (PPRE) of the Ucp1 gene not only decreases levels of H3K9me2 (dimethylation of lysine 9 of histone H3) at the PPRE, but also facilitates the recruitment of Ppar gamma and Rxr alpha and their co-activators Pgc1 alpha (also known as Ppargc1a), CBP/p300 (Crebbp) and Src1 (Ncoa1) to the PPRE. Our studies thus demonstrate an essential role for Jhdm2a in regulating metabolic gene expression and normal weight control in mice.	[Tateishi, Keisuke; Okada, Yuki; Kallin, Eric M.; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Tateishi, Keisuke; Okada, Yuki; Kallin, Eric M.; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811	UNC Clinical Nutrition Research Unit [DK56350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	UNC Clinical Nutrition Research Unit; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. M. Spiegelman for the HIB1B cells, L. Xia for construction of the targeting vector, K. E. Gardner for critical reading of the manuscript, D. Pump and K. Hua (UNC Clinical Nutrition Research Unit, DK56350) for calorimetry and MRI, and N. Takahashi for helpful comments. Y.Z. is an investigator of the Howard Hughes Medical Institute.	Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bedu E, 2007, BIOCHEM BIOPH RES CO, V357, P877, DOI 10.1016/j.bbrc.2007.04.003; CASSARDDOULCIER AM, 1993, MOL ENDOCRINOL, V7, P497, DOI 10.1210/me.7.4.497; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lomax MA, 2007, ENDOCRINOLOGY, V148, P461, DOI 10.1210/en.2006-0918; Lopez D, 2003, MOL CELL ENDOCRINOL, V205, P169, DOI 10.1016/S0303-7207(02)00300-3; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; ROSS SR, 1992, P NATL ACAD SCI USA, V89, P7561, DOI 10.1073/pnas.89.16.7561; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Wang ZY, 2006, CELL METAB, V3, P111, DOI 10.1016/j.cmet.2006.01.002; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	23	331	356	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					757	761		10.1038/nature07777	http://dx.doi.org/10.1038/nature07777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19194461	Green Published, Green Accepted			2022-12-24	WOS:000265193600040
J	Ghosh, B; Urban, MW				Ghosh, Biswajit; Urban, Marek W.			Self-Repairing Oxetane-Substituted Chitosan Polyurethane Networks	SCIENCE			English	Article								Polyurethanes have many properties that qualify them as high-performance polymeric materials, but they still suffer from mechanical damage. We report the development of polyurethane networks that exhibit self-repairing characteristics upon exposure to ultraviolet light. The network consists of an oxetane-substituted chitosan precursor incorporated into a two-component polyurethane. Upon mechanical damage of the network, four-member oxetane rings open to create two reactive ends. When exposed to ultraviolet light, chitosan chain scission occurs, which forms crosslinks with the reactive oxetane ends, thus repairing the network. These materials are capable of repairing themselves in less than an hour and can be used in many coatings applications, ranging from transportation to packaging or fashion and biomedical industries.	[Ghosh, Biswajit; Urban, Marek W.] Univ So Mississippi, Sch Polymers & High Performance Mat, Shelby F Thames Polymer Sci Res Ctr, Hattiesburg, MS 39406 USA	University of Southern Mississippi	Urban, MW (corresponding author), Univ So Mississippi, Sch Polymers & High Performance Mat, Shelby F Thames Polymer Sci Res Ctr, Hattiesburg, MS 39406 USA.	marek.urban@usm.edu			National Science Foundation MRSEC [DMR 0213883]; Materials Research Instrumentation (MRI) program [DMR 0215873]; Mississippi Division of Marine Resources	National Science Foundation MRSEC(National Science Foundation (NSF)); Materials Research Instrumentation (MRI) program; Mississippi Division of Marine Resources	These studies were primarily supported by the National Science Foundation MRSEC under DMR 0213883 and the Materials Research Instrumentation (MRI) Program under DMR 0215873. We thank the Mississippi Division of Marine Resources for partial support.	Brown EN, 2004, J MATER SCI, V39, P1703, DOI 10.1023/B:JMSC.0000016173.73733.dc; Brown EN, 2003, J MICROENCAPSUL, V20, P719, DOI 10.1080/0265204031000154160; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Gheneim R, 2002, MACROMOLECULES, V35, P7246, DOI 10.1021/ma020343c; Henry G, 2003, LANCET, V361, P574, DOI 10.1016/S0140-6736(03)12510-X; Kessler MR, 2003, COMPOS PART A-APPL S, V34, P743, DOI 10.1016/S1359-835X(03)00138-6; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Mann KG, 2006, BLOOD CELL MOL DIS, V36, P108, DOI 10.1016/j.bcmd.2005.12.034; Nagaya K, 2006, JSME INT J C-MECH SY, V49, P379, DOI 10.1299/jsmec.49.379; Otts DB, 2002, LANGMUIR, V18, P6473, DOI 10.1021/la025684y; Pang JWC, 2005, COMPOS PART A-APPL S, V36, P183, DOI 10.1016/j.compositesa.2004.06.016; Pang JWC, 2005, COMPOS SCI TECHNOL, V65, P1791, DOI 10.1016/j.compscitech.2005.03.008; Paris R, 2007, PLANT PHYSIOL BIOCH, V45, P80, DOI 10.1016/j.plaphy.2006.12.001; Sonntag P, 2004, NAT MATER, V3, P311, DOI 10.1038/nmat1113; Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934; Trask RS, 2007, BIOINSPIR BIOMIM, V2, pP1, DOI 10.1088/1748-3182/2/1/P01; Urban MW., 1996, ATTENUATED TOTAL REF; Wan Y, 2004, J POLYM SCI POL PHYS, V42, P1379, DOI 10.1002/polb.20007	20	553	576	17	683	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1458	1460		10.1126/science.1167391	http://dx.doi.org/10.1126/science.1167391			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286550				2022-12-24	WOS:000264101700035
J	Tsuji, M; Komatsu, N; Kawamoto, S; Suzuki, K; Kanagawa, O; Honjo, T; Hori, S; Fagarasan, S				Tsuji, Masayuki; Komatsu, Noriko; Kawamoto, Shimpei; Suzuki, Keiichiro; Kanagawa, Osami; Honjo, Tasuku; Hori, Shohei; Fagarasan, Sidonia			Preferential Generation of Follicular B Helper T Cells from Foxp3(+) T Cells in Gut Peyer's Patches	SCIENCE			English	Article							GERMINAL CENTER FORMATION; CXC CHEMOKINE RECEPTOR-5; RETINOIC-ACID; DENDRITIC CELLS; LAMINA PROPRIA; DIFFERENTIATION; INTERLEUKIN-21; POPULATION; ACTIVATION; EXPRESSION	Most of the immunoglobulin A (IgA) in the gut is generated by B cells in the germinal centers of Peyer's patches through a process that requires the presence of CD4(+) follicular B helper T (T-FH) cells. The nature of these T-FH cells in Peyer's patches has been elusive. Here, we demonstrate that suppressive Foxp3(+)CD4(+) T cells can differentiate into T-FH cells in mouse Peyer's patches. The conversion of Foxp3(+) T cells into T-FH cells requires the loss of Foxp3 expression and subsequent interaction with B cells. Thus, environmental cues present in gut Peyer's patches promote the selective differentiation of distinct helper T cell subsets, such as T-FH cells.	[Komatsu, Noriko; Hori, Shohei] RIKEN, Res Unit Immune Homeostasis, Yokohama, Kanagawa 2300045, Japan; [Tsuji, Masayuki; Kawamoto, Shimpei; Suzuki, Keiichiro; Fagarasan, Sidonia] RIKEN, Lab Mucosal Immun, Yokohama, Kanagawa 2300045, Japan; [Kanagawa, Osami] RIKEN, Res Ctr Allergy & Immunol, Lab Autoimmune Regulat, Yokohama, Kanagawa 2300045, Japan; [Kawamoto, Shimpei; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dep Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; RIKEN; RIKEN; Kyoto University	Hori, S (corresponding author), RIKEN, Res Unit Immune Homeostasis, Yokohama 1-7-22, Yokohama, Kanagawa 2300045, Japan.	shohei@rcai.riken.jp; sidonia-f@rcai.riken.jp	Hori, Shohei/O-6163-2019; Honjo, Tasuku/N-4470-2016; Fagarasan, Sidonia/A-5258-2016	Hori, Shohei/0000-0001-8770-4593; Fagarasan, Sidonia/0000-0003-2086-6402	Uehara Memorial Foundation;  [Grants-in-Aid]	Uehara Memorial Foundation(Uehara Memorial Foundation); 	We thank Y. Doi, A. Yagisawa, T. Miyao, and H. Fujimoto for technical assistance; B. Malissen and K. Itoh for mice; D. Littman and A. Coutinho for inspiring discussions; I. Taniuchi for discussion and for critically reading of the manuscript. This work is supported in part by Grants-in-Aid for Scientific Research in Priority Areas (S.F., S.H.) and for Young Scientists (A) (S.H.), and by the Uehara Memorial Foundation (S.H.). S.H. and S.F. contributed as senior authors.	Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Fagarasan S, 2006, CURR TOP MICROBIOL, V308, P137; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fillatreau S, 2003, J EXP MED, V197, P195, DOI 10.1084/jem.20021750; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Macpherson AJ, 2006, CURR TOP MICROBIOL, V308, P117; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wen L, 1996, J EXP MED, V183, P2271, DOI 10.1084/jem.183.5.2271; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007	29	455	477	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1488	1492		10.1126/science.1169152	http://dx.doi.org/10.1126/science.1169152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286559				2022-12-24	WOS:000264101700044
J	Garvin, J; Buick, R; Anbar, AD; Arnold, GL; Kaufman, AJ				Garvin, Jessica; Buick, Roger; Anbar, Ariel D.; Arnold, Gail L.; Kaufman, Alan J.			Isotopic Evidence for an Aerobic Nitrogen Cycle in the Latest Archean	SCIENCE			English	Article							FIXATION; PARTICLES; EVOLUTION; SINKING; RECORD; OCEAN	The nitrogen cycle provides essential nutrients to the biosphere, but its antiquity in modern form is unclear. In a drill core though homogeneous organic- rich shale in the 2.5- billion- year- old Mount McRae Shale, Australia, nitrogen isotope values vary from +1.0 to +7.5 per mil (parts per thousand) and back to +2.5 parts per thousand over similar to 30 meters. These changes evidently record a transient departure from a largely anaerobic to an aerobic nitrogen cycle complete with nitrification and denitrification. Complementary molybdenum abundance and sulfur isotopic values suggest that nitrification occurred in response to a small increase in surface- ocean oxygenation. These data imply that nitrifying and denitrifying microbes had already evolved by the late Archean and were present before oxygen first began to accumulate in the atmosphere.	[Garvin, Jessica; Buick, Roger] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Garvin, Jessica; Buick, Roger] Univ Washington, Astrobiol Program, Seattle, WA 98195 USA; [Anbar, Ariel D.; Arnold, Gail L.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.; Arnold, Gail L.] Arizona State Univ, Sch Earth & Space Sci, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Kaufman, Alan J.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University System of Maryland; University of Maryland College Park	Buick, R (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	buick@ess.washington.edu	Arnold, Gail L/A-5572-2010	Arnold, Gail L/0000-0001-9631-9830; Buick, Roger/0000-0003-0139-1659	NASA Astrobiology Drilling Program; NSF Geobiology and Low Temperature Geochemistry	NASA Astrobiology Drilling Program(National Aeronautics & Space Administration (NASA)); NSF Geobiology and Low Temperature Geochemistry(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank L. C. Bonser, J.S.R. Dunlop, A. H. Hickman, M. van Kranendonk, the Geological Survey of Western Australia, P. van Loenhout, and Mount Magnet Drilling for assistance with core recovery; the NASA Astrobiology Drilling Program and NSF Geobiology and Low Temperature Geochemistry for funding; and H. Knoll, J. Farquhar, R. E. Summons, and T. W. Lyons for advice.	Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; ALTABET MA, 1988, DEEP-SEA RES, V35, P535, DOI 10.1016/0198-0149(88)90130-6; Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Beaumont V, 1999, PRECAMBRIAN RES, V96, P63, DOI 10.1016/S0301-9268(99)00005-4; BEBOUT GE, 1992, GEOCHIM COSMOCHIM AC, V56, P2839, DOI 10.1016/0016-7037(92)90363-N; Berman-Frank I., 2005, BIOGEOSCIENCES DISCU, V2005, P261, DOI DOI 10.5194/BGD-2-261-2005; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4289, DOI 10.1016/S0016-7037(03)00208-4; Fogel M.L., 1993, ORGANIC GEOCHEMISTRY, P73, DOI DOI 10.1007/978-1-4615-2890-6_3; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Jia YF, 2004, TERRA NOVA, V16, P102, DOI 10.1111/j.1365-3121.2004.00535.x; Kaplan WA., 1983, NITROGEN MARINE ENV, P139; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Navarro-Gonzalez R, 2001, NATURE, V412, P61, DOI 10.1038/35083537; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PINTI DL, 2005, LECT ASTROBIOLOGY, V1; Rasmussen B, 2005, GEOLOGY, V33, P725, DOI 10.1130/G21616.1; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; SHEN Y, 2005, ARCHEAN GEODYNAMIC E, P309; Sigman D.M., 2001, ENCY OCEAN SCI, P1884, DOI DOI 10.1006/RWOS.2001.0172; SUMMERS DP, 1993, NATURE, V365, P630, DOI 10.1038/365630a0; Thunell RC, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI [10.1029/2002GB002028, 10.1029/2003GB002185]; WADA E., 1990, NITROGEN SEA FORMS A; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; ZERKLE AL, 2006, GEOBIOLOGY, V4, P285	27	163	172	5	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1045	1048		10.1126/science.1165675	http://dx.doi.org/10.1126/science.1165675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229033				2022-12-24	WOS:000263478400037
J	Kim, JB; Sebastiano, V; Wu, GM; Arauzo-Bravo, MJ; Sasse, P; Gentile, L; Ko, K; Ruau, D; Ehrich, M; van den Boom, D; Meyer, J; Hubner, K; Bernemann, C; Ortmeier, C; Zenke, M; Fleischmann, BK; Zaehres, H; Scholer, HR				Kim, Jeong Beom; Sebastiano, Vittorio; Wu, Guangming; Arauzo-Bravo, Marcos J.; Sasse, Philipp; Gentile, Luca; Ko, Kinarm; Ruau, David; Ehrich, Mathias; van den Boom, Dirk; Meyer, Johann; Huebner, Karin; Bernemann, Christof; Ortmeier, Claudia; Zenke, Martin; Fleischmann, Bernd K.; Zaehres, Holm; Schoeler, Hans R.			Oct4-Induced Pluripotency in Adult Neural Stem Cells	CELL			English	Article							PRIMORDIAL GERM-CELLS; HUMAN FIBROBLASTS; SELF-RENEWAL; MOUSE; GENERATION; EXPRESSION; DERIVATION; INDUCTION; OCT4; MYC	The four transcription factors Oct4, Sox2, Klf4, and c-Myc can induce pluripotency in mouse and human fibroblasts. We previously described direct reprogramming of adult mouse neural stem cells (NSCs) by Oct4 and either Klf4 or c-Myc. NSCs endogenously express Sox2, c-Myc, and Klf4 as well as several intermediate reprogramming markers. Here we report that exogenous expression of the germline-specific transcription factor Oct4 is sufficient to generate pluripotent stem cells from adult mouse NSCs. These one-factor induced pluripotent stem cells (1F iPS) are similar to embryonic stem cells in vitro and in vivo. Not only can these cells can be efficiently differentiated into NSCs, cardiomyocytes, and germ cells in vitro, but they are also capable of teratoma formation and germline transmission in vivo. Our results demonstrate that Oct4 is required and sufficient to directly reprogram NSCs to pluripotency.	[Kim, Jeong Beom; Sebastiano, Vittorio; Wu, Guangming; Arauzo-Bravo, Marcos J.; Gentile, Luca; Ko, Kinarm; Huebner, Karin; Bernemann, Christof; Ortmeier, Claudia; Zaehres, Holm; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, NRW, Germany; [Sasse, Philipp; Fleischmann, Bernd K.] Univ Bonn, Inst Physiol 1, Life & Brain Ctr, D-53105 Bonn, NRW, Germany; [Ruau, David; Zenke, Martin] RWTH Aachen Univ Med Sch, Inst Biomed Engn, Dept Cell Biol, D-52074 Aachen, NRW, Germany; [Ehrich, Mathias; van den Boom, Dirk] SEQUENOM Inc, San Diego, CA 92121 USA; [Meyer, Johann] Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany	Max Planck Society; University of Bonn; RWTH Aachen University; Sequenom; Hannover Medical School	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, NRW, Germany.	office@mpi-muenster.mpg.de	Gentile, Luca/E-4908-2019; Marcos, Arauzo-Bravo/A-1706-2011; Gentile, Luca/L-4473-2014; Sasse, Philipp/G-9866-2013; , HS/AAB-4434-2019	Gentile, Luca/0000-0002-7393-7502; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Sasse, Philipp/0000-0002-8502-9472; , HS/0000-0003-2643-5136; Wu, Guangming/0000-0003-1923-7609; Ehrich, Mathias/0000-0001-8415-0310; Kim, Jeong Beom/0000-0001-6230-8826	Deutsche Forschungsgemeinschaft DFG [SPP1356, SPP1109]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	We thank J. Muller-Keuker and S. Kolsch for critically reviewing the manuscript, M. Stehling for FACS analysis, B. Schafer for histology, C. Becker, B. Kratz, and B. Denecke for probe processing and array hybridization, F. Holst for technical help, and Dr. Toshio Kitamura for the pMX retroviral vector. The project was funded in part by a grant from the Deutsche Forschungsgemeinschaft DFG within the Priority Programme SPP 1356 "Pluripotency and Cellular Reprogramming.'' The microarray analyses were funded in part by a grant from the Deutsche Forschungsgemeinschaft DFG SPP1109. M. E. and D. v. d. B. are employees of SEQUENOM, Inc.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fu LJ, 2008, STEM CELLS DEV, V17, P1109, DOI 10.1089/scd.2008.0068; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Hubner K, 2006, METHOD ENZYMOL, V418, P284, DOI 10.1016/S0076-6879(06)18017-9; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kolossov E, 1998, J CELL BIOL, V143, P2045, DOI 10.1083/jcb.143.7.2045; Lee J, 2003, CANCER RES, V63, P8877; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McLaren A., 1981, GERM CELLS SOMA NEW; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Weismann A., 1892, KEIMPLASMA THEORIE V; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2006, METHOD ENZYMOL, V420, P49, DOI 10.1016/S0076-6879(06)20004-1	41	737	896	2	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					411	419		10.1016/j.cell.2009.01.023	http://dx.doi.org/10.1016/j.cell.2009.01.023			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203577	Bronze			2022-12-24	WOS:000263120600012
J	Bach, PB				Bach, Peter B.			Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHEMOTHERAPY; CARE; PRESCRIPTION; PAYMENT; REIMBURSEMENT; INTERFERON; HEALTH; COSTS; PRICE		[Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, 1275 York Ave, New York, NY 10021 USA.							Bach PB, 2006, NEW ENGL J MED, V354, P2312, DOI 10.1056/NEJMp068108; Bach PB, 2005, NEW ENGL J MED, V353, P2733, DOI 10.1056/NEJMp058249; Bach PB, 2005, J CLIN ONCOL, V23, P9041, DOI 10.1200/JCO.2005.03.6111; Bach PB, 2007, J CLIN ONCOL, V25, P187, DOI 10.1200/JCO.2006.08.6116; Berenson Alex, 2006, N Y Times Web, pC2; Berenson Robert A., 2006, MEDICARE PROSPECTIVE; Bowman J, 2006, HEALTH AFFAIR, V25, P1240, DOI 10.1377/hlthaff.25.5.1240; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; *CTR MED MED SERV, 2007, PROP DEC MEM ER STIM; Culliton BJ, 2008, HEALTH AFFAIR, V27, pW41, DOI 10.1377/hlthaff.27.1.w41; *DEP HHS, 2004, MED REIMB LUPR; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; FLAHERTY T, 2007, HME NEWS        0625; Garber AM, 2007, NEW ENGL J MED, V357, P1575, DOI 10.1056/NEJMp078204; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; *HOUS REPR, 2008, MED COMP BIDD MED EQ; Jacobson M, 2006, HEALTH AFFAIR, V25, P437, DOI 10.1377/hlthaff.25.2.437; Kanavos P, 2003, HEALTH AFFAIR, V22, P16, DOI 10.1377/hlthaff.22.3.16; Lee TH, 2008, NEW ENGL J MED, V359, P333, DOI 10.1056/NEJMp0804261; LICHTENBERG FR, 2004, EXPANDING PHARM ARSE; LOHR KN, 1986, MED CARE, V24, pUS1; Meropol NJ, 2007, J CLIN ONCOL, V25, P180, DOI 10.1200/JCO.2006.09.6081; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; RUSSELL LB, 1989, NEW ENGL J MED, V320, P439, DOI 10.1056/NEJM198902163200706; Schneeweiss S, 2002, J AM GERIATR SOC, V50, P521, DOI 10.1046/j.1532-5415.2002.50120.x; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Schrag D, 2004, NEW ENGL J MED, V351, P317, DOI 10.1056/NEJMp048143; Schrag D, 2007, J CLIN ONCOL, V25, P233, DOI 10.1200/JCO.2006.09.2437; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; Weight CJ, 2008, CANCER-AM CANCER SOC, V112, P2195, DOI 10.1002/cncr.23421; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572; WITTES RE, 2004, WASHINGTON POST 0615, pA23	34	295	299	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					626	633		10.1056/NEJMhpr0807774	http://dx.doi.org/10.1056/NEJMhpr0807774			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402QS	19176475				2022-12-24	WOS:000263028800012
J	Bannard, O; Kraman, M; Fearon, DT				Bannard, Oliver; Kraman, Matthew; Fearon, Douglas T.			Secondary Replicative Function of CD8(+) T Cells That Had Developed an Effector Phenotype	SCIENCE			English	Article							MEMORY; DIFFERENTIATION; LYMPHOCYTES; EXPRESSION	Models of the differentiation of memory CD8+ T cells that replicate during secondary infections differ over whether such cells had acquired effector function during primary infections. We created a transgenic mouse line that permits mapping of the fate of granzyme B (gzmB)- expressing CD8(+) T cells and their progeny by indelibly marking them with enhanced yellow fluorescent protein ( EYFP). Virus- specific CD8(+) T cells express gzmB within the first 2 days of a primary response to infection with influenza, without impairment of continued primary clonal expansion. On secondary infection, virus- specific CD8(+) T cells that became EYFP+ during a primary infection clonally expand as well as all virus- specific CD8(+) T cells. Thus, CD8(+) T cells that have acquired an effector phenotype during primary infection may function as memory cells with replicative function.	[Bannard, Oliver; Kraman, Matthew; Fearon, Douglas T.] Univ Cambridge, Ctr Mrc, Wellcome Trust Immunol Unit, Dept Med, Cambridge CB2 2QH, England	University of Cambridge	Fearon, DT (corresponding author), Univ Cambridge, Ctr Mrc, Wellcome Trust Immunol Unit, Dept Med, Hills Rd, Cambridge CB2 2QH, England.	dtf1000@cam.ac.uk		Kraman, Matthew/0000-0002-5040-0067	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank D. Winton for ROSA26EYFP mice, B. Crombrugghe for the CreER<SUP>12</SUP> construct, G. Eberl for the recombineering shuttle vector, and P. Digard and E. Hutchinson for help with viruses. This work was funded by the Wellcome Trust.	Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; HANSON RD, 1991, J BIOL CHEM, V266, P24433; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jenkins MR, 2008, J IMMUNOL, V181, P3818, DOI 10.4049/jimmunol.181.6.3818; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	13	126	128	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					505	509		10.1126/science.1166831	http://dx.doi.org/10.1126/science.1166831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164749	Green Accepted			2022-12-24	WOS:000262587900043
J	de Ruijter, W; Westendorp, RGJ; Assendelft, WJJ; den Elzen, WPJ; de Craen, AJM; le Cessie, S; Gussekloo, J				de Ruijter, Wouter; Westendorp, Rudi G. J.; Assendelft, Willem J. J.; den Elzen, Wendy P. J.; de Craen, Anton J. M.; le Cessie, Saskia; Gussekloo, Jacobijn			Use of Framinghamrisk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; RISK-FACTORS; INFLAMMATORY MARKERS; PLASMA HOMOCYSTEINE; NATRIURETIC PEPTIDE; MULTIPLE BIOMARKERS; PRIMARY PREVENTION	Objectives To investigate the performance of classic risk factors, and of some new biomarkers, in predicting cardiovascular mortality in very old people from the general population with no history of cardiovascular disease. Design The Leiden 85-plus Study (1997-2004) is an observational prospective cohort study with 5 years of follow-up. Setting General population of the city of Leiden, the Netherlands. Participants Population based sample of participants aged 85 years (215 women and 87 men) with no history of cardiovascular disease; no other exclusion criteria. Main measurements Cause specific mortality was registered during follow-up. All classic risk factors included in the Framingham risk score (sex, systolic blood pressure, total and high density lipoprotein cholesterol, diabetes mellitus, smoking and electrocardiogram based left ventricular hypertrophy), as well as plasma concentrations of the new biomarkers homocysteine, folic acid, C reactive protein, and interleukin 6, were assessed at baseline. Results During follow-up, 108 of the 302 participants died; 32% (35/108) of deaths were from cardiovascular causes. Classic risk factors did not predict cardiovascular mortality when used in the Framingham risk score (area under receiver operating characteristic curve 0.53, 95% confidence interval 0.42 to 0.63) or in a newly calibrated model (0.53, 0.43 to 0.64). Of the new biomarkers studied, homocysteine had most predictive power (0.65, 0.55 to 0.75). Entering any additional risk factor or combination of factors into the homocysteine prediction model did not increase its discriminative power. Conclusions In very old people from the general population with no history of cardiovascular disease, concentrations of homocysteine alone can accurately identify those at high risk of cardiovascular mortality, whereas classic risk factors included in the Framingham risk score do not. These preliminary findings warrant validation in a separate cohort.	[Assendelft, Willem J. J.; den Elzen, Wendy P. J.; Gussekloo, Jacobijn] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, NL-2300 RA Leiden, Netherlands; [Westendorp, Rudi G. J.; de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriat, NL-2300 RA Leiden, Netherlands; [le Cessie, Saskia] Leiden Univ, Dept Med Stat, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	de Ruijter, W (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, PO Box 9600, NL-2300 RA Leiden, Netherlands.	w.de_ruijter@lumc.nl	Assendelft, W.J.J./H-8008-2014; le+Cessie, Saskia/HGC-8966-2022; de Ruijter, Wouter/GRF-3867-2022; assendelft, willem/AAW-1854-2021; Gussekloo, Jacobijn/ABE-3879-2021	Assendelft, W.J.J./0000-0002-2966-3778; assendelft, willem/0000-0002-2966-3778; Gussekloo, Jacobijn/0000-0001-7186-8278; le Cessie, Saskia/0000-0003-2154-4923; den Elzen, Wendy/0000-0002-6774-4077	Dutch Ministry of Health, Welfare and Sports	Dutch Ministry of Health, Welfare and Sports	The Leiden 85-plus Study was partly funded by an unrestricted grant from the Dutch Ministry of Health, Welfare and Sports. The funder played no role in study design, collection, analysis and interpretation of data, writing of the report, nor in the decision to submit the article for publication. Independence of researchers: All researchers were independent from the funder.	Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; Afilalo J, 2008, J AM COLL CARDIOL, V51, P37, DOI 10.1016/j.jacc.2007.06.063; Ali Robin, 2007, Am J Geriatr Pharmacother, V5, P52, DOI 10.1016/j.amjopharm.2007.03.008; Ammar KA, 2004, AM HEART J, V148, P277, DOI 10.1016/j.ahj.2004.03.019; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Andrawes WF, 2005, DRUG AGING, V22, P859, DOI 10.2165/00002512-200522100-00005; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; BEMMEL T, 2006, J HYPERTENS, V24, P287; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Boshuizen HC, 1998, BMJ-BRIT MED J, V316, P1780, DOI 10.1136/bmj.316.7147.1780; Bots ML, 1999, ARCH INTERN MED, V159, P38, DOI 10.1001/archinte.159.1.38; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Chobanian AV, 2007, NEW ENGL J MED, V357, P789, DOI 10.1056/NEJMcp071137; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; De Ruijter W, 2008, SCAND J PRIM HEALTH, V26, P147, DOI 10.1080/02813430802095812; de Ruijter W, 2007, J AM GERIATR SOC, V55, P872, DOI 10.1111/j.1532-5415.2007.01180.x; Dornbrook-Lavender KA, 2003, ANN PHARMACOTHER, V37, P1654, DOI 10.1345/aph.1D025; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; KAGAN A, 1962, FED PROC, V21, P52; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kannel William B., 1995, Am J Geriatr Cardiol, V4, P10; Kannel WB, 2006, AM J GERIATR CARDIOL, V15, P382, DOI 10.1111/j.1076-7460.2006.04397.x; Kannel William B, 2002, Am J Geriatr Cardiol, V11, P101, DOI 10.1111/j.1076-7460.2002.00995.x; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Kritchevsky SB, 2005, CARDIOVASC RES, V66, P265, DOI 10.1016/j.cardiores.2004.12.026; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; MCCULLY KS, 1969, AM J PATHOL, V56, P111; McDermott MM, 2007, JAMA-J AM MED ASSOC, V297, P1253, DOI 10.1001/jama.297.11.1253; MULROW CD, 1994, JAMA-J AM MED ASSOC, V272, P1932, DOI 10.1001/jama.272.24.1932; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Oates DJ, 2007, J AM GERIATR SOC, V55, P383, DOI 10.1111/j.1532-5415.2007.01069.x; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PRINEAS RJ, 1982, MINNESOTA CODE MAN; Raggi P, 2008, J AM COLL CARDIOL, V52, P17, DOI 10.1016/j.jacc.2008.04.004; Rastas S, 2006, J AM GERIATR SOC, V54, P912, DOI 10.1111/j.1532-5415.2006.00742.x; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rothenbacher D, 2006, ARCH INTERN MED, V166, P2455, DOI 10.1001/archinte.166.22.2455; Sattar N, 2006, CIRCULATION, V114, P143; Schmitt J, 2005, EUR CARDIOL REV, DOI 10.15420/ecr.2005.1w; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Strandberg TE, 2000, ARTERIOSCL THROM VAS, V20, P1057, DOI 10.1161/01.ATV.20.4.1057; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; van der Steeg WA, 2007, ANN INTERN MED, V146, P640, DOI 10.7326/0003-4819-146-9-200705010-00007; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; *WHO, 2006, INT CLASS DIS; Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	64	236	240	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2009	338								a3083	10.1136/bmj.a3083	http://dx.doi.org/10.1136/bmj.a3083			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AA	19131384	hybrid, Green Published			2022-12-24	WOS:000263193100021
J	Turanov, AA; Lobanov, AV; Fomenko, DE; Morrison, HG; Sogin, ML; Klobutcher, LA; Hatfield, DL; Gladyshev, VN				Turanov, Anton A.; Lobanov, Alexey V.; Fomenko, Dmitri E.; Morrison, Hilary G.; Sogin, Mitchell L.; Klobutcher, Lawrence A.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Genetic Code Supports Targeted Insertion of Two Amino Acids by One Codon	SCIENCE			English	Article							SEQUENCE ELEMENT; TRANSFER-RNA; EXPRESSION	Strict one- to- one correspondence between codons and amino acids is thought to be an essential feature of the genetic code. However, we report that one codon can code for two different amino acids with the choice of the inserted amino acid determined by a specific 3 ' untranslated region structure and location of the dual- function codon within the messenger RNA ( mRNA). We found that the codon UGA specifies insertion of selenocysteine and cysteine in the ciliate Euplotes crassus, that the dual use of this codon can occur even within the same gene, and that the structural arrangements of Euplotes mRNA preserve location- dependent dual function of UGA when expressed in mammalian cells. Thus, the genetic code supports the use of one codon to code for multiple amino acids.	[Turanov, Anton A.; Lobanov, Alexey V.; Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Turanov, Anton A.; Lobanov, Alexey V.; Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Morrison, Hilary G.; Sogin, Mitchell L.] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA; [Klobutcher, Lawrence A.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06032 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Marine Biological Laboratory - Woods Hole; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013; Sogin, Mitchell/AAE-7186-2019	Morrison, Hilary/0000-0003-0281-326X; Gladyshev, Vadim/0000-0002-0372-7016; Klobutcher, Lawrence/0000-0001-9485-3482	NIH [GM061603, GM065204, AI058054]; NSF [0343813]; Intramural Research Program; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM061603, R01GM065204] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Intramural Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Hammar for constructing the EST library and I. Sorokina (Midwest Bio Services) for protein sequencing. This work was supported by NIH GM061603 and GM065204 to V.N.G., AI058054 to M.L.S., NSF 0343813 to L.A.K., and the Intramural Research Program, National Cancer Institute, NIH, to D.L.H. Sequences for tRNA and selenoprotein genes have been deposited in the GenBank database under accession numbers FJ440148 to FJ440159.	Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Atkins JF, 2007, NATURE, V448, P1004, DOI 10.1038/4481004a; Berry MJ, 2002, METHOD ENZYMOL, V347, P17; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; MEYER F, 1991, P NATL ACAD SCI USA, V88, P3758, DOI 10.1073/pnas.88.9.3758; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Suzuki T, 1997, EMBO J, V16, P1122, DOI 10.1093/emboj/16.5.1122	10	83	93	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					259	261		10.1126/science.1164748	http://dx.doi.org/10.1126/science.1164748			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131629	Green Accepted, Green Submitted			2022-12-24	WOS:000262290600040
J	Vasconcelos, C; McKenzie, JA				Vasconcelos, Crisogono; McKenzie, Judith A.			GEOCHEMISTRY The Descent of Minerals	SCIENCE			English	Editorial Material							MICROBIAL MATS		[Vasconcelos, Crisogono; McKenzie, Judith A.] ETH, Inst Geol, Geomicrobiol Lab, CH-8092 Zurich, Switzerland	ETH Zurich	Vasconcelos, C (corresponding author), ETH, Inst Geol, Geomicrobiol Lab, CH-8092 Zurich, Switzerland.	cris.vasconcelos@erdw.ethz.ch						Hazen RM, 2008, AM MINERAL, V93, P1693, DOI 10.2138/am.2008.2955; Konhauser KO, 2005, GEOBIOLOGY, V3, P167, DOI 10.1111/j.1472-4669.2005.00055.x; SEMIKHATOV MA, 1979, CAN J EARTH SCI, V16, P992, DOI 10.1139/e79-088; Vasconcelos C, 2006, SEDIMENT GEOL, V185, P175, DOI 10.1016/j.sedgeo.2005.12.022; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016	5	6	6	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					218	219		10.1126/science.1168807	http://dx.doi.org/10.1126/science.1168807			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131619				2022-12-24	WOS:000262290600025
J	Husseini, A; Abu-Rmeileh, NME; Mikki, N; Ramahi, TM; Abu Ghosh, H; Barghuthi, N; Khalili, M; Bjertness, E; Holmboe-Ottesen, G; Jervell, J				Husseini, Abdullatif; Abu-Rmeileh, Niveen M. E.; Mikki, Nahed; Ramahi, Tarik M.; Abu Ghosh, Heidar; Barghuthi, Nadim; Khalili, Mohammad; Bjertness, Espen; Holmboe-Ottesen, Gerd; Jervell, Jak			Health in the Occupied Palestinian Territory 3 Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory	LANCET			English	Article							CORONARY-HEART-DISEASE; PREVENTING CHRONIC DISEASES; UNIVERSITY-STUDENTS; MEDITERRANEAN DIET; METABOLIC SYNDROME; PUBLIC-HEALTH; RISK-FACTORS; OBESITY; ADOLESCENTS; UNDERNUTRITION	Heart disease, cerebrovascular disease, and cancer are the major causes of morbidity and mortality in the occupied Palestinian territory, resulting in a high direct cost of care, high indirect cost in loss of production, and much societal stress. The rates of the classic risk factors for atherosclerotic disease-namely, hypertension, diabetes mellitus, tobacco smoking, and dyslipidaemia-are high and similar to those in neighbouring countries. The urbanisation and continuing nutritional change from a healthy Mediterranean diet to an increasingly western-style diet is associated with reduced activity, obesity and a loss of the protective effect of the traditional diet. Rates of cancer seem to be lower than those in neighbouring countries, with the leading causes of death being lung cancer in Palestinian men and breast cancer in women. The response of society and the health-care system to this epidemic is inadequate. A large proportion of health-care expenditure is on expensive curative care outside the area. Effective comprehensive prevention programmes should be implemented, and the health-care system should be redesigned to address these diseases.	[Husseini, Abdullatif; Abu-Rmeileh, Niveen M. E.; Mikki, Nahed] Birzeit Univ, Inst Community & Publ Hlth, POB 14, Birzeit, Israel; [Mikki, Nahed; Bjertness, Espen; Holmboe-Ottesen, Gerd; Jervell, Jak] Univ Oslo, Inst Gen Practice & Community Med, Oslo, Norway; [Ramahi, Tarik M.] Yale Univ, Council Middle E Studies, New Haven, CT USA; [Abu Ghosh, Heidar] Palestinian Med Relief Soc, Chron Dis Ctr, Ramallah, Palestine; [Barghuthi, Nadim] Minist Hlth, Dept Noncommunicable dis, Ramallah, Palestine; [Khalili, Mohammad] UN, Relief & Works Agcy, Jerusalem, Israel; [Bjertness, Espen] Tibet Univ, Coll Med, Lhasa, Peoples R China	Birzeit University; University of Oslo; Yale University; Tibet University	Husseini, A (corresponding author), Birzeit Univ, Inst Community & Publ Hlth, POB 14, Birzeit, Israel.	abdullatif@birzeit.edu	Abu-Rmeileh, Niveen ME/H-7135-2019; Husseini, Abdullatif/E-8377-2015	Husseini, Abdullatif/0000-0001-8767-5956	Norwegian Programme for Development, Research and Education	Norwegian Programme for Development, Research and Education	We thank the Lancet Palestine Steering Group (lain Chalmers, Rita Giacaman, Jennifer Leaning, Harry Shannon, and Huda Zurayk) for reading, discussing, and commenting on several drafts of this report; Graham Watt, and Karl Sabbagh for their valuable comments and support; Medical Aid for Palestinians UK, University of Oslo, Institute for General Practice and Community Medicine, and the Norwegian Programme for Development, Research and Education for their financial contributions that made the workshops related to this Series possible; and the reviewers ofthis report, whose comments improved this final draft substantially for their support and valuable advice.	Abdul-Rahim HF, 2003, INT J OBESITY, V27, P140, DOI 10.1038/sj.ijo.0802160; Abdul-Rahim HF, 2001, DIABETES CARE, V24, P275, DOI 10.2337/diacare.24.2.275; ABDULRAHIM HF, 2002, U OSLO, P35; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abudayya A, 2007, NUTR RES, V27, P762, DOI 10.1016/j.nutres.2007.09.017; ABURMEILEH NME, 2008, PREV CHRONIC DIS, P5; Al Sabbah H, 2007, PUBLIC HEALTH NUTR, V10, P739, DOI 10.1017/S1368980007665501; Al-Isa AN, 2004, EUR J CLIN NUTR, V58, P1273, DOI 10.1038/sj.ejcn.1601961; Al-Rukban MO, 2003, SAUDI MED J, V24, P27; Al-Saeed WY, 2007, OBES REV, V8, P93, DOI 10.1111/j.1467-789X.2006.00287.x; Al-Sendi AM, 2003, EUR J CLIN NUTR, V57, P471, DOI 10.1038/sj.ejcn.1601560; [Anonymous], 2005, PREV CHRON DIS VIT I; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Batniji R, 2008, LANCET, V372, P805, DOI 10.1016/S0140-6736(08)61334-3; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; BENDEL M, 2005, BREAST CANC GAZA STR, P1; Berenson GS, 2005, NEUROBIOL AGING, V26, P303, DOI 10.1016/j.neurobiolaging.2004.05.009; Britt K, 2007, ENDOCR-RELAT CANCER, V14, P907, DOI 10.1677/ERC-07-0137; *CENTR BUR STAT, HLTH SURV 2003 2004; *DEP HLTH, 1946, ANN HLTH REP 1945; Dominguez LJ, 2020, ENCYCLOPEDIA OF BIOMEDICAL GERONTOLOGY, VOL 2, P400, DOI 10.1016/B978-0-12-801238-3.62178-5; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; FARRAKH A, GLOBAL BURDEN CANC; Freedman L. S., CANC INCIDENCE 4 MEM; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Giacaman R., 1994, HLTH CONDITIONS SERV; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; Hamdan M, 2003, HEALTH POLICY, V64, P243, DOI 10.1016/S0168-8510(03)00004-6; Husseini A, 2000, DIABETIC MED, V17, P746, DOI 10.1046/j.1464-5491.2000.00355.x; HUSSEINI A, 2002, THESIS U OSLO PALEST, P32; Jabara R, 2007, ISRAEL MED ASSOC J, V9, P316; Jackson M, 2002, PUBLIC HEALTH NUTR, V5, P281, DOI 10.1079/PHN2002262; *JORD MED ASS, 2008, MED HUM RES PAL; JUBRAN J, 2005, HLTH SEGREGATION H I; KALUSKI DN, 2008, PUBLIC HEALTH NUTR, P1; Kandela P, 2000, LANCET, V356, P1175, DOI 10.1016/S0140-6736(05)72871-3; Kark JD, 2000, LANCET, V356, P1410, DOI 10.1016/S0140-6736(00)02849-X; Kark JD, 2006, INT J EPIDEMIOL, V35, P448, DOI 10.1093/ije/dyl012; Khatib O, 2004, East Mediterr Health J, V10, P778; Kligler IJ, 1932, ANN AM ACAD POLIT SS, V164, P167, DOI 10.1177/000271623216400119; Kulwicki A, 2003, PUBLIC HEALTH NURS, V20, P177, DOI 10.1046/j.0737-1209.2003.20304.x; La Vecchia C, 2004, PUBLIC HEALTH NUTR, V7, P965, DOI 10.1079/PHN2004562; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MASTERMAN EW, 1920, HYGIENE DIS PALESTIN; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; Maziak W, 2004, ANN EPIDEMIOL, V14, P646, DOI 10.1016/j.annepidem.2003.11.003; Maziak W, 2004, INT J TUBERC LUNG D, V8, P882; *MIN HLTH, 2004, QUAL IMPR PROGR PAL; *MIN HLTH, 2002, HLTH STAT PAL 2001; *MIN HLTH, 2005, HLTH STAT PAL 2004; *MIN HLTH, 2006, HLTH STAT PAL 2005; *MIN HLTH, 2002, CANC 1995 2000; *MIN HLTH, 2003, HLTH STAT PAL 2002; *MIN HLTH, 2004, HLTH STAT PAL 2003; *MIN HLTH, 2001, CANC INC PAL 1998 19; *MIN HLTH, NAT STRAT HLTH PLAN; Palestinian Central Bureau of Statistics, 2007, PAL FAM HLTH SURV 20; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; RIONDA Z, 2000, BURDEN DIS W BANK GA; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Salameh Shaden, 2008, J Cardiometab Syndr, V3, P26, DOI 10.1111/j.1559-4572.2008.07315.x; SALHAB A, 2005, PALESTINIAN NATL CAN; Sawaya AL, 2003, NUTR REV, V61, P168, DOI 10.1301/nr.2003.may.168-175; Shamseddine A, 2004, ANN EPIDEMIOL, V14, P663, DOI 10.1016/j.annepidem.2003.12.002; Stabouli S, 2005, J PEDIATR-US, V147, P651, DOI 10.1016/j.jpeds.2005.06.008; Stene LCM, 1999, EUR J CLIN NUTR, V53, P953, DOI 10.1038/sj.ejcn.1600878; Stene LCM, 2001, EUR J CLIN NUTR, V55, P805, DOI 10.1038/sj.ejcn.1601230; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; *UN REL WORKS AG, 2007, ANN REP DEP HLTH; *UN REL WORKS AG H, 2005, TECHN INSTR MAN PROT; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; *WFP FAO, 2007, COMPR FOOD SEC VUL A; WHO, 2008, ACC HLTH SERV PAL PE; *WHO EMRO, COUNTR PROF WHO E ME; *WHO EMRO, REG DAT NONC DIS THE; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252; BTSELEM SEPARATION B	80	96	97	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1041	1049		10.1016/S0140-6736(09)60109-4	http://dx.doi.org/10.1016/S0140-6736(09)60109-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19268350				2022-12-24	WOS:000264398200032
J	Zhang, Q; Li, YL; Tsien, RW				Zhang, Qi; Li, Yulong; Tsien, Richard W.			The Dynamic Control of Kiss-And-Run and Vesicular Reuse Probed with Single Nanoparticles	SCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ADRENAL CHROMAFFIN CELLS; READILY RELEASABLE POOL; HIPPOCAMPAL SYNAPSES; SYNAPTIC VESICLES; QUANTUM DOTS; FUSION PORE; TRANSMITTER RELEASE; EXOCYTOSIS; NEURONS	Vesicular secretion of neurotransmitter is essential for neuronal communication. Kiss-and-run is a mode of membrane fusion and retrieval without the full collapse of the vesicle into the plasma membrane and de novo regeneration. The importance of kiss-and-run during efficient neurotransmission has remained in doubt. We developed an approach for loading individual synaptic vesicles with single quantum dots. Their size and pH-dependent photoluminescence change allowed us to distinguish kiss-and-run from full-collapse fusion and to track single vesicles through multiple rounds of kiss-and-run and reuse, without perturbing vesicle cycling. Kiss-and-run dominated at the beginning of stimulus trains, reflecting the preference of vesicles with high release probability. Its incidence was increased by rapid firing, a response appropriate to shape the kinetics of neurotransmission during a wide range of firing patterns.	[Zhang, Qi; Li, Yulong; Tsien, Richard W.] Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Tsien, RW (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	rwtsien@stanford.edu		Li, Yulong/0000-0002-9166-9919	Grass Foundation; National Institute of Mental Health; Burnett Family Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA025143] Funding Source: NIH RePORTER	Grass Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Burnett Family Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. C. Harata for help with high-frequency imaging and data analysis, R. J. Reimer and members of the Tsien lab for comments, J. W. Mulholland and J. J. Perrino for help with imaging, and X. Gao and M. Bruchez for consultation on quantum dots. Supported by grants from the Grass Foundation (Q.Z.), the National Institute of Mental Health, and the Burnett Family Fund (R.W.T.).	Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; An S, 2004, CURR OPIN NEUROBIOL, V14, P522, DOI 10.1016/j.conb.2004.08.008; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Chan SA, 2001, J PHYSIOL-LONDON, V537, P871; Chen X, 2008, J NEUROSCI, V28, P1894, DOI 10.1523/JNEUROSCI.4518-07.2008; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Franks KM, 2003, J NEUROSCI, V23, P3186; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gao XH, 2002, J BIOMED OPT, V7, P532, DOI 10.1117/1.1506706; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Zhang Q, 2007, P NATL ACAD SCI USA, V104, P17843, DOI 10.1073/pnas.0706906104; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	39	252	257	5	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1448	1453		10.1126/science.1167373	http://dx.doi.org/10.1126/science.1167373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19213879	Green Accepted			2022-12-24	WOS:000264101700032
J	Quirke, P; Steele, R; Monson, J; Grieve, R; Khanna, S; Couture, J; O'Callaghan, C; Myint, AS; Bessell, E; Thompson, LC; Parmar, M; Stephens, RJ; Sebag-Montefiore, D				Quirke, Phil; Steele, Robert; Monson, John; Grieve, Robert; Khanna, Subhash; Couture, Jean; O'Callaghan, Chris; Myint, Arthur Sun; Bessell, Eric; Thompson, Lindsay C.; Parmar, Mahesh; Stephens, Richard J.; Sebag-Montefiore, David		MRC CR07 NCIC-CTG CO16 Trial; NCRI Colorectal Canc Study Grp	Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial	LANCET			English	Article							TOTAL MESORECTAL EXCISION; RESECTION MARGIN INVOLVEMENT; PREOPERATIVE RADIOTHERAPY; POSTOPERATIVE CHEMORADIOTHERAPY; ABDOMINOPERINEAL EXCISION; SURGICAL RESECTION; SURVIVAL; CARCINOMA; MULTICENTER; STOCKHOLM	Background Local recurrence rates in operable rectal cancer are improved by radiotherapy (with or without chemotherapy) and surgical techniques such as total mesorectal excision. However, the contributions of surgery and radiotherapy to outcomes are unclear. We assessed the effect of the involvement of the circumferential resection margin and the plane of surgery achieved. Methods In this prospective study, the plane of surgery achieved and the involvement of the circumferential resection margin were assessed by local pathologists, using a standard pathological protocol in 1156 patients with operable rectal cancer from the CR07 and NCIC-CTG CO16 trial, which compared short-course (5 days) preoperative radiotherapy and selective postoperative chemoradiotherapy, between March, 1998, and August, 2005. All analyses were by intention to treat. This trial is registered, number ISRCTN 28785842. Findings 128 patients (11%) had involvement of the circumferential resection margin, and the plane of surgery achieved was classified as good (mesorectal) in 604 (52%), intermediate (intramesorectal) in 398 (34%), and poor (muscularis propria plane) in 154 (13%). We found that both a negative circumferential resection margin and a superior plane of surgery achieved were associated with low local recurrence rates. Hazard ratio (HR) was 0 - 32 (95% CI 0.16-0.63, p=0.0011) with 3-year local recurrence rates of 6% (5-8%) and 17% (10-26%) for patients who were negative and positive for circumferential resection margin, respectively. For plane of surgery achieved, HRs for mesorectal and intramesorectal groups compared with the muscularis propria group were 0 - 32 (0.16-0.64) and 0.48 (0.25-0.93), respectively. At 3 years, the estimated local recurrence rates were 4% (3-6%) for mesorectal, 7% (5-11%) for intramesorectal, and 13% (8-21%) for muscularis propria groups. The benefit of short-course preoperative radiotherapy did not differ in the three plane of surgery groups (p=0.30 for trend). Patients in the short-course preoperative radiotherapy group who had a resection in the mesorectal plane had a 3-year local recurrence rate of only 1%. Interpretation In rectal cancer, the plane of surgery achieved is an important prognostic factor for local recurrence. Short-course preoperative radiotherapy reduced the rate of local recurrence for all three plane of surgery groups, almost abolishing local recurrence in short-course preoperative radiotherapy patients who had a resection in the mesorectal plane. The plane of surgery achieved should therefore be assessed and reported routinely. Funding Medical Research Council (UK) and the National Cancer Institute of Canada.	[Quirke, Phil] Univ Leeds, Leeds Inst Mol Med, St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Quirke, Phil] Univ Leeds, Leeds LS9 7TF, W Yorkshire, England; [Steele, Robert] Ninewells Hosp, Dundee DD1 9SY, Scotland; [Monson, John] Castle Hill Hosp, Kingston Upon Hull, N Humberside, England; [Grieve, Robert] Walsgrave Gen Hosp, Coventry CV2 2DY, W Midlands, England; [Khanna, Subhash] Leicester Royal Infirm, Leicester, Leics, England; [Couture, Jean; O'Callaghan, Chris] Natl Canc Inst Canada, Kingston, ON, Canada; [Myint, Arthur Sun] Clatterbridge Ctr Oncol, Wirral, Merseyside, England; [Bessell, Eric] City Hosp Nottingham, Nottingham, England; [Thompson, Lindsay C.; Parmar, Mahesh; Stephens, Richard J.] MRC, Clin Trial Unit, London, England	Saint James's University Hospital; University of Leeds; University of Leeds; University of Dundee; University of Hull; University of Leicester; Queens University - Canada; Canadian Cancer Trials Group; Clatterbridge Cancer Centre; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Medical Research Council Clinical Trials Unit	Quirke, P (corresponding author), Univ Leeds, Leeds Inst Mol Med, St James Univ Hosp, Wellcome Trust Brenner Bldg,Beckett St, Leeds LS9 7TF, W Yorkshire, England.	patpq@leeds.ac.uk	Quirke, Philip/AAI-1362-2019; Myint, Arthur Sun/AAO-7695-2020	Myint, Arthur Sun/0000-0001-5323-5696; Sebag-Montefiore, David/0000-0002-5978-9259; Quirke, Philip/0000-0002-3597-5444; Steele, Robert JC/0000-0003-4248-6785	Medical Research Council (MRC); Canadian Cancer Society; Yorkshire Cancer Research; Experimental Cancer Medicine Centre programme; Trial Management Group; Protocol Development Group; Independent Data Monitoring Committee; Trial Steering Committee; MRC [MC_U122861325] Funding Source: UKRI; Medical Research Council [MC_U122861325] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Yorkshire Cancer Research; Experimental Cancer Medicine Centre programme; Trial Management Group; Protocol Development Group; Independent Data Monitoring Committee; Trial Steering Committee; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Medical Research Council (MRC) and the Canadian Cancer Society for supporting this study; the Yorkshire Cancer Research and the Experimental Cancer Medicine Centre programme, ",Inch supported PQ; the Trial Management Group, other members of the Protocol Development Group, the Independent Data Monitoring Committee, the Trial Steering Committee, the staff at the MRC Clinical Trial Unit, arid the oncologists, surgeons, pathologists, research staff. arid all the patients who participated in this trial.	ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; Birbeck KF, 2002, ANN SURG, V235, P449, DOI 10.1097/00000658-200204000-00001; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO.2005.02.9017; Cedermark B, 1996, ANN SURG ONCOL, V3, P423; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; Dahlberg M, 2002, INT J RADIAT ONCOL, V54, P654, DOI 10.1016/S0360-3016(02)02880-8; Dexter SPL, 2001, GUT, V48, P667, DOI 10.1136/gut.48.5.667; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; HEALD RJ, 1986, LANCET, V1, P1479; HOHENBERGER W, 1997, RECTAL CANC SURG OPT, P353; Kapiteijn E, 2002, BRIT J SURG, V89, P1142, DOI 10.1046/j.1365-2168.2002.02196.x; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Marr R, 2005, ANN SURG, V242, P74, DOI 10.1097/01.sla.0000167926.60908.15; Martling A, 2005, BRIT J SURG, V92, P225, DOI 10.1002/bjs.4834; MCCALL JL, 1995, INT J COLORECTAL DIS, V10, P126, DOI 10.1007/BF00298532; Nagtegaal ID, 2005, J CLIN ONCOL, V23, P9257, DOI 10.1200/JCO.2005.02.9231; Nagtegaal ID, 2002, J CLIN ONCOL, V20, P1729, DOI 10.1200/JCO.2002.07.010; Nagtegaal ID, 2002, AM J SURG PATHOL, V26, P350, DOI 10.1097/00000478-200203000-00009; Pahlman L, 1997, NEW ENGL J MED, V336, P980; QUIRKE P, 1986, LANCET, V2, P996, DOI 10.1016/s0140-6736(86)92612-7; Quirke P, 2003, LANCET ONCOL, V4, P695, DOI 10.1016/S1470-2045(03)01248-8; QUIRKE P, 1997, RECTAL CANC SURG OPT, P63; SAGAR PM, 1993, BRIT J SURG, V80, P1386, DOI 10.1002/bjs.1800801109; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; West NP, 2008, LANCET ONCOL, V9, P857, DOI 10.1016/S1470-2045(08)70181-5; West NP, 2008, J CLIN ONCOL, V26, P3517, DOI 10.1200/JCO.2007.14.5961; Wibe A, 2002, BRIT J SURG, V89, P327, DOI 10.1046/j.0007-1323.2001.02024.x; Wibe A, 2002, DIS COLON RECTUM, V45, P857, DOI 10.1007/s10350-004-6317-7	33	709	738	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2009	373	9666					821	828		10.1016/S0140-6736(09)60485-2	http://dx.doi.org/10.1016/S0140-6736(09)60485-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416BT	19269520	Green Published			2022-12-24	WOS:000263980900032
J	Kozhimannil, KB; Pereira, MA; Harlow, BL				Kozhimannil, Katy Backes; Pereira, Mark A.; Harlow, Bernard L.			Association Between Diabetes and Perinatal Depression Among Low-Income Mothers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTPARTUM MOOD DISORDERS; ADMINISTRATIVE DATA; PSYCHIATRIC DIAGNOSES; POSTNATAL DEPRESSION; MAJOR DEPRESSION; PREGNANCY; WOMEN; PREVALENCE; RISK; MEDICAID	Context Perinatal depression affects at least 10% to 12% of new mothers, and diabetes complicates up to 9% of pregnancies. Prior research shows a higher rate of major depression among individuals with diabetes. Objective To examine the association between diabetes and depression during pregnancy and the postpartum period among a sample of low- income women. Design, Setting, and Patients Retrospective cohort study using data from New Jersey's Medicaid administrative claims database of 11 024 women who gave birth between July 1, 2004, and September 30, 2006, and who were continuously enrolled in Medicaid for 6 months prior to delivery and 1 year after giving birth. Main Outcome Measures Multivariate logistic regression was used to assess the association between prepregnancy diabetes or gestational diabetes and perinatal depression. Depression was defined as an International Classification of Diseases, Ninth Revision, diagnosis for depression or a prescription drug claim for an antidepressant medication, and diabetes was defined as having a diabetes diagnosis or filling a prescription for a diabetes medication. Both measures were assessed during the 6 months prior to and up to 1 year following delivery. Results In the sample of women who gave birth, 15.2% ( n= 100) with prepregnancy or gestational diabetes and 8.5% ( n= 886) without diabetes were depressed during pregnancy or postpartum. After adjusting for age, race, year of delivery, and gestational age at birth, women with diabetes compared with those without diabetes had nearly double the odds of experiencing depression during the perinatal period ( odds ratio, 1.85; 95% confidence interval, 1.45- 2.36). Women with diabetes and no prenatal indication of depression ( n= 62, 9.6%) had higher odds than their counterparts without diabetes ( n= 604, 5.9%) of receiving a postpartum depression diagnosis or taking an antidepressant medication in the year following delivery ( odds ratio, 1.69; 95% confidence interval, 1.27- 2.23). Conclusion Prepregnancy or gestational diabetes was independently associated with perinatal depression, including new onset of postpartum depression, in our sample of low-income new mothers.	[Pereira, Mark A.; Harlow, Bernard L.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Kozhimannil, Katy Backes] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Kozhimannil, Katy Backes] Harvard Pilgrim Hlth Care, Boston, MA USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Harlow, BL (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, 1300 S 2nd St,Ste 300, Minneapolis, MN 55454 USA.	harlow@umn.edu		Pereira, Mark/0000-0002-6704-5276; Harlow, Bernard/0000-0002-6735-8862	Fellowship in Pharmaceutical Policy Research at the Department of Ambulatory Care and Prevention, Harvard Medical School; Harvard University Dissertation Completion Grant; Harvard University PhD Program in Health Policy; Harvard Pilgrim Health Care Foundation	Fellowship in Pharmaceutical Policy Research at the Department of Ambulatory Care and Prevention, Harvard Medical School; Harvard University Dissertation Completion Grant; Harvard University PhD Program in Health Policy; Harvard Pilgrim Health Care Foundation	This study was supported by the Fellowship in Pharmaceutical Policy Research at the Department of Ambulatory Care and Prevention, Harvard Medical School; a Harvard University Dissertation Completion Grant; the Harvard University PhD Program in Health Policy; and the Harvard Pilgrim Health Care Foundation.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; American College of Obstetricians and Gynecologists, 2001, CLIN MAN GUID OBST G; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; [Anonymous], 2005, PERINATAL DEPRESSION; Brummelte S, 2006, HORM BEHAV, V50, P370, DOI 10.1016/j.yhbeh.2006.04.008; Busch AB, 2006, MED CARE, V44, P506, DOI 10.1097/01.mlr.0000215890.30756.b2; Chen TH, 2006, MED HYPOTHESES, V66, P820, DOI 10.1016/j.mehy.2005.09.032; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Feig DS, 2002, LANCET, V359, P1690, DOI 10.1016/S0140-6736(02)08599-9; Fergerson SS, 2002, AM J OBSTET GYNECOL, V186, P899, DOI 10.1067/mob.2002.123404; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gilmer T, 2001, MED CARE, V39, P1188, DOI 10.1097/00005650-200111000-00006; Golden SH, 2007, PSYCHOSOM MED, V69, P529, DOI 10.1097/PSY.0b013e3180f61c5c; GOTLIB IH, 1989, J CONSULT CLIN PSYCH, V57, P269, DOI 10.1037/0022-006X.57.2.269; HOBFOLL SE, 1995, J CONSULT CLIN PSYCH, V63, P445, DOI 10.1037/0022-006X.63.3.445; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; *KAIS COMM MED UN, 2007, NEW JERS US STAT MED; Kammerer M, 2006, ARCH WOMEN MENT HLTH, V9, P187, DOI 10.1007/s00737-006-0131-2; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Kressin NR, 2003, AM J PUBLIC HEALTH, V93, P1734, DOI 10.2105/AJPH.93.10.1734; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Mezey G, 2005, BJOG-INT J OBSTET GY, V112, P197, DOI 10.1111/j.1471-0528.2004.00307.x; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.1111/j.1467-8624.1996.tb01871.x; OHARA MW, 1991, J ABNORM PSYCHOL, V100, P63, DOI 10.1037/0021-843X.100.1.63; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Ritter C, 2000, HEALTH PSYCHOL, V19, P576, DOI 10.1037/0278-6133.19.6.576; SCHWARTZ AH, 1980, AM J PUBLIC HEALTH, V70, P406, DOI 10.2105/AJPH.70.4.406; SEGUIN L, 1995, OBSTET GYNECOL, V85, P583, DOI 10.1016/0029-7844(94)00449-N; Setse R, 2008, MATERN CHILD HLTH J, V12, P119, DOI 10.1007/s10995-007-0211-6; Spettell CM, 2003, HEALTH SERV RES, V38, P1081, DOI 10.1111/1475-6773.00164; STEIN A, 1991, BRIT J PSYCHIAT, V158, P46, DOI 10.1192/bjp.158.1.46; STOWE ZN, 1995, AM J OBSTET GYNECOL, V173, P639, DOI 10.1016/0002-9378(95)90296-1; Waldo DP, 2004, HEALTH CARE FINANC R, V26, P61; Walkup JT, 2000, ADM POLICY MENT HLTH, V27, P129, DOI 10.1023/A:1021308007343; Weech-Maldonado R, 2003, HEALTH SERV RES, V38, P789, DOI 10.1111/1475-6773.00147; Weinberg MK, 1998, J CLIN PSYCHIAT, V59, P53; Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089	44	124	130	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					842	847		10.1001/jama.2009.201	http://dx.doi.org/10.1001/jama.2009.201			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410WV	19244191				2022-12-24	WOS:000263609900025
J	Roberts, TL; Idris, A; Dunn, JA; Kelly, GM; Burnton, CM; Hodgson, S; Hardy, LL; Garceau, V; Sweet, MJ; Ross, IL; Hume, DA; Stacey, KJ				Roberts, Tara L.; Idris, Adi; Dunn, Jasmyn A.; Kelly, Greg M.; Burnton, Carol M.; Hodgson, Samantha; Hardy, Lani L.; Garceau, Valerie; Sweet, Matthew J.; Ross, Ian L.; Hume, David A.; Stacey, Katryn J.			HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA	SCIENCE			English	Article							CELL-DEATH; INTERFERON; GENE; RECOGNITION; SIGNALS; FAMILY	The mammalian innate immune system is activated by foreign nucleic acids. Detection of double- stranded DNA ( dsDNA) in the cytoplasm triggers characteristic antiviral responses and macrophage cell death. Cytoplasmic dsDNA rapidly activated caspase 3 and caspase 1 in bone marrow- derived macrophages. We identified the HIN- 200 family member and candidate lupus susceptibility factor, p202, as a dsDNA binding protein that bound stably and rapidly to transfected DNA. Knockdown studies showed p202 to be an inhibitor of DNA- induced caspase activation. Conversely, the related pyrin domain- containing HIN- 200 factor, AIM2 ( p210), was required for caspase activation by cytoplasmic dsDNA. This work indicates that HIN- 200 proteins can act as pattern recognition receptors mediating responses to cytoplasmic dsDNA.	[Roberts, Tara L.; Idris, Adi; Dunn, Jasmyn A.; Kelly, Greg M.; Burnton, Carol M.; Hodgson, Samantha; Hardy, Lani L.; Garceau, Valerie; Sweet, Matthew J.; Ross, Ian L.; Hume, David A.; Stacey, Katryn J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Roberts, Tara L.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Sweet, Matthew J.; Stacey, Katryn J.] Univ Queensland, Sch Chem & Biomol Sci, Brisbane, Qld 4072, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland	Stacey, KJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	k.stacey@imb.uq.edu.au	Sweet, Matthew J/F-2229-2011; Roberts, Tara L/B-7278-2011; Ross, Ian/A-8622-2011; Hume, David A/C-7695-2013; Idris, Adi/N-3500-2016	Sweet, Matthew J/0000-0002-0406-8139; Roberts, Tara L/0000-0001-9266-0943; Ross, Ian/0000-0002-2389-4292; Idris, Adi/0000-0002-0562-1549; Hume, David/0000-0002-2615-1478; Stacey, Katryn/0000-0002-3992-7802	National Health and Medical Research Council (NHMRC) of Australia [455920, 455882]; Cooperative Research Centre for Chronic Inflammatory Diseases; NHMRC Peter Doherty Fellowship; Australian Research Council Special Research Centre for Functional and Applied Genomics; Australian Cancer Research Foundation; Medical Research Council [G9900991B] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Chronic Inflammatory Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NHMRC Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Special Research Centre for Functional and Applied Genomics(Australian Research Council); Australian Cancer Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (grants 455920 and 455882), and by the Cooperative Research Centre for Chronic Inflammatory Diseases. T. L. R. is the recipient of an NHMRC Peter Doherty Fellowship. Mass spectrometry facilities are supported by the Australian Research Council Special Research Centre for Functional and Applied Genomics. Confocalmicroscopy was performed at the Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology funded by the Australian Cancer Research Foundation. R. Johnstone and C. Clarke provided materials and valuable advice on the HIN-200 family proteins. S. Akira provided TLR9<SUP>-/-</SUP> mice. The work presented here is related to International Patent Application PCT/AU2007/001330.	Asefa B, 2004, BLOOD CELL MOL DIS, V32, P155, DOI 10.1016/j.bcmd.2003.10.002; Choubey D, 2000, FEBS LETT, V474, P38, DOI 10.1016/S0014-5793(00)01571-4; Choubey D, 1996, BIOCHEM BIOPH RES CO, V221, P396, DOI 10.1006/bbrc.1996.0607; Haywood M, 2006, GENES IMMUN, V7, P250, DOI 10.1038/sj.gene.6364294; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Liu T, 2003, PROTEIN SCI, V12, P1872, DOI 10.1110/ps.0359603; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; STACEY KJ, 1993, IMMUNOL CELL BIOL, V71, P75, DOI 10.1038/icb.1993.8; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Van de Parre TJL, 2005, BIOCHEM BIOPH RES CO, V327, P356, DOI 10.1016/j.bbrc.2004.12.027; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	20	641	680	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1057	1060		10.1126/science.1169841	http://dx.doi.org/10.1126/science.1169841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19131592				2022-12-24	WOS:000263478400041
J	Schmitt, J; Romanos, M; Schmitt, NM; Meurer, M; Kirch, W				Schmitt, Jochen; Romanos, Marcel; Schmitt, Natalie M.; Meurer, Michael; Kirch, Wilhelm			Atopic Eczema and Attention-Deficit/Hyperactivity Disorder in a Population-Based Sample of Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DERMATITIS; ADHD		[Schmitt, Jochen; Meurer, Michael] Tech Univ Dresden, Dept Dermatol, Med Fac Carl Gustav Carus, Dresden, Germany; [Romanos, Marcel] Univ Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, Hosp Clin, Wurzburg, Germany; [Schmitt, Natalie M.; Kirch, Wilhelm] Tech Univ Dresden, Inst Clin Pharmacol, Med Fac Carl Gustav Carus, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Wurzburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Schmitt, J (corresponding author), Tech Univ Dresden, Dept Dermatol, Med Fac Carl Gustav Carus, Dresden, Germany.	jochen.schmitt@uniklinikum-dresden.de	Romanos, Marcel/D-7695-2017	Romanos, Marcel/0000-0001-7628-8299				Birnbaum HG, 2005, CURR MED RES OPIN, V21, P195, DOI 10.1185/030079904X20303; Lewis-Jones S, 2006, INT J CLIN PRACT, V60, P984, DOI 10.1111/j.1742-1241.2006.01047.x; Pelsser LMJ, 2009, PEDIAT ALLERG IMM-UK, V20, P107, DOI 10.1111/j.1399-3038.2008.00749.x; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Smaldone A, 2007, PEDIATRICS, V119, pS29, DOI 10.1542/peds.2006-2089F; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803	6	135	140	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					724	726		10.1001/jama.2009.136	http://dx.doi.org/10.1001/jama.2009.136			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224748				2022-12-24	WOS:000263370100014
J	Islam, SM; Shinmyo, Y; Okafuji, T; Su, YH; Bin Naser, I; Ahmed, G; Zhang, SB; Chen, S; Ohta, K; Kiyonari, H; Abe, T; Tanaka, S; Nishinakamura, R; Terashima, T; Kitamura, T; Tanaka, H				Islam, Shahidul M.; Shinmyo, Yohei; Okafuji, Tatsuya; Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Chen, Sandy; Ohta, Kunimasa; Kiyonari, Hiroshi; Abe, Takaya; Tanaka, Satomi; Nishinakamura, Ryuichi; Terashima, Toshio; Kitamura, Toshio; Tanaka, Hideaki			Draxin, a Repulsive Guidance Protein for Spinal Cord and Forebrain Commissures	SCIENCE			English	Article							AXON GUIDANCE; CORPUS-CALLOSUM; CHEMOATTRACTANT; NETRIN-1; RYK	Axon guidance proteins are critical for the correct wiring of the nervous system during development. Several axon guidance cues and their family members have been well characterized. More unidentified axon guidance cues are assumed to participate in the formation of the extremely complex nervous system. We identified a secreted protein, draxin, that shares no homology with known guidance cues. Draxin inhibited or repelled neurite outgrowth from dorsal spinal cord and cortical explants in vitro. Ectopically expressed draxin inhibited growth or caused misrouting of chick spinal cord commissural axons in vivo. draxin knockout mice showed defasciculation of spinal cord commissural axons and absence of all forebrain commissures. Thus, draxin is a previously unknown chemorepulsive axon guidance molecule required for the development of spinal cord and forebrain commissures.	[Islam, Shahidul M.; Shinmyo, Yohei; Okafuji, Tatsuya; Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Chen, Sandy; Ohta, Kunimasa; Tanaka, Hideaki] Kumamoto Univ, Div Dev Neurobiol, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Islam, Shahidul M.; Shinmyo, Yohei; Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Tanaka, Hideaki] Kumamoto Univ, 21st Century COE Ctr Excellence, Cell Fate Regulat Res & Educ Unit, Kumamoto 8600811, Japan; [Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Nishinakamura, Ryuichi; Tanaka, Hideaki] Kumamoto Univ, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto 8600811, Japan; [Kiyonari, Hiroshi; Abe, Takaya] RIKEN Kobe, Chuo Ku, Lab Anim Resources & Genet Engn, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Tanaka, Satomi; Nishinakamura, Ryuichi] Kumamoto Univ, Div Integrat Cell Biol, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Terashima, Toshio] Kobe Univ, Grad Sch Med, Div Anat & Neurobiol, Kobe, Hyogo 6500017, Japan; [Kitamura, Toshio] Univ Tokyo, Minato Ku, Div Cellular Therapy, Inst Med Sci, Tokyo 1088639, Japan	Kumamoto University; Kumamoto University; Kumamoto University; RIKEN; Kumamoto University; Kobe University; University of Tokyo	Tanaka, H (corresponding author), Kumamoto Univ, Div Dev Neurobiol, Grad Sch Med Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hitanaka@kumamoto-u.ac.jp	Islam, Shahidul/N-5897-2013; Kiyonari, Hiroshi/N-7936-2015; Kitamura, Toshio/AAA-2071-2021; Ohta, Kunimasa/AAW-6993-2020	Ohta, Kunimasa/0000-0002-4564-9757	Ministry of Education, Science, Sports, and Culture of Japan (MEXT); (Cell Fate Regulation Research and Education Unit), MEXT, Japan	Ministry of Education, Science, Sports, and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); (Cell Fate Regulation Research and Education Unit), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank D. S. Campbell for careful reading of the manuscript, C. Krull for the pMES-internal ribosome entry site (IRES)-EGFP vector, J. G. Flanagan for APTag-2 vector, H. Fujisawa for helpful discussions, and the Developmental Studies Hybridoma Bank for antibodies. This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT), by the 21st Century COE Program and by the Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan.	Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shu TZ, 2003, J NEUROSCI, V23, P8176; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006	15	116	128	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					388	393		10.1126/science.1165187	http://dx.doi.org/10.1126/science.1165187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150847				2022-12-24	WOS:000262481400041
J	Landers, SH				Landers, Steven H.			The Other Medical Home	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Landers, Steven H.] Ctr Home Hlth Serv, Cleveland Clin Rehabil Inst, Independence, OH 44131 USA	Cleveland Clinic Foundation	Landers, SH (corresponding author), Ctr Home Hlth Serv, Cleveland Clin Rehabil Inst, 6801 Brecksville Rd, Independence, OH 44131 USA.	landers@ccf.org						Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Goldman DP, 2005, HLTH AFF MILLWOO S2, V24; Hackbarth G, 2008, NEW ENGL J MED, V359, P3, DOI 10.1056/NEJMp0803749; Johnson L.B., 1965, REMARKS PRESIDENT TR; Leff B, 2005, ANN INTERN MED, V143, P798, DOI 10.7326/0003-4819-143-11-200512060-00008; Leff B, 1996, J AM GERIATR SOC, V44, P603, DOI 10.1111/j.1532-5415.1996.tb01452.x; Levine SA, 2003, JAMA-J AM MED ASSOC, V290, P1203, DOI 10.1001/jama.290.9.1203; Medalie J, 1978, FAMILY MED PRINCIPLE; Sands LP, 2006, J AM GERIATR SOC, V54, P339, DOI 10.1111/j.1532-5415.2005.00590.x; 2005, RAND HLTH WORKING PA	11	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					97	99		10.1001/jama.2008.917	http://dx.doi.org/10.1001/jama.2008.917			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	391FY	19126815				2022-12-24	WOS:000262220400026
J	Parker, SCJ; Hansen, L; Abaan, HO; Tullius, TD; Margulies, EH				Parker, Stephen C. J.; Hansen, Loren; Abaan, Hatice Ozel; Tullius, Thomas D.; Margulies, Elliott H.			Local DNA Topography Correlates with Functional Noncoding Regions of the Human Genome	SCIENCE			English	Article							REGULATORY SEQUENCES; MOUSE GENOME; CONSTRAINT; ELEMENTS; SITES; IDENTIFICATION; TRANSCRIPTION; RECOGNITION; 1-PERCENT	The three-dimensional molecular structure of DNA, specifically the shape of the backbone and grooves of genomic DNA, can be dramatically affected by nucleotide changes, which can cause differences in protein-binding affinity and phenotype. We developed an algorithm to measure constraint on the basis of similarity of DNA topography among multiple species, using hydroxyl radical cleavage patterns to interrogate the solvent-accessible surface area of DNA. This algorithm found that 12% of bases in the human genome are evolutionarily constrained-double the number detected by nucleotide sequence-based algorithms. Topography-informed constrained regions correlated with functional noncoding elements, including enhancers, better than did regions identified solely on the basis of nucleotide sequence. These results support the idea that the molecular shape of DNA is under selection and can identify evolutionary history.	[Parker, Stephen C. J.; Hansen, Loren; Tullius, Thomas D.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Hansen, Loren] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Abaan, Hatice Ozel; Margulies, Elliott H.] NIH, NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Tullius, Thomas D.] Boston Univ, Dept Chem, Boston, MA 02215 USA	Boston University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University	Margulies, EH (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	tullius@bu.edu; elliott@nhgri.nih.gov	Tullius, Thomas D./A-9685-2008; Parker, Stephen/ABF-1063-2021	Tullius, Thomas D./0000-0003-4425-796X; 	National Human Genome Research Institute (NHGRI), NIH [R01 HG003541]; Research Corporation for Science Advancement; Intramural Research Program of the NHGRI, NIH; National Academies Ford Foundation Dissertation Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003541, ZIAHG200341] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Research Corporation for Science Advancement(Research Corporation for Science Advancement); Intramural Research Program of the NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Academies Ford Foundation Dissertation Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank E. D. Green and L. C. Brody for feedback on the manuscript, E. Bishop and D. Landsman for discussion, and G. K. McEwen for assistance with experimental steps. Funded by the National Human Genome Research Institute (NHGRI) of the NIH (grant R01 HG003541) to T.D.T. and by the Research Corporation for Science Advancement. E.H.M. was supported by the Intramural Research Program of the NHGRI, NIH. S.C.J.P. was supported by a National Academies Ford Foundation Dissertation Fellowship.	Asthana S, 2007, PLOS COMPUT BIOL, V3, P2559, DOI 10.1371/journal.pcbi.0030254; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; DICKERSON RE, 1992, METHOD ENZYMOL, V211, P67; Elnitski L, 2003, GENOME RES, V13, P64, DOI 10.1101/gr.817703; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Giardine B, 2007, HUM MUTAT, V28, P554, DOI 10.1002/humu.20484; Greenbaum JA, 2007, GENOME RES, V17, P947, DOI 10.1101/gr.6073107; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Ohyama T., 2005, DNA CONFORMATION TRA; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Petrykowska HM, 2008, GENOME RES, V18, P1238, DOI 10.1101/gr.073817.107; PRICE MA, 1992, METHOD ENZYMOL, V212, P194; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930	27	152	159	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					389	392		10.1126/science.1169050	http://dx.doi.org/10.1126/science.1169050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19286520	Green Accepted			2022-12-24	WOS:000265221600043
J	Pouget, EM; Bomans, PHH; Goos, JACM; Frederik, PM; de With, G; Sommerdijk, NAJM				Pouget, Emilie M.; Bomans, Paul H. H.; Goos, Jeroen A. C. M.; Frederik, Peter M.; de With, Gijsbertus; Sommerdijk, Nico A. J. M.			The Initial Stages of Template-Controlled CaCO3 Formation Revealed by Cryo-TEM	SCIENCE			English	Article							CRYSTALLIZATION; MONOLAYERS; CALCITE; PHASE; MINERALIZATION; NANOSCALE	Biogenic calcium carbonate forms the inorganic component of seashells, otoliths, and many marine skeletons, and its formation is directed by an ordered template of macromolecules. Classical nucleation theory considers crystal formation to occur from a critical nucleus formed by the assembly of ions from solution. Using cryotransmission electron microscopy, we found that template-directed calcium carbonate formation starts with the formation of prenucleation clusters. Their aggregation leads to the nucleation of amorphous nanoparticles in solution. These nanoparticles assemble at the template and, after reaching a critical size, develop dynamic crystalline domains, one of which is selectively stabilized by the template. Our findings have implications for template-directed mineral formation in biological as well as in synthetic systems.	[Pouget, Emilie M.; Bomans, Paul H. H.; Goos, Jeroen A. C. M.; de With, Gijsbertus; Sommerdijk, Nico A. J. M.] Eindhoven Univ Technol, Lab Mat & Interface Chem, NL-5600 MB Eindhoven, Netherlands; [Pouget, Emilie M.; Bomans, Paul H. H.; Frederik, Peter M.; de With, Gijsbertus; Sommerdijk, Nico A. J. M.] Eindhoven Univ Technol, SoftMatter CryoTEM Unit, NL-5600 MB Eindhoven, Netherlands; [Frederik, Peter M.] Univ Maastricht, Dept Pathol, EM Unit, NL-6229 ER Maastricht, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Maastricht University	Sommerdijk, NAJM (corresponding author), Eindhoven Univ Technol, Lab Mat & Interface Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.	n.sommerdijk@tue.nl	de With, G./E-3235-2014; Sommerdijk, Nico A.J.M./B-7239-2013; goos, jeroen/AAL-8405-2020	Sommerdijk, Nico A.J.M./0000-0002-8956-195X; Goos, Jeroen/0000-0003-2010-7377; Pouget, Emilie/0000-0002-3175-6201	European Community [NMP4-CT-2006-033277]; Netherlands Organization for Scientific Research (NWO)	European Community(European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Supported by the European Community (project code NMP4-CT-2006-033277) and the Netherlands Organization for Scientific Research (NWO). We thank A. Volkel and H. Colfen for performing and evaluating the ultracentrifugation measurements; D. Gebauer and A. Verch for time-dependent solution composition determination of the mineralization solutions; F. L. Boogaard, E. J. Creusen, J. J. van Roosmalen, and P. Moeskops for their contribution to the 3D reconstructions of the tomograms; and P. T. K. Chin for providing the CdSe nanorods.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; Davis ME, 2004, SCIENCE, V305, P480, DOI 10.1126/science.1099773; DiMasi E, 2003, CRYSTENGCOMM, V5, P346, DOI 10.1039/b309800a; Donners JJJM, 2002, CHEM-EUR J, V8, P2561, DOI 10.1002/1521-3765(20020603)8:11<2561::AID-CHEM2561>3.0.CO;2-3; Freeman CL, 2008, LANGMUIR, V24, P9607, DOI 10.1021/la800389g; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Lam RSK, 2007, CRYSTENGCOMM, V9, P1226, DOI 10.1039/b710895h; Lee JRI, 2007, J AM CHEM SOC, V129, P10370, DOI 10.1021/ja071535w; Loste E, 2003, LANGMUIR, V19, P2830, DOI 10.1021/la026837k; Lowenstam HA, 1989, BIOMINERALIZATION; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; MANN S, 1988, NATURE, V334, P692, DOI 10.1038/334692a0; Michel FM, 2008, CHEM MATER, V20, P4720, DOI 10.1021/cm800324v; Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861; Pichon BP, 2008, J AM CHEM SOC, V130, P4034, DOI 10.1021/ja710416h; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Politi Y, 2006, ADV FUNCT MATER, V16, P1289, DOI 10.1002/adfm.200600134; POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003; Quigley D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2940322; RAJAM S, 1991, J CHEM SOC FARADAY T, V87, P727, DOI 10.1039/ft9918700727; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o; Tang RK, 2004, ANGEW CHEM INT EDIT, V43, P2697, DOI 10.1002/anie.200353652; VOLMER M, 1939, KINETIK PHASENDBILDU; YOUNG JR, 1992, NATURE, V356, P516, DOI 10.1038/356516a0	29	690	703	22	613	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1455	1458		10.1126/science.1169434	http://dx.doi.org/10.1126/science.1169434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286549				2022-12-24	WOS:000264101700034
J	Harmon, JP; Moran, NA; Ives, AR				Harmon, Jason P.; Moran, Nancy A.; Ives, Anthony R.			Species Response to Environmental Change: Impacts of Food Web Interactions and Evolution	SCIENCE			English	Article							CLIMATE-CHANGE; GENETIC RESPONSES; PLANT; BIODIVERSITY; POPULATIONS; SYMBIONTS; STRESS; APHIDS; COSTS	How environmental change affects species abundances depends on both the food web within which species interact and their potential to evolve. Using field experiments, we investigated both ecological and evolutionary responses of pea aphids (Acyrthosiphon pisum), a common agricultural pest, to increased frequency of episodic heat shocks. One predator species ameliorated the decrease in aphid population growth with increasing heat shocks, whereas a second predator did not, with this contrast caused by behavioral differences between predators. We also compared aphid strains with stably inherited differences in heat tolerance caused by bacterial endosymbionts and showed the potential for rapid evolution for heat-shock tolerance. Our results illustrate how ecological and evolutionary complexities should be incorporated into predictions of the consequences of environmental change for species' populations.	[Harmon, Jason P.; Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Moran, Nancy A.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Wisconsin System; University of Wisconsin Madison; University of Arizona	Harmon, JP (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	jharmon@wisc.edu	Moran, Nancy A/G-1591-2010; Ives, Anthony/A-5698-2008; Harmon, Jason/AAW-3036-2021	Ives, Anthony/0000-0001-9375-9523; Harmon, Jason/0000-0002-2533-5005	US-NSF;  [0313737]	US-NSF(National Science Foundation (NSF)); 	We thank G. Burke for screening aphids for symbionts; M. Meisner, D. Rowlands, and K. Smith for assistance with experiments; D. Frye and the staff of the University of Wisconsin Arlington Research Station for establishment and maintenance of alfalfa fields; and K. C. Abbott, S. R. Carpenter, M. A. Duffy, R. T. Gilman, C. Gratton, and W. E Snyder for insights and help with the manuscript. Supported by US-NSF grants 0313737 to N.A.M. and A.R.I.	Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Cardinale BJ, 2003, ECOL LETT, V6, P857, DOI 10.1046/j.1461-0248.2003.00508.x; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; DAVIS JJ, 1915, USDA B, V276, P5; de Mazancourt C, 2008, ECOL LETT, V11, P380, DOI 10.1111/j.1461-0248.2008.01152.x; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FROST TM, 1995, LINKING SPECIES & ECOSYSTEMS, P224; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Jiang L, 2004, J ANIM ECOL, V73, P569, DOI 10.1111/j.0021-8790.2004.00830.x; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Millenium Ecosystem Assessment, 2005, EC HUM WELLB GEN SYN; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448	27	167	178	4	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 6	2009	323	5919					1347	1350		10.1126/science.1167396	http://dx.doi.org/10.1126/science.1167396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265021				2022-12-24	WOS:000263876700043
J	Gillick, MR				Gillick, Muriel R.			Controlling Off-Label Medication Use	ANNALS OF INTERNAL MEDICINE			English	Article							DRUGS	Off-label prescribing may lead to innovative new uses of old medications, is essential in such fields as pediatrics, and avoids the lengthy and expensive process of modifying U. S. Food and Drug Administration (FDA) drug labeling. Using medications for unapproved indications, however, raises concerns about patient safety when the drugs have a high potential for toxicity and generates economic concerns when their cost is high. A possible means of controlling the use of off-label drugs is to focus on medications used off-label that are both expensive and potentially risky. These are principally biotechnology drugs, such as recombinant enzymes, cytokines, and monoclonal antibodies. This article suggests a 2-step process for controlling use of such drugs, analogous to that used for devices. Once a drug is FDA approved, it would undergo scrutiny using the Centers for Medicare & Medicaid Services (CMS) National Coverage Determination method if its cost exceeds a specified benchmark-for example, $12 000, which is the average cost of a pacemaker. The CMS would pay only for off-label uses for which there is adequate evidence in its National Coverage Determination process. Other insurance companies would probably adopt the recommendations of CMS.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Gillick, MR (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	mgillick@partners.org						Aggarwal S, 2008, NAT BIOTECHNOL, V26, P1227, DOI 10.1038/nbt1108-1227; [Anonymous], 2005, J ONCOL PRACT, V1, P102; Ansani N, 2006, AM J MED QUAL, V21, P255, DOI 10.1177/1062860606289020; Bennett WM, 2004, J AM SOC NEPHROL, V15, P830, DOI 10.1097/01.ASN.0000118323.41076.01; *BIOT IND ORG, GUID BIOT 2007; Boos J, 2003, ANN ONCOL, V14, P1, DOI 10.1093/annonc/mdg035; Centers for Medicare & Medicaid Services, 2021, MED COV DET PROC; *CTR MED MED SERV, NAT HLTH EXP 2007; EASTMAN P, 2005, ONCOLOGY TIMES, V27, P10; Eastman P., 2005, ONCOLOGY TIMES, V27, P8, DOI DOI 10.1097/01.COT.0000290944.45158.35; Gazarian M, 2006, MED J AUSTRALIA, V185, P544, DOI 10.5694/j.1326-5377.2006.tb00689.x; Giezen TJ, 2008, JAMA-J AM MED ASSOC, V300, P1887, DOI 10.1001/jama.300.16.1887; Graves Julia E, 2007, J Am Acad Dermatol, V56, pe55, DOI 10.1016/j.jaad.2006.07.019; Jacobson PD, 2007, JAMA-J AM MED ASSOC, V297, P205, DOI 10.1001/jama.297.2.205; Keenan PS, 2006, HEALTH AFFAIR, V25, P1260, DOI 10.1377/hlthaff.25.5.1260; Kocs D, 2003, AM J MANAG CARE, V9, P393; Maisel WH, 2004, ANN INTERN MED, V140, P296, DOI 10.7326/0003-4819-140-4-200402170-00012; Moore TJ, 2007, ARCH INTERN MED, V167, P1752, DOI 10.1001/archinte.167.16.1752; Rader RA, 2008, NAT BIOTECHNOL, V26, P743, DOI 10.1038/nbt0708-743; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Ramsey SD, 2007, J CLIN ONCOL, V25, P175, DOI 10.1200/JCO.2006.08.9805; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Tunis SR, 2006, HEALTH AFFAIR, V25, P1218, DOI 10.1377/hlthaff.25.5.1218; Ward RM, 2002, PEDIATRICS, V110, P181; [No title captured]; 2003, HCUP FACT BOOK	26	52	56	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					344	347		10.7326/0003-4819-150-5-200903030-00108	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00108			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19221367				2022-12-24	WOS:000264051700006
J	Myint, PK; Luben, RN; Wareham, NJ; Bingham, SA; Khaw, KT				Myint, Phyo K.; Luben, Robert N.; Wareham, Nicholas J.; Bingham, Sheila A.; Khaw, Kay-Tee			Combined effect of health behaviours and risk of first ever stroke in 20 040 men and women over 11 years' follow-up in Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): prospective population study	BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; CORONARY HEART-DISEASE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; VITAMIN-C; MORTALITY; REPEATABILITY; VALIDITY; MARKERS	Objective To quantify the potential combined impact of four health behaviours on incidence of stroke in men and women living in the general community. Design Population based prospective study (EPIC-Norfolk). Setting Norfolk, United Kingdom. Participants 20 040 men and women aged 40-79 with no known stroke or myocardial infarction at baseline survey in 1993-7, living in the general community, and followed up to 2007. Main outcome measure Participants scored one point for each health behaviour: current non-smoking, physically not inactive, moderate alcohol intake (1-14 units a week), and plasma concentration of vitamin C >= 50 mu mol/l, indicating fruit and vegetable intake of at least five servings a day, for a total score ranging from 0 to 4. Results There were 599 incident strokes over 229 993 person years of follow-up; the average follow-up was 11. 5 years. After adjustment for age, sex, body mass index (BMI), systolic blood pressure, cholesterol concentration, history of diabetes and aspirin use, and social class, compared with people with the four health behaviours the relative risks for stroke for men and women were 1.15 (95% confidence interval 0.89 to 1.49) for three health behaviours, 1.58 (1.22 to 2.05) for two, 2.18 (1.63 to 2.92) for one, and 2.31 (1.33 to 4.02) for none (P<0.001 for trend). The relations were consistent in subgroups stratified by sex, age, body mass index, and social class, and after exclusion of deaths within two years. Conclusion Four health behaviours combined predict more than a twofold difference in incidence of stroke in men and women.	[Myint, Phyo K.] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Myint, Phyo K.; Luben, Robert N.; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Wareham, Nicholas J.] MRC, Epidemiol Unit, Cambridge, England; [Bingham, Sheila A.] MRC, Ctr Nutr Epidemiol Canc Prevent & Survival, Cambridge, England	University of East Anglia; University of Cambridge	Myint, PK (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.	phyo.k.myint@uea.ac.uk	Luben, Robert N/H-5519-2015; Khaw, Kay-Tee/AAZ-3209-2021	Luben, Robert N/0000-0002-5088-6343; 	Cancer Research UK; Medical Research Council; Stroke Association; British Heart Foundation; Research Into Ageing; Academy of Medical Sciences; Wellcome Trust; MRC [MC_U105630924] Funding Source: UKRI; Medical Research Council [MC_U105630924, G0401527, MC_U106179471] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; British Heart Foundation(British Heart Foundation); Research Into Ageing; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	EPIC-Norfolk is supported by research programme grant funding from Cancer Research UK and the Medical Research Council with additional support from the Stroke Association, British Heart Foundation, Research Into Ageing, Academy of Medical Sciences, and Wellcome Trust.	Andersson SW, 2004, EUR J CLIN NUTR, V58, P1378, DOI 10.1038/sj.ejcn.1601980; BAIN C, 1978, LANCET, V1, P1087; BINGHAM SA, 1995, BRIT J NUTR, V73, P531, DOI 10.1079/BJN19950057; Day N, 1999, BRIT J CANCER, V80, P95; *DEP HLTH, 2005, NAT AUD OFF REP RED; Department of Health, 1999, SAV LIV OUR HLTH NAT; Goldstein LB, 2006, CIRCULATION, V113, pE873, DOI 10.1161/01.STR.0000223048.70103.F1; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Hu G, 2005, STROKE, V36, P1994, DOI 10.1161/01.STR.0000177868.89946.0c; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Kelly TN, 2008, STROKE, V39, P1688, DOI 10.1161/STROKEAHA.107.505305; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; Liu S, 2000, AM J CLIN NUTR, V72, P922; Myint PK, 2008, AM J CLIN NUTR, V87, P64, DOI 10.1093/ajcn/87.1.64; Myint PK, 2006, NEUROEPIDEMIOLOGY, V27, P122, DOI 10.1159/000095551; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Psaltopoulou T, 2004, AM J CLIN NUTR, V80, P1012, DOI 10.1093/ajcn/80.4.1012; PURDON S, 1997, HLTH SURVEY ENGLAND, P123; RIEMERSMA RA, 1990, EUR J CLIN NUTR, V44, P143; Sauvaget C, 2003, STROKE, V34, P2355, DOI 10.1161/01.STR.0000089293.29739.97; Shohaimi S, 2004, EUR RESPIR J, V24, P157, DOI 10.1183/09031936.04.00088303; Wagner A, 2002, CIRCULATION, V105, P2247, DOI 10.1161/01.CIR.0000016345.58696.4F; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168	25	108	110	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 19	2009	338								b349	10.1136/bmj.b349	http://dx.doi.org/10.1136/bmj.b349			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228771	hybrid, Green Published			2022-12-24	WOS:000264052200001
J	Solberg, KE				Solberg, Kristin Elisabeth			Iranian doctors' conviction could damage public health	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					533	533		10.1016/S0140-6736(09)60184-7	http://dx.doi.org/10.1016/S0140-6736(09)60184-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19230077	Green Published, Bronze			2022-12-24	WOS:000263333600014
J	Pope, CA; Ezzati, M; Dockery, DW				Pope, C. Arden, III; Ezzati, Majid; Dockery, Douglas W.			Fine-Particulate Air Pollution and Life Expectancy in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM EXPOSURE; MORTALITY; HEALTH; MATTER; ASSOCIATION; CANCER; RATES	Background: Exposure to fine-particulate air pollution has been associated with increased morbidity and mortality, suggesting that sustained reductions in pollution exposure should result in improved life expectancy. This study directly evaluated the changes in life expectancy associated with differential changes in fine particulate air pollution that occurred in the United States during the 1980s and 1990s. Methods: We compiled data on life expectancy, socioeconomic status, and demographic characteristics for 211 county units in the 51 U.S. metropolitan areas with matching data on fine-particulate air pollution for the late 1970s and early 1980s and the late 1990s and early 2000s. Regression models were used to estimate the association between reductions in pollution and changes in life expectancy, with adjustment for changes in socioeconomic and demographic variables and in proxy indicators for the prevalence of cigarette smoking. Results: A decrease of 10 microg per cubic meter in the concentration of fine particulate matter was associated with an estimated increase in mean (+/-SE) life expectancy of 0.61+/-0.20 year (P=0.004). The estimated effect of reduced exposure to pollution on life expectancy was not highly sensitive to adjustment for changes in socioeconomic, demographic, or proxy variables for the prevalence of smoking or to the restriction of observations to relatively large counties. Reductions in air pollution accounted for as much as 15% of the overall increase in life expectancy in the study areas. Conclusions: A reduction in exposure to ambient fine-particulate air pollution contributed to significant and measurable improvements in life expectancy in the United States. N Engl J Med 2009;360:376-86.	[Pope, C. Arden, III] Brigham Young Univ, Dept Econ, Provo, UT 84602 USA; [Ezzati, Majid; Dockery, Douglas W.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Initiat Global Hlth, Cambridge, MA USA	Brigham Young University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Pope, CA (corresponding author), Brigham Young Univ, Dept Econ, 142 FOB, Provo, UT 84602 USA.	cap3@byu.edu	Pope, C. Arden/ABD-5522-2021; , dwdockery/AAO-7272-2021	Dockery, Douglas/0000-0002-6052-4880	Association of Schools of Public Health [U36/CCU300430-23)]; Harvard Environmental Protection Agency (EPA) Particulate Matter Center [EPA RD832416]; National Institute of Environmental Health Sciences [ES0002]; Mary Lou Fulton Professorship; Brigham Young University; Health Effects Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	Association of Schools of Public Health; Harvard Environmental Protection Agency (EPA) Particulate Matter Center(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Mary Lou Fulton Professorship; Brigham Young University; Health Effects Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by a cooperative agreement with the Centers for Disease Control and Prevention; by grants from the Association of Schools of Public Health (U36/CCU300430-23), the Harvard Environmental Protection Agency (EPA) Particulate Matter Center (EPA RD832416), and the National Institute of Environmental Health Sciences (ES0002); and funds from the Mary Lou Fulton Professorship, Brigham Young University.; Dr. Dockery reports receiving grant support from the Health Effects Institute. No other potential conflict of interest relevant to this article was reported.; The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Association of Schools of Public Health. Although funded in part by the EPA, this study has not been subjected to the agency's peer- and policy- review process and therefore does not necessarily reflect the views of the agency, and no official endorsement should be inferred.	Anderson HR, 2005, EPIDEMIOLOGY, V16, P155, DOI 10.1097/01.ede.0000152528.22746.0f; Brunekreef B, 1997, OCCUP ENVIRON MED, V54, P781, DOI 10.1136/oem.54.11.781; BURNETT RT, 2003, REVISED ANAL TIME SE, P85; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Eftim SE, 2008, EPIDEMIOLOGY, V19, P209, DOI 10.1097/EDE.0b013e3181632c09; EVANS JS, 1984, ENVIRON INT, V10, P55, DOI 10.1016/0160-4120(84)90233-2; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Krewski D., 2000, REANALYSIS HARVARD 6; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; LAVE LB, 1970, SCIENCE, V169, P723, DOI 10.1126/science.169.3947.723; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; OZKAYNAK H, 1987, RISK ANAL, V7, P449, DOI 10.1111/j.1539-6924.1987.tb00482.x; Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pope CA, 2007, ENVIRON HEALTH PERSP, V115, P679, DOI 10.1289/ehp.9762; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope C. Arden III, 2000, Environmental Health Perspectives, V108, P713, DOI 10.2307/3454408; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Preston, 2001, DEMOGRAPHY; Schwartz J, 2008, ENVIRON HEALTH PERSP, V116, P64, DOI 10.1289/ehp.9955; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; 1997, FED REG, V62, P5725	28	1474	1519	8	445	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					376	386		10.1056/NEJMsa0805646	http://dx.doi.org/10.1056/NEJMsa0805646			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395JH	19164188	Green Accepted			2022-12-24	WOS:000262519900009
J	Wilson, RW; Millero, FJ; Taylor, JR; Walsh, PJ; Christensen, V; Jennings, S; Grosell, M				Wilson, R. W.; Millero, F. J.; Taylor, J. R.; Walsh, P. J.; Christensen, V.; Jennings, S.; Grosell, M.			Contribution of Fish to the Marine Inorganic Carbon Cycle	SCIENCE			English	Article							INTESTINAL BICARBONATE SECRETION; CALCIUM-CARBONATE; ACID-BASE; OCEAN; DISSOLUTION; ARAGONITE; IMPACT; CO2; SEDIMENTATION; CHEMISTRY	Oceanic production of calcium carbonate is conventionally attributed to marine plankton (coccolithophores and foraminifera). Here we report that marine fish produce precipitated carbonates within their intestines and excrete these at high rates. When combined with estimates of global fish biomass, this suggests that marine fish contribute 3 to 15% of total oceanic carbonate production. Fish carbonates have a higher magnesium content and solubility than traditional sources, yielding faster dissolution with depth. This may explain up to a quarter of the increase in titratable alkalinity within 1000 meters of the ocean surface, a controversial phenomenon that has puzzled oceanographers for decades. We also predict that fish carbonate production may rise in response to future environmental changes in carbon dioxide, and thus become an increasingly important component of the inorganic carbon cycle.	[Wilson, R. W.] Univ Exeter, Sch Biosci, Exeter EX4 4PS, Devon, England; [Millero, F. J.; Taylor, J. R.; Walsh, P. J.; Grosell, M.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Walsh, P. J.] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Christensen, V.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada; [Jennings, S.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Jennings, S.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of Exeter; University of Miami; University of Ottawa; University of British Columbia; Centre for Environment Fisheries & Aquaculture Science; University of East Anglia	Wilson, RW (corresponding author), Univ Exeter, Sch Biosci, Exeter EX4 4PS, Devon, England.	r.w.wilson@ex.ac.uk; fmillero@rsmas.miami.edu; mgrosell@rsmas.miami.edu	Jennings, Simon/F-5085-2012; Christensen, Villy/C-3945-2009	Jennings, Simon/0000-0002-2390-7225; Christensen, Villy/0000-0003-0688-2633	UK Biotechnology and Biological Sciences Research Council [BB/D005108/1, BB/F009364/1, ISIS 1766]; The Royal Society [RSRG 24241]; Oceanographic Section of the U.S. National Science Foundation; Natural Sciences and Engineering Research Council; Canada and the Canada Research Chair; NSERC; Global Environment Facility's UNEP/UNESCO/IOC (Intergovernmental Oceanographic Commission); LME; The Pew Charitable Trusts; European Commission; UK Department of Environment, Food, and Rural Affairs; NSF [0416440, 0714024, 0743903]; Directorate For Geosciences [0752972] Funding Source: National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/F009364/1, BB/D005108/1] Funding Source: researchfish; BBSRC [BB/F009364/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The Royal Society(Royal Society of London); Oceanographic Section of the U.S. National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada and the Canada Research Chair; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Global Environment Facility's UNEP/UNESCO/IOC (Intergovernmental Oceanographic Commission); LME; The Pew Charitable Trusts; European Commission(European CommissionEuropean Commission Joint Research Centre); UK Department of Environment, Food, and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	R.W.W. acknowledges support from the UK Biotechnology and Biological Sciences Research Council (awards BB/D005108/1 , BB/F009364/1, and ISIS 1766) and The Royal Society (award RSRG 24241). F.J.M. acknowledges the Oceanographic Section of the U.S. National Science Foundation (NSF). P.J.W. is supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada and the Canada Research Chair program. V. C. acknowledges support from NSERC, the Global Environment Facility's UNEP/UNESCO/IOC (Intergovernmental Oceanographic Commission) LME (Large Marine Ecosystem) activities, and from the Sea Around Us Project, initiated and funded by The Pew Charitable Trusts. S.J. thanks the European Commission and the UK Department of Environment, Food, and Rural Affairs for funding support, and A. Clarke (British Antarctic Survey, Cambridge) for providing a compilation of fish oxygen consumption data. M.G. and S.J. are supported by the NSF (awards 0416440, 0714024, and 0743903). We also thank referees for their insightful comments; K. Knapp (School of Physics, University of Exeter) for the fish x-ray images (Fig. 2); R. Walton (University of Warwick, UK) for the powder x-ray diffraction analysis (fig. S1); H. Stoll (Department of Geoscience, Williams College, Williamstown, MA) and A. Pritchard (University of Exeter, Biosciences) for the scanning electron micrographs of sediment trap samples and fish carbonates, respectively (fig. S3); R. Forster (Centre for Environment, Fisheries and Aquaculture Science, Lowestoft) for plotting fig. S4; FishBase (www.fishbase.org) for providing fish species' information; J. Whittamore for preparation of flounder for x-ray imaging; J. Corcoran and C. Cooper for the sheepshead minnow experiments in the Supporting Online Material; and R. van Aerle for assistance with graphical illustrations.	BISHOP JKB, 1986, PROG OCEANOGR, V17, P1, DOI 10.1016/0079-6611(86)90024-8; BROECKER WS, 1977, FATE FOSSIL CO2 OCEA, P207; BYRNE RH, 1984, NATURE, V312, P321, DOI 10.1038/312321a0; Christensen V, 2008, IOC TECHNICAL SERIES, V80; Chung SN, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002001; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; FABRY VJ, 1991, DEEP-SEA RES, V38, P713, DOI 10.1016/0198-0149(91)90008-4; FEELY RA, 1988, MAR CHEM, V25, P227, DOI 10.1016/0304-4203(88)90052-7; Feely RA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001866; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Genz J, 2008, J EXP BIOL, V211, P2327, DOI 10.1242/jeb.016832; Grosell M, 2005, AM J PHYSIOL-REG I, V288, pR936, DOI 10.1152/ajpregu.00684.2003; Grosell M, 2006, J EXP BIOL, V209, P2813, DOI 10.1242/jeb.02345; HARRIS RP, 1994, MAR BIOL, V119, P431, DOI 10.1007/BF00347540; Iglesias-Rodriguez MD., 2002, EOS T AM GEOPHYS UN, V83, P365, DOI [10.1029/2002EO000267, DOI 10.1029/2002EO000267]; Jansen H, 2001, MAR ECOL PROG SER, V221, P199, DOI 10.3354/meps221199; Jennings S, 2008, P ROY SOC B-BIOL SCI, V275, P1375, DOI 10.1098/rspb.2008.0192; Lee K, 2001, LIMNOL OCEANOGR, V46, P1287, DOI 10.4319/lo.2001.46.6.1287; Millero F. J., 2006, CHEM OCEANOGRAPHY; Milliman JD, 1999, DEEP-SEA RES PT I, V46, P1653, DOI 10.1016/S0967-0637(99)00034-5; Milliman JD, 1996, GEOL RUNDSCH, V85, P496, DOI 10.1007/s005310050090; Morse J. W., 1990, GEOCHEMISTRY SEDIMEN; Morse JW, 2003, GEOCHIM COSMOCHIM AC, V67, P2819, DOI 10.1016/S0016-7037(03)00103-0; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; POND DW, 1995, MAR BIOL, V123, P75, DOI 10.1007/BF00350325; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Sabine CL, 2004, SCOPE SER, V62, P17; Sabine CL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001869; Schiebel R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001459; Seibel BA, 2001, SCIENCE, V294, P319, DOI 10.1126/science.1065301; TAKAHASHI T, 1975, Cushman Foundation for Foraminiferal Research Special Publication, V13, P11; VANDERWAL P, 1995, MAR ECOL PROG SER, V126, P247, DOI 10.3354/meps126247; WALSH PJ, 1991, LIMNOL OCEANOGR, V36, P1227, DOI 10.4319/lo.1991.36.6.1227; Wilson RW, 2003, BBA-BIOMEMBRANES, V1618, P163, DOI 10.1016/j.bbamem.2003.09.014; Wilson RW, 2002, BBA-BIOMEMBRANES, V1566, P182, DOI 10.1016/S0005-2736(02)00600-4; Wilson RW, 1996, J EXP BIOL, V199, P2331	37	175	182	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					359	362		10.1126/science.1157972	http://dx.doi.org/10.1126/science.1157972			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150840				2022-12-24	WOS:000262481400032
J	Chi, AS; Bernstein, BE				Chi, Andrew S.; Bernstein, Bradley E.			DEVELOPMENTAL BIOLOGY Pluripotent Chromatin State	SCIENCE			English	Editorial Material							EMBRYONIC STEM-CELLS; POLYCOMB; TRANSCRIPTION; REGULATORS		[Chi, Andrew S.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Chi, Andrew S.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Canc Res Ctr, Charlestown, MA 02129 USA; [Chi, Andrew S.; Bernstein, Bradley E.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02139 USA; [Chi, Andrew S.] Massachusetts Gen Hosp, Stephen E & Catherine Pappas Ctr Neurooncol, Dept Neurol, Boston, MA 02114 USA; [Bernstein, Bradley E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Chi, AS (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	bernstein.bradley@mgh.harvard.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG004570, U54 HG004570-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	17	43	43	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					220	221		10.1126/science.1166261	http://dx.doi.org/10.1126/science.1166261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131621	Green Accepted			2022-12-24	WOS:000262290600027
J	Han, J; Pedersen, JS; Kwon, SC; Belair, CD; Kim, YK; Yeom, KH; Yang, WY; Haussler, D; Blelloch, R; Kim, VN				Han, Jinju; Pedersen, Jakob S.; Kwon, S. Chul; Belair, Cassandra D.; Kim, Young-Kook; Yeom, Kyu-Hyeon; Yang, Woo-Young; Haussler, David; Blelloch, Robert; Kim, V. Narry			Posttranscriptional Crossregulation between Drosha and DGCR8	CELL			English	Article							MICROPROCESSOR COMPLEX; MICRORNA BIOGENESIS; ALZHEIMERS-DISEASE; RNA INTERFERENCE; EXPRESSION; PROLIFERATION; DROSOPHILA; MIR-222; PATHWAY; CELLS	The Drosha-DGCR8 complex, also known as Microprocessor, is essential for microRNA (miRNA) maturation. Drosha functions as the catalytic subunit, while DGCR8 (also known as Pasha) recognizes the RNA substrate. Although the action mechanism of this complex has been intensively studied, it remains unclear how Drosha and DGCR8 are regulated and if these proteins have any additional role(s) apart from miRNA processing. Here, we report that Drosha and DGCR8 regulate each other posttranscriptionally. The Drosha-DGCR8 complex cleaves the hairpin structures embedded in the DGCR8 mRNA and thereby destabilizes the mRNA. We further find that DGCR8 stabilizes the Drosha protein via protein-protein interaction. This crossregulation between Drosha and DGCR8 may contribute to the homeostatic control of miRNA biogenesis. Furthermore, microarray analyses suggest that a number of mRNAs may be downregulated in a Microprocessor-dependent, miRNA-independent manner. Our study reveals a previously unsuspected function of Microprocessor in mRNA stability control.	[Han, Jinju; Kwon, S. Chul; Kim, Young-Kook; Yeom, Kyu-Hyeon; Yang, Woo-Young; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Pedersen, Jakob S.] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Belair, Cassandra D.; Blelloch, Robert] Univ Calif San Francisco, Inst Regenerat Med, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Belair, Cassandra D.; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA	Seoul National University (SNU); University of Copenhagen; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Kim, VN (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Kwon, S. Chul/K-2515-2017; Kwon, S. Chul/ABG-9415-2020; Pedersen, Jakob/C-4985-2009; Pedersen, Jakob/G-3382-2012; Han, Jinju/D-9091-2017; Kim, Young-Kook/AAE-8306-2020	Kwon, S. Chul/0000-0002-9519-5132; Pedersen, Jakob/0000-0002-7236-4001; Kim, Young-Kook/0000-0001-6434-2235; Kim, Young Kook/0000-0002-6037-8449; HAN, Jinju/0000-0003-1844-2301	Creative Research Initiatives Program [R16-2007-073-01000-0]; BK21 Research Fellowships; Ministry of Education, Science, and Technology of Korea; Danish Medical Research Council [271-06-0711]; University of California, San Francisco, Urology Developmental Award; Prostate Cancer Foundation; National Institutes of Health [K08 NS48118, RO1 NS057221]; Stem Cell Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048118, R01NS057221] Funding Source: NIH RePORTER	Creative Research Initiatives Program; BK21 Research Fellowships(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of California, San Francisco, Urology Developmental Award(University of California System); Prostate Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stem Cell Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Dr. Seogang Hyun for help with S2 transfection, to Dr. Chirlmin Joo for critical reading of this manuscript, and to members of our laboratory for helpful discussion. We also thank Dr. Young-Joon Kim for kindly providing S2 cell. This work was supported by the Creative Research Initiatives Program (R16-2007-073-01000-0) (V.N.K.) and the BK21 Research Fellowships (J.H. and S.C.K.) from the Ministry of Education, Science, and Technology of Korea. J.S.P. was supported by the Danish Medical Research Council (271-06-0711). C.B. was supported through a University of California, San Francisco, Urology Developmental Award and the Prostate Cancer Foundation. R.B. is a Pew Scholar and was supported by National Institutes of Health grants (K08 NS48118, RO1 NS057221), the Prostate Cancer Foundation, and Stem Cell Research Foundation. J.H., S.C.K., Y.K.K., K.H.Y., and W.Y.Y. performed the experiments and analyzed the data. C.B. and R.B. carried out experiments with Dgcr8 KO mES cells, generated Dgcr8 KO MEF, and helped with manuscript preparation. J.S.P. performed bioinformatics analyses with D.H. and helped with editing of paper. J.H. and V.N.K. designed the study and wrote the paper.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2008, BRAIN PATHOL, V18, P113, DOI 10.1111/j.1750-3639.2007.00121.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zeng Y, 2002, RNA, V8, P855, DOI 10.1017/S1355838202020071	41	308	324	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					75	84		10.1016/j.cell.2008.10.053	http://dx.doi.org/10.1016/j.cell.2008.10.053			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135890	Green Accepted, Bronze			2022-12-24	WOS:000262318400016
J	Pandey, S; Nelson, DC; Assmann, SM				Pandey, Sona; Nelson, David C.; Assmann, Sarah M.			Two Novel GPCR-Type G Proteins Are Abscisic Acid Receptors in Arabidopsis	CELL			English	Article							EARLY SEEDLING DEVELOPMENT; COUPLED RECEPTORS; BINDING PROTEIN; GUARD-CELLS; ABA CONTROL; SUBUNIT; GERMINATION; EXPRESSION; GCR2; RICE	In plants, G proteins modulate signaling by the stress hormone, abscisic acid (ABA). We identify and characterize two novel Arabidopsis proteins that show homology to an orphan vertebrate GPCR (GPR89) and interact with the sole Arabidopsis G protein a subunit, GPA1, but also have intrinsic GTP-binding and GTPase activity. We have named these proteins GPCR-type G proteins (GTG1 and GTG2). Arabidopsis mutants lacking both GTG1 and GTG2 exhibit ABA hyposensitivity. GTG1 and GTG2 bind ABA specifically. The GDP-bound form of the GTGs exhibits greater ABA binding than the GTP-bound form, the GTPase activity of the GTGs is inhibited by GPA1, and gpa1 null mutants exhibit ABA-hypersensitive phenotypes. These results predict that, unusually, it is the GDP-bound, not the GTP-ound, form of the GTGs that actively relays the signal. We propose that GTG proteins function both as a new type of G protein and as a class of membrane-localized ABA receptors.	[Pandey, Sona; Assmann, Sarah M.] Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; [Pandey, Sona] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Nelson, David C.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA; [Nelson, David C.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Donald Danforth Plant Science Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Assmann, SM (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	sma3@psu.edu	Pandey, Sona/M-2847-2013	Pandey, Sona/0000-0002-5570-3120; Nelson, David/0000-0001-9792-5015	UW College of Agricultural and Life Sciences, the Morgridge family; NSF [0209694]	UW College of Agricultural and Life Sciences, the Morgridge family; NSF(National Science Foundation (NSF))	Single gtg1-1 and gtg2-1 mutants were isolated and the gtg1 gtg2 mutant created by D.C.N. in the laboratory of Professor Michael R. Sussman at the University of Wisconsin-Madison, under the support of funds from the UW College of Agricultural and Life Sciences, the Morgridge family, and an NIH Graduate Fellowship Training Grant administered through the Department of Genetics. Other research was performed at Penn State and supported by NSF grant 0209694 and the Penn State Waller Professorship to S. M. A. Technical assistance from Ms. Liza A. Wilson, Ms. Anne Gibson, and Ms. Heather Burch, the pGW series of binary vectors from Dr. Tsuyoshi Nakagawa, modified pEarleyGate 102 vector from Dr. Gabriele Monshausen, advice on phylogenetic analysis from Professor Claude dePamphilis, and access to the FLx800 from Professor Doug Cavener are gratefully acknowledged. D.C.N. isolated the single gtg1-1 and gtg2-1mutants and created the gtg1 gtg2 double mutant. S.P. and D.C.N. performed initial phenotypic analyses. S. P. and S. M. A. designed, performed, and interpreted all other experiments. S. P. and S. M. A. wrote the paper, with input from all authors.	ASSMANN SM, 1994, PLANT CELL, V6, P1187, DOI 10.1105/tpc.6.9.1187; ASSMANN SM, 2004, SCI STKE, V264, pRE20; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chow B, 2006, GENE DEV, V20, P1998, DOI 10.1101/gad.1432806; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ding L, 2008, PLANT J, V53, P248, DOI 10.1111/j.1365-313X.2007.03335.x; FAIRLEYGRENOT K, 1991, PLANT CELL, V3, P1037; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Gookin TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r120; Guo JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002982; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Illingworth CJR, 2008, BIOPHYS CHEM, V133, P28, DOI 10.1016/j.bpc.2007.11.004; Jang YH, 2008, PLANT CELL PHYSIOL, V49, P1898, DOI 10.1093/pcp/pcn151; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Mancia F, 2007, MOL BIOSYST, V3, P723, DOI 10.1039/B713558K; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Mhaouty-Kodja S, 2004, BIOL CELL, V96, P363, DOI 10.1016/j.biolcel.2004.03.003; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Razem FA, 2004, J BIOL CHEM, V279, P9922, DOI 10.1074/jbc.M311064200; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seo HS, 1997, BIOCHEM J, V324, P273, DOI 10.1042/bj3240273; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Sutton F, 2000, PLANT PHYSIOL, V124, P223, DOI 10.1104/pp.124.1.223; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Tsugeki R, 1999, P NATL ACAD SCI USA, V96, P12941, DOI 10.1073/pnas.96.22.12941; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; Willard FS, 2005, ANAL BIOCHEM, V340, P341, DOI 10.1016/j.ab.2005.02.015; Zhang DP, 2002, PLANT PHYSIOL, V128, P714, DOI 10.1104/pp.010531	46	323	368	4	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					136	148		10.1016/j.cell.2008.12.026	http://dx.doi.org/10.1016/j.cell.2008.12.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135895	Bronze			2022-12-24	WOS:000262318400021
J	Muscat, M; Bang, H; Wohlfahrt, J; Glismann, S; Molbak, K				Muscat, Mark; Bang, Henrik; Wohlfahrt, Jan; Glismann, Steffen; Molbak, Kare		EUVAC NET Grp	Measles in Europe: an epidemiological assessment	LANCET			English	Article							DEATH CERTIFICATION; ELIMINATION	Background Measles persists in Europe despite the incorporation of the measles vaccine into routine childhood vaccination programmes more than 20 years ago. Our aim was therefore to review the epidemiology of measles in relation to the goal of elimination by 2010. Methods National surveillance institutions from 32 European countries submitted data for 2006-07. Data for age-group, diagnosis confirmation, vaccination, hospital treatment, the presence of acute encephalitis as a complication of disease, and death were obtained. 30 countries also supplied data about importation of disease. Clinical, laboratory-confirmed, and epidemiologically linked cases that met the requirements for national surveillance were analysed. Cases were separated by age: younger than 1 year, 1-4 years, 5-9 years, 10-14 years, 15-19 years, and older than 20 years. Countries with indigenous measles incidence per 100000 inhabitants per year of 0, less than 0.1, 0 . 1-1, and more than 1 were grouped into categories of zero, low, moderate, and high incidence, respectively. Findings For the 2 years of the study, 12132 cases of measles were recorded with most cases (n=10329; 85%) from five countries: Romania, Germany, UK, Switzerland, and Italy. Most cases were unvaccinated or incompletely vaccinated children; however, almost a fifth were aged 20 years or older. For the same 2 years, seven measles-related deaths were recorded. High measles incidence in some European countries revealed suboptimum vaccination coverage. Of the 210 cases that were reported as being imported, 117 (56%) came from another country within Europe and 43 (20%) from Asia. Interpretation The suboptimum vaccination coverage raises serious doubts that the goal of elimination by 2010 can be attained. Achievement and maintenance of optimum vaccination coverage and improved surveillance are the cornerstones of the measles elimination plan for Europe. Funding European Commission and the Statens Serum Institut, Denmark.	[Muscat, Mark; Bang, Henrik; Glismann, Steffen; Molbak, Kare] Statens Serum Inst, Dept Epidemiol, EUVAC NET Hub, DK-2300 Copenhagen S, Denmark; [Wohlfahrt, Jan] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut; Statens Serum Institut	Muscat, M (corresponding author), Statens Serum Inst, Dept Epidemiol, EUVAC NET Hub, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	mmc@ssi.dk		Molbak, Kare/0000-0002-3100-4990	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank the following collaborators within various public health and surveillance institutions: Vanya Mehandzhieva (Bulgaria); Jitka Castkova and Marcela SmelhausovA (Czech Republic); Ulpu Elonsalo (Finland); Theano Georgakopoulou and Elem Kalamara (Greece); Massimo De Crescenzo, Corrado Cenci, and Lucia Virtuani, (Italy); leleria Curikova (Latvia); Andrew Amato Gauci (Malta), and Miroslaw P Czarkowski (Poland); Judite Catarino (Portugal); Mateja Blasko Markic (Slovenia); Eva Miderovd and Alexandra Zampachova (Slovakia); Solveig Olsson (Sweden); and Kevin Brown, Claire Cameron, and Mary Ramsay (UK). We also thank Paolo Guglielmetti (SANCO C3, European Commission) for contributing valuable suggestions and Hannah Lewis (Statens Serum Insfitut) for proof-reading the first submitted version and adding useful comments. EUVAC.NET is jointly funded by the European Commission under the public health programme 2003-08 (DG SANCO) under grant agreement number 2004205 and the Statens Serum Institut, Denmark. The network is co-ordinated by the EUVAC.NET hub within the Department of Epidemiology, Statens Serum Instimt, and is composed ofpublic health and surveillance institutions from the 27 EU member states together with Croatia, Iceland, Norway, Switzerland, and Turkey.	Andrews N, 2008, B WORLD HEALTH ORGAN, V86, P197, DOI 10.2471/BLT.07.041129; Armour A, 1997, ULSTER MED J, V66, P13; Atti MLC, 2004, VACCINE, V22, P4351, DOI 10.1016/j.vaccine.2004.04.026; Bernard H, 2008, Euro Surveill, V13; COLNUET S, 2007, EURO SURVEILL, V12; *COMM DIS CTR I PU, ANN REP COV 1999 200; Filia A, 2006, EUROSURVEILLANCE, V11; Filia Antonietta, 2008, Euro Surveill, V13; Garg RK, 2002, POSTGRAD MED J, V78, P63, DOI 10.1136/pmj.78.916.63; GEORGAKOPOULOU T, 2006, EUROSURVEILLANCE, V11; *HLTH PROT AG, CONF MEASL MUMPS RUB; *HLTH PROT AG UK, CONF MEASL CAS ENGL; *HLTH PROT AG UK, ANN COV VACC EV RAP; *HLTH PROT AG UK, INCR MEASL CAS 2006; *HLTH PROT SURV CT, ANN REP 2006; *HUNG CENTR STAT O, YB HLTH STAT 2000 20; Hutchins SS, 2004, J INFECT DIS, V189, pS153, DOI 10.1086/379652; IOVOLL O, 2007, EURO SURVEILL, V12; Kalies H, 2006, EUR J PEDIATR, V165, P30, DOI 10.1007/s00431-005-1758-0; Kremer JR, 2008, EMERG INFECT DIS, V14, P107, DOI 10.3201/eid1401.070778; LERNOUT T, 2007, EUROSURVEILLANCE, V12; *MIN HLTH, 2007, DGPREVV10606P14CA9 P; *MIN HLTH IT, VACC COV; Mulders MN, 2001, VACCINE, V19, P2245, DOI 10.1016/S0264-410X(00)00453-9; Muscat M, 2007, VACCINE, V25, P6232, DOI 10.1016/j.vaccine.2007.05.063; *NAT PUBL HLTH I F, VACC COV; Pritt BS, 2005, ARCH PATHOL LAB MED, V129, P1476; *PUBL HLTH AUTH SL, EV ADM INSP VACC SLO; Richard J l, 2008, Euro Surveill, V13; RICHARD JL, 2007, EUROSURVEILLANCE, V12; Rota PA, 2003, J INFECT DIS, V187, pS270, DOI 10.1086/368042; Schmid D., 2008, Eurosurveillance, V13, P18838; TORNER N, 2007, EUROSURVEILLANCE, V12; *WHO, 2005, EL MEASL RUB PREV CO; World Health Organization, 2003, SURV GUID MEASL CONG	35	158	164	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					383	389		10.1016/S0140-6736(08)61849-8	http://dx.doi.org/10.1016/S0140-6736(08)61849-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401BC	19131097				2022-12-24	WOS:000262912100029
J	Povelones, M; Waterhouse, RM; Kafatos, FC; Christophides, GK				Povelones, Michael; Waterhouse, Robert M.; Kafatos, Fotis C.; Christophides, George K.			Leucine-Rich Repeat Protein Complex Activates Mosquito Complement in Defense Against Plasmodium Parasites	SCIENCE			English	Article							VECTOR ANOPHELES-GAMBIAE; IMMUNE-RESPONSES; MALARIA; PHAGOCYTOSIS; LAMPREY; GENES	Leucine-rich repeat-containing proteins are central to host defense in plants and animals. We show that in the mosquito Anopheles gambiae, two such proteins that antagonize malaria parasite infections, LRIM1 and APL1C, circulate in the hemolymph as a high-molecular-weight complex held together by disulfide bridges. The complex interacts with the complement C3-like protein, TEP1, promoting its cleavage or stabilization and its subsequent localization on the surface of midgut-invading Plasmodium berghei parasites, targeting them for destruction. LRIM1 and APL1C are members of a protein family with orthologs in other disease vector mosquitoes and appear to be important effectors in innate mosquito defenses against human pathogens.	[Povelones, Michael; Waterhouse, Robert M.; Kafatos, Fotis C.; Christophides, George K.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Christophides, GK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Dept Life Sci, Exhibit Rd, London SW7 2AZ, England.	g.christophides@imperial.ac.uk	Waterhouse, Robert M/A-1858-2010	Waterhouse, Robert M/0000-0003-4199-9052; Christophides, George/0000-0002-3323-1687; Povelones, Michael/0000-0002-3766-2097	Wellcome Trust Program [GR077229/Z/05/Z]; NIH [2PO1AI044220-06A1]; Biotechnology and Biological Sciences Research Council [BB/E002641/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; BBSRC [BB/E002641/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C519670/1] Funding Source: researchfish	Wellcome Trust Program(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank A. C. Koutsos for generating the LRIM1 antibody and sharing it before publication and F. M. Ausubel for critically reviewing the manuscript. Fluorescence microscopy was performed at the Imperial College Facility for Imaging by Light Microscopy imaging facility. This work was supported by a Wellcome Trust Program grant (GR077229/Z/05/Z), an NIH Program Project (2PO1AI044220-06A1), and a Biotechnology and Biological Sciences Research Council grant (BB/E002641/1). R.M.W. was supported by a Wellcome Trust Ph.D. fellowship.	Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; DONG Y, J BIOL CHEM; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Warr E, 2006, INSECT BIOCHEM MOLEC, V36, P769, DOI 10.1016/j.ibmb.2006.07.006	22	181	183	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					258	261		10.1126/science.1171400	http://dx.doi.org/10.1126/science.1171400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19264986	Green Accepted			2022-12-24	WOS:000265024400048
J	Parashar, UD; Glass, RI				Parashar, Umesh D.; Glass, Roger I.			Global Health: Rotavirus Vaccines - Early Success, Remaining Questions.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EFFICACY; SAFETY		[Parashar, Umesh D.] Ctr Dis Control & Prevent, Div Viral Dis, Viral Gastroenteritis Epidemiol Team, Atlanta, GA USA; [Glass, Roger I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Parashar, UD (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Viral Gastroenteritis Epidemiol Team, Atlanta, GA USA.							Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P398; Haber P, 2008, PEDIATRICS, V121, P1206, DOI 10.1542/peds.2007-3793; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Staat A. M., 2008, Morbidity and Mortality Weekly Report, V57, P697; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664	5	60	62	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1063	1065		10.1056/NEJMp0810154	http://dx.doi.org/10.1056/NEJMp0810154			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417BW	19279338				2022-12-24	WOS:000264051000003
J	Wu, PYJ; Nurse, P				Wu, Pei-Yun Jenny; Nurse, Paul			Establishing the Program of Origin Firing during S Phase in Fission Yeast	CELL			English	Article							DNA-REPLICATION ORIGINS; CYCLE-DEPENDENT REGULATION; CEREVISIAE CHROMOSOME VI; SACCHAROMYCES-CEREVISIAE; RECOGNITION COMPLEX; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; EGG EXTRACTS; CHROMATIN; PROTEINS	Initiation of eukaryotic DNA synthesis occurs at origins of replication that are utilized with characteristic times and frequencies during S phase. We have investigated origin usage by evaluating the kinetics of replication factor binding in fission yeast and show that similar to metazoa, ORC binding is periodic during the cell cycle, increasing during mitosis and peaking at M/G1. At an origin, the timing of ORC binding in M and pre-RC assembly in G1 correlates with the timing of firing during S, and the level of pre-IC formation reflects origin efficiency. Extending mitosis allows ORC to become more equally associated with origins and leads to genome-wide changes in origin usage, while overproduction of pre-IC factors increases replication of both efficient and inefficient origins. We propose that differential recruitment of ORC to origins during mitosis followed by competition among origins for limiting replication factors establishes the timing and efficiency of origin firing.	[Wu, Pei-Yun Jenny; Nurse, Paul] Rockefeller Univ, Lab Yeast Genet & Cell Biol, New York, NY 10065 USA	Rockefeller University	Wu, PYJ (corresponding author), Rockefeller Univ, Lab Yeast Genet & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	pwu@rockefeller.edu		Wu, Pei-Yun/0000-0002-7965-583X	National Institutes of Health Postdoctoral Fellowship [GM075572]; Stanley Shuman Postdoctoral Fellowship; Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075572] Funding Source: NIH RePORTER	National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Shuman Postdoctoral Fellowship; Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Shah-an Yang for help with the bioinformatics analysis. We are grateful to Supriya Prasanth and Bruce Stillman for sharing unpublished data and to all the members of the Laboratory of Yeast Genetics and Cell Biology for critical reading of the manuscript. This study was supported by National Institutes of Health Postdoctoral Fellowship GM075572, the Sydney and Stanley Shuman Postdoctoral Fellowship, and the Breast Cancer Research Foundation.	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; DePamphilis ML, 2005, CELL CYCLE, V4, P70, DOI 10.4161/cc.4.1.1333; DIFFLEY JFX, 1994, CURR OPIN CELL BIOL, V6, P368, DOI 10.1016/0955-0674(94)90028-0; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; HAYLES J, 1992, ANNU REV GENET, V26, P373, DOI 10.1146/annurev.ge.26.120192.002105; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Li CJ, 2002, MOL CELL BIOL, V22, P105, DOI 10.1128/MCB.22.1.105-116.2002; Lucas I, 2007, EMBO REP, V8, P770, DOI 10.1038/sj.embor.7401026; Lygerou Z, 1999, J CELL SCI, V112, P3703; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; MAUNDRELL K, 1988, EMBO J, V7, P2203, DOI 10.1002/j.1460-2075.1988.tb03059.x; Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538; Mesner LD, 2006, MOL CELL, V21, P719, DOI 10.1016/j.molcel.2006.01.015; Mickle KL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-112; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Okuno Y, 1999, MOL CELL BIOL, V19, P6699; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Okuno Y, 1997, NUCLEIC ACIDS RES, V25, P530, DOI 10.1093/nar/25.3.530; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; Patel PK, 2008, MOL BIOL CELL, V19, P5550, DOI 10.1091/mbc.E08-06-0645; Pollok S, 2007, FEBS J, V274, P3669, DOI 10.1111/j.1742-4658.2007.05900.x; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Remus D, 2005, J BIOL CHEM, V280, P39740, DOI 10.1074/jbc.M508515200; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; ROWLEY A, 1995, EMBO J, V14, P2631, DOI 10.1002/j.1460-2075.1995.tb07261.x; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; SHINOMIYA T, 1991, NUCLEIC ACIDS RES, V19, P3935, DOI 10.1093/nar/19.14.3935; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Sun WH, 2002, EMBO J, V21, P1437, DOI 10.1093/emboj/21.6.1437; Takahashi T, 2003, EMBO J, V22, P964, DOI 10.1093/emboj/cdg079; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	56	103	103	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					852	864		10.1016/j.cell.2009.01.017	http://dx.doi.org/10.1016/j.cell.2009.01.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269364	Green Accepted, Bronze			2022-12-24	WOS:000263930900009
J	Bristol, N				Bristol, Nellie			Medicare drug expansion causes controversy in the USA	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					532	532		10.1016/S0140-6736(09)60183-5	http://dx.doi.org/10.1016/S0140-6736(09)60183-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19230076	Green Submitted			2022-12-24	WOS:000263333600013
J	Krug, AZ; Jablonski, D; Valentine, JW				Krug, Andrew Z.; Jablonski, David; Valentine, James W.			Signature of the End-Cretaceous Mass Extinction in the Modern Biota	SCIENCE			English	Article							LATITUDINAL DIVERSITY GRADIENT; RECENT BIVALVE FAUNAS; INDO-WEST PACIFIC; FOSSIL RECORD; MARINE REALM; DIVERSIFICATION; ORIGINATION; SPECIATION; EVOLUTION; PATTERNS	The long- term effects of mass extinctions on spatial and evolutionary dynamics have been poorly studied. Here we show that the evolutionary consequences of the end- Cretaceous [ Cretaceous/ Paleogene ( K/ Pg)] mass extinction persist in present- day biogeography. The geologic ages of genera of living marine bivalves show a significant break from a smooth exponential distribution, corresponding to the K/ Pg boundary. The break reflects a permanent increase in origination rates, intermediate between the Mesozoic rate and the post- extinction recovery pulse. This global rate shift is most clearly seen today in tropical bioprovinces and weakens toward the poles. Coupled with the modern geographic distributions of taxa originating before and after the K/ Pg boundary, this spatial pattern indicates that tropical origination rates after the K/ Pg event have left a permanent mark on the taxonomic and biogeographic structure of the modern biota, despite the complex Cenozoic history of marine environments.	[Krug, Andrew Z.; Jablonski, David] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Valentine, James W.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Valentine, James W.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	University of Chicago; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Krug, AZ (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.				NASA	NASA(National Aeronautics & Space Administration (NASA))	We thank M. Foote, S. M. Kidwell, T. D. Price, K. Roy, and three anonymous reviewers for comments and M. Foote for programming assistance. This research was supported by NASA.	Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Behrensmeyer AK, 2005, PALEOBIOLOGY, V31, P607, DOI 10.1666/0094-8373(2005)031[0607:ATMDST]2.0.CO;2; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Crame JA, 2002, PALEOBIOLOGY, V28, P184; Foote M, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P245; Foote M, 2003, J GEOL, V111, P125, DOI 10.1086/345841; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; MILLER AI, 1988, PALEOBIOLOGY, V14, P364, DOI 10.1017/S0094837300012100; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Nee S, 2001, EVOLUTION, V55, P661, DOI 10.1554/0014-3820(2001)055[0661:ISRFP]2.0.CO;2; Nee S, 2004, PALEOBIOLOGY, V30, P172, DOI 10.1666/0094-8373(2004)030<0172:EMESMI>2.0.CO;2; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; PEASE CM, 1987, PALEOBIOLOGY, V13, P484; RAUP D M, 1975, Paleobiology, V1, P333; RAUP DM, 1978, PALEOBIOLOGY, V4, P1; RAUP DM, 1993, SCIENCE, V260, P971, DOI 10.1126/science.11537491; Reaka ML, 2008, P NATL ACAD SCI USA, V105, P11474, DOI 10.1073/pnas.0802594105; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Roy K, 2007, AM NAT, V170, pS71, DOI 10.1086/519403; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Stanley SM, 2008, PALEOBIOLOGY, V34, P1, DOI 10.1666/07026.1; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Vermeij G.J, 1987, EVOLUTION ESCALATION; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x	31	54	54	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					767	771		10.1126/science.1164905	http://dx.doi.org/10.1126/science.1164905			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197060				2022-12-24	WOS:000263066800042
J	Moses, M				Moses, Melanie			Being Human: Engineering: Worldwide ebb	NATURE			English	Editorial Material									[Moses, Melanie] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA	University of New Mexico	Moses, M (corresponding author), Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA.	melaniem@unm.edu							0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 5	2009	457	7230					660	661		10.1038/457660a	http://dx.doi.org/10.1038/457660a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	403EA	19194432	Bronze			2022-12-24	WOS:000263064700021
J	Koppel, DA				Koppel, David A.			Medicine and the Media Serious documentary or freak show?	BRITISH MEDICAL JOURNAL			English	Editorial Material									So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow	Koppel, DA (corresponding author), So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland.	David.Koppel@ggc.scot.nhs.uk							0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 4	2009	338								b71	10.1136/bmj.b71	http://dx.doi.org/10.1136/bmj.b71			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OY	19193688				2022-12-24	WOS:000263876300013
J	Young, LJ				Young, Larry J.			Being Human: Love: Neuroscience reveals all	NATURE			English	Editorial Material									[Young, Larry J.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University	Young, LJ (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30322 USA.	lyoun03@emory.edu	Young, Larry/HGE-5031-2022						0	52	56	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					148	148		10.1038/457148a	http://dx.doi.org/10.1038/457148a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19129828				2022-12-24	WOS:000262360200017
J	Park, BS; Song, DH; Kim, HM; Choi, BS; Lee, H; Lee, JO				Park, Beom Seok; Song, Dong Hyun; Kim, Ho Min; Choi, Byong-Seok; Lee, Hayyoung; Lee, Jie-Oh			The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex	NATURE			English	Article							TOLL-LIKE RECEPTORS; CRYSTAL-STRUCTURE; HUMAN MD-2; LIPID-A; ENDOTOXIN; RESPONSIVENESS; BINDING; ROLES; TLR4; BACTERIAL	The lipopolysaccharide (LPS) of Gram negative bacteria is a well-known inducer of the innate immune response(1). Toll-like receptor (TLR) 4 and myeloid differentiation factor 2 (MD-2) form a heterodimer that recognizes a common 'pattern' in structurally diverse LPS molecules. To understand the ligand specificity and receptor activation mechanism of the TLR4-MD-2-LPS complex we determined its crystal structure. LPS binding induced the formation of an m-shaped receptor multimer composed of two copies of the TLR4-MD-2-LPS complex arranged symmetrically. LPS interacts with a large hydrophobic pocket in MD-2 and directly bridges the two components of the multimer. Five of the six lipid chains of LPS are buried deep inside the pocket and the remaining chain is exposed to the surface of MD-2, forming a hydrophobic interaction with the conserved phenylalanines of TLR4. The F126 loop of MD-2 undergoes localized structural change and supports this core hydrophobic interface by making hydrophilic interactions with TLR4. Comparison with the structures of tetra-acylated antagonists bound to MD-2 indicates that two other lipid chains in LPS displace the phosphorylated glucosamine backbone by similar to 5 angstrom towards the solvent area(2,3). This structural shift allows phosphate groups of LPS to contribute to receptor multimerization by forming ionic interactions with a cluster of positively charged residues in TLR4 and MD-2. The TLR4-MD-2-LPS structure illustrates the remarkable versatility of the ligand recognition mechanisms employed by the TLR family(4,5), which is essential for defence against diverse microbial infection.	[Park, Beom Seok; Song, Dong Hyun; Kim, Ho Min; Choi, Byong-Seok; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea; [Lee, Hayyoung] Chungnam Natl Univ, Sch Biosci & Biotechnol, Dept Biol, Taejon 305764, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	jieoh.lee@kaist.ac.kr	Kim, Ho Min/G-2712-2011; Choi, Byong-Seok/C-1937-2011; Lee, Jie-Oh/AAG-4302-2020; Lee, Jie-Oh/C-1581-2011	Lee, Jie-Oh/0000-0001-6519-6049	Ministry of Education, Science and Technology of Korea	Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank the staff of beamline 4A at the Pohang Accelerator Laboratory and beamline ID23-2 at ESRF for help with data collection. We thank J. Gross for critical reading of the manuscript. J.-O.L and co-workers are funded by the Creative Research Initiative (Center for Membrane Receptor Research) from the Ministry of Education, Science and Technology of Korea.	Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MEDZHITOV R, 1997, NATURE, V388, P397; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; RIETSCHEL ET, 1993, IMMUNOBIOLOGY, V187, P169, DOI 10.1016/S0171-2985(11)80338-4; Rossignol Daniel P, 2005, Curr Opin Investig Drugs, V6, P496; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; ULMER AJ, 1992, INFECT IMMUN, V60, P3309, DOI 10.1128/IAI.60.8.3309-3314.1992; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245	34	1483	1553	8	270	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1191	U130		10.1038/nature07830	http://dx.doi.org/10.1038/nature07830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19252480				2022-12-24	WOS:000265754600051
J	Panstruga, R; Parker, JE; Schulze-Lefert, P				Panstruga, Ralph; Parker, Jane E.; Schulze-Lefert, Paul			SnapShot: Plant Immune Response Pathways	CELL			English	Editorial Material							RESISTANCE		[Panstruga, Ralph; Parker, Jane E.; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Max Planck Society	Panstruga, R (corresponding author), Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany.		Schulze-Lefert, Paul/B-6707-2011; Panstruga, Ralph/F-3340-2011	Panstruga, Ralph/0000-0002-3756-8957	Deutsche Forschungsgemeinschaft [SFB670]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Authors are supported by the Deutsche Forschungsgemeinschaft (SFB670).	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042	9	74	81	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					978	U6	978.e1	10.1016/j.cell.2009.02.020	http://dx.doi.org/10.1016/j.cell.2009.02.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269372	Bronze			2022-12-24	WOS:000263930900019
J	Neovius, M; Sundstrom, J; Rasmussen, F				Neovius, Martin; Sundstrom, Johan; Rasmussen, Finn			Combined effects of overweight and smoking in late adolescence on subsequent mortality: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; FOLLOW-UP; OBESITY; MEN; UNDERWEIGHT; WEIGHT; METAANALYSIS; PREVALENCE; HEIGHT; TRENDS	Objective To investigate the combined effects on adult mortality of overweight and smoking in late adolescence. Design Record linkage study with Cox proportional hazard ratios adjusted for muscle strength, socioeconomic position, and age. Setting Swedish military service conscription register, cause of death register, and census data. Participants 45920 Swedish men (mean age 18.7, SD 0.5) followed for 38 years. Main outcome measures Body mass index (underweight (BMI < 18.5), normal weight (18.5-24.9), overweight (25-29.9), and obesity (>= 30)), muscle strength, and self reported smoking (non-smoker, light smoker (1-10 cigarettes/day), heavy smoker (> 10/day)) at mandatory military conscription tests in 1969-70. All cause mortality. Results Over 1.7 million person years, 2897 men died. Compared with normal weight men (incidence rate 17/10000 person years, 95% confidence interval 16 to 18), risk of mortality was increased in overweight (hazard ratio 1.33, 1.15 to 1.53; incidence rate 23, 20 to 26) and obese men (hazard ratio 2.14,1.61 to 2.85; incidence rate 38,27 to 48), with similar relative estimates in separate analyses of smokers and non-smokers. No increased risk was detected in underweight men (hazard ratio 0.97, 0.86 to 1.08; incidence rate 18, 16 to 19), though extreme underweight (BMI < 17) was associated with increased mortality (hazard ratio 1.33, 1.07 to 1.64; incidence rate 24, 19 to 29). The relative excess risk due to interaction between BMI and smoking status was not significant in any stratum. Furthermore, all estimates of interaction were of small magnitude, except for the combination of obesity and heavy smoking (relative excess risk 1.5,-0.7 to 3.7). Compared with non-smokers (incidence rate 14, 13 to 15), risk was increased in both light (hazard ratio 1.54, 1.41 to 1.70; incidence rate 15, 14 to 16) and heavy smokers (hazard ratio 2.11, 1.92 to 2.31; incidence rate 26, 24 to 27). Conclusions Regardless of smoking status, overweight and obesity in late adolescence increases the risk of adult mortality. Obesity and overweight were as hazardous as heavy and light smoking, respectively, but there was no interaction between BMI and smoking status. The global obesity epidemic and smoking among adolescents remain important targets for intensified public health initiatives.	[Sundstrom, Johan] Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden	Uppsala University; Uppsala University Hospital		martin.neovius@ki.se	Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009	Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454; Rasmussen, Finn/0000-0001-7915-7809; Neovius, Martin/0000-0003-2300-3055	Arbetsmarknadens Forsakrings-och Aktiebolag (AFA); Swedish Heart-Lung Foundation and the Swedish Research Council [2007-5942]	Arbetsmarknadens Forsakrings-och Aktiebolag (AFA); Swedish Heart-Lung Foundation and the Swedish Research Council	MN was funded by Arbetsmarknadens Forsakrings-och Aktiebolag (AFA) and JS by the Swedish Heart-Lung Foundation and the Swedish Research Council (2007-5942). The funding sources did not read or comment on any version of the manuscript, nor influence the analyses in any way.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; *CAN, 2006, 95 CAN; COX DR, 1972, J R STAT SOC B, V34, P187; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Falkstedt D, 2007, INT J OBESITY, V31, P777, DOI 10.1038/sj.ijo.0803480; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; HOFFMANS MDAF, 1988, J CLIN EPIDEMIOL, V41, P749, DOI 10.1016/0895-4356(88)90161-8; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Hublet A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-280; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Neovius M, 2008, INT J OBESITY, V32, P1319, DOI 10.1038/ijo.2008.70; Neovius M, 2008, OBESITY, V16, P671, DOI 10.1038/oby.2007.115; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Nyholm M, 2008, OBESITY, V16, P896, DOI 10.1038/oby.2007.134; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Popkin BM, 2006, OBESITY, V14, P1846, DOI 10.1038/oby.2006.213; Rasmussen F, 2007, EUR J CLIN NUTR, V61, P870, DOI 10.1038/sj.ejcn.1602595; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; SONNEHOLM S, 1983, BRIT MED J, V287, P795, DOI 10.1136/bmj.287.6395.795; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Strickler HD, 2005, JAMA-J AM MED ASSOC, V294, P551, DOI 10.1001/jama.294.5.551-b; van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]	34	82	84	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2009	338								b496	10.1136/bmj.b496	http://dx.doi.org/10.1136/bmj.b496			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DQ	19244221	Green Published, hybrid			2022-12-24	WOS:000264056100004
J	Grande, D; Asch, DA				Grande, David; Asch, David A.			Commercial versus Social Goals of Tracking What Doctors Do	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Grande, David] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Asch, David A.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Asch, David A.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center	Grande, D (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.		Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735; Asch, David/0000-0002-7970-286X				*IMS HLTH, IMS CORP OV; POTTENGER B, FREECONOMICS HLTH CA	2	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					747	749		10.1056/NEJMp0810410	http://dx.doi.org/10.1056/NEJMp0810410			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408CN	19228616				2022-12-24	WOS:000263411300002
J	Fontanilla, D; Johannessen, M; Hajipour, AR; Cozzi, NV; Jackson, MB; Ruoho, AE				Fontanilla, Dominique; Johannessen, Molly; Hajipour, Abdol R.; Cozzi, Nicholas V.; Jackson, Meyer B.; Ruoho, Arnold E.			The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator	SCIENCE			English	Article							TRACE AMINES; BINDING-SITE; IN-VIVO; CHANNELS; IDENTIFICATION; TRYPTAMINES; MODULATION; TERMINALS; LIGANDS; MOUSE	The sigma-1 receptor is widely distributed in the central nervous system and periphery. Originally mischaracterized as an opioid receptor, the sigma-1 receptor binds a vast number of synthetic compounds but does not bind opioid peptides; it is currently considered an orphan receptor. The sigma- 1 receptor pharmacophore includes an alkylamine core, also found in the endogenous compound N, N- dimethyltryptamine ( DMT). DMT acts as a hallucinogen, but its receptor target has been unclear. DMT bound to sigma- 1 receptors and inhibited voltage- gated sodium ion ( Na+) channels in both native cardiac myocytes and heterologous cells that express sigma- 1 receptors. DMT induced hypermobility in wild- type mice but not in sigma- 1 receptor knockout mice. These biochemical, physiological, and behavioral experiments indicate that DMT is an endogenous agonist for the sigma- 1 receptor.	[Fontanilla, Dominique; Cozzi, Nicholas V.; Ruoho, Arnold E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA; [Johannessen, Molly; Jackson, Meyer B.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Physiol, Madison, WI 53706 USA; [Hajipour, Abdol R.] Isfahan Univ Technol, Pharmaceut Res Lab, Dept Chem, Esfahan 84156, Iran	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Isfahan University of Technology	Ruoho, AE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA.	aeruoho@wisc.edu	Cozzi, Nicholas/AAT-1633-2020		Molecular and Cellular Pharmacology (MCP) Graduate Program; NIH [T32 GM08688, R01 MH065503, NS30016]; NIH Ruth L. Kirschstein National Research Service Award [F31 DA022932]; National Institute on Drug Abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030016, R01NS030016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA022932] Funding Source: NIH RePORTER	Molecular and Cellular Pharmacology (MCP) Graduate Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Corinna Burger laboratory for use of their mouse behavior equipment, and A. Paul and T. Mavlyutov for providing [<SUP>125</SUP>I] IAF and [<SUP>125</SUP>I]- IACoc, respectively. Supported by the Molecular and Cellular Pharmacology (MCP) Graduate Program training grant from NIH T32 GM08688 and by the NIH Ruth L. Kirschstein National Research Service Award (NRSA) (F31 DA022932) from the National Institute on Drug Abuse ( to D.F.). This work was funded by NIH grants R01 MH065503 ( to A. E. R.) and NS30016 ( to M. B. J.).	AXELROD J, 1961, SCIENCE, V134, P343, DOI 10.1126/science.134.3475.343; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Barker S A, 1981, Int Rev Neurobiol, V22, P83, DOI 10.1016/S0074-7742(08)60291-3; BEATON JM, 1984, MECH AGEING DEV, V25, P343, DOI 10.1016/0047-6374(84)90007-1; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; BOUCHARD P, 1995, EUR J NEUROSCI, V7, P1952, DOI 10.1111/j.1460-9568.1995.tb00718.x; Burchett SA, 2006, PROG NEUROBIOL, V79, P223, DOI 10.1016/j.pneurobio.2006.07.003; Chen YM, 2007, BIOCHEMISTRY-US, V46, P3532, DOI 10.1021/bi061727o; FRANZEN F, 1965, NATURE, V206, P1052, DOI 10.1038/2061052a0; GLENNON RA, 1994, J MED CHEM, V37, P1214, DOI 10.1021/jm00034a020; Hayashi T, 2004, CNS DRUGS, V18, P269, DOI 10.2165/00023210-200418050-00001; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Jacob MS, 2005, MED HYPOTHESES, V64, P930, DOI 10.1016/j.mehy.2004.11.005; JENNER P, 1980, BRIT J PHARMACOL, V69, P69, DOI 10.1111/j.1476-5381.1980.tb10884.x; JOHANNESSEN MA, 2007, ANN NEUR M SAN DIEG; KAHOUN JR, 1992, P NATL ACAD SCI USA, V89, P1393, DOI 10.1073/pnas.89.4.1393; KENNEDY C, 1990, NEUROSCIENCE, V35, P725, DOI 10.1016/0306-4522(90)90343-3; Langa F, 2003, EUR J NEUROSCI, V18, P2188, DOI 10.1046/j.1460-9568.2003.02950.x; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; Matsumoto RR, 2000, EUR J PHARMACOL, V401, P155, DOI 10.1016/S0014-2999(00)00430-1; Moebius FF, 1997, BRIT J PHARMACOL, V121, P1, DOI 10.1038/sj.bjp.0701079; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; SAAVEDRA JM, 1972, SCIENCE, V175, P1365, DOI 10.1126/science.175.4028.1365; SU TP, 1986, LIFE SCI, V38, P2199; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Wilke RA, 1999, J PHYSIOL-LONDON, V517, P391, DOI 10.1111/j.1469-7793.1999.00391.x; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152; Zhang HL, 2002, J NEUROPHYSIOL, V87, P2867, DOI 10.1152/jn.2002.87.6.2867	29	375	383	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					934	937		10.1126/science.1166127	http://dx.doi.org/10.1126/science.1166127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213917	Green Accepted			2022-12-24	WOS:000263295400042
J	Thathiah, A; Spittaels, K; Hoffmann, M; Staes, M; Cohen, A; Horre, K; Vanbrabant, M; Coun, F; Baekelandt, V; Delacourte, A; Fischer, DF; Pollet, D; De Strooper, B; Merchiers, P				Thathiah, Amantha; Spittaels, Kurt; Hoffmann, Marcel; Staes, Mik; Cohen, Adrian; Horre, Katrien; Vanbrabant, Mieke; Coun, Frea; Baekelandt, Veerle; Delacourte, Andre; Fischer, David F.; Pollet, Dirk; De Strooper, Bart; Merchiers, Pascal			The Orphan G Protein-Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons	SCIENCE			English	Article							GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; TRANSGENIC MICE; LIPID RAFTS; EXPRESSION; PRESENILIN; NICASTRIN; REQUIRES; GOLGI; PEN-2	Deposition of the amyloid-beta peptide is a pathological hallmark of Alzheimer's disease. A high- throughput functional genomics screen identified G protein- coupled receptor 3 ( GPR3), a constitutively active orphan G protein- coupled receptor, as a modulator of amyloid-beta production. Overexpression of GPR3 stimulated amyloid-beta production, whereas genetic ablation of GPR3 prevented accumulation of the amyloid-beta peptide in vitro and in an Alzheimer's disease mouse model. GPR3 expression led to increased formation and cell- surface localization of the mature gamma-secretase complex in the absence of an effect on Notch processing. GPR3 is highly expressed in areas of the normal human brain implicated in Alzheimer's disease and is elevated in the sporadic Alzheimer's disease brain. Thus, GPR3 represents a potential therapeutic target for the treatment of Alzheimer's disease.	[Fischer, David F.] BioFocus DPI, Galapagos Co, NL-2333 CR Leiden, Netherlands; [Delacourte, Andre] Jean Pierre Aubert Res Ctr, INSERM, Unit 837, F-59045 Lille, France; [Thathiah, Amantha; Horre, Katrien; Vanbrabant, Mieke; De Strooper, Bart] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Thathiah, Amantha; Horre, Katrien; Vanbrabant, Mieke; De Strooper, Bart] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Spittaels, Kurt; Hoffmann, Marcel; Staes, Mik; Cohen, Adrian; Pollet, Dirk; Merchiers, Pascal] Galapagos, B-2800 Mechelen, Belgium; [Coun, Frea; Baekelandt, Veerle] Catholic Univ Louvain, Lab Neurobiol & Gene Therapy, Div Mol Med, B-3000 Louvain, Belgium	Galapagos NV; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Catholique Louvain; Galapagos NV; Universite Catholique Louvain	Fischer, DF (corresponding author), BioFocus DPI, Galapagos Co, Darwinweg 24, NL-2333 CR Leiden, Netherlands.	david.fischer@glpg.com; bart.destrooper@med.kuleuven.be	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012; Baekelandt, Veerle/ABB-9736-2020	De Strooper, Bart/0000-0001-5455-5819; Baekelandt, Veerle/0000-0001-8966-2921; Fischer, David/0000-0002-6690-0197; Horre, Katrien/0000-0002-6801-3137	Methusalem grant from the Flemish government [IWT990363, IWT010512, IWT030623]; Fund for Scientific Research (Flanders, Belgium); Federal Office for Scientific Affairs, Belgium [IUAP P6/43/]	Methusalem grant from the Flemish government; Fund for Scientific Research (Flanders, Belgium)(FWO); Federal Office for Scientific Affairs, Belgium	We acknowledge the contributions of W. Laenen, H. Klaassen, S. Hinnekint, S. de Vos, E. van Rossen, A. Van de Poel, M. De Raeymaeker, K. Thys, J. Vandersmissen, J. van der Schueren, R. Brown, K. Albert, V. Coose, K. Pittois, S. Theunissen, V. Hendrix, E. Maes, K. Craessaerts, J. Prennen, A. Deelder, P. Scheltens, and M. Mercken. We are grateful to G. Vassart and C. Ledent (Universit, Libre de Bruxelles, Brussels, Belgium) for the RT-GPR3 and RT-TSHr cDNA and assistance with cAMP assays, C. H. Berlot (Geisinger Medical Center, Danville, PA) for the GsDN and R280K cDNA, and Murat Bastepe (Harvard Medical School, Boston, MA) for the G<INF>s alpha</INF>-null mouse embryo fibroblasts. This project was supported by IWT990363, IWT010512, and IWT030623, a Methusalem grant from the Flemish government, the Fund for Scientific Research (Flanders, Belgium), and the Federal Office for Scientific Affairs (IUAP P6/43/), Belgium. B. D. S. has been a paid consultant for Galapagos, a drug discovery company. Galapagos holds U. S. patent 7429459 on the GPR3 findings and the technology and library used in this study.	Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HEIBER M, 1995, DNA CELL BIOL, V14, P25, DOI 10.1089/dna.1995.14.25; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; IISMAA TP, 1994, GENOMICS, V24, P391, DOI 10.1006/geno.1994.1635; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Pooler AM, 2004, NEUROSCI LETT, V362, P127, DOI 10.1016/j.neulet.2004.03.013; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Saunders AJ, 1999, SCIENCE, V286; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001	27	114	127	5	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					946	951		10.1126/science.1160649	http://dx.doi.org/10.1126/science.1160649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213921				2022-12-24	WOS:000263295400046
J	Worth, A; Irshad, T; Bhopal, R; Brown, D; Lawton, J; Grant, E; Murray, S; Kendall, M; Adam, J; Gardee, R; Sheikh, A				Worth, Allison; Irshad, Tasneem; Bhopal, Raj; Brown, Duncan; Lawton, Julia; Grant, Elizabeth; Murray, Scott; Kendall, Marilyn; Adam, James; Gardee, Rafik; Sheikh, Aziz			Vulnerability and access to care for South Asian Sikh and Muslim patients with life limiting illness in Scotland: prospective longitudinal qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SPECIALIST PALLIATIVE CARE; HEALTH-CARE; ETHNIC DIVERSITY; SERVICES; CANCER; COMMUNITY; VIEWS; END; UK; PROFESSIONALS	Objectives To examine the care experiences of South Asian Sikh and Muslim patients in Scotland with life limiting illness and their families and to understand the reasons for any difficulties with access to services and how these might be overcome. Design Prospective, longitudinal, qualitative design using in-depth interviews. Setting Central Scotland. Participants 25 purposively selected South Asian Sikh and Muslim patients, 18 family carers, and 20 key health professionals. Results 92 interviews took place. Most services struggled to deliver responsive, culturally appropriate care. Barriers to accessing effective end of life care included resource constrained services; institutional and, occasionally, personal racial and religious discrimination; limited awareness and understanding among South Asian people of the role of hospices; and difficulty discussing death. The most vulnerable patients, including recent migrants and those with poor English language skills, with no family advocate, and dying of non-malignant diseases were at particularly high risk of inadequate care. Conclusions Despite a robust Scottish diversity policy, services for South Asian Sikh and Muslim patients with life limiting illness were wanting in many key areas. Active case management of the most vulnerable patients and carers, and "real time" support, from where professionals can obtain advice specific to an individual patient and family, are the approaches most likely to instigate noticeable improvements in access to high quality end of life care. Improving access to palliative care for all, particularly those with non-malignant illnesses, as well as focusing on the specific needs of ethnic minority groups, is required.	[Bhopal, Raj; Murray, Scott; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland; [Brown, Duncan] St Columbas Hosp, Edinburgh, Midlothian, Scotland; [Adam, James] Marie Curie Hosp, Glasgow, Lanark, Scotland; [Gardee, Rafik] Natl Resource Ctr Ethn Minor Hlth, Glasgow, Lanark, Scotland	University of Edinburgh; University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland.	Aziz.Sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056	Chief Scientist Office, Scottish Government Health Department	Chief Scientist Office, Scottish Government Health Department	Chief Scientist Office, Scottish Government Health Department. The research team is independent of the funders and the views expressed are those of the researchers, not the funding body.	Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; Bhopal R, 2007, ETHNICITY RACE HLTH; Boyd KJ, 2004, EUR J HEART FAIL, V6, P585, DOI 10.1016/j.ejheart.2003.11.018; Carstairs V., 1991, DEPRIVATION HLTH SCO; Clark J, 2003, BRIT MED J, V327, P174, DOI 10.1136/bmj.327.7408.174; CONILL C, 1990, CANCER, V65, P1864, DOI 10.1002/1097-0142(19900415)65:8<1864::AID-CNCR2820650832>3.0.CO;2-U; Darzi A., 2008, HIGH QUALITY CARE AL; DAVIES E, 2004, PALLIATIVE CARE SOLI; Davies E, 2004, BETTER PALLIATIVE CA; Elkan R, 2007, EUR J CANCER CARE, V16, P109, DOI 10.1111/j.1365-2354.2006.00726.x; Equalities Review, 2007, FAIRN FREED FIN REP; Exley C, 2005, PALLIATIVE MED, V19, P76, DOI 10.1191/0269216305pm973oa; Firth S, 2001, WIDER HORIZONS CARE; Gatrad AR, 2003, BRIT MED J, V327, P176, DOI 10.1136/bmj.327.7408.176; GATRAD R, 2007, PALLIATIVE CARE S AS; *GEN REG OFF SCOTL, 2008, SCOTL CENS 2001; Grande GE, 2006, AGE AGEING, V35, P267, DOI 10.1093/ageing/afj071; Gunaratnam Y., 2007, IMPROVING QUALITY PA; Higginson IJ, 1999, J PUBLIC HEALTH MED, V21, P22, DOI 10.1093/pubmed/21.1.22; HILL D, 1995, OPENING DOORS IMPROV; Jones K, 2005, J RES NURS, V10, P431, DOI 10.1177/174498710501000406; Kai J, 2001, MED EDUC, V35, P262, DOI 10.1046/j.1365-2923.2001.00880.x; Kai J, 2006, VALUING DIVERSITY RE; Kai J, 2007, PLOS MED, V4, P1766, DOI 10.1371/journal.pmed.0040323; Karim K, 2000, PALLIATIVE MED, V14, P471, DOI 10.1191/026921600701536390; Kendall M, 2007, BMJ-BRIT MED J, V334, P521, DOI 10.1136/bmj.39097.582639.55; Kessler D, 2005, PALLIATIVE MED, V19, P105, DOI 10.1191/0269216305pm980oa; Koffman J, 2007, PALLIATIVE MED, V21, P145, DOI 10.1177/0269216306074639; Krakauer EL, 2002, J AM GERIATR SOC, V50, P182, DOI 10.1046/j.1532-5415.2002.50027.x; Lingard L, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39602.690162.47; Merrell J, 2006, HEALTH SOC CARE COMM, V14, P197, DOI 10.1111/j.1365-2524.2006.00610.x; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2008, BRIT MED J, V336, P958, DOI 10.1136/bmj.39535.491238.94; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; Nazroo JY, 1998, SOCIOL HEALTH ILL, V20, P710, DOI 10.1111/1467-9566.00126; NBCWN, 2008, WE CAR TOO PUTT BLAC; Netuveli G, 2005, LANCET, V365, P312, DOI 10.1016/S0140-6736(05)17785-X; Owens A, 2004, HEALTH SOC CARE COMM, V12, P414, DOI 10.1111/j.1365-2524.2004.00511.x; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Richardson A, 2006, EUR J ONCOL NURS, V10, P93, DOI 10.1016/j.ejon.2005.05.002; ROBINSON LA, 1995, BRIT MED J, V311, P315, DOI 10.1136/bmj.311.7000.315; Sadiq A, 2008, CARING MUSLIM PATIEN, V2nd; Salway S., 2007, LONG TERM ILL HLTH P; *SCOTT EX, 2002, 200251 NHS HDL SCOTT; Seamark DA, 2007, J ROY SOC MED, V100, P225, DOI 10.1258/jrsm.100.5.225; Sheikh A, 2006, PLOS MED, V3, P166, DOI 10.1371/journal.pmed.0030049; Sheikh A, 2007, BRIT MED J, V334, P74, DOI 10.1136/bmj.39072.347720.68; Shi LY, 2005, J GEN INTERN MED, V20, P148, DOI 10.1111/j.1525-1497.2005.40136.x; Shipman C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1720; Sultana K, 2008, J ROY SOC MED, V101, P463, DOI 10.1258/jrsm.2008.080007; Szczepura A, 2005, POSTGRAD MED J, V81, P141, DOI 10.1136/pgmj.2004.026237; WEBB E, 2005, ARCH DIS CHILDHOOD-E, V90, P11; Wild SH, 2006, BRIT J CANCER, V94, P1079, DOI 10.1038/sj.bjc.6603031	53	76	76	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2009	338								b183	10.1136/bmj.b183	http://dx.doi.org/10.1136/bmj.b183			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OX	19190015	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000263876200003
J	Jinnah, S; Jungcurt, S				Jinnah, Sikina; Jungcurt, Stefan			GLOBAL BIOLOGICAL RESOURCES Could Access Requirements Stifle Your Research?	SCIENCE			English	Editorial Material							GENETIC-RESOURCES; SCIENCE; PREDICAMENT		[Jinnah, Sikina] Brown Univ, Watson Inst Int Studies, Providence, RI 02912 USA; [Jungcurt, Stefan] Int Inst Sustainable Dev, Winnipeg, MB R3B 0Y4, Canada	Brown University	Jinnah, S (corresponding author), Brown Univ, Watson Inst Int Studies, Providence, RI 02912 USA.	sikina_jinnah@brown.edu; stefan@iisd.org	Jungcurt, Stefan/AAI-9864-2020; Jinnah, Sikina/AAI-9231-2020	Jungcurt, Stefan/0000-0001-9520-613X; Jinnah, Sikina/0000-0003-4528-3000				Bawa KS, 2006, CURR SCI INDIA, V91, P1005; Check E, 2007, NATURE, V448, P634, DOI 10.1038/448634a; Cooper H.D., 2002, REV EUROPEAN COMMUNI, V11, P1, DOI [https://doi.org/10.1111/1467-9388.00298, DOI 10.1111/1467-9388.00298]; Fowler C, 2004, GENET RESOUR CROP EV, V51, P609, DOI 10.1023/B:GRES.0000024646.81612.1f; Fowler C, 2002, SCIENCE, V297, P157, DOI 10.1126/science.297.5579.157; Gaillard J.F., 1994, KNOWL TECH POL, V7, P31, DOI [DOI 10.1007/BF02692761, https://doi.org/10.1007/BF02692761]; *INT I SUST DEV, 2007, EARTH NEG B, V398; *INT I SUST DEV, 2008, EARTH NEG B, V452; *INT I SUST DEV, 2008, EARTH NEG B, V416; Jayaraman KS, 2008, NATURE, V452, P7, DOI 10.1038/452007a; Jungcurt S., 2008, I INTERPLAY INT ENV; Madhusudan MD, 2006, CURR SCI INDIA, V91, P1015; MASOOD E, 2004, SCIDEVNET NEWS  0415; Pethiyagoda R, 2007, CURR SCI INDIA, V92, P426; Prathapan KD, 2008, CURR SCI INDIA, V94, P170; REVKIN A, 2002, NY TIMES        1203, pF1; Sauve R, 2003, AGR SYST, V78, P307, DOI 10.1016/S0308-521X(03)00131-8; ten Kate K, 2002, SCIENCE, V295, P2371, DOI 10.1126/science.1070725	18	33	35	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					464	465		10.1126/science.1167234	http://dx.doi.org/10.1126/science.1167234			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396JL	19164733				2022-12-24	WOS:000262587900026
J	Piddini, E; Vincent, JP				Piddini, Eugenia; Vincent, Jean-Paul			Interpretation of the Wingless Gradient Requires Signaling-Induced Self-Inhibition	CELL			English	Article							LONG-RANGE ACTION; MORPHOGEN GRADIENT; POSITIONAL INFORMATION; DISC DEVELOPMENT; SONIC HEDGEHOG; BETA-CATENIN; DROSOPHILA; ENCODES; AXIN; PROTEINS	In a classical view of development, a cell can acquire positional information by reading the local concentration of a morphogen independently of its neighbors. Accordingly, in Drosophila, the morphogen Wingless produced in the wing's prospective distal region activates target genes in a dose-dependent fashion to organize the proximodistal pattern. Here, we show that, in parallel, Wingless triggers two nonautonomous inhibitory programs that play an important role in the establishment of positional information. Cells flanking the source of Wingless produce a negative signal (encoded by notum) that inhibits Wingless signaling in nearby cells. Additionally, in response to Wingless, all prospective wing cells produce an unidentified signal that dampens target gene expression in surrounding cells. Thus, cells influence each other's response to Wingless through at least two modes of lateral inhibition. Without lateral inhibition, some cells acquire ectopic fates. Lateral inhibition may be a general mechanism behind the interpretation of morphogen gradients.	[Piddini, Eugenia; Vincent, Jean-Paul] Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Vincent, JP (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jvincen@nimr.mrc.ac.uk		Piddini, Eugenia/0000-0003-3901-076X	MRC [MC_U117584268] Funding Source: UKRI; Medical Research Council [MC_U117584268] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Arias AM, 2003, NAT REV MOL CELL BIO, V4, P321, DOI 10.1038/nrm1078; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Chen CM, 1999, DEVELOPMENT, V126, P5441; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Day SJ, 2000, DEVELOPMENT, V127, P2977; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Feldman B, 2002, CURR BIOL, V12, P2129, DOI 10.1016/S0960-9822(02)01361-1; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Gurdon JB, 1999, DEVELOPMENT, V126, P5309; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hoffmans R, 2005, CURR BIOL, V15, P1207, DOI 10.1016/j.cub.2005.05.054; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jaeger J, 2008, DEVELOPMENT, V135, P3175, DOI 10.1242/dev.018697; Jaiswal M, 2006, DEVELOPMENT, V133, P925, DOI 10.1242/dev.02243; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Klein T, 1999, DEVELOPMENT, V126, P913; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Lawrence PA, 2001, NAT CELL BIOL, V3, pE151, DOI 10.1038/35083096; Liem KF, 2000, DEVELOPMENT, V127, P4855; Masland RH, 2005, CURR BIOL, V15, pR808, DOI 10.1016/j.cub.2005.09.023; Meinhardt H, 2001, INT J DEV BIOL, V45, P177; MORATA G, 1977, DEV BIOL, V56, P227, DOI 10.1016/0012-1606(77)90266-4; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Ng M, 1996, NATURE, V381, P316, DOI 10.1038/381316a0; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Patten I, 2002, CURR BIOL, V12, P47, DOI 10.1016/S0960-9822(01)00631-5; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Sato A, 1999, DEVELOPMENT, V126, P4421; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; SHARMA RP, 1976, DEV BIOL, V48, P461, DOI 10.1016/0012-1606(76)90108-1; Sivasankaran R, 2000, MECH DEVELOP, V91, P427, DOI 10.1016/S0925-4773(99)00313-5; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vincent JP, 2001, CURR BIOL, V11, pR851, DOI 10.1016/S0960-9822(01)00514-0; Wang SH, 2000, GENE DEV, V14, P2271, DOI 10.1101/gad.827000; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wu J, 2002, DEVELOPMENT, V129, P2411; XU T, 1993, DEVELOPMENT, V117, P1223; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zecca M, 2007, DEVELOPMENT, V134, P3001, DOI 10.1242/dev.006411; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	59	47	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					296	307		10.1016/j.cell.2008.11.036	http://dx.doi.org/10.1016/j.cell.2008.11.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167331	Bronze			2022-12-24	WOS:000262648800018
J	Morrow, TJ; Li, MW; Kim, J; Mayer, TS; Keating, CD				Morrow, Thomas J.; Li, Mingwei; Kim, Jaekyun; Mayer, Theresa S.; Keating, Christine D.			Programmed Assembly of DNA-Coated Nanowire Devices	SCIENCE			English	Article							ARRAYS; BOTTOM		[Li, Mingwei; Kim, Jaekyun; Mayer, Theresa S.] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA; [Morrow, Thomas J.; Keating, Christine D.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mayer, TS (corresponding author), Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.	tsm2@psu.edu; keating@chem.psu.edu		Keating, Christine/0000-0001-6039-1961	NIH; NSF; Semiconductor Research Corporation-Nanoelectronics Research Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000268] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Semiconductor Research Corporation-Nanoelectronics Research Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Supported by NIH, NSF, and Semiconductor Research Corporation-Nanoelectronics Research Initiative.	Ahn JH, 2006, SCIENCE, V314, P1754, DOI 10.1126/science.1132394; Ho TT, 2008, NANO LETT, V8, P4359, DOI 10.1021/nl8022059; Ito T, 2000, NATURE, V406, P1027, DOI 10.1038/35023233; Li MW, 2008, NAT NANOTECHNOL, V3, P88, DOI 10.1038/nnano.2008.26; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640	6	99	105	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					352	352		10.1126/science.1165921	http://dx.doi.org/10.1126/science.1165921			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150837	Green Accepted			2022-12-24	WOS:000262481400029
J	Viale, A; De Franco, F; Orleth, A; Cambiaghi, V; Giuliani, V; Bossi, D; Ronchini, C; Ronzoni, S; Muradore, I; Monestiroli, S; Gobbi, A; Alcalay, M; Minucci, S; Pelicci, PG				Viale, Andrea; De Franco, Francesca; Orleth, Annette; Cambiaghi, Valeria; Giuliani, Virginia; Bossi, Daniela; Ronchini, Chiara; Ronzoni, Simona; Muradore, Ivan; Monestiroli, Silvia; Gobbi, Alberto; Alcalay, Myriam; Minucci, Saverio; Pelicci, Pier Giuseppe			Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; ONCOGENE-INDUCED SENESCENCE; HEMATOPOIETIC STEM; REPOPULATING ABILITY; PROGENITOR CELLS; GENE-TRANSFER; REPAIR; REPLICATION; EXPRESSION; BREAKS	Rare cells with the properties of stem cells are integral to the development and perpetuation of leukaemias. A defining characteristic of stem cells is their capacity to self- renew, which is markedly extended in leukaemia stem cells. The underlying molecular mechanisms, however, are largely unknown. Here we demonstrate that expression of the cell- cycle inhibitor p21 is indispensable for maintaining self- renewal of leukaemia stem cells. Expression of leukaemia- associated oncogenes in mouse haematopoietic stem cells ( HSCs) induces DNA damage and activates a p21- dependent cellular response, which leads to reversible cell- cycle arrest and DNA repair. Activated p21 is critical in preventing excess DNA- damage accumulation and functional exhaustion of leukaemic stem cells. These data unravel the oncogenic potential of p21 and suggest that inhibition of DNA repair mechanisms might function as potent strategy for the eradication of the slowly proliferating leukaemia stem cells.	[Viale, Andrea; De Franco, Francesca; Orleth, Annette; Cambiaghi, Valeria; Giuliani, Virginia; Bossi, Daniela; Ronchini, Chiara; Ronzoni, Simona; Muradore, Ivan; Monestiroli, Silvia; Gobbi, Alberto; Alcalay, Myriam; Minucci, Saverio; Pelicci, Pier Giuseppe] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; [De Franco, Francesca; Orleth, Annette] Univ Perugia, Dipartimento Med Clin & Sperimentale, Monteluce Policlin, I-06100 Perugia, Italy; [Minucci, Saverio] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20100 Milan, Italy; [Alcalay, Myriam; Pelicci, Pier Giuseppe] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20100 Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Perugia; University of Milan; University of Milan	Viale, A (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus, I-20141 Milan, Italy.	andrea.viale@ifom-ieo-campus.it; piergiuseppe.pelicci@ifom-ieo-campus.it	Ronchini, Chiara/K-3935-2013; Alcalay, Myriam/AAB-4300-2019; Pelicci, Pier Giuseppe/AAL-6572-2020; Bossi, Daniela/G-2401-2015; Minucci, Saverio/J-9669-2012; Alcalay, Myriam/B-3182-2016; Ronzoni, Simona/AAQ-1669-2020	Ronchini, Chiara/0000-0003-3908-4021; Alcalay, Myriam/0000-0002-5558-4272; Bossi, Daniela/0000-0002-8507-6754; Alcalay, Myriam/0000-0002-5558-4272; 	Italian Association on Cancer Research; Ministero Italiano della Salute, Cariplo; European Community (FP6: EPITRON and GENICA); Vollaro Foundation	Italian Association on Cancer Research(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano della Salute, Cariplo(Fondazione Cariplo); European Community (FP6: EPITRON and GENICA)(European Commission); Vollaro Foundation	We thank L. Luzi, D. Shing and M. Faretta for discussions and suggestions; M. Capillo, M. Stendardo and D. Sardella for assistance in maintenance of mouse colonies and for mouse genotyping; B. Amati, G. McVie, P. P. Di Fiore and C. Basilico for reviewing the manuscript; and P. Dalton for editing the manuscript. This study was supported by grants from the Italian Association on Cancer Research (AIRC), Ministero Italiano della Salute, Cariplo and the European Community (FP6: EPITRON and GENICA) to P. G.P.A.V. is a fellow of the Vollaro Foundation.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cheng T, 2004, ONCOGENE, V23, P7256, DOI 10.1038/sj.onc.1207945; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Furuta T, 2006, ONCOGENE, V25, P2839, DOI 10.1038/sj.onc.1209313; Grignani F, 1998, CANCER RES, V58, P14; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; HARRISON DE, 1983, J EXP MED, V157, P1496, DOI 10.1084/jem.157.5.1496; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; HEYTING C, 1980, CARCINOGENESIS, V1, P769, DOI 10.1093/carcin/1.9.769; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Insinga A, 2004, EMBO J, V23, P1144, DOI 10.1038/sj.emboj.7600109; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ishikawa K, 2006, DNA CELL BIOL, V25, P406, DOI 10.1089/dna.2006.25.406; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Livneh Z, 2001, J BIOL CHEM, V276, P25639, DOI 10.1074/jbc.R100019200; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Minucci S, 2002, BLOOD, V100, P2989, DOI 10.1182/blood-2001-11-0089; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Paulson QX, 2008, ONCOGENE, V27, P4954, DOI 10.1038/onc.2008.138; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Shepherd BE, 2007, BLOOD, V110, P1806, DOI 10.1182/blood-2007-02-075382; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; SZILVASSY SJ, 1989, BLOOD, V74, P930; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhou CX, 2006, MUTAT RES-GEN TOX EN, V604, P8, DOI 10.1016/j.mrgentox.2005.12.004	46	236	250	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 1	2009	457	7225					51	U52		10.1038/nature07618	http://dx.doi.org/10.1038/nature07618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122635				2022-12-24	WOS:000262104900028
J	Ritz, E; Bakris, G				Ritz, E.; Bakris, G.			World Kidney Day: hypertension and chronic kidney disease	LANCET			English	Editorial Material							CKD		[Ritz, E.] Nierenzentrum, Dept Internal Med, Organising Comm, D-69100 Heidelberg, Germany; [Bakris, G.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Ritz, E (corresponding author), Nierenzentrum, Dept Internal Med, Organising Comm, D-69100 Heidelberg, Germany.	prof.e.ritz@t-online.de						Alebiosu CO, 2005, ETHNIC DIS, V15, P418; Atkins RC, 2005, KIDNEY INT, V67, pS14, DOI 10.1111/j.1523-1755.2005.09403.x; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Khosla N, 2006, CLIN J AM SOC NEPHRO, V1, P229, DOI 10.2215/CJN.00840805; KLAHR S, 1989, NEW ENGL J MED, V320, P731, DOI 10.1056/NEJM198903163201110; Lea JP, 2006, AM J KIDNEY DIS, V47, P72, DOI 10.1053/j.ajkd.2005.09.027; Perico N, 2005, KIDNEY INT, V68, pS87, DOI 10.1111/j.1523-1755.2005.09715.x; Rao MV, 2008, AM J KIDNEY DIS, V51, pS30, DOI 10.1053/j.ajkd.2007.12.012; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415	9	33	36	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2009	373	9670					1157	1158		10.1016/S0140-6736(09)60355-X	http://dx.doi.org/10.1016/S0140-6736(09)60355-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429SO	19282027				2022-12-24	WOS:000264940600009
J	Saito, T; Fujii, T; Kanatani, Y; Saijo, M; Morikawa, S; Yokote, H; Takeuchi, T; Kuwabara, N				Saito, Tomoya; Fujii, Tatsuya; Kanatani, Yasuhiro; Saijo, Masayuki; Morikawa, Shigeru; Yokote, Hiroyuki; Takeuchi, Tsutomu; Kuwabara, Noriyuki			Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC16m8	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; ANTIVIRAL IMMUNITY; REVACCINATION; DURATION; PROTECTION; STRAIN	Context The attenuated, tissue-cultured, third-generation smallpox vaccine LC16m8 was administered to vaccinia-naive infants in Japan during the 1970s without serious adverse events. It is a good candidate for use as part of a prevention plan for bio-terrorism. Objective To assess the immunogenicity and frequency of adverse events of LC16m8 vaccine in unvaccinated and previously vaccinated adults. Design, Setting, and Participants Between 2002 and 2005 we vaccinated and revaccinated 1529 and 1692 adults, respectively, in the Japan Self-Defense Forces with LC16m8 vaccine, given intraepidermally using a bifurcated needle. Vaccinees were examined 10 to 14 days after vaccination to determine if they had developed a major skin reaction ("take"). Neutralizing antibody responses among 200 participants were assessed using a plaque-reduction neutralization test 30 days postvaccination. We monitored vaccinees for adverse events for 30 days postvaccination. Main Outcome Measures Documentation of a vaccine take, presence of neutralizing antibody response, and frequency of adverse events. Results The proportions of take in vaccinia-naive and previously vaccinated individuals were 1443 of 1529 (94.4% [95% confidence interval {CI}, 93.2%-95.9%] and 1465 of 1692 (86.6% [95% CI, 85.0%-88.2%]), respectively. Seroconversion or an effective booster response among the individuals with take was elicited in 37 of 41 (90.2% [95% CI, 81.2%-99.3%]) vaccinia-naive participants and in 93 of 155 (60.0% [95% CI, 52.3%-67.7%]) previously vaccinated participants. One case of allergic dermatitis and another of erythema multiforme, both of which were mild and self-limited, were suspected to be caused by vaccination. No severe adverse events were observed. Conclusion Administration of an attenuated tissue-cultured smallpox vaccine (LC16m8) to healthy adults was associated with high levels of vaccine take and seroconversion in those who were vaccinia-naive and yielded an effective booster response in some previously vaccinated individuals.	[Kanatani, Yasuhiro] Natl Def Med Coll, Res Inst, Tokorozawa, Saitama 3598513, Japan; [Saito, Tomoya; Takeuchi, Tsutomu] Keio Univ, Dept Trop Med & Parasitol, Sch Med, Biopreparedness Res Lab, Tokyo, Japan; [Fujii, Tatsuya] Japan Self Def Forces Cen Hosp, Dept Internal Med, Tokyo, Japan; [Kuwabara, Noriyuki] Japan Self Def Forces Cen Hosp, Ctr Hlth Management, Tokyo, Japan; [Saijo, Masayuki; Morikawa, Shigeru] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Yokote, Hiroyuki] Chemosero Therapeut Res Inst Kaketsuken, Kumamoto, Japan	National Defense Medical College - Japan; Keio University; National Institute of Infectious Diseases (NIID)	Kanatani, Y (corresponding author), Natl Def Med Coll, Res Inst, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	ykanatan@ndmc.ac.jp	Saijo, Masayuki/L-2697-2019; Kanatani, Yasuhiro/AAE-5551-2019; 金谷, 泰宏/GQZ-8179-2022	Kanatani, Yasuhiro/0000-0001-5790-4084; Saito, Tomoya/0000-0001-6250-4464; MORIKAWA, SHIGERU/0000-0001-6249-6716	Japan Ministry of Health, Labour and Welfare	Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by research funding from the Japan Ministry of Health, Labour and Welfare in fiscal year 2004-2006.	*AC INC, VACC REL BIOL PROD A; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Arita I, 2005, LANCET INFECT DIS, V5, P647, DOI 10.1016/S1473-3099(05)70242-5; Arita I, 2002, JPN J INFECT DIS, V55, P112; Balicer RD, 2005, HUM VACCINES, V1, P224, DOI 10.4161/hv.1.6.2279; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Empig C, 2006, VACCINE, V24, P3686, DOI 10.1016/j.vaccine.2005.03.029; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P241, DOI 10.1086/375824; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hashizume S., 1985, VACCINIA VIRUSES VEC, P87; Hatakeyama S, 2005, CLIN DIAGN LAB IMMUN, V12, P520, DOI 10.1128/CDLI.12.4.520-524.2005; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; HIRAYAMA M, 1975, SMALLPOX VACCINATION; *JAP DEF AG, 2002, GUID SMALLP VACC; *JAP DEF AG, 2005, DEF JAP 2005; Jezek Z, 1988, HUMAN MONKEYPOX; Kidokoro M, 2005, P NATL ACAD SCI USA, V102, P4152, DOI 10.1073/pnas.0406671102; Manischewitz J, 2003, J INFECT DIS, V188, P440, DOI 10.1086/376557; Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; Neff J, 2008, CLIN INFECT DIS, V46, pS258, DOI 10.1086/524749; Nishiura H, 2006, EPIDEMIOLOGY, V17, P576, DOI 10.1097/01.ede.0000229196.41862.c2; Orr N, 2004, J INFECT DIS, V190, P1295, DOI 10.1086/423851; Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05; Sejvar JJ, 2005, JAMA-J AM MED ASSOC, V294, P2744, DOI 10.1001/jama.294.21.2744; SHINMURA Y, 2007, 55 ANN M JAP SOC VIR; *WHO ADV COMM VAR, 2007, REP 9 M NOV 29 30 GE; Yamaguchi M, 1975, RINSHO UIRUSU, V3, P269	31	47	48	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1025	1033		10.1001/jama.2009.289	http://dx.doi.org/10.1001/jama.2009.289			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416OQ	19278946	Bronze			2022-12-24	WOS:000264015800026
J	Clevers, H				Clevers, Hans			Inflammatory Bowel Disease, Stress, and the Endoplasmic Reticulum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LINKS		[Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Clevers, H (corresponding author), Hubrecht Inst, Utrecht, Netherlands.				Agamyxis	Agamyxis	Dr. Clevers reports having an equity interest in Agamyxis. No potential conflict of interest relevant to this article was reported.	Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199	5	13	15	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					726	727		10.1056/NEJMcibr0809591	http://dx.doi.org/10.1056/NEJMcibr0809591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405YQ	19213688				2022-12-24	WOS:000263260500013
J	Ping, PP				Ping, Peipei			Getting to the Heart of Proteomics.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ping, Peipei] Univ Calif Los Angeles, David Geffen Sch Med, NHLBI, Program Project Myocardial Ischemia Injury & Prot, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ping, PP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, NHLBI, Program Project Myocardial Ischemia Injury & Prot, Los Angeles, CA 90095 USA.			Ping, Peipei/0000-0003-3583-3881	NHLBI NIH HHS [R37 HL063901, P01 HL080111-04, P01 HL080111, R01 HL101228] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063901, R01HL101228, P01HL080111] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Ping PP, 1997, CIRC RES, V81, P404, DOI 10.1161/01.RES.81.3.404; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; YTREHUS K, 1994, AM J PHYSIOL, V266, pH1145, DOI 10.1152/ajpheart.1994.266.3.H1145	5	22	22	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					532	534		10.1056/NEJMcibr0808487	http://dx.doi.org/10.1056/NEJMcibr0808487			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179323	Green Accepted			2022-12-24	WOS:000262812400018
J	Yang, JJ; Cheng, C; Yang, WJ; Pei, DQ; Cao, XY; Fan, YP; Pounds, SB; Neale, G; Trevino, LR; French, D; Campana, D; Downing, JR; Evans, WE; Pui, CH; Devidas, M; Bowman, WP; Camitta, BM; Willman, CL; Davies, SM; Borowitz, MJ; Carroll, WL; Hunger, SP; Relling, MV				Yang, Jun J.; Cheng, Cheng; Yang, Wenjian; Pei, Deqing; Cao, Xueyuan; Fan, Yiping; Pounds, Stanley B.; Neale, Geoffrey; Trevino, Lisa R.; French, Deborah; Campana, Dario; Downing, James R.; Evans, William E.; Pui, Ching-Hon; Devidas, Meenakshi; Bowman, W. P.; Camitta, Bruce M.; Willman, Cheryl L.; Davies, Stella M.; Borowitz, Michael J.; Carroll, William L.; Hunger, Stephen P.; Relling, Mary V.			Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic Leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMAL RESIDUAL DISEASE; CHILDRENS ONCOLOGY GROUP; CORONARY-ARTERY-DISEASE; P-GLYCOPROTEIN; RISK; METHOTREXATE; EXPRESSION; INTERLEUKIN-15; POLYMORPHISMS; IDENTIFICATION	Context Pediatric acute lymphoblastic leukemia ( ALL) is the prototype for a drug-responsive malignancy. Although cure rates exceed 80%, considerable unexplained interindividual variability exists in treatment response. Objectives To assess the contribution of inherited genetic variation to therapy response and to identify germline single- nucleotide polymorphisms ( SNPs) associated with risk of minimal residual disease ( MRD) after remission induction chemotherapy. Design, Setting, and Patients Genome- wide interrogation of 476 796 germline SNPs to identify genotypes that were associated with MRD in 2 independent cohorts of children with newly diagnosed ALL: 318 patients in St Jude Total Therapy protocols XIIIB and XV and 169 patients in Children's Oncology Group trial P9906. Patients were enrolled between 1994 and 2006 and last follow- up was in 2006. Main Outcome Measures Minimal residual disease at the end of induction therapy, measured by flow cytometry. Results There were 102 SNPs associated with MRD in both cohorts ( median odds ratio, 2.18; P <=. 0125), including 5 SNPs in the interleukin 15 ( IL15) gene. Of these 102 SNPs, 21 were also associated with hematologic relapse ( P <. 05). Of 102 SNPs, 21 were also associated with antileukemic drug disposition, generally linking MRD eradication with greater drug exposure. In total, 63 of 102 SNPs were associated with early response, relapse, or drug disposition. Conclusion Host genetic variations are associated with treatment response for childhood ALL, with polymorphisms related to leukemia cell biology and host drug disposition associated with lower risk of residual disease.	[Yang, Jun J.; Cheng, Cheng; Yang, Wenjian; Pei, Deqing; Cao, Xueyuan; Fan, Yiping; Pounds, Stanley B.; Neale, Geoffrey; Trevino, Lisa R.; French, Deborah; Campana, Dario; Downing, James R.; Evans, William E.; Pui, Ching-Hon; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Devidas, Meenakshi] Univ Florida, Gainesville, FL USA; [Bowman, W. P.] Cook Childrens Med Ctr, Ft Worth, TX USA; [Camitta, Bruce M.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Willman, Cheryl L.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Davies, Stella M.] Cincinnati Childrens Hosp & Med Ctr, Cincinnati, OH USA; [Borowitz, Michael J.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Carroll, William L.] NYU Med Ctr, New York, NY 10016 USA; [Hunger, Stephen P.] Childrens Hosp, Aurora, CO USA; [Hunger, Stephen P.] Univ Colorado, Ctr Canc, Aurora, CO USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; State University System of Florida; University of Florida; Cook Children's Medical Center; Medical College of Wisconsin; University of New Mexico; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Medicine; New York University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Relling, MV (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas Pl,MS313, Memphis, TN 38105 USA.	mary.relling@stjude.org	Pounds, Stanley B/N-2480-2018; Cheng, Cheng/N-8075-2018; Yang, Jun/B-6976-2008; Yang, Jun J./ABG-5646-2020; Relling, Mary/N-5032-2018; Devidas, Meenakshi/H-1170-2019; Pui, Ching-Hon/N-8076-2018; Evans, William E./C-2069-2012; Downing, James R./N-8102-2018	Pounds, Stanley B/0000-0002-9167-2114; Yang, Jun/0000-0002-0770-9659; Yang, Jun J./0000-0002-0770-9659; Devidas, Meenakshi/0000-0002-1099-3478; Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322; 	National Institutes of Health [CA 093552-02, CA 51001, CA 78224, CA 21765, CA R3736401, CA 60419, CA 086011, CA 98543, CA 29139]; National Institute of General Medical Sciences; Pharmacogenetics Research Network and Database [U01 GM61393, U01 GM61374]; NATIONAL CANCER INSTITUTE [R37CA036401, R01CA093552, P30CA021765, U10CA029139, U10CA098543, R29CA051001, R01CA051001, R01CA078224, R01CA060419, U10CA098413, R01CA086011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM061374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pharmacogenetics Research Network and Database(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants CA 093552-02, CA 51001, CA 78224, CA 21765, CA R3736401, CA 60419, CA 086011, CA 98543, CA 29139, and National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) Pharmacogenetics Research Network and Database grants U01 GM61393 and U01 GM61374 (http://www.pharmgkb.org) from the National Cancer Institute and NIGMS; by the American Lebanese Syrian Associated Charities; and by CureSearch.	Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Bleyer WA, 1997, J PEDIAT HEMATOL ONC, V19, P530, DOI 10.1097/00043426-199711000-00008; Borowitz MJ, 2003, LEUKEMIA, V17, P1566, DOI 10.1038/sj.leu.2403001; Bostrom BC, 2003, J PEDIAT HEMATOL ONC, V25, P114, DOI 10.1097/00043426-200302000-00006; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cario G, 2007, J CLIN ONCOL, V25, P4813, DOI 10.1200/JCO.2007.11.8166; Carroll WL, 2006, PEDIATR BLOOD CANCER, V46, P570, DOI 10.1002/pbc.20722; Carroll WL, 2003, JAMA-J AM MED ASSOC, V290, P2061, DOI 10.1001/jama.290.15.2061; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; Cheng C, 2004, STAT APPL GENET MOL, V3, P36; CONTER V, 1995, J CLIN ONCOL, V13, P2497, DOI 10.1200/JCO.1995.13.10.2497; Coustan-Smith E, 2000, BLOOD, V96, P2691, DOI 10.1182/blood.V96.8.2691; Coustan-Smith E, 1998, LANCET, V351, P550, DOI 10.1016/S0140-6736(97)10295-1; Davies SM, 2008, BLOOD, V111, P2984, DOI 10.1182/blood-2007-09-114082; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fleury Isabelle, 2004, Am J Pharmacogenomics, V4, P331, DOI 10.2165/00129785-200404050-00006; Flohr T, 2008, LEUKEMIA, V22, P771, DOI 10.1038/leu.2008.5; Holleman A, 2006, BLOOD, V107, P769, DOI 10.1182/blood-2005-07-2930; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Kadan-Lottick NS, 2003, JAMA-J AM MED ASSOC, V290, P2008, DOI 10.1001/jama.290.15.2008; Kager L, 2005, J CLIN INVEST, V115, P110, DOI 10.1172/JCI200522477; Kishi S, 2004, BLOOD, V103, P67, DOI 10.1182/blood-2003-06-2105; Kishi S, 2007, BLOOD, V109, P4151, DOI 10.1182/blood-2006-10-054528; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LEU BL, 1995, CANCER CHEMOTH PHARM, V35, P432, DOI 10.1007/s002800050258; LEWIS AD, 1992, CANCER RES, V52, P4379; Lugthart S, 2005, CANCER CELL, V7, P375, DOI 10.1016/j.ccr.2005.03.002; Malo N, 2008, AM J HUM GENET, V82, P375, DOI 10.1016/j.ajhg.2007.10.012; Masson E, 1996, J CLIN INVEST, V97, P73, DOI 10.1172/JCI118409; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Plasschaert SLA, 2004, CLIN PHARMACOL THER, V76, P220, DOI 10.1016/j.clpt.2004.05.007; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pui C.-H., 2004, Annals of Hematology, V83, pS124; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Relling MV, 1999, BLOOD, V93, P2817; RELLING MV, 1994, MOL PHARMACOL, V45, P352; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rocha JCC, 2005, BLOOD, V105, P4752, DOI 10.1182/blood-2004-11-4544; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schmidt S, 2006, BLOOD, V107, P2061, DOI 10.1182/blood-2005-07-2853; Schultz KR, 2007, BLOOD, V109, P926, DOI 10.1182/blood-2006-01-024729; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Sorich MJ, 2008, PLOS MED, V5, P646, DOI 10.1371/journal.pmed.0050083; Stanulla M, 2005, JAMA-J AM MED ASSOC, V293, P1485, DOI 10.1001/jama.293.12.1485; Szczepanski T, 2001, LANCET ONCOL, V2, P409, DOI 10.1016/S1470-2045(00)00418-6; Tinhofer I, 2000, BLOOD, V95, P610, DOI 10.1182/blood.V95.2.610; Tissing WJE, 2007, BLOOD, V109, P3929, DOI 10.1182/blood-2006-11-056366; Valdes AM, 2008, AM J HUM GENET, V82, P1231, DOI 10.1016/j.ajhg.2008.04.006; van Asperen J, 2000, DRUG METAB DISPOS, V28, P264; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6; Villikka K, 1999, CLIN PHARMACOL THER, V66, P589, DOI 10.1016/S0009-9236(99)90067-X; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yates CR, 2003, PHARM RES-DORDR, V20, P1794, DOI 10.1023/B:PHAM.0000003377.39548.f6; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang XJ, 2007, J INVEST DERMATOL, V127, P2544, DOI 10.1038/sj.jid.5700896; Zhou JB, 2007, BLOOD, V110, P1607, DOI 10.1182/blood-2006-09-045369	65	171	177	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2009	301	4					393	403		10.1001/jama.2009.7	http://dx.doi.org/10.1001/jama.2009.7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CE	19176441	Green Accepted			2022-12-24	WOS:000262777200019
J	Graham, SM; English, M				Graham, Stephen M.; English, Mike			Non-typhoidal salmonellae: a management challenge for children with community-acquired invasive disease in tropical African countries	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; MALAWIAN CHILDREN; SEVERE PNEUMONIA; BACTEREMIA; INFECTIONS; MENINGITIS; RESISTANCE; ETIOLOGY; MALARIA; GAMBIA		[Graham, Stephen M.] Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Dept Paediat, Parkville, Vic 3052, Australia; [Graham, Stephen M.] Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [English, Mike] Ctr Geog Med Res, Kenya Med Res Inst, Nairobi, Kenya	Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Kenya Medical Research Institute	Graham, SM (corresponding author), Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Dept Paediat, Parkville, Vic 3052, Australia.	steve.graham@rch.org.au		Graham, Stephen/0000-0003-3525-2294; English, Michael/0000-0002-7427-0826	Wellcome Trust [076827, 097170, 074124/Z/04/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Asghar R, 2008, BMJ-BRIT MED J, V336, P80, DOI 10.1136/bmj.39421.435949.BE; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Bahwere P, 2004, PEDIATR INFECT DIS J, V23, P739, DOI 10.1097/01.inf.0000135663.17018.51; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Cardoso MRA, 2008, ARCH DIS CHILD, V93, P221, DOI 10.1136/adc.2006.111625; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Falade AG, 1997, ANN TROP PAEDIATR, V17, P315, DOI 10.1080/02724936.1997.11747904; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Graham SM, 2002, CURR OPIN INFECT DIS, V15, P507, DOI 10.1097/00001432-200210000-00009; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; KABRA SK, 2006, COCHRANE DB SYST REV, V3, P4874; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086; World Health Organization, 2005, POCK HOSP CAR CHILDR	23	38	39	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2009	373	9659					267	269		10.1016/S0140-6736(09)60073-8	http://dx.doi.org/10.1016/S0140-6736(09)60073-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150705	Green Accepted			2022-12-24	WOS:000262537500029
J	Tigges, M; Marquez-Lago, TT; Stelling, J; Fussenegger, M				Tigges, Marcel; Marquez-Lago, Tatiana T.; Stelling, Joerg; Fussenegger, Martin			A tunable synthetic mammalian oscillator	NATURE			English	Article							CIRCADIAN GENE-EXPRESSION; CLOCK	Autonomous and self- sustained oscillator circuits mediating the periodic induction of specific target genes are minimal genetic time- keeping devices found in the central and peripheral circadian clocks(1,2). They have attracted significant attention because of their intriguing dynamics and their importance in controlling critical repair(3), metabolic(4) and signalling pathways(5). The precise molecular mechanism and expression dynamics of this mammalian circadian clock are still not fully understood. Here we describe a synthetic mammalian oscillator based on an auto- regulated sense - antisense transcription control circuit encoding a positive and a time- delayed negative feedback loop, enabling autonomous, self- sustained and tunable oscillatory gene expression. After detailed systems design with experimental analyses and mathematical modelling, we monitored oscillating concentrations of green fluorescent protein with tunable frequency and amplitude by time- lapse microscopy in real time in individual Chinese hamster ovary cells. The synthetic mammalian clock may provide an insight into the dynamics of natural periodic processes and foster advances in the design of prosthetic networks in future gene and cell therapies.	[Tigges, Marcel; Marquez-Lago, Tatiana T.; Stelling, Joerg; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Marquez-Lago, Tatiana T.; Stelling, Joerg] ETH, Inst Computat Sci, CH-8092 Zurich, Switzerland; [Marquez-Lago, Tatiana T.; Stelling, Joerg] ETH, Swiss Inst Bioinformat, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	joerg.stelling@bsse.ethz.ch; fussenegger@bsse.ethz.ch	Stelling, Joerg/F-7499-2010	Stelling, Joerg/0000-0002-1145-891X	Swiss National Science Foundation; EC Framework 6 (COBIOS)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC Framework 6 (COBIOS)(European Commission)	We thank H. Meyer for providing pcDNA3.1-Ub<SUP>V76</SUP>-GFP; and B. Kramer, M. Gitzinger, D. Greber and W. Weber for conceptual input and/or critical comments on the manuscript. This work was supported by the Swiss National Science Foundation and the EC Framework 6 (COBIOS).	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Chilov D, 2004, BIOTECHNOL BIOENG, V87, P234, DOI 10.1002/bit.20143; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Crosthwaite SK, 2004, FEBS LETT, V567, P49, DOI 10.1016/j.febslet.2004.04.073; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P1203, DOI 10.1038/81208; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; Fux C, 2001, Nucleic Acids Res, V29, pE19, DOI 10.1093/nar/29.4.e19; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kramer Beat P., 2005, V308, P123; LAHAV G, 2004, SCI STKE, pPE55, DOI DOI 10.1126/STKE.2642004PE55; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Moser S, 2001, J GENE MED, V3, P529, DOI 10.1002/jgm.219; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reppert SM, 1997, CELL, V89, P487, DOI 10.1016/S0092-8674(00)80229-9; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rossmanith W, 2002, DNA CELL BIOL, V21, P847, DOI 10.1089/104454902320908496; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Wu YH, 2006, FASEB J, V20, P1874, DOI 10.1096/fj.05-4446fje	29	420	448	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					309	312		10.1038/nature07616	http://dx.doi.org/10.1038/nature07616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19148099				2022-12-24	WOS:000262440900038
J	Walsh, S; Fan, SL				Walsh, Stephen; Fan, Stanley L.			Visualising rhabdomyolysis	LANCET			English	Editorial Material									[Walsh, Stephen] UCL, Royal Free & Univ Coll Med Sch, Ctr Neprhol, London, England; [Fan, Stanley L.] Barts & London Hosp NHS Trust, Dept Renal Med & Transplantat, London, England	University of London; University College London; Barts Health NHS Trust	Walsh, S (corresponding author), Royal Free Hosp, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	stephen.walsh@ucl.ac.uk	Walsh, Stephen Benedict/AAB-9930-2020; Fan, Stanley/ABA-1363-2020	Fan, Stanley/0000-0002-7323-1489; Walsh, Stephen/0000-0002-8693-1353					0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					154	154		10.1016/S0140-6736(09)60039-8	http://dx.doi.org/10.1016/S0140-6736(09)60039-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135612				2022-12-24	WOS:000262340900030
J	Li, QS; Estes, JD; Schlievert, PM; Duan, LJ; Brosnahan, AJ; Southern, PJ; Reilly, CS; Peterson, ML; Schultz-Darken, N; Brunner, KG; Nephew, KR; Pambuccian, S; Lifson, JD; Carlis, JV; Haase, AT				Li, Qingsheng; Estes, Jacob D.; Schlievert, Patrick M.; Duan, Lijie; Brosnahan, Amanda J.; Southern, Peter J.; Reilly, Cavan S.; Peterson, Marnie L.; Schultz-Darken, Nancy; Brunner, Kevin G.; Nephew, Karla R.; Pambuccian, Stefan; Lifson, Jeffrey D.; Carlis, John V.; Haase, Ashley T.			Glycerol monolaurate prevents mucosal SIV transmission	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; VAGINAL TRANSMISSION; EPITHELIAL-CELLS; INFECTION; HIV; RESPONSES; INNATE	Although there has been great progress in treating human immunodeficiency virus 1 (HIV-1) infection(1), preventing transmission has thus far proven an elusive goal. Indeed, recent trials of a candidate vaccine and microbicide have been disappointing, both for want of efficacy and concerns about increased rates of transmission(2-4). Nonetheless, studies of vaginal transmission in the simian immunodeficiency virus (SIV)-rhesus macaque (Macacca mulatta) model point to opportunities at the earliest stages of infection in which a vaccine or microbicide might be protective, by limiting the expansion of infected founder populations at the portal of entry(5,6). Here we show in this SIV-macaque model, that an outside-in endocervical mucosal signalling system, involving MIP-3 alpha (also known as CCL20), plasmacytoid dendritic cells and CCR5(+) cell-attracting chemokines produced by these cells, in combination with the innate immune and inflammatory responses to infection in both cervix and vagina, recruits CD4(+) T cells to fuel this obligate expansion. We then show that glycerol monolaurate-a widely used antimicrobial compound(7) with inhibitory activity against the production of MIP-3 alpha and other proinflammatory cytokines(8)-can inhibit mucosal signalling and the innate and inflammatory response to HIV-1 and SIV in vitro, and in vivo it can protect rhesus macaques from acute infection despite repeated intra-vaginal exposure to high doses of SIV. This new approach, plausibly linked to interfering with innate host responses that recruit the target cells necessary to establish systemic infection, opens a promising new avenue for the development of effective interventions to blockHIV-1 mucosal transmission.	[Li, Qingsheng; Schlievert, Patrick M.; Duan, Lijie; Brosnahan, Amanda J.; Southern, Peter J.; Haase, Ashley T.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Estes, Jacob D.; Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, Sci Applicat Int Corp Frederick Inc, Frederick, MD 21702 USA; [Reilly, Cavan S.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Peterson, Marnie L.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Schultz-Darken, Nancy; Brunner, Kevin G.; Nephew, Karla R.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Pambuccian, Stefan] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Carlis, John V.] Univ Minnesota, Inst Technol, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Haase, AT (corresponding author), Univ Minnesota, Dept Microbiol, MMC 196,420 Delaware St SE, Minneapolis, MN 55455 USA.	haase001@umn.edu		Schlievert, Patrick/0000-0001-8314-9369	National Institute of Health (NIH) [R21 AI071976, P01 AI066314]; National Cancer Institute, NIH [N01-CO-12400, HHSN266200400088C]; National Center for Research Resources [P51 RR000167]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, P51RR000167, C06RR015459, G20RR022780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI066314, R21AI071976] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Miller and D. Lu at the California National Primate Research Center, for helpful discussion and virus stocks, J. Kemnitz at the Wisconsin National Primate Research Center, for discussion and administrative support, and C. O'Neill and T. Leonard for help with the manuscript and figures. This work was supported in part by National Institute of Health (NIH) grants R21 AI071976 and P01 AI066314 (A. T. H.), funds from the National Cancer Institute, NIH, under contracts N01-CO-12400 and HHSN266200400088C (J. D. L.), and grant number P51 RR000167 from the National Center for Research Resources, a component of the NIH, to the Wisconsin National Primate Research Center. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or NIH.	CHECK E, 2007, NATURE, V446, P12; Cline AN, 2005, J MED PRIMATOL, V34, P303; Cohen J, 2008, SCIENCE, V319, P1026, DOI 10.1126/science.319.5866.1026b; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Crane-Godreau MA, 2005, INFECT IMMUN, V73, P476, DOI 10.1128/IAI.73.1.476-484.2005; Dieu-Nosjean MC, 1999, J LEUKOCYTE BIOL, V66, P252, DOI 10.1002/jlb.66.2.252; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Johnston R, 2002, AIDS PATIENT CARE ST, V16, P419, DOI 10.1089/108729102760330263; KABARA JJ, 1984, COSMETIC DRUG PRESER, P305; Klasse PJ, 2006, PLOS MED, V3, P1501, DOI 10.1371/journal.pmed.0030351; Ledford H, 2007, NATURE, V450, P325, DOI 10.1038/450325a; Li QS, 2004, J INFECT DIS, V189, P572, DOI 10.1086/381396; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Ma ZM, 2004, J VIROL, V78, P14048, DOI 10.1128/JVI.78.24.14048-14052.2004; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Narimatsu R, 2005, AIDS RES HUM RETROV, V21, P228, DOI 10.1089/aid.2005.21.228; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Schlievert PM, 2008, ANTIMICROB AGENTS CH, V52, P4448, DOI 10.1128/AAC.00989-08; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x	26	494	516	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1034	U113		10.1038/nature07831	http://dx.doi.org/10.1038/nature07831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262509	Green Published, Green Accepted			2022-12-24	WOS:000265412900044
J	Lourenco, D; Brauner, R; Lin, L; De Perdigo, A; Weryha, G; Muresan, M; Boudjenah, R; Guerra, G; Maciel-Guerra, AT; Achermann, JC; McElreavey, K; Bashamboo, A				Lourenco, Diana; Brauner, Raja; Lin, Lin; De Perdigo, Arantzazu; Weryha, Georges; Muresan, Mihaela; Boudjenah, Radia; Guerra-Junior, Gil; Maciel-Guerra, Andrea T.; Achermann, John C.; McElreavey, Ken; Bashamboo, Anu			Mutations in NR5A1 Associated with Ovarian Insufficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEROIDOGENIC FACTOR-I; LIGAND-BINDING DOMAIN; XY SEX REVERSAL; ADRENAL INSUFFICIENCY; NUCLEAR RECEPTOR; GONADAL DEVELOPMENT; GENETIC-DISEASE; 46,XY PATIENT; FACTOR-1; FAILURE	Background The genetic causes of nonsyndromic ovarian insufficiency are largely unknown. A nuclear receptor, NR5A1 (also called steroidogenic factor 1), is a key transcriptional regulator of genes involved in the hypothalamic-pituitary-steroidogenic axis. Mutation of NR5A1 causes 46, XY disorders of sex development, with or without adrenal failure, but growing experimental evidence from studies in mice suggests a key role for this factor in ovarian development and function as well. Methods To test the hypothesis that mutations in NR5A1 cause disorders of ovarian development and function, we sequenced NR5A1 in four families with histories of both 46, XY disorders of sex development and 46, XX primary ovarian insufficiency and in 25 subjects with sporadic ovarian insufficiency. None of the affected subjects had clinical signs of adrenal insufficiency. Results Members of each of the four families and 2 of the 25 subjects with isolated ovarian insufficiency carried mutations in the NR5A1 gene. In-frame deletions and frame-shift and missense mutations were detected. Functional studies indicated that these mutations substantially impaired NR5A1 transactivational activity. Mutations were associated with a range of ovarian anomalies, including 46, XX gonadal dysgenesis and 46, XX primary ovarian insufficiency. We did not observe these mutations in more than 700 control alleles. Conclusions NR5A1 mutations are associated with 46, XX primary ovarian insufficiency and 46, XY disorders of sex development.	[Lourenco, Diana; Boudjenah, Radia; McElreavey, Ken; Bashamboo, Anu] Inst Pasteur, F-75724 Paris, France; [Brauner, Raja] Univ Paris 05, Paris, France; [Brauner, Raja] AP HP, Paris, France; [Brauner, Raja] Hop Bicetre, Le Kremlin Bicetre, France; [Lin, Lin; Achermann, John C.] UCL Inst Child Hlth, Clin & Mol Genet Unit, Dev Endocrinol Res Grp, London, England; [De Perdigo, Arantzazu] Lab Cytogenet, Luxembourg, Luxembourg; [Weryha, Georges] CHU Brabois, Serv Endocrinol, Vandoeuvre Les Nancy, France; [Muresan, Mihaela] Hop Notre Dame de Bon Secours, Unite Endocrinol, Metz, France; [Guerra-Junior, Gil] Univ Estadual Campinas, Dept Pediat, Fac Med Sci, Campinas, Brazil; [Maciel-Guerra, Andrea T.] Univ Estadual Campinas, Dept Med Genet, Fac Med Sci, Campinas, Brazil	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; CHU de Nancy; CHR Metz-Thionville; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual de Campinas	Bashamboo, A (corresponding author), Inst Pasteur, 25 Rue Doctor Roux, F-75724 Paris, France.	kenmce@pasteur.fr	Guerra-Junior, Gil/C-1609-2012; Lin, Lin/A-3532-2010; Achermann, John/C-5476-2008; Maciel-Guerra, Andrea T/E-9130-2016; Achermann, John/N-2906-2019	Guerra-Junior, Gil/0000-0002-2991-7678; Achermann, John/0000-0001-8787-6272; Maciel-Guerra, Andrea T/0000-0002-4850-8079; Achermann, John/0000-0001-8787-6272; WERYHA, Georges/0000-0003-2062-3419	March of Dimes Foundation [1-FY07-490)]; National Institute for Health Research; Wellcome Trust Senior Research Fellowship in Clinical Science [079666]	March of Dimes Foundation(March of Dimes); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust)	Supported by grants from the Agence Nationale de la Recherche- GIS Institut des Maladies Rares (to Dr. McElreavey and Ms. Lourenco); by a research grant (1-FY07-490) from the March of Dimes Foundation (to Dr. McElreavey); by the National Institute for Health Research (to UCL Institute of Child Health Biomedical Research Centre); and a Wellcome Trust Senior Research Fellowship in Clinical Science (079666, to Dr. Achermann).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Achermann JC, 2002, J CLIN ENDOCR METAB, V87, P1829, DOI 10.1210/jc.87.4.1829; Biason-Lauber A, 2000, AM J HUM GENET, V67, P1563, DOI 10.1086/316893; Correa RV, 2004, J CLIN ENDOCR METAB, V89, P1767, DOI 10.1210/jc.2003-031240; COULAM CB, 1983, FERTIL STERIL, V40, P693; Coutant R, 2007, J CLIN ENDOCR METAB, V92, P2868, DOI 10.1210/jc.2007-0024; Desclozeaux M, 2002, MOL CELL BIOL, V22, P7193, DOI 10.1128/MCB.22.20.7193-7203.2002; Fan WQ, 2003, BIOCHEM BIOPH RES CO, V311, P987, DOI 10.1016/j.bbrc.2003.10.096; Fogli Anne, 2004, BMC Womens Health, V4, P8, DOI 10.1186/1472-6874-4-8; Gurates B, 2003, MOL CELL ENDOCRINOL, V208, P61, DOI 10.1016/S0303-7207(03)00198-9; Hanley NA, 1999, MECH DEVELOP, V87, P175, DOI 10.1016/S0925-4773(99)00123-9; Hanley NA, 2001, MOL ENDOCRINOL, V15, P57, DOI 10.1210/me.15.1.57; Hasegawa T, 2004, J CLIN ENDOCR METAB, V89, P5930, DOI 10.1210/jc.2004-0935; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Keri RA, 1996, J BIOL CHEM, V271, P10782, DOI 10.1074/jbc.271.18.10782; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kohler B, 2008, HUM MUTAT, V29, P59, DOI 10.1002/humu.20588; Lacombe A, 2006, AM J HUM GENET, V79, P113, DOI 10.1086/505406; Laissue P, 2008, MOL CELL ENDOCRINOL, V282, P101, DOI 10.1016/j.mce.2007.11.005; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; Leslie ND, 2003, ANNU REV NUTR, V23, P59, DOI 10.1146/annurev.nutr.23.011702.073135; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; Luborsky JL, 2003, HUM REPROD, V18, P199, DOI 10.1093/humrep/deg005; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Mallet D, 2004, J CLIN ENDOCR METAB, V89, P4829, DOI 10.1210/jc.2004-0670; Mendelson CR, 2007, J STEROID BIOCHEM, V106, P62, DOI 10.1016/j.jsbmb.2007.05.001; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Philibert P, 2007, HUM REPROD, V22, P3255, DOI 10.1093/humrep/dem278; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; Reuter AL, 2007, EUR J ENDOCRINOL, V157, P233, DOI 10.1530/EJE-07-0113; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; Sugawara T, 1997, BIOCHEMISTRY-US, V36, P7249, DOI 10.1021/bi9628984; TAKAYAMA K, 1995, J CLIN ENDOCR METAB, V80, P2815, DOI 10.1210/jc.80.9.2815; Toniolo D, 2007, SEMIN REPROD MED, V25, P264, DOI 10.1055/s-2007-980220; van Kasteren YM, 1999, HUM REPROD, V14, P2455, DOI 10.1093/humrep/14.10.2455; Weck J, 2006, MOL ENDOCRINOL, V20, P1090, DOI 10.1210/me.2005-0199; Zhao HJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3398, DOI 10.2741/2321	39	251	271	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1200	1210		10.1056/NEJMoa0806228	http://dx.doi.org/10.1056/NEJMoa0806228			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19246354	Green Accepted, Bronze			2022-12-24	WOS:000264283400006
J	Richter, DD; Jenkins, DH; Karakash, JT; Knight, J; McCreery, LR; Nemestothy, KP				Richter, Daniel deB., Jr.; Jenkins, Dylan H.; Karakash, John T.; Knight, Josiah; McCreery, Lew R.; Nemestothy, Kasimir P.			Wood Energy in America	SCIENCE			English	Editorial Material									[Richter, Daniel deB., Jr.] Duke Univ, Nicholas Sch Environm, So Ctr Sustainable Forests, Univ Program Ecol, Durham, NC 27708 USA; [Jenkins, Dylan H.] Penn Forest Conservat Program, Nat Conservancy, Williamsport, PA 17701 USA; [Karakash, John T.] Resource Profess Grp, Durham, NC 27707 USA; [Knight, Josiah] Duke Univ, Pratt Sch Engn, Durham, NC 27708 USA; [McCreery, Lew R.] USDA, Forest Serv, State & Private Forestry, Morgantown, WV 26505 USA; [Nemestothy, Kasimir P.] Austrian Chamber Agr, Dept Forestry & Energy, A-1014 Vienna, Austria	Duke University; Nature Conservancy; Duke University; United States Department of Agriculture (USDA); United States Forest Service	Richter, DD (corresponding author), Duke Univ, Nicholas Sch Environm, So Ctr Sustainable Forests, Univ Program Ecol, Durham, NC 27708 USA.	drichter@duke.edu	Richter, D.D./AAN-4583-2021					*EIA, 2008, ANN EN REV 2007; *EIA, 2008, NAT GAS PRIC; *EIA, 2008, HEAT OIL PROP UPD; *EN EFF REN EN OFF, 2007, BUILD EN DAT BOOK; HACKSTOCK R, 2008, RENEWABLE ENERGY WAY; Hagauer D, 2008, INSTRUCTION MANUAL C; Keoleian GA, 2005, CRIT REV PLANT SCI, V24, P385, DOI 10.1080/07352680500316334; KIPPEL N, 2007, EINFLUSS BETRIEBSWEI; *LACAPRA ASS TEAM, 2006, AN REN PORTF STAND N; Madlener R, 2007, ENERG POLICY, V35, P1075, DOI 10.1016/j.enpol.2006.01.022; *NAT COMM SCI SUST, 2007, CONS BIOD SUST FOR; PERLACK RD, 2005, TM200566 ORNL USDA D; Perlin J., 1989, FOREST JOURNEY ROLE; Perry DA, 2008, FOREST ECOSYSTEMS; Rakos C, 2005, BIOENERGY - REALIZING THE POTENTIAL, P47, DOI 10.1016/B978-008044661-5/50005-2; *REN21 CENT, 2008, REN 2007 GLOB STAT R; RISTINEN RA, 2005, ENERGY ENV; SCHILL SR, 2008, BIOMASS; Serup H., 2002, WOOD ENERGY PRODUCTI, VSecond Revised; Victor DG, 2008, FOREIGN AFF, V87, P70; VOGLAUER B, 2004, AUSTRIAN BIOMASS BOI; WORGETTER M, 2002, BIOENERGY AUSTRIA PO; 2008, TIMBER MART S	23	58	60	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1432	1433		10.1126/science.1166214	http://dx.doi.org/10.1126/science.1166214			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417TP	19286539				2022-12-24	WOS:000264101700023
J	Silverberg, MJ; Leyden, W; Hurley, L; Go, AS; Quesenberry, CP; Klein, D; Horberg, MA				Silverberg, Michael J.; Leyden, Wendy; Hurley, Leo; Go, Alan S.; Quesenberry, Charles P., Jr.; Klein, Daniel; Horberg, Michael A.			Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIRETROVIRAL THERAPY; CLINICAL-TRIALS; MYOCARDIAL-INFARCTION; PROTEASE INHIBITORS; STATINS; RISK; HYPERLIPIDEMIA; DYSLIPIDEMIA; PRAVASTATIN; MANAGEMENT	Background: Antiretroviral agents, particularly protease inhibitors (PIs), may adversely affect lipid levels in patients with HIV infection. However, it is not known whether HIV-associated dyslipidemia is more difficult to treat. Objective: To compare the effectiveness and safety of lipid-lowering therapy in patients with and without HIV infection. Design: Retrospective cohort study. Setting: Integrated health care delivery system from 1996 to 2005. Patients: 829 patients with HIV infection and 6941 patients without HIV infection beginning lipid-lowering therapy for elevated low-density lipoprotein cholesterol or triglyceride levels. Measurements: Percentage change in lipids within 12 months and adverse liver- and muscle-related clinical and laboratory events. Results: Compared with patients without HIV infection, patients with HIV infection beginning statin therapy had smaller reductions in low-density lipoprotein cholesterol levels (25.6% vs. 28.3%; P = 0.001), which did not vary by antiretroviral therapy class. Patients with HIV infection beginning gemfibrozil therapy had substantially smaller reductions in triglyceride levels than patients without HIV infection (44.2% vs. 59.3%; P < 0.001), and reductions with gemfibrozil varied by antiretroviral therapy class (44.0% [P = 0.001] in patients receiving PIs only, 26.4% [P < 0.001] in patients receiving PIs and nonnucleoside reverse transcriptase inhibitors [NNRTIs], and 60.3% [P = 0.94] in patients receiving NNRTIs only). Rhabdomyolysis was diagnosed in 3 patients with HIV infection and 1 patient without HIV infection. No clinically recognized cases of myositis or myopathy were observed. The risk for laboratory adverse events was low (< 5%), although it was increased in patients with HIV infection. Limitations: Laboratory measurements were not uniformly performed according to HIV status, and adequate fasting before lipoprotein testing could not be verified. Results may not be completely generalizable to uninsured persons, women, or certain racial or ethnic minorities. Conclusion: Dyslipidemia, particularly hypertriglyceridemia, is more difficult to treat in patients with HIV infection than in the general population. However, patients with HIV infection receiving NNRTI-based antiretroviral therapy and gemfibrozil had triglyceride responses similar to those in patients without HIV infection.	[Silverberg, Michael J.] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Kaiser Permanente; University of California System; University of California San Francisco	Silverberg, MJ (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	Michael.J.Silverberg@kp.org	Go, Alan S./AAE-7745-2019		GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funding: GlaxoSmithKline.	Aberg JA, 2005, AIDS RES HUM RETROV, V21, P757, DOI 10.1089/aid.2005.21.757; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Badiou S, 2004, ATHEROSCLEROSIS, V172, P273, DOI 10.1016/j.atherosclerosis.2003.10.006; Benard A, 2006, INT J TUBERC LUNG D, V10, P378; Benesic A, 2004, INFECTION, V32, P229, DOI 10.1007/s15010-004-3136-7; Bennett MT, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-15; Bonnet F, 2004, HIV MED, V5, P133, DOI 10.1111/j.1468-1293.2004.00200.x; *CAL DEP HLTH SERV, 2005, CAL AIDS SURV REP CU; Calza L, 2005, AIDS, V19, P1103, DOI 10.1097/01.aids.0000174458.86121.43; Calza L, 2003, AIDS, V17, P851, DOI 10.1097/00002030-200304110-00010; Dube MP, 2003, CLIN INFECT DIS, V37, P613, DOI 10.1086/378131; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gerber MT, 2004, CLIN INFECT DIS, V39, P419, DOI 10.1086/422144; Gordon N, 2006, KAISER PERMANENTE ME; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Henry K, 1998, LANCET, V352, P1031, DOI 10.1016/S0140-6736(98)00022-1; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Hurlimann D, 2006, HEART, V92, P110, DOI 10.1136/hrt.2004.056523; Johns KW, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-27; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Kamal-Bahl SJ, 2007, AM J CARDIOL, V99, P530, DOI 10.1016/j.amjcard.2006.08.063; Klein D, 2002, J ACQ IMMUN DEF SYND, V30, P471, DOI 10.1097/00126334-200208150-00002; Koppel K, 2002, J ACQ IMMUN DEF SYND, V29, P441, DOI 10.1097/00042560-200204150-00003; Miller J, 2002, AIDS, V16, P2195, DOI 10.1097/00002030-200211080-00012; *NAT I ALL INF DIS, 2004, TABL GRAD SEV AD PED; Negredo E, 2006, AIDS, V20, P2159, DOI 10.1097/01.aids.0000247573.95880.db; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; *PAN ANT GUID AD A, 2008, DEP HLTH HUMAN  0109, P1; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Riddler SA, 2007, HIV MED, V8, P280, DOI 10.1111/j.1468-1293.2007.00470.x; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sax PE, 2006, AIDS CARE, V18, P149, DOI 10.1080/09540120500161843; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Stein JH, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.018; Townsend ML, 2007, INT J STD AIDS, V18, P851, DOI 10.1258/095646207782716974; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Visnegarwala F, 2004, J INFECTION, V49, P283, DOI 10.1016/j.jinf.2003.09.006	39	76	77	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					301	+		10.7326/0003-4819-150-5-200903030-00006	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19258558				2022-12-24	WOS:000264051700002
J	Antonakis, J; Dalgas, O				Antonakis, John; Dalgas, Olaf			Predicting Elections: Child's Play!	SCIENCE			English	Article							INTELLIGENCE; ORIGINS		[Antonakis, John; Dalgas, Olaf] Univ Lausanne, Fac Business & Econ, CH-1015 Lausanne, Switzerland	University of Lausanne	Antonakis, J (corresponding author), Univ Lausanne, Fac Business & Econ, CH-1015 Lausanne, Switzerland.	john.antonakis@unil.ch	Antonakis, John/B-3409-2008	Antonakis, John/0000-0001-8811-5117				PLATO, 1901, REPUBLIC; Ramsey JL, 2004, DEVELOPMENTAL SCI, V7, P201, DOI 10.1111/j.1467-7687.2004.00339.x; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Simonton DK, 2002, ADV PSY RES, V14, P143; Slater A, 2001, INFANT CHILD DEV, V10, P21, DOI 10.1002/icd.241; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Zebrowitz LA, 2002, PERS SOC PSYCHOL B, V28, P238, DOI 10.1177/0146167202282009	7	236	237	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2009	323	5918					1183	1183		10.1126/science.1167748	http://dx.doi.org/10.1126/science.1167748			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251621	Green Submitted			2022-12-24	WOS:000263687600029
J	Baillargeon, J; Giordano, TP; Rich, JD; Wu, ZH; Wells, K; Pollock, BH; Paar, DP				Baillargeon, Jacques; Giordano, Thomas P.; Rich, Josiah D.; Wu, Z. Helen; Wells, Katherine; Pollock, Brad H.; Paar, David P.			Accessing Antiretroviral Therapy Following Release From Prison	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE; ADHERENCE; INFECTION; STIGMA; COHORT; INCARCERATION; INTERRUPTION; COMMUNITY; OUTCOMES; INMATES	from prison may increase risk for adverse clinical outcomes, transmission of human immunodeficiency virus ( HIV), and drug- resistant HIV reservoirs in the community. The extent to which HIV- infected inmates experience ART interruption following release from prison is unknown. Objectives To determine the proportion of inmates who filled an ART prescription within 60 days after release from prison and to examine predictors of this outcome. Design, Setting, and Participants Retrospective cohort study of all 2115 HIV-infected inmates released from the Texas Department of Criminal Justice prison system between January 2004 and December 2007 and who were receiving ART before release. Main Outcome Measure Proportion of inmates who filled an ART prescription within 10, 30, and 60 days of release from prison. Results Among the entire study cohort ( N= 2115), an initial prescription for ART was filled by 115 ( 5.4%) inmates within 10 days of release ( 95% confidence interval [ CI], 4.5%- 6.5%), by 375 ( 17.7%) within 30 days ( 95% CI, 16.2%- 19.4%), and by 634 ( 30.0%) within 60 days ( 95% CI, 28.1%- 32.0%). In a multivariate analysis of predictors ( including sex, age, race/ ethnicity, viral load, duration of ART, year of discharge, duration of incarceration, parole, and AIDS Drug Assistance Program application assistance), Hispanic and African American inmates were less likely to fill a prescription within 10 days ( adjusted estimated risk ratio [ RR], 0.4 [ 95% CI, 0.2- 0.8] and 0.4 [ 95% CI, 0.3- 0.7], respectively) and 30 days ( adjusted estimated RR, 0.7 [ 95% CI, 0.5- 0.9] and 0.7 [ 95% CI, 0.5- 0.9]). Inmates with an undetectable viral load were more likely to fill a prescription within 10 days ( adjusted estimated RR, 1.8 [ 95% CI, 1.2- 2.7]), 30 days ( 1.5 [ 95% CI, 1.2- 1.8]), and 60 days ( 1.3 [ 95% CI, 1.1- 1.5]). Inmates released on parole were more likely to fill a prescription within 30 days ( adjusted estimated RR, 1.3 [ 95% CI, 1.1- 1.6]) and 60 days ( 1.5 [ 95% CI, 1.4- 1.7]). Inmates who received assistance completing a Texas AIDS Drug Assistance Program application were more likely to fill a prescription within 10 days ( adjusted estimated RR, 3.1 [ 95% CI, 2.0- 4.9]), 30 days ( 1.8 [ 95% CI, 1.4- 2.2]), and 60 days ( 1.3 [ 95% CI, 1.1- 1.4]). Conclusion Only a small percentage of Texas prison inmates receiving ART while incarcerated filled an initial ART prescription within 60 days of their release.	[Baillargeon, Jacques] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Baillargeon, Jacques; Paar, David P.] Univ Texas Med Branch, Correct Managed Care Div, Galveston, TX 77555 USA; [Wu, Z. Helen] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Paar, David P.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Giordano, Thomas P.] Michael E DeBakey VA Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Houston, TX USA; [Rich, Josiah D.] Brown Med Sch, Dept Med, Providence, RI USA; [Wells, Katherine] Dept State Hlth Serv, Texas HIV Medicat Program, Austin, TX USA; [Pollock, Brad H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Baylor College of Medicine; Brown University; University of Texas System; University of Texas Health San Antonio	Baillargeon, J (corresponding author), Univ Texas Med Branch, Dept Prevent Med & Community Hlth, 301 Univ Blvd,Mail Route 1007, Galveston, TX 77555 USA.	jbaillar@utmb.edu		Giordano, Thomas/0000-0002-9346-5530	National Institute on Drug Abuse [R03DA023870-02, K24DA022112]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA023870, K24DA022112] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grant R03DA023870-02 from the National Institute on Drug Abuse. Dr Rich was supported by National Institute on Drug Abuse grant K24DA022112.	Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Baillargeon J, 2000, CLIN INFECT DIS, V31, P1476, DOI 10.1086/317478; Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Boutwell A, 2004, CLIN INFECT DIS, V38, P1761, DOI 10.1086/421410; *COUNC STAT GOV JU, EXPL FED MED DIS PRO; Derlega VJ, 2008, INT J STD AIDS, V19, P259, DOI 10.1258/ijsa.2007.007141; DIXON PS, 1993, AM J MED, V95, P629, DOI 10.1016/0002-9343(93)90359-W; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Giordano TP, 2005, AIDS CARE, V17, P773, DOI 10.1080/09540120412331336652; Glass TR, 2006, JAIDS-J ACQ IMM DEF, V41, P385, DOI 10.1097/01.qai.0000186371.95301.52; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; *HJ KAIS FAM FDN N, 2008, NAT ADAP MON PROJ AN; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Kahn JG, 2002, PUBLIC HEALTH REP, V117, P252, DOI 10.1016/S0033-3549(04)50159-0; Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320; MacGowan RJ, 2003, INT J STD AIDS, V14, P519, DOI 10.1258/095646203767869110; Mallik-Kane K, 2008, HLTH PRISONER REENTR; MARUSCHAK L, 2007, HIV PRISONS 2005; Menke TJ, 2003, J NATL MED ASSOC, V95, P853; Morrow K. M., 2007, Journal of Correctional Health Care, V13, P27, DOI 10.1177/1078345807299457; Mumola C. J., 1999, SUBSTANCE ABUSE TREA; Palacio H, 2002, PUBLIC HEALTH REP, V117, P233, DOI 10.1016/S0033-3549(04)50158-9; Palepu A, 2004, ANTIVIR THER, V9, P713; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Pence BW, 2007, JAIDS-J ACQ IMM DEF, V44, P159, DOI 10.1097/QAI.0b013e31802c2f51; *PEW CTR STAT, ONE 100 BARS AM 2008; Raimer BG, 2004, JAMA-J AM MED ASSOC, V292, P485, DOI 10.1001/jama.292.4.485; Rao D, 2008, AIDS BEHAV, V12, P265, DOI 10.1007/s10461-007-9268-x; Rich JD, 2001, J URBAN HEALTH, V78, P279, DOI 10.1093/jurban/78.2.279; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Shannon Kate, 2005, J Int Assoc Physicians AIDS Care (Chic), V4, P66, DOI 10.1177/1545109705284353; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Stokes ME, 2000, CATEGORICAL DATA ANA; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; WOHL DA, 2003, 10 C RETR OPP INF FE; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	39	202	205	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					848	857		10.1001/jama.2009.202	http://dx.doi.org/10.1001/jama.2009.202			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244192	Green Accepted			2022-12-24	WOS:000263609900026
J	Bergkessel, M; Wilmes, GM; Guthrie, C				Bergkessel, Megan; Wilmes, Gwendolyn M.; Guthrie, Christine			SnapShot: Formation of mRNPs	CELL			English	Editorial Material							MESSENGER-RNA; CYTOPLASM; CODE		[Bergkessel, Megan; Wilmes, Gwendolyn M.; Guthrie, Christine] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bergkessel, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Bergkessel, Megan/0000-0002-4530-1224				Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Rougemaille M, 2008, BIOL CELL, V100, P327, DOI 10.1042/BC20070143; Sanford JR, 2005, BIOCHEM SOC T, V33, P443, DOI 10.1042/BST0330443; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308	10	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					794	U1	794.e1	10.1016/j.cell.2009.01.047	http://dx.doi.org/10.1016/j.cell.2009.01.047			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239896	Bronze			2022-12-24	WOS:000263688200026
J	Burton, DC; Edwards, JR; Horan, TC; Jernigan, JA; Fridkin, SK				Burton, Deron C.; Edwards, Jonathan R.; Horan, Teresa C.; Jernigan, John A.; Fridkin, Scott K.			Methicillin-Resistant Staphylococcus aureus Central Line-Associated Bloodstream Infections in US Intensive Care Units, 1997-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CATHETER-RELATED INFECTIONS; SURVEILLANCE SYSTEM; NOSOCOMIAL INFECTIONS; SAFETY NETWORK; RISK-FACTORS; PREVENTION; BACTEREMIA; IMPACT; INTERVENTION; TRANSMISSION	Context Concerns about rates of methicillin- resistant Staphylococcus aureus ( MRSA) health care - associated infections have prompted calls for mandatory screening or reporting in efforts to reduce MRSA infections. Objective To examine trends in the incidence of MRSA central line - associated blood-stream infections ( BSIs) in US intensive care units ( ICUs). Design, Setting, and Participants Data reported by hospitals to the Centers for Disease Control and Prevention ( CDC) from 1997- 2007 were used to calculate pooled mean annual central line - associated BSI incidence rates for 7 types of adult and non-neonatal pediatric ICUs. Percent MRSA was defined as the proportion of S aureus central line - associated BSIs that were MRSA. We used regression modeling to estimate percent changes in central line - associated BSI metrics over the analysis period. Main Outcome Measures Incidence rate of central line - associated BSIs per 1000 central line days; percent MRSA among S aureus central line - associated BSIs. Results Overall, 33 587 central line - associated BSIs were reported from 1684 ICUs representing 16 225 498 patient- days of surveillance; 2498 reported central line - associated BSIs ( 7.4%) were MRSA and 1590 ( 4.7%) were methicillin- susceptible S aureus ( MSSA). Of evaluated ICU types, surgical, nonteaching- affiliated medical- surgical, cardiothoracic, and coronary units experienced increases in MRSA central line - associated BSI incidence in the 1997- 2001 period; however, medical, teaching- affiliated medical-surgical, and pediatric units experienced no significant changes. From 2001 through 2007, MRSA central line - associated BSI incidence declined significantly in all ICU types except in pediatric units, for which incidence rates remained static. Declines in MRSA central line associated BSI incidence ranged from - 51.5% ( 95% CI, - 33.7% to - 64.6%; P <. 001) in nonteaching- affiliated medical- surgical ICUs ( 0.31 vs 0.15 per 1000 central line days) to - 69.2% ( 95% CI, - 57.9% to - 77.7%; P <. 001) in surgical ICUs ( 0.58 vs 0.18 per 1000 central line days). In all ICU types, MSSA central line - associated BSI incidence declined from 1997 through 2007, with changes in incidence ranging from - 60.1% ( 95% CI, - 41.2% to - 73.1%; P <. 001) in surgical ICUs ( 0.24 vs 0.10 per 1000 central line days) to - 77.7% ( 95% CI, - 68.2% to - 84.4%; P <. 001) in medical ICUs ( 0.40 vs 0.09 per 1000 central line days). Although the overall proportion of S aureus central line associated BSIs due to MRSA increased 25.8% ( P=. 02) in the 1997- 2007 period, overall MRSA central line - associated BSI incidence decreased 49.6% ( P <. 001) over this period. Conclusions The incidence of MRSA central line - associated BSI has been decreasing in recent years in most ICU types reporting to the CDC. These trends are not apparent when only percent MRSA is monitored.	[Burton, Deron C.; Edwards, Jonathan R.; Horan, Teresa C.; Jernigan, John A.; Fridkin, Scott K.] Ctr Dis Control & Prevent, Surveillance Branch, Div Healthcare Qual Promot, Natl Ctr Preparedness Detect & Control Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Burton, DC (corresponding author), Ctr Dis Control & Prevent, Surveillance Branch, Div Healthcare Qual Promot, Natl Ctr Preparedness Detect & Control Infect Dis, Mailstop A-24,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	dburton@cdc.gov		Jernigan, John/0000-0001-8163-925X				Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; [Anonymous], 2005, MMWR MORB MORTAL WKL; Bearman GML, 2005, ARCH MED RES, V36, P646, DOI 10.1016/j.arcmed.2005.02.005; Ben-David D, 2008, AM J INFECT CONTROL, V36, P93, DOI 10.1016/j.ajic.2007.05.013; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P149; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P149; Centers for Disease Control and Prevention, NAT HEALTHC SAF NETW; Cimolai N, 2007, INFECT CONT HOSP EP, V28, P896, DOI 10.1086/519913; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Crum NF, 2006, AM J MED, V119, P943, DOI 10.1016/j.amjmed.2006.01.004; Edmond MB, 2007, J HOSP INFECT, V65, P182, DOI 10.1016/S0195-6701(07)60040-1; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Eggimann P, 2001, CHEST, V120, P2059, DOI 10.1378/chest.120.6.2059; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; Emori TG, 1998, INFECT CONT HOSP EP, V19, P308; Gastmeier P, 2006, J HOSP INFECT, V64, P16, DOI 10.1016/j.jhin.2006.04.017; Gerberding J, 1999, AM J INFECT CONTROL, V27, P520; Gnass SA, 2004, INFECT CONT HOSP EP, V25, P675, DOI 10.1086/502461; Hageman JC, 2003, INFECT CONT HOSP EP, V24, P356, DOI 10.1086/502214; *HEALTHC ASS INF A, UK HLTH PROT AG SURV; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; HORAN TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; Karchmer AW, 2000, CLIN INFECT DIS, V31, pS139, DOI 10.1086/314078; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Larson EL, 2007, AM J INFECT CONTROL, V35, P666, DOI 10.1016/j.ajic.2006.10.006; Mermel LA, 2001, EMERG INFECT DIS, V7, P197, DOI 10.3201/eid0702.010208; Mermel LA, 2007, J HOSP INFECT, V65, P30, DOI 10.1016/S0195-6701(07)60011-5; Meyer E, 2006, INFECT CONT HOSP EP, V27, P146, DOI 10.1086/500619; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Oztoprak N, 2006, AM J INFECT CONTROL, V34, P1, DOI 10.1016/j.ajic.2005.07.005; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; RAAD I, 1997, SUPPORT CARE CANCER, V7, P386; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Richards C, 2001, AM J INFECT CONTROL, V29, P400, DOI 10.1067/mic.2001.118408; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Warren DK, 2006, INFECT CONT HOSP EP, V27, P662, DOI 10.1086/506184; Weber SG, 2007, AM J INFECT CONTROL, V35, P73, DOI 10.1016/j.ajic.2007.01.001	42	191	204	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					727	736		10.1001/jama.2009.153	http://dx.doi.org/10.1001/jama.2009.153			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224749	Bronze			2022-12-24	WOS:000263370100015
J	McMorran, BJ; Marshall, VM; de Graaf, C; Drysdale, KE; Shabbar, M; Smyth, GK; Corbin, JE; Alexander, WS; Foote, SJ				McMorran, Brendan J.; Marshall, Vikki M.; de Graaf, Carolyn; Drysdale, Karen E.; Shabbar, Meriam; Smyth, Gordon K.; Corbin, Jason E.; Alexander, Warren S.; Foote, Simon J.			Platelets Kill Intraerythrocytic Malarial Parasites and Mediate Survival to Infection	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; VIVAX MALARIA; BLOOD-CELLS; THROMBOCYTOPENIA; CHILDREN; PATHOLOGY; ANEMIA	Platelets play a critical role in the pathogenesis of malarial infections by encouraging the sequestration of infected red blood cells within the cerebral vasculature. But platelets also have well- established roles in innate protection against microbial infections. We found that purified human platelets killed Plasmodium falciparum parasites cultured in red blood cells. Inhibition of platelet function by aspirin and other platelet inhibitors abrogated the lethal effect human platelets exert on P. falciparum parasites. Likewise, platelet- deficient and aspirin- treated mice were more susceptible to death during erythrocytic infection with Plasmodium chabaudi. Both mouse and human platelets bind malarial- infected red cells and kill the parasite within. These results indicate a protective function for platelets in the early stages of erythrocytic infection distinct from their role in cerebral malaria.	[McMorran, Brendan J.; Drysdale, Karen E.; Shabbar, Meriam; Foote, Simon J.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Marshall, Vikki M.; de Graaf, Carolyn; Smyth, Gordon K.; Corbin, Jason E.; Alexander, Warren S.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [de Graaf, Carolyn] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	University of Tasmania; Menzies Institute for Medical Research; Walter & Eliza Hall Institute; University of Melbourne	McMorran, BJ (corresponding author), Univ Tasmania, Menzies Res Inst, Private Bag 23, Hobart, Tas 7000, Australia.	brendan.mcmorran@utas.edu.au	Foote, Simon J/F-2802-2013; Smyth, Gordon/B-5276-2008	Smyth, Gordon/0000-0001-9221-2892; Foote, Simon/0000-0002-9142-2107; McMorran, Brendan/0000-0003-1845-8872	National Health and Medical Research Council of Australia [490037, 461219]; Australian Cancer Research Foundation; Howard Hughes Medical Institute; Human Research Ethics Committee (Tasmania) Network [H0009004]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Research Ethics Committee (Tasmania) Network	We thank M. Cozens for flow cytometry support; D. Senyschen, G. Panoschi, and F. Rodda for technical support; the Australian Red Cross Blood Service for providing purified red blood cells; S. Jackson for advice; R. Anders for providing the P. falciparum parasites; and C. Flowers for manuscript preparation. Funding support was from the National Health and Medical Research Council of Australia ( Program Grants 490037 and 461219), Australian Cancer Research Foundation, and Howard Hughes Medical Institute. Statistical Analysis. P values were calculated by means of two-tailed t tests, except where specifically mentioned. Ethics approval for animal experiments was received from the Royal Melbourne Hospital, Melbourne, Australia (2002.053), and University of Tasmania ( 0008702). Ethics approval for the platelet donations was received from Human Research Ethics Committee (Tasmania) Network (H0009004).	Adedapo Aduragbenro D., 2007, Journal of Vector Borne Diseases, V44, P266; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Brass LF, 2007, PLATELETS, 2ND EDITION, P319, DOI 10.1016/B978-012369367-9/50778-3; Cattaneo M, 2007, PLATELETS, 2ND EDITION, P201, DOI 10.1016/B978-012369367-9/50772-2; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; DEGRAVES FJ, 1983, J PARASITOL, V69, P262, DOI 10.2307/3281215; English M, 1996, LANCET, V347, P1736, DOI 10.1016/S0140-6736(96)90809-0; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1993, EUR CYTOKINE NETW, V4, P415; HELLGREN U, 1989, B WORLD HEALTH ORGAN, V67, P197; HORSTMANN RD, 1981, BLUT, V42, P157, DOI 10.1007/BF01026385; Jeremiah ZA, 2007, PLATELETS, V18, P469, DOI 10.1080/09537100701194871; Kakar A, 1999, DIAGN MICR INFEC DIS, V35, P243, DOI 10.1016/S0732-8893(99)00069-3; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Lou JN, 1997, AM J PATHOL, V151, P1397; Min-Oo G, 2005, CELL MICROBIOL, V7, P753, DOI 10.1111/j.1462-5822.2005.00524.x; Oh MD, 2001, AM J TROP MED HYG, V65, P143, DOI 10.4269/ajtmh.2001.65.143; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; PEYRON F, 1989, PARASITOLOGY, V99, P317, DOI 10.1017/S0031182000059011; Polack B, 1997, HAEMOSTASIS, V27, P278; Rex S, 2007, PLATELETS, 2ND EDITION, P251, DOI 10.1016/B978-012369367-9/50775-8; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; WEISS HJ, 1968, J CLIN INVEST, V47, P2169, DOI 10.1172/JCI105903; Yeaman MR, 2007, PLATELETS, 2ND EDITION, P727, DOI 10.1016/B978-012369367-9/50802-8	25	184	191	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					797	800		10.1126/science.1166296	http://dx.doi.org/10.1126/science.1166296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197068				2022-12-24	WOS:000263066800051
J	Ruth, T				Ruth, Thomas			Accelerating production of medical isotopes	NATURE			English	Editorial Material									[Ruth, Thomas] TRIUMF, Vancouver, BC V6T 2A3, Canada; [Ruth, Thomas] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; British Columbia Cancer Agency	Ruth, T (corresponding author), TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.	truth@triumf.ca							0	73	73	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 29	2009	457	7229					536	537		10.1038/457536a	http://dx.doi.org/10.1038/457536a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177112	Bronze			2022-12-24	WOS:000262852200023
J	Broadfield, E; Doshi, N; Alexander, PDG; Greaves, M; Woodcock, A				Broadfield, Emma; Doshi, Neelam; Alexander, Peter D. G.; Greaves, Melanie; Woodcock, Ashley			Cunning and community-acquired pneumonia	LANCET			English	Editorial Material							ASSOCIATION; MRSA		[Broadfield, Emma; Alexander, Peter D. G.] Univ S Manchester Hosp, Dept Intens Care Med, Manchester M20 8LR, Lancs, England; [Doshi, Neelam] Univ S Manchester Hosp, Dept Med Microbiol, Manchester M20 8LR, Lancs, England; [Greaves, Melanie] Univ S Manchester Hosp, Dept Radiol, Manchester M20 8LR, Lancs, England; [Woodcock, Ashley] Univ S Manchester Hosp, Dept Resp Med, Manchester M20 8LR, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Broadfield, E (corresponding author), Wythenshawe Hosp, Univ S Manchester Hosp, Southmoor Rd, Manchester M23 9LT, Lancs, England.	emma@ejcbroad.fsnet.co.uk		Woodcock, Ashley/0000-0002-5428-8578				Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Nathwani D, 2008, J ANTIMICROB CHEMOTH, V61, P976, DOI 10.1093/jac/dkn096; Yamaoka Toshimori, 2007, Journal of Infection and Chemotherapy, V13, P141, DOI 10.1007/s10156-007-0521-z	4	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					270	270		10.1016/S0140-6736(09)60074-X	http://dx.doi.org/10.1016/S0140-6736(09)60074-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150706				2022-12-24	WOS:000262537500030
J	Ghosh, D; Griswold, J; Erman, M; Pangborn, W				Ghosh, Debashis; Griswold, Jennifer; Erman, Mary; Pangborn, Walter			Structural basis for androgen specificity and oestrogen synthesis in human aromatase	NATURE			English	Article							HUMAN PLACENTAL AROMATASE; CYTOCHROME-P450 AROMATASE; KINETIC-PROPERTIES; CRYSTAL-STRUCTURES; DIOXYGEN COMPLEX; WILD-TYPE; PURIFICATION; INHIBITORS; MODEL; MECHANISM	Aromatase cytochrome P450 is the only enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens(1-3). Aromatase inhibitors therefore constitute a front-line therapy for oestrogen- dependent breast cancer(3,4). In a three-step process, each step requiring 1 mol of O-2, 1 mol of NADPH, and coupling with its redox partner cytochrome P450 reductase, aromatase converts androstenedione, testosterone and 16 alpha-hydroxytestosterone to oestrone, 17 beta-oestradiol and 17 beta, 16 alpha-oestriol, respectively(1-3). The first two steps are C19- methyl hydroxylation steps, and the third involves the aromatization of the steroid A- ring, unique to aromatase. Whereas most P450s are not highly substrate selective, it is the hallmark androgenic specificity that sets aromatase apart. The structure of this enzyme of the endoplasmic reticulum membrane has remained unknown for decades, hindering elucidation of the biochemical mechanism. Here we present the crystal structure of human placental aromatase, the only natural mammalian, full- length P450 and P450 in hormone biosynthetic pathways to be crystallized so far. Unlike the active sites of many microsomal P450s that metabolize drugs and xenobiotics, aromatase has an androgen- specific cleft that binds the androstenedione molecule snugly. Hydrophobic and polar residues exquisitely complement the steroid backbone. The locations of catalytically important residues shed light on the reaction mechanism. The relative juxtaposition of the hydrophobic amino- terminal region and the opening to the catalytic cleft shows why membrane anchoring is necessary for the lipophilic substrates to gain access to the active site. The molecular basis for the enzyme's androgenic specificity and unique catalytic mechanism can be used for developing next- generation aromatase inhibitors.	[Ghosh, Debashis; Griswold, Jennifer; Erman, Mary; Pangborn, Walter] Hauptman Woodward Res Inst, Buffalo, NY 14203 USA; [Ghosh, Debashis] Roswell Pk Canc Inst, Buffalo, NY 14263 USA	Hauptman Woodward Medical Research Institute; Roswell Park Cancer Institute	Ghosh, D (corresponding author), Hauptman Woodward Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	ghosh@hwi.buffalo.edu			National Institutes of Health [GM62794, GM59450]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM059450, R01GM086893, R01GM062794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Osawa, who pioneered aromatase research and its purification from human placenta at the institute, for many discussions and encouragement; past graduate students, postdoctoral scientists and research associates for contributions to the initial purification and crystallization efforts; H. Davies for discussions; D. Gewirth, V. Cody, G. DeTitta and J. Griffin for critically reading the manuscript; staff at the Women's and Children's Hospital of Buffalo for providing the placenta used in this work; and staffs of the Cornell High Energy Synchrotron Source and the Advanced Photon Source, Argonne National Laboratory, for helping with the synchrotron X- ray data collection. The research is supported in part by grants GM62794 and GM59450 (to D.G.) from the National Institutes of Health.	AKHTAR M, 1993, J STEROID BIOCHEM, V44, P375, DOI 10.1016/0960-0760(93)90241-N; AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; AMARNEH B, 1995, MOL CELL ENDOCRINOL, V109, pR1, DOI 10.1016/0303-7207(95)03524-B; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen SA, 2003, J STEROID BIOCHEM, V86, P231, DOI 10.1016/S0960-0760(03)00361-3; CHEN SU, 1993, J STEROID BIOCHEM, V44, P347, DOI 10.1016/0960-0760(93)90238-R; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Eisen A, 2008, CANCER TREAT REV, V34, P157, DOI 10.1016/j.ctrv.2007.11.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GRAHAMLORENCE S, 1995, PROTEIN SCI, V4, P1065, DOI 10.1002/pro.5560040605; Guallar V, 2003, P NATL ACAD SCI USA, V100, P6998, DOI 10.1073/pnas.0732000100; Hackett JC, 2005, J AM CHEM SOC, V127, P5224, DOI 10.1021/ja044716w; Hong Y, 2008, BIOCHEM PHARMACOL, V75, P1161, DOI 10.1016/j.bcp.2007.11.010; Johnston JO, 1998, CRIT REV BIOCHEM MOL, V33, P375; KADOHAMA N, 1992, J STEROID BIOCHEM, V43, P693, DOI 10.1016/0960-0760(92)90295-T; Kao YC, 2001, EUR J BIOCHEM, V268, P243, DOI 10.1046/j.1432-1033.2001.01886.x; KELLIS JT, 1987, J BIOL CHEM, V262, P4413; Lala P, 2004, J STEROID BIOCHEM, V88, P235, DOI 10.1016/j.jsbmb.2003.12.010; LAUGHTON CA, 1993, J STEROID BIOCHEM, V44, P399, DOI 10.1016/0960-0760(93)90243-P; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; NAKAJIN S, 1986, BIOCHEM BIOPH RES CO, V134, P704, DOI 10.1016/S0006-291X(86)80477-6; OH SS, 1993, J STEROID BIOCHEM, V44, P389, DOI 10.1016/0960-0760(93)90242-O; Omura T, 1978, CYTOCHROME P 450; OTNINOWSKI Z, 1995, HKL MANUAL; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Sansen S, 2007, ARCH BIOCHEM BIOPHYS, V464, P197, DOI 10.1016/j.abb.2007.04.028; SHIMOZAWA O, 1993, J BIOL CHEM, V268, P21399; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; THOMPSON EA, 1974, J BIOL CHEM, V249, P5364; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; YOSHIDA N, 1991, BIOCHEMISTRY-US, V30, P3003, DOI 10.1021/bi00226a004; ZHOU DJ, 1991, P NATL ACAD SCI USA, V88, P410, DOI 10.1073/pnas.88.2.410	36	390	399	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					219	U119		10.1038/nature07614	http://dx.doi.org/10.1038/nature07614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19129847	Green Accepted			2022-12-24	WOS:000262360200038
J	Schneider, MC; Prosser, BE; Caesar, JJE; Kugelberg, E; Li, S; Zhang, Q; Quoraishi, S; Lovett, JE; Deane, JE; Sim, RB; Roversi, P; Johnson, S; Tang, CM; Lea, SM				Schneider, Muriel C.; Prosser, Beverly E.; Caesar, Joseph J. E.; Kugelberg, Elisabeth; Li, Su; Zhang, Qian; Quoraishi, Sadik; Lovett, Janet E.; Deane, Janet E.; Sim, Robert B.; Roversi, Pietro; Johnson, Steven; Tang, Christoph M.; Lea, Susan M.			Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates	NATURE			English	Article							MACULAR DEGENERATION; MENINGOCOCCAL DISEASE; ALTERNATIVE PATHWAY; MAXIMUM-LIKELIHOOD; COMPLEMENT; BINDING; LIPOPROTEIN; ANTIBODIES; GNA1870; REFINEMENT	The complement system is an essential component of the innate and acquired immune system(1), and consists of a series of proteolytic cascades that are initiated by the presence of microorganisms. In health, activation of complement is precisely controlled through membrane-bound and soluble plasma-regulatory proteins including complement factor H (fH; ref.2), a 155 kDa protein composed of 20 domains (termed complement control protein repeats). Many pathogens have evolved the ability to avoid immune-killing by recruiting host complement regulators(3) and several pathogens have adapted to avoid complement-mediated killing by sequestering fH to their surface(4). Here we present the structure of a complement regulator in complex with its pathogen surface-protein ligand. This reveals how the important human pathogen Neisseria meningitidis subverts immune responses by mimicking the host, using protein instead of charged-carbohydrate chemistry to recruit the host complement regulator, fH. The structure also indicates the molecular basis of the host-specificity of the interaction between fH and the meningococcus, and informs attempts to develop novel therapeutics and vaccines.	[Prosser, Beverly E.; Caesar, Joseph J. E.; Quoraishi, Sadik; Lovett, Janet E.; Deane, Janet E.; Roversi, Pietro; Johnson, Steven; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Schneider, Muriel C.; Kugelberg, Elisabeth; Li, Su; Zhang, Qian; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Sim, Robert B.] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England	University of Oxford; Imperial College London; University of Oxford	Lea, SM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	c.tang@imperial.ac.uk; susan.lea@path.ox.ac.uk	Tuluc, Petronel/C-2527-2011; Johnson, Steven J/F-9182-2016; Lea, Susan M/B-7678-2009; Roversi, Pietro/F-8925-2011; Roversi, Pietro/AAK-4241-2021; Sim, Bob/A-1354-2008	Johnson, Steven J/0000-0002-7877-3543; Lea, Susan M/0000-0001-9287-8053; Roversi, Pietro/0000-0001-9280-9437; Roversi, Pietro/0000-0001-9280-9437; Sim, Bob/0000-0002-2855-7455; Deane, Janet/0000-0002-4863-0330; Lovett, Janet Eleanor/0000-0002-3561-450X; Kugelberg, Elisabeth/0000-0002-8302-3595	Wellcome Trust; Medical Research Council; Engineering and Physical Sciences Research; EMBO; Medical Research Council [G0601195, G0500367, G0400775] Funding Source: researchfish; MRC [G0500367, G0601195, G0400775] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EMBO(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Thanks are due to G. Bricogne and the Global Phasing Consortium for access to a beta version of autoSHARP and autoBUSTER, to the beamline staff of the European Synchrotron Radiation Source (particularly G. Leonard) and DIAMOND (UK), and to many members of the Laboratory of Molecular Biophysics, Oxford, and the Lea group for help with X-ray data collection. B. E. P. was funded by a Wellcome Trust studentship; P. R. and S. J. by Medical Research Council grants to S. M. L.; J. E. D. by a Wellcome Trust grant to SM.L.; and J. E. L. by an Engineering and Physical Sciences Research Grant to S. M. L. Work in C. M. T.'s laboratory is funded by the Wellcome Trust and the Medical Research Council. E. K. is an EMBO fellow.	Bahar M, 2006, ACTA CRYSTALLOGR D, V62, P1170, DOI 10.1107/S0907444906032197; Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Cantini F, 2006, J BIOL CHEM, V281, P7220, DOI 10.1074/jbc.M508595200; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Feavers IM, 2000, NATURE, V404, P451, DOI 10.1038/35006546; Fedtke I, 2004, INT J MED MICROBIOL, V294, P189, DOI 10.1016/j.ijmm.2004.06.016; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Haralambous E, 2006, SCAND J INFECT DIS, V38, P764, DOI 10.1080/00365540600643203; Harrison LH, 2006, CLIN MICROBIOL REV, V19, P142, DOI 10.1128/CMR.19.1.142-164.2006; Heckenberg SGB, 2008, MEDICINE, V87, P185, DOI 10.1097/MD.0b013e318180a6b4; Jokiranta TS, 1996, FEBS LETT, V393, P297; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LACHMANN PJ, 1990, BIOCHEM SOC T, V18, P1143, DOI 10.1042/bst0181143; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Prosser BE, 2007, ACTA CRYSTALLOGR F, V63, P480, DOI 10.1107/S1744309107020052; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; SIM E, 1983, BIOSCIENCE REP, V3, P1119, DOI 10.1007/BF01120205; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6	40	252	285	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					890	U9		10.1038/nature07769	http://dx.doi.org/10.1038/nature07769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19225461	Green Accepted			2022-12-24	WOS:000265182500043
J	Meguid, T				Meguid, Tarek			Lack of political will is a clinical issue	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MATERNAL MORTALITY; SAFE MOTHERHOOD; HUMAN-RIGHTS; HEALTH; CARE; ACCESS		[Meguid, Tarek] Kamuzu Cent Hosp, Lilongwe, Malawi; [Meguid, Tarek] Bwaila Hosp, Lilongwe, Malawi		Meguid, T (corresponding author), Kamuzu Cent Hosp, Lilongwe, Malawi.	meguid@globemw.net		McAuliffe, Eilish/0000-0002-9714-5040				AbouZahr C, 2003, BRIT MED BULL, V67, P13, DOI 10.1093/bmb/ldg014; ANDERSON T, 2005, ACTA OBSTET GYNECOL, V70, P679; BERGSTROM S, 2007, ACTA OBSTET GYNECOL, V84, P105; Bhutta ZA, 2000, BRIT MED J, V321, P809, DOI 10.1136/bmj.321.7264.809; Bristol N, 2008, LANCET, V371, P2162, DOI 10.1016/S0140-6736(08)60937-X; *BRIT MED ASS, 2001, MED PROF HUM RIGHTS; Centre on Housing Rights and Evictions, 2003, LIT EC SOC CULT RIGH; Cook RJ, 2006, INT J GYNECOL OBSTET, V94, P216, DOI 10.1016/j.ijgo.2006.04.009; Daniels Norman, 2008, JUST HLTH M HLTH NEE; EISENBERG L, 1984, AM J MED, V77, P524, DOI 10.1016/0002-9343(84)90114-1; Farmer Paul, 2008, Health Hum Rights, V10, P5; FATHALLA MF, 1997, OBSTET GYNECOLOGY WO; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Freedman LP, 2003, INT J GYNECOL OBSTET, V82, P111, DOI 10.1016/S0020-7292(03)00147-4; HELLMAN H, 2002, GREAT FEUDS MED; HERRING J, 2008, MED LAW ETHICS; Hogerzeil HV, 2006, LANCET, V368, P305, DOI 10.1016/S0140-6736(06)69076-4; Hurwitz B, 1997, BRIT MED J, V315, P1671, DOI 10.1136/bmj.315.7123.1671; Kassirer JP, 1998, NEW ENGL J MED, V339, P397, DOI 10.1056/NEJM199808063390608; Marmot MG., 2006, SOCIAL DETERMINANTS; Meguid Tarek, 2007, Malawi Med J, V19, P9; Meguid Tarek, 2008, Health Hum Rights, V10, P105; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P77; Pond B, 2006, LANCET, V367, P1448, DOI 10.1016/S0140-6736(06)68346-3; Record R, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-12; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Rosenfield A, 2007, NEW ENGL J MED, V356, P1395, DOI 10.1056/NEJMp078026; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Singer Peter, 2004, ETHICS ASSISTANCE MO; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; Tita ATN, 2007, OBSTET GYNECOL, V110, P972, DOI 10.1097/01.AOG.0000281668.71111.ea; UDOMBANA NJ, 2007, CASTING NET WIDER HU; Van Dillen J, 2006, ACTA OBSTET GYN SCAN, V85, P499, DOI 10.1080/00016340600555884; VANROOSMALEN J, 2008, ORATIE HOOGLERAARSCH; Weise S, 2007, AM J PHYS ANTHROPOL, P246; *WHO, MAT MORT RAT FALL TO; Winterton W R, 1980, Hist Med, V8, P11; WYKLICKY H, 1983, Infection Control (Thorofare), V4, P367; Yamin AE, 2005, HUM RIGHTS QUART, V27, P1200, DOI 10.1353/hrq.2005.0056; YAMIN AE, 2005, LEARNING DANCE ADV W	40	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2009	338								b1013	10.1136/bmj.b1013	http://dx.doi.org/10.1136/bmj.b1013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419GA	19279055				2022-12-24	WOS:000264206100006
J	Bennett, MR; Harris, JWK; Richmond, BG; Braun, DR; Mbua, E; Kiura, P; Olago, D; Kibunjia, M; Omuombo, C; Behrensmeyer, AK; Huddart, D; Gonzalez, S				Bennett, Matthew R.; Harris, John W. K.; Richmond, Brian G.; Braun, David R.; Mbua, Emma; Kiura, Purity; Olago, Daniel; Kibunjia, Mzalendo; Omuombo, Christine; Behrensmeyer, Anna K.; Huddart, David; Gonzalez, Silvia			Early Hominin Foot Morphology Based on 1.5-Million-Year-Old Footprints from Ileret, Kenya	SCIENCE			English	Article							TURKANA-BASIN; PLIOPLEISTOCENE HOMINIDS; LAKE TURKANA; KOOBI FORA; LAETOLI; AUSTRALOPITHECUS; CHIMPANZEE; BIPEDALISM; ETHIOPIA; WALKING	Hominin footprints offer evidence about gait and foot shape, but their scarcity, combined with an inadequate hominin fossil record, hampers research on the evolution of the human gait. Here, we report hominin footprints in two sedimentary layers dated at 1.51 to 1.53 million years ago (Ma) at Ileret, Kenya, providing the oldest evidence of an essentially modern human-like foot anatomy, with a relatively adducted hallux, medial longitudinal arch, and medial weight transfer before push-off. The size of the Ileret footprints is consistent with stature and body mass estimates for Homo ergaster/erectus, and these prints are also morphologically distinct from the 3.75-million-year-old footprints at Laetoli, Tanzania. The Ileret prints show that by 1.5 Ma, hominins had evolved an essentially modern human foot function and style of bipedal locomotion.	[Bennett, Matthew R.] Bournemouth Univ, Sch Conservat Sci, Poole BH12 5BB, Dorset, England; [Harris, John W. K.] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08901 USA; [Richmond, Brian G.] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC 20052 USA; [Richmond, Brian G.] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20013 USA; [Braun, David R.] Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa; [Mbua, Emma; Kiura, Purity; Kibunjia, Mzalendo] Natl Museums Kenya, Nairobi, Kenya; [Olago, Daniel; Omuombo, Christine] Univ Nairobi, Dept Geol, Nairobi, Kenya; [Behrensmeyer, Anna K.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, MRC 121, Washington, DC 20013 USA; [Huddart, David; Gonzalez, Silvia] Liverpool John Moores Univ, Sch Biol & Earth Sci, Liverpool L3 3AF, Merseyside, England	Bournemouth University; Rutgers State University New Brunswick; George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Cape Town; University of Nairobi; Smithsonian Institution; Smithsonian National Museum of Natural History; Liverpool John Moores University	Bennett, MR (corresponding author), Bournemouth Univ, Sch Conservat Sci, Poole BH12 5BB, Dorset, England.	mbennett@bmth.ac.uk	Braun, David/C-9680-2009	Omuombo, Christine Atieno/0000-0003-3966-2610; Bennett, Matthew/0000-0002-3063-8844	Holt Family Foundation; Wenner-Gren Foundation for Anthropological Research; Natural Environment Research Council [NE/C519446/1] Funding Source: researchfish	Holt Family Foundation; Wenner-Gren Foundation for Anthropological Research; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project is part of the Koobi Fora Research and Training Program, which is jointly run by the National Museum of Kenya and Rutgers University and supported by the Holt Family Foundation, M. Weiss, B. Mortenson, G. Noland, C. Chip, and the Wenner-Gren Foundation for Anthropological Research. B. Wood provided valuable comments on a draft of the paper, and the dating was undertaken by F. Brown. The field assistance of H. Manley, S. A. Morse, and M. J. Steele is acknowledged.	Allen JRL, 1997, PHILOS T ROY SOC B, V352, P481, DOI 10.1098/rstb.1997.0035; Anton SC, 2002, J HUM EVOL, V43, P773, DOI 10.1006/jhev.2002.0602; BEHRENSMEYER AK, 1981, NATURE, V289, P167, DOI 10.1038/289167a0; BRAUN DR, 2008, ARCHAEOMETRY, DOI DOI 10.1111/J.1475-4754.2008.00399; Brown FH, 2006, J GEOL SOC LONDON, V163, P185, DOI 10.1144/0016-764904-165; CHARTERIS J, 1982, AM J PHYS ANTHROPOL, V58, P133, DOI 10.1002/ajpa.1330580205; Elftman H, 1935, AM J PHYS ANTHROPOL, V20, P69, DOI 10.1002/ajpa.1330200109; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; Griffin N., 2006, HUMAN FOOT COMPANION, P27; Harris JWK, 2002, J HUM EVOL, V42, pA15; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Meldrum DJ, 2004, FROM BIPED TO STRIDER, P63; Morag E, 1999, J BIOMECH, V32, P359, DOI 10.1016/S0021-9290(98)00188-2; Pobiner BL, 2008, J HUM EVOL, V55, P103, DOI 10.1016/j.jhevol.2008.02.001; Pontzer H, 2007, J EXP BIOL, V210, P1752, DOI 10.1242/jeb.002246; Richmond BG, 2002, J HUM EVOL, V43, P529, DOI 10.1006/jhev.2002.0594; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; ROGERS MJ, 1994, J HUM EVOL, V27, P139, DOI 10.1006/jhev.1994.1039; Ruff Christopher B., 1993, P234; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; TUTTLE R, 1990, J ARCHAEOL SCI, V17, P347, DOI 10.1016/0305-4403(90)90028-4; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; Webb S, 2006, J HUM EVOL, V50, P405, DOI 10.1016/j.jhevol.2005.10.002; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409	27	151	153	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2009	323	5918					1197	1201		10.1126/science.1168132	http://dx.doi.org/10.1126/science.1168132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	411XT	19251625				2022-12-24	WOS:000263687600034
J	Barbero, F; Thomas, JA; Bonelli, S; Balletto, E; Schonrogge, K				Barbero, Francesca; Thomas, Jeremy A.; Bonelli, Simona; Balletto, Emilio; Schonrogge, Karsten			Queen Ants Make Distinctive Sounds That Are Mimicked by a Butterfly Social Parasite	SCIENCE			English	Article							MACULINEA-REBELI; STRIDULATORY ORGAN; HOST-SPECIFICITY; HYMENOPTERA; SIGNALS; COMMUNICATION; CATERPILLARS; ECOLOGY	Ants dominate terrestrial ecosystems through living in complex societies whose organization is maintained via sophisticated communication systems. The role of acoustics in information exchange may be underestimated. We show that Myrmica schencki queens generate distinctive sounds that elicit increased benevolent responses from workers, reinforcing their supreme social status. Although fiercely defended by workers, ant societies are infiltrated by specialist insects that exploit their resources. Sounds produced by pupae and larvae of the parasitic butterfly Maculinea rebeli mimic those of queen ants more closely than those of workers, enabling them to achieve high status within ant societies. We conclude that acoustical mimicry provides another route for infiltration for similar to 10,000 species of social parasites that cheat ant societies.	[Barbero, Francesca; Thomas, Jeremy A.] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Barbero, Francesca; Bonelli, Simona; Balletto, Emilio] Univ Turin, Dipartimento Biol Anim, Uomo Lab Zool, I-10123 Turin, Italy; [Thomas, Jeremy A.; Schonrogge, Karsten] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	UK Centre for Ecology & Hydrology (UKCEH); University of Turin; University of Oxford	Thomas, JA (corresponding author), Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England.	jeremy.thomas@zoo.ox.ac.uk	Thomas, Jeremy/A-9619-2013; Barbero, Francesca/J-3555-2016; Schonrogge, Karsten/M-9935-2019	Barbero, Francesca/0000-0003-2667-0435; Schonrogge, Karsten/0000-0003-0122-6493; Bonelli, Simona/0000-0001-5185-8136; BALLETTO, Emilio/0000-0003-1168-2791	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; DEVRIES PJ, 1993, BIOL J LINN SOC, V49, P229, DOI 10.1111/j.1095-8312.1993.tb00902.x; Downey J.C., 1973, Bulletin Allyn Mus, VNo. 14, P1; Elmes GW, 2004, ENTOMOL EXP APPL, V110, P53, DOI 10.1111/j.0013-8703.2004.00121.x; Fiedler K, 1996, EXPERIENTIA, V52, P14, DOI 10.1007/BF01922410; Grasso DA, 1998, ITAL J ZOOL, V65, P167, DOI 10.1080/11250009809386741; Hickling R, 2000, J ACOUST SOC AM, V108, P1920, DOI 10.1121/1.1290515; HILL CJ, 1993, J AUST ENTOMOL SOC, V32, P283; Holldobler B, 1999, J COMP PHYSIOL A, V184, P129, DOI 10.1007/s003590050313; Holldobler B., 1990, pi; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; MARKL H, 1968, Z VERGL PHYSIOL, V60, P103, DOI 10.1007/BF00878447; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; MARKL H, 1978, BEHAV ECOL SOCIOBIOL, V4, P183, DOI 10.1007/BF00354979; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Roces F, 2001, J ACOUST SOC AM, V109, P3080, DOI 10.1121/1.1370085; Ruiz E, 2006, ANN SOC ENTOMOL FR, V42, P99, DOI 10.1080/00379271.2006.10697454; Schonrogge K, 2004, J CHEM ECOL, V30, P91, DOI 10.1023/B:JOEC.0000013184.18176.a9; Schurian Klaus G., 1994, Nachrichten des Entomologischen Vereins Apollo, V14, P339; Scott-Phillips TC, 2008, J EVOLUTION BIOL, V21, P387, DOI 10.1111/j.1420-9101.2007.01497.x; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; Thomas JA, 1998, P ROY SOC B-BIOL SCI, V265, P1895, DOI 10.1098/rspb.1998.0517; Thomas Jeremy A., 2005, P479, DOI 10.1079/9780851998121.0479; Travassos MA, 2000, ANIM BEHAV, V60, P13, DOI 10.1006/anbe.1999.1364	25	125	131	0	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					782	785		10.1126/science.1163583	http://dx.doi.org/10.1126/science.1163583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197065				2022-12-24	WOS:000263066800047
J	Kleinman, A				Kleinman, Arthur			Caregiving: the odyssey of becoming more human	LANCET			English	Editorial Material									[Kleinman, Arthur] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University	Kleinman, A (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	kleinman@wjh.harvard.edu						Abel E. K., 2000, HEARTS WISDOM AM WOM; Alterra Aaron, 1999, CAREGIVER LIFE ALZHE; Kleinman Arthur, 2006, WHAT REALLY MATTERS; Reiff David, 2008, SWIMMING SEA DEATH S; Tronto J.C., 1993, MORAL BOUNDARIES POL	5	93	96	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 24	2009	373	9660					292	293		10.1016/S0140-6736(09)60087-8	http://dx.doi.org/10.1016/S0140-6736(09)60087-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19177629	Green Submitted			2022-12-24	WOS:000262728100014
J	Farquhar, C				Farquhar, Cynthia			Do uterine fibroids cause infertility and should they be removed to increase fertility?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Farquhar, Cynthia] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand	University of Auckland	Farquhar, C (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand.	c.farquhar@auckland.ac.nz		Farquhar, Cynthia/0000-0002-3685-3553				[Anonymous], 2004, FERT ASS TREATM PEOP; Bajekal N, 2000, HUM REPROD UPDATE, V6, P614, DOI 10.1093/humupd/6.6.614; Bradford Hill A., 1991, BRADFORD HILLS PRINC; Bulletti C, 1999, J AM ASSOC GYN LAP, V6, P441, DOI 10.1016/S1074-3804(99)80008-5; BUTTRAM VC, 1981, FERTIL STERIL, V36, P433; Casini ML, 2006, GYNECOL ENDOCRINOL, V22, P106, DOI 10.1080/09513590600604673; DANGELO AG, 2006, COCHRANE DB SYST REV; Donnez J, 2002, HUM REPROD, V17, P1424, DOI 10.1093/humrep/17.6.1424; Gupta JK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005073.pub2; PRITTS EA, 2008, FERTIL STERIL   0311; VERKAUF BS, 1992, FERTIL STERIL, V58, P1	11	11	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 16	2009	338								b126	10.1136/bmj.b126	http://dx.doi.org/10.1136/bmj.b126			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AE	19151067				2022-12-24	WOS:000263193500003
J	Aron, D; Pogach, L				Aron, David; Pogach, Leonard			Transparency Standards for Diabetes Performance Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TARGETS		[Aron, David] Louis Stokes Cleveland VA Med Ctr, Educ Off 14W, Cleveland, OH 44106 USA; [Aron, David] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Pogach, Leonard] New Jersey Vet Hlth Adm Healthcare Syst, E Orange, NJ USA; [Pogach, Leonard] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; New Jersey Department of Health & Senior Services; US Department of Veterans Affairs; Veterans Health Administration (VHA); Rutgers State University New Brunswick; Rutgers State University Medical Center	Aron, D (corresponding author), Louis Stokes Cleveland VA Med Ctr, Educ Off 14W, 10701 E Blvd, Cleveland, OH 44106 USA.	david.aron@va.gov						*AG HEALTHC RES QU, ASS QUAL CAR DIAB; Baumann MH, 2007, CHEST, V132, P1015, DOI 10.1378/chest.07-1271; *BRIDG EXC, DIAB CAR LINK; *BURS, NAT DIAB CALL ACT BL; Coyne DW, 2007, CLIN J AM SOC NEPHRO, V2, P3, DOI 10.2215/CJN.02170606; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hayward RA, 2007, AM J MANAG CARE, V13, P126; *NAT COMM QUAL ASS, QUAL MATT; *NAT QUAL FOR, NAT VOL CONS STAND 2; National Committee for Quality Assurance, 2008, HEDIS, V2; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Rose Johnie, 2008, Qual Manag Health Care, V17, P27, DOI 10.1097/01.QMH.0000308635.59108.29; SMITH PC, 2008, HLTH POLICY, V41, P37; WORKING GROUP, 1998, REP WORK GROUP TRANS	15	19	19	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					210	212		10.1001/jama.2008.930	http://dx.doi.org/10.1001/jama.2008.930			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141769				2022-12-24	WOS:000262405500023
J	Hirsch, IB				Hirsch, Irl B.			Sliding Scale Insulin-Time to Stop Sliding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIABETES-MELLITUS; HOSPITALIZED-PATIENTS; GLYCEMIC CONTROL; MANAGEMENT; THERAPY; HYPERGLYCEMIA; INPATIENTS; OUTCOMES; GLUCOSE		[Hirsch, Irl B.] Univ Washington, Sch Med, Diabet Care Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hirsch, IB (corresponding author), UWMC Roosevelt, 4225 Roosevelt Way NE,Ste 101, Seattle, WA 98105 USA.	ihirsch@u.washington.edu						Becker T, 2007, DIABETES RES CLIN PR, V78, P392, DOI 10.1016/j.diabres.2007.05.003; Bolli Geremia B, 2003, Pediatr Endocrinol Rev, V1, P9; Braithwaite SS, 2008, CURR OPIN ENDOCRINOL, V15, P159, DOI 10.1097/MED.0b013e3282f827e7; Browning LA, 2004, AM J HEALTH-SYST PH, V61, P1611, DOI 10.1093/ajhp/61.15.1611; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254; FORMAN BH, 1974, PEDIATRICS, V53, P257; Joslin EP, 1934, DIABETIC MANUAL MUTU, P108; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Mooradian AD, 2006, ANN INTERN MED, V145, P125, DOI 10.7326/0003-4819-145-2-200607180-00010; Queale WS, 1997, ARCH INTERN MED, V157, P545, DOI 10.1001/archinte.157.5.545; ROBBINS L, 1963, Med Rec Ann, V56, P201; Trence DL, 2003, J CLIN ENDOCR METAB, V88, P2430, DOI 10.1210/jc.2003-030347; Umpierrez GE, 2007, DIABETES CARE, V30, P2181, DOI 10.2337/dc07-0295	15	77	83	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					213	214		10.1001/jama.2008.943	http://dx.doi.org/10.1001/jama.2008.943			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141770				2022-12-24	WOS:000262405500024
J	Gooskens, J; Jonges, M; Claas, ECJ; Meijer, A; van den Broek, PJ; Kroes, ACM				Gooskens, Jairo; Jonges, Marcel; Claas, Eric C. J.; Meijer, Adam; van den Broek, Peterhans J.; Kroes, Aloys C. M.			Morbidity and Mortality Associated With Nosocomial Transmission of Oseltamivir-Resistant Influenza A(H1N1) Virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-VITRO; NEURAMINIDASE; VIVO	Context The sudden emergence and rapid spread of oseltamivir-resistant influenza A(H1N1) viruses with neuraminidase (NA) gene H274Y amino acid substitution is the hallmark of global seasonal influenza since January 2008. Viruses carrying this mutation are widely presumed to exhibit attenuated pathogenicity, compromised transmission, and reduced lethality. Objective To investigate nosocomial viral transmission in a cluster of patients with influenza A(H1N1) virus infection. Design, Setting, and Patients Descriptive outbreak investigation of 2 hematopoietic stem cell transplant recipients and an elderly patient who developed hospital-acquired influenza A virus infection following exposure to an index patient with community-acquired H274Y-mutated influenza A(H1N1) virus infection in a medical ward at a Dutch university hospital in February 2008. The investigation included a review of the medical records, influenza virus polymerase chain reaction and culture, phenotypic oseltamivir and zanamivir susceptibility determination, and hemagglutinin chain 1(HA(1)) gene and NA gene sequence analysis. Main Outcome Measure Phylogenetic relationship of patient cluster influenza A(H1N1) viruses and other 2007-2008 seasonal influenza A(H1N1) viruses. Results Viral HA1 and NA gene sequence analysis from the 4 patients revealed indistinguishable nucleotide sequences and phylogenetic clustering of H274Y-mutated, oseltamivir-resistant influenza A(H1N1) virus, confirming nosocomial transmission. Influenza virus pneumonia (3 patients) and attributable mortality (2 patients) during active infection was observed in patients with lymphocytopenia at onset. Conclusion Seasonal oseltamivir-resistant influenza A(H1N1) viruses with NA gene H274Y mutation are transmitted and retain significant pathogenicity and lethality in high-risk patients.	[Gooskens, Jairo; Claas, Eric C. J.; Kroes, Aloys C. M.] Leiden Univ, Med Ctr, Dept Med Microbiol, Ctr Infect Dis, NL-2300 RC Leiden, Netherlands; [van den Broek, Peterhans J.] Leiden Univ, Med Ctr, Dept Infect Dis, Ctr Infect Dis, NL-2300 RC Leiden, Netherlands; [Jonges, Marcel; Meijer, Adam] Natl Inst Publ Hlth & Environm, Virol Sect, NL-3720 BA Bilthoven, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands National Institute for Public Health & the Environment	Gooskens, J (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Ctr Infect Dis, E4-65,POB 9600, NL-2300 RC Leiden, Netherlands.	j.gooskens@lumc.nl	Gooskens, Jairo/A-6634-2009	Gooskens, Jairo/0000-0002-8381-7870; Kroes, Aloysius/0000-0002-9866-2461				*CDCP, 2008, CDC ISS INT REC US I; Gooskens J, 2007, J CLIN VIROL, V39, P136, DOI 10.1016/j.jcv.2007.03.010; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Lackenby A., 2008, Eurosurveillance, V13, P8026; Nicoll A., 2008, EUROSURVEILLANCE, V13, P8025, DOI [10.2807/ese.13.05.08025-en, DOI 10.2807/ESE.13.05.08025-EN]; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; van der Vries E, 2008, NEW ENGL J MED, V359, P1074, DOI 10.1056/NEJMc0803120; *WHO, 2008, EP PAND AL RESP INFL; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07	12	80	88	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1042	1046		10.1001/jama.2009.297	http://dx.doi.org/10.1001/jama.2009.297			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416OQ	19255111	Bronze			2022-12-24	WOS:000264015800028
J	Mumma, MJ; Villanueva, GL; Novak, RE; Hewagama, T; Bonev, BP; DiSanti, MA; Mandell, AM; Smith, MD				Mumma, Michael J.; Villanueva, Geronimo L.; Novak, Robert E.; Hewagama, Tilak; Bonev, Boncho P.; DiSanti, Michael A.; Mandell, Avi M.; Smith, Michael D.			Strong Release of Methane on Mars in Northern Summer 2003	SCIENCE			English	Article							MARTIAN DUST DEVILS; MU-M; OXIDANT ENHANCEMENT; ATMOSPHERE; ORIGIN; LIFE; SPECTRUM; SEARCH; STORMS; MODEL	Living systems produce more than 90% of Earth's atmospheric methane; the balance is of geochemical origin. On Mars, methane could be a signature of either origin. Using high- dispersion infrared spectrometers at three ground- based telescopes, we measured methane and water vapor simultaneously on Mars over several longitude intervals in northern early and late summer in 2003 and near the vernal equinox in 2006. When present, methane occurred in extended plumes, and the maxima of latitudinal profiles imply that the methane was released from discrete regions. In northern midsummer, the principal plume contained similar to 19,000 metric tons of methane, and the estimated source strength (>= 0.6 kilogram per second) was comparable to that of the massive hydrocarbon seep at Coal Oil Point in Santa Barbara, California.	[Mumma, Michael J.; Villanueva, Geronimo L.; Hewagama, Tilak; Bonev, Boncho P.; DiSanti, Michael A.; Mandell, Avi M.; Smith, Michael D.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Villanueva, Geronimo L.; Bonev, Boncho P.] Univ Amer, Dept Phys, Washington, DC 20008 USA; [Novak, Robert E.] Iona Coll, Dept Phys, New Rochelle, NY 10801 USA; [Hewagama, Tilak] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Iona College; University System of Maryland; University of Maryland College Park	Mumma, MJ (corresponding author), NASA, Goddard Space Flight Ctr, Mailstop 690-3, Greenbelt, MD 20771 USA.	michael.j.mumma@nasa.gov	Smith, Michael/C-8875-2012; Hewagama, T/C-8488-2012; mumma, michael j/I-2764-2013; Mandell, Avi M/F-9361-2012	mumma, michael j/0000-0003-4627-750X; Mandell, Avi M/0000-0002-8119-3355	NASA the Planetary Astronomy Program [RTOP 344-32-07]; Astrobiology Institute [RTOP 344-53-51]; NSF Research at Undergraduate Institutions Program [AST-0505765]	NASA the Planetary Astronomy Program(National Aeronautics & Space Administration (NASA)); Astrobiology Institute; NSF Research at Undergraduate Institutions Program(National Science Foundation (NSF))	We thank T. C. Onstott and L. M. Pratt for helpful comments and two anonymous referees for their comments and suggestions. This work was supported by NASA [the Planetary Astronomy Program (RTOP 344-32-07 to M.J.M), Astrobiology Institute (RTOP 344-53-51, to M.J.M), and Postdoctoral Program (G.L.V.)] by NSF (Research at Undergraduate Institutions Program AST-0505765 to R.E.N.). We thank the director and staff of NASA's InfraRed Telescope Facility (operated for NASA by the University of Hawaii) for exceptional support throughout our long Mars observing program. Data were also obtained at the W. M. Keck Observatory, operated as a scientific partnership by CalTech, the University of California Los Angeles, and NASA.	Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Atreya SK, 2006, ASTROBIOLOGY, V6, P439, DOI 10.1089/ast.2006.6.439; Baratoux D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002890; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Delory GT, 2006, ASTROBIOLOGY, V6, P451, DOI 10.1089/ast.2006.6.451; Encrenaz T, 2008, ICARUS, V195, P547, DOI 10.1016/j.icarus.2008.01.022; Farrell WM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027210; Formisano V, 2005, PLANET SPACE SCI, V53, P1043, DOI 10.1016/j.pss.2005.03.009; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Geminale A, 2008, PLANET SPACE SCI, V56, P1194, DOI 10.1016/j.pss.2008.03.004; HECHT MH, 2008, EOS S, V89; Hiesinger H, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002143; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; KOUNAVES SP, 2008, EOS S, V89; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Krasnopolsky VA, 2006, ICARUS, V180, P359, DOI 10.1016/j.icarus.2005.10.015; Krasnopolsky VA, 1997, J GEOPHYS RES-PLANET, V102, P6525, DOI 10.1029/96JE03766; Krasnopolsky VA, 2007, ICARUS, V190, P93, DOI 10.1016/j.icarus.2007.02.014; Lellouch E, 2000, PLANET SPACE SCI, V48, P1393, DOI 10.1016/S0032-0633(00)00118-5; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Lyons JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022161; MAGUIRE WC, 1977, ICARUS, V32, P85, DOI 10.1016/0019-1035(77)90051-3; Mau S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031344; Max MD, 2000, J GEOPHYS RES-PLANET, V105, P4165, DOI 10.1029/1999JE001119; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; MUMMA M. J., 2003, B AM ASTRON SOC, V35, P937; Mumma M.J., 2004, AM ASTRON SOC DPS ME, V36, P1127; MUMMA MJ, 2008, B AM ASTRON SOC, V40, P396; MUMMA MJ, 2007, B AM ASTRON SOC, V39, P471; MUMMA MJ, 2005, B AM ASTRON SOC, V37, P669; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; NAIR H, 1994, ICARUS, V111, P124, DOI 10.1006/icar.1994.1137; Onstott TC, 2006, GEOMICROBIOL J, V23, P369, DOI 10.1080/01490450600875688; Onstott TC, 2006, ASTROBIOLOGY, V6, P377, DOI 10.1089/ast.2006.6.377; Oze C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022691; Pellenbarg RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001901; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Summers ME, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015377; Villanueva GL, 2008, ICARUS, V195, P34, DOI 10.1016/j.icarus.2007.11.014; Wille C, 2008, GLOBAL CHANGE BIOL, V14, P1395, DOI 10.1111/j.1365-2486.2008.01586.x; Wong AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002003	42	422	434	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1041	1045		10.1126/science.1165243	http://dx.doi.org/10.1126/science.1165243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19150811				2022-12-24	WOS:000263478400036
J	Marintchev, A; Edmonds, KA; Marintcheva, B; Hendrickson, E; Oberer, M; Suzuki, C; Herdy, B; Sonenberg, N; Wagner, G				Marintchev, Assen; Edmonds, Katherine A.; Marintcheva, Boriana; Hendrickson, Elthea; Oberer, Monika; Suzuki, Chikako; Herdy, Barbara; Sonenberg, Nahum; Wagner, Gerhard			Topology and Regulation of the Human eIF4A/4G/4H Helicase Complex in Translation Initiation	CELL			English	Article							BOX PROTEIN EIF4A; FACTOR 4G EIF4G; MESSENGER-RNA; CRYSTAL-STRUCTURE; BINDING; CAP; DOMAINS; FRAMEWORK; SITES	The RNA helicase eIF4A plays a key role in unwinding of mRNA and scanning during translation initiation. Free eIF4A is a poor helicase and requires the accessory proteins eIF4G and eIF4H. However, the structure of the helicase complex and the mechanisms of stimulation of eIF4A activity have remained elusive. Here we report the topology of the eIF4A/4G/4H helicase complex, which is built from multiple experimentally observed domain-domain contacts. Remarkably, some of the interactions are continuously rearranged during the ATP binding/hydrolysis cycle of the helicase. We show that the accessory proteins modulate the affinity of eIF4A for ATP by interacting simultaneously with both helicase domains and promoting either the closed, ATP-bound conformation or the open, nucleotide-free conformation. The topology of the complex and the spatial arrangement of the RNA-binding surfaces offer insights into their roles in stimulation of helicase activity and the mechanisms of mRNA unwinding and scanning.	[Oberer, Monika] Graz Univ, Inst Mol Biosci, Graz, Austria; [Herdy, Barbara; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Marintchev, Assen; Edmonds, Katherine A.; Hendrickson, Elthea; Suzuki, Chikako; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Graz; McGill University; Harvard University; Harvard Medical School	Marintchev, A (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.	amarint@bu.edu; gerhard_wagner@hms.harvard.edu		Oberer, Monika/0000-0003-2525-9513; Marintchev, Assen/0000-0002-9901-3500	NATIONAL CANCER INSTITUTE [R01CA068262, K01CA119107, R01CA127990] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000995, S10RR015742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467, P41GM066360, R01GM038608] Funding Source: NIH RePORTER; NCI NIH HHS [K01CA119107, R01 CA068262-12, CA68262, R01 CA068262-13, R01 CA127990-03, K01 CA119107, R01 CA068262-14, R01 CA068262, R01 CA127990, R01 CA068262-11] Funding Source: Medline; NCRR NIH HHS [P41 RR000995-26, S10 RR015742-01, P41 RR000995-27] Funding Source: Medline; NIBIB NIH HHS [P41 EB002026] Funding Source: Medline; NIGMS NIH HHS [P01 GM047467-179001, P41 GM066360-05, P01 GM047467-170011, R01 GM038608, P41 GM066360, P01 GM047467-170010, P41 GM066360-04, R01 GM038608-13, GM47467, P01 GM047467-179002, R01 GM038608-12, R01 GM038608-11A2, P01 GM047467] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Bellsolell L, 2006, STRUCTURE, V14, P913, DOI 10.1016/j.str.2006.03.012; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Feng PH, 2005, J VIROL, V79, P9651, DOI 10.1128/JVI.79.15.9651-9664.2005; Fersht A., 1999, STRUCTURE MECH PROTE, P125; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Jackson RJ, 2000, COLD SPRING HARBOR M, V39, P127; Korneeva NL, 2001, J BIOL CHEM, V276, P2872, DOI 10.1074/jbc.M006345200; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; Marintchev A, 2007, METHOD ENZYMOL, V430, P283, DOI 10.1016/S0076-6879(07)30012-8; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Prevot D, 2003, EMBO J, V22, P1909, DOI 10.1093/emboj/cdg175; Richter-Cook NJ, 1998, J BIOL CHEM, V273, P7579, DOI 10.1074/jbc.273.13.7579; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Rozovsky N, 2008, RNA, V14, P2136, DOI 10.1261/rna.1049608; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	33	172	175	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					447	460		10.1016/j.cell.2009.01.014	http://dx.doi.org/10.1016/j.cell.2009.01.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203580	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000263120600015
J	Marenzi, G; Assanelli, E; Campodonico, J; Lauri, G; Marana, I; De Metrio, M; Moltrasio, M; Grazi, M; Rubino, M; Veglia, F; Fabbiocchi, F; Bartorelli, AL				Marenzi, Giancarlo; Assanelli, Emilio; Campodonico, Jeness; Lauri, Gianfranco; Marana, Ivana; De Metrio, Monica; Moltrasio, Marco; Grazi, Marco; Rubino, Mara; Veglia, Fabrizio; Fabbiocchi, Franco; Bartorelli, Antonio L.			Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PRIMARY ANGIOPLASTY; RENAL DYSFUNCTION; CREATININE CLEARANCE; N-ACETYLCYSTEINE; PREDICTION; INSUFFICIENCY; FAILURE; IMPACT; MEDIA	Background: Contrast-induced nephropathy (CIN) frequently occurs in patients with acute ST-segment elevation myocardial infarction (STEMI) who are undergoing primary percutaneous coronary intervention, and CIN is associated with a more complicated clinical course and increased mortality. Objective: To investigate the association between absolute and weight- and creatinine-adjusted contrast volume, CIN incidence, and clinical outcome in the era of mechanical reperfusion of STEMI. Design: Prospective, observational study. Setting: A university cardiology center in Milan, Italy. Patients: 561 consecutive patients with STEMI who were undergoing primary percutaneous coronary intervention. Measurements: For each patient, the maximum contrast dose was calculated, according to the formula (5 X body weight [kg])/serum creatinine, and the contrast ratio, defined as the ratio between the contrast volume administered and the maximum dose calculated, was assessed. An increase in serum creatinine of more than 25% from baseline was defined as CIN. Results: 115 (20.5%) patients developed CIN. In-hospital mortality was higher among patients with CIN than those without CIN (21.4% vs. 0.9%; P < 0.001). The maximum contrast dose was exceeded in 130 (23%) patients. Patients who received more than the maximum contrast dose (contrast ratio >1) had a more complicated in-hospital clinical course and higher mortality rate (13% vs. 2.8%; P < 0.001) than did patients with a contrast ratio less than 1. Development of CIN was associated with both contrast volume and contrast ratio. Limitation: The association between contrast volume and outcomes was observed in a single center and could be due to comorbid conditions, disease severity, or an unknown factor. Conclusion: During primary percutaneous coronary intervention for STEMI, higher contrast volume is associated with higher rates of CIN and mortality; however, further study is needed to determine whether limiting contrast volume would improve patient outcome.	[Marenzi, Giancarlo; Assanelli, Emilio; Campodonico, Jeness; Lauri, Gianfranco; Marana, Ivana; De Metrio, Monica; Moltrasio, Marco; Grazi, Marco; Rubino, Mara; Veglia, Fabrizio; Fabbiocchi, Franco; Bartorelli, Antonio L.] Univ Milan, Ctr Cardiol Monzino, I-20138 Milan, Italy	IRCCS Centro Cardiologico Monzino; University of Milan	Marenzi, G (corresponding author), Univ Milan, Ctr Cardiol Monzino, Via Parea 4, I-20138 Milan, Italy.	giancarlo.marenzi@ccfm.it	De Metrio, Monica/ABH-6561-2020; Grazi, Marco/ABH-5946-2020; Bartorelli, Antonio Luca/ABG-9593-2020; Rubino, Mara/K-1537-2016; Veglia, Fabrizio/K-1958-2016; Assanelli, Emilio/ABH-4902-2020; Bartorelli, Antonio/K-3955-2018; campodonico, jeness/AAC-2284-2022	Grazi, Marco/0000-0003-1518-3199; Rubino, Mara/0000-0001-7820-9814; Veglia, Fabrizio/0000-0002-9378-8874; Marenzi, Giancarlo/0000-0003-4410-4461; De Metrio, Monica/0000-0002-1955-747X	Centro Cardiologico Monzino; Institute of Cardiology, University of Milan	Centro Cardiologico Monzino; Institute of Cardiology, University of Milan	Centro Cardiologico Monzino, Institute of Cardiology, University of Milan.	Addala S, 2004, AM J CARDIOL, V93, P629, DOI 10.1016/j.amjcard.2003.11.036; Baumgart D, 1997, CATHETER CARDIO DIAG, V40, P241; BOURDILLON PD, 1985, J AM COLL CARDIOL, V6, P845, DOI 10.1016/S0735-1097(85)80493-9; Brodie BR, 1996, J AM COLL CARDIOL, V28, P319, DOI 10.1016/0735-1097(96)00152-0; CIGARROA RG, 1989, AM J MED, V86, P649, DOI 10.1016/0002-9343(89)90437-3; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; CRUZ C, 1986, RADIOLOGY, V158, P109, DOI 10.1148/radiology.158.1.3079623; De Luca G, 2004, CIRCULATION, V109, P2737, DOI 10.1161/01.CIR.0000131765.73959.87; DeGeare VS, 2000, AM J CARDIOL, V86, P30, DOI 10.1016/S0002-9149(00)00824-9; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Freeman RV, 2002, AM J CARDIOL, V90, P1068, DOI 10.1016/S0002-9149(02)02771-6; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Heggunje PS, 2004, J AM COLL CARDIOL, V44, P1400, DOI 10.1016/j.jacc.2004.06.065; Jaumdally RJ, 2007, J THROMB THROMBOLYS, V23, P189, DOI 10.1007/s11239-006-9048-x; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; Laskey WK, 2007, J AM COLL CARDIOL, V50, P584, DOI 10.1016/j.jacc.2007.03.058; MANSKE CL, 1990, AM J MED, V89, P615, DOI 10.1016/0002-9343(90)90180-L; Marenzi G, 2004, J AM COLL CARDIOL, V44, P1780, DOI 10.1016/j.jacc.2004.07.043; Marenzi G, 2007, AM HEART J, V153, P755, DOI 10.1016/j.ahj.2007.02.018; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; MASON RA, 1985, JAMA-J AM MED ASSOC, V253, P1001, DOI 10.1001/jama.253.7.1001; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; MILLER DL, 1988, RADIOLOGY, V167, P607, DOI 10.1148/radiology.167.3.3363118; Moscucci M, 2005, J AM COLL CARDIOL, V46, P625, DOI 10.1016/j.jacc.2005.05.048; Nyman U, 2008, ACTA RADIOL, V49, P658, DOI 10.1080/02841850802050762; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Pradhan J, 2007, CORONARY ARTERY DIS, V18, P275, DOI 10.1097/MCA.0b013e328056dd46; Recio-Mayoral A, 2007, J AM COLL CARDIOL, V49, P1283, DOI 10.1016/j.jacc.2006.11.034; Sadeghi HM, 2003, CIRCULATION, V108, P2769, DOI 10.1161/01.CIR.0000103623.63687.21; Solomon R, 2006, KIDNEY INT, V69, pS46, DOI 10.1038/sj.ki.5000374; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; TALIERCIO CP, 1986, ANN INTERN MED, V104, P501, DOI 10.7326/0003-4819-104-4-501; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Vlietstra RE, 1996, AM HEART J, V132, P1049, DOI 10.1016/S0002-8703(96)90021-6	38	251	271	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2009	150	3					170	+		10.7326/0003-4819-150-3-200902030-00006	http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402RA	19189906				2022-12-24	WOS:000263029600003
J	Giraudo, CG; Garcia-Diaz, A; Eng, WS; Chen, YH; Hendrickson, WA; Melia, TJ; Rothman, JE				Giraudo, Claudio G.; Garcia-Diaz, Alejandro; Eng, William S.; Chen, Yuhang; Hendrickson, Wayne A.; Melia, Thomas J.; Rothman, James E.			Alternative Zippering as an On-Off Switch for SNARE-Mediated Fusion	SCIENCE			English	Article							SYNAPTIC VESICLE CYCLE; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; DISTINCT DOMAINS; SYNAPTOTAGMIN-I; CA2+ SENSOR; COMPLEX; EXOCYTOSIS	Membrane fusion between vesicles and target membranes involves the zippering of a four- helix bundle generated by constituent helices derived from target- and vesicle- soluble N-ethylmaleimide- sensitive factor attachment protein receptors (SNAREs). In neurons, the protein complexin clamps otherwise spontaneous fusion by SNARE proteins, allowing neurotransmitters and other mediators to be secreted when and where they are needed as this clamp is released. The membrane- proximal accessory helix of complexin is necessary for clamping, but its mechanism of action is unknown. Here, we present experiments using a reconstituted fusion system that suggest a simple model in which the complexin accessory helix forms an alternative four- helix bundle with the target- SNARE near the membrane, preventing the vesicle- SNARE from completing its zippering.	[Giraudo, Claudio G.; Garcia-Diaz, Alejandro; Eng, William S.; Melia, Thomas J.; Rothman, James E.] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Eng, William S.; Chen, Yuhang; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Eng, William S.; Chen, Yuhang; Hendrickson, Wayne A.] Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Giraudo, CG (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	claudio.giraudo@yale.edu; james.rothman@yale.edu			NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071458] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH grant to J.E.R.	Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Giraudo CG, 2008, J BIOL CHEM, V283, P21211, DOI 10.1074/jbc.M803478200; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; JONES A, 2008, O VERSION 12 0; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292	23	121	121	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					512	516		10.1126/science.1166500	http://dx.doi.org/10.1126/science.1166500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164750	Green Accepted			2022-12-24	WOS:000262587900045
J	Li, S; Makovets, S; Matsuguchi, T; Blethrow, JD; Shokat, KM; Blackburn, EH				Li, Shang; Makovets, Svetlana; Matsuguchi, Tetsuya; Blethrow, Justin D.; Shokat, Kevan M.; Blackburn, Elizabeth H.			Cdk1-Dependent Phosphorylation of Cdc13 Coordinates Telomere Elongation during Cell-Cycle Progression	CELL			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERES; DEPENDENT KINASE CDK1; DNA-BINDING PROTEIN; LENGTH REGULATION; YEAST TELOMERES; END PROTECTION; IN-VIVO; REPLICATION; EST1P; MEC1	Elongation of telomeres by telomerase replenishes the loss of terminal telomeric DNA repeats during each cell cycle. In budding yeast, Cdc13 plays an essential role in telomere length homeostasis, partly through its interactions with both the telomerase complex and the competing Stn1-Ten1 complex. Previous studies in yeast have shown that telomere elongation by telomerase is cell cycle dependent, but the mechanism underlying this dependence is unclear. In S. cerevisiae, a single cyclin-dependent kinase Cdk1 (Cdc28) coordinates the serial events required for the cell division cycle, but no Cdk1 substrate has been identified among telomerase and telomere-associated factors. Here we show that Cdk1-dependent phosphorylation of Cdc13 is essential for efficient recruitment of the yeast telomerase complex to telomeres by favoring the interaction of Cdc13 with Est1 rather than the competing Stn1-Ten1 complex. These results provide a direct mechanistic link between coordination of telomere elongation and cell-cycle progression in vivo.	[Li, Shang; Makovets, Svetlana; Matsuguchi, Tetsuya; Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Blethrow, Justin D.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blackburn, EH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Box 2200, San Francisco, CA 94143 USA.	elizabeth.blackburn@ucsf.edu	Matsuguchi, Tetsuya/HGU-0412-2022; LI, SHANG/HII-4989-2022	LI, SHANG/0000-0002-6226-3362; Matsuguchi, Tetsuya/0000-0003-2018-4575; Makovets, Svetlana/0000-0002-0226-2093	NIH; UC BREP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC BREP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bradley Stohr, Jennifer Fung, Jeff Seidel, and Tanya Williams for critical reading of the manuscript. This work was supported by grants from the NIH to E.H.B. and K.M.S. J.D.B. was supported by a UC BREP great fellowship.	Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bourns BD, 1998, MOL CELL BIOL, V18, P5600, DOI 10.1128/MCB.18.9.5600; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Chan SWL, 2001, CURR BIOL, V11, P1240, DOI 10.1016/S0960-9822(01)00391-8; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Chen JL, 2004, TRENDS BIOCHEM SCI, V29, P183, DOI 10.1016/j.tibs.2004.02.003; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Dahlseid JN, 2003, EUKARYOT CELL, V2, P134, DOI 10.1128/EC.2.1.134-142.2003; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Frank CJ, 2006, MOL CELL, V24, P423, DOI 10.1016/j.molcel.2006.10.020; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Goudsouzian LK, 2006, MOL CELL, V24, P603, DOI 10.1016/j.molcel.2006.10.005; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Hirano Y, 2007, MOL BIOL CELL, V18, P2026, DOI 10.1091/mbc.E06-12-1074; Hsu CL, 2004, NUCLEIC ACIDS RES, V32, P511, DOI 10.1093/nar/gkh203; Hughes TR, 2000, P NATL ACAD SCI USA, V97, P6457, DOI 10.1073/pnas.97.12.6457; Laroche T, 2000, J STRUCT BIOL, V129, P159, DOI 10.1006/jsbi.2000.4240; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lendvay TS, 1996, GENETICS, V144, P1399; Levy DL, 2004, MOL CELL BIOL, V24, P10857, DOI 10.1128/MCB.24.24.10857-10867.2004; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Osterhage JL, 2006, NAT STRUCT MOL BIOL, V13, P720, DOI 10.1038/nsmb1125; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Petreaca RC, 2007, GENETICS, V177, P1459, DOI 10.1534/genetics.107.078840; Petreaca RC, 2006, NAT CELL BIOL, V8, P748, DOI 10.1038/ncb1430; Puglisi A, 2008, EMBO J, V27, P2328, DOI 10.1038/emboj.2008.158; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vodenicharov MD, 2006, MOL CELL, V24, P127, DOI 10.1016/j.molcel.2006.07.035; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; WRIGHT JH, 1995, NUCLEIC ACIDS RES, V23, P1454, DOI 10.1093/nar/23.9.1454; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141	52	102	103	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					50	61		10.1016/j.cell.2008.11.027	http://dx.doi.org/10.1016/j.cell.2008.11.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135888	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000262318400014
J	Lowther, SA; Curriero, FC; Kalish, BT; Shields, TM; Monze, M; Moss, WJ				Lowther, Sara A.; Curriero, Frank C.; Kalish, Brian T.; Shields, Timothy M.; Monze, Mwaka; Moss, William J.			Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey	LANCET			English	Article							ORAL-FLUID; ETHIOPIA; HETEROSKEDASTICITY; ELIMINATION; EPIDEMIC; OUTBREAK; RUBELLA; IMPACT	Background Measles control efforts are hindered by challenges in sustaining high vaccination coverage, waning immunity in HIV-1-infected children, and clustering of susceptible individuals. Our aim was to assess population immunity to measles virus after a mass vaccination campaign in a region with high HIV prevalence. Methods 3 years after a measles supplemental immunisation activity (SIA), we undertook a cross-sectional survey in Lusaka, Zambia. Households were randomly selected from a satellite image. Children aged 9 months to 5 years from selected households were eligible for enrolment. A questionnaire was administered to the children's caregivers to obtain information about measles vaccination history and history of measles. Oral fluid samples were obtained from children and tested for antibodies to measles virus and HIV-1 by EIA. Findings 1015 children from 668 residences provided adequate specimens. 853 (84%) children had a history of measles vaccination according to either caregiver report or immunisation card. 679 children (67%) had antibodies to measles virus, and 64 (6%) children had antibodies to HIV-1. Children with antibodies to HIV-1 were as likely to have no history of measles vaccination as those without antibodies to HIV-1 (odds ratio [OR] 1.17, 95% CI 0.57-2.41). Children without measles antibodies were more likely to have never received measles vaccine than those with antibodies (adjusted OR 2.50, 1.69-3.71). In vaccinated children, 33 (61%) of 54 children with antibodies to HIV-1 also had antibodies to measles virus, compared with 568 (71%) of 796 children without antibodies to HIV-1 (p=0.1). Interpretation 3 years after an SIA, population immunity to measles was insufficient to interrupt measles virus transmission. The use of oral fluid and satellite images for sampling are potential methods to assess population immunity and the timing of SIAs. Funding Thrasher Research Fund.	[Lowther, Sara A.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Curriero, Frank C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Curriero, Frank C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Shields, Timothy M.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Monze, Mwaka] Univ Teaching Hosp, Virol Lab, Lusaka, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Zambia	Moss, WJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St, Baltimore, MD 21205 USA.	wmoss@jhsph.edu			Thrasher Research Fund [02829-9]; National Eye Institute Training Grant [EY 07127]; National Institutes of Health; Department of Health and Human Services; pre-doctoral Clinical Trials Training Program in Vision Research	Thrasher Research Fund; National Eye Institute Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; pre-doctoral Clinical Trials Training Program in Vision Research	This work was supported by the Thrasher Research Fund (02829-9). SAL was supported by the National Eye Institute Training Grant (EY 07127), pre-doctoral Clinical Trials Training Program in Vision Research, National Institutes of Health, Department of Health and Human Services. We thank Cliansa Nkojiga-Mwangilwa for administrative assistance, the students and community health workers for assistance in undertaking the survey, the Tianjane Community Theater Group for creative and motivational performances as part ofthe community scusitisation activities, Felicity Cutts for contributions to die early conception of the study, and Greg Glass for expertise and support of the spatial analyses.	*CDC, 2003, MMWR-MORBID MORTAL W, V52, P1044; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P581; Centers for Disease Control and Prevention (CDC), 2007, MMWR Morb Mortal Wkly Rep, V56, P1237; Cressie N. A. C., 1993, STAT SPATIAL DATA WI; DIGGLE PJ, 2006, STAT ANAL SPATIAL PO; Enquselassie F, 2003, EPIDEMIOL INFECT, V130, P507, DOI 10.1017/S0950268803008446; FROOT KA, 1989, J FINANC QUANT ANAL, V24, P333, DOI 10.2307/2330815; Grais RF, 2006, T ROY SOC TROP MED H, V100, P867, DOI 10.1016/j.trstmh.2005.10.014; Hassidim A., 2008, Morbidity and Mortality Weekly Report, V57, P203; Helfand RF, 2005, B WORLD HEALTH ORGAN, V83, P329; Helfand RF, 2004, EPIDEMIOL INFECT, V132, P7, DOI 10.1017/S0950268803001547; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Kleinschmidt I, 2007, AM J TROP MED HYG, V77, P1163, DOI 10.4269/ajtmh.2007.77.1163; Kremer JR, 2005, CLIN DIAGN LAB IMMUN, V12, P668, DOI 10.1128/CDLI.12.5.668-670.2005; Lowther SA, 2009, TROP MED INT HEALTH, V14, P70, DOI 10.1111/j.1365-3156.2008.02185.x; Moss WJ, 2007, J INFECT DIS, V196, P347, DOI 10.1086/519169; Muller CP, 2007, VACCINE, V25, P1, DOI 10.1016/j.vaccine.2006.07.039; Nigatu W, 2008, VACCINE, V26, P4769, DOI 10.1016/j.vaccine.2008.07.005; Nokes DJ, 2001, B WORLD HEALTH ORGAN, V79, P588; Ohuma EO, 2009, EPIDEMIOL INFECT, V137, P227, DOI 10.1017/S0950268808000848; Orenstein WA, 2000, AM J PUBLIC HEALTH, V90, P1521, DOI 10.2105/AJPH.90.10.1521; Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775; Ray Sandip Kumar, 2004, Indian Journal of Pediatrics, V71, P583, DOI 10.1007/BF02724116; Scott S, 2008, INT J EPIDEMIOL, V37, P356, DOI 10.1093/ije/dyn007; Setse RW, 2006, J TROP PEDIATRICS, V52, P324, DOI 10.1093/tropej/fmk002; van den Hof S, 2001, EMERG INFECT DIS, V7, P593; Waller L.A., 2004, APPL SPATIAL STAT PU; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; *WHO, IMM SURV ASS MON ZAM; WHO, 2008, MMWR-MORBID MORTAL W, V57, P657; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; World Health Organization United Nations Children's Fund, 2001, MEASL MORT RED REG E; World Health Organization & United Nations Children's Fund, 2005, GLOB IMM VIS STRAT 2	33	19	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1025	1032		10.1016/S0140-6736(09)60142-2	http://dx.doi.org/10.1016/S0140-6736(09)60142-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19211140				2022-12-24	WOS:000264398200030
J	Sokol, DK				Sokol, Daniel K.			Observations Ethics Man Rethinking ward rounds	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, London WC1E 7HU, England.	daniel.sokol@talk21.com						GODLEE F, 2009, BRIT MED J, V338, pB913; Soar J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b220	2	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 4	2009	338								b879	10.1136/bmj.b879	http://dx.doi.org/10.1136/bmj.b879			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417EC	19261674				2022-12-24	WOS:000264058300005
J	Lowman, M; D'Avanzo, C; Brewer, C				Lowman, Margaret; D'Avanzo, Charlene; Brewer, Carol			A National Ecological Network for Research and Education	SCIENCE			English	Editorial Material							OBSERVATORY NETWORK; NEON		[Lowman, Margaret] New Coll Florida, Dept Biol, Sarasota, FL 34243 USA; [Lowman, Margaret] New Coll Florida, Dept Environm Studies, Sarasota, FL 34243 USA; [D'Avanzo, Charlene] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA; [Brewer, Carol] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	State University System of Florida; New College Florida; State University System of Florida; New College Florida; University of Montana System; University of Montana	Lowman, M (corresponding author), New Coll Florida, Dept Biol, Sarasota, FL 34243 USA.	canopymeg@gmail.com						American Association for the Advancement of Science. (AAAS), 1993, 2061 AAAS; BOTKIN D, 1995, OUR NATL HIST LESSON; Brewer C, 2006, CONSERV BIOL, V20, P689, DOI 10.1111/j.1523-1739.2006.00467.x; D'Avanzo C, 2003, FRONT ECOL ENVIRON, V1, P533, DOI 10.1890/1540-9295(2003)001[0533:ROLPFI]2.0.CO;2; DAVANZO C, 2008, NEON ED OUTREACH STR; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; Mervis J, 2003, SCIENCE, V300, P1869, DOI 10.1126/science.300.5627.1869; National Research Council, 2000, INQ NAT SCI ED STAND; National Research Council, 2001, GRAND CHALL ENV SCI; National Research Council (NRC), 1996, NAT SCI ED STAND; *NEON, NEON INT SCI ED PLAN; Senkowsky S, 2005, BIOSCIENCE, V55, P106, DOI 10.1641/0006-3568(2005)055[0106:PONMA]2.0.CO;2; Teeri JA, 2002, SCIENCE, V298, P1893, DOI 10.1126/science.298.5600.1893; THOREAU HD, 1865, W POND	14	20	24	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1172	1173		10.1126/science.1166945	http://dx.doi.org/10.1126/science.1166945			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251614				2022-12-24	WOS:000263687600022
J	Long, JA; Trinajstic, K; Johanson, Z				Long, John A.; Trinajstic, Kate; Johanson, Zerina			Devonian arthrodire embryos and the origin of internal fertilization in vertebrates	NATURE			English	Article							LIVE BIRTH; FISHES; VIVIPARITY; PHYLOGENY; AUSTRALIA; EVOLUTION; FOSSIL	Evidence of reproductive biology is extremely rare in the fossil record. Recently the first known embryos were discovered within the Placodermi(1), an extinct class of armoured fish, indicating a viviparous mode of reproduction in a vertebrate group outside the crown-group Gnathostomata (Chondrichthyes and Osteichthyes). These embryos were found in ptyctodontids, a small group of placoderms phylogenetically basal to the largest group, the Arthrodira(2,3). Here we report the discovery of embryos in the Arthrodira inside specimens of Incisoscutum ritchiei from the Upper Devonian Gogo Formation of Western Australia(4) (approximately 380 million years ago), providing the first evidence, to our knowledge, for reproduction using internal fertilization in this diverse group. We show that Incisoscutum and some phyllolepid arthrodires possessed pelvic girdles with long basipterygia that articulated distally with an additional cartilaginous element or series, as in chondrichthyans, indicating that the pelvic fin was used in copulation. As homology between similar pelvic girdle skeletal structures in ptyctodontids, arthrodires and chondrichthyans is difficult to reconcile in the light of current phylogenies of lower gnathostomes(2,3,5), we explain these similarities as being most likely due to convergence (homoplasy). These new finds confirm that reproduction by internal fertilization and viviparity was much more widespread in the earliest gnathostomes than had been previously appreciated.	[Long, John A.] Victoria & Albert Museum, Melbourne, Vic 3001, Australia; [Long, John A.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2600, Australia; [Long, John A.] Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia; [Trinajstic, Kate] Univ Western Australia, Sch Earth & Geog Sci, Perth, WA 6009, Australia; [Johanson, Zerina] Nat Hist Museum, London SW7 5BD, England	Australian National University; Monash University; University of Western Australia; Natural History Museum London	Long, JA (corresponding author), Victoria & Albert Museum, POB 666, Melbourne, Vic 3001, Australia.	jlong@museum.vic.gov.au	Trinajstic, Kate/B-2537-2009	Johanson, Zerina/0000-0002-8444-6776; Trinajstic, Kate/0000-0002-6519-6396; Long, John/0000-0001-8012-0114	Australian Research Council	Australian Research Council(Australian Research Council)	We thank M. Brazeau for access to his manuscript before publication, A. Ritchie for discussions, and G. Young and G. Edgecombe for reviewing the manuscript. We also thank K. Bifield for the photograph of WAM 04.10.02, and the Centre for Microscopy, Characterisation and Analysis, UWA, for microscopy assistance. J.A.L. and K.T. are supported by Australian Research Council Discovery grants.	Blackburn D.G., 2005, VIVIPAROUS FISHES, P287; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; BURGIN T, 1990, ZOOL J LINN SOC-LOND, V100, P379, DOI 10.1111/j.1096-3642.1990.tb01866.x; Chiappe LM, 2004, NATURE, V432, P571, DOI 10.1038/432571a; Davidson RG, 2005, SCOT J GEOL, V41, P129, DOI 10.1144/sjg41020129; DENNIS K, 1981, ZOOL J LINN SOC-LOND, V73, P213, DOI 10.1111/j.1096-3642.1981.tb01594.x; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Janvier P, 2001, SYST ASSOC SPEC VOL, V61, P172; LEE MYS, 1998, HERPETOLOGICA, V55, P538; Long J.A., 1984, Proceedings of the Linnean Society of New South Wales, V107, P263; LONG JA, 2006, SWIMMING STONE AMAZI, P320; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Lopez JA, 2006, MOL PHYLOGENET EVOL, V40, P50, DOI 10.1016/j.ympev.2006.02.011; LUND R, 1980, SCIENCE, V209, P697, DOI 10.1126/science.209.4457.697; Mank JE, 2006, J EVOLUTION BIOL, V19, P734, DOI 10.1111/j.1420-9101.2005.01060.x; Maxwell EE, 2003, P ROY SOC B-BIOL SCI, V270, pS104, DOI 10.1098/rsbl.2003.0029; Miles R. S., 1967, ZOOLOGICAL J LINNEAN, V47, P99; Ritchie A, 2005, P LINN SOC N S W, V126, P215; SCHULTZE HP, 1972, NATURE-NEW BIOL, V236, P90, DOI 10.1038/newbio236090a0; Sewertzoff AN, 1926, J MORPHOL PHYSIOL, V41, P547, DOI 10.1002/jmor.1050410208; Stensio E., 1963, Kungliga Svenska Vetenskapsakademiens Handlingar (4), V9, P1; TREWIN N H, 1986, Transactions of the Royal Society of Edinburgh Earth Sciences, V77, P21; Upeniece Ieva, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P101; Webb SA, 2004, MOL PHYLOGENET EVOL, V30, P527, DOI 10.1016/S1055-7903(03)00257-4; WOURMS JP, 1981, AM ZOOL, V21, P473; YOUNG G C, 1988, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V202, P1; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x	27	54	56	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					1124	1127		10.1038/nature07732	http://dx.doi.org/10.1038/nature07732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242474				2022-12-24	WOS:000263680100039
J	Pham, HH; O'Malley, AS; Bach, PB; Saiontz-Martinez, C; Schrag, D				Pham, Hoangmai H.; O'Malley, Ann S.; Bach, Peter B.; Saiontz-Martinez, Cynthia; Schrag, Deborah			Primary Care Physicians' Links to Other Physicians Through Medicare Patients: The Scope of Care Coordination	ANNALS OF INTERNAL MEDICINE			English	Article							PERFORMANCE	Background: Primary care physicians are expected to coordinate care for their patients. Objective: To assess the number of physician peers providing care to the Medicare patients of a primary care physician. Design: Cross-sectional analysis of claims data. Setting: Fee-for-service Medicare in 2005. Participants: 2284 primary care physicians who responded to the 2004 to 2005 Community Tracking Study Physician Survey. Measurements: Primary patients for each physician were defined as beneficiaries for whom the physician billed for more evaluation and management visits than any other physician in 2005. The number of physician peers for each physician was the sum of other unique physicians that the index physician's primary patients visited plus other unique physicians who served as the primary physician for each of the index physician's nonprimary patients during 2005. Results: The typical primary care physician has 229 (interquartile range, 125 to 340) other physicians working in 117 ( interquartile range, 66 to 175) practices with which care must be coordinated, equivalent to an additional 99 physicians and 53 practices for every 100 Medicare beneficiaries managed by the primary care physician. When only the 31% of a primary care physician's primary patients who had 4 or more chronic conditions was considered, the median number of peers involved was still substantial ( 86 physicians in 36 practices). The number of peers varied with geographic region, practice type, and reliance on Medicaid revenues. Limitations: Estimates are based only on fee-for-service Medicare patients and physician peers, and the number of peers is therefore probably an underestimate. The modest response rate of the Community Tracking Study Physician Survey may bias results in unpredictable directions. Conclusion: In caring for his or her own primary and nonprimary patients during a single year, each primary care physician potentially must coordinate with a large number of individual physician colleagues who also provide care to these patients.	[Pham, Hoangmai H.] Ctr Studying Hlth Syst Change, Washington, DC 20024 USA; Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA; Social & Sci Syst, Silver Spring, MD USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Social & Scientific Systems; Harvard University; Dana-Farber Cancer Institute	Pham, HH (corresponding author), Ctr Studying Hlth Syst Change, 600 Maryland Ave SW,Suite 550, Washington, DC 20024 USA.	mpham@hschange.org			National Institute on Aging; American Medical Group Association; Robert Wood Johnson Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025687] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Medical Group Association; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging, American Medical Group Association, and the Robert Wood Johnson Foundation.	*AG HEALTHC RES QU, PUBL AG HEALTHC RES; Agency for Healthcare Research and Quality, CAHPS CLIN GROUP SUR; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Barr M, 2008, ADV MED HOME PATIENT; Bartschat Wanda, 2006, J AHIMA, V77, p64A; BERENSON RA, 2003, HLTH AFF MILLWOOD S; Bynum JPW, 2007, HEALTH SERV RES, V42, P45, DOI 10.1111/j.1475-6773.2006.00633.x; *CTR STUD HLTH SYS, TECHN PUBL CTR STUD, V38; Druss BG, 2003, NEW ENGL J MED, V348, P130, DOI 10.1056/NEJMsa020993; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 1996, PRIM CAR AM HLTH NEW; Kwait J, 2001, J URBAN HEALTH, V78, P468, DOI 10.1093/jurban/78.3.468; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Schrag D, 2006, MED CARE, V44, P560, DOI 10.1097/01.mlr.0000215811.68308.ae; Starfield B, 1998, PRIMARY CARE BALANCI; US Census Bureau, CENS REG DIV US; WEINER JP, 1995, JAMA-J AM MED ASSOC, V273, P1503, DOI 10.1001/jama.273.19.1503	20	162	162	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4					236	U23		10.7326/0003-4819-150-4-200902170-00004	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19221375	Green Accepted			2022-12-24	WOS:000263562500002
J	Woodcock, A				Woodcock, Ashley			The Montreal Protocol: getting over the finishing line?	LANCET			English	Editorial Material							OZONE DEPLETION		Univ Manchester, Sch Translat Med, Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Woodcock, A (corresponding author), Univ Manchester, Sch Translat Med, Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England.	ashley.woodcock@manchester.ac.uk		Woodcock, Ashley/0000-0002-5428-8578				Anderson SO, 2007, TECHNOLOGY TRANSFER, P23; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Hendeles L, 2007, NEW ENGL J MED, V356, P1344, DOI 10.1056/NEJMra050380; LePrestre P, 1998, PROTECTING OZONE LAY; LLOYD SA, 1993, LANCET, V342, P1156, DOI 10.1016/0140-6736(93)92130-L; MOLINA MJ, 1974, NATURE, V249, P810, DOI 10.1038/249810a0; Slaper H, 1996, NATURE, V384, P256, DOI 10.1038/384256a0; Velders GJM, 2007, P NATL ACAD SCI USA, V104, P4814, DOI 10.1073/pnas.0610328104	8	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2009	373	9665					705	706		10.1016/S0140-6736(09)60418-9	http://dx.doi.org/10.1016/S0140-6736(09)60418-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	412LD	19249618	Green Submitted			2022-12-24	WOS:000263725400010
J	Nilewski, C; Geisser, RW; Carreira, EM				Nilewski, Christian; Geisser, Roger W.; Carreira, Erick M.			Total synthesis of a chlorosulpholipid cytotoxin associated with seafood poisoning	NATURE			English	Article							COUPLING-CONSTANTS; ADRIATIC MUSSELS; CHLOROSULFOLIPIDS; TOXINS; STEREOCHEMISTRY; OCHROMONAS; OXIDATION; SHELLFISH; LIPIDS	Each year, there are many cases of seafood poisoning in humans worldwide(1). Among the various toxins isolated that contribute to these poisonings(2,3), the chlorosulpholipids are particularly intriguing because of their structural and stereochemical complexity(4-12). The mechanism of biological activity remains unknown and, although chlorosulpholipids are associated with membranes in the organisms from which they are isolated, little is understood about their role within biological membranes. The lack of availability of the natural products has impaired more in-depth biochemical studies. So far, none of the chlorosulpholipids have been obtained from total synthesis, and efficient routes to their synthesis would be desirable for the preparation ofmaterial for pharmacological characterization and proper evaluation of the risk to human health. Despite the notable advances in the science of organic synthesis, reliable methods for stereoselective construction of polychlorinated acyclic substrates are lacking, although some preliminary investigations have appeared(13-15). Here we report the synthesis of a chlorosulpholipid cytotoxin, leading to confirmation of the proposed structure and the discovery of unanticipated reactivity of polychlorinated hydrocarbons. The concise synthetic approach should enable the preparation of material in sufficient quantities to facilitate biological studies.	[Nilewski, Christian; Geisser, Roger W.; Carreira, Erick M.] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Carreira, EM (corresponding author), ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland.	carreira@org.chem.ethz.ch		Carreira, Erick/0000-0003-1472-490X	Swiss National Science Foundation; ETH Zurich; F. Hoffmann-La Roche; Eli Lilly; Boehringer Ingelheim	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); F. Hoffmann-La Roche(Hoffmann-La Roche); Eli Lilly(Eli Lilly); Boehringer Ingelheim(Boehringer Ingelheim)	We thank M.-O. Ebert for acquisition and discussion of the NMR data needed for J-based configuration analysis as well as W. B. Schweizer for the X-ray crystallographic analysis. C.N. thanks the Stiftung Stipendien-Fonds des Verbandes der Chemischen Industrie for a Kekule-Fellowship. This research was supported by the Swiss National Science Foundation and ETH Zurich. We are grateful for support for our program from F. Hoffmann-La Roche, Eli Lilly and Boehringer Ingelheim.	AHMED FE, 1991, J TOXICOL-TOXIN REV, V10, P263, DOI 10.3109/15569549109053858; CHA JK, 1984, TETRAHEDRON, V40, P2247, DOI 10.1016/0040-4020(84)80008-3; CHEN JL, 1994, J NAT PROD, V57, P524, DOI 10.1021/np50106a015; Ciminiello P, 2004, TETRAHEDRON, V60, P7093, DOI 10.1016/j.tet.2003.12.072; Ciminiello P, 2004, EUR J ORG CHEM, V2004, P2533, DOI 10.1002/ejoc.200300769; Ciminiello P, 2002, J AM CHEM SOC, V124, P13114, DOI 10.1021/ja0207347; Ciminiello P, 2001, J ORG CHEM, V66, P578, DOI 10.1021/jo001437s; ELOVSON J, 1969, P NATL ACAD SCI USA, V62, P957, DOI 10.1073/pnas.62.3.957; ELOVSON J, 1970, BIOCHEMISTRY-US, V9, P3110, DOI 10.1021/bi00818a002; HAINES TH, 1973, ANNU REV MICROBIOL, V27, P403, DOI 10.1146/annurev.mi.27.100173.002155; Hunter L, 2006, J AM CHEM SOC, V128, P16422, DOI 10.1021/ja066188p; Kang SH, 2005, CHEM REV, V105, P4537, DOI 10.1021/cr040608g; Kozminski W, 1997, J MAGN RESON, V124, P383, DOI 10.1006/jmre.1996.1016; MacCoss RN, 2003, TETRAHEDRON LETT, V44, P7779, DOI 10.1016/j.tetlet.2003.08.081; Matsumori N, 1999, J ORG CHEM, V64, P866, DOI 10.1021/jo981810k; MERCER EI, 1974, PHYTOCHEMISTRY, V13, P1607, DOI 10.1016/0031-9422(74)80337-7; MERCER EI, 1975, PHYTOCHEMISTRY, V14, P1545, DOI 10.1016/0031-9422(75)85348-9; Nakata T, 2005, CHEM REV, V105, P4314, DOI 10.1021/cr040627q; PADDONROW MN, 1982, J AM CHEM SOC, V104, P7162, DOI 10.1021/ja00389a045; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; PETERSON PE, 1967, J AM CHEM SOC, V89, P5902, DOI 10.1021/ja00999a029; PETERSON PE, 1971, TETRAHEDRON LETT, V12, P13; Schlama T, 1997, ANGEW CHEM INT EDIT, V36, P2342, DOI 10.1002/anie.199723421; Shibuya GM, 2008, J AM CHEM SOC, V130, P12514, DOI 10.1021/ja804167v; TAKAI K, 1986, J AM CHEM SOC, V108, P7408, DOI 10.1021/ja00283a046; YASUMOTO T, 1993, CHEM REV, V93, P1897, DOI 10.1021/cr00021a011; Yoshimitsu T, 2009, J ORG CHEM, V74, P696, DOI 10.1021/jo802093d	27	117	118	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					573	U76		10.1038/nature07734	http://dx.doi.org/10.1038/nature07734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	400FA	19177127				2022-12-24	WOS:000262852200039
J	Towse, A				Towse, Adrian			Should NICE's threshold range for cost per QALY be raised? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Towse, Adrian] Off Hlth Econ, London SW1A 2DY, England		Towse, A (corresponding author), Off Hlth Econ, London SW1A 2DY, England.	atowse@ohe.org	Towse, Adrian/M-3760-2014					[Anonymous], 2008, GUID METH TECHN APPR; APPLEBY J, HLTH POLICY IN PRESS; Culyer Anthony, 2007, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567; *DEP TRANSP, 2007, 12005 DEP TRANSP; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; *HOUS COMM HLTH SE, 2008, 1 REP SESS 2007 08, P103; MARTIN S, 2007, LINK HLTH CARE SPEND; MASON H, 2008, HLTH EC         1014; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; *NAT I HLTH CLIN E, 2008, NICES RESP COMM 1 RE; NICE, 2009, APPR LIF EXT END LIF; WILLIAMS A, 2002, COST EFFECTIVENESS T, P85; Williams I, 2008, HEALTH TECHNOL ASSES, V12, P1	13	55	55	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2009	338								b181	10.1136/bmj.b181	http://dx.doi.org/10.1136/bmj.b181			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405EK	19171561				2022-12-24	WOS:000263205300011
J	Parati, G; Pickering, TG				Parati, Gianfranco; Pickering, Thomas G.			Home blood-pressure monitoring: US and European consensus	LANCET			English	Editorial Material							HYPERTENSION; SOCIETY		[Parati, Gianfranco] Univ Milan, Dept Clin Med & Prevent, Milan, Italy; [Parati, Gianfranco] IRCCS, Ist Auxol Italiano, S Luca Hosp, Dept Cardiol, I-20149 Milan, Italy; [Pickering, Thomas G.] Columbia Presbyterian Med Ctr, Behav Cardiovasc Hlth & Hypertens Program, New York, NY 10032 USA	University of Milan; IRCCS Istituto Auxologico Italiano; Columbia University; NewYork-Presbyterian Hospital	Parati, G (corresponding author), Univ Milan, Dept Clin Med & Prevent, Milan, Italy.	gianfranco.parati@unimib.it	Parati, Gianfranco/K-7151-2016	Parati, Gianfranco/0000-0001-9402-7439				O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Parati G, 2004, CURR OPIN NEPHROL HY, V13, P343, DOI 10.1097/00041552-200405000-00013; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Pickering TG, 2008, HYPERTENSION, V52, P1, DOI 10.1161/HYPERTENSIONAHA.107.189011; Stergiou G, 2004, BMJ-BRIT MED J, V329, P870, DOI 10.1136/bmj.329.7471.870	5	63	63	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					876	878		10.1016/S0140-6736(09)60526-2	http://dx.doi.org/10.1016/S0140-6736(09)60526-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19286071				2022-12-24	WOS:000264158700009
J	Bayer, M; Nawy, T; Giglione, C; Galli, M; Meinnel, T; Lukowitz, W				Bayer, Martin; Nawy, Tal; Giglione, Carmela; Galli, Mary; Meinnel, Thierry; Lukowitz, Wolfgang			Paternal Control of Embryonic Patterning in Arabidopsis thaliana	SCIENCE			English	Article							RECEPTOR-LIKE KINASES; SEED DEVELOPMENT; STOMATAL DEVELOPMENT; PROTEIN-KINASES; MAPKK KINASE; PLANTS; ELEMENTS	The YODA (YDA) mitogen-activated protein kinase pathway promotes elongation of the Arabidopsis zygote and development of its basal daughter cell into the extra-embryonic suspensor. Here, we show that the interleukin-1 receptor-associated kinase (IRAK)/Pelle-like kinase gene SHORT SUSPENSOR (SSP) regulates this pathway through a previously unknown parent-of-origin effect. SSP transcripts are produced in mature pollen but do not appear to be translated. Instead, they are delivered via the sperm cells to the zygote and the endosperm, where SSP protein transiently accumulates. Ectopic expression of SSP protein in the leaf epidermis is sufficient to activate YDA-dependent signaling. We propose that SSP protein produced from paternal transcripts upon fertilization triggers zygotic YDA activity, providing an essential temporal cue for the regulation of the asymmetric first division.	[Bayer, Martin; Nawy, Tal; Galli, Mary; Lukowitz, Wolfgang] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Giglione, Carmela; Meinnel, Thierry] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; [Lukowitz, Wolfgang] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA	Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University System of Georgia; University of Georgia	Lukowitz, W (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lukowitz@uga.edu	Meinnel, Thierry/B-9813-2016; Bayer, Martin/AAP-3372-2020	Bayer, Martin/0000-0001-5806-2253; Meinnel, Thierry/0000-0001-5642-8637; Nawy, Tal/0000-0003-3720-3699; Giglione, Carmela/0000-0002-7475-1558	NSF [IOB-0446103]; Deutsche Forschungsgemeinschaft; Cold Spring Harbor Laboratory Association; Association pour le Recherche sur le Cancer [4920]	NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cold Spring Harbor Laboratory Association; Association pour le Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the NSF (grant IOB-0446103 to W.L.), the Deutsche Forschungsgemeinschaft (M.B.), the Cold Spring Harbor Laboratory Association (T.N.), and the Association pour le Recherche sur le Cancer (grant 4920 to T.M.). Seed of ssp-1 have been deposited with the Arabidopsis stock center. Materials were kindly made available by P. Das (Caltech), F. Besnard and T. Vernoux (Ecole Normale Superieure Lyon, pENTR triple Venus), S. McCormick (University of California Berkeley, GEX2 marker), N. Sauer (Erlangen University, SUC3 marker), A. Schnittger (Strasbourg University, cdc2a;fie1), and K. Slotkin and R. Martienssen (Cold Spring Harbor Laboratory, met1, ddm1, cmt3, drm2, and rdr1; rdr2; rdr6). S. Alabaster and J. A. Traverso provided help in the early phases of the project. We thank T. Berleth (University of Toronto), C. S. Gillmor and M. Willman (University of Pennsylvania), S. Jeong and C. Schulz (University of Georgia), R. Schwab (Cold Spring Harbor Laboratory), and D. Weijers (Wageningen University) for comments on the manuscript.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Boisson B, 2003, ANAL BIOCHEM, V322, P116, DOI 10.1016/j.ab.2003.07.007; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Castells E, 2007, J EXP BOT, V58, P3503, DOI 10.1093/jxb/erm226; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Huh JH, 2007, CURR OPIN GENET DEV, V17, P480, DOI 10.1016/j.gde.2007.08.011; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jenik PD, 2007, ANNU REV CELL DEV BI, V23, P207, DOI 10.1146/annurev.cellbio.22.011105.102609; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Meyer S, 2004, PLANT PHYSIOL, V134, P684, DOI 10.1104/pp.103.033399; Meyer S, 2007, CURR BIOL, V17, P1686, DOI 10.1016/j.cub.2007.08.046; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nowack MK, 2007, NATURE, V447, P312, DOI 10.1038/nature05770; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Spillane C, 2007, NATURE, V448, P349, DOI 10.1038/nature05984; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wardlaw CW, 1955, EMBRYOGENESIS PLANTS	21	249	260	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1485	1488		10.1126/science.1167784	http://dx.doi.org/10.1126/science.1167784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286558				2022-12-24	WOS:000264101700043
J	Schwenk, J; Harmel, N; Zolles, G; Bildl, W; Kulik, A; Heimrich, B; Chisaka, O; Jonas, P; Schulte, U; Fakler, B; Klocker, N				Schwenk, Jochen; Harmel, Nadine; Zolles, Gerd; Bildl, Wolfgang; Kulik, Akos; Heimrich, Bernd; Chisaka, Osamu; Jonas, Peter; Schulte, Uwe; Fakler, Bernd; Kloecker, Nikolaj			Functional Proteomics Identify Cornichon Proteins as Auxiliary Subunits of AMPA Receptors	SCIENCE			English	Article							EXCITATORY POSTSYNAPTIC CURRENTS; 2 DISTINCT MECHANISMS; GLUTAMATE RECEPTORS; KINETIC-PROPERTIES; CA2+ PERMEABILITY; GAMMA-SUBUNIT; MUTANT MOUSE; ION CHANNELS; TIME-COURSE; STARGAZIN	Glutamate receptors of the AMPA-subtype (AMPARs), together with the transmembrane AMPAR regulatory proteins (TARPs), mediate fast excitatory synaptic transmission in the mammalian brain. Here, we show by proteomic analysis that the majority of AMPARs in the rat brain are coassembled with two members of the cornichon family of transmembrane proteins, rather than with the TARPs. Coassembly with cornichon homologs 2 and 3 affects AMPARs in two ways: Cornichons increase surface expression of AMPARs, and they alter channel gating by markedly slowing deactivation and desensitization kinetics. These results demonstrate that cornichons are intrinsic auxiliary subunits of native AMPARs and provide previously unknown molecular determinants for glutamatergic neurotransmission in the central nervous system.	[Schwenk, Jochen; Harmel, Nadine; Zolles, Gerd; Bildl, Wolfgang; Schulte, Uwe; Fakler, Bernd; Kloecker, Nikolaj] Univ Freiburg, Inst Physiol 2, D-79108 Freiburg, Germany; [Schulte, Uwe] Logopharm GmbH, D-79108 Freiburg, Germany; [Jonas, Peter] Univ Freiburg, Inst Physiol 1, D-79108 Freiburg, Germany; [Kulik, Akos; Heimrich, Bernd] Univ Freiburg, Inst Anat & Cell Biol, D-79104 Freiburg, Germany; [Fakler, Bernd] Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany; [Chisaka, Osamu] Kyoto Univ, Dept Cell & Dev Biol, Kyoto 6068502, Japan	University of Freiburg; University of Freiburg; University of Freiburg; Kyoto University	Fakler, B (corresponding author), Univ Freiburg, Inst Physiol 2, Engesserstr 4, D-79108 Freiburg, Germany.	bernd.fakler@physiologie.uni-freiburg.de; kloecker@physiologie.uni-freiburg.de		Jonas, Peter/0000-0001-5001-4804; Schwenk, Jochen/0000-0003-3664-9795	Deutsche Forschungsgemeinschaft [SFB 746/TP16, SFB780/TPA3, EXC 294, SFB780/TPB4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. P. Adelman for insightful comments and critical reading of the manuscript and A. Haupt for help with bioinformatics. This work was supported by grants of the Deutsche Forschungsgemeinschaft to B.F. (SFB 746/TP16, SFB780/TPA3, EXC 294) and to N.K. (SFB780/TPB4).	Antz C, 1999, NAT STRUCT BIOL, V6, P146; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Hoshino H, 2007, MOL BIOL CELL, V18, P1143, DOI 10.1091/mbc.E06-08-0733; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Menuz K, 2008, J NEUROSCI, V28, P8740, DOI 10.1523/JNEUROSCI.1319-08.2008; Menuz K, 2009, NEUROPHARMACOLOGY, V56, P22, DOI 10.1016/j.neuropharm.2008.06.037; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Perez Castro C, 2007, J CELL SCI, V120, P2454, DOI 10.1242/jcs.004200; RAMAN IM, 1992, NEURON, V9, P173, DOI 10.1016/0896-6273(92)90232-3; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; SAH P, 1990, J PHYSIOL-LONDON, V430, P605, DOI 10.1113/jphysiol.1990.sp018310; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102	49	289	301	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1313	1319		10.1126/science.1167852	http://dx.doi.org/10.1126/science.1167852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265014				2022-12-24	WOS:000263876700034
J	Kim, JH; Woo, HR; Kim, J; Lim, PO; Lee, IC; Choi, SH; Hwang, D; Nam, HG				Kim, Jin Hee; Woo, Hye Ryun; Kim, Jeongsik; Lim, Pyung Ok; Lee, In Chul; Choi, Seung Hee; Hwang, Daehee; Nam, Hong Gil			Trifurcate Feed-Forward Regulation of Age-Dependent Cell Death Involving miR164 in Arabidopsis	SCIENCE			English	Article							LATERAL ROOT DEVELOPMENT; LEAF SENESCENCE; SIGNALING PATHWAYS; STRESS RESPONSES; THALIANA; MICRORNA; ETHYLENE; TRANSCRIPTOME; TARGETS	Aging induces gradual yet massive cell death in higher organisms, including annual plants. Even so, the underlying regulatory mechanisms are barely known, despite the long- standing interest in this topic. Here, we demonstrate that ORE1, which is a NAC ( NAM, ATAF, and CUC) transcription factor, positively regulates aging- induced cell death in Arabidopsis leaves. ORE1 expression is up- regulated concurrently with leaf aging by EIN2 but is negatively regulated by miR164. miR164 expression gradually decreases with aging through negative regulation by EIN2, which leads to the elaborate up- regulation of ORE1 expression. However, EIN2 still contributes to aging- induced cell death in the absence of ORE1. The trifurcate feed- forward pathway involving ORE1, miR164, and EIN2 provides a highly robust regulation to ensure that aging induces cell death in Arabidopsis leaves.	[Kim, Jin Hee; Woo, Hye Ryun; Kim, Jeongsik; Lee, In Chul; Choi, Seung Hee; Nam, Hong Gil] Pohang Univ Sci & Technol, Div Mol Life Sci, Pohang 790784, South Korea; [Lim, Pyung Ok] Cheju Natl Univ, Dept Sci Educ, Cheju, South Korea; [Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea; [Hwang, Daehee; Nam, Hong Gil] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH); Jeju National University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Nam, HG (corresponding author), Pohang Univ Sci & Technol, Div Mol Life Sci, Pohang 790784, South Korea.	nam@postech.ac.kr	Kim, Jeongsik/I-6184-2019	Kim, Jeongsik/0000-0002-2729-6003	Korea Science and Engineering Foundation National Core Research Center [R15-2004-033-05002-0)]; Crop Functional Genomics Frontier Research Program [CG3132]	Korea Science and Engineering Foundation National Core Research Center(Korea Science and Engineering Foundation); Crop Functional Genomics Frontier Research Program	We thank E. M. Meyerowitz and P. Sieber for the mir164abc triple mutant line; J. Traas for the miR164A- and miR164B-overexpressing lines; and K. H. Suh, B. H. Kim, and Y. S. Park for technical assistance. This research was supported by grants from the Korea Science and Engineering Foundation National Core Research Center (no. R15-2004-033-05002-0) and the Crop Functional Genomics Frontier Research Program (CG3132) from the Korean government (Ministry of Education, Science, and Technology).	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Oh SA, 1997, PLANT J, V12, P527, DOI 10.1046/j.1365-313X.1997.00527.x; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521	20	481	523	8	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1053	1057		10.1126/science.1166386	http://dx.doi.org/10.1126/science.1166386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229035				2022-12-24	WOS:000263478400040
J	Waldman, SA; Hyslop, T; Schulz, S; Barkun, A; Nielsen, K; Haaf, J; Bonaccorso, C; Li, YY; Weinberg, DS				Waldman, Scott A.; Hyslop, Terry; Schulz, Stephanie; Barkun, Alan; Nielsen, Karl; Haaf, Janis; Bonaccorso, Christine; Li, Yanyan; Weinberg, David S.			Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease-Free Survival in pN0 Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUANYLYL CYCLASE-C; II COLON-CANCER; STAGE-II; ADJUVANT CHEMOTHERAPY; PREDICT RECURRENCE; MESSENGER-RNA; DUKES-B; MICROMETASTASES; PROGNOSIS; THERAPY	Context The established relationship between lymph node metastasis and prognosis in colorectal cancer suggests that recurrence in 25% of patients with lymph nodes free of tumor cells by histopathology ( pN0) reflects the presence of occult metastases. Guanylyl cyclase 2C ( GUCY2C) is a marker expressed by colorectal tumors that could reveal occult metastases in lymph nodes and better estimate recurrence risk. Objective To examine the association of occult lymph node metastases detected by quantifying GUCY2C messenger RNA, using the reverse transcriptase - polymerase chain reaction, with recurrence and survival in patients with colorectal cancer. Design, Setting, and Participants Prospective study of 257 patients with pN0 colorectal cancer enrolled between March 2002 and June 2007 at 9 US and Canadian centers ( 7 academic medical centers and 2 community hospitals) provided 2570 fresh lymph nodes measuring 5 mm or larger for histopathology and GUCY2C messenger RNA analysis. Patients were followed up for a median of 24 months ( range, 2- 63 months) for disease recurrence or death. Main Outcome Measures Time to recurrence ( primary outcome) and diseasefree survival ( secondary outcome) relative to expression of GUCY2C in lymph nodes. Results Thirty- two patients ( 12.5%) had lymph nodes negative for GUCY2C ( pN0 [ mol-]), and all but 2 remained free of disease during follow- up ( recurrence rate, 6.3%; 95% confidence interval [ CI], 0.8%- 20.8%). Conversely, 225 patients ( 87.5%) had lymph nodes positive for GUCY2C ( pN0 [ mol +]), and 47 developed recurrent disease ( 20.9%; 95% CI, 15.8%- 26.8%) ( P=. 006). Multivariate analyses revealed that GUCY2C in lymph nodes was an independent marker of prognosis. Patients who were pN0 ( mol +) exhibited earlier time to recurrence ( adjusted hazard ratio, 4.66; 95% CI, 1.11- 19.57; P=. 04) and reduced disease- free survival ( adjusted hazard ratio, 3.27; 95% CI, 1.15-9.29; P=. 03). Conclusion Expression of GUCY2C in histologically negative lymph nodes appears to be independently associated with time to recurrence and disease- free survival in patients with pN0 colorectal cancer.	[Waldman, Scott A.; Hyslop, Terry; Schulz, Stephanie; Nielsen, Karl; Haaf, Janis; Bonaccorso, Christine; Li, Yanyan] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA; [Barkun, Alan] McGill Univ, Dept Med, Div Gastroenterol, Montreal, PQ, Canada; [Weinberg, David S.] Fox Chase Canc Ctr, Dept Med, Philadelphia, PA 19111 USA	Jefferson University; McGill University; Fox Chase Cancer Center	Waldman, SA (corresponding author), Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, 132 S 10th St, Philadelphia, PA 19107 USA.	Scott.Waldman@jefferson.edu		Waldman, Scott/0000-0001-6619-175X	National Institutes of Health [CA75123, CA95026, CA112147]; Targeted Diagnostic and Therapeutics Inc; NATIONAL CANCER INSTITUTE [R33CA112147, R21CA112147, R01CA095026, R01CA075123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Targeted Diagnostic and Therapeutics Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grants CA75123 and CA95026 (to Dr Waldman) and CA112147 (to Dr Hyslop) and by funding from the Targeted Diagnostic and Therapeutics Inc (to Dr Waldman). Dr Waldman is the Samuel M. V. Hamilton Endowed Professor of Thomas Jefferson University.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Bilchik AJ, 2007, ANN SURG, V246, P568, DOI 10.1097/SLA.0b013e318155a9c7; Birbe R, 2005, HUM PATHOL, V36, P170, DOI 10.1016/j.humpath.2004.12.002; Brown HG, 2004, MODERN PATHOL, V17, P402, DOI 10.1038/modpathol.3800071; Cagir B, 1999, ANN INTERN MED, V131, P805, DOI 10.7326/0003-4819-131-11-199912070-00002; Carrithers SL, 1996, P NATL ACAD SCI USA, V93, P14827, DOI 10.1073/pnas.93.25.14827; Chervoneva I, 2007, STAT MED, V26, P5596, DOI 10.1002/sim.3127; Compton CC, 2004, CA-CANCER J CLIN, V54, P295, DOI 10.3322/canjclin.54.6.295; Figueredo A, 2004, J CLIN ONCOL, V22, P3395, DOI 10.1200/JCO.2004.03.087; Frick GS, 2005, EXPERT REV MOL DIAGN, V5, P701, DOI 10.1586/14737159.5.5.701; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Groner RS, 2005, CANCER-AM CANCER SOC, V104, P395, DOI 10.1002/cncr.21170; HERRERAORNELAS L, 1987, ARCH SURG-CHICAGO, V122, P1253; Hitchcock CL, 1999, DIS COLON RECTUM, V42, P1046, DOI 10.1007/BF02236701; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Iddings D, 2006, ANN SURG ONCOL, V13, P1386, DOI 10.1245/s10434-006-9120-y; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Li P, 2007, GASTROENTEROLOGY, V133, P599, DOI 10.1053/j.gastro.2007.05.052; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; MOERTEL CG, 1986, CANCER, V58, P603, DOI 10.1002/1097-0142(19860801)58:3<603::AID-CNCR2820580302>3.0.CO;2-K; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Nicastri DG, 2007, J MOL DIAGN, V9, P563, DOI 10.2353/jmoldx.2007.070032; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pitari GM, 2007, CLIN PHARMACOL THER, V82, P441, DOI 10.1038/sj.clpt.6100325; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; Ratto C, 1999, DIS COLON RECTUM, V42, P143, DOI 10.1007/BF02237119; Schulz S, 2006, CLIN CANCER RES, V12, P4545, DOI 10.1158/1078-0432.CCR-06-0865; Swanson RS, 2003, ANN SURG ONCOL, V10, P65, DOI 10.1245/ASO.2003.03.058; Waldman SA, 2007, CLIN PHARMACOL THER, V82, P343, DOI 10.1038/sj.clpt.6100360; Waldman SA, 2007, CLIN PHARMACOL THER, V81, P3, DOI 10.1038/sj.clpt.6100032; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Witek ME, 2005, CLIN CANCER RES, V11, P8549, DOI 10.1158/1078-0432.CCR-05-1624; Wolpin BM, 2007, CA-CANCER J CLIN, V57, P168, DOI 10.3322/canjclin.57.3.168	42	96	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					745	752		10.1001/jama.2009.141	http://dx.doi.org/10.1001/jama.2009.141			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224751	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000263370100017
J	Hammarlund, M; Nix, P; Hauth, L; Jorgensen, EM; Bastiani, M				Hammarlund, Marc; Nix, Paola; Hauth, Linda; Jorgensen, Erik M.; Bastiani, Michael			Axon Regeneration Requires a Conserved MAP Kinase Pathway	SCIENCE			English	Article							ZIPPER-BEARING KINASE; GROWTH; OUTGROWTH; SYNAPTOGENESIS; NERVE; RPM-1; STAGE; GENE; CAMP	Regeneration of injured neurons can restore function, but most neurons regenerate poorly or not at all. The failure to regenerate in some cases is due to a lack of activation of cell- intrinsic regeneration pathways. These pathways might be targeted for the development of therapies that can restore neuron function after injury or disease. Here, we show that the DLK- 1 mitogen-activated protein ( MAP) kinase pathway is essential for regeneration in Caenorhabditis elegans motor neurons. Loss of this pathway eliminates regeneration, whereas activating it improves regeneration. Further, these proteins also regulate the later step of growth cone migration. We conclude that after axon injury, activation of this MAP kinase cascade is required to switch the mature neuron from an aplastic state to a state capable of growth.	[Hammarlund, Marc; Nix, Paola; Hauth, Linda; Jorgensen, Erik M.; Bastiani, Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Hammarlund, Marc; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Bastiani, M (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	bastiani@bioscience.utah.edu		Nix, Paul/0000-0002-7284-710X	Craig H. Neilsen Foundation; McKnight Endowment Fund for Neuroscience; NIH [1R21NS060275, NS034307]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060275, R01NS034307, R37NS034307] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0950955] Funding Source: National Science Foundation	Craig H. Neilsen Foundation; McKnight Endowment Fund for Neuroscience; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is dedicated to the memory of Craig H. Neilsen. We thank C.- B. Chen, D. Gard, W. Davis, J. White, and K. Schuske for helpful discussions. Supported by the Craig H. Neilsen Foundation, the McKnight Endowment Fund for Neuroscience, and NIH 1R21NS060275 to M. B. and NIH NS034307 to E. M.	Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Daviau A, 2006, J BIOL CHEM, V281, P31467, DOI 10.1074/jbc.M607612200; Erez H, 2007, J CELL BIOL, V176, P497, DOI 10.1083/jcb.200607098; Ewbank Jonathan J, 2006, WormBook, P1; Gabel CV, 2008, DEVELOPMENT, V135, P1129, DOI 10.1242/dev.013995; Gitler D, 2002, J NEUROBIOL, V52, P267, DOI 10.1002/neu.10084; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Reynolds AJ, 2001, NEUROSCIENCE, V105, P761, DOI 10.1016/S0306-4522(01)00235-4; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sung YJ, 2001, J NEUROBIOL, V47, P67, DOI 10.1002/neu.1016; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Wu Z, 2007, P NATL ACAD SCI USA, V104, P15132, DOI 10.1073/pnas.0707001104; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Zrouri H, 2004, EUR J NEUROSCI, V20, P1811, DOI 10.1111/j.1460-9568.2004.03641.x	31	308	320	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					802	806		10.1126/science.1165527	http://dx.doi.org/10.1126/science.1165527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19164707	Green Accepted			2022-12-24	WOS:000263066800053
J	Cummings, JH; Mann, JI; Nishida, C; Vorster, HH				Cummings, J. H.; Mann, J. I.; Nishida, C.; Vorster, H. H.			Dietary fibre: an agreed definition	LANCET			English	Editorial Material									[Cummings, J. H.] Univ Dundee, Ninewells Hosp, Dundee DD1 4HN, Scotland; [Mann, J. I.] Univ Otago, Edgar Natl Ctr Diabet Res, Dunedin, New Zealand; [Nishida, C.] WHO, Dept Nutr Hlth Dev, CH-1211 Geneva, Switzerland; [Vorster, H. H.] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa	University of Dundee; University of Otago; World Health Organization; North West University - South Africa	Cummings, JH (corresponding author), Univ Dundee, Ninewells Hosp, Dundee DD1 4HN, Scotland.	j.h.cummings@dundee.ac.uk	Cummings, John/AAC-2007-2019					Cummings JH, 2007, EUR J CLIN NUTR, V61, pS5, DOI 10.1038/sj.ejcn.1602936; *FOOD STAND AG, 2002, MCC WIDD COMP FOODS; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Mann J, 2007, EUR J CLIN NUTR, V61, pS132, DOI 10.1038/sj.ejcn.1602943; *UN FAO, 1998, 66 UN FAO	5	64	70	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2009	373	9661					365	366		10.1016/S0140-6736(09)60117-3	http://dx.doi.org/10.1016/S0140-6736(09)60117-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401BC	19186261				2022-12-24	WOS:000262912100010
J	Ohtsuki, H; Iwasa, Y; Nowak, MA				Ohtsuki, Hisashi; Iwasa, Yoh; Nowak, Martin A.			Indirect reciprocity provides only a narrow margin of efficiency for costly punishment	NATURE			English	Article							SOCIAL NORMS; ALTRUISTIC PUNISHMENT; COOPERATION; EVOLUTION; REPUTATION; HUMANS; RULES	Indirect reciprocity(1-5) is a key mechanism for the evolution of human cooperation. Our behaviour towards other people depends not only on what they have done to us but also on what they have done to others. Indirect reciprocity works through reputation(5-17). The standard model of indirect reciprocity offers a binary choice: people can either cooperate or defect. Cooperation implies a cost for the donor and a benefit for the recipient. Defection has no cost and yields no benefit. Currently there is considerable interest in studying the effect of costly (or altruistic) punishment on human behaviour(18-25). Punishment implies a cost for the punished person. Costly punishment means that the punisher also pays a cost. It has been suggested that costly punishment between individuals can promote cooperation. Here we study the role of costly punishment in an explicit model of indirect reciprocity. We analyse all social norms, which depend on the action of the donor and the reputation of the recipient. We allow errors in assigning reputation and study gossip as a mechanism for establishing coherence. We characterize all strategies that allow the evolutionary stability of cooperation. Some of those strategies use costly punishment; others do not. We find that punishment strategies typically reduce the average payoff of the population. Consequently, there is only a small parameter region where costly punishment leads to an efficient equilibrium. In most cases the population does better by not using costly punishment. The efficient strategy for indirect reciprocity is to withhold help for defectors rather than punishing them.	[Ohtsuki, Hisashi] Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo 1528552, Japan; [Ohtsuki, Hisashi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Iwasa, Yoh] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Dept Organism & Evolut Biol, Dept Math, Cambridge, MA 02138 USA	Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Kyushu University; Harvard University	Ohtsuki, H (corresponding author), Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo 1528552, Japan.	ohtsuki.h.aa@m.titech.ac.jp	Nowak, Martin A/A-6977-2008; Iwasa, Yoh/G-5368-2010	Iwasa, Yoh/0000-0003-0691-1852	John Templeton Foundation; Japan Society for the Promotion of Science; NSF/NIH joint program in mathematical biology; NIH [R01GM078986]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	John Templeton Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NSF/NIH joint program in mathematical biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support from the John Templeton Foundation, the Japan Society for the Promotion of Science, the NSF/NIH joint program in mathematical biology (NIH grant R01GM078986) and J. Epstein is gratefully acknowledged.	Alexander R., 2008, ESSAYS PEDAGOGY; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bolton GE, 2005, J PUBLIC ECON, V89, P1457, DOI 10.1016/j.jpubeco.2004.03.008; Brandt H, 2005, P NATL ACAD SCI USA, V102, P2666, DOI 10.1073/pnas.0407370102; Brandt H, 2004, J THEOR BIOL, V231, P475, DOI 10.1016/j.jtbi.2004.06.032; Chalub FACC, 2006, J THEOR BIOL, V241, P233, DOI 10.1016/j.jtbi.2005.11.028; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Colman AM., 1995, GAME THEORY ITS APPL; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Dufwenberg Martin, 2001, HOMO OECON, V18, P19; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fishman MA, 2003, J THEOR BIOL, V225, P285, DOI 10.1016/S0022-5193(03)00246-7; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; KANDORI M, 1992, REV ECON STUD, V59, P63, DOI 10.2307/2297925; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; OKUNOFUJIWARA M, 1995, GAME ECON BEHAV, V9, P79, DOI 10.1006/game.1995.1006; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Rutte C, 2008, BEHAV ECOL SOCIOBIOL, V62, P499, DOI 10.1007/s00265-007-0474-3; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Sugden R, 1986, EC RIGHTS COOPERATIO; Suzuki S, 2005, P ROY SOC B-BIOL SCI, V272, P1373, DOI 10.1098/rspb.2005.3072; Takahashi N, 2006, J THEOR BIOL, V243, P418, DOI 10.1016/j.jtbi.2006.05.014; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; YAMAGISHI T, 1988, SOC PSYCHOL QUART, V51, P32, DOI 10.2307/2786982	30	225	230	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 1	2009	457	7225					79	82		10.1038/nature07601	http://dx.doi.org/10.1038/nature07601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122640	Green Accepted			2022-12-24	WOS:000262104900034
J	Scott-Browne, JP; White, J; Kappler, JW; Gapin, L; Marrack, P				Scott-Browne, James P.; White, Janice; Kappler, John W.; Gapin, Laurent; Marrack, Philippa			Germline-encoded amino acids in the alpha beta T-cell receptor control thymic selection	NATURE			English	Article							POSITIVE SELECTION; MHC; ANTIGEN; RECOGNITION; REPERTOIRE; H-2-ANTIGENS; HYBRIDOMAS; PEPTIDE	An alpha beta T-cell response depends on the recognition of antigen plus major histocompatibility complex (MHC) proteins(1) by its antigen receptor (TCR). The ability of peripheral alpha beta T cells to recognize MHC is at least partly determined by MHC-dependent thymic selection, by which an immature T cell survives only if its TCR can recognize self MHC2-7. This process may allow MHC-reactive TCRs to be selected from a repertoire with completely random and unbiased specificities. However, analysis of thymocytes before positive selection indicated that TCR proteins might have a predetermined ability to bind MHC8-11. Here we show that specific germline-encoded amino acids in the TCR promote 'generic' MHC recognition and control thymic selection. In mice expressing single, rearranged TCR beta-chains, individual mutation of amino acids in the complementarity-determining region (CDR) 2 beta to Ala reduced development of the entire TCR repertoire. Altogether, these results show that thymic selection is controlled by germline-encoded MHC contact points in the alpha beta TCR and indicate that the diversity of the peripheral T-cell repertoire is enhanced by this 'built-in' specificity.	[Scott-Browne, James P.; White, Janice; Kappler, John W.; Gapin, Laurent; Marrack, Philippa] Natl Jewish Hlth & Univ Colorado Denver, Integrated Dept Immunol, Denver, CO 80206 USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado Denver, Howard Hughes Med Inst, Aurora, CO 80220 USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado Denver, Dept Med, Aurora, CO 80220 USA; [Kappler, John W.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80220 USA; [Kappler, John W.] Univ Colorado Denver, Program Biomol Struct, Aurora, CO 80220 USA; [Marrack, Philippa] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80220 USA	National Jewish Health; Children's Hospital Colorado; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Marrack, P (corresponding author), Natl Jewish Hlth & Univ Colorado Denver, Integrated Dept Immunol, Denver, CO 80206 USA.	james.scott-browne@ucdenver.edu; marrackp@njhealth.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	National Institutes of Health [AI18785, AI22295, AI057485]; NIH [T32 AI07405]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI017134, R56AI018785, R37AI018785, T32AI007405, P01AI022295, R21AI076463, R01AI018785, R01AI057485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Acknowledgements We thank E. Huseby, K. Urdahl, C. Hsieh, G. Hernandez-Hoyos and members of the Kappler/Marrack and Gapin laboratories for discussion. We thank the flow cytometry facilities at NJH and UCD for technical assistance with cell sorting and E. Kushnir for assistance with generating bone marrow chimaeras. We thank R. O'Brien and W. Born for providing Tcrb<SUP>-/-</SUP> Tcrd<SUP>-/-</SUP> mice and Y. Refaeli for providing stem cell cytokines. This work was supported by grants from the National Institutes of Health (AI18785 and AI22295 to P. M. and J. W. K. and AI057485 to L. G.). P. M. and J. W. K. are investigators of the Howard Hughes Medical Institute. J. P. S.-B. was supported by an NIH training grant (T32 AI07405).	Arden Bernhard, 1995, Immunogenetics, V42, P501; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; MARCIN P, 2006, BMC BIOINFORMATICS, V7, P225; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; WHITE J, 1989, J IMMUNOL, V143, P1822; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; YAGUE J, 1985, CELL, V42, P81, DOI 10.1016/S0092-8674(85)80103-3; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	29	123	124	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1043	U124		10.1038/nature07812	http://dx.doi.org/10.1038/nature07812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262510	Green Accepted			2022-12-24	WOS:000265412900046
J	Sanghavi, P; Bhalla, K; Das, V				Sanghavi, Prachi; Bhalla, Kavi; Das, Veena			Fire-related deaths in India in 2001: a retrospective analysis of data	LANCET			English	Article							BURN MORTALITY; EPIDEMIOLOGY; SUICIDE; AUTOPSY; RATES	Background Hospital-based studies have suggested that fire-related deaths might be a neglected public-health issue in India. However, no national estimates of these deaths exist and the only numbers reported in published literature come from the Indian police. We combined multiple health datasets to assess the extent of the problem. Methods We computed age-sex-specific fire-related mortality fractions nationally using a death registration system based on medically certified causes of death in urban areas and a verbal autopsy based sample survey for rural populations. We combined these data with all-cause mortality estimates based on the sample registration system and the population census. We adjusted for ill-defined injury categories that might contain misclassified fire-related deaths, and estimated the proportion of suicides due to self-immolation when deaths were reported by external causes. Findings We estimated over 163 000 fire-related deaths in 2001 in India, which is about 2% of all deaths. This number was six times that reported by police. About 106 000 of these deaths occurred in women, mostly between 15 and 34 years of age. This age-sex pattern was consistent across multiple local studies, and the average ratio of fire-related deaths of young women to young men was 3:1. Interpretation The high frequency of fire-related deaths in young women suggests that these deaths share common causes, including kitchen accidents, self-immolation, and different forms of domestic violence. Identification of populations at risk and description of structural determinants from existing data sources are urgently needed so that interventions can be rapidly implemented.	[Bhalla, Kavi] Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; [Das, Veena] Johns Hopkins Univ, Dept Anthropol, Baltimore, MD USA	Harvard University; Johns Hopkins University	Sanghavi, P (corresponding author), 15-42 Everett St, Cambridge, MA 02138 USA.	prachi.sanghavi@gmail.com						Ahuja RB, 2002, BURNS, V28, P555, DOI 10.1016/S0305-4179(02)00069-4; Alexandrescu R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-80; Ambade VN, 2006, BURNS, V32, P902, DOI 10.1016/j.burns.2006.03.001; Amoros E, 2007, ACCIDENT ANAL PREV, V39, P483, DOI 10.1016/j.aap.2006.09.006; Batra AK, 2003, BURNS, V29, P270, DOI 10.1016/S0305-4179(02)00306-6; BAWABHALLA KS, 2000, ACCIDENT ANAL PREV, V32, P407; Eddleston M, 2006, INJURY PREV, V12, P333, DOI 10.1136/ip.2006.012641; Gajalakshmi V, 2007, INT J EPIDEMIOL, V36, P203, DOI 10.1093/ije/dyl308; GUPTA M, 1993, BURNS, V19, P47, DOI 10.1016/0305-4179(93)90100-M; GUPTA RK, 1988, FORENSIC SCI INT, V37, P81, DOI 10.1016/0379-0738(88)90096-5; GURURAJ G, 2005, INJURIES INDIA NATL; HADDON W, 1972, J TRAUM, V12, P193, DOI 10.1097/00005373-197203000-00002; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; *INT I POP STUD, 1999, NAT FAM HLTH SURV, V2; JAYARAMAN V, 1993, BURNS, V19, P339, DOI 10.1016/0305-4179(93)90124-Q; Kumar V, 2004, LANCET, V364, P18, DOI 10.1016/S0140-6736(04)17625-3; Lester D, 1999, ARCH SUICIDE RES, V5, P91, DOI 10.1080/13811119908258320; MAHAPATRA P, 2001, ESTIMATING NATL BURD; *MIN HOM AFF REG G, 2001, SAMPL REG SYST; *MIN HOM AFF REG G, 1999, CIV REG SYST; *MIN HOM AFF REG G, 2001, CENS IND; *MIN HOM AFF REG G, 2001, MED CERT CAUS DEATH; *MIN HOM NAT CRIM, 2005, CRIM IND; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327; Murray CJL, 2007, PLOS MED, V4, P1754, DOI 10.1371/journal.pmed.0040326; Oldenburg V.T., 2002, DOWRY MURDER IMPERIA; Prasad S, 1999, Violence Against Women, V5, P478, DOI 10.1177/10778019922181338; Runyan C W, 1998, Inj Prev, V4, P302; SAWHNEY CP, 1989, BURNS, V15, P362, DOI 10.1016/0305-4179(89)90099-5; Sharma BR, 2002, BURNS, V28, P250, DOI 10.1016/S0305-4179(02)00003-7; Singh D, 1998, BURNS, V24, P150, DOI 10.1016/S0305-4179(97)00106-X; Subrahmanyam M, 1996, BURNS, V22, P439, DOI 10.1016/0305-4179(96)00001-0; SUBRAHMANYAM M, 2003, ANN BURNS FIRE DISAS, V16, P74; *VIT STAT DIV REG, 1998, SURV CAUS DEATH; *WHO, 2005, WORLD HLTH SURV	35	72	72	3	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1282	1288		10.1016/S0140-6736(09)60235-X	http://dx.doi.org/10.1016/S0140-6736(09)60235-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432PN	19250664				2022-12-24	WOS:000265146300031
J	Licht, JD				Licht, Jonathan D.			Acute Promyelocytic Leukemia -- Weapons of Mass Differentiation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENES		Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol & Oncol, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Licht, JD (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol & Oncol, Chicago, IL 60611 USA.		Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019	Licht, Jonathan/0000-0002-3942-1369; 	NATIONAL CANCER INSTITUTE [R01CA059936] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA059936] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Yuan W, 2007, BLOOD, V109, P961, DOI 10.1182/blood-2006-07-036640; Zheng XM, 2007, HAEMATOLOGICA, V92, P323, DOI 10.3324/haematol.10541	5	37	40	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					928	930		10.1056/NEJMcibr0810371	http://dx.doi.org/10.1056/NEJMcibr0810371			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246367				2022-12-24	WOS:000263624700015
J	Smith, RD; Correa, C; Oh, C				Smith, Richard D.; Correa, Carlos; Oh, Cecilia			Trade and Health 5 Trade, TRIPS, and pharmaceuticals	LANCET			English	Article							AFFORDABILITY; ACCESS; DRUGS	The World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) set global minimum standards for the protection of intellectual property, substantially increasing and expanding intellectual-property rights, and generated clear gains for the pharmaceutical industry and the developed world. The question of whether TRIPS generates gains for developing countries, in the form of increased exports, is addressed in this paper through consideration of the importance of pharmaceuticals in health-care trade, outlining the essential requirements, implications, and issues related to TRIPS, and TRIPS-plus, in which increased restrictions are imposed as part of bilateral free-trade agreements. TRIPS has not generated substantial gains for developing countries, but has further increased pharmaceutical trade in developed countries. The unequal trade between developed and developing countries (ie, exporting and importing high-value patented drugs, respectively) raises the issue of access to medicines, which is exacerbated by TRIPS-plus provisions, although many countries have not even enacted provision for TRIPS flexibilities. Therefore this paper focuses on options that are available to the health community for negotiation to their advantage under TRIPS, and within the presence of TRIPS-plus.	[Smith, Richard D.] Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Correa, Carlos] Univ Buenos Aires, Ctr Interdisciplinary Studies Ind Property & Econ, Buenos Aires, DF, Argentina; [Oh, Cecilia] UNDP Reg Ctr, Colombo, Sri Lanka	University of London; London School of Hygiene & Tropical Medicine; University of Buenos Aires	Smith, RD (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Dept Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	Richard.Smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559				ABBOTT F, 2007, WORLD TRADE ORG ACCE; *AGCM, 2007, DEC A364 MERCK PRINC; ANDO G, 2006, PHARM MARKET MALAYSI; *ASEAN SECR, 2005, REG REP ASEAN ROCK F; Azmi IM, 2001, J WORLD INTELLECTUAL, V4, P947; Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; BASU S, 2003, ZNET GLOBAL EC  0529; BLOUIN C, 2007, WHO SEARO M TRAD HLT; *BURR LIF SCI MED, 2007, BURR Q IND LIF SCI; Commission on Intellectual Property Rights, INT INT PROP RIGHTS; Correa CM, 2006, B WORLD HEALTH ORGAN, V84, P399, DOI 10.2471/BLT.05.023432; DEEPTI R, 2007, CHEM WEEK, P169; Dzung N.N, 2007, CHICAGO KENT J INTEL, V6, P138; Endeshaw A, 2005, J WORLD INTELLECT PR, V8, P211, DOI 10.1111/j.1747-1796.2005.tb00247.x; *FED TRAD COMM, 2002, GEN DRUG ENTR PRIOR; *GLOB TRAD INF SER, UK CUST EXC; Haakonsson SJ, 2007, DEV POLICY REV, V25, P71, DOI 10.1111/j.1467-7679.2007.00360.x; *KEI, 2007, KEI RES NOT 2007 REC; Kerry VB, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-3; Kinnon CM, 1998, WORLD HEALTH FORUM, V19, P397; KRAUS L, 2004, VANDERBILT J TRANSNA, V37, pL527; MILSTIEN J, B WHO, V84, P360; *MIN INT TRAD IND, 3 IND MAST 1996 2020; *MITI, 2007, IND PROF CHEM MAL TR; MUSUNGU SF, 2004, S PERSPECTIVES R APR; *MYLPO, 2008, CALC PAT STAT INT PR; Oh C., 2006, International Journal of Intellectual Property Management, V1, P22, DOI 10.1504/IJIPM.2006.011020; Oxfam International, 2007, 102 OXF INT; *PIR1BO, 2007, 200711 PIR1BO; Priapantja Priapantja, 2000, ASEAN WORKSH TRIPS A; Schaffer Gregory C., 2003, DEFENDING INTERESTS; Smith R., 2003, GLOBAL PUBLIC GOODS; Smith RD, 2004, B WORLD HEALTH ORGAN, V82, P385; SMITH RD, 2009, LANCET          0122; Steinbrook R, 2007, NEW ENGL J MED, V357, P1996, DOI 10.1056/NEJMp0706918; *UNCTAD, 2005, W MACK PROD VIEW PHA; USTR (Office of the United States Trade Representative), 2007, SPEC 301 REP; *WHO, 2006, COMM INT PROP INN PU; WILBULPROPRASER.S, 2001, WORKSH DIFF PRIC FIN	39	94	94	2	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					684	691		10.1016/S0140-6736(08)61779-1	http://dx.doi.org/10.1016/S0140-6736(08)61779-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19167054	Green Submitted			2022-12-24	WOS:000263563500033
J	Bar-Yam, Y; Harmon, D; de Bivort, B				Bar-Yam, Yaneer; Harmon, Dion; de Bivort, Benjamin			SYSTEMS BIOLOGY Attractors and Democratic Dynamics	SCIENCE			English	Editorial Material							TRANSCRIPTIONAL REGULATORY NETWORK; ESCHERICHIA-COLI; CELL FATE; EVOLUTION		[Bar-Yam, Yaneer; Harmon, Dion; de Bivort, Benjamin] New England Complex Syst Inst, Cambridge, MA 02138 USA; [de Bivort, Benjamin] Harvard Univ, Roland Inst, Cambridge, MA 02139 USA	Harvard University	Bar-Yam, Y (corresponding author), New England Complex Syst Inst, 24 Mt Auburn St, Cambridge, MA 02138 USA.	yaneer@necsi.edu						Ao P, 2008, MED HYPOTHESES, V70, P678, DOI 10.1016/j.mehy.2007.03.043; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Bang AG, 2008, SCIENCE, V320, P58, DOI 10.1126/science.1157042; Bar-Yam Y, 2004, P NATL ACAD SCI USA, V101, P4341, DOI 10.1073/pnas.0400673101; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Waddington C.H., 1956, PRINCIPLES EMBRYOLOG	14	70	73	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2009	323	5917					1016	1017		10.1126/science.1163225	http://dx.doi.org/10.1126/science.1163225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	409AK	19229023				2022-12-24	WOS:000263478400025
J	Stutchbury, BJM; Tarof, SA; Done, T; Gow, E; Kramer, PM; Tautin, J; Fox, JW; Afanasyev, V				Stutchbury, Bridget J. M.; Tarof, Scott A.; Done, Tyler; Gow, Elizabeth; Kramer, Patrick M.; Tautin, John; Fox, James W.; Afanasyev, Vsevolod			Tracking Long-Distance Songbird Migration by Using Geolocators	SCIENCE			English	Article							STABLE-ISOTOPES; RANGES		[Stutchbury, Bridget J. M.; Tarof, Scott A.; Done, Tyler; Gow, Elizabeth; Kramer, Patrick M.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Tautin, John] Tom Ridge Environm Ctr, Purple Martin Conservat Assoc, Erie, PA 16505 USA; [Fox, James W.; Afanasyev, Vsevolod] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	York University - Canada; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Stutchbury, BJM (corresponding author), York Univ, Dept Biol, 4700 Keele St, N York, ON M3J 1P3, Canada.	bstutch@yorku.ca			Natural Sciences and Engineering Research Council of Canada; National Geographic Society; Purple Martin Conservation Association; NERC [bas010013] Funding Source: UKRI; Natural Environment Research Council [bas010013] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Geographic Society(National Geographic Society); Purple Martin Conservation Association; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank C. Graziano, R. Kresnik, T. MacIntosh, M. MacPherson, E. Pifer, T. Piraino, S. Puppi, C. Silverio, and C. Stanley for field assistance. For funding, we thank the Natural Sciences and Engineering Research Council of Canada, the National Geographic Society, the Purple Martin Conservation Association, and proceeds from (10).	Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Gauthreaux SA, 2003, AUK, V120, P266, DOI 10.1642/0004-8038(2003)120[0266:ROABC]2.0.CO;2; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Stutchbury B., 2007, SILENCE SONGBIRDS; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Yong W, 1997, AUK, V114, P263, DOI 10.2307/4089167	10	340	369	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					896	896		10.1126/science.1166664	http://dx.doi.org/10.1126/science.1166664			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213909				2022-12-24	WOS:000263295400031
J	Takahashi, H; Kato, M; Matsuura, M; Mobbs, D; Suhara, T; Okubo, Y				Takahashi, Hidehiko; Kato, Motoichiro; Matsuura, Masato; Mobbs, Dean; Suhara, Tetsuya; Okubo, Yoshiro			When Your Gain Is My Pain and Your Pain Is My Gain: Neural Correlates of Envy and Schadenfreude	SCIENCE			English	Article							BRAIN ACTIVITY; FMRI; BIAS	We often evaluate the self and others from social comparisons. We feel envy when the target person has superior and self- relevant characteristics. Schadenfreude occurs when envied persons fall from grace. To elucidate the neurocognitive mechanisms of envy and schadenfreude, we conducted two functional magnetic resonance imaging studies. In study one, the participants read information concerning target persons characterized by levels of possession and self- relevance of comparison domains. When the target person's possession was superior and self- relevant, stronger envy and stronger anterior cingulate cortex ( ACC) activation were induced. In study two, stronger schadenfreude and stronger striatum activation were induced when misfortunes happened to envied persons. ACC activation in study one predicted ventral striatum activation in study two. Our findings document mechanisms of painful emotion, envy, and a rewarding reaction, schadenfreude.	[Takahashi, Hidehiko; Suhara, Tetsuya] Natl Inst Radiol Sci, Dept Mol Neuroimaging, Inage Ku, Chiba 2638555, Japan; [Takahashi, Hidehiko; Matsuura, Masato] Tokyo Med & Dent Univ, Dept Life Sci & Bioinformat, Grad Sch Hlth Sci, Bunkyo Ku, Tokyo 1138549, Japan; [Takahashi, Hidehiko] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kato, Motoichiro] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo 1608582, Japan; [Mobbs, Dean] Univ Cambridge, MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Okubo, Yoshiro] Nippon Med Sch, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138603, Japan	National Institutes for Quantum Science & Technology; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Keio University; University of Cambridge; Nippon Medical School	Takahashi, H (corresponding author), Natl Inst Radiol Sci, Dept Mol Neuroimaging, Inage Ku, 9-1, 4 Chome Anagawa, Chiba 2638555, Japan.	hidehiko@nirs.go.jp		Takahashi, Hidehiko/0000-0002-5102-1982	Health and Labor Sciences Research Grant for Comprehensive Research on Disability, Health, and Welfare [H20-SYOGAI-011]; Japanese Ministry of Health, Labor, and Welfare; Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health [H20-KOKORO-025]; MRC (UK)	Health and Labor Sciences Research Grant for Comprehensive Research on Disability, Health, and Welfare; Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health; MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully thank C. Frith for his valuable comments. This study was supported by a Health and Labor Sciences Research Grant for Comprehensive Research on Disability, Health, and Welfare (H20-SYOGAI-011) from the Japanese Ministry of Health, Labor, and Welfare, and a Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H20-KOKORO-025) from the Japanese Ministry of Health, Labor, and Welfare. D.M. is support by MRC (UK).	Amodio DM, 2004, PSYCHOL SCI, V15, P88, DOI 10.1111/j.0963-7214.2004.01502003.x; Aristotle, 1981, ART RHETORIC; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; de Spinoza B., 2006, ETHICS; Eisenberg Nancy, 2007, Novartis Found Symp, V278, P71; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Hume D., 1978, TREATISE HUMAN NATUR, V2nd; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LAZEAR EP, 1989, J POLIT ECON, V97, P561, DOI 10.1086/261616; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; Mora Gonzalo Fernandez de la, 1987, EGALITARIAN ENVY POL; Nozick R., 1971, ANARCHY STATE UTOPIA; PARROTT WG, 1993, J PERS SOC PSYCHOL, V64, P906, DOI 10.1037/0022-3514.64.6.906; Rawls J., 1971, THEORY JUSTICE; Russell Bertrand., 1930, CONQUEST HAPPINESS; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Smith RH, 1999, PERS SOC PSYCHOL B, V25, P1007, DOI 10.1177/01461672992511008; TESSER A, 1991, J EXP SOC PSYCHOL, V27, P501, DOI 10.1016/0022-1031(91)90023-Y; Tesser A., 1988, ADV EXP SOC PSYCHOL, V21, P181, DOI 10.1016/S0065-2601(08)60227-0; van Dijk WW, 2006, EMOTION, V6, P156, DOI 10.1037/1528-3542.6.1.156	28	314	334	9	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					937	939		10.1126/science.1165604	http://dx.doi.org/10.1126/science.1165604			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406KW	19213918				2022-12-24	WOS:000263295400043
J	Sumara, G; Formentini, I; Collins, S; Sumara, I; Windak, R; Bodenmiller, B; Ramracheya, R; Caille, D; Jiang, HP; Platt, KA; Meda, P; Aebersold, R; Rorsman, P; Ricci, R				Sumara, Grzegorz; Formentini, Ivan; Collins, Stephan; Sumara, Izabela; Windak, Renata; Bodenmiller, Bernd; Ramracheya, Reshma; Caille, Dorothee; Jiang, Huiping; Platt, Kenneth A.; Meda, Paolo; Aebersold, Rudolf; Rorsman, Patrik; Ricci, Romeo			Regulation of PKD by the MAPK p38 delta in Insulin Secretion and Glucose Homeostasis	CELL			English	Article							PROTEIN-KINASE-D; BETA-CELL; NEUROTENSIN SECRETION; TRANSPORT CARRIERS; DIABETES-MELLITUS; SKELETAL-MUSCLE; P38 MAPK; P38-ALPHA; MECHANISMS; RESISTANCE	Dysfunction and loss of insulin-producing pancreatic beta cells represent hallmarks of diabetes mellitus. Here, we show that mice lacking the mitogen-activated protein kinase (MAPK) p38 delta display improved glucose tolerance due to enhanced insulin secretion from pancreatic beta cells. Deletion of p38 delta results in pronounced activation of protein kinase D (PKD), the latter of which we have identified as a pivotal regulator of stimulated insulin exocytosis. p38 delta catalyzes an inhibitory phosphorylation of PKD1, thereby attenuating stimulated insulin secretion. In addition, p38 delta null mice are protected against high-fat-feeding induced insulin resistance and oxidative stress-mediated b cell failure. Inhibition of PKD1 reverses enhanced insulin secretion from p38 delta-deficient islets and glucose tolerance in p38 delta null mice as well as their susceptibility to oxidative stress. In conclusion, the p38 delta-PKD pathway integrates regulation of the insulin secretory capacity and survival of pancreatic b cells, pointing to a pivotal role for this pathway in the development of overt diabetes mellitus.	[Sumara, Grzegorz; Formentini, Ivan; Windak, Renata; Ricci, Romeo] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Collins, Stephan; Ramracheya, Reshma; Rorsman, Patrik] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Sumara, Izabela] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Bodenmiller, Bernd; Aebersold, Rudolf] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Bodenmiller, Bernd; Aebersold, Rudolf] Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland; [Caille, Dorothee; Meda, Paolo] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Jiang, Huiping] Boehringer Ingelheim Pharmaceut Inc, Dept Biotherapeut & Integrat Biol, Ridgefield, CT 06877 USA; [Platt, Kenneth A.] Lexicon Pharmaceut, The Woodlands, TX 77381 USA; [Aebersold, Rudolf] Inst Syst Physiol, Seattle, WA 98103 USA; [Aebersold, Rudolf; Ricci, Romeo] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Geneva; Boehringer Ingelheim; Lexicon Pharmaceuticals	Ricci, R (corresponding author), ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland.	romeo.ricci@cell.biol.ethz.ch	collins, stephan c/P-4409-2016; Rorsman, Patrik/A-4331-2016; Ricci, Romeo/K-3009-2013	collins, stephan c/0000-0002-1533-3380; Rorsman, Patrik/0000-0001-7578-0767; Ricci, Romeo/0000-0002-9766-4369; Sumara, Izabela/0000-0002-5968-3358; Sumara, Grzegorz/0000-0003-1502-6265; Ramracheya, Reshma/0000-0001-6117-1936	Boehringer Ingelheim Pharmeaceuticals, Inc; Ridgefield, CT; Forschungskredit 2003 of the University of Zurich; Swiss National Science Foundation (SNF) [PP00A114856]; Roche Research Foundation; Bonizzi-Theler Foundation; ETHZ; Boehringer Ingelheim Fonds; Swiss National Science Foundation [310000-122430]; Juvenile Diabetes Research Foundation [1-2007-158]; Novo Nordisk; SNF [31000-10767]; Competence Center for Systems Physiology and Metabolic Diseases, Zurich; Wellcome Trust; European Union (Eurodia);  [337-2004];  [FP-7 BETAIMAGE 222980]	Boehringer Ingelheim Pharmeaceuticals, Inc(Boehringer Ingelheim); Ridgefield, CT; Forschungskredit 2003 of the University of Zurich; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Roche Research Foundation; Bonizzi-Theler Foundation; ETHZ(ETH Zurich); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Novo Nordisk(Novo Nordisk); SNF; Competence Center for Systems Physiology and Metabolic Diseases, Zurich; Wellcome Trust(Wellcome TrustEuropean Commission); European Union (Eurodia)(European Commission); ; 	We are grateful to Boehringer Ingelheim Pharmeaceuticals, Inc., Ridgefield, CT, for their generous financial support. We also would like to thank Markus Stoffel and Arne Ittner for numerous fruitful scientific discussions; Olga Herdzina for careful reading; Ana Cuenda for providing us with an antibody against p38d; David Engelberg for providing us with plasmids to express constitutive active p38d; Angelika Hausser and Vivek Malhotra for providing us with PKD plasmids; and Mary McFarland and Lynn Pantages-Torok for organizing mouse shipments. G. S. was supported by the Forschungskredit 2003 of the University of Zurich, the Swiss National Science Foundation (SNF) (PP00A114856), and the Roche Research Foundation (337-2004). I. F. was supported by the Bonizzi-Theler Foundation. I. S. is a senior research associate in the M. Peter laboratory, and her work was supported by grants from the SNF and the ETHZ to M. Peter. B. B. is the recipient of a fellowship by the Boehringer Ingelheim Fonds. The Meda team is supported by grants from the Swiss National Science Foundation (310000-122430), the Juvenile Diabetes Research Foundation (1-2007-158), the European Union (FP-7 BETAIMAGE 222980), and Novo Nordisk. The R. A. team is supported by the SNF (31000-10767) and by the Competence Center for Systems Physiology and Metabolic Diseases, Zurich. Work in Oxford was funded by the Wellcome Trust and the European Union (Eurodia).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Aston-Mourney K, 2008, DIABETOLOGIA, V51, P540, DOI 10.1007/s00125-008-0930-2; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Feijoo C, 2005, J CELL SCI, V118, P397, DOI 10.1242/jcs.01655; Fridlyand LE, 2006, CURR DIABETES REV, V2, P241, DOI 10.2174/157339906776818541; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Haxhinasto SA, 2003, J IMMUNOL, V171, P4655, DOI 10.4049/jimmunol.171.9.4655; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Koistinen HA, 2003, DIABETOLOGIA, V46, P1324, DOI 10.1007/s00125-003-1196-3; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Li J, 2004, J BIOL CHEM, V279, P28466, DOI 10.1074/jbc.M314307200; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Makeeva N, 2006, BIOCHEM J, V393, P129, DOI 10.1042/BJ20050814; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; PETERRIESCH B, 1988, J CLIN INVEST, V81, P1154, DOI 10.1172/JCI113430; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Thore S, 2007, DIABETES, V56, P818, DOI 10.2337/db06-0843; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vertommen D, 2000, J BIOL CHEM, V275, P19567, DOI 10.1074/jbc.M001357200; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; WIEDENKELLER DE, 1983, ENDOCRINOLOGY, V113, P2311, DOI 10.1210/endo-113-6-2311; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200	46	177	190	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					235	248		10.1016/j.cell.2008.11.018	http://dx.doi.org/10.1016/j.cell.2008.11.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19135240	hybrid, Green Published			2022-12-24	WOS:000262648800013
J	Attia, J; Ioannidis, JPA; Thakkinstian, A; McEvoy, M; Scott, RJ; Minelli, C; Thompson, J; Infante-Rivard, C; Guyatt, G				Attia, John; Ioannidis, John P. A.; Thakkinstian, Ammarin; McEvoy, Mark; Scott, Rodney J.; Minelli, Cosetta; Thompson, John; Infante-Rivard, Claire; Guyatt, Gordon			How to Use an Article About Genetic Association B: Are the Results of the Study Valid?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HARDY-WEINBERG EQUILIBRIUM; GENOME-WIDE ASSOCIATION; FALSE DISCOVERY RATE; GENOTYPING ERRORS; POPULATION STRATIFICATION; EMPIRICAL-EVALUATION; MEDICAL LITERATURE; ALZHEIMER-DISEASE; METAANALYSIS; REPLICATION	In the first article of this series, we reviewed the basic genetics concepts necessary to understand genetic association studies. In this second article, we enumerate the major issues in judging the validity of these studies, framed as critical appraisal questions. Was the disease phenotype properly defined and accurately recorded by someone blind to the genetic information? Have any potential differences between disease and nondisease groups, particularly ethnicity, been properly addressed? In genetic studies, one potential cause of spurious associations is differences between cases and controls in ethnicity, a situation termed population stratification. Was measurement of the genetic variants unbiased and accurate? Methods for determining DNA sequence variation are not perfect and may have some measurement error. Do the genotype proportions observe Hardy- Weinberg equilibrium? This simple mathematic rule about the distribution of genetic groups may be one way to check for errors in reading DNA information. Have the investigators adjusted their inferences for multiple comparisons? Given the thousands of genetic markers tested in genome- wide association studies, the potential for false- positive and false-negative results is much higher than in traditional medical studies, and it is particularly important to look for replication of results.	[Attia, John] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2308, Australia; [Attia, John] John Hunter Hosp, Hunter Med Res Inst, Newcastle, NSW, Australia; [Attia, John] John Hunter Hosp, Dept Gen Med, Newcastle, NSW, Australia; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Ctr Genet Epidemiol & Modeling, Tufts Med Ctr,Dept Med, Boston, MA 02111 USA; [Thakkinstian, Ammarin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Clin Epidemiol Unit, Bangkok 10400, Thailand; [McEvoy, Mark] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2308, Australia; [Scott, Rodney J.] John Hunter Hosp, Hunter Area Pathol Serv, Div Genet, New Lambton, Australia; [Scott, Rodney J.] Univ Newcastle, Hunter Med Res Inst, Fac Hlth, Ctr Informat Based Med, Newcastle, NSW 2308, Australia; [Minelli, Cosetta] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Thompson, John] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Infante-Rivard, Claire] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; John Hunter Hospital; University of Ioannina; Tufts Medical Center; Tufts University; Mahidol University; University of Newcastle; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; Imperial College London; University of Leicester; McGill University; McMaster University	Attia, J (corresponding author), Univ Newcastle, Royal Newcastle Hosp, Ctr Clin Epidemiol & Biostat, Level 3,David Maddison Bldg, Newcastle, NSW 2300, Australia.	john.attia@newcastle.edu.au	Scott, Rodney J/B-2827-2013; Attia, John R/F-5376-2013; Ioannidis, John P. A./G-9836-2011; Thakkinstian, Ammarin/J-4788-2019	Scott, Rodney J/0000-0001-7724-3404; Attia, John R/0000-0001-9800-1308; McEvoy, Mark/0000-0002-5505-5557				Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P74, DOI 10.1001/jama.2008.901; Barnholtz-Sloan JS, 2008, CANCER EPIDEM BIOMAR, V17, P471, DOI 10.1158/1055-9965.EPI-07-0491; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Contopoulos-Ioannidis DG, 2006, PHARMACOGENET GENOM, V16, P705, DOI 10.1097/01.fpc.0000236332.11304.8f; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Cox DG, 2006, HUM HERED, V61, P10, DOI 10.1159/000091787; Evangelou E, 2006, PLOS GENET, V2, P1147, DOI 10.1371/journal.pgen.0020123; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; *HUM GEN EP NETW, NAV HUM GEN EP; Ioannidis JPA, 2008, AM J MED GENET B, V147B, P964, DOI 10.1002/ajmg.b.30721; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Khoury MJ, 1998, AM J EPIDEMIOL, V148, P1; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; Leal SM, 2005, GENET EPIDEMIOL, V29, P204, DOI 10.1002/gepi.20086; LEVINE M, 1994, JAMA-J AM MED ASSOC, V271, P1615, DOI 10.1001/jama.271.20.1615; Levine M, 2008, USERS GUIDES MED LIT; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; LITTLE J, 2008, HUGENET HUGHE REV HD; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Montoya-Delgado LE, 2001, GENETICS, V158, P875; Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Province MA, 2001, ADV GENET, V42, P499, DOI 10.1016/S0065-2660(01)42039-6; Randolph A, 2008, USERS GUIDES MED LIT; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rubinsztein DC, 1999, DEMENT GERIATR COGN, V10, P199, DOI 10.1159/000017120; Sabatti Chiara, 2007, Methods Mol Biol, V376, P195; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Slooter AJC, 2004, NEUROLOGY, V62, P1196, DOI 10.1212/01.WNL.0000118302.66674.E1; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; *TUFTS U COMP MOL, SIMPL CALC DET WHETH; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; WACHOLDER S, ASSESSING PROBABILIT; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	59	121	125	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					191	197		10.1001/jama.2008.946	http://dx.doi.org/10.1001/jama.2008.946			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141767				2022-12-24	WOS:000262405500021
J	Chen, B; Cepko, CL				Chen, Bo; Cepko, Constance L.			HDAC4 Regulates Neuronal Survival in Normal and Diseased Retinas	SCIENCE			English	Article							CONTROLS CHONDROCYTE HYPERTROPHY; MEF2 TRANSCRIPTION FACTOR; CELL-DEATH; INTRACELLULAR TRAFFICKING; RETINITIS-PIGMENTOSA; BETA-SUBUNIT; MOUSE; PHOSPHODIESTERASE; DIFFERENTIATION; DEGENERATION	Histone deacetylase 4 ( HDAC4) shuttles between the nucleus and cytoplasm and serves as a nuclear co- repressor that regulates bone and muscle development. We report that HDAC4 regulates the survival of retinal neurons in the mouse in normal and pathological conditions. Reduction in HDAC4 expression during normal retinal development led to apoptosis of rod photoreceptors and bipolar ( BP) interneurons, whereas overexpression reduced naturally occurring cell death of the BP cells. HDAC4 overexpression in a mouse model of retinal degeneration prolonged photoreceptor survival. The survival effect was due to the activity of HDAC4 in the cytoplasm and relied at least partly on the activity of hypoxia- inducible factor 1 alpha (HIF1 alpha). These data provide evidence that HDAC4 plays an important role in promoting the survival of retinal neurons.	[Chen, Bo; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Chen, Bo; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Chen, Bo; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Chen, B (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	bochen@genetics.med.harvard.edu; cepko@genetics.med.harvard.edu			NIH [EYO 14466]; Foundation for Retinal Research; Merck; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY014466] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Retinal Research; Merck(Merck & Company); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J.R. Lu for providing HDAC4, HDAC5, and HDAC6 expression constructs; T.P. Yao for providing HDAC4-3SA mutant; X.J. Yang for providing HDAC4-L175A mutant; G.L. Semenza for providing dnHIF1 alpha constructs and K.W. Kim for providing HIF1 alpha and HIF1 alpha K532R constructs; and T. Matsuda for assistance with various techniques. Supported by NIH grant EYO 14466, the Foundation for Retinal Research, a gift from Merck, and the Howard Hughes Medical Institute (HHMI). C.L.C. is an Investigator of HHMI and B.C. is a postdoctoral fellow of HHMI. C.L.C. and B.C. have filed a U.S. patent application, 61/088,455, based on the work in this paper.	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bolger TA, 2007, J BIOL CHEM, V282, P29186, DOI 10.1074/jbc.M704182200; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Voyvodic JT, 1995, EUR J NEUROSCI, V7, P2469, DOI 10.1111/j.1460-9568.1995.tb01045.x; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	22	157	180	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					256	259		10.1126/science.1166226	http://dx.doi.org/10.1126/science.1166226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131628	Green Accepted			2022-12-24	WOS:000262290600039
J	Baid, SK; Lai, EW; Wesley, RA; Ling, A; Timmers, HJLM; Adams, KT; Kozupa, A; Pacak, K				Baid, Smita K.; Lai, Edwin W.; Wesley, Robert A.; Ling, Alex; Timmers, Henri J. L. M.; Adams, Karen T.; Kozupa, Anna; Pacak, Karel			Brief Communication: Radiographic Contrast Infusion and Catecholamine Release in Patients With Pheochromocytoma	ANNALS OF INTERNAL MEDICINE			English	Article								Background: Contrast-enhanced computed tomography (CT) is useful for localizing pheochromocytoma. However, in patients with suspected pheochromocytoma, CT is often canceled or not performed because of the strong belief that intravenous contrast may induce hypertensive crisis. Objective: To examine whether intravenous low-osmolar contrast administration during CT induces catecholamine release that increases blood pressure or heart rate. Design: Prospective study. Setting: Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland. Participants: 22 patients with pheochromocytoma (15 nonadrenal and 7 adrenal) and 8 unmatched control participants without pheochromocytoma. Measurements: Plasma catecholamine levels, blood pressure, and heart rate. Results: Plasma catecholamine levels within and between groups did not significantly differ before and after intravenous administration of low-osmolar CT contrast. Patients with pheochromocytoma experienced a clinically and statistically significant increase in diastolic blood pressure that was not accompanied by corresponding increases in plasma catecholamine levels. The difference became non -statistically significant after adjustment for use of alpha-and beta-blockers. Limitation: The study lacked a placebo group, and the sample was relatively small. Conclusion: Intravenous low-osmolar contrast-enhanced CT can safely be used in patients with pheochromocytoma who are not receiving alpha-or beta-blockers.	[Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Dev, Adult Endocrinol Program, Sect Med Neuroendocrinol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pacak, K (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Dev, Adult Endocrinol Program, Sect Med Neuroendocrinol, NIH, Bldg 10,CRC,Room 1E-1-3140,10 Ctr Dr,MSC-1109, Bethesda, MD 20892 USA.	karel@mail.nih.gov	Timmers, Henri JLM/A-4641-2010		Eunice Kennedy Shriver National Institute of Child Health and Development; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Eunice Kennedy Shriver National Institute of Child Health and Development, National Institutes of Health.	Aspelin P, 2006, EUR RADIOL, V16, P1041, DOI 10.1007/s00330-005-0081-5; EISENHOFER G, 1986, CLIN CHEM, V32, P2030; Ilias I, 2004, J CLIN ENDOCR METAB, V89, P479, DOI 10.1210/jc.2003-031091; Mukherjee JJ, 1997, RADIOLOGY, V202, P227, DOI 10.1148/radiology.202.1.8988215; ROSSI P, 1968, J AMER MED ASSOC, V205, P547, DOI 10.1001/jama.205.8.547	5	20	21	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2009	150	1					27	W6		10.7326/0003-4819-150-1-200901060-00006	http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397IC	19124817	Green Accepted			2022-12-24	WOS:000262655100004
J	Bradshaw, N; Neher, SB; Booth, DS; Walter, P				Bradshaw, Niels; Neher, Saskia B.; Booth, David S.; Walter, Peter			Signal Sequences Activate the Catalytic Switch of SRP RNA	SCIENCE			English	Article							RECOGNITION PARTICLE; CONFORMATIONAL-CHANGES; PROTEIN TRANSLOCATION; CRYSTAL-STRUCTURE; 4.5S RNA; RECEPTOR; BINDING; PEPTIDES; RIBONUCLEOPROTEIN; SUBUNIT	The signal recognition particle ( SRP) recognizes polypeptide chains bearing a signal sequence as they emerge from the ribosome, and then binds its membrane- associated receptor ( SR), thereby delivering the ribosome- nascent chain complex to the endoplasmic reticulum in eukaryotic cells and the plasma membrane in prokaryotic cells. SRP RNA catalytically accelerates the interaction of SRP and SR, which stimulates their guanosine triphosphatase ( GTPase) activities, leading to dissociation of the complex. We found that although the catalytic activity of SRP RNA appeared to be constitutive, SRP RNA accelerated complex formation only when SRP was bound to a signal sequence. This crucial control step was obscured because a detergent commonly included in the reaction buffer acted as a signal peptide mimic. Thus, SRP RNA is a molecular switch that renders the SRP- SR GTPase engine responsive to signal peptide recruitment, coupling GTP hydrolysis to productive protein targeting.	[Bradshaw, Niels; Neher, Saskia B.; Booth, David S.; Walter, Peter] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Bradshaw, Niels; Neher, Saskia B.; Booth, David S.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Walter, P (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.	pwalter@biochem.ucsf.edu	Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Booth, David/0000-0002-4724-4702; Neher, Saskia/0000-0003-4165-6674; Bradshaw, Niels/0000-0002-6845-4717	NIH [ROI GM32384]; NSF; Jane Coffin Childs Memorial Fund; National Institute of General Medical Sciences [R25 GM56847]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032384, R25GM056847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Weissman, C. Gross, P. Egea, C. Gallagher, A. Korennykh, A. Acevedo, W. Weare, and J. Kardon for assistance and comments. Supported by NIH grant ROI GM32384 (P.W.), an NSF predoctoral fellowship (N.B.), the Jane Coffin Childs Memorial Fund (S.B.N.), and National Institute of General Medical Sciences fellowship R25 GM56847 (D.S.B.). P.W. is an Investigator of the Howard Hughes Medical Institute.	Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Bradshaw N, 2007, MOL BIOL CELL, V18, P2728, DOI 10.1091/mbc.e07-02-0117; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; Neher SB, 2008, NAT STRUCT MOL BIOL, V15, P916, DOI 10.1038/nsmb.1467; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Swain JF, 2001, J BIOL CHEM, V276, P12222, DOI 10.1074/jbc.M011128200; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	19	67	67	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					127	130		10.1126/science.1165971	http://dx.doi.org/10.1126/science.1165971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119234	Green Accepted			2022-12-24	WOS:000262104100057
J	Smith, M				Smith, Malcolm			Year of astronomy: Time to turn off the lights	NATURE			English	Editorial Material							POLLUTION; NIGHT		[Smith, Malcolm] Cerro Tololo Interamer Observ, La Serena, Chile	National Optical Astronomy Observatory	Smith, M (corresponding author), Cerro Tololo Interamer Observ, Casilla 603, La Serena, Chile.	msmith@ctio.noao.edu						Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; DEDA P, 2007, STARLIGHT COMMON HER, P177; Isobe S, 2000, ASTROPHYS SPACE SCI, V273, P289, DOI 10.1023/A:1002719404278; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.1890/1540-9295(2004)002[0191:ELP]2.0.CO;2; Marin C., 2007, STARLIGHT COMMON HER; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Rich C., 2006, ECOLOGICAL CONSEQUEN; UNFPA, 2007, STAT WORLD POP 2007	8	38	39	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 1	2009	457	7225					27	27		10.1038/457027a	http://dx.doi.org/10.1038/457027a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122621				2022-12-24	WOS:000262104900015
J	Song, AH; Wang, D; Chen, G; Li, Y; Luo, J; Duan, SM; Poo, MM				Song, Ai-hong; Wang, Dong; Chen, Gang; Li, Yuju; Luo, Jianhong; Duan, Shumin; Poo, Mu-ming			A Selective Filter for Cytoplasmic Transport at the Axon Initial Segment	CELL			English	Article							HIPPOCAMPAL-NEURONS; ANKYRIN-G; MEMBRANE-PROTEINS; GLUTAMATE RECEPTORS; DIFFUSION BARRIER; LATERAL DIFFUSION; KINESIN; TRAFFICKING; MECHANISMS; CHANNELS	Distinct molecules are segregated into somatodendritic and axonal compartments of polarized neurons, but mechanisms underlying the development and maintenance of such segregation remain largely unclear. In cultured hippocampal neurons, we observed an ankyrin G-and F-actin-dependent structure that emerged in the cytoplasm of the axon initial segment (AIS) within 2 days after axon/dendrite differentiation, imposing a selective filter for diffusion of macromolecules and transport of vesicular carriers into the axon. Axonal entry was allowed for KIF5-driven carriers of synaptic vesicle protein VAMP2, but not for KIF17-driven carriers of dendrite-targeting NMDA receptor subunit NR2B. Comparisons of transport rates between chimeric forms of KIF17 and KIF5B, with the motor and cargo-binding domains switched, and between KIF5 loaded with VAMP2 versus GluR2 suggest that axonal entry of vesicular carriers depends on the transport efficacy of KIF-cargo complexes. This selective AIS filtering may contribute to preferential trafficking and segregation of cellular components in polarized neurons.	[Song, Ai-hong; Wang, Dong; Chen, Gang; Li, Yuju; Duan, Shumin; Poo, Mu-ming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurobiol, Shanghai 200031, Peoples R China; [Luo, Jianhong] Zhejiang Univ, Dept Neurobiol, Sch Med, Hangzhou 310031, Zhejiang, Peoples R China; [Poo, Mu-ming] Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurobiol, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn; mpoo@berkeley.edu		Chen, Gang/0000-0003-3669-5687	Major State Basic Research Program of China [2006CB806600]; National Natural Science Foundation of China [30730037]	Major State Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank J.G. Chen, V. Bennett, C. Gu, and D. B. Arnold for providing cDNA clones and J.Y. Shen for technical assistance with siRNA constructs. This work was supported by grants from the Major State Basic Research Program of China (2006CB806600) and the National Natural Science Foundation of China (30730037).	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; BENSHALOM G, 1985, J NEUROCYTOL, V14, P943, DOI 10.1007/BF01224806; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Brown MD, 1997, BRAIN RES, V747, P313, DOI 10.1016/S0006-8993(96)01321-2; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Guillaud L, 2003, J NEUROSCI, V23, P131; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; Hemar A, 1997, J NEUROSCI, V17, P9026; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; KILLISCH I, 1991, NEURON, V7, P927, DOI 10.1016/0896-6273(91)90338-Z; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nishimura K, 2007, MOL CELL NEUROSCI, V34, P422, DOI 10.1016/j.mcn.2006.11.017; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; POO MM, 1982, NATURE, V295, P332, DOI 10.1038/295332a0; POPOV S, 1992, J NEUROSCI, V12, P77; PROVANCE DW, 1993, J CELL SCI, V106, P565; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143	40	243	250	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1148	1160		10.1016/j.cell.2009.01.016	http://dx.doi.org/10.1016/j.cell.2009.01.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19268344	Bronze			2022-12-24	WOS:000264403900019
J	Guan, N; Fan, QF; Ding, J; Zhao, YM; Lu, JQ; Ai, Y; Xu, GB; Zhu, SN; Yao, C; Jiang, LN; Miao, J; Zhang, H; Zhao, D; Liu, XY; Yao, Y				Guan, Na; Fan, Qingfeng; Ding, Jie; Zhao, Yiming; Lu, Jingqiao; Ai, Yi; Xu, Guobin; Zhu, Sainan; Yao, Chen; Jiang, Lina; Miao, Jing; Zhang, Han; Zhao, Dan; Liu, Xiaoyu; Yao, Yong			Melamine-Contaminated Powdered Formula and Urolithiasis in Young Children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: A recent epidemic of melamine contamination of baby formula in China has been associated with the development of urinary tract stones, though the clinical manifestations and predisposing factors are incompletely delineated. Methods: We administered a questionnaire to the parents of children 36 months of age or younger who were being screened for a history of exposure to melamine and symptoms of, and possible predisposing factors for, urinary tract stones. In addition, we performed urinalysis, renal-function and liver-function tests, urinary tests for biochemical markers and the calcium:creatinine ratio, and ultrasonography. Powdered-milk infant formulas were classified as having a high melamine content (>500 ppm), a moderate melamine content (<150 ppm), or no melamine (0 ppm); no formulas contained between 150 and 500 ppm of melamine. Results: Contaminated formula was ingested by 421 of 589 children. Fifty had urinary stones, including 8 who had not received melamine-contaminated formula; 112 were suspected to have stones; and 427 had no stones. Among children with stones, 5.9% had hematuria and 2.9% had leukocyturia, percentages that did not differ significantly from those among children who were suspected to have stones or those who did not have stones. Serum creatinine, urea nitrogen, and alanine aminotransferase levels were normal in the 22 children with stones who were tested. Four of the 41 children (9.8%) who had stones and in whom urinary markers of glomerular function were measured had evidence of abnormalities; none had tubular dysfunction. Children exposed to high-melamine formula were 7.0 times as likely to have stones as those exposed to no-melamine formula. Preterm infants were 4.5 times as likely to have stones as term infants. Conclusions: Prematurity and exposure to melamine-contaminated formula were associated with urinary stones. Affected children lacked typical signs and symptoms of urolithiasis. N Engl J Med 2009;360:1067-74.	[Guan, Na; Fan, Qingfeng; Ding, Jie; Ai, Yi; Xu, Guobin; Zhu, Sainan; Yao, Chen; Jiang, Lina; Miao, Jing; Zhang, Han; Zhao, Dan; Liu, Xiaoyu; Yao, Yong] Peking Univ, Hosp 1, Beijing 100034, Peoples R China; [Zhao, Yiming; Lu, Jingqiao] Peking Univ, Hosp 3, Res Ctr Clin Epidemiol, Beijing 100034, Peoples R China	Peking University; Peking University	Ding, J (corresponding author), Peking Univ, Hosp 1, 1 Xi An Men Da Jie, Beijing 100034, Peoples R China.	djnc_5855@126.com	Fan, Qingfeng/F-4778-2012	Miao, Jing/0000-0003-0642-9740; Fan, Qingfeng/0000-0002-7100-7766	National Key Technology Research and Development Program of China	National Key Technology Research and Development Program of China(National Key Technology R&D Program)	Supported by a grant from the National Key Technology Research and Development Program of China.	Chertow GM, 1996, JAMA-J AM MED ASSOC, V276, P1732, DOI 10.1001/jama.276.21.1732; COWARD RJ, 2004, ARCH DIS CHILD, V89, P797; Coward RJM, 2003, ARCH DIS CHILD, V88, P962, DOI 10.1136/adc.88.11.962; GILSANZ V, 1985, RADIOLOGY, V154, P107, DOI 10.1148/radiology.154.1.3964925; Sun Ning, 2008, Zhonghua Er Ke Za Zhi, V46, P810; Thompson ME, 2008, VET PATHOL, V45, P417, DOI 10.1354/vp.45-3-417	6	203	233	0	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1067	1074		10.1056/NEJMoa0809550	http://dx.doi.org/10.1056/NEJMoa0809550			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19196669				2022-12-24	WOS:000264051000004
J	Jerrett, M; Burnett, RT; Pope, CA; Ito, K; Thurston, G; Krewski, D; Shi, YL; Calle, E; Thun, M				Jerrett, Michael; Burnett, Richard T.; Pope, C. Arden, II; Ito, Kazuhiko; Thurston, George; Krewski, Daniel; Shi, Yuanli; Calle, Eugenia; Thun, Michael			Long-Term Ozone Exposure and Mortality.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AIR-POLLUTION; LUNG-FUNCTION; CANCER PREVENTION; SPATIAL-ANALYSIS; AMBIENT OZONE; CHILDREN; ASSOCIATION; POLLUTANTS; HEALTH; FEV1	Background: Although many studies have linked elevations in tropospheric ozone to adverse health outcomes, the effect of long-term exposure to ozone on air pollution-related mortality remains uncertain. We examined the potential contribution of exposure to ozone to the risk of death from cardiopulmonary causes and specifically to death from respiratory causes. Methods: Data from the study cohort of the American Cancer Society Cancer Prevention Study II were correlated with air-pollution data from 96 metropolitan statistical areas in the United States. Data were analyzed from 448,850 subjects, with 118,777 deaths in an 18-year follow-up period. Data on daily maximum ozone concentrations were obtained from April 1 to September 30 for the years 1977 through 2000. Data on concentrations of fine particulate matter (particles that are lessthan/equal 2.5 microm in aerodynamic diameter [PM(sub 2.5)]) were obtained for the years 1999 and 2000. Associations between ozone concentrations and the risk of death were evaluated with the use of standard and multilevel Cox regression models. Results: In single-pollutant models, increased concentrations of either PM(sub 2.5) or ozone were significantly associated with an increased risk of death from cardiopulmonary causes. In two-pollutant models, PM(sub 2.5) was associated with the risk of death from cardiovascular causes, whereas ozone was associated with the risk of death from respiratory causes. The estimated relative risk of death from respiratory causes that was associated with an increment in ozone concentration of 10 ppb was 1.040 (95% confidence interval, 1.010 to 1.067). The association of ozone with the risk of death from respiratory causes was insensitive to adjustment for confounders and to the type of statistical model used. Conclusions: In this large study, we were not able to detect an effect of ozone on the risk of death from cardiovascular causes when the concentration of PM(sub 2.5) was taken into account. We did, however, demonstrate a significant increase in the risk of death from respiratory causes in association with an increase in ozone concentration. N Engl J Med 2009;360:1085-95.	[Jerrett, Michael] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Burnett, Richard T.] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Pope, C. Arden, II] Brigham Young Univ, Provo, UT 84602 USA; [Ito, Kazuhiko; Thurston, George] NYU, Sch Med, New York, NY USA; [Krewski, Daniel; Shi, Yuanli] Univ Ottawa, Ottawa, ON, Canada; [Calle, Eugenia; Thun, Michael] Amer Canc Soc, Atlanta, GA 30329 USA	University of California System; University of California Berkeley; Health Canada; Brigham Young University; New York University; University of Ottawa; American Cancer Society	Jerrett, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, 710 Univ Hall, Berkeley, CA 94720 USA.	jerrett@berkeley.edu	Jerrett, Michael/CAA-2482-2022; Pope, C. Arden/ABD-5522-2021; Thurston, George/ABB-1359-2021		Health Effects Institute; Natural Sciences and Engineering Research Council of Canada; National Institute of Environmental Health Sciences [ES00260]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	Health Effects Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Health Effects Institute. Dr. Krewski reports receiving grant support from the Natural Sciences and Engineering Research Council of Canada as holder of the Industrial Research Chair in Risk Science. This chair is funded by a peer- reviewed university- industry partnership program. No other potential conflict of interest relevant to this article was reported. We thank the National Institute of Environmental Health Sciences for providing grant support ( ES00260) to the New York University School of Medicine.	Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; AckermannLiebrich U, 1997, AM J RESP CRIT CARE, V155, P122, DOI 10.1164/ajrccm.155.1.9001300; *AM CANC SOC, 2009, CANC PREV STUD OV; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brown JS, 2008, ENVIRON HEALTH PERSP, V116, P1023, DOI 10.1289/ehp.11396; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888; Chen C, 2007, ENVIRON HEALTH PERSP, V115, P1732, DOI 10.1289/ehp.10294; *COMM MED EFF AIR, 2007, EFF HLTH LONG TERM E; Committee on Estimating Mortality Risk Reduction Benefits from Decreasing Tropospheric Ozone Exposure, 2008, EST MORT RISK RED EC; Delfino RJ, 2004, ENVIRON HEALTH PERSP, V112, P932, DOI 10.1289/ehp.6815; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; *ENV PROT AG, 2007, EPA452R07007; Galizia A, 1999, ENVIRON HEALTH PERSP, V107, P675, DOI 10.2307/3434461; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Jerrett M, 2003, J TOXICOL ENV HEAL A, V66, P1735, DOI 10.1080/15287390306438; KREWSKI D, EXTENDED FO IN PRESS; Krewski D, 2000, REANALYSIS HARVARD 2; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Ma RJ, 2003, BIOMETRIKA, V90, P157, DOI 10.1093/biomet/90.1.157; McConnell R, 2002, LANCET, V359, P386, DOI 10.1016/S0140-6736(02)07597-9; McConnell R, 2002, LANCET, V359, P896; McConnell R, 2006, SCI TOTAL ENVIRON, V363, P166, DOI 10.1016/j.scitotenv.2005.06.028; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mudway IS, 2004, AM J RESP CRIT CARE, V169, P1089, DOI 10.1164/rccm.200309-1325PP; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rojas-Martinez R, 2007, AM J RESP CRIT CARE, V176, P377, DOI 10.1164/rccm.200510-1678OC; Schachter J., 2001, GEOGRAPHICAL MOBILIT; Siemiatycki J, 2003, J TOXICOL ENV HEAL A, V66, P1591, DOI 10.1080/15287390306428; SPEKTOR DM, 1988, AM REV RESPIR DIS, V137, P313, DOI 10.1164/ajrccm/137.2.313; Tager IB, 2005, EPIDEMIOLOGY, V16, P751, DOI 10.1097/01.ede.0000183166.68809.b0; THUN MJ, 1992, JNCI-J NATL CANCER I, V84, P1491, DOI 10.1093/jnci/84.19.1491; Thurston GD, 1997, AM J RESP CRIT CARE, V155, P654, DOI 10.1164/ajrccm.155.2.9032209; Willis A, 2003, J TOXICOL ENV HEAL A, V66, P1563, DOI 10.1080/15287390306425; Yang QY, 2003, INHAL TOXICOL, V15, P1297, DOI 10.1080/08958370390241768; Zidek JV, 1996, ENVIRONMETRICS, V7, P441, DOI 10.1002/(SICI)1099-095X(199607)7:4<441::AID-ENV226>3.0.CO;2-V	39	928	959	19	409	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1085	1095		10.1056/NEJMoa0803894	http://dx.doi.org/10.1056/NEJMoa0803894			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279340	Bronze, Green Accepted			2022-12-24	WOS:000264051000006
J	Buller, HR; ten Cate-Hoek, AJ; Hoes, AW; Joore, MA; Moons, KGM; Oudega, R; Prins, MH; Stoffers, HEJH; Toll, DB; van der Velde, EF; van Weert, HCPM				Buller, Harry R.; ten Cate-Hoek, Arina J.; Hoes, Arno W.; Joore, Manuela A.; Moons, Karel G. M.; Oudega, Ruud; Prins, Martin H.; Stoffers, Henri E. J. H.; Toll, Diane B.; van der Velde, Eit F.; van Weert, Henk C. P. M.		AMUSE	Safely Ruling Out Deep Venous Thrombosis in Primary Care	ANNALS OF INTERNAL MEDICINE			English	Article							SUSPECTED PULMONARY-EMBOLISM; DIAGNOSTIC WORK-UP; D-DIMER CONCENTRATION; SIMPLIFY D-DIMER; VEIN THROMBOSIS; CLINICAL PROBABILITY; EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; DECISION RULE; MANAGEMENT	Background: Up to 90% of patients referred for ultrasonography with suspected deep venous thrombosis (DVT) of the leg do not have the disease. Objective: To evaluate the safety and efficiency of using a clinical decision rule that includes a point-of-care D-dimer assay at initial presentation in primary care to exclude DVT. Design: A prospective management study. Setting: Approximately 300 primary care practices in 3 regions of the Netherlands ( Amsterdam, Maastricht, and Utrecht). Patients: 1028 consecutive patients with clinically suspected DVT. Intervention: Patients were managed on the basis of the result of the clinical decision rule, which included a D-dimer result. Patients with a score of 3 or less were not referred for ultrasonography and received no anticoagulant treatment; patients with a score of 4 or more were referred for ultrasonography. Measurements: The primary outcome was symptomatic, objectively confirmed, venous thromboembolism during 3-month follow-up. Results: The mean age of the 1028 study patients was 58 years, and 37% of patients were men. A valid score was obtained in 1002 patients (98%). In 500 patients (49%), with a score of 3 or less, 7 developed venous thromboembolism within 3 months ( incidence, 1.4% [95% CI, 0.6% to 2.9%]). A total of 502 patients ( 49%) had a score of 4 or more; 3 did not have ultrasonography. Ultrasonography showed DVT in 125 patients (25%), for an overall prevalence in evaluable patients of 13% ( 125 of 1002). Of the 374 patients who had normal ultrasonography results, 4 developed venous thromboembolism within 3 months (1.1% [ CI, 0.3% to 2.7%]). Limitation: The study lacked a randomized design and relied on clinical follow-up to detect missed thrombotic disease. Conclusion: A diagnostic management strategy in primary care by using a simple clinical decision rule and a point-of-care D-dimer assay reduces the need for referral to secondary care of patients with clinically suspected DVT by almost 50% and is associated with a low risk for subsequent venous thromboembolic events.	Univ Amsterdam, Amsterdam, Netherlands; Univ Med Ctr Utrecht, Utrecht, Netherlands	University of Amsterdam; Utrecht University; Utrecht University Medical Center	Prins, MH (corresponding author), Univ Limburg, Dept Epidemiol, P Debyepl 1, NL-6200 MD Maastricht, Netherlands.	mh.prins@epid.unimaas.nl	Stoffers, Henri E.J.H./N-3785-2019	Stoffers, Henri E.J.H./0000-0002-7908-5101	Netherlands Organization for Scientific Research.	Netherlands Organization for Scientific Research.(Netherlands Organization for Scientific Research (NWO))	The Netherlands Organization for Scientific Research.	Anderson DR, 2003, J THROMB HAEMOST, V1, P645, DOI 10.1046/j.1538-7836.2003.00131.x; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Cini M, 2003, J THROMB HAEMOST, V1, P2681, DOI 10.1111/j.1538-7836.2003.0543d.x; ELF JL, 2008, THROMB RES; Goekoop RJ, 2007, THROMB HAEMOSTASIS, V97, P146, DOI 10.1160/TH06-09-0529; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; Janes S, 2001, BRIT J HAEMATOL, V112, P1079, DOI 10.1046/j.1365-2141.2001.02607.x; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Kilroy DA, 2003, EMERG MED J, V20, P29, DOI 10.1136/emj.20.1.29; Kraaijenhagen R A, 1997, Curr Opin Pulm Med, V3, P268, DOI 10.1097/00063198-199707000-00006; Kruip MJHA, 2002, ARCH INTERN MED, V162, P1631, DOI 10.1001/archinte.162.14.1631; Leclercq MGL, 2003, THROMB HAEMOSTASIS, V89, P97; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; Ljungqvist M, 2008, EUR J INTERN MED, V19, P285, DOI 10.1016/j.ejim.2007.08.007; Neale D, 2004, EMERG MED J, V21, P663, DOI 10.1136/emj.2003.011049; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Oudega R, 2005, ANN INTERN MED, V143, P100, DOI 10.7326/0003-4819-143-2-200507190-00008; Parent F, 2007, THROMB RES, V120, P195, DOI 10.1016/j.thromres.2006.09.012; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Schutgens REG, 2003, CIRCULATION, V107, P593, DOI 10.1161/01.CIR.0000045670.12988.1E; Subramaniam Rathan M, 2006, Emerg Med Australas, V18, P457, DOI 10.1111/j.1742-6723.2006.00866.x; Ten Cate-Hoek AJ, 2005, J THROMB HAEMOST, V3, P2465, DOI 10.1111/j.1538-7836.2005.01556.x; Ten Wolde M, 2004, J THROMB HAEMOST, V2, P1110, DOI 10.1111/j.1538-7836.2004.00769.x; Toll DB, 2006, J FAM PRACTICE, V55, P613; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Velde EF, 2007, J THROMB HAEMOST, V5, P1327, DOI 10.1111/j.1538-7836.2007.02567.x; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 2006, JAMA-J AM MED ASSOC, V295, P199, DOI 10.1001/jama.295.2.199; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	31	74	79	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4					229	U13		10.7326/0003-4819-150-4-200902170-00003	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19221374				2022-12-24	WOS:000263562500001
J	Ploss, A; Evans, MJ; Gaysinskaya, VA; Panis, M; You, HN; de Jong, YP; Rice, CM				Ploss, Alexander; Evans, Matthew J.; Gaysinskaya, Valeriya A.; Panis, Maryline; You, Hana; de Jong, Ype P.; Rice, Charles M.			Human occludin is a hepatitis C virus entry factor required for infection of mouse cells	NATURE			English	Article							EPITHELIAL TIGHT JUNCTIONS; COXSACKIEVIRUS ENTRY; REPLICATION; CD81; GLYCOPROTEINS; PROTEINS; CULTURE	Hepatitis C virus ( HCV) is a leading cause of liver disease worldwide. The development of much needed specific antiviral therapies and an effective vaccine has been hampered by the lack of a convenient small animal model. The determinants restricting HCV tropism to human and chimpanzee hosts are unknown. Replication of the viral RNA has been demonstrated in mouse cells(1,2), but these cells are not infectable with either lentiviral particles bearing HCV glycoproteins (HCVpp)(3) or HCV produced in cell culture ( HCVcc) ( A. P., M. E. and C. M. R., unpublished observations), suggesting that there is a block at the level of entry. Here we show, using an iterative complementary DNA library screening approach, that human occludin ( OCLN) is an essential HCV cell entry factor that is able to render murine cells infectable with HCVpp. Similarly, OCLN is required for the HCV- susceptibility of human cells, because its overexpression in uninfectable cells specifically enhanced HCVpp uptake, whereas its silencing in permissive cells impaired both HCVpp and HCVcc infection. In addition to OCLN, HCVpp infection of murine cells required expression of the previously identified HCV entry factors CD81 ( ref. 4), scavenger receptor class B type I ( SR- BI, also known as SCARB1) 5 and claudin- 1 (CLDN1)(6). Although the mouse versions of SR- BI and CLDN1 function at least as well as the human proteins in promoting HCV entry, both OCLN and CD81 must be of human origin to allow efficient infection. The species- specific determinants of OCLN were mapped to its second extracellular loop. The identification of OCLN as a new HCV entry factor further highlights the importance of the tight junction complex in the viral entry process, and provides an important advance towards efforts to develop small animal models for HCV.	[Ploss, Alexander; Evans, Matthew J.; Gaysinskaya, Valeriya A.; Panis, Maryline; You, Hana; de Jong, Ype P.; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA; [de Jong, Ype P.] Mt Sinai Sch Med, Div Gastroenterol, New York, NY 10029 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA.	ricec@rockefeller.edu	Ploss, Alexander/ABG-2330-2020	Ploss, Alexander/0000-0001-9322-7252; Evans, Matthew/0000-0002-4991-3877	Greenberg Medical Research Institute; Ellison Medical Foundation; Starr Foundation; Ronald A. Shellow Memorial Fund; Richard Salomon Family Foundation; Foundation for the National Institutes of Health; Grand Challenges in Global Health initiative; National Institutes of Health; Ellison Medical Foundation Senior Scholar in Global Infectious Diseases; Kimberly Lawrence-Netter Cancer Research Discovery Fund Award Postdoctoral Fellowships; Charles H. Revson Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072613] Funding Source: NIH RePORTER	Greenberg Medical Research Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Starr Foundation; Ronald A. Shellow Memorial Fund; Richard Salomon Family Foundation; Foundation for the National Institutes of Health; Grand Challenges in Global Health initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation Senior Scholar in Global Infectious Diseases(Lawrence Ellison Foundation); Kimberly Lawrence-Netter Cancer Research Discovery Fund Award Postdoctoral Fellowships; Charles H. Revson Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Bowman, K. Mu, M. Hunter, J. Tassello and M. Holz for excellent technical assistance, J. L. Law and N. Shohdy for advice on siRNA experiments, T. von Hahn and A. J. Syder for helpful discussions and C. Murray for editing the manuscript. S. Mazel, C. Bare and X. Fan provided outstanding technical support. This work was supported by the Greenberg Medical Research Institute, the Ellison Medical Foundation, the Starr Foundation, the Ronald A. Shellow Memorial Fund, the Richard Salomon Family Foundation and funded in part by a Grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative (to C.M.R.), and the National Institutes of Health (to M.J.E. and C.M.R.). C.M.R. is an Ellison Medical Foundation Senior Scholar in Global Infectious Diseases. A.P. and M.J.E. were supported by Kimberly Lawrence-Netter Cancer Research Discovery Fund Award Postdoctoral Fellowships. M.J.E. was also supported by the Charles H. Revson Postdoctoral Fellowship. We would like to thank P.D. Bieniasz and T. Hatziioannou for providing reagents, including the LMN8 retroviral plasmid, and expertise necessary for the cDNA library construction and screening. R. Tsien provided the mCherry fluorescent protein encoding plasmid, A. Miyawaki the Venus/YFP plasmid and D. W. Piston the Cerulean/CFP plasmid. Constructs expressing HCV glycoproteins of diverse genotypes and the JFH-1 subgenomic replicon cDNA were provided by J. Bukh and T. Wakita, respectively.	Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	19	693	739	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					882	886		10.1038/nature07684	http://dx.doi.org/10.1038/nature07684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19182773	Green Accepted			2022-12-24	WOS:000263266700045
J	Ruiz-Canada, C; Kelleher, DJ; Gilmore, R				Ruiz-Canada, Catalina; Kelleher, Daniel J.; Gilmore, Reid			Cotranslational and Posttranslational N-Glycosylation of Polypeptides by Distinct Mammalian OST Isoforms	CELL			English	Article							DIPEPTIDYL PEPTIDASE-I; ENDOPLASMIC-RETICULUM; RIBOPHORIN-I; LINKED GLYCOSYLATION; OLIGOSACCHARYLTRANSFERASE COMPLEX; TRYPANOSOMA-BRUCEI; CATHEPSIN-C; PROTEIN; MEMBRANE; SUBUNIT	Asparagine-linked glycosylation of polypeptides in the lumen of the endoplasmic reticulum is catalyzed by the hetero-oligomeric oligosaccharyltransferase (OST). OST isoforms with different catalytic subunits (STT3A versus STT3B) and distinct enzymatic properties are coexpressed in mammalian cells. Using siRNA to achieve isoform-specific knockdowns, we show that the OST isoforms cooperate and act sequentially to mediate protein N-glycosylation. The STT3A OST isoform is primarily responsible for cotranslational glycosylation of the nascent polypeptide as it enters the lumen of the endoplasmic reticulum. The STT3B isoform is required for efficient cotranslational glycosylation of an acceptor site adjacent to the N-terminal signal sequence of a secreted protein. Unlike STT3A, STT3B efficiently mediates posttranslational glycosylation of a carboxyl-terminal glycosylation site in an unfolded protein. These distinct and complementary roles for the OST isoforms allow sequential scanning of polypeptides for acceptor sites to insure the maximal efficiency of N-glycosylation.	[Ruiz-Canada, Catalina; Kelleher, Daniel J.; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Gilmore, R (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	reid.gilmore@umassmed.edu			Public Health Services [GM 43768]; Ministerio de Educacion y Ciencia, Spain; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043768] Funding Source: NIH RePORTER	Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); Ministerio de Educacion y Ciencia, Spain(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Katherine High for providing the plasmid for FVII and Professor Konrad Sandhoff for the SAP D antisera. We also thank members of the Gilmore laboratory for helpful discussions. This work was supported by Public Health Services grant GM 43768 (R. G.) and a fellowship from the Ministerio de Educacion y Ciencia, Spain (C. R.-C.).	Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; ALLEN S, 1995, J BIOL CHEM, V270, P4797, DOI 10.1074/jbc.270.9.4797; Ben-Dor S, 2004, GLYCOBIOLOGY, V14, P95, DOI 10.1093/glycob/cwh004; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Chen XM, 2001, J BIOL CHEM, V276, P2411, DOI 10.1074/jbc.M007723200; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; Duvet S, 2002, GLYCOBIOLOGY, V12, P95, DOI 10.1093/glycob/12.2.95; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Guth S, 2004, EUR J BIOCHEM, V271, P3200, DOI 10.1111/j.1432-1033.2004.04252.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Horn M, 2002, PROTEIN SCI, V11, P933, DOI 10.1110/ps.2910102; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Kolhekar AS, 1998, J BIOL CHEM, V273, P23012, DOI 10.1074/jbc.273.36.23012; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; KRETZ KA, 1990, P NATL ACAD SCI USA, V87, P2541, DOI 10.1073/pnas.87.7.2541; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; NILSSON I, 1993, J BIOL CHEM, V268, P5798; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P4862; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; Sanjay A, 1998, J BIOL CHEM, V273, P26094, DOI 10.1074/jbc.273.40.26094; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Wrobe D, 2000, J INHERIT METAB DIS, V23, P63, DOI 10.1023/A:1005603014401; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; YU Y, 1990, J CELL BIOL, V111, P1335, DOI 10.1083/jcb.111.4.1335; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	45	250	260	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					272	283		10.1016/j.cell.2008.11.047	http://dx.doi.org/10.1016/j.cell.2008.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167329	Green Accepted, Bronze			2022-12-24	WOS:000262648800016
J	Kawashima, Y; Pfafferott, K; Frater, J; Matthews, P; Payne, R; Addo, M; Gatanaga, H; Fujiwara, M; Hachiya, A; Koizumi, H; Kuse, N; Oka, S; Duda, A; Prendergast, A; Crawford, H; Leslie, A; Brumme, Z; Brumme, C; Allen, T; Brander, C; Kaslow, R; Tang, J; Hunter, E; Allen, S; Mulenga, J; Branch, S; Roach, T; John, M; Mallal, S; Ogwu, A; Shapiro, R; Prado, JG; Fidler, S; Weber, J; Pybus, OG; Klenerman, P; Ndung'u, T; Phillips, R; Heckerman, D; Harrigan, PR; Walker, BD; Takiguchi, M; Goulder, P				Kawashima, Yuka; Pfafferott, Katja; Frater, John; Matthews, Philippa; Payne, Rebecca; Addo, Marylyn; Gatanaga, Hiroyuki; Fujiwara, Mamoru; Hachiya, Atsuko; Koizumi, Hirokazu; Kuse, Nozomi; Oka, Shinichi; Duda, Anna; Prendergast, Andrew; Crawford, Hayley; Leslie, Alasdair; Brumme, Zabrina; Brumme, Chanson; Allen, Todd; Brander, Christian; Kaslow, Richard; Tang, James; Hunter, Eric; Allen, Susan; Mulenga, Joseph; Branch, Songee; Roach, Tim; John, Mina; Mallal, Simon; Ogwu, Anthony; Shapiro, Roger; Prado, Julia G.; Fidler, Sarah; Weber, Jonathan; Pybus, Oliver G.; Klenerman, Paul; Ndung'u, Thumbi; Phillips, Rodney; Heckerman, David; Harrigan, P. Richard; Walker, Bruce D.; Takiguchi, Masafumi; Goulder, Philip			Adaptation of HIV-1 to human leukocyte antigen class I	NATURE			English	Article							T-LYMPHOCYTE RESPONSE; MHC-CLASS-I; ESCAPE MUTATIONS; CELL RESPONSES; VIRAL LOAD; HLA-B; GAG; TRANSMISSION; POLYMORPHISMS; ASSOCIATIONS	The rapid and extensive spread of the human immunodeficiency virus (HIV) epidemic provides a rare opportunity to witness host-pathogen co-evolution involving humans. A focal point is the interaction between genes encoding human leukocyte antigen (HLA) and those encoding HIV proteins. HLA molecules present fragments (epitopes) of HIV proteins on the surface of infected cells to enable immune recognition and killing by CD8(+) T cells; particular HLA molecules, such as HLA-B*57, HLA-B*27 and HLA-B*51, are more likely to mediate successful control of HIV infection(1). Mutation within these epitopes can allow viral escape from CD8(+) T-cell recognition. Here we analysed viral sequences and HLA alleles from. 2,800 subjects, drawn from 9 distinct study cohorts spanning 5 continents. Initial analysis of the HLA-B*51-restricted epitope, TAFTIPSI (reverse transcriptase residues 128135), showed a strong correlation between the frequency of the escape mutation I135X and HLA-B*51 prevalence in the 9 study cohorts (P=0.0001). Extending these analyses to incorporate other well-defined CD8(+) T-cell epitopes, including those restricted by HLA-B*57 and HLA-B*27, showed that the frequency of these epitope variants (n=14) was consistently correlated with the prevalence of the restricting HLA allele in the different cohorts (together, P < 0.0001), demonstrating strong evidence of HIV adaptation to HLA at a population level. This process of viral adaptation may dismantle the well-established HLA associations with control of HIV infection that are linked to the availability of key epitopes, and highlights the challenge for a vaccine to keep pace with the changing immunological landscape presented by HIV.	[Pfafferott, Katja; Matthews, Philippa; Payne, Rebecca; Prendergast, Andrew; Crawford, Hayley; Leslie, Alasdair; Prado, Julia G.; Goulder, Philip] Dept Paediat, Oxford OX1 3SY, England; [Frater, John; Duda, Anna; Klenerman, Paul; Phillips, Rodney] Nuffield Dept Clin Med, Oxford OX1 3SY, England; [Frater, John; Duda, Anna; Klenerman, Paul; Phillips, Rodney] James Martin 21st Century Sch, Oxford OX1 3SY, England; [Kawashima, Yuka; Fujiwara, Mamoru; Hachiya, Atsuko; Koizumi, Hirokazu; Kuse, Nozomi; Takiguchi, Masafumi] Kumamoto Univ, Div Viral Immunol, Kumamoto 8600811, Japan; [Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Div Infect Dis, Ctr AIDS Res, Kumamoto 8600811, Japan; [Pfafferott, Katja; John, Mina; Mallal, Simon; Goulder, Philip] Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; [Pfafferott, Katja; John, Mina; Mallal, Simon; Goulder, Philip] Murdoch Univ, Murdoch, WA 6000, Australia; [Addo, Marylyn; Brumme, Zabrina; Brumme, Chanson; Allen, Todd; Brander, Christian; Walker, Bruce D.] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02129 USA; [Gatanaga, Hiroyuki; Hachiya, Atsuko; Oka, Shinichi] Int Med Ctr Japan, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Brander, Christian] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa HIVACAT, Badalona, Spain; [Brander, Christian] ICREA, Barcelona 08916, Spain; [Kaslow, Richard; Tang, James] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Hunter, Eric] Emory Univ, Vaccine Ctr, Atlanta, GA 30329 USA; [Hunter, Eric] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Allen, Susan; Mulenga, Joseph] Zambia Emory HIV Res Project, Lusaka, Zambia; [Allen, Susan; Mulenga, Joseph] Zambia Blood Transfus Serv, Lusaka, Zambia; [Branch, Songee; Roach, Tim] Univ W Indies, Ladymeade Reference Unit, BB-11156 Bridgetown, Barbados; [Ogwu, Anthony; Shapiro, Roger] Botswana Harvard Sch Publ Hlth, AIDS Initiat Partnership, Gaborone, Botswana; [Fidler, Sarah; Weber, Jonathan] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Wright Fleming Inst, Div Med, London W2 1PG, England; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3SY, England; [Ndung'u, Thumbi; Walker, Bruce D.; Goulder, Philip] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4013 Durban, South Africa; [Harrigan, P. Richard] Miscrosoft Res, Redmond, WA USA; [Heckerman, David] BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20185 USA	University of Oxford; University of Oxford; Kumamoto University; Kumamoto University; Royal Perth Hospital; University of Western Australia; Murdoch University; Harvard University; Massachusetts General Hospital; National Center for Global Health & Medicine - Japan; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA; University of Alabama System; University of Alabama Birmingham; Emory University; University West Indies Mona Jamaica; University of the West Indies Open Campus; Imperial College London; University of Oxford; University of Kwazulu Natal; B.C. Centre for Excellence in HIV/AIDS; Howard Hughes Medical Institute	Goulder, P (corresponding author), Dept Paediat, Peter Medawar Bldg Pathogen Res,S Parks Rd, Oxford OX1 3SY, England.	philip.goulder@paediatrics.ox.ac.uk	Pybus, Oliver G/B-2640-2012; Matthews, Philippa/P-7810-2019; Prado, Julia Garcia/R-7177-2019; Addo, Marylyn M./GNP-2548-2022; Takiguchi, Masafumi/E-7468-2013; Payne, Rebecca/AAC-4783-2022; Tang, Jianming "James"/O-4980-2019; Mallal, Simon Alexander/HDM-9561-2022; Allen, Todd/F-5473-2011	Pybus, Oliver G/0000-0002-8797-2667; Matthews, Philippa/0000-0002-4036-4269; Prado, Julia Garcia/0000-0002-5439-4645; Payne, Rebecca/0000-0002-9037-7367; Tang, Jianming "James"/0000-0003-0137-7486; Mallal, Simon Alexander/0000-0002-7036-1309; Allen, Todd/0000-0002-6609-1318; Brumme, Chanson/0000-0003-2722-5288; Fidler, Sarah/0000-0003-1676-7583; klenerman, paul/0000-0003-4307-9161; Oka, Shinichi/0000-0002-9283-2167; Brander, Christian/0000-0002-0548-5778; Brumme, Zabrina/0000-0002-8157-1037; Frater, John/0000-0001-7163-7277; Addo, Marylyn/0000-0003-2836-9224; Prendergast, Andrew/0000-0001-7904-7992; Ndung'u, Thumbi/0000-0003-2962-3992	National Institutes of Health [RO1AI46995, 1 R01 AI067073, R01AI64060]; Wellcome Trust; UK Medical Research Council; Mark and Lisa Schwartz Foundation; Ministry of Health, Labour and Welfare [012]; Ministry of Education, Science, Sports and Culture [18390141]; NIHR Biomedical Research Centre Programme; Elizabeth Glaser Pediatric AIDS Foundation Scientist; Marie Curie Fellow [IEF-041811]; MRC [G0501777, G0500384, G108/626] Funding Source: UKRI; Medical Research Council [G0501777, G0500384, G108/626] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067073, R01AI064060, R01AI046995, R01AI060460] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mark and Lisa Schwartz Foundation; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIHR Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); Elizabeth Glaser Pediatric AIDS Foundation Scientist; Marie Curie Fellow(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	This work is funded by grants from the National Institutes of Health (RO1AI46995 ( P. G.), 1 R01 AI067073 ( B. D. W.), R01AI64060 ( E. H.)), the Wellcome Trust ( P. G., P. K.), the UK Medical Research Council (J.F., A. P. and P. M.), and the Mark and Lisa Schwartz Foundation, the Ministry of Health, Labour and Welfare (Health and Labour HIV/AIDS Research Grants 012), the NIHR Biomedical Research Centre Programme and the Ministry of Education, Science, Sports and Culture ( number 18390141), Japan ( M. T.). P. G. is an Elizabeth Glaser Pediatric AIDS Foundation Scientist; J.G.P. is a Marie Curie Fellow (contract number IEF-041811). The authors are also grateful to A. McLean and H. Fryer for discussions of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2008, AIDS, V22, P1277, DOI 10.1097/QAD.0b013e3283021a8c; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Gallimore A, 1998, J EXP MED, V187, P1647; Gatanaga H, 2006, VIROLOGY, V344, P354, DOI 10.1016/j.virol.2005.09.005; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Holtappels R, 2008, J VIROL, V82, P5781, DOI 10.1128/JVI.00155-08; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Seki S, 2008, J VIROL, V82, P5093, DOI 10.1128/JVI.02607-07; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Tomiyama H, 2002, J VIROL, V76, P7535, DOI 10.1128/JVI.76.15.7535-7543.2002; Tomiyama H, 1999, HUM IMMUNOL, V60, P177, DOI 10.1016/S0198-8859(98)00113-X	30	344	360	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					641	U108		10.1038/nature07746	http://dx.doi.org/10.1038/nature07746			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19242411	Green Accepted			2022-12-24	WOS:000264796200043
J	Inomata, K; Ohno, A; Tochio, H; Isogai, S; Tenno, T; Nakase, I; Takeuchi, T; Futaki, S; Ito, Y; Hiroaki, H; Shirakawa, M				Inomata, Kohsuke; Ohno, Ayako; Tochio, Hidehito; Isogai, Shin; Tenno, Takeshi; Nakase, Ikuhiko; Takeuchi, Toshihide; Futaki, Shiroh; Ito, Yutaka; Hiroaki, Hidekazu; Shirakawa, Masahiro			High-resolution multi-dimensional NMR spectroscopy of proteins in human cells	NATURE			English	Article							INTERNALIZATION MECHANISMS; PENETRATING PEPTIDES; LIVING CELLS; UBIQUITIN; DELIVERY; TRANSDUCTION; DOMAINS; OOCYTES; DESIGN; FK506	In-cell NMR is an isotope-aided multi-dimensional NMR technique that enables observations of conformations and functions of proteins in living cells at the atomic level(1). This method has been successfully applied to proteins overexpressed in bacteria, providing information on protein-ligand interactions(2) and conformations(3,4). However, the application of in-cell NMR to eukaryotic cells has been limited to Xenopus laevis oocytes(5-7). Wider application of the technique is hampered by inefficient delivery of isotope-labelled proteins into eukaryote somatic cells. Here we describe a method to obtain high-resolution two-dimensional (2D) heteronuclear NMR spectra of proteins inside living human cells. Proteins were delivered to the cytosol by the pyrenebutyrate-mediated action of cell-penetrating peptides(8) linked covalently to the proteins. The proteins were subsequently released from cell-penetrating peptides by endogenous enzymatic activity or by autonomous reductive cleavage. The heteronuclear 2D spectra of three different proteins inside human cells demonstrate the broad application of this technique to studying interactions and protein processing. The in-cell NMR spectra of FKBP12 (also known as FKBP1A) show the formation of specific complexes between the protein and extracellularly administered immunosuppressants, demonstrating the utility of this technique in drug screening programs. Moreover, in-cell NMRspectroscopy demonstrates that ubiquitin has much higher hydrogen exchange rates in the intracellular environment, possibly due to multiple interactions with endogenous proteins.	[Inomata, Kohsuke; Ohno, Ayako; Tochio, Hidehito; Isogai, Shin; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Inomata, Kohsuke; Tochio, Hidehito; Tenno, Takeshi; Ito, Yutaka; Hiroaki, Hidekazu; Shirakawa, Masahiro] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Futaki, Shiroh] JST, SORST, Kawaguchi, Saitama 3320012, Japan; [Tenno, Takeshi; Hiroaki, Hidekazu] Kobe Univ, Grad Sch Med, Div Struct Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nakase, Ikuhiko; Takeuchi, Toshihide; Futaki, Shiroh] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Ito, Yutaka] Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; [Shirakawa, Masahiro] RIKEN, Yokohama Inst, Yokohama, Kanagawa 2300045, Japan	Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kobe University; Kyoto University; Tokyo Metropolitan University; RIKEN	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan.	tochio@moleng.kyoto-u.ac.jp; shirakawa@moleng.kyoto-u.ac.jp	Tochio, Hidehito/GWV-0429-2022; HIROAKI, HIDEKAZU/N-1658-2019; Hiroaki, Hidekazu/G-9564-2012; Tochio, Hidehito/F-6109-2011; Inomata, Kohsuke/H-9189-2017; Ito, Yutaka/P-2604-2015	Tochio, Hidehito/0000-0003-3843-3330; HIROAKI, HIDEKAZU/0000-0003-1621-5893; Inomata, Kohsuke/0000-0002-6816-7961; Ito, Yutaka/0000-0002-1030-4660; Isogai, Shin/0000-0002-3768-6427; Futaki, Shiroh/0000-0002-0124-4002	Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT); Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' [B-09]; Japan Society for the Promotion of Science; Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology, from MEXT; MEXT;  [FKBP12]	Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science'(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology, from MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	We thank M. Waelchli, A. Kidera and H. Akutsu for discussion, T. Kokubo for monkey COS-7 cells, H. Ohnishi for the plasmid for production of FKBP12 and M. Imanishi for taking gel fluorimaging. This work was supported by grants to M. S. from Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT), and also in part by the Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' ( No. B-09) of MEXT, administered by the Japan Society for the Promotion of Science. This work was partly supported by the Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology, from MEXT to A. O. and M. S., and by grants from MEXT to S. F. and H. T.	Bai YW, 1995, METHOD ENZYMOL, V259, P344; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; CARLSON N, 1987, J CELL BIOL, V104, P537, DOI 10.1083/jcb.104.3.537; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delom F, 2007, BIOCHEM BIOPH RES CO, V352, P587, DOI 10.1016/j.bbrc.2006.11.046; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Futaki S, 2006, BIOPOLYMERS, V84, P241, DOI 10.1002/bip.20421; Giriat I, 2003, J AM CHEM SOC, V125, P7180, DOI 10.1021/ja034736i; Goddard T. D., 1999, SPARKY 3; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; ITOH S, 1995, PROTEIN SCI, V4, P2261, DOI 10.1002/pro.5560041103; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; LAUE ED, 1986, J MAGN RESON, V68, P14, DOI 10.1016/0022-2364(86)90312-4; Loison F, 2005, MOL THER, V11, P205, DOI 10.1016/j.ymthe.2004.10.010; Mezo G, 2000, BIOCONJUGATE CHEM, V11, P484, DOI 10.1021/bc990116o; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; OBRIEN R, 1970, J HISTOCHEM CYTOCHEM, V18, P581, DOI 10.1177/18.8.581; ROSEN MK, 1991, BIOCHEMISTRY-US, V30, P4774, DOI 10.1021/bi00233a020; Sakai T, 2006, J BIOMOL NMR, V36, P179, DOI 10.1007/s10858-006-9079-9; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Serber Z, 2001, BIOCHEMISTRY-US, V40, P14317, DOI 10.1021/bi011751w; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Wender PA, 2008, ADV DRUG DELIVER REV, V60, P452, DOI 10.1016/j.addr.2007.10.016	28	331	336	2	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					106	U11		10.1038/nature07839	http://dx.doi.org/10.1038/nature07839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262675				2022-12-24	WOS:000263836000042
J	Eisenberg, MS; Psaty, BM				Eisenberg, Mickey S.; Psaty, Bruce M.			Defining and Improving Survival Rates From Cardiac Arrest in US Communities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMERICAN-HEART-ASSOCIATION; HEALTH-PROFESSIONALS; CARE COMMITTEE; RESUSCITATION; STATEMENT; CARDIOPULMONARY; OUTCOMES; COUNCIL		[Eisenberg, Mickey S.] Seattle King Cty Dept Publ Hlth, King Cty Emergency Med Serv Div, Seattle, WA USA; [Eisenberg, Mickey S.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Psaty, BM (corresponding author), Cardiovasc Hlth Res Unit, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NHLBI NIH HHS [HL085251, HL087652, HL74745, HL080295] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, R01HL087652, U01HL080295, R01HL074745, R01HL085251] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; Holzer M, 2002, NEW ENGL J MED, V346, P549; Institute of Medicine, EM MED SERV CROSSR; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Lombardi Gary, 1994, JAMA (Journal of the American Medical Association), V271, P678, DOI 10.1001/jama.271.9.678; National Cancer Institute, 1975, SEER CANC STAT REV; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nichol G, 2008, CIRCULATION, V117, P2299, DOI 10.1161/CIRCULATIONAHA.107.189472; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; White RD, 2005, RESUSCITATION, V65, P279, DOI 10.1016/j.resuscitation.2004.10.018	15	12	12	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					860	862		10.1001/jama.2009.193	http://dx.doi.org/10.1001/jama.2009.193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244194				2022-12-24	WOS:000263609900028
J	Salomon, R; Webster, RG				Salomon, Rachelle; Webster, Robert G.			The Influenza Virus Enigma	CELL			English	Review							A H5N1 VIRUSES; PANDEMIC INFLUENZA; INTERSPECIES TRANSMISSION; CYTOKINE RESPONSES; HIGH VIRULENCE; PROTECTS MICE; HEMAGGLUTININ; RESISTANT; INFECTION; COMPLEX	Both seasonal and pandemic influenza continue to challenge both scientists and clinicians. Drug-resistant H1N1 influenza viruses have dominated the 2009 flu season, and the H5N1 avian influenza virus continues to kill both people and poultry in Eurasia. Here, we discuss the pathogenesis and transmissibility of influenza viruses and we emphasize the need to find better predictors of both seasonal and potentially pandemic influenza.	[Salomon, Rachelle; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Webster, RG (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA.	robert.webster@stjude.org			NIAID NIH HHS [HHSN266200700005C] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belser JA, 2007, J INFECT DIS, V196, P1493, DOI 10.1086/522609; Budd A, 2007, ANTIMICROB AGENTS CH, V51, P2965, DOI 10.1128/AAC.00219-07; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Fedson DS, 2006, CLIN INFECT DIS, V43, P199, DOI 10.1086/505116; Fouchier RAM, 2003, VACCINE, V21, P1754, DOI 10.1016/S0264-410X(03)00067-7; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Ito T, 2000, MICROBIOL IMMUNOL, V44, P423, DOI 10.1111/j.1348-0421.2000.tb02516.x; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; LACKENBY A, 2008, EUROSURVEILLANCE, V13; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; LUDWIG S, 1995, VIROLOGY, V212, P555, DOI 10.1006/viro.1995.1513; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wang J, 2008, J VIROL, V82, P3405, DOI 10.1128/JVI.02468-07; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Watanabe T, 2008, J VIROL, V82, P2486, DOI 10.1128/JVI.01899-07; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	70	168	183	3	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					402	410		10.1016/j.cell.2009.01.029	http://dx.doi.org/10.1016/j.cell.2009.01.029			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203576	Green Accepted, Bronze			2022-12-24	WOS:000263120600011
J	Alio, AP; Nana, PN; Salihu, HM				Alio, Amina P.; Nana, Philip N.; Salihu, Hamisu M.			Spousal violence and potentially preventable single and recurrent spontaneous fetal loss in an African setting: cross-sectional study	LANCET			English	Article							INTIMATE PARTNER VIOLENCE; DOMESTIC VIOLENCE; WOMEN; OUTCOMES; MISCARRIAGE; PREVALENCE; STILLBIRTH; PREGNANCY; HEALTH; ABUSE	Background Spousal violence is a global issue, with ramifications for the reproductive health of women. We aimed to investigate the effect of physical, sexual, and emotional violence on potentially preventable single and recurrent spontaneous fetal loss. Methods We analysed data from the Cameroon Demographic Health Survey. In the violence module of this survey, women were questioned about their experience of physical, emotional, and sexual violence inflicted by their spouses. Respondents were also asked about any stillbirths and spontaneous abortions. We measured risk for single and recurrent fetal loss with odds ratios, with adjustment for intracluster correlations as appropriate. We also estimated the proportion of preventable excess fetal loss at various levels of violence reduction. Findings 2562 women responded to the violence module. Those exposed to spousal violence (n=1307) were 50% more likely to experience at least one episode of fetal loss compared with women not exposed to abuse (odds ratio 1.5; 95% CI 1. 3-1 . 8). Recurrent fetal mortality was associated with all forms of spousal violence, but emotional violence had the strongest association (1 . 7; 1 . 2-2.3). If the prevalence of spousal abuse could be reduced to 50%, 25%, or entirely eliminated, preventable excess recurrent fetal demise would be 17%, 25%, and 33%, respectively. Interpretation Spousal violence increases the likelihood of single and repeated fetal loss. A large proportion of risk for recurrent fetal mortality is attributable to spousal violence and, therefore, is potentially preventable. Our findings support the idea of routine prenatal screening for spousal violence in the African setting, a region with the highest rate of fetal death in the world. Funding None.	[Alio, Amina P.] Univ S Florida, Dept Community & Family Hlth, Tampa, FL 33612 USA; [Salihu, Hamisu M.] Univ S Florida, Dept Epidemiol & Biostat, Tampa, FL 33612 USA; [Salihu, Hamisu M.] Univ S Florida, Dept Obstet & Gynecol, Tampa, FL 33612 USA; [Nana, Philip N.] Univ Yaounde, Dept Obstet & Gynecol, Yaounde, Cameroon	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Yaounde I	Alio, AP (corresponding author), Univ S Florida, Dept Community & Family Hlth, 13201 Bruce B Downs Blvd,MDC 56, Tampa, FL 33612 USA.	aalio@health.usf.edu						ADJETEY FNA, 1995, RIGHTS WOM NAT INT L, P26; Bowman CG, 2003, INT J LAW PSYCHIAT, V26, P473, DOI 10.1016/S0160-2527(03)00082-7; Boy A, 2004, INT J FERTIL WOMEN M, V49, P159; Curry MA, 1998, OBSTET GYNECOL, V92, P530, DOI 10.1016/S0029-7844(98)00258-0; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Hadi A, 2000, J INTERPERS VIOLENCE, V15, P787, DOI 10.1177/088626000015008001; Hills, 1993, STAT MODELS EPIDEMIO; *INS ORC MACR, 2004, ENQ DEM SANT CAM 200; Janssen PA, 2003, AM J OBSTET GYNECOL, V188, P1341, DOI 10.1067/mob.2003.274; JOHNSON MP, 1995, J MARRIAGE FAM, V57, P283, DOI 10.2307/353683; Jones RF, 1997, INT J GYNECOL OBSTET, V58, P43, DOI 10.1016/S0020-7292(97)02863-4; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Morland LA, 2008, J INTERPERS VIOLENCE, V23, P652, DOI 10.1177/0886260507313533; PEARCE TO, 1995, CONCEIVING NEW WORLD, P195; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Rothman K., 1998, MODERN EPIDEMIOLOGY; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; RUBIN DB, 1996, J AM STAT ASSOC, V91, P473, DOI DOI 10.2307/2291635; Salihu HM, 2003, OBSTET GYNECOL, V102, P679, DOI 10.1016/S0029-7844(03)00768-3; Schroth HA, 2005, INT J CONFL MANAGE, V16, P102, DOI 10.1108/eb022925; Silverman JG, 2007, BJOG-INT J OBSTET GY, V114, P1246, DOI 10.1111/j.1471-0528.2007.01481.x; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Szklo M., 2007, EPIDEMIOLOGY BASICS; WALKER A, 2002, PSYCHOL SEXUAL HLTH; Watts C, 2004, INT FAM PLAN PERSPEC, V30, P207, DOI 10.1363/3020704; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; *WHO DEP RHR, 2000, MON EV REPR HLTH IND; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; [No title captured]	30	52	52	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2009	373	9660					318	324		10.1016/S0140-6736(09)60096-9	http://dx.doi.org/10.1016/S0140-6736(09)60096-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19167571				2022-12-24	WOS:000262728100027
J	Lee, SSJ; Mudaliar, A				Lee, Sandra Soo-Jin; Mudaliar, Ashwin			MEDICINE Racing Forward: The Genomics and Personalized Medicine Act	SCIENCE			English	Editorial Material							RACE; GENETICS		[Lee, Sandra Soo-Jin; Mudaliar, Ashwin] Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA	Stanford University	Lee, SSJ (corresponding author), Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA.	sandra.lee@stanford.edu		Lee, Sandra Soo-Jin/0000-0002-2312-9814	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389, K01HG002883] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003389, K01 HG002883, K01 HG002883-05] Funding Source: Medline; NHLBI NIH HHS [K01 HL72465] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; *KAIS FAM FDN, 2008, TOD TOP HLTH DISP RA; Lee SSJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-404; Lee SSJ, 2005, AM J PUBLIC HEALTH, V95, P2133, DOI 10.2105/AJPH.2005.068676; *PHARM RES MAN ASS, 2007, MED DEV MAJ DIS AFF; Rotimi CN, 2004, NAT GENET, V36, pS43, DOI 10.1038/ng1439; Royal CDM, 2004, NAT GENET, V36, pS5, DOI 10.1038/ng1454; Yancy CW, 2008, CURR HYPERTENS REP, V10, P276, DOI 10.1007/s11906-008-0052-8	8	23	25	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2009	323	5912					342	342		10.1126/science.1165768	http://dx.doi.org/10.1126/science.1165768			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150830	Green Accepted			2022-12-24	WOS:000262481400022
J	Ainsworth, S; Jones, W				Ainsworth, Sean; Jones, Wendy			It sticks in our throats too	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ainsworth, Sean] Forth Pk Hosp, Kirkcaldy, Fife, Scotland; [Jones, Wendy] Breastfeeding Network, Paisley, Renfrew, Scotland		Ainsworth, S (corresponding author), Forth Pk Hosp, Kirkcaldy, Fife, Scotland.	sean.ainsworth@nhs.net						*DEP HLTH, NURS PRESCR FAQ; DEVRIES TW, 2006, NED TIDSCHR GENEESKD, V148, P1598; HEY E, 2007, NEONATAL FORMULARY, P158; Hoppe JE, 1997, PEDIATR INFECT DIS J, V16, P288, DOI 10.1097/00006454-199703000-00007; *JANSS CIL, DAKT OR GEL; *MED HEALTHC PROD, OUR MISS VAL	6	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 5	2009	338								a3178	10.1136/bmj.a3178	http://dx.doi.org/10.1136/bmj.a3178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PM	19124549				2022-12-24	WOS:000263165500004
J	Sheather, J				Sheather, Julian			Landscape and health	LANCET			English	Editorial Material									[Sheather, Julian] British Med Assoc, London WC1H 9JP, England		Sheather, J (corresponding author), British Med Assoc, London WC1H 9JP, England.	JSheather@bma.org.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 3	2009	373	9657					22	23		10.1016/S0140-6736(08)61943-1	http://dx.doi.org/10.1016/S0140-6736(08)61943-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SK	19125445				2022-12-24	WOS:000262183800014
J	Clare, DK; Bakkes, PJ; van Heerikhuizen, H; van der Vies, SM; Saibil, HR				Clare, D. K.; Bakkes, P. J.; van Heerikhuizen, H.; van der Vies, S. M.; Saibil, H. R.			Chaperonin complex with a newly folded protein encapsulated in the folding chamber	NATURE			English	Article							GROEL-GROES; ELECTRON-MICROSCOPY; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CENTRAL CAVITY; HEAD PROTEIN; BINDING; CAGE; ATP	A subset of essential cellular proteins requires the assistance of chaperonins (in Escherichia coli, GroEL and GroES), double-ring complexes in which the two rings act alternately to bind, encapsulate and fold a wide range of nascent or stress- denatured proteins(1-5). This process starts by the trapping of a substrate protein on hydrophobic surfaces in the central cavity of a GroEL ring(6-10). Then, binding of ATP and co- chaperonin GroES to that ring ejects the non- native protein from its binding sites, through forced unfolding or other major conformational changes, and encloses it in a hydrophilic chamber for folding(11-15). ATP hydrolysis and subsequent ATP binding to the opposite ring trigger dissociation of the chamber and release of the substrate protein(3). The bacteriophage T4 requires its own version of GroES, gp31, which forms a taller folding chamber, to fold the major viral capsid protein gp23 ( refs 16-20). Polypeptides are known to fold inside the chaperonin complex, but the conformation of an encapsulated protein has not previously been visualized. Here we present structures of gp23-chaperonin complexes, showing both the initial captured state and the final, close-to-native state with gp23 encapsulated in the folding chamber. Although the chamber is expanded, it is still barely large enough to contain the elongated gp23 monomer, explaining why the GroEL-GroES complex is not able to fold gp23 and showing how the chaperonin structure distorts to enclose a large, physiological substrate protein.	[Clare, D. K.; Saibil, H. R.] Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; [Clare, D. K.; Saibil, H. R.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Bakkes, P. J.; van Heerikhuizen, H.; van der Vies, S. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands	University of London; Birkbeck University London; University of London; Birkbeck University London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Saibil, HR (corresponding author), Univ London Birkbeck Coll, Dept Crystallog, Malet St, London WC1E 7HX, England.	vdvies@vumc.nl; h.saibil@mail.cryst.bbk.ac.uk		Bakkes, Patrick/0000-0003-1876-7384; Clare, daniel/0000-0002-3372-8378	Wellcome Trust programme; EU 3D EM Network of Excellence; 3D Repertoire	Wellcome Trust programme(Wellcome Trust); EU 3D EM Network of Excellence(European Commission); 3D Repertoire	We thank R. Westlake, D. Houldershaw and L. Wang for computing and EM support. This work was carried out at the School of Crystallography, Birkbeck College, and was supported by a Wellcome Trust programme grant, EU 3D EM Network of Excellence and 3D Repertoire grants.	Bakkes PJ, 2005, P NATL ACAD SCI USA, V102, P8144, DOI 10.1073/pnas.0500048102; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Clare DK, 2006, J MOL BIOL, V358, P905, DOI 10.1016/j.jmb.2006.02.033; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Elad N, 2008, J STRUCT BIOL, V162, P108, DOI 10.1016/j.jsb.2007.11.007; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Falke S, 2005, J MOL BIOL, V348, P219, DOI 10.1016/j.jmb.2005.02.027; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; LIN ZL, 1995, J BIOL CHEM, V270, P1011, DOI 10.1074/jbc.270.3.1011; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Motojima F, 2004, P NATL ACAD SCI USA, V101, P15005, DOI 10.1073/pnas.0406132101; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Snyder L, 2005, J MOL BIOL, V345, P375, DOI 10.1016/j.jmb.2004.10.052; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; van Duijn E, 2006, J AM CHEM SOC, V128, P4694, DOI 10.1021/ja056756l; van Duijn E, 2005, NAT METHODS, V2, P371, DOI 10.1038/nmeth753; Van Duijn E, 2007, PROTEIN SCI, V16, P956, DOI 10.1110/ps.062713607; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	36	76	77	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					107	U113		10.1038/nature07479	http://dx.doi.org/10.1038/nature07479			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122642	Green Accepted			2022-12-24	WOS:000262104900040
J	Herzog, F; Primorac, I; Dube, P; Lenart, P; Sander, B; Mechtler, K; Stark, H; Peters, JM				Herzog, Franz; Primorac, Ivana; Dube, Prakash; Lenart, Peter; Sander, Bjoern; Mechtler, Karl; Stark, Holger; Peters, Jan-Michael			Structure of the Anaphase-Promoting Complex/Cyclosome Interacting with a Mitotic Checkpoint Complex	SCIENCE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; DESTRUCTION BOX; BUDDING YEAST; PROTEIN MAD2; AURORA-B; APC/C; CDC20; INHIBITION; MITOSIS; BUBR1	Once all chromosomes are connected to the mitotic spindle (bioriented), anaphase is initiated by the protein ubiquitylation activity of the anaphase-promoting complex/cyclosome (APC/C) and its coactivator Cdc20 (APC/C-Cdc20). Before chromosome biorientation, anaphase is delayed by a mitotic checkpoint complex (MCC) that inhibits APC/C-Cdc20. We used single-particle electron microscopy to obtain three-dimensional models of human APC/C in various functional states: bound to MCC, to Cdc20, or to neither (apo-APC/C). These experiments revealed that MCC associates with the Cdc20 binding site on APC/C, locks the otherwise flexible APC/C in a "closed" state, and prevents binding and ubiquitylation of a wide range of different APC/C substrates. These observations clarify the structural basis for the inhibition of APC/C by spindle checkpoint proteins.	[Dube, Prakash; Sander, Bjoern; Stark, Holger] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Herzog, Franz; Primorac, Ivana; Mechtler, Karl; Peters, Jan-Michael] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Lenart, Peter] European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); European Molecular Biology Laboratory (EMBL)	Stark, H (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	hstark1@gwdg.de; peters@imp.univie.ac.at	Sander, Bjoern/AAO-9021-2021; Herzog, Franz/G-4832-2012; Mechtler, Karl/AAF-2717-2019	Sander, Bjoern/0000-0001-8495-2321; Herzog, Franz/0000-0001-8270-1449; Mechtler, Karl/0000-0002-3392-9946; Lenart, Peter/0000-0002-3927-248X; Holger, Stark/0000-0002-6161-1118	Federal Ministry of Education and Research, Germany; Sixth Framework Programme of the European Union; Boehringer Ingelheim; Vienna Spots of Excellence Programme; Austrian Science Fund	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Sixth Framework Programme of the European Union(European Commission); Boehringer Ingelheim(Boehringer Ingelheim); Vienna Spots of Excellence Programme; Austrian Science Fund(Austrian Science Fund (FWF))	We are grateful to M. Madalinski, M. Gmachl, and G. Kohlmaier for reagents; J. Deckert and R. Luhrmann for support; and S. Westermann for comments on the manuscript. Research in the laboratory of H.S. was supported by grants from the Federal Ministry of Education and Research, Germany, and the Sixth Framework Programme of the European Union via the Integrated Project 3DRepertoire. Research in the laboratories of J.-M.P. and K.M. were supported by Boehringer Ingelheim, the Vienna Spots of Excellence Programme, and the Austrian Science Fund. The structural coordinates have been deposited in the Electron Microscopy Data Bank Database at the European Molecular Biology Laboratory European Bioinformatics Institute. The structures of APC/CMCC and apo-APC/C can be accessed under the codes EMD-1591 and EMD-1592, respectively.	Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; DeAntoni A, 2005, PHILOS T R SOC B, V360, P637, DOI 10.1098/rstb.2004.1618; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5	28	170	177	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1477	1481		10.1126/science.1163300	http://dx.doi.org/10.1126/science.1163300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286556	Green Accepted			2022-12-24	WOS:000264101700041
J	Sanchez, PA				Sanchez, Pedro A.			A smarter way to combat hunger	NATURE			English	Editorial Material									Columbia Univ, Earth Inst, Palisades, NY 10964 USA	Columbia University	Sanchez, PA (corresponding author), Columbia Univ, Earth Inst, 61 Route 9W, Palisades, NY 10964 USA.	psanchez@ei.columbia.edu						*CHIC IN GLOB AGR, 2009, REN AM LEAD FIGHT GL; Denning G, 2009, PLOS BIOL, V7, P2, DOI 10.1371/journal.pbio.1000023; DIOUF J, 2009, HIGH LEV M FOOD SEC; Garrett Laurie, 2008, FOOD FAILURES FUTURE; JURY A, 2008, WORLD FOOD PRIZ S 22; Sanchez PA, 2005, SCIENCE, V307, P357, DOI 10.1126/science.1109057; Sanchez PA, 2009, FOOD SECUR, V1, P37, DOI 10.1007/s12571-009-0011-5; von Braun J, 2008, NATURE, V456, P701, DOI 10.1038/456701a	8	11	11	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 12	2009	458	7235					148	148		10.1038/458148a	http://dx.doi.org/10.1038/458148a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417EQ	19279615	Bronze			2022-12-24	WOS:000264059700022
J	Briffa, T; Hickling, S; Knuiman, M; Hobbs, M; Hung, J; Sanfilippo, FM; Jamrozik, K; Thompson, PL				Briffa, Tom; Hickling, S.; Knuiman, M.; Hobbs, M.; Hung, J.; Sanfilippo, F. M.; Jamrozik, K.; Thompson, P. L.			Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; CASE-FATALITY RATES; WESTERN-AUSTRALIA; UNSTABLE ANGINA; MEDICAL-CARE; EVENT RATES; TRENDS; MORTALITY; MORBIDITY; PROGNOSIS	Objective To examine trends in long term survival in patients alive 28 days after myocardial infarction and the impact of evidence based medical treatments and coronary revascularisation during or near the event. Design Population based cohort with 12 year follow- up. Setting Perth, Australia. Participants 4451 consecutive patients with a definite acute myocardial infarction according to the World Health Organization MONICA ( monitoring trends and determinants in cardiovascular disease) criteria admitted to hospital during 1984- 7, 1988- 90, and 1991- 3. Main outcome measures All cause mortality identified from official mortality records and the hospital morbidity data, with death from cardiovascular disease as a secondary end point. Results In the 1991- 3 cohort, 28 day survivors of acute myocardial infarction had a 7.6% absolute event reduction ( 95% confidence interval 4% to 11%) or a 28% lower relative risk reduction ( 16% to 38%), unadjusted for risk of death, over 12 years after the incident admission compared with the 1984- 7 cohort, similar to the survival of the 1988- 90 cohort. The improved survival for the 1991- 3 cohort persisted after adjustment for demographic factors, coronary risk factors, severity of disease, and event complications with an adjusted relative risk reduction of 26%( 14% to 37%), but this was not apparent after further adjustment for medical treatments in hospital and coronary revascularisation procedures within 12 months of the incident myocardial infarction. Conclusion The improving trends in 12 year survival after a definite acute myocardial infarction are associated with progressive use of evidence based treatments during the initial admission to hospital and in the 12 months after the event. These changes in the management of acute myocardial infarction are probably contributing to the continuing decline in mortality from coronary heart disease in Australia.	[Briffa, Tom; Hickling, S.; Knuiman, M.; Hobbs, M.; Sanfilippo, F. M.] Univ Western Australia, Sch Populat Hlth M431, Crawley, WA 6009, Australia; [Hung, J.; Thompson, P. L.] Univ Western Australia, Sch Med & Pharmacol M503, Crawley, WA 6009, Australia; [Jamrozik, K.] Univ Adelaide, Sch Populat Hlth & Clin Sci NG45, Adelaide, SA 5005, Australia	University of Western Australia; University of Western Australia; University of Adelaide	Briffa, T (corresponding author), Univ Western Australia, Sch Populat Hlth M431, Crawley, WA 6009, Australia.	tom.briffa@uwa.edu.au	Knuiman, Matthew W/I-5549-2013; Thompson, Peter L/P-1071-2014; Sanfilippo, Frank M/H-9334-2013	Sanfilippo, Frank M/0000-0003-3639-0787; Hickling, Siobhan/0000-0001-8337-2894; Knuiman, Matthew/0000-0001-8874-2305	University of Western Australia; WHO MONICA	University of Western Australia; WHO MONICA	The study was supported by the University of Western Australia and the WHO MONICA project.	[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1988, BRIT MED J, V296, P320; Beaglehole R, 1997, AM J EPIDEMIOL, V145, P707, DOI 10.1093/aje/145.8.707; Botkin NF, 2006, AM HEART J, V151, P199, DOI 10.1016/j.ahj.2005.03.016; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; CZARN AOS, 1992, MED J AUSTRALIA, V157, P302, DOI 10.5694/j.1326-5377.1992.tb137179.x; Department of Health, 2000, NAT SERV FRAM NSF CO; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Glesby MJ, 1996, ANN INTERN MED, V124, P999, DOI 10.7326/0003-4819-124-11-199606010-00008; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Herlitz J, 1996, CARDIOVASC DRUG THER, V10, P485, DOI 10.1007/BF00051115; Hobbs MS, 2008, EUR J CARDIOV PREV R, V15, P319, DOI 10.1097/HJR.0b013e3282f3c76b; Hobbs MST, 2004, HEART, V90, P1036, DOI 10.1136/hrt.2003.022160; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; JAMROZIK K, 2001, CARDIOVASCULAR DIS S, V17; Kattainen A, 2006, EUR HEART J, V27, P296, DOI 10.1093/eurheartj/ehi630; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; MARTIN CA, 1987, J CHRON DIS, V40, P661, DOI 10.1016/0021-9681(87)90102-0; MARTIN CA, 1989, AM J EPIDEMIOL, V129, P655, DOI 10.1093/oxfordjournals.aje.a115182; MARTIN CA, 1986, J CHRON DIS, V39, P683, DOI 10.1016/0021-9681(86)90151-7; MCELDUFF P, 2000, 11 AIHW; MCGOVERN PG, 1992, CIRCULATION, V85, P172, DOI 10.1161/01.CIR.85.1.172; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; Norman PE, 1998, BMJ-BRIT MED J, V317, P852, DOI 10.1136/bmj.317.7162.852; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; SALA J, 1995, EUR HEART J, V16, P779, DOI 10.1093/oxfordjournals.eurheartj.a060996; Setoguchi S, 2008, J AM COLL CARDIOL, V51, P1247, DOI 10.1016/j.jacc.2007.10.063; Taylor R, 2006, EUR J CARDIOV PREV R, V13, P760, DOI 10.1097/01.hjr.0000220581.42387.d4; THOMPSON PL, 1991, J HYPERTENS, V9, pS35, DOI 10.1097/00004872-199112007-00009; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088	34	62	64	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2009	338								b36	10.1136/bmj.b36	http://dx.doi.org/10.1136/bmj.b36			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EK	19171564	Green Published, hybrid			2022-12-24	WOS:000263205300001
J	Moran, NA; McLaughlin, HJ; Sorek, R				Moran, Nancy A.; McLaughlin, Heather J.; Sorek, Rotem			The Dynamics and Time Scale of Ongoing Genomic Erosion in Symbiotic Bacteria	SCIENCE			English	Article							EVOLUTION; SEQUENCE	Among cellular organisms, symbiotic bacteria provide the extreme examples of genome degradation and reduction. However, only isolated snapshots of eroding symbiont genomes have previously been available. We documented the dynamics of symbiont genome evolution by sequencing seven strains of Buchnera aphidicola from pea aphid hosts. We estimated a spontaneous mutation rate of at least 4 x 10(-9) substitutions per site per replication, which is more than 10 times as high as the rates previously estimated for any bacteria. We observed a high rate of small insertions and deletions associated with abundant DNA homopolymers, and occasional larger deletions. Although purifying selection eliminates many mutations, some persist, resulting in ongoing loss of genes and DNA from this already tiny genome. Our results provide a general model for the stepwise process leading to genome reduction.	[Moran, Nancy A.; McLaughlin, Heather J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	University of Arizona; Weizmann Institute of Science	Moran, NA (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	nmoran@email.arizona.edu	Moran, Nancy A/G-1591-2010		NSF [0723472]; Y. Leon Benoziyo Institute for Molecular Medicine; U. S. Department of Energy	NSF(National Science Foundation (NSF)); Y. Leon Benoziyo Institute for Molecular Medicine; U. S. Department of Energy(United States Department of Energy (DOE))	We thank staff at the Joint Genome Institute for the Solexa sequencing runs, E. Rubin for support and facilities, and H. Ochman for comments on the manuscript. Aphid samples were donated by G. Powell and J. C. Simon. K. Hammond maintained insect cultures, and B. Nankivell prepared figures. Funding was provided by NSF award 0723472 (to N.A.M.), the Y. Leon Benoziyo Institute for Molecular Medicine (to R. S.), and the U. S. Department of Energy (to the Joint Genome Institute supporting the sequencing). GenBank accession numbers are CP00158 and CP00161 for the genomic sequences and FJ357501 to FJ357538 for sequences used for the phylogeny of fig. S2.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Coenye T, 2005, DNA RES, V12, P221, DOI 10.1093/dnares/dsi009; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; HARPER AM, 1978, SPECIAL PUBLICATION, V50, P1; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; PARKER BO, 1992, P NATL ACAD SCI USA, V89, P1730, DOI 10.1073/pnas.89.5.1730; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Tamas I, 2008, P NATL ACAD SCI USA, V105, P14934, DOI 10.1073/pnas.0806554105; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	19	224	724	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					379	382		10.1126/science.1167140	http://dx.doi.org/10.1126/science.1167140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150844				2022-12-24	WOS:000262481400038
J	Maki, DG				Maki, Dennis G.			Coming to Grips with Foodborne Infection - Peanut Butter, Peppers, and Nationwide Salmonella Outbreaks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Maki, Dennis G.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Maki, Dennis G.] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.							Centers for Disease Control and Prevention (CDC), 2008, INV OUTBR INF CAUS S; Centers for Disease Control and Prevention (CDC), 2009, INV UPD OUTBR SALM T; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Maki DG, 2006, NEW ENGL J MED, V355, P1952, DOI 10.1056/NEJMp068225; Osterholm MT, 2004, NEW ENGL J MED, V350, P1898, DOI 10.1056/NEJMsb032657	5	48	48	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					949	953		10.1056/NEJMp0806575	http://dx.doi.org/10.1056/NEJMp0806575			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413WX	19213675	Bronze			2022-12-24	WOS:000263824500001
J	Sakakibara, D; Sasaki, A; Ikeya, T; Hamatsu, J; Hanashima, T; Mishima, M; Yoshimasu, M; Hayashi, N; Mikawa, T; Walchli, M; Smith, BO; Shirakawa, M; Guntert, P; Ito, Y				Sakakibara, Daisuke; Sasaki, Atsuko; Ikeya, Teppei; Hamatsu, Junpei; Hanashima, Tomomi; Mishima, Masaki; Yoshimasu, Masatoshi; Hayashi, Nobuhiro; Mikawa, Tsutomu; Waelchli, Markus; Smith, Brian O.; Shirakawa, Masahiro; Guentert, Peter; Ito, Yutaka			Protein structure determination in living cells by in-cell NMR spectroscopy	NATURE			English	Article							TRIPLE-RESONANCE SPECTRA; TORSION ANGLE DYNAMICS; SUBCELLULAR-LOCALIZATION; ESCHERICHIA-COLI; SIGNAL PEPTIDES; PREDICTION; ASSIGNMENT; RESOLUTION; PROGRAM; DOMAIN	Investigating proteins 'at work' in a living environment at atomic resolution is a major goal of molecular biology, which has not been achieved even though methods for the three-dimensional (3D) structure determination of purified proteins in single crystals or in solution are widely used. Recent developments in NMR hardware and methodology have enabled the measurement of high-resolution heteronuclear multi-dimensional NMR spectra of macromolecules in living cells (in-cell NMR)(1-5). Various intracellular events such as conformational changes, dynamics and binding events have been investigated by this method. However, the low sensitivity and the short lifetime of the samples have so far prevented the acquisition of sufficient structural information to determine protein structures by in-cell NMR. Here we show the first, to our knowledge, 3D protein structure calculated exclusively on the basis of information obtained in living cells. The structure of the putative heavy-metal binding protein TTHA1718 from Thermus thermophilus HB8 overexpressed in Escherichia coli cells was solved by in-cell NMR. Rapid measurement of the 3D NMR spectra by nonlinear sampling of the indirectly acquired dimensions was used to overcome problems caused by the instability and low sensitivity of living E. coli samples. Almost all of the expected backbone NMR resonances and most of the side-chain NMR resonances were observed and assigned, enabling high quality (0.96 angstrom backbone root mean squared deviation) structures to be calculated that are very similar to the in vitro structure of TTHA1718 determined independently. The in-cell NMR approach can thus provide accurate high-resolution structures of proteins in living environments.	[Sakakibara, Daisuke; Sasaki, Atsuko; Ikeya, Teppei; Hamatsu, Junpei; Hanashima, Tomomi; Mishima, Masaki; Guentert, Peter; Ito, Yutaka] Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; [Sakakibara, Daisuke; Sasaki, Atsuko; Hamatsu, Junpei; Mishima, Masaki; Shirakawa, Masahiro; Ito, Yutaka] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Ikeya, Teppei; Guentert, Peter] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Ikeya, Teppei; Guentert, Peter] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Yoshimasu, Masatoshi] RIKEN, Cellular & Mol Biol Lab, Wako, Saitama 3510198, Japan; [Hayashi, Nobuhiro] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Biomed Polymer Sci, Toyoake, Aichi 4701192, Japan; [Mikawa, Tsutomu; Ito, Yutaka] RIKEN, Res Grp Biosupramol Struct Funct, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Waelchli, Markus] Bruker BioSpin, Tsukuba, Ibaraki 3050051, Japan; [Smith, Brian O.] Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow G12 8QQ, Lanark, Scotland; [Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Guentert, Peter] Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany	Tokyo Metropolitan University; Japan Science & Technology Agency (JST); Goethe University Frankfurt; Goethe University Frankfurt; RIKEN; Fujita Health University; RIKEN; Bruker Corporation; Bruker BioSpin GmbH; University of Glasgow; Kyoto University	Ito, Y (corresponding author), Tokyo Metropolitan Univ, Dept Chem, 1-1 Minami Osawa, Tokyo 1920397, Japan.	ito-yutaka@tmu.ac.jp	Güntert, Peter/L-5577-2013; Ito, Yutaka/P-2604-2015; Smith, Brian O/J-1899-2015; Smith, Brian/AAJ-9393-2020; Hayashi, Nobuhiro/F-6088-2011; Mikawa, Tsutomu/E-6510-2013	Güntert, Peter/0000-0002-2911-7574; Ito, Yutaka/0000-0002-1030-4660; Smith, Brian O/0000-0003-3363-4168; Smith, Brian/0000-0003-3363-4168; Hayashi, Nobuhiro/0000-0002-9950-094X; Mikawa, Tsutomu/0000-0003-2325-5084	CREST, Japan Science and Technology Agency (JST); Molecular Ensemble Program, RIKEN; Japanese Ministry of Education, Sports, Culture, Science, and Technology; Volkswagen Foundation;  [TTHA1718]	CREST, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Molecular Ensemble Program, RIKEN; Japanese Ministry of Education, Sports, Culture, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Volkswagen Foundation(Volkswagen); 	The authors thank S. Kuramitsu for providing the plasmid encoding TTHA1718, and D. Nietlispach for setting up 3D NMR experiments with nonlinear sampling schemes and <SUP>15</SUP>N relaxation experiments, T. Anzai for assistance with NMR measurements, and H. Koyama and A. Iwasaki for sample preparations. This work was supported in part by CREST, Japan Science and Technology Agency (JST), the Molecular Ensemble Program, RIKEN, Grants-in-Aid for Scientific Research of Priority Areas from the Japanese Ministry of Education, Sports, Culture, Science, and Technology on 'Molecular Soft Interactions Regulating Membrane Interface of Biological Systems' and 'Molecular Science for Supra Functional Systems - Development of Advanced Methods for Exploring Elementary Process', and by the Volkswagen Foundation.	BARNA JCJ, 1987, J MAGN RESON, V73, P69, DOI 10.1016/0022-2364(87)90225-3; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; LAUE ED, 1986, J MAGN RESON, V68, P14, DOI 10.1016/0022-2364(86)90312-4; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Mueller GA, 2000, J MOL BIOL, V300, P197, DOI 10.1006/jmbi.2000.3842; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Reardon PN, 2005, J AM CHEM SOC, V127, P10848, DOI 10.1021/ja053145k; Reckel S, 2007, PROG NUCL MAG RES SP, V51, P91, DOI 10.1016/j.pnmrs.2007.02.002; Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603; Rovnyak D, 2004, J MAGN RESON, V170, P15, DOI 10.1016/j.jmr.2004.05.016; Sakai T, 2006, J BIOMOL NMR, V36, P179, DOI 10.1007/s10858-006-9079-9; SCHMEIDER P, 1994, J BIOMOL NMR, V4, P483, DOI 10.1007/BF00156615; Selenko P, 2007, J STRUCT BIOL, V158, P244, DOI 10.1016/j.jsb.2007.04.001; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Serber Z, 2005, METHOD ENZYMOL, V394, P17, DOI 10.1016/S0076-6879(05)94002-0; Serber Z, 2004, J AM CHEM SOC, V126, P7119, DOI 10.1021/ja049977k; Serber Z, 2001, J AM CHEM SOC, V123, P8895, DOI 10.1021/ja0112846; Serber Z, 2001, J AM CHEM SOC, V123, P2446, DOI 10.1021/ja0057528; Serber Z, 2006, NAT PROTOC, V1, P2701, DOI 10.1038/nprot.2006.181; Thorstenson YR, 1997, J BACTERIOL, V179, P5333, DOI 10.1128/jb.179.17.5333-5339.1997; Wuthrich K, 1986, NMR PROTEINS NUCL AC	37	270	277	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					102	U10		10.1038/nature07814	http://dx.doi.org/10.1038/nature07814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262674				2022-12-24	WOS:000263836000041
J	Willis, HWM; Willis, NM; Willis, GW; Ali, FR; Ball, C				Willis, Henry W. M.; Willis, Nichola M.; Willis, George W.; Ali, Faisal R.; Ball, Colin			A Patient's Journey Coeliac disease in childhood	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ali, Faisal R.; Ball, Colin] Kings Coll Hosp London, Dept Child Hlth, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Ali, FR (corresponding author), Kings Coll Hosp London, Dept Child Hlth, London SE5 9RS, England.	f.r.ali.01@cantab.net		Ali, Faisal/0000-0002-8588-791X				GODLEE F, 2009, BRIT MED J, V338, pB821; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b491; Jones R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3058; Silvester JA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b380	4	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2009	338								a3066	10.1136/bmj.a3066	http://dx.doi.org/10.1136/bmj.a3066			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228764				2022-12-24	WOS:000264052200004
J	Kuhl, G; Briggs, DEG; Rust, J				Kuehl, Gabriele; Briggs, Derek E. G.; Rust, Jes			A Great-Appendage Arthropod with a Radial Mouth from the Lower Devonian Hunsruck Slate, Germany	SCIENCE			English	Article							BURGESS-SHALE; ANOMALOCARIS; PHYLOGENY; EVOLUTION; HEAD; MORPHOLOGY; HOMOLOGY; ORIGIN	Great- appendage arthropods, characterized by a highly modified anterior limb, were previously unknown after the Middle Cambrian. One fossil from the Lower Devonian Hunsruck Slate, Germany, extends the stratigraphic range of these arthropods by similar to 100 million years. Schinderhannes bartelsi shows an unusual combination of anomalocaridid and euarthropod characters, including a highly specialized swimming appendage. A cladistic analysis indicates that the new taxon is basal to crown- group euarthropods and that the great- appendage arthropods are paraphyletic. This new fossil shows that features of the anomalocaridids, including the multisegmented raptorial appendage and circular plated mouth, persisted long after the initial radiation of the euarthropods.	[Kuehl, Gabriele; Rust, Jes] Univ Bonn, Div Palaeontol, Steinmann Inst, D-53115 Bonn, Germany; [Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Briggs, Derek E. G.] Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA	University of Bonn; Yale University; Yale University	Kuhl, G (corresponding author), Univ Bonn, Div Palaeontol, Steinmann Inst, Nussallee 8, D-53115 Bonn, Germany.				German Science Foundation [PN RU 665/5-1]; Humboldt Foundation	German Science Foundation(German Research Foundation (DFG)); Humboldt Foundation(Alexander von Humboldt Foundation)	We thank the German Science Foundation (grant PN RU 665/5-1) and the Humboldt Foundation (Research Award to D.E.G.B.) for support; the Museum of Natural History in Mainz for access to the material; C. Bartels for information; G. Oleschinski for radiographs and photography; E. Groning for the reconstruction; and A. Maas, R. Willmann, G. D. Edgecombe, and two other reviewers for comments.	[Anonymous], 2002, METALLA; BARTELS C, 1998, FOSSILS HONSRUCK SLA; Bitsch J, 2007, ACTA ZOOL-STOCKHOLM, V88, P317, DOI 10.1111/j.1463-6395.2007.00284.x; BRIGGS DEG, 1979, PALAEONTOLOGY, V22, P77; Budd G.E., 1998, ARTHROPOD RELATIONSH, V55, P125; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; BUTTERFIELD NJ, 1995, LETHAIA, V28, P1, DOI 10.1111/j.1502-3931.1995.tb01587.x; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; Cotton TJ, 2004, T ROY SOC EDIN-EARTH, V94, P169, DOI 10.1017/S0263593300000596; Dunlop JA, 2006, ACTA ZOOLOGICA BUL S, P9; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Jager M, 2006, NATURE, V441, P506, DOI 10.1038/nature04591; Kuhl G, 2008, PALAEONTOGR ABT A, V286, P123; Maas A, 2004, PROG NAT SCI-MATER, V14, P158, DOI 10.1080/10020070412331343301; Maxmen A, 2005, NATURE, V437, P1144, DOI 10.1038/nature03984; Scholtz G, 2005, CRUSTACEAN ISS, V16, P139, DOI 10.1201/9781420037548.ch6; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Siveter DJ, 2007, P ROY SOC B-BIOL SCI, V274, P2223, DOI 10.1098/rspb.2007.0712; VAN ROY P., 2006, THESIS U GHENT GHENT; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Waloszek D, 2007, PALAEOGEOGR PALAEOCL, V254, P273, DOI 10.1016/j.palaeo.2007.03.027; Whittington H.B., 1971, Bull geol Surv Can, VNo. 209, P1; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096	26	84	89	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					771	773		10.1126/science.1166586	http://dx.doi.org/10.1126/science.1166586			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197061				2022-12-24	WOS:000263066800043
J	Das, M; Sabio, G; Jiang, F; Rincon, M; Flavell, RA; Davis, RJ				Das, Madhumita; Sabio, Guadalupe; Jiang, Feng; Rincon, Mercedes; Flavell, Richard A.; Davis, Roger J.			Induction of Hepatitis by JNK-Mediated Expression of TNF-alpha	CELL			English	Article							TUMOR-NECROSIS-FACTOR; A-INDUCED HEPATITIS; SIGNAL-TRANSDUCTION PATHWAY; NECROTIC CELL-DEATH; CONCANAVALIN-A; IN-VIVO; LIVER-INJURY; INDUCED APOPTOSIS; INDUCED ACTIVATION; CRUCIAL ROLE	The c-Jun NH2-terminal kinase (JNK) signaling pathway has been implicated in the development of tumor necrosis factor (TNF)-dependent hepatitis. JNK may play a critical role in hepatocytes during TNF-stimulated cell death in vivo. To test this hypothesis, we examined the phenotype of mice with compound disruption of the Jnk1 and Jnk2 genes. Mice with loss of JNK1/2 expression in hepatocytes exhibited no defects in the development of hepatitis compared with control mice, whereas mice with loss of JNK1/2 in the hematopoietic compartment exhibited a profound defect in hepatitis that was associated with markedly reduced expression of TNF-alpha. These data indicate that JNK is required for TNF-alpha expression but not for TNF-alpha-stimulated death of hepatocytes. Indeed, TNF-alpha induced similar hepatic damage in both mice with hepatocyte-specific JNK1/2 deficiency and control mice. These observations confirm a role for JNK in the development of hepatitis but identify hematopoietic cells as the site of the essential function of JNK.	[Das, Madhumita; Sabio, Guadalupe; Jiang, Feng; Davis, Roger J.] Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA; [Sabio, Guadalupe; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Rincon, Mercedes] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Vermont; Howard Hughes Medical Institute; Yale University; Yale University	Davis, RJ (corresponding author), Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA.	roger.davis@umassmed.edu	Sabio, Guadalupe/H-9733-2015	Sabio, Guadalupe/0000-0002-2822-0625	NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA065861-14, R01 CA065861] Funding Source: Medline; NIAID NIH HHS [R01 AI051454] Funding Source: Medline; NIDDK NIH HHS [P30 DK 32520, P30 DK032520, P30 DK032520-26] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dietrich N, 2004, CELL DEATH DIFFER, V11, P301, DOI 10.1038/sj.cdd.4401353; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong ZJ, 2007, CELL MOL IMMUNOL, V4, P241; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; EISSNER G, 1995, BLOOD, V86, P4184, DOI 10.1182/blood.V86.11.4184.bloodjournal86114184; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hatada S, 2005, CELL IMMUNOL, V233, P23, DOI 10.1016/j.cellimm.2005.03.003; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kusters S, 1997, EUR J IMMUNOL, V27, P2870, DOI 10.1002/eji.1830271119; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liedtke C, 2002, HEPATOLOGY, V36, P315, DOI 10.1053/jhep.2002.34615; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Louis H, 2002, GASTROENTEROLOGY, V122, P2001, DOI 10.1053/gast.2002.33620; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Morita A, 2003, HEPATOL RES, V27, P143, DOI 10.1016/S1386-6346(03)00206-7; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Reuther-Madrid JY, 2002, MOL CELL BIOL, V22, P8175, DOI 10.1128/MCB.22.23.8175-8183.2002; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tagawa Y, 1998, EUR J IMMUNOL, V28, P4105, DOI 10.1002/(SICI)1521-4141(199812)28:12<4105::AID-IMMU4105>3.3.CO;2-#; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023	69	109	111	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					249	260		10.1016/j.cell.2008.11.017	http://dx.doi.org/10.1016/j.cell.2008.11.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167327	Green Accepted, Bronze			2022-12-24	WOS:000262648800014
J	Shen, GJ; Gao, X; Gao, B; Granger, DE				Shen, Guanjun; Gao, Xing; Gao, Bin; Granger, Darryl E.			Age of Zhoukoudian Homo erectus determined with Al-26/Be-10 burial dating	NATURE			English	Article							MIDDLE PLEISTOCENE; CHINA; SITE; CALIBRATION; LOCALITY-1; CHRONOLOGY; LOESS	The age of Zhoukoudian Homo erectus, commonly known as 'Peking Man', has long been pursued, but has remained problematic owing to the lack of suitable dating methods(1-7). Here we report cosmogenic Al-26/Be-10 burial dating of quartz sediments and artefacts from the lower strata of Locality 1 in the southwestern suburb of Beijing, China, where early representatives of Zhoukoudian Homo erectus were discovered. This study marks the first radioisotopic dating of any early hominin site in China beyond the range of mass spectrometric U-series dating. The weighted mean of six meaningful age measurements, 0.77 +/- 0.08 million years (Myr, mean +/- s.e.m.), provides the best age estimate for lower cultural layers 7-10. Together with previously reported U-series dating of speleothem calcite(3) and palaeomagnetic stratigraphy(4), as well as sedimentological considerations(8,9), these layers may be further correlated to S6-S7 in Chinese loess stratigraphy or marine isotope stages (MIS) 17-19, in the range of similar to 0.68 to 0.78 Myr ago. These ages are substantially older than previously supposed and may imply early hominin's presence at the site in northern China through a relatively mild glacial period corresponding to MIS 18.	[Shen, Guanjun; Gao, Bin] Nanjing Normal Univ, Coll Geog Sci, Nanjing 210046, Jiangsu, Peoples R China; [Gao, Xing] Acad Sinica, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Granger, Darryl E.] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA	Nanjing Normal University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shen, GJ (corresponding author), Nanjing Normal Univ, Coll Geog Sci, Nanjing 210046, Jiangsu, Peoples R China.	gjshen@njnu.edu.cn; dgranger@purdue.edu			National Natural Science Foundation of China; Wenner-Gren Foundation; NSF	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenner-Gren Foundation; NSF(National Science Foundation (NSF))	This project was jointly supported by the National Natural Science Foundation of China and Wenner-Gren Foundation. Accelerator mass spectrometer 26 Al and 10 Be measurements were supported by an NSF facility grant to PRIME Lab. We thank Zhoukoudian Site Museum for assistance in sample collection, L. Zhou, T.-	Aigner J. S., 1986, ANTHROPOS, V23, P157; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; CLARK JD, 1994, SCIENCE, V264, P1907, DOI 10.1126/science.8009220; Dong W., 2000, ACTA ANTHR SINICA, V19, P246; Gaboardi M, 2005, QUATERNARY RES, V63, P329, DOI 10.1016/j.yqres.2005.02.006; Goldberg P, 2001, J HUM EVOL, V41, P483, DOI 10.1006/jhev.2001.0498; Granger DE, 2006, GEOL SOC AM SPEC PAP, V415, P1, DOI 10.1130/2006.2415(01); Granger DE, 2001, EARTH PLANET SC LETT, V188, P269, DOI 10.1016/S0012-821X(01)00309-0; Grun R, 1997, J HUM EVOL, V32, P83; GUO SL, 1991, ACTA ANTHR SINICA, V10, P73; LIU ZC, 1985, QUATERNARY RES, V23, P139; Ludwig KR, 2000, EVOL ANTHROPOL, V9, P101, DOI 10.1002/(SICI)1520-6505(2000)9:2<101::AID-EVAN4>3.3.CO;2-N; Nishiizumi K, 2007, NUCL INSTRUM METH B, V258, P403, DOI 10.1016/j.nimb.2007.01.297; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Pike AWG, 2003, REV MINERAL GEOCHEM, V52, P607, DOI 10.2113/0520607; QIAN F, 1985, MULTIDISCIPLINARY ST, P251; Richards DA, 2003, REV MINERAL GEOCHEM, V52, P407, DOI 10.2113/0520407; Rightmire GP, 1998, EVOL ANTHROPOL, V6, P218, DOI 10.1002/(SICI)1520-6505(1998)6:6<218::AID-EVAN4>3.0.CO;2-6; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; Shen GJ, 2004, QUATERNARY RES, V62, P208, DOI 10.1016/j.yqres.2004.06.004; Shen GJ, 2001, J HUM EVOL, V41, P679, DOI 10.1006/jhev.2001.0516; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; Wu, 1990, ACTA ANTHR SINICA, V9, P312; Wu R., 1985, MULTIDISCIPLINARY ST; YANG Z, 1985, MULTIDISCIPLINARY ST, P1; Yuan S., 1991, ACTA ANTHROPOL SIN, V10, P189; Zhao JX, 2001, GEOLOGY, V29, P27, DOI 10.1130/0091-7613(2001)029<0027:TIMSUS>2.0.CO;2; Zhao S.S., 1985, MULTIDISCIPLINARY ST, P239; Zhou C, 2000, J ARCHAEOL SCI, V27, P101, DOI 10.1006/jasc.1999.0428; Zhou LP, 1999, EARTH PLANET SC LETT, V168, P117, DOI 10.1016/S0012-821X(99)00052-7	30	148	191	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					198	200		10.1038/nature07741	http://dx.doi.org/10.1038/nature07741			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417EQ	19279636				2022-12-24	WOS:000264059700042
J	Roehr, B				Roehr, Bob			Should men who have ever had sex with men be allowed to give blood? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSFUSION					bobroehr@aol.com						Brooks JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b318; Germain M, 2003, TRANSFUSION, V43, P25, DOI 10.1046/j.1537-2995.2003.00281.x; Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009; Hurley R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b779; Lebbe Celeste, 2008, Transplant Rev (Orlando), V22, P252, DOI 10.1016/j.trre.2008.05.004; Moore R J, 1991, Transfus Med, V1, P201, DOI 10.1111/j.1365-3148.1991.tb00034.x; O'Brien SF, 2007, TRANSFUSION, V47, P316, DOI 10.1111/j.1537-2995.2007.01108.x; Schrimshaw EW, 2006, ARCH SEX BEHAV, V35, P225, DOI 10.1007/s10508-005-9006-2; VAMVAKAS EC, 2009, BLOOD           0202; Weber B, 2006, EXPERT REV MOL DIAGN, V6, P399, DOI 10.1586/14737159.6.3.399	10	12	12	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 26	2009	338								b311	10.1136/bmj.b311	http://dx.doi.org/10.1136/bmj.b311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417DS	19246548				2022-12-24	WOS:000264056300006
J	Strangfeld, A; Listing, J; Herzer, P; Liebhaber, A; Rockwitz, K; Richter, C; Zink, A				Strangfeld, Anja; Listing, Joachim; Herzer, Peter; Liebhaber, Anke; Rockwitz, Karin; Richter, Constanze; Zink, Angela			Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti-TNF-alpha Agents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUMOR-NECROSIS-FACTOR; POSTHERPETIC NEURALGIA; MONOCLONAL-ANTIBODY; INFECTIONS; THERAPY; EPIDEMIOLOGY; METHOTREXATE; ETANERCEPT; INFLIXIMAB; ADALIMUMAB	Context The risk of bacterial infection is increased in patients treated with drugs that inhibit tumor necrosis factor alpha ( TNF- alpha). Little is known about the reactivation of latent viral infections during treatment with TNF- alpha inhibitors. Objective To investigate whether TNF- alpha inhibitors together as a class, or separately as either monoclonal anti-TNF-alpha antibodies (adalimumab, infliximab) or a fusion protein ( etanercept), are related to higher rates of herpes zoster in patients with rheumatoid arthritis. Design, Setting, and Patients Patients were enrolled in the German biologics register RABBIT, a prospective cohort, between May 2001 and December 2006 at the initiation of treatment with infliximab, etanercept, adalimumab, or anakinra, or when they changed conventional disease- modifying antirheumatic drug ( DMARD). Treatment, clinical status, and adverse events were assessed by rheumatologists at fixed points during follow- up. Main Outcome Measures Hazard ratio ( HR) of herpes zoster episodes following anti - TNF- alpha treatment. Study aims were to detect a clinically significant difference ( HR, 2.0) between TNF- alpha inhibitors as a class compared with DMARDs and to detect an HR of at least 2.5 for each of 2 types of TNF- alpha inhibitors, the monoclonal antibodies or the fusion protein, compared with conventional DMARDs. Results Among 5040 patients receiving TNF- alpha inhibitors or conventional DMARDs, 86 episodes of herpes zoster occurred in 82 patients. Thirty- nine occurrences could be attributed to treatment with anti - TNF- alpha antibodies, 23 to etanercept, and 24 to conventional DMARDs. The crude incidence rate per 1000 patient- years was 11.1 ( 95% confidence interval [ CI], 7.9- 15.1) for the monoclonal antibodies, 8.9 ( 95% CI, 5.6-13.3) for etanercept, and 5.6 ( 95% CI, 3.6- 8.3) for conventional DMARDs. Adjusted for age, rheumatoid arthritis severity, and glucocorticoid use, a significantly increased risk was observed for treatment with the monoclonal antibodies ( HR, 1.82 [ 95% CI, 1.05- 3.15]), although this risk was lower than the threshold for clinical significance. No significant associations were found for etanercept use ( HR, 1.36 [ 95% CI, 0.73-2.55]) or for anti - TNF- alpha treatment ( HR, 1.63 [ 95% CI, 0.97- 2.74]) as a class. Conclusion Treatment with monoclonal anti - TNF- alpha antibodies may be associated with increased risk of herpes zoster, but this requires further study.	[Strangfeld, Anja; Listing, Joachim; Zink, Angela] German Rheumatism Res Ctr, Epidemiol Unit, D-10117 Berlin, Germany; [Zink, Angela] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Strangfeld, A (corresponding author), German Rheumatism Res Ctr, Epidemiol Unit, Charitepl 1, D-10117 Berlin, Germany.	strangfeld@drfz.de						ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Askling J, 2007, ANN RHEUM DIS, V66, P1339, DOI 10.1136/ard.2006.062760; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Curtis JR, 2007, ARTHRITIS RHEUM-US, V56, P1125, DOI 10.1002/art.22504; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2896, DOI 10.1002/art.22808; Furst DE, 2003, J RHEUMATOL, V30, P2563; GLYNN C, 1990, J ROY SOC MED, V83, P617, DOI 10.1177/014107689008301007; Gupta G, 2006, CLIN GASTROENTEROL H, V4, P1483, DOI 10.1016/j.cgh.2006.09.019; *INT C HARM, CLIN SAF DAT MAN DEF; Kengsakul Kitisak, 2002, J Med Assoc Thai, V85, P131; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Lautenschlager J, 1997, Z RHEUMATOL, V56, P144, DOI 10.1007/s003930050030; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Listing J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1933; LOCKSLEY RM, 1985, J INFECT DIS, V152, P1172, DOI 10.1093/infdis/152.6.1172; Maini RN, 2004, ARTHRITIS RHEUM-US, V50, P1051, DOI 10.1002/art.20159; Moreland LW, 2006, J RHEUMATOL, V33, P854; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Pham Thao, 2005, Joint Bone Spine, V72 Suppl 1, pS1; Pope JE, 2004, J RHEUMATOL, V31, P274; Schrauder A, 2007, LANCET, V369, P1232, DOI 10.1016/S0140-6736(07)60567-4; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; Strangfeld A, 2006, BEST PRACT RES CL RH, V20, P1181, DOI 10.1016/j.berh.2006.08.010; The British Society for Rheumatology, 2002, VACC IMM PERS GUID P; THEMEAU TM, 2000, MODELLING SURVIVAL D; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; VEENSTRA J, 1995, AIDS, V9, P1153, DOI 10.1097/00002030-199510000-00006; Wallis RS, 2004, CLIN INFECT DIS, V39, P1254, DOI 10.1086/424455; Wallis RS, 2005, SEMIN ARTHRITIS RHEU, V34, P34, DOI 10.1016/j.semarthrit.2005.01.009; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Wolfe F, 2006, RHEUMATOLOGY, V45, P1370, DOI 10.1093/rheumatology/kel328; Woodworth TG, 2001, J RHEUMATOL, V28, P1163; Zink A, 2005, ANN RHEUM DIS, V64, P1274, DOI 10.1136/ard.2004.031476	38	396	413	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					737	744		10.1001/jama.2009.146	http://dx.doi.org/10.1001/jama.2009.146			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224750	Bronze			2022-12-24	WOS:000263370100016
J	Kawase, T; Ohki, R; Shibata, T; Tsutsumi, S; Kamimura, N; Inazawa, J; Ohta, T; Ichikawa, H; Aburatani, H; Tashiro, F; Taya, Y				Kawase, Tatsuya; Ohki, Rieko; Shibata, Tatsuhiro; Tsutsumi, Shuichi; Kamimura, Naoko; Inazawa, Johji; Ohta, Tsutomu; Ichikawa, Hitoshi; Aburatani, Hiroyuki; Tashiro, Fumio; Taya, Yoichi			PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt	CELL			English	Article							GENOMIC HYBRIDIZATION ANALYSIS; PLECKSTRIN-HOMOLOGY DOMAINS; CANDIDATE MEDIATOR; KINASE B; P53; ACTIVATION; PATHWAY; LUNG; FAMILY; CANCER	p53 and Akt are critical players regulating tumorigenesis with opposite effects: whereas p53 transactivates target genes to exert its function as a tumor suppressor, Akt phosphorylates its substrates and transduces downstream survival signals. In addition, p53 and Akt negatively regulate each other to balance survival and death signals within a cell. We now identify PHLDA3 as a p53 target gene that encodes a PH domain-only protein. We find that PHLDA3 competes with the PH domain of Akt for binding of membrane lipids, thereby inhibiting Akt translocation to the cellular membrane and activation. Ablation of endogenous PHLDA3 results in enhanced Akt activity and decrease of p53-dependent apoptosis. We also demonstrate the suppression of anchorage-independent cell growth by PHLDA3. Loss of the PHLDA3 genomic locus was frequently observed in primary lung cancers, suggesting a role of PHLDA3 in tumor suppression. Our results reveal a new mode of coordination between the p53 and Akt pathways.	[Kawase, Tatsuya; Ohki, Rieko; Taya, Yoichi] Natl Canc Ctr, Res Inst, Div Radiobiol, Chuo Ku, Tokyo 1040045, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Canc Genom Project, Chuo Ku, Tokyo 1040045, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, Tokyo 1040045, Japan; [Ohta, Tsutomu] Natl Canc Ctr, Res Inst, Ctr Med Genom, Chuo Ku, Tokyo 1040045, Japan; [Ichikawa, Hitoshi] Natl Canc Ctr, Res Inst, Canc Transcriptome Project, Chuo Ku, Tokyo 1040045, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, Tokyo 1138510, Japan; [Tsutsumi, Shuichi; Kamimura, Naoko; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Meguro Ku, Tokyo 1538904, Japan; [Kawase, Tatsuya; Tashiro, Fumio] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 2708510, Japan; [Kawase, Tatsuya; Ohki, Rieko; Taya, Yoichi] SORST JST, Kawaguchi, Saitama 3320012, Japan; [Taya, Yoichi] Natl Univ Singapore, Ctr Life Sci, Canc Res Ctr Excellence, Singapore 117456, Singapore	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo University of Science; Japan Science & Technology Agency (JST); National University of Singapore	Ohki, R (corresponding author), Natl Canc Ctr, Res Inst, Div Radiobiol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	rohki@ncc.go.jp	Shibata, Tatsuhiro/ABA-8234-2020; Shibata, Tatsuhiro/AAO-1278-2021		Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare, Japan; Japan Society for the Promotion of Science for Young Scientists	Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to Atsushi Okabe for production of ChIP-chip and ChIP sequence data and Hiroko Meguro and Kaori Shiina for analysis of ChIP-chip and ChIP sequence samples. This study was supported by the program for the promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency ( to T. O. and H. I.), a Grant-in-Aid for Scientific Research and a grant of the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( to H. A.), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( to Y. T.), and a Grant-in-Aid for Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor and Welfare, Japan ( to T. S. and Y. T.). T. K. is a recipient of a research fellowship from the Japan Society for the Promotion of Science for Young Scientists.	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Frank D, 1999, MAMM GENOME, V10, P1150, DOI 10.1007/s003359901182; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jen KY, 2005, CANCER RES, V65, P7666, DOI 10.1158/0008-5472.CAN-05-1039; Kawase T, 2008, ONCOGENE, V27, P3797, DOI 10.1038/onc.2008.32; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Moore SM, 1998, CANCER RES, V58, P5239; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Peng WX, 2005, CANCER SCI, V96, P661, DOI 10.1111/j.1349-7006.2005.00092.x; Ren Y, 2003, ANTICANCER RES, V23, P3231; Righi L, 2007, VIRCHOWS ARCH, V451, pS51, DOI 10.1007/s00428-007-0445-0; Saxena A, 2002, J BIOL CHEM, V277, P49935, DOI 10.1074/jbc.M206497200; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Stambolic V, 1999, ONCOGENE, V18, P6094, DOI 10.1038/sj.onc.1203126; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	37	151	160	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					535	550		10.1016/j.cell.2008.12.002	http://dx.doi.org/10.1016/j.cell.2008.12.002			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203586	Bronze			2022-12-24	WOS:000263120600022
J	Slutsky, AS; Hudson, LD; Dubler, NN; Weijer, C; Tonelli, MR				Slutsky, Arthur S.; Hudson, Leonard D.; Dubler, Nancy N.; Weijer, Charles; Tonelli, Mark R.			Care of an Unresponsive Patient with a Poor Prognosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SURVIVAL		[Slutsky, Arthur S.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Slutsky, Arthur S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Hudson, Leonard D.] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Hudson, Leonard D.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Dubler, Nancy N.] Montefiore Med Ctr, Montefiore Einstein Ctr Bioeth, Bronx, NY 10467 USA; [Weijer, Charles] Univ Western Ontario, Dept Philosophy, London, ON, Canada; [Weijer, Charles] Univ Western Ontario, Dept Med, London, ON, Canada; [Tonelli, Mark R.] Univ Washington, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Tonelli, Mark R.] Univ Washington, Med Ctr, Dept Bioeth & Humanities, Seattle, WA 98195 USA	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Slutsky, AS (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Slutsky, Arthur/M-3325-2019					Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643; Berger JT, 2008, ANN INTERN MED, V149, P48, DOI 10.7326/0003-4819-149-1-200807010-00010; Buchanan AE, 1990, DECIDING OTHERS ETHI; Dubler N. N., 2004, BIOETHICS MEDIATION; DUBLER NN, 1995, KENNEDY INST ETHIC J, V5, P289; Helft PR, 2000, NEW ENGL J MED, V343, P293, DOI 10.1056/NEJM200007273430411; Kapp M B, 1997, Univ Toledo Law Rev, V28, P521; LUCE JM, 1995, CRIT CARE MED, V23, P760, DOI 10.1097/00003246-199504000-00027; *PC, 1983, DEC FOR LIF SUST TRE; Reisfield GM, 2006, RESUSCITATION, V71, P152, DOI 10.1016/j.resuscitation.2006.02.022; Tonelli MR, 1997, J LAW MED ETHICS, V25, P22, DOI 10.1111/j.1748-720X.1997.tb01392.x; Toussaint LG, 2005, NEUROSURGERY, V57, P25, DOI 10.1227/01.NEU.0000163086.23124.70; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; Weijer C, 1998, CAN MED ASSOC J, V159, P817	14	13	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					527	531		10.1056/NEJMclde0808330	http://dx.doi.org/10.1056/NEJMclde0808330			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179322				2022-12-24	WOS:000262812400017
J	Scheibert, J; Leurent, S; Prevost, A; Debregeas, G				Scheibert, J.; Leurent, S.; Prevost, A.; Debregeas, G.			The Role of Fingerprints in the Coding of Tactile Information Probed with a Biomimetic Sensor	SCIENCE			English	Article							TEXTURE; FINE; SKIN; DISCRIMINATION; PERCEPTION; RESOLUTION; MECHANICS; FILTER	In humans, the tactile perception of fine textures (spatial scale <200 micrometers) is mediated by skin vibrations generated as the finger scans the surface. To establish the relationship between texture characteristics and subcutaneous vibrations, a biomimetic tactile sensor has been designed whose dimensions match those of the fingertip. When the sensor surface is patterned with parallel ridges mimicking the fingerprints, the spectrum of vibrations elicited by randomly textured substrates is dominated by one frequency set by the ratio of the scanning speed to the interridge distance. For human touch, this frequency falls within the optimal range of sensitivity of Pacinian afferents, which mediate the coding of fine textures. Thus, fingerprints may perform spectral selection and amplification of tactile information that facilitate its processing by specific mechanoreceptors.	[Debregeas, G.] Univ Paris 06, Ecole Normale Super, Lab Phys Stat, CNRS,UMR 8550, F-75231 Paris 05, France; Univ Paris 07, F-75231 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Debregeas, G (corresponding author), Univ Paris 06, Ecole Normale Super, Lab Phys Stat, CNRS,UMR 8550, 24 Rue Lhomond, F-75231 Paris 05, France.	georges.debregeas@lps.ens.fr	Scheibert, Julien/C-5892-2009	Scheibert, Julien/0000-0002-9600-3796; Prevost, Alexis Michel/0000-0002-4588-3316; Debregeas, Georges/0000-0003-3698-4497; LEURENT, Sebastien/0000-0003-3847-8352	CNRS; EU-NEST; MONAT [contract 21, number 29000]	CNRS(Centre National de la Recherche Scientifique (CNRS)); EU-NEST(European Commission); MONAT	This project was supported primarily by CNRS basic funding and in part by the EU-NEST (New and Emerging Science and Technology) program, MONAT (Measurement of Naturalness) project (contract 21, number 29000). We are grateful to D. Chatenay and L. Bourdieu for fruitful discussions and careful reading of the manuscript.	Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P842, DOI 10.3758/BF03193537; Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; CARTMILL M, 1979, AM J PHYS ANTHROPOL, V50, P497, DOI 10.1002/ajpa.1330500402; CAUNA N, 1954, ANAT RECORD, V119, P449, DOI 10.1002/ar.1091190405; Crowder R, 2006, SCIENCE, V312, P1478, DOI 10.1126/science.1129110; Dandekar K, 2003, J BIOMECH ENG-T ASME, V125, P682, DOI 10.1115/1.1613673; DARIANSMITH I, 1984, HDB PHYSL NERVOUS SY, V3, pCH17; FEARING RS, 1985, INT J ROBOT RES, V4, P40, DOI 10.1177/027836498500400304; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; HOWE RD, 1993, IEEE T ROBOTIC AUTOM, V9, P140, DOI 10.1109/70.238278; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177, DOI 10.1152/jn.1981.46.6.1177; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Jones L.A., 2006, HUMAN HAND FUNCTION; Katz, 1989, THE WORLD OF TOUCH; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; Maheshwari V, 2006, SCIENCE, V312, P1501, DOI 10.1126/science.1126216; MAKOUS JC, 1995, J NEUROSCI, V15, P2808; Rieke F., 1999, SPIKES EXPLORING NEU; Scheibert J, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/34003; SRINIVASAN MA, 1990, J NEUROPHYSIOL, V63, P1323, DOI 10.1152/jn.1990.63.6.1323; Wang Q, 2007, J BIOMECH, V40, P851, DOI 10.1016/j.jbiomech.2006.03.004; WIENER N, 1958, NONLINEAR PROBLEMS R	26	252	264	9	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1503	1506		10.1126/science.1166467	http://dx.doi.org/10.1126/science.1166467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19179493	Green Submitted			2022-12-24	WOS:000264101700048
J	Chapman, HA; Kim, DA; Susskind, JM; Anderson, AK				Chapman, H. A.; Kim, D. A.; Susskind, J. M.; Anderson, A. K.			In Bad Taste: Evidence for the Oral Origins of Moral Disgust	SCIENCE			English	Article							ANGER	In common parlance, moral transgressions "leave a bad taste in the mouth." This metaphor implies a link between moral disgust and more primitive forms of disgust related to toxicity and disease, yet convincing evidence for this relationship is still lacking. We tested directly the primitive oral origins of moral disgust by searching for similarity in the facial motor activity evoked by gustatory distaste (elicited by unpleasant tastes), basic disgust (elicited by photographs of contaminants), and moral disgust (elicited by unfair treatment in an economic game). We found that all three states evoked activation of the levator labii muscle region of the face, characteristic of an oral-nasal rejection response. These results suggest that immorality elicits the same disgust as disease vectors and bad tastes.	[Chapman, H. A.; Kim, D. A.; Susskind, J. M.; Anderson, A. K.] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Anderson, A. K.] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest	Chapman, HA (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada.	hanah@aclab.ca; anderson@psych.utoronto.ca		Kim, David/0000-0003-0151-5121	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs)	Supported by the Natural Sciences and Engineering Research Council of Canada and by the Canada Research Chairs Program (A.K.A.). We thank G. Cosgrove, S. Couto, R. Landy, A. Meyers, J. Robinson, and M. Sutrisno for assistance in collecting and processing the data, and W. Grabski for technical assistance.	Bloom Paul, 2004, DESCARTES BABY SCI C; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Ekman P., 2002, MANUAL INVESTIGATORS; Garcia J., 1975, OLFACTION TASTE, P39, DOI DOI 10.1016/B978-0-12-209750-8.50014-7; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Harmon-Jones E, 2003, PERS INDIV DIFFER, V35, P995, DOI 10.1016/S0191-8869(02)00313-6; HENRICH SR, 2004, FDN HUMAN SOCIALITY; Jones D, 2007, NATURE, V447, P768, DOI 10.1038/447768a; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kohlberg L., 1969, HDB SOCIALIZATION TH, P347, DOI DOI 10.12691/EDUCATION-3-9-16; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Matsumoto D, 1988, JAPANESE CAUCASIAN F; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Nabi RL, 2002, COGNITION EMOTION, V16, P695, DOI 10.1080/02699930143000437; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; Rozin P., 2000, HDB EMOTIONS, P637; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Simmons A, 2008, NEUROSCI LETT, V430, P92, DOI 10.1016/j.neulet.2007.10.030; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tassinary L. G., 2000, HDB PSYCHOPHYSIOLOGY, P163; Turiel E., 1987, EMERGENCE MORALITY Y, P155; VRANA SR, 1993, PSYCHOPHYSIOLOGY, V30, P279, DOI 10.1111/j.1469-8986.1993.tb03354.x	30	422	437	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1222	1226		10.1126/science.1165565	http://dx.doi.org/10.1126/science.1165565			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251631				2022-12-24	WOS:000263687600041
J	Liaw, YF; Chu, CM				Liaw, Yun-Fan; Chu, Chia-Ming			Hepatitis B virus infection	LANCET			English	Review							E-ANTIGEN SEROCONVERSION; LIVER-DISEASE PROGRESSION; CORE PROMOTER MUTATIONS; HBEAG-POSITIVE PATIENTS; ACUTE VIRAL-HEPATITIS; TERM-FOLLOW-UP; NATURAL-HISTORY; HEPATOCELLULAR-CARCINOMA; GENOTYPE-C; PEGINTERFERON ALPHA-2A	Since the introduction of the hepatitis B vaccine and other preventive measures, the worldwide prevalence of hepatitis B infection has fallen. However, chronic infection remains a challenging global health problem, with more than 350 million people chronically infected and at risk of hepatic decompensation, cirrhosis, and hepatocellular carcinoma. An improved understanding of hepatitis B virology, immunology, and the natural course of chronic infection, has identified hepatitis B virus replication as the key driver of immune-mediated liver injury and disease progression. The approval of potent oral antiviral agents has revolutionised hepatitis B treatment since 1998. Conventional and pegylated interferon alfa and nucleoside and nucleotide analogues are widely authorised treatments, and monotherapy with these drugs greatly suppresses virus replication, reduces hepatitis activity, and halts disease progression. However, hepatitis B virus is rarely eliminated, and drug resistance is a major drawback during long term therapy. The development of new drugs and strategies is needed to improve treatment outcomes.	[Liaw, Yun-Fan; Chu, Chia-Ming] Chang Gung Univ, Chang Gung Mem Hosp, Liver Res Unit, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Liaw, YF (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Liver Res Unit, Coll Med, 199 Tung Hwa North Rd, Taipei, Taiwan.	liveryfl@so-net.net.tw	Liaw, Yun-Fan/B-4305-2009		Chang-Gung Medical Research Fund; Prosperous Foundation, Taipei, Taiwan	Chang-Gung Medical Research Fund; Prosperous Foundation, Taipei, Taiwan	We thank Chang-Gung Medical Research Fund and the Prosperous Foundation, Taipei, Taiwan, for long term grant support: Elicit Donaldson and Eric Matluck for English editing; and Su-Chiung Chu for secretarial assistance.	Bertoletti A, 2003, ANTIVIR RES, V60, P61, DOI 10.1016/j.antiviral.2003.08.012; Boni C, 1998, J CLIN INVEST, V102, P968, DOI 10.1172/JCI3731; Bonino F, 2007, GUT, V56, P699, DOI 10.1136/gut.2005.089722; Bonino F, 2003, J HEPATOL, V39, pS160, DOI 10.1016/S0168-8278(03)00319-2; Bortolotti F, 2006, HEPATOLOGY, V43, P556, DOI 10.1002/hep.21077; BOTHA JF, 1984, LANCET, V1, P1210; Brunetto MR, 2002, J HEPATOL, V36, P263, DOI 10.1016/S0168-8278(01)00266-5; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen HL, 2004, HEPATOLOGY, V39, P58, DOI 10.1002/hep.20006; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Chen YC, 2007, HEPATOL INT, V1, P267, DOI 10.1007/s12072-007-5001-0; Chien RN, 1999, HEPATOLOGY, V30, P770, DOI 10.1002/hep.510300313; Chien RN, 2003, J HEPATOL, V38, P322, DOI 10.1016/S0168-8278(02)00419-1; Chien RN, 2006, ANTIVIR THER, V11, P947; Chien YC, 2006, EPIDEMIOL REV, V28, P126, DOI 10.1093/epirev/mxj010; Chou YC, 2008, GUT, V57, P91, DOI 10.1136/gut.2006.114066; Chu CM, 2007, J VIRAL HEPATITIS, V14, P147, DOI 10.1111/j.1365-2893.2006.00810.x; Chu CM, 2007, HEPATOL INT, V1, P311, DOI 10.1007/s12072-007-9002-9; Chu CM, 2007, GASTROENTEROLOGY, V133, P1458, DOI 10.1053/j.gastro.2007.08.039; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Chu CJ, 2003, HEPATOLOGY, V38, P619, DOI 10.1053/jhep.2003.50352; Chu CJ, 2002, GASTROENTEROLOGY, V122, P1756, DOI 10.1053/gast.2002.33588; CHU CM, 1995, GASTROENTEROLOGY, V109, P1926, DOI 10.1016/0016-5085(95)90760-2; Chu CM, 2006, SEMIN LIVER DIS, V26, P142, DOI 10.1055/s-2006-939752; Chu CM, 2005, J HEPATOL, V43, P411, DOI 10.1016/j.jhep.2005.03.018; Chu CM, 2005, INFECTION, V33, P136, DOI 10.1007/s15010-005-4094-4; Chu CM, 2002, J CLIN MICROBIOL, V40, P16, DOI 10.1128/JCM.40.1.16-21.2002; Chu CM, 2004, AM J MED, V116, P829, DOI 10.1016/j.amjmed.2003.12.040; CHU CM, 1985, HEPATOLOGY, V5, P431, DOI 10.1002/hep.1840050315; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Craxi A, 2003, J HEPATOL, V39, pS99, DOI 10.1016/S0168-8278(03)00154-5; Di Marco V, 2004, HEPATOLOGY, V40, P883, DOI 10.1002/hep.20381; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Duong TN, 2004, J MED VIROL, V72, P551, DOI 10.1002/jmv.20044; Fattovich G, 2002, AM J GASTROENTEROL, V97, P2886, DOI 10.1111/j.1572-0241.2002.07057.x; Fattovich G, 2008, GUT, V57, P84, DOI 10.1136/gut.2007.128496; Feld JJ, 2007, HEPATOLOGY, V46, P1057, DOI 10.1002/hep.21811; Flink HJ, 2006, AM J GASTROENTEROL, V101, P2523, DOI 10.1111/j.1572-0241.2006.00812.x; Fontana RJ, 2002, GASTROENTEROLOGY, V123, P719, DOI 10.1053/gast.2002.35352; Fried MW, 2008, HEPATOLOGY, V47, P428, DOI 10.1002/hep.22065; Friedt M, 1999, HEPATOLOGY, V29, P1252, DOI 10.1002/hep.510290418; Gish RG, 2006, CLIN GASTROENTEROL H, V4, P666, DOI 10.1016/j.cgh.2006.03.017; Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Hadziyannis SJ, 2007, HEPATOL INT, V1, P281, DOI 10.1007/s12072-007-9004-7; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Hann HWL, 2003, LIVER TRANSPLANT, V9, P49, DOI 10.1053/jlts.2003.50005; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Hsu YS, 2002, HEPATOLOGY, V35, P1522, DOI 10.1053/jhep.2002.33638; Hui CK, 2007, HEPATOLOGY, V46, P395, DOI 10.1002/hep.21724; Ikeda K, 2006, AM J MED, V119, P977, DOI 10.1016/j.amjmed.2005.02.033; Iloeje UH, 2007, CLIN GASTROENTEROL H, V5, P921, DOI 10.1016/j.cgh.2007.06.015; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kao JH, 2007, HEPATOL INT, V1, P415, DOI 10.1007/s12072-007-9033-2; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI 10.1053/j.gastro.2005.05.053; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lampertico PF, 2007, GASTROENTEROLOGY, V133, P1445, DOI 10.1053/j.gastro.2007.08.079; Lau G, 2007, HEPATOL INT, V1, P316, DOI 10.1007/s12072-007-9006-5; Lau GKK, 2008, HEPATOL INT, V2, P152, DOI 10.1007/s12072-008-9056-3; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Liaw YF, 1999, HEPATOLOGY, V30, P567, DOI 10.1002/hep.510300221; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; Liaw YF, 2004, GASTROENTEROLOGY, V126, P1024, DOI 10.1053/j.gastro.2004.01.011; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P246, DOI 10.1046/j.1440-1746.2003.02976.x; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liaw YF, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2006.01372.x; Liaw YF, 2006, ANTIVIR THER, V11, P669; Lin HH, 2003, J MED VIROL, V69, P466, DOI 10.1002/jmv.10332; Lin SM, 2007, J HEPATOL, V46, P45, DOI 10.1016/j.jhep.2006.08.021; Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Manesis EK, 2006, J HEPATOL, V45, P343, DOI 10.1016/j.jhep.2006.07.001; Manno M, 2004, GASTROENTEROLOGY, V127, P756, DOI 10.1053/j.gastro.2004.06.021; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; MARCELLIN P, 2008, HEPATOL INT, V2, pA139; MARCELLIN P, 2008, HEPATOL INT, V2, pA114; McKnight C. A., 2007, Morbidity and Mortality Weekly Report, V56, P1164; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; Ni YH, 2007, GASTROENTEROLOGY, V132, P2340, DOI 10.1053/j.gastro.2007.03.111; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Ni YH, 2004, GASTROENTEROLOGY, V127, P1733, DOI 10.1053/j.gastro.2004.09.048; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; OKADA K, 1976, NEW ENGL J MED, V294, P746, DOI 10.1056/NEJM197604012941402; Ong SC, 2008, HEPATOLOGY, V47, P1108, DOI 10.1002/hep.22138; Papatheodoridis GV, 2005, HEPATOLOGY, V42, P121, DOI 10.1002/hep.20760; Park BK, 2007, J GASTROEN HEPATOL, V22, P383, DOI 10.1111/j.1440-1746.2007.04857.x; Perrillo RP, 2002, HEPATOLOGY, V36, P186, DOI 10.1053/jhep.2002.34294; Piratvisuth T, 2008, HEPATOL INT, V2, P102, DOI 10.1007/s12072-007-9022-5; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Rapti I, 2007, HEPATOLOGY, V45, P307, DOI 10.1002/hep.21534; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Sumi H, 2003, HEPATOLOGY, V37, P19, DOI 10.1053/jhep.2003.50036; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Sung JJY, 2008, J HEPATOL, V48, P728, DOI 10.1016/j.jhep.2007.12.026; Tassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; van Zonneveld M, 2004, HEPATOLOGY, V39, P804, DOI 10.1002/hep.20128; Visvanathan K, 2006, SEMIN LIVER DIS, V26, P104, DOI 10.1055/s-2006-939755; Wasley Annemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; YF Liaw, 2006, ASIA PACIFIC POCKET; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; Yu MW, 2000, J NATL CANCER I, V92, P1159, DOI 10.1093/jnci/92.14.1159; Yuen MF, 2004, HEPATOLOGY, V39, P1694, DOI 10.1002/hep.20240; Yuen MF, 2004, J HEPATOL, V41, P119, DOI 10.1016/j.jhep.2004.03.004; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Yuen MF, 2003, CLIN INFECT DIS, V36, P979, DOI 10.1086/374226; Yuen MF, 2003, HEPATOLOGY, V37, P562, DOI 10.1053/jhep.2003.50098; Yuen MF, 2002, J INFECT DIS, V186, P1335, DOI 10.1086/344327; Zacharakis GH, 2005, J MED VIROL, V77, P173, DOI 10.1002/jmv.20434; Zoulim F, 2008, J HEPATOL, V48, pS2, DOI 10.1016/j.jhep.2008.01.011; Zuckerman J, 2007, LANCET INFECT DIS, V7, P410, DOI 10.1016/S1473-3099(07)70136-6; [No title captured]	131	960	1052	5	217	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					582	592		10.1016/S0140-6736(09)60207-5	http://dx.doi.org/10.1016/S0140-6736(09)60207-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406ZO	19217993				2022-12-24	WOS:000263333600037
J	Lancrin, C; Sroczynska, P; Stephenson, C; Allen, T; Kouskoff, V; Lacaud, G				Lancrin, Christophe; Sroczynska, Patrycja; Stephenson, Catherine; Allen, Terry; Kouskoff, Valerie; Lacaud, Georges			The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage	NATURE			English	Article							EMBRYONIC STEM-CELL; DEFINITIVE HEMATOPOIESIS; MOUSE EMBRYO; YOLK-SAC; COMMON PRECURSOR; TYROSINE KINASE; IN-VITRO; EXPRESSION; HEMANGIOBLAST; COMMITMENT	It has been proposed that during embryonic development haematopoietic cells arise from a mesodermal progenitor with both endothelial and haematopoietic potential called the haemangioblast(1,2). A conflicting theory instead associates the first haematopoietic cells with a phenotypically differentiated endothelial cell that has haematopoietic potential ( that is, a haemogenic endothelium) (3-5). Support for the haemangioblast concept was initially provided by the identification during mouse embryonic stem cell differentiation of a clonal precursor, the blast colony- forming cell (BL-CFC), which gives rise to blast colonies with both endothelial and haematopoietic components(6,7). Although recent studies have now provided evidence for the presence of this bipotential precursor in vivo(8,9), the precise mechanism for generation of haematopoietic cells from the haemangioblast still remains completely unknown. Here we demonstrate that the haemangioblast generates haematopoietic cells through the formation of a haemogenic endothelium intermediate, providing the first direct link between these two precursor populations. The cell population containing the haemogenic endothelium is transiently generated during BL-CFC development. This cell population is also present in gastrulating mouse embryos and generates haematopoietic cells on further culture. At the molecular level, we demonstrate that the transcription factor Tal1 ( also known as Scl; ref. 10) is indispensable for the establishment of this haemogenic endothelium population whereas the core binding factor Runx1 ( also known as AML1; ref. 11) is critical for generation of definitive haematopoietic cells from haemogenic endothelium. Together our results merge the two a priori conflicting theories on the origin of haematopoietic development into a single linear developmental process.	[Lancrin, Christophe; Sroczynska, Patrycja; Stephenson, Catherine; Lacaud, Georges] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Stem Cell Biol Grp, Manchester M20 4BX, Lancs, England; [Allen, Terry] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Struct Cell Biol Grp, Manchester M20 4BX, Lancs, England; [Kouskoff, Valerie] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Stem Cell Haematopoiesis Grp, Manchester M20 4BX, Lancs, England	Paterson Institute for Cancer Research; University of Manchester; Paterson Institute for Cancer Research; University of Manchester; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester	Lacaud, G (corresponding author), Univ Manchester, Paterson Inst Canc Res, Canc Res UK Stem Cell Biol Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	glacaud@picr.man.ac.uk	lacaud, Georges/ABH-5215-2020; Lancrin, Christophe/AAG-8169-2019	Lancrin, Christophe/0000-0003-0028-7374; Lacaud, Georges/0000-0002-5630-2417	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank K. Labib, C. Miller and T. Somervaille for critical reading of the manuscript, J. Barry and M. Hughes for cell sorting, S. Bagley for help with the time-lapse photography, G. Ashton for help with preparation of sections, and L. Gautreau for advice with the OP9 cultures. Cancer Research UK supported this work.	Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Choi K, 1998, DEVELOPMENT, V125, P725; D'Souza SL, 2005, BLOOD, V105, P3862, DOI 10.1182/blood-2004-09-3611; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Faloon P, 2000, DEVELOPMENT, V127, P1931; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; Hirai H, 2003, BLOOD, V101, P886, DOI 10.1182/blood-2002-02-0655; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li WM, 2005, STEM CELLS DEV, V14, P44, DOI 10.1089/scd.2005.14.44; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mukouyama Y, 2000, DEV BIOL, V220, P27, DOI 10.1006/dbio.2000.9617; MURRAY PDF, 1932, P R SOC LOND, V11, P497; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Palis J, 1999, DEVELOPMENT, V126, P5073; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Sabin F, 1920, CONTRIB EMBRYOL, V9, P213; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; YOUNG PE, 1995, BLOOD, V85, P96, DOI 10.1182/blood.V85.1.96.bloodjournal85196	30	461	482	4	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					892	895		10.1038/nature07679	http://dx.doi.org/10.1038/nature07679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19182774	Green Accepted			2022-12-24	WOS:000263266700047
J	Ludwig, DS; Pollack, HA				Ludwig, David S.; Pollack, Harold A.			Obesity and the Economy From Crisis to Opportunity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONSEQUENCES		[Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Pollack, Harold A.] Univ Chicago, Ctr Hlth Adm Studies, Chicago, IL 60637 USA	Harvard University; Boston Children's Hospital; University of Chicago	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu	Pollack, Harold A/A-1166-2007	Ludwig, David/0000-0003-3307-8544				*BUR LAB STAT, JUN 2008 CPI DET REP; Caroli M, 2004, INT J OBESITY, V28, pS104, DOI 10.1038/sj.ijo.0802802; Economos CD, 2007, OBESITY, V15, P1325, DOI 10.1038/oby.2007.155; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1808, DOI 10.1001/jama.300.15.1808; Marniemi J, 2002, J INTERN MED, V251, P35, DOI 10.1046/j.1365-2796.2002.00921.x; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Rose D, 1999, J NUTR, V129, p517S, DOI 10.1093/jn/129.2.517S; Roux L, 2006, OBESITY, V14, P1093, DOI 10.1038/oby.2006.125; SHAND D, STANDARD POORS; Wang LY, 2003, OBES RES, V11, P1313, DOI 10.1038/oby.2003.178	14	79	79	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					533	535		10.1001/jama.2009.52	http://dx.doi.org/10.1001/jama.2009.52			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402CS	19190318				2022-12-24	WOS:000262992400024
J	Arias, CA; Murray, BE				Arias, Cesar A.; Murray, Barbara E.			Antibiotic-Resistant Bugs in the 21st Century -- A Clinical Super-Challenge.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Arias, Cesar A.; Murray, Barbara E.] Univ Texas Houston, Sch Med, Dept Internal Med, Houston, TX 77025 USA; [Arias, Cesar A.] Univ El Bosque, Mol Genet & Antimicrobial Resistance Unit, Bogota, Colombia; [Murray, Barbara E.] Univ Texas Houston, Sch Med, Div Infect Dis, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Universidad El Bosque; University of Texas System; University of Texas Health Science Center Houston	Arias, CA (corresponding author), Univ Texas Houston, Sch Med, Dept Internal Med, Houston, TX 77025 USA.							Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; LAX E, 2004, MOLD FLOREYS COAT ST; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Schwartz BS, 2008, ANN PHARMACOTHER, V42, P289, DOI 10.1345/aph.1K548	5	730	821	6	190	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					439	443		10.1056/NEJMp0804651	http://dx.doi.org/10.1056/NEJMp0804651			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179312				2022-12-24	WOS:000262812400002
J	Brandt, F; Etchells, SA; Ortiz, JO; Elcock, AH; Hartl, FU; Baumeister, W				Brandt, Florian; Etchells, Stephanie A.; Ortiz, Julio O.; Elcock, Adrian H.; Hartl, F. Ulrich; Baumeister, Wolfgang			The Native 3D Organization of Bacterial Polysomes	CELL			English	Article							COLI 70S RIBOSOME; TRIGGER FACTOR; NASCENT CHAIN; ESCHERICHIA-COLI; MESSENGER-RNA; ELECTRON TOMOGRAPHY; ANGSTROM RESOLUTION; INITIATION-FACTORS; PROTEIN-SYNTHESIS; BINDING-PROTEIN	Recent advances have led to insights into the structure of the bacterial ribosome, but little is known about the 3D organization of ribosomes in the context of translating polysomes. We employed cryoelectron tomography and a template-matching approach to map 70S ribosomes in vitrified bacterial translation extracts and in lysates of active E. coli spheroplasts. In these preparations, polysomal arrangements were observed in which neighboring ribosomes are densely packed and exhibit preferred orientations. Analysis of characteristic examples of polysomes reveals a staggered or pseudohelical organization of ribosomes along the mRNA trace, with the transcript being sequestered on the inside, the tRNA entrance sites being accessible, and the polypeptide exit sites facing the cytosol. Modeling of elongating nascent polypeptide chains suggests that this arrangement maximizes the distance between nascent chains on adjacent ribosomes, thereby reducing the probability of intermolecular interactions that would give rise to aggregation and limit productive folding.	[Brandt, Florian; Etchells, Stephanie A.; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Brandt, Florian; Ortiz, Julio O.; Baumeister, Wolfgang] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Hartl, F. Ulrich; Baumeister, Wolfgang] Univ Munich, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Elcock, Adrian H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Max Planck Society; Max Planck Society; University of Munich; University of Iowa	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; baumeist@biochem.mpg.de	Elcock, Adrian H./F-4799-2010; Hartl, F. Ulrich/Y-8206-2019	Ortiz, Julio/0000-0001-7470-5546; Elcock, Adrian/0000-0003-2820-1376	European Union; Deutsche Forschungsgemeinschaft [FOR 967]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank S. K. Lakshmipathy for providing the pBAD Luc-SecM-GFP construct. This work was supported by Framework 7 Program of the European Union, by "Fondation Fourmentin Guilbert,'' and by the Deutsche Forschungsgemeinschaft (FOR 967).	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Antoun A, 2006, EMBO J, V25, P2539, DOI 10.1038/sj.emboj.7601140; Arnold TE, 1998, RNA, V4, P319; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; Bashan A, 2005, BIOCHEM SOC T, V33, P488, DOI 10.1042/BST0330488; Bohm J, 2000, P NATL ACAD SCI USA, V97, P14245, DOI 10.1073/pnas.230282097; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Elcock AH, 2006, PLOS COMPUT BIOL, V2, P824, DOI 10.1371/journal.pcbi.0020098; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; Evans MS, 2005, PROTEIN PEPTIDE LETT, V12, P189, DOI 10.2174/0929866053005908; Forster F, 2008, J STRUCT BIOL, V161, P276, DOI 10.1016/j.jsb.2007.07.006; Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299; FRIEDBERG I, 1975, FEBS LETT, V56, P108, DOI 10.1016/0014-5793(75)80121-9; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hsu STD, 2007, P NATL ACAD SCI USA, V104, P16516, DOI 10.1073/pnas.0704664104; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; KIHO Y, 1964, P NATL ACAD SCI USA, V51, P111, DOI 10.1073/pnas.51.1.111; Kopeina GS, 2008, NUCLEIC ACIDS RES, V36, P2476, DOI 10.1093/nar/gkm1177; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Madin K, 2004, FEBS LETT, V562, P155, DOI 10.1016/S0014-5793(04)00221-2; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Ortiz JO, 2006, J STRUCT BIOL, V156, P334, DOI 10.1016/j.jsb.2006.04.014; RICH A, 1963, SCI AM, V209, P44, DOI 10.1038/scientificamerican1263-44; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; SLAYTER H, 1968, J CELL BIOL, V37, P583, DOI 10.1083/jcb.37.2.583; Spirin AS, 2004, TRENDS BIOTECHNOL, V22, P538, DOI 10.1016/j.tibtech.2004.08.012; STAEHELIN T, 1963, NATURE, V199, P865, DOI 10.1038/199865a0; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vanzi F, 2005, BIOPHYS J, V89, P1909, DOI 10.1529/biophysj.104.056283; WARNER JR, 1962, SCIENCE, V138, P1399, DOI 10.1126/science.138.3548.1399; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOOLHEAD CA, 2004, NATURE, V444, P391	44	182	186	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					261	271		10.1016/j.cell.2008.11.016	http://dx.doi.org/10.1016/j.cell.2008.11.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167328	Bronze			2022-12-24	WOS:000262648800015
J	Lyle, K; Kumar, P; Wittmann, T				Lyle, Karen; Kumar, Praveen; Wittmann, Torsten			SnapShot: Microtubule Regulators I	CELL			English	Editorial Material							NUCLEATION; ARRAYS		[Lyle, Karen; Kumar, Praveen; Wittmann, Torsten] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lyle, K (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.		Wittmann, Torsten/F-9833-2013	Wittmann, Torsten/0000-0001-9134-691X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079139] Funding Source: NIH RePORTER; NIDCR NIH HHS [T32 DE007306, 5T32DE007306] Funding Source: Medline; NIGMS NIH HHS [R01 GM079139, R01GM079139] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baas PW, 2005, TRENDS CELL BIOL, V15, P518, DOI 10.1016/j.tcb.2005.08.004; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Ehrhardt DW, 2008, CURR OPIN CELL BIOL, V20, P107, DOI 10.1016/j.ceb.2007.12.004; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Manning J, 2007, INT J BIOCHEM CELL B, V39, P7, DOI 10.1016/j.biocel.2006.08.012; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wordeman L, 2005, CURR OPIN CELL BIOL, V17, P82, DOI 10.1016/j.ceb.2004.12.003	8	10	10	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					379	U189	380.e1	10.1016/j.cell.2009.01.010	http://dx.doi.org/10.1016/j.cell.2009.01.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167337	Bronze, Green Accepted			2022-12-24	WOS:000262648800025
J	Mayor, S				Mayor, Susan			Unravelling the secrets of ageing	BRITISH MEDICAL JOURNAL			English	Editorial Material							LEUKOCYTE TELOMERE LENGTH; DISEASE; CANCER					susanmayor@mac.com						ABRAHAM A, 2004, SCI AGING KNOW ENV, V51, P43; ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Guralnih JM, 2008, ARCH INTERN MED, V168, P131, DOI 10.1001/archinternmed.2007.11; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Poonepalli A, 2008, GENE CHROMOSOME CANC, V47, P1098, DOI 10.1002/gcc.20608; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011	9	2	2	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 8	2009	338								a3024	10.1136/bmj.a3024	http://dx.doi.org/10.1136/bmj.a3024			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PQ	19131385				2022-12-24	WOS:000263165900006
J	Schwartz, LM; Woloshin, S; Welch, HG				Schwartz, Lisa M.; Woloshin, Steven; Welch, H. Gilbert			Using a Drug Facts Box to Communicate Drug Benefits and Harms Two Randomized Trials	ANNALS OF INTERNAL MEDICINE			English	Article							TO-CONSUMER ADVERTISEMENTS; PRESCRIPTION DRUGS; TELEPHONE SURVEY; NONRESPONSE; EXPERIENCE; RISK	Background: Direct-to-consumer prescription drug ads typically fail to provide fundamental information that consumers need to make informed decisions: data on how well the drug works. Objective: To see whether providing consumers with a drug facts box-a table quantifying outcomes with and without the drug improves knowledge and affects judgments about prescription medications. Design: Two randomized, controlled trials conducted between October 2006 and April 2007: a symptom drug box trial using direct-to-consumer ads for a histamine-2 blocker and a proton-pump inhibitor to treat heartburn, and a prevention drug box trial using direct-to-consumer ads for a statin and clopidogrel to prevent cardiovascular events. Setting: National sample of U. S. adults identified by random-digit dialing. Participants: Adults age 35 to 70 years who completed a mailed survey; the final samples comprised 231 participants with completed surveys in the symptom drug box trial (49% response rate) and 219 in the prevention drug box trial (46% response rate). Intervention: In both trials, the control group received 2 actual drug ads (including both the front page and brief summary). The drug box group received the same ads, except that the brief summary was replaced by a drug facts box. Measurements: Choice between drugs (primary outcome of the symptom drug box trial) and accurate perceptions of drug benefits and side effects (primary outcome of the prevention drug box trial). Results: In the symptom drug box trial, 70% of the drug box group and 8% of the control group correctly identified the PPI as being "a lot more effective" than the histamine-2 blocker (P < 0.001), and 80% and 38% correctly recognized that the side effects of the 2 drugs were similar (P < 0.001). When asked what they would do if they had bothersome heartburn and could have either drug for free, 68% of the drug box group and 31% of the control group chose the proton-pump inhibitor, the superior drug (P < 0.001). In the prevention drug box trial, the drug box improved consumers' knowledge of the benefits and side effects of a statin and clopidogrel. For example, 72% of the drug box group and 9% of the control group correctly quantified the benefit (absolute risk reduction) of the statin (P < 0.001). Most of the control participants overestimated this benefit, and 65% did so by a factor of 10 or more. Limitations: The trials tested drug boxes in only 4 direct-to-consumer ads. If other direct-to-consumer ads were to communicate outcome data better, the effect of the drug box would be reduced. Conclusion: A drug facts box improved U. S. consumers' knowledge of prescription drug benefits and side effects. It resulted in better choices between drugs for current symptoms and corrected the overestimation of benefit in the setting of prevention.	Dartmouth Inst Hlth Policy & Clin Practice, Ctr Med Media, Hanover, NH USA; Vet Affairs Outcomes Grp, White River Jct, VT USA	Dartmouth College	Woloshin, S (corresponding author), Vet Affairs Outcomes Grp 111B, Dept Vet Affairs Med Ctr, White River Jct, VT 05009 USA.	steven.woloshin@dartmouth.edu			Robert Wood Johnson; National Cancer Institute [R01CA104721]; Attorney General Consumer and Prescriber Education; NATIONAL CANCER INSTITUTE [R01CA104721] Funding Source: NIH RePORTER	Robert Wood Johnson(Robert Wood Johnson Foundation (RWJF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Attorney General Consumer and Prescriber Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Drs. Schwartz and Woloshin were supported by Robert Wood Johnson Generalist Faculty Scholars Awards. The study was supported by the National Cancer Institute (grant R01CA104721) and the Attorney General Consumer and Prescriber Education grant program.	Avorn J, 2008, NEW ENGL J MED, V359, P991, DOI 10.1056/NEJMp0805922; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bell RA, 2000, J FAM PRACTICE, V49, P1092; Biener L, 2004, AM J PREV MED, V27, P254, DOI 10.1016/j.amepre.2004.05.006; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; *COMM ASS US DRUG, 2006, FUT DRUG SAF PROM PR; Curtin R, 2005, PUBLIC OPIN QUART, V69, P87, DOI 10.1093/poq/nfi002; Davis J, 2007, J HEALTH COMMUN, V12, P607, DOI 10.1080/10810730701615164; Davis JJ, 2007, HEALTH AFFAIR, V26, P863, DOI 10.1377/hlthaff.26.3.863; Frosch DL, 2007, ANN FAM MED, V5, P6, DOI 10.1370/afm.611; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; *I MED, 2007, UND BEN RISKS PHARM; Johnsson F, 2003, SCAND J GASTROENTERO, V38, P347, DOI 10.1080/00365520310002157; Kallen A, 2007, HEALTH AFFAIR, V26, P1392, DOI 10.1377/hlthaff.26.5.1392; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; National Center for Health Statistics, NAT HLTH NUTR EX SUR; *OR HLTH SCI U, DRUG EFF REV PROJ DE; RUSH DR, 1995, J FAM PRACTICE, V41, P126; Schwartz LM, 2007, MED DECIS MAKING, V27, P655, DOI 10.1177/0272989x07306786; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; The American Association for Public Opinion Research, 2008, STAND DEF FIN DISP C; *US FDA, 2004, GUID IND BRIEF SUMM; *US FDA, 2007, 020839 NDA US FDA; *US FDA, OFF MAN BUDG FORM PR; VANPINXTEREN B, 2001, COCHRANE DB SYST REV, P2095; Woloshin S, 2001, LANCET, V358, P1141, DOI 10.1016/S0140-6736(01)06254-7; WOLOSHIN S, 2004, HLTH AFFAIRS S   JAN; Woloshin S, 2008, KNOW YOUR CHANCES UN; Woloshin S, 2007, ANN INTERN MED, V146, P256, DOI 10.7326/0003-4819-146-4-200702200-00004; 2008, DTC PERSPECTIVES, V7, P10	31	186	186	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					516	W93		10.7326/0003-4819-150-8-200904210-00106	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00106			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437AD	19221371				2022-12-24	WOS:000265457000002
J	Sancho, D; Joffre, OP; Keller, AM; Rogers, NC; Martinez, D; Hernanz-Falcon, P; Rosewell, I; Sousa, CRE				Sancho, David; Joffre, Olivier P.; Keller, Anna M.; Rogers, Neil C.; Martinez, Dolores; Hernanz-Falcon, Patricia; Rosewell, Ian; Reis e Sousa, Caetano			Identification of a dendritic cell receptor that couples sensing of necrosis to immunity	NATURE			English	Article							ACTIVATION; ADJUVANTS; DANGER; CLEC9A; DEATH	Injury or impaired clearance of apoptotic cells leads to the pathological accumulation of necrotic corpses, which induce an inflammatory response that initiates tissue repair(1). In addition, antigens present in necrotic cells can sometimes provoke a specific immune response(2-4) and it has been argued that necrosis could explain adaptive immunity in seemingly infection-free situations, such as after allograft transplantation or in spontaneous and therapy-induced tumour rejection(5,6). In the mouse, the CD8 alpha(+) subset of dendritic cells phagocytoses dead cell remnants and cross-primes CD8(+) T cells against cell-associated antigens(7). Here we show that CD8 alpha(+) dendritic cells use CLEC9A (also known as DNGR-1), a recently-characterized C-type lectin(8-10), to recognize a preformed signal that is exposed on necrotic cells. Loss or blockade of CLEC9A does not impair the uptake of necrotic cell material by CD8 alpha(+) dendritic cells, but specifically reduces cross-presentation of dead-cell-associated antigens in vitro and decreases the immunogenicity of necrotic cells in vivo. The function of CLEC9A requires a key tyrosine residue in its intracellular tail that allows the recruitment and activation of the tyrosine kinase SYK, which is also essential for cross-presentation of dead-cell-associated antigens. Thus, CLEC9A functions as a SYK-coupled C-type lectin receptor to mediate sensing of necrosis by the principal dendritic-cell subset involved in regulating cross-priming to cell-associated antigens.	[Sancho, David; Joffre, Olivier P.; Keller, Anna M.; Rogers, Neil C.; Hernanz-Falcon, Patricia; Reis e Sousa, Caetano] Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3PX, England; [Sancho, David; Joffre, Olivier P.; Keller, Anna M.; Rogers, Neil C.; Hernanz-Falcon, Patricia; Reis e Sousa, Caetano] Lincolns Inn Fields Labs, London Res Inst, Canc Res UK, FACS Lab, London WC2A 3PX, England; [Martinez, Dolores; Rosewell, Ian] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, Trangen Serv, Potters Bar EN6 3LD, Herts, England	Cancer Research UK; Cancer Research UK	Sousa, CRE (corresponding author), Lincolns Inn Fields Labs, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@cancer.org.uk	Martinez, Lola/L-2308-2014; Reis e Sousa, Caetano/ABD-7322-2021; Martinez, Lola/ABG-2474-2020; Joffre, Olivier P/K-1235-2014; Reis e Sousa, Caetano/O-1657-2014; Sancho, David/D-3433-2009	Martinez, Lola/0000-0001-6273-6724; Reis e Sousa, Caetano/0000-0001-7392-2119; Joffre, Olivier P/0000-0003-1168-8165; Reis e Sousa, Caetano/0000-0001-7392-2119; Sancho, David/0000-0003-2890-3984; Rogers, Neil/0000-0001-8977-7585	Cancer Research UK; EMBO [ALTF 336-2004]; European Community [MEIF-CT-2005-009205]	Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); European Community(European Commission)	This work was funded by Cancer Research UK. D. S. was supported by an EMBO long-term fellowship (ALTF 336-2004) and by a Marie Curie Intra-European Fellowship within the sixth European Community Framework Programme (MEIF-CT-2005-009205). We thank E. Schweighoffer and V. Tybulewicz for fetal liver from Syk<SUP>-/-</SUP> embryos. We also thank N. Shastri for B3Z and BWZ cell lines and A. Eddaoudi for assistance with cell sorting. We are grateful to members of the Immunobiology Laboratory, Cancer Research UK, for advice and discussions and the Biological Resources staff for animal care and assistance with mouse experiments.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	26	500	522	4	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					899	903		10.1038/nature07750	http://dx.doi.org/10.1038/nature07750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19219027	Green Accepted			2022-12-24	WOS:000265182500045
J	Clemente-Blanco, A; Mayan-Santos, M; Schneider, DA; Machin, F; Jarmuz, A; Tschochner, H; Aragon, L				Clemente-Blanco, Andres; Mayan-Santos, Maria; Schneider, David A.; Machin, Felix; Jarmuz, Adam; Tschochner, Herbert; Aragon, Luis			Cdc14 inhibits transcription by RNA polymerase I during anaphase	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CHROMOSOME CONDENSATION; NUCLEOLAR SEGREGATION; RIBOSOMAL DNA; MITOTIC EXIT; CELL-CYCLE; RDNA; PHOSPHATASE; MITOSIS	Chromosome condensation and the global repression of gene transcription(1) are features of mitosis inmost eukaryotes. The logic behind this phenomenon is that chromosome condensation prevents the activity of RNA polymerases. In budding yeast, however, transcription was proposed to be continuous during mitosis(2). Here we show that Cdc14, a protein phosphatase required for nucleolar segregation(3) and mitotic exit(4), inhibits transcription of yeast ribosomal genes (rDNA) during anaphase. The phosphatase activity of Cdc14 is required for RNA polymerase I (Pol I) inhibition in vitro and in vivo. Moreover Cdc14-dependent inhibition involves nucleolar exclusion of Pol I subunits. We demonstrate that transcription inhibition is necessary for complete chromosome disjunction, because ribosomal RNA (rRNA) transcripts block condensin binding to rDNA, and show that bypassing the role of Cdc14 in nucleolar segregation requires in vivo degradation of nascent transcripts. Our results show that transcription interferes with chromosome condensation, not the reverse. We conclude that budding yeast, like most eukaryotes, inhibit Pol I transcription before segregation as a prerequisite for chromosome condensation and faithful genome separation.	[Clemente-Blanco, Andres; Mayan-Santos, Maria; Machin, Felix; Jarmuz, Adam; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Cell Cycle Grp, London W12 0NN, England; [Schneider, David A.] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Tschochner, Herbert] Univ Regensburg, Inst Biochem Mikrobiol & Genet, Munich, Germany	Imperial College London; University of Alabama System; University of Alabama Birmingham; University of Regensburg	Aragon, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Cell Cycle Grp, Du Cane Rd, London W12 0NN, England.	luis.aragon@csc.mrc.ac.uk	Mayán, María D./AAR-9227-2021; Blanco, Andrés Clemente/D-4255-2014; Machín, Félix/K-6569-2017; Mayan, Maria D./C-8813-2012	Mayán, María D./0000-0002-5809-9440; Blanco, Andrés Clemente/0000-0002-3674-0671; Machín, Félix/0000-0003-4559-7798; Mayan, Maria D./0000-0002-5809-9440; Schneider, David/0000-0003-0635-5091	Medical Research Council of the UK; UAB HSF-GEF; La Junta de Extremadura; MRC [MC_U120074328] Funding Source: UKRI; Medical Research Council [MC_U120074328] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946] Funding Source: NIH RePORTER	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UAB HSF-GEF; La Junta de Extremadura; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Amon, D. Morgan, K. Kitamoto and J. Van Etten for providing reagents, and M. Nomura for advice. We thank members of the Aragon laboratory for discussions. Weacknowledge grant support from UAB HSF-GEF to D. A. S. and from 'La Junta de Extremadura' to A. C.-B. The Aragon laboratory is supported by the Medical Research Council of the UK.	Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; D'Ambrosio C, 2008, CURR BIOL, V18, P1084, DOI 10.1016/j.cub.2008.06.058; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; ELLIOTT SG, 1979, MOL GEN GENET, V169, P237, DOI 10.1007/BF00382269; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; FUJII T, 1995, BIOSCI BIOTECH BIOCH, V59, P1869, DOI 10.1271/bbb.59.1869; Gerber J, 2008, NUCLEIC ACIDS RES, V36, P793, DOI 10.1093/nar/gkm1093; GRANOT D, 1991, CELL MOTIL CYTOSKEL, V20, P47, DOI 10.1002/cm.970200106; Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Machin F, 2005, J CELL BIOL, V168, P209, DOI 10.1083/jcb.200408087; Machin F, 2006, J CELL BIOL, V173, P893, DOI 10.1083/jcb.200511129; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; TAYLOR JH, 1960, ANN NY ACAD SCI, V90, P409, DOI 10.1111/j.1749-6632.1960.tb23259.x; Tomson BN, 2006, MOL CELL BIOL, V26, P6239, DOI 10.1128/MCB.00693-06; Torres-Rosell J, 2004, CELL CYCLE, V3, P496; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Wang BD, 2004, CELL CYCLE, V3, P960; Wang BD, 2006, CELL CYCLE, V5, P2260, DOI 10.4161/cc.5.19.3292	30	94	95	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					219	U8		10.1038/nature07652	http://dx.doi.org/10.1038/nature07652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19158678	Green Accepted			2022-12-24	WOS:000264059700047
J	Leidel, S; Pedrioli, PGA; Bucher, T; Brost, R; Costanzo, M; Schmidt, A; Aebersold, R; Boone, C; Hofmann, K; Peter, M				Leidel, Sebastian; Pedrioli, Patrick G. A.; Bucher, Tamara; Brost, Renee; Costanzo, Michael; Schmidt, Alexander; Aebersold, Ruedi; Boone, Charles; Hofmann, Kay; Peter, Matthias			Ubiquitin-related modifier Urm1 acts as a sulphur carrier in thiolation of eukaryotic transfer RNA	NATURE			English	Article							PROTEIN CONJUGATION; STATISTICAL-MODEL; MASS-SPECTROMETRY; ESCHERICHIA-COLI; BIOSYNTHESIS; YEAST; IDENTIFICATION; THIAMIN; TANDEM; GENES	Ubiquitin-like proteins (UBLs) can change protein function, localization or turnover by covalent attachment to lysine residues(1). Although UBLs achieve this conjugation through an intricate enzymatic cascade, their bacterial counterparts MoaD and ThiS function as sulphur carrier proteins(2,3). Here we show that Urm1p, the most ancient UBL3, acts as a sulphur carrier in the process of eukaryotic transfer RNA ( tRNA) modification, providing a possible evolutionary link between UBL and sulphur transfer. Moreover, we identify Uba4p, Ncs2p, Ncs6p and Yor251cp as components of this conserved pathway. Using in vitro assays, we show that Ncs6p binds to tRNA, whereas Uba4p first adenylates and then directly transfers sulphur onto Urm1p. Finally, functional analysis reveals that the thiolation function of Urm1p is critical to regulate cellular responses to nutrient starvation and oxidative stress conditions, most likely by increasing translation fidelity.	[Leidel, Sebastian; Pedrioli, Patrick G. A.; Bucher, Tamara; Peter, Matthias] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Brost, Renee; Costanzo, Michael; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Brost, Renee; Costanzo, Michael; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Schmidt, Alexander; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Aebersold, Ruedi] Inst Syst Biol, Seattle, WA 98103 USA; [Schmidt, Alexander; Aebersold, Ruedi; Peter, Matthias] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Hofmann, Kay] Miltenyi Biotec GmbH, Bioinformat Grp, D-51429 Bergisch Gladbach, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Toronto; University of Toronto; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Institute for Systems Biology (ISB); Miltenyi Biotec	Peter, M (corresponding author), ETH, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	kay.hofmann@miltenyibiotec.de; matthias.peter@bc.biol.ethz.ch	Bucher, Tamara/AAR-9797-2020; Hofmann, Kay/D-6714-2011; Schmidt, Alexander/D-6426-2011; Leidel, Sebastian/K-9507-2019	Bucher, Tamara/0000-0003-3244-5867; Hofmann, Kay/0000-0002-2289-9083; Schmidt, Alexander/0000-0002-3149-2381; Leidel, Sebastian/0000-0002-0523-6325; Peter, Matthias/0000-0002-2160-6824	EuroDyna; Roche Research Foundation; ETHZ; SNF; Canadian Institutes of Health Research; Genome Canada through the Ontario Genomics Institute	EuroDyna; Roche Research Foundation; ETHZ(ETH Zurich); SNF; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada)	We thank C. Rupp for technical support, M. Sohrmann for yeast strains, G. Rabut for the gift of the pGR51 plasmid, G. L. Igloi and K.-H. Altmann for providing APM, S. Mitani for tut-1(tm1297), B. Casado-Fernandez and D. Hilvert for discussion and technical advice, and T. Kurz and J. D. Alfonzo for reading the manuscript. This work was supported by grants from EuroDyna ( to S. L.), the Roche Research Foundation ( to P. G. A. P.), ETHZ ( to S. L. and M. P.), the SNF ( to M. P.), the Canadian Institutes of Health Research ( to C. B.) and Genome Canada through the Ontario Genomics Institute ( to C. B.).	Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; BRENNER S, 1974, GENETICS, V77, P71; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; Jager G, 2004, J BACTERIOL, V186, P750, DOI 10.1128/JB.186.3.750-757.2004; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Jeong JS, 1999, BIOCHEMISTRY-US, V38, P776, DOI 10.1021/bi9817818; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Mueller EG, 1999, PROTEIN SCI, V8, P2424; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Rubio-Texeira M, 2007, FEBS LETT, V581, P541, DOI 10.1016/j.febslet.2007.01.019; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Shigi N, 2006, J BIOL CHEM, V281, P14296, DOI 10.1074/jbc.M511675200; Suzuki T, 2007, METHOD ENZYMOL, V425, P231, DOI 10.1016/S0076-6879(07)25010-4; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Tong A. H. Y., 2007, METHD MICROBIOL, V36, p[369, 706]; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Xu JJ, 2006, P NATL ACAD SCI USA, V103, P11625, DOI 10.1073/pnas.0604876103	49	197	212	4	33	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					228	U9		10.1038/nature07643	http://dx.doi.org/10.1038/nature07643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19145231				2022-12-24	WOS:000264059700049
J	Van Mooy, BAS; Fredricks, HF; Pedler, BE; Dyhrman, ST; Karl, DM; Koblizek, M; Lomas, MW; Mincer, TJ; Moore, LR; Moutin, T; Rappe, MS; Webb, EA				Van Mooy, Benjamin A. S.; Fredricks, Helen F.; Pedler, Byron E.; Dyhrman, Sonya T.; Karl, David M.; Koblizek, Michal; Lomas, Michael W.; Mincer, Tracy J.; Moore, Lisa R.; Moutin, Thierry; Rappe, Michael S.; Webb, Eric A.			Phytoplankton in the ocean use non-phosphorus lipids in response to phosphorus scarcity	NATURE			English	Article							NITROGEN-FIXATION; N-P; LIMITATION; PHOSPHATE; GROWTH; BACTERIOPLANKTON; PROCHLOROCOCCUS; TRICHODESMIUM; BIOSYNTHESIS; AVAILABILITY	Phosphorus is an obligate requirement for the growth of all organisms; major biochemical reservoirs of phosphorus in marine plankton include nucleic acids and phospholipids(1-3). However, eukaryotic phytoplankton and cyanobacteria (that is, 'phytoplankton' collectively) have the ability to decrease their cellular phosphorus content when phosphorus in their environment is scarce(1,4,5). The biochemical mechanisms that allow phytoplankton to limit their phosphorus demand and still maintain growth are largely unknown. Here we show that phytoplankton, in regions of oligotrophic ocean where phosphate is scarce, reduce their cellular phosphorus requirements by substituting non-phosphorus membrane lipids for phospholipids. In the Sargasso Sea, where phosphate concentrations were less than 10 nmol l(-1), we found that only 1.3 +/- 0.6% of phosphate uptake was used for phospholipid synthesis; in contrast, in the South Pacific subtropical gyre, where phosphate was greater than 100 nmol l(-1), plankton used 17 +/- 6% (ref. 6). Examination of the planktonic membrane lipids at these two locations showed that classes of sulphur- and nitrogen-containing membrane lipids, which are devoid of phosphorus, were more abundant in the Sargasso Sea than in the South Pacific. Furthermore, these non-phosphorus, 'substitute lipids' were dominant in phosphorus-limited cultures of all of the phytoplankton species we examined. In contrast, the marine heterotrophic bacteria we examined contained no substitute lipids and only phospholipids. Thus heterotrophic bacteria, which compete with phytoplankton for nutrients in oligotrophic regions like the Sargasso Sea, appear to have a biochemical phosphorus requirement that phytoplankton avoid by using substitute lipids. Our results suggest that phospholipid substitutions are fundamental biochemical mechanisms that allow phytoplankton to maintain growth in the face of phosphorus limitation.	[Van Mooy, Benjamin A. S.; Fredricks, Helen F.; Pedler, Byron E.; Mincer, Tracy J.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Dyhrman, Sonya T.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Karl, David M.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Koblizek, Michal] Acad Sci Czech Republ, Inst Microbiol, Trebon, Czech Republic; [Koblizek, Michal] Univ S Bohemia, Inst Phys Biol, Nove Hrady, Czech Republic; [Lomas, Michael W.] Bermuda Inst Ocean Sci, St George, Bermuda; [Moore, Lisa R.] Univ So Maine, Dept Biol Sci, Portland, ME 04103 USA; [Moutin, Thierry] Aix Marseille Univ, Ctr Oceanol Marseille, Lab Oceanog Phys & Biogeochim, Marseille, France; [Rappe, Michael S.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Webb, Eric A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; University of Hawaii System; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Bermuda Institute of Ocean Sciences; University of Maine System; University of Southern Maine; UDICE-French Research Universities; Aix-Marseille Universite; University of Hawaii System; University of Southern California	Van Mooy, BAS (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	bvanmooy@whoi.edu	Koblizek, Michal/H-2851-2014; Karl, David/AFP-3837-2022	Webb, Eric/0000-0003-4085-7730; Lomas, Michael/0000-0003-1209-3753; Moore, Lisa/0000-0002-4114-1518; Pedler Sherwood, Byron/0000-0001-9578-0481; Mincer, Tracy/0000-0002-4644-5609; Karl, David/0000-0002-6660-6721	National Science Foundation [OCE-0646944, OCE-0451419, OCE-0326616, OCE-0453023, OCE-0453019, DEB-0207085]; Office of Naval Research [N00014-06-1-0134, GAAV-1QS500200570]; Centre National de la Recherche Scientifique; Institut des Sciences de l'Univers; Gordon and Betty Moore Foundation; Center for Microbial Oceanography: Research and Education; Woods Hole Oceanographic Institution Ocean Life Institute; Woods Hole Oceanographic Institution Mary Sears Travel Fund	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut des Sciences de l'Univers; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Center for Microbial Oceanography: Research and Education; Woods Hole Oceanographic Institution Ocean Life Institute; Woods Hole Oceanographic Institution Mary Sears Travel Fund	We thank the captains and crews of the RVs L'Atalante, Atlantic Explorer, Kilo Moana and Ka'imikai-o-Kanaloa. J. Dacey, R. Johnson, N. Levine, T. Gregory, D. Sadler, H. Claustre and A. Sciandra provided access and logistical support for our cruises. K. Bjorkman and P. Rimmelin provided phosphate data. N. Trowbridge, M. Brandon, S. Haley, E. Orchard and K. Roache-Johnson assisted with cultures. D. Glover provided input on data treatment and presentation. This research was supported by grants from the National Science Foundation (OCE-0646944 to B. A. S. V. M., OCE-0451419 to S. T. D., OCE-0326616 to D. M. K., OCE-0453023 to M. W. L., OCE-0453019 to L. R. M. and DEB-0207085 to M. S. R.), the Office of Naval Research (N00014-06-1-0134 to B. A. S. V. M.) and Czech Republic research grants (GACR-206/07/0241 and GAAV-1QS500200570 to M. K.). The BIOSOPE campaign was a contribution of the French LEFE-CYBER program funded by the Centre National de la Recherche Scientifique and the Institut des Sciences de l'Univers. Funding was also provided by the Gordon and Betty Moore Foundation, the Center for Microbial Oceanography: Research and Education, the Woods Hole Oceanographic Institution Ocean Life Institute and the Woods Hole Oceanographic Institution Mary Sears Travel Fund.	Ammerman J.W., 2003, EOS T AM GEOPHYS UN, V84, P165, DOI [10.1029/2003-o180001, DOI 10.1029/2003EO180001, 10.1029/2003EO180001]; BENNING C, 1993, P NATL ACAD SCI USA, V90, P1561, DOI 10.1073/pnas.90.4.1561; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bjorkman KM, 2003, LIMNOL OCEANOGR, V48, P1049; Carlson CA, 1996, DEEP-SEA RES PT II, V43, P491, DOI 10.1016/0967-0645(95)00101-8; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Guler S, 2000, J BACTERIOL, V182, P543, DOI 10.1128/JB.182.2.543-545.2000; Koblizek M, 2007, ENVIRON MICROBIOL, V9, P2401, DOI 10.1111/j.1462-2920.2007.01354.x; Krauk JM, 2006, AQUAT MICROB ECOL, V42, P243, DOI 10.3354/ame042243; Lomas MW, 2004, LIMNOL OCEANOGR, V49, P2303, DOI 10.4319/lo.2004.49.6.2303; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Mills MM, 2008, LIMNOL OCEANOGR, V53, P824, DOI 10.4319/lo.2008.53.2.0824; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Moutin T, 2008, BIOGEOSCIENCES, V5, P95, DOI 10.5194/bg-5-95-2008; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Riekhof WR, 2005, ARCH BIOCHEM BIOPHYS, V441, P96, DOI 10.1016/j.abb.2005.07.001; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; SATO N, 2000, RECENT ADV BIOCH PLA; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632; Van Mooy BAS, 2008, BIOGEOSCIENCES, V5, P133, DOI 10.5194/bg-5-133-2008; Van Mooy BAS, 2008, LIMNOL OCEANOGR, V53, P78, DOI 10.4319/lo.2008.53.1.0078; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; Webb EA, 2007, LIMNOL OCEANOGR, V52, P2221, DOI 10.4319/lo.2007.52.5.2221; Weissenmayer B, 2002, MOL MICROBIOL, V45, P721, DOI 10.1046/j.1365-2958.2002.03043.x; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zubkov MV, 2007, ENVIRON MICROBIOL, V9, P2079, DOI 10.1111/j.1462-2920.2007.01324.x	30	505	517	17	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					69	72		10.1038/nature07659	http://dx.doi.org/10.1038/nature07659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19182781				2022-12-24	WOS:000263836000034
J	Epstein, SS				Epstein, Slava S.			Microbial awakenings	NATURE			English	Editorial Material									Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Northeastern University	Epstein, SS (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	s.epstein@neu.edu							0	121	123	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					1083	1083		10.1038/4571083a	http://dx.doi.org/10.1038/4571083a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242455				2022-12-24	WOS:000263680100020
J	Cam, HP; Chen, ES; Grewal, SIS				Cam, Hugh P.; Chen, Ee Sin; Grewal, Shiv I. S.			Transcriptional Scaffolds for Heterochromatin Assembly	CELL			English	Article							RNA; CHROMATIN; COMPLEX; GENES; ROLES	Heterochromatin is dynamically regulated during the cell cycle and in response to developmental signals. Recent findings from diverse systems suggest an extensive role for transcription in the assembly of heterochromatin, highlighting the emerging theme that transcription and noncoding RNAs can provide the initial scaffold for the formation of heterochromatin, which serves as a versatile recruiting platform for diverse factors involved in many cellular processes.	[Cam, Hugh P.; Chen, Ee Sin; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Grewal, Shiv/0000-0002-4552-9261	NATIONAL CANCER INSTITUTE [Z01BC010523, ZIABC010523, ZIABC011208] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA BC011208-04, Z01 BC010523-05, Z01 BC010523-04, ZIA BC011208-05, Z99 CA999999] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	20	58	60	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					610	614		10.1016/j.cell.2009.02.004	http://dx.doi.org/10.1016/j.cell.2009.02.004			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239883	Bronze, Green Accepted			2022-12-24	WOS:000263688200013
J	Rothman, JS; Cathala, L; Steuber, V; Silver, RA				Rothman, Jason S.; Cathala, Laurence; Steuber, Volker; Silver, R. Angus			Synaptic depression enables neuronal gain control	NATURE			English	Article							SHUNTING INHIBITION; PYRAMIDAL NEURONS; NMDA RECEPTORS; SINGLE; NOISE; TRANSMISSION; INVARIANCE; SYNAPSES; CELLS; MODEL	To act as computational devices, neurons must perform mathematical operations as they transform synaptic and modulatory input into output firing rate(1). Experiments and theory indicate that neuronal firing typically represents the sum of synaptic inputs(1-3), an additive operation, but multiplication of inputs is essential for many computations(1). Multiplication by a constant produces a change in the slope, or gain, of the input - output relationship, amplifying or scaling down the sensitivity of the neuron to changes in its input. Such gain modulation occurs in vivo, during contrast invariance of orientation tuning(4), attentional scaling(5), translation- invariant object recognition(6), auditory processing(7) and coordinate transformations(8,9). Moreover, theoretical studies highlight the necessity of gain modulation in several of these tasks(9-11). Although potential cellular mechanisms for gain modulation have been identified, they often rely on membrane noise and require restrictive conditions to work(3,12-18). Because nonlinear components are used to scale signals in electronics, we examined whether synaptic nonlinearities are involved in neuronal gain modulation. We used synaptic stimulation and the dynamic- clamp technique to investigate gain modulation in granule cells in acute slices of rat cerebellum. Here we show that when excitation is mediated by synapses with short- term depression ( STD), neuronal gain is controlled by an inhibitory conductance in a noise-independent manner, allowing driving and modulatory inputs to be multiplied together. The nonlinearity introduced by STD transforms inhibition- mediated additive shifts in the input - output relationship into multiplicative gain changes. When granule cells were driven with bursts of high- frequency mossy fibre input, as observed in vivo(19,20), larger inhibition- mediated gain changes were observed, as expected with greater STD. Simulations of synaptic integration in more complex neocortical neurons suggest that STD- based gain modulation can also operate in neurons with large dendritic trees. Our results establish that neurons receiving depressing excitatory inputs can act as powerful multiplicative devices even when integration of postsynaptic conductances is linear.	[Rothman, Jason S.; Cathala, Laurence; Steuber, Volker; Silver, R. Angus] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Silver, RA (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk		Steuber, Volker/0000-0003-0186-3580; Silver, Robin/0000-0002-5480-6638; Rothman, Jason/0000-0003-3036-2291	Wellcome Trust; MRC [G0400598]; EU EUSynapse [LSHM-CT-2005-019055]; Wellcome Senior Research Fellowship; BBSRC [BB/F005369/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005369/1] Funding Source: researchfish; Medical Research Council [G0400598] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU EUSynapse; Wellcome Senior Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This was supported by the Wellcome Trust, MRC (G0400598) and EU (EUSynapse, LSHM-CT-2005-019055). R.A.S. is in receipt of a Wellcome Senior Research Fellowship. We thank P. Gleeson for help with neuroConstruct, D. Ward and R. Kanichay for their experimental support, D. Digregorio and P. Kirkby for discussions, and A. Arenz, D. Attwell, G. Billings, E. Chaigneau, D. DiGregorio, M. Farrant, F. Minneci and K. Vervaeke for their comments on the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; Berends M, 2005, NEURAL COMPUT, V17, P2531, DOI 10.1162/089976605774320520; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Cathala L, 2000, J NEUROSCI, V20, P5899, DOI 10.1523/JNEUROSCI.20-16-05899.2000; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Gleeson P, 2007, NEURON, V54, P219, DOI 10.1016/j.neuron.2007.03.025; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Ingham NJ, 2005, J NEUROSCI, V25, P6187, DOI 10.1523/JNEUROSCI.0146-05.2005; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Koch Christof, 1999, P1; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Murphy BK, 2003, J NEUROSCI, V23, P10040; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; SALINAS E, 1995, J NEUROSCI, V15, P6461; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Schwindt P, 1997, J NEUROPHYSIOL, V77, P2484, DOI 10.1152/jn.1997.77.5.2484; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Tiesinga PHE, 2000, PHYS REV E, V62, P8413, DOI 10.1103/PhysRevE.62.8413; TOVEE MJ, 1994, J NEUROPHYSIOL, V72, P1049, DOI 10.1152/jn.1994.72.3.1049; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P5495; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Varela JA, 1997, J NEUROSCI, V17, P7926; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003	44	157	157	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1015	U6		10.1038/nature07604	http://dx.doi.org/10.1038/nature07604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19145233	Green Accepted			2022-12-24	WOS:000263425400043
J	Ricardo, S; Lehmann, R				Ricardo, Sara; Lehmann, Ruth			An ABC Transporter Controls Export of a Drosophila Germ Cell Attractant	SCIENCE			English	Article							GENE ENCODES; A-FACTOR; P-GLYCOPROTEIN; MELANOGASTER; PROTEOLYSIS; SECRETION; MIGRATION; RAS; RHO	Directed cell migration, which is critical for embryonic development, leukocyte trafficking, and cell metastasis, depends on chemoattraction. 3-hydroxy-3-methylglutaryl coenzyme A reductase regulates the production of an attractant for Drosophila germ cells that may itself be geranylated. Chemoattractants are commonly secreted through a classical, signal peptide- dependent pathway, but a geranyl- modified attractant would require an alternative pathway. In budding yeast, pheromones produced by a-cells are farnesylated and secreted in a signal peptide- independent manner, requiring the adenosine triphosphate- binding cassette ( ABC) transporter Ste6p. Here we show that Drosophila germ cell migration uses a similar pathway, demonstrating that invertebrate germ cells, like yeast cells, are attracted to lipid- modified peptides. Components of this unconventional export pathway are highly conserved, suggesting that this pathway may control the production of similarly modified chemoattractants in organisms ranging from yeast to humans.	[Ricardo, Sara; Lehmann, Ruth] NYU, Helen L & Martin S Kimmel Ctr Biol & Med, Howard Hughes Med Inst, Sch Med,Skirball Inst,Dept Cell Biol, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University	Lehmann, R (corresponding author), NYU, Helen L & Martin S Kimmel Ctr Biol & Med, Howard Hughes Med Inst, Sch Med,Skirball Inst,Dept Cell Biol, 550 1st Ave, New York, NY 10016 USA.	lehmann@saturn.med.nyu.edu	Ricardo, Sara/I-1653-2015	Lehmann, Ruth/0000-0002-8454-5651; Ricardo, Sara/0000-0002-8605-2500	NIH [HD49100]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041900] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD049100] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank P. Lopez and G. de la Cruz for FACS sorting; S. Michaelis for reagents and discussions; J. Treisman, Blomington stock center, and the Drosophila Genomics Resource Center for fly lines and reagents; the Lehmann Lab; and D. Siekhaus and S. Burden for comments on the manuscript. This work was supported by NIH grant HD49100. S. R. is a HHMI research associate; R. L. is an HHMI investigator and a member of the Kimmel Stem Cell Center.	Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Christensen PU, 1997, MOL GEN GENET, V255, P226, DOI 10.1007/s004380050493; Dean M, 2001, J LIPID RES, V42, P1007; ECHALIER G, 1969, CR ACAD SCI D NAT, V268, P1771; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Johndrow JE, 2004, BIOCHEM CELL BIOL, V82, P643, DOI 10.1139/O04-118; Leung GK, 2001, J BIOL CHEM, V276, P29051, DOI 10.1074/jbc.M102908200; Magie CR, 1999, DEVELOPMENT, V126, P5353; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; RAYMOND M, 1992, SCIENCE, V256, P232, DOI 10.1126/science.1348873; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; Sano H, 2005, J CELL BIOL, V171, P675, DOI 10.1083/jcb.200506038; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; Settleman J, 2001, DEV CELL, V1, P321, DOI 10.1016/S1534-5807(01)00053-3; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612	21	83	84	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					943	946		10.1126/science.1166239	http://dx.doi.org/10.1126/science.1166239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213920	Green Accepted			2022-12-24	WOS:000263295400045
J	Hemerly, AS; Prasanth, SG; Siddiqui, K; Stillman, B				Hemerly, Adriana S.; Prasanth, Supriya G.; Siddiqui, Khalid; Stillman, Bruce			Orc1 Controls Centriole and Centrosome Copy Number in Human Cells	SCIENCE			English	Article							ORIGIN RECOGNITION COMPLEX; CYCLIN-E; DNA-REPLICATION; DUPLICATION; AMPLIFICATION; OVERDUPLICATION; LOCALIZATION; ACCUMULATION; CDK2-CYCLIN; LICENSES	Centrosomes, each containing a pair of centrioles, organize microtubules in animal cells, particularly during mitosis. DNA and centrosomes are normally duplicated once before cell division to maintain optimal genome integrity. We report a new role for the Orc1 protein, a subunit of the origin recognition complex ( ORC) that is a key component of the DNA replication licensing machinery, in controlling centriole and centrosome copy number in human cells, independent of its role in DNA replication. Cyclin A promotes Orc1 localization to centrosomes where Orc1 prevents Cyclin E- dependent reduplication of both centrioles and centrosomes in a single cell division cycle. The data suggest that Orc1 is a regulator of centriole and centrosome reduplication as well as the initiation of DNA replication.	[Hemerly, Adriana S.; Prasanth, Supriya G.; Siddiqui, Khalid; Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hemerly, Adriana S.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil	Cold Spring Harbor Laboratory; Universidade Federal do Rio de Janeiro	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stillman@cshl.edu		Stillman, Bruce/0000-0002-9453-4091; /0000-0001-6448-0902	National Institutes of Health [CA13106]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Spector for critical reading of the manuscript, P. Wendel for technical support, and J. Salisbury and S. Doxsey for providing antibodies to centrin 2 and centriolin, respectively. This work was supported by a grant from the National Institutes of Health (CA13106), a fellowship from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) to A.S.H., and a Special Fellow award from the Leukemia and Lymphoma Society to S.G.P.	Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Duensing A, 2006, ONCOGENE, V25, P2943, DOI 10.1038/sj.onc.1209310; Ferguson RL, 2008, J CELL SCI, V121, P3224, DOI 10.1242/jcs.034702; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Gillingham AK, 2000, EMBO REP, V1, P524; Hanashiro K, 2008, ONCOGENE, V27, P5288, DOI 10.1038/onc.2008.161; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Laman H, 2001, EXP CELL RES, V271, P230, DOI 10.1006/excr.2001.5360; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Saavedra HI, 2003, CANCER CELL, V3, P333, DOI 10.1016/S1535-6108(03)00083-7; Sasaki T, 2007, CURR OPIN CELL BIOL, V19, P337, DOI 10.1016/j.ceb.2007.04.007; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Sugihara E, 2006, CANCER RES, V66, P4020, DOI 10.1158/0008-5472.CAN-05-3250; Tachibana KEK, 2005, EMBO REP, V6, P1052, DOI 10.1038/sj.embor.7400527; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993	30	114	118	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					789	793		10.1126/science.1166745	http://dx.doi.org/10.1126/science.1166745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197067	Green Accepted			2022-12-24	WOS:000263066800049
J	Paynter, NP; Chasman, DI; Buring, JE; Shiffman, D; Cook, NR; Ridker, PM				Paynter, Nina P.; Chasman, Daniel I.; Buring, Julie E.; Shiffman, Dov; Cook, Nancy R.; Ridker, Paul M.			Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3	ANNALS OF INTERNAL MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; MYOCARDIAL-INFARCTION; POLYMORPHISMS; REPLICATION; VALIDATION; MODELS	Background: Although genetic variation at chromosome 9p21.3 is associated with incident cardiovascular disease, it is unclear whether screening for this polymorphism improves risk prediction. Objective: To determine whether knowledge of variation at chromosome 9p21.3 provides predictive information beyond that from other readily available risk factors. Design: Prospective cohort study. Setting: United States. Patients: 22 129 female white health professionals participating in the Women's Genome Health Study, initially without any major chronic disease, who were prospectively followed over a median of 10.2 years for incident cardiovascular disease. Measurements: Polymorphism at rs10757274 in chromosome 9p21.3 and additional cardiovascular disease risk factors (blood pressure, smoking status, diabetes, blood levels of cholesterol, highsensitivity C-reactive protein, and family history of premature myocardial infarction). Results: Polymorphism at rs10757274 was associated with an adjusted hazard ratio for incident cardiovascular disease of 1.25 (95% CI, 1.04 to 1.51) for the AG genotype and 1.32 (CI, 1.07 to 1.63) for the GG genotype. However, the addition of the genotype to a prediction model based on traditional risk factors, high-sensitivity C-reactive protein, and family history of premature myocardial infarction had no effect on model discrimination as measured by the c-index (0.807 to 0.809) and did not improve the Net Reclassification Improvement score (-0.2%; P = 0.59) or the Integrated Discrimination Improvement score (0.0; P = 0.18). Limitation: Study participants were all white women. Conclusion: In this large prospective cohort of white women, genetic variation in chromosome 9p21.3 was associated with incident cardiovascular disease but did not improve on the discrimination or classification of predicted risk achieved with traditional risk factors, high-sensitivity C-reactive protein, and family history of premature myocardial infarction.	[Paynter, Nina P.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Celera, Alameda, CA USA	Harvard University; Brigham & Women's Hospital	Paynter, NP (corresponding author), Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	npaynter@partners.org			National Heart, Lung, and Blood Institute and National Cancer Institute; Donald W. Reynolds Foundation; Leducq Foundation; Celera; Roche Diagnostics; Amgen; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Foundation; Leducq Foundation; Celera(Leducq Foundation); Roche Diagnostics; Amgen(Amgen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute and National Cancer Institute; Donald W. Reynolds Foundation; Leducq Foundation; Celera; Roche Diagnostics; and Amgen.	Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	22	195	199	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					65	U16		10.7326/0003-4819-150-2-200901200-00003	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19153409	Green Accepted			2022-12-24	WOS:000262655200001
J	Fischer, J; Koch, L; Emmerling, C; Vierkotten, J; Peters, T; Bruning, JC; Ruther, U				Fischer, Julia; Koch, Linda; Emmerling, Christian; Vierkotten, Jeanette; Peters, Thomas; Bruening, Jens C.; Ruether, Ulrich			Inactivation of the Fto gene protects from obesity	NATURE			English	Article							FUSED TOES FT; GENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; HORMONAL-CONTROL; ADULT OBESITY; FAT MASS; ADIPONECTIN; WEIGHT; HUMANS; MICE	Several independent, genome-wide association studies have identified a strong correlation between body mass index and polymorphisms in the human FTO gene(1-4). Common variants in the first intron define a risk allele predisposing to obesity, with homozygotes for the risk allele weighing approximately 3 kilograms more than homozygotes for the low risk allele(1). Nevertheless, the functional role of FTO in energy homeostasis remains elusive. Here we show that the loss of Fto in mice leads to postnatal growth retardation and a significant reduction in adipose tissue and lean body mass. The leanness of Fto-deficient mice develops as a consequence of increased energy expenditure and systemic sympathetic activation, despite decreased spontaneous locomotor activity and relative hyperphagia. Taken together, these experiments provide, to our knowledge, the first direct demonstration that Fto is functionally involved in energy homeostasis by the control of energy expenditure.	[Fischer, Julia; Emmerling, Christian; Vierkotten, Jeanette; Peters, Thomas; Ruether, Ulrich] Univ Dusseldorf, Inst Anim Dev & Mol Biol, D-40225 Dusseldorf, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, Dept Mouse Genet & Metab, Inst Genet, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, Dept Internal Med 2, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, CMMC, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Max Planck Inst Biol Ageing, D-50674 Cologne, Germany	Heinrich Heine University Dusseldorf; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society	Ruther, U (corresponding author), Univ Dusseldorf, Inst Anim Dev & Mol Biol, Univ Str 1, D-40225 Dusseldorf, Germany.	jens.bruening@uni-koeln.de; ruether@uni-duesseldorf.de	Peters, Thomas/GQB-3622-2022	Koch, Linda/0000-0002-2943-1993	Deutsche Forschungsgemeinschaft; NGFNplus	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NGFNplus	The authors thank S. Kuschel and B. Hampel for technical assistance, S. Fischer for critical reading of this manuscript, as well as W. Stoffel, B. Jehnke and H. Bronneke for support during assessment of energy expenditure. This work was supported by the Deutsche Forschungsgemeinschaft (to U.R. and J.C.B.) and in part by NGFNplus (to U.R.).	Caro JF, 1996, DIABETES, V45, P1455, DOI 10.2337/diab.45.11.1455; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grunnet LG, 2009, J CLIN ENDOCR METAB, V94, P596, DOI 10.1210/jc.2008-1592; Jeon JY, 2006, DIABETES, V55, P428, DOI 10.2337/diabetes.55.02.06.db05-0203; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; MIYOSHI H, 1988, J CLIN INVEST, V81, P1545, DOI 10.1172/JCI113487; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; VANDERHOEVEN F, 1994, DEVELOPMENT, V120, P2601; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; WOLFE RR, 1987, NEW ENGL J MED, V317, P403, DOI 10.1056/NEJM198708133170702; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	30	690	732	3	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 16	2009	458	7240					894	U10		10.1038/nature07848	http://dx.doi.org/10.1038/nature07848			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19234441				2022-12-24	WOS:000265182500044
J	Perros, P; Neoh, C; Dickinson, J				Perros, Petros; Neoh, Christopher; Dickinson, Jane			Thyroid eye disease	BRITISH MEDICAL JOURNAL			English	Review							GRAVES OPHTHALMOPATHY; EUROPEAN GROUP; ORBITOPATHY; MANAGEMENT; GLUCOCORTICOIDS; HYPERTHYROIDISM; PATHOGENESIS; THERAPY		[Perros, Petros] Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Neoh, Christopher; Dickinson, Jane] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Perros, P (corresponding author), Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	petros.perros@ncl.ac.uk		Perros, Petros/0000-0001-7320-5574				BALDESCHI L, 2008, GRAVES ORBITOPATHY M, P160; Bartalena L, 2005, EUR J ENDOCRINOL, V153, P13, DOI 10.1530/eje.1.01938; Bartalena L, 2008, EUR J ENDOCRINOL, V158, P273, DOI 10.1530/EJE-07-0666; BARTLEY GB, 1995, AM J OPHTHALMOL, V120, P511, DOI 10.1016/S0002-9394(14)72666-2; Boboridis K, 2008, GRAVES ORBITOPATHY M, P88; Coulter I, 2007, EUR J ENDOCRINOL, V157, P127, DOI 10.1530/EJE-07-0205; Dickinson AJ, 2001, CLIN ENDOCRINOL, V55, P283, DOI 10.1046/j.1365-2265.2001.01349.x; Gianoukakis AG, 2008, THYROID, V18, P953, DOI 10.1089/thy.2007.0405; Hart R H, 2003, Minerva Endocrinol, V28, P223; Hart RH, 2005, J OCUL PHARMACOL TH, V21, P328, DOI 10.1089/jop.2005.21.328; KENDALLTAYLOR P, 2008, GRAVES ORBITOPATHY M, P78; Khoo TK, 2007, THYROID, V17, P1013, DOI 10.1089/thy.2007.0185; Krassas Gerasimos E, 2007, Pediatr Endocrinol Rev, V4, P218; Mourits MP, 2002, BRIT J OPHTHALMOL, V86, P104; NEOH C, 2008, GRAVES ORBITOPATHY M, P188; ORGIAZZI J, 2008, GRAVES ORBITOPATHY M, P41; Perros P, 2006, EUR J ENDOCRINOL, V155, P207, DOI 10.1530/eje.1.02201; Perros P, 2005, J CLIN ENDOCR METAB, V90, P5321, DOI 10.1210/jc.2005-0507; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; SALVI M, 1990, J CLIN ENDOCR METAB, V70, P89, DOI 10.1210/jcem-70-1-89; Wiersinga WM, 2006, EUR J ENDOCRINOL, V155, P387, DOI 10.1530/eje.1.02230; Wiersinga WM, 2007, NAT CLIN PRACT ENDOC, V3, P396, DOI 10.1038/ncpendmet0497	22	45	47	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 6	2009	338								b560	10.1136/bmj.b560	http://dx.doi.org/10.1136/bmj.b560			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417EE	19270020				2022-12-24	WOS:000264058500001
J	Hurley, R				Hurley, Richard			Public Health Bad blood: gay men and blood donation	BRITISH MEDICAL JOURNAL			English	Editorial Material							EVER HAD SEX		BMJ, London WC1H 9JR, England		Hurley, R (corresponding author), BMJ, London WC1H 9JR, England.	rhurley@bmj.com						[Anonymous], 2008, BBC NEWS        1104; Brooks JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b318; *CAN BLOOD SERV, IND DEF; *CARE2PETITIONSITE, ALL GAY PEOPL BLOOD; *DEP HLTH HUM SERV, 2006, BLOOD SAF AV ADV COM; *FOOD DRUG ADM, FDA POL BLOOD DON ME; *HLTH PROT AG, 2007, TEST TIM HIV OTH SEX; IRVINE C, 2008, DAILY TELEGRAPH 1112; *NAT BLOOD SERV EN, WHO CAN GIV BLOOD; *NHS BLOOD TRANSP, 2008, EXCL MEN WHO HAV SEX; *PRIM MIN OFF, 2007, BLOODB EP RESP; Roehr B, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b311; *SCOTT PARL INF CT, 2008, BRIEF PUBL PET COMM; Soldan K, 2003, VOX SANG, V84, P265, DOI 10.1046/j.1423-0410.2003.00295.x; *STON, STON CALLS END BLOOD; *TERR HIGG TRUST, BLOOD DON PEOPL HIGH; *UK BLOOD TRANSF S, 2007, BLOOD DON SEL MIN RI; 2008, BEHAV DONOR DEFERRAL; 2007, MCGILL TRIBUNE  0306; 2008, US NEWS         0204	20	12	12	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2009	338								b779	10.1136/bmj.b779	http://dx.doi.org/10.1136/bmj.b779			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DS	19246551				2022-12-24	WOS:000264056300003
J	Mammoto, A; Connor, KM; Mammoto, T; Yung, CW; Huh, D; Aderman, CM; Mostoslavsky, G; Smith, LEH; Ingber, DE				Mammoto, Akiko; Connor, Kip M.; Mammoto, Tadanori; Yung, Chong Wing; Huh, Dongeun; Aderman, Christopher M.; Mostoslavsky, Gustavo; Smith, Lois E. H.; Ingber, Donald E.			A mechanosensitive transcriptional mechanism that controls angiogenesis	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-SHAPE; EXTRACELLULAR-MATRIX; RETINAL NEOVASCULARIZATION; LINEAGE SPECIFICATION; CYTOSKELETAL TENSION; REGULATORY NETWORKS; GEOMETRIC CONTROL; TFII-I; VEGF	Angiogenesis is controlled by physical interactions between cells and extracellular matrix as well as soluble angiogenic factors, such as VEGF. However, the mechanism by which mechanical signals integrate with other microenvironmental cues to regulate neovascularization remains unknown. Here we show that the Rho inhibitor, p190RhoGAP (also known as GRLF1), controls capillary network formation in vitro in human microvascular endothelial cells and retinal angiogenesis in vivo by modulating the balance of activities between two antagonistic transcription factors, TFII-I (also known as GTF2I) and GATA2, that govern gene expression of the VEGF receptor VEGFR2 (also known as KDR). Moreover, this new angiogenesis signalling pathway is sensitive to extracellular matrix elasticity as well as soluble VEGF. This is, to our knowledge, the first known functional cross-antagonism between transcription factors that controls tissue morphogenesis, and that responds to both mechanical and chemical cues.	[Mammoto, Akiko; Mammoto, Tadanori; Yung, Chong Wing; Huh, Dongeun; Ingber, Donald E.] Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA; [Mammoto, Akiko; Mammoto, Tadanori; Yung, Chong Wing; Huh, Dongeun; Ingber, Donald E.] Childrens Hosp, Dept Pathol, Dept Surg, Boston, MA 02115 USA; [Connor, Kip M.; Aderman, Christopher M.; Smith, Lois E. H.] Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Mostoslavsky, Gustavo] Harvard Univ, Sch Med, Harvard Inst Med, Dept Genet, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ingber, Donald E.] Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Ingber, DE (corresponding author), Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA.	donald.ingber@childrens.harvard.edu	Ingber, Donald E/AAC-5894-2019; Huh, Dong Eun/J-5715-2012; Huh, Dongeun/I-4152-2013	Connor, Kip/0000-0002-2048-9080; Mostoslavsky, Gustavo/0000-0002-0784-2169	NIH; V. Kann Rasmussen Foundation; Children's Hospital Mental Retardation and Developmental Disabilities Research Center; Research to Prevent Blindness Lew Wasserman Merit Award; American Heart Association; Children's Hospital House Officer Development Award; DoD Breast Cancer Innovator Award; NATIONAL CANCER INSTITUTE [P01CA045548] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V. Kann Rasmussen Foundation; Children's Hospital Mental Retardation and Developmental Disabilities Research Center; Research to Prevent Blindness Lew Wasserman Merit Award(Research to Prevent Blindness (RPB)); American Heart Association(American Heart Association); Children's Hospital House Officer Development Award; DoD Breast Cancer Innovator Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Polte, E. Pravda, M. de Bruijn and K. Johnson for their technical suggestions and assistance, T. Nakano and H. Sabe for providing plasmids, the National Institutes of Health (NIH) for providing VEGF, and D. Weitz for providing assistance with rheometry measurements. This work was supported by funds from the NIH (to D. E. I., L. E. H. S. and K. M. C.), V. Kann Rasmussen Foundation (to L. E. H. S.), Children's Hospital Mental Retardation and Developmental Disabilities Research Center (to L. E. H. S.), a Research to Prevent Blindness Lew Wasserman Merit Award (to L. E. H. S.), American Heart Association (to A. M.), and a Children's Hospital House Officer Development Award (to A. M.); D. E. I. is a recipient of a DoD Breast Cancer Innovator Award.	Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Jackson TA, 2005, J BIOL CHEM, V280, P29856, DOI 10.1074/jbc.M500335200; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Minami T, 2001, J BIOL CHEM, V276, P5395, DOI 10.1074/jbc.M008798200; Moore KA, 2005, DEV DYNAM, V232, P268, DOI 10.1002/dvdy.20237; Numaguchi Yasushi, 2003, Angiogenesis, V6, P55, DOI 10.1023/A:1025821517679; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Polte TR, 2004, AM J PHYSIOL-CELL PH, V286, pC518, DOI 10.1152/ajpcell.00280.2003; Robinson CJ, 2001, J CELL SCI, V114, P853; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Roy AL, 2007, BBA-GENE STRUCT EXPR, V1769, P613, DOI 10.1016/j.bbaexp.2007.10.002; Sheibani N, 1998, MOL BIOL CELL, V9, P701, DOI 10.1091/mbc.9.4.701; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Su ZJ, 2004, P NATL ACAD SCI USA, V101, P12212, DOI 10.1073/pnas.0404631101; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wei J, 2005, MOL CELL, V17, P23, DOI 10.1016/j.molcel.2004.11.024; Wong CG, 2001, CURR EYE RES, V22, P140, DOI 10.1076/ceyr.22.2.140.5528; Yung CW, 2007, J BIOMED MATER RES A, V83A, P1039, DOI 10.1002/jbm.a.31431	47	389	408	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1103	U57		10.1038/nature07765	http://dx.doi.org/10.1038/nature07765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242469	Green Accepted			2022-12-24	WOS:000263680100034
J	Tricoci, P; Allen, JM; Kramer, JM; Califf, RM; Smith, SC				Tricoci, Pierluigi; Allen, Joseph M.; Kramer, Judith M.; Califf, Robert M.; Smith, Sidney C., Jr.			Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION TASK-FORCE; ACUTE MYOCARDIAL-INFARCTION; PERIOPERATIVE CARDIOVASCULAR EVALUATION; ACUTE CORONARY SYNDROMES; CHRONIC HEART-FAILURE; CHRONIC STABLE ANGINA; ACC AHA GUIDELINES; AMERICAN-COLLEGE; EUROPEAN-SOCIETY; CARDIAC-CATHETERIZATION	Context The joint cardiovascular practice guidelines of the American College of Cardiology ( ACC) and the American Heart Association ( AHA) have become important documents for guiding cardiology practice and establishing benchmarks for quality of care. Objective To describe the evolution of recommendations in ACC/ AHA cardiovascular guidelines and the distribution of recommendations across classes of recommendations and levels of evidence. Data Sources and Study Selection Data from all ACC/ AHA practice guidelines issued from 1984 to September 2008 were abstracted by personnel in the ACC Science and Quality Division. Fifty- three guidelines on 22 topics, including a total of 7196 recommendations, were abstracted. Data Extraction The number of recommendations and the distribution of classes of recommendation ( I, II, and III) and levels of evidence ( A, B, and C) were determined. The subset of guidelines that were current as of September 2008 was evaluated to describe changes in recommendations between the first and current versions as well as patterns in levels of evidence used in the current versions. Results Among guidelines with at least 1 revision or update by September 2008, the number of recommendations increased from 1330 to 1973 ( + 48%) from the first to the current version, with the largest increase observed in use of class II recommendations. Considering the 16 current guidelines reporting levels of evidence, only 314 recommendations of 2711 total are classified as level of evidence A ( median, 11%), whereas 1246 ( median, 48%) are level of evidence C. Level of evidence significantly varies across categories of guidelines ( disease, intervention, or diagnostic) and across individual guidelines. Recommendations with level of evidence A are mostly concentrated in class I, but only 245 of 1305 class I recommendations have level of evidence A ( median, 19%). Conclusions Recommendations issued in current ACC/ AHA clinical practice guidelines are largely developed from lower levels of evidence or expert opinion. The proportion of recommendations for which there is no conclusive evidence is also growing. These findings highlight the need to improve the process of writing guidelines and to expand the evidence base from which clinical practice guidelines are derived.	[Tricoci, Pierluigi] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; [Tricoci, Pierluigi; Califf, Robert M.] Duke Univ, Div Cardiol, Durham, NC 27705 USA; [Kramer, Judith M.] Duke Univ, Div Gen Internal Med, Durham, NC 27705 USA; [Kramer, Judith M.] Duke Univ, Duke Ctr Educ & Res Therapeut, Durham, NC 27705 USA; [Califf, Robert M.] Duke Univ, Duke Translat Med Inst, Durham, NC 27705 USA; [Allen, Joseph M.] Amer Coll Cardiol Sci, Washington, DC USA; [Allen, Joseph M.] Qual Div, Washington, DC USA; [Smith, Sidney C., Jr.] Univ N Carolina, Ctr Cardiovasc Sci & Med, Chapel Hill, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; American College of Cardiology; University of North Carolina; University of North Carolina Chapel Hill	Tricoci, P (corresponding author), Duke Univ, Duke Clin Res Inst, 2400 Pratt St,Room 0311,Terrace Level, Durham, NC 27705 USA.	trico001@dcri.duke.edu			Agency for Healthcare Research and Quality [U18HS010548]; Rose Azus Cardiac Research Education Fund; Sharp Hospital Foundation, San Diego, California; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010548] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Rose Azus Cardiac Research Education Fund; Sharp Hospital Foundation, San Diego, California; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was supported by grant U18HS010548 from the Agency for Healthcare Research and Quality. Dr Smith's efforts in this work were supported by a Distinguished Scholarship from the Rose Azus Cardiac Research Education Fund, Sharp Hospital Foundation, San Diego, California.	*ACC AHA SUBC NUCL, 1986, J AM COLL CARDIOL, V8, P1471; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Anderson HV, 2005, CIRCULATION, V112, P2786, DOI 10.1161/CIRCULATIONAHA.105.553727; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; [Anonymous], 2001, CIRCULATION, V104, P2118; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Armstrong PW, 2003, HEART, V89, P349, DOI 10.1136/heart.89.3.349; Bassand JP, 2008, EUR HEART J SUPPL, V10, pC22, DOI 10.1093/eurheartj/sun001; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Blomstrom-Lundqvist Carina, 2003, Journal of the American College of Cardiology, V42, P1493, DOI 10.1016/j.jacc.2003.08.013; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bonow RO, 1998, J AM COLL CARDIOL, V32, P1486, DOI 10.1016/S0735-1097(98)00454-9; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Califf RM, 2007, EUR HEART J SUPPL, V9, pB8, DOI 10.1093/eurheartj/sum002; Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9; Cheitlin MD, 1997, CIRCULATION, V95, P1686; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Crawford MH, 1999, J AM COLL CARDIOL, V34, P912, DOI 10.1016/S0735-1097(99)00354-X; Crowley WF, 2004, JAMA-J AM MED ASSOC, V291, P1120, DOI 10.1001/jama.291.9.1120; Dubois Robert W, 2006, Dis Manag, V9, P210, DOI 10.1089/dis.2006.9.210; Eagle KA, 2002, J AM COLL CARDIOL, V39, P542, DOI 10.1016/S0735-1097(01)01788-0; Eagle KA, 1999, J AM COLL CARDIOL, V34, P1262, DOI 10.1016/S0735-1097(99)00389-7; Eagle KA, 1996, J AM COLL CARDIOL, V27, P910; Eagle Kim A, 2004, Circulation, V110, pe340; FEILD DJ, 1987, J AM COLL CARDIOL, V10, P935, DOI 10.1016/S0735-1097(87)80294-2; Field MJ., 1992, GUIDELINES CLIN PRAC; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; FORCINITO M, 1991, J AM COLL CARDIOL, V18, P1, DOI 10.1016/S0735-1097(10)80209-8; FORCINITO M, 1989, J AM COLL CARDIOL, V14, P1827; FORCINITO M, 1990, J AM COLL CARDIOL, V16, P1505; Frye R L, 1984, Circulation, V70, p331A; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Gregoratos G, 2002, J AM COLL CARDIOL, V40, P1703, DOI 10.1016/S0735-1097(02)02528-7; Gregoratos G, 1998, J AM COLL CARDIOL, V31, P1175; Gunnar R M, 1990, Circulation, V82, P664; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; KIRKLIN JW, 1991, CIRCULATION, V83, P1125; Klocke FJ, 2003, J AM COLL CARDIOL, V42, P1318, DOI 10.1016/j.jacc.2003.08.011; KNOEBEL SB, 1989, J AM COLL CARDIOL, V13, P249, DOI 10.1016/0735-1097(89)90578-0; Ko DT, 2008, J AM COLL CARDIOL, V51, P716, DOI 10.1016/j.jacc.2007.10.039; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; Manchanda Puneet, 2005, Yale J Health Policy Law Ethics, V5, P785; McMurray J, 2006, EUR HEART J, V27, P1773, DOI 10.1093/eurheartj/ehl123; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; PEPINE CJ, 1991, CIRCULATION, V84, P2213, DOI 10.1161/01.CIR.84.5.2213; RITCHIE JL, 1995, J AM COLL CARDIOL, V25, P521, DOI 10.1016/0735-1097(95)90027-6; RYAN TJ, 1993, CIRCULATION, V88, P2987, DOI 10.1161/01.CIR.88.6.2987; RYAN TJ, 1988, CIRCULATION, V78, P486, DOI 10.1161/01.CIR.78.2.486; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Sawaya GF, 2007, ANN INTERN MED, V147, P871, DOI 10.7326/0003-4819-147-12-200712180-00007; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; SCHLANT RC, 1992, J AM COLL CARDIOL, V19, P473; SCHLANT RC, 1986, CIRCULATION, V74, pA653; Shea AM, 2007, AM J MED QUAL, V22, P170, DOI 10.1177/1062860607300291; Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Sood R, 2007, NETH J MED, V65, P167; Strom BL, 2006, JAMA-J AM MED ASSOC, V295, P2072, DOI 10.1001/jama.295.17.2072; Taylor R, 2005, NATURE, V437, P1070, DOI 10.1038/4371070a; Tunis SR, 2007, HEALTH AFFAIR, V26, pW500, DOI 10.1377/hlthaff.26.4.w500; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; *US FOOD DRUG ADM, FDA DUK LAUNCH PUBL; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572; WILLIAMS JF, 1995, J AM COLL CARDIOL, V26, P1376; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001; ZIPES DP, 1995, J AM COLL CARDIOL, V26, P555, DOI 10.1016/0735-1097(95)80037-H; Zipes DP, 2006, J AM COLL CARDIOL, V48, pe247, DOI [10.1016/j.jacc.2006.07.010, DOI 10.1016/J.JACC.2006.07.010]	80	644	659	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					831	841		10.1001/jama.2009.205	http://dx.doi.org/10.1001/jama.2009.205			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244190	Bronze, Green Published			2022-12-24	WOS:000263609900024
J	Parker, C				Parker, Charles			Eculizumab for paroxysmal nocturnal haemoglobinuria	LANCET			English	Article							COMPLEMENT INHIBITOR ECULIZUMAB; TERMINAL COMPLEMENT; NATURAL-HISTORY; COMPONENT; ANTIBODY; MENINGITIS; DEFICIENCY; DIAGNOSIS; DRUGS	The complement system plays a central part in both innate and acquired immunity, but the contribution of complement activation to pathobiology is largely ancillary. An exception to the non-dominant role of complement in disease is the haemolytic anaemia of paroxysmal nocturnal haemoglobinuria (PNH). The intravascular haemolysis that is the clinical hallmark of PNH is a consequence of deficiency of the complement inhibitory proteins decay accelerating factor (DAF, CD55) and membrane inhibitor of reactive lysis (MIRL, CD59). Eculizumab is a humanised monoclonal antibody that binds and prevents activation of complement C5 and the subsequent formation of the cytolytic membrane attack complex of complement. Eculizumab inhibits the intravascular haemolysis of PNH, reduces transfusion requirements, stabilises haemoglobin concentration, and improves quality of life. Although chronic treatment with eculizumab increases the risk of infections with Neisseria meningitides, the drug is generally safe and well tolerated. But as is the case with other drugs developed for treatment of ultra-orphan diseases, eculizumab is expensive, and treatment must continue indefinitely because C5 inhibition does not affect the process (ie, clonal proliferation of haemopoietic stem cells with a mutant phosphatidylinositol glycan complementation class A [PIGA] gene) that underlies PNH. Moreover, due to the heterogeneous nature of the disease, treatment with eculizumab is not appropriate for all patients with PNH.	Univ Utah, Sch Med, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Parker, C (corresponding author), Univ Utah, Sch Med, 30 N 1900 E, Salt Lake City, UT 84132 USA.	Charles.Parker@hsc.utah.edu						Bao L, 2007, SEMIN NEPHROL, V27, P69, DOI 10.1016/j.semnephrol.2006.09.009; Brodsky RA, 2008, ANN INTERN MED, V148, P587, DOI 10.7326/0003-4819-148-8-200804150-00003; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; DACIE J V, 1972, Series Haematologica, V5, P3; de Latour RP, 2008, BLOOD, V112, P3099, DOI 10.1182/blood-2008-01-133918; Ferreira VP, 2007, BLOOD, V110, P2190, DOI 10.1182/blood-2007-04-083170; HAENEY MR, 1980, CLIN EXP IMMUNOL, V40, P16; Hall C, 2003, BLOOD, V102, P3587, DOI 10.1182/blood-2003-01-0009; Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316; HARRIMAN GR, 1981, J IMMUNOL, V127, P2386; Hill A, 2005, BLOOD, V106, P2559, DOI 10.1182/blood-2005-02-0564; Hill Anita, 2008, Clin Adv Hematol Oncol, V6, P499; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Hillmen P, 2007, BLOOD, V110, P4123, DOI 10.1182/blood-2007-06-095646; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Hughes DA, 2005, QJM-INT J MED, V98, P829, DOI 10.1093/qjmed/hci128; Kinoshita T, 1995, ADV IMMUNOL, V60, P57, DOI 10.1016/S0065-2776(08)60584-2; Luzzatto L, 2006, INT J HEMATOL, V84, P104, DOI 10.1532/IJH97.06117; MATIS LA, 1995, NAT MED, V1, P839, DOI 10.1038/nm0895-839; McCabe C, 2005, BRIT MED J, V331, P1016, DOI 10.1136/bmj.331.7523.1016; Moyo VM, 2004, BRIT J HAEMATOL, V126, P133, DOI 10.1111/j.1365-2141.2004.04992.x; Nishimura JI, 2004, MEDICINE, V83, P193, DOI 10.1097/01.md.0000126763.68170.46; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Parker CJ, 2007, NAT REV DRUG DISCOV, V6, P515, DOI 10.1038/nrd2369; Parker CJ, 2007, EXP HEMATOL, V35, P523, DOI 10.1016/j.exphem.2007.01.046; Parker CJ, 2003, PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND RELATED DISORDERS, P11; PETER G, 1981, PEDIATRICS, V67, P882; Platonov AE, 2003, VACCINE, V21, P4437, DOI 10.1016/S0264-410X(03)00440-7; Richards SJ, 2000, CYTOMETRY, V42, P223, DOI 10.1002/1097-0320(20000815)42:4<223::AID-CYTO2>3.0.CO;2-D; Rother RP, 2004, LUPUS, V13, P328, DOI 10.1191/0961203303lu1021oa; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Ruggenenti P, 2007, EXPERT OPIN PHARMACO, V8, P3159, DOI 10.1517/14656566.8.18.3159; Socie G, 1996, LANCET, V348, P573, DOI 10.1016/S0140-6736(95)12360-1; Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; Wang Y, 1996, P NATL ACAD SCI USA, V93, P8563, DOI 10.1073/pnas.93.16.8563; YONEMURA Y, 1990, BRIT J HAEMATOL, V74, P108, DOI 10.1111/j.1365-2141.1990.tb02546.x	39	118	122	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					759	767		10.1016/S0140-6736(09)60001-5	http://dx.doi.org/10.1016/S0140-6736(09)60001-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19144399				2022-12-24	WOS:000263725400035
J	Ibrahim, HN; Foley, R; Tan, LP; Rogers, T; Bailey, RF; Guo, HF; Gross, CR; Matas, AJ				Ibrahim, Hassan N.; Foley, Robert; Tan, LiPing; Rogers, Tyson; Bailey, Robert F.; Guo, Hongfei; Gross, Cynthia R.; Matas, Arthur J.			Long-Term Consequences of Kidney Donation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-FUNCTION; FOLLOW-UP; UNILATERAL NEPHRECTOMY; BLOOD-PRESSURE; DONORS; TRANSPLANTATION; METAANALYSIS; HYPERTENSION; FILTRATION; RISK	Background: The long-term renal consequences of kidney donation by a living donor are attracting increased appropriate interest. The overall evidence suggests that living kidney donors have survival similar to that of nondonors and that their risk of end-stage renal disease (ESRD) is not increased. Previous studies have included relatively small numbers of donors and a brief follow-up period. Methods: We ascertained the vital status and lifetime risk of ESRD in 3698 kidney donors who donated kidneys during the period from 1963 through 2007; from 2003 through 2007, we also measured the glomerular filtration rate (GFR) and urinary albumin excretion and assessed the prevalence of hypertension, general health status, and quality of life in 255 donors. Results: The survival of kidney donors was similar to that of controls who were matched for age, sex, and race or ethnic group. ESRD developed in 11 donors, a rate of 180 cases per million persons per year, as compared with a rate of 268 per million per year in the general population. At a mean (+/-SD) of 12.2+/-9.2 years after donation, 85.5% of the subgroup of 255 donors had a GFR of 60 ml per minute per 1.73 m(sup 2) of body-surface area or higher, 32.1% had hypertension, and 12.7% had albuminuria. Older age and higher body-mass index, but not a longer time since donation, were associated with both a GFR that was lower than 60 ml per minute per 1.73 m(sup 2) and hypertension. A longer time since donation, however, was independently associated with albuminuria. Most donors had quality-of-life scores that were better than population norms, and the prevalence of coexisting conditions was similar to that among controls from the National Health and Nutrition Examination Survey (NHANES) who were matched for age, sex, race or ethnic group, and body-mass index. Conclusions: Survival and the risk of ESRD in carefully screened kidney donors appear to be similar to those in the general population. Most donors who were studied had a preserved GFR, normal albumin excretion, and an excellent quality of life. N Engl J Med 2009;360:459-69.	[Ibrahim, Hassan N.; Tan, LiPing; Rogers, Tyson] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Bailey, Robert F.; Matas, Arthur J.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Guo, Hongfei] Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA; [Guo, Hongfei] Univ Minnesota, Off Clin Res, Minneapolis, MN 55455 USA; [Gross, Cynthia R.] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA; [Gross, Cynthia R.] Univ Minnesota, Sch Nursing, Minneapolis, MN 55455 USA; [Foley, Robert] Chron Dis Res Grp, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ibrahim, HN (corresponding author), Univ Minnesota, Div Renal Dis & Hypertens, Suite 353,717 Delaware St SE, Minneapolis, MN 55414 USA.	ibrah007@umn.edu	matas, arthur/ABE-1018-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK013083] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000400, M01-RR00400] Funding Source: Medline; NIDDK NIH HHS [P01 DK013083, P01DK13083] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2007, US REN DAT SYST USRD; BAUDOIN P, 1993, AM J KIDNEY DIS, V21, P603, DOI 10.1016/S0272-6386(12)80032-1; BAY WH, 1987, ANN INTERN MED, V106, P719, DOI 10.7326/0003-4819-106-5-719; BOHANNON LL, 1988, J UROLOGY, V140, P810, DOI 10.1016/S0022-5347(17)41822-2; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; BOURGOIGNIE JJ, 1989, KIDNEY INT, V36, pS86; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; DUNN JF, 1986, ANN SURG, V203, P637, DOI 10.1097/00000658-198606000-00008; Ellison MD, 2002, TRANSPLANTATION, V74, P1349, DOI 10.1097/00007890-200211150-00025; Fehrman-Ekholm I, 2006, TRANSPLANTATION, V82, P1646, DOI 10.1097/01.tp.0000250728.73268.e3; FehrmanEkholm I, 1997, TRANSPLANTATION, V64, P976, DOI 10.1097/00007890-199710150-00007; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; GASPARI F, 1995, J AM SOC NEPHROL, V6, P257; Gibney EM, 2007, TRANSPLANTATION, V84, P647, DOI 10.1097/01.tp.0000277288.78771.c2; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Ibrahim HN, 2006, AM J TRANSPLANT, V6, P1479, DOI 10.1111/j.1600-6143.2006.01335.x; KAPLAN C, 1975, AM J PATHOL, V80, P227; KROHN AG, 1966, J AMER MED ASSOC, V196, P322, DOI 10.1001/jama.196.4.322; NAJARIAN JS, 1992, LANCET, V340, P807, DOI 10.1016/0140-6736(92)92683-7; NARKUNBURGESS DM, 1993, KIDNEY INT, V43, P1110, DOI 10.1038/ki.1993.156; Ramcharan T, 2002, AM J TRANSPLANT, V2, P959, DOI 10.1034/j.1600-6143.2002.21013.x; ROBERTSON JL, 1986, KIDNEY INT, V29, P511, DOI 10.1038/ki.1986.29; SOBH M, 1989, International Urology and Nephrology, V21, P547, DOI 10.1007/BF02549594; THORNER PS, 1984, PEDIATRICS, V73, P806; TORRES VE, 1987, KIDNEY INT, V31, P1383, DOI 10.1038/ki.1987.153; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; WATNICK TJ, 1988, TRANSPLANTATION, V45, P59	29	749	770	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					459	469		10.1056/NEJMoa0804883	http://dx.doi.org/10.1056/NEJMoa0804883			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179315	Green Accepted			2022-12-24	WOS:000262812400005
J	Pollard, RT; Salter, I; Sanders, RJ; Lucas, MI; Moore, CM; Mills, RA; Statham, PJ; Allen, JT; Baker, AR; Bakker, DCE; Charette, MA; Fielding, S; Fones, GR; French, M; Hickman, AE; Holland, RJ; Hughes, JA; Jickells, TD; Lampitt, RS; Morris, PJ; Nedelec, FH; Nielsdottir, M; Planquette, H; Popova, EE; Poulton, AJ; Read, JF; Seeyave, S; Smith, T; Stinchcombe, M; Taylor, S; Thomalla, S; Venables, HJ; Williamson, R; Zubkov, MV				Pollard, Raymond T.; Salter, Ian; Sanders, Richard J.; Lucas, Mike I.; Moore, C. Mark; Mills, Rachel A.; Statham, Peter J.; Allen, John T.; Baker, Alex R.; Bakker, Dorothee C. E.; Charette, Matthew A.; Fielding, Sophie; Fones, Gary R.; French, Megan; Hickman, Anna E.; Holland, Ross J.; Hughes, J. Alan; Jickells, Timothy D.; Lampitt, Richard S.; Morris, Paul J.; Nedelec, Florence H.; Nielsdottir, Maria; Planquette, Helene; Popova, Ekaterina E.; Poulton, Alex J.; Read, Jane F.; Seeyave, Sophie; Smith, Tania; Stinchcombe, Mark; Taylor, Sarah; Thomalla, Sandy; Venables, Hugh J.; Williamson, Robert; Zubkov, Mike V.			Southern Ocean deep-water carbon export enhanced by natural iron fertilization	NATURE			English	Article							PHYTOPLANKTON BLOOM; CROZET PLATEAU; RADIUM ISOTOPES; CO2; SEQUESTRATION; RESPONSES; NORTH; SCALE; SI	The addition of iron to high- nutrient, low- chlorophyll regions induces phytoplankton blooms that take up carbon(1-3). Carbon export from the surface layer and, in particular, the ability of the ocean and sediments to sequester carbon for many years remains, however, poorly quantified(3). Here we report data from the CROZEX experiment(4) in the Southern Ocean, which was conducted to test the hypothesis that the observed north - south gradient in phytoplankton concentrations in the vicinity of the Crozet Islands is induced by natural iron fertilization that results in enhanced organic carbon flux to the deep ocean. We report annual particulate carbon fluxes out of the surface layer, at three kilometres below the ocean surface and to the ocean floor. We find that carbon fluxes from a highly productive, naturally iron-fertilized region of the sub- Antarctic Southern Ocean are two to three times larger than the carbon fluxes from an adjacent high-nutrient, low- chlorophyll area not fertilized by iron. Our findings support the hypothesis that increased iron supply to the glacial sub- Antarctic may have directly enhanced carbon export to the deep ocean(5). The CROZEX sequestration efficiency(6) ( the amount of carbon sequestered below the depth of winter mixing for a given iron supply) of 8,600 mol mol(-1) was 18 times greater than that of a phytoplankton bloom induced artificially by adding iron(7), but 77 times smaller than that of another bloom(8) initiated, like CROZEX, by a natural supply of iron. Large losses of purposefully added iron can explain the lower efficiency of the induced bloom(6). The discrepancy between the blooms naturally supplied with iron may result in part from an underestimate of horizontal iron supply.	[Pollard, Raymond T.; Salter, Ian; Sanders, Richard J.; Moore, C. Mark; Mills, Rachel A.; Statham, Peter J.; Allen, John T.; Holland, Ross J.; Hughes, J. Alan; Lampitt, Richard S.; Morris, Paul J.; Nielsdottir, Maria; Popova, Ekaterina E.; Poulton, Alex J.; Read, Jane F.; Seeyave, Sophie; Smith, Tania; Stinchcombe, Mark; Taylor, Sarah; Zubkov, Mike V.] Natl Environm Res Council, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Pollard, Raymond T.; Salter, Ian; Sanders, Richard J.; Moore, C. Mark; Mills, Rachel A.; Statham, Peter J.; Allen, John T.; Holland, Ross J.; Hughes, J. Alan; Lampitt, Richard S.; Morris, Paul J.; Nielsdottir, Maria; Popova, Ekaterina E.; Poulton, Alex J.; Read, Jane F.; Seeyave, Sophie; Smith, Tania; Stinchcombe, Mark; Taylor, Sarah; Zubkov, Mike V.] Univ Southampton, Southampton SO14 3ZH, Hants, England; [Salter, Ian] Observ Oceanol, BP44, F-66651 Banyuls Sur Mer, France; [Lucas, Mike I.] Univ Cape Town, Dept Zool, ZA-7701 Rondebosch, South Africa; [Baker, Alex R.; Bakker, Dorothee C. E.; French, Megan; Jickells, Timothy D.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Charette, Matthew A.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem MS25, Woods Hole, MA 02543 USA; [Fielding, Sophie; Venables, Hugh J.] British Antarctic Survey, Cambridge CB3 0ET, England; [Fones, Gary R.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth PO1 3QL, Hants, England; [Hickman, Anna E.] Univ Liverpool, Dept Earth & Ocean Sci, Liverpool L69 3GP, Merseyside, England; [Nedelec, Florence H.] IFREMER, Lab Environm & Resources Normandie, F-14520 Port En Bessen, France; [Planquette, Helene] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Thomalla, Sandy; Williamson, Robert] Univ Cape Town, Dept Oceanog, ZA-7701 Rondebosch, South Africa	NERC National Oceanography Centre; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Southampton; University of Southampton; UDICE-French Research Universities; Sorbonne Universite; University of Cape Town; University of East Anglia; Woods Hole Oceanographic Institution; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Portsmouth; University of Liverpool; Ifremer; Rutgers State University New Brunswick; University of Cape Town	Sanders, RJ (corresponding author), Natl Environm Res Council, Natl Oceanog Ctr Southampton, European Way, Southampton SO14 3ZH, Hants, England.	rics@noc.soton.ac.uk	Thomalla, Sandy/AAS-4133-2021; Hickman, Anna E/A-9351-2011; Zubkov, Mikhail/AAW-9674-2020; Popova, Ekaterina E/B-4520-2012; Salter, Ian/A-7404-2011; Bakker, Dorothee C E/E-4951-2015; Mills, Rachel A/A-1150-2011; Menet-Nedelec, Florence H. A./K-2262-2015; Fones, Gary/G-2489-2010; Sanders, Richard J/B-8717-2012; Fielding, Sophie/E-5137-2012; Seas, Deep/J-9245-2014; Charette, Matthew/I-9495-2012; Baker, Alex R/D-1233-2011; Salter, Ian/AAI-1015-2021; Allen, John Taylor/AHB-3419-2022; Poulton, Alex J/A-9859-2012; Planquette, Helene/B-4990-2013	Zubkov, Mikhail/0000-0001-7723-6810; Popova, Ekaterina E/0000-0002-2012-708X; Bakker, Dorothee C E/0000-0001-9234-5337; Mills, Rachel A/0000-0002-9811-246X; Menet-Nedelec, Florence H. A./0000-0002-0933-2509; Fones, Gary/0000-0002-1999-0716; Sanders, Richard J/0000-0002-6884-7131; Fielding, Sophie/0000-0002-3152-4742; Baker, Alex R/0000-0002-8365-8953; Allen, John Taylor/0000-0001-7357-6623; Poulton, Alex J/0000-0002-5149-6961; French, Megan Anne/0000-0002-5837-1360; Seeyave, Sophie/0000-0002-4583-2869; Williamson, Robert/0000-0002-7288-1762; Moore, Mark/0000-0002-9541-6046; Salter, Ian/0000-0002-4513-0314; Hickman, Anna/0000-0002-2774-3934; Planquette, Helene/0000-0002-2235-5158	Natural Environment Research Council; NERC [soc010008, NE/F017359/1, bas010017] Funding Source: UKRI; Natural Environment Research Council [soc010008, NE/F017359/1, NE/B502844/1, bas010017, NE/C507353/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the operators, master and crew of RRS Discovery for their support. CROZEX was a component of Biophysical Interactions and Controls on Export Production, a five-year project at the National Oceanography Centre, Southampton, supported by the Natural Environment Research Council (NERC).	Bakker DCE, 2007, DEEP-SEA RES PT II, V54, P2174, DOI 10.1016/j.dsr2.2007.06.009; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2004, NATURE, V428, P549, DOI 10.1038/nature02437; Brown L, 2003, LIMNOL OCEANOGR, V48, P1831, DOI 10.4319/lo.2003.48.5.1831; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Buesseler KO, 2003, SCIENCE, V300, P67, DOI 10.1126/science.1082959; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Charette MA, 2007, DEEP-SEA RES PT II, V54, P1989, DOI 10.1016/j.dsr2.2007.06.003; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Franck VM, 2000, DEEP-SEA RES PT II, V47, P3315; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Lucas M, 2007, DEEP-SEA RES PT II, V54, P2138, DOI 10.1016/j.dsr2.2007.06.017; Marsh R, 2007, DEEP-SEA RES PT II, V54, P2260, DOI 10.1016/j.dsr2.2007.06.004; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Mongin M, 2008, DEEP-SEA RES PT II, V55, P880, DOI 10.1016/j.dsr2.2007.12.039; Moore CM, 2007, DEEP-SEA RES PT II, V54, P2066, DOI 10.1016/j.dsr2.2007.06.015; Morris PJ, 2007, DEEP-SEA RES PT II, V54, P2208, DOI 10.1016/j.dsr2.2007.06.002; Planquette H, 2007, DEEP-SEA RES PT II, V54, P1999, DOI 10.1016/j.dsr2.2007.06.019; PLANQUETTE HF, 2008, THESIS SOUTHAMPTON U; Pollard RT, 2007, DEEP-SEA RES PT II, V54, P1915, DOI 10.1016/j.dsr2.2007.06.012; Pollard R, 2007, DEEP-SEA RES PT II, V54, P1905, DOI 10.1016/j.dsr2.2007.07.023; Poulton AJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002712; Poulton AJ, 2007, DEEP-SEA RES PT II, V54, P2085, DOI 10.1016/j.dsr2.2007.06.005; Sanders R, 2007, DEEP-SEA RES PT II, V54, P2191, DOI 10.1016/j.dsr2.2007.06.007; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; van Beek P, 2008, DEEP-SEA RES PT II, V55, P622, DOI 10.1016/j.dsr2.2007.12.025; Venables HJ, 2007, DEEP-SEA RES PT II, V54, P1949, DOI 10.1016/j.dsr2.2007.06.014; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Zhang Y, 2008, DEEP-SEA RES PT II, V55, P638, DOI 10.1016/j.dsr2.2007.12.029	32	249	253	0	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					577	U81		10.1038/nature07716	http://dx.doi.org/10.1038/nature07716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177128				2022-12-24	WOS:000262852200040
J	Vetter, ML; Cardillo, S; Rickels, MR; Iqbal, N				Vetter, Marion L.; Cardillo, Serena; Rickels, Michael R.; Iqbal, Nayyar			Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Review							GASTRIC BYPASS-SURGERY; GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; WEIGHT-LOSS; PLASMA GHRELIN; INHIBITORY POLYPEPTIDE; GUT HORMONE; BILIOPANCREATIC DIVERSION; INSULIN SENSITIVITY; GLUCOSE-METABOLISM	Bariatric surgery leads to substantial and durable weight reduction. Nearly 30% of patients who undergo bariatric surgery have type 2 diabetes, and for many of them, diabetes resolves after surgery (84% to 98% for bypass procedures and 48% to 68% for restrictive procedures). Glycemic control improves in part because of caloric restriction but also because gut peptide secretion changes. Gut peptides, which mediate the enteroinsular axis, include the incretins glucagon-like peptide-1 and glucose-dependent insulinotropic peptide, as well as ghrelin and peptide YY. Bariatric surgery (particularly bypass procedures) alters secretion of these gut hormones, which results in enhanced insulin secretion and sensitivity. This review discusses the various bariatric procedures and how they alter the enteroinsular axis. Familiarity with these effects can help physicians decide among the different surgical procedures and avoid postoperative hypoglycemia.	[Vetter, Marion L.] Hosp Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Vetter, ML (corresponding author), Hosp Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, 1 Maloney Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	marion.vetter@uphs.upenn.edu	Rickels, Michael/D-1380-2009	Rickels, Michael/0000-0002-9253-838X				Ballantyne GH, 2006, OBES SURG, V16, P651, DOI 10.1381/096089206776944959; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Bult MJF, 2008, EUR J ENDOCRINOL, V158, P135, DOI 10.1530/EJE-07-0145; Clements RH, 2004, AM SURGEON, V70, P1; Cohen RV, 2007, SURG OBES RELAT DIS, V3, P195, DOI 10.1016/j.soard.2007.01.009; Colquitt J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub2; Creutzfeldt W, 2005, REGUL PEPTIDES, V128, P87, DOI 10.1016/j.regpep.2004.08.004; CREUTZFELDT W, 1979, DIABETOLOGIA, V16, P75, DOI 10.1007/BF01225454; CROCKETT SE, 1976, DIABETES, V25, P931, DOI 10.2337/diabetes.25.10.931; Cummings DE, 2007, SURG OBES RELAT DIS, V3, P109, DOI 10.1016/j.soard.2007.02.003; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Cummings DE, 2003, J CLIN ENDOCR METAB, V88, P2999, DOI 10.1210/jc.2003-030705; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Deacon CF, 2005, REGUL PEPTIDES, V128, P117, DOI 10.1016/j.regpep.2004.06.007; Dixon JB, 2003, DIABETIC MED, V20, P127, DOI 10.1046/j.1464-5491.2003.00889.x; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Dunn JP., 2007, CLIN DIABETES, V25, P112, DOI [10.2337/diaclin.25.3.112, DOI 10.2337/DIACLIN.25.3.112]; Faraj M, 2003, J CLIN ENDOCR METAB, V88, P1594, DOI 10.1210/jc.2002-021309; Ferchak CV, 2004, DIABETES-METAB RES, V20, P438, DOI 10.1002/dmrr.507; Fetner R, 2005, SURG OBES RELAT DIS, V1, P597; Fetner Rachel, 2005, Surg Obes Relat Dis, V1, P589, DOI 10.1016/j.soard.2005.09.001; Flint A, 2001, INT J OBESITY, V25, P781, DOI 10.1038/sj.ijo.0801627; Folli F, 2007, MED CLIN N AM, V91, P393, DOI 10.1016/j.mcna.2007.01.005; Fruhbeck G, 2004, OBES SURG, V14, P606, DOI 10.1381/096089204323093363; Geloneze B, 2003, OBES SURG, V13, P17, DOI 10.1381/096089203321136539; Goldfine AB, 2007, J CLIN ENDOCR METAB, V92, P4678, DOI 10.1210/jc.2007-0918; Gould J, 2005, J GASTROINTEST SURG, V9, P1117; GREY N, 1971, NEW ENGL J MED, V285, P827, DOI 10.1056/NEJM197110072851504; Gumbs AA, 2005, OBES SURG, V15, P462, DOI 10.1381/0960892053723367; Gutzwiller JP, 1999, GUT, V44, P81, DOI 10.1136/gut.44.1.81; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Holdstock C, 2003, J CLIN ENDOCR METAB, V88, P3177, DOI 10.1210/jc.2002-021734; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 1997, DIABETOLOGIA, V40, P984, DOI 10.1007/s001250050779; HOROWITZ M, 1984, BRIT J SURG, V71, P435, DOI 10.1002/bjs.1800710610; Kageyama H, 2005, REGUL PEPTIDES, V126, P67, DOI 10.1016/j.regpep.2004.08.031; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; KELLEY DE, 1993, J CLIN ENDOCR METAB, V77, P1287, DOI 10.1210/jc.77.5.1287; Korner J, 2005, J CLIN ENDOCR METAB, V90, P359, DOI 10.1210/jc.2004-1076; Korner J, 2007, SURG OBES RELAT DIS, V3, P597, DOI 10.1016/j.soard.2007.08.004; Korner J, 2006, OBESITY, V14, P1553, DOI 10.1038/oby.2006.179; LAFERRERE B, 2007, OBESITY, V15, P7; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Laferrere B, 2007, DIABETES CARE, V30, P1709, DOI 10.2337/dc06-1549; le Roux CW, 2007, ANN SURG, V246, P780, DOI 10.1097/SLA.0b013e3180caa3e3; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Levy P, 2007, OBES SURG, V17, P1248, DOI 10.1007/BF02802098; Luque MA, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730465; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Marceau P, 1998, WORLD J SURG, V22, P947, DOI 10.1007/s002689900498; Meier JJ, 2002, REGUL PEPTIDES, V107, P1, DOI 10.1016/S0167-0115(02)00039-3; Morinigo R, 2006, J CLIN ENDOCR METAB, V91, P1735, DOI 10.1210/jc.2005-0904; Morinigo R, 2008, ANN SURG, V247, P270, DOI 10.1097/SLA.0b013e31815f6e77; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Naslund E, 1998, DIGEST DIS SCI, V43, P945, DOI 10.1023/A:1018806129102; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Nijhuis J, 2004, OBES SURG, V14, P783, DOI 10.1381/0960892041590980; Patriti A, 2004, OBES SURG, V14, P840, DOI 10.1381/0960892041590818; Patriti A, 2007, SURGERY, V142, P74, DOI 10.1016/j.surg.2007.03.001; Patti ME, 2005, DIABETOLOGIA, V48, P2236, DOI 10.1007/s00125-005-1933-x; PERLEY MJ, 1967, J CLIN INVEST, V46, P1954, DOI 10.1172/JCI105685; Ponce J, 2004, OBES SURG, V14, P1335, DOI 10.1381/0960892042583932; Pontiroli AE, 2002, J CLIN ENDOCR METAB, V87, P3555, DOI 10.1210/jc.87.8.3555; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Poykko SM, 2003, DIABETES, V52, P2546, DOI 10.2337/diabetes.52.10.2546; Rodieux F, 2008, OBESITY, V16, P298, DOI 10.1038/oby.2007.83; ROSS SA, 1977, DIABETES, V26, P525, DOI 10.2337/diabetes.26.6.525; Rubino F, 2004, ANN SURG, V240, P236, DOI 10.1097/01.sla.0000133117.12646.48; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Rubino F, 2006, CURR OPIN CLIN NUTR, V9, P497, DOI 10.1097/01.mco.0000232914.14978.c5; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Schneider BE, 2005, DIABETES CARE, V28, P475, DOI 10.2337/diacare.28.2.475; Scopinaro N, 2005, DIABETES CARE, V28, P2406, DOI 10.2337/diacare.28.10.2406; Shah M, 2006, J CLIN ENDOCR METAB, V91, P4223, DOI 10.1210/jc.2006-0557; Shak JR, 2008, OBES SURG, V18, P1089, DOI 10.1007/s11695-008-9454-6; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sugerman HJ, 2003, ANN SURG, V237, P751, DOI 10.1097/00000658-200306000-00002; Toft-Nielsen MB, 1999, DIABETES CARE, V22, P1137, DOI 10.2337/diacare.22.7.1137; Torquati A, 2005, J GASTROINTEST SURG, V9, P1112, DOI 10.1016/j.gassur.2005.07.016; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tseng CC, 1996, AM J PHYSIOL-ENDOC M, V270, pE661, DOI 10.1152/ajpendo.1996.270.4.E661; UNGER RH, 1969, ARCH INTERN MED, V123, P261, DOI 10.1001/archinte.123.3.261; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Whitson BA, 2007, J SURG RES, V141, P31, DOI 10.1016/j.jss.2007.02.022	89	127	140	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					94	U54		10.7326/0003-4819-150-2-200901200-00007	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19153412				2022-12-24	WOS:000262655200004
J	Neugebauer, JM; Amack, JD; Peterson, AG; Bisgrove, BW; Yost, HJ				Neugebauer, Judith M.; Amack, Jeffrey D.; Peterson, Annita G.; Bisgrove, Brent W.; Yost, H. Joseph			FGF signalling during embryo development regulates cilia length in diverse epithelia	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; ZEBRAFISH FIN REGENERATION; KUPFFERS VESICLE; LEFTWARD FLOW; CELLS; SPECIFICATION; INHIBITION; XENOPUS; MUTANT	Cilia are cell surface organelles found on most epithelia in vertebrates. Specialized groups of cilia have critical roles in embryonic development, including left-right axis formation. Recently, cilia have been implicated as recipients of cell-cell signalling(1,2). However, little is known about cell-cell signalling pathways that control the length of cilia(3). Here we provide several lines of evidence showing that fibroblast growth factor (FGF) signalling regulates cilia length and function in diverse epithelia during zebrafish and Xenopus development. Morpholino knockdown of FGF receptor 1 (Fgfr1) in zebrafish cell-autonomously reduces cilia length in Kupffer's vesicle and perturbs directional fluid flow required for left-right patterning of the embryo. Expression of a dominant-negative FGF receptor (DN-Fgfr1), treatment with SU5402 ( a pharmacological inhibitor of FGF signalling) or genetic and morpholino reduction of redundant FGF ligands Fgf8 and Fgf24 reproduces this cilia length phenotype. Knockdown of Fgfr1 also results in shorter tethering cilia in the otic vesicle and shorter motile cilia in the pronephric ducts. In Xenopus, expression of a dn-fgfr1 results in shorter monocilia in the gastrocoel roof plate that control left-right patterning(4) and in shorter multicilia in external mucociliary epithelium. Together, these results indicate a fundamental and highly conserved role for FGF signalling in the regulation of cilia length in multiple tissues. Abrogation of Fgfr1 signalling downregulates expression of two ciliogenic transcription factors, foxj1 and rfx2, and of the intraflagellar transport gene ift88 (also known as polaris), indicating that FGF signalling mediates cilia length through an Fgf8/Fgf24-Fgfr1-intraflagellar transport pathway. We propose that a subset of developmental defects and diseases ascribed to FGF signalling are due in part to loss of cilia function.	[Neugebauer, Judith M.; Amack, Jeffrey D.; Peterson, Annita G.; Bisgrove, Brent W.; Yost, H. Joseph] Univ Utah, Sch Med, Dept Neurobiol & Anat, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Yost, HJ (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Eccles Inst Human Genet, Bldg 533,Room 3160,15 North 2030 East, Salt Lake City, UT 84112 USA.	jyost@genetics.utah.edu		Amack, Jeffrey/0000-0002-5465-9754	American Heart Association; NRSA Postdoctoral fellowship; NHLBI; NICHD; Primary Children's Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD048886] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066292, R01HL075472] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NRSA Postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Primary Children's Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Moon and M. Condic for critical discussions on the manuscript; M. Karthikeyan, J. Shen, D. Coombs and E. Martini for technical help; and S. Miyagawa- Tomita, K. Poss and H. Issacs for reagents. This work was supported by American Heart Association predoctoral fellowship to J. M. N., NRSA Postdoctoral fellowship to J. D. A. and grants from NHLBI, NICHD and Primary Children's Medical Foundation to H. J. Y.	Albertson RC, 2005, DEV BIOL, V283, P310, DOI 10.1016/j.ydbio.2005.04.025; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Amack JD, 2007, DEV BIOL, V310, P196, DOI 10.1016/j.ydbio.2007.05.039; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fischer A, 2002, CURR BIOL, V12, P1807, DOI 10.1016/S0960-9822(02)01222-8; Fischer S, 2003, DEVELOPMENT, V130, P3515, DOI 10.1242/dev.00537; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Pownall ME, 2003, DEV BIOL, V256, P89, DOI 10.1016/S0012-1606(02)00120-3; R Development Core Team, 2007, R FDN STAT COMP; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Scholpp S, 2004, DEV GENES EVOL, V214, P285, DOI 10.1007/s00427-004-0409-1; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Urban AE, 2006, DEV BIOL, V297, P103, DOI 10.1016/j.ydbio.2006.04.469; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	33	186	188	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					651	U119		10.1038/nature07753	http://dx.doi.org/10.1038/nature07753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19242413	Green Accepted			2022-12-24	WOS:000264796200045
J	Mandel, MJ; Wollenberg, MS; Stabb, EV; Visick, KL; Ruby, EG				Mandel, Mark J.; Wollenberg, Michael S.; Stabb, Eric V.; Visick, Karen L.; Ruby, Edward G.			A single regulatory gene is sufficient to alter bacterial host range	NATURE			English	Article							VIBRIO-FISCHERI; SYMBIOTIC COLONIZATION; BIOFILM FORMATION; COMPARATIVE GENOMICS; EUPRYMNA-SCOLOPES; SEQUENCE; INTERFACE; EVOLUTION; ALIGNMENT; ISLANDS	Microbial symbioses are essential for the normal development and growth of animals(1-3). Often, symbionts must be acquired from the environment during each generation, and identification of the relevant symbiotic partner against a myriad of unwanted relationships is a formidable task(4). Although examples of this specificity are well-documented, the genetic mechanisms governing it are poorly characterized(5). Here we show that the two-component sensor kinase RscS is necessary and sufficient for conferring efficient colonization of Euprymna scolopes squid by bioluminescent Vibrio fischeri from the North Pacific Ocean. In the squid symbiont V. fischeri ES114, RscS controls light-organ colonization by inducing the Syp exopolysaccharide, a mediator of biofilm formation during initial infection. A genome-level comparison revealed that rscS, although present in squid symbionts, is absent from the fish symbiont V. fischeri MJ11. We found that heterologous expression of RscS in strain MJ11 conferred the ability to colonize E. scolopes in a manner comparable to that of natural squid isolates. Furthermore, phylogenetic analyses support an important role for rscS in the evolution of the squid symbiosis. Our results demonstrate that a regulatory gene can alter the host range of animal-associated bacteria. We show that, by encoding a regulator and not an effector that interacts directly with the host, a single gene can contribute to the evolution of host specificity by switching 'on' pre-existing capabilities for interaction with animal tissue.	[Mandel, Mark J.; Wollenberg, Michael S.; Ruby, Edward G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Stabb, Eric V.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Visick, Karen L.] Loyola Univ Chicago, Dept Microbiol & Immunol, Maywood, IL 60153 USA	University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; University of Georgia; Loyola University Chicago	Mandel, MJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, 1550 Linden Dr, Madison, WI 53706 USA.	mmandel@wisc.edu		Mandel, Mark/0000-0001-6506-6711; Visick, Karen/0000-0002-2400-2591	Gordon and Betty Moore Foundation Marine Microbial Genome Sequencing Project; National Institutes of Health - National Center for Research Resources; National Science Foundation Division of Integrative Organismal Systems; National Science Foundation CAREER Award; National Institute of General Medical Sciences; National Institute of General Medical Sciences National Research Service Award Postdoctoral Fellowship; National Science Foundation Predoctoral Fellowship and a National Institutes of Health Molecular Biosciences Training; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR012294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059690, F32GM078760, T32GM007215] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation Marine Microbial Genome Sequencing Project; National Institutes of Health - National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation Division of Integrative Organismal Systems(National Science Foundation (NSF)); National Science Foundation CAREER Award(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Predoctoral Fellowship and a National Institutes of Health Molecular Biosciences Training; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank: P. Dunlap for sharing bacterial strains; N. Perna, J. Glasner, K. Geszvain, D. Baum, J. Johnson, M. Sarmiento and S. Ferriera for technical assistance; A. Wier, N. Bekiares, R. Gates and the Hawaii Institute of Marine Biology for animal facilities and care; J. McCosker and the Steinhart Aquarium for access to fish specimens; M. McFall- Ngai, H. Goodrich- Blair, C. Brennan and J. Troll for discussions; and L. Proctor for project support. MJ11 genome sequencing was funded by the Gordon and Betty Moore Foundation Marine Microbial Genome Sequencing Project; E. G. R. and co- workers are funded by the National Institutes of Health - National Center for Research Resources and the National Science Foundation Division of Integrative Organismal Systems; E. V. S. is funded by a National Science Foundation CAREER Award; K. L. V. is funded by the National Institute of General Medical Sciences; M. J. M. is funded by a National Institute of General Medical Sciences National Research Service Award Postdoctoral Fellowship; M. S. W. is funded by a National Science Foundation Predoctoral Fellowship and a National Institutes of Health Molecular Biosciences Training Grant to the University of Wisconsin.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bose JL, 2008, ARCH MICROBIOL, V190, P169, DOI 10.1007/s00203-008-0387-1; Brinig MM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r81; Cowles CE, 2008, J BACTERIOL, V190, P4121, DOI 10.1128/JB.00123-08; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Foster JS, 2002, B MAR SCI, V70, P141; Geszvain K, 2008, FEMS MICROBIOL LETT, V285, P33, DOI 10.1111/j.1574-6968.2008.01209.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Groisman EA, 2005, MOL MICROBIOL, V56, P1, DOI 10.1111/j.1365-2958.2005.04564.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HAYGOOD MG, 1993, CRIT REV MICROBIOL, V19, P191, DOI 10.3109/10408419309113529; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hussa EA, 2008, J BACTERIOL, V190, P4576, DOI 10.1128/JB.00130-08; Hussa EA, 2007, J BACTERIOL, V189, P5825, DOI 10.1128/JB.00242-07; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; Long SR, 2001, PLANT PHYSIOL, V125, P69, DOI 10.1104/pp.125.1.69; Mandel MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-138; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rajashekara G, 2004, J BACTERIOL, V186, P5040, DOI 10.1128/jb.186.15.5040-5051.2004; RUBY EG, 1977, APPL ENVIRON MICROB, V34, P164, DOI 10.1128/AEM.34.2.164-169.1977; Ruby EG, 2005, P NATL ACAD SCI USA, V102, P3004, DOI 10.1073/pnas.0409900102; RUBY EG, 1976, BIOL BULL, V151, P574, DOI 10.2307/1540507; Silhavy T.J., 1984, EXPT GENE FUSIONS; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stabb EV, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P233; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; STABB EV, 2001, RECENT ADV MARINE SC, P269; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Hijum SAFT, 2005, NUCLEIC ACIDS RES, V33, pW560, DOI 10.1093/nar/gki356; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Visick KL, 2001, J BACTERIOL, V183, P835, DOI 10.1128/JB.183.3.835-842.2001; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yip ES, 2006, MOL MICROBIOL, V62, P1586, DOI 10.1111/j.1365-2958.2006.05475.x; Yip ES, 2005, MOL MICROBIOL, V57, P1485, DOI 10.1111/j.1365-2958.2005.04784.x; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	45	151	151	0	63	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					215	U7		10.1038/nature07660	http://dx.doi.org/10.1038/nature07660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19182778	Green Accepted			2022-12-24	WOS:000264059700046
J	Mazzone, M; Dettori, D; de Oliveira, RL; Loges, S; Schmidt, T; Jonckx, B; Tian, YM; Lanahan, AA; Pollard, P; de Almodovar, CR; De Smet, F; Vinckier, S; Aragones, J; Debackere, K; Luttun, A; Wyns, S; Jordan, B; Pisacane, A; Gallez, B; Lampugnani, MG; Dejana, E; Simons, M; Ratcliffe, P; Maxwell, P; Carmeliet, P				Mazzone, Massimiliano; Dettori, Daniela; de Oliveira, Rodrigo Leite; Loges, Sonja; Schmidt, Thomas; Jonckx, Bart; Tian, Ya-Min; Lanahan, Anthony A.; Pollard, Patrick; de Almodovar, Carmen Ruiz; De Smet, Frederik; Vinckier, Stefan; Aragones, Julian; Debackere, Koen; Luttun, Aemout; Wyns, Sabine; Jordan, Benedicte; Pisacane, Alberto; Gallez, Bernard; Lampugnani, Maria Grazia; Dejana, Elisabetta; Simons, Michael; Ratcliffe, Peter; Maxwell, Patrick; Carmeliet, Peter			Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization	CELL			English	Article							INDUCIBLE FACTOR-I; VASCULAR NORMALIZATION; ANGIOGENESIS; VEGF; HYPOXIA; CADHERIN; CELLS; ACTIVATION; VESSELS; CANCER	A key function of blood vessels, to supply oxygen, is impaired in tumors because of abnormalities in their endothelial lining. PHD proteins serve as oxygen sensors and may regulate oxygen delivery. We therefore studied the role of endothelial PHD2 in vessel shaping by implanting tumors in PHD2(+/-) mice. Haplodeficiency of PHD2 did not affect tumor vessel density or lumen size, but normalized the endothelial lining and vessel maturation. This resulted in improved tumor perfusion and oxygenation and inhibited tumor cell invasion, intravasation, and metastasis. Haplodeficiency of PHD2 redirected the specification of endothelial tip cells to a more quiescent cell type, lacking filopodia and arrayed in a phalanx formation. This transition relied on HIF-driven upregulation of (soluble) VEGFR-1 and VE-cadherin. Thus, decreased activity of an oxygen sensor in hypoxic conditions prompts endothelial cells to readjust their shape and phenotype to restore oxygen supply. Inhibition of PHD2 may offer alternative therapeutic opportunities for anticancer therapy.	[Mazzone, Massimiliano; Dettori, Daniela; de Oliveira, Rodrigo Leite; Loges, Sonja; Schmidt, Thomas; Jonckx, Bart; de Almodovar, Carmen Ruiz; De Smet, Frederik; Vinckier, Stefan; Aragones, Julian; Debackere, Koen; Wyns, Sabine; Carmeliet, Peter] VIB Vlaams Inst Biotechnol, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Mazzone, Massimiliano; Dettori, Daniela; de Oliveira, Rodrigo Leite; Loges, Sonja; Schmidt, Thomas; Jonckx, Bart; de Almodovar, Carmen Ruiz; De Smet, Frederik; Vinckier, Stefan; Aragones, Julian; Debackere, Koen; Wyns, Sabine; Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Dettori, Daniela] Univ Turin, Sch Med, Canc Genet Lab, Inst Canc Res & Treatment, I-10060 Turin, Italy; [Tian, Ya-Min; Pollard, Patrick; Ratcliffe, Peter] Henry Wellcome Bldg Genom Med, Oxford OX3 7BN, England; [Lanahan, Anthony A.] Yale Univ, New Haven, CT 06510 USA; [Luttun, Aemout] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium; [Jordan, Benedicte; Gallez, Bernard] Med Chem & Radiopharm UC Louvain, Biomed Magnet Resonance Unit, B-1000 Brussels, Belgium; [Pisacane, Alberto] Inst Canc Res & Treatment, Anat Pathol Unit, I-10060 Turin, Italy; [Lampugnani, Maria Grazia; Dejana, Elisabetta] Italian Fdn Canc Res, Inst Mol Oncol, Vasc Biol Unit, I-20139 Milan, Italy; [Maxwell, Patrick] UCL, Rayne Inst, London WC1E 6JJ, England	Flanders Institute for Biotechnology (VIB); KU Leuven; University of Turin; University of Oxford; Yale University; KU Leuven; IFOM - FIRC Institute of Molecular Oncology; University of London; King's College London; University College London	Carmeliet, P (corresponding author), VIB Vlaams Inst Biotechnol, Vesalius Res Ctr, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.be	Simons, Michael/G-8553-2014; Pollard, Patrick/F-7516-2012; Maxwell, Patrick H/C-5557-2008; Carmeliet, Peter/AAQ-5140-2020; De Smet, Frederik/Q-7808-2016; Loges, Sonja/ABE-9868-2021; Schmidt, Thomas/Y-8431-2019; pisacane, alberto/AAB-9001-2020; Luttun, Aernout/AAZ-6540-2020	Simons, Michael/0000-0003-0348-7734; Pollard, Patrick/0000-0002-4459-4993; Maxwell, Patrick H/0000-0002-0338-2679; Carmeliet, Peter/0000-0001-7961-1821; De Smet, Frederik/0000-0002-6669-3335; Loges, Sonja/0000-0002-7650-8527; Schmidt, Thomas/0000-0002-7166-3675; pisacane, alberto/0000-0002-5143-8980; Luttun, Aernout/0000-0001-7902-9524; Lampugnani, Maria Grazia/0000-0002-4802-7064; Aragones Lopez, Julian/0000-0002-0193-4679; Ratcliffe, Peter/0000-0002-2853-806X; Mazzone, Massimiliano/0000-0001-8824-4015; Ruiz de Almodovar, Carmen/0000-0001-5975-7815; DEJANA, ELISABETTA/0000-0002-0007-0426; Debackere, Koen/0000-0002-7701-326X; Leite de Oliveira, Rodrigo/0000-0002-9696-2014	FWO [G0125.00, G0121.02]; British Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053793] Funding Source: NIH RePORTER	FWO(FWO); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	M. M. is supported by the European Molecular Biology Organization, R. L. O. by the Fonds Wetenschappelijk Onderzoek ( FWO), S. L. by the Deutsche Krebshilfe, T. S. by the Deutsche Forschungsgemeinschaft, C. R. A. by the Federation of European Biochemical Societies and the FWO, and A. L. by the FWO and a Katholieke Universiteit Leuven Center of Excellence grant. The authors thank Vesalius Research Center technicians for assistance. This work was supported by grants from (to P. C.) Methusalem, the FWO (G0125.00; G0121.02), the European Union (QLRT- 2001- 0195), the Concerted Research Activities (# GOA2001/ 09; GOA/2006/11), the Belgian Science Policy (IAP- P5/02), and (to P. H. M. and P. J. R.) the British Heart Foundation (Programme Grant). P. R. and P. M. are scientific cofounders of and hold equity in ReOx Ltd., a University spin-out company that aims to develop inhibitors of the HIF hydroxylases.	Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Couvelard A, 2008, CLIN CANCER RES, V14, P6634, DOI 10.1158/1078-0432.CCR-07-5258; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H, 2008, J MOL MED, V86, P135, DOI 10.1007/s00109-007-0258-2; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Lee K, 2008, MOL CANCER RES, V6, P829, DOI 10.1158/1541-7786.MCR-07-2113; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Nangaku M, 2007, ARTERIOSCL THROM VAS, V27, P2548, DOI 10.1161/ATVBAHA.107.148551; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2007, HYPERTENSION, V49, P178, DOI 10.1161/01.HYP.0000251360.40838.0f; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wu SR, 2008, MOL THER, V16, P1227, DOI 10.1038/mt.2008.90; Yamashita T, 2008, J BIOL CHEM, V283, P18926, DOI 10.1074/jbc.M709133200	41	594	615	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 6	2009	136	5					839	851		10.1016/j.cell.2009.01.020	http://dx.doi.org/10.1016/j.cell.2009.01.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19217150	Bronze, Green Accepted			2022-12-24	WOS:000263930900008
J	Padmanabhan, S; Mukhopadhyay, A; Narasimhan, SD; Tesz, G; Czech, MP; Tissenbaum, HA				Padmanabhan, Srivatsan; Mukhopadhyay, Arnab; Narasimhan, Sri Devi; Tesz, Gregory; Czech, Michael P.; Tissenbaum, Heidi A.			A PP2A Regulatory Subunit Regulates C-elegans Insulin/IGF-1 Signaling by Modulating AKT-1 Phosphorylation	CELL			English	Article							PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR GENE; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; STRESS RESISTANCE; DAUER FORMATION; CELL-PROLIFERATION; LARVAL DEVELOPMENT	The C. elegans insulin/IGF-1 signaling (IIS) cascade plays a central role in regulating life span, dauer, metabolism, and stress. The major regulatory control of IIS is through phosphorylation of its components by serine/threonine-specific protein kinases. An RNAi screen for serine/threonine protein phosphatases that counterbalance the effect of the kinases in the IIS pathway identified pptr-1, a B56 regulatory subunit of the PP2A holoenzyme. Modulation of pptr-1 affects IIS pathway-associated phenotypes including life span, dauer, stress resistance, and fat storage. We show that PPTR-1 functions by regulating worm AKT-1 phosphorylation at Thr 350. With striking conservation, mammalian B56 beta regulates Akt phosphorylation at Thr 308 in 3T3-L1 adipocytes. In C. elegans, this ultimately leads to changes in subcellular localization and transcriptional activity of the forkhead transcription factor DAF-16. This study reveals a conserved role for the B56 regulatory subunit in regulating insulin signaling through AKT dephosphorylation, thereby having widespread implications in cancer and diabetes research.	[Padmanabhan, Srivatsan; Mukhopadhyay, Arnab; Narasimhan, Sri Devi; Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Tesz, Gregory; Czech, Michael P.; Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Tissenbaum, HA (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	heidi.tissenbaum@umassmed.edu	Mukhopadhyay, Arnab/N-6005-2016	Mukhopadhyay, Arnab/0000-0002-5266-7849; Padmanabhan, Srivatsan/0000-0003-2958-1390	National Institute of Aging [AG025891]; Glenn Foundation; William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING [R01AG025891] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation; William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Eun-soo Kwon, Kelvin Yen, Craig Mello, and Marian Walhout for advice and critical comments on the manuscript, Paul Furcinitti of the UMass Medical School Digital Light Microscopy Core Facility for help with the confocal microscopy, Nina Bhabhalia for technical support, and Sandhya Pande for help with the phospho- westerns. We thank Marian Walhout, Gary Ruvkun, Maren Hertweck, and Ralf Baumeister for plasmids and strains. Some of the strains were kindly provided by Theresa Stiernagle at the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. H. A. T. is a William Randolph Hearst Young Investigator. This project was funded in part by the National Institute of Aging (AG025891), the Glenn Foundation, and an endowment from the William Randolph Hearst Foundation.	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; da Graca LS, 2004, DEVELOPMENT, V131, P435, DOI 10.1242/dev.00922; DORMAN JB, 1995, GENETICS, V141, P1399; Eichhorn P.J., 2008, BBA-REV CANCER, V1795, P1, DOI DOI 10.1016/J.BBCAN.2008.05.005; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gems D, 1998, GENETICS, V150, P129; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gunther CV, 2000, DEVELOPMENT, V127, P3337; Hakem R, 2001, ANNU REV GENET, V35, P209, DOI 10.1146/annurev.genet.35.102401.090432; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hojlund K, 2002, EUR J CLIN INVEST, V32, P918, DOI 10.1046/j.1365-2362.2002.01098.x; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jensen VL, 2007, GENETICS, V177, P661, DOI 10.1534/genetics.107.076703; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIMBLE J, 1984, DEV BIOL, V105, P234, DOI 10.1016/0012-1606(84)90279-3; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lithgow GJ, 2002, MECH AGEING DEV, V123, P765, DOI 10.1016/S0047-6374(01)00422-5; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Munoz MJ, 2003, GENETICS, V163, P171; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; PILGRIM D, 1995, MOL BIOL CELL, V6, P1159, DOI 10.1091/mbc.6.9.1159; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Riddle DL, 1997, C ELEGANS; Rondinone CM, 1999, DIABETOLOGIA, V42, P819, DOI 10.1007/s001250051232; Rouault JP, 1999, CURR BIOL, V9, P329, DOI 10.1016/S0960-9822(99)80143-2; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaoka T, 2006, PHARMACOL THERAPEUT, V112, P799, DOI 10.1016/j.pharmthera.2006.06.001; Savage-Dunn C., 2005, WORMBOOK; Smith U, 1999, ANN NY ACAD SCI, V892, P119, DOI 10.1111/j.1749-6632.1999.tb07790.x; SRINIVASAN M, 1994, J BIOL CHEM, V269, P12514; Stiernagle T., 2006, MAINTENANCE C ELEGAN; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; VOWELS JJ, 1992, GENETICS, V130, P105; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200; Zdychova J, 2005, PHYSIOL RES, V54, P1, DOI 10.33549/physiolres.930582	80	122	142	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					939	951		10.1016/j.cell.2009.01.025	http://dx.doi.org/10.1016/j.cell.2009.01.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19249087	Green Accepted, Bronze			2022-12-24	WOS:000263930900016
J	Rosen, CJ				Rosen, Clifford J.			Serotonin Rising - The Bone, Brain, Bowel Connection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Haney E. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P133; Rosen CJ, 2008, CELL METAB, V7, P7, DOI 10.1016/j.cmet.2007.12.004; Tam J, 2008, FASEB J, V22, P285, DOI 10.1096/fj.06-7957com; Warden SJ, 2008, MENOPAUSE, V15, P1176, DOI 10.1097/gme.0b013e318173566b; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059	5	42	45	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					957	959		10.1056/NEJMp0810058	http://dx.doi.org/10.1056/NEJMp0810058			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19264685				2022-12-24	WOS:000263824500003
J	Sena, G; Wang, XN; Liu, HY; Hofhuis, H; Birnbaum, KD				Sena, Giovanni; Wang, Xiaoning; Liu, Hsiao-Yun; Hofhuis, Hugo; Birnbaum, Kenneth D.			Organ regeneration does not require a functional stem cell niche in plants	NATURE			English	Article							ROOT; EXPRESSION; SCARECROW; POLARITY	Plants rely on the maintenance of stem cell niches at their apices for the continuous growth of roots and shoots. However, although the developmental plasticity of plant cells has been demonstrated(1), it is not known whether the stem cell niche is required for organogenesis. Here we explore the capacity of a broad range of differentiating cells to regenerate an organ without the activity of a stem cell niche. Using a root-tip regeneration system in Arabidopsis thaliana to track the molecular and functional recovery of cell fates, we show that respecification of lost cell identities begins within hours of excision and that the function of specialized cells is restored within one day. Critically, regeneration proceeds in plants with mutations that fail to maintain the stem cell niche. These results show that stem-cell-like properties that mediate complete organ regeneration are dispersed in plant meristems and are not restricted to niches, which nonetheless seem to be necessary for indeterminate growth. This regenerative reprogramming of an entire organ without transition to a stereotypical stem cell environment has intriguing parallels to recent reports of induced transdifferentiation of specific cell types in the adult organs of animals(2,3).	[Sena, Giovanni; Wang, Xiaoning; Liu, Hsiao-Yun; Birnbaum, Kenneth D.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Hofhuis, Hugo] Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands	New York University; Utrecht University	Birnbaum, KD (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, Silver Bldg,100 Washington Sq E, New York, NY 10003 USA.	ken.birnbaum@nyu.edu	Sena, Giovanni/C-3297-2012	Sena, Giovanni/0000-0003-3626-5038; hofhuis, hugo/0000-0001-7882-7380	National Institutes of Health [5R01GM078279]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Scheres and R. Heidstra for mutant and reporter lines and for comments. We thank P. Doerner for the CYCB1;1::GFP reporter, J. Friml for the PINFORMED (PIN) reporter lines, and C. Desplan, T. Nawy, B. Bargmann and M. Gifford for comments. This work was supported by the National Institutes of Health grant 5R01GM078279 (K. D. B.)	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Beemster GTS, 2006, J PLANT RES, V119, P43, DOI 10.1007/s10265-005-0234-2; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blancaflor EB, 1998, PLANT PHYSIOL, V116, P213, DOI 10.1104/pp.116.1.213; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; FELDMAN LJ, 1976, PLANTA, V128, P207, DOI 10.1007/BF00393230; FIGDOR W, 1907, JB WISS BOT, V44, P41; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; ROST TL, 1988, ANN BOT-LONDON, V61, P513, DOI 10.1093/oxfordjournals.aob.a087583; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sack FD, 1997, PLANTA, V203, pS63, DOI 10.1007/PL00008116; STEWARD FC, 1970, ANN BOT-LONDON, V34, P761, DOI 10.1093/oxfordjournals.aob.a084408; Thowfeequ S, 2007, DEV DYNAM, V236, P3208, DOI 10.1002/dvdy.21336; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	25	168	176	0	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1150	U110		10.1038/nature07597	http://dx.doi.org/10.1038/nature07597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19182776	Green Submitted, Green Accepted			2022-12-24	WOS:000263680100045
J	Benazet, JD; Bischofberger, M; Tiecke, E; Goncalves, A; Martin, JF; Zuniga, A; Naef, F; Zeller, R				Benazet, Jean-Denis; Bischofberger, Mirko; Tiecke, Eva; Goncalves, Alexandre; Martin, James F.; Zuniga, Aimee; Naef, Felix; Zeller, Rolf			A Self-Regulatory System of Interlinked Signaling Feedback Loops Controls Mouse Limb Patterning	SCIENCE			English	Article							VERTEBRATE LIMB; BUD; EXPRESSION; ROBUSTNESS; OUTGROWTH; EXPANSION; MESODERM; BMP4; SHH; CRE	Embryogenesis depends on self- regulatory interactions between spatially separated signaling centers, but few of these are well understood. Limb development is regulated by epithelial- mesenchymal (e-m) feedback loops between sonic hedgehog ( SHH) and fibroblast growth factor ( FGF) signaling involving the bone morphogenetic protein ( BMP) antagonist Gremlin1 ( GREM1). By combining mouse molecular genetics with mathematical modeling, we showed that BMP4 first initiates and SHH then propagates e- m feedback signaling through differential transcriptional regulation of Grem1 to control digit specification. This switch occurs by linking a fast BMP4/ GREM1 module to the slower SHH/ GREM1/ FGF e- m feedback loop. This self- regulatory signaling network results in robust regulation of distal limb development that is able to compensate for variations by interconnectivity among the three signaling pathways.	[Benazet, Jean-Denis; Tiecke, Eva; Goncalves, Alexandre; Zuniga, Aimee; Zeller, Rolf] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Bischofberger, Mirko; Naef, Felix] Swiss Inst Expt Canc Res, Computat Syst Biol Grp, Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Bischofberger, Mirko; Naef, Felix] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Martin, James F.] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	University of Basel; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Zeller, R (corresponding author), Univ Basel, Dept Biomed, Mattenstr 28, CH-4058 Basel, Switzerland.	rolf.zeller@unibas.ch	Naef, Felix/C-9527-2011; Benazet, Jean-Denis/I-8495-2016; Zuniga, Aimée/Q-2692-2018; Zeller, Rolf/C-2610-2013	Zuniga, Aimée/0000-0002-9953-3637; Naef, Felix/0000-0001-9786-3037; Bischofberger, Mirko/0000-0002-0878-8184; Zeller, Rolf/0000-0002-3186-7403	Swiss National Science Foundation [3100A0-100240, 3100A0-113866, 3100A0- 113617, 3100A0- 112607]; Novartis Foundation; NIH [2R01DE12324-12, R01DE16329]; FCT [SFRH/BD/24301/2005]; University of Basel; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016329] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); University of Basel; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank B. Hogan, C. Hoffmann, and G. Hollander for making Bmp mutant alleles available to us; F. Lehembre for help with quantitative polymerase chain reaction (QPCR); J. Lopez-Rios for input into the design of the network architecture; and M. Affolter, M. Kmita, and group members for input. This research is supported by the Swiss National Science Foundation (grants 3100A0-100240 and 3100A0-113866 to R.Z., grant 3100A0- 113617 to F.N., and grant 3100A0-112607 to AZ), the Novartis Foundation (to R.Z. and E.T.), the NIH (grants 2R01DE12324-12 and R01DE16329 to J.F.M.), the FCT (SFRH/BD/24301/2005 to A.G.), and the University of Basel. The authors declare no competing financial interests.	Ahn K, 2001, DEVELOPMENT, V128, P4449; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hockman D, 2008, P NATL ACAD SCI USA, V105, P16982, DOI 10.1073/pnas.0805308105; Hofmann C, 1996, DEV GENET, V19, P43, DOI 10.1002/(SICI)1520-6408(1996)19:1&lt;43::AID-DVG5&gt;3.0.CO;2-0; Kerszberg M, 2004, CURR OPIN GENET DEV, V14, P440, DOI 10.1016/j.gde.2004.06.001; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kulessa H, 2002, GENESIS, V32, P66, DOI 10.1002/gene.10032; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Nissim S, 2006, DEV BIOL, V299, P12, DOI 10.1016/j.ydbio.2006.05.026; Ovchinnikov DA, 2006, DEV BIOL, V295, P103, DOI 10.1016/j.ydbio.2006.03.013; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	27	150	153	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1050	1053		10.1126/science.1168755	http://dx.doi.org/10.1126/science.1168755			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229034				2022-12-24	WOS:000263478400039
J	Jones, R; Sleet, S				Jones, Roger; Sleet, Sarah			Easily Missed? Coeliac disease	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; DIAGNOSIS; POPULATION; PEOPLE; LESSON		[Jones, Roger] Kings Coll London, Dept Gen Practice & Primary Care, London SE11 6SP, England; [Sleet, Sarah] Coeliac UK, High Wycombe HP11 2HS, Bucks, England	University of London; King's College London	Jones, R (corresponding author), Kings Coll London, Dept Gen Practice & Primary Care, London SE11 6SP, England.	roger.jones@kcl.ac.uk						Corazza GR, 1999, AM J GASTROENTEROL, V94, P391; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; DUBE C, 2005, GASTROENTEROLOGY, V128, pS1; Furse RM, 2005, BMJ-BRIT MED J, V330, P773, DOI 10.1136/bmj.330.7494.773; GODLEE F, 2009, BRIT MED J, V338, pB821; Graber ML, 2007, BRIT MED J, V334, P732, DOI 10.1136/bmj.39161.587720.BE; Green PHR, 2005, GASTROENTEROLOGY, V128, pS74, DOI 10.1053/j.gastro.2005.02.016; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b491; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Jones R, 2007, BRIT MED J, V334, P704, DOI 10.1136/bmj.39170.410347.80; Lewis NR, 2006, ALIMENT PHARM THER, V24, P47, DOI 10.1111/j.1365-2036.2006.02967.x; *NIH CLIN EXC, 2008, CLIN GUID NICE, V61; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Sanders DS, 2005, BMJ-BRIT MED J, V330, P775, DOI 10.1136/bmj.330.7494.775; Sanders DS, 2003, EUR J GASTROEN HEPAT, V15, P407, DOI 10.1097/00042737-200304000-00012; Silvester JA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b380; Tikkakoski S, 2007, SCAND J GASTROENTERO, V42, P60, DOI 10.1080/00365520600789974; Watson RGP, 2005, BRIT MED J, V330, P739, DOI 10.1136/bmj.330.7494.739; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; Willis HWM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3066	20	10	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 19	2009	338								a3058	10.1136/bmj.a3058	http://dx.doi.org/10.1136/bmj.a3058			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228763				2022-12-24	WOS:000264052200002
J	Williamson, CE; Saros, JE; Schindler, DW				Williamson, Craig E.; Saros, Jasmine E.; Schindler, David W.			CLIMATE CHANGE Sentinels of Change	SCIENCE			English	Editorial Material							TERRESTRIAL; LAKES		[Williamson, Craig E.] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Saros, Jasmine E.] Univ Maine, Climate Change Inst, Orono, ME 04469 USA; [Saros, Jasmine E.] Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA; [Schindler, David W.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University System of Ohio; Miami University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Alberta	Williamson, CE (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	craig.williamson@muohio.edu; jasmine.saros@maine.edu; d.schindler@ualberta.ca	Schindler, David/A-3752-2014					[Anonymous], 2005, MILLENNIUM ECOSYSTEM; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Ding JQ, 2008, BIOSCIENCE, V58, P317, DOI 10.1641/B580407; Downing JA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002854; Duarte CM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000637; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Johnson P. T. J., 2008, FRONT ECOL ENVIRON, V6, P357, DOI DOI 10.1890/070156; Kelly EN, 2006, P NATL ACAD SCI USA, V103, P19380, DOI 10.1073/pnas.0609798104; Lewis C.F.M., 2008, EOS T AM GEOPHYS UN, V89, P541, DOI DOI 10.1029/2008EO520001; Lewis CFM, 2001, GEOLOGY, V29, P743, DOI 10.1130/0091-7613(2001)029<0743:UDEDBM>2.0.CO;2; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Stow C.A., 2008, EOS T AM GEOPHYSICAL, V89, P389; van der Kamp G, 2008, CAN WATER RESOUR J, V33, P23, DOI 10.4296/cwrj3301023; von Wachenfeldt E, 2008, LIMNOL OCEANOGR, V53, P2416, DOI 10.4319/lo.2008.53.6.2416; Wilcox D.A., 2007, GEOL SURV CIRCULAR, P1, DOI [10.3133/cir1311, DOI 10.3133/CIR1311]; Williamson CE, 2008, FRONT ECOL ENVIRON, V6, P247, DOI 10.1890/070140; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2	19	186	192	12	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					887	888		10.1126/science.1169443	http://dx.doi.org/10.1126/science.1169443			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213905				2022-12-24	WOS:000263295400027
J	Ndrepepa, G; Kastrati, A; Mehilli, J; Antoniucci, D; Schomig, A				Ndrepepa, Gjin; Kastrati, Adnan; Mehilli, Julinda; Antoniucci, David; Schoemig, Albert			Mechanical Reperfusion and Long-term Mortality in Patients With Acute Myocardial Infarction Presenting 12 to 48 Hours From Onset of Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ndrepepa, Gjin; Kastrati, Adnan; Mehilli, Julinda; Schoemig, Albert] Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany; [Antoniucci, David] Azienda Osped Careggi, Florence, Italy	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; University of Florence; Azienda Ospedaliero Universitaria Careggi	Ndrepepa, G (corresponding author), Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany.	kastrati@dhm.mhn.de	Mehilli, Julinda/F-2629-2016; , Kastrati/Y-2389-2019					Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Parodi G, 2006, AM HEART J, V152, P1133, DOI 10.1016/j.ahj.2006.08.007; Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865	4	40	47	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					487	488		10.1001/jama.2009.32	http://dx.doi.org/10.1001/jama.2009.32			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402CS	19190313	Bronze			2022-12-24	WOS:000262992400017
J	El Harchaoui, K; Arsenault, BJ; Franssen, R; Despres, JP; Hovingh, K; Stroes, ESG; Otvos, JD; Wareham, NJ; Kastelein, JJP; Khaw, KT; Boekholdt, SM				El Harchaoui, Karim; Arsenault, Benoit J.; Franssen, Remco; Despres, Jean-Pierre; Hovingh, Kees; Stroes, Erik S. G.; Otvos, James D.; Wareham, Nicholas J.; Kastelein, John J. P.; Khaw, Kay-Tee; Boekholdt, S. Matthijs			High-Density Lipoprotein Particle Size and Concentration and Coronary Risk	ANNALS OF INTERNAL MEDICINE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; APOLIPOPROTEIN-A-I; INTIMA-MEDIA THICKNESS; ARTERY-DISEASE; EPIC-NORFOLK; INSULIN-RESISTANCE; NONFASTING TRIGLYCERIDES; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; HEART-DISEASE	Background: High-density lipoprotein (HDL) cholesterol levels are inversely related to risk for coronary artery disease (CAD). Because HDL particles are heterogeneous in size and composition, they may be differentially associated with other cardiovascular risk factors and with cardiovascular risk. Objective: To study the independent relationships of HDL size and particle concentration to risk for future CAD. Design: Nested case-control study within the EPIC (European Prospective Investigation into Cancer and Nutrition)-Norfolk cohort; baseline survey between 1993 and 1997, follow-up until November 2003. Setting: Norfolk, United Kingdom. Participants: Case patients were 822 apparently healthy men and women who developed CAD during follow-up. Control participants were 1401 participants who remained without CAD and were matched to case patients by sex, age, and enrollment time. Measurements: First CAD event leading to either hospitalization or death. Results: Nuclear magnetic resonance spectroscopy-measured HDL particle concentration (mean, 33.9 mu mol/L [SD, 5] vs. 32.9 mu mol/L [SD, 6]; P < 0.001) and HDL size (mean, 8.9 nm [SD, 0.5] vs. 8.8 nm [SD, 0.5]; P < 0.001), as well as gradient gel electrophoresis measured HDL size (mean, 8.9 nm [SD, 0.4] vs. 8.8 nm [SD, 0.4]; P = 0.005) were lower in case patients than in control participants. High-density lipoprotein size and HDL particle concentration were only weakly correlated (r = 0.08, for those measured with nuclear magnetic resonance spectroscopy; r = 0.10, for those measured with gradient gel electrophoresis). High-density lipoprotein size was strongly associated with risk factors characteristic of the metabolic syndrome, including waist-to-hip ratio, triglyceride level, and apolipoprotein B level, whereas HDL particle concentration was not. Both HDL size and HDL particle concentration were independently associated with CAD risk. The association between HDL size and CAD risk was abolished on adjustment for apolipoprotein B and triglyceride levels (adjusted odds ratio, 1.00 [95% CI, 0.71 to 1.39] for top vs. bottom quartile), whereas HDL particle concentration remained independently associated with CAD risk (adjusted odds ratio, 0.50 [CI, 0.37 to 0.66]). Limitation: Measurements were performed in nonfasting blood samples, and residual confounding cannot be excluded. Conclusion: Both HDL size and HDL particle concentration were independently associated with other cardiovascular risk factors and with the risk for CAD. The relationship between HDL size and CAD risk was explained by markers associated with the metabolic syndrome, indicating that part of the relationship between HDL cholesterol and CAD risk is merely a reflection of this metabolic risk.	[Boekholdt, S. Matthijs] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands; Hop Laval, Res Ctr, Quebec Heart Inst, Quebec City, PQ, Canada; LipoSci, Raleigh, NC USA; Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; Univ Cambridge, Inst Publ Hlth & Primary Care, Cambridge, England	University of Amsterdam; Academic Medical Center Amsterdam; Laval University; LipoScience, Inc; University of Cambridge; University of Cambridge	Boekholdt, SM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, F4-159-2,POB 22660, NL-1100 DD Amsterdam, Netherlands.	s.m.boekholdt@amc.uva.nl	Boekholdt, Matthijs S.M./G-7562-2014; Kastelein, John/AAF-7950-2020; Khaw, Kay-Tee/AAZ-3209-2021	Boekholdt, Matthijs/0000-0002-0861-0765	The Medical Research Council and Cancer Research UK; European Union; Stroke Association; British Heart Foundation; United Kingdom Department of Health; Food Standards Agency; Wellcome Trust; Future Forum	The Medical Research Council and Cancer Research UK; European Union(European Commission); Stroke Association; British Heart Foundation(British Heart Foundation); United Kingdom Department of Health; Food Standards Agency; Wellcome Trust(Wellcome TrustEuropean Commission); Future Forum	The Medical Research Council and Cancer Research UK, European Union, Stroke Association, British Heart Foundation, United Kingdom Department of Health, Food Standards Agency, the Wellcome Trust, and the Future Forum.	ALBERS JJ, 1992, CLIN CHEM, V38, P658; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Bruins P, 1997, CIRCULATION, V96, P3542; CHEUNG MC, 1991, J LIPID RES, V32, P383; Colhoun HM, 2002, DIABETES, V51, P1949, DOI 10.2337/diabetes.51.6.1949; Day N, 1999, BRIT J CANCER, V80, P95; Festa A, 2005, CIRCULATION, V111, P3465, DOI 10.1161/CIRCULATIONAHA.104.512079; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; Freedman DS, 1998, ARTERIOSCL THROM VAS, V18, P1046, DOI 10.1161/01.ATV.18.7.1046; Garvey WT, 2003, DIABETES, V52, P453, DOI 10.2337/diabetes.52.2.453; Grundy SM, 1999, J LIPID RES, V40, P229; Jeyarajah EJ, 2006, CLIN LAB MED, V26, P847, DOI 10.1016/j.cll.2006.07.006; JOHANSSON J, 1991, ARTERIOSCLER THROMB, V11, P174, DOI 10.1161/01.ATV.11.1.174; Josse D, 2002, J BIOL CHEM, V277, P33386, DOI 10.1074/jbc.M200108200; Kontush A, 2003, ARTERIOSCL THROM VAS, V23, P1881, DOI 10.1161/01.ATV.0000091338.93223.E8; Lyons TJ, 2006, DIABETIC MED, V23, P955, DOI 10.1111/j.1464-5491.2006.01905.x; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; MacLean PS, 2000, METABOLISM, V49, P285, DOI 10.1016/S0026-0495(00)80002-5; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Mora S, 2008, CIRCULATION, V118, P993, DOI 10.1161/CIRCULATIONAHA.108.777334; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P2416, DOI 10.1161/01.ATV.0000184760.95957.d6; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; Pascot A, 2001, J LIPID RES, V42, P2007; Perusse M, 2001, J LIPID RES, V42, P1331; Pussinen PJ, 2004, J LIPID RES, V45, P139, DOI 10.1194/jlr.M300250-JLR200; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Shah PK, 2001, CIRCULATION, V103, P3047, DOI 10.1161/hc2501.092494; Syvanne M, 1998, CIRCULATION, V98, P1993, DOI 10.1161/01.CIR.98.19.1993; SYVANNE M, 1995, J LIPID RES, V36, P573; Thuahnai ST, 2004, J BIOL CHEM, V279, P12448, DOI 10.1074/jbc.M311718200; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van der Steeg WA, 2008, J AM COLL CARDIOL, V51, P634, DOI 10.1016/j.jacc.2007.09.060; VANDERPOLL T, 1995, INFECT IMMUN, V63, P3396, DOI 10.1128/IAI.63.9.3396-3400.1995; Wang L, 2006, J AM COLL CARDIOL, V48, P1459, DOI 10.1016/j.jacc.2006.07.040; Watanabe H, 2006, ARTERIOSCL THROM VAS, V26, P897, DOI 10.1161/01.ATV.0000209577.04246.c0; WILSON PW, 1980, AM J CARDIOL, V46, P649, DOI 10.1016/0002-9149(80)90516-0; Yancey PG, 2004, J LIPID RES, V45, P337, DOI 10.1194/jlr.M300231-JLR200	42	186	190	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					84	U43		10.7326/0003-4819-150-2-200901200-00006	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19153411				2022-12-24	WOS:000262655200003
J	Bettencourt-Dias, M; Glover, DM				Bettencourt-Dias, Monica; Glover, David M.			SnapShot: Centriole Biogenesis	CELL			English	Editorial Material							CENTROSOME; DUPLICATION; CELLS		[Bettencourt-Dias, Monica] Gulbenkian Inst Sci, Oeiras, Portugal; [Glover, David M.] Univ Cambridge, Cambridge, England	University of Cambridge	Bettencourt-Dias, M (corresponding author), Gulbenkian Inst Sci, Oeiras, Portugal.		Bettencourt-Dias, Monica/B-5176-2015	Bettencourt-Dias, Monica/0000-0003-1987-5598; Glover, David/0000-0003-0956-0103				Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985	9	11	11	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 9	2009	136	1					188	U1		10.1016/j.cell.2008.12.035	http://dx.doi.org/10.1016/j.cell.2008.12.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135899	Bronze			2022-12-24	WOS:000262318400025
J	Cochran, JC; Sindelar, CV; Mulko, NK; Collins, KA; Kong, SE; Hawley, RS; Kull, FJ				Cochran, Jared C.; Sindelar, Charles V.; Mulko, Natasha K.; Collins, Kimberly A.; Kong, Stephanie E.; Hawley, R. Scott; Kull, F. Jon			ATPase Cycle of the Nonmotile Kinesin NOD Allows Microtubule End Tracking and Drives Chromosome Movement	CELL			English	Article							DROSOPHILA-MELANOGASTER; MONASTROL INHIBITION; MOTOR PROTEINS; EG5; SEGREGATION; MECHANISM; PATHWAY; BINDING; MYOSIN; MODEL	Segregation of nonexchange chromosomes during Drosophila melanogaster meiosis requires the proper function of NOD, a nonmotile kinesin-10. We have determined the X-ray crystal structure of the NOD catalytic domain in the ADP- and AMPPNP-bound states. These structures reveal an alternate conformation of the microtubule binding region as well as a nucleotide-sensitive relay of hydrogen bonds at the active site. Additionally, a cryo-electron microscopy reconstruction of the nucleotide-free microtubule-NOD complex shows an atypical binding orientation. Thermodynamic studies show that NOD binds tightly to microtubules in the nucleotide-free state, yet other nucleotide states, including AMPPNP, are weakened. Our pre-steady-state kinetic analysis demonstrates that NOD interaction with microtubules occurs slowly with weak activation of ADP product release. Upon rapid substrate binding, NOD detaches from the microtubule prior to the rate-limiting step of ATP hydrolysis, which is also atypical for a kinesin. We propose a model for NOD's microtubule plus-end tracking that drives chromosome movement.	[Cochran, Jared C.; Mulko, Natasha K.; Kull, F. Jon] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA; [Sindelar, Charles V.] Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Collins, Kimberly A.; Kong, Stephanie E.; Hawley, R. Scott] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Hawley, R. Scott] Univ Kansas, Med Ctr, Dept Physiol, Kansas City, KS 66160 USA	Dartmouth College; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Kull, FJ (corresponding author), Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA.	f.jon.kull@dartmouth.edu		Hawley, R. Scott/0000-0002-6478-0494	National Institutes of Health (NIH) [F32AR054653 from the]; NIH [GM46033, GM51487, F32GM082104, GM-0080]; American Heart Association Scientist Development [0330345N]; U. S. Department of Energy [DE-AC02-98CH10886, DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR054653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM051487, R01GM046033, F32GM082104] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of National Synchrotron Light Source (NSLS) beamline X6A, particularly Vivian Stojanoff and Jean Jakoncic, for beam time and help with data collection. We also thank Susan P. Gilbert (Rensselaer Polytechnic Institute) and Heinrich J. Matthies (Vanderbilt University) for their insightful comments on this manuscript and our colleagues in the Kull lab for their intellectual discussions. The project described was supported by F32AR054653 from the National Institutes of Health (NIH) (National Institute of Arthritis and Musculoskeletal and Skin Diseases) to J.C.C., GM46033 and GM51487 from the NIH to C. V. S., F32GM082104 from the NIH (National Institute of General Medical Sciences [NIGMS]) to K. A. C., and also by American Heart Association Scientist Development Grant 0330345N to F.J.K. Research carried out at X6A beam line was funded by the NIH (NIGMS) under agreement GM-0080. The NSLS, Brookhaven National Laboratory is supported by the U. S. Department of Energy under contract DE-AC02-98CH10886. Lawrence Berkeley National Laboratory is supported by the U. S. DOE under contract DE-AC02-05CH11231.	AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARPENTER AT, 1973, GENETICS, V73, P393; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Cui W, 2005, GENETICS, V171, P1823, DOI 10.1534/genetics.105.047464; Cui W, 2005, MOL BIOL CELL, V16, P5400, DOI 10.1091/mbc.E05-06-0582; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; DeBonis S, 2003, BIOCHEMISTRY-US, V42, P338, DOI 10.1021/bi026716j; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; JOHNSON KA, 1983, J BIOL CHEM, V258, P3825; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Klumpp LM, 2004, BIOCHEMISTRY-US, V43, P2792, DOI 10.1021/bi035830e; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Kull FJ, 2004, TRENDS BIOCHEM SCI, V29, P103, DOI 10.1016/j.tibs.2004.01.001; Kull FJ, 2002, J CELL SCI, V115, P15; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Matthies HJG, 2001, MOL BIOL CELL, V12, P4000, DOI 10.1091/mbc.12.12.4000; Matthies HJG, 1999, J CELL BIOL, V147, P1137, DOI 10.1083/jcb.147.6.1137; Meneely PM, 2002, GENETICS, V162, P1169; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; RASOOLY RS, 1994, MOL GEN GENET, V242, P145, DOI 10.1007/BF00391007; Shipley K, 2004, EMBO J, V23, P1422, DOI 10.1038/sj.emboj.7600165; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tan DY, 2006, J CELL BIOL, V175, P25, DOI 10.1083/jcb.200605194; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P	49	48	48	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					110	122		10.1016/j.cell.2008.11.048	http://dx.doi.org/10.1016/j.cell.2008.11.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135893	Bronze, Green Accepted			2022-12-24	WOS:000262318400019
J	Kawahara, TLA; Michishita, E; Adler, AS; Damian, M; Berber, E; Lin, M; McCord, RA; Ongaigui, KCL; Boxer, LD; Chang, HY; Chua, KF				Kawahara, Tiara L. A.; Michishita, Eriko; Adler, Adam S.; Damian, Mara; Berber, Elisabeth; Lin, Meihong; McCord, Ron A.; Ongaigui, Kristine C. L.; Boxer, Lisa D.; Chang, Howard Y.; Chua, Katrin F.			SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-kappa B-Dependent Gene Expression and Organismal Life Span	CELL			English	Article							CHROMATIN MODIFICATIONS; CELLULAR SENESCENCE; CALORIE RESTRICTION; TRANSCRIPTION; CELLS; REVEALS; MODULE	Members of the sirtuin (SIRT) family of NAD-dependent deacetylases promote longevity in multiple organisms. Deficiency of mammalian SIRT6 leads to shortened life span and an aging-like phenotype in mice, but the underlying molecular mechanisms are unclear. Here we show that SIRT6 functions at chromatin to attenuate NF-kappa B signaling. SIRT6 interacts with the NF-kappa B RELA subunit and deacetylates histone H3 lysine 9 (H3K9) at NF-kappa B target gene promoters. In SIRT6-deficient cells, hyperacetylation of H3K9 at these target promoters is associated with increased RELA promoter occupancy and enhanced NF-kappa B-dependent modulation of gene expression, apoptosis, and cellular senescence. Computational genomics analyses revealed increased activity of NF-kappa B-driven gene expression programs in multiple Sirt6-deficient tissues in vivo. Moreover, haploinsufficiency of RelA rescues the early lethality and degenerative syndrome of Sirt6-deficient mice. We propose that SIRT6 attenuates NF-kappa B signaling via H3K9 deacetylation at chromatin, and hyperactive NF-kappa B signaling may contribute to premature and normal aging.	[Kawahara, Tiara L. A.; Adler, Adam S.; Lin, Meihong; Ongaigui, Kristine C. L.; Chang, Howard Y.] Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Program Epithelial Biol, Stanford, CA 94305 USA; [Kawahara, Tiara L. A.; Adler, Adam S.; McCord, Ron A.; Chang, Howard Y.; Chua, Katrin F.] Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Canc Biol Program, Stanford, CA 94305 USA; [Michishita, Eriko; Damian, Mara; Berber, Elisabeth; McCord, Ron A.; Boxer, Lisa D.; Chua, Katrin F.] Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Dept Med, Stanford, CA 94305 USA; [Michishita, Eriko; Damian, Mara; Berber, Elisabeth; McCord, Ron A.; Boxer, Lisa D.; Chua, Katrin F.] VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Chang, HY (corresponding author), Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu; kfchua@stanford.edu		Boxer, Lisa/0000-0002-4402-1060; Adler, Adam/0000-0001-9301-0037	NIH; Department of Veterans Affairs Merit Review; Stanford Graduate Fellowship; California Breast Cancer Research Program; American Cancer Society; Damon Runyon Cancer Research Foundation; Paul B. Beeson Aging Research Program; NATIONAL CANCER INSTITUTE [R01CA118750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG028961, R01AG028867] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); Stanford Graduate Fellowship(Stanford University); California Breast Cancer Research Program; American Cancer Society(American Cancer Society); Damon Runyon Cancer Research Foundation; Paul B. Beeson Aging Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank O. Gozani, P. Khavari, R. Mostoslavsky, and T. Rando for comments or advice, T. Hong for assistance with primer design, Regeneron Pharmaceuticals for generation of the Sirt6 gene-targeted mouse embryonic stem cell line, and R. Mostoslavsky and F. W. Alt for generation of the Sirt6 mutant mice. This work was supported by the NIH (K.F.C., T.L.A.K., R.A.M.), Department of Veterans Affairs Merit Review (K.F.C.), Stanford Graduate Fellowship (T.L.A.K.), California Breast Cancer Research Program (A.S.A.), and American Cancer Society (H.Y.C.). H.Y.C. is the Kenneth G. and Elaine A. Langone Scholar of the Damon Runyon Cancer Research Foundation. K. F. C. is a Scholar of the Paul B. Beeson Aging Research Program.	Adler AS, 2008, CELL CYCLE, V7, P556, DOI 10.4161/cc.7.5.5490; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chi JT, 2003, P NATL ACAD SCI USA, V100, P6343, DOI 10.1073/pnas.1037853100; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.E04-05-0392; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	38	783	841	4	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					62	74		10.1016/j.cell.2008.10.052	http://dx.doi.org/10.1016/j.cell.2008.10.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135889	Bronze, Green Accepted			2022-12-24	WOS:000262318400015
J	Wright, CW; Duckett, CS				Wright, Casey W.; Duckett, Colin S.			The Aryl Hydrocarbon Nuclear Translocator Alters CD30-Mediated NF-kappa B-Dependent Transcription	SCIENCE			English	Article							ACTIVATION; CD30; RECEPTOR; FAMILY; RELB; CELL; EXPRESSION; INDUCTION; TRAF2; MICE	Expression and signaling of CD30, a tumor necrosis factor receptor family member, is up- regulated in numerous lymphoid- derived neoplasias, most notably anaplastic large- cell lymphoma ( ALCL) and Hodgkin's lymphoma. To gain insight into the mechanism of CD30 signaling, we used an affinity purification strategy that led to the identification of the aryl hydrocarbon receptor nuclear translocator ( ARNT) as a CD30- interacting protein that modulated the activity of the RelB subunit of the transcription factor nuclear factor kappa B (NF-kappa B). ALCL cells that were deficient in ARNT exhibited defects in RelB recruitment to NF-kappa B-responsive promoters, whereas RelA recruitment to the same sites was potentiated, resulting in the augmented expression of these NF-kappa B-responsive genes. These findings indicate that ARNT functions in concert with RelB in a CD30- induced negative feedback mechanism.	[Wright, Casey W.; Duckett, Colin S.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Duckett, Colin S.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Duckett, CS (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	colind@umich.edu		Wright, Casey/0000-0002-9512-1264; Duckett, Colin/0000-0001-9413-2263	NIH [R01 GM067827]; Cancer Research Fund of the University of Michigan Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067827] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Fund of the University of Michigan Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Burstein and members of the Duckett laboratory for helpful discussions, C. Duvauchelle for assistance with statistical analyses, and A. Savory for assistance with the manuscript. This work was supported by NIH grant R01 GM067827 and an award from the Cancer Research Fund of the University of Michigan Comprehensive Cancer Center to C. S. D.	Aizawa S, 1997, J BIOL CHEM, V272, P2042; Boucher LM, 1997, BIOCHEM BIOPH RES CO, V233, P592, DOI 10.1006/bbrc.1997.6509; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Chandel NS, 2008, CELL DEATH DIFFER, V15, P619, DOI 10.1038/cdd.2008.11; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chiarle R, 1999, CLIN IMMUNOL, V90, P157, DOI 10.1006/clim.1998.4636; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Horie R, 2004, CANCER CELL, V5, P353, DOI 10.1016/S1535-6108(04)00084-4; Horie R, 2002, ONCOGENE, V21, P2493, DOI 10.1038/sj.onc.1205337; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sutherland MSK, 2006, J BIOL CHEM, V281, P10540, DOI 10.1074/jbc.M510026200; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wolke C, 2006, INT J MOL MED, V17, P275; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Younes A, 2003, CANCER-AM CANCER SOC, V98, P458, DOI 10.1002/cncr.11524; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080	27	41	42	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					251	255		10.1126/science.1162818	http://dx.doi.org/10.1126/science.1162818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131627	Green Accepted			2022-12-24	WOS:000262290600038
J	Zhao, C; Chen, A; Jamieson, CH; Fereshteh, M; Abrahamsson, A; Blum, J; Kwon, HY; Kim, J; Chute, JP; Rizzieri, D; Munchhof, M; VanArsdale, T; Beachy, PA; Reya, T				Zhao, Chen; Chen, Alan; Jamieson, Catriona H.; Fereshteh, Mark; Abrahamsson, Annelie; Blum, Jordan; Kwon, Hyog Young; Kim, Jynho; Chute, John P.; Rizzieri, David; Munchhof, Michael; VanArsdale, Todd; Beachy, Philip A.; Reya, Tannishtha			Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; SONIC HEDGEHOG; RESISTANCE; GENE; PROLIFERATION; PROGENITORS; MECHANISMS; PATHWAYS; THERAPY	Although the role of Hedgehog (Hh) signalling in embryonic pattern formation is well established(1), its functions in adult tissue renewal and maintenance remain unclear, and the relationship of these functions to cancer development has not been determined. Here we show that the loss of Smoothened (Smo), an essential component of the Hh pathway(2), impairs haematopoietic stem cell renewal and decreases induction of chronic myelogenous leukaemia (CML) by the BCR-ABL1 oncoprotein(3). Loss of Smo causes depletion of CML stem cells-the cells that propagate the leukaemia-whereas constitutively active Smo augments CML stem cell number and accelerates disease. As a possible mechanism for Smo action, we show that the cell fate determinant Numb, which depletes CML stem cells, is increased in the absence of Smo activity. Furthermore, pharmacological inhibition of Hh signalling impairs not only the propagation of CML driven by wild-type BCR-ABL1, but also the growth of imatinib-resistant mouse and human CML. These data indicate that Hh pathway activity is required for maintenance of normal and neoplastic stem cells of the haematopoietic system and raise the possibility that the drug resistance and disease recurrence associated with imatinib treatment of CML4,5 might be avoided by targeting this essential stem cell maintenance pathway.	[Zhao, Chen; Chen, Alan; Fereshteh, Mark; Blum, Jordan; Kwon, Hyog Young; Reya, Tannishtha] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Chute, John P.; Rizzieri, David] Duke Univ, Med Ctr, Dept Med, Div Cellular Therapy, Durham, NC 27710 USA; [Jamieson, Catriona H.; Abrahamsson, Annelie] Moores UCSD Canc Ctr Jolla, Stem Cell Res Program, Dept Med, La Jolla, CA 92093 USA; [Kim, Jynho; Beachy, Philip A.] Stanford Univ, Med Ctr, Howard Hughes Med Inst, Dept Dev Biol,Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Munchhof, Michael] Pfizer Labs, Div Med Chem, Groton, CT 06340 USA; [VanArsdale, Todd] Pfizer Labs, Div Oncol, La Jolla, CA 92121 USA	Duke University; Duke University; Howard Hughes Medical Institute; Stanford University; Pfizer; Pfizer	Reya, T (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	t.reya@duke.edu	Chen, Alan/HGD-3414-2022; Kwon, Hyog/T-7915-2019	Kwon, Hyog/0000-0003-1663-5118	CRI; EMF; Leukemia and Lymphoma Society; Duke Molecular Cancer Biology Training; California Institute of Regenerative Medicine; National Institutes of Health [DK63031, DK072234, AI067798]; Lisa Stafford Memorial Prize; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063031, R01DK072234] Funding Source: NIH RePORTER	CRI; EMF; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Duke Molecular Cancer Biology Training; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lisa Stafford Memorial Prize; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We wish to thank R. Wechsler-Reya for critical advice, D. Kioussis for Vav-Cre transgenic mice, A. M. Pendergast, A. Means and B. Hogan for review of the manuscript, S. Li for advice on mouse CML experiments, G. Daley, M. Azam and S. Li for the T315I BCR-ABL1 construct, B. Harvat for cell sorting, and J. Harris, B. Zimdahl, N. D'Amato and S. Honeycutt for experimental help. T. R. is a recipient of a CRI Investigator Award, an EMF New Scholar award and a Leukemia and Lymphoma Society Scholar Award, M. F. is supported by the Duke Molecular Cancer Biology Training grant and C. H. J. is funded by the California Institute of Regenerative Medicine and a sponsored research agreement with Pfizer. This work was also supported by National Institutes of Health grants DK63031, DK072234, AI067798 and the Lisa Stafford Memorial Prize to T. R.	Adams JM, 2007, SCIENCE, V318, DOI 10.1126/science.1149672; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; Long FX, 2001, DEVELOPMENT, V128, P5099; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	30	678	726	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					776	U117		10.1038/nature07737	http://dx.doi.org/10.1038/nature07737			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19169242	Green Accepted			2022-12-24	WOS:000265193600044
J	Wilson, TJ; Lilley, DMJ				Wilson, Timothy J.; Lilley, David M. J.			The Evolution of Ribozyme Chemistry	SCIENCE			English	Editorial Material							DELTA VIRUS RIBOZYME; ACTIVE-SITE; CRYSTAL-STRUCTURE; TRANSITION-STATE; CATALYTIC RNA; SPLICEOSOME; MECHANISM; GUANINE; INTRON; DOMAIN		[Wilson, Timothy J.; Lilley, David M. J.] Univ Dundee, Canc Res UK Nucle Acid Struct Res Grp, Dundee DD1 5EH, Scotland	University of Dundee	Wilson, TJ (corresponding author), Univ Dundee, Canc Res UK Nucle Acid Struct Res Grp, MSI WTB Complex,Dow St, Dundee DD1 5EH, Scotland.	d.m.j.lilley@dundee.ac.uk			Biotechnology and Biological Sciences Research Council [B17092] Funding Source: Medline; Cancer Research UK [11722] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)		Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Das SR, 2005, NAT CHEM BIOL, V1, P45, DOI 10.1038/nchembio703; Forconi M, 2008, BIOCHEMISTRY-US, V47, P6883, DOI 10.1021/bi800519a; Kingery DA, 2008, CHEM BIOL, V15, P493, DOI 10.1016/j.chembiol.2008.04.005; Klein DJ, 2007, J AM CHEM SOC, V129, P14858, DOI 10.1021/ja0768441; Lee TS, 2008, J AM CHEM SOC, V130, P3053, DOI 10.1021/ja076529e; LILLEY DMJ, 2008, RIBOYZMES RNA CATALY; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Pena V, 2008, EMBO J, V27, P2929, DOI 10.1038/emboj.2008.209; Ritchie DB, 2008, NAT STRUCT MOL BIOL, V15, P1199, DOI 10.1038/nsmb.1505; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Wilson TJ, 2007, EMBO J, V26, P2489, DOI 10.1038/sj.emboj.7601698	20	29	29	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1436	1438		10.1126/science.1169231	http://dx.doi.org/10.1126/science.1169231			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286542				2022-12-24	WOS:000264101700026
J	Streiff, MB; Haut, ER				Streiff, Michael B.; Haut, Elliott R.			The CMS Ruling on Venous Thromboembolism After Total Knee or Hip Arthroplasty Weighing Risks and Benefits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIRECT THROMBIN INHIBITOR; DOUBLE-BLIND; DABIGATRAN ETEXILATE; PREVENTION; ENOXAPARIN; REPLACEMENT; XIMELAGATRAN; PROPHYLAXIS; TRIAL; THROMBOPROPHYLAXIS		[Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Streiff, MB (corresponding author), Johns Hopkins Med Inst, Dept Med, 1830 E Monument St,Ste 7300, Baltimore, MD 21205 USA.	mstreif@jhmi.edu	Haut, Elliott R./J-3948-2019	Haut, Elliott/0000-0001-7075-771X				Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Colwell CW, 2003, J THROMB HAEMOST, V1, P2119, DOI 10.1046/j.1538-7836.2003.00368.x; Colwell CW, 2005, J BONE JOINT SURG AM, V87A, P2169, DOI 10.2106/JBJS.D.02184; Deep vein thrombosis (DVT)/pulmonary embolism (PE), 2008, FED REG, V73, P48480; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Francis CW, 2003, NEW ENGL J MED, V349, P1703, DOI 10.1056/NEJMoa035162; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goldhaber SZ, 2000, CHEST, V118, P1680, DOI 10.1378/chest.118.6.1680; Larson DM, 2007, JAMA-J AM MED ASSOC, V298, P2754, DOI 10.1001/jama.298.23.2754; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Michota FA, 2007, J GEN INTERN MED, V22, P1762, DOI 10.1007/s11606-007-0369-z; Turpie AGG, 2002, LANCET, V359, P1721, DOI 10.1016/S0140-6736(02)08648-8	15	62	66	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1063	1065		10.1001/jama.301.10.1063	http://dx.doi.org/10.1001/jama.301.10.1063			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416OQ	19278950				2022-12-24	WOS:000264015800032
J	Fiedler, D; Braberg, H; Mehta, M; Chechik, G; Cagney, G; Mukherjee, P; Silva, AC; Shales, M; Collins, SR; van Wageningen, S; Kemmeren, P; Holstege, FCP; Weissman, JS; Keogh, MC; Koller, D; Shokat, KM; Krogan, NJ				Fiedler, Dorothea; Braberg, Hannes; Mehta, Monika; Chechik, Gal; Cagney, Gerard; Mukherjee, Paromita; Silva, Andrea C.; Shales, Michael; Collins, Sean R.; van Wageningen, Sake; Kemmeren, Patrick; Holstege, Frank C. P.; Weissman, Jonathan S.; Keogh, Michael-Christopher; Koller, Daphne; Shokat, Kevan M.; Krogan, Nevan J.			Functional Organization of the S-cerevisiae Phosphorylation Network	CELL			English	Article							H2A VARIANT HTZ1; PROTEIN-KINASES; TRANSCRIPTION ELONGATION; SIGNALING PATHWAYS; GENETIC-ANALYSIS; IN-VIVO; YEAST; PHOSPHATASE; COMPLEX; ROLES	Reversible protein phosphorylation is a signaling mechanism involved in all cellular processes. To create a systems view of the signaling apparatus in budding yeast, we generated an epistatic miniarray profile (E-MAP) comprised of 100,000 pairwise, quantitative genetic interactions, including virtually all protein and small-molecule kinases and phosphatases as well as key cellular regulators. Quantitative genetic interaction mapping reveals factors working in compensatory pathways (negative genetic interactions) or those operating in linear pathways (positive genetic interactions). We found an enrichment of positive genetic interactions between kinases, phosphatases, and their substrates. In addition, we assembled a higher-order map from sets of three genes that display strong interactions with one another: triplets enriched for functional connectivity. The resulting network view provides insights into signaling pathway regulation and reveals a link between the cell-cycle kinase, Cak1, the Fus3 MAP kinase, and a pathway that regulates chromatin integrity during transcription by RNA polymerase II.	[Fiedler, Dorothea; Braberg, Hannes; Cagney, Gerard; Shales, Michael; Collins, Sean R.; Weissman, Jonathan S.; Shokat, Kevan M.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Fiedler, Dorothea; Collins, Sean R.; Weissman, Jonathan S.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Braberg, Hannes; Cagney, Gerard; Shales, Michael; Collins, Sean R.; Weissman, Jonathan S.; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Mehta, Monika; Mukherjee, Paromita; Silva, Andrea C.; Keogh, Michael-Christopher] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Chechik, Gal; Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Cagney, Gerard] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [van Wageningen, Sake; Kemmeren, Patrick; Holstege, Frank C. P.] Univ Med Ctr Utrect, Dept Physiol Chem, Utrecht, Netherlands	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; Stanford University; University College Dublin; Utrecht University; Utrecht University Medical Center	Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	shokat@cmp.ucsf.edu; krogan@cmp.ucsf.edu	Silva, Andrea Cristina/K-8837-2014; Holstege, Frank/AAM-9944-2021; Silva, Andrea/O-8852-2019	Silva, Andrea Cristina/0000-0001-5248-5511; Chechik, Gal/0000-0001-9164-5303; Mehta, Monika/0000-0003-3928-3733; Kemmeren, Patrick/0000-0003-2237-7354; Collins, Sean/0000-0002-4276-5840; Cagney, Gerard/0000-0001-7189-9496; Weissman, Jonathan/0000-0003-2445-670X	Ernst Schering Postdoctoral Fellowship; Biophysics Graduate Group at UCSF; National Science Foundation; New York Speakers Fund for Biomedical Research; Howard Hughes Medical Institute; NIH; Sandler Family Funding; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER	Ernst Schering Postdoctoral Fellowship; Biophysics Graduate Group at UCSF; National Science Foundation(National Science Foundation (NSF)); New York Speakers Fund for Biomedical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Funding; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank A. Roguev, C. Kaplan, C. J. Ingles, P. Aguilar, T. Walther, J. H. Morris, and members of the Krogan, Shokat, and Keogh labs for advice and comments. We also thank W. A. Lim for discussion on MAP kinase cascades. We are grateful to A. Chan, E. Cheng, Y. Nijati, and Li Jieying for technical assistance. We thank F. Winston and S. Buratowski for providing yeast strains and B. Strahl, S. Hahn, and D. Morgan for sharing unpublished data. The work was supported by an Ernst Schering Postdoctoral Fellowship (D.F.), the Biophysics Graduate Group at UCSF (H.B.), the National Science Foundation (G.C. and D. K.), the New York Speakers Fund for Biomedical Research (M.-C.K.), the Howard Hughes Medical Institute (K.M.S.), the NIH (N.J.K. and K. M. S.), and Sandler Family Funding (N.J.K.).	Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Cullen PJ, 2002, EUKARYOT CELL, V1, P884, DOI 10.1128/EC.1.6.884-894.2002; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Espinoza FH, 1998, MOL CELL BIOL, V18, P6365, DOI 10.1128/MCB.18.11.6365; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Green KD, 2007, J AM CHEM SOC, V129, P10, DOI 10.1021/ja066828o; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lee TY, 2006, NUCLEIC ACIDS RES, V34, pD622, DOI 10.1093/nar/gkj083; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Luke MM, 1996, MOL CELL BIOL, V16, P2744; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nourani A, 2006, MOL CELL BIOL, V26, P1496, DOI 10.1128/MCB.26.4.1496-1509.2006; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ostapenko D, 2005, MOL CELL BIOL, V25, P3906, DOI 10.1128/MCB.25.10.3906-3913.2005; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Rua D, 2001, CURR OPIN MICROBIOL, V4, P720, DOI 10.1016/S1369-5274(01)00274-0; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Schaber M, 2002, MOL CELL BIOL, V22, P57, DOI 10.1128/MCB.22.1.57-68.2002; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Wu C, 1997, J BIOL CHEM, V272, P30623, DOI 10.1074/jbc.272.49.30623; Yao S, 2002, MOL CELL BIOL, V22, P6750, DOI 10.1128/MCB.22.19.6750-6758.2002; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zanzoni A, 2007, NUCLEIC ACIDS RES, V35, pD229, DOI 10.1093/nar/gkl922	68	198	202	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					952	963		10.1016/j.cell.2008.12.039	http://dx.doi.org/10.1016/j.cell.2008.12.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269370	Green Accepted, Bronze			2022-12-24	WOS:000263930900017
J	Gago, S; Elena, SF; Flores, R; Sanjuan, R				Gago, Selma; Elena, Santiago F.; Flores, Ricardo; Sanjuan, Rafael			Extremely High Mutation Rate of a Hammerhead Viroid	SCIENCE			English	Article							EVOLUTION		[Gago, Selma; Elena, Santiago F.; Flores, Ricardo; Sanjuan, Rafael] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Valencia 46022, Spain; [Sanjuan, Rafael] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia 46980, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of Valencia	Sanjuan, R (corresponding author), Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Valencia 46022, Spain.	rafael.sanjuan@uv.es	Elena, Santiago F./A-4191-2011; Flores, Ricardo/K-2788-2014; Gago Zachert, Selma/N-2902-2017	Elena, Santiago F./0000-0001-8249-5593; Flores, Ricardo/0000-0002-3033-5077; Gago Zachert, Selma/0000-0002-1084-2119; Sanjuan, Rafael/0000-0002-1844-545X	Spanish Ministerio de Ciencia e Innovacion [BFU2006-14819-C02-01/BMC, BFU2008-03154/BMC, BFU2008-03978/BMC]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from the Spanish Ministerio de Ciencia e Innovacion: BFU2006-14819-C02-01/BMC to S.F.E., BFU2008-03154/BMC to R.F., and BFU2008-03978/BMC to R.S. GenBank sequence accession numbers are FJ647228 to FJ647553.	DIENER TO, 1989, P NATL ACAD SCI USA, V86, P9370, DOI 10.1073/pnas.86.23.9370; Drake JW, 1998, GENETICS, V148, P1667; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Duran-Vila N, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P43, DOI 10.1016/B978-0-12-374153-0.00002-3; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W	8	154	162	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1308	1308		10.1126/science.1169202	http://dx.doi.org/10.1126/science.1169202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265013				2022-12-24	WOS:000263876700032
J	Lewis, SL; Lopez-Gonzalez, G; Sonke, B; Affum-Baffoe, K; Baker, TR; Ojo, LO; Phillips, OL; Reitsma, JM; White, L; Comiskey, JA; Djuikouo, MN; Ewango, CEN; Feldpausch, TR; Hamilton, AC; Gloor, M; Hart, T; Hladik, A; Lloyd, J; Lovett, JC; Makana, JR; Malhi, Y; Mbago, FM; Ndangalasi, HJ; Peacock, J; Peh, KSH; Sheil, D; Sunderland, T; Swaine, MD; Taplin, J; Taylor, D; Thomas, SC; Votere, R; Woll, H				Lewis, Simon L.; Lopez-Gonzalez, Gabriela; Sonke, Bonaventure; Affum-Baffoe, Kofi; Baker, Timothy R.; Ojo, Lucas O.; Phillips, Oliver L.; Reitsma, Jan M.; White, Lee; Comiskey, James A.; Djuikouo K., Marie-Noel; Ewango, Corneille E. N.; Feldpausch, Ted R.; Hamilton, Alan C.; Gloor, Manuel; Hart, Terese; Hladik, Annette; Lloyd, Jon; Lovett, Jon C.; Makana, Jean-Remy; Malhi, Yadvinder; Mbago, Frank M.; Ndangalasi, Henry J.; Peacock, Julie; Peh, Kelvin S. -H.; Sheil, Douglas; Sunderland, Terry; Swaine, Michael D.; Taplin, James; Taylor, David; Thomas, Sean C.; Votere, Raymond; Woell, Hannsjoerg			Increasing carbon storage in intact African tropical forests	NATURE			English	Article							CLIMATE; BIOMASS; IMPACTS; BALANCE; CYCLE	The response of terrestrial vegetation to a globally changing environment is central to predictions of future levels of atmospheric carbon dioxide(1,2). The role of tropical forests is critical because they are carbon- dense and highly productive(3,4). Inventory plots across Amazonia show that old- growth forests have increased in carbon storage over recent decades(5-7), but the response of one- third of the world's tropical forests in Africa(8) is largely unknown owing to an absence of spatially extensive observation networks(9,10). Here we report data from a ten- country network of long- term monitoring plots in African tropical forests. We find that across 79 plots ( 163 ha) above- ground carbon storage in live trees increased by 0.63 Mg C ha(-1) yr(-1) between 1968 and 2007 ( 95% confidence interval ( CI), 0.22 - 0.94; mean interval, 1987 - 96). Extrapolation to unmeasured forest components ( live roots, small trees, necromass) and scaling to the continent implies a total increase in carbon storage in African tropical forest trees of 0.34 Pg C yr(-1) ( CI, 0.15 - 0.43). These reported changes in carbon storage are similar to those reported for Amazonian forests per unit area(6,7), providing evidence that increasing carbon storage in old- growth forests is a pan- tropical phenomenon. Indeed, combining all standardized inventory data from this study and from tropical America and Asia(5,6,11) together yields a comparable figure of 0.49 Mg C ha(-1) yr(-1) (n = 156; 562 ha; CI, 0.29 - 0.66; mean interval, 1987 - 97). This indicates a carbon sink of 1.3 Pg C yr(-1) ( CI, 0.8 - 1.6) across all tropical forests during recent decades. Taxon- specific analyses of African inventory and other data(12) suggest that widespread changes in resource availability, such as increasing atmospheric carbon dioxide concentrations, may be the cause of the increase in carbon stocks(13), as some theory(14) and models(2,10,15) predict.	[Lewis, Simon L.; Lopez-Gonzalez, Gabriela; Baker, Timothy R.; Phillips, Oliver L.; Feldpausch, Ted R.; Gloor, Manuel; Lloyd, Jon; Peacock, Julie; Peh, Kelvin S. -H.] Univ Leeds, Earth & Biosphere Inst, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Sonke, Bonaventure; Djuikouo K., Marie-Noel] Univ Yaounde I, Plant Systemat & Ecol Lab, Yaounde, Cameroon; [Affum-Baffoe, Kofi; Votere, Raymond] Forestry Commiss Ghana, Resource Management Support Ctr, Kumasi, Ghana; [Ojo, Lucas O.] Univ Agr, Dept Environm Management & Toxicol, Abeokuta, Ogun, Nigeria; [Reitsma, Jan M.] Bur Waardenburg BV, NL-4100 AJ Culemborg, Netherlands; [White, Lee] IRET, Libreville, Gabon; [Comiskey, James A.; Sunderland, Terry] Smithsonian Inst, SI MAB Biodivers Program, Washington, DC 20560 USA; [Ewango, Corneille E. N.] Univ Wageningen & Res Ctr, Dept Environm Sci, Forest Ecol & Management Grp, NL-6700 Wageningen, Netherlands; [Hamilton, Alan C.] Plantlife Int, Salisbury SP1 1DX, Wilts, England; [Hart, Terese; Makana, Jean-Remy] Wildlife Conservat Soc DRC, Kinshasa, DEM REP CONGO; [Hladik, Annette] MNHN, Dept Hommes Nat Soc, F-91800 Brunoy, France; [Lovett, Jon C.; Taplin, James] Univ York, Dept Environm, Ctr Ecol Law & Policy, York YO10 5DD, N Yorkshire, England; [Malhi, Yadvinder] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford OX1 3QY, England; [Mbago, Frank M.; Ndangalasi, Henry J.] Univ Dar Es Salaam, Dept Bot, Dar Es Salaam, Tanzania; [Sheil, Douglas] Ctr Int Forestry Res, Bogor 16000, Indonesia; [Swaine, Michael D.] Univ Aberdeen, Dept Plant & Soil Sci, Sch Biol Sci, Aberdeen AB24 3UU, Scotland; [Taylor, David] Univ Dublin Trinity Coll, Sch Nat Sci, Dept Geog, Dublin 2, Ireland; [Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON M5S 3B3, Canada	University of Leeds; University of Yaounde I; University of Agriculture, Abeokuta; Smithsonian Institution; Wageningen University & Research; Museum National d'Histoire Naturelle (MNHN); University of York - UK; University of Oxford; University of Dar es Salaam; CGIAR; Center for International Forestry Research (CIFOR); University of Aberdeen; Trinity College Dublin; University of Toronto	Lewis, SL (corresponding author), Univ Leeds, Earth & Biosphere Inst, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	s.l.lewis@leeds.ac.uk	Phillips, Oliver/A-1523-2011; Sheil, Douglas/N-3291-2019; Sunderland, Terence/AAE-7851-2019; Lloyd, Jonathan J/F-8893-2010; Mitchard, Edward T A/C-6346-2009; Ndangalasi, Henry Joseph/ABD-8651-2020; Sheil, Douglas/A-3867-2015; THOMAS, Sean C./B-6089-2008; Sheil, Douglas/H-1466-2012; Peh, Kelvin/C-3408-2013; Feldpausch, Ted/D-3436-2009; Feldpausch, Ted/ABH-3123-2020	Phillips, Oliver/0000-0002-8993-6168; Sunderland, Terence/0000-0002-1985-9849; Lloyd, Jonathan J/0000-0002-5458-9960; Mitchard, Edward T A/0000-0002-5690-4055; Ndangalasi, Henry Joseph/0000-0003-3738-6405; Sheil, Douglas/0000-0002-1166-6591; THOMAS, Sean C./0000-0002-0686-2483; Peh, Kelvin/0000-0002-2921-1341; Feldpausch, Ted/0000-0002-6631-7962; Feldpausch, Ted/0000-0002-6631-7962; Taylor, David/0000-0002-6098-5636; Lopez-Gonzalez, Gabriela/0000-0002-0814-8830; Makana, Jean-Remy/0000-0002-6006-2938; Lewis, Simon/0000-0002-8066-6851; Comiskey, James/0000-0001-6710-1269	Royal Society and the Natural Environment Research Council (UK); NERC [NE/D005590/1] Funding Source: UKRI; Natural Environment Research Council [NE/D005590/1, NE/D000300/1, NE/B503384/1, NE/B504630/1] Funding Source: researchfish	Royal Society and the Natural Environment Research Council (UK); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the villagers from Oban (Nigeria), Prince Town, Baneekurom and Dadieso (Ghana), Somolomo, Mekas, Lomie and Alat Makay (Cameroon) and Ekobakoba (Gabon) for hosting our fieldwork, and A. Moungazi, S. Mbadinga, H. Bourobou, L. N. Banak, T. Nzebi, K. Jeffery, SEGC/CIRMF/WCS Research Station Lope, K. Ntim, K. Opoku, Forestry Commission of Ghana, T. Tafoek, Federal University of Agriculture, Abeokuta, Nigeria, ECOFAC- Cameroon, Cameroon Ministry Scientific Research and Innovation, Cameroon Ministry of Forests and Fauna (MINFOF), Forest Development Authority (Liberia), S. Grahame, R. Lowe, L. Banin and K. C. Nguembou for field assistance and logistical support. We thank R. Condit for helping access the Edoro and Lenda data sets, C. Chatelain for providing data from the African Flowering Plants database to standardize our species identifications, J. Chave for providing allometric data, L. Poorter for providing gap size- frequency data, B. Nelson for providing large- scale blow- down data, D. Appleyard for assistance with the plot map, and the Network for Vegetation Function (Nation Evolutionary Synthesis Center and ARC-NZ) for providing some wood mass density data. This work was supported by the Royal Society and the Natural Environment Research Council ( UK).	Achard F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002142; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Brncic TM, 2007, PHILOS T R SOC B, V362, P229, DOI 10.1098/rstb.2006.1982; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Ciais P, 2008, BIOGEOSCIENCES, V5, P1259, DOI 10.5194/bg-5-1259-2008; Cramer W, 2004, PHILOS T R SOC B, V359, P331, DOI 10.1098/rstb.2003.1428; Deans JD, 1996, FOREST ECOL MANAG, V88, P215, DOI 10.1016/S0378-1127(96)03843-1; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Houghton RA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000076; Katz RW, 2005, ECOLOGY, V86, P1124, DOI 10.1890/04-0606; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Lloyd J, 1996, FUNCT ECOL, V10, P4, DOI 10.2307/2390258; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Mayaux P, 2005, PHILOS T R SOC B, V360, P373, DOI 10.1098/rstb.2004.1590; NELSON BW, 1994, ECOLOGY, V75, P853, DOI 10.2307/1941742; Ngomanda A, 2007, QUATERNARY RES, V67, P411, DOI 10.1016/j.yqres.2007.01.006; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Urquiza-Haas T, 2007, FOREST ECOL MANAG, V247, P80, DOI 10.1016/j.foreco.2007.04.015; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Williams Christopher A, 2007, Carbon Balance Manag, V2, P3, DOI 10.1186/1750-0680-2-3	30	651	687	12	352	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1003	U3		10.1038/nature07771	http://dx.doi.org/10.1038/nature07771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225523				2022-12-24	WOS:000263425400040
J	Post, R				Post, Robert			Prescribing Records and the First Amendment-New Hampshire's Data-Mining Statute	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Post, Robert] Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Post, R (corresponding author), Yale Univ, Sch Law, New Haven, CT 06520 USA.							Post R, 2000, UCLA LAW REV, V48, P1; Post R, 2007, U ILLINOIS LAW REV, P939	2	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					745	747		10.1056/NEJMp0810339	http://dx.doi.org/10.1056/NEJMp0810339			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408CN	19228615				2022-12-24	WOS:000263411300001
J	Rousseau, P				Rousseau, Paul			Southern Comfort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												palliativedoctor@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					704	704		10.1001/jama.2009.142	http://dx.doi.org/10.1001/jama.2009.142			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224740				2022-12-24	WOS:000263370100001
J	Marques-Bonet, T; Kidd, JM; Ventura, M; Graves, TA; Cheng, Z; Hillier, LW; Jiang, ZS; Baker, C; Malfavon-Borja, R; Fulton, LA; Alkan, C; Aksay, G; Girirajan, S; Siswara, P; Chen, L; Cardone, MF; Navarro, A; Mardis, ER; Wilson, RK; Eichler, EE				Marques-Bonet, Tomas; Kidd, Jeffrey M.; Ventura, Mario; Graves, Tina A.; Cheng, Ze; Hillier, LaDeana W.; Jiang, Zhaoshi; Baker, Carl; Malfavon-Borja, Ray; Fulton, Lucinda A.; Alkan, Can; Aksay, Gozde; Girirajan, Santhosh; Siswara, Priscillia; Chen, Lin; Cardone, Maria Francesca; Navarro, Arcadi; Mardis, Elaine R.; Wilson, Richard K.; Eichler, Evan E.			A burst of segmental duplications in the genome of the African great ape ancestor	NATURE			English	Article							COPY NUMBER VARIATION; STRUCTURAL VARIATION; EVOLUTION	It is generally accepted that the extent of phenotypic change between human and great apes is dissonant with the rate of molecular change(1). Between these two groups, proteins are virtually identical(1,2), cytogenetically there are few rearrangements that distinguish ape - human chromosomes(3), and rates of single- base- pair change(4-7) and retrotransposon activity(8-10) have slowed particularly within hominid lineages when compared to rodents or monkeys. Studies of gene family evolution indicate that gene loss and gain are enriched within the primate lineage(11,12). Here, we perform a systematic analysis of duplication content of four primate genomes ( macaque, orang- utan, chimpanzee and human) in an effort to understand the pattern and rates of genomic duplication during hominid evolution. We find that the ancestral branch leading to human and African great apes shows the most significant increase in duplication activity both in terms of base pairs and in terms of events. This duplication acceleration within the ancestral species is significant when compared to lineage- specific rate estimates even after accounting for copy- number polymorphism and homoplasy. We discover striking examples of recurrent and independent gene- containing duplications within the gorilla and chimpanzee that are absent in the human lineage. Our results suggest that the evolutionary properties of copy- number mutation differ significantly from other forms of genetic mutation and, in contrast to the hominid slowdown of single- base- pair mutations, there has been a genomic burst of duplication activity at this period during human evolution.	[Marques-Bonet, Tomas; Kidd, Jeffrey M.; Cheng, Ze; Jiang, Zhaoshi; Baker, Carl; Malfavon-Borja, Ray; Alkan, Can; Aksay, Gozde; Girirajan, Santhosh; Siswara, Priscillia; Chen, Lin; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Marques-Bonet, Tomas; Kidd, Jeffrey M.; Cheng, Ze; Jiang, Zhaoshi; Baker, Carl; Malfavon-Borja, Ray; Alkan, Can; Aksay, Gozde; Girirajan, Santhosh; Siswara, Priscillia; Chen, Lin; Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Marques-Bonet, Tomas; Navarro, Arcadi] UPF CSIC, Inst Biol Evolut, Barcelona 08003, Spain; [Ventura, Mario; Cardone, Maria Francesca] Univ Bari, Sez Genet, Dipartimento Anat Patol & Genet, I-70125 Bari, Italy; [Graves, Tina A.; Hillier, LaDeana W.; Fulton, Lucinda A.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Navarro, Arcadi] ICREA, Barcelona 08003, Spain; [Navarro, Arcadi] INB, Barcelona 08003, Spain	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universita degli Studi di Bari Aldo Moro; Washington University (WUSTL); ICREA	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Alkan, Can/D-2982-2009; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Marques-Bonet, Tomas/I-4618-2014; Marques-Bonet, Tomas/ABF-3734-2020; Cardone, Maria Francesca/G-8818-2012; Navarro, Arcadi/F-1592-2011; Girirajan, Santhosh/A-5280-2010; Ventura, Mario/E-6420-2011	Alkan, Can/0000-0002-5443-0706; Wilson, Richard K./0000-0002-1992-1358; Marques-Bonet, Tomas/0000-0002-5597-3075; Marques-Bonet, Tomas/0000-0002-5597-3075; Cardone, Maria Francesca/0000-0002-7597-7313; Navarro, Arcadi/0000-0003-2162-8246; Ventura, Mario/0000-0001-7762-8777; Kidd, Jeffrey/0000-0002-9631-1465	NIH [HG002385, U54 HG003079]; Marie Curie fellowship; Departament d'Educacio i Universitats de la Generalitat de Catalunya; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, R01HG002385] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie fellowship(European Commission); Departament d'Educacio i Universitats de la Generalitat de Catalunya(Generalitat de Catalunya); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ICREA(ICREA)	We thank H. Mefford, A. Itsara, G. Cooper, T. Brown and G. McVicker for comments during the preparation of this manuscript. The authors are also grateful to J. Sikela and L. Dumas for assistance with the comparison to cDNA microarray data sets. We are grateful to L. Faust, J. Rogers, Southwest National Primate Research Center (P51- RR013986) and P. Parham for providing some of the primate material used in this study and to M. Adams for providing the alignments for the positive selection analysis. We also thank the large genome sequencing centres for early access to the whole genome sequence data for targeted analysis of segmental duplications. This work was supported, in part, by an NIH grant HG002385 to E.E.E. and NIH grant U54 HG003079 to R.K.W. and E.R.M. INB is a platform of Genoma Espana. T.M.-B. is supported by a Marie Curie fellowship and by Departament d'Educacio i Universitats de la Generalitat de Catalunya. E.E.E. is an investigator of the Howard Hughes Medical Institute.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; GOODMAN M, 1961, HUM BIOL, V33, P131; Hahn MW, 2007, GENETICS, V177, P1941, DOI 10.1534/genetics.107.080077; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Jiang ZS, 2008, GENOME RES, V18, P1362, DOI 10.1101/gr.078477.108; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lee AS, 2008, HUM MOL GENET, V17, P1127, DOI 10.1093/hmg/ddn002; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Steiper ME, 2004, P NATL ACAD SCI USA, V101, P17021, DOI 10.1073/pnas.0407270101; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	30	167	169	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					877	881		10.1038/nature07744	http://dx.doi.org/10.1038/nature07744			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212409	Green Accepted			2022-12-24	WOS:000263266700044
J	Kafri, R; Springer, M; Pilpel, Y				Kafri, Ran; Springer, Michael; Pilpel, Yitzhak			Genetic Redundancy: New Tricks for Old Genes	CELL			English	Editorial Material							DUPLICATED GENES; YEAST; EVOLUTION; GENOME	Many crucial components of signal transduction, developmental, and metabolic pathways have functionally redundant copies. Further, these redundancies show surprising evolutionary stability over prolonged time scales. We propose that redundancies are not just archeological leftovers of ancient gene duplications, but rather that synergy arising from feedback between redundant copies may serve as an information processing element that facilitates signal transduction and the control of gene expression.	[Kafri, Ran; Springer, Michael] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Harvard University; Harvard Medical School; Weizmann Institute of Science	Kafri, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	ran_kafri@hms.harvard.edu; pilpel@weizmann.ac.il						Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Kafri R, 2008, P NATL ACAD SCI USA, V105, P1243, DOI 10.1073/pnas.0711043105; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kirschner M, 2005, PLAUSIBILITY LIFE RE; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; TISCHLER J, 2006, MOL BIOL EVOL, V20, P772	15	125	126	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 6	2009	136	3					389	392		10.1016/j.cell.2009.01.027	http://dx.doi.org/10.1016/j.cell.2009.01.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203571	Bronze			2022-12-24	WOS:000263120600006
J	Gotzsche, PC; Hartling, OJ; Nielsen, M; Brodersen, J; Jorgensen, KJ				Gotzsche, Peter C.; Hartling, Ole J.; Nielsen, Margrethe; Brodersen, John; Jorgensen, Karsten Juhl			Breast screening: the facts-or maybe not	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; WOMEN		[Gotzsche, Peter C.; Nielsen, Margrethe; Jorgensen, Karsten Juhl] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Hartling, Ole J.] Dept Nucl Med, Vejle Sygehus, Denmark; [Brodersen, John] Univ Copenhagen, Dept Gen Practice, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Gotzsche, PC (corresponding author), Rigshosp, Nord Cochrane Ctr, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	pcg@cochrane.dk		Jorgensen, Karsten/0000-0001-8554-0388; Brodersen, John Brandt/0000-0001-9369-3376	KraeftFonden	KraeftFonden	Production and distribution of our leaflet in Denmark was funded by KraeftFonden.	Barton MB, 2001, J GEN INTERN MED, V16, P150, DOI 10.1111/j.1525-1497.2001.00329.x; Brodersen J., 2006, MEASURING PSYCHOSOCI; Brodersen J, 2007, VALUE HEALTH, V10, P294, DOI 10.1111/j.1524-4733.2007.00184.x; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; *DEP HLTH, 2006, NHS CANC SCREEN PROG; Domenighetti G, 2003, INT J EPIDEMIOL, V32, P816, DOI 10.1093/ije/dyg257; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; General Medical Council, 2008, CONS PAT DOCT MAK DE; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Hofvind S, 2004, CANCER-AM CANCER SOC, V101, P1501, DOI 10.1002/cncr.20528; Jorgensen KJ, 2006, BMJ-BRIT MED J, V332, P538, DOI 10.1136/bmj.332.7540.538; JORGENSEN KJ, BMJ IN PRESS; Perry N., 2006, EUROPEAN GUIDELINES; Raffle AE, 2007, SCREENING EVIDENCE P; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Thornton H, 2003, BMJ-BRIT MED J, V327, P101, DOI 10.1136/bmj.327.7406.101; Vainio H, 2002, IARC HDB CANC PREVEN, V7; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	18	76	77	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2009	338								b86	10.1136/bmj.b86	http://dx.doi.org/10.1136/bmj.b86			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EL	19174442				2022-12-24	WOS:000263205400003
J	Das, C; Lucia, MS; Hansen, KC; Tyler, JK				Das, Chandrima; Lucia, M. Scott; Hansen, Kirk C.; Tyler, Jessica K.			CBP/p300-mediated acetylation of histone H3 on lysine 56	NATURE			English	Article							IN-GEL DIGESTION; DNA-REPLICATION; S-PHASE; H3K56 ACETYLATION; CHAPERONE ASF1; CELL-CYCLE; PROTEIN; REPAIR; RTT109; ACETYLTRANSFERASE	Acetylation within the globular core domain of histone H3 on lysine 56 (H3K56) has recently been shown to have a critical role in packaging DNA into chromatin following DNA replication and repair in budding yeast(1,2). However, the function or occurrence of this specific histone mark has not been studied in multicellular eukaryotes, mainly because the Rtt109 enzyme that is known to mediate acetylation of H3K56 (H3K56ac) is fungal-specific(3,4). Here we demonstrate that the histone acetyl transferase CBP (also known as Nejire) in flies and CBP and p300 (Ep300) in humans acetylate H3K56, whereas Drosophila Sir2 and human SIRT1 and SIRT2 deacetylate H3K56ac. The histone chaperones ASF1A in humans and Asf1 in Drosophila are required for acetylation of H3K56 in vivo, whereas the histone chaperone CAF-1 (chromatin assembly factor 1) in humans and Caf1 in Drosophila are required for the incorporation of histones bearing this mark into chromatin. We show that, in response to DNA damage, histones bearing acetylated K56 are assembled into chromatin in Drosophila and human cells, forming foci that colocalize with sites of DNA repair. Furthermore, acetylation of H3K56 is increased in multiple types of cancer, correlating with increased levels of ASF1A in these tumours. Our identification of multiple proteins regulating the levels of H3K56 acetylation in metazoans will allow future studies of this critical and unique histone modification that couples chromatin assembly to DNA synthesis, cell proliferation and cancer.	[Das, Chandrima; Tyler, Jessica K.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Lucia, M. Scott] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80045 USA; [Hansen, Kirk C.] Univ Colorado, Sch Med, Canc Ctr Prote Core, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Tyler, JK (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, POB 6511, Aurora, CO 80045 USA.	jessica.tyler@uchsc.edu	Das, Chandrima/AAI-7398-2021	Tyler, Jessica/0000-0001-9765-1659; Das, Chandrima/0000-0002-8117-2810	National Institutes of Health [GM64475, CA95641]; NATIONAL CANCER INSTITUTE [R01CA095641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kadonaga for Drosophila embryos and the Sir2 antibody, A. Mazo for the CBP antisera, and E. Nigg for ASF1A/B antisera. We thank C. Wike and the UC microscope core, and the UCCC flow cytometry core for assistance. This work was supported by funding from the National Institutes of Health (grants GM64475 and CA95641) to J. K. T.	Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Florence B, 1998, GENETICS, V150, P1497; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Frei C, 2000, GENE DEV, V14, P81; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kuninger D, 2004, HUM GENE THER, V15, P1287, DOI 10.1089/hum.2004.15.1287; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Marcu MG, 2006, MED CHEM, V2, P169, DOI 10.2174/157340606776056133; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Megiorni F, 2005, NEUROSCI LETT, V381, P169, DOI 10.1016/j.neulet.2005.02.027; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sanematsu F, 2006, J BIOL CHEM, V281, P13817, DOI 10.1074/jbc.M511590200; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Tamburini BA, 2005, EUKARYOT CELL, V4, P1583, DOI 10.1128/EC.4.9.1583-1590.2005; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	41	515	532	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					113	U123		10.1038/nature07861	http://dx.doi.org/10.1038/nature07861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19270680	Green Accepted			2022-12-24	WOS:000265801300040
J	Wolf, D; Goff, SP				Wolf, Daniel; Goff, Stephen P.			Embryonic stem cells use ZFP809 to silence retroviral DNAs	NATURE			English	Article							PRIMER-BINDING-SITE; MURINE LEUKEMIA-VIRUS; CARCINOMA-CELLS; TRANSFER-RNA; HTLV-I; PROTEIN; EXPRESSION; TRIM28; ASSAYS; ZINC	Embryonic stem cells (ESCs) and other primitive stem cells of mice have been known for more than 30 years to potently block retrovirus replication(1). Infection of ESCs by the murine leukaemia viruses (MLVs) results in the normal establishment of integrated proviral DNA, but this DNA is then transcriptionally silenced, preventing further viral spread. The repression is largely mediated by transacting factors that recognize a conserved sequence element termed the primer binding site, an 18-base pair sequence complementary to the 39 end of a cellular transfer RNA(2-6). A specific tRNA is annealed to the primer binding site sequence of the viral genomic RNA, and is used to prime DNA synthesis(7). This same sequence in the context of the integrated proviral DNA is targeted for silencing in ESCs. We have recently shown that a large protein complex binding to the primer binding site in ESCs contains TRIM28 (refs 8, 9), a well-characterized transcriptional co-repressor(10-12). An important question remains as to the identity of the factor that directly recognizes integrated retroviral DNAs and recruits TRIM28 to mediate their specific silencing. Here we identify the zinc finger protein ZFP809 as the recognition molecule that bridges the integrated proviral DNA and TRIM28. We show that expression of ZFP809 is sufficient to render even differentiated cells highly resistant to MLV infection. Furthermore, we demonstrate that ZFP809 is able to potently block transcription from DNA constructs of human T-cell lymphotropic virus-1 (HTLV-1), which use the same primer tRNA. These results identify ZFP809 as a DNA-binding factor that specifically recognizes a large subset of mammalian retroviruses and retroelements, targeting them for transcriptional silencing. We propose that ZFP809 evolved as a stem-cell-specific retroviral restriction factor, and therefore constitutes a new component of the intrinsic immune system of stem cells.	[Wolf, Daniel; Goff, Stephen P.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Goff, SP (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, HHSC 1310,701 W 168th St, New York, NY 10032 USA.	spg1@columbia.edu	Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547	National Cancer Institute [R37 CA 30488]; NATIONAL CANCER INSTITUTE [R37CA030488] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service grant R37 CA 30488 from the National Cancer Institute. We thank D. Derse, F. Bouamr and E. Barklis for their generosity with reagents. We are grateful to M. de los Santos, H. Nickerson and M. A. Gawinowicz (Protein Core Facility Columbia University) for technical assistance. We would also like to thank P. Adusumilli, M. Banes, M. Bilsky, J. Yamada and co-workers, without whose help this paper would never have been written. D. W. is an Associate, and S. P. G. is an Investigator of the Howard Hughes Medical Institute.	Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; BARKLIS E, 1986, CELL, V47, P391, DOI 10.1016/0092-8674(86)90596-9; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bex F, 1998, METHODS, V16, P83, DOI 10.1006/meth.1998.0646; FELBER BK, 1985, SCIENCE, V229, P675, DOI 10.1126/science.2992082; FEUER G, 1989, J VIROL, V63, P2317, DOI 10.1128/JVI.63.5.2317-2324.1989; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; HARADA F, 1979, J BIOL CHEM, V254, P979; Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; PETERSEN R, 1991, MOL CELL BIOL, V11, P1214, DOI 10.1128/MCB.11.3.1214; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; Telesnitsky A, 1995, METHOD ENZYMOL, V262, P347; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; YAMAUCHI M, 1995, J VIROL, V69, P1142, DOI 10.1128/JVI.69.2.1142-1149.1995	22	260	265	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1201	1204		10.1038/nature07844	http://dx.doi.org/10.1038/nature07844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19270682	Green Accepted			2022-12-24	WOS:000265754600053
J	Yuan, PW; Bartlam, M; Lou, ZY; Chen, SD; Zhou, J; He, XJ; Lv, ZY; Ge, RW; Li, XM; Deng, T; Fodor, E; Rao, ZH; Liu, YF				Yuan, Puwei; Bartlam, Mark; Lou, Zhiyong; Chen, Shoudeng; Zhou, Jie; He, Xiaojing; Lv, Zongyang; Ge, Ruowen; Li, Xuemei; Deng, Tao; Fodor, Ervin; Rao, Zihe; Liu, Yingfang			Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site	NATURE			English	Article							RNA-POLYMERASE; PA SUBUNIT; A VIRUS; TERMINAL REGION; CAP-BINDING; REPLICATION; PROTEIN; PB2; IDENTIFICATION; RESIDUES	The heterotrimeric influenza virus polymerase, containing the PA, PB1 and PB2 proteins, catalyses viral RNA replication and transcription in the nucleus of infected cells. PB1 holds the polymerase active site(1) and reportedly harbours endonuclease activity(2), whereas PB2 is responsible for cap binding(2-4). The PA amino terminus is understood to be the major functional part of the PA protein and has been implicated in several roles, including endonuclease(5) and protease activities(6) as well as viral RNA/complementary RNA promoter binding(7). Here we report the 2.2 angstrom (angstrom) crystal structure of the N-terminal 197 residues of PA, termed PA(N), from an avian influenza H5N1 virus. The PA(N) structure has an alpha/beta architecture and reveals a bound magnesium ion coordinated by a motif similar to the (P) DXN(D/E) XK motif characteristic of many endonucleases. Structural comparisons and mutagenesis analysis of the motif identified in PA(N) provide further evidence that PA(N) holds an endonuclease active site. Furthermore, functional analysis with in vivo ribonucleoprotein reconstitution and direct in vitro endonuclease assays strongly suggest that PA(N) holds the endonuclease active site and has critical roles in endonuclease activity of the influenza virus polymerase, rather than PB1. The high conservation of this endonuclease active site among influenza strains indicates that PA(N) is an important target for the design of new anti-influenza therapeutics.	[Yuan, Puwei; Chen, Shoudeng; Zhou, Jie; He, Xiaojing; Lv, Zongyang; Li, Xuemei; Rao, Zihe; Liu, Yingfang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Bartlam, Mark; Deng, Tao; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Bartlam, Mark; Deng, Tao; Rao, Zihe] Nankai Univ, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Lou, Zhiyong; Li, Xuemei; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Deng, Tao; Fodor, Ervin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University; Nankai University; Tsinghua University; National University of Singapore; University of Oxford	Rao, ZH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	raozh@xtal.tsinghua.edu.cn; liuy@ibp.ac.cn	chen, shoudeng/G-3556-2012; Ge, Ruowen/D-8352-2012; Lv, Zongyang/M-9307-2018; chen, shoudeng/AAX-8738-2021; HE, XIAOJING/A-6040-2013; Rao, Zihe/HCH-6944-2022	Ge, Ruowen/0000-0002-0750-7336; Lv, Zongyang/0000-0002-8862-113X; chen, shoudeng/0000-0002-7634-2141; Fodor, Ervin/0000-0003-3249-196X; Bartlam, Mark/0000-0001-5173-5080	National Natural Science Foundation of China [30599432, 30221003, 30721003]; Ministry of Science and Technology International Cooperation [2006DFB32420]; Ministry of Science and Technology 863 Project [2006AA02A314, 2006AA02A322]; Ministry of Science and Technology 973 Project [2006CB504300, 2007CB914300]; Medical Research Council [G0700848]; MRC [G0700848] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology International Cooperation; Ministry of Science and Technology 863 Project(National High Technology Research and Development Program of China); Ministry of Science and Technology 973 Project(National Basic Research Program of China); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank H. Chen and K. Yu for providing the A/goose/Guangdong/1/96 influenza PA gene, R. Zhang and A. Joachimiak for assistance with data collection, and G. G. Brownlee for providing materials and for valuable advice. This work was supported by the National Natural Science Foundation of China (grant numbers 30599432, 30221003 and 30721003), the Ministry of Science and Technology International Cooperation Project (2006DFB32420), the Ministry of Science and Technology 863 Project (2006AA02A314 and 2006AA02A322), the Ministry of Science and Technology 973 Project (2006CB504300 and 2007CB914300) and the Medical Research Council (G0700848).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blok V, 1996, J GEN VIROL, V77, P1025, DOI 10.1099/0022-1317-77-5-1025; BROWNLEE GG, 1995, NUCLEIC ACIDS RES, V23, P2641, DOI 10.1093/nar/23.14.2641; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Guu TSY, 2008, VIROLOGY, V379, P135, DOI 10.1016/j.virol.2008.06.022; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Huarte M, 2003, J VIROL, V77, P6007, DOI 10.1128/JVI.77.10.6007-6013.2003; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Lukacs CM, 2000, NAT STRUCT BIOL, V7, P134; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Naffakh N, 2001, VIROLOGY, V285, P244, DOI 10.1006/viro.2001.0956; NEWMAN M, 1994, NATURE, V368, P660, DOI 10.1038/368660a0; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; NIETO A, 1992, VIRUS RES, V24, P65, DOI 10.1016/0168-1702(92)90031-4; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perales B, 2000, J VIROL, V74, P1307, DOI 10.1128/JVI.74.3.1307-1312.2000; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHI LC, 1995, VIROLOGY, V208, P38, DOI 10.1006/viro.1995.1127; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	35	386	418	5	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					909	U12		10.1038/nature07720	http://dx.doi.org/10.1038/nature07720			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19194458				2022-12-24	WOS:000265182500047
J	Long, YW; Hayashi, N; Saito, T; Azuma, M; Muranaka, S; Shimakawa, Y				Long, Y. W.; Hayashi, N.; Saito, T.; Azuma, M.; Muranaka, S.; Shimakawa, Y.			Temperature-induced A-B intersite charge transfer in an A-site-ordered LaCu3Fe4O12 perovskite	NATURE			English	Article							HIGH-DIELECTRIC-CONSTANT; CRYSTAL-STRUCTURE; PRESSURE; MAGNETORESISTANCE; INSULATOR; PHYSICS	Changes of valence states in transition-metal oxides often cause significant changes in their structural and physical properties(1,2). Chemical doping is the conventional way of modulating these valence states. In ABO(3) perovskite and/or perovskite-like oxides, chemical doping at the A site can introduce holes or electrons at the B site, giving rise to exotic physical properties like high-transition-temperature superconductivity and colossal magneto-resistance(3,4). When valence-variable transition metals at two different atomic sites are involved simultaneously, we expect to be able to induce charge transfer-and, hence, valence changes by using a small external stimulus rather than by introducing a doping element. Materials showing this type of charge transfer are very rare, however, and such externally induced valence changes have been observed only under extreme conditions like high pressure(5,6). Here we report unusual temperature-induced valence changes at the A and B sites in the A-site-ordered double perovskite LaCu3Fe4O12; the underlying intersite charge transfer is accompanied by considerable changes in the material's structural, magnetic and transport properties. When cooled, the compound shows a first-order, reversible transition at 393 K from LaCu32+Fe43.75+O12 with Fe3.75+ ions at the B site to LaCu33+Fe43+O12 with rare Cu3+ ions at the A site. Intersite charge transfer between the A-site Cu and B-site Fe ions leads to paramagnetism-to-antiferromagnetism and metal-to-insulator isostructural phase transitions. What is more interesting in relation to technological applications is that this above-room-temperature transition is associated with a large negative thermal expansion.	[Long, Y. W.; Saito, T.; Azuma, M.; Shimakawa, Y.] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Hayashi, N.; Muranaka, S.] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Long, YW (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	ywlong@msk.kuicr.kyoto-u.ac.jp; shimak@scl.kyoto-u.ac.jp	Azuma, Masaki/C-2945-2009; Saito, Takashi/G-9102-2011; Shimakawa, Yuichi/L-3231-2017; Long, Youwen/B-2930-2011	Azuma, Masaki/0000-0002-8378-321X; Saito, Takashi/0000-0002-2565-8795; Shimakawa, Yuichi/0000-0003-1019-2512; Long, Youwen/0000-0002-8587-7818	Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' [19GS0207, 18350097, 17038014, 19014010, 19340098]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science'(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Nishimura and K. Oka for help with the high-pressure synthesis and magnetic measurements, and we thank K. Jungeun for help with the SXRD experiments. Thanks are also due to M. Takano for discussions. This work was partly supported by Grants-in-Aid for Scientific Research (19GS0207, 18350097, 17038014, 19014010 and 19340098), by the Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' and by a grant for the Joint Project of Chemical Synthesis Core Research Institutions from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alonso JA, 2003, APPL PHYS LETT, V83, P2623, DOI 10.1063/1.1611647; Azuma M, 2007, J AM CHEM SOC, V129, P14433, DOI 10.1021/ja074880u; BLAAUW C, 1973, J PHYS C SOLID STATE, V6, P1422, DOI 10.1088/0022-3719/6/8/009; BOCQUET AE, 1992, PHYS REV B, V45, P1561, DOI 10.1103/PhysRevB.45.1561; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Goto T, 2003, ADV PHYS, V52, P67, DOI 10.1080/0001873021000057114; Homes CC, 2001, SCIENCE, V293, P673, DOI 10.1126/science.1061655; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; IMAI K, 1992, J PHYS SOC JPN, V61, P1819, DOI 10.1143/JPSJ.61.1819; Kawasaki S, 1996, J SOLID STATE CHEM, V121, P174, DOI 10.1006/jssc.1996.0025; Larson A.C., 1994, 86748 LAUR LOS AL NA; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; LI X, 1991, HYPERFINE INTERACT, V69, P851, DOI 10.1007/BF02401960; Prodi A, 2004, NAT MATER, V3, P48, DOI 10.1038/nmat1038; RIESEMEIER H, 1994, J PHYS CHEM SOLIDS, V55, P613, DOI 10.1016/0022-3697(94)90060-4; Salamon MB, 2001, REV MOD PHYS, V73, P583, DOI 10.1103/RevModPhys.73.583; Sanchez-Benitez J, 2003, CHEM MATER, V15, P2193, DOI 10.1021/cm0212616; Seda T, 2004, J PHYS-CONDENS MAT, V16, P2707, DOI 10.1088/0953-8984/16/15/021; Shimakawa Y, 2008, INORG CHEM, V47, P8562, DOI 10.1021/ic800696u; Sleight AW, 1998, ANNU REV MATER SCI, V28, P29, DOI 10.1146/annurev.matsci.28.1.29; Subramanian MA, 2000, J SOLID STATE CHEM, V151, P323, DOI 10.1006/jssc.2000.8703; TAKANO M, 1977, MATER RES BULL, V12, P923, DOI 10.1016/0025-5408(77)90104-0; TAKANO M, 1981, J SOLID STATE CHEM, V39, P75, DOI 10.1016/0022-4596(81)90304-2; Takata K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024429; Takenaka K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2147726; Takenaka K, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2831715; Yamada I, 2008, ANGEW CHEM INT EDIT, V47, P7032, DOI 10.1002/anie.200801482; Zeng Z, 1999, PHYS REV LETT, V82, P3164, DOI 10.1103/PhysRevLett.82.3164	28	292	297	16	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 5	2009	458	7234					60	U3		10.1038/nature07816	http://dx.doi.org/10.1038/nature07816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262669				2022-12-24	WOS:000263836000032
J	Cullen, BR				Cullen, Bryan R.			Viral RNAs: Lessons from the Enemy	CELL			English	Article							MESSENGER-RNA; NUCLEAR EXPORT; GENE-EXPRESSION; VIRUS GENOME; ENTRY SITE; HIV-1; TRANSLATION; INITIATION; MICRORNAS; CYTOPLASM	Viruses are adept at evolving or co-opting genomic elements that allow them to maximize their replication potential in the infected host. This evolutionary plasticity makes viruses an invaluable system to identify new mechanisms used not only by viruses but also by vertebrate cells to modulate gene expression. Here, I discuss the identification and characterization of viral mRNA structures and noncoding RNAs that have led to important insights into the molecular mechanisms of eukaryotic cells.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Ctr Virol, Durham, NC 27710 USA	Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Ctr Virol, Durham, NC 27710 USA.	bryan.cullen@duke.edu						Atanasiu D, 2007, J VIROL, V81, P7695, DOI 10.1128/JVI.00282-07; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P362, DOI 10.1073/pnas.72.1.362; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KATES J, 1970, COLD SPRING HARB SYM, V35, P743, DOI 10.1101/SQB.1970.035.01.090; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; LeBlanc JJ, 2007, VIROLOGY, V363, P376, DOI 10.1016/j.virol.2007.01.026; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; Sullivan Christopher S., 2009, P645, DOI 10.1007/978-0-387-68945-6_25; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3	39	31	31	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					592	597		10.1016/j.cell.2009.01.048	http://dx.doi.org/10.1016/j.cell.2009.01.048			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239880	Green Published, Bronze			2022-12-24	WOS:000263688200010
J	Nikolaev, A; McLaughlin, T; O'Leary, DDM; Tessier-Lavigne, M				Nikolaev, Anatoly; McLaughlin, Todd; O'Leary, Dennis D. M.; Tessier-Lavigne, Marc			APP binds DR6 to trigger axon pruning and neuron death via distinct caspases	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; PROGRAMMED CELL-DEATH; BAX-DEFICIENT MICE; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; COMMISSURAL AXONS; GENE-EXPRESSION; FAMILY-MEMBERS; TNF RECEPTOR; DEGENERATION	Naturally occurring axonal pruning and neuronal cell death help to sculpt neuronal connections during development, but their mechanistic basis remains poorly understood. Here we report that beta-amyloid precursor protein ( APP) and death receptor 6 ( DR6, also known as TNFRSF21) activate a widespread caspase- dependent self- destruction program. DR6 is broadly expressed by developing neurons, and is required for normal cell body death and axonal pruning both in vivo and after trophic- factor deprivation in vitro. Unlike neuronal cell body apoptosis, which requires caspase 3, we show that axonal degeneration requires caspase 6, which is activated in a punctate pattern that parallels the pattern of axonal fragmentation. DR6 is activated locally by an inactive surface ligand( s) that is released in an active form after trophic- factor deprivation, and we identify APP as a DR6 ligand. Trophic- factor deprivation triggers the shedding of surface APP in a beta-secretase ( BACE)- dependent manner. Loss- and gain- of- function studies support a model in which a cleaved amino- terminal fragment of APP ( N- APP) binds DR6 and triggers degeneration. Genetic support is provided by a common neuromuscular junction phenotype in mutant mice. Our results indicate that APP and DR6 are components of a neuronal self- destruction pathway, and suggest that an extracellular fragment of APP, acting via DR6 and caspase 6, contributes to Alzheimer's disease.	[Nikolaev, Anatoly; Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA; [McLaughlin, Todd; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Roche Holding; Genentech; Salk Institute	Tessier-Lavigne, M (corresponding author), Genentech Inc, Div Res, 1 DNA Way, San Francisco, CA 94080 USA.	marctl@gene.com		Nikolaev, Anatoly/0000-0003-2818-5839	Genentech; National Eye Institute [R01 EY07025]; NATIONAL EYE INSTITUTE [R01EY007025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025970] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Axel, C. Bargmann, B. de Strooper, V. Dixit, C. Henderson, J. Lewcock, R. Scheller, R. Vassar, R. Watts, and members of the M. T.- L. laboratory for helpful discussions and suggestions, and critical reading of the manuscript, and A. Bruce for making the diagrams. We thank P. Hass and members of his laboratory (Genentech) for generation and purification of the DR6 ectodomain and APP(1-286), and W.-C. Liang and Y. Wu (Genentech) for binding experiments with purified proteins. Supported by Genentech (A.N. and M.T.-L.) and National Eye Institute grant R01 EY07025 (D.D.M.O.'L.).	Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; CAMPENOT RB, 1991, J NEUROSCI, V11, P1126; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Chiang LW, 2001, P NATL ACAD SCI USA, V98, P2814, DOI 10.1073/pnas.051630598; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Edwards PD, 2007, J MED CHEM, V50, P5912, DOI 10.1021/jm070829p; Finn JT, 2000, J NEUROSCI, V20, P1333; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heber S, 2000, J NEUROSCI, V20, P7951; Higuchi H, 2003, BIOCHEM BIOPH RES CO, V301, P804, DOI 10.1016/S0006-291X(03)00029-9; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Matrone C, 2008, P NATL ACAD SCI USA, V105, P13139, DOI 10.1073/pnas.0806133105; Matrone C, 2008, J ALZHEIMERS DIS, V13, P81; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; PALMERT MR, 1988, BIOCHEM BIOPH RES CO, V156, P432, DOI 10.1016/S0006-291X(88)80859-3; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Perez RG, 1997, J NEUROSCI, V17, P9407; PETTMANN B, 1988, J NEUROSCI, V8, P3624; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schmidt CS, 2003, J EXP MED, V197, P51, DOI 10.1084/jem.20020617; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; VANGOOL D, 1995, DEMENTIA, V6, P63, DOI 10.1159/000106923; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; White FA, 1998, J NEUROSCI, V18, P1428; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhao HR, 2001, J EXP MED, V194, P1441, DOI 10.1084/jem.194.10.1441	59	795	843	0	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					981	U1		10.1038/nature07767	http://dx.doi.org/10.1038/nature07767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225519	Green Accepted			2022-12-24	WOS:000263425400036
J	Hafed, ZM; Goffart, L; Krauzlis, RJ				Hafed, Ziad M.; Goffart, Laurent; Krauzlis, Richard J.			A Neural Mechanism for Microsaccade Generation in the Primate Superior Colliculus	SCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; COVERT ATTENTION; TARGET SELECTION; VISUAL-CORTEX; NEURONS; INACTIVATION; FIXATION; TRACKING; STRIATE; PURSUIT	During fixation, the eyes are not still but often exhibit microsaccadic movements. The function of microsaccades is controversial, largely because the neural mechanisms responsible for their generation are unknown. Here, we show that the superior colliculus ( SC), a retinotopically organized structure involved in voluntary- saccade target selection, plays a causal role in microsaccade generation. Neurons in the foveal portion of the SC increase their activity before and during microsaccades with sizes of only a few minutes of arc and exhibit selectivity for the direction and amplitude of these movements. Reversible inactivation of these neurons significantly reduces microsaccade rate without otherwise compromising fixation. These results, coupled with computational modeling of SC activity, demonstrate that microsaccades are controlled by the SC and explain the link between microsaccades and visual attention.	[Hafed, Ziad M.; Krauzlis, Richard J.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Goffart, Laurent] Univ Aix Marseille 1, CNRS, Inst Neurosci Cognit Mediterranee, UMR 6193, F-13402 Marseille, France	Salk Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Hafed, ZM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	zhafed@salk.edu	Goffart, Laurent/AEX-7821-2022	Goffart, Laurent/0000-0001-8767-1867; Richard, Krauzlis/0000-0002-1826-0447	NIH [EY12212]; Agence Nationale de la Recherche; RETINAE; NATIONAL EYE INSTITUTE [R01EY012212] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); RETINAE; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by NIH grant EY12212 and Agence Nationale de la Recherche grant RETINAE. We thank K. Nielsen and V. Ciaramitaro for helpful comments.	Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARLOW HB, 1952, J PHYSIOL-LONDON, V116, P290, DOI 10.1113/jphysiol.1952.sp004706; BRIDGEMAN B, 1980, VISION RES, V20, P813, DOI 10.1016/0042-6989(80)90013-9; Carello CD, 2004, NEURON, V43, P575, DOI 10.1016/j.neuron.2004.07.026; CORNSWEET TN, 1956, J OPT SOC AM, V46, P987, DOI 10.1364/JOSA.46.000987; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Hafed ZM, 2008, J NEUROSCI, V28, P9426, DOI 10.1523/JNEUROSCI.1313-08.2008; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; KINGSTONE A, 1995, PERCEPT PSYCHOPHYS, V57, P796, DOI 10.3758/BF03206795; KOWLER E, 1980, VISION RES, V20, P273, DOI 10.1016/0042-6989(80)90113-3; Krauzlis RJ, 2003, J NEUROSCI, V23, P4333; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; RATLIFF F, 1950, J EXP PSYCHOL, V40, P687, DOI 10.1037/h0057754; Snodderly DM, 2001, VISUAL NEUROSCI, V18, P259, DOI 10.1017/S0952523801182118; STEINMAN RM, 1967, SCIENCE, V155, P1577, DOI 10.1126/science.155.3769.1577; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; VANGISBERGEN JAM, 1981, J NEUROPHYSIOL, V45, P417, DOI 10.1152/jn.1981.45.3.417; WINTERSON BJ, 1976, VISION RES, V16, P1387, DOI 10.1016/0042-6989(76)90156-5; ZUBER BL, 1965, SCIENCE, V150, P1459, DOI 10.1126/science.150.3702.1459	27	280	283	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					940	943		10.1126/science.1166112	http://dx.doi.org/10.1126/science.1166112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213919	Green Accepted			2022-12-24	WOS:000263295400044
J	Wilczek, AM; Roe, JL; Knapp, MC; Cooper, MD; Lopez-Gallego, C; Martin, LJ; Muir, CD; Sim, S; Walker, A; Anderson, J; Egan, JF; Moyers, BT; Petipas, R; Giakountis, A; Charbit, E; Coupland, G; Welch, SM; Schmitt, J				Wilczek, Amity M.; Roe, Judith L.; Knapp, Mary C.; Cooper, Martha D.; Lopez-Gallego, Cristina; Martin, Laura J.; Muir, Christopher D.; Sim, Sheina; Walker, Alexis; Anderson, Jillian; Egan, J. Franklin; Moyers, Brook T.; Petipas, Renee; Giakountis, Antonis; Charbit, Erika; Coupland, George; Welch, Stephen M.; Schmitt, Johanna			Effects of Genetic Perturbation on Seasonal Life History Plasticity	SCIENCE			English	Article							FLOWERING TIME CONTROL; LOCUS-C ACTIVITY; ARABIDOPSIS-THALIANA; VERNALIZATION; PHOTOPERIOD; PHENOTYPE; PLANTS; TEMPERATURE; CONSTANS; GIGANTEA	Like many species, the model plant Arabidopsis thaliana exhibits multiple different life histories in natural environments. We grew mutants impaired in different signaling pathways in field experiments across the species' native European range in order to dissect the mechanisms underlying this variation. Unexpectedly, mutational loss at loci implicated in the cold requirement for flowering had little effect on life history except in late- summer cohorts. A genetically informed photothermal model of progression toward flowering explained most of the observed variation and predicted an abrupt transition from autumn flowering to spring flowering in late- summer germinants. Environmental signals control the timing of this transition, creating a critical window of acute sensitivity to genetic and climatic change that may be common for seasonally regulated life history traits.	[Wilczek, Amity M.; Cooper, Martha D.; Lopez-Gallego, Cristina; Martin, Laura J.; Muir, Christopher D.; Walker, Alexis; Anderson, Jillian; Egan, J. Franklin; Moyers, Brook T.; Petipas, Renee; Schmitt, Johanna] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Roe, Judith L.; Knapp, Mary C.; Sim, Sheina; Charbit, Erika; Welch, Stephen M.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Giakountis, Antonis; Coupland, George] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Brown University; Kansas State University; Max Planck Society	Schmitt, J (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	johanna_schmitt@brown.edu	Coupland, George/AAP-8609-2020; Lopez-Gallego, Cristina/F-5034-2015; Muir, Christopher/V-4461-2017; Moyers, Brook T./E-1516-2012	Coupland, George/0000-0001-6988-4172; Muir, Christopher/0000-0003-2555-3878; Moyers, Brook T./0000-0003-0340-9488; Petipas, Renee/0000-0002-8712-8183; Lopez-Gallego, Cristina/0000-0002-5872-6053; Giakountis, Antonis/0000-0001-8648-9908	NSF Frontiers in Integrative Biological Research [EF- 0425759]; Alexander von Humboldt Research Award	NSF Frontiers in Integrative Biological Research(National Science Foundation (NSF)); Alexander von Humboldt Research Award(Alexander von Humboldt Foundation)	We thank M. Blazquez, C. Dean, M. Hoffmann, M. Koornneef, H. Kuittinen, and O. Savolainen for hosting these experiments at the European field sites; L. Albertson, L. Burghardt, C. Cooper, M.F. Cooper, Josephs, A. Lockwood, S. Myllyla, C. Oakley, R. Palmer, S. Rudder, and E. vonWettberg for assistance with planting and censusing; B. Robertson, M. Gosling, C. Lister, F. Eikelmann, G. Leuffen, W. Schuchert, T. Kauppila, and H. Eissner for technical and field assistance; R. Griffin, J. Kreikemeier, and G. Ragusa for assistance with the chamber experiment; A. Heim for contributions to the processing of temperature data; R. Amasino and J. Martinez- Zapater for sharing lines; S. Ruzsa of the Purugganan lab, who bulked lines for the experiments; and R. Amasino and C. Dean for manuscript comments. Supported by NSF Frontiers in Integrative Biological Research program grant EF- 0425759 and an Alexander von Humboldt Research Award.	Ausin I, 2005, INT J DEV BIOL, V49, P689, DOI 10.1387/ijdb.052022ia; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; BURGHARDT LT, 2008, 19 INT C AR RES MONT; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; De Melo-Abreu JP, 2004, AGR FOREST METEOROL, V125, P117, DOI 10.1016/j.agrformet.2004.02.009; Dennis ES, 2007, CURR OPIN PLANT BIOL, V10, P520, DOI 10.1016/j.pbi.2007.06.009; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; LAIBACH F, 1965, ARABIDOPSIS INFORMAT; LEE I, 1995, PLANT PHYSIOL, V108, P157, DOI 10.1104/pp.108.1.157; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; McMaster GS, 2008, ANN BOT-LONDON, V102, P561, DOI 10.1093/aob/mcn115; Michaels SD, 2003, P NATL ACAD SCI USA, V100, P10102, DOI 10.1073/pnas.1531467100; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Schmitz RJ, 2007, BBA-GENE STRUCT EXPR, V1769, P269, DOI 10.1016/j.bbaexp.2007.02.003; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; THOMPSON L, 1994, J ECOL, V82, P63, DOI 10.2307/2261386; Welch SM, 2005, AUST J AGR RES, V56, P919, DOI 10.1071/AR05155; Welch SM, 2003, AGRON J, V95, P71, DOI 10.2134/agronj2003.0071; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403	28	288	293	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					930	934		10.1126/science.1165826	http://dx.doi.org/10.1126/science.1165826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19150810				2022-12-24	WOS:000263295400041
J	McNab, F; Varrone, A; Farde, L; Jucaite, A; Bystritsky, P; Forssberg, H; Klingberg, T				McNab, Fiona; Varrone, Andrea; Farde, Lars; Jucaite, Aurelija; Bystritsky, Paulina; Forssberg, Hans; Klingberg, Torkel			Changes in Cortical Dopamine D1 Receptor Binding Associated with Cognitive Training	SCIENCE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; WORKING-MEMORY; PREFRONTAL CORTEX; MODULATION; DEPLETION; CHILDREN	Working memory is a key function for human cognition, dependent on adequate dopamine neurotransmission. Here we show that the training of working memory, which improves working memory capacity, is associated with changes in the density of cortical dopamine D1 receptors. Fourteen hours of training over 5 weeks was associated with changes in both prefrontal and parietal D1 binding potential. This plasticity of the dopamine D1 receptor system demonstrates a reciprocal interplay between mental activity and brain biochemistry in vivo.	[McNab, Fiona; Bystritsky, Paulina; Forssberg, Hans; Klingberg, Torkel] Karolinska Inst, Neuropediat Unit, Dept Woman & Child Hlth, Stockholm Brain Inst, Stockholm, Sweden; [Varrone, Andrea; Farde, Lars; Jucaite, Aurelija] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm Brain Inst, Stockholm, Sweden; [Farde, Lars; Jucaite, Aurelija] AstraZeneca Res & Dev, Sodertalje, Sweden	Karolinska Institutet; Karolinska Institutet; AstraZeneca	Klingberg, T (corresponding author), Karolinska Inst, Neuropediat Unit, Dept Woman & Child Hlth, Stockholm Brain Inst, Stockholm, Sweden.	torkel.klingberg@ki.se	Forssberg, Hans/A-2944-2009	Klingberg, Torkel/0000-0002-3175-2171; Forssberg, Hans/0000-0003-2069-6618	Swedish Foundation for Strategic Research; Swedish Research Council; VINNOVA ( the Swedish Governmental Agency for Innovation Systems); Knut and Alice Wallenberg Foundation	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA ( the Swedish Governmental Agency for Innovation Systems)(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	The authors thank C. Halldin, K. Kolaas, G. Lei, J. Macoveanu, and members of the Karolinska Institutet PET center for assistance in the PET measurements. This work was supported by the Swedish Foundation for Strategic Research, Swedish Research Council, VINNOVA (the Swedish Governmental Agency for Innovation Systems), and Knut and Alice Wallenberg Foundation.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Cai JX, 1997, J PHARMACOL EXP THER, V283, P183; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Guo NN, 2003, NEUROPSYCHOPHARMACOL, V28, P1703, DOI 10.1038/sj.npp.1300224; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Laruelle M, 1998, Q J NUCL MED, V42, P211; Lidow MS, 1998, TRENDS PHARMACOL SCI, V19, P136, DOI 10.1016/S0165-6147(98)01186-9; Muller U, 1998, J NEUROSCI, V18, P2720; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Postle BR, 1999, J COGNITIVE NEUROSCI, V11, P585, DOI 10.1162/089892999563652; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; Soiza-Reilly M, 2004, BRAIN RES, V1004, P217, DOI 10.1016/j.brainres.2004.01.050; Suss HM, 2002, INTELLIGENCE, V30, P261, DOI 10.1016/S0160-2896(01)00100-3; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	27	363	384	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					800	802		10.1126/science.1166102	http://dx.doi.org/10.1126/science.1166102			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197069				2022-12-24	WOS:000263066800052
J	Rowland, JM; Emlen, DJ				Rowland, J. Mark; Emlen, Douglas J.			Two Thresholds, Three Male Forms Result in Facultative Male Trimorphism in Beetles	SCIENCE			English	Article							HORN LENGTH DIMORPHISM; SEXUAL-DIMORPHISM; SCARAB BEETLE; BODY-SIZE; EVOLUTION; COLEOPTERA; TACTICS; MODELS	Male animals of many species deploy conditional reproductive strategies that contain distinct alternative phenotypes. Such facultatively expressed male tactics are assumed to be due to a single developmental threshold mechanism switching between the expression of two alternative phenotypes. However, we discovered a clade of dung beetles that commonly expresses two threshold mechanisms, resulting in three alternative phenotypes (male trimorphism). Once recognized, we found trimorphism in other beetle families that involves different types of male weapons. Evidence that insects assumed to be dimorphic can express three facultative male forms suggests that we need to adjust how we think about animal mating systems and the evolution of conditional strategies.	[Rowland, J. Mark] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Emlen, Douglas J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of New Mexico; University of Montana System; University of Montana	Rowland, JM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rowland@unm.edu			NSF [IOS-0642409]	NSF(National Science Foundation (NSF))	We thank S. Spector, T. Larsen, A. Solis, T. Gardner, J. Louzada, P. Skelley, D. Almquist, C. Gillett, D. Edmonds, D. Lewis, L. Herman, T. Fincher, M. Barclay, C. O'Brien, J. Prena, F. Genier, G. and J. Lewallern, R. Veal, D. Heinicke, and B. Raber for providing critical samples; assistance of the Scarabaeine Research Network; K. Bright, W. Eberhard, E. Greene, A. Kodric- Brown, T. Maginnis, E. McCullough, C. Qualls, and two anonymous reviewers for ideas and comments on the manuscript; J. Driver and the University of Montana Electron Microscopy facility for the weevil images; and the NSF (IOS-0642409) (to D.J.E.) for funding.	Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; EBERHARD WG, 1991, EVOLUTION, V45, P18, DOI 10.1111/j.1558-5646.1991.tb05262.x; Eberhard WG, 2000, P ROY SOC B-BIOL SCI, V267, P1129, DOI 10.1098/rspb.2000.1118; Emlen DJ, 2006, HEREDITY, V97, P179, DOI 10.1038/sj.hdy.6800868; Emlen DJ, 2005, AM NAT, V166, pS42, DOI 10.1086/444599; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; EMLEN DJ, 1994, P ROY SOC B-BIOL SCI, V256, P131, DOI 10.1098/rspb.1994.0060; HAZEL WN, 1990, P ROY SOC B-BIOL SCI, V242, P181, DOI 10.1098/rspb.1990.0122; HUNT J, 2001, P ROY SOC LOND B BIO, V26, P2409; Iguchi Y, 1998, ANN ENTOMOL SOC AM, V91, P845, DOI 10.1093/aesa/91.6.845; Iguchi Yutaka, 2000, Kogane, V1, P21; Jukema J, 2006, BIOL LETTERS, V2, P161, DOI 10.1098/rsbl.2005.0416; Karino K, 2004, ECOL RES, V19, P663, DOI 10.1111/j.1440-1703.2004.00681.x; Kelly CD, 2008, BEHAV ECOL, V19, P1018, DOI 10.1093/beheco/arn058; Kotiaho JS, 2001, BEHAV ECOL, V12, P553, DOI 10.1093/beheco/12.5.553; Maddison DR, 2000, MACCLADE 4 0 ANAL PH; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; Moczek AP, 2002, EVOL DEV, V4, P252, DOI 10.1046/j.1525-142X.2002.02014.x; Moczek AP, 2006, AM NAT, V168, P711, DOI 10.1086/509051; Moczek AP, 2006, DEV GENES EVOL, V216, P655, DOI 10.1007/s00427-006-0087-2; Moore JC, 2004, BEHAV ECOL, V15, P735, DOI 10.1093/beheco/arh069; OLIVEIRA RF, 2008, ALTERNATIVE REPROD T, P507; Plaistow SJ, 2004, BEHAV ECOL, V15, P534, DOI 10.1093/beheco/arh029; Price DL, 2007, INSECT SYST EVOL, V38, P1, DOI 10.1163/187631207788784058; RASMUSSEN JL, 1994, J INSECT BEHAV, V7, P67, DOI 10.1007/BF01989828; Rowland JM, 2005, EVOL ECOL RES, V7, P421; RYAN MJ, 1992, AM NAT, V139, P21, DOI 10.1086/285311; SHUSTER SM, 1989, EVOLUTION, V43, P1683, DOI 10.1111/j.1558-5646.1989.tb02618.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Sinervo A, 2001, J HERED, V92, P198, DOI 10.1093/jhered/92.2.198; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2007, AM NAT, V170, P663, DOI 10.1086/522092; Tomkins JL, 2005, AM NAT, V165, P389, DOI 10.1086/427732; West-Eberhard Mary Jane, 2003, pi	34	59	62	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					773	776		10.1126/science.1167345	http://dx.doi.org/10.1126/science.1167345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197062				2022-12-24	WOS:000263066800044
J	Kim, AH; Puram, SV; Bilimoria, PM; Ikeuchi, Y; Keough, S; Wong, M; Rowitch, D; Bonni, A				Kim, Albert H.; Puram, Sidharth V.; Bilimoria, Parizad M.; Ikeuchi, Yoshiho; Keough, Samantha; Wong, Michael; Rowitch, David; Bonni, Azad			A Centrosomal Cdc20-APC Pathway Controls Dendrite Morphogenesis in Postmitotic Neurons	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; MAMMALIAN BRAIN; AXONAL GROWTH; UBIQUITINATION; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; DEGRADATION; MECHANISMS; COMPONENTS	The ubiquitin ligase anaphase-promoting complex (APC) recruits the coactivator Cdc20 to drive mitosis in cycling cells. However, the nonmitotic functions of Cdc20-APC have remained unexplored. We report that Cdc20-APC plays an essential role in dendrite morphogenesis in postmitotic neurons. Knockdown of Cdc20 in cerebellar slices and in postnatal rats in vivo profoundly impairs the formation of granule neuron dendrite arbors in the cerebellar cortex. Remarkably, Cdc20 is enriched at the centrosome in neurons, and the centrosomal localization is critical for Cdc20-dependent dendrite development. We also find that the centrosome-associated protein histone deacetylase 6 (HDAC6) promotes the poly-ubiquitination of Cdc20, stimulates the activity of centrosomal Cdc20-APC, and drives the differentiation of dendrites. These findings define a postmitotic function for Cdc20-APC in the morphogenesis of dendrites in the mammalian brain. The identification of a centrosomal Cdc20-APC ubiquitin signaling pathway holds important implications for diverse biological processes, including neuronal connectivity and plasticity.	[Kim, Albert H.; Puram, Sidharth V.; Bilimoria, Parizad M.; Ikeuchi, Yoshiho; Keough, Samantha; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Puram, Sidharth V.; Bonni, Azad] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Bilimoria, Parizad M.; Bonni, Azad] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Kim, Albert H.] Childrens Hosp, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Wong, Michael; Rowitch, David] Univ Calif San Francisco, Howard Hughes Med Inst, Inst Regenerat Med, San Francisco, CA 94143 USA; [Rowitch, David] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Rowitch, David] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Ikeuchi, Yoshiho/N-1057-2019; ikeuchi, yoshiho/C-1713-2014; Kim, Albert H./HGF-0057-2022	ikeuchi, yoshiho/0000-0002-2829-3840; Puram, Sidharth/0000-0003-3543-889X; Rowitch, David/0000-0002-0079-0060	National Institutes of Health [NS051255, NS41021]; National Research Service; National Cancer Institute; Brain Science Foundation; Albert J Ryan Foundation; Human Frontier Science Program Long-Term Fellowship; NATIONAL CANCER INSTITUTE [F32CA124028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051255, R01NS041021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brain Science Foundation; Albert J Ryan Foundation; Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grants NS051255 and NS41021 (A. B.), a Ruth L. Kirschstein National Research Service Award research fellowship, the National Cancer Institute, and Brain Science Foundation grant (A. H. K.), the Albert J Ryan Foundation (P. B.), and a Human Frontier Science Program Long-Term Fellowship (Y.I.). We thank members of the Bonni laboratory for helpful discussions and critical reading of the manuscript.	ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; Becker EBE, 2005, SEMIN CELL DEV BIOL, V16, P439, DOI 10.1016/j.semcdb.2005.02.006; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gillingham AK, 2000, EMBO REP, V1, P524; GOSLIN K, 1998, RAT HIPPOCAMPAL NEUR; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; Hasskarl J, 2004, ONCOGENE, V23, P1930, DOI 10.1038/sj.onc.1207310; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2003, J NEUROSCI, V23, P1649; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pietromonaco SF, 1996, BLOOD CELL MOL DIS, V22, P225, DOI 10.1006/bcmd.1996.0103; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	32	150	152	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					322	336		10.1016/j.cell.2008.11.050	http://dx.doi.org/10.1016/j.cell.2008.11.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167333	Bronze, Green Accepted			2022-12-24	WOS:000262648800020
J	Raj, A; Saggurti, N; Balaiah, D; Silverman, JG				Raj, Anita; Saggurti, Niranjan; Balaiah, Donta; Silverman, Jay G.			Prevalence of child marriage and its effect on fertility and fertility-control outcomes of young women in India: a cross-sectional, observational study	LANCET			English	Article							HEALTH	Background Child marriage is a substantial barrier to social and economic development in India, and a primary concern for women's health. We assessed the prevalence of child marriage-ie, before 18 years of age-in young adult women in India, and the associations between child marriage and women's fertility and fertility-control outcomes. Methods Data from the National Family Health Survey-3 (2005-06) were limited to a sample of Indian women aged 20-24 years (n=22807), of whom 14813 had been or were presently married (ever-married). Prevalence of child marriage was estimated for the whole sample. We used regression models adjusted for demographics, and models adjusted for demographics and duration of marriage to estimate odds ratios (ORs) for the associations between child marriage and both fertility and fertility-control outcomes, in the ever-married subsample. Findings 44.5% of women aged 20-24 years were married before age 18 years, 22.6% were married before age 16 years, and 2.6% were married before age 13 years. Child marriage was significantly associated with no contraceptive use before first childbirth (adjusted OR 1.37 [95% CI 1.22-1.54]), high fertility (three or more births) (7.40 [6.45-8.50]), a repeat childbirth in less than 24 months (3.00 [2.74-3.29]), multiple unwanted pregnancies (2.36 [1.90-2.94]), pregnancy termination (1.48 [1.34-1.63]), and female sterilisation (6.68 [5.78-7.60]). The association between child marriage and high fertility, a repeat childbirth in less than 24 months, multiple unwanted pregnancies, pregnancy termination, and sterilisation all remained significant after controlling for duration of marriage. Interpretation Increased enforcement of existing policies is crucial for prevention of child marriage. improved family-planning education, access, and support are urgently needed for women married as children, their husbands, and their families to reduce the high fertility and poor fertility-control outcomes of this practice. Funding US National Institutes of Health and Indian Council of Medical Research.	[Raj, Anita] Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA; [Saggurti, Niranjan] Populat Council, New Delhi, India; [Balaiah, Donta] Indian Council Med Res, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India; [Silverman, Jay G.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Boston University; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Harvard University; Harvard T.H. Chan School of Public Health	Raj, A (corresponding author), Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, 801 Massachusetts Ave,C-O 715 Albany St, Boston, MA 02118 USA.	anitaraj@bu.edu		Saggurti, Niranjan/0000-0002-5267-8425	US National Institutes of Health; Indian Council of Medical Research Indo-US Program on Maternal and Child Health and Human Development [1 R03 HD055120-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD055120] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Council of Medical Research Indo-US Program on Maternal and Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a grant from the US National Institutes of Health and the Indian Council of Medical Research Indo-US Program on Maternal and Child Health and Human Development to JGS (grant number 1 R03 HD055120-01).	AUDINARAYANA N, 1993, DEMOGRAPHY INDIA, V22, P169; AUDINARAYANA N, 1986, J FAM WELFARE, V31, P56; BHAGAT RB, 2002, EARLY MARRIAGES INDI; Bhattacharya G, 2004, HEALTH EDUC BEHAV, V31, P101, DOI 10.1177/1090198103259204; Bhutta ZA, 2004, BMJ-BRIT MED J, V328, P816, DOI 10.1136/bmj.328.7443.816; Chatterjee P, 2007, LANCET, V370, P1023, DOI 10.1016/S0140-6736(07)61460-3; Chatterjee P, 2006, LANCET, V368, P1483, DOI 10.1016/S0140-6736(06)69620-7; DATT G, 2846 WPS; *GOV IND MIN HUM R, 2007, SEL ED STAT; *I SOC STUD TRUST, 2007, PROGR WOM S AS; *INT CTR RES WOM, NEW INS PREV CHILD M; *INT I POP SCI MAC, 2007, NAT FAM HLTH SURV NF; KROLL L, 2008, FORBES MAGAZINE 0305; Mensch B., 2003, TRENDS TIMING 1 MARR; Ministry of Health and Family Welfare (MOHFW), NAT RUR HLTH MISS 20; PANAGARIYA A, 2008, BROOKINGS WASHI 0124; PATIL PA, 2002, J 3 WORLD STUD, V19, P195; RAO GR, 1998, DEMOGRAPHY INDIA, V27, P401; RICHARD J, 1997, DEMOGRAPHY INDIA, V24, P81; Rigsby D C, 1998, J Pediatr Adolesc Gynecol, V11, P115; Saardchom N, 2005, MARRIAGE FAM REV, V37, P73, DOI 10.1300/J002v37n03_05; SIVARAM M, 1995, J BIOSOC SCI, V27, P325, DOI 10.1017/S0021932000022847; SUREENDER S, 1993, NEW TIMES BOMBAY, P5; THENMOZHI N, 1992, INDIAN J PUBL ADMIN, V38, P341; *UN, MILL DEV GOALS; *UNFPA, STAT WORLD POP 2005; UNICEF, 2001, EARL MARR CHILD SPOU; United Nations Children's Fund (UNICEF), PROGR CHILDR WORLD F; *WOLD BANK, IND COUNTR OV 2008	29	203	203	1	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1883	1889		10.1016/S0140-6736(09)60246-4	http://dx.doi.org/10.1016/S0140-6736(09)60246-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19278721	Green Accepted			2022-12-24	WOS:000266616400031
J	Wittebolle, L; Marzorati, M; Clement, L; Balloi, A; Daffonchio, D; Heylen, K; De Vos, P; Verstraete, W; Boon, N				Wittebolle, Lieven; Marzorati, Massimo; Clement, Lieven; Balloi, Annalisa; Daffonchio, Daniele; Heylen, Kim; De Vos, Paul; Verstraete, Willy; Boon, Nico			Initial community evenness favours functionality under selective stress	NATURE			English	Article							CURRENT KNOWLEDGE; SPECIES RICHNESS; BIODIVERSITY; DIVERSITY; STABILITY; ECOLOGY; PRODUCTIVITY; REDUNDANCY; SYSTEMS	Owing to the present global biodiversity crisis, the biodiversity-stability relationship and the effect of biodiversity on ecosystem functioning have become major topics in ecology(1-3). Biodiversity is a complex term that includes taxonomic, functional, spatial and temporal aspects of organismic diversity, with species richness (the number of species) and evenness (the relative abundance of species) considered among the most important measures(4,5). With few exceptions (see, for example, ref. 6), the majority of studies of biodiversity-functioning and biodiversity-stability theory have predominantly examined richness(7-11). Here we show, using microbial microcosms, that initial community evenness is a key factor in preserving the functional stability of an ecosystem. Using experimental manipulations of both richness and initial evenness in microcosms with denitrifying bacterial communities, we found that the stability of the net ecosystem denitrification in the face of salinity stress was strongly influenced by the initial evenness of the community. Therefore, when communities are highly uneven, or there is extreme dominance by one or a few species, their functioning is less resistant to environmental stress. Further unravelling how evenness influences ecosystem processes in natural and humanized environments constitutes a major future conceptual challenge.	[Wittebolle, Lieven; Marzorati, Massimo; Verstraete, Willy; Boon, Nico] Univ Ghent, Lab Microbial Ecol & Technol, LabMET, B-9000 Ghent, Belgium; [Clement, Lieven] Univ Ghent, BIOSTAT, Dept Appl Math Biometr & Proc Control, B-9000 Ghent, Belgium; [Heylen, Kim; De Vos, Paul] Univ Ghent, Microbiol Lab, Dept Biochem Physiol & Microbiol, LM UGent, B-9000 Ghent, Belgium; [Balloi, Annalisa; Daffonchio, Daniele] Univ Milan, Dipartimento Sci & Tecnol Alimentari & Microbiol, DISTAM, I-20133 Milan, Italy	Ghent University; Ghent University; Ghent University; University of Milan	Boon, N (corresponding author), Univ Ghent, Lab Microbial Ecol & Technol, LabMET, B-9000 Ghent, Belgium.	nico.boon@ugent.be	Clement, Lieven/G-5143-2012; Daffonchio, Daniele/AAF-4922-2019; Marzorati, Massimo/A-3419-2013; Boon, Nico/B-4083-2011; Heylen, Kim/G-4085-2011; De Vos, Paul/J-5392-2013	Daffonchio, Daniele/0000-0003-0947-925X; Boon, Nico/0000-0002-7734-3103; clement, lieven/0000-0002-9050-4370	Institute for the Promotion of Innovation through Science and Technology in Flanders; Interuniversity Attraction Pole research network grant of the Belgian government, Belgian Science Policy; 'Program Master and Back' from Regione Sardegna; 'Programma dell'Universita' per la Ricerca,; Geconcerteerde Onderzoeksactie of Ghent University; Ministerie van de Vlaamse Gemeenschap; Bestuur Wetenschappelijk Onderzoek	Institute for the Promotion of Innovation through Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Interuniversity Attraction Pole research network grant of the Belgian government, Belgian Science Policy(Belgian Federal Science Policy Office); 'Program Master and Back' from Regione Sardegna; 'Programma dell'Universita' per la Ricerca,; Geconcerteerde Onderzoeksactie of Ghent University(Ghent University); Ministerie van de Vlaamse Gemeenschap; Bestuur Wetenschappelijk Onderzoek	We are grateful to R. Amann for comments on the original manuscript and to P. Van Damme for practical assistance. This work was supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders ( IWT- Vlaanderen) ( to L. W.), by an Interuniversity Attraction Pole research network grant of the Belgian government, Belgian Science Policy ( to L. C.), by 'Program Master and Back' from Regione Sardegna ( Italy; to A. B.), by 'Programma dell'Universita' per la Ricerca, PUR 2008' (ex FIRST) of the University of Milan ( to D. D.), and by the Geconcerteerde Onderzoeksactie of Ghent University contract grant of the Ministerie van de Vlaamse Gemeenschap, Bestuur Wetenschappelijk Onderzoek ( Belgium; to K. H., P. D. V., W. V. and N. B.). Author Contributions L. W., M. M. and N. B. had the original idea for the experiment.	Balvanera P, 2005, ECOL APPL, V15, P360, DOI 10.1890/03-5192; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4; Gitay H, 1996, J ECOL, V84, P121, DOI 10.2307/2261706; Griffiths BS, 2001, APPL SOIL ECOL, V16, P49, DOI 10.1016/S0929-1393(00)00081-0; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kutner M. H., 2004, APPL LINEAR REGRESSI; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MONTGOMERY H, 1961, ANALYST, V86, P414; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Philippot L, 2005, CURR OPIN MICROBIOL, V8, P234, DOI 10.1016/j.mib.2005.04.003; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Sankaran M, 1999, NATURE, V401, P691, DOI 10.1038/44368; Symonds MRE, 2008, AM NAT, V171, P480, DOI 10.1086/528960; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Wilsey BJ, 2002, ECOL LETT, V5, P676, DOI 10.1046/j.1461-0248.2002.00372.x; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yang DR, 2008, SYMBIOSIS, V45, P153	30	674	702	18	393	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					623	626		10.1038/nature07840	http://dx.doi.org/10.1038/nature07840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19270679				2022-12-24	WOS:000264796200039
J	Sun, JC; Beilke, JN; Lanier, LL				Sun, Joseph C.; Beilke, Joshua N.; Lanier, Lewis L.			Adaptive immune features of natural killer cells	NATURE			English	Article							CD8(+) T-CELLS; MURINE CYTOMEGALOVIRUS; ACTIVATION RECEPTOR; VIRAL-INFECTION; NK CELLS; IN-VIVO; MEMORY; EFFECTOR; RECOGNITION; ANTIGEN	In an adaptive immune response, naive T cells proliferate during infection and generate long- lived memory cells that undergo secondary expansion after a repeat encounter with the same pathogen. Although natural killer (NK) cells have traditionally been classified as cells of the innate immune system, they share many similarities with cytotoxic T lymphocytes. We use a mouse model of cytomegalovirus infection to show that, like T cells, NK cells bearing the virus-specific Ly49H receptor proliferate 100-fold in the spleen and 1,000- fold in the liver after infection. After a contraction phase, Ly49H- positive NK cells reside in lymphoid and non- lymphoid organs for several months. These self- renewing 'memory' NK cells rapidly degranulate and produce cytokines on reactivation. Adoptive transfer of these NK cells into naive animals followed by viral challenge results in a robust secondary expansion and protective immunity. These findings reveal properties of NK cells that were previously attributed only to cells of the adaptive immune system.	[Sun, Joseph C.; Beilke, Joshua N.; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Sun, Joseph C.; Beilke, Joshua N.; Lanier, Lewis L.] Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lewis.lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	National Institutes of Health [AI068129]; Irvington Institute for Immunological Research; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute for Immunological Research; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Lanier laboratory for comments and discussions, and R. Locksley and W. Seaman for critical reading of this manuscript. The work was supported by National Institutes of Health grant AI068129. J.C.S. is supported by the Irvington Institute for Immunological Research. J.N.B. is supported by the Juvenile Diabetes Research Foundation. L.L.L. is an American Cancer Society Research Professor.	Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Badovinac VP, 2003, J IMMUNOL, V170, P4933, DOI 10.4049/jimmunol.170.10.4933; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; BUKOWSKI JF, 1985, J EXP MED, V161, P40, DOI 10.1084/jem.161.1.40; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Lanier LL, 2007, EUR J IMMUNOL, V37, P1424, DOI 10.1002/eji.200737418; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lefrancois L, 2002, CURR OPIN IMMUNOL, V14, P503, DOI 10.1016/S0952-7915(02)00360-6; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; Vidal SM, 2006, CURR TOP MICROBIOL, V298, P183; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	36	1061	1113	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					557	561		10.1038/nature07665	http://dx.doi.org/10.1038/nature07665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19136945	Green Accepted			2022-12-24	WOS:000262852200035
J	Malizia, BA; Hacker, MR; Penzias, AS				Malizia, Beth A.; Hacker, Michele R.; Penzias, Alan S.			Cumulative Live-Birth Rates after In Vitro Fertilization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; ONGOING PREGNANCY; SPERM INJECTION; AGE; IVF; PROBABILITY; CONCEPTION; CYCLES; NUMBER; DIAGNOSIS	BACKGROUND Outcomes of in vitro fertilization ( IVF) treatment are traditionally reported as pregnancies per IVF cycle. However, a couple's primary concern is the chance of a live birth over an entire treatment course. METHODS We estimated cumulative live- birth rates among patients undergoing their first fresh-embryo, nondonor IVF cycle between 2000 and 2005 at one large center. Couples were followed until either discontinuation of treatment or delivery of a live- born infant. Analyses were stratified according to maternal age and performed with the use of both optimistic and conservative methods. Optimistic methods assumed that patients who did not return for subsequent IVF cycles would have the same chance of a pregnancy resulting in a live birth as patients who continued treatment; conservative methods assumed no live births among patients who did not return. RESULTS Among 6164 patients undergoing 14,248 cycles, the cumulative live- birth rate after 6 cycles was 72% ( 95% confidence interval [ CI], 70 to 74) with the optimistic analysis and 51% ( 95% CI, 49 to 52) with the conservative analysis. Among patients who were younger than 35 years of age, the corresponding rates after six cycles were 86% ( 95% CI, 83 to 88) and 65% ( 95% CI, 64 to 67). Among patients who were 40 years of age or older, the corresponding rates were 42% ( 95% CI, 37 to 47) and 23% ( 95% CI, 21 to 25). The cumulative live- birth rate decreased with increasing age, and the age-stratified curves (< 35 vs. = 40 years) were significantly different from one another ( P< 0.001). CONCLUSIONS Our results indicate that IVF may largely overcome infertility in younger women, but it does not reverse the age- dependent decline in fertility.	[Malizia, Beth A.; Penzias, Alan S.] Boston IVF, Waltham, MA 02451 USA; [Malizia, Beth A.; Hacker, Michele R.; Penzias, Alan S.] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Boston, MA 02215 USA; [Malizia, Beth A.; Hacker, Michele R.; Penzias, Alan S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Penzias, AS (corresponding author), Boston IVF, 130 2nd Ave, Waltham, MA 02451 USA.	apenzias@bidmc.harvard.edu	Hacker, Michele/ABC-5031-2021	Penzias, Alan/0000-0002-7160-494X; Hacker, Michele/0000-0003-0217-9991	Ferring Pharmaceuticals; EMD Serono; Organon; Repromedix	Ferring Pharmaceuticals(Ferring Pharmaceuticals); EMD Serono; Organon; Repromedix	Dr. Malizia reports receiving an educational grant from Ferring Pharmaceuticals for work unrelated to this study, and Dr. Penzias, receiving consulting and lecture fees and grant support (to Boston IVF) from Ferring Pharmaceuticals and grant support (to Boston IVF) from EMD Serono, Organon, and Repromedix. No other potential conflict of interest relevant to this article was reported. We thank Benjamin B. Taylor, M.D., M.P.H., for his assistance with revisions of an earlier version of the manuscript, Emily B. Levitan, Sc.D., for her statistical review, and the many nurses, assistants, scientists, and physicians at Boston IVF for their care of the patients in this study.	*AM SOC REPR MED S, 2007, 2005 ASS REPR TECHN; Andersen AN, 2008, HUM REPROD, V23, P756, DOI 10.1093/humrep/den014; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; Dickey RP, 2002, FERTIL STERIL, V78, P1088, DOI 10.1016/S0015-0282(02)04212-7; EATON JL, 2008, FERTIL STERIL   0426; Elizur SE, 2006, GYNECOL ENDOCRINOL, V22, P25, DOI 10.1080/09513590500453916; Engmann L, 1999, BRIT J OBSTET GYNAEC, V106, P165, DOI 10.1111/j.1471-0528.1999.tb08217.x; Fukuda J, 2001, ACTA OBSTET GYN SCAN, V80, P71, DOI 10.1080/791201838; Gnoth C, 2003, HUM REPROD, V18, P1959, DOI 10.1093/humrep/deg366; GUTTMACHER AF, 1956, JAMA-J AM MED ASSOC, V161, P855, DOI 10.1001/jama.1956.02970090081016; GUZICK DS, 1986, FERTIL STERIL, V46, P663; HULL MGR, 1992, BRIT MED J, V304, P1465, DOI 10.1136/bmj.304.6840.1465; Jain T, 2005, FERTIL STERIL, V84, P221, DOI 10.1016/j.fertnstert.2005.01.118; Jain T, 2002, NEW ENGL J MED, V347, P661, DOI 10.1056/NEJMsa013491; Klipstein S, 2005, FERTIL STERIL, V84, P435, DOI 10.1016/j.fertnstert.2005.02.020; Land JA, 1997, FERTIL STERIL, V68, P278, DOI 10.1016/S0015-0282(97)81515-4; Lintsen AME, 2007, HUM REPROD, V22, P2455, DOI 10.1093/humrep/dem183; Olivius K, 2002, FERTIL STERIL, V77, P505, DOI 10.1016/S0015-0282(01)03217-4; Pandian Z, 2005, HUM REPROD, V20, P2681, DOI 10.1093/humrep/dei153; Seif MM, 2006, COCHRANE DB SYST REV, V1; Stem JE, 2007, FERTIL STERIL, V88, P275, DOI 10.1016/j.fertnstert.2006.09.016; Stolwijk AM, 2000, HUM REPROD, V15, P203, DOI 10.1093/humrep/15.1.203; TAN SL, 1992, LANCET, V339, P1390, DOI 10.1016/0140-6736(92)91205-M; TAN SL, 1994, AM J OBSTET GYNECOL, V171, P513, DOI 10.1016/0002-9378(94)90291-7; TIETZE C, 1957, FERTIL STERIL, V8, P89; van Disseldorp J, 2007, REPROD BIOMED ONLINE, V14, P455, DOI 10.1016/S1472-6483(10)60893-0; Witsenburg C, 2005, FERTIL STERIL, V84, P99, DOI 10.1016/j.fertnstert.2005.02.013; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8; 2006, FERTIL STERIL S, V86, pS51	29	286	303	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					236	243		10.1056/NEJMoa0803072	http://dx.doi.org/10.1056/NEJMoa0803072			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144939				2022-12-24	WOS:000262434500006
J	Acosta, IF; Laparra, H; Romero, SP; Schmelz, E; Hamberg, M; Mottinger, JP; Moreno, MA; Dellaporta, SL				Acosta, Ivan F.; Laparra, Helene; Romero, Sandra P.; Schmelz, Eric; Hamberg, Mats; Mottinger, John P.; Moreno, Maria A.; Dellaporta, Stephen L.			tasselseed1 Is a Lipoxygenase Affecting Jasmonic Acid Signaling in Sex Determination of Maize	SCIENCE			English	Article							ZEA-MAYS; ANTHER DEHISCENCE; ARCHITECTURE; ARABIDOPSIS; PLANTS; GENE; INFLORESCENCES; BIOSYNTHESIS; GRASSES; ENCODES	Sex determination in maize is controlled by a developmental cascade leading to the formation of unisexual florets derived from an initially bisexual floral meristem. Abortion of pistil primordia in staminate florets is controlled by a tasselseed- mediated cell death process. We positionally cloned and characterized the function of the sex determination gene tasselseed1 ( ts1). The TS1 protein encodes a plastid- targeted lipoxygenase with predicted 13- lipoxygenase specificity, which suggests that TS1 may be involved in the biosynthesis of the plant hormone jasmonic acid. In the absence of a functional ts1 gene, lipoxygenase activity was missing and endogenous jasmonic acid concentrations were reduced in developing inflorescences. Application of jasmonic acid to developing inflorescences rescued stamen development in mutant ts1 and ts2 inflorescences, revealing a role for jasmonic acid in male flower development in maize.	[Acosta, Ivan F.; Laparra, Helene; Romero, Sandra P.; Moreno, Maria A.; Dellaporta, Stephen L.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Schmelz, Eric] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, S-17177 Stockholm, Sweden; [Mottinger, John P.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA	Yale University; United States Department of Agriculture (USDA); Karolinska Institutet; University of Rhode Island	Dellaporta, SL (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	stephen.dellaporta@yale.edu	Acosta, Ivan/Q-2274-2018	Acosta, Ivan/0000-0001-7080-3384; Schmelz, Eric/0000-0002-2837-734X; Hamberg, Mats/0000-0002-8910-7810	NIH [R01 GM38148]; USDA [99-35301-8048]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Hake, P. Chomet, and B. Lowe for providing ts1 mutant alleles; A. Signorovitch and R. Rosengarten for help with phylogenetic analyses; E. Bortiri, C. Whipple, P. Bommet, and D. Jackson for advice on in situ hybridizations; I. Hwang for the pRbcSnt: GFP construct; and R. Tsien for the mCherry gene. Supported by NIH grant R01 GM38148 (S.L.D.) and USDA grant 99-35301-8048 (J.P.M.). Sequences obtained in this study were deposited in GenBank (accession numbers FJ360855 and FJ360856).	Ainsworth C, 1998, CURR TOP DEV BIOL, V38, P167; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bonnett OT, 1940, J AGRIC RES, V60, P0025; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Calderon-Urrea A, 1999, DEVELOPMENT, V126, P435; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; DELLAPORTA SL, 1994, SCIENCE, V266, P1501, DOI 10.1126/science.7985019; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emerson RA, 1920, J HERED, V11, P65, DOI 10.1093/oxfordjournals.jhered.a101971; Engelberth J, 2007, MOL PLANT MICROBE IN, V20, P707, DOI 10.1094/MPMI-20-6-0707; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Gaut BS, 2001, GENOME RES, V11, P55, DOI 10.1101/gr.160601; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; Hornung E, 1999, P NATL ACAD SCI USA, V96, P4192, DOI 10.1073/pnas.96.7.4192; Irish EE, 1996, BIOESSAYS, V18, P363, DOI 10.1002/bies.950180506; IRISH EE, 1993, AM J BOT, V80, P292, DOI 10.2307/2445352; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Kiesselbach T.A., 1949, STRUCTURE REPROD COR; Kim JC, 2007, GENETICS, V177, P2547, DOI 10.1534/genetics.107.082446; Lee KH, 2002, MOL CELLS, V14, P388; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; NICKERSON NORTON H., 1955, ANN MISSOURI BOT GARDEN, V42, P195, DOI 10.2307/2394655; Salse J, 2004, PLANT J, V38, P396, DOI 10.1111/j.1365-313X.2004.02058.x; Sanders PM, 2005, SEX PLANT REPROD, V17, P219, DOI 10.1007/s00497-004-0231-y; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; SHIBATA D, 1995, J LIPID MEDIAT CELL, V12, P213, DOI 10.1016/0929-7855(95)00020-Q; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; WEILER EW, 1993, PHYTOCHEMISTRY, V32, P591, DOI 10.1016/S0031-9422(00)95142-2; Wu XQ, 2007, FEBS J, V274, P1172, DOI 10.1111/j.1742-4658.2007.05642.x; Yamasaki S, 2005, VITAM HORM, V72, P79, DOI 10.1016/S0083-6729(05)72003-3	34	194	223	4	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					262	265		10.1126/science.1164645	http://dx.doi.org/10.1126/science.1164645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131630				2022-12-24	WOS:000262290600041
J	Phillips, OL; Aragao, LEOC; Lewis, SL; Fisher, JB; Lloyd, J; Lopez-Gonzalez, G; Malhi, Y; Monteagudo, A; Peacock, J; Quesada, CA; van der Heijden, G; Almeida, S; Amaral, I; Arroyo, L; Aymard, G; Baker, TR; Banki, O; Blanc, L; Bonal, D; Brando, P; Chave, J; de Oliveira, ACA; Cardozo, ND; Czimczik, CI; Feldpausch, TR; Freitas, MA; Gloor, E; Higuchi, N; Jimenez, E; Lloyd, G; Meir, P; Mendoza, C; Morel, A; Neill, DA; Nepstad, D; Patino, S; Penuela, MC; Prieto, A; Ramirez, F; Schwarz, M; Silva, J; Silveira, M; Thomas, AS; ter Steege, H; Stropp, J; Vasquez, R; Zelazowski, P; Davila, EA; Andelman, S; Andrade, A; Chao, KJ; Erwin, T; Di Fiore, A; Honorio, E; Keeling, H; Killeen, TJ; Laurance, WF; Cruz, AP; Pitman, NCA; Vargas, PN; Ramirez-Angulo, H; Rudas, A; Salamao, R; Silva, N; Terborgh, J; Torres-Lezama, A				Phillips, Oliver L.; Aragao, Luiz E. O. C.; Lewis, Simon L.; Fisher, Joshua B.; Lloyd, Jon; Lopez-Gonzalez, Gabriela; Malhi, Yadvinder; Monteagudo, Abel; Peacock, Julie; Quesada, Carlos A.; van der Heijden, Geertje; Almeida, Samuel; Amaral, Ieda; Arroyo, Luzmila; Aymard, Gerardo; Baker, Tim R.; Banki, Olaf; Blanc, Lilian; Bonal, Damien; Brando, Paulo; Chave, Jerome; Alves de Oliveira, Atila Cristina; Cardozo, Nallaret Davila; Czimczik, Claudia I.; Feldpausch, Ted R.; Freitas, Maria Aparecida; Gloor, Emanuel; Higuchi, Niro; Jimenez, Eliana; Lloyd, Gareth; Meir, Patrick; Mendoza, Casimiro; Morel, Alexandra; Neill, David A.; Nepstad, Daniel; Patino, Sandra; Cristina Penuela, Maria; Prieto, Adriana; Ramirez, Fredy; Schwarz, Michael; Silva, Javier; Silveira, Marcos; Thomas, Anne Sota; ter Steege, Hans; Stropp, Juliana; Vasquez, Rodolfo; Zelazowski, Przemyslaw; Alvarez Davila, Esteban; Andelman, Sandy; Andrade, Ana; Chao, Kuo-Jung; Erwin, Terry; Di Fiore, Anthony; Honorio C, Euridice; Keeling, Helen; Killeen, Tim J.; Laurance, William F.; Pena Cruz, Antonio; Pitman, Nigel C. A.; Nunez Vargas, Percy; Ramirez-Angulo, Hirma; Rudas, Agustin; Salamao, Rafael; Silva, Natalino; Terborgh, John; Torres-Lezama, Armando			Drought Sensitivity of the Amazon Rainforest	SCIENCE			English	Article							TROPICAL FORESTS; CLIMATE-CHANGE; CARBON; MORTALITY; IMPACT; TREE; DYNAMICS; EXCHANGE; TRENDS; XYLEM	Amazon forests are a key but poorly understood component of the global carbon cycle. If, as anticipated, they dry this century, they might accelerate climate change through carbon losses and changed surface energy balances. We used records from multiple long-term monitoring plots across Amazonia to assess forest responses to the intense 2005 drought, a possible analog of future events. Affected forest lost biomass, reversing a large long-term carbon sink, with the greatest impacts observed where the dry season was unusually intense. Relative to pre-2005 conditions, forest subjected to a 100-millimeter increase in water deficit lost 5.3 megagrams of aboveground biomass of carbon per hectare. The drought had a total biomass carbon impact of 1.2 to 1.6 petagrams (1.2 x 10(15) to 1.6 x 10(15) grams). Amazon forests therefore appear vulnerable to increasing moisture stress, with the potential for large carbon losses to exert feedback on climate change.	[Phillips, Oliver L.; Lewis, Simon L.; Lloyd, Jon; Lopez-Gonzalez, Gabriela; Peacock, Julie; Quesada, Carlos A.; van der Heijden, Geertje; Baker, Tim R.; Feldpausch, Ted R.; Gloor, Emanuel; Patino, Sandra; Schwarz, Michael; Chao, Kuo-Jung; Keeling, Helen] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Aragao, Luiz E. O. C.; Lewis, Simon L.; Fisher, Joshua B.; Lloyd, Jon; Malhi, Yadvinder; Morel, Alexandra; Silva, Javier; Zelazowski, Przemyslaw] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford OX1 3QY, England; [Monteagudo, Abel; Vasquez, Rodolfo; Pena Cruz, Antonio] Jardin Bot Missouri, Oxapampa, Pasco, Peru; [Quesada, Carlos A.; Amaral, Ieda; Alves de Oliveira, Atila Cristina; Andrade, Ana; Laurance, William F.] Inst Nacl de Pesquisas da Amazonia, BR-69060011 Manaus, Amazonas, Brazil; [Almeida, Samuel; Freitas, Maria Aparecida; Salamao, Rafael] Museu Paraense Emilio Goeldi, BR-66077830 Belem, Para, Brazil; [Amaral, Ieda; Andelman, Sandy] Conservat Int, Trop Ecol Assessment & Monitoring Network, Arlington, VA 22202 USA; [Arroyo, Luzmila; Killeen, Tim J.] Museo Hist Nat Noel Kempff Mercado, Santa Cruz, Bolivia; [Arroyo, Luzmila; Neill, David A.] Missouri Bot Garden, St Louis, MO 63166 USA; [Aymard, Gerardo] Univ Nacl Expt Los Llanos Occidentales Ezequiel Z, Herbario Univ PORTI, Programa Ciencias Agro & Mar, Mesa De Cavacas 3350, Portuguesa, Venezuela; [Banki, Olaf] Natl Herbarium Nederland, NL-3584 CS Utrecht, Netherlands; [Blanc, Lilian; Patino, Sandra] CIRAD, UMR EcoFoG, Kourou 97387, French Guiana; [Bonal, Damien] INRA, UMR EcoFoG, Kourou 97387, French Guiana; [Brando, Paulo] Inst Pesquisa Ambiental Amazonia, BR-66035 Belem, Para, Brazil; [Brando, Paulo] Univ Florida, Dept Bot, Gainesville, FL 32611 USA; [Brando, Paulo] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Chave, Jerome] Univ Toulouse 3, Lab EDB, F-31062 Toulouse, France; [Cardozo, Nallaret Davila; Ramirez, Fredy] Univ Nacl Amazonia Peruana, Iquitos, Loreto, Peru; [Czimczik, Claudia I.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Higuchi, Niro] Inst Nacl de Pesquisas da Amazonia, Dept Silvicultura Trop, Manaus, Amazonas, Brazil; [Jimenez, Eliana; Cristina Penuela, Maria] Univ Nacl Colombia, Leticia, Amazonas, Colombia; [Lloyd, Gareth] Natl Australia Bank, UB2211, Docklands, Vic 3008, Australia; [Meir, Patrick] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland; [Mendoza, Casimiro] FOMABO Manejo Forestal Tierras Trop Bolivia, Sacta, Bolivia; [Neill, David A.] Jatun Sacha Fdn, Quito, Ecuador; [Nepstad, Daniel] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Nepstad, Daniel] Gordon & Betty Moore Fdn, San Francisco, CA 94129 USA; [Prieto, Adriana] Inst Alexander von Humboldt, Villa De Leyva, Boyaca, Colombia; [Schwarz, Michael] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res, D-95440 Bayreuth, Germany; [Silveira, Marcos] Univ Fed Acre, Dept Ciencias Nat, BR-69910900 Rio Branco, AC, Brazil; [Thomas, Anne Sota] Humboldt Univ, Fac Agr & Hort, D-10557 Berlin, Germany; [ter Steege, Hans; Stropp, Juliana] Univ Utrecht, Fac Sci, Dept Biol, Inst Environm Biol, NL-3584 CA Utrecht, Netherlands; [Alvarez Davila, Esteban] Univ Tolima, Fac Ingn Forestal, Ibague 546, Colombia; [Erwin, Terry] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20013 USA; [Di Fiore, Anthony] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Honorio C, Euridice] Inst Invest Amazonia Peruana, Loreto, Peru; [Laurance, William F.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Pitman, Nigel C. A.] Ctr Invest & Capacitac Rio de Los Amigos, Madre De Dios, Peru; [Nunez Vargas, Percy] Univ Nacl San Antonio Abad Cusco, Cuzco, Peru; [Ramirez-Angulo, Hirma; Torres-Lezama, Armando] Univ Los Andes, Fac Ciencias Forestales, INDEFOR, Merida, Venezuela; [Rudas, Agustin] Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Colombia; [Silva, Natalino] Serv Florestal Brasileiro, BR-70818900 Brasilia, DF, Brazil; [Terborgh, John] Duke Univ, Ctr Trop Conservat, Durham, NC 27708 USA	University of Leeds; University of Oxford; Institute Nacional de Pesquisas da Amazonia; Museu Paraense Emilio Goeldi; Conservation International; Missouri Botanical Gardens; CIRAD; INRAE; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universidad Nacional de la Amazonia Peruana; University of California System; University of California Irvine; Institute Nacional de Pesquisas da Amazonia; Universidad Nacional de Colombia; University of Edinburgh; Woods Hole Research Center; University of Bayreuth; Universidade Federal do Acre (UFAC); Humboldt University of Berlin; Utrecht University; Universidad del Tolima; Smithsonian Institution; Smithsonian National Museum of Natural History; New York University; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Nacional de San Antonio Abad del Cusco; University of Los Andes Venezuela; Universidad Nacional de Colombia; Duke University	Phillips, OL (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	o.phillips@leeds.ac.uk	Silveira, Marcos/H-7906-2013; Pitman, Nigel C A/A-7681-2008; Feldpausch, Ted/D-3436-2009; aragao, luiz eoc/G-8387-2012; Feldpausch, Ted/ABH-3123-2020; Meir, Patrick/J-8344-2012; Phillips, Oliver/A-1523-2011; Coronado, Eurídice Nora Honorio/K-3412-2015; Steege, Hans ter/B-5866-2011; Aymard, Gerardo/ABE-9203-2020; Laurance, William F/B-2709-2012; Lloyd, Jonathan J/F-8893-2010; van der Heijden, Geertje/AAB-4102-2019; Brando, Paulo/AAC-9396-2019; BONAL, Damien/B-2384-2009; Higuchi, Niro/ABC-8890-2020; Brando, Paulo M/C-4302-2012; Andrade, Ana Cristina/E-8218-2013; Higuchi, Niro/ABC-9134-2020; Alvarez-Davila, Esteban/AAP-4231-2020; Higuchi, Niro/J-1287-2016; Stropp, Juliana/AAF-7946-2020; Morel, Alexandra/J-4071-2019; Ramirez, Fredy/R-1522-2016	Silveira, Marcos/0000-0003-0485-7872; Pitman, Nigel C A/0000-0002-9211-2880; Feldpausch, Ted/0000-0002-6631-7962; aragao, luiz eoc/0000-0002-4134-6708; Feldpausch, Ted/0000-0002-6631-7962; Phillips, Oliver/0000-0002-8993-6168; Coronado, Eurídice Nora Honorio/0000-0003-2314-590X; Steege, Hans ter/0000-0002-8738-2659; Aymard, Gerardo/0000-0001-9405-0508; Laurance, William F/0000-0003-4430-9408; Lloyd, Jonathan J/0000-0002-5458-9960; van der Heijden, Geertje/0000-0002-2110-5173; Brando, Paulo/0000-0001-8952-7025; Brando, Paulo M/0000-0001-8952-7025; Higuchi, Niro/0000-0002-1203-4502; Alvarez-Davila, Esteban/0000-0001-9032-0099; Higuchi, Niro/0000-0002-1203-4502; Stropp, Juliana/0000-0002-2831-4066; Morel, Alexandra/0000-0002-0905-8079; Lopez-Gonzalez, Gabriela/0000-0002-0814-8830; Ramirez, Fredy/0000-0003-2441-9984; Fisher, Joshua/0000-0003-4734-9085; Lewis, Simon/0000-0002-8066-6851; Zelazowski, Przemyslaw/0000-0003-0442-2529; Jimenez, Eliana M./0000-0002-8610-1771; Neill, David Alan/0000-0002-5143-9430; Czimczik, Claudia/0000-0002-8251-6603; Banki, Olaf/0000-0001-6197-9951; Penuela Mora, Maria Cristina/0000-0002-9611-1359; Silva, Jose/0000-0003-4068-2432; Blanc, Lilian/0000-0003-3605-4230	Leverhulme Trust; NERC [NE/B503384/1, NE/D01025X/1, NER/A/S/2003/00608/2]; WOTRO [W84-581]; Royal Society; University of Leeds; Gordon and Betty Moore Foundation; Natural Environment Research Council [NE/B503384/1, NE/D01025X/1, NE/D010306/1] Funding Source: researchfish; NERC [NE/D010306/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); WOTRO; Royal Society(Royal Society of London); University of Leeds; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This paper is a product of the RAINFOR network. Funding for the 2006 recensuses came primarily from a Natural Environment Research Council (NERC) Urgency Grant. The results summarized here also depend on contributions from numerous field assistants and rural communities in Brazil, Bolivia, Colombia, Ecuador, French Guiana, Guyana, Peru, and Venezuela, many previously acknowledged. I. Huamantupa, N. Jaramillo, N. Saavedram (Peru), V. Pena (Ecuador), J.-C. Arias, and D. Navarrete (Colombia) assisted with recent censuses. We thank CNPQ (Brazil), MCT (Brazil), Ministerio del Medio Ambiente, Vivienda y Desarrollo Territorial (Colombia), Ministerio de Ambiente (Ecuador), the Forestry Commission (Guyana), INRENA (Peru), and Ministerio del Ambiente para el Poder Popular (Venezuela) for research permissions, and the Large Scale Biosphere-Atmosphere Experiment in Amazonia (LBA) for logistical support. This paper was supported by the Leverhulme Trust (O.L.P.), NERC grants NE/B503384/1 and NE/D01025X/1 (O.L.P.), NER/A/S/2003/00608/2 (Y.M.), WOTRO (W84-581) (H.t.S., O.B.), the Royal Society (S.L.L., Y.M.), University of Leeds (T.R.B., K.-J.C., G.L.-G.), and a Gordon and Betty Moore Foundation grant to RAINFOR. Some of the data used in these analyses were collected with support from the TEAM Network of Conservation International, funded by the Gordon and Betty Moore Foundation. We thank D. Galbraith, L. Anderson, C. Michelaki, J. Ratnam, and M. Wagner for discussions; three anonymous reviewers for comments on the manuscript; M. Garcia-Hernandez for help in managing co-author contributions; and A. Manson and D. Appleyard for help in creating the figures.	Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; Brando PM, 2008, PHILOS T R SOC B, V363, P1839, DOI 10.1098/rstb.2007.0031; Christensen J.H., 2007, CLIMATE CHANGE 2007; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Harris PP, 2008, PHILOS T R SOC B, V363, P1753, DOI 10.1098/rstb.2007.0037; Hasler N, 2007, J HYDROMETEOROL, V8, P380, DOI 10.1175/JHM587.1; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Ichii K, 2005, GLOBAL PLANET CHANGE, V48, P274, DOI 10.1016/j.gloplacha.2005.02.005; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Li WH, 2008, PHILOS T R SOC B, V363, P1767, DOI 10.1098/rstb.2007.0022; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Meir P, 2008, PHILOS T R SOC B, V363, P1849, DOI 10.1098/rstb.2007.0021; *NAT OC ATM ADM, 2008, TRENDS ATM CARB DIOX; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; von Randow C, 2004, THEOR APPL CLIMATOL, V78, P5, DOI 10.1007/s00704-004-0041-z; Williamson GB, 2000, CONSERV BIOL, V14, P1538, DOI 10.1046/j.1523-1739.2000.99298.x	32	1161	1193	28	838	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1344	1347		10.1126/science.1164033	http://dx.doi.org/10.1126/science.1164033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265020	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000263876700042
J	Murayama, M; Perez-Garci, E; Nevian, T; Bock, T; Senn, W; Larkum, ME				Murayama, Masanori; Perez-Garci, Enrique; Nevian, Thomas; Bock, Tobias; Senn, Walter; Larkum, Matthew E.			Dendritic encoding of sensory stimuli controlled by deep cortical interneurons	NATURE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; PRIMARY SOMATOSENSORY CORTEX; DISTAL APICAL DENDRITES; MOUSE SMI CORTEX; ACTION-POTENTIALS; IN-VIVO; LAYER-I; PROJECTION NEURONS; CELLS; RAT	The computational power of single neurons is greatly enhanced by active dendritic conductances(1) that have a large influence on their spike activity(2-4). In cortical output neurons such as the large pyramidal cells of layer 5 (L5), activation of apical dendritic calcium channels leads to plateau potentials that increase the gain of the input/output function(5) and switch the cell to burst-firing mode(6-9). The apical dendrites are innervated by local excitatory and inhibitory inputs as well as thalamic(10-13) and corticocortical projections(14-16), which makes it a formidable task to predict how these inputs influence active dendritic properties in vivo. Here we investigate activity in populations of L5 pyramidal dendrites of the somatosensory cortex in awake and anaesthetized rats following sensory stimulation using a new fibre-optic method(17) for recording dendritic calcium changes. We show that the strength of sensory stimulation is encoded in the combined dendritic calcium response of a local population of L5 pyramidal cells in a graded manner. The slope of the stimulus-response function was under the control of a particular subset of inhibitory neurons activated by synaptic inputs predominantly in L5. Recordings from single apical tuft dendrites in vitro showed that activity in L5 pyramidal neurons disynaptically coupled via interneurons directly blocks the initiation of dendritic calcium spikes in neighbouring pyramidal neurons. The results constitute a functional description of a cortical microcircuit in awake animals that relies on the active properties of L5 pyramidal dendrites and their very high sensitivity to inhibition. The microcircuit is organized so that local populations of apical dendrites can adaptively encode bottom-up sensory stimuli linearly across their full dynamic range.	[Murayama, Masanori; Perez-Garci, Enrique; Nevian, Thomas; Bock, Tobias; Senn, Walter; Larkum, Matthew E.] Univ Bern, Inst Physiol, CH-3012 Bern, Switzerland	University of Bern	Larkum, ME (corresponding author), Univ Bern, Inst Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	larkum@pyl.unibe.ch	Senn, Walter/D-6308-2014; Murayama, Masanori/B-4319-2009; Murayama, Masanori/G-5457-2015; Murayama, Masanori/AHA-9840-2022	Senn, Walter/0000-0003-3622-0497; Murayama, Masanori/0000-0001-7623-010X; Nevian, Thomas/0000-0001-9804-608X; Bock, Tobias/0000-0002-7734-1183; Larkum, Matthew/0000-0001-9799-2656	Swiss National Science Foundation [PP00A-102721/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank K. Martin, H.-R. Luscher and Y. Kudo for their comments on the manuscript, O. Gschwend for support in the laboratory, D. Morris for software development, D. Limoges and J. Burkhalter for their expert technical support and K. Fischer for Neurolucida reconstructions of the biocytin-filled neurons. We also thank Sumitomo Electric Industries for their generous donation of the optical fibre. This work was supported by the Swiss National Science Foundation (grant no. PP00A-102721/1).	Budd JML, 1998, P ROY SOC B-BIOL SCI, V265, P1037, DOI 10.1098/rspb.1998.0396; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; ELHANANY E, 1990, J COMP NEUROL, V291, P43, DOI 10.1002/cne.902910105; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; HERSCH SM, 1981, NEUROSCI LETT, V24, P207, DOI 10.1016/0304-3940(81)90157-9; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Murayama M, 2007, J NEUROPHYSIOL, V98, P1791, DOI 10.1152/jn.00082.2007; Oda S, 2004, NEUROSCI LETT, V367, P394, DOI 10.1016/j.neulet.2004.06.042; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Tan ZJ, 2008, P NATL ACAD SCI USA, V105, P2187, DOI 10.1073/pnas.0710628105; WHITE EL, 1982, J NEUROCYTOL, V11, P137, DOI 10.1007/BF01258009; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Zhu YH, 2004, J NEUROSCI, V24, P1272, DOI 10.1523/JNEUROSCI.4805-03.2004	26	259	263	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1137	U95		10.1038/nature07663	http://dx.doi.org/10.1038/nature07663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19151696				2022-12-24	WOS:000263680100042
J	Xu, ZY; Wei, W; Gagneur, J; Perocchi, F; Clauder-Munster, S; Camblong, J; Guffanti, E; Stutz, F; Huber, W; Steinmetz, LM				Xu, Zhenyu; Wei, Wu; Gagneur, Julien; Perocchi, Fabiana; Clauder-Muenster, Sandra; Camblong, Jurgi; Guffanti, Elisa; Stutz, Francoise; Huber, Wolfgang; Steinmetz, Lars M.			Bidirectional promoters generate pervasive transcription in yeast	NATURE			English	Article							GENOME-WIDE TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; ANTISENSE TRANSCRIPTION; TILING ARRAYS; IDENTIFICATION; RESOLUTION; NUCLEOSOMES; POLYMERASE; LANDSCAPE; MAP	Genome- wide pervasive transcription has been reported in many eukaryotic organisms(1-7), revealing a highly interleaved transcriptome organization that involves hundreds of previously unknown non- codingRNAs(8). These recently identified transcripts either exist stably in cells ( stable unannotated transcripts, SUTs) or are rapidly degraded by the RNA surveillance pathway ( cryptic unstable transcripts, CUTs). One characteristic of pervasive transcription is the extensive overlap of SUTs and CUTs with previously annotated features, which prompts questions regarding how these transcripts are generated, and whether they exert function(9). Single- gene studies have shown that transcription of SUTs and CUTs can be functional, through mechanisms involving the generated RNAs10,11 or their generation itself(12-14). So far, a complete transcriptome architecture including SUTs and CUTs has not been described in any organism. Knowledge about the position and genome- wide arrangement of these transcripts will be instrumental in understanding their function(8,15). Here we provide a comprehensive analysis of these transcripts in the context of multiple conditions, a mutant of the exosome machinery and different strain backgrounds of Saccharomyces cerevisiae. We show that both SUTs and CUTs display distinct patterns of distribution at specific locations. Most of the newly identified transcripts initiate from nucleosome- free regions ( NFRs) associated with the promoters of other transcripts ( mostly protein- coding genes), or from NFRs at the 3 ' ends of protein- coding genes. Likewise, about half of all coding transcripts initiate from NFRs associated with promoters of other transcripts. These data change our view of how a genome is transcribed, indicating that bidirectionality is an inherent feature of promoters. Such an arrangement of divergent and overlapping transcripts may provide a mechanism for local spreading of regulatory signals - that is, coupling the transcriptional regulation of neighbouring genes by means of transcriptional interference or histone modification.	[Xu, Zhenyu; Wei, Wu; Gagneur, Julien; Perocchi, Fabiana; Clauder-Muenster, Sandra; Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Camblong, Jurgi] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Guffanti, Elisa; Stutz, Francoise] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Huber, Wolfgang] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England	European Molecular Biology Laboratory (EMBL); University of Oxford; University of Geneva; European Molecular Biology Laboratory (EMBL)	Steinmetz, LM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de	Wei, Wu/AAC-8285-2020; Stutz, Françoise C/N-4329-2017	Wei, Wu/0000-0001-5643-8739; Huber, Wolfgang/0000-0002-0474-2218; Clauder-Muenster, Sandra/0000-0002-9530-2938; Gagneur, Julien/0000-0002-8924-8365; perocchi, fabiana/0000-0002-1102-6500; Steinmetz, Lars/0000-0002-3962-2865	National Institutes of Health; Deutsche Forschungsgemeinschaft; SystemsX fellowship; Roche fellowship; SNF; NCCR Frontiers in Genetics; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SystemsX fellowship; Roche fellowship; SNF; NCCR Frontiers in Genetics(Swiss National Science Foundation (SNSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Akhtar, A. Ladurner, S. Blandin, R. Aiyar, E. Mancera and E. Fritsch for comments on the manuscript, J. Toedling for discussion and for the template of the website, C. Girardot for data submission to ArrayExpress, N. Proudfoot for access to experimental equipment, and the contributors to the Bioconductor (www.bioconductor.org) and R (http://www.r-project.org) projects for their software. This work was supported by grants to L.M.S. from the National Institutes of Health and Deutsche Forschungsgemeinschaft, by a SystemsX fellowship to E.G., by a Roche fellowship to J.C. and by grants to F.S. from SNF and NCCR Frontiers in Genetics.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Hermsen R, 2008, TRENDS GENET, V24, P216, DOI 10.1016/j.tig.2008.02.004; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	30	667	680	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1033	U7		10.1038/nature07728	http://dx.doi.org/10.1038/nature07728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19169243	Green Accepted			2022-12-24	WOS:000263425400047
J	Scheid, JF; Mouquet, H; Feldhahn, N; Seaman, MS; Velinzon, K; Pietzsch, J; Ott, RG; Anthony, RM; Zebroski, H; Hurley, A; Phogat, A; Chakrabarti, B; Li, YX; Connors, M; Pereyra, F; Walker, BD; Wardemann, H; Ho, D; Wyatt, RT; Mascola, JR; Ravetch, JV; Nussenzweig, MC				Scheid, Johannes F.; Mouquet, Hugo; Feldhahn, Niklas; Seaman, Michael S.; Velinzon, Klara; Pietzsch, John; Ott, Rene G.; Anthony, Robert M.; Zebroski, Henry; Hurley, Arlene; Phogat, Adhuna; Chakrabarti, Bimal; Li, Yuxing; Connors, Mark; Pereyra, Florencia; Walker, Bruce D.; Wardemann, Hedda; Ho, David; Wyatt, Richard T.; Mascola, John R.; Ravetch, Jeffrey V.; Nussenzweig, Michel C.			Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; PASSIVE TRANSFER; BINDING-SITE; TYPE-1; EPITOPE; GLYCOPROTEIN; GENERATION; GP41	Antibodies to conserved epitopes on the human immunodeficiency virus (HIV) surface protein gp140 can protect against infection in non-human primates, and some infected individuals show high titres of broadly neutralizing immunoglobulin (Ig)G antibodies in their serum. However, little is known about the specificity and activity of these antibodies(1-3). To characterize the memory antibody responses to HIV, we cloned 502 antibodies from HIV envelope-binding memory B cells from six HIV-infected patients with broadly neutralizing antibodies and low to intermediate viral loads. We show that in these patients, the B-cell memory response to gp140 is composed of up to 50 independent clones expressing high affinity neutralizing antibodies to the gp120 variable loops, the CD4-binding site, the co-receptor-binding site, and to a new neutralizing epitope that is in the same region of gp120 as the CD4-binding site. Thus, the IgG memory B-cell compartment in the selected group of patients with broad serum neutralizing activity to HIV is comprised of multiple clonal responses with neutralizing activity directed against several epitopes on gp120.	[Scheid, Johannes F.; Mouquet, Hugo; Feldhahn, Niklas; Velinzon, Klara; Pietzsch, John; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Ott, Rene G.; Anthony, Robert M.; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Zebroski, Henry] Rockefeller Univ, Prote Resource Ctr, New York, NY 10065 USA; [Hurley, Arlene] Rockefeller Univ, Rockefeller Univ Hosp, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Pietzsch, John] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Phogat, Adhuna; Chakrabarti, Bimal; Li, Yuxing; Wyatt, Richard T.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Pereyra, Florencia; Walker, Bruce D.] Mass Gen Hosp, Partners AIDS Res Ctr, Charlestown, MA 02129 USA; [Wardemann, Hedda] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Pereyra, Florencia; Walker, Bruce D.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Ho, David] Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Beth Israel Deaconess Medical Center; Free University of Berlin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Max Planck Society; Harvard University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu	Mouquet, Hugo/M-2750-2014; Mascola, John/AAI-7193-2021; Ravetch, Jeffrey/Z-1596-2019; Nussenzweig, Michel/AAE-7292-2019	Mouquet, Hugo/0000-0002-4230-610X; Ravetch, Jeffrey/0000-0003-2024-9041; Wardemann, Hedda/0000-0003-3921-5933	Rockefeller University; International Aids Vaccine Initiative; Bill and Melinda Gates Foundation; Intramural Research Program of the Vaccine Research Center; Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Deutscher Akademischer Austauschdienst; Fondation Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005069, Z01AI005089, ZIAAI005095, ZIAAI001090, Z01AI005095, ZIAAI005010, Z01AI005069, ZIAAI005089] Funding Source: NIH RePORTER	Rockefeller University; International Aids Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Intramural Research Program of the Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Fondation Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Wycuff, E. Lybarger and B. Dey for supplying gp120 proteins for mapping studies, K. McKee for serum adsorption studies and N. Doria- Rose for her work with patient material from patients 4 and 6. This research was supported by the Rockefeller University, the International Aids Vaccine Initiative, the Bill and Melinda Gates Foundation, the Intramural Research Program of the Vaccine Research Center ( R. T. W., J. R. M.), and the Division of Intramural Research ( M. C.), National Institute of Allergy and Infectious Diseases, National Institutes of Health. J. F. S. was supported by the Deutscher Akademischer Austauschdienst, H. M. was supported by the Fondation Recherche Medicale. M. C. N. is a Howard Hughes Medical Institute investigator.	BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Mascola JR, 2007, NATURE, V449, P29, DOI 10.1038/449029a; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	29	685	763	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					636	640		10.1038/nature07930	http://dx.doi.org/10.1038/nature07930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19287373				2022-12-24	WOS:000264796200042
J	Chen, GY; Tang, J; Zheng, P; Liu, Y				Chen, Guo-Yun; Tang, Jie; Zheng, Pan; Liu, Yang			CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses	SCIENCE			English	Article							MOBILITY GROUP BOX-1; HEAT-STABLE ANTIGEN; T-CELL GROWTH; ISCHEMIA-REPERFUSION; PROTEIN; HMGB1; ACTIVATION; SYSTEM; AUTOIMMUNITY; INFLAMMATION	Patten recognition receptors, which recognize pathogens or components of injured cells (danger), trigger activation of the innate immune system. Whether and how the host distinguishes between danger-versus pathogen-associated molecular patterns remains unresolved. We report that CD24-deficient mice exhibit increased susceptibility to danger- but not pathogen-associated molecular patterns. CD24 associates with high mobility group box 1, heat shock protein 70, and heat shock protein 90; negatively regulates their stimulatory activity; and inhibits nuclear factor kappa B (NF-kappa B) activation. This occurs at least in part through CD24 association with Siglec-10 in humans or Siglec-G in mice. Our results reveal that the CD24-Siglec G pathway protects the host against a lethal response to pathological cell death and discriminates danger-versus pathogen-associated molecular patterns.	[Chen, Guo-Yun; Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Dept Surg, Div Immunotherapy, Ann Arbor, MI 48109 USA; [Zheng, Pan] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Liu, Yang] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Tang, Jie] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zheng, P (corresponding author), Univ Michigan, Sch Med, Dept Surg, Div Immunotherapy, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@umich.edu	Chen, Guo-yun/C-2436-2011; Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	NIH [AI064350, CA58033, CA112001]; U.S. department of Defense [W81XWH-08-1-0036]; Natural Science Foundation of China [30640420558]; Ministry of Science and Technology of China [2006CB910901]; NATIONAL CANCER INSTITUTE [R01CA058033, R01CA112001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064350] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. department of Defense(United States Department of Defense); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the NIH (AI064350, CA58033, and CA112001), U.S. department of Defense (W81XWH-08-1-0036), and Natural Science Foundation of China (30640420558) and Ministry of Science and Technology of China (2006CB910901). The authors have no conflicts of interest. We dedicate this study to Dr. Charles A. Janeway Jr.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bai XF, 2000, J CLIN INVEST, V105, P1227, DOI 10.1172/JCI9012; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Ding C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000997; Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Li O, 2006, J EXP MED, V203, P1713, DOI 10.1084/jem.20052293; LIU Y, 1992, J EXP MED, V175, P437, DOI 10.1084/jem.175.2.437; LIU Y, 1991, INT IMMUNOL, V3, P323, DOI 10.1093/intimm/3.4.323; Liu Y, 2007, TRENDS IMMUNOL, V28, P315, DOI 10.1016/j.it.2007.05.001; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Ochsner SA, 2007, STEM CELLS, V25, P2476, DOI 10.1634/stemcells.2007-0101; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang Y, 2007, MICROW OPT TECHN LET, V49, P100, DOI 10.1002/mop.22056; Whitney G, 2001, EUR J BIOCHEM, V268, P6083, DOI 10.1046/j.0014-2956.2001.02543.x; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100	26	524	556	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1722	1725		10.1126/science.1168988	http://dx.doi.org/10.1126/science.1168988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19264983	Green Accepted			2022-12-24	WOS:000264559800038
J	Ressl, S; van Scheltinga, ACT; Vonrhein, C; Ott, V; Ziegler, C				Ressl, Susanne; van Scheltinga, Anke C. Terwisscha; Vonrhein, Clemens; Ott, Vera; Ziegler, Christine			Molecular basis of transport and regulation in the Na+/betaine symporter BetP	NATURE			English	Article							SOLUTES GLYCINE BETAINE; RENAL MEDULLARY CELLS; CORYNEBACTERIUM-GLUTAMICUM; COMPATIBLE SOLUTES; ORGANIC OSMOLYTES; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; OSMOTIC REGULATION; CRYSTAL-STRUCTURE; VOLUME REGULATION	Osmoregulated transporters sense intracellular osmotic pressure and respond to hyperosmotic stress by accumulation of osmolytes to restore normal hydration levels. Here we report the determination of the X-ray structure of a member of the family of betaine/choline/carnitine transporters, the Na+-coupled symporter BetP from Corynebacterium glutamicum, which is a highly effective osmoregulated uptake system for glycine betaine. Glycine betaine is bound in a tryptophan box occluded from both sides of the membrane with aromatic side chains lining the transport pathway. BetP has the same overall fold as three unrelated Na+-coupled symporters. Whereas these are crystallized in either the outward-facing or the inward-facing conformation, the BetP structure reveals a unique intermediate conformation in the Na+-coupled transport cycle. The trimeric architecture of BetP and the break in three-fold symmetry by the osmosensing C-terminal helices suggest a regulatory mechanism of Na+-coupled osmolyte transport to counteract osmotic stress.	[Ressl, Susanne; van Scheltinga, Anke C. Terwisscha; Ziegler, Christine] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany; [Vonrhein, Clemens] Global Phasing Ltd, Sheraton House, Cambridge CB3 0AX, England; [Ott, Vera] Univ Cologne, Inst Biochem, D-50937 Cologne, Germany	Max Planck Society; Global Phasing Limited; University of Cologne	Ziegler, C (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany.	christine.ziegler@mpibp-frankfurt.mpg.de	Ressl, Susanne/AAT-2517-2021	Ziegler, Christine Maria/0000-0003-3439-7213	German Research Foundation; Collaborative Research Centre 807 'Transport and Communication across Biological Membranes'	German Research Foundation(German Research Foundation (DFG)); Collaborative Research Centre 807 'Transport and Communication across Biological Membranes'	The authors thank W. Kuhlbrandt and R. Kramer for support and comments on the manuscript; J. StandfuB for contributions in the early stages of the project; O. Yildiz, T. Barros and R. Wouts for computational support; S. Schulze, S. Morbach, S. Nicklisch and L. Forrest for discussions; J. Hakulinen and J. Carrera for cloning, C. Perez for the reconstitution and freeze fracture experiments; and H. Volk for help with the figures. Special thanks are due to E. Pohl and the X10SA beamline staff at the Swiss Light Source, as well as the European Synchrotron Radiation Facility. This work is supported by the German Research Foundation, Collaborative Research Centre 807 'Transport and Communication across Biological Membranes'.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Athawale MV, 2005, BIOPHYS J, V89, P858, DOI 10.1529/biophysj.104.056671; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Blomberg A, 1997, ELECTROPHORESIS, V18, P1429, DOI 10.1002/elps.1150180818; Bolen DW, 2008, ANNU REV BIOCHEM, V77, P339, DOI 10.1146/annurev.biochem.77.061306.131357; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; da Costa M. S., 1998, V61, P117; Empadinhas N, 2006, INT MICROBIOL, V9, P199; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FARWICK M, 1995, J BACTERIOL, V177, P4690, DOI 10.1128/jb.177.16.4690-4695.1995; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; GARCIAPEREZ A, 1990, HYPERTENSION, V16, P595, DOI 10.1161/01.HYP.16.6.595; Horn C, 2006, J MOL BIOL, V357, P592, DOI 10.1016/j.jmb.2005.12.085; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kappes RM, 1996, J BACTERIOL, V178, P5071, DOI 10.1128/jb.178.17.5071-5079.1996; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kempson SA, 2004, PFLUG ARCH EUR J PHY, V449, P227, DOI 10.1007/s00424-004-1338-6; KINNE RKH, 1993, J EXP ZOOL, V265, P346, DOI 10.1002/jez.1402650403; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lim CH, 2007, METHOD ENZYMOL, V428, P325, DOI 10.1016/S0076-6879(07)28019-x; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Neuhofer W, 2005, CONTRIB NEPHROL, V148, P21, DOI 10.1159/000086041; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Peter H, 1998, J BIOL CHEM, V273, P2567, DOI 10.1074/jbc.273.5.2567; Peter H, 1996, J BACTERIOL, V178, P5229, DOI 10.1128/jb.178.17.5229-5234.1996; Pfluger K, 2004, J BIOENERG BIOMEMBR, V36, P17, DOI 10.1023/B:JOBB.0000019594.43450.c5; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Roberts MF, 2000, FRONT BIOSCI-LANDMRK, V5, pD796, DOI 10.2741/roberts; Rosgen J, 2007, METHOD ENZYMOL, V428, P459, DOI 10.1016/S0076-6879(07)28026-7; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Schiefner A, 2004, J BIOL CHEM, V279, P48270, DOI 10.1074/jbc.M403540200; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Schiller D, 2004, FEBS LETT, V563, P108, DOI 10.1016/S0014-5793(04)00279-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Ziegler C, 2004, J MOL BIOL, V337, P1137, DOI 10.1016/j.jmb.2004.02.026	59	257	258	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					47	U1		10.1038/nature07819	http://dx.doi.org/10.1038/nature07819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262666	Green Published, Green Submitted			2022-12-24	WOS:000263836000029
J	Stewart, GS; Panier, S; Townsend, K; Al-Hakim, AK; Kolas, NK; Miller, ES; Nakada, S; Ylanko, J; Olivarius, S; Mendez, M; Oldreive, C; Wildenhain, J; Tagliaferro, A; Pelletier, L; Taubenheim, N; Durandy, A; Byrd, PJ; Stankovic, T; Taylor, AMR; Durocher, D				Stewart, Grant S.; Panier, Stephanie; Townsend, Kelly; Al-Hakim, Abdallah K.; Kolas, Nadine K.; Miller, Edward S.; Nakada, Shinichiro; Ylanko, Jarkko; Olivarius, Signe; Mendez, Megan; Oldreive, Ceri; Wildenhain, Jan; Tagliaferro, Andrea; Pelletier, Laurence; Taubenheim, Nadine; Durandy, Anne; Byrd, Philip J.; Stankovic, Tatjana; Taylor, A. Malcolm R.; Durocher, Daniel			The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage	CELL			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; 53BP1; GENE; ATM; REPAIR; MDC1; PATHWAY	The biological response to DNA double-strand breaks acts to preserve genome integrity. Individuals bearing inactivating mutations in components of this response exhibit clinical symptoms that include cellular radiosensitivity, immunodeficiency, and cancer predisposition. The archetype for such disorders is Ataxia-Telangiectasia caused by biallelic mutation in ATM, a central component of the DNA damage response. Here, we report that the ubiquitin ligase RNF168 is mutated in the RIDDLE syndrome, a recently discovered immuno-deficiency and radiosensitivity disorder. We show that RNF168 is recruited to sites of DNA damage by binding toubiquitylated histone H2A. RNF168 acts with UBC13 to amplify the RNF8-dependent histone ubiquitylation by targeting H2A-type histones and by promoting the formation of lysine 63-linked ubiquitin conjugates. These RNF168-dependent chromatin modifications orchestrate the accumulation of 53BP1 and BRCA1 to DNA lesions, and their loss is the likely cause of the cellular and developmental phenotypes associated with RIDDLE syndrome.	[Stewart, Grant S.; Townsend, Kelly; Miller, Edward S.; Oldreive, Ceri; Byrd, Philip J.; Stankovic, Tatjana; Taylor, A. Malcolm R.] Univ Birmingham, Canc Res UK, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; [Panier, Stephanie; Al-Hakim, Abdallah K.; Kolas, Nadine K.; Nakada, Shinichiro; Ylanko, Jarkko; Olivarius, Signe; Mendez, Megan; Wildenhain, Jan; Tagliaferro, Andrea; Pelletier, Laurence; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Panier, Stephanie; Ylanko, Jarkko; Pelletier, Laurence; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Taubenheim, Nadine; Durandy, Anne] Hop Necker Enfants Malad, INSERM, U768, F-75015 Paris, France	Cancer Research UK; University of Birmingham; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Stewart, GS (corresponding author), Univ Birmingham, Canc Res UK, Inst Canc Studies, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	g.s.stewart@bham.ac.uk; durocher@lunenfeld.ca	Wildenhain, Jan/E-5597-2011; Durandy, Anne/H-7475-2017; Pelletier, Laurence/F-8858-2013; Wildenhain, Jan/Q-6596-2019; Durocher, Daniel/A-7733-2010; Panier, Stephanie/GVT-6365-2022; OsakaU/AAY-3661-2020	Wildenhain, Jan/0000-0002-5461-3828; Durandy, Anne/0000-0001-7706-8466; Wildenhain, Jan/0000-0002-5461-3828; Durocher, Daniel/0000-0003-3863-8635; Nakada, Shinichiro/0000-0001-9297-1565; Stankovic, Tatjana/0000-0002-3780-274X; Stewart, Grant/0000-0002-0960-3241				Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Callen E, 2007, ONCOGENE, V26, P7759, DOI 10.1038/sj.onc.1210873; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	33	562	589	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					420	434		10.1016/j.cell.2008.12.042	http://dx.doi.org/10.1016/j.cell.2008.12.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203578	Bronze			2022-12-24	WOS:000263120600013
J	Nakahata, Y; Sahar, S; Astarita, G; Kaluzova, M; Sassone-Corsi, P				Nakahata, Yasukazu; Sahar, Saurabh; Astarita, Giuseppe; Kaluzova, Milota; Sassone-Corsi, Paolo			Circadian Control of the NAD(+) Salvage Pathway by CLOCK-SIRT1	SCIENCE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROTEIN SIR2; CLOCK; DEACETYLASE; BIOSYNTHESIS; MECHANISM	Many metabolic and physiological processes display circadian oscillations. We have shown that the core circadian regulator, CLOCK, is a histone acetyltransferase whose activity is counterbalanced by the nicotinamide adenine dinucleotide (NAD(+))-dependent histone deacetylase SIRT1. Here we show that intracellular NAD(+) levels cycle with a 24-hour rhythm, an oscillation driven by the circadian clock. CLOCK: BMAL1 regulates the circadian expression of NAMPT (nicotinamide phosphoribosyltransferase), an enzyme that provides a rate-limiting step in the NAD(+) salvage pathway. SIRT1 is recruited to the Nampt promoter and contributes to the circadian synthesis of its own coenzyme. Using the specific inhibitor FK866, we demonstrated that NAMPT is required to modulate circadian gene expression. Our findings in mouse embryo fibroblasts reveal an interlocked transcriptional-enzymatic feedback loop that governs the molecular interplay between cellular metabolism and circadian rhythms.	[Nakahata, Yasukazu; Sahar, Saurabh; Astarita, Giuseppe; Kaluzova, Milota; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Pharmacol, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Pharmacol, Sch Med, Irvine, CA 92697 USA.	psc@uci.edu	Sassone-Corsi, Paolo/H-6182-2011; Astarita, Giuseppe/AAD-1239-2019; Astarita, Giuseppe/N-7346-2014	Nakahata, Yasukazu/0000-0003-3814-5822; Astarita, Giuseppe/0000-0001-6700-301X	Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad; postdoctoral fellowship from the American Heart Association, Western States Affiliate; Cancer Research Coordinating Committee of the University of California; NIH [R01-GM081634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081634] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); postdoctoral fellowship from the American Heart Association, Western States Affiliate(American Heart Association); Cancer Research Coordinating Committee of the University of California(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to D. Piomelli for insightful discussions and help. Thanks also to L. Guarente, K. Yamagata, and members of the Sassone-Corsi's laboratory for help, reagents, and support. Y.N. was supported by the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad. S.S. was supported by a postdoctoral fellowship from the American Heart Association, Western States Affiliate. Work supported by the Cancer Research Coordinating Committee of the University of California and NIH (R01-GM081634 [GenBank] -01).	Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; ECKELMAHAN K, NAT STRUCT IN PRESS; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hasmann M, 2003, CANCER RES, V63, P7436; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035	27	848	883	6	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					654	657		10.1126/science.1170803	http://dx.doi.org/10.1126/science.1170803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19286518	Green Accepted			2022-12-24	WOS:000265608800048
J	Harrison, SA; Tong, F				Harrison, Stephenie A.; Tong, Frank			Decoding reveals the contents of visual working memory in early visual areas	NATURE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; PERSISTENT ACTIVITY; NEURAL MECHANISMS; TEMPORAL CORTEX; MOTION TASK; CAPACITY; PERFORMANCE; CORRELATE; NEURONS	Visual working memory provides an essential link between perception and higher cognitive functions, allowing for the active maintenance of information about stimuli no longer in view(1,2). Research suggests that sustained activity in higher-order prefrontal, parietal, inferotemporal and lateral occipital areas supports visual maintenance(3-11), and may account for the limited capacity of working memory to hold up to 3-4 items(9-11). Because higher-order areas lack the visual selectivity of early sensory areas, it has remained unclear how observers can remember specific visual features, such as the precise orientation of a grating, with minimal decay in performance over delays of many seconds(12). One proposal is that sensory areas serve to maintain fine-tuned feature information(13), but early visual areas show little to no sustained activity over prolonged delays(14-16). Here we show that orientations held in working memory can be decoded from activity patterns in the human visual cortex, even when overall levels of activity are low. Using functional magnetic resonance imaging and pattern classification methods, we found that activity patterns in visual areas V1-V4 could predict which of two oriented gratings was held in memory with mean accuracy levels upwards of 80%, even in participants whose activity fell to baseline levels after a prolonged delay. These orientation-selective activity patterns were sustained throughout the delay period, evident in individual visual areas, and similar to the responses evoked by unattended, task-irrelevant gratings. Our results demonstrate that early visual areas can retain specific information about visual features held in working memory, over periods of many seconds when no physical stimulus is present.	[Tong, Frank] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; Vanderbilt Univ, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University	Tong, F (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	frank.tong@vanderbilt.edu			National Eye Institute; National Institutes of Health; Natural Sciences and Engineering Research Council of Canada; NATIONAL EYE INSTITUTE [R01EY017082] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Brady and B. Wolfe for technical support, and J. Gore and the Vanderbilt University Institute of Imaging Science for MRI support. This work was supported by a grant from the National Eye Institute, National Institutes of Health to F. T. and a postgraduate fellowship from the Natural Sciences and Engineering Research Council of Canada to S. A. H.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bisley JW, 2004, J NEUROPHYSIOL, V91, P286, DOI 10.1152/jn.00870.2003; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Geng JJ, 2009, J COGNITIVE NEUROSCI, V21, P230, DOI 10.1162/jocn.2008.21025; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Magnussen S, 1999, PSYCHOL RES-PSYCH FO, V62, P81, DOI 10.1007/s004260050043; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Offen S, 2009, VISION RES, V49, P1352, DOI 10.1016/j.visres.2007.12.022; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Roelfsema PR, 2005, TRENDS COGN SCI, V9, P226, DOI 10.1016/j.tics.2005.03.012; Sasaki Y, 2006, NEURON, V51, P661, DOI 10.1016/j.neuron.2006.07.021; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zaksas D, 2006, J NEUROSCI, V26, P11726, DOI 10.1523/JNEUROSCI.3420-06.2006	30	785	805	6	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					632	635		10.1038/nature07832	http://dx.doi.org/10.1038/nature07832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19225460	Green Accepted			2022-12-24	WOS:000264796200041
J	Brinster, S; Lamberet, G; Staels, B; Trieu-Cuot, P; Gruss, A; Poyart, C				Brinster, Sophie; Lamberet, Gilles; Staels, Bart; Trieu-Cuot, Patrick; Gruss, Alexandra; Poyart, Claire			Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens	NATURE			English	Article							GROUP-B STREPTOCOCCUS; BIOSYNTHESIS; VIRULENCE; BACTERIA; DISEASE; MUTANS; GROWTH; CONTRIBUTES; INHIBITOR; DISCOVERY	Antimicrobial drugs targeting the reportedly essential type II fatty acid synthesis (FASII) pathway(1-5) have been recently acclaimed for their efficacy against infections caused by multiresistant Gram-positive bacteria(6-8). Our findings show that the strategy for antibiotic development based on FASII pathway targets is fundamentally flawed by the fact that exogenous fatty acids fully bypass inhibition of this pathway in both in vitro and in vivo conditions. We demonstrate that major Gram-positive pathogens-such as streptococci, pneumococci, enterococci and staphylococci-overcome drug-induced FASII pathway inhibition when supplied with exogenous fatty acids, and human serum proves to be a highly effective source of fatty acids. For opportunist pathogen Streptococcus agalactiae, growth in serum leads to an overall decrease of FASII gene expression. No antibiotic inhibitor could have a stronger effect than the inactivation of the target gene, so we challenged the role of FASII using deletion mutants. Our results unequivocally show that the FASII target enzymes are dispensable in vivo during S. agalactiae infection. The results of this study largely compromise the use of FASII-based antimicrobials for treating sepsis caused by Gram-positive pathogens.	[Brinster, Sophie; Poyart, Claire] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Brinster, Sophie; Poyart, Claire] INSERM, U567, Paris, France; [Lamberet, Gilles; Gruss, Alexandra] INRA, Unite Bacteries Lact & Pathogenes Opportunistes, UR888, F-78350 Jouy En Josas, France; [Staels, Bart] Univ Lille 2, Inst Pasteur Lille, UMR545, Lille, France; [Trieu-Cuot, Patrick; Poyart, Claire] Inst Pasteur, CNRS, URA 2172, Unite Biol Bacteries Pathogenes Gram Posi, Paris, France; [Poyart, Claire] Hop Cochin, Ctr Natl Reference Streptocoques, AP HP, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Poyart, C (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	Alexandra.gruss@jouy.inra.fr; claire.poyart@cch.aphp.fr	Staels, Bart/N-9497-2016; POYART, Claire/P-4225-2017	Staels, Bart/0000-0002-3784-1503; POYART, Claire/0000-0003-2158-6293; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Gruss, Alexandra/0000-0001-7426-5229	French Agence Nationale de la Recherche; INSERM; INRA; Universite Paris Descartes; Institut Pasteur; ANR StrepRespire Project	French Agence Nationale de la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; Universite Paris Descartes; Institut Pasteur(European Commission); ANR StrepRespire Project(French National Research Agency (ANR))	We are grateful to I. Tardieux, P. Bouloc and L. Gutmann for critical reading and discussion of the manuscript, and P. Gaudu and Y. Yamamoto for discussion. We thank A. Bouaboud for technical assistance, and C. Fievet and N. Hennuye for mouse serum fatty acid analyses and advice. This work was supported by research funding from the French Agence Nationale de la Recherche (ANR, StrepRespire Project), INSERM, INRA, Universite Paris Descartes, and the Institut Pasteur. S. B. was a recipient of a post-doctoral fellowship from the ANR StrepRespire Project.	Altabe S, 2007, J BACTERIOL, V189, P8139, DOI 10.1128/JB.01275-07; ALTENBERN RA, 1977, ANTIMICROB AGENTS CH, V11, P574, DOI 10.1128/AAC.11.3.574; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bhargava HN, 1996, AM J INFECT CONTROL, V24, P209, DOI 10.1016/S0196-6553(96)90017-6; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Fozo EM, 2007, INFECT IMMUN, V75, P1537, DOI 10.1128/IAI.01938-06; Fozo EM, 2004, J BACTERIOL, V186, P4152, DOI 10.1128/JB.186.13.4152-4158.2004; Gill CJ, 1998, ANTIMICROB AGENTS CH, V42, P1996, DOI 10.1128/AAC.42.8.1996; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Hamilton JA, 2002, PROSTAG LEUKOTR ESS, V67, P65, DOI 10.1054/plef.2002.0400; JOHNSSON T, 1995, APPL ENVIRON MICROB, V61, P4497, DOI 10.1128/AEM.61.12.4497-4499.1995; Kankaanpaa P, 2004, APPL ENVIRON MICROB, V70, P129, DOI 10.1128/AEM.70.1.129-136.2004; Lai CY, 2003, J BIOL CHEM, V278, P51494, DOI 10.1074/jbc.M308638200; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Marrakchi H, 2002, BIOCHEM SOC T, V30, P1050, DOI 10.1042/bst0301050; MOELLERI.RC, 1971, J CLIN INVEST, V50, P2580, DOI 10.1172/JCI106758; Nakamura T, 2003, BRIT J NUTR, V89, P267, DOI 10.1079/BJN2002747; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Scortti M, 2006, NAT MED, V12, P515, DOI 10.1038/nm1396; Staels B, 2008, NAT CLIN PRACT CARD, V5, P542, DOI 10.1038/ncpcardio1278; Tomita Y, 2008, J OLEO SCI, V57, P115, DOI 10.5650/jos.57.115; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang J, 2007, P NATL ACAD SCI USA, V104, P7612, DOI 10.1073/pnas.0700746104; Wright HT, 2007, CURR OPIN MICROBIOL, V10, P447, DOI 10.1016/j.mib.2007.07.001; Yamamoto Y, 2005, MOL MICROBIOL, V56, P525, DOI 10.1111/j.1365-2958.2005.04555.x; Yamamoto Y, 2006, MOL MICROBIOL, V62, P772, DOI 10.1111/j.1365-2958.2006.05406.x; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200	31	234	237	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					83	U5		10.1038/nature07772	http://dx.doi.org/10.1038/nature07772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262672				2022-12-24	WOS:000263836000037
J	Kuiken, TA; Li, GL; Lock, BA; Lipschutz, RD; Miller, LA; Stubblefield, KA; Englehart, KB				Kuiken, Todd A.; Li, Guanglin; Lock, Blair A.; Lipschutz, Robert D.; Miller, Laura A.; Stubblefield, Kathy A.; Englehart, Kevin B.			Targeted Muscle Reinnervation for Real-time Myoelectric Control of Multifunction Artificial Arms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURAL-MACHINE INTERFACE; PROSTHESIS CONTROL; AMPUTEES; NERVE; EMG; ELECTROMYOGRAM; STIMULATION; SCHEME	Context Improving the function of prosthetic arms remains a challenge, because access to the neural- control information for the arm is lost during amputation. A surgical technique called targeted muscle reinnervation ( TMR) transfers residual arm nerves to alternative-muscle sites. After reinnervation, these target muscles produce electromyogram( EMG) signals on the surface of the skin that can be measured and used to control prosthetic arms. Objective To assess the performance of patients with upper- limb amputation who had undergone TMR surgery, using a pattern- recognition algorithm to decode EMG signals and control prosthetic- arm motions. Design, Setting, and Participants Study conducted between January 2007 and January 2008 at the Rehabilitation Institute of Chicago among 5 patients with shoulder-disarticulation or transhumeral amputations who underwent TMR surgery between February 2002 and October 2006 and 5 control participants without amputation. Surface EMG signals were recorded from all participants and decoded using a pattern-recognition algorithm. The decoding program controlled the movement of a virtual prosthetic arm. All participants were instructed to perform various arm movements, and their abilities to control the virtual prosthetic arm were measured. In addition, TMR patients used the same control system to operate advanced arm prosthesis prototypes. Main Outcome Measure Performance metrics measured during virtual arm movements included motion selection time, motion completion time, and motion completion ("success") rate. Results The TMR patients were able to repeatedly perform 10 different elbow, wrist, and hand motions with the virtual prosthetic arm. For these patients, the mean motion selection and motion completion times for elbow and wrist movements were 0.22 seconds ( SD, 0.06) and 1.29 seconds ( SD, 0.15), respectively. These times were 0.06 seconds and 0.21 seconds longer than the mean times for control participants. For TMR patients, the mean motion selection and motion completion times for hand-grasp patterns were 0.38 seconds ( SD, 0.12) and 1.54 seconds ( SD, 0.27), respectively. These patients successfully completed a mean of 96.3% ( SD, 3.8) of elbow and wrist movements and 86.9% ( SD, 13.9) of hand movements within 5 seconds, compared with 100% ( SD, 0) and 96.7% ( SD, 4.7) completed by controls. Three of the patients were able to demonstrate the use of this control system in advanced prostheses, including motorized shoulders, elbows, wrists, and hands. Conclusion These results suggest that reinnervated muscles can produce sufficient EMG information for real- time control of advanced artificial arms.	[Kuiken, Todd A.; Li, Guanglin; Lock, Blair A.; Lipschutz, Robert D.; Miller, Laura A.; Stubblefield, Kathy A.] Rehabil Inst Chicago, Neural Engn Ctr Artificial Limbs, Chicago, IL 60611 USA; [Kuiken, Todd A.; Li, Guanglin; Miller, Laura A.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Kuiken, Todd A.] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA; [Englehart, Kevin B.] Univ New Brunswick, Inst Biomed Engn, Fredericton, NB, Canada	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; University of New Brunswick	Kuiken, TA (corresponding author), Rehabil Inst Chicago, Neural Engn Ctr Artificial Limbs, 345 E Super St,Room 1309, Chicago, IL 60611 USA.	tkuiken@northwestern.edu	Miller, Laura A/E-1110-2011	Miller, Laura A/0000-0002-7271-6214; Li, Guanglin/0000-0001-9016-2617; Englehart, Kevin/0000-0003-4525-1121	Defense Advanced Research Projects Agency; Army Research Office; DEKA Integrated Solution Corp Prime [W911NF-06-C-001]; National Institute of Child Health and Human Development [R01 HD-043137, JHU-APL-DARPA 908090, N66001-06-C8006R01 HD0-044798]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043137, R01HD044798] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office; DEKA Integrated Solution Corp Prime; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Defense Advanced Research Projects Agency, Army Research Office, DEKA Integrated Solution Corp Prime contract W911NF-06-C-001, the National Institute of Child Health and Human Development grant R01 HD-043137, JHU-APL-DARPA contract 908090 under Prime Contract N66001-06-C8006R01 HD0-044798, and National Institute of Child Health and Human Development grant R01 HD-043137.	Ajiboye AB, 2005, IEEE T NEUR SYS REH, V13, P280, DOI 10.1109/TNSRE.2005.847357; Branner A, 2004, IEEE T BIO-MED ENG, V51, P146, DOI 10.1109/TBME.2003.820321; Duda R.O., 2000, PATTERN CLASSIFICATI; EDELL DJ, 1986, IEEE T BIO-MED ENG, V33, P203, DOI 10.1109/TBME.1986.325892; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Englehart K., 2003, TECHNOL DISAB, V15, P95; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; FARREL TR, 2007, THESIS NW U EVANSTON; HEFFTNER G, 1988, IEEE T BIO-MED ENG, V35, P230, DOI 10.1109/10.1370; Hijjawi JB, 2006, PLAST RECONSTR SURG, V118, P1573, DOI 10.1097/01.prs.0000242487.62487.fb; Huang H, 2008, IEEE T NEUR SYS REH, V16, P37, DOI 10.1109/TNSRE.2007.910282; Huang YH, 2005, IEEE T BIO-MED ENG, V52, P1801, DOI 10.1109/TBME.2005.856295; HUDGINS B, 1993, IEEE T BIO-MED ENG, V40, P82, DOI 10.1109/10.204774; Kuiken TA, 2004, PROSTHET ORTHOT INT, V28, P245; Kuiken TA., 2003, TECHNOL DISABIL, V15, P105, DOI [10.3233/TAD-2003-15206, DOI 10.3233/TAD-2003-15206]; Kuiken Todd, 2006, Phys Med Rehabil Clin N Am, V17, P1, DOI 10.1016/j.pmr.2005.10.001; Kuiken TA, 2007, P NATL ACAD SCI USA, V104, P20061, DOI 10.1073/pnas.0706525104; Kuiken TA, 2007, LANCET, V369, P371, DOI 10.1016/S0140-6736(07)60193-7; LOCK BA, 2005, MYOEL CONTR S AUG 15; O'Shaughnessy KD, 2008, J BONE JOINT SURG AM, V90A, P393, DOI 10.2106/JBJS.G.00268; PARKER PA, 1986, CRIT REV BIOMED ENG, V13, P283; Sears H., 1992, ATLAS LIMB PROSTHETI; Strange K D, 1999, IEEE Trans Rehabil Eng, V7, P289, DOI 10.1109/86.788466; WEIR RF, 2003, P 25 SILV ANN INT C; Zhou P, 2007, J NEUROPHYSIOL, V98, P2974, DOI 10.1152/jn.00178.2007	25	650	691	8	163	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					619	628		10.1001/jama.2009.116	http://dx.doi.org/10.1001/jama.2009.116			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405MN	19211469	Bronze, Green Accepted			2022-12-24	WOS:000263229000026
J	Bikard, D; Patel, D; Le Mette, C; Giorgi, V; Camilleri, C; Bennett, MJ; Loudet, O				Bikard, David; Patel, Dhaval; Le Mette, Claire; Giorgi, Veronica; Camilleri, Christine; Bennett, Malcolm J.; Loudet, Olivier			Divergent Evolution of Duplicate Genes Leads to Genetic Incompatibilities Within A-thaliana	SCIENCE			English	Article							INBRED LINE POPULATIONS; ARABIDOPSIS-THALIANA; SPECIATION; DROSOPHILA; CONSEQUENCES; LOCI; REVEALS; MODEL	Genetic incompatibilities resulting from interactions between two loci represent a potential source of postzygotic barriers and may be an important factor in evolution when they impair the outcome of interspecific crosses. We show that, in crosses between strains of the plant Arabidopsis thaliana, loci interact epistatically, controlling a recessive embryo lethality. This interaction is explained by divergent evolution occurring among paralogs of an essential duplicate gene, for which the functional copy is not located at the same locus in different accessions. These paralogs demonstrate genetic heterogeneity in their respective evolutionary trajectories, which results in widespread incompatibility among strains. Our data suggest that these passive mechanisms, gene duplication and extinction, could represent an important source of genetic incompatibilities across all taxa.	[Bikard, David; Le Mette, Claire; Giorgi, Veronica; Camilleri, Christine; Loudet, Olivier] INRA, SGAP UR254, F-78026 Versailles, France; [Patel, Dhaval; Bennett, Malcolm J.] Univ Nottingham, Sch Biosci, Ctr Plant Integrat Biol, Div Plant Sci, Loughborough LE12 5RD, Leics, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Nottingham	Loudet, O (corresponding author), INRA, SGAP UR254, F-78026 Versailles, France.	loudet@versailles.inra.fr	Bikard, David/AAZ-3752-2021; Bennett, Malcolm/G-4004-2010; Loudet, Olivier/CAF-7559-2022; Patel, Dhaval/D-2745-2013; Bikard, David/L-2971-2015; Loudet, Olivier/K-8266-2012; Giorgi, Veronica/GQA-4191-2022	Bikard, David/0000-0002-5729-1211; Bennett, Malcolm/0000-0003-0475-390X; Bikard, David/0000-0002-5729-1211; Loudet, Olivier/0000-0003-3717-0137; Giorgi, Veronica/0000-0002-8917-3949	INRA-Departement de Genetique et d'Amelioration des Plantes Innovative Project; University of Nottingham; Biotechnology and Biological Sciences Research Council/Engineering; Physical Sciences Research Council Centres for Integrative Systems Biology	INRA-Departement de Genetique et d'Amelioration des Plantes Innovative Project; University of Nottingham; Biotechnology and Biological Sciences Research Council/Engineering(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Physical Sciences Research Council Centres for Integrative Systems Biology	We thank K. Bomblies and D. Weigel for providing F2 seeds for specific test crosses (Bay-0 x Cvi and Tsu-0 x Cvi), X. Mo for hpa1 seeds, and R. Mercier and F. Roux for discussion and critical reading of the manuscript. Funded partly by an INRA-Departement de Genetique et d'Amelioration des Plantes Innovative Project grant to C.C. and O.L. Funding by the University of Nottingham to D.P. and the Biotechnology and Biological Sciences Research Council/Engineering and Physical Sciences Research Council Centres for Integrative Systems Biology program to M.J.B. Sequences have been deposited in GenBank under accessions FJ436446 and FJ436447.	Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2007, CURR OPIN GENET DEV, V17, P500, DOI 10.1016/j.gde.2007.09.006; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Coyne JA, 2004, SPECIATION, V37; Dobzhansky T., 1937; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Kopp A, 2005, GENETICA, V125, P55, DOI 10.1007/s10709-005-4787-8; Loudet O, 2005, THEOR APPL GENET, V110, P742, DOI 10.1007/s00122-004-1900-9; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, AM NAT, V156, P590, DOI 10.1086/316992; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mallet J, 2006, TRENDS ECOL EVOL, V21, P386, DOI 10.1016/j.tree.2006.05.004; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Mo XR, 2006, PLANT PHYSIOL, V141, P1425, DOI 10.1104/pp.106.084178; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Muralla R, 2007, PLANT PHYSIOL, V144, P890, DOI 10.1104/pp.107.096511; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Orr HA, 2007, J HERED, V98, P103, DOI 10.1093/jhered/esl060; Orr HA, 2004, CURR OPIN GENET DEV, V14, P675, DOI 10.1016/j.gde.2004.08.009; Orr HA, 2001, EVOLUTION, V55, P1085; Ostrowski MF, 2006, MOL ECOL, V15, P1507, DOI 10.1111/j.1365-294X.2006.02865.x; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Staal J, 2006, PLANT J, V46, P218, DOI 10.1111/j.1365-313X.2006.02688.x; Torjek O, 2006, THEOR APPL GENET, V113, P1551, DOI 10.1007/s00122-006-0402-3; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; WERTH CR, 1991, AM NAT, V137, P515, DOI 10.1086/285180	33	198	201	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					623	626		10.1126/science.1165917	http://dx.doi.org/10.1126/science.1165917			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179528				2022-12-24	WOS:000262862800040
J	Kaji, K; Norrby, K; Paca, A; Mileikovsky, M; Mohseni, P; Woltjen, K				Kaji, Keisuke; Norrby, Katherine; Paca, Agnieszka; Mileikovsky, Maria; Mohseni, Paria; Woltjen, Knut			Virus-free induction of pluripotency and subsequent excision of reprogramming factors	NATURE			English	Article							EMBRYONIC STEM-CELLS; HUMAN SOMATIC-CELLS; C-MYC; MOUSE; GENERATION; FIBROBLASTS; EXPRESSION; DIFFERENTIATION; BLOCKS	Reprogramming of somatic cells to pluripotency, thereby creating induced pluripotent stem (iPS) cells, promises to transform regenerative medicine. Most instances of direct reprogramming have been achieved by forced expression of defined factors using multiple viral vectors(1-7). However, such iPS cells contain a large number of viral vector integrations(1,8), any one of which could cause unpredictable genetic dysfunction. Whereas c-Myc is dispensable for reprogramming(9,10), complete elimination of the other exogenous factors is also desired because ectopic expression of either Oct4 (also known as Pou5f1) or Klf4 can induce dysplasia(11,12). Two transient transfection-reprogramming methods have been published to address this issue(13,14). However, the efficiency of both approaches is extremely low, and neither has been applied successfully to human cells so far. Here we show that non-viral transfection of a single multiprotein expression vector, which comprises the coding sequences of c-Myc, Klf4, Oct4 and Sox2 linked with 2A peptides, can reprogram both mouse and human fibroblasts. Moreover, the transgene can be removed once reprogramming has been achieved. iPS cells produced with this nonviral vector show robust expression of pluripotency markers, indicating a reprogrammed state confirmed functionally by in vitro differentiation assays and formation of adult chimaeric mice. When the single-vector reprogramming system was combined with a piggyBac transposon(15,16), we succeeded in establishing reprogrammed human cell lines from embryonic fibroblasts with robust expression of pluripotency markers. This system minimizes genome modification in iPS cells and enables complete elimination of exogenous reprogramming factors, efficiently providing iPS cells that are applicable to regenerative medicine, drug screening and the establishment of disease models.	[Kaji, Keisuke; Norrby, Katherine; Paca, Agnieszka] Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh EH9 3JQ, Midlothian, Scotland; [Mileikovsky, Maria; Mohseni, Paria; Woltjen, Knut] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Mohseni, Paria] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Edinburgh; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Kaji, K (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh EH9 3JQ, Midlothian, Scotland.	keisuke.kaji@ed.ac.uk	Wilson, Matthew H/K-3193-2013	Woltjen, Knut/0000-0003-2293-1183; Kaji, Keisuke/0000-0001-5946-8415	MRC; BBSRC; Canadian Stem Cell Network; Juvenile Diabetes Research Foundation; Medical Research Council [G0700672, G0700711B] Funding Source: researchfish; MRC [G0700672] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Stem Cell Network; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Tsakiridis for advice on using the 2A peptide sequence and A. Nagy for providing data from his laboratory on generating human reprogrammed cell lines by combining the PB transposon system and the 2A-sequence-joined reprogramming factors (or MKOS single vector reprogramming system) as well as for his comments on the manuscript. We also thank I. Chambers for providing TNG MEFs and for discussion and comments on the manuscript, V. Wilson for advice on teratoma analysis, T. Kunath, S. Lowell, C. Blackburn and K. Vintersten for discussions and comments on the manuscript, and B. Hendrich for permission to start preliminary experiments of this work in his laboratory. We also thank J. Ure, L. Robertson, R. McLay and R. Wilkie for technical assistance, and Biomed unit staff for mouse husbandry. K. K. is the recipient of MRC career development fellowship in stem cell research. A. P. is the recipient of a BBSRC CASE PhD studentship. M. M., P. M. and K. W. were supported by grants from the Canadian Stem Cell Network and Juvenile Diabetes Research Foundation.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Brueckner B, 2007, CANCER J, V13, P17, DOI 10.1097/PPO.0b013e31803c7245; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; SOMMER CA, 2008, STEM CELLS, DOI DOI 10.1634/STEMCELLS.2008; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	919	1102	3	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					771	U112		10.1038/nature07864	http://dx.doi.org/10.1038/nature07864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19252477	Green Accepted			2022-12-24	WOS:000265193600043
J	Hearn, EM; Patel, DR; Lepore, BW; Indic, M; van den Berg, B				Hearn, Elizabeth M.; Patel, Dimki R.; Lepore, Bryan W.; Indic, Mridhu; van den Berg, Bert			Transmembrane passage of hydrophobic compounds through a protein channel wall	NATURE			English	Article							FATTY-ACID TRANSPORT; ESCHERICHIA-COLI; MULTIDRUG TRANSPORTER; MEMBRANE-PROTEIN; P-GLYCOPROTEIN; CYTOPLASMIC LEAFLET; LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; FADL GENE	Membrane proteins that transport hydrophobic compounds have important roles in multi-drug resistance(1-3) and can cause a number of diseases(4,5), underscoring the importance of protein-mediated transport of hydrophobic compounds. Hydrophobic compounds readily partition into regular membrane lipid bilayers(6), and their transport through an aqueous protein channel is energetically unfavourable(3). Alternative transport models involving acquisition from the lipid bilayer by lateral diffusion have been proposed for hydrophobic substrates(3,4,7-12). So far, all transport proteins for which a lateral diffusion mechanism has been proposed function as efflux pumps. Here we present the first example of a lateral diffusion mechanism for the uptake of hydrophobic substrates by the Escherichia coli outer membrane long-chain fatty acid transporter FadL. A FadL mutant in which a lateral opening in the barrel wall is constricted, but which is otherwise structurally identical to wild-type FadL, does not transport substrates. A crystal structure of FadL from Pseudomonas aeruginosa shows that the opening in the wall of the beta-barrel is conserved and delineates a long, hydrophobic tunnel that could mediate substrate passage from the extracellular environment, through the polar lipopolysaccharide layer and, by means of the lateral opening in the barrel wall, into the lipid bilayer from where the substrate can diffuse into the periplasm. Because FadL homologues are found in pathogenic and biodegrading bacteria, our results have implications for combating bacterial infections and bioremediating xenobiotics in the environment.	[Hearn, Elizabeth M.; Patel, Dimki R.; Lepore, Bryan W.; Indic, Mridhu; van den Berg, Bert] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	van den Berg, B (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	bert.vandenberg@umassmed.edu		van den Berg, Bert/0000-0003-1966-8804	National Insitutes of Health; NIH [1R01GM074824]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074824, F32GM079820] Funding Source: NIH RePORTER	National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel of the National Synchrotron Light Source (NSLS) beamlines X6A and X29 for beam time and beamline support. We are grateful to P. Black and C. Petteys for the strain D10 and for their technical advice on the fatty acid transport assays. This work was supported by a training grant from the National Insitutes of Health (to E. M. H.) and by a NIH research grant (1R01GM074824 to B. v. d. B.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLACK PN, 1987, J BIOL CHEM, V262, P1412; BLACK PN, 1990, BIOCHIM BIOPHYS ACTA, V1046, P97, DOI 10.1016/0005-2760(90)90099-J; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DiRusso CC, 2004, J BIOL CHEM, V279, P49563, DOI 10.1074/jbc.R400026200; Eastcott L., 1988, OIL CHEM POLLUT, V4, P191, DOI DOI 10.1016/S0269-8579(88)80020-0; EATON RW, 1994, J BACTERIOL, V176, P7757, DOI 10.1128/JB.176.24.7757-7762.1994; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GINSBURGH CL, 1984, J BIOL CHEM, V259, P8437; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hearn EM, 2008, P NATL ACAD SCI USA, V105, P8601, DOI 10.1073/pnas.0801264105; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Kahng HY, 2000, J BACTERIOL, V182, P1232, DOI 10.1128/JB.182.5.1232-1242.2000; KUMAR GB, 1991, J BIOL CHEM, V266, P1348; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NUNN WD, 1978, P NATL ACAD SCI USA, V75, P3377, DOI 10.1073/pnas.75.7.3377; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Shapiro AB, 1998, EUR J BIOCHEM, V254, P181, DOI 10.1046/j.1432-1327.1998.2540181.x; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Sun PD, 2002, ACTA CRYSTALLOGR D, V58, P1092, DOI 10.1107/S0907444902006510; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; van Veen HW, 1999, BBA-BIOMEMBRANES, V1461, P201, DOI 10.1016/S0005-2736(99)00172-8; VANBEILEN JB, 1992, MOL MICROBIOL, V6, P3121; VORUM H, 1992, BIOCHIM BIOPHYS ACTA, V1126, P135, DOI 10.1016/0005-2760(92)90283-2; WANG Y, 1995, MOL GEN GENET, V246, P570, DOI 10.1007/BF00298963; Ye JQ, 2004, EMBO J, V23, P3187, DOI 10.1038/sj.emboj.7600330	41	106	114	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					367	U134		10.1038/nature07678	http://dx.doi.org/10.1038/nature07678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19182779	Green Accepted			2022-12-24	WOS:000264285600047
J	Ju, SY; Kopcha, WP; Papadimitrakopoulos, F				Ju, Sang-Yong; Kopcha, William P.; Papadimitrakopoulos, Fotios			Brightly Fluorescent Single-Walled Carbon Nanotubes via an Oxygen-Excluding Surfactant Organization	SCIENCE			English	Article							OPTICAL SENSORS; SPECTROSCOPY; SUSPENSIONS; DISPERSION; EXCITONS; SPECTRA	Attaining high photoluminescence quantum yields for single-walled carbon nanotubes (SWNTs) in order to broaden their optoelectronics and sensing applications has been a challenging task. Among various nonradiative pathways, sidewall chemisorption of oxygen provides a known defect for exciton quenching through nanotube hole doping. We found that an aliphatic ( dodecyl) analog of flavin mononucleotide, FC12, leads to high dispersion of SWNTs, which tend to aggregate into bundles. Unlike other surfactants, the surface organization of FC12 is sufficiently tight to exclude oxygen from the SWNT surface, which led to quantum yields as high as 20%. Toluene-dispersed, FC12-wrapped nanotubes exhibited an absorption spectrum with ultrasharp peaks (widths of 12 to 25 milli-electron volts) devoid of the characteristic background absorption of most nanotube dispersions.	[Ju, Sang-Yong; Papadimitrakopoulos, Fotios] Univ Connecticut, Polymer Program, Nanomat Optoelect Lab, Storrs, CT 06269 USA; [Kopcha, William P.; Papadimitrakopoulos, Fotios] Univ Connecticut, Inst Mat Sci, Dept Chem, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Papadimitrakopoulos, F (corresponding author), Univ Connecticut, Polymer Program, Nanomat Optoelect Lab, Storrs, CT 06269 USA.	papadim@mail.ims.uconn.edu	Ju, Sang-Yong/GQG-8696-2022; Ju, Sang-Yong/A-5257-2009	Ju, Sang-Yong/0000-0002-6939-5296; Kopcha, William/0000-0001-8811-1669	Air Force Office of Scientific Research [FA9550-06-1-0030]; NSF [NIRT DMI-0422724, CBET-0828771/0828824]; NIH [ES013557]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013557] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Vaddiraju, J. Doll, D. Abanulo, A. Nish, and R. J. Nicholas for useful discussions. Supported mainly by Air Force Office of Scientific Research grant FA9550-06-1-0030, and in part by NSF grants NIRT DMI-0422724 and CBET-0828771/0828824 and NIH grant ES013557.	Bachilo SM, 2003, J AM CHEM SOC, V125, P11186, DOI 10.1021/ja036622c; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Badaire S, 2004, LANGMUIR, V20, P10367, DOI 10.1021/la049096r; Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; Crochet J, 2007, J AM CHEM SOC, V129, P8058, DOI 10.1021/ja071553d; Dukovic G, 2004, J AM CHEM SOC, V126, P15269, DOI 10.1021/ja046526r; Fantini C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.147406; Hagen A, 2003, NANO LETT, V3, P383, DOI 10.1021/nl020237o; Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477; Ju SY, 2008, NAT NANOTECHNOL, V3, P356, DOI 10.1038/nnano.2008.148; Kiowski O, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.075421; Krevelen D.W.V., 1990, PROPERTIES POLYM; Lin CS, 2007, J PHYS CHEM C, V111, P4069, DOI 10.1021/jp068846y; Luo ZT, 2006, J AM CHEM SOC, V128, P15511, DOI 10.1021/ja0657096; Miyamoto Y, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.121413; Nish A, 2007, NAT NANOTECHNOL, V2, P640, DOI 10.1038/nnano.2007.290; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Oyama Y, 2006, CARBON, V44, P873, DOI 10.1016/j.carbon.2005.10.024; Perebeinos V, 2005, NANO LETT, V5, P2495, DOI 10.1021/nl051828s; Reich S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.077402; Strano MS, 2003, J PHYS CHEM B, V107, P6979, DOI 10.1021/jp027664a; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Tan PH, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.137402; Tan YQ, 2005, J PHYS CHEM B, V109, P14454, DOI 10.1021/jp052217r; Tsyboulski DA, 2007, NANO LETT, V7, P3080, DOI 10.1021/nl071561s; Wang B, 2007, J AM CHEM SOC, V129, P9014, DOI 10.1021/ja070808k; Wang F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.241403; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Zheng M, 2007, J AM CHEM SOC, V129, P6084, DOI 10.1021/ja071577k	30	192	192	1	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1319	1323		10.1126/science.1166265	http://dx.doi.org/10.1126/science.1166265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265015				2022-12-24	WOS:000263876700035
J	van der Flier, LG; van Gijn, ME; Hatzis, P; Kujala, P; Haegebarth, A; Stange, DE; Begthel, H; van den Born, M; Guryev, V; Oving, I; van Es, JH; Barker, N; Peters, PJ; van de Wetering, M; Clevers, H				van der Flier, Laurens G.; van Gijn, Marielle E.; Hatzis, Pantelis; Kujala, Pekka; Haegebarth, Andrea; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Guryev, Victor; Oving, Irma; van Es, Johan H.; Barker, Nick; Peters, Peter J.; van de Wetering, Marc; Clevers, Hans			Transcription Factor Achaete Scute-Like 2 Controls Intestinal Stem Cell Fate	CELL			English	Article							PERIPHERAL NERVOUS-SYSTEM; COLORECTAL-CANCER CELLS; MOUSE SMALL INTESTINE; GENE-EXPRESSION; BETA-CATENIN; PANETH CELLS; ADULT-MOUSE; IN-VIVO; DIFFERENTIATION; EPITHELIUM	The small intestinal epithelium is the most rapidly self-renewing tissue of mammals. Proliferative cells are confined to crypts, while differentiated cell types predominantly occupy the villi. We recently demonstrated the existence of a long-lived pool of cycling stem cells defined by Lgr5 expression and intermingled with post-mitotic Paneth cells at crypt bottoms. We have now determined a gene signature for these Lgr5 stem cells. One of the genes within this stem cell signature is the Wnt target Achaete scute-like 2 (Ascl2). Transgenic expression of the Ascl2 transcription factor throughout the intestinal epithelium induces crypt hyperplasia and ectopic crypts on villi. Induced deletion of the Ascl2 gene in adult small intestine leads to disappearance of the Lgr5 stem cells within days. The combined results from these gain- and loss-of-function experiments imply that Ascl2 controls intestinal stem cell fate.	[van der Flier, Laurens G.; van Gijn, Marielle E.; Hatzis, Pantelis; Haegebarth, Andrea; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Guryev, Victor; Oving, Irma; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; Clevers, Hans] Hubert Inst KNAW, NL-3584 CT Utrecht, Netherlands; [van der Flier, Laurens G.; van Gijn, Marielle E.; Hatzis, Pantelis; Haegebarth, Andrea; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Guryev, Victor; Oving, Irma; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Kujala, Pekka; Peters, Peter J.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute	Clevers, H (corresponding author), Hubert Inst KNAW, Uppsalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl	van+Es, Johan/ABD-5411-2021; Barker, Nick/AAE-9833-2021; Stange, Daniel E/O-1837-2015; Barker, Nick/AAS-2774-2020; Barker, Nick/A-5535-2011	Barker, Nick/0000-0003-3566-4475; Stange, Daniel E/0000-0003-4246-2230; Oving, Irma/0000-0002-6149-2171; Guryev, Victor/0000-0002-5810-6022				Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x; CAIRNIE AB, 1975, CELL TISSUE KINET, V8, P189, DOI 10.1111/j.1365-2184.1975.tb01219.x; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; SIMPSON P, 1990, DEVELOPMENT, V109, P509; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6	49	506	518	2	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 6	2009	136	5					903	912		10.1016/j.cell.2009.01.031	http://dx.doi.org/10.1016/j.cell.2009.01.031			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269367	Bronze			2022-12-24	WOS:000263930900013
J	Budd, GE; Telford, MJ				Budd, Graham E.; Telford, Maximilian J.			The origin and evolution of arthropods	NATURE			English	Review							AMINO-ACID REPLACEMENTS; GENOME-WIDE ANALYSIS; BURGESS SHALE; PHYLOGENETIC ANALYSIS; HEAD SEGMENTATION; FOSSIL RECORD; ECDYSOZOA; CRUSTACEAN; SUPPORT; COELOMATA	The past two decades have witnessed profound changes in our understanding of the evolution of arthropods. Many of these insights derive from the adoption of molecular methods by systematists and developmental biologists, prompting a radical reordering of the relationships among extant arthropod classes and their closest non- arthropod relatives, and shedding light on the developmental basis for the origins of key characteristics. A complementary source of data is the discovery of fossils from several spectacular Cambrian faunas. These fossils form well- characterized groupings, making the broad pattern of Cambrian arthropod systematics increasingly consensual.	[Budd, Graham E.] Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden; [Telford, Maximilian J.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	Uppsala University; University of London; University College London	Budd, GE (corresponding author), Uppsala Univ, Dept Earth Sci, Villavagen 16, SE-75236 Uppsala, Sweden.	graham.budd@pal.uu.se; m.telford@ucl.ac.uk	Telford, Maximilian J/B-7178-2008	Telford, Maximilian J/0000-0002-3749-5620; Budd, Graham/0000-0001-9007-4369	Marie Curie Research Training Network ZOONET [MRTN-CT-2004-005624]	Marie Curie Research Training Network ZOONET(European Commission)	We thank A. Daley for assistance with photography and R. Copley for critically reading an earlier draft. Our research is supported by the Marie Curie Research Training Network ZOONET (grant number MRTN-CT-2004-005624).	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; BALLARD JWO, 1992, SCIENCE, V258, P1345, DOI 10.1126/science.1455227; BERGSTROM J, 1986, LETHAIA, V19, P241, DOI 10.1111/j.1502-3931.1986.tb00738.x; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Bourlat SJ, 2008, MOL PHYLOGENET EVOL, V49, P23, DOI 10.1016/j.ympev.2008.07.008; Bowler PJ., 1996, LIFES SPLENDID DRAMA; Boxshall GA, 2007, ZOOTAXA, P313, DOI 10.11646/zootaxa.1668.1.16; Briggs DEG, 1999, PALAEONTOLOGY, V42, P953, DOI 10.1111/1475-4983.00104; BUDD G, 1993, NATURE, V364, P709, DOI 10.1038/364709a0; Budd GE, 1998, LETHAIA, V31, P197, DOI 10.1111/j.1502-3931.1998.tb00508.x; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2003, INTEGR COMP BIOL, V43, P157, DOI 10.1093/icb/43.1.157; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Budd GE, 1996, LETHAIA, V29, P1, DOI 10.1111/j.1502-3931.1996.tb01831.x; Budd GE, 2008, PALAEONTOLOGY, V51, P561, DOI 10.1111/j.1475-4983.2008.00752.x; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; CHEN JY, 1995, SCIENCE, V268, P1339, DOI 10.1126/science.268.5215.1339; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; Copley RR, 2004, EVOL DEV, V6, P164, DOI 10.1111/j.1525-142X.2004.04021.x; Cotton TJ, 2004, T ROY SOC EDIN-EARTH, V94, P169, DOI 10.1017/S0263593300000596; Damen WGM, 2002, CURR BIOL, V12, P1711, DOI 10.1016/S0960-9822(02)01126-0; Darwin C., 1859, ORIGIN SPECIES MEANS; DUNLOP JA, 2005, ACTA ZOOL BULG S, V1, P9; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; DZIK J, 1989, LETHAIA, V22, P169, DOI 10.1111/j.1502-3931.1989.tb01679.x; Edgecombe GD, 2004, CONTRIB ZOOL, V73, P207, DOI 10.1163/18759866-07303002; EERNISSE DJ, 1992, SYST BIOL, V41, P305, DOI 10.1093/sysbio/41.3.305; Eriksson BJ, 2003, J MORPHOL, V255, P1, DOI 10.1002/jmor.10034; Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X; Fanenbruck M, 2005, ARTHROPOD STRUCT DEV, V34, P343, DOI 10.1016/j.asd.2005.01.007; Fayers SR, 2005, PALAEONTOLOGY, V48, P1117, DOI 10.1111/j.1475-4983.2005.00501.x; Fortey RA, 1996, BIOL J LINN SOC, V57, P13, DOI 10.1006/bijl.1995.0002; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; GEHLING JG, 1991, MEMOIRS GEOLOGICAL S, V20, P181; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Harzsch S, 2006, ARTHROPOD STRUCT DEV, V35, P319, DOI 10.1016/j.asd.2006.08.009; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; HOU XG, 1997, FOSSILS STRATA, V45; Irimia M, 2007, MOL BIOL EVOL, V24, P1604, DOI 10.1093/molbev/msm105; Ivantsov A.Y., 2001, PALEONTOL J+, V35, P335; Jensen S, 2003, INTEGR COMP BIOL, V43, P219, DOI 10.1093/icb/43.1.219; Liu JN, 2007, ACTA ZOOL-STOCKHOLM, V88, P279, DOI 10.1111/j.1463-6395.2007.00281.x; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Manton, 1977, ARTHROPODA HABITS FU; MORRIS SC, 1987, NATURE, V326, P181, DOI 10.1038/326181a0; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; Philip GK, 2005, MOL BIOL EVOL, V22, P1175, DOI 10.1093/molbev/msi102; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; Pisani D, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-1; Richter S, 2002, ORG DIVERS EVOL, V2, P217, DOI 10.1078/1439-6092-00048; Rogozin IB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-7; Rogozin IB, 2007, MOL BIOL EVOL, V24, P2594, DOI 10.1093/molbev/msm218; Rogozin IB, 2007, MOL BIOL EVOL, V24, P1080, DOI 10.1093/molbev/msm029; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; SANDERS HL, 1957, SYST ZOOL, V6, P112, DOI 10.2307/2411750; Schmidt-Rhaesa A, 1998, J MORPHOL, V238, P263, DOI 10.1002/(SICI)1097-4687(199812)238:3<263::AID-JMOR1>3.0.CO;2-L; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Siveter DJ, 2007, P ROY SOC B-BIOL SCI, V274, P2099, DOI 10.1098/rspb.2007.0429; Siveter DJ, 2001, SCIENCE, V293, P479, DOI 10.1126/science.1061697; StOrmer L., 1944, SKR NORSKE VIDENS MN, V5, P1; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; TELFORD MJ, 1995, NATURE, V376, P123, DOI 10.1038/376123a0; Thomas RH, 1999, ACTA ZOOL-STOCKHOLM, V80, P193, DOI 10.1046/j.1463-6395.1999.00016.x; Ungerer P, 2008, P ROY SOC B-BIOL SCI, V275, P369, DOI 10.1098/rspb.2007.1391; Wagele JW, 1999, J ZOOL SYST EVOL RES, V37, P211; Waggoner BM, 1996, SYST BIOL, V45, P190, DOI 10.2307/2413615; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Webster BL, 2006, EVOL DEV, V8, P502, DOI 10.1111/j.1525-142X.2006.00123.x; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Wilson HM, 2006, J PALEONTOL, V80, P638, DOI 10.1666/0022-3360(2006)80[638:JMFTLD]2.0.CO;2; Zhang XG, 2007, NATURE, V449, P595, DOI 10.1038/nature06138; Zheng J, 2007, MOL BIOL EVOL, V24, P2583, DOI 10.1093/molbev/msm207	77	134	142	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					812	817		10.1038/nature07890	http://dx.doi.org/10.1038/nature07890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212398				2022-12-24	WOS:000263266700030
J	Tang, SW; Presgraves, DC				Tang, Shanwu; Presgraves, Daven C.			Evolution of the Drosophila Nuclear Pore Complex Results in Multiple Hybrid Incompatibilities	SCIENCE			English	Article							ADAPTIVE PROTEIN EVOLUTION; DOSAGE COMPENSATION; POSITIVE SELECTION; INVIABILITY GENE; LETHAL COMPLEX; MELANOGASTER; HITCHHIKING; SPECIATION; STERILITY; PATTERNS	Speciation often involves the evolution of incompatible gene interactions that cause sterility or lethality in hybrids between populations. These so- called hybrid incompatibilities occur between two or more functionally divergent loci. We show that the nucleoporin 160kDa ( Nup160) gene of the fruitfly Drosophila simulans is incompatible with one or more factors on the D. melanogaster X chromosome, causing hybrid lethality. Nup160 encodes a nuclear pore complex protein and shows evidence of adaptive evolution. Furthermore, the protein encoded by Nup160 directly interacts with that of another hybrid lethality gene, Nup96, indicating that at least two lethal hybrid incompatibility genes have evolved as byproducts of divergent coevolution among interacting components of the Drosophila nuclear pore complex.	[Tang, Shanwu; Presgraves, Daven C.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Presgraves, Daven C.] Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA	University of Rochester; Harvard University	Tang, SW (corresponding author), Univ Rochester, Dept Biol, 601 Elmwood Ave, Rochester, NY 14627 USA.				NIH [R01GM079543]; University of Rochester; Radcliffe Institute for Advanced Study at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester; Radcliffe Institute for Advanced Study at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Drosophila Genome Resource Center for cloning vectors and the D. melanogaster Nup160 cDNA; the Bloomington Stock Center and the Exelixis Stock Collection at Harvard Medical School for fly stocks; and V. Cattani, P. Gerard, C. Meiklejohn, A. Orr, A. Sweigart, and two anonymous reviewers for comments. This work was supported by funds to D. C. P. from NIH grant R01GM079543, the University of Rochester, and the Radcliffe Institute for Advanced Study at Harvard University. Sequences have been deposited in GenBank under accession numbers FJ600378 to FJ600401.	Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Ashburner M., 2004, DROSOPHILA LAB HDB; Bachtrog D, 2008, GENETICS, V180, P1123, DOI 10.1534/genetics.107.084244; Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Barbash DA, 2007, GENETICS, V176, P543, DOI 10.1534/genetics.107.072827; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Chakraborty P, 2008, DEV CELL, V15, P657, DOI 10.1016/j.devcel.2008.08.020; Coyne J.A., 1989, P180; COYNE JA, 1989, EVOLUTION, V43, P362, DOI 10.1111/j.1558-5646.1989.tb04233.x; Coyne JA, 2004, SPECIATION, V37; Dobzhansky T., 1937; Fay JC, 2000, GENETICS, V155, P1405; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; KAPLAN NL, 1989, GENETICS, V123, P887; Levine MT, 2007, GENETICS, V177, P1959, DOI 10.1534/genetics.107.079459; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; ORR HA, 1995, GENETICS, V139, P1805; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Presgraves DC, 2007, BIOESSAYS, V29, P386, DOI 10.1002/bies.20555; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 2003, GENETICS, V163, P955; Rodriguez MA, 2007, P NATL ACAD SCI USA, V104, P15412, DOI 10.1073/pnas.0707445104; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; TAJIMA F, 1989, GENETICS, V123, P585; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; TURELLI M, 1995, GENETICS, V140, P389; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	36	115	120	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					779	782		10.1126/science.1169123	http://dx.doi.org/10.1126/science.1169123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197064	Green Accepted			2022-12-24	WOS:000263066800046
J	Maximov, A; Tang, J; Yang, XF; Pang, ZPP; Sudhof, TC				Maximov, Anton; Tang, Jiong; Yang, Xiaofei; Pang, Zhiping P.; Sudhof, Thomas C.			Complexin Controls the Force Transfer from SNARE Complexes to Membranes in Fusion	SCIENCE			English	Article							SYNAPTOTAGMIN-I FUNCTIONS; NEUROTRANSMITTER RELEASE; DISTINCT DOMAINS; EXOCYTOSIS; SENSOR	Trans- SNAP receptor ( SNARE, where SNAP is defined as soluble NSF attachment protein, and NSF is defined as N- ethylmaleimide- sensitive factor) complexes catalyze synaptic vesicle fusion and bind complexin, but the function of complexin binding to SNARE complexes remains unclear. Here we show that in neuronal synapses, complexin simultaneously suppressed spontaneous fusion and activated fast calcium ion- evoked fusion. The dual function of complexin required SNARE binding and also involved distinct amino- terminal sequences of complexin that localize to the point where trans- SNARE complexes insert into the fusing membranes, suggesting that complexin controls the force that trans- SNARE complexes apply onto the fusing membranes. Consistent with this hypothesis, a mutation in the membrane insertion sequence of the v- SNARE synaptobrevin/ vesicle- associated membrane protein ( VAMP) phenocopied the complexin loss- of- function state without impairing complexin binding to SNARE complexes. Thus, complexin probably activates and clamps the force transfer from assembled trans- SNARE complexes onto fusing membranes.	[Maximov, Anton; Tang, Jiong; Yang, Xiaofei; Pang, Zhiping P.; Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Yang, Xiaofei; Pang, Zhiping P.; Sudhof, Thomas C.] Stanford Univ, Dept Cellular & Mol Physiol, Palo Alto, CA 94304 USA; [Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Sudhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	tcs1@stanford.edu	Pang, Zhiping/AAF-5757-2020	Pang, Zhiping/0000-0002-6183-1233	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. Rizo and L. Chen for advice and critical comments. This study was supported by an investigatorship to T. C. S. from the Howard Hughes Medical Institute.	Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2008, J BIOL CHEM, V283, P21211, DOI 10.1074/jbc.M803478200; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Guan R, 2008, BIOCHEMISTRY-US, V47, P1474, DOI 10.1021/bi702345m; Hu KA, 2002, J BIOL CHEM, V277, P41652, DOI 10.1074/jbc.M205044200; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Verhage M, 2007, CURR OPIN CELL BIOL, V19, P402, DOI 10.1016/j.ceb.2007.05.002; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6	22	244	251	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					516	521		10.1126/science.1166505	http://dx.doi.org/10.1126/science.1166505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164751	Green Accepted			2022-12-24	WOS:000262587900046
J	Nejentsev, S; Walker, N; Riches, D; Egholm, M; Todd, JA				Nejentsev, Sergey; Walker, Neil; Riches, David; Egholm, Michael; Todd, John A.			Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; LYMPHOID TYROSINE PHOSPHATASE; COMMON DISEASES; SUSCEPTIBILITY; LOCUS; POLYMORPHISMS; RECOGNITION; CONTRIBUTE; MUTATION; VIRUSES	Genome-wide association studies (GWASs) are regularly used to map genomic regions contributing to common human diseases, but they often do not identify the precise causative genes and sequence variants. To identify causative type 1 diabetes (T1D) variants, we resequenced exons and splice sites of 10 candidate genes in pools of DNA from 480 patients and 480 controls and tested their disease association in over 30,000 participants. We discovered four rare variants that lowered T1D risk independently of each other (odds ratio = 0.51 to 0.74; P = 1.3 x 10(-3) to 2.1 x 10(-16)) in IFIH1 (interferon induced with helicase C domain 1), a gene located in a region previously associated with T1D by GWASs. These variants are predicted to alter the expression and structure of IFIH1 [MDA5 (melanoma differentiation-associated protein 5)], a cytoplasmic helicase that mediates induction of interferon response to viral RNA. This finding firmly establishes the role of IFIH1 in T1D and demonstrates that resequencing studies can pinpoint disease-causing genes in genomic regions initially identified by GWASs.	[Nejentsev, Sergey; Walker, Neil; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 0XY, England; [Nejentsev, Sergey] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Riches, David; Egholm, Michael] 454 Life Sci, Branford, CT 06405 USA	University of Cambridge; University of Cambridge	Nejentsev, S (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 0XY, England.	sn262@cam.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Walker, Neil/0000-0001-9796-7688	Diabetes Research and Wellness Foundation Non-Clinical Fellowship; Royal Society University Research Fellowship; Juvenile Diabetes Research Foundation; Wellcome Trust; National Institute for Health Research Biomedical Research Centre; Cambridge Institute for Medical Research [079895]; MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish	Diabetes Research and Wellness Foundation Non-Clinical Fellowship; Royal Society University Research Fellowship(Royal Society of London); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Institute for Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the patients, control participants, and family members for participating in the study. S.N. held the Diabetes Research and Wellness Foundation Non-Clinical Fellowship at the early stages of the project and now holds the Royal Society University Research Fellowship. The Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory is funded by the Juvenile Diabetes Research Foundation, the Wellcome Trust, and the National Institute for Health Research Biomedical Research Centre. The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (079895). Full acknowledgements are in the supporting online material. Previously unseen SNPs were submitted to dbSNP database (www.ncbi.nlm.nih.gov/SNP/); their submission numbers are in table S3.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068	25	710	728	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					387	389		10.1126/science.1167728	http://dx.doi.org/10.1126/science.1167728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19264985	Green Accepted			2022-12-24	WOS:000265221600042
J	Jones, S; Hruban, RH; Kamiyama, M; Borges, M; Zhang, XS; Parsons, DW; Lin, JCH; Palmisano, E; Brune, K; Jaffee, EM; Iacobuzio-Donahue, CA; Maitra, A; Parmigiani, G; Kern, SE; Velculescu, VE; Kinzler, KW; Vogelstein, B; Eshleman, JR; Goggins, M; Klein, AP				Jones, Sian; Hruban, Ralph H.; Kamiyama, Mihoko; Borges, Michael; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Palmisano, Emily; Brune, Kieran; Jaffee, Elizabeth M.; Iacobuzio-Donahue, Christine A.; Maitra, Anirban; Parmigiani, Giovanni; Kern, Scott E.; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert; Eshleman, James R.; Goggins, Michael; Klein, Alison P.			Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene	SCIENCE			English	Article							BREAST-CANCER; FUTURE		[Jones, Sian; Hruban, Ralph H.; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Palmisano, Emily; Brune, Kieran; Jaffee, Elizabeth M.; Iacobuzio-Donahue, Christine A.; Maitra, Anirban; Parmigiani, Giovanni; Kern, Scott E.; Vogelstein, Bert; Eshleman, James R.; Goggins, Michael; Klein, Alison P.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Jones, Sian; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert] Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Jones, Sian; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Hruban, Ralph H.; Kamiyama, Mihoko; Borges, Michael; Jaffee, Elizabeth M.; Iacobuzio-Donahue, Christine A.; Maitra, Anirban; Parmigiani, Giovanni; Kern, Scott E.; Eshleman, James R.; Goggins, Michael; Klein, Alison P.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA; [Goggins, Michael] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Med, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Eshleman, JR (corresponding author), Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA.	aklein1@jhmi.edu	Velculescu, Victor/ABF-4846-2020; Jones, Sian/A-5050-2012; Iacobuzio-Donahue, Christine/ABF-1295-2020	Velculescu, Victor/0000-0003-1195-438X; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Parsons, Donald/0000-0002-8775-3501; Jaffee, Elizabeth/0000-0003-3841-6549	Sol Goldman Pancreatic Cancer Research Center; Lustgarten Foundation for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; NIH [CA62924, CA123483, RO1CA97075]; Michael Rolfe Pancreatic Cancer Foundation; NATIONAL CANCER INSTITUTE [R37CA057345, P50CA062924, R01CA123483, R37CA043460, R01CA121113, R01CA097075] Funding Source: NIH RePORTER	Sol Goldman Pancreatic Cancer Research Center; Lustgarten Foundation for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Rolfe Pancreatic Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Sol Goldman Pancreatic Cancer Research Center; the Lustgarten Foundation for Pancreatic Cancer Research; the Virginia and D. K. Ludwig Fund for Cancer Research; NIH grants CA62924, CA123483, and RO1CA97075; and the Michael Rolfe Pancreatic Cancer Foundation.	Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; *LUSTG FDN PANCR C, CA62924 NIH LUSTG FD; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; McGuire AL, 2007, SCIENCE, V317, P1687, DOI 10.1126/science.1147475; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	9	560	579	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					217	217		10.1126/science.1171202	http://dx.doi.org/10.1126/science.1171202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19264984	Green Accepted			2022-12-24	WOS:000265024400036
J	Tanaka, H; Kato, K; Yamashita, E; Sumizawa, T; Zhou, Y; Yao, M; Iwasaki, K; Yoshimura, M; Tsukihara, T				Tanaka, Hideaki; Kato, Koji; Yamashita, Eiki; Sumizawa, Tomoyuki; Zhou, Yong; Yao, Min; Iwasaki, Kenji; Yoshimura, Masato; Tsukihara, Tomitake			The Structure of Rat Liver Vault at 3.5 Angstrom Resolution	SCIENCE			English	Article							RIBONUCLEOPROTEIN-PARTICLES; PROTEIN; CELLS; RESISTANCE; DOMAIN; RNA; ASSOCIATION; POLYMERASE; STOMATIN; SYMMETRY	Vaults are among the largest cytoplasmic ribonucleoprotein particles and are found in numerous eukaryotic species. Roles in multidrug resistance and innate immunity have been suggested, but the cellular function remains unclear. We have determined the x-ray structure of rat liver vault at 3.5 angstrom resolution and show that the cage structure consists of a dimer of half-vaults, with each half-vault comprising 39 identical major vault protein (MVP) chains. Each MVP monomer folds into 12 domains: nine structural repeat domains, a shoulder domain, a cap-helix domain, and a cap-ring domain. Interactions between the 42-turn-long cap-helix domains are key to stabilizing the particle. The shoulder domain is structurally similar to a core domain of stomatin, a lipid-raft component in erythrocytes and epithelial cells.	[Tanaka, Hideaki; Kato, Koji; Yamashita, Eiki; Iwasaki, Kenji; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Sumizawa, Tomoyuki] Univ Occupat & Environm Hlth, Fukuoka, Japan; [Zhou, Yong; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; [Iwasaki, Kenji] RIKEN, Harima Inst, Biomultisome Res Team, Struct Physiol Res Grp, Mikazuki, Hyogo 6795148, Japan; [Yoshimura, Masato] Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan; [Tsukihara, Tomitake] Univ Hyogo, Dept Life Sci, Akoh, Hyogo 6781297, Japan	Osaka University; University of Occupational & Environmental Health - Japan; Hokkaido University; RIKEN; National Synchrotron Radiation Research Center; University of Hyogo	Tsukihara, T (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsuki@protein.osaka-u.ac.jp	yao, min/F-5287-2011; Tanaka, Hideaki/AGY-8426-2022; Kato, Koji/H-8502-2017; Yamashita, Eiki/V-6758-2019	yao, min/0000-0003-1687-5904; Kato, Koji/0000-0001-9846-5903; Yamashita, Eiki/0000-0002-4278-0039; Yoshimura, Masato/0000-0002-7466-2192	Ministry of Education, Culture, Sports, Science, and Technology of Japan [10188101, 10179101, A-041, 19770082, 16048216, 20051001]; Japan Space Forum	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum	We thank T. Tomizaki for help in the diffraction data collection on X10SA (PX II) at the Swiss Light Source (Villigen, Switzerland). This work was supported in part by a Grant-in-Aid for Scientific Research in a Priority Area ( 10188101 and 10179101) and the Global Center of Excellence (GCOE) program (A-041) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. T.) and by a Ground-Based Research Announcement for Space Utilization provided by the Japan Space Forum (T. T.). This work was also supported in part by a Grant-in-Aid for Young Scientists (B) 19770082 (H. T.) and Grant-in-Aids for Scientific Research in a Priority Area 16048216 ( H. T.) and 20051001 (M. Y.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Coordinates and structure factors have been deposited with the PDB under accession codes 2ZUO, 2ZV4, and 2ZV5. The three entries were made because the number of coordinates exceeded the limits of a PDB file. A PDB formatted file that contains whole coordinates and structure factors is available from www.protein.osaka-u.ac.jp/crystallograpy/mvp/.	Anderson DH, 2007, PLOS BIOL, V5, P2661, DOI 10.1371/journal.pbio.0050318; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHUGANI DC, 1993, J CELL SCI, V106, P23; Gopinath SCB, 2005, NUCLEIC ACIDS RES, V33, P4874, DOI 10.1093/nar/gki809; Hamill DR, 1997, DEV BIOL, V190, P117, DOI 10.1006/dbio.1997.8676; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kato K, 2008, ACTA CRYSTALLOGR D, V64, P525, DOI 10.1107/S0907444908004277; KEDERSHA NL, 1991, J CELL BIOL, V112, P225, DOI 10.1083/jcb.112.2.225; KEDERSHA NL, 1990, J CELL BIOL, V110, P895, DOI 10.1083/jcb.110.4.895; KICKHOEFER VA, 1993, J BIOL CHEM, V268, P7868; Kickhoefer VA, 1999, J BIOL CHEM, V274, P32712, DOI 10.1074/jbc.274.46.32712; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kickhoefer VA, 2001, J CELL BIOL, V152, P157, DOI 10.1083/jcb.152.1.157; Kim E, 2006, FEBS J, V273, P793, DOI 10.1111/j.1742-4658.2006.05112.x; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Kong LB, 2000, RNA, V6, P890, DOI 10.1017/S1355838200000157; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Kozlov G, 2006, J MOL BIOL, V356, P444, DOI 10.1016/j.jmb.2005.11.064; Mikyas Y, 2004, J MOL BIOL, V344, P91, DOI 10.1016/j.jmb.2004.09.021; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Scheffer GL, 2000, CURR OPIN ONCOL, V12, P550, DOI 10.1097/00001622-200011000-00007; SCHEFFER GL, 1995, NAT MED, V1, P578, DOI 10.1038/nm0695-578; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; Stephen AG, 2001, J BIOL CHEM, V276, P23217, DOI 10.1074/jbc.C100226200; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Yokoyama H, 2008, J MOL BIOL, V376, P868, DOI 10.1016/j.jmb.2007.12.024; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	30	101	110	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					384	388		10.1126/science.1164975	http://dx.doi.org/10.1126/science.1164975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150846				2022-12-24	WOS:000262481400040
J	McMeniman, CJ; Lane, RV; Cass, BN; Fong, AWC; Sidhu, M; Wang, YF; O'Neill, SL				McMeniman, Conor J.; Lane, Roxanna V.; Cass, Bodil N.; Fong, Amy W. C.; Sidhu, Manpreet; Wang, Yu-Feng; O'Neill, Scott L.			Stable Introduction of a Life-Shortening Wolbachia Infection into the Mosquito Aedes aegypti	SCIENCE			English	Article							CYTOPLASMIC INCOMPATIBILITY; VIRULENT WOLBACHIA; TRANSMISSION; DROSOPHILA; AGE; TEMPERATURE; STRAIN	Most pathogens require a relatively long period of development in their mosquito vector before they can be transmitted to a new human host; hence, only older insects are of epidemiological importance. The successful transfer of a life- shortening strain of the inherited bacterial symbiont, Wolbachia, into the major mosquito vector of dengue, Aedes aegypti, halved adult life span under laboratory conditions. The association is stable, and the Wolbachia strain is maternally inherited at high frequency. It is capable of inducing complete cytoplasmic incompatibility, which should facilitate its invasion into natural field populations and its persistence over time. Our data suggest that targeting mosquito age with inherited Wolbachia infections may be a viable strategy to reduce the transmission of pathogens such as dengue viruses.	[McMeniman, Conor J.; Lane, Roxanna V.; Cass, Bodil N.; Fong, Amy W. C.; Sidhu, Manpreet; Wang, Yu-Feng; O'Neill, Scott L.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; [Wang, Yu-Feng] Cent China Normal Univ, Coll Life Sci, Wuhan 430079, Peoples R China	University of Queensland; Central China Normal University	O'Neill, SL (corresponding author), Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia.	scott.oneill@uq.edu.au	O'Neill, Scott L/B-3568-2009; O'Neill, Scott/R-9560-2019; wang, yufeng/E-5122-2010	O'Neill, Scott L/0000-0002-4131-3615; O'Neill, Scott/0000-0002-4131-3615; McMeniman, Conor/0000-0001-8502-8712	Foundation for the NIH; Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation	Foundation for the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank S. Dobson, Z. Xi, and Y. Fu for their advice on microinjection of mosquito eggs; C. Williams and S. Ritchie for supplying the JCU mosquito strain; and E. McGraw and members of the O'Neill laboratory for helpful comments. This research was supported by a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation.	Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Rasgon JL, 2003, J MED ENTOMOL, V40, P125, DOI 10.1603/0022-2585-40.2.125; Reynolds KT, 2003, GENETICS, V164, P1027; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Warrell DA., 2002, ESSENTIAL MALARIOLOG; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607	25	642	678	6	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					141	144		10.1126/science.1165326	http://dx.doi.org/10.1126/science.1165326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119237				2022-12-24	WOS:000262104100061
J	Fernandes-Alnemri, T; Yu, JW; Datta, P; Wu, JH; Alnemri, ES				Fernandes-Alnemri, Teresa; Yu, Je-Wook; Datta, Pinaki; Wu, Jianghong; Alnemri, Emad S.			AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA	NATURE			English	Article							INNATE IMMUNE-RESPONSE; NALP3 INFLAMMASOME; ASC PYROPTOSOME; CASPASE-1; SILICA; FAMILY; GENES; BETA	Host-and pathogen-associated cytoplasmic double-stranded DNA triggers the activation of a NALP3 (also known as cryopyrin and NLRP3)-independent inflammasome(1), which activates caspase-1 leading to maturation of pro-interleukin-1 beta and inflammation. The nature of the cytoplasmic-DNA-sensing inflammasome is currently unknown. Here we show that AIM2 (absent in melanoma 2), an interferon-inducible HIN-200 family member that contains an amino-terminal pyrin domain and a carboxy-terminal oligonucleotide/oligosaccharide-binding domain(2,3), senses cytoplasmic DNA by means of its oligonucleotide/oligosaccharide-binding domain and interacts with ASC (apoptosis-associated speck-like protein containing a CARD) through its pyrin domain to activate caspase-1. The interaction of AIM2 with ASC also leads to the formation of the ASC pyroptosome(4), which induces pyroptotic cell death in cells containing caspase-1. Knockdown of AIM2 by short interfering RNA reduced inflammasome/pyroptosome activation by cytoplasmic DNA in human and mouse macrophages, whereas stable expression of AIM2 in the non-responsive human embryonic kidney 293T cell line conferred responsiveness to cytoplasmic DNA. Our results show that cytoplasmic DNA triggers formation of the AIM2 inflammasome by inducing AIM2 oligomerization. This study identifies AIM2 as an important inflammasome component that senses potentially dangerous cytoplasmic DNA, leading to activation of the ASC pyroptosome and caspase-1.	[Fernandes-Alnemri, Teresa; Yu, Je-Wook; Datta, Pinaki; Wu, Jianghong; Alnemri, Emad S.] Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Alnemri, ES (corresponding author), Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	E_Alnemri@lac.jci.tju.edu	Alnemri, Emad S/B-4526-2010	Yu, Je-Wook/0000-0001-5943-4071	NIH [AG14357, AR055398]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AG14357 and AR055398 to E. S. A. We thank M. McCormick and D. Wang for technical assistance, X. Jiao for help with the confocal microscopy, J. Sagara for the anti-human ASC antibody, J. Yuan for the anti-mouse caspase-1 antibody, R. Johnstone for the anti-human AIM2 antibody, M.-C. Hung for the anti-human IFIX antibody, T. Ouchi for the IFI16 complementary DNA and E. Latz for the immortalized mouse bone marrow macrophages.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Albrecht M, 2005, BIOCHEM BIOPH RES CO, V327, P679, DOI 10.1016/j.bbrc.2004.12.056; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Meier O, 2005, J VIROL, V79, P2604, DOI 10.1128/JVI.79.4.2604-2613.2005; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	18	1260	1315	4	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					509	U5		10.1038/nature07710	http://dx.doi.org/10.1038/nature07710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19158676	Green Accepted			2022-12-24	WOS:000264532400045
J	Westerheide, SD; Anckar, J; Stevens, SM; Sistonen, L; Morimoto, RI				Westerheide, Sandy D.; Anckar, Julius; Stevens, Stanley M., Jr.; Sistonen, Lea; Morimoto, Richard I.			Stress-Inducible Regulation of Heat Shock Factor 1 by the Deacetylase SIRT1	SCIENCE			English	Article							DNA-BINDING ACTIVITY; TRANSCRIPTION FACTOR-1; IN-VIVO; INHIBITION; ACTIVATION; LONGEVITY; SIRTUINS; DOMAIN; P53	Heat shock factor 1 ( HSF1) is essential for protecting cells from protein- damaging stress associated with misfolded proteins and regulates the insulin- signaling pathway and aging. Here, we show that human HSF1 is inducibly acetylated at a critical residue that negatively regulates DNA binding activity. Activation of the deacetylase and longevity factor SIRT1 prolonged HSF1 binding to the heat shock promoter Hsp70 by maintaining HSF1 in a deacetylated, DNA- binding competent state. Conversely, down- regulation of SIRT1 accelerated the attenuation of the heat shock response ( HSR) and release of HSF1 from its cognate promoter elements. These results provide a mechanistic basis for the requirement of HSF1 in the regulation of life span and establish a role for SIRT1 in protein homeostasis and the HSR.	[Westerheide, Sandy D.; Morimoto, Richard I.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Anckar, Julius; Sistonen, Lea] Abo Akad Univ, Dept Biol, Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Stevens, Stanley M., Jr.] Univ Florida, Prot Chem Core Facil, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32610 USA	Northwestern University; Abo Akademi University; University of Turku; State University System of Florida; University of Florida	Morimoto, RI (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu	Longo, Kenneth A/A-5631-2010; Stevens, Stanley M./E-4120-2013	Stevens, Stanley/0000-0002-1399-0256; Sistonen, Lea/0000-0003-1341-2867	NIH; Turku Graduate School of Biomedical Sciences; Academy of Finland; Sigrid Juselius Foundation; Abo Akademi University; National Institute for General Medical Science; National Institute for Aging; Rice Institute for Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038109, R01GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026647] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Turku Graduate School of Biomedical Sciences; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Abo Akademi University; National Institute for General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute for Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Rice Institute for Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Denslow, S. McClung, A. Schilling, and the Chicago Biomedical Consortium for assistance with the mass spectrometry; A. Mondragon for assistance with the molecular modeling; S. Raju for technical assistance; I. Benjamin for the hsf1<SUP>-/-</SUP> fibroblasts; and J. Brickner and members of the Morimoto laboratory for critical reading of the manuscript. This work was supported by an NIH training grant (S.D.W); Turku Graduate School of Biomedical Sciences (J.A.); Academy of Finland, Sigrid Juselius Foundation, and Abo Akademi University (L.S.); and the National Institute for General Medical Science, the National Institute for Aging, and the Rice Institute for Biomedical Research (R.I.M.).	Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; HUBL ST, 1994, NAT STRUCT BIOL, V1, P615, DOI 10.1038/nsb0994-615; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jolly C, 2002, J CELL BIOL, V156, P775, DOI 10.1083/jcb.200109018; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; RABINDRAN SK, 1994, MOL CELL BIOL, V14, P6552, DOI 10.1128/MCB.14.10.6552; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; TORRES FAG, 1995, MOL CELL BIOL, V15, P5063; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	23	528	556	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1063	1066		10.1126/science.1165946	http://dx.doi.org/10.1126/science.1165946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229036	Green Accepted			2022-12-24	WOS:000263478400043
J	Neil, H; Malabat, C; d'Aubenton-Carafa, Y; Xu, ZY; Steinmetz, LM; Jacquier, A				Neil, Helen; Malabat, Christophe; d'Aubenton-Carafa, Yves; Xu, Zhenyu; Steinmetz, Lars M.; Jacquier, Alain			Widespread bidirectional promoters are the major source of cryptic transcripts in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; UNSTABLE TRANSCRIPTS; RNA; GENOME; GENE; TERMINATION; EXPRESSION; PATHWAY; POLYMERASE; INITIATION	Pervasive and hidden transcription is widespread in eukaryotes(1-4), but its global level, the mechanisms from which it originates and its functional significance are unclear. Cryptic unstable transcripts ( CUTs) were recently described as a principal class of RNA polymerase II transcripts in Saccharomyces cerevisiae(5). These transcripts are targeted for degradation immediately after synthesis by the action of the Nrd1 - exosome - TRAMP complexes(6,7). Although CUT degradation mechanisms have been analysed in detail, the genome- wide distribution at the nucleotide resolution and the prevalence of CUTs are unknown. Here we report the first high- resolution genomic map of CUTs in yeast, revealing a class of potentially functional CUTs and the intrinsic bidirectional nature of eukaryotic promoters. An RNA fraction highly enriched in CUTs was analysed by a 3 ' Long- SAGE ( serial analysis of gene expression) approach adapted to deep sequencing. The resulting detailed genomic map of CUTs revealed that they derive from extremely widespread and very well defined transcription units and do not result from unspecific transcriptional noise. Moreover, the transcription of CUTs predominantly arises within nucleosome- free regions, most of which correspond to promoter regions of bona fide genes. Some of the CUTs start upstream from messenger RNAs and overlap their 59 end. Our study of glycolysis genes, as well as recent results from the literature(8-11), indicate that such concurrent transcription is potentially associated with regulatory mechanisms. Our data reveal numerous new CUTs with such a potential regulatory role. However, most of the identified CUTs corresponded to transcripts divergent from the promoter regions of genes, indicating that they represent by- products of divergent transcription occurring at many and possibly most promoters. Eukaryotic promoter regions are thus intrinsically bidirectional, a fundamental property that escaped previous analyses because in most cases divergent transcription generates short- lived unstable transcripts present at very low steady- state levels.	[Neil, Helen; Malabat, Christophe; Jacquier, Alain] CNRS, Inst Pasteur, Unite Genet Interact Macromol, URA2171, F-75015 Paris, France; [d'Aubenton-Carafa, Yves] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Xu, Zhenyu; Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; European Molecular Biology Laboratory (EMBL)	Jacquier, A (corresponding author), CNRS, Inst Pasteur, Unite Genet Interact Macromol, URA2171, F-75015 Paris, France.	alain.jacquier@pasteur.fr		Malabat, Christophe/0000-0003-2551-2355; Steinmetz, Lars/0000-0002-3962-2865; JACQUIER, ALAIN/0000-0001-5707-9184	Institut Pasteur; CNRS; ANR (CUT program); European Science Foundation (RNA quality program); National Institutes of Health; Deutsche Forschungsgemeinschaft	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (CUT program)(French National Research Agency (ANR)); European Science Foundation (RNA quality program)(European Science Foundation (ESF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank D. Libri for the gift of strains, D. Libri, C. Thermes, C. Saveanu and M. Fromont- Racine for discussions and for critical reading of the manuscript, staff of the Genoscope ( Evry) for sequencing, and A. Doyen, L. Decourty, S. Clauder- Muenster and T. Bahr-Ivacevic for technical assistance. This work was supported by the Institut Pasteur, the CNRS, the ANR (CUT program), the European Science Foundation (RNA quality program), and the National Institutes of Health and the Deutsche Forschungsgemeinschaft. H. N. is supported by the ANR (CUT program).	Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Ito T, 2008, IUBMB LIFE, V60, P775, DOI 10.1002/iub.121; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kuehner JN, 2008, MOL CELL, V31, P201, DOI 10.1016/j.molcel.2008.05.018; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCOTT EW, 1993, MOL CELL BIOL, V13, P543, DOI 10.1128/MCB.13.1.543; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	25	433	447	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1038	U8		10.1038/nature07747	http://dx.doi.org/10.1038/nature07747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19169244				2022-12-24	WOS:000263425400048
J	Creppe, C; Malinouskaya, L; Volvert, ML; Gillard, M; Close, P; Malaise, O; Laguesse, S; Cornez, I; Rahmouni, S; Ormenese, S; Belachew, S; Malgrange, B; Chapelle, JP; Siebenlist, U; Moonen, G; Chariot, A; Nguyen, L				Creppe, Catherine; Malinouskaya, Lina; Volvert, Marie-Laure; Gillard, Magali; Close, Pierre; Malaise, Olivier; Laguesse, Sophie; Cornez, Isabelle; Rahmouni, Souad; Ormenese, Sandra; Belachew, Shibeshih; Malgrange, Brigitte; Chapelle, Jean-Paul; Siebenlist, Ulrich; Moonen, Gustave; Chariot, Alain; Nguyen, Laurent			Elongator Controls the Migration and Differentiation of Cortical Neurons through Acetylation of alpha-Tubulin	CELL			English	Article							FAMILIAL DYSAUTONOMIA; IN-VIVO; CEREBRAL-CORTEX; CELL-MIGRATION; HISTONE ACETYLTRANSFERASE; ACTIN CYTOSKELETON; FILAMIN-A; PROTEIN; RNA; TRANSPORT	The generation of cortical projection neurons relies on the coordination of radial migration with branching. Here, we report that the multisubunit histone acetyltransferase Elongator complex, which contributes to transcript elongation, also regulates the maturation of projection neurons. Indeed, silencing of its scaffold (Elp1) or catalytic subunit (Elp3) cell-autonomously delays the migration and impairs the branching of projection neurons. Strikingly, neurons defective in Elongator show reduced levels of acetylated alpha-tubulin. Reduction of alpha-tubulin acetylation via expression of a nonacetylatable alpha-tubulin mutant leads to comparable defects in cortical neurons and suggests that alpha-tubulin is a target of Elp3. This is further supported by the demonstration that Elp3 promotes acetylation and counteracts HDAC6-mediated deacetylation of this substrate in vitro. Our results uncover alpha-tubulin as a target of the Elongator complex and suggest that a tight regulation of its acetylation underlies the maturation of cortical projection neurons.	[Creppe, Catherine; Gillard, Magali; Close, Pierre; Cornez, Isabelle; Chapelle, Jean-Paul; Chariot, Alain] Univ Liege, CHU Sart Tilman, GIGA Signal Transduct, B-4000 Liege, Belgium; [Malinouskaya, Lina; Volvert, Marie-Laure; Malaise, Olivier; Laguesse, Sophie; Belachew, Shibeshih; Malgrange, Brigitte; Moonen, Gustave; Nguyen, Laurent] Univ Liege, CHU Sart Tilman, GIGA Neurosci, B-4000 Liege, Belgium; [Rahmouni, Souad] Univ Liege, CHU Sart Tilman, GIGA Infect Immun & Inflammat, B-4000 Liege, Belgium; [Ormenese, Sandra] Univ Liege, CHU Sart Tilman, GIGA Imaging & Flow Cytometry, B-4000 Liege, Belgium; [Belachew, Shibeshih; Moonen, Gustave] Univ Liege, CHU Sart Tilman, Dept Neurol, B-4000 Liege, Belgium; [Siebenlist, Ulrich] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chariot, A (corresponding author), Univ Liege, CHU Sart Tilman, GIGA Signal Transduct, B-4000 Liege, Belgium.	alain.chariot@ulg.ac.be; lnguyen@ulg.ac.be	Malgrange, Brigitte/F-8384-2010; Belachew, Shibeshih/V-9185-2019; Nguyen, Laurent/E-9882-2016; malgrange, brigitte/A-4887-2019	Belachew, Shibeshih/0000-0003-3976-1950; malgrange, brigitte/0000-0002-8957-2528; Chariot, Alain/0000-0002-1691-4347; Laguesse, Sophie/0000-0002-9217-0087; CLOSE, PIERRE/0000-0002-8844-9616; Nguyen, Laurent/0000-0002-8560-3008	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000431] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Cau E, 1997, DEVELOPMENT, V124, P1611; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Fujita T, 2007, BIOCHEM BIOPH RES CO, V361, P605, DOI 10.1016/j.bbrc.2007.07.050; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; KOZMINSKI KG, 1993, CELL MOTIL CYTOSKEL, V25, P158, DOI 10.1002/cm.970250205; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Lom B, 1999, J NEUROSCI, V19, P9928; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mezey E, 2003, BRAIN RES, V983, P209, DOI 10.1016/S0006-8993(03)03090-7; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Petrakis TG, 2004, J BIOL CHEM, V279, P32087, DOI 10.1074/jbc.M403361200; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roy S, 2000, J NEUROSCI, V20, P6849, DOI 10.1523/JNEUROSCI.20-18-06849.2000; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Tabata H, 2003, J NEUROSCI, V23, P9996; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yokota Y, 2007, NEURON, V54, P429, DOI 10.1016/j.neuron.2007.04.016; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	50	372	381	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					551	564		10.1016/j.cell.2008.11.043	http://dx.doi.org/10.1016/j.cell.2008.11.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19185337	Bronze			2022-12-24	WOS:000263120600023
J	Gerke, J; Lorenz, K; Cohen, B				Gerke, Justin; Lorenz, Kim; Cohen, Barak			Genetic Interactions Between Transcription Factors Cause Natural Variation in Yeast	SCIENCE			English	Article							COMMON HUMAN-DISEASES; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE TRAITS; POSITIVE REGULATOR; EVOLUTION; MEIOSIS; EPISTASIS; SPORULATION; LOCUS; IME1	Our understanding of the genetic basis of phenotypic diversity is limited by the paucity of examples in which multiple, interacting loci have been identified. We show that natural variation in the efficiency of sporulation, the program in yeast that initiates the sexual phase of the life cycle, between oak tree and vineyard strains is due to allelic variation between four nucleotide changes in three transcription factors: IME1, RME1, and RSF1. Furthermore, we identified that selection has shaped quantitative variation in yeast sporulation between strains. These results illustrate how genetic interactions between transcription factors are a major source of phenotypic diversity within species.	[Gerke, Justin; Lorenz, Kim; Cohen, Barak] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA	Washington University (WUSTL)	Cohen, B (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA.	cohen@genetics.wustl.edu		Lorenz, Kim/0000-0001-8674-2942	 [NSF-MCB-0543156];  [NHGRI-T32HG000045]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Kyro for technical assistance and J. Fay, B. Engle, H.-S. Kim, and M. Johnston for sharing reagents. We also thank J. Fay, S. Doniger, C. Hittinger, and members of the Cohen laboratory for helpful advice and discussions. Funded by NSF-MCB-0543156. J.P.G. has received support from NHGRI-T32HG000045. Sequences were deposited in GenBank accessions FJ446649 to FJ446698.	Ben-Ari G, 2006, PLOS GENET, V2, P1815, DOI 10.1371/journal.pgen.0020195; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000123; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000103; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Gerke JP, 2006, GENETICS, V174, P985, DOI 10.1534/genetics.106.058453; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Heck JA, 2006, P NATL ACAD SCI USA, V103, P3256, DOI 10.1073/pnas.0510998103; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; Jambhekar A, 2008, CURR BIOL, V18, P969, DOI 10.1016/j.cub.2008.05.047; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Kim HS, 2007, P NATL ACAD SCI USA, V104, P19387, DOI 10.1073/pnas.0708194104; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; KUPIEC M, 1997, MOL CELLULAR BIOL YE, V3, P889; Lu L, 2003, CURR GENET, V43, P263, DOI 10.1007/s00294-003-0398-z; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P557, DOI 10.1128/JCM.36.2.557-562.1998; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Naumov GI, 1998, CAN J MICROBIOL, V44, P1045, DOI 10.1139/cjm-44-11-1045; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; SMITH HE, 1993, GENETICS, V133, P775; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Wagner GP, 2008, TRENDS ECOL EVOL, V23, P377, DOI 10.1016/j.tree.2008.03.006; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	42	152	152	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					498	501		10.1126/science.1166426	http://dx.doi.org/10.1126/science.1166426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164747	Green Accepted			2022-12-24	WOS:000262587900041
J	Gao, P; Tchernyshyov, I; Chang, TC; Lee, YS; Kita, K; Ochi, T; Zeller, KI; De Marzo, AM; Van Eyk, JE; Mendell, JT; Dang, CV				Gao, Ping; Tchernyshyov, Irina; Chang, Tsung-Cheng; Lee, Yun-Sil; Kita, Kayoko; Ochi, Takafumi; Zeller, Karen I.; De Marzo, Angelo M.; Van Eyk, Jennifer E.; Mendell, Joshua T.; Dang, Chi V.			c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism	NATURE			English	Article							TUMOR-CELLS; PROTEIN; GROWTH; INHIBITION; APOPTOSIS; DATABASE; GENES; ACID	Altered glucose metabolism in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen(1,2). Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metabolism, specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate(3). Glutamine, which is highly transported into proliferating cells(4,5), is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metabolism is not well understood(1,6). Here we report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs(7,8) and stimulate cell proliferation(9), transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells. This leads to upregulation of glutamine catabolism(10). Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the production of ATP or serves as substrate for glutathione synthesis(11). The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metabolism, and energy and reactive oxygen species homeostasis.	[Gao, Ping; Zeller, Karen I.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Tchernyshyov, Irina; Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Div Cardiol, Dept Med, Baltimore, MD 21205 USA; [Chang, Tsung-Cheng; Lee, Yun-Sil; Mendell, Joshua T.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Mendell, Joshua T.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [De Marzo, Angelo M.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [De Marzo, Angelo M.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Kita, Kayoko; Ochi, Takafumi] Teikyo Univ, Fac Pharmaceut Sci, Toxicol Lab, Kanagawa 2290195, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Teikyo University	Dang, CV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA.	pgao2@jhmi.edu; cvdang@jhmi.edu	Chang, Tsung-Cheng/C-2761-2008; Dang, Chi/Y-3375-2019; Zhang, Huafeng/A-7188-2012	Chang, Tsung-Cheng/0000-0003-4706-0468; Dang, Chi/0000-0002-4031-2522	NIH [NHLBI NO1-HV-28180, NCI R01CA051497, NCI R01CA57341, NCI R01CA120185, NCI P50CA58236]; Rita Allen Foundation; Leukemia and Lymphoma Society; Sol Goldman Center for Pancreatic Cancer Research; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA051497, P50CA058236, R37CA051497, R01CA120185, R01CA057341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Sol Goldman Center for Pancreatic Cancer Research; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors want to thank L. Blosser and A. Tam for their help in flow cytometry analysis, and H. Y. Zhang for her help with statistical analysis. This work was partially supported by NIH Awards NHLBI NO1-HV-28180, NCI R01CA051497, NCI R01CA57341, NCI R01CA120185, NCI P50CA58236, Rita Allen Foundation, Leukemia and Lymphoma Society, and Sol Goldman Center for Pancreatic Cancer Research.	Anderson TJ, 2007, PROTEOMICS, V7, P1197, DOI 10.1002/pmic.200600374; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Gallagher FA, 2008, MAGN RESON MED, V60, P253, DOI 10.1002/mrm.21650; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kita K, 2007, TOXICOL APPL PHARM, V220, P262, DOI 10.1016/j.taap.2007.01.009; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Lobo C, 2000, BIOCHEM J, V348, P257, DOI 10.1042/0264-6021:3480257; LOMBARDI L, 1987, CELL, V49, P161, DOI 10.1016/0092-8674(87)90556-3; Lora J, 2004, EUR J BIOCHEM, V271, P4298, DOI 10.1111/j.1432-1033.2004.04370.x; MATSUNO T, 1986, J CELL PHYSIOL, V128, P397, DOI 10.1002/jcp.1041280308; Nikiforov MA, 2000, ONCOGENE, V19, P4828, DOI 10.1038/sj.onc.1203880; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Perez-Gomez C, 2005, BIOCHEM J, V386, P535, DOI 10.1042/BJ20040996; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rabilloud T, 2001, PROTEOMICS, V1, P1105, DOI 10.1002/1615-9861(200109)1:9<1105::AID-PROT1105>3.0.CO;2-M; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Turner A, 2003, BIOCHEM J, V370, P403, DOI 10.1042/BJ20021360; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099	30	1480	1547	7	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					762	U100		10.1038/nature07823	http://dx.doi.org/10.1038/nature07823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19219026	Green Accepted			2022-12-24	WOS:000265193600041
J	Schacherer, J; Shapiro, JA; Ruderfer, DM; Kruglyak, L				Schacherer, Joseph; Shapiro, Joshua A.; Ruderfer, Douglas M.; Kruglyak, Leonid			Comprehensive polymorphism survey elucidates population structure of Saccharomyces cerevisiae	NATURE			English	Article							QUANTITATIVE TRAIT; NUCLEOTIDE RESOLUTION; GENETIC DIVERSITY; GENOME EVOLUTION; DNA-SEQUENCES; YEAST; STRAINS; MAP	Comprehensive identification of polymorphisms among individuals within a species is essential both for studying the genetic basis of phenotypic differences and for elucidating the evolutionary history of the species. Large-scale polymorphism surveys have recently been reported for human(1), mouse(2) and Arabidopsis thaliana(3). Here we report a nucleotide-level survey of genomic variation in a diverse collection of 63 Saccharomyces cerevisiae strains sampled from different ecological niches (beer, bread, vineyards, immunocompromised individuals, various fermentations and nature) and from locations on different continents. We hybridized genomic DNA from each strain to whole-genome tiling microarrays and detected 1.89 million single nucleotide polymorphisms, which were grouped into 101,343 distinct segregating sites. We also identified 3,985 deletion events of length >200 base pairs among the surveyed strains. We analysed the genome-wide patterns of nucleotide polymorphism and deletion variants, and measured the extent of linkage disequilibrium in S. cerevisiae. These results and the polymorphism resource we have generated lay the foundation for genome-wide association studies in yeast. We also examined the population structure of S. cerevisiae, providing support for multiple domestication events as well as insight into the origins of pathogenic strains.	[Schacherer, Joseph; Shapiro, Joshua A.; Ruderfer, Douglas M.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Gen, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Schacherer, Joseph; Shapiro, Joshua A.; Ruderfer, Douglas M.; Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Howard Hughes Medical Institute; Princeton University	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Gen, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu	Ruderfer, Douglas M/M-5795-2016; Shapiro, Joshua/B-5948-2008	Ruderfer, Douglas M/0000-0002-2365-386X; Shapiro, Joshua/0000-0002-6224-0347	NIH [R37 MH059520, GM071508]; James S. McDonnell Foundation Centennial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation Centennial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to all the researchers and institutions, and especially J. Fay, for sharing yeast strains. We thank K. Dolinski and J. Matese for technical support and D. Gresham for comments on the manuscript. The authors acknowledge discussions with members of the Kruglyak and Botstein laboratories. This work was supported by NIH grant R37 MH059520 and a James S. McDonnell Foundation Centennial Fellowship to L. K., and NIH grant GM071508 to the Lewis- Sigler Institute.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; CARTER DM, NATURE UNPUB; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; de Llanos R, 2006, INT J FOOD MICROBIOL, V110, P286, DOI 10.1016/j.ijfoodmicro.2006.04.023; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Enache-Angoulvant A, 2005, CLIN INFECT DIS, V41, P1559, DOI 10.1086/497832; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; FU YX, 1994, GENETICS, V138, P1375; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Marjoram P, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-16; MORTIMER RK, 1986, GENETICS, V113, P35; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Pritchard JK, 2000, GENETICS, V155, P945; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Schacherer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000322; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; TAJIMA F, 1983, GENETICS, V105, P437; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Winzeler EA, 2003, GENETICS, V163, P79; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	30	335	343	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					342	U103		10.1038/nature07670	http://dx.doi.org/10.1038/nature07670			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19212320	Green Accepted			2022-12-24	WOS:000264285600042
J	Sheridan, DJ; Heusch, G				Sheridan, Desmond John; Heusch, Gerd			Threats to the future of cardiovascular research	LANCET			English	Editorial Material							ACADEMIC MEDICINE; DISEASE; BURDEN		[Sheridan, Desmond John] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Heusch, Gerd] Univ Klinikum Essen, Inst Pathophysiol, Essen, Germany	Imperial College London; University of Duisburg Essen	Sheridan, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England.	d.sheridan@ic.ac.uk	Heusch, Gerd/ABE-6675-2020					Garnier JP, 2008, HARVARD BUS REV, V86, P68; HERPER M, 2008, FORBES          0930; Heusch G, 2008, CIRCULATION, V117, pF67, DOI 10.1161/CIRCULATIONAHA.107.189067; Kaplan W., 2004, PRIORITY MED EUROPE; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; OXTOBY K, 2009, BMJ CAREERS, V338, P11; Sheridan DJ, 2006, LANCET, V367, P1698, DOI 10.1016/S0140-6736(06)68739-4; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6	9	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					875	876		10.1016/S0140-6736(09)60525-0	http://dx.doi.org/10.1016/S0140-6736(09)60525-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286070				2022-12-24	WOS:000264158700008
J	Krattinger, SG; Lagudah, ES; Spielmeyer, W; Singh, RP; Huerta-Espino, J; McFadden, H; Bossolini, E; Selter, LL; Keller, B				Krattinger, Simon G.; Lagudah, Evans S.; Spielmeyer, Wolfgang; Singh, Ravi P.; Huerta-Espino, Julio; McFadden, Helen; Bossolini, Eligio; Selter, Liselotte L.; Keller, Beat			A Putative ABC Transporter Confers Durable Resistance to Multiple Fungal Pathogens in Wheat	SCIENCE			English	Article							LEAF RUST RESISTANCE; TRITICUM-AESTIVUM L.; NONHOST RESISTANCE; COMMON WHEAT; BREAD WHEAT; STRIPE RUST; GENE LR34; SENESCENCE; ASSOCIATION; LOCUS	Agricultural crops benefit from resistance to pathogens that endures over years and generations of both pest and crop. Durable disease resistance, which may be partial or complete, can be controlled by several genes. Some of the most devastating fungal pathogens in wheat are leaf rust, stripe rust, and powdery mildew. The wheat gene Lr34 has supported resistance to these pathogens for more than 50 years. Lr34 is now shared by wheat cultivars around the world. Here, we show that the LR34 protein resembles adenosine triphosphate-binding cassette transporters of the pleiotropic drug resistance subfamily. Alleles of Lr34 conferring resistance or susceptibility differ by three genetic polymorphisms. The Lr34 gene, which functions in the adult plant, stimulates senescence-like processes in the flag leaf tips and edges.	[Lagudah, Evans S.; Spielmeyer, Wolfgang; McFadden, Helen] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT 2601, Australia; [Krattinger, Simon G.; Bossolini, Eligio; Selter, Liselotte L.; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Singh, Ravi P.] CIMMYT, Int Maize & Wheat Improvement Ctr, Mexico City 06600, DF, Mexico; [Huerta-Espino, Julio] Campo Expt Valle Mexico INIFAP, Chapingo 56230, Edo De Mexico, Mexico	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Zurich; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Lagudah, ES (corresponding author), Commonwealth Sci & Ind Res Org Plant Ind, GPO Box 1600, Canberra, ACT 2601, Australia.	evans.lagudah@csiro.au; bkeller@botinst.uzh.ch	Spielmeyer, Wolfgang/M-3254-2018; Singh, Ravi Prakash/I-5575-2019; Lagudah, Evans/A-2007-2010; Krattinger, Simon/AAA-2098-2021; Huerta-Espino, Julio/E-7345-2010; Krattinger, Simon/C-2863-2012; Huerta-Espino, Julio JH/N-9840-2018; Keller, Beat/K-3093-2019	Spielmeyer, Wolfgang/0000-0002-5115-7820; Lagudah, Evans/0000-0002-6234-1789; Huerta-Espino, Julio/0000-0001-8334-9862; Huerta-Espino, Julio JH/0000-0001-8334-9862; Keller, Beat/0000-0003-2379-9225; Krattinger, Simon/0000-0001-6912-7411	Swiss National Science Foundation; Indo-Swiss Collaboration in Biotechnology; Grains Research and Development Corporation, Australia	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Indo-Swiss Collaboration in Biotechnology; Grains Research and Development Corporation, Australia(Grains R&D Corp)	This work was supported by the Swiss National Science Foundation (B.K.), the Indo-Swiss Collaboration in Biotechnology (B.K.), and the Grains Research and Development Corporation, Australia (E.S.L and R.P.S.). We thank B. Senger for support in field experiments; P. Streckeisen for advice on infection; L. Viccars and S. Chandramohan for technical assistance; M. Ayliffe, M. Talbot, and R. White for assistance with histology; T. Wicker for bioinformatic support; and S. Hortensteiner for nonfluorescent chlorophyll catabolite analysis. GenBank accession numbers: FJ436983 and FJ436985. Patents: CSIRO, Grains Research and Development Corporation, University of Zurich, Australian Provisional Patent Application 2008904364.	Bossolini E, 2006, THEOR APPL GENET, V113, P1049, DOI 10.1007/s00122-006-0364-5; BOWDEN RL, 2007, PLANT BIOTECHNOL J, V1083, P5; Cloutier S, 2007, PLANT MOL BIOL, V65, P93, DOI 10.1007/s11103-007-9201-8; DYCK PL, 1991, CROP SCI, V31, P309, DOI 10.2135/cropsci1991.0011183X003100020016x; DYCK PL, 1966, CAN J GENET CYTOL, V8, P665, DOI 10.1139/g66-082; DYCK PL, 1987, GENOME, V29, P467, DOI 10.1139/g87-081; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Graveley BR, 2008, NATURE, V453, P1197, DOI 10.1038/4531197b; Gregersen PL, 2007, PLANT BIOTECHNOL J, V5, P192, DOI 10.1111/j.1467-7652.2006.00232.x; GREGERSEN PL, 2007, ANNU REV PLANT BIOL, P192; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083; Keller Beat, 2007, P103, DOI 10.1007/978-1-4020-6297-1_5; Krupinska K, 2002, PLANT PHYSIOL, V130, P1172, DOI 10.1104/pp.008565; KRUPINSKA K, 2002, REV PLANT BIOL, V1172, P57; LIM PO, 2007, PLANT PHYSIOL, V115, P130; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lipka U, 2008, CURR OPIN PLANT BIOL, V11, P404, DOI 10.1016/j.pbi.2008.04.004; Marasas CN, 2003, AGR ECON, V29, P253, DOI 10.1111/j.1574-0862.2003.tb00162.x; Panter SN, 2002, ADV BOT RES, V38, P251, DOI 10.1016/S0065-2296(02)38032-7; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; RUBIALES D, 1995, PLANT DIS, V79, P1208, DOI 10.1094/PD-79-1208; Singh Ravi P., 2007, P109; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; SINGH RP, 1992, CROP SCI, V32, P874, DOI 10.2135/cropsci1992.0011183X003200040008x; Spielmeyer W, 2008, THEOR APPL GENET, V116, P481, DOI 10.1007/s00122-007-0684-0; Spielmeyer W, 2005, THEOR APPL GENET, V111, P731, DOI 10.1007/s00122-005-2058-9; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Webb CA, 2002, GENETICS, V162, P381	29	810	894	11	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1360	1363		10.1126/science.1166453	http://dx.doi.org/10.1126/science.1166453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19229000				2022-12-24	WOS:000263876700047
J	Soldner, F; Hockemeyer, D; Beard, C; Gao, Q; Bell, GW; Cook, EG; Hargus, G; Blak, A; Cooper, O; Mitalipova, M; Isacson, O; Jaenisch, R				Soldner, Frank; Hockemeyer, Dirk; Beard, Caroline; Gao, Qing; Bell, George W.; Cook, Elizabeth G.; Hargus, Gunnar; Blak, Alexandra; Cooper, Oliver; Mitalipova, Maisam; Isacson, Ole; Jaenisch, Rudolf			Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors	CELL			English	Article							HUMAN SOMATIC-CELLS; DOPAMINERGIC-NEURONS; HUMAN FIBROBLASTS; GENERATION; MOUSE; INDUCTION; EXPRESSION; EFFICIENT; UPDATE; SYSTEM	Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients represent a powerful tool for biomedical research and may provide a source for replacement therapies. However, the use of viruses encoding the reprogramming factors represents a major limitation of the current technology since even low vector expression may alter the differentiation potential of the iPSCs or induce malignant transformation. Here, we show that fibroblasts from five patients with idiopathic Parkinson's disease can be efficiently reprogrammed and subsequently differentiated into dopaminergic neurons. Moreover, we derived hiPSCs free of reprogramming factors using Cre-recombinase excisable viruses. Factor-free hiPSCs maintain a pluripotent state and show a global gene expression profile, more closely related to hESCs than to hiPSCs carrying the transgenes. Our results indicate that residual transgene expression in virus-carrying hiPSCs can affect their molecular characteristics and that factor-free hiPSCs therefore represent a more suitable source of cells for modeling of human disease.	[Soldner, Frank; Hockemeyer, Dirk; Beard, Caroline; Gao, Qing; Bell, George W.; Cook, Elizabeth G.; Mitalipova, Maisam; Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Hargus, Gunnar; Blak, Alexandra; Cooper, Oliver; Isacson, Ole] Harvard Univ, Sch Med, McLean Hosp, Ctr Neurodegenerat Res,Udall Parkinson Dis Res Ct, Belmont, MA 02478 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; McLean Hospital	Jaenisch, R (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Hockemeyer, Dirk/0000-0002-5598-5092; Isacson, Ole/0000-0001-8091-8302; Cooper, Oliver/0000-0001-6567-7491	NIH [R37-CA084198, RO1-CA087869, RO1-HD045022]; Udall Parkinson's Disease Center [P50NS39793]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA087869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039793] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Udall Parkinson's Disease Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Tobias Brambrink for providing the FUGW- loxP plasmid. We thank Raaji Alagappan, Ping Xu, Kristen Lee, and Elizabeth Marlow for technical support and Jessica Daussman, Ruth Flannery, and Dongdong Fu for their help with animal husbandry and processing of teratomas. We would like to thank the members of the Whitehead Genome Technology Core for their help with the microarray expression analysis. We thank all the members of the Jaenisch lab for helpful discussions and comments on the manuscript. D. H. is a Merck Fellow of the Life Science Research Foundation. R. J. was supported by NIH grants R37-CA084198, RO1-CA087869, and RO1-HD045022. This research was supported in part by a Collaborative Innovation Award from the Howard Hughes Medical Institute. O. I. is supported by Udall Parkinson's Disease Center of Excellence grant P50NS39793 and the Michael Stern Foundation. R. J. is an advisor to Stemgent, which has obtained a license from the Massachusetts Institute of Technology (MIT) to distribute some of the reagents used in this paper. F. S., D. H., and R. J. designed the experiments and wrote the paper. C. B. designed and performed Southern blot analysis. Q. G. analyzed all teratomas. G. B. analyzed the gene expression profile. E. G. C. assisted with the NotI/BSU36I sites of the FUGW- loxP, which contains a loxP site in the 30 LTR (Hanna et al., 2007).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Allen JD, 1996, SEMIN CANCER BIOL, V7, P299, DOI 10.1006/scbi.1996.0038; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Gasser T, 2007, MOVEMENT DISORD, V22, pS343, DOI 10.1002/mds.21676; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim BK, 2006, FEBS LETT, V580, P5869, DOI 10.1016/j.febslet.2006.09.053; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schulz JB, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-5011-4; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Trounson A, 2009, CELL STEM CELL, V4, P3, DOI 10.1016/j.stem.2008.12.002; von Kalle C, 2004, SEMIN HEMATOL, V41, P303, DOI 10.1053/j.seminhematol.2004.07.007; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	1126	1242	1	218	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					964	977		10.1016/j.cell.2009.02.013	http://dx.doi.org/10.1016/j.cell.2009.02.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269371	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000263930900018
J	Saksena, S; Wahlman, J; Teis, D; Johnson, AE; Emr, SD				Saksena, Suraj; Wahlman, Judit; Teis, David; Johnson, Arthur E.; Emr, Scott D.			Functional Reconstitution of ESCRT-III Assembly and Disassembly	CELL			English	Article							STRUCTURAL BASIS; VPS4; RECOGNITION; FILAMENTS; PROTEINS; DOMAIN	Receptor downregulation in the MVB pathway is mediated by the ESCRT complexes. ESCRT-III is composed of four protein subunits that are monomeric in the cytosol and oligomerize into a protein lattice only upon membrane binding. Recent studies have shown that the ESCRT-III protein Snf7 can form a filament by undergoing homo-oligomerization. To examine the role of membrane binding and of interactions with other ESCRT components in initiating Snf7 oligomerization, we used fluorescence spectroscopy to directly detect and characterize the assembly of the Snf7 oligomer on liposomes using purified ESCRT components. The observed fluorescence changes reveal an obligatory sequence of membrane-protein and protein-protein interactions that generate the active conformation of Snf7. Also, we demonstrate that ESCRT-III assembly drives membrane deformation. Furthermore, usingan in vitro disassembly assay, we directly demonstrate that Vps24 and Vps2 function as adaptors in the ATP-dependent membrane disassembly of the ESCRT-III complex by recruiting the AAA ATPase Vps4.	[Wahlman, Judit; Johnson, Arthur E.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Saksena, Suraj; Teis, David; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Saksena, Suraj; Teis, David; Emr, Scott D.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Cornell University; Cornell University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Johnson, AE (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	ajohnson@medicine.tamhsc.edu; sde26@cornell.edu	Johnson, Arthur E/G-3457-2012	Teis, David/0000-0002-8181-0253	American Heart Association (AHA) [0826060D]; HFSP [LT00634/2006-L]; National Institutes of Health [GM26494]; Robert A. Welch Foundation [BE-0017]; Weill Institute for Cell and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494, T32GM007273] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); HFSP(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Weill Institute for Cell and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Y. Miao, Y. Shao, and S. Weys for technical assistance; B. Judson for EM expertise; and E. V. MacGurn for assistance with graphics. S.S. and D.T. were supported by fellowships from American Heart Association (AHA 0826060D) and HFSP (LT00634/2006-L), respectively. This work was supported by National Institutes of Health grant GM26494 and the Robert A. Welch Foundation (Chair Grant BE-0017) (A.E.J.) and funds from the Weill Institute for Cell and Molecular Biology (S.D.E.).	Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	13	216	216	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					97	109		10.1016/j.cell.2008.11.013	http://dx.doi.org/10.1016/j.cell.2008.11.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135892	Bronze, Green Accepted			2022-12-24	WOS:000262318400018
J	Goodman, AA; Rosolowsky, EW; Borkin, MA; Foster, JB; Halle, M; Kauffmann, J; Pineda, JE				Goodman, Alyssa A.; Rosolowsky, Erik W.; Borkin, Michelle A.; Foster, Jonathan B.; Halle, Michael; Kauffmann, Jens; Pineda, Jaime E.			A role for self-gravity at multiple length scales in the process of star formation	NATURE			English	Article							TURBULENCE; CLOUDS	Self-gravity plays a decisive role in the final stages of star formation, where dense cores (size similar to 0.1 parsecs) inside molecular clouds collapse to form star- plus- disk systems(1). But self- gravity's role at earlier times ( and on larger length scales, such as similar to 1 parsec) is unclear; some molecular cloud simulations that do not include self- gravity suggest that 'turbulent fragmentation' alone is sufficient to create a mass distribution of dense cores that resembles, and sets, the stellar initial mass function(2). Here we report a 'dendrogram' (hierarchical tree- diagram) analysis that reveals that self- gravity plays a significant role over the full range of possible scales traced by (CO)-C-13 observations in the L1448 molecular cloud, but not everywhere in the observed region. In particular, more than 90 per cent of the compact 'pre- stellar cores' traced by peaks of dust emission(3) are projected on the sky within one of the dendrogram's self- gravitating 'leaves'. As these peaks mark the locations of already- forming stars, or of those probably about to form, a self- gravitating cocoon seems a critical condition for their existence. Turbulent fragmentation simulations without self- gravity even of unmagnetized isothermal material - can yield mass and velocity power spectra very similar to what is observed in clouds like L1448. But a dendrogram of such a simulation(4) shows that nearly all the gas in it ( much more than in the observations) appears to be self- gravitating. A potentially significant role for gravity in ` non- self- gravitating' simulations suggests inconsistency in simulation assumptions and output, and that it is necessary to include self- gravity in any realistic simulation of the star- formation process on subparsec scales.	[Goodman, Alyssa A.; Borkin, Michelle A.; Halle, Michael; Kauffmann, Jens] Harvard Univ, Initiat Innovat Comp, Cambridge, MA 02138 USA; [Goodman, Alyssa A.; Rosolowsky, Erik W.; Foster, Jonathan B.; Kauffmann, Jens; Pineda, Jaime E.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Rosolowsky, Erik W.] Univ British Columbia, Dept Phys, Kelowna, BC V1V 1V7, Canada; [Halle, Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Surg Planning Lab, Boston, MA 02115 USA; [Halle, Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of British Columbia; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Goodman, AA (corresponding author), Harvard Univ, Initiat Innovat Comp, Cambridge, MA 02138 USA.	agoodman@cfa.harvard.edu	Pineda, Jaime/AAX-3157-2021; Pineda, Jaime/J-7405-2013; Rosolowsky, Erik/ABI-3078-2020; Goodman, Alyssa A/A-6007-2010	Pineda, Jaime/0000-0002-3972-1978; Pineda, Jaime/0000-0002-3972-1978; Goodman, Alyssa A/0000-0003-1312-0477; Borkin, Michelle/0000-0002-8016-355X; Kauffmann, Jens/0000-0002-5094-6393	National Institutes of Health [U54-EB005149]; National Science Foundation [AST-0502605]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank A. Munshi for putting us in touch with M. Thomas and colleagues at Right Hemisphere, whose software and assistance enabled the interactive PDF in this paper; P. Padoan for providing the simulated data cube; R. Shetty for comments on the paper; F. Shu for suggesting we extend our analysis to measure boundedness of p-p-v 'bound' objects in p-p-p space using simulations; and S. Hyman, Provost of Harvard University, for supporting the start- up of the Initiative in Innovative Computing at Harvard, which substantially enabled the creation of this work. 3D Slicer is developed by the National Alliance for Medical Image Computing and funded by the National Institutes of Health grant U54-EB005149. The COMPLETE group is supported in part by the National Science Foundation. E.W.R. is supported by the NSF AST-0502605.	BERTOLDI F, 1992, ASTROPHYS J, V395, P140, DOI 10.1086/171638; di Francesco J., 2007, PROTOSTARS PLANETS, P17; Enoch ML, 2006, ASTROPHYS J, V638, P293, DOI 10.1086/498678; Foster JB, 2006, ASTROPHYS J, V636, pL105, DOI 10.1086/500131; GOODMAN A, 2008, ASTROPHYS J IN PRESS; Heine C, 2006, IEEE T VIS COMPUT GR, V12, P781, DOI 10.1109/TVCG.2006.196; HOULAHAN P, 1992, ASTROPHYS J, V393, P172, DOI 10.1086/171495; Jorgensen JK, 2008, ASTROPHYS J, V683, P822, DOI 10.1086/589956; KAUFFMANN G, 1993, MON NOT R ASTRON SOC, V261, P921, DOI 10.1093/mnras/261.4.921; KAUFFMANN J, ASTROPHYS J UNPUB; LARSON RB, 1981, MON NOT R ASTRON SOC, V194, P809, DOI 10.1093/mnras/194.4.809; Ostriker EC, 2001, ASTROPHYS J, V546, P980, DOI 10.1086/318290; Padoan P, 2002, ASTROPHYS J, V576, P870, DOI 10.1086/341790; Padoan P, 2006, ASTROPHYS J, V653, pL125, DOI 10.1086/510620; Pineda JE, 2008, ASTROPHYS J, V679, P481, DOI 10.1086/586883; Ridge NA, 2006, ASTRON J, V131, P2921, DOI 10.1086/503704; Rosolowsky EW, 2008, ASTROPHYS J, V679, P1338, DOI 10.1086/587685; Rosolowsky EW, 2008, ASTROPHYS J SUPPL S, V175, P509, DOI 10.1086/524299; STUTZKI J, 1990, ASTROPHYS J, V356, P513, DOI 10.1086/168859; Vliegen R, 2006, IEEE T VIS COMPUT GR, V12, P789, DOI 10.1109/TVCG.2006.200; WILLIAMS JP, 1994, ASTROPHYS J, V428, P693, DOI 10.1086/174279	21	103	104	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					63	66		10.1038/nature07609	http://dx.doi.org/10.1038/nature07609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122636	Green Accepted			2022-12-24	WOS:000262104900030
J	Ingolia, NT; Ghaemmaghami, S; Newman, JRS; Weissman, JS				Ingolia, Nicholas T.; Ghaemmaghami, Sina; Newman, John R. S.; Weissman, Jonathan S.			Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling	SCIENCE			English	Article							OPEN READING FRAMES; NON-AUG CODONS; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; PROTEIN-SYNTHESIS; EUKARYOTIC TRANSLATION; GENE-EXPRESSION; INITIATION; YEAST; MICRORNAS	Techniques for systematically monitoring protein translation have lagged far behind methods for measuring messenger RNA ( mRNA) levels. Here, we present a ribosome-profiling strategy that is based on the deep sequencing of ribosome-protected mRNA fragments and enables genome-wide investigation of translation with subcodon resolution. We used this technique to monitor translation in budding yeast under both rich and starvation conditions. These studies defined the protein sequences being translated and found extensive translational control in both determining absolute protein abundance and responding to environmental stress. We also observed distinct phases during translation that involve a large decrease in ribosome density going from early to late peptide elongation as well as widespread regulated initiation at non-adenine-uracil-guanine (AUG) codons. Ribosome profiling is readily adaptable to other organisms, making high-precision investigation of protein translation experimentally accessible.	[Ingolia, Nicholas T.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Ingolia, NT (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	ingolia@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X	NIH [AG10770]; Ruth L. Kirschstein National Research Service Award [GM080853]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Chu, J. deRisi, and K. Fischer for help with sequencing; D. Bartel, H. Guo, D. Herschlag, J. Hollien, S. Luo, and G. Schroth for helpful discussions of RNA methods; P. Walter and T. Aragon for the use of a density gradient fractionator; the 2008 Woods Hole Physiology course students for data analysis; and members of the Weissman lab, L. Lareau, and T. Ingolia for critical commentary on the manuscript. Sequencing data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE13750. This investigation was supported by a NIH P01 grant (AG10770) and a Ruth L. Kirschstein National Research Service Award (GM080853) (to N.T.I.) and by the Howard Hughes Medical Institute (to J.S.W.). N.T.I. and J.S.W. are the inventors on a patent application, assigned to the Regents of the University of California, on the ribosome profiling and sequencing library generation techniques described in this work. S.G. and J.R.S.N. developed a microarray-based approach that served as a proof of principle for the present studies; N.T.I. and J.S.W. designed the experiments; N.T.I. performed the experiments and analyzed the data; and N.T.I. and J.S.W. interpreted the results and wrote the manuscript.	Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; GRANT CM, 1995, NUCLEIC ACIDS RES, V23, P3980, DOI 10.1093/nar/23.19.3980; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; ROMANIUK E, 1982, EUR J BIOCHEM, V125, P639, DOI 10.1111/j.1432-1033.1982.tb06730.x; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; YOON H, 1992, MOL MICROBIOL, V6, P1413, DOI 10.1111/j.1365-2958.1992.tb00861.x; Zhang ZH, 2005, CURR GENET, V48, P77, DOI 10.1007/s00294-005-0001-x	35	2288	2414	12	358	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					218	223		10.1126/science.1168978	http://dx.doi.org/10.1126/science.1168978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19213877	Green Accepted			2022-12-24	WOS:000265024400037
J	Kalaany, NY; Sabatini, DM				Kalaany, Nada Y.; Sabatini, David M.			Tumours with PI3K activation are resistant to dietary restriction	NATURE			English	Article							GROWTH-FACTOR-I; CALORIC RESTRICTION; LIFE-SPAN; PHOSPHATIDYLINOSITOL 3-KINASES; ENERGY RESTRICTION; HUMAN CANCER; CELL-GROWTH; MUTATIONS; INSULIN; GENE	Dietary restriction delays the incidence and decreases the growth of various types of tumours, but the mechanisms underlying the sensitivity of tumours to food restriction remain unknown. Here we show that certain human cancer cell lines, when grown as tumour xenografts in mice, are highly sensitive to the anti-growth effects of dietary restriction, whereas others are resistant. Cancer cells that form dietary-restriction-resistant tumours carry mutations that cause constitutive activation of the phosphatidylinositol-3-kinase (PI3K) pathway and in culture proliferate in the absence of insulin or insulin-like growth factor 1. Substitution of an activated mutant allele of PI3K with wild-type PI3K in otherwise isogenic cancer cells, or the restoration of PTEN expression in a PTEN-null cancer cell line, is sufficient to convert a dietary-restriction-resistant tumour into one that is dietary-restriction-sensitive. Dietary restriction does not affect a PTEN-null mouse model of prostate cancer, but it significantly decreases tumour burden in a mouse model of lung cancer lacking constitutive PI3K signalling. Thus, the PI3K pathway is an important determinant of the sensitivity of tumours to dietary restriction, and activating mutations in the pathway may influence the response of cancers to dietary restriction-mimetic therapies.	[Kalaany, Nada Y.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kalaany, Nada Y.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Kalaany, Nada Y.; Sabatini, David M.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256; Kalaany, Nada/0000-0001-7489-1035	Alexander and Margaret Stewart Trust Award; David H. Koch Cancer Research Award; National Institutes of Health [R01 AI04389, R01 CA129105]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER	Alexander and Margaret Stewart Trust Award; David H. Koch Cancer Research Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Vogelstein for providing the isogenic DLD-1 cell lines and M. M. Georgescu for the doxycycline-inducible U87-MG cell line; T. Jacks for the KRAS<SUP>LA2</SUP>; p53<SUP>LSL/WT</SUP> mice and H. Wu for the Pb-Cre; PTEN<SUP>L/L</SUP> mice; F. Reinhardt for assistance with animal experiments; R. Bronson for histological analysis; the Histology Facility at the Koch Institute for Integrative Cancer Research and the Histology Core Laboratory at MIT for assistance with sectioning and immunohistochemistry; the Imaging Platform at the Broad Institute for assistance with image analysis; R. Weinberg, D. Guertin, Y. Chudnovsky and Y. Sancak for critical reading of the manuscript; and members of the Sabatini and Weinberg laboratories for support and discussions. This research is supported by the Alexander and Margaret Stewart Trust Award, the David H. Koch Cancer Research Award and National Institutes of Health grants R01 AI04389 and R01 CA129105. D. M. S. is an investigator of the Howard Hughes Medical Institute.	BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHENEY KE, 1983, J GERONTOL, V38, P420, DOI 10.1093/geronj/38.4.420; CHENEY KE, 1980, EXP GERONTOL, V15, P237, DOI 10.1016/0531-5565(80)90029-7; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KLURFELD DM, 1989, J NUTR, V119, P286, DOI 10.1093/jn/119.2.286; Kritchevsky D, 2001, J NUTR SCI VITAMINOL, V47, P13, DOI 10.3177/jnsv.47.13; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Moreschi C., 1909, ZIMMUNITATSFORSCH, V2, P651; Pugh TD, 1999, CANCER RES, V59, P1642; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rous P, 1914, J EXP MED, V20, P413, DOI 10.1084/jem.20.4.413; RUGGERI BA, 1989, CANCER RES, V49, P4130; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sell C, 2003, HORM METAB RES, V35, P705, DOI 10.1055/s-2004-814156; TANNENBAUM A, 1949, CANCER RES, V9, P724; TANNENBAUM A, 1953, CANCER RES, V13, P532; Thompson HJ, 2003, J MAMMARY GLAND BIOL, V8, P133, DOI 10.1023/A:1025743607445; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wapnir IL, 1996, BREAST CANCER RES TR, V41, P15, DOI 10.1007/BF01807032; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhu ZJ, 1997, CARCINOGENESIS, V18, P1007, DOI 10.1093/carcin/18.5.1007	38	333	345	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					725	U61		10.1038/nature07782	http://dx.doi.org/10.1038/nature07782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19279572	Green Accepted			2022-12-24	WOS:000265193600032
J	Cartwright, HN; Humphries, JA; Smith, LG				Cartwright, Heather N.; Humphries, John A.; Smith, Laurie G.			PAN1: A Receptor-Like Protein That Promotes Polarization of an Asymmetric Cell Division in Maize	SCIENCE			English	Article							STOMATAL DEVELOPMENT; KINASES; ARABIDOPSIS; MECHANISM; LEPRK2; PLANTS; LEAF	Polarization of cell division is essential for eukaryotic development, but little is known about how this is accomplished in plants. The formation of stomatal complexes in maize involves the polarization of asymmetric subsidiary mother cell ( SMC) divisions toward the adjacent guard mother cell ( GMC), apparently under the influence of a GMC- derived signal. We found that the maize pan1 gene promotes the premitotic polarization of SMCs and encodes a leucine- rich repeat receptor- like protein that becomes localized in SMCs at sites of GMC contact. PAN1 has an inactive kinase domain but is required for the accumulation of a membrane- associated phosphoprotein, suggesting a function for PAN1 in signal transduction. Our findings implicate PAN1 in the transmission of an extrinsic signal that polarizes asymmetric SMC divisions toward GMCs.	[Cartwright, Heather N.; Humphries, John A.; Smith, Laurie G.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Smith, LG (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lgsmith@ucsd.edu		Cartwright, Heather/0000-0001-6639-5808	NSF [IOB-0544226]	NSF(National Science Foundation (NSF))	We thank A. Wright and F. Delgado for help with experiments and J. Bolado, J. Chory, and R. Boston for reagents. This work was supported by NSF grant IOB-0544226. pan1 gene and PAN1 protein sequences are available at GenBank (accession number FJ231525).	Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Chevalier D, 2005, P NATL ACAD SCI USA, V102, P9074, DOI 10.1073/pnas.0503526102; CHO SO, 1990, PROTOPLASMA, V157, P154, DOI 10.1007/BF01322648; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Gallagher K, 2000, CURR BIOL, V10, P1229, DOI 10.1016/S0960-9822(00)00730-2; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Llompart B, 2003, J BIOL CHEM, V278, P48105, DOI 10.1074/jbc.M307482200; Muschietti J, 1998, PLANT CELL, V10, P319, DOI 10.1105/tpc.10.3.319; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Panteris E, 2006, CELL MOTIL CYTOSKEL, V63, P696, DOI 10.1002/cm.20155; Scheres B, 1999, ANNU REV PLANT PHYS, V50, P505, DOI 10.1146/annurev.arplant.50.1.505; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; STEBBINS GL, 1960, DEV BIOL, V2, P477, DOI 10.1016/0012-1606(60)90050-6; ten Hove CA, 2008, CURR OPIN PLANT BIOL, V11, P34, DOI 10.1016/j.pbi.2007.11.001; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104	18	91	100	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					649	651		10.1126/science.1161686	http://dx.doi.org/10.1126/science.1161686			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179535				2022-12-24	WOS:000262862800047
J	Kim, S; Takahashi, H; Lin, WW; Descargues, P; Grivennikov, S; Kim, Y; Luo, JL; Karin, M				Kim, Sunhwa; Takahashi, Hiroyuki; Lin, Wan-Wan; Descargues, Pascal; Grivennikov, Sergei; Kim, Youngjun; Luo, Jun-Li; Karin, Michael			Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis	NATURE			English	Article							LEWIS-LUNG-CARCINOMA; CANCER METASTASIS; PROSTATE-CANCER; INNATE IMMUNITY; TUMOR-GROWTH; PROTEOGLYCAN; INFLAMMATION; MACROPHAGES; ANGIOGENESIS; HYALURONAN	Metastatic progression depends on genetic alterations intrinsic to cancer cells as well as the inflammatory microenvironment of advanced tumours(1,2). To understand how cancer cells affect the inflammatory microenvironment, we conducted a biochemical screen for macrophage- activating factors secreted by metastatic carcinomas. Here we show that, among the cell lines screened, Lewis lung carcinoma (LLC)(3) were the most potent macrophage activators leading to production of interleukin-6 (IL-6) and tumour-necrosis factor-alpha (TNF-alpha) through activation of the Toll-like receptor (TLR) family members(4) TLR2 and TLR6. Both TNF-alpha and TLR2 were found to be required for LLC metastasis. Biochemical purification of LLC- conditioned medium ( LCM) led to identification of the extracellular matrix proteoglycan versican, which is upregulated in many human tumours including lung cancer(5,6), as a macrophage activator that acts through TLR2 and its coreceptors TLR6 and CD14. By activating TLR2: TLR6 complexes and inducing TNF-alpha secretion by myeloid cells, versican strongly enhances LLC metastatic growth. These results explain how advanced cancer cells usurp components of the host innate immune system, including bone- marrow- derived myeloid progenitors(7), to generate an inflammatory microenvironment hospitable for metastatic growth.	[Kim, Sunhwa; Takahashi, Hiroyuki; Lin, Wan-Wan; Descargues, Pascal; Grivennikov, Sergei; Kim, Youngjun; Luo, Jun-Li; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Kim, Sunhwa; Takahashi, Hiroyuki; Lin, Wan-Wan; Descargues, Pascal; Grivennikov, Sergei; Kim, Youngjun; Luo, Jun-Li; Karin, Michael] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; [Lin, Wan-Wan] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan	University of California System; University of California San Diego; University of California System; University of California San Diego; National Taiwan University	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Grivennikov, Sergei/AAE-7365-2019	Grivennikov, Sergei/0000-0003-2987-0555; Luo, Jun-Li/0000-0002-7625-4766; Lin, Wan Wan/0000-0002-3207-734X	International Human Frontier Science Program Organization; National Cancer Institute-sponsored Cancer Therapeutic Training Program; Ruth L. Kirschstein National Research Service Award; California Institute of Regenerative Medicine; Japanese Respiratory Society; Life Science Research Foundation; IHFSPO; Crohn's and Colitis Foundation of America; National Institutes of Health; Littlefield-AACR; NATIONAL CANCER INSTITUTE [R01CA118165, R01CA132586, T32CA121938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006376] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); National Cancer Institute-sponsored Cancer Therapeutic Training Program; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Japanese Respiratory Society; Life Science Research Foundation; IHFSPO; Crohn's and Colitis Foundation of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Littlefield-AACR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	S.K. was supported by the International Human Frontier Science Program Organization (IHFSPO), the National Cancer Institute-sponsored Cancer Therapeutic Training Program and a Ruth L. Kirschstein National Research Service Award. Y.K., H.T., J.-L.L., P.D. and S.G. were supported by the California Institute of Regenerative Medicine, the Japanese Respiratory Society, the Life Science Research Foundation, IHFSPO and the Crohn's and Colitis Foundation of America, respectively. Work in the M. K. laboratory was supported by grants from the National Institutes of Health and a Littlefield-AACR grant in Metastatic Colon Cancer Research. M. K. is an American Cancer Society Research Professor. We thank S. Akira and B. Beutler for TLR and adaptor protein deficient mice, D. Zimmermann for human versican construct, R. Hoffman for DsRed-LLC cells and K. Takenaga for LLC-P29 cells. We also thank R. Gallo and K. Yamasaki for the hyaluronan- inhibiting peptides and advice, J. Varner for analysing cell migration and Santa Cruz Biotechnology for gifts of antibodies.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bas S, 2008, J IMMUNOL, V180, P1158, DOI 10.4049/jimmunol.180.2.1158; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Eckmann L, 1996, J IMMUNOL, V156, P2894; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Isogai Z, 1996, CANCER RES, V56, P3902; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; NAKANISHI H, 1992, BIOCHEM J, V288, P215, DOI 10.1042/bj2880215; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Pirinen R, 2005, HUM PATHOL, V36, P44, DOI 10.1016/j.humpath.2004.10.010; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Urosevic M, 2004, BLOOD, V103, P1796, DOI 10.1182/blood-2003-10-3372; WEISS L, 1987, INT J CANCER, V40, P570, DOI 10.1002/ijc.2910400423; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	27	828	884	0	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					102	U108		10.1038/nature07623	http://dx.doi.org/10.1038/nature07623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122641	Green Accepted			2022-12-24	WOS:000262104900039
J	Dias, A; Bouvier, D; Crepin, T; McCarthy, AA; Hart, DJ; Baudin, F; Cusack, S; Ruigrok, RWH				Dias, Alexandre; Bouvier, Denis; Crepin, Thibaut; McCarthy, Andrew A.; Hart, Darren J.; Baudin, Florence; Cusack, Stephen; Ruigrok, Rob W. H.			The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit	NATURE			English	Article							RNA-POLYMERASE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; MESSENGER-RNA; CLEAVAGE; BINDING; SITES; PB2; TRANSCRIPTION; RECOGNITION	The influenza virus polymerase, a heterotrimer composed of three subunits, PA, PB1 and PB2, is responsible for replication and transcription of the eight separate segments of the viral RNA genome in the nuclei of infected cells. The polymerase synthesizes viral messenger RNAs using short capped primers derived from cellular transcripts by a unique 'cap-snatching' mechanism(1). The PB2 subunit binds the 59 cap of host pre-mRNAs(2-4), which are subsequently cleaved after 10-13 nucleotides by the viral endonuclease, hitherto thought to reside in the PB2 (ref. 5) or PB1 (ref. 2) subunits. Here we describe biochemical and structural studies showing that the amino-terminal 209 residues of the PA subunit contain the endonuclease active site. We show that this domain has intrinsic RNA and DNA endonuclease activity that is strongly activated by manganese ions, matching observations reported for the endonuclease activity of the intact trimeric polymerase(6,7). Furthermore, this activity is inhibited by 2,4-dioxo-4-phenylbutanoic acid, a known inhibitor of the influenza endonuclease(8). The crystal structure of the domain reveals a structural core closely resembling resolvases and type II restriction endonucleases. The active site comprises a histidine and a cluster of three acidic residues, conserved in all influenza viruses, which bind two manganese ions in a configuration similar to other two-metal-dependent endonucleases. Two active site residues have previously been shown to specifically eliminate the polymerase endonuclease activity when mutated(9). These results will facilitate the optimisation of endonuclease inhibitors(10-12) as potential new anti-influenza drugs.	[Dias, Alexandre; Bouvier, Denis; Crepin, Thibaut; McCarthy, Andrew A.; Hart, Darren J.; Baudin, Florence; Cusack, Stephen; Ruigrok, Rob W. H.] UJF, EMBL, CNRS, Unit Virus Host Cell Interact,UMR 5233, F-38042 Grenoble 9, France; [McCarthy, Andrew A.; Hart, Darren J.; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL)	Cusack, S (corresponding author), UJF, EMBL, CNRS, Unit Virus Host Cell Interact,UMR 5233, 6 Rue Jules Horowitz,BP181, F-38042 Grenoble 9, France.	cusack@embl.fr	McCarthy, Andrew A/A-5926-2013; Hart, Darren/C-4858-2015	McCarthy, Andrew A/0000-0003-4478-0136; Hart, Darren/0000-0002-3502-2002; Baudin, Florence/0000-0003-0816-0861; CREPIN, Thibaut/0000-0003-2663-1794; Cusack, Stephen/0000-0002-9324-0796	EU FLUPOL [SP5B-CT-2007-044263]; ANR FLU INTERPOL [ANR-06-MIME-014-02]; MENRT	EU FLUPOL; ANR FLU INTERPOL(French National Research Agency (ANR)); MENRT	We thank the ESRF, EMBL and MRC-France for access to synchrotron facilities and the Partnership for Structural Biology for an integrated structural biology environment. The work was partially funded by the EU FLUPOL contract (SP5B-CT-2007-044263) and the ANR FLU INTERPOL contract (ANR-06-MIME-014-02). A. D. has a PhD fellowship from the MENRT. We thank J.-L. Decout for advice about the inhibitor, E. Kowalinski and C. Swale for RNA transcripts, and C. Petosa and J. Perona for a critical reading of the manuscript.	BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Doan L, 1999, BIOCHEMISTRY-US, V38, P5612, DOI 10.1021/bi9828932; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; HAGEN M, 1994, J VIROL, V68, P1509, DOI 10.1128/JVI.68.3.1509-1515.1994; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hastings JC, 1996, ANTIMICROB AGENTS CH, V40, P1304, DOI 10.1128/AAC.40.5.1304; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Horton NC, 2004, BIOCHEMISTRY-US, V43, P6841, DOI 10.1021/bi0499056; Klumpp K, 2000, J BIOL CHEM, V275, P6181, DOI 10.1074/jbc.275.9.6181; Knizewski L, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-40; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Nishino T, 2001, STRUCTURE, V9, P197, DOI 10.1016/S0969-2126(01)00576-7; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Parkes KEB, 2003, J MED CHEM, V46, P1153, DOI 10.1021/jm020334u; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; SHI LC, 1995, VIROLOGY, V208, P38, DOI 10.1006/viro.1995.1127; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; TOMASSINI J, 1994, ANTIMICROB AGENTS CH, V38, P2827, DOI 10.1128/AAC.38.12.2827; Tomassini JE, 1996, ANTIMICROB AGENTS CH, V40, P1189, DOI 10.1128/AAC.40.5.1189; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352	30	543	585	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					914	918		10.1038/nature07745	http://dx.doi.org/10.1038/nature07745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19194459				2022-12-24	WOS:000265182500048
J	Yu, YC; Bultje, RS; Wang, XQ; Shi, SH				Yu, Yong-Chun; Bultje, Ronald S.; Wang, Xiaoqun; Shi, Song-Hai			Specific synapses develop preferentially among sister excitatory neurons in the neocortex	NATURE			English	Article							RADIAL GLIAL-CELLS; CORTICAL-NEURONS; SYNAPTIC CONNECTIONS; CEREBRAL-CORTEX; VISUAL-CORTEX; RAT; PLASTICITY; CIRCUITS; LAYERS; MIGRATION	Neurons in the mammalian neocortex are organized into functional columns(1,2). Within a column, highly specific synaptic connections are formed to ensure that similar physiological properties are shared by neuron ensembles spanning from the pia to the white matter. Recent studies indicate that synaptic connectivity in the neocortex is sparse and highly specific(3-8) to allow even adjacent neurons to convey information independently(9-12). How this fine-scale microcircuit is constructed to create a functional columnar architecture at the level of individual neurons largely remains a mystery. Here we investigate whether radial clones of excitatory neurons arising from the same mother cell in the developing neocortex serve as a substrate for the formation of this highly specific microcircuit. We labelled ontogenetic radial clones of excitatory neurons in the mouse neocortex by in utero intraventricular injection of enhanced green fluorescent protein (EGFP)-expressing retroviruses around the onset of the peak phase of neocortical neurogenesis. Multiple-electrode whole-cell recordings were performed to probe synapse formation among these EGFP-labelled sister excitatory neurons in radial clones and the adjacent non-siblings during postnatal stages. We found that radially aligned sister excitatory neurons have a propensity for developing unidirectional chemical synapses with each other rather than with neighbouring non-siblings. Moreover, these synaptic connections display the same interlaminar directional preference as those observed in the mature neocortex. These results indicate that specific microcircuits develop preferentially within ontogenetic radial clones of excitatory neurons in the developing neocortex and contribute to the emergence of functional columnar micro-architectures in the mature neocortex.	[Yu, Yong-Chun; Bultje, Ronald S.; Wang, Xiaoqun; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Bultje, Ronald S.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Shi, SH (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	shis@mskcc.org			March of Dimes Foundation; Whitehall Foundation; Klingenstein Foundation; DANA Foundation; Autism Speaks Foundation; National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); Whitehall Foundation; Klingenstein Foundation(Klingenstein Philanthropies); DANA Foundation; Autism Speaks Foundation; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. L. Joyner, J. Kaltschmidt, Y. Hayashi and Y. Chin for comments on the manuscript; and S. C. Noctor and F. H. Gage for providing the 293gp NIT - GFP retrovirus packaging cell line; and the Shi laboratory members for insightful discussion. We are grateful for support from the March of Dimes Foundation, the Whitehall Foundation, the Klingenstein Foundation, the DANA Foundation, the Autism Speaks Foundation, the National Alliance for Research on Schizophrenia and Depression (NARSAD) and the National Institutes of Health ( to S.-H. S.).	CEPKO CL, 1990, COLD SH Q B, V55, P265; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P374, DOI 10.1152/jn.1957.20.4.374; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	30	226	228	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					501	U3		10.1038/nature07722	http://dx.doi.org/10.1038/nature07722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19204731	Green Accepted			2022-12-24	WOS:000264532400043
J	Kwiatkowski, TJ; Bosco, DA; LeClerc, AL; Tamrazian, E; Vanderburg, CR; Russ, C; Davis, A; Gilchrist, J; Kasarskis, EJ; Munsat, T; Valdmanis, P; Rouleau, GA; Hosler, BA; Cortelli, P; de Jong, PJ; Yoshinaga, Y; Haines, JL; Pericak-Vance, MA; Yan, J; Ticozzi, N; Siddique, T; McKenna-Yasek, D; Sapp, PC; Horvitz, HR; Landers, JE; Brown, RH				Kwiatkowski, T. J., Jr.; Bosco, D. A.; LeClerc, A. L.; Tamrazian, E.; Vanderburg, C. R.; Russ, C.; Davis, A.; Gilchrist, J.; Kasarskis, E. J.; Munsat, T.; Valdmanis, P.; Rouleau, G. A.; Hosler, B. A.; Cortelli, P.; de Jong, P. J.; Yoshinaga, Y.; Haines, J. L.; Pericak-Vance, M. A.; Yan, J.; Ticozzi, N.; Siddique, T.; McKenna-Yasek, D.; Sapp, P. C.; Horvitz, H. R.; Landers, J. E.; Brown, R. H., Jr.			Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis	SCIENCE			English	Article							RNA-BINDING PROTEIN; PRO-ONCOPROTEIN TLS/FUS; TARDBP MUTATIONS; TLS; IDENTIFICATION; TRANSCRIPTION; LIPOSARCOMA; ACTIVATION; NUCLEAR; DISEASE	Amyotrophic lateral sclerosis (ALS) is a fatal degenerative motor neuron disorder. Ten percent of cases are inherited; most involve unidentified genes. We report here 13 mutations in the fused in sarcoma/translated in liposarcoma (FUS/TLS) gene on chromosome 16 that were specific for familial ALS. The FUS/TLS protein binds to RNA, functions in diverse processes, and is normally located predominantly in the nucleus. In contrast, the mutant forms of FUS/TLS accumulated in the cytoplasm of neurons, a pathology that is similar to that of the gene TAR DNA-binding protein 43 (TDP43), whose mutations also cause ALS. Neuronal cytoplasmic protein aggregation and defective RNA metabolism thus appear to be common pathogenic mechanisms involved in ALS and possibly in other neurodegenerative disorders.	[Kwiatkowski, T. J., Jr.; Bosco, D. A.; LeClerc, A. L.; Tamrazian, E.; Russ, C.; Davis, A.; Hosler, B. A.; Yan, J.; Ticozzi, N.; McKenna-Yasek, D.; Sapp, P. C.; Landers, J. E.; Brown, R. H., Jr.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Bosco, D. A.; LeClerc, A. L.; Landers, J. E.; Brown, R. H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; [Vanderburg, C. R.] Massachusetts Gen Hosp, Massachusetts Gen Inst Neurodegenerat, Charlestown, MA 02129 USA; [Russ, C.] MIT, Broad Inst, Cambridge, MA 02141 USA; [Gilchrist, J.] Rhode Isl Hosp, Dept Neurol, Providence, RI 02912 USA; [Kasarskis, E. J.] Univ Kentucky, Vet Affairs Med Ctr, Dept Neurol, Lexington, KY 40511 USA; [Munsat, T.] Tufts Univ, Tufts New England Med Ctr, Dept Neurol, Boston, MA 02111 USA; [Valdmanis, P.; Rouleau, G. A.] Univ Montreal, Ctr Hosp, Ctr Rech, Dept Neurol, Montreal, PQ H2L 4M1, Canada; [Cortelli, P.] Univ Bologna, Dipartimento Sci Neurol, Neurol Clin, I-40123 Bologna, Italy; [de Jong, P. J.; Yoshinaga, Y.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Haines, J. L.] Vanderbilt Univ, Ctr Human Genet Res Mol Physiol & Biophys, Nashville, TN 37240 USA; [Pericak-Vance, M. A.] Miami Inst Human Genet, Miami, FL 33136 USA; [Yan, J.; Siddique, T.] NW Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Yan, J.; Siddique, T.] NW Feinberg Sch Med, Dept Mol & Cell Biol, Chicago, IL 60611 USA; [Ticozzi, N.] Univ Milan, Sch Med, Dept Neurol, Dino Ferrari Ctr,Ist Auxol Italiano, I-20149 Milan, Italy; [Sapp, P. C.; Horvitz, H. R.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Lifespan Health Rhode Island; Rhode Island Hospital; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; Tufts Medical Center; Tufts University; Universite de Montreal; University of Bologna; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; IRCCS Istituto Auxologico Italiano; University of Milan; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Kwiatkowski, TJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, 114 16th St, Charlestown, MA 02129 USA.	tkwiatkowski@partners.org; robert.brown@umassmed.edu	Siddique, Teepu/AAT-8166-2021; Cortelli, Pietro/K-6063-2016; Ticozzi, Nicola/K-8094-2016; Haines, Jonathan/C-3374-2012; Vanderburg, Charles/C-4516-2013	Ticozzi, Nicola/0000-0001-5963-7426; Haines, Jonathan/0000-0002-4351-4728; Landers, John/0000-0001-8084-5043; Siddique, Teepu/0000-0001-7293-9146; Valdmanis, Paul/0000-0001-8840-6969; Cortelli, Pietro/0000-0002-3633-8818; Tamrazian, Eric/0000-0003-1935-5277; Vanderburg, Charles/0000-0001-8979-5054	NIH [NS050557, NS050641]; Angel Fund; ALS Therapy Alliance; ALS Association Project ALS; Al-Athel ALS Research Foundation; Pierre L. de Bourgknecht ALS Research Foundation; The Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; Ralph and Marian Falk Medical Research Trust; The David C. Asselin M.D. Memorial Fund; Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship; Help America Foundation; ALS Therapy Alliance, Inc.; Howard Hughes Medical Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Angel Fund; ALS Therapy Alliance; ALS Association Project ALS; Al-Athel ALS Research Foundation; Pierre L. de Bourgknecht ALS Research Foundation; The Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; Ralph and Marian Falk Medical Research Trust; The David C. Asselin M.D. Memorial Fund; Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship; Help America Foundation; ALS Therapy Alliance, Inc.; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We gratefully acknowledge I. Carr (University of Leeds, UK) for support with AutoSNPa and IBDfinder software, A. Storey for assistance with sequencing, C. LeClerc for genealogical investigations, and D. Crowe for administrative assistance. This work was supported by NIH grants NS050557 (R.H.B. and T.K.) and NS050641 (T.S., R.H.B., J.L. H., and M.P.-V.). R.H.B. also receives support from the Angel Fund, the ALS Therapy Alliance, the ALS Association Project ALS, the Al-Athel ALS Research Foundation, and the Pierre L. de Bourgknecht ALS Research Foundation. T.S. also receives support from The Les Turner ALS Foundation, Vena E. Schaff ALS Research Fund, Harold Post Research Professorship, Herbert and Florence C. Wenske Foundation, Ralph and Marian Falk Medical Research Trust, The David C. Asselin M.D. Memorial Fund, Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship, Help America Foundation and the ALS Therapy Alliance, Inc. H.R.H. is an investigator of and was supported by the Howard Hughes Medical Institute. R.H.B. is a cofounder of AviTx Inc., which targets development of ALS therapies. R.H.B. and T.J.K. have applied for a patent covering FUS mutations in ALS. We dedicate this report to the memories of Jimmy and Christopher Kennedy, Sharon Timlin, and Ginny Delvecchio.	Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; Bertrand P, 1999, ONCOGENE, V18, P4515, DOI 10.1038/sj.onc.1203048; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Morohoshi F, 1998, GENE, V221, P191, DOI 10.1016/S0378-1119(98)00463-6; Nelson LM, 1996, CLIN NEUROSCI, V3, P327; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761	22	1853	1915	4	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1205	1208		10.1126/science.1166066	http://dx.doi.org/10.1126/science.1166066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251627				2022-12-24	WOS:000263687600036
J	Chandler, RK; Fletcher, BW; Volkow, ND				Chandler, Redonna K.; Fletcher, Bennett W.; Volkow, Nora D.			Treating Drug Abuse and Addiction in the Criminal Justice System Improving Public Health and Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CLINICAL-TRIAL; HIV-INFECTED PRISONERS; METHADONE-MAINTENANCE; COCAINE ADDICTION; HEPATITIS-C; CORRECTIONAL POPULATIONS; COOCCURRING DISORDERS; ORBITOFRONTAL CORTEX; NEURAL SYSTEMS; SELF-CONTROL	Despite increasing evidence that addiction is a treatable disease of the brain, most individuals do not receive treatment. Involvement in the criminal justice system often results from illegal drug- seeking behavior and participation in illegal activities that reflect, in part, disrupted behavior ensuing from brain changes triggered by repeated drug use. Treating drug- involved offenders provides a unique opportunity to decrease substance abuse and reduce associated criminal behavior. Emerging neuroscience has the potential to transform traditional sanction- oriented public safety approaches by providing new therapeutic strategies against addiction that could be used in the criminal justice system. We summarize relevant neuroscientific findings and evidence- based principles of addiction treatment that, if implemented in the criminal justice system, could help improve public heath and reduce criminal behavior.	[Chandler, Redonna K.; Fletcher, Bennett W.; Volkow, Nora D.] Natl Inst Drug Abuse, Serv Res Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Volkow, ND (corresponding author), Natl Inst Drug Abuse, Serv Res Branch, 6001 Execut Blvd,Room 5274, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			Intramural NIH HHS [Z99 DA999999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABRAM KM, 1991, AM PSYCHOL, V46, P1036, DOI 10.1037/0003-066X.46.10.1036; Allen SA, 2003, ANN INTERN MED, V138, P187, DOI 10.7326/0003-4819-138-3-200302040-00010; [Anonymous], 1999, PRISON J, DOI DOI 10.1177/0032885599079003002; [Anonymous], 1999, PRISON J, DOI DOI 10.1177/0032885599079004003; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bickel WK, 2007, DRUG ALCOHOL DEPEN, V90, pS85, DOI 10.1016/j.drugalcdep.2006.09.016; Binswanger IA, 2007, NEW ENGL J MED, V356, P536; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Boutwell AE, 2005, CLIN INFECT DIS, V40, pS367, DOI 10.1086/427455; Butzin CA, 2006, J CRIM JUST, V34, P557, DOI 10.1016/j.jcrimjus.2006.09.010; Chandler RK, 2004, BEHAV SCI LAW, V22, P431, DOI 10.1002/bsl.598; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; Comer SD, 2002, PSYCHOPHARMACOLOGY, V159, P351, DOI 10.1007/s002130100909; Cropsey KL, 2005, SUBST USE MISUSE, V40, P1983, DOI 10.1080/10826080500294866; Dackis C, 2005, NAT NEUROSCI, V8, P1431, DOI 10.1038/nn1105-1431; Daley M., 2004, J OFFENDER REHABILIT, V39, P69, DOI DOI 10.1300/J076V39N03_04; DELEON G, 1997, COMMUNITY METHOD THE, P3; Desai AA, 2002, AIDS EDUC PREV, V14, P45, DOI 10.1521/aeap.14.7.45.23867; Ersche KD, 2007, NEUROPSYCHOL REV, V17, P317, DOI 10.1007/s11065-007-9033-y; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fellows LK, 2007, ANN NY ACAD SCI, V1121, P421, DOI 10.1196/annals.1401.023; FIELD G, 2004, TREATING ADDICTED OF; FLETCHER BW, 2006, NIH PUBLICATION; Flynn PM, 1999, DRUG ALCOHOL DEPEN, V57, P167, DOI 10.1016/S0376-8716(99)00083-6; Freudenberg N, 2001, J URBAN HEALTH, V78, P214, DOI 10.1093/jurban/78.2.214; GLAZE LE, 2006, DEP JUSTICE PUBLICAT; Gordon MS, 2008, ADDICTION, V103, P1333, DOI 10.1111/j.1360-0443.2008.002238.x; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P737, DOI 10.1001/jama.297.7.737; Gray MA, 2007, NEURON, V54, P183, DOI 10.1016/j.neuron.2007.03.024; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Hammett TM, 2001, CRIME DELINQUENCY, V47, P390, DOI 10.1177/0011128701047003006; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Humphreys K, 2004, J SUBST ABUSE TREAT, V26, P151, DOI 10.1016/S0740-5472(03)00212-5; Inciardi JA, 1997, J DRUG ISSUES, V27, P261, DOI 10.1177/002204269702700206; Jensen EL., 2004, CRIMINAL JUSTICE POL, V15, P100, DOI [10.1177/0887403403255315, DOI 10.1177/0887403403255315]; Johnson BA, 2007, JAMA-J AM MED ASSOC, V298, P1641, DOI 10.1001/jama.298.14.1641; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Karberg J. C., 2005, DEP JUSTICE PUBLICAT, VNCJ209588; Kinlock TW, 2008, CRIM JUSTICE BEHAV, V35, P34, DOI 10.1177/0093854807309111; Kinlock TW, 2007, DRUG ALCOHOL DEPEN, V91, P220, DOI 10.1016/j.drugalcdep.2007.05.022; Knight K, 2004, TREATING ADDICTED OF; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kosten TR, 1998, AM J PSYCHIAT, V155, P711; Kosten TR, 1998, J NERV MENT DIS, V186, P737, DOI 10.1097/00005053-199812000-00001; LANGAN PA, 2002, DEP JUSTICE PUBLICAT; LEUKEFELD CG, 2002, TREATMENT DRUG OFFEN; Logan TK, 2004, EVAL PROGRAM PLANN, V27, P381, DOI 10.1016/j.evalprogplan.2004.04.012; Lurigio AJ, 2000, CRIM JUSTICE BEHAV, V27, P495, DOI 10.1177/0093854800027004005; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; McCollister KE, 2004, JUSTICE Q, V21, P659, DOI 10.1080/07418820400095941; MITCHELL O, 2007, J EXPT CRIMINOLOGY, V0003; Mumola CJ, 2006, DEP JUSTICE PUBLICAT; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Peters RH, 2000, CRIM JUSTICE BEHAV, V27, P72, DOI 10.1177/0093854800027001005; Prendergast ML, 2002, DRUG ALCOHOL DEPEN, V67, P53, DOI 10.1016/S0376-8716(02)00014-5; Rich JD, 2005, J ADDICT DIS, V24, P49, DOI 10.1300/J069v24n03_04; Rich JD, 2005, J URBAN HEALTH, V82, P411, DOI 10.1093/jurban/jti072; Rich JD, 2001, J URBAN HEALTH, V78, P279, DOI 10.1093/jurban/78.2.279; Sabin KM, 2001, J URBAN HEALTH, V78, P241, DOI 10.1093/jurban/78.2.241; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Shivy VA, 2007, J COUNS PSYCHOL, V54, P466, DOI 10.1037/0022-0167.54.4.466; Simpler AH, 2005, ADDICT RES THEORY, V13, P503, DOI 10.1080/16066350500151739; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; STEPHAN JJ, 2004, DEP JUSTICE PUBLICAT; Taxman FS, 2007, J SUBST ABUSE TREAT, V32, P239, DOI 10.1016/j.jsat.2006.12.019; Uhl GR, 2004, NEUROPHARMACOLOGY, V47, P140, DOI 10.1016/j.neuropharm.2004.07.029; Uhl GR, 2004, ARCH GEN PSYCHIAT, V61, P223, DOI 10.1001/archpsyc.61.3.223; Vallabhaneni S, 2006, EPIDEMIOL INFECT, V134, P243, DOI 10.1017/S0950268805004991; Volkow N, 2005, NAT NEUROSCI, V8, P1429, DOI 10.1038/nn1105-1429; Volkow ND, 2005, PHARMACOL THERAPEUT, V108, P3, DOI 10.1016/j.pharmthera.2005.06.021; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Weinbaum CA, 2005, AIDS, V19, pS41, DOI 10.1097/01.aids.0000192069.95819.aa; Wexler HK, 2007, PRISON J, V87, P9, DOI 10.1177/0032885506299036; Wilson DB, 2005, CRIM JUSTICE BEHAV, V32, P172, DOI 10.1177/0093854804272889; Winstanley CA, 2007, ANN NY ACAD SCI, V1121, P639, DOI 10.1196/annals.1401.024; Wormith JS, 2007, CRIM JUSTICE BEHAV, V34, P879, DOI 10.1177/0093854807301552; Yucel M, 2007, AUST NZ J PSYCHIAT, V41, P957, DOI 10.1080/00048670701689444; Zaller N, 2007, PUBLIC HEALTH REP, V122, P49, DOI 10.1177/003335490712200107; Zarkin GA, 2005, HEALTH ECON, V14, P1133, DOI 10.1002/hec.999	82	357	359	2	52	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					183	190		10.1001/jama.2008.976	http://dx.doi.org/10.1001/jama.2008.976			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	393VV	19141766	Green Accepted			2022-12-24	WOS:000262405500020
J	Serganov, A; Huang, LL; Patel, DJ				Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.			Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch	NATURE			English	Article							MESSENGER-RNA; STRUCTURAL BASIS; BINDING; EXPRESSION; TRANSCRIPTION; RIBOSOME	The biosynthesis of several protein cofactors is subject to feedback regulation by riboswitches(1-3). Flavin mononucleotide (FMN)specific riboswitches(4,5), also known as RFN elements(6), direct expression of bacterial genes involved in the biosynthesis and transport of riboflavin (vitamin B-2) and related compounds. Here we present the crystal structures of the Fusobacterium nucleatum riboswitch bound to FMN, riboflavin and antibiotic roseoflavin(7). The FMN riboswitch structure, centred on an FMN-bound six-stem junction, does not fold by collinear stacking of adjacent helices, typical for folding of large RNAs. Rather, it adopts a butterfly-like scaffold, stapled together by opposingly directed but nearly identically folded peripheral domains. FMN is positioned asymmetrically within the junctional site and is specifically bound to RNA through interactions with the isoalloxazine ring chromophore and direct and Mg2+-mediated contacts with the phosphate moiety. Our structural data, complemented by binding and footprinting experiments, imply a largely pre-folded tertiary RNA architecture and FMN recognition mediated by conformational transitions within the junctional binding pocket. The inherent plasticity of the FMN-binding pocket and the availability of large openings make the riboswitch an attractive target for structure-based design of FMN-like antimicrobial compounds. Our studies also explain the effects of spontaneous and antibiotic-induced deregulatory mutations and provided molecular insights into FMN-based control of gene expression in normal and riboflavin-overproducing bacterial strains.	[Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Serganov, A (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	serganoa@mskcc.org; pateld@mskcc.org		Serganov, Alexander/0000-0001-8328-9310	the US Department of Energy; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073618] Funding Source: NIH RePORTER	the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel of beamline X29 at the Brookhaven National Laboratory and beamline 24-ID-C at the Advanced Photon Source, Argonne National Laboratory, funded by the US Department of Energy. We thank L. Jaeger (University of California, Santa Barbara) for discussions and O. Ouerfelli (Memorial Sloan-Kettering Cancer Center, New York) for the synthesis of iridium hexamine. D. J. P. was supported by funds from the National Institutes of Health.	Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Burgess C, 2004, APPL ENVIRON MICROB, V70, P5769, DOI 10.1128/AEM.70.10.5769-5777.2004; Burgess Catherine M, 2006, Microb Cell Fact, V5, P24, DOI 10.1186/1475-2859-5-24; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Fan P, 1996, J MOL BIOL, V258, P480, DOI 10.1006/jmbi.1996.0263; Feig A. L., 1999, RNA WORLD, P287; Garst AD, 2008, J BIOL CHEM, V283, P22347, DOI 10.1074/jbc.C800120200; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Jaeger L, 2009, NUCLEIC ACIDS RES, V37, P215, DOI 10.1093/nar/gkn911; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Serganov A, 1997, EUR J BIOCHEM, V246, P291, DOI 10.1111/j.1432-1033.1997.00291.x; Serganov A, 2003, EMBO J, V22, P1898, DOI 10.1093/emboj/cdg170; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899	35	181	198	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					233	U10		10.1038/nature07642	http://dx.doi.org/10.1038/nature07642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19169240	Green Accepted			2022-12-24	WOS:000264059700050
J	Lincoln, TA; Joyce, GF				Lincoln, Tracey A.; Joyce, Gerald F.			Self-Sustained Replication of an RNA Enzyme	SCIENCE			English	Article							LIGASE RIBOZYME; ORIGIN	An RNA enzyme that catalyzes the RNA-templated joining of RNA was converted to a format whereby two enzymes catalyze each other's synthesis from a total of four oligonucleotide substrates. These cross-replicating RNA enzymes undergo self-sustained exponential amplification in the absence of proteins or other biological materials. Amplification occurs with a doubling time of about 1 hour and can be continued indefinitely. Populations of various cross-replicating enzymes were constructed and allowed to compete for a common pool of substrates, during which recombinant replicators arose and grew to dominate the population. These replicating RNA enzymes can serve as an experimental model of a genetic system. Many such model systems could be constructed, allowing different selective outcomes to be related to the underlying properties of the genetic system.	[Lincoln, Tracey A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	gjoyce@scripps.edu			NASA [NNX07AJ23G]; NIH [R01GM065130]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065130] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Orgel for many stimulating discussions. This research was supported by grants from NASA (NNX07AJ23G) and NIH (R01GM065130) and by the Skaggs Institute for Chemical Biology.	CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kim DE, 2004, CHEM BIOL, V11, P1505, DOI 10.1016/j.chembiol.2004.08.021; Kim KS, 2008, FEBS LETT, V582, P2745, DOI 10.1016/j.febslet.2008.07.013; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Paul N, 2002, P NATL ACAD SCI USA, V99, P12733, DOI 10.1073/pnas.202471099; Rogers J, 2001, RNA, V7, P395, DOI 10.1017/S135583820100228X; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176	8	413	431	17	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1229	1232		10.1126/science.1167856	http://dx.doi.org/10.1126/science.1167856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19131595	Green Accepted			2022-12-24	WOS:000263687600043
J	Brown, SP; Hestrin, S				Brown, Solange P.; Hestrin, Shaul			Intracortical circuits of pyramidal neurons reflect their long-range axonal targets	NATURE			English	Article							VISUAL-CORTEX; LAYER-V; CORTICOSTRIATAL NEURONS; SYNAPTIC CONNECTIONS; PROJECTION NEURONS; MORPHOLOGY; CELLS; CORTICOPONTINE; ORGANIZATION; PATTERNS	Cortical columns generate separate streams of information that are distributed to numerous cortical and subcortical brain regions(1). We asked whether local intracortical circuits reflect these different processing streams by testing whether the intracortical connectivity among pyramidal neurons reflects their long-range axonal targets. We recorded simultaneously from up to four retrogradely labelled pyramidal neurons that projected to the superior colliculus, the contralateral striatum or the contralateral cortex to assess their synaptic connectivity. Here we show that the probability of synaptic connection depends on the functional identities of both the presynaptic and postsynaptic neurons. We first found that the frequency of monosynaptic connections among corticostriatal pyramidal neurons is significantly higher than among corticocortical or corticotectal pyramidal neurons. We then show that the probability of feed-forward connections from corticocortical neurons to corticotectal neurons is approximately three- to four-fold higher than the probability of monosynaptic connections among corticocortical or corticotectal cells. Moreover, we found that the average axodendritic overlap of the presynaptic and postsynaptic pyramidal neurons could not fully explain the differences in connection probability that we observed. The selective synaptic interactions we describe demonstrate that the organization of local networks of pyramidal cells reflects the long-range targets of both the presynaptic and postsynaptic neurons.	[Brown, Solange P.; Hestrin, Shaul] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA	Stanford University	Hestrin, S (corresponding author), Stanford Univ, Sch Med, Dept Comparat Med, 300 Pasteur Dr,Edwards Bldg,R314, Stanford, CA 94305 USA.	shaul.hestrin@stanford.edu	Brown, Solange/H-1615-2012; Hestrin, Shaul/F-4410-2010		National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY009120, R01EY012114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Li and S. Pak for technical assistance. This work was supported by National Institutes of Health grants to S. P. B and to S. H.	Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1998, CORTEX STAT GEOMETRY; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frick A, 2008, CEREB CORTEX, V18, P397, DOI 10.1093/cercor/bhm074; HALLMAN LE, 1988, J COMP NEUROL, V272, P149, DOI 10.1002/cne.902720111; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; HUBENER M, 1988, NEUROSCI LETT, V94, P76, DOI 10.1016/0304-3940(88)90273-X; Jones E. G., 1984, CELLULAR COMPONENTS, P521; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; KASPER EM, 1994, J COMP NEUROL, V339, P459, DOI 10.1002/cne.903390402; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; KISVARDAY ZF, 1986, EXP BRAIN RES, V64, P541, DOI 10.1007/BF00340492; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Larsen DD, 2008, FRONT NEURAL CIRCUIT, V1, DOI 10.3389/neuro.04.005.2007; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MCGUIRE BA, 1984, J NEUROSCI, V4, P3021; Mercer A, 2005, CEREB CORTEX, V15, P1485, DOI 10.1093/cercor/bhi027; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; SINGER W, 1975, J NEUROPHYSIOL, V38, P1080, DOI 10.1152/jn.1975.38.5.1080; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; SWADLOW HA, 1988, J NEUROPHYSIOL, V59, P1162, DOI 10.1152/jn.1988.59.4.1162; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WANG Z, 1993, J NEUROSCI, V13, P2199; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	36	239	242	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1133	U89		10.1038/nature07658	http://dx.doi.org/10.1038/nature07658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19151698	Green Accepted			2022-12-24	WOS:000263680100041
J	Petreanu, L; Mao, TY; Sternson, SM; Svoboda, K				Petreanu, Leopoldo; Mao, Tianyi; Sternson, Scott M.; Svoboda, Karel			The subcellular organization of neocortical excitatory connections	NATURE			English	Article							RAT BARREL CORTEX; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; PYRAMIDAL NEURONS; SYNAPTIC CONNECTIVITY; VISUAL-CORTEX; MOTOR CORTEX; DENDRITES; CIRCUIT; CHANNELRHODOPSIN-2; PROJECTIONS	Understanding cortical circuits will require mapping the connections between specific populations of neurons(1), as well as determining the dendritic locations where the synapses occur(2). The dendrites of individual cortical neurons overlap with numerous types of local and long-range excitatory axons, but axodendritic overlap is not always a good predictor of actual connection strength(3-5). Here we developed an efficient channelrhodopsin-2 (ChR2)-assisted method(6-8) to map the spatial distribution of synaptic inputs, defined by presynaptic ChR2 expression, within the dendritic arborizations of recorded neurons. We expressed ChR2 in two thalamic nuclei, the whisker motor cortex and local excitatory neurons and mapped their synapses with pyramidal neurons in layers 3, 5A and 5B (L3, L5A and L5B) in the mouse barrel cortex. Within the dendritic arborizations of L3 cells, individual inputs impinged onto distinct single domains. These domains were arrayed in an orderly, monotonic pattern along the apical axis: axons from more central origins targeted progressively higher regions of the apical dendrites. In L5 arborizations, different inputs targeted separate basal and apical domains. Input to L3 and L5 dendrites in L1 was related to whisker movement and position, suggesting that these signals have a role in controlling the gain of their target neurons(9). Our experiments reveal high specificity in the subcellular organization of excitatory circuits.	[Petreanu, Leopoldo; Mao, Tianyi; Sternson, Scott M.; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org		Petreanu, Leopoldo/0000-0003-1434-4691; Mao, Tianyi/0000-0002-3532-8319	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Liao GY, 2008, GENESIS, V46, P289, DOI 10.1002/dvg.20393; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; White EL, 2002, J NEUROCYTOL, V31, P195, DOI 10.1023/A:1024109606722; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	34	670	674	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1142	U100		10.1038/nature07709	http://dx.doi.org/10.1038/nature07709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19151697	Green Accepted			2022-12-24	WOS:000263680100043
J	Durham, WM; Kessler, JO; Stocker, R				Durham, William M.; Kessler, John O.; Stocker, Roman			Disruption of Vertical Motility by Shear Triggers Formation of Thin Phytoplankton Layers	SCIENCE			English	Article							MICROORGANISMS; BLOOM; MECHANISMS; PATTERNS; PLANKTON; MODEL; FLOW	Thin layers of phytoplankton are important hotspots of ecological activity that are found in the coastal ocean, meters beneath the surface, and contain cell concentrations up to two orders of magnitude above ambient concentrations. Current interpretations of their formation favor abiotic processes, yet many phytoplankton species found in these layers are motile. We demonstrated that layers formed when the vertical migration of phytoplankton was disrupted by hydrodynamic shear. This mechanism, which we call gyrotactic trapping, can be responsible for the thin layers of phytoplankton commonly observed in the ocean. These results reveal that the coupling between active microorganism motility and ambient fluid motion can shape the macroscopic features of the marine ecological landscape.	[Durham, William M.; Stocker, Roman] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Kessler, John O.] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA	Massachusetts Institute of Technology (MIT); University of Arizona	Stocker, R (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	romans@mit.edu	Stocker, Roman/N-8987-2019; Stocker, Roman/T-9456-2017	Stocker, Roman/0000-0002-3199-0508	National Defense Science and Engineering Graduate Fellowship; Department of Energy [W31-109-ENG38]; NSF [OCE 0526241, OCE CAREER 0744641]; MIT's Earth Systems Initiative; Doherty Professorship	National Defense Science and Engineering Graduate Fellowship; Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); MIT's Earth Systems Initiative; Doherty Professorship	We thank P. Franks, W. Young, D. Grunbaum, T. Cowles, R. Bearon, M. Bees, D. Hader, D. Anderson, M. McManus, and L. Karp-Boss for helpful discussions; T. Peacock for the loan of experimental equipment; T. Clay and S. Stransky for developing BacTrack; R. A. Cattolico for providing H. akashiwo; and J. Mitchell, E. DeLong, S. Chisholm, M. Polz, H. Nepf, J. Seymour, J. Bragg, B. Kirkup, P. Reis, D. Birch, and S. Sunghwan for comments on the manuscript. W. M. D. acknowledges a National Defense Science and Engineering Graduate Fellowship. J.O.K. acknowledges support from Department of Energy grant W31-109-ENG38. R. S. acknowledges support from NSF (OCE 0526241 and OCE CAREER 0744641), MIT's Earth Systems Initiative, and a Doherty Professorship.	Alldredge AL, 2002, MAR ECOL PROG SER, V233, P1, DOI 10.3354/meps233001; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Birch DA, 2008, DEEP-SEA RES PT I, V55, P277, DOI 10.1016/j.dsr.2007.11.009; BJORNSEN PK, 1991, MAR ECOL PROG SER, V73, P263, DOI 10.3354/meps073263; Cowles T., 2003, HDB SCALING METHODS, P31; Cowles T.J., 1998, OCEANOGRAPHY, V11, P4, DOI [DOI 10.5670/OCEANOG.1998.08, DOI 10.5670/0CEAN0G.1998.08]; Dekshenieks MM, 2001, MAR ECOL PROG SER, V223, P61, DOI 10.3354/meps223061; Donaghay PL, 1997, LIMNOL OCEANOGR, V42, P1283, DOI 10.4319/lo.1997.42.5_part_2.1283; FRANKS PJS, 1995, DEEP-SEA RES PT I, V42, P75, DOI 10.1016/0967-0637(94)00028-Q; Genin A, 2005, SCIENCE, V308, P860, DOI 10.1126/science.1107834; Hill J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068101; Hill NA, 1997, J THEOR BIOL, V186, P503, DOI 10.1006/jtbi.1997.0421; JONES MS, 1994, J FLUID MECH, V281, P137, DOI 10.1017/S002211209400306X; KAMYKOWSKI D, 1992, MAR BIOL, V113, P319; Kessler J.O., 1986, Progress phycol. Res., V4, P257; KESSLER JO, 1985, NATURE, V313, P218, DOI 10.1038/313218a0; LASKER R, 1975, FISH B-NOAA, V73, P453; Lebert M, 1996, NATURE, V379, P590, DOI 10.1038/379590a0; McManus MA, 2003, MAR ECOL PROG SER, V261, P1, DOI 10.3354/meps261001; Mitchell JG, 2008, J MARINE SYST, V69, P247, DOI 10.1016/j.jmarsys.2006.01.019; Mouritsen LT, 2003, J PLANKTON RES, V25, P783, DOI 10.1093/plankt/25.7.783; NIELSEN TG, 1990, MAR ECOL PROG SER, V62, P21, DOI 10.3354/meps062021; PEDLEY TJ, 1988, J FLUID MECH, V195, P223, DOI 10.1017/S0022112088002393; Roberts AM, 2002, J FLUID MECH, V452, P405, DOI 10.1017/S0022112001006772; Ryan JP, 2008, MAR ECOL PROG SER, V354, P21, DOI 10.3354/meps07222; Stacey MT, 2007, LIMNOL OCEANOGR, V52, P1523, DOI 10.4319/lo.2007.52.4.1523; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Townsend DW, 2005, DEEP-SEA RES PT II, V52, P2603, DOI 10.1016/j.dsr2.2005.06.028; YAMOCHI S, 1984, MAR BIOL, V83, P255, DOI 10.1007/BF00397457	30	203	205	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1067	1070		10.1126/science.1167334	http://dx.doi.org/10.1126/science.1167334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229037				2022-12-24	WOS:000263478400044
J	Gerber, LR; Morissette, L; Kaschner, K; Pauly, D				Gerber, Leah R.; Morissette, Lyne; Kaschner, Kristin; Pauly, Daniel			ECOLOGY Should Whales Be Culled to Increase Fishery Yield?	SCIENCE			English	Editorial Material							DIVERSITY; ISSUE		[Gerber, Leah R.; Morissette, Lyne; Kaschner, Kristin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Morissette, Lyne] Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Kaschner, Kristin] Univ Freiburg, Inst Biol & Zool, Evolut Biol & Ecol Lab, Freiburg, Germany; [Pauly, Daniel] Univ British Columbia, Sea Around Us Project, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	Arizona State University; Arizona State University-Tempe; University of Freiburg; University of British Columbia	Gerber, LR (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	leah.gerber@asu.edu	Kaschner, Kristin/GQQ-6475-2022; Pauly, Daniel Marc/AAY-2316-2021	Gerber, Leah/0000-0002-6763-6842; Pauly, Daniel/0000-0003-3756-4793; Kaschner, Kristin/0000-0002-4061-626X				3rd Millennium Foundation, 2007, JAP VOT CONS OP INT; Acevedo J, 2007, MAR MAMMAL SCI, V23, P453, DOI 10.1111/j.1748-7692.2007.00116.x; Bogstad Bjarte, 1997, Journal of Northwest Atlantic Fishery Science, V22, P317; BUSBY L, 2004, GLOBAL CORRUPTION RE, P76; Clapham PJ, 2007, MAR POLICY, V31, P314, DOI 10.1016/j.marpol.2006.09.004; Corkeron PJ, 2009, MAR ECOL PROG SER, V375, P305, DOI 10.3354/meps07882; Corkeron PJ, 2004, CONSERV BIOL, V18, P847, DOI 10.1111/j.1523-1739.2004.00255.x; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Gales NJ, 2005, NATURE, V435, P883, DOI 10.1038/435883a; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Herrera GE, 2006, MAR POLICY, V30, P261, DOI 10.1016/j.marpol.2004.12.005; Higham JES, 2007, CONSERV BIOL, V21, P554, DOI 10.1111/j.1523-1739.2006.00580.x; Holt SJ, 2007, MAR POLLUT BULL, V54, P1081, DOI 10.1016/j.marpolbul.2007.05.011; Hoyt E, 2002, COAST MANAGE, V30, P381, DOI 10.1080/089207502900273; *IWC, 2002, ICES J MAR SCI, V4, P325; *IWC, 2008, S UT DUR RESS MAR VI; *IWC, 2008, SCI COMM REP 60 ANN; *IWC, 2006, CHAIRM REP INT WHAL; *IWC, 2004, ICES J MAR SCI S, V6, P413; Jann B., 2003, Journal of Cetacean Research and Management, V5, P125; KASCHNER K, 2005, STATE ANIMALS, V3, P95; KATONA S. K., 1990, REPORT INT WHALING C, P295; Komatsu M., 2001, TRUTH WHALING DISPUT; Miller AR, 2007, GLOBAL ENVIRON POLIT, V7, P69, DOI 10.1162/glep.2007.7.1.69; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; PAULY D, 2008, SEA AROUND US PROJEC; Perrin WF, 2002, ENCY MARINE MAMMALS; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Stefansson Gunnar, 1997, Journal of Northwest Atlantic Fishery Science, V22, P357; Stringer KD, 2006, DIPL STATECRAFT, V17, P547, DOI 10.1080/09592290600867636; Tamura T, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P143, DOI 10.1079/9780851996332.0143; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	37	48	49	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					880	881		10.1126/science.1169981	http://dx.doi.org/10.1126/science.1169981			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213900				2022-12-24	WOS:000263295400022
J	Paterson, AH; Bowers, JE; Bruggmann, R; Dubchak, I; Grimwood, J; Gundlach, H; Haberer, G; Hellsten, U; Mitros, T; Poliakov, A; Schmutz, J; Spannagl, M; Tang, HB; Wang, XY; Wicker, T; Bharti, AK; Chapman, J; Feltus, FA; Gowik, U; Grigoriev, IV; Lyons, E; Maher, CA; Martis, M; Narechania, A; Otillar, RP; Penning, BW; Salamov, AA; Wang, Y; Zhang, LF; Carpita, NC; Freeling, M; Gingle, AR; Hash, CT; Keller, B; Klein, P; Kresovich, S; McCann, MC; Ming, R; Peterson, DG; Mehboob-ur-Rahman; Ware, D; Westhoff, P; Mayer, KFX; Messing, J; Rokhsar, DS				Paterson, Andrew H.; Bowers, John E.; Bruggmann, Remy; Dubchak, Inna; Grimwood, Jane; Gundlach, Heidrun; Haberer, Georg; Hellsten, Uffe; Mitros, Therese; Poliakov, Alexander; Schmutz, Jeremy; Spannagl, Manuel; Tang, Haibao; Wang, Xiyin; Wicker, Thomas; Bharti, Arvind K.; Chapman, Jarrod; Feltus, F. Alex; Gowik, Udo; Grigoriev, Igor V.; Lyons, Eric; Maher, Christopher A.; Martis, Mihaela; Narechania, Apurva; Otillar, Robert P.; Penning, Bryan W.; Salamov, Asaf A.; Wang, Yu; Zhang, Lifang; Carpita, Nicholas C.; Freeling, Michael; Gingle, Alan R.; Hash, C. Thomas; Keller, Beat; Klein, Patricia; Kresovich, Stephen; McCann, Maureen C.; Ming, Ray; Peterson, Daniel G.; Mehboob-ur-Rahman; Ware, Doreen; Westhoff, Peter; Mayer, Klaus F. X.; Messing, Joachim; Rokhsar, Daniel S.			The Sorghum bicolor genome and the diversification of grasses	NATURE			English	Article							RICE GENOME; WIDE ANALYSIS; MAIZE GENOME; CELL-WALLS; EVOLUTION; SEQUENCE; IDENTIFICATION; RECOMBINATION; DUPLICATION; REVEALS	Sorghum, an African grass related to sugar cane and maize, is grown for food, feed, fibre and fuel. We present an initial analysis of the similar to 730- megabase Sorghumbicolor ( L.) Moench genome, placing, 98% of genes in their chromosomal context using whole- genome shotgun sequence validated by genetic, physical and syntenic information. Genetic recombination is largely confined to about one- third of the sorghum genome with gene order and density similar to those of rice. Retrotransposon accumulation in recombinationally recalcitrant heterochromatin explains the similar to 75% larger genome size of sorghum compared with rice. Although gene and repetitive DNA distributions have been preserved since palaeopolyploidization similar to 70 million years ago, most duplicated gene sets lost one member before the sorghum - rice divergence. Concerted evolution makes one duplicated chromosomal segment appear to be only a few million years old. About 24% of genes are grass- specific and 7% are sorghum- specific. Recent gene and microRNA duplications may contribute to sorghum's drought tolerance.	[Paterson, Andrew H.; Bowers, John E.; Tang, Haibao; Wang, Xiyin; Feltus, F. Alex; Gingle, Alan R.; Peterson, Daniel G.; Mehboob-ur-Rahman] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Bruggmann, Remy; Bharti, Arvind K.; Messing, Joachim] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Dubchak, Inna; Hellsten, Uffe; Poliakov, Alexander; Chapman, Jarrod; Grigoriev, Igor V.; Otillar, Robert P.; Salamov, Asaf A.; Rokhsar, Daniel S.] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Grimwood, Jane; Schmutz, Jeremy; Rokhsar, Daniel S.] Stanford Univ, Stanford Human Genome Ctr, Palo Alto, CA 94304 USA; [Gundlach, Heidrun; Haberer, Georg; Spannagl, Manuel; Martis, Mihaela; Wang, Yu; Mayer, Klaus F. X.] Helmholtz Zentrum Munchen, MIPS IBIS, D-85764 Neuherberg, Germany; [Mitros, Therese] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Wang, Xiyin] Hebei Polytech Univ, Coll Sci, Tangshan 063000, Hebei, Peoples R China; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Feltus, F. Alex] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29631 USA; [Gowik, Udo; Westhoff, Peter] Univ Dusseldorf, Inst Entwicklungs & Mol Biol Pflanzen, D-40225 Dusseldorf, Germany; [Lyons, Eric; Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA; [Maher, Christopher A.; Narechania, Apurva; Zhang, Lifang] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Penning, Bryan W.; McCann, Maureen C.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Carpita, Nicholas C.] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Hash, C. Thomas] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Andhra Pradesh, India; [Klein, Patricia] Texas A&M Univ, Dept Hort, College Stn, TX 77843 USA; [Klein, Patricia] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; [Kresovich, Stephen] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Ming, Ray] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Peterson, Daniel G.] Mississippi State Univ, Mississippi Genome Explorat Lab, Starkville, MS 39762 USA; [Mehboob-ur-Rahman] NIBGE, Faisalabad, Pakistan; [Ware, Doreen] USDA, NAA Robert Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	University System of Georgia; University of Georgia; Rutgers State University New Brunswick; United States Department of Energy (DOE); Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California Berkeley; North China University of Science & Technology; University of Zurich; Clemson University; Heinrich Heine University Dusseldorf; University of California System; University of California Berkeley; Cold Spring Harbor Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Cornell University; University of Illinois System; University of Illinois Urbana-Champaign; Mississippi State University; Pakistan Institute of Engineering & Applied Science; United States Department of Agriculture (USDA)	Paterson, AH (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@uga.edu	Mayer, Klaus FX/M-7941-2015; Bowers, John/B-9245-2009; Wicker, Thomas/Z-1978-2019; Rahman, Mehboob-ur-/I-7983-2015; Grimwood, Jane/ABD-5737-2021; Tang, Haibao/A-6715-2011; Keller, Beat/K-3093-2019; McCann, Maureen C/T-9258-2017; Bowers, John/AAD-7601-2019; Schmutz, Jeremy/N-3173-2013	Mayer, Klaus FX/0000-0001-6484-1077; Bowers, John/0000-0001-8984-9796; Tang, Haibao/0000-0002-3460-8570; Keller, Beat/0000-0003-2379-9225; McCann, Maureen C/0000-0001-6956-4216; Schmutz, Jeremy/0000-0001-8062-9172; Lyons, Eric/0000-0002-3348-8845; Gowik, Udo/0000-0002-8986-7318; Grigoriev, Igor/0000-0002-3136-8903; Spannagl, Manuel/0000-0003-0701-7035; Bruggmann, Remy/0000-0001-5629-6363; Messing, Joachim/0000-0001-8260-2643; , Thomas/0000-0002-6777-7135; Haberer, Georg/0000-0002-6612-6939; Penning, Bryan/0000-0002-0374-8693; Martis, Mihaela-Maria/0000-0001-7509-2446; Bowers, John/0000-0001-5693-2796; Gundlach, Heidrun/0000-0002-6757-0943; Peterson, Daniel/0000-0002-0274-5968; Rokhsar, Daniel/0000-0002-8704-2224; Feltus, Frank/0000-0002-2123-6114	US National Science Foundation [DBI-9872649, DBI-0115903, MCB-0450260, DBI-0321467]; International Consortium for Sugarcane Biotechnology; National Sorghum Producers; John Simon Guggenheim Foundation; US Department of Energy [DE-FG05-95ER20194]; German Federal Ministry of Education GABI initiative [0313117, 0314000C]; US Department of Agriculture-Agricultural Research Service	US National Science Foundation(National Science Foundation (NSF)); International Consortium for Sugarcane Biotechnology; National Sorghum Producers; John Simon Guggenheim Foundation; US Department of Energy(United States Department of Energy (DOE)); German Federal Ministry of Education GABI initiative; US Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	We thank the US Department of Energy Joint Genome Institute Community Sequencing Program, J. Bristow, S. Lucas and the JGI production sequencing team for sequencing sorghum; and L. Lin for contributions to Fig. 1. We appreciate funding from the US National Science Foundation (NSF DBI-9872649, 0115903; MCB-0450260), International Consortium for Sugarcane Biotechnology, National Sorghum Producers, and a John Simon Guggenheim Foundation fellowship to A.H.P.; US Department of Energy (DE-FG05-95ER20194) to J.M.; German Federal Ministry of Education GABI initiative to MIPS (0313117 and 0314000C); NSF DBI-0321467 to A.N.; and US Department of Agriculture-Agricultural Research Service to C.A.M., L.Z. and D.W.	Bowers JE, 2005, P NATL ACAD SCI USA, V102, P13206, DOI 10.1073/pnas.0502365102; Bowers JE, 2003, GENETICS, V165, P367; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Choisne N, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-20; Devos KM, 2000, THEOR APPL GENET, V100, P190, DOI 10.1007/s001220050026; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; GARDNER RC, 1981, NUCLEIC ACIDS RES, V9, P2871, DOI 10.1093/nar/9.12.2871; Haas B, 2002, GENOME BIOL, V3; Haberer G, 2005, PLANT PHYSIOL, V139, P1612, DOI 10.1104/pp.105.068718; Hamblin MT, 2005, GENETICS, V171, P1247, DOI 10.1534/genetics.105.041566; HATCH MD, 1966, BIOCHEM J, V101, P103, DOI 10.1042/bj1010103; Hazen SP, 2003, PLANT PHYSIOL, V132, P263, DOI 10.1104/pp.103.020016; HUO N, 2007, GENOMICS, V8, P135; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kim JS, 2005, GENETICS, V169, P1169, DOI 10.1534/genetics.104.035980; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Lohithaswa HC, 2007, THEOR APPL GENET, V115, P237, DOI 10.1007/s00122-007-0559-4; Lu C, 2008, P NATL ACAD SCI USA, V105, P4951, DOI 10.1073/pnas.0708743105; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCann MC, 1991, CYTOSKELETAL BASIS P, P109; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Miller JT, 1998, THEOR APPL GENET, V96, P832, DOI 10.1007/s001220050809; Ming R, 2006, PL BRED RE, V27, P15; Morrell PL, 2005, MOL ECOL, V14, P2143, DOI 10.1111/j.1365-294X.2005.02579.x; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; PATERSON AH, 1995, P NATL ACAD SCI USA, V92, P6127, DOI 10.1073/pnas.92.13.6127; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Singh NK, 2007, FUNCT INTEGR GENOMIC, V7, P17, DOI 10.1007/s10142-006-0033-4; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Swigonova Z, 2005, GENETICS, V169, P891, DOI 10.1534/genetics.104.034629; Swigonova Z, 2004, COMP FUNCT GENOM, V5, P281, DOI 10.1002/cfg.395; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Wang XY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-447; Wang XY, 2007, GENETICS, V177, P1753, DOI 10.1534/genetics.107.073197; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Xu JH, 2008, P NATL ACAD SCI USA, V105, P14330, DOI 10.1073/pnas.0807026105; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022	50	1964	2255	8	379	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					551	556		10.1038/nature07723	http://dx.doi.org/10.1038/nature07723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19189423	Green Submitted, Green Accepted, hybrid			2022-12-24	WOS:000262852200034
J	Oda, T; Iwasa, M; Aihara, T; Maeda, Y; Narita, A				Oda, Toshiro; Iwasa, Mitsusada; Aihara, Tomoki; Maeda, Yuichiro; Narita, Akihiro			The nature of the globular-to fibrous-actin transition	NATURE			English	Article							FIBER DIFFRACTION DATA; F-ACTIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MONOMERIC ACTIN; ARP2/3 COMPLEX; ELECTRON CRYOMICROSCOPY; MOLECULAR-DYNAMICS; NORMAL-MODES; YEAST ACTIN	Actin plays crucial parts in cell motility through a dynamic process driven by polymerization and depolymerization, that is, the globular ( G) to fibrous ( F) actin transition. Although our knowledge about the actin- based cellular functions and the molecules that regulate the G- to F- actin transition is growing, the structural aspects of the transition remain enigmatic. We created a model of F- actin using X- ray fibre diffraction intensities obtained from well oriented sols of rabbit skeletal muscle F- actin to 3.3 A in the radial direction and 5.6 A along the equator. Here we show that the G- to F- actin conformational transition is a simple relative rotation of the two major domains by about 20 degrees. As a result of the domain rotation, the actin molecule in the filament is flat. The flat form is essential for the formation of stable, helical F- actin. Our F- actin structure model provides the basis for understanding actin polymerization as well as its molecular interactions with actin- binding proteins.	[Oda, Toshiro; Aihara, Tomoki] RIKEN, Harima Inst, Xray Struct Anal Res Team, SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Oda, Toshiro; Iwasa, Mitsusada; Maeda, Yuichiro] Japan Sci & Technol Agcy, ERATO Project Actin Filament Dynam, Mikazuki, Hyogo 6795148, Japan; [Maeda, Yuichiro; Narita, Akihiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Nagoya, Aichi 4648601, Japan; [Maeda, Yuichiro; Narita, Akihiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan	Japan Synchrotron Radiation Research Institute; RIKEN; Japan Science & Technology Agency (JST); Nagoya University; Nagoya University	Oda, T (corresponding author), RIKEN, Harima Inst, Xray Struct Anal Res Team, SPring 8 Ctr, 1-1-1 Kouto, Mikazuki, Hyogo 6795148, Japan.	toda@spring8.or.jp	Oda, Toshiro/F-6151-2011		Kazato Research Foundation	Kazato Research Foundation(Kazato Research Foundation)	We thank K. C. Holmes for continuous encouragement and D. Hanein for the gift of the atomic coordinates of the Volkmann et al. model ( ref. 24). We thank K. Namba, K. Makino and K. Hasegwa for comments on the manuscript, the gift of software package for the fibre analysis and help with recording the diffraction patterns. We also thank S. Fujiwara and K. Mihashi for comments on the manuscript. We finally thank beam- line staffs at SPring-8 BL40B2, BL41XU and BL45XU-SAX, especially M. Kawamoto and K. Ito. The electron microscopy section of this study is partially supported by the Kazato Research Foundation (A.N.).	Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; Allingham JS, 2005, P NATL ACAD SCI USA, V102, P14527, DOI 10.1073/pnas.0502089102; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; Dalhaimer P, 2008, J MOL BIOL, V376, P166, DOI 10.1016/j.jmb.2007.11.068; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FURUHASHI K, 1992, J BIOL CHEM, V267, P9326; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; Joel PB, 2004, BIOCHEMISTRY-US, V43, P11554, DOI 10.1021/bi048899a; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kudryashov DS, 2005, P NATL ACAD SCI USA, V102, P13105, DOI 10.1073/pnas.0506429102; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Narita A, 2006, EMBO J, V25, P5626, DOI 10.1038/sj.emboj.7601395; Narita A, 2007, J MOL BIOL, V365, P480, DOI 10.1016/j.jmb.2006.06.056; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; Oda T, 1998, BIOPHYS J, V75, P2672, DOI 10.1016/S0006-3495(98)77712-4; Oda T, 2007, ADV EXP MED BIOL, V592, P385; Oosawa F., 1975, THERMODYNAMICS POLYM; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rizvi SA, 2006, J AM CHEM SOC, V128, P3882, DOI 10.1021/ja058319c; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Straub FB, 1942, STUD I MED CHEM U SZ, V2, P3; TIRION MM, 1995, BIOPHYS J, V68, P5, DOI 10.1016/S0006-3495(95)80156-6; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; WANG H, 1993, ACTA CRYSTALLOGR A, V49, P504, DOI 10.1107/S0108767392011255; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; WERTMAN KF, 1992, GENETICS, V132, P337; Wu YH, 2004, BIOPHYS J, V86, P116, DOI 10.1016/S0006-3495(04)74089-8; Yao XY, 2002, J BIOL CHEM, V277, P22875, DOI 10.1074/jbc.M201685200	50	446	448	5	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					441	445		10.1038/nature07685	http://dx.doi.org/10.1038/nature07685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158791				2022-12-24	WOS:000262519200038
J	Zheng, Y; Chaudhry, A; Kas, A; deRoos, P; Kim, JM; Chu, TT; Corcoran, L; Treuting, P; Klein, U; Rudensky, AY				Zheng, Ye; Chaudhry, Ashutosh; Kas, Arnold; deRoos, Paul; Kim, Jeong M.; Chu, Tin-Tin; Corcoran, Lynn; Treuting, Piper; Klein, Ulf; Rudensky, Alexander Y.			Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses	NATURE			English	Article							SELF-TOLERANCE; TARGET GENES; DIFFERENTIATION; FOXP3; LINEAGE; TH2; INTERLEUKIN-10; ADENOSINE; DISEASE; ABSENCE	In the course of infection or autoimmunity, particular transcription factors orchestrate the differentiation of T(H)1, T(H)2 or T(H)17 effector cells, the responses of which are limited by a distinct lineage of suppressive regulatory T cells (T-reg). T-reg cell differentiation and function are guided by the transcription factor Foxp3, and their deficiency due to mutations in Foxp3 results in aggressive fatal autoimmune disease associated with sharply augmented T(H)1 and T(H)2 cytokine production(1-3). Recent studies suggested that Foxp3 regulates the bulk of the Foxp3-dependent transcriptional program indirectly through a set of transcriptional regulators serving as direct Foxp3 targets(4,5). Here we show that in mouse T-reg cells, high amounts of interferon regulatory factor-4 (IRF4), a transcription factor essential for T(H)2 effector cell differentiation, is dependent on Foxp3 expression. We proposed that IRF4 expression endows T-reg cells with the ability to suppress T(H)2 responses. Indeed, ablation of a conditional Irf4 allele in T-reg cells resulted in selective dysregulation of T(H)2 responses, IL4-dependent immunoglobulin isotype production, and tissue lesions with pronounced plasma cell infiltration, in contrast to the mononuclear-cell-dominated pathology typical of mice lacking T-reg cells. Our results indicate that T-reg cells use components of the transcriptional machinery, promoting a particular type of effector CD4(+) T cell differentiation, to efficiently restrain the corresponding type of the immune response.	[Zheng, Ye; Chaudhry, Ashutosh; Kas, Arnold; deRoos, Paul; Kim, Jeong M.; Chu, Tin-Tin; Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Zheng, Ye; Chaudhry, Ashutosh; Kas, Arnold; deRoos, Paul; Kim, Jeong M.; Chu, Tin-Tin; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Treuting, Piper] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Corcoran, Lynn] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia; [Klein, Ulf] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Klein, Ulf] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Columbia University; Columbia University	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA.	rudenska@mskcc.org	Corcoran, Lynn M/C-9316-2013; Treuting, Piper M./AAB-2721-2019; Zheng, Ye/G-4866-2015	Treuting, Piper M./0000-0002-1812-1519; Zheng, Ye/0000-0001-5012-4309; Chaudhry, Ashutosh/0000-0003-3379-5236	CRI-Irvington Institute; Howard Hughes Medical Institute; National Institutes of Health	CRI-Irvington Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Acknowledgements We thank K. Hilgner and K. Murphy for providing TH1, TH2 and TH0 gene expression data sets, B. Sullivan, R. Locksley, S. Quezada and J. Allison for critical reagents, K. Forbush and L. Karpik for expert technical assistance and mouse colony management, and R. Dalla- Favera for discussions. This work was supported by grants from the National Institutes of Health (A.Y.R.). Y. Z. and J. M. K. were supported by the CRI-Irvington Institute postdoctoral fellowship. A. Y. R. is an investigator with the Howard Hughes Medical Institute.	Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	30	686	704	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 19	2009	458	7236					351	U116		10.1038/nature07674	http://dx.doi.org/10.1038/nature07674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19182775	Green Accepted			2022-12-24	WOS:000264285600044
J	Saito, K; Chen, M; Bard, F; Chen, SH; Zhou, HL; Woodley, D; Polischuk, R; Schekman, R; Malhotra, V				Saito, Kota; Chen, Mei; Bard, Fred; Chen, Shenghong; Zhou, Huilin; Woodley, David; Polischuk, Roman; Schekman, Randy; Malhotra, Vivek			TANGO1 Facilitates Cargo Loading at Endoplasmic Reticulum Exit Sites	CELL			English	Article							VII COLLAGEN EXPRESSION; COPII COAT; PROTEIN SECRETION; ER; TRANSPORT; ERGIC-53; GOLGI; IDENTIFICATION; FIBROBLASTS; VESICLES	A genome-wide screen revealed previously unidentified components required for transport and Golgi organization ( TANGO). We now provide evidence that one of these proteins, TANGO1, is an integral membrane protein localized to endoplasmic reticulum ( ER) exit sites, with a luminal SH3 domain and a cytoplasmic proline-rich domain (PRD). Knockdown of TANGO1 inhibits export of bulky collagen VII from the ER. The SH3 domain of TANGO1 binds to collagen VII; the PRD binds to the COPII coat subunits, Sec23/24. In this scenario, PRD binding to Sec23/24 subunits could stall COPII carrier biogenesis to permit the luminal domain of TANGO1 to guide SH3-bound cargo into a growing carrier. All cells except those of hematopoietic origin express TANGO1. We propose that TANGO1 exports other cargoes in cells that do not secrete collagen VII. However, TANGO1 does not enter the budding carrier, which represents a unique mechanism to load cargo into COPII carriers.	[Saito, Kota; Malhotra, Vivek] CRG, Dept Cell & Dev Biol, Barcelona 08003, Spain; [Malhotra, Vivek] Inst Catalana Rec & Estudis Avancats, Barcelona 08003, Spain; [Chen, Mei; Woodley, David] Univ So Calif, USC Norris Comprehens Canc Ctr, Dept Dermatol, Los Angeles, CA 90033 USA; [Bard, Fred] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Chen, Shenghong; Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Polischuk, Roman] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy; [Schekman, Randy] Univ Calif Berkeley, HHMI, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; University of Southern California; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of California System; University of California San Diego; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Malhotra, V (corresponding author), CRG, Dept Cell & Dev Biol, Dr Aiguader 88, Barcelona 08003, Spain.	vivek.malhotra@crg.es	BARD, Frederic/G-9914-2011; Malhotra, Vivek/O-9811-2014; Chen, Sheng-hong/AAU-4018-2021	BARD, Frederic/0000-0002-3783-4805; Malhotra, Vivek/0000-0001-6198-7943; Chen, Sheng-hong/0000-0002-7722-2221; Saito, Kota/0000-0003-2478-2687; Zhou, Huilin/0000-0002-1350-4430	Japanese Society for Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	We thank members of the Malhotra lab, especially Yuichi Wakana and Matt Pecot, for valuable discussions and Anne-Marie Alleaume for drawing the model shown in Figure 7. We also thank Kanika Bajaj of the Schekman lab for technical help. K. S. was supported by a fellowship from the Japanese Society for Promotion of Science.	Baines AC, 2007, TRENDS BIOCHEM SCI, V32, P381, DOI 10.1016/j.tibs.2007.06.006; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bosserhoff AK, 2004, GENE EXPR PATTERNS, V4, P473, DOI 10.1016/j.modgep.2003.12.002; Chen M, 2002, NAT GENET, V32, P670, DOI 10.1038/ng1041; Chen M, 1997, J INVEST DERMATOL, V108, P125, DOI 10.1111/1523-1747.ep12332300; CHEN YQ, 1994, J INVEST DERMATOL, V102, P205, DOI 10.1111/1523-1747.ep12371763; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Herrmann JM, 1999, TRENDS CELL BIOL, V9, P5, DOI 10.1016/S0962-8924(98)01414-7; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; PINNELL SR, 1987, ARCH DERMATOL, V123, P1684, DOI 10.1001/archderm.123.12.1684; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shugrue CA, 1999, J CELL SCI, V112, P4547; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Woodley DT, 2007, CLIN REV ALLERG IMMU, V33, P78, DOI 10.1007/s12016-007-0027-6	29	239	244	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					891	902		10.1016/j.cell.2008.12.025	http://dx.doi.org/10.1016/j.cell.2008.12.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269366	Bronze			2022-12-24	WOS:000263930900012
J	Moscona, A				Moscona, Anne			Global Transmission of Oseltamivir-Resistant Influenza	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS NEURAMINIDASE		[Moscona, Anne] Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA; [Moscona, Anne] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University; Cornell University	Moscona, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA.							Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; DIAS A, 2009, NATURE          0204; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6	5	380	439	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					953	956		10.1056/NEJMp0900648	http://dx.doi.org/10.1056/NEJMp0900648			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413WX	19258250				2022-12-24	WOS:000263824500002
J	Slotkin, RK; Vaughn, M; Borges, F; Tanurdzic, M; Becker, JD; Feijo, JA; Martienssen, RA				Slotkin, R. Keith; Vaughn, Matthew; Borges, Filipe; Tanurdzic, Milos; Becker, Joerg D.; Feijo, Jose A.; Martienssen, Robert A.			Epigenetic Reprogramming and Small RNA Silencing of Transposable Elements in Pollen	CELL			English	Article							MALE GAMETOPHYTE DEVELOPMENT; TISSUE-SPECIFIC CONTROL; DNA METHYLATION; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; MUTATOR TRANSPOSONS; INTERFERING RNA; H3 METHYLATION; FLAMENCO GENE; ARABIDOPSIS	The mutagenic activity of transposable elements (TEs) is suppressed by epigenetic silencing and small interfering RNAs (siRNAs), especially in gametes that could transmit transposed elements to the next generation. In pollen from the model plant Arabidopsis, we show that TEs are unexpectedly reactivated and transpose, but only in the pollen vegetative nucleus, which accompanies the sperm cells but does not provide DNA to the fertilized zygote. TE expression coincides with downregulation of the heterochromatin remodeler DECREASE IN DNA METHYLATION 1 and of many TE siRNAs. However, 21 nucleotide siRNAs from Athila retrotransposons are generated and accumulate in pollen and sperm, suggesting that siRNA from TEs activated in the vegetative nucleus can target silencing in gametes. We propose a conserved role for reprogramming in germline companion cells, such as nurse cells in insects and vegetative nuclei in plants, to reveal intact TEs in the genome and regulate their activity in gametes.	[Slotkin, R. Keith; Vaughn, Matthew; Tanurdzic, Milos; Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Borges, Filipe; Becker, Joerg D.; Feijo, Jose A.] Ctr Biol Desenvolvimento, Inst Gulbenkian Ciencia, P-2780901 Oeiras, Portugal; [Feijo, Jose A.] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, Lisbon, MS, Portugal	Cold Spring Harbor Laboratory; Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Feijo, Jose A./ADM-0262-2022; Slotkin, R. Keith/H-6965-2013; Tanurdzic, Milos/A-5712-2012; Becker, Jorg/A-5930-2011	Feijo, Jose A./0000-0002-1100-5478; Slotkin, R. Keith/0000-0001-9582-3533; Tanurdzic, Milos/0000-0002-7564-0868; Becker, Jorg/0000-0002-6845-6122; Borges, Filipe/0000-0002-7388-2118; Vaughn, Matthew/0000-0002-1384-4283	National Institutes of Health (NIH) [F32 CA125977]; National Science Foundation [DBI-0733857]; Robertson Research Fund; NIH [R01 GM067014]; Fundacao para a Ciencia e a Tecnologia [PPCDT/BIA-BCM/61270/2004, PTDC/AGR-GPL/70592/2006]; NATIONAL CANCER INSTITUTE [F32CA125977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Robertson Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Simorowski, M. Galli, T. Nawy, M. Bayer, and S. Hearn, for assistance with GUS staining and microscopy and T. Stokes, E. Richards, R. Gardner, T. Mulligan, Y. Fang, D. Spector, D. Lisch, and R. Schwab for providing tools and stocks. We additionally thank Dennis Stevenson ( New York Botanical Garden) for discussions. R. K. S. is a recipient of a National Institutes of Health (NIH) postdoctoral fellowship (F32 CA125977). This work was supported by grants from the National Science Foundation (DBI-0733857), the Robertson Research Fund, and the NIH (R01 GM067014) to R. A. M., as well as grants PPCDT/BIA-BCM/61270/2004 and PTDC/AGR-GPL/70592/2006 from Fundacao para a Ciencia e a Tecnologia (FCT) to J. D. B.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Becker JD, 2007, ANN BOT-LONDON, V100, P1117, DOI 10.1093/aob/mcm208; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; CALVI BR, 1994, EMBO J, V13, P1636, DOI 10.1002/j.1460-2075.1994.tb06427.x; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Casa AM, 2004, METH MOL B, V260, P175, DOI 10.1385/1-59259-755-6:175; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dupressoir A, 1996, MOL CELL BIOL, V16, P4495; EADY C, 1995, PLANT CELL, V7, P65, DOI 10.1105/tpc.7.1.65; Engel ML, 2005, PLANT PHYSIOL, V138, P2124, DOI 10.1104/pp.104.054213; Friedman WE, 1999, DEVELOPMENT, V126, P1065; Galli M, 2003, GENETICS, V165, P2093; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gruntman E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-371; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Janousek B, 2000, PROTOPLASMA, V211, P116, DOI 10.1007/BF01279904; Johnson-Brousseau SA, 2004, PLANT J, V39, P761, DOI 10.1111/j.1365-313X.2004.02147.x; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; MCCORMICK S, 1993, PLANT CELL, V5, P1265, DOI 10.1105/tpc.5.10.1265; MEYER E, 2007, EPIGENETICS, P127; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Okada T, 2006, PLANT MOL BIOL, V62, P503, DOI 10.1007/s11103-006-9036-8; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Pasyukova E, 1997, MOL GEN GENET, V255, P115, DOI 10.1007/s004380050479; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Raizada MN, 2001, PLANT J, V25, P79, DOI 10.1046/j.1365-313x.2001.00939.x; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; UEDA K, 1995, DEV BIOL, V169, P210, DOI 10.1006/dbio.1995.1138; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; YU S, 1989, PROTOPLASMA, V152, P29; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305	59	707	730	2	149	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 6	2009	136	3					461	472		10.1016/j.cell.2008.12.038	http://dx.doi.org/10.1016/j.cell.2008.12.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203581	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000263120600016
J	del Rio, A; Perez-Jimenez, R; Liu, RC; Roca-Cusachs, P; Fernandez, JM; Sheetz, MP				del Rio, Armando; Perez-Jimenez, Raul; Liu, Ruchuan; Roca-Cusachs, Pere; Fernandez, Julio M.; Sheetz, Michael P.			Stretching Single Talin Rod Molecules Activates Vinculin Binding	SCIENCE			English	Article							FORCE; PROTEIN; SITES; STABILITY; UBIQUITIN; COMPLEX; BUNDLE	The molecular mechanism by which a mechanical stimulus is translated into a chemical response in biological systems is still unclear. We show that mechanical stretching of single cytoplasmic proteins can activate binding of other molecules. We used magnetic tweezers, total internal reflection fluorescence, and atomic force microscopy to investigate the effect of force on the interaction between talin, a protein that links liganded membrane integrins to the cytoskeleton, and vinculin, a focal adhesion protein that is activated by talin binding, leading to reorganization of the cytoskeleton. Application of physiologically relevant forces caused stretching of single talin rods that exposed cryptic binding sites for vinculin. Thus in the talin- vinculin system, molecular mechanotransduction can occur by protein binding after exposure of buried binding sites in the talin-vinculin system. Such protein stretching may be a more general mechanism for force transduction.	[del Rio, Armando; Perez-Jimenez, Raul; Roca-Cusachs, Pere; Fernandez, Julio M.; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Liu, Ruchuan] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore	Columbia University; National University of Singapore	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ms2001@columbia.edu	del rio hernandez, armando e/N-4262-2013; Liu, Ruchuan/G-2279-2012; del Río Hernández, Armando E/D-3555-2012; Liu, Ruchuan/K-8376-2019; Roca-Cusachs, Pere/D-4309-2009; Perez-Jimenez, Raul/C-3085-2017	del rio hernandez, armando e/0000-0001-5062-8910; del Río Hernández, Armando E/0000-0001-5062-8910; Roca-Cusachs, Pere/0000-0001-6947-961X; Perez-Jimenez, Raul/0000-0001-7094-6799	NIH; Spanish Ministry of Science and Education; Marie Curie international fellowship; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001480] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Education(Spanish Government); Marie Curie international fellowship(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank D. Critchley and N. Bate for Vh and TR monomer constructs, C. Badilla-Fernandez for advisement with constructs, and V. Hytonen for contribution to Fig. 1. This work was supported by NIH grants to J.M.F. and M.P.S., an NIH award to A.d.R., a grant from the Spanish Ministry of Science and Education to R.P.-J.,and a Marie Curie international fellowship to P.R.-C.	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Critchley DR, 2005, BIOCHEM SOC T, V33, P1308, DOI 10.1042/BST0331308; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Tanase M, 2007, METHOD CELL BIOL, V83, P473, DOI 10.1016/S0091-679X(07)83020-2; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890	25	1020	1028	9	265	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					638	641		10.1126/science.1162912	http://dx.doi.org/10.1126/science.1162912			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179532	Green Accepted			2022-12-24	WOS:000262862800044
J	Zhang, YX; Yan, LB; Zhou, Z; Yang, PG; Tian, E; Zhang, K; Zhao, Y; Li, ZP; Song, B; Han, JH; Miao, L; Zhang, H				Zhang, Yuxia; Yan, Libo; Zhou, Zhi; Yang, Peiguo; Tian, E.; Zhang, Kai; Zhao, Yu; Li, Zhipeng; Song, Bing; Han, Jinghua; Miao, Long; Zhang, Hong			SEPA-1 Mediates the Specific Recognition and Degradation of P Granule Components by Autophagy in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; GERM GRANULES; MOLECULAR MACHINERY; SELF-DIGESTION; MECHANISMS; MICE; NEURODEGENERATION; PROTEINS; DISEASE; P62	How autophagy, an evolutionarily conserved intracellular catabolic system for bulk degradation, selectively degrades protein aggregates is poorly understood. Here, we show that several maternally derived germ P granule components are selectively eliminated by autophagy in somatic cells during C. elegans embryogenesis. The activity of sepa-1 is required for the degradation of these P granule components and for their accumulation into aggregates, termed PGL granules, in autophagy mutants. SEPA-1 forms protein aggregates and is also a preferential target of autophagy. SEPA-1 directly binds to the P granule component PGL-3 and also to the autophagy protein LGG-1/Atg8. SEPA-1 aggregates consistently colocalize with PGL granules and with LGG-1 puncta. Thus, SEPA-1 functions as a bridging molecule in mediating the specific recognition and degradation of P granule components by autophagy. Our study reveals a mechanism for preferential degradation of protein aggregates by autophagy and emphasizes the physiological significance of selective autophagy during animal development.	[Zhang, Yuxia; Yan, Libo; Zhou, Zhi; Yang, Peiguo; Tian, E.; Zhao, Yu; Li, Zhipeng; Song, Bing; Han, Jinghua; Zhang, Hong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yan, Libo] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Yan, Libo] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Kai; Miao, Long] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, H (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	zhanghong@nibs.ac.cn	Zhang, Yuxia/J-3449-2013; Yan, Libo/H-2328-2012; yan, libo/H-9533-2013; Zhang, Kai/M-9831-2017	Yan, Libo/0000-0002-4204-3397; Zhang, Kai/0000-0003-2962-3976; Zhang, Hong/0000-0002-3342-5377; YANG, PEIGUO/0000-0002-2334-5664; Miao, Long/0000-0002-0562-6681; Li, Zhipeng/0000-0001-8806-9667	National High Technology Projects 863 [2005AA210910]	National High Technology Projects 863	We thank Drs. Susan Strome and Xiaodong Wang for their helpful comments on the manuscript, Dr. David Hall for his advice on immuno EM, and Dr. Isabel Hanson for editing the manuscript. This work was supported by the National High Technology Projects 863 (2005AA210910).	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hird SN, 1996, DEVELOPMENT, V122, P1303; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kawasaki L, 2004, GENETICS, V167, P645, DOI 10.1534/genetics.103.023093; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rowland AM, 2006, J NEUROSCI, V26, P1711, DOI 10.1523/JNEUROSCI.2279-05.2006; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; van der Vaart A, 2008, TRAFFIC, V9, P281, DOI 10.1111/j.1600-0854.2007.00674.x	20	169	187	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					308	321		10.1016/j.cell.2008.12.022	http://dx.doi.org/10.1016/j.cell.2008.12.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167332	Bronze			2022-12-24	WOS:000262648800019
J	Zaghloul, KA; Blanco, JA; Weidemann, CT; McGill, K; Jaggi, JL; Baltuch, GH; Kahana, MJ				Zaghloul, Kareem A.; Blanco, Justin A.; Weidemann, Christoph T.; McGill, Kathryn; Jaggi, Jurg L.; Baltuch, Gordon H.; Kahana, Michael J.			Human Substantia Nigra Neurons Encode Unexpected Financial Rewards	SCIENCE			English	Article							MIDBRAIN DOPAMINE NEURONS; BASAL GANGLIA; PARKINSONS-DISEASE; AVERSIVE STIMULI; PREDICTION ERROR; MONKEY; MEDICATION; ACTIVATION; RESPONSES; TASK	The brain's sensitivity to unexpected outcomes plays a fundamental role in an organism's ability to adapt and learn new behaviors. Emerging research suggests that midbrain dopaminergic neurons encode these unexpected outcomes. We used microelectrode recordings during deep brain stimulation surgery to study neuronal activity in the human substantia nigra (SN) while patients with Parkinson's disease engaged in a probabilistic learning task motivated by virtual financial rewards. Based on a model of the participants' expected reward, we divided trial outcomes into expected and unexpected gains and losses. SN neurons exhibited significantly higher firing rates after unexpected gains than unexpected losses. No such differences were observed after expected gains and losses. This result provides critical support for the hypothesized role of the SN in human reinforcement learning.	[Zaghloul, Kareem A.; McGill, Kathryn; Jaggi, Jurg L.; Baltuch, Gordon H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Blanco, Justin A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Weidemann, Christoph T.; Kahana, Michael J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Zaghloul, KA (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	zaghlouk@uphs.upenn.edu; kahana@psych.upenn.edu	Zaghloul, Kareem/AAV-4208-2020; Weidemann, Christoph T./E-8857-2011	Weidemann, Christoph T./0000-0002-4280-2744	NIH [MH61975]; Conte Center [MH062196]; Dana Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196, R01MH061975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048598] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conte Center; Dana Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is partially supported by NIH grant MH61975, Conte Center grant MH062196, and the Dana Foundation. We thank the staff of the Pennsylvania Neurological Institute for their assistance. We also thank J. Wachter and A. Krieger for statistical advice, A. Geller for cognitive task programming, and M. Kilpatrick and P. Connolly for assistance with DBS surgery.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rubin DC, 1996, PSYCHOL REV, V103, P734, DOI 10.1037/0033-295X.103.4.734; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1983, EXP BRAIN RES, V51, P377; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x	26	147	149	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1496	1499		10.1126/science.1167342	http://dx.doi.org/10.1126/science.1167342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286561	Green Accepted			2022-12-24	WOS:000264101700046
J	Zehn, D; Lee, SY; Bevan, MJ				Zehn, Dietmar; Lee, Sarah Y.; Bevan, Michael J.			Complete but curtailed T-cell response to very low-affinity antigen	NATURE			English	Article							LISTERIA-MONOCYTOGENES; PRECURSOR FREQUENCY; MEMORY; EFFECTOR; INFECTION; SELECTION; DIFFERENTIATION; RECOGNITION; ACTIVATION; EXPRESSION	After an infection, T cells that carry the CD8 marker are activated and undergo a characteristic kinetic sequence of rapid expansion, subsequent contraction and formation of memory cells(1-3). The pool of naive T-cell clones is diverse and contains cells bearing T-cell antigen receptors (TCRs) that differ in their affinity for the same antigen(4,5). How these differences in affinity affect the function and the response kinetics of individual T-cell clones was previously unknown. Here we show that during the in vivo response to microbial infection, even very weak TCR-ligand interactions are sufficient to activate naive T cells, induce rapid initial proliferation and generate effector and memory cells. The strength of the TCR ligand interaction critically affects when expansion stops, when the cells exit lymphoid organs and when contraction begins; that is, strongly stimulated T cells contract and exit lymphoid organs later than weakly stimulated cells. Our data challenge the prevailing view that strong TCR ligation is a prerequisite for CD8(+) T-cell activation. Instead, very weak interactions are sufficient for activation, but strong TCR ligation is required to sustain T-cell expansion. We propose that in response to microbial challenge, T-cell clones with a broad range of avidities for foreign ligands are initially recruited, and that the pool of T cells subsequently matures in affinity owing to the more prolonged expansion of high-affinity T-cell clones.	[Zehn, Dietmar; Lee, Sarah Y.; Bevan, Michael J.] Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Immunol, Box 357370, Seattle, WA 98195 USA.	mbevan@u.washington.edu			National Institutes of Health; Howard Hughes Medical Institute; Juvenile Diabetes Research Foundation; German Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Gallegos for advice in making the recombinant Listeria, and X.- C. Pan, B. Dere, B. Paul and K. Rider for technical support. Financial support was received from the National Institutes of Health and the Howard Hughes Medical Institute ( M. J. B.), and from the Juvenile Diabetes Research Foundation and the German Research Foundation ( D. Z.).	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Gronski MA, 2004, NAT MED, V10, P1234, DOI 10.1038/nm1114; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Xiao ZG, 2007, J EXP MED, V204, P2667, DOI 10.1084/jem.20062376	26	460	465	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					211	214		10.1038/nature07657	http://dx.doi.org/10.1038/nature07657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19182777	Green Accepted			2022-12-24	WOS:000264059700045
J	Christensen, J; Pedersen, MG; Pedersen, CB; Sidenius, P; Olsen, J; Vestergaard, M				Christensen, Jakob; Pedersen, Marianne G.; Pedersen, Carsten B.; Sidenius, Per; Olsen, Jorn; Vestergaard, Mogens			Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study	LANCET			English	Article							POSTTRAUMATIC EPILEPSY; PUBLIC-HEALTH; SEIZURES; EPIDEMIOLOGY; PREVENTION; DENMARK; DRUGS	Background The risk of epilepsy shortly after traumatic brain injury is high, but how long this high risk lasts is unknown. We aimed to assess the risk of epilepsy up to 10 years or longer after traumatic brain injury, taking into account sex, age, severity and family history. Methods We identified 1605 216 people born in Denmark (1977-2002) from the Civil Registration System. We obtained information on traumatic brain injury and epilepsy from the National Hospital Register and estimated relative risks (RR) with Poisson analyses. Findings Risk of epilepsy was increased after a mild brain injury (RR 2.22, 95% CI 2.07-2.38), severe brain injury (7.40, 6.16-8.89), and skull fracture (2.17, 1.73-2.71). The risk was increased more than 10 years after mild brain injury (1.51, 1.24-1.85), severe brain injury (4.29, 2.04-9.00), and skull fracture (2.06, 1.37-3.11). RR increased with age at mild and severe injury and was especially high among people older than 15 years of age with mild (3.51, 2.90-4.26) and severe (12.24, 8.52-17.57) injury. The risk was slightly higher in women (2.49, 2.25-2.76) than in men (2.01, 1.83-2.22). Patients with a family history of epilepsy had a notably high risk of epilepsy after mild (5.75, 4.56-7.27) and severe brain injury (10.09, 4.20-24.26). Interpretation The longlasting high risk of epilepsy after brain injury might provide a window for prevention of post-traumatic epilepsy. Funding Danish Research Agency, P A Messerschmidt and Wife's Foundation, Mrs Grethe Bonnelycke's Foundation.	[Christensen, Jakob; Sidenius, Per] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Christensen, Jakob] Univ Aarhus, Dept Clin Pharmacol, DK-8000 Aarhus C, Denmark; [Pedersen, Marianne G.; Pedersen, Carsten B.] Univ Aarhus, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, So Calif Injury Prevent Res Ctr, Los Angeles, CA 90024 USA; [Olsen, Jorn] Univ Aarhus, Inst Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Vestergaard, Mogens] Univ Aarhus, Inst Publ Hlth, Dept Gen Practice, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; University of California System; University of California Los Angeles; Aarhus University; Aarhus University	Christensen, J (corresponding author), Aarhus Univ Hosp, Dept Neurol, Norrebrogade 44, DK-8000 Aarhus C, Denmark.	jakob@farm.au.dk	Pedersen, Carsten Bøcker/B-8441-2013; Vestergaard, Mogens/M-9333-2014	Pedersen, Carsten Bøcker/0000-0003-2077-8533; Vestergaard, Mogens/0000-0001-8830-2174; Christensen, Jakob/0000-0002-9385-6435				Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Andersen TF, 1999, DAN MED BULL, V46, P263; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Breslow N E, 1987, IARC Sci Publ, P1; BRESLOW NE, 1996, STAT APPL, V8, P23; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; Christensen J, 2007, EPILEPSY RES, V76, P60, DOI 10.1016/j.eplepsyres.2007.06.012; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; *DAN NAT BOARD HLT, 1997, 1208 DAN NAT BOARD H; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Engberg Aase Worsaae, 2007, Ugeskr Laeger, V169, P199; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Hewson Paul J, 2005, Traffic Inj Prev, V6, P127, DOI 10.1080/15389580590931590; Hills, 1993, STAT MODELS EPIDEMIO; Kjeldsen MJ, 2003, EPILEPSY RES, V55, P137, DOI 10.1016/S0920-1211(03)00117-7; Macpherson A., 2008, COCHRANE DB SYST REV, V3; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Pedersen CB, 2006, DAN MED BULL, V53, P441; PINNER M, KONSENSUSRAPPORT COM; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; ROBINSON DL, 2006, BRIT MED J, V332, P722; Rothman K, 1986, MODERN EPIDEMIOLOGY; Sun YL, 2006, EPIDEMIOLOGY, V17, P296, DOI 10.1097/01.ede.0000208478.47401.b6; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thompson DC, 2000, COCHRANE DB SYST REV, V2; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vestergaard M, 2007, AM J EPIDEMIOL, V165, P911, DOI 10.1093/aje/kwk086	37	229	238	0	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1105	1110		10.1016/S0140-6736(09)60214-2	http://dx.doi.org/10.1016/S0140-6736(09)60214-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19233461				2022-12-24	WOS:000264773600031
J	Leaver, M; Dominguez-Cuevas, P; Coxhead, JM; Daniel, RA; Errington, J				Leaver, M.; Dominguez-Cuevas, P.; Coxhead, J. M.; Daniel, R. A.; Errington, J.			Life without a wall or division machine in Bacillus subtilis	NATURE			English	Article							DIPHOSPHATE SYNTHASE ACTIVITY; STABLE L-FORM; ESCHERICHIA-COLI; CELL-DIVISION; PEPTIDOGLYCAN SYNTHESIS; GROWTH; SEQUENCE; GENOME; MREB; LICHENIFORMIS	The cell wall is an essential structure for virtually all bacteria, forming a tough outer shell that protects the cell from damage and osmotic lysis. It is the target of our best antibiotics. L- form strains are wall- deficient derivatives of common bacteria that have been studied for decades. However, they are difficult to generate and typically require growth for many generations on osmotically protective media with antibiotics or enzymes that kill walled forms. Despite their potential importance for understanding antibiotic resistance and pathogenesis, little is known about their basic cell biology or their means of propagation. We have developed a controllable system for generating L- forms in the highly tractable model bacterium Bacillus subtilis. Here, using genome sequencing, we identify a single point mutation that predisposes cells to grow without a wall. We show that propagation of L- forms does not require the normal FtsZ- dependent division machine but occurs by a remarkable extrusion- resolution mechanism. This novel form of propagation provides insights into how early forms of cellular life may have proliferated.	[Leaver, M.; Dominguez-Cuevas, P.; Daniel, R. A.; Errington, J.] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Coxhead, J. M.] Univ Newcastle, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Errington, J (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jeff.errington@newcastle.ac.uk	Leaver, Mark/GLR-0282-2022; Daniel, Richard A./I-2850-2019; Errington, Jeff/G-1832-2011; Dominguez-Cuevas, Patricia/D-6608-2017	Daniel, Richard A./0000-0002-6483-5897; Errington, Jeff/0000-0002-6977-9388; Dominguez-Cuevas, Patricia/0000-0002-9343-091X	UK Biotechnology and Biological Sciences Research Council; EMBO Long-Term Fellowship	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO))	We thank D. Swan for assistance with bioinformatics; A. Danchin for providing unpublished sequence data; E. J. Allan for providing the L- form strain that sparked our interest; T. Davey and V. Thompson of the Electron Microscopy Research Service of Newcastle University for technical assistance with electron microscopy; S. Gruber for help with quantitative real time PCR; J.-W. Veening and H. Murray for supplying strains and advice; and D. Claessen, K. Gerdes, H. Murray and W. Vollmer for critical reading of the manuscript. M. L. was supported by the UK Biotechnology and Biological Sciences Research Council. P.D.-C. was supported by an EMBO Long-Term Fellowship.	ABHAYAWARDHANE Y, 1995, J BACTERIOL, V177, P765, DOI 10.1128/jb.177.3.765-773.1995; ALLAN EJ, 1991, J APPL BACTERIOL, V70, P339, DOI 10.1111/j.1365-2672.1991.tb02946.x; ALLAN EJ, ADV APPL MI IN PRESS; BEALL B, 1991, GENE DEV, V5, P447, DOI 10.1101/gad.5.3.447; BURMEISTER HR, 1968, J BACTERIOL, V95, P1857, DOI 10.1128/JB.95.5.1857-1861.1968; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; DANIEL RA, 1993, J GEN MICROBIOL, V139, P361, DOI 10.1099/00221287-139-2-361; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; FUJISAKI S, 1990, J BIOCHEM-TOKYO, V108, P995, DOI 10.1093/oxfordjournals.jbchem.a123327; GILPIN RW, 1973, J BACTERIOL, V113, P486, DOI 10.1128/JB.113.1.486-499.1973; GILPIN RW, 1976, J BACTERIOL, V127, P1018, DOI 10.1128/JB.127.2.1018-1021.1976; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Hosfield DJ, 2004, J BIOL CHEM, V279, P8526, DOI 10.1074/jbc.C300511200; JOLY A, 1993, J BIOL CHEM, V268, P26983; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Joseleau-Petit D, 2007, J BACTERIOL, V189, P6512, DOI 10.1128/JB.00273-07; Kandler O, 1998, CELL MOL LIFE SCI, V54, P305, DOI 10.1007/s000180050156; King J R, 1970, J Bacteriol, V102, P196; Klieneberger E, 1935, J PATHOL BACTERIOL, V40, P93, DOI 10.1002/path.1700400108; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moszer I, 2002, NUCLEIC ACIDS RES, V30, P62, DOI 10.1093/nar/30.1.62; Murray T, 1998, J BACTERIOL, V180, P4555, DOI 10.1128/JB.180.17.4555-4563.1998; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; ROGERS HJ, 1976, J BACTERIOL, V125, P556, DOI 10.1128/JB.125.2.556-564.1976; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; Vicente M, 1998, CELL MOL LIFE SCI, V54, P317, DOI 10.1007/s000180050158; WARD JB, 1975, J BACTERIOL, V124, P668, DOI 10.1128/JB.124.2.668-678.1975; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; WYRICK PB, 1973, J BACTERIOL, V116, P456, DOI 10.1128/JB.116.1.456-465.1973	35	193	195	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					849	853		10.1038/nature07742	http://dx.doi.org/10.1038/nature07742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212404				2022-12-24	WOS:000263266700038
J	Losos, JB; Ricklefs, RE				Losos, Jonathan B.; Ricklefs, Robert E.			Adaptation and diversification on islands	NATURE			English	Review							SPECIES-AREA RELATIONSHIP; ADAPTIVE RADIATION; CHARACTER DISPLACEMENT; OCEANIC ISLAND; ECOLOGICAL SPECIATION; SYMPATRIC SPECIATION; MOLECULAR EVIDENCE; TERRESTRIAL FAUNA; DARWINS FINCHES; CANARY-ISLANDS	Charles Darwin's travels on HMS Beagle taught him that islands are an important source of evidence for evolution. Because many islands are young and have relatively few species, evolutionary adaptation and species proliferation are obvious and easy to study. In addition, the geographical isolation of many islands has allowed evolution to take its own course, free of influence from other areas, resulting in unusual faunas and floras, often unlike those found anywhere else. For these reasons, island research provides valuable insights into speciation and adaptive radiation, and into the relative importance of contingency and determinism in evolutionary diversification.	[Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Ricklefs, Robert E.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Harvard University; University of Missouri System; University of Missouri Saint Louis	Losos, JB (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	jlosos@oeb.harvard.edu			National Science Foundation; National Geographic Society; Smithsonian Institution	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Smithsonian Institution(Smithsonian Institution)	For comments on drafts, we thank A. Berry, R. Gillespie, R. Glor, P. Grant, L. Harmon, C. Parent, T. Price, D. Schluter and R. Whittaker. The National Science Foundation, the National Geographic Society and the Smithsonian Institution have supported our research on island faunas. We are also grateful to numerous individuals and governmental institutions throughout the West Indies for logistical and other support in the field.	[Anonymous], NATURAL HIST MADAGAS; Berry A, 2008, NATURE, V453, P1188, DOI 10.1038/4531188a; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Carlquist S., 2003, TARWEEDS SILVERSWORD; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; Chiba S, 2004, J EVOLUTION BIOL, V17, P131, DOI 10.1046/j.1420-9101.2004.00639.x; Conway Morris S., 2003, LIFES SOLUTION INEVI; Coyne JA, 2000, EVOLUTION, V54, P2166; DAMUTH J, 1993, NATURE, V365, P748, DOI 10.1038/365748a0; Darwin C., 1859, ORIGIN SPECIES MEANS; DAUGHERTY CH, 1993, TRENDS ECOL EVOL, V8, P437, DOI 10.1016/0169-5347(93)90006-B; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; De Geer C, 1771, J RES NATURAL HIST G, VII; DIAMOND JM, 1977, SYST ZOOL, V26, P263, DOI 10.2307/2412673; DIAMOND JM, 1990, ECOLOGICAL RESTORATI, P3; Douglas Pratt H., 2005, HAWAIIAN HONEYCREEPE; Emerson BC, 2005, EVOLUTION, V59, P586; FranciscoOrtega J, 1996, P NATL ACAD SCI USA, V93, P4085, DOI 10.1073/pnas.93.9.4085; Fryer G, 1996, ENVIRON BIOL FISH, V45, P109, DOI 10.1007/BF00005225; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Gavrilets S, 2007, MOL ECOL, V16, P2910, DOI 10.1111/j.1365-294X.2007.03304.x; Gifford ME, 2008, MOL PHYLOGENET EVOL, V49, P277, DOI 10.1016/j.ympev.2008.06.003; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Gillespie RG, 2008, PHILOS T R SOC B, V363, P3335, DOI 10.1098/rstb.2008.0124; Givnish Thomas J., 1997, P1; Givnish TJ, 2004, AM J BOT, V91, P228, DOI 10.3732/ajb.91.2.228; Goldberg J, 2008, PHILOS T R SOC B, V363, P3319, DOI 10.1098/rstb.2008.0114; Gould S. J., 1989, WONDERFUL LIFE; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; GRANT PR, THEORY ISLA IN PRESS; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Kambysellis Michael P., 1997, P475; Kirkendall LR, 2006, BIOL J LINN SOC, V89, P729, DOI 10.1111/j.1095-8312.2006.00698.x; Lack D., 1947, DARWINS FINCHES; Leigh EG, 2007, REV ECOL-TERRE VIE, V62, P105; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; LOSOS JB, THEORY ISLA IN PRESS; Losos JB, 2006, SCIENCE, V314, P1111, DOI 10.1126/science.1133584; Lovette IJ, 2002, P ROY SOC B-BIOL SCI, V269, P37, DOI 10.1098/rspb.2001.1789; MAC ARTHUR ROBERT H., 1967; Mayr E., 2001, BIRDS NO MELANESIA S; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Meimberg H, 2006, MOL PHYLOGENET EVOL, V41, P566, DOI 10.1016/j.ympev.2006.05.037; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Nicholson KE, 2005, J BIOGEOGR, V32, P929, DOI 10.1111/j.1365-2699.2004.01222.x; Otte D., 1989, P482; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Parent CE, 2006, EVOLUTION, V60, P2311, DOI 10.1554/06-366.1; Rand A. S., 1969, Breviora, VNo. 319, P1; Ricklefs RE, 2004, AM NAT, V163, P227, DOI 10.1086/381002; RICKLEFS RE, 1980, AUK, V97, P321; Rubinoff D, 2008, PHILOS T R SOC B, V363, P3459, DOI 10.1098/rstb.2008.0115; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; SCHLUTER D, 1990, AM NAT, V136, P560, DOI 10.1086/285115; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shaw Kerry L., 1995, P39; SIMBERLOFF D, 1981, EVOLUTION, V35, P1206, DOI 10.1111/j.1558-5646.1981.tb04990.x; SLATKIN M, 1980, ECOLOGY, V61, P163, DOI 10.2307/1937166; Thorpe RS, 2008, PHILOS T R SOC B, V363, P3071, DOI 10.1098/rstb.2008.0077; WALLACE AR, 1881, ISLAND LIFE OR PHENO; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; WIENS JA, 1991, ECOLOGY, V72, P479, DOI 10.2307/2937189; Williams E.E., 1983, P326; WILSON EO, 1959, EVOLUTION, V13, P122, DOI 10.1111/j.1558-5646.1959.tb02996.x; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174	75	596	612	11	373	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					830	836		10.1038/nature07893	http://dx.doi.org/10.1038/nature07893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212401				2022-12-24	WOS:000263266700033
J	Mullighan, CG; Su, XP; Zhang, JH; Radtke, I; Phillips, LAA; Miller, CB; Ma, J; Liu, W; Cheng, C; Schulman, BA; Harvey, RC; Chen, I; Clifford, RJ; Carroll, WL; Reaman, G; Bowman, WP; Devidas, M; Gerhard, DS; Yang, WJ; Relling, MV; Shurtleff, SA; Campana, D; Borowitz, MJ; Pui, C; Smith, M; Hunger, SP; Willman, CL; Downing, JR				Mullighan, Charles G.; Su, Xiaoping; Zhang, Jinghui; Radtke, Ina; Phillips, Letha A. A.; Miller, Christopher B.; Ma, Jing; Liu, Wei; Cheng, Cheng; Schulman, Brenda A.; Harvey, Richard C.; Chen, I-Ming; Clifford, Robert J.; Carroll, William L.; Reaman, Gregory; Bowman, W. Paul; Devidas, Meenakshi; Gerhard, Daniela S.; Yang, Wenjian; Relling, Mary V.; Shurtleff, Sheila A.; Campana, Dario; Borowitz, Michael J.; Pui, Ching-Hon; Smith, Malcolm; Hunger, Stephen P.; Willman, Cheryl L.; Downing, James R.		Childrens Oncology Grp	Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; TOTAL THERAPY; IKAROS GENE; CHILDHOOD; CHILDREN; EXPRESSION; TRANSCRIPTION	Background: Despite best current therapy, up to 20% of pediatric patients with acute lymphoblastic leukemia (ALL) have a relapse. Recent genomewide analyses have identified a high frequency of DNA copy-number abnormalities in ALL, but the prognostic implications of these abnormalities have not been defined. Methods: We studied a cohort of 221 children with high-risk B-cell-progenitor ALL with the use of single-nucleotide-polymorphism microarrays, transcriptional profiling, and resequencing of samples obtained at diagnosis. Children with known very-high-risk ALL subtypes (i.e., BCR-ABL1-positive ALL, hypodiploid ALL, and ALL in infants) were excluded from this cohort. A copy-number abnormality was identified as a predictor of poor outcome, and it was then tested in an independent validation cohort of 258 patients with B-cell-progenitor ALL. Results: More than 50 recurring copy-number abnormalities were identified, most commonly involving genes that encode regulators of B-cell development (in 66.8% of patients in the original cohort); PAX5 was involved in 31.7% and IKZF1 in 28.6% of patients. Using copy-number abnormalities, we identified a predictor of poor outcome that was validated in the independent validation cohort. This predictor was strongly associated with alteration of IKZF1, a gene that encodes the lymphoid transcription factor IKAROS. The gene-expression signature of the group of patients with a poor outcome revealed increased expression of hematopoietic stem-cell genes and reduced expression of B-cell-lineage genes, and it was similar to the signature of BCR-ABL1-positive ALL, another high-risk subtype of ALL with a high frequency of IKZF1 deletion. Conclusions: Genetic alteration of IKZF1 is associated with a very poor outcome in B-cell-progenitor ALL. N Engl J Med 2009;360:470-80.	[Mullighan, Charles G.; Su, Xiaoping; Radtke, Ina; Phillips, Letha A. A.; Miller, Christopher B.; Shurtleff, Sheila A.; Campana, Dario; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Liu, Wei; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Yang, Wenjian; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Campana, Dario; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Zhang, Jinghui] NCI, Ctr Biomed Informat & Informat Technol, NIH, Bethesda, MD 20892 USA; [Clifford, Robert J.] NCI, Lab Populat Genet, NIH, Bethesda, MD 20892 USA; [Gerhard, Daniela S.] NCI, Off Canc Genom, NIH, Bethesda, MD 20892 USA; [Smith, Malcolm] NCI, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA; [Schulman, Brenda A.] Johns Hopkins Med Inst, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Borowitz, Michael J.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Harvey, Richard C.; Chen, I-Ming; Willman, Cheryl L.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Carroll, William L.] NYU, Inst Canc, New York, NY USA; [Reaman, Gregory] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Bowman, W. Paul] Cook Childrens Med Ctr, Dept Hematol & Oncol, Ft Worth, TX USA; [Devidas, Meenakshi] Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA; [Devidas, Meenakshi] Childrens Oncol Grp, Gainesville, FL USA; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Aurora, CO USA; [Hunger, Stephen P.] Childrens Hosp, Aurora, CO USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of New Mexico; New York University; Children's National Health System; Cook Children's Medical Center; State University System of Florida; University of Florida; Children's Oncology Group (COG); University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Downing, JR (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 262 Danny Thomas Pl,MS 271, Memphis, TN 38105 USA.	james.downing@stjude.org	Cheng, Cheng/N-8075-2018; Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018; Mullighan, Charles/H-3253-2011; Downing, James R./N-8102-2018; Zhang, Jing/GWZ-7332-2022; Zhang, Jing/HII-4294-2022; Devidas, Meenakshi/H-1170-2019	Pui, Ching-Hon/0000-0003-0303-5658; Mullighan, Charles/0000-0002-1871-1850; Devidas, Meenakshi/0000-0002-1099-3478; Harvey, Richard/0000-0002-4904-9767; Clifford, Robert/0000-0001-8888-897X	Children's Oncology Group Chair's Award [CA098543]; Strategic Partnering to Evaluate Cancer Signatures Program [CA114762]; National Cancer Institute; National Institute of General Medical Sciences Pharmacogenetics Research Network and Database [U01 GM61393, U01GM61374]; Cancer Center [21765]; National Institutes of Health [R01 CA86011, N01-C0-12400]; Leukemia and Lymphoma Society Specialized Center of Research [7388-06]; CureSearch National Childhood Cancer Foundation; National Health and Medical Research Council (Australia); Australia) C. J. Martin Traveling Fellowship; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NCI; Becton Dickinson Biosciences; Xanthus Pharmaceuticals; NATIONAL CANCER INSTITUTE [R01CA086011, U01CA114762, U01CA157937, ZIHBC010470, ZIACP010141, U10CA098413, U10CA098543, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM061374] Funding Source: NIH RePORTER	Children's Oncology Group Chair's Award; Strategic Partnering to Evaluate Cancer Signatures Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences Pharmacogenetics Research Network and Database(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Specialized Center of Research(Leukemia and Lymphoma Society); CureSearch National Childhood Cancer Foundation; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australia) C. J. Martin Traveling Fellowship; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Becton Dickinson Biosciences; Xanthus Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by funds provided as a supplement to the Children's Oncology Group Chair's Award (CA098543, to Dr. Hunger); a Strategic Partnering to Evaluate Cancer Signatures Program award (CA114762, to Drs. Carroll, Chen, Harvey, and Willman) from the National Cancer Institute ( NCI); grants from the National Institute of General Medical Sciences Pharmacogenetics Research Network and Database (U01 GM61393 and U01GM61374, to Dr. Relling), a Cancer Center core grant (21765, to Drs. Downing, Mullighan, and Pui), and a grant R01 CA86011, to Dr. Borowitz) from the National Institutes of Health ( NIH); a Leukemia and Lymphoma Society Specialized Center of Research grant (7388-06, to Dr. Willman); a grant from CureSearch National Childhood Cancer Foundation; a National Health and Medical Research Council (Australia) C. J. Martin Traveling Fellowship ( to Dr. Mullighan); and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. The sequencing was supported by funds from the NCI and NIH to Agencourt Bioscience under contract N01-C0-12400.; Dr. Cheng reports serving on the advisory board for Enzon Pharmaceuticals; Dr. Borowitz, receiving consulting fees and grant support from Becton Dickinson Biosciences; Dr. Reaman, serving on the advisory board for Enzon Pharmaceuticals; Dr. Willman, receiving grant support from Xanthus Pharmaceuticals; and Drs. Downing and Mullighan, being co-inventors on a pending patent application concerning tests for IKZF1 mutations that was filed by St. Jude Children's Research Hospital, which has not entered into any licenses related to this application. No other potential conflict of interest relevant to this article was reported.; We thank Zhongling Cai and Claire Boltz for technical assistance and Stephen Smale for helpful discussions.	Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Buhl AM, 2000, IMMUNOL REV, V176, P141; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Coustan-Smith E, 2000, BLOOD, V96, P2691, DOI 10.1182/blood.V96.8.2691; Coustan-Smith E, 1998, LANCET, V351, P550, DOI 10.1016/S0140-6736(97)10295-1; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Georgantas RW, 2004, CANCER RES, V64, P4434, DOI 10.1158/0008-5472.CAN-03-3247; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Kishi S, 2003, J CLIN ONCOL, V21, P3084, DOI 10.1200/JCO.2003.07.056; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; Mirebeau D, 2006, HAEMATOL-HEMATOL J, V91, P881; Moreno TMC, 2002, LEUKEMIA, V16, P2037, DOI 10.1038/sj.leu.2402697; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pui CH, 2006, ANN HEMATOL, V85, P88; Pui CH, 2000, LEUKEMIA, V14, P2286, DOI 10.1038/sj.leu.2401938; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Rivera GK, 2005, CANCER-AM CANCER SOC, V103, P368, DOI 10.1002/cncr.20743; Shuster J, 1999, CANC RES THER CONTRO, V9, P101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Tonnelle C, 2001, BLOOD, V98, P2673, DOI 10.1182/blood.V98.9.2673; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1	34	951	1006	2	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					470	480		10.1056/NEJMoa0808253	http://dx.doi.org/10.1056/NEJMoa0808253			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19129520	Green Accepted			2022-12-24	WOS:000262812400006
J	D'Angelo, MA; Raices, M; Panowski, SH; Hetzer, MW				D'Angelo, Maximiliano A.; Raices, Marcela; Panowski, Siler H.; Hetzer, Martin W.			Age-Dependent Deterioration of Nuclear Pore Complexes Causes a Loss of Nuclear Integrity in Postmitotic Cells	CELL			English	Article							OXIDATIVE STRESS RESISTANCE; CAENORHABDITIS-ELEGANS; C-ELEGANS; GERM-LINE; ENVELOPE; DISEASE; PROTEIN; CYCLE; ORGANIZATION; LONGEVITY	In dividing cells, nuclear pore complexes (NPCs) disassemble during mitosis and reassemble into the newly forming nuclei. However, the fate of nuclear pores in postmitotic cells is unknown. Here, we show that NPCs, unlike other nuclear structures, do not turn over in differentiated cells. While a subset of NPC components, like Nup153 and Nup50, are continuously exchanged, scaffold nucleoporins, like the Nup107/160 complex, are extremely long-lived and remain incorporated in the nuclear membrane during the entire cellular life span. Besides the lack of nucleoporin expression and NPC turnover, we discovered an age-related deterioration of NPCs, leading to an increase in nuclear permeability and the leaking of cytoplasmic proteins into the nucleus. Our finding that nuclear "leakiness'' is dramatically accelerated during aging and that a subset of nucleoporins is oxidatively damaged in old cells suggests that the accumulation of damage at the NPC might be a crucial aging event.	[D'Angelo, Maximiliano A.; Raices, Marcela; Panowski, Siler H.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		D'Angelo, Maximiliano/0000-0001-7025-0142	NIH [R01 GM057438 .]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057438] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Dillin, P. Askjaer, B. Burke, J. Ellenberg, R. Foisner, M. Hengartner, Y. Gruenbaum, U. Kutay, and E. Schirmer for reagents; M. Downes for mammalian Q-PCR assays; J. Jepsen for isolation of rat brains; and the Hetzer lab, C. Hetzer-Egger, T. Hunter, W. Eckhart, F. Gage, and S. Pfaff for critical discussion and reading of the manuscript. This work was funded by the NIH R01 GM057438 grant.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; D'Angelo MA, 2006, CELL MOL LIFE SCI, V63, P316, DOI 10.1007/s00018-005-5361-3; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Danielson SR, 2008, FREE RADICAL BIO MED, V44, P1787, DOI 10.1016/j.freeradbiomed.2008.03.005; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim Y, 2007, AGING CELL, V6, P489, DOI 10.1111/j.1474-9726.2007.00302.x; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Lenart P, 2006, METHODS, V38, P17, DOI 10.1016/j.ymeth.2005.07.010; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; LOVTRUPREIN H, 1966, J CELL BIOL, V30, P405, DOI 10.1083/jcb.30.2.405; MAUL GG, 1972, J CELL BIOL, V55, P433, DOI 10.1083/jcb.55.2.433; Oeda T, 2001, HUM MOL GENET, V10, P2013, DOI 10.1093/hmg/10.19.2013; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Woulfe JM, 2007, NEUROPATH APPL NEURO, V33, P2, DOI 10.1111/j.1365-2990.2006.00819.x; Zhu X, 2007, CELL MOL LIFE SCI, V64, P2202, DOI 10.1007/s00018-007-7218-4	44	363	369	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					284	295		10.1016/j.cell.2008.11.037	http://dx.doi.org/10.1016/j.cell.2008.11.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167330	Bronze, Green Accepted			2022-12-24	WOS:000262648800017
J	Kelly, BT; McCoy, AJ; Spate, K; Miller, SE; Evans, PR; Honing, S; Owen, DJ				Kelly, Bernard T.; McCoy, Airlie J.; Spaete, Kira; Miller, Sharon E.; Evans, Philip R.; Hoening, Stefan; Owen, David J.			A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex	NATURE			English	Article							SORTING-SIGNAL RECOGNITION; CLATHRIN-COATED VESICLES; DI-LEUCINE MOTIF; ADAPTER; PHOSPHORYLATION; SUBUNIT; PROTEIN; CLUSTER; SOFTWARE; RECEPTOR	Most transmembrane proteins are selected as transport- vesicle cargo through the recognition of short, linear amino- acid motifs in their cytoplasmic portions by vesicle coat proteins. For clathrin-coated vesicles, the motifs are recognized by clathrin adaptors. The AP2 adaptor complex (subunits alpha, beta 2, mu 2 and sigma 2) recognizes both major endocytic motifs: Yxx Phi motifs(1) ( where Phi can be F, I, L, Mor V) and [ED] xxxL[ LI] acidic dileucine motifs. Here we describe the binding of AP2 to the endocytic dileucine motif from CD4 ( ref. 2). The major recognition events are the two leucine residues binding in hydrophobic pockets on sigma 2. The hydrophilic residue four residues upstream from the first leucine sits on a positively charged patch made from residues on the sigma 2 and a subunits. Mutations in key residues inhibit the binding of AP2 to 'acidic dileucine' motifs displayed in liposomes containing phosphatidylinositol-4,5-bisphosphate,but do not affect binding to Yxx Phi motifs through mu 2. In the 'inactive' AP2 core structure(3) both motif- binding sites are blocked by different parts of the beta 2 subunit. To allow a dileucine motif to bind, the beta 2 amino terminus is displaced and becomes disordered; however, in this structure the Yxx Phi-binding site on mu 2 remains blocked.	[Kelly, Bernard T.; McCoy, Airlie J.; Miller, Sharon E.; Owen, David J.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Kelly, Bernard T.; McCoy, Airlie J.; Miller, Sharon E.; Owen, David J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0XY, England; [Spaete, Kira; Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Spaete, Kira; Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Evans, Philip R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cologne; University of Cologne; MRC Laboratory Molecular Biology	Owen, DJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	djo30@cam.ac.uk			Wellcome Trust Senior Research Fellowship; Deutsche Forschungsgemeinschaft [SFB635, SFB670]; MRC [MC_U105178845] Funding Source: UKRI; Medical Research Council [MC_U105178845] Funding Source: researchfish	Wellcome Trust Senior Research Fellowship(Wellcome Trust); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the protein crystallography beamline staff at Diamond, especially E. Duke, K. McAuley and R. Flaig, for their support and assistance. D.J. O., B.T.K. and S.E.M. are funded by a Wellcome Trust Senior Research Fellowship to D.J.O.S.H. and K.S. are supported by grants from the Deutsche Forschungsgemeinschaft (SFB635 and SFB670).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; DORAY B, IDENTIFICAT IN PRESS; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Huang FT, 2003, J BIOL CHEM, V278, P43411, DOI 10.1074/jbc.M306072200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a	27	224	231	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					976	U81		10.1038/nature07422	http://dx.doi.org/10.1038/nature07422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19140243	Green Accepted, Green Submitted			2022-12-24	WOS:000261768300051
J	Nienborg, H; Cumming, BG				Nienborg, Hendrikje; Cumming, Bruce G.			Decision-related activity in sensory neurons reflects more than a neuron's causal effect	NATURE			English	Article							EARLY VISUAL-CORTEX; PERCEPTUAL DECISION; TASK STRATEGY; V2 NEURONS; AREA MT; CHOICE; RESPONSES; DISCRIMINATION; REPRESENTATION; VARIABILITY	During perceptual decisions, the activity of sensory neurons correlates with a subject's percept, even when the physical stimulus is identical(1-9). The origin of this correlation is unknown. Current theory proposes a causal effect of noise in sensory neurons on perceptual decisions(10-12), but the correlation could result from different brain states associated with the perceptual choice(13) (a top-down explanation). These two schemes have very different implications for the role of sensory neurons in forming decisions(14). Here we use white-noise analysis(15) to measure tuning functions of V2 neurons associated with choice and simultaneously measure how the variation in the stimulus affects the subjects' (two macaques) perceptual decisions(16-18). In causal models, stronger effects of the stimulus upon decisions, mediated by sensory neurons, are associated with stronger choice-related activity. However, we find that over the time course of the trial these measures change in different directions-at odds with causal models. An analysis of the effect of reward size also supports this conclusion. Finally, we find that choice is associated with changes in neuronal gain that are incompatible with causal models. All three results are readily explained if choice is associated with changes in neuronal gain caused by top-down phenomena that closely resemble attention(19). We conclude that top-down processes contribute to choice-related activity. Thus, even forming simple sensory decisions involves complex interactions between cognitive processes and sensory neurons.	[Nienborg, Hendrikje; Cumming, Bruce G.] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Nienborg, H (corresponding author), NEI, Sensorimotor Res Lab, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	hnienb@gmail.com			US National Institutes of Health; National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000404] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the Intramural Research Program of the US National Institutes of Health, National Eye Institute. We are grateful to J.A. Movshon and M. Shadlen for discussions and to the members of the Laboratory of Sensorimotor Research for comments on an earlier version of this manuscript. We also thank D. Parker and B. Nagy for excellent animal care.	AHUMADA AJ, 1996, PERCEPTION, V26, P18; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Cumming BG, 1999, J NEUROSCI, V19, P5602; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Krug K, 2004, PHILOS T R SOC B, V359, P929, DOI 10.1098/rstb.2003.1415; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Neri P, 1999, NATURE, V401, P695, DOI 10.1038/44409; Nienborg H, 2007, NAT NEUROSCI, V10, P1608, DOI 10.1038/nn1991; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	31	212	213	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					89	U93		10.1038/nature07821	http://dx.doi.org/10.1038/nature07821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19270683	Green Accepted			2022-12-24	WOS:000265801300035
J	Baugh, LR; DeModena, J; Sternberg, PW				Baugh, L. Ryan; DeModena, John; Sternberg, Paul W.			RNA Pol II Accumulates at Promoters of Growth Genes During Developmental Arrest	SCIENCE			English	Article							POLYMERASE-II; IN-VIVO; RECEPTOR NHR-49; HUMAN GENOME; C-ELEGANS; TRANSCRIPTION; DROSOPHILA; NELF; PHOSPHORYLATION	When Caenorhabditis elegans larvae hatch from the egg case in the absence of food, their development is arrested (L1 arrest), and they show increased stress resistance until food becomes available. To study nutritional control of larval development, we analyzed growth and gene expression profiles during L1 arrest and recovery. Larvae that were fed responded relatively slowly to starvation compared with the rapid response of arrested larvae to feeding. Chromatin immunoprecipitation of RNA polymerase II (Pol II) followed by deep sequencing showed that during L1 arrest, Pol II continued transcribing starvation-response genes, but the enzyme accumulated on the promoters of growth and development genes. In response to feeding, promoter accumulation decreased, and elongation and messenger RNA levels increased. Therefore, accumulation of Pol II at promoters anticipates nutritionally controlled gene expression during C. elegans development.	[Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	pws@caltech.edu	Baugh, L. Ryan/GRS-0507-2022	Baugh, L. Ryan/0000-0003-2148-5492; Sternberg, Paul/0000-0002-7699-0173	American Cancer Society; Howard Hughes Medical Institute	American Cancer Society(American Cancer Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank L. Schaeffer, D. Trout, A. Mortazavi, J. L. Riechmann, and B. Wold for assistance and discussions. We thank E. H. Davidson for sharing his COPAS Biosorter and B. Hwang for sharing his destabilized YFP plasmid. L.R.B. was supported by the American Cancer Society. P.W.S. is an investigator with the Howard Hughes Medical Institute, which supported this work. Microarray analysis and sequencing were performed in the Millard and Muriel Jacobs Genetics and Genomics Laboratory at Caltech. Data and analysis available for download from NCBI Gene Expression Omnibus (accession GSE14009) at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE14009.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	20	128	130	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					92	94		10.1126/science.1169628	http://dx.doi.org/10.1126/science.1169628			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19251593				2022-12-24	WOS:000264802100039
J	Starr, TK; Allaei, R; Silverstein, KAT; Staggs, RA; Sarver, AL; Bergemann, TL; Gupta, M; O'Sullivan, MG; Matise, I; Dupuy, AJ; Collier, LS; Powers, S; Oberg, AL; Asmann, YW; Thibodeau, SN; Tessarollo, L; Copeland, NG; Jenkins, NA; Cormier, RT; Largaespada, DA				Starr, Timothy K.; Allaei, Raha; Silverstein, Kevin A. T.; Staggs, Rodney A.; Sarver, Aaron L.; Bergemann, Tracy L.; Gupta, Mihir; O'Sullivan, M. Gerard; Matise, Ilze; Dupuy, Adam J.; Collier, Lara S.; Powers, Scott; Oberg, Ann L.; Asmann, Yan W.; Thibodeau, Stephen N.; Tessarollo, Lino; Copeland, Neal G.; Jenkins, Nancy A.; Cormier, Robert T.; Largaespada, David A.			A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer	SCIENCE			English	Article							TUMOR-SUPPRESSOR; EXPRESSION; CELLS; METHYLATION; INSTABILITY; MUTAGENESIS; EPITHELIUM; MOUSE	Human colorectal cancers (CRCs) display a large number of genetic and epigenetic alterations, some of which are causally involved in tumorigenesis (drivers) and others that have little functional impact (passengers). To help distinguish between these two classes of alterations, we used a transposon-based genetic screen in mice to identify candidate genes for CRC. Mice harboring mutagenic Sleeping Beauty (SB) transposons were crossed with mice expressing SB transposase in gastrointestinal tract epithelium. Most of the offspring developed intestinal lesions, including intraepithelial neoplasia, adenomas, and adenocarcinomas. Analysis of over 16,000 transposon insertions identified 77 candidate CRC genes, 60 of which are mutated and/or dysregulated in human CRC and thus are most likely to drive tumorigenesis. These genes include APC, PTEN, and SMAD4. The screen also identified 17 candidate genes that had not previously been implicated in CRC, including POLI, PTPRK, and RSPO2.	[Starr, Timothy K.; Allaei, Raha; Largaespada, David A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Ctr Genome Engn, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Silverstein, Kevin A. T.; Staggs, Rodney A.; Sarver, Aaron L.] Univ Minnesota, Dept Biostat & Informat, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Bergemann, Tracy L.] Univ Minnesota, Sch Publ Hlth, Dept Biostat, Minneapolis, MN 55455 USA; [Gupta, Mihir] Harvard Univ, Dept Phys & Chem Biol, Cambridge, MA 02138 USA; [O'Sullivan, M. Gerard; Matise, Ilze] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Dupuy, Adam J.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Collier, Lara S.] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA; [Powers, Scott] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Oberg, Ann L.; Asmann, Yan W.; Thibodeau, Stephen N.] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Tessarollo, Lino] NCI, Neural Dev Grp, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA; [Copeland, Neal G.; Jenkins, Nancy A.] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Cormier, Robert T.] Univ Minnesota, Sch Med, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Wisconsin System; University of Wisconsin Madison; Cold Spring Harbor Laboratory; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Minnesota System; University of Minnesota Duluth	Starr, TK (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Ctr Genome Engn, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	star0044@umn.edu; larga002@umn.edu	Starr, Tim/AAX-9342-2021; Largaespada, David/C-9832-2014	Dupuy, Adam/0000-0002-8561-4911; Powers, Scott/0000-0003-2769-1932; Starr, Timothy/0000-0002-6308-3451; Bergemann, Tracy/0000-0003-3902-2605	American Cancer Society fellowship [PF-06-282-01-MGO]; NIH [R01CA113636-01A1]; NCI [K01CA122183-03]; Biomedical Research Council of A*STAR, Singapore; NCI Intramural Research Program of NIH; University of Minnesota Academic Health Center; NATIONAL CANCER INSTITUTE [R01CA113636, ZICBC011198] Funding Source: NIH RePORTER	American Cancer Society fellowship(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); NCI Intramural Research Program of NIH; University of Minnesota Academic Health Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Insertion data are deposited in the Retrovirus Tagged Cancer Gene Database (RTCGD). We thank S. Singh for help with GSFlex 454 sequencing; K. Akagi for maintaining the RTCGD; A. Weber-Main and K. Stone for editing assistance; the Masonic Cancer Center shared resources including Biostatistics and Bioinformatics, Comparative Pathology, and the Mouse Genetics Laboratory; and the Minnesota Supercomputing Institute for providing computational resources. Research was funded by the American Cancer Society fellowship PF-06-282-01-MGO (to T.K.S.), NIH grant R01CA113636-01A1 (to D.A.L.), NCI grant K01CA122183-03 (to L.S.C.), the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research) Singapore (N.A.J. and N.G.C.), and the NCI Intramural Research Program of NIH (L.T.). A University of Minnesota Academic Health Center Faculty Development Grant provided additional funding to D.A.L. and R.T.C. D.A.L. is a cofounder of, and has an equity interest in, Discovery Genomics, Inc., a biotechnology company that is pursuing SB technology for human gene therapy. The University of Minnesota has filed a patent related to the work described in this paper.	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Fukuyama R, 2008, ONCOGENE, V27, P6044, DOI 10.1038/onc.2008.204; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hayashi H, 2007, HUM GENET, V120, P701, DOI 10.1007/s00439-006-0254-6; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Staub E, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-79; Stoler DL, 1999, P NATL ACAD SCI USA, V96, P15121, DOI 10.1073/pnas.96.26.15121; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Wang Y, 2007, CANCER RES, V67, P3018, DOI 10.1158/0008-5472.CAN-06-3073; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	25	263	270	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1747	1750		10.1126/science.1163040	http://dx.doi.org/10.1126/science.1163040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19251594	Green Accepted			2022-12-24	WOS:000264559800045
J	Schuckit, MA				Schuckit, Marc A.			Alcohol-use disorders	LANCET			English	Review							SUBSTANCE-USE DISORDERS; RECEPTOR GENE OPRM1; AT-RISK DRINKING; UNITED-STATES; DSM-IV; IDENTIFICATION TEST; BRIEF INTERVENTIONS; RELAPSE PREVENTION; LABORATORY MARKERS; DEPENDENT PATIENTS	Alcohol dependence and alcohol abuse or harmful use cause substantial morbidity and mortality. Alcohol-use disorders are associated with depressive episodes, severe anxiety, insomnia, suicide, and abuse of other drugs. Continued heavy alcohol use also shortens the onset of heart disease, stroke, cancers, and liver cirrhosis, by affecting the cardiovascular, gastrointestinal, and immune systems. Heavy drinking can also cause mild anterograde amnesias, temporary cognitive deficits, sleep problems, and peripheral neuropathy; cause gastroinestinal problems; decrease bone density and production of blood cells; and cause fetal alcohol syndrome. Alcohol-use disorders complicate assessment and treatment of other medical and psychiatric problems. Standard criteria for alcohol dependence-the more severe disorder-can be used to reliably identify people for whom drinking causes major physiological consequences and persistent impairment of quality of life and ability to function. Clinicians should routinely screen for alcohol disorders, using clinical interviews, questionnaires, blood tests, or a combination of these methods. Causes include environmental factors and specific genes that affect the risk of alcohol-use disorders, including genes for enzymes that metabolise alcohol, such as alcohol dehydrogenase and aldehyde dehydrogenase; those associated with disinhibition; and those that confer a low sensitivity to alcohol. Treatment can include motivational interviewing to help people to evaluate their situations, brief interventions to facilitate more healthy behaviours, detoxification to address withdrawal symptoms, cognitive-behavioural therapies to avoid relapses, and judicious use of drugs to diminish cravings or discourage relapses.	[Schuckit, Marc A.] VA San Diego Healthcare Syst, La Jolla, CA 92161 USA; [Schuckit, Marc A.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Schuckit, MA (corresponding author), VA San Diego Healthcare Syst, 3350 Jolla Village Dr, La Jolla, CA 92161 USA.	mschuckit@ucsd.edu			Veterans Affairs Research Service [NIAAA 2R01, NIAAA AA05526, NIAAA U10, NIAAA AA08401, NIAAA 5R01AA15760]; State of California; University of California, San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015760, R01AA005526, U10AA008401] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); State of California; University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Veterans Affairs Research Service (NIAAA grants 2R01 AA05526, U10 AA08401, and 5ROIAA5760), and by funds provided by the, State of California for medical research oil alcohol and substance abuse through the University of California, San Francisco.	Alati R, 2006, ARCH GEN PSYCHIAT, V63, P1009, DOI 10.1001/archpsyc.63.9.1009; Alte D, 2003, J STUD ALCOHOL, V64, P75, DOI 10.15288/jsa.2003.64.75; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anton RF, 2006, ALCOHOL CLIN EXP RES, V30, P1878, DOI 10.1111/j.1530-0277.2006.00225.x; BABOR TF, 1992, ARCH GEN PSYCHIAT, V49, P599; Babor TF, 2006, ALCOHOL ALCOHOLISM, V41, P624, DOI 10.1093/alcalc/agl078; BARR C, 2005, ALCOHOL CLIN EXP RES, V27, P812; Bartsch AJ, 2007, BRAIN, V130, P36, DOI 10.1093/brain/awl303; Berner MM, 2007, J STUD ALCOHOL DRUGS, V68, P461, DOI 10.15288/jsad.2007.68.461; Blednov YA, 2007, NEUROPSYCHOPHARMACOL, V32, P1570, DOI 10.1038/sj.npp.1301274; Bodin MC, 2006, J STUD ALCOHOL, V67, P139, DOI 10.15288/jsa.2006.67.139; Borghese CM, 2002, ALCOHOL CLIN EXP RES, V26, P1764, DOI 10.1097/01.ALC.0000042012.58231.D9; Bottlender M, 2005, DRUG ALCOHOL DEPEN, V80, P83, DOI 10.1016/j.drugalcdep.2005.03.011; Carroll KM, 2006, DRUG ALCOHOL DEPEN, V81, P301, DOI 10.1016/j.drugalcdep.2005.08.002; Clark DB, 2004, ADDICTION, V99, P5, DOI 10.1111/j.1360-0443.2004.00851.x; Conigrave KM, 2002, ALCOHOL CLIN EXP RES, V26, P332, DOI 10.1097/00000374-200203000-00005; Conroy DA, 2006, ALCOHOL CLIN EXP RES, V30, P1992, DOI 10.1111/j.1530-0277.2006.00245.x; Cook TAR, 2005, J STUD ALCOHOL, V66, P196, DOI 10.15288/jsa.2005.66.196; Cox WM, 2004, ALCOHOL ALCOHOLISM, V39, P130, DOI 10.1093/alcalc/agh035; Crawford M, 2004, LANCET, V364, P1334, DOI 10.1016/S0140-6736(04)17190-0; Dawson DA, 2005, ADDICTION, V100, P281, DOI 10.1111/j.1360-0443.2004.00964.x; Dick DM, 2006, BEHAV GENET, V36, P577, DOI 10.1007/s10519-005-9041-8; Dickson PA, 2006, ALCOHOL CLIN EXP RES, V30, P1093, DOI 10.1111/j.1530-0277.2006.00128.x; Duranceaux NCE, 2006, ALCOHOL CLIN EXP RES, V30, P1470, DOI 10.1111/j.1530-0277.2006.00178.x; Enoch MA, 2006, AM J MED GENET B, V141B, P599, DOI 10.1002/ajmg.b.30336; Fatjo F, 2007, ALCOHOL CLIN EXP RES, V31, P1099, DOI 10.1111/j.1530-0277.2007.00404.x; Feeney GFX, 2006, ALCOHOL ALCOHOLISM, V41, P321, DOI 10.1093/alcalc/agl007; Fuller RK, 2004, ADDICTION, V99, P21, DOI 10.1111/j.1360-0443.2004.00597.x; Gelernter J, 2007, ALCOHOL CLIN EXP RES, V31, P555, DOI 10.1111/j.1530-0277.2007.00339.x; Hamilton SP, 2004, NEUROPSYCHOPHARMACOL, V29, P558, DOI 10.1038/sj.npp.1300311; Harford TC, 2006, J STUD ALCOHOL, V67, P803, DOI 10.15288/jsa.2006.67.803; Hasin D, 1997, DRUG ALCOHOL DEPEN, V47, P217, DOI 10.1016/S0376-8716(97)00092-6; Hasin D, 1996, ADDICTION, V91, P1517; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Heather N, 2000, J STUD ALCOHOL, V61, P561, DOI 10.15288/jsa.2000.61.561; Hietala J, 2006, ALCOHOL ALCOHOLISM, V41, P528, DOI 10.1093/alcalc/agl050; Hinckers AS, 2006, BIOL PSYCHIAT, V60, P282, DOI 10.1016/j.biopsych.2005.12.009; Ho MP, 2007, AM J MED SCI, V333, P53, DOI 10.1097/00000441-200701000-00007; Hughes JR, 2006, DRUG ALCOHOL DEPEN, V82, P91, DOI 10.1016/j.drugalcdep.2005.08.018; Humphreys K, 2007, ALCOHOL CLIN EXP RES, V31, P64, DOI 10.1111/j.1530-0277.2006.00273.x; IRWIN M, 1988, AM J PSYCHIAT, V145, P595; Johnson BA, 2006, ALCOHOL CLIN EXP RES, V30, P567, DOI 10.1111/j.1530-0277.2005.00066.x; Johnson BA, 2007, JAMA-J AM MED ASSOC, V298, P1641, DOI 10.1001/jama.298.14.1641; Johnston L. D., 2007, NIH PUBLICATION, VI; Jones KA, 2006, BEHAV GENET, V36, P627, DOI 10.1007/s10519-006-9075-6; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kaukonen JP, 2006, ALCOHOL ALCOHOLISM, V41, P345, DOI 10.1093/alcalc/agh259; Kendler KS, 2006, ALCOHOL CLIN EXP RES, V30, P1972, DOI 10.1111/j.1530-0277.2006.00243.x; Kiefer F, 2003, ARCH GEN PSYCHIAT, V60, P92, DOI 10.1001/archpsyc.60.1.92; Kodituwakku PW, 2006, J STUD ALCOHOL, V67, P502, DOI 10.15288/jsa.2006.67.502; Krampe H, 2006, ALCOHOL CLIN EXP RES, V30, P86, DOI 10.1111/j.1530-0277.2006.00013.x; Kranzler HR, 2006, ALCOHOL CLIN EXP RES, V30, P272, DOI 10.1111/j.1530-0277.2006.00022.x; Krishnan-Sarin S, 2007, BIOL PSYCHIAT, V62, P694, DOI 10.1016/j.biopsych.2006.11.018; Krystal JH, 2006, ARCH GEN PSYCHIAT, V63, P957, DOI 10.1001/archpsyc.63.9.957; Kuperman S, 2005, ALCOHOL CLIN EXP RES, V29, P1869, DOI 10.1097/01.alc.0000183190.32692.c7; Laucht M, 2007, BIOL PSYCHIAT, V61, P87, DOI 10.1016/j.biopsych.2006.05.025; Lemke S, 2005, J STUD ALCOHOL, V66, P756, DOI 10.15288/jsa.2005.66.756; Li TK, 2007, BIOL PSYCHIAT, V61, P1, DOI 10.1016/j.biopsych.2006.11.004; Lingford-Hughes AR, 2004, J PSYCHOPHARMACOL, V18, P293, DOI 10.1177/026988110401800321; Maddrey W C, 2000, Clin Liver Dis, V4, P115, DOI 10.1016/S1089-3261(05)70099-4; Maisto SA, 2006, J STUD ALCOHOL, V67, P823, DOI 10.15288/jsa.2006.67.823; Mann K, 2004, ALCOHOL CLIN EXP RES, V28, P51, DOI 10.1097/01.ALC.0000108656.81563.05; Mann K, 2005, ADDICTION, V100, P797, DOI 10.1111/j.1360-0443.2005.01065.x; Mason BJ, 2006, J PSYCHIATR RES, V40, P383, DOI 10.1016/j.jpsychires.2006.02.002; McKellar JD, 2006, J STUD ALCOHOL, V67, P685, DOI 10.15288/jsa.2006.67.685; Mertens JR, 2005, ALCOHOL CLIN EXP RES, V29, P989, DOI 10.1097/01.ALC.0000167958.68586.3D; Moos RH, 2006, ADDICTION, V101, P212, DOI 10.1111/j.1360-0443.2006.01310.x; Moos RH, 2000, ADDICTION, V95, P833, DOI 10.1046/j.1360-0443.2000.9568332.x; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; Mundt MP, 2005, J STUD ALCOHOL, V66, P389, DOI 10.15288/jsa.2005.66.389; Nelson EC, 2004, ARCH GEN PSYCHIAT, V61, P257, DOI 10.1001/archpsyc.61.3.257; Niemela O, 2007, CLIN CHIM ACTA, V377, P39, DOI 10.1016/j.cca.2006.08.035; Norstrom T, 2004, ADDICTION, V99, P1274, DOI [10.1111/j.1360-0443.2004.00849.x, 10.1111/j.1360-0443.2004.00894.x]; Nurnberger JI, 2007, SCI AM, V296, P46, DOI 10.1038/scientificamerican0407-46; O'Malley SS, 2007, J CLIN PSYCHOPHARM, V27, P507, DOI 10.1097/jcp.0b013e31814ce50d; Palmieri VO, 2006, ADV EXP MED BIOL, V578, P125; Parker AJR, 2008, BMJ-BRIT MED J, V336, P496, DOI 10.1136/bmj.39483.457708.80; Pastor R, 2006, NEUROPSYCHOPHARMACOL, V31, P1489, DOI 10.1038/sj.npp.1300928; Peters TJ, 2006, ALCOHOL ALCOHOLISM, V41, P636, DOI 10.1093/alcalc/agl058; Pitel AL, 2007, ALCOHOL CLIN EXP RES, V31, P1169, DOI 10.1111/j.1530-0277.2007.00418.x; Polednak AP, 2005, ALCOHOL ALCOHOLISM, V40, P234, DOI 10.1093/alcalc/agh150; Ramstedt M, 2004, ADDICTION, V99, P1255, DOI 10.1111/j.1360-0443.2004.00798.x; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Reoux JP, 2000, AM J ADDICTION, V9, P135; Rivara FP, 2004, J STUD ALCOHOL, V65, P530, DOI 10.15288/jsa.2004.65.530; ROMEROGOMEZ M, 2002, ALCOHOL RES, V7, P66; Rosenbloom MJ, 2007, J STUD ALCOHOL DRUGS, V68, P115, DOI 10.15288/jsad.2007.68.115; Rumpf HJ, 2006, ALCOHOL ALCOHOLISM, V41, P311, DOI 10.1093/alcalc/agl008; Rush A.J., 2000, HDB PSYCHIAT MEASURE; Sannibale C, 2005, DRUG ALCOHOL REV, V24, P475, DOI 10.1080/09595230500292912; Saremi A, 2001, J STUD ALCOHOL, V62, P294, DOI 10.15288/jsa.2001.62.294; Saxena S, 1997, ADDICTION, V92, pS43, DOI 10.1111/j.1360-0443.1997.tb03394.x; Schellenberg F, 2005, ALCOHOL ALCOHOLISM, V40, P531, DOI 10.1093/alcalc/agh194; Schuckit M., 2006, DRUG ALCOHOL ABUSE C; Schuckit M.A., 2002, NEUROPSYCHOPHARMACOL, P1399; Schuckit MA, 2006, J STUD ALCOHOL, V67, P215, DOI 10.15288/jsa.2006.67.215; Schuckit MA, 2005, AM J PSYCHIAT, V162, P350, DOI 10.1176/appi.ajp.162.2.350; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; Schuckit MA, 2008, J PSYCHIATR RES, V42, P644, DOI 10.1016/j.jpsychires.2007.07.013; Schuckit MA, 2006, ADDICTION, V101, P76, DOI 10.1111/j.1360-0443.2006.01592.x; Schumann G, 2005, NERVENARZT, V76, P1355, DOI 10.1007/s00115-005-1917-6; Smith TL, 1999, ALCOHOL CLIN EXP RES, V23, P1772, DOI 10.1111/j.1530-0277.1999.tb04072.x; Srisurapanont M, 2005, INT J NEUROPSYCHOPH, V8, P267, DOI 10.1017/S1461145704004997; Stahlbrandt H, 2007, ALCOHOL CLIN EXP RES, V31, P458, DOI 10.1111/j.1530-0277.2006.00327.x; Stecker T, 2007, J STUD ALCOHOL DRUGS, V68, P510, DOI 10.15288/jsad.2007.68.510; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Suh JJ, 2006, J CLIN PSYCHOPHARM, V26, P290, DOI 10.1097/01.jcp.0000222512.25649.08; Szucs S, 2005, ADDICTION, V100, P536, DOI 10.1111/j.1360-0443.2005.01009.x; Teesson M, 2006, DRUG ALCOHOL DEPEN, V81, P149, DOI 10.1016/j.drugalcdep.2005.06.007; Thomson AD, 2006, ALCOHOL ALCOHOLISM, V41, P151, DOI 10.1093/alcalc/agh249; Timberlake DS, 2007, ALCOHOL CLIN EXP RES, V31, P1020, DOI 10.1111/j.1530-0277.2007.00383.x; Uyarel H, 2005, J STUD ALCOHOL, V66, P555, DOI 10.15288/jsa.2005.66.555; van den Wildenberg E, 2007, ALCOHOL CLIN EXP RES, V31, P1, DOI 10.1111/j.1530-0277.2006.00258.x; Van Reen E, 2006, ALCOHOL CLIN EXP RES, V30, P974, DOI 10.1111/j.1530-0277.2006.00111.x; Vasilaki EI, 2006, ALCOHOL ALCOHOLISM, V41, P328, DOI 10.1093/alcalc/agl016; Verge C, 2006, WORLD J GASTROENTERO, V12, P5078, DOI 10.3748/wjg.v12.i31.5078; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Weinshenker D, 2007, NEUROPSYCHOPHARMACOL, V32, P1433, DOI 10.1038/sj.npp.1301263; Witkiewitz K, 2004, AM PSYCHOL, V59, P224, DOI 10.1037/0003-066X.59.4.224; Witkiewitz K, 2008, J STUD ALCOHOL DRUGS, V69, P594, DOI 10.15288/jsad.2008.69.594; World Health Organisation, 1993, ICD 10 CLASS MENT BE	121	407	422	3	131	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					492	501		10.1016/S0140-6736(09)60009-X	http://dx.doi.org/10.1016/S0140-6736(09)60009-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19168210				2022-12-24	WOS:000263132800032
J	Gao, B; Hu, JX; Stricker, S; Cheung, M; Ma, G; Law, KF; Witte, F; Briscoe, J; Mundlos, S; He, L; Cheah, KSE; Chan, D				Gao, Bo; Hu, Jianxin; Stricker, Sigmar; Cheung, Martin; Ma, Gang; Law, Kit Fong; Witte, Florian; Briscoe, James; Mundlos, Stefan; He, Lin; Cheah, Kathryn S. E.; Chan, Danny			A mutation in Ihh that causes digit abnormalities alters its signalling capacity and range	NATURE			English	Article							SONIC HEDGEHOG; INDIAN HEDGEHOG; ENDOCHONDRAL BONE; GROWTH-PLATE; EXPRESSION; GENE; DIFFERENTIATION; CARTILAGE; PROTEIN; EMBRYO	Brachydactyly type A1 (BDA1) was the first recorded disorder of the autosomal dominant Mendelian trait in humans, characterized by shortened or absent middle phalanges in digits. It is associated with heterozygous missense mutations in indian hedgehog (IHH)(1,2). Hedgehog proteins are important morphogens for a wide range of developmental processes(3,4). The capacity and range of signalling is thought to be regulated by its interaction with the receptor PTCH1 and antagonist HIP1. Here we show that a BDA1 mutation (E95K) in Ihh impairs the interaction of IHH with PTCH1 and HIP1. This is consistent with a recent paper showing that BDA1 mutations cluster in a calcium-binding site essential for the interaction with its receptor and cell-surface partners(5). Furthermore, we show that in a mouse model that recapitulates the E95K mutation, there is a change in the potency and range of signalling. The mice have digit abnormalities consistent with the human disorder.	[Gao, Bo; Hu, Jianxin; Cheung, Martin; Law, Kit Fong; Cheah, Kathryn S. E.; Chan, Danny] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Gao, Bo; Hu, Jianxin; Ma, Gang; He, Lin] Shanghai Jiao Tong Univ, BioX Ctr, Shanghai 200030, Peoples R China; [Stricker, Sigmar; Witte, Florian; Mundlos, Stefan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Stricker, Sigmar; Witte, Florian; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany; [Cheah, Kathryn S. E.; Chan, Danny] Univ Hong Kong, LKS Fac Med, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Witte, Florian] Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany; [Briscoe, James] Natl Inst Med Res, London NW7 1AA, England; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	University of Hong Kong; Shanghai Jiao Tong University; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hong Kong; Free University of Berlin; MRC National Institute for Medical Research; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Chan, D (corresponding author), Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	helinhelin@gmail.com; chand@hkusua.hku.hk	Stricker, Sigmar/B-9169-2009; Mundlos, Stefan/ABH-9585-2020; Gao, Bo/F-4688-2013; Chan, Danny/C-4203-2009	Stricker, Sigmar/0000-0002-7174-5363; Mundlos, Stefan/0000-0002-9788-3166; Gao, Bo/0000-0002-8684-5199; Briscoe, James/0000-0002-1020-5240; Chan, Danny/0000-0003-3824-5778	Research Grants Council [N_HKU705/02, HKU2/02C]; University Grants Council of Hong Kong [AoE/M-04/04]; National Key Scientific Program [2007CB947300]; MRC [MC_U117560541] Funding Source: UKRI; Medical Research Council [MC_U117560541] Funding Source: researchfish	Research Grants Council(Hong Kong Research Grants Council); University Grants Council of Hong Kong; National Key Scientific Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Research Grants Council and University Grants Council of Hong Kong (N_HKU705/02, HKU2/02C and AoE/M-04/04), and The National Key Scientific Program (2007CB947300). We thank P. Tam for suggestions and comments, P. Beachy and D. Leahy for sharing unpublished data, and K. Leung for blastocyst injections.	ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Haaf T, 1996, BIOTECHNIQUES, V21, P1050; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee K, 1996, ENDOCRINOLOGY, V137, P5109, DOI 10.1210/en.137.11.5109; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; McCready ME, 2005, HUM GENET, V117, P285, DOI 10.1007/s00439-005-1289-9; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mundlos S, 2000, METH MOL B, V136, P61; Nagy A., 2003, MANIPULATING MOUSE E; Niedermaier M, 2005, J CLIN INVEST, V115, P900, DOI 10.1172/JCI200523675; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Schmahl J, 2000, DEVELOPMENT, V127, P65; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; St-Jacques B, 1999, GENE DEV, V13, P2617; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wai AWK, 1998, DEV GENET, V22, P349, DOI 10.1002/(SICI)1520-6408(1998)22:4<349::AID-DVG5>3.0.CO;2-6; Wallis D, 2000, HUM MUTAT, V16, P99, DOI 10.1002/1098-1004(200008)16:2<99::AID-HUMU2>3.0.CO;2-0; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	44	70	78	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1196	U136		10.1038/nature07862	http://dx.doi.org/10.1038/nature07862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19252479				2022-12-24	WOS:000265754600052
J	Lyras, D; O'Connor, JR; Howarth, PM; Sambol, SP; Carter, GP; Phumoonna, T; Poon, R; Adams, V; Vedantam, G; Johnson, S; Gerding, DN; Rood, JI				Lyras, Dena; O'Connor, Jennifer R.; Howarth, Pauline M.; Sambol, Susan P.; Carter, Glen P.; Phumoonna, Tongted; Poon, Rachael; Adams, Vicki; Vedantam, Gayatri; Johnson, Stuart; Gerding, Dale N.; Rood, Julian I.			Toxin B is essential for virulence of Clostridium difficile	NATURE			English	Article							ESCHERICHIA-COLI; EXPRESSION; HAMSTERS; DISEASE; SYSTEM; STRAIN; INFECTION; EPIDEMIC	Clostridium difficile is the leading cause of infectious diarrhoea in hospitals worldwide, because of its virulence, spore-forming ability and persistence(1,2). C. difficile-associated diseases are induced by antibiotic treatment or disruption of the normal gastrointestinal flora(3,4). Recently, morbidity and mortality resulting from C. difficile-associated diseases have increased significantly due to changes in the virulence of the causative strains and antibiotic usage patterns(1,2,5,6). Since 2002, epidemic toxinotype III NAP1/027 strains(1,2), which produce high levels of the major virulence factors, toxin A and toxin B, have emerged. These toxins have 63 % amino acid sequence similarity(7) and are members of the large clostridial glucosylating toxin family, which are monoglucosyltransferases that are pro-inflammatory, cytotoxic and enterotoxic in the human colon(8-10). Inside host cells, both toxins catalyse the transfer of glucose onto the Rho family of GTPases, leading to cell death(8,11). However, the role of these toxins in the context of a C. difficile infection is unknown. Here we describe the construction of isogenic tcdA and tcdB (encoding toxin A and B, respectively) mutants of a virulent C. difficile strain and their use in the hamster disease model to show that toxin B is a key virulence determinant. Previous studies showed that purified toxin A alone can induce most of the pathology observed after infection of hamsters with C. difficile(8,9,12) and that toxin B is not toxic in animals unless it is co-administered with toxin A, suggesting that the toxins act synergistically(12). Our work provides evidence that toxin B, not toxin A, is essential for virulence. Furthermore, it is clear that the importance of these toxins in the context of infection cannot be predicted exclusively from studies using purified toxins, reinforcing the importance of using the natural infection process to dissect the role of toxins in disease.	[Lyras, Dena; O'Connor, Jennifer R.; Howarth, Pauline M.; Carter, Glen P.; Phumoonna, Tongted; Poon, Rachael; Adams, Vicki; Rood, Julian I.] Monash Univ, Dept Microbiol, Australian Bacterial Pathogenesis Program, Clayton, Vic 3800, Australia; [Poon, Rachael; Rood, Julian I.] Monash Univ, Dept Microbiol, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [O'Connor, Jennifer R.; Sambol, Susan P.; Vedantam, Gayatri; Johnson, Stuart; Gerding, Dale N.] Hines VA Hosp, Med Serv, Hines, IL 60141 USA; [O'Connor, Jennifer R.; Sambol, Susan P.; Vedantam, Gayatri; Johnson, Stuart; Gerding, Dale N.] Hines VA Hosp, Res Serv, Hines, IL 60141 USA; Loyola Univ, Stritch Sch Med, Infect Dis Sect, Maywood, IL 60153 USA	Monash University; Monash University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago	Rood, JI (corresponding author), Monash Univ, Dept Microbiol, Australian Bacterial Pathogenesis Program, Clayton, Vic 3800, Australia.	julian.rood@med.monash.edu.au	Adams, Vicki/V-7077-2019; Rood, Julian I/A-4858-2008	Adams, Vicki/0000-0002-1506-1864; Rood, Julian I/0000-0003-2126-7209; Carter, Glen/0000-0002-7306-9362; Lyras, Dena/0000-0003-2345-9271; Das, Tongted/0000-0002-5331-4420; Johnson, Stuart/0000-0001-9548-229X	Australian National Health and Medical Research Council [284214]; ARC Centre of Excellence in Structural and Functional Microbial Genomics; United States National Institute of Allergy and Infectious Diseases [AIO57637]; United States Department of Veterans Affairs Research Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057637] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); United States National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Veterans Affairs Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research at Monash University was supported by Program Grant 284214 from the Australian National Health and Medical Research Council, funding from the ARC Centre of Excellence in Structural and Functional Microbial Genomics and grant AIO57637 from the United States National Institute of Allergy and Infectious Diseases. S.J., D.N.G., and G.V. were supported by Merit Review Grants from the United States Department of Veterans Affairs Research Service. We thank D. Lyerly, K. Aktories and C. von-Eichel Streiber for providing toxin-A-specific and toxin-B-specific antibodies, K. Nagaro and A. Cheknis for assistance with the hamster experiments, V.K. Viswanathan for providing intestinal epithelial cell lines, E. Hartland for providing the HT29 cell line, and M. Merrigan for adherence assays.	Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; BARTLETT JG, 1978, GASTROENTEROLOGY, V75, P778; Benson L, 2007, INFECT CONT HOSP EP, V28, P1233, DOI 10.1086/520732; Burger S, 2003, BIOCHEM BIOPH RES CO, V307, P584, DOI 10.1016/S0006-291X(03)01234-8; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; Du Tim, 2004, Can J Infect Dis, V15, P83; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Johnson S, 2001, ANN INTERN MED, V135, P434, DOI 10.7326/0003-4819-135-6-200109180-00012; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KIM PH, 1987, INFECT IMMUN, V55, P2984, DOI 10.1128/IAI.55.12.2984-2992.1987; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2000, MOL MICROBIOL, V38, P588, DOI 10.1046/j.1365-2958.2000.02154.x; Lyras D, 1998, PLASMID, V39, P160, DOI 10.1006/plas.1997.1325; Mani N, 2002, J BACTERIOL, V184, P5971, DOI 10.1128/JB.184.21.5971-5978.2002; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; O'Brien JA, 2007, INFECT CONT HOSP EP, V28, P1219, DOI 10.1086/522676; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Razaq N, 2007, J INFECT DIS, V196, P1813, DOI 10.1086/523106; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Sambrook J, 2001, MOL CLONING LAB MANU; Schirmer J, 2004, BBA-GEN SUBJECTS, V1673, P66, DOI 10.1016/j.bbagen.2004.03.014; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SMITH CJ, 1981, ANTIMICROB AGENTS CH, V19, P997, DOI 10.1128/AAC.19.6.997; Tang-Feldman YJ, 2002, MOL CELL PROBE, V16, P179, DOI 10.1006/mcpr.2002.0409; TORRES J, 1992, TOXICON, V30, P419, DOI 10.1016/0041-0101(92)90538-G; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	38	533	572	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1176	1181		10.1038/nature07822	http://dx.doi.org/10.1038/nature07822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19252482	Green Accepted			2022-12-24	WOS:000265754600055
J	Ramamurthi, KS; Lecuyer, S; Stone, HA; Losick, R				Ramamurthi, Kumaran S.; Lecuyer, Sigolene; Stone, Howard A.; Losick, Richard			Geometric Cue for Protein Localization in a Bacterium	SCIENCE			English	Article							BACILLUS-SUBTILIS; SUBCELLULAR-LOCALIZATION; MEMBRANE; CURVATURE; SPORULATION; INHIBITOR	Proteins in bacteria often deploy to particular places within the cell, but the cues for localization are frequently mysterious. We found that the peripheral membrane protein SpoVM (VM) recognizes a geometric cue when localizing to a particular membrane during sporulation in Bacillus subtilis. Sporulation involves an inner cell maturing into a spore and an outer cell nurturing the developing spore. VM is produced in the outer cell, where it embeds in the membrane that surrounds the inner cell but not in the cytoplasmic membrane of the outer cell. We found that VM localized by discriminating between the positive curvature of the membrane surrounding the inner cell and the negative curvature of the cytoplasmic membrane. Membrane curvature could be a general cue for protein localization in bacteria.	[Ramamurthi, Kumaran S.; Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lecuyer, Sigolene; Stone, Howard A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	losick@mcb.harvard.edu	Ramamurthi, Kumaran/P-3516-2015; lecuyer, sigolene/E-7626-2012	lecuyer, sigolene/0000-0001-7393-2667	arvard Nanoscale Science and Engineering Center [Fulbright grant]; NIH [GM18568]; NATIONAL CANCER INSTITUTE [ZIABC011211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018568, R37GM018568] Funding Source: NIH RePORTER	arvard Nanoscale Science and Engineering Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Gaudet, D. Rudner, C. Schmidt, L. Shapiro, R. Schekman, D. Weitz, and N. Wingreen for discussions and S. Lacefield, B. Scheid, and P. de Boer for advice. This work was supported by the Harvard Nanoscale Science and Engineering Center, a Fulbright grant to S.L., and NIH grant GM18568 to R.L.	BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; GOULIAN M, 1993, EUROPHYS LETT, V22, P145, DOI 10.1209/0295-5075/22/2/012; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Kim KS, 1998, BIOPHYS J, V75, P2274, DOI 10.1016/S0006-3495(98)77672-6; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Mackenzie C, 2007, ANNU REV MICROBIOL, V61, P283, DOI 10.1146/annurev.micro.61.080706.093402; Parthasarathy R, 2007, SOFT MATTER, V3, P24, DOI 10.1039/b608631d; Prajapati RS, 2000, BBA-GEN SUBJECTS, V1475, P353, DOI 10.1016/S0304-4165(00)00089-1; Ramamurthi KS, 2006, MOL MICROBIOL, V62, P1547, DOI 10.1111/j.1365-2958.2006.05468.x; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; van Ooij C, 2003, J BACTERIOL, V185, P1391, DOI 10.1128/JB.185.4.1391-1398.2003	17	162	163	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1354	1357		10.1126/science.1169218	http://dx.doi.org/10.1126/science.1169218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265022	Green Accepted			2022-12-24	WOS:000263876700045
J	Ventura, A; Jacks, T				Ventura, Andrea; Jacks, Tyler			MicroRNAs and Cancer: Short RNAs Go a Long Way	CELL			English	Article							MIR-17-92 CLUSTER; MIR-200 FAMILY; LET-7; EXPRESSION; GENE; MYC; ACTIVATION; SUPPRESSOR; PROFILES; PROLIFERATION	MicroRNAs (miRNAs) may be important regulators of gene expression. By modulating oncogenic and tumor suppressor pathways they could, in principle, contribute to tumorigenesis. Consistent with this hypothesis, recurrent genetic and epigenetic alterations of individual miRNAs are found in some tumors. Functional studies are now elucidating the mechanism of action of putative oncogenic and tumor suppressor miRNAs.	[Jacks, Tyler] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Memorial Sloan Kettering Cancer Center	Jacks, T (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Ventura, Andrea/F-1789-2011	Ventura, Andrea/0000-0003-4320-9907	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	50	753	797	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					586	591		10.1016/j.cell.2009.02.005	http://dx.doi.org/10.1016/j.cell.2009.02.005			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239879	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000263688200009
J	Barr, AJ; Ugochukwu, E; Lee, WH; King, ONF; Filippakopoulos, P; Alfano, I; Savitsky, P; Burgess-Brown, NA; Muller, S; Knapp, S				Barr, Alastair J.; Ugochukwu, Emilie; Lee, Wen Hwa; King, Oliver N. F.; Filippakopoulos, Panagis; Alfano, Ivan; Savitsky, Pavel; Burgess-Brown, Nicola A.; Mueller, Susanne; Knapp, Stefan			Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome	CELL			English	Article							RECEPTOR-TYPE-Z; CRYSTAL-STRUCTURE; RPTP-ALPHA; SUBSTRATE-SPECIFICITY; DIFFRACTION DATA; PTP-SIGMA; 1B; INHIBITOR; MECHANISM; GROWTH	Protein tyrosine phosphatases (PTPs) play a critical role in regulating cellular functions by selectively dephosphorylating their substrates. Here we present 22 human PTP crystal structures that, together with prior structural knowledge, enable a comprehensive analysis of the classical PTP family. Despite their largely conserved fold, surface properties of PTPs are strikingly diverse. A potential secondary substrate-binding pocket is frequently found in phosphatases, and this has implications for both substrate recognition and development of selective inhibitors. Structural comparison identified four diverse catalytic loop (WPD) conformations and suggested a mechanism for loop closure. Enzymatic assays revealed vast differences in PTP catalytic activity and identified PTPD1, PTPD2, and HDPTP as catalytically inert protein phosphatases. We propose a "head-totoe'' dimerization model for RPTP gamma/zeta that is distinct from the "inhibitory wedge'' model and that provides a molecular basis for inhibitory regulation. This phosphatome resource gives an expanded insight into intrafamily PTP diversity, catalytic activity, substrate recognition, and autoregulatory self-association.	[Barr, Alastair J.; Ugochukwu, Emilie; Lee, Wen Hwa; King, Oliver N. F.; Filippakopoulos, Panagis; Alfano, Ivan; Savitsky, Pavel; Burgess-Brown, Nicola A.; Mueller, Susanne; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England	University of Oxford; University of Oxford	Barr, AJ (corresponding author), Univ Oxford, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.	alastair.barr@sgc.ox.ac.uk; stefan.knapp@sgc.ox.ac.uk	Lee, Wen Hwa/GZA-8183-2022; Lee, Wen Hwa/G-1250-2013; Knapp, Stefan/AAG-2347-2019	Lee, Wen Hwa/0000-0002-4098-5225; Lee, Wen Hwa/0000-0002-4098-5225; Knapp, Stefan/0000-0001-5995-6494; Barr, Alastair/0000-0001-7738-8419; Savitsky, Pavel/0000-0001-8584-7750; Muller-Knapp, Susanne/0000-0003-2402-4157; King, Oliver/0000-0002-6152-7207; Filippakopoulos, Panagis/0000-0002-1515-1317	Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation, Genome Canada; Glaxo Smith Kline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada(Genome CanadaCanada Foundation for Innovation); Glaxo Smith Kline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	We gratefully acknowledge all our colleagues at the SGC, in particular J. Elkins, C. Johansson, E. Salah, J. Eswaran, and T. Keates. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, Glaxo Smith Kline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Barrett AC, 2006, EXP CLIN PSYCHOPHARM, V14, P1, DOI 10.1037/1064-1297.14.1.1; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanchetot C, 2002, EMBO J, V21, P493, DOI 10.1093/emboj/21.4.493; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2006, BIOCHEM J, V395, P483, DOI 10.1042/BJ20051931; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Groen A, 2008, FEBS J, V275, P2597, DOI 10.1111/j.1742-4658.2008.06407.x; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Jui HY, 2000, J BIOL CHEM, V275, P41124, DOI 10.1074/jbc.M007772200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lee S, 2007, MOL CELL BIOL, V27, P1795, DOI 10.1128/MCB.00535-06; Leslie AGW, 1992, RECENT CHANGES MOSFL; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; Nakamura M, 2003, CANCER RES, V63, P737; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Ogata M, 1999, J BIOL CHEM, V274, P12905, DOI 10.1074/jbc.274.18.12905; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Pedersen AK, 2004, ACTA CRYSTALLOGR D, V60, P1527, DOI 10.1107/S0907444904015094; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Peters GH, 2000, J BIOL CHEM, V275, P18201, DOI 10.1074/jbc.M910273199; Puius YA, 1997, P NATL ACAD SCI USA, V94, P13420, DOI 10.1073/pnas.94.25.13420; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Siu R, 2007, MOL CELL BIOL, V27, P208, DOI 10.1128/MCB.00707-06; Sonnenburg ED, 2003, BIOCHEMISTRY-US, V42, P7904, DOI 10.1021/bi0340503; Tautz L, 2006, EXPERT OPIN THER TAR, V10, P157, DOI 10.1517/14728222.10.1.157; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Villa F, 2005, J BIOL CHEM, V280, P8180, DOI 10.1074/jbc.M412211200; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wallace MJ, 1998, MOL CELL BIOL, V18, P2608, DOI 10.1128/MCB.18.5.2608; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	55	345	368	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 23	2009	136	2					352	363		10.1016/j.cell.2008.11.038	http://dx.doi.org/10.1016/j.cell.2008.11.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167335	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000262648800022
J	van Mantgem, PJ; Stephenson, NL; Byrne, JC; Daniels, LD; Franklin, JF; Fule, PZ; Harmon, ME; Larson, AJ; Smith, JM; Taylor, AH; Veblen, TT				van Mantgem, Phillip J.; Stephenson, Nathan L.; Byrne, John C.; Daniels, Lori D.; Franklin, Jerry F.; Fule, Peter Z.; Harmon, Mark E.; Larson, Andrew J.; Smith, Jeremy M.; Taylor, Alan H.; Veblen, Thomas T.			Widespread Increase of Tree Mortality Rates in the Western United States	SCIENCE			English	Article							CLIMATE-CHANGE; NORTH-AMERICA; LONG-TERM; FOREST; DROUGHT; GROWTH; DISTURBANCES; RESTORATION; DYNAMICS; FIRE	Persistent changes in tree mortality rates can alter forest structure, composition, and ecosystem services such as carbon sequestration. Our analyses of longitudinal data from unmanaged old forests in the western United States showed that background ( noncatastrophic) mortality rates have increased rapidly in recent decades, with doubling periods ranging from 17 to 29 years among regions. Increases were also pervasive across elevations, tree sizes, dominant genera, and past fire histories. Forest density and basal area declined slightly, which suggests that increasing mortality was not caused by endogenous increases in competition. Because mortality increased in small trees, the overall increase in mortality rates cannot be attributed solely to aging of large trees. Regional warming and consequent increases in water deficits are likely contributors to the increases in tree mortality rates.	[van Mantgem, Phillip J.; Stephenson, Nathan L.] Western Ecol Res Ctr, US Geol Survey, Three Rivers, CA 93271 USA; [Byrne, John C.] USDA Forest Serv, Rocky Mt Res Stn, Moscow, ID 83843 USA; [Daniels, Lori D.] Univ British Columbia, Dept Geog, Vancouver, BC V6T 1Z2, Canada; [Franklin, Jerry F.; Larson, Andrew J.] Univ Washington, Coll Forest Resources, Seattle, WA 98195 USA; [Fule, Peter Z.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Fule, Peter Z.] No Arizona Univ, Ecol Restorat Inst, Flagstaff, AZ 86011 USA; [Harmon, Mark E.] Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; [Smith, Jeremy M.; Veblen, Thomas T.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [Taylor, Alan H.] Penn State Univ, Dept Geog, University Pk, PA 16802 USA	United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service; University of British Columbia; University of Washington; University of Washington Seattle; Northern Arizona University; Northern Arizona University; Oregon State University; University of Colorado System; University of Colorado Boulder; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	van Mantgem, PJ (corresponding author), Western Ecol Res Ctr, US Geol Survey, Arcata, CA 95521 USA.	pvanmantgem@usgs.gov; nstephenson@usgs.gov	Noojipady, Praveen/B-2511-2010; Veblen, Thomas T./U-6461-2018	Daniels, Lori/0000-0002-5015-8311	NSF's Long-term Studies Program [DEB-0218088]; Wind River Canopy Crane Program [PNW 08-DG- 11261952488]; USDA Forest Service's Pacific Northwest; Pacific Southwest; Rocky Mountain research stations; McIntire-Stennis Cooperative Forestry Program; NSF [DEB-0743498, BCS-0825823]; Natural Science and Engineering Research Council of Canada; U.S. National Park Service; U.S. Geological Survey	NSF's Long-term Studies Program(National Science Foundation (NSF)); Wind River Canopy Crane Program; USDA Forest Service's Pacific Northwest(United States Department of Agriculture (USDA)United States Forest Service); Pacific Southwest; Rocky Mountain research stations; McIntire-Stennis Cooperative Forestry Program; NSF(National Science Foundation (NSF)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. National Park Service; U.S. Geological Survey(United States Geological Survey)	We thank the many people involved in establishing and maintaining the permanent forest plots; C. Allen, A. Das, J. Halofsky, J. Hicke, J. Lutz, and four anonymous reviewers for helpful comments on the manuscript; and J. Yee for essential statistical advice. The forest plots were funded by NSF's Long- term Studies Program (DEB- 0218088); the Wind River Canopy Crane Program through cooperative agreement PNW 08-DG- 11261952488 with the USDA Forest Service Pacific Northwest Research Station; various awards through the USDA Forest Service's Pacific Northwest, Pacific Southwest, and Rocky Mountain research stations and the McIntire-Stennis Cooperative Forestry Program; NSF awards DEB- 0743498 and BCS- 0825823; the Natural Science and Engineering Research Council of Canada; various awards through the U.S. National Park Service and U.S. Geological Survey (USGS). This work is a contribution of the Western Mountain Initiative (a USGS global change research project) and the Cordillera Forest Dynamics Network (CORFOR).	Bigler C, 2007, OIKOS, V116, P1983, DOI 10.1111/j.2007.0030-1299.16034.x; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brown RT, 2004, CONSERV BIOL, V18, P903, DOI 10.1111/j.1523-1739.2004.521_1.x; Diaz HF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GLO31253; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Fellows AW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033965; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Hicke JA, 2007, ECOL APPL, V17, P2387, DOI 10.1890/06-1951.1; Jump AS, 2006, GLOBAL CHANGE BIOL, V12, P2163, DOI 10.1111/j.1365-2486.2006.01250.x; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Kobe RK, 1996, ECOL MONOGR, V66, P181, DOI 10.2307/2963474; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; McDonald G.I., 2001, WHITEBARK PINE COMMU, P193; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; North M, 2007, CAN J FOREST RES, V37, P331, DOI 10.1139/X06-236; Oliver C.D., 1990, FOREST STAND DYNAMIC; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x	24	1193	1234	21	564	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					521	524		10.1126/science.1165000	http://dx.doi.org/10.1126/science.1165000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164752				2022-12-24	WOS:000262587900047
J	Chuang, JS; Rivoire, O; Leibler, S				Chuang, John S.; Rivoire, Olivier; Leibler, Stanislas			Simpson's Paradox in a Synthetic Microbial System	SCIENCE			English	Article							BACTERIAL-POPULATIONS; COOPERATION; COMMUNICATION; EVOLUTION; BEHAVIOR; COMPETITION	The maintenance of "public" or "common good" producers is a major question in the evolution of cooperation. Because nonproducers benefit from the shared resource without bearing its cost of production, they may proliferate faster than producers. We established a synthetic microbial system consisting of two Escherichia coli strains of common- good producers and nonproducers. Depending on the population structure, which was varied by forming groups with different initial compositions, an apparently paradoxical situation could be attained in which nonproducers grew faster within each group, yet producers increased overall. We show that a simple way to generate the variance required for this effect is through stochastic fluctuations via population bottlenecks. The synthetic approach described here thus provides a way to study generic mechanisms of natural selection.	[Chuang, John S.; Rivoire, Olivier; Leibler, Stanislas] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA; [Chuang, John S.; Rivoire, Olivier; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Chuang, JS (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10065 USA.	chuangj@rockefeller.edu			NIH fellowship; Human Frontier Science Program	NIH fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program)	We are grateful to C. Bargmann, C. Guet, L. Keller, E. Kussell, R. Losick, and A. Murray for comments on the manuscript and members of our laboratory for advice and discussion. We also thank the Yale Coli Genetic Stock Center and the National BioResource Project (NIG, Japan) for strains and the Rockefeller Flow Cytometry Resource Center for help. J.S.C. was partly supported by a NIH fellowship and O.R. by a Human Frontier Science Program fellowship.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; BICKEL PJ, 1975, SCIENCE, V187, P398, DOI 10.1126/science.187.4175.398; BLYTH CR, 1972, J AM STAT ASSOC, V67, P364, DOI 10.2307/2284382; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Brockhurst MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000634; Chin JW, 2006, NAT CHEM BIOL, V2, P304, DOI 10.1038/nchembio789; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dunny GM, 2008, BIOESSAYS, V30, P296, DOI 10.1002/bies.20740; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Haldane J. B. S., 1932, CAUSES EVOLUTION; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1975, ASA STUDIES, V4, P133; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Keller L, 1999, LEVELS SELECTION EVO; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Sober Elliott, 1998, OTHERS EVOLUTION PSY; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104	28	192	199	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					272	275		10.1126/science.1166739	http://dx.doi.org/10.1126/science.1166739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131632				2022-12-24	WOS:000262290600044
J	Erhard, KF; Stonaker, JL; Parkinson, SE; Lim, JP; Hale, CJ; Hollick, JB				Erhard, Karl F., Jr.; Stonaker, Jennifer L.; Parkinson, Susan E.; Lim, Jana P.; Hale, Christopher J.; Hollick, Jay B.			RNA Polymerase IV Functions in Paramutation in Zea mays	SCIENCE			English	Article							ALPHA-AMANITIN; MAIZE; DNA; TRANSCRIPTION; STATES; REPRESSION; PATHWAY; PLANTS; GENES	Plants have distinct RNA polymerase complexes (Pol IV and Pol V) with largely unknown roles in maintaining small RNA-associated gene silencing. Curiously, the eudicot Arabidopsis thaliana is not affected when either function is lost. By use of mutation selection and positional cloning, we showed that the largest subunit of the presumed maize Pol IV is involved in paramutation, an inherited epigenetic change facilitated by an interaction between two alleles, as well as normal maize development. Bioinformatics analyses and nuclear run-on transcription assays indicate that Pol IV does not engage in the efficient RNA synthesis typical of the three major eukaryotic DNA-dependent RNA polymerases. These results indicate that Pol IV employs abnormal RNA polymerase activities to achieve genome-wide silencing and that its absence affects both maize development and heritable epigenetic changes.	[Erhard, Karl F., Jr.; Stonaker, Jennifer L.; Parkinson, Susan E.; Lim, Jana P.; Hale, Christopher J.; Hollick, Jay B.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hollick, JB (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	hollick@nature.berkeley.edu			National Research Initiative of the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service [99-35301-7753, 2001-35301-10641, 2006-35304-17399]; NSF [MCB-0419909]	National Research Initiative of the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NSF(National Science Foundation (NSF))	We thank X. Parisky for technical assistance; N. Bolduc for providing nucleic acid samples; S. McCormick and D. Zilberman for comments; and the maize, Sorghum bicolor, and Brachypodium genome-sequencing projects for providing sequence information before publication. Brachypodium and Sorghum bicolor sequences were produced by the U.S. Department of Energy Joint Genome Institute (www.jgi.doe.gov/). cDNA sequences for Rmr6-A619, rmr6-1, rmr6-7, rmr6-8, and rmr6-14 are archived under GenBank accession numbers FJ426107 to FJ426111, respectively. Germ plasm containing mutations in the rmr6 gene is covered by U.S. patent 07264970 awarded to the Regents of the University of California. Supported by the National Research Initiative of the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service (grants 99-35301-7753, 2001-35301-10641, and 2006-35304-17399) and NSF (grant MCB-0419909).	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; BRINK RA, 1964, AM NAT, V98, P193, DOI 10.1086/282320; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Calderon-Urrea A, 1999, DEVELOPMENT, V126, P435; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; CONE KC, 1993, PLANT CELL, V5, P1807, DOI 10.1105/tpc.5.12.1807; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Hale CJ, 2007, PLOS BIOL, V5, P2156, DOI 10.1371/journal.pbio.0050275; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hollick JB, 2005, GENETICS, V171, P725, DOI 10.1534/genetics.105.045260; Hollick JB, 2001, GENETICS, V157, P369; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; KERMICLE JL, 1990, DEVELOPMENT, P9; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Luo J, 2007, J MOL EVOL, V64, P101, DOI 10.1007/s00239-006-0093-z; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MCMULLEN MD, 1986, NUCLEIC ACIDS RES, V14, P4953, DOI 10.1093/nar/14.12.4953; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mroczek RJ, 2003, GENETICS, V165, P809; Parkinson SE, 2007, DEV BIOL, V308, P462, DOI 10.1016/j.ydbio.2007.06.004; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Ream TS, 2009, MOL CELL, V33, P192, DOI 10.1016/j.molcel.2008.12.015; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Woodhouse MR, 2006, PLOS BIOL, V4, P1678, DOI 10.1371/journal.pbio.0040339; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	31	109	110	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1201	1205		10.1126/science.1164508	http://dx.doi.org/10.1126/science.1164508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251626				2022-12-24	WOS:000263687600035
J	Kuchibhotla, KV; Lattarulo, CR; Hyman, BT; Bacskai, BJ				Kuchibhotla, Kishore V.; Lattarulo, Carli R.; Hyman, Bradley T.; Bacskai, Brian J.			Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice	SCIENCE			English	Article							MOUSE MODEL; AMYLOID DEPOSITION; BETA-PLAQUES; IN-VIVO; DISEASE; PROPAGATION	Although senile plaques focally disrupt neuronal health, the functional response of astrocytes to Alzheimer's disease pathology is unknown. Using multiphoton fluorescence lifetime imaging microscopy in vivo, we quantitatively imaged astrocytic calcium homeostasis in a mouse model of Alzheimer's disease. Resting calcium was globally elevated in the astrocytic network, but was independent of proximity to individual plaques. Time-lapse imaging revealed that calcium transients in astrocytes were more frequent, synchronously coordinated across long distances, and uncoupled from neuronal activity. Furthermore, rare intercellular calcium waves were observed, but only in mice with amyloid-beta plaques, originating near plaques and spreading radially at least 200 micrometers. Thus, although neurotoxicity is observed near amyloid-beta deposits, there exists a more general astrocyte-based network response to focal pathology.	[Kuchibhotla, Kishore V.; Lattarulo, Carli R.; Hyman, Bradley T.; Bacskai, Brian J.] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Lab, Charlestown, MA 02129 USA; [Kuchibhotla, Kishore V.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Bacskai, BJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Lab, 114 16th St, Charlestown, MA 02129 USA.	bbacskai@partners.org	Bacskai, Brian/AAE-9583-2021		NIH [EB000768, AG08487, NS580752]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS058075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, R01AG008487] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. O. Ohki and R. C. Reid for assistance with the multicell bolus loading technique. This work was supported by NIH grants EB000768 (B.J.B.), AG08487 (B.T.H.), and NS580752 (K.V.K.).	Abramov AY, 2003, J NEUROSCI, V23, P5088; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Garcia-Alloza M, 2006, J NEUROPATH EXP NEUR, V65, P1082, DOI 10.1097/01.jnen.0000240468.12543.af; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Takano T, 2007, ANN NY ACAD SCI, V1097, P40, DOI 10.1196/annals.1379.004; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Wegiel J, 2001, NEUROBIOL AGING, V22, P49, DOI 10.1016/S0197-4580(00)00181-0; Wilms CD, 2006, CELL CALCIUM, V40, P73, DOI 10.1016/j.ceca.2006.03.006; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838	24	485	496	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1211	1215		10.1126/science.1169096	http://dx.doi.org/10.1126/science.1169096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251629	Green Accepted			2022-12-24	WOS:000263687600038
J	Chen, MJ; Yokomizo, T; Zeigler, BM; Dzierzak, E; Speck, NA				Chen, Michael J.; Yokomizo, Tomomasa; Zeigler, Brandon M.; Dzierzak, Elaine; Speck, Nancy A.			Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter	NATURE			English	Article							STEM-CELLS; MOUSE EMBRYO; ADULT HEMATOPOIESIS; FETAL LIVER; MURINE ALLANTOIS; VE-CADHERIN; EXPRESSION; VASCULOGENESIS; CIRCULATION; COMPARTMENT	Haematopoietic stem cells ( HSCs) are the founder cells of the adult haematopoietic system, and thus knowledge of the molecular program directing their generation during development is important for regenerative haematopoietic strategies. Runx1 is a pivotal transcription factor required for HSC generation in the vascular regions of the mouse conceptus - the aorta, vitelline and umbilical arteries, yolk sac and placenta(1,2). It is thought that HSCs emerge from vascular endothelial cells through the formation of intra-arterial clusters(3) and that Runx1 functions during the transition from 'haemogenic endothelium' to HSCs4,5. Here we show by conditional deletion that Runx1 activity in vascular- endothelial- cadherin-positive endothelial cells is indeed essential for intra-arterial cluster, haematopoietic progenitor and HSC formation in mice. In contrast, Runx1 is not required in cells expressing Vav1, one of the first pan- haematopoietic genes expressed in HSCs. Collectively these data show that Runx1 function is essential in endothelial cells for haematopoietic progenitor and HSC formation from the vasculature, but its requirement ends once or before Vav is expressed.	[Chen, Michael J.; Zeigler, Brandon M.; Speck, Nancy A.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Chen, Michael J.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Yokomizo, Tomomasa; Dzierzak, Elaine] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands	Dartmouth College; Dartmouth College; Erasmus University Rotterdam; Erasmus MC	Speck, NA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	nancyas@exchange.upenn.edu		Zeigler, Brandon/0000-0002-1258-7780	Norris Cotton Cancer Center [NIH CA23108]; Abramson Family Cancer Research Institute;  [R01HL091724];  [R01DK54077];  [T32 AI-07519]; NATIONAL CANCER INSTITUTE [R01CA058343, P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054077, R01DK054077] Funding Source: NIH RePORTER	Norris Cotton Cancer Center; Abramson Family Cancer Research Institute; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank G. Ward for his assistance with flow, K. Downs for technical advice, T. Graf for the Vav-Cre mice, and P. Huber for the Cdh5 sequences. This work was supported by R01HL091724 (N.A.S.), R01DK54077 (E.D.) and T32 AI-07519 (B.M.Z.). Core services were supported in part by the Norris Cotton Cancer Center (NIH CA23108) and the Abramson Family Cancer Research Institute.	Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Downs KM, 2004, DEVELOPMENT, V131, P37, DOI 10.1242/dev.00906; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Gory S, 1999, BLOOD, V93, P184, DOI 10.1182/blood.V93.1.184.401a20_184_192; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Inman KE, 2006, DEVELOPMENT, V133, P2947, DOI 10.1242/dev.02454; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kim I, 2005, BLOOD, V106, P903, DOI 10.1182/blood-2004-12-4960; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Ogilvy S, 1999, BLOOD, V94, P1855; Okada H, 1998, ONCOGENE, V17, P2287, DOI 10.1038/sj.onc.1202151; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Yokomizo T, 2007, EMBO J, V26, P184, DOI 10.1038/sj.emboj.7601480; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596	31	683	707	4	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					887	891		10.1038/nature07619	http://dx.doi.org/10.1038/nature07619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19129762	Green Accepted			2022-12-24	WOS:000263266700046
J	Forbes, AA; Powell, THQ; Stelinski, LL; Smith, JJ; Feder, JL				Forbes, Andrew A.; Powell, Thomas H. Q.; Stelinski, Lukasz L.; Smith, James J.; Feder, Jeffrey L.			Sequential Sympatric Speciation Across Trophic Levels	SCIENCE			English	Article							RHAGOLETIS-POMONELLA DIPTERA; APPLE MAGGOT FLY; HOST RACES; MATING BEHAVIOR; TEPHRITIDAE; DIVERSITY	A major cause for biodiversity may be biodiversity itself. As new species form, they may create new niches for others to exploit, potentially catalyzing a chain reaction of speciation events across trophic levels. We tested for such sequential radiation in the Rhagoletis pomonella ( Diptera: Tephritidae) complex, a model for sympatric speciation via host plant shifting. We report that the parasitic wasp Diachasma alloeum ( Hymenoptera: Braconidae) has formed new incipient species as a result of specializing on diversifying fly hosts, including the recently derived apple- infesting race of R. pomonella. Furthermore, we show that traits that differentially adapt R. pomonella flies to their host plants have also quickly evolved and serve as ecological barriers to reproduction, isolating the wasps. Speciation therefore cascades as the effects of new niche construction move across trophic levels.	[Forbes, Andrew A.; Powell, Thomas H. Q.; Feder, Jeffrey L.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Stelinski, Lukasz L.] Univ Florida, Ctr Agr Res & Educ, Dept Entomol & Nematol, Lake Alfred, FL 33850 USA; [Smith, James J.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Smith, James J.] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA	University of Notre Dame; State University System of Florida; University of Florida; Michigan State University; Michigan State University	Forbes, AA (corresponding author), Univ Calif Davis, Dept Entomol, 1 Shields Ave, Davis, CA 95616 USA.	aaforbes@ucdavis.edu	Powell, Thomas/B-8575-2013	Powell, Thomas/0000-0002-4780-5215; Forbes, Andrew/0000-0001-8332-6652	NSF; American Museum of Natural History Theodore Roosevelt Fund Grant; Wissenschaftskolleg zu Berlin	NSF(National Science Foundation (NSF)); American Museum of Natural History Theodore Roosevelt Fund Grant; Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF))	We thank M. Aluja, S. H. Berlocher, H. R. Dambroski, F. Footman, T. M. Forbes, E. Luecke, A. P. Michel, M. A. F. Noor, J. Rull, D. Schwarz, S. Velez, F. Wang, and R. A. Wharton for their technical, physical, intellectual, and moral support. Funded by a NSF doctoral dissertation improvement grant to A. A. F. and J. L. F., an American Museum of Natural History Theodore Roosevelt Fund Grant to A. A. F., and support to J. L. F. from the Wissenschaftskolleg zu Berlin. GenBank accession numbers for the mtDNA COI sequences are EU881512 to EU881682.	Abrahamson WG, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P188; Berlocher SH, 1999, HEREDITY, V83, P652, DOI 10.1038/sj.hdy.6885910; Berlocher SH, 2000, EVOLUTION, V54, P543, DOI 10.1111/j.0014-3820.2000.tb00057.x; Butterfield NJ, 2001, ECOLOGY CAMBRIAN REG; Coyne JA, 2004, SPECIATION, V37; Dilcher D, 2000, P NATL ACAD SCI USA, V97, P7030, DOI 10.1073/pnas.97.13.7030; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Erwin DH, 2005, SCIENCE, V308, P1752, DOI 10.1126/science.1113416; Feder Jeffrey L., 1998, P408; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; FEDER JL, 1995, ECOLOGY, V76, P801, DOI 10.2307/1939346; FEDER JL, 1988, NATURE, V336, P61, DOI 10.1038/336061a0; FEDER JL, 1998, ENDLESS FORMS SPECIE; LaSalle J., 1991, Redia, V74, P315; Linn C, 2003, P NATL ACAD SCI USA, V100, P11490, DOI 10.1073/pnas.1635049100; MCPHERON BA, 1988, NATURE, V336, P64, DOI 10.1038/336064a0; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Price P. W., 1980, EVOLUTIONARY BIOL PA; PROKOPY RJ, 1971, CAN ENTOMOL, V103, P1405, DOI 10.4039/Ent1031405-10; PROKOPY RJ, 1972, CAN ENTOMOL, V104, P97, DOI 10.4039/Ent10497-1; Smith JJ, 1997, MOL PHYLOGENET EVOL, V7, P33, DOI 10.1006/mpev.1996.0374; Strong D.R., 1984, INSECTS PLANTS COMMU; TURLINGS TCJ, 1993, INSECT LEARNING ECOL, P398; Wharton R.A., 1978, Journal of the Washington Academy of Sciences, V68, P147	24	132	136	0	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					776	779		10.1126/science.1166981	http://dx.doi.org/10.1126/science.1166981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197063				2022-12-24	WOS:000263066800045
J	Steig, EJ; Schneider, DP; Rutherford, SD; Mann, ME; Comiso, JC; Shindell, DT				Steig, Eric J.; Schneider, David P.; Rutherford, Scott D.; Mann, Michael E.; Comiso, Josefino C.; Shindell, Drew T.			Warming of the Antarctic ice-sheet surface since the 1957 International Geophysical Year	NATURE			English	Article							SOUTHERN-HEMISPHERE CLIMATE; IN-SITU; VARIABILITY; TRENDS; TEMPERATURES; SIMULATION; LENGTH; SEASON	Assessments of Antarctic temperature change have emphasized the contrast between strong warming of the Antarctic Peninsula and slight cooling of the Antarctic continental interior in recent decades(1). This pattern of temperature change has been attributed to the increased strength of the circumpolar westerlies, largely in response to changes in stratospheric ozone(2). This picture, however, is substantially incomplete owing to the sparseness and short duration of the observations. Here we show that significant warming extends well beyond the Antarctic Peninsula to cover most of West Antarctica, an area of warming much larger than previously reported. West Antarctic warming exceeds 0.1 degrees C per decade over the past 50 years, and is strongest in winter and spring. Although this is partly offset by autumn cooling in East Antarctica, the continent- wide average near- surface temperature trend is positive. Simulations using a general circulation model reproduce the essential features of the spatial pattern and the long- term trend, and we suggest that neither can be attributed directly to increases in the strength of the westerlies. Instead, regional changes in atmospheric circulation and associated changes in sea surface temperature and sea ice are required to explain the enhanced warming in West Antarctica.	[Steig, Eric J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Steig, Eric J.] Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; [Schneider, David P.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Rutherford, Scott D.] Roger Williams Univ, Dept Environm Sci, Bristol, RI 02809 USA; [Mann, Michael E.] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; [Mann, Michael E.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Comiso, Josefino C.] NASA, Goddard Space Flight Ctr, NASA Lab Hydrospher & Biospher Sci, Greenbelt, MD 20771 USA; [Shindell, Drew T.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Shindell, Drew T.] Columbia Univ, Ctr Climate Syst Res, New York, NY 10025 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Center Atmospheric Research (NCAR) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University	Steig, EJ (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	steig@ess.washington.edu	Schneider, David/E-2726-2010; Mann, Michael E/B-8472-2017; Steig, Eric J/G-9088-2015; Shindell, Drew/D-4636-2012	Schneider, David/0000-0001-5308-1834; Mann, Michael E/0000-0003-3067-296X; Steig, Eric J/0000-0002-8191-5549; Shindell, Drew/0000-0003-1552-4715	US National Science Foundation [OPP-0440414, OPP-0126161, OPP-0125670]; US ITASE	US National Science Foundation(National Science Foundation (NSF)); US ITASE	E.J.S. and D.P.S. were supported by the US National Science Foundation, grant numbers OPP-0440414 and OPP-0126161, as part of the US ITASE programme. M.E.M. was supported by the US National Science Foundation, grant number OPP-0125670. We thank D. Winebrenner, A. Monaghan, D. Bromwich, J. Turner, P. Mayewski, T. Scambos, E. Bard and O. Bellier.	Bromwich DH, 2004, J CLIMATE, V17, P4603, DOI 10.1175/3241.1; Bromwich DH, 2008, EOS; Chapman WL, 2007, J CLIMATE, V20, P4096, DOI 10.1175/JCLI4236.1; Comiso JC, 2000, J CLIMATE, V13, P1674, DOI 10.1175/1520-0442(2000)013<1674:VATIAS>2.0.CO;2; CONOLLEY WM, 2007, GEOPHYS RES LETT, V34, DOI DOI 10.1029/2007GL031648; Doran PT, 2002, NATURE, V415, P517, DOI 10.1038/nature710; Fierro RD, 1997, SIAM J SCI COMPUT, V18, P1223, DOI 10.1137/S1064827594263837; Gillett NP, 2003, SCIENCE, V302, P273, DOI 10.1126/science.1087440; Hansen J, 2007, CLIM DYNAM, V29, P661, DOI 10.1007/s00382-007-0255-8; Holland MM, 2006, CLIM DYNAM, V26, P229, DOI 10.1007/s00382-005-0087-3; Johanson CM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029108; Jones PD, 2003, J CLIMATE, V16, P206, DOI 10.1175/1520-0442(2003)016<0206:HALSSA>2.0.CO;2; Keeley SPE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031238; Kwok R, 2002, J CLIMATE, V15, P487, DOI 10.1175/1520-0442(2002)015<0487:SOCASI>2.0.CO;2; Mann ME, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008272; Miller RL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006323; Monaghan AJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009094; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rutherford S, 2005, J CLIMATE, V18, P2308, DOI 10.1175/JCLI3351.1; Schneider DP, 2008, P NATL ACAD SCI USA, V105, P12154, DOI 10.1073/pnas.0803627105; Schneider DP, 2004, J CLIMATE, V17, P1569, DOI 10.1175/1520-0442(2004)017<1569:RCVIAF>2.0.CO;2; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Shindell DT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020724; Shuman CA, 2001, J CLIMATE, V14, P1977, DOI 10.1175/1520-0442(2001)014<1977:DLCIWA>2.0.CO;2; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Turner J, 2006, SCIENCE, V311, P1914, DOI 10.1126/science.1121652; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991	30	493	517	6	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					459	462		10.1038/nature07669	http://dx.doi.org/10.1038/nature07669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158794	Green Published			2022-12-24	WOS:000262519200042
J	Woltjen, K; Michael, IP; Mohseni, P; Desai, R; Mileikovsky, M; Hamalainen, R; Cowling, R; Wang, W; Liu, PT; Gertsenstein, M; Kaji, K; Sung, HK; Nagy, A				Woltjen, Knut; Michael, Iacovos P.; Mohseni, Paria; Desai, Ridham; Mileikovsky, Maria; Haemaelaeinen, Riikka; Cowling, Rebecca; Wang, Wei; Liu, Pentao; Gertsenstein, Marina; Kaji, Keisuke; Sung, Hoon-Ki; Nagy, Andras			piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells	NATURE			English	Article							MAMMALIAN-CELLS; MOUSE; EXPRESSION; GENERATION; INDUCTION; MICE; INSERTIONS; VECTORS; GENE	Transgenic expression of just four defined transcription factors (c-Myc, Klf4, Oct4 and Sox2) is sufficient to reprogram somatic cells to a pluripotent state(1-4). The resulting induced pluripotent stem (iPS) cells resemble embryonic stem cells in their properties and potential to differentiate into a spectrum of adult cell types. Current reprogramming strategies involve retroviral(1), lentiviral(5), adenoviral(6) and plasmid(7) transfection to deliver reprogramming factor transgenes. Although the latter two methods are transient and minimize the potential for insertion mutagenesis, they are currently limited by diminished reprogramming efficiencies. piggyBac (PB) transposition is host-factor independent, and has recently been demonstrated to be functional in various human and mouse cell lines(8-11). The PB transposon/transposase system requires only the inverted terminal repeats flanking a transgene and transient expression of the transposase enzyme to catalyse insertion or excision events(12). Here we demonstrate successful and efficient reprogramming of murine and human embryonic fibroblasts using doxycycline-inducible transcription factors delivered by PB transposition(13). Stable iPS cells thus generated express characteristic pluripotency markers and succeed in a series of rigorous differentiation assays. By taking advantage of the natural propensity of the PB system for seamless excision(12), we show that the individual PB insertions can be removed from established iPS cell lines, providing an invaluable tool for discovery. In addition, we have demonstrated the traceless removal of reprogramming factors joined with viral 2A sequences(14) delivered by a single transposon from murine iPS lines. We anticipate that the unique properties of this virus-independent simplification of iPS cell production will accelerate this field further towards full exploration of the reprogramming process and future cell-based therapies.	[Woltjen, Knut; Michael, Iacovos P.; Mohseni, Paria; Desai, Ridham; Mileikovsky, Maria; Haemaelaeinen, Riikka; Cowling, Rebecca; Gertsenstein, Marina; Sung, Hoon-Ki; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Michael, Iacovos P.; Mohseni, Paria; Desai, Ridham; Nagy, Andras] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Wang, Wei; Liu, Pentao] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Kaji, Keisuke] Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Wellcome Trust Sanger Institute; University of Edinburgh	Nagy, A (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	nagy@lunenfeld.ca	Wilson, Matthew H/K-3193-2013; Martikainen, Riikka/AAR-8397-2020; Sung, Hoon-Ki/G-3049-2013; Sung, Hoon-Ki/A-1922-2016; Nagy, Andras/G-6465-2013; Michael, Iacovos P/C-8695-2016	Martikainen, Riikka/0000-0002-5102-0672; Sung, Hoon-Ki/0000-0001-6677-9385; Nagy, Andras/0000-0003-4311-0413; Michael, Iacovos P/0000-0001-7674-1233; Kaji, Keisuke/0000-0001-5946-8415; Woltjen, Knut/0000-0003-2293-1183	Wellcome Trust; Canadian Stem Cell Network; JDRF; Medical Research Council [G0700711B, G0700672] Funding Source: researchfish; MRC [G0700672] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Stem Cell Network; JDRF(Juvenile Diabetes Research Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Moffat for time-lapse image acquisition, P.-A. Pentilla for cell sorting, M.-S. Eiymo for assisting with initial PB test vector construction, J. Ure and M. Kownacka for technical assistance, M. Kibschull for establishing human embryonic fibroblasts, A. Cheung for discussions, and K. Vintersten for critical reading of the manuscript. This work was supported by the Wellcome Trust to P. L., and grants awarded to A. N. from the Canadian Stem Cell Network and JDRF.	Agha-Mohammadi S, 2004, J GENE MED, V6, P817, DOI 10.1002/jgm.566; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103	29	1297	1538	4	340	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					766	U106		10.1038/nature07863	http://dx.doi.org/10.1038/nature07863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19252478	Green Accepted			2022-12-24	WOS:000265193600042
J	Saleh, MC; Tassetto, M; van Rij, RP; Goic, B; Gausson, V; Berry, B; Jacquier, C; Antoniewski, C; Andino, R				Saleh, Maria-Carla; Tassetto, Michel; van Rij, Ronald P.; Goic, Bertsy; Gausson, Valerie; Berry, Bassam; Jacquier, Caroline; Antoniewski, Christophe; Andino, Raul			Antiviral immunity in Drosophila requires systemic RNA interference spread	NATURE			English	Article							DOUBLE-STRANDED-RNA; DISTINCT ROLES; PATHWAY; DSRNA; GENE; MELANOGASTER; VIRUSES; DICER-2; ENTRY	Multicellular organisms evolved sophisticated defence systems to confer protection against pathogens. An important characteristic of these immune systems is their ability to act both locally at the site of infection and at distal uninfected locations(1-4). In insects, such as Drosophila melanogaster, RNA interference (RNAi) mediates antiviral immunity(5-7). However, the antiviral RNAi defence in flies seems to be a local, cell-autonomous process, as flies are thought to be unable to generate a systemic RNAi response(8). Here we show that a recently defined double-stranded RNA(dsRNA) uptake pathway(9) is essential for effective antiviral RNAi immunity in adult flies. Mutant flies defective in this dsRNA uptake pathway were hypersensitive to infection with Drosophila C virus and Sindbis virus. Mortality in dsRNA-uptake-defective flies was accompanied by 100-to 10(5)-fold increases in viral titres and higher levels of viral RNA. Furthermore, inoculating naked dsRNA into flies elicited a sequence-specific antiviral immune response that required an intact dsRNA uptake pathway. These findings suggest that spread of dsRNA to uninfected sites is essential for effective antiviral immunity. Notably, infection with green fluorescent protein (GFP)-tagged Sindbis virus suppressed expression of host-encoded GFP at a distal site. Thus, similar to protein-based immunity in vertebrates, the antiviral RNAi response in flies also relies on the systemic spread of a virus-specific immunity signal.	[Saleh, Maria-Carla; Tassetto, Michel; van Rij, Ronald P.; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA; [Goic, Bertsy; Gausson, Valerie; Berry, Bassam; Jacquier, Caroline; Antoniewski, Christophe] Inst Pasteur, F-75015 Paris, France; [Berry, Bassam; Jacquier, Caroline; Antoniewski, Christophe] CNRS, URA 2578, F-75015 Paris, France	University of California System; University of California San Francisco; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA.	raul.andino@ucsf.edu	Saleh, Maria-Carla/ABC-2527-2021; BERRY, Bassam/D-1666-2009; Van Rij, Ronald/I-7073-2012; Antoniewski, Christophe/G-4519-2011	Saleh, Maria-Carla/0000-0001-8593-4117; Van Rij, Ronald/0000-0003-0221-4689; Antoniewski, Christophe/0000-0001-7709-2116; Dorey, valerie/0000-0002-9727-3448	NIH [AI40085, AI064738]; Institut Pasteur; CNRS; ANR; ARC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064738, R01AI040085, R21AI040085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	d We are grateful to members of the Andino and the O'Farrell laboratories for discussion, technical support and advice on fly work. We thank J. Frydman, P. O'Farrell and M. Vignuzzi for discussions and comments on the manuscript. We also thank T. Cook for advice on the IR EcR eye phenotype, R. Carthew for providing the GMR. IR[white] and Dcr2 fly stocks and M. Siomi for the Ago2 fly stock. B. G. is a Manlio Cantarini fellow. B. B. is a Lebanese CNRSL Fellow. C. J. is a University of Paris VI and Ministere de la Recherche fellow. This work was financially supported by NIH grants AI40085 and AI064738 to R. A., the Institut Pasteur to M.-C. S. and C. A., and CNRS, ANR and ARC grants to C.	Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Goto A, 2003, NUCLEIC ACIDS RES, V31, P6619, DOI 10.1093/nar/gkg852; HAHN CS, 1992, P NATL ACAD SCI USA, V89, P2679, DOI 10.1073/pnas.89.7.2679; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Roitt I., 2001, IMMUNOLOGY, V6th; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Schubiger M, 2005, DEVELOPMENT, V132, P5239, DOI 10.1242/dev.02093; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Voinnet O, 2005, FEBS LETT, V579, P5858, DOI 10.1016/j.febslet.2005.09.039; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694	24	205	220	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					346	U109		10.1038/nature07712	http://dx.doi.org/10.1038/nature07712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19204732	Green Accepted			2022-12-24	WOS:000264285600043
J	Yorozu, S; Wong, A; Fischer, BJ; Dankert, H; Kernan, MJ; Kamikouchi, A; Ito, K; Anderson, DJ				Yorozu, Suzuko; Wong, Allan; Fischer, Brian J.; Dankert, Heiko; Kernan, Maurice J.; Kamikouchi, Azusa; Ito, Kei; Anderson, David J.			Distinct sensory representations of wind and near-field sound in the Drosophila brain	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; MELANOGASTER; HEARING; TRANSDUCTION; DISPERSAL; SONG; MAP	Behavioural responses to wind are thought to have a critical role in controlling the dispersal and population genetics of wild Drosophila species(1,2), as well as their navigation in flight(3), but their underlying neurobiological basis is unknown. We show that Drosophila melanogaster, like wild-caught Drosophila strains(4), exhibits robust wind-induced suppression of locomotion in response to air currents delivered at speeds normally encountered in nature(1,2). Here we identify wind-sensitive neurons in Johnston's organ, an antennal mechanosensory structure previously implicated in near-field sound detection (reviewed in refs 5 and 6). Using enhancer trap lines targeted to different subsets of Johnston's organ neurons(7), and a genetically encoded calcium indicator(8), we show that wind and near-field sound (courtship song) activate distinct populations of Johnston's organ neurons, which project to different regions of the antennal and mechanosensory motor centre in the central brain. Selective genetic ablation of wind-sensitive Johnston's organ neurons in the antenna abolishes wind-induced suppression of locomotion behaviour, without impairing hearing. Moreover, different neuronal subsets within the wind-sensitive population respond to different directions of arista deflection caused by air flow and project to different regions of the antennal and mechanosensory motor centre, providing a rudimentary map of wind direction in the brain. Importantly, sound- and wind-sensitive Johnston's organ neurons exhibit different intrinsic response properties: the former are phasically activated by small, bi-directional, displacements of the aristae, whereas the latter are tonically activated by unidirectional, static deflections of larger magnitude. These different intrinsic properties are well suited to the detection of oscillatory pulses of near-field sound and laminar air flow, respectively. These data identify wind-sensitive neurons in Johnston's organ, a structure that has been primarily associated with hearing, and reveal how the brain can distinguish different types of air particle movements using a common sensory organ.	[Yorozu, Suzuko; Wong, Allan; Fischer, Brian J.; Dankert, Heiko; Anderson, David J.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Yorozu, Suzuko; Wong, Allan; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Dankert, Heiko] CALTECH, Div Engn & Appl Sci 136 93, Pasadena, CA 91125 USA; [Kernan, Maurice J.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Kamikouchi, Azusa; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kamikouchi, Azusa] Univ Cologne, Inst Zool, Sensory Syst Lab, D-50923 Cologne, Germany	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tokyo; University of Cologne	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	yorozu@caltech.edu; mancusog@caltech.edu		Kamikouchi, Azusa/0000-0003-1552-6892; Kernan, Maurice/0000-0002-1546-6159; Dankert, Heiko/0000-0002-0096-8455	NSF [EF-0623527]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002780] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank U. Heberlein and F. Wolf for hosting a sabbatical that led to the discovery of WISL; J. S. Johnson for helpful discussions; L. Zelnik, M. Reiser and P. Perona for creating locomotor tracking software; D. Eberl and J. Hall for D. melanogaster courtship song recordings; G. Maimon for making fly holders for imaging experiments; M. Roy for building behavioral chambers for WISL and female receptivity assays; H. Inagaki for JO-CE-GAL4; eyFLP flies; B. Hay for UAS-hid flies; D. Berdnik for UAS-FRT-STOP-FRT-Ricin flies; M. Dickinson for anemometers and discussions; J. L. Anderson for advice on fluid mechanics; M. Gopfert for providing a pressure gradient microphone; M. Konishi for advice and use of laboratory facilities; and G. Mosconi for laboratory management. D. J. A. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by NSF grant EF-0623527.	BENNETCLARK HC, 1971, NATURE, V234, P255, DOI 10.1038/234255a0; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Budick SA, 2007, J EXP BIOL, V210, P4092, DOI 10.1242/jeb.006502; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; EWING AW, 1978, PHYSIOL ENTOMOL, V3, P33, DOI 10.1111/j.1365-3032.1978.tb00129.x; Gopfert MC, 2002, J EXP BIOL, V205, P1199; Hoffmann JN, 2004, ANAT REC PART A, V281A, P1138, DOI 10.1002/ar.a.20119; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247, DOI 10.1113/jphysiol.1994.sp020292; Johnston J.S., 1982, P241; JOHNSTON JS, 1976, AM NAT, V110, P629, DOI 10.1086/283095; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Mamiya A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004063; MANNING A, 1967, SCIENCE, V158, P136, DOI 10.1126/science.158.3797.136; MOFFAT KG, 1992, DEVELOPMENT, V114, P681; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; RICHARDSON RH, 1975, OECOLOGIA, V20, P287, DOI 10.1007/BF00345519; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; WHEELER DA, 1988, BEHAV GENET, V18, P675, DOI 10.1007/BF01066850; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	25	168	170	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					201	U4		10.1038/nature07843	http://dx.doi.org/10.1038/nature07843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279637	Green Accepted			2022-12-24	WOS:000264059700043
J	Luo, J; Solimini, NL; Elledge, SJ				Luo, Ji; Solimini, Nicole L.; Elledge, Stephen J.			Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction	CELL			English	Review							DNA-DAMAGE RESPONSE; GROWTH-FACTOR RECEPTOR; HUMAN BREAST; NEOPLASTIC PHENOTYPE; GENOMIC INSTABILITY; SIGNALING PATHWAYS; MITOTIC CHECKPOINT; INDUCED SENESCENCE; RNA INTERFERENCE; P53 RESTORATION	Cancer is a complex collection of distinct genetic diseases united by common hallmarks. Here, we expand upon the classic hallmarks to include the stress phenotypes of tumorigenesis. We describe a conceptual framework of how oncogene and non-oncogene addictions contribute to these hallmarks and how they can be exploited through stress sensitization and stress overload to selectively kill cancer cells. In particular, we present evidence for a large class of non-oncogenes that are essential for cancer cell survival and present attractive drug targets. Finally, we discuss the path ahead to therapeutic discovery and provide theoretical considerations for combining orthogonal cancer therapies.	[Luo, Ji; Solimini, Nicole L.; Elledge, Stephen J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Dept Med,Div Genet,Dept Ge, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Dept Med,Div Genet,Dept Ge, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu			NIH; HHMI; NATIONAL CANCER INSTITUTE [R33CA140039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank O.Cohen-Fix, J. Glaven, S. M. Lewis, W. G. Kaelin, and G. M. Wahl for critical reading of the manuscript. J. L. is supported by a fellowship from the American Association of Cancer Research. N. L. S. is a fellow of the Susan G. Komen for the Cure Foundation. This work is supported by grants from the NIH and the U.S. Department of Defense to S. J. E. S. J. E. is an investigator with HHMI. We dedicate this review to I. Bernard Weinstein for his contributions to cancer biology.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Ashwell S, 2008, CLIN CANCER RES, V14, P4032, DOI 10.1158/1078-0432.CCR-07-5138; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Carlo-Stella C, 2007, CLIN CANCER RES, V13, P2313, DOI 10.1158/1078-0432.CCR-06-2774; Carpinelli P, 2008, ADV EXP MED BIOL, V610, P54, DOI 10.1007/978-0-387-73898-7_5; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Druker BJ, 2002, ONCOGENE, V21, P8541, DOI 10.1038/sj.onc.1206081; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Fiorentini Giammaria, 2006, J Cancer Res Ther, V2, P41; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Garrido F, 2001, ADV CANCER RES, V83, P117, DOI 10.1016/S0065-230X(01)83005-0; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kennedy RD, 2007, J CLIN INVEST, V117, P1440, DOI 10.1172/JCI31245; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Komarova NL, 2002, CANCER BIOL THER, V1, P685, DOI 10.4161/cbt.321; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee YM, 2006, CELL CYCLE, V5, P2110, DOI 10.4161/cc.5.18.3218; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; MACDONALD C, 2005, NATURE, V438, P820; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Moreira JN, 2006, REV RECENT CLIN TRIA, V1, P217, DOI 10.2174/157488706778250050; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Muller AJ, 2006, NAT REV CANCER, V6, P613, DOI 10.1038/nrc1929; Nava-Parada P, 2007, CURR OPIN MOL THER, V9, P490; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roccaro AM, 2006, CURR PHARM BIOTECHNO, V7, P441, DOI 10.2174/138920106779116865; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Spira AI, 2003, CURR OPIN PHARMACOL, V3, P338, DOI 10.1016/S1471-4892(03)00081-X; Stauffer SR, 2007, CURR TOP MED CHEM, V7, P961, DOI 10.2174/156802607780906843; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Su Z, 2005, J IMMUNOL, V174, P3798, DOI 10.4049/jimmunol.174.6.3798; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	124	1289	1455	4	201	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					823	837		10.1016/j.cell.2009.02.024	http://dx.doi.org/10.1016/j.cell.2009.02.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269363	Bronze, Green Accepted			2022-12-24	WOS:000263930900007
J	Liu, J; Ghanim, M; Xue, L; Brown, CD; Iossifov, I; Angeletti, C; Hua, SJ; Negre, N; Ludwig, M; Stricker, T; Al-Ahmadie, HA; Tretiakova, M; Camp, RL; Perera-Alberto, M; Rimm, DL; Xu, T; Rzhetsky, A; White, KP				Liu, Jiang; Ghanim, Murad; Xue, Lei; Brown, Christopher D.; Iossifov, Ivan; Angeletti, Cesar; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; Al-Ahmadie, Hikmat A.; Tretiakova, Maria; Camp, Robert L.; Perera-Alberto, Montse; Rimm, David L.; Xu, Tian; Rzhetsky, Andrey; White, Kevin P.			Analysis of Drosophila Segmentation Network Identifies a JNK Pathway Factor Overexpressed in Kidney Cancer	SCIENCE			English	Article							CARBONIC-ANHYDRASE-IX; RENAL-CELL CARCINOMA; DIFFERENTIAL-DIAGNOSIS; UBIQUITIN LIGASE; GENE-EXPRESSION; MELANOGASTER; PROTEINS; MARKERS; SYSTEM; MAP	We constructed a large-scale functional network model in Drosophila melanogaster built around two key transcription factors involved in the process of embryonic segmentation. Analysis of the model allowed the identification of a new role for the ubiquitin E3 ligase complex factor SPOP. In Drosophila, the gene encoding SPOP is a target of segmentation transcription factors. Drosophila SPOP mediates degradation of the Jun kinase phosphatase Puckered, thereby inducing tumor necrosis factor (TNF)/Eiger-dependent apoptosis. In humans, we found that SPOP plays a conserved role in TNF-mediated JNK signaling and was highly expressed in 99% of clear cell renal cell carcinomas (RCCs), the most prevalent form of kidney cancer. SPOP expression distinguished histological subtypes of RCC and facilitated identification of clear cell RCC as the primary tumor for metastatic lesions.	[Liu, Jiang; Ghanim, Murad; Brown, Christopher D.; Iossifov, Ivan; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; Rzhetsky, Andrey; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Liu, Jiang; Ghanim, Murad; Brown, Christopher D.; Iossifov, Ivan; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; Rzhetsky, Andrey; White, Kevin P.] Argonne Natl Lab, Chicago, IL 60637 USA; [Liu, Jiang; Ghanim, Murad; Brown, Christopher D.; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Xue, Lei; Xu, Tian] Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Iossifov, Ivan; Rzhetsky, Andrey] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Angeletti, Cesar; Camp, Robert L.; Rimm, David L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Ludwig, Michael; White, Kevin P.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Stricker, Thomas; Al-Ahmadie, Hikmat A.; Tretiakova, Maria] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Perera-Alberto, Montse] Univ La Laguna, Dept Anat, E-38320 Tenerife, Spain	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Howard Hughes Medical Institute; Yale University; University of Chicago; Yale University; University of Chicago; University of Chicago; Universidad de la Laguna	White, KP (corresponding author), Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA.	kpwhite@uchicago.edu	rzhetsky, andrey/B-6118-2012; Tretiakova, Maria/U-3320-2019	rzhetsky, andrey/0000-0001-6959-7405; Liu, Jiang/0000-0002-5687-5047; Brown, Christopher/0000-0002-3785-5008; Negre, Nicolas/0000-0001-9727-3416; Rimm, David/0000-0001-5820-4397	Vaadia-BARD Postdoctoral Fellowship Award; United States Israel Binational Agricultural Research and Development Fund; Lilly [Life Science Research Fellowship]; W. M. Keck Foundation; Arnold and Mabel Beckman Foundation; Searle Funds at The Chicago Community Trust from the Chicago Biomedical Consortium;  [FI-315-2001]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER	Vaadia-BARD Postdoctoral Fellowship Award(US-Israel Binational Science Foundation); United States Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Lilly(Eli Lilly); W. M. Keck Foundation(W.M. Keck Foundation); Arnold and Mabel Beckman Foundation; Searle Funds at The Chicago Community Trust from the Chicago Biomedical Consortium; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jiang, M. Van Lohuizen, C. Chung, D. McEwen for providing expression vectors. Microarray data described in this paper have been deposited in the NCBI Gene Expression Omnibus (GEO) under accession code GSE14086 (expression data) and GSE14289 (ChIP data). M.G. was supported by Vaadia-BARD Postdoctoral Fellowship Award No. FI-315-2001 from BARD, The United States Israel Binational Agricultural Research and Development Fund. C.D.B was supported by a Lilly Life Science Research Fellowship. This work was supported by grants from the W. M. Keck Foundation, the Arnold and Mabel Beckman Foundation, and the Searle Funds at The Chicago Community Trust from the Chicago Biomedical Consortium to K.P.W.	Al-Ahmadie HA, 2008, AM J SURG PATHOL, V32, P377, DOI 10.1097/PAS.0b013e3181570343; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HARDING K, 1986, SCIENCE, V233, P953, DOI 10.1126/science.3755551; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Leibovich BC, 2007, J CLIN ONCOL, V25, P4757, DOI 10.1200/JCO.2007.12.1087; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Nasiadka A., 2002, AD DEV BIOL, V12, P155; Potter C, 2004, CELL CYCLE, V3, P164; Potter CJ, 2000, TRENDS GENET, V16, P33, DOI 10.1016/S0168-9525(99)01878-8; Rosai J., 2004, ROSAI ACKERMANS SURG; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Skinnider BF, 2005, SEMIN DIAGN PATHOL, V22, P51, DOI 10.1053/j.semdp.2005.11.004; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Wang HS, 2006, EMBO J, V25, P5783, DOI 10.1038/sj.emboj.7601461; Weiss C, 2004, CELL CYCLE, V3, P111; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhou M, 2005, CLIN LAB MED, V25, P247, DOI 10.1016/j.cll.2005.01.004	29	96	105	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1218	1222		10.1126/science.1157669	http://dx.doi.org/10.1126/science.1157669			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19164706	Green Accepted, Green Submitted			2022-12-24	WOS:000263687600040
J	Roberts, AJ; Numata, N; Walker, ML; Kato, YS; Malkova, B; Kon, T; Ohkura, R; Arisaka, F; Knight, PJ; Sutoh, K; Burgess, SA				Roberts, Anthony J.; Numata, Naoki; Walker, Matt L.; Kato, Yusuke S.; Malkova, Bara; Kon, Takahide; Ohkura, Reiko; Arisaka, Fumio; Knight, Peter J.; Sutoh, Kazuo; Burgess, Stan A.			AAA plus Ring and Linker Swing Mechanism in the Dynein Motor	CELL			English	Article							DICTYOSTELIUM CYTOPLASMIC DYNEIN; ARMS IN-SITU; MOLECULAR MOTOR; ELECTRON-MICROSCOPY; NEGATIVE STAIN; RESOLUTION; FAMILY; DOMAIN; COORDINATION; MICROTUBULES	Dynein ATPases power diverse microtubule-based motilities. Each dynein motor domain comprises a ring-like head containing six AAA+ modules and N- and C-terminal regions, together with a stalk that binds microtubules. How these subdomains are arranged and generate force remains poorly understood. Here, using electron microscopy and image processing of tagged and truncated Dictyostelium cytoplasmic dynein constructs, we show that the heart of the motor is a hexameric ring of AAA+ modules, with the stalk emerging opposite the primary ATPase site (AAA1). The C-terminal region is not an integral part of the ring but spans between AAA6 and near the stalk base. The N- terminal region includes a lever-like linker whose N terminus swings by similar to 17 nm during the ATPase cycle between AAA2 and the stalk base. Together with evidence of stalk tilting, which may communicate changes in microtubule binding affinity, these findings suggest a model for dynein's structure and mechanism.	[Roberts, Anthony J.; Kato, Yusuke S.; Malkova, Bara; Knight, Peter J.; Burgess, Stan A.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Roberts, Anthony J.; Kato, Yusuke S.; Malkova, Bara; Knight, Peter J.; Burgess, Stan A.] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Numata, Naoki; Kon, Takahide; Ohkura, Reiko; Sutoh, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Walker, Matt L.] MLW Consulting, Launceston PL15 9BB, Cornwall, England; [Arisaka, Fumio] Tokyo Inst Technol, Grad Sch, Yokohama, Kanagawa 2268501, Japan; [Arisaka, Fumio] Tokyo Inst Technol, Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	University of Leeds; University of Leeds; University of Tokyo; Tokyo Institute of Technology; Tokyo Institute of Technology	Burgess, SA (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	sutoh@bio.c.u-tokyo.ac.jp; s.a.burgess@leeds.ac.uk	Kon, Takahide/AAG-6975-2021	Kon, Takahide/0000-0002-1231-7609	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; BBSRC (UK) [24/B19478, BB/E00928X/1]; BBSRC Japan Partnering Award; Wellcome Trust [078115/Z/05/Z, 080709/Z/06/Z]; BBSRC [BB/E00928X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E00928X/1] Funding Source: researchfish	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Japan Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to Dr. N. A. Ranson, Dr. D. P. Mulvihill, and Dr. T. A. Edwards for comments on an earlier draft. This work was supported by a Grant-in-Aid for Scientific Research ( S) from the Japan Society for the Promotion of Science (JSPS); a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to K. S.; by the BBSRC (UK) to P. J. K. (24/B19478) and to S. A. B. (BB/E00928X/1); a BBSRC Japan Partnering Award to P. J. K. and S. A. B.; and the Wellcome Trust to A. J. R. (078115/Z/05/Z) and B. M. (080709/Z/06/Z).	Burgess SA, 2004, J STRUCT BIOL, V146, P205, DOI 10.1016/j.jsb.2003.10.005; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; Burgess SA, 2004, CURR OPIN STRUC BIOL, V14, P138, DOI 10.1016/j.sbi.2004.03.013; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Cavalier-Smith T, 2006, PHILOS T R SOC B, V361, P969, DOI 10.1098/rstb.2006.1842; DiBella LM, 2001, INT REV CYTOL, V210, P227; ELLIOTT A, 1976, PROC R SOC SER B-BIO, V193, P45, DOI 10.1098/rspb.1976.0030; Frank J, 2006, 3 DIMENSIONAL ELECT; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Ishikawa T, 2007, J MOL BIOL, V368, P1249, DOI 10.1016/j.jmb.2007.02.072; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SM, 2000, J CELL SCI, V113, P2521; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Koonce MP, 2004, TRENDS CELL BIOL, V14, P612, DOI 10.1016/j.tcb.2004.09.013; Koonce MP, 1996, MOL BIOL CELL, V7, P935, DOI 10.1091/mbc.7.6.935; Kotani N, 2007, BIOPHYS J, V93, P886, DOI 10.1529/biophysj.106.101964; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupetti P, 2005, CELL MOTIL CYTOSKEL, V62, P69, DOI 10.1002/cm.20084; Meng X, 2006, J MOL BIOL, V357, P701, DOI 10.1016/j.jmb.2006.01.028; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Mogami T, 2007, J BIOL CHEM, V282, P21639, DOI 10.1074/jbc.M701914200; Neuwald AF, 1999, GENOME RES, V9, P27; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nishiura M, 2004, J BIOL CHEM, V279, P22799, DOI 10.1074/jbc.M313362200; Numata N, 2008, BIOCHEM SOC T, V36, P131, DOI 10.1042/BST0360131; Oda T, 2007, J CELL BIOL, V177, P243, DOI 10.1083/jcb.200609038; Oiwa K, 2005, CURR OPIN CELL BIOL, V17, P98, DOI 10.1016/j.ceb.2004.12.006; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Serohijos AWR, 2006, P NATL ACAD SCI USA, V103, P18540, DOI 10.1073/pnas.0602867103; Shima T, 2006, P NATL ACAD SCI USA, V103, P17736, DOI 10.1073/pnas.0606794103; Shima T, 2006, J STRUCT BIOL, V156, P182, DOI 10.1016/j.jsb.2006.03.014; Takahashi Y, 2004, P NATL ACAD SCI USA, V101, P12865, DOI 10.1073/pnas.0403429101; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Yagi T, 2005, J BIOL CHEM, V280, P41412, DOI 10.1074/jbc.M509072200; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zhao L, 2003, J BACTERIOL, V185, P1693, DOI 10.1128/JB.185.5.1693-1700.2003	48	162	163	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					485	495		10.1016/j.cell.2008.11.049	http://dx.doi.org/10.1016/j.cell.2008.11.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203583	hybrid, Green Published			2022-12-24	WOS:000263120600018
J	Moffitt, JR; Chemla, YR; Aathavan, K; Grimes, S; Jardine, PJ; Anderson, DL; Bustamante, C				Moffitt, Jeffrey R.; Chemla, Yann R.; Aathavan, K.; Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.; Bustamante, Carlos			Intersubunit coordination in a homomeric ring ATPase	NATURE			English	Article							DNA PACKAGING MOTOR; REPLICATIVE HEXAMERIC HELICASE; OPTICAL TWEEZERS; PORTAL MOTOR; BACTERIOPHAGE PHI-29; TERMINATION FACTOR; INTERNAL FORCE; MECHANISM; TRANSLOCATION; MECHANOCHEMISTRY	Homomeric ring ATPases perform many vital and varied tasks in the cell, ranging from chromosome segregation to protein degradation. Here we report the direct observation of the intersubunit coordination and step size of such a ring ATPase, the double- stranded- DNA packaging motor in the bacteriophage phi 29. Using high- resolution optical tweezers, we find that packaging occurs in increments of 10 base pairs ( bp). Statistical analysis of the preceding dwell times reveals that multiple ATPs bind during each dwell, and application of high force reveals that these 10- bp increments are composed of four 2.5- bp steps. These results indicate that the hydrolysis cycles of the individual subunits are highly coordinated by means of a mechanism novel for ring ATPases. Furthermore, a step size that is a non- integer number of base pairs demands new models for motor - DNA interactions.	[Moffitt, Jeffrey R.; Chemla, Yann R.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Moffitt, Jeffrey R.; Chemla, Yann R.; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Aathavan, K.; Bustamante, Carlos] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Anderson, Dwight L.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Jardine, Paul/0000-0002-1090-0550; Chemla, Yann/0000-0001-9167-0234; Bustamante, Carlos/0000-0002-2970-0073	National Science Foundation's Graduate Research Fellowship; Burroughs Welcome Fund's Career Awards at the Scientific Interface; NIH [GM-071552, DE-003606, GM-059604]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE003606, R01DE003606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059604, R01GM071552] Funding Source: NIH RePORTER	National Science Foundation's Graduate Research Fellowship(National Science Foundation (NSF)); Burroughs Welcome Fund's Career Awards at the Scientific Interface(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. L. Hetherington, M. Nollmann and G. Chistol for a critical reading of the manuscript; C. L. Hetherington, A. Politzer, M. Strycharska, M. Kopaczynska and J. Yu for critical discussions; and J. Choy, S. Grill and S. Smith for advice regarding instrumentation. J.R.M. acknowledges the National Science Foundation's Graduate Research Fellowship and Y.R.C. the Burroughs Welcome Fund's Career Awards at the Scientific Interface for funding. This research was supported in part by NIH grants GM-071552, DE-003606 and GM-059604. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; BLOCK SM, 1995, BIOPHYS J, V68, pS230; Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Bustamante C., 2008, SINGLE MOL TECHNIQUE, P297; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Chemla YR, 2008, J PHYS CHEM B, V112, P6025, DOI 10.1021/jp076153r; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chen CP, 1997, J VIROL, V71, P3864, DOI 10.1128/JVI.71.5.3864-3871.1997; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P11245, DOI 10.1073/pnas.0701323104; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Grimes S, 2002, ADV VIRUS RES, V58, P255, DOI 10.1016/S0065-3527(02)58007-6; Grimes S, 1997, J MOL BIOL, V266, P901, DOI 10.1006/jmbi.1996.0843; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1986, P NATL ACAD SCI USA, V83, P3505, DOI 10.1073/pnas.83.10.3505; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kainov DE, 2006, CELL MOL LIFE SCI, V63, P1095, DOI 10.1007/s00018-005-5450-3; Kellner L., 1937, P ROY SOC LOND A MAT, V159, P0410; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Koza Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031905; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lisal J, 2005, NAT STRUCT MOL BIOL, V12, P460, DOI 10.1038/nsmb927; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Morais MC, 2001, J STRUCT BIOL, V135, P38, DOI 10.1006/jsbi.2001.4379; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Segel I.H., 1975, ENZYME KINETICS; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; YANAGI K, 1991, J MOL BIOL, V217, P201, DOI 10.1016/0022-2836(91)90620-L	50	215	218	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					446	U2		10.1038/nature07637	http://dx.doi.org/10.1038/nature07637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19129763	Green Accepted			2022-12-24	WOS:000262519200039
J	Powers, AF; Franck, AD; Gestaut, DR; Cooper, J; Gracyzk, B; Wei, RR; Wordeman, L; Davis, TN; Asbury, CL				Powers, Andrew F.; Franck, Andrew D.; Gestaut, Daniel R.; Cooper, Jeremy; Gracyzk, Beth; Wei, Ronnie R.; Wordeman, Linda; Davis, Trisha N.; Asbury, Charles L.			The Ndc80 Kinetochore Complex Forms Load-Bearing Attachments to Dynamic Microtubule Tips via Biased Diffusion	CELL			English	Article							CHROMOSOME MOTION; BUDDING YEAST; DAM1 COMPLEX; MITOSIS; DEPOLYMERIZATION; MOVEMENT; DRIVEN; HEC1; ARCHITECTURE; CHECKPOINT	Kinetochores couple chromosomes to the assembling and disassembling tips of microtubules, a dynamic behavior that is fundamental to mitosis in all eukaryotes but poorly understood. Genetic, biochemical, and structural studies implicate the Ndc80 complex as a direct point of contact between kinetochores and microtubules, but these approaches provide only a static view. Here, using techniques for manipulating and tracking individual molecules in vitro, we demonstrate that the Ndc80 complex is capable of forming the dynamic, load-bearing attachments to assembling and disassembling tips required for coupling in vivo. We also establish that Ndc80-based coupling likely occurs through a biased diffusion mechanism and that this activity is conserved from yeast to humans. Our findings demonstrate how an ensemble of Ndc80 complexes may provide the combination of plasticity and strength that allows kinetochores to maintain load-bearing tip attachments during both microtubule assembly and disassembly.	[Powers, Andrew F.; Franck, Andrew D.; Cooper, Jeremy; Wordeman, Linda; Asbury, Charles L.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Gestaut, Daniel R.; Gracyzk, Beth; Davis, Trisha N.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Wei, Ronnie R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School	Asbury, CL (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	casbury@u.washington.edu	Davis, Trisha/F-8584-2010	Davis, Trisha/0000-0003-4797-3152; Wordeman, Linda/0000-0002-9444-0650	NIH [T32 GM07270]; NSF IGERT [DGE-0504573]; Packard Fellowship for Science and Engineering [2006-30521]; National Institute of General Medical Sciences [R01GM40506, R01GM79373, R01GM69429]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040506, R01GM069429, T32GM007270, R01GM079373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IGERT(National Science Foundation (NSF)); Packard Fellowship for Science and Engineering; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stephen Harrison and Jennifer DeLuca for plasmids, Anthony Azevedo for conducting early experiments with the 2NCC: 2S construct, Ryan Lemke for technical assistance, Jason Stumpff for helpful comments on the manuscript, and all members of the Seattle Mitosis Club for valuable discussion. This work was supported by an NIH traineeship (T32 GM07270 awarded to A. F. P.), an NSF IGERT traineeship (DGE-0504573 to A. D. F.), a Searle Scholar Award (06- L-111 to C. L. A.), a Packard Fellowship for Science and Engineering (2006-30521 to C. L. A.), and by grants R01GM40506, R01GM79373, and R01GM69429 from the National Institute of General Medical Sciences (to T. N. D., C. L. A., and L. W., respectively).	Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Emanuele MJ, 2005, MOL BIOL CELL, V16, P4882, DOI 10.1091/mbc.E05-03-0239; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Grishchuk EL, 2006, EMBO J, V25, P4888, DOI 10.1038/sj.emboj.7601353; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	39	203	204	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 6	2009	136	5					865	875		10.1016/j.cell.2008.12.045	http://dx.doi.org/10.1016/j.cell.2008.12.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269365	Bronze, Green Accepted			2022-12-24	WOS:000263930900010
J	Sreekumar, A; Poisson, LM; Rajendiran, TM; Khan, AP; Cao, Q; Yu, JD; Laxman, B; Mehra, R; Lonigro, RJ; Li, Y; Nyati, MK; Ahsan, A; Kalyana-Sundaram, S; Han, B; Cao, XH; Byun, J; Omenn, GS; Ghosh, D; Pennathur, S; Alexander, DC; Berger, A; Shuster, JR; Wei, JT; Varambally, S; Beecher, C; Chinnaiyan, AM				Sreekumar, Arun; Poisson, Laila M.; Rajendiran, Thekkelnaycke M.; Khan, Amjad P.; Cao, Qi; Yu, Jindan; Laxman, Bharathi; Mehra, Rohit; Lonigro, Robert J.; Li, Yong; Nyati, Mukesh K.; Ahsan, Aarif; Kalyana-Sundaram, Shanker; Han, Bo; Cao, Xuhong; Byun, Jaeman; Omenn, Gilbert S.; Ghosh, Debashis; Pennathur, Subramaniam; Alexander, Danny C.; Berger, Alvin; Shuster, Jeffrey R.; Wei, John T.; Varambally, Sooryanarayana; Beecher, Christopher; Chinnaiyan, Arul M.			Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression	NATURE			English	Article							MOLECULAR-GENETICS; POLYCOMB; EZH2; EXPRESSION	Multiple, complex molecular events characterize cancer development and progression(1,2). Deciphering the molecular networks that distinguish organ- confined disease from metastatic disease may lead to the identification of critical biomarkers for cancer invasion and disease aggressiveness. Although gene and protein expression have been extensively profiled in human tumours, little is known about the global metabolomic alterations that characterize neoplastic progression. Using a combination of high- throughput liquid- and- gas- chromatography- based mass spectrometry, we profiled more than 1,126 metabolites across 262 clinical samples related to prostate cancer ( 42 tissues and 110 each of urine and plasma). These unbiased metabolomic profiles were able to distinguish benign prostate, clinically localized prostate cancer and metastatic disease. Sarcosine, an N- methyl derivative of the amino acid glycine, was identified as a differential metabolite that was highly increased during prostate cancer progression to metastasis and can be detected non- invasively in urine. Sarcosine levels were also increased in invasive prostate cancer cell lines relative to benign prostate epithelial cells. Knockdown of glycine- N- methyl transferase, the enzyme that generates sarcosine from glycine, attenuated prostate cancer invasion. Addition of exogenous sarcosine or knockdown of the enzyme that leads to sarcosine degradation, sarcosine dehydrogenase, induced an invasive phenotype in benign prostate epithelial cells. Androgen receptor and the ERG gene fusion product coordinately regulate components of the sarcosine pathway. Here, by profiling the metabolomic alterations of prostate cancer progression, we reveal sarcosine as a potentially important metabolic intermediary of cancer cell invasion and aggressivity.	[Sreekumar, Arun; Rajendiran, Thekkelnaycke M.; Khan, Amjad P.; Cao, Qi; Yu, Jindan; Laxman, Bharathi; Mehra, Rohit; Lonigro, Robert J.; Li, Yong; Kalyana-Sundaram, Shanker; Han, Bo; Cao, Xuhong; Varambally, Sooryanarayana; Beecher, Christopher; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Sreekumar, Arun; Omenn, Gilbert S.; Pennathur, Subramaniam; Beecher, Christopher; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Sreekumar, Arun; Rajendiran, Thekkelnaycke M.; Khan, Amjad P.; Cao, Qi; Yu, Jindan; Laxman, Bharathi; Mehra, Rohit; Li, Yong; Kalyana-Sundaram, Shanker; Han, Bo; Cao, Xuhong; Varambally, Sooryanarayana; Beecher, Christopher; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Sreekumar, Arun; Lonigro, Robert J.; Nyati, Mukesh K.; Ghosh, Debashis; Pennathur, Subramaniam; Wei, John T.; Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Poisson, Laila M.; Ghosh, Debashis] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; [Nyati, Mukesh K.; Ahsan, Aarif] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Byun, Jaeman; Omenn, Gilbert S.; Pennathur, Subramaniam] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Wei, John T.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ghosh, Debashis] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Ghosh, Debashis] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Alexander, Danny C.; Berger, Alvin; Shuster, Jeffrey R.] Metabolon Inc, Durham, NC 27713 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Metabolon	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Wei, John T/E-8967-2012; Cao, Qi/A-5517-2010; Berger, Alvin/AAE-5353-2022; Kalyana-Sundaram, Shanker/F-6860-2012	Cao, Qi/0000-0002-5140-3681; Ghosh, Debashis/0000-0001-6618-1316; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Varambally, Sooryanarayana/0000-0002-2277-1127; Omenn, Gilbert S./0000-0002-8976-6074	Early Detection Research Network; National Institutes of Health; MTTC; Clinical Translational Science Award; Fund for Discovery of the University of Michigan Comprehensive Cancer Center; University of Michigan Cancer Biostatistics Training Grant; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [K99CA129565, U01CA111275, T32CA083654, R01CA133458] Funding Source: NIH RePORTER	Early Detection Research Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MTTC; Clinical Translational Science Award; Fund for Discovery of the University of Michigan Comprehensive Cancer Center; University of Michigan Cancer Biostatistics Training Grant(University of Michigan System); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Granger for help in manuscript preparation, J. Siddiqui and R. Varambally for help with the clinical database, and A. Vellaichamy and S. Pullela for technical assistance. We thank K. Pienta for access to metastatic prostate cancer samples from the University of Michigan Prostate SPORE rapid autopsy programme. This work is supported in part by the Early Detection Research Network (A.M.C., J.T.W.), National Institutes of Health (A.S., S.P., J.B., T.M.R., D.G., G.S.O. and A.M.C.) and an MTTC grant (G.S.O. and A.S.). A.M.C. is supported by a Clinical Translational Science Award from the Burroughs Welcome Foundation. A. S. is supported by a grant from the Fund for Discovery of the University of Michigan Comprehensive Cancer Center. L. M. P. is supported by the University of Michigan Cancer Biostatistics Training Grant. A. M. C and S. P. are supported by the Doris Duke Charitable Foundation.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Ruijter E, 1999, ENDOCR REV, V20, P22, DOI 10.1210/er.20.1.22; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498	18	1645	1723	22	794	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					910	914		10.1038/nature07762	http://dx.doi.org/10.1038/nature07762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212411	Green Accepted, Green Published			2022-12-24	WOS:000263266700051
J	Cardone, G; Purdy, JG; Cheng, NQ; Craven, RC; Steven, AC				Cardone, Giovanni; Purdy, John G.; Cheng, Naiqian; Craven, Rebecca C.; Steven, Alasdair C.			Visualization of a missing link in retrovirus capsid assembly	NATURE			English	Article							ROUS-SARCOMA-VIRUS; AMINO-TERMINAL DOMAIN; 3-DIMENSIONAL STRUCTURE; DIMERIZATION DOMAIN; CA PROTEIN; HIV-1 CORE; RESOLUTION; RECONSTRUCTIONS; ORGANIZATION; MODELS	For a retrovirus such as HIV to be infectious, a properly formed capsid is needed; however, unusually among viruses, retrovirus capsids are highly variable in structure. According to the fullerene conjecture, they are composed of hexamers and pentamers of capsid protein (CA), with the shape of a capsid varying according to how the twelve pentamers are distributed and its size depending on the number of hexamers. Hexamers have been studied in planar and tubular arrays, but the predicted pentamers have not been observed. Here we report cryo- electron microscopic analyses of two in- vitro- assembled capsids of Rous sarcoma virus. Both are icosahedrally symmetric: one is composed of 12 pentamers, and the other of 12 pentamers and 20 hexamers. Fitting of atomic models of the two CA domains into the reconstructions shows three distinct inter- subunit interactions. These observations substantiate the fullerene conjecture, show how pentamers are accommodated at vertices, support the inference that nucleation is a crucial morphologic determinant, and imply that electrostatic interactions govern the differential assembly of pentamers and hexamers.	[Cardone, Giovanni; Cheng, Naiqian; Steven, Alasdair C.] NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Purdy, John G.; Craven, Rebecca C.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Steven, AC (corresponding author), NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA.	rcc6@psu.edu; stevena@mail.nih.gov		Cardone, Giovanni/0000-0003-4712-1451; Purdy, John/0000-0001-7460-7567	Intramural Research Program of NIAMS; IATAP Program; NIH [CA100322]; Pennsylvania Department of Health; Penn State Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA100322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041166, ZIAAR027002] Funding Source: NIH RePORTER	Intramural Research Program of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); IATAP Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Penn State Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Flanagan for advice on protein purification and analytic methods and access to equipment, R. Meyers for assistance in electron microscopy at the Penn State College of Medicine and B. Heymann for advice on data analysis. This work was supported by the Intramural Research Program of NIAMS and the IATAP Program (A.C.S.), and funding from NIH grant CA100322, the Pennsylvania Department of Health and the Penn State Cancer Institute (R.C.C.).	Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Butan C, 2008, J MOL BIOL, V376, P1168, DOI 10.1016/j.jmb.2007.12.003; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cantele F, 2003, J STRUCT BIOL, V141, P84, DOI 10.1016/S1047-8477(02)00577-4; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; Cheng N, 2002, J VIROL, V76, P7855, DOI 10.1128/JVI.76.15.7855-7859.2002; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 2003, EMBO J, V22, P2886, DOI 10.1093/emboj/cdg276; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Heymann JB, 2008, COMPUT MATH METHOD M, V9, P197, DOI 10.1080/17486700802168106; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Kingston RL, 2001, J STRUCT BIOL, V136, P67, DOI 10.1006/jsbi.2001.4423; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Lokhandwala PM, 2008, VIROLOGY, V376, P191, DOI 10.1016/j.virol.2008.03.001; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mayo K, 2003, J MOL BIOL, V325, P225, DOI 10.1016/S0022-2836(02)01176-2; Mayo K, 2002, J MOL BIOL, V316, P667, DOI 10.1006/jmbi.2001.5354; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purdy JG, 2008, J VIROL, V82, P5951, DOI 10.1128/JVI.00214-08; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Vogt V. M., 1997, P27; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yeager M, 1998, P NATL ACAD SCI USA, V95, P7299, DOI 10.1073/pnas.95.13.7299	43	81	81	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					694	U3		10.1038/nature07724	http://dx.doi.org/10.1038/nature07724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19194444	Green Accepted			2022-12-24	WOS:000263064700034
J	Canto, C; Gerhart-Hines, Z; Feige, JN; Lagouge, M; Noriega, L; Milne, JC; Elliott, PJ; Puigserver, P; Auwerx, J				Canto, Carles; Gerhart-Hines, Zachary; Feige, Jerome N.; Lagouge, Marie; Noriega, Lilia; Milne, Jill C.; Elliott, Peter J.; Puigserver, Pere; Auwerx, Johan			AMPK regulates energy expenditure by modulating NAD(+) metabolism and SIRT1 activity	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; MITOCHONDRIAL-FUNCTION; GLUCOSE-HOMEOSTASIS; SKELETAL-MUSCLE; RECEPTOR-GAMMA; PGC-1-ALPHA; MECHANISM; OXIDATION	AMP-activated protein kinase (AMPK) is a metabolic fuel gauge conserved along the evolutionary scale in eukaryotes that senses changes in the intracellular AMP/ATP ratio(1). Recent evidence indicated an important role for AMPK in the therapeutic benefits of metformin(2,3), thiazolidinediones(4) and exercise(5), which form the cornerstones of the clinical management of type 2 diabetes and associated metabolic disorders. In general, activation of AMPK acts to maintain cellular energy stores, switching on catabolic pathways that produce ATP, mostly by enhancing oxidative metabolism and mitochondrial biogenesis, while switching off anabolic pathways that consume ATP(1). This regulation can take place acutely, through the regulation of fast post-translational events, but also by transcriptionally reprogramming the cell to meet energetic needs. Here we demonstrate that AMPK controls the expression of genes involved in energy metabolism in mouse skeletal muscle by acting in coordination with another metabolic sensor, the NAD(+)-dependent type III deacetylase SIRT1. AMPK enhances SIRT1 activity by increasing cellular NAD(+) levels, resulting in the deacetylation and modulation of the activity of downstream SIRT1 targets that include the peroxisome proliferator-activated receptor-gamma coactivator 1 alpha and the forkhead box O1 (FOXO1) and O3 (FOXO3a) transcription factors. The AMPK-induced SIRT1-mediated deacetylation of these targets explains many of the convergent biological effects of AMPK and SIRT1 on energy metabolism.	[Canto, Carles; Feige, Jerome N.; Lagouge, Marie; Noriega, Lilia; Auwerx, Johan] CNRS INSERM ULP, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Canto, Carles; Noriega, Lilia; Auwerx, Johan] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Gerhart-Hines, Zachary; Puigserver, Pere] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Gerhart-Hines, Zachary; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Milne, Jill C.; Elliott, Peter J.] Sirtris Pharmaceut Inc, Cambridge, MA 02139 USA; [Auwerx, Johan] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Auwerx, J (corresponding author), CNRS INSERM ULP, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.	admin.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Noriega, Lilia G./ABF-4876-2020	Noriega, Lilia G./0000-0003-2156-9872; Canto, Carles/0000-0002-5167-7922; Auwerx, Johan/0000-0002-5065-5393	CNRS; Ecole Polytechnique Federale de Lausanne; INSERM; ULP; NIH [DK59820, DK069966]; EU [LSHM-CT-2004-512013, ERC-2008-AdG-23118]; Fondation de la Recherche Medicale (FRM); EMBO; FEBS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069966, P01DK059820] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Polytechnique Federale de Lausanne; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ULP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); EMBO(European Molecular Biology Organization (EMBO)); FEBS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants of CNRS, Ecole Polytechnique Federale de Lausanne, INSERM, ULP, NIH (DK59820 and DK069966), EU FP6 (EUGENE2; LSHM-CT-2004-512013) and EU Ideas programme (sirtuins; ERC-2008-AdG-23118). C. C. has been supported by grants of Fondation de la Recherche Medicale (FRM) and EMBO. J. N. F. was supported by a FEBS grant. The authors thank F. Foufelle and P. Ferre, B. Spiegelman, D. P. Kelly, S.-i. Imai, G. Hardie, C. Ammann (Topotarget) and F. Alt for providing materials, and members of the Auwerx and Puigserver laboratories for discussion.	Barnes BR, 2005, DIABETES, V54, P3484, DOI 10.2337/diabetes.54.12.3484; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hasmann M, 2003, CANCER RES, V63, P7436; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	33	2202	2299	17	493	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 23	2009	458	7241					1056	U140		10.1038/nature07813	http://dx.doi.org/10.1038/nature07813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262508	Green Accepted			2022-12-24	WOS:000265412900049
J	Vance, C; Rogelj, B; Hortobagyi, T; De Vos, KJ; Nishimura, AL; Sreedharan, J; Hu, X; Smith, B; Ruddy, D; Wright, P; Ganesalingam, J; Williams, KL; Tripathi, V; Al-Saraj, S; Al-Chalabi, A; Leigh, PN; Blair, IP; Nicholson, G; de Belleroche, J; Gallo, JM; Miller, CC; Shaw, CE				Vance, Caroline; Rogelj, Boris; Hortobagyi, Tibor; De Vos, Kurt J.; Nishimura, Agnes Lumi; Sreedharan, Jemeen; Hu, Xun; Smith, Bradley; Ruddy, Deborah; Wright, Paul; Ganesalingam, Jeban; Williams, Kelly L.; Tripathi, Vineeta; Al-Saraj, Safa; Al-Chalabi, Ammar; Leigh, P. Nigel; Blair, Ian P.; Nicholson, Garth; de Belleroche, Jackie; Gallo, Jean-Marc; Miller, Christopher C.; Shaw, Christopher E.			Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6	SCIENCE			English	Article							FRONTOTEMPORAL DEMENTIA; TARDBP MUTATIONS; CHROMOSOME 9P; TDP-43; LOCUS; ALS; ACCUMULATION; DEGENERATION; PATIENT; LINKAGE	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is familial in 10% of cases. We have identified a missense mutation in the gene encoding fused in sarcoma (FUS) in a British kindred, linked to ALS6. In a survey of 197 familial ALS index cases, we identified two further missense mutations in eight families. Postmortem analysis of three cases with FUS mutations showed FUS-immunoreactive cytoplasmic inclusions and predominantly lower motor neuron degeneration. Cellular expression studies revealed aberrant localization of mutant FUS protein. FUS is involved in the regulation of transcription and RNA splicing and transport, and it has functional homology to another ALS gene, TARDBP, which suggests that a common mechanism may underlie motor neuron degeneration.	[Vance, Caroline; Rogelj, Boris; Hortobagyi, Tibor; Nishimura, Agnes Lumi; Sreedharan, Jemeen; Hu, Xun; Smith, Bradley; Ruddy, Deborah; Wright, Paul; Ganesalingam, Jeban; Tripathi, Vineeta; Al-Saraj, Safa; Al-Chalabi, Ammar; Leigh, P. Nigel; Gallo, Jean-Marc; Miller, Christopher C.; Shaw, Christopher E.] Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, Dept Clin Neurosci,MRC, London SE5 8AF, England; [De Vos, Kurt J.; Miller, Christopher C.] Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, Dept Neurosci,MRC, London SE5 8AF, England; [Williams, Kelly L.; Blair, Ian P.; Nicholson, Garth] ANSAC Res Inst, Northcott Neurosci Lab, Concord, NSW 2139, Australia; [Nicholson, Garth] Concord Hosp, Mol Med Lab, Sydney, NSW 2139, Australia; [Blair, Ian P.; Nicholson, Garth] Univ Sydney, Fac Med, Sydney, NSW 2139, Australia; [de Belleroche, Jackie] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Div Neurosci & Mental Hlth, London W12 0NN, England	University of London; King's College London; University of London; King's College London; Concord Repatriation General Hospital; University of Sydney; Imperial College London	Shaw, CE (corresponding author), Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, Dept Clin Neurosci,MRC, London SE5 8AF, England.	chris.shaw@iop.kcl.ac.uk	Nishimura, Agnes L/B-2905-2011; Leigh, Peter/AAD-5638-2019; Williams, Kelly L/A-5545-2010; Miller, Christopher/H-5733-2012; Vance, Caroline/Q-2633-2019; Smith, Bradley/H-6107-2013; Rogelj, Boris/G-9252-2011; Al-Chalabi, Ammar/E-5361-2010; De Vos, Kurt/D-8380-2011; Vance, Caroline/C-3047-2012; Wright, Paul/K-9171-2013; sreedharan, jemeen/E-7327-2016	Williams, Kelly L/0000-0001-6319-9473; Vance, Caroline/0000-0001-5780-6951; Rogelj, Boris/0000-0003-3898-1943; Al-Chalabi, Ammar/0000-0002-4924-7712; De Vos, Kurt/0000-0003-2161-6309; Vance, Caroline/0000-0001-5780-6951; Wright, Paul/0000-0002-0359-9683; Shaw, Christopher/0000-0003-0251-0146; Nicholson, Garth/0000-0001-9694-066X; Wright, Paul/0000-0001-8367-5529; Smith, Bradley/0000-0002-6980-2453; sreedharan, jemeen/0000-0002-8682-6844; Blair, Ian/0000-0003-3083-0075; Miller, Christopher/0000-0002-5130-1845; Nishimura, Agnes/0000-0001-5295-797X; Gallo, Jean-Marc/0000-0003-0214-4545	American ALS Association; Lady Edith Wolfson Trust; Motor Neurone Disease Association UK; The Wellcome Trust; European Union [LSHM-CT-2003-503330]; National Institute for Health Research Biomedical Research Centre for Mental Health; The South London and Maudsley National Health Service Foundation Trust; Medical Research Council UK; King's College Hospital Charity [Jack Cigman]; The Heaton-Ellis Trust; The Psychiatry Research Trust of the Institute of Psychiatry; Australian National Health and Medical Research Council [CDA 511941]; Motor Neuron Disease Research Institute of Australia [Peter Stearne]; Medical Research Council [MC_G1000733, G0500289B, G0501573, G0600676, G0300329, G0900688, G0500289, G0600974] Funding Source: researchfish; MRC [G0600974, G0600676, G0900688, MC_G1000733, G0501573, G0500289, G0300329] Funding Source: UKRI	American ALS Association; Lady Edith Wolfson Trust; Motor Neurone Disease Association UK; The Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); National Institute for Health Research Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); The South London and Maudsley National Health Service Foundation Trust; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); King's College Hospital Charity; The Heaton-Ellis Trust; The Psychiatry Research Trust of the Institute of Psychiatry; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Motor Neuron Disease Research Institute of Australia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This publication is dedicated to the patients and families who have contributed to this project and to B. Coote and C. Cecere for blood sample collection. Postmortem tissues were provided by MRC Neurodegenerative Diseases Brain Bank. This work was supported in the United Kingdom by grants from the American ALS Association, the Middlemass family, Lady Edith Wolfson Trust, Motor Neurone Disease Association UK, The Wellcome Trust, European Union (APOPIS consortium, contract LSHM-CT-2003-503330, and NeuroNE Consortium), National Institute for Health Research Biomedical Research Centre for Mental Health, The South London and Maudsley National Health Service Foundation Trust, Medical Research Council UK, a Jack Cigman grant from King's College Hospital Charity, The Heaton-Ellis Trust, and The Psychiatry Research Trust of the Institute of Psychiatry. In Australia the work was supported by the Australian National Health and Medical Research Council (CDA 511941) and a Peter Stearne grant from the Motor Neuron Disease Research Institute of Australia.	Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Conforti FL, 2008, NEUROMUSCULAR DISORD, V18, P68, DOI 10.1016/j.nmd.2007.07.003; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Paubel A, 2008, ARCH NEUROL-CHICAGO, V65, P1333, DOI 10.1001/archneur.65.10.1333; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Ruddy DM, 2003, AM J HUM GENET, V73, P390, DOI 10.1086/377157; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; Shaw C E, 2001, Curr Neurol Neurosci Rep, V1, P69, DOI 10.1007/s11910-001-0078-7; Shaw CE, 1998, ANN NEUROL, V43, P390, DOI 10.1002/ana.410430319; Shaw CE, 1997, NEUROLOGY, V49, P1612, DOI 10.1212/WNL.49.6.1612; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Valdmanis PN, 2007, ARCH NEUROL-CHICAGO, V64, P240, DOI 10.1001/archneur.64.2.240; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024	27	1835	1884	9	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1208	1211		10.1126/science.1165942	http://dx.doi.org/10.1126/science.1165942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251628	Green Accepted			2022-12-24	WOS:000263687600037
J	Doil, C; Mailand, N; Bekker-Jensen, S; Menard, P; Larsen, DH; Pepperkok, R; Ellenberg, J; Panier, S; Durocher, D; Bartek, J; Lukas, J; Lukas, C				Doil, Carsten; Mailand, Niels; Bekker-Jensen, Simon; Menard, Patrice; Larsen, Dorthe Helena; Pepperkok, Rainer; Ellenberg, Jan; Panier, Stephanie; Durocher, Daniel; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia			RNF168 Binds and Amplifies Ubiquitin Conjugates on Damaged Chromosomes to Allow Accumulation of Repair Proteins	CELL			English	Article							DNA; H2AX; CHECKPOINT; COMPLEX; BRCA1; PHOSPHORYLATION; UBIQUITYLATION; ORGANIZATION; ACETYLATION; RECOGNITION	DNA double-strand breaks (DSBs) not only interrupt the genetic information, but also disrupt the chromatin structure, and both impairments require repair mechanisms to ensure genome integrity. We showed previously that RNF8-mediated chromatin ubiquitylation protects genome integrity by promoting the accumulation of repair factors at DSBs. Here, we provide evidence that, while RNF8 is necessary to trigger the DSB-associated ubiquitylations, it is not sufficient to sustain conjugated ubiquitin in this compartment. We identified RNF168 as a novel chromatin-associated ubiquitin ligase with an ability to bind ubiquitin. We show that RNF168 interacts with ubiquitylated H2A, assembles at DSBs in an RNF8-dependent manner, and, by targeting H2A and H2AX, amplifies local concentration of lysine 63-linked ubiquitin conjugates to the threshold required for retention of 53BP1 and BRCA1. Thus, RNF168 defines a new pathway involving sequential ubiquitylations on damaged chromosomes and uncovers a functional cooperation between E3 ligases in genome maintenance.	[Doil, Carsten; Mailand, Niels; Bekker-Jensen, Simon; Menard, Patrice; Larsen, Dorthe Helena; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; [Doil, Carsten; Mailand, Niels; Bekker-Jensen, Simon; Menard, Patrice; Larsen, Dorthe Helena; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia] Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Pepperkok, Rainer] European Mol Biol Lab, Cell Biol Biophys Units, D-69117 Heidelberg, Germany; [Ellenberg, Jan] European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany; [Panier, Stephanie; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Danish Cancer Society; Danish Cancer Society; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Lukas, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jil@cancer.dk	Bartek, Jiri/G-5870-2014; Larsen, Dorthe Helena/E-9771-2010; Durocher, Daniel/A-7733-2010; Larsen, Dorthe Helena/Z-6206-2019; Panier, Stephanie/GVT-6365-2022; Ellenberg, Jan/I-4688-2014	Larsen, Dorthe Helena/0000-0002-8280-1252; Durocher, Daniel/0000-0003-3863-8635; Larsen, Dorthe Helena/0000-0002-8280-1252; Ellenberg, Jan/0000-0001-5909-701X; Lukas, Claudia/0000-0001-7169-6883; Pepperkok, Rainer/0000-0002-9762-3583; Menard, Patrice/0000-0001-8844-3727; Bekker-Jensen, Simon/0000-0002-7308-4597; Lukas, Jiri/0000-0001-9087-506X	Danish Cancer Society; Danish National Research Foundation; European Commission Integrated Projects "DNA Repair'' and "GENICA,'' Lundbeck Foundation [R13-A1287]; Danish Research Council; John and Birthe Meyer Foundation; German Federal Ministry of Education and Research ( BMBF); National Genome Research Network [01GR0403]; European Commission Integrated Project Mitocheck [FP6-503464]	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); European Commission Integrated Projects "DNA Repair'' and "GENICA,'' Lundbeck Foundation(European CommissionEuropean Commission Joint Research Centre); Danish Research Council(Det Frie Forskningsrad (DFF)); John and Birthe Meyer Foundation; German Federal Ministry of Education and Research ( BMBF)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network; European Commission Integrated Project Mitocheck(European CommissionEuropean Commission Joint Research Centre)	We thank Junjie Chen, Stephen Jackson, Thanos Halazonetis, Ze'ev Ronai, Kim Newton, and Vishva M. Dixit for reagents; Mark R. Payne for help with statistical analysis; and Holger Erfle and Beate Neumann for assistance with the siRNA screen. This work was supported by the Danish Cancer Society, Danish National Research Foundation, European Commission Integrated Projects "DNA Repair'' and "GENICA,'' Lundbeck Foundation (R13-A1287), Danish Research Council, and the John and Birthe Meyer Foundation. J.E. and R. P. acknowledge support from the German Federal Ministry of Education and Research ( BMBF) grant within the National Genome Research Network (NGFN-1, SMP-RNAi, 01GR0403) and the European Commission Integrated Project Mitocheck (FP6-503464).	Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924	35	664	693	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					435	446		10.1016/j.cell.2008.12.041	http://dx.doi.org/10.1016/j.cell.2008.12.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203579	Bronze			2022-12-24	WOS:000263120600014
J	Anderson, LL; Mao, XR; Scott, BA; Crowder, CM				Anderson, Lori L.; Mao, Xianrong; Scott, Barbara A.; Crowder, C. Michael			Survival from Hypoxia in C-elegans by Inactivation of Aminoacyl-tRNA Synthetases	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; LIFE-SPAN; TRANSLATION; INHIBITION; PATHWAYS; COMPLEX; BRAIN; DEATH	Hypoxia is important in a wide range of biological processes, such as animal hibernation and cell survival, and is particularly relevant in many diseases. The sensitivity of cells and organisms to hypoxic injury varies widely, but the molecular basis for this variation is incompletely understood. Using forward genetic screens in Caenorhabditis elegans, we isolated a hypoxia- resistant reduction- of- function mutant of rrt- 1 that encodes an arginyl- transfer RNA ( tRNA) synthetase, an enzyme essential for protein translation. Knockdown of rrt- 1, and of most other genes encoding aminoacyl- tRNA synthetases, rescued animals from hypoxia- induced death, and the level of hypoxia resistance was inversely correlated with translation rate. The unfolded protein response was induced by hypoxia and was required for the hypoxia resistance of the reduction- of- function mutant of rrt- 1. Thus, translational suppression produces hypoxia resistance, in part by reducing unfolded protein toxicity.	[Anderson, Lori L.; Mao, Xianrong; Scott, Barbara A.; Crowder, C. Michael] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Crowder, C. Michael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Crowder, CM (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	crowderm@morpheus.wustl.edu			National Institute of Neurological Disorders and Stroke; Neuroscience of Brain Disorders Award; McKnight Endowment Fund for Neuroscience; American Heart Association Established Investigator Award; NIH National Center for Research Resources; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045905] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Neuroscience of Brain Disorders Award; McKnight Endowment Fund for Neuroscience; American Heart Association Established Investigator Award(American Heart Association); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Mabon for early efforts on screen design, L. Metz for technical help, and M. Hansen for advice and strains. Supported by the National Institute of Neurological Disorders and Stroke, a Neuroscience of Brain Disorders Award from the McKnight Endowment Fund for Neuroscience, and an American Heart Association Established Investigator Award. Some of the strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources.	Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Dasgupta N, 2007, CURR BIOL, V17, P1954, DOI 10.1016/j.cub.2007.10.017; DeGracia DJ, 2002, J CEREBR BLOOD F MET, V22, P127, DOI 10.1097/00004647-200202000-00001; DeGracia DJ, 2007, J CEREBR BLOOD F MET, V27, P875, DOI 10.1038/sj.jcbfm.9600388; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Koumenis C, 2007, METHOD ENZYMOL, V435, P275, DOI 10.1016/S0076-6879(07)35014-3; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; LANDES C, 1995, BIOCHIMIE, V77, P194, DOI 10.1016/0300-9084(96)88125-9; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Paschen W, 2007, CURR PHARM DESIGN, V13, P1887; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	25	75	82	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					630	633		10.1126/science.1166175	http://dx.doi.org/10.1126/science.1166175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179530	Green Accepted			2022-12-24	WOS:000262862800042
J	Das, J; Ho, M; Zikherman, J; Govern, C; Yang, M; Weiss, A; Chakraborty, AK; Roose, JP				Das, Jayajit; Ho, Mary; Zikherman, Julie; Govern, Christopher; Yang, Ming; Weiss, Arthur; Chakraborty, Arup K.; Roose, Jeroen P.			Digital Signaling and Hysteresis Characterize Ras Activation in Lymphoid Cells	CELL			English	Article							NUCLEOTIDE EXCHANGE FACTOR; T-CELLS; POSITIVE FEEDBACK; DENDRITIC CELLS; SOS; SEVENLESS; GENE; TRANSDUCTION; REQUIREMENT; LYMPHOCYTES	Activation of Ras proteins underlies functional decisions in diverse cell types. Two molecules, RasGRP and SOS, catalyze Ras activation in lymphocytes. Binding of active Ras to SOS' allosteric pocket markedly increases SOS' activity establishing a positive feedback loop for SOS-mediated Ras activation. Integrating in silico and in vitro studies, we demonstrate that digital signaling in lymphocytes (cells are "on'' or "off'') is predicated upon feedback regulation of SOS. SOS' feedback loop leads to hysteresis in the dose-response curve, which can enable a capacity to sustain Ras activation as stimuli are withdrawn and exhibit "memory'' of past encounters with antigen. Ras activation via RasGRP alone is analog (graded increase in amplitude with stimulus). We describe how complementary analog (RasGRP) and digital (SOS) pathways act on Ras to efficiently convert analog input to digital output. Numerous predictions regarding the impact of our findings on lymphocyte function and development are noted.	[Zikherman, Julie; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Ho, Mary; Roose, Jeroen P.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Das, Jayajit; Govern, Christopher; Yang, Ming; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, Div Rheumatol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu; arupc@mit.edu; jeroen.roose@ucsf.edu	Das, Jayajit/AAD-8502-2022; Das, Jayajit/E-2951-2011	Das, Jayajit/0000-0001-9649-4698; Zikherman, Julie/0000-0002-0873-192X; Roose, Jeroen/0000-0003-4746-2811	NIH Director's Pioneer [1PO1/AI071195/01]; Rosalind Russell Medical Research Center for Arthritis; NCI [K01CA113367]; Arthritis Foundation; Sandler Foundation; NATIONAL CANCER INSTITUTE [K01CA113367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI071195] Funding Source: NIH RePORTER	NIH Director's Pioneer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosalind Russell Medical Research Center for Arthritis; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Arthritis Foundation; Sandler Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Kurosaki for DT40 lines and Dr. Dafna Bar-sagi for the H-RasG59E38 plasmid. We are grateful to Dr. DeFranco and members of the Weiss, Chakraborty, and Roose labs for critical reading of the manuscript. We apologize to colleagues we could not cite due to space constraints. Financial support: NIH Director's Pioneer Award and 1PO1/AI071195/01 (A. K. C.), the Howard Hughes Medical Institute as well as the Rosalind Russell Medical Research Center for Arthritis (A. W.), and the NCI (K01CA113367), Arthritis Foundation, and Sandler Foundation (J.P.R.).	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BORTZ AB, 1975, J COMPUT PHYS, V17, P10, DOI 10.1016/0021-9991(75)90060-1; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 2000, BLOOD, V95, P3199; Elf J., 2004, Systems Biology, V1, P230, DOI 10.1049/sb:20045021; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Gilbert JJ, 1996, J IMMUNOL, V156, P2054; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Prasad A, 2009, P NATL ACAD SCI USA, V106, P528, DOI 10.1073/pnas.0805981105; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Ruiz S, 2007, MOL CELL BIOL, V27, P8127, DOI 10.1128/MCB.00912-07; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Wang DZM, 1997, GENE DEV, V11, P309, DOI 10.1101/gad.11.3.309; WEISS A, 1987, J IMMUNOL, V138, P2169	39	281	285	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					337	351		10.1016/j.cell.2008.11.051	http://dx.doi.org/10.1016/j.cell.2008.11.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167334	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000262648800021
J	Yang, AHJ; Moore, SD; Schmidt, BS; Klug, M; Lipson, M; Erickson, D				Yang, Allen H. J.; Moore, Sean D.; Schmidt, Bradley S.; Klug, Matthew; Lipson, Michal; Erickson, David			Optical manipulation of nanoparticles and biomolecules in sub-wavelength slot waveguides	NATURE			English	Article							DNA-MOLECULES; MICROPARTICLES; PARTICLES; CELLS; TWEEZERS; PARALLEL; FORCES; LIGHT	The ability to manipulate nanoscopic matter precisely is critical for the development of active nanosystems. Optical tweezers(1-4) are excellent tools for transporting particles ranging in size fromseveral micrometres to a few hundred nanometres. Manipulation of dielectric objects with much smaller diameters, however, requires stronger optical confinement and higher intensities than can be provided by these diffraction- limited(5) systems. Here we present an approach to optofluidic transport that overcomes these limitations, using sub-wavelength liquid- core slot waveguides(6). The technique simultaneously makes use of near- field optical forces to confine matter inside the waveguide and scattering/ adsorption forces to transport it. The ability of the slot waveguide to condense the accessible electromagnetic energy to scales as small as 60 nm allows us also to overcome the fundamental diffraction problem. We apply the approach here to the trapping and transport of 75- nm dielectric nanoparticles and lambda-DNA molecules. Because trapping occurs along a line, rather than at a point as with traditional point traps(7,8), the method provides the ability to handle extended biomolecules directly. We also carry out a detailed numerical analysis that relates the near- field optical forces to release kinetics. We believe that the architecture demonstrated here will help to bridge the gap between optical manipulation and nanofluidics.	[Moore, Sean D.; Klug, Matthew; Erickson, David] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Yang, Allen H. J.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Schmidt, Bradley S.; Lipson, Michal] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Erickson, D (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	de54@cornell.edu	Erickson, David/A-3319-2009; Yang, Allen/A-7155-2008; Han, Kyuhee/B-6201-2009; Abrams, William R/A-5782-2008	Erickson, David/0000-0002-1624-9711; Yang, Allen/0000-0003-3733-4066; 	US National Science Foundation NIRT [0708599]	US National Science Foundation NIRT(National Science Foundation (NSF))	We thank A. Stroock for discussions, and A. Nitkowski and S. Manipatruni for technical support. This work was done in part at the Cornell NanoScale Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by the US National Science Foundation. This work was funded by the US National Science Foundation NIRT: Active Nanophotofluidic Systems for Single Molecule/Particle Analysis (award number 0708599).	Almeida VR, 2004, OPT LETT, V29, P1209, DOI 10.1364/OL.29.001209; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Born M., 2003, PRINCIPLES OPTICS; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Chiou PY, 2005, NATURE, V436, P370, DOI 10.1038/nature0383l; Chiu DT, 1996, J AM CHEM SOC, V118, P6512, DOI 10.1021/ja960978p; Cizmar T, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035105; Dholakia K, 2008, STRUCTURED LIGHT AND ITS APPLICATIONS: AN INTRODUCTION TO PHASE-STRUCTURED BEAMS AND NANOSCALE OPTICAL FORCES, P107, DOI 10.1016/B978-0-12-374027-4.00005-0; Gaugiran S, 2007, OPT EXPRESS, V15, P8146, DOI 10.1364/OE.15.008146; Gaugiran S, 2005, OPT EXPRESS, V13, P6956, DOI 10.1364/OPEX.13.006956; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Grigorenko AN, 2008, NAT PHOTONICS, V2, P365, DOI 10.1038/nphoton.2008.78; Grujic K, 2005, OPT EXPRESS, V13, P1, DOI 10.1364/OPEX.13.000001; Hart SJ, 2006, ANAL CHEM, V78, P3221, DOI 10.1021/ac052221z; Hirano K, 2008, ANAL CHEM, V80, P5197, DOI 10.1021/ac8003538; Liu GL, 2006, NAT MATER, V5, P27, DOI 10.1038/nmat1528; MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144; Marchington RF, 2008, OPT EXPRESS, V16, P3712, DOI 10.1364/OE.16.003712; Monat C, 2007, NAT PHOTONICS, V1, P106, DOI 10.1038/nphoton.2006.96; Neale SL, 2005, NAT MATER, V4, P530, DOI 10.1038/nmat1411; Ng LN, 2002, OPT COMMUN, V208, P117, DOI 10.1016/S0030-4018(02)01590-0; Ng LN, 2000, J LIGHTWAVE TECHNOL, V18, P388, DOI 10.1109/50.827512; Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060; Righini M, 2007, NAT PHYS, V3, P477, DOI 10.1038/nphys624; Schmidt BS, 2007, OPT EXPRESS, V15, P14322, DOI 10.1364/OE.15.014322; Sinclair G, 2004, OPT EXPRESS, V12, P5475, DOI 10.1364/OPEX.12.005475; SVOBODA K, 1994, OPT LETT, V19, P930, DOI 10.1364/OL.19.000930; Wang MM, 2005, NAT BIOTECHNOL, V23, P83, DOI 10.1038/nbt1050; Woolley AT, 2000, NAT BIOTECHNOL, V18, P760, DOI 10.1038/77760; Yang AHJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/04/045704	30	634	648	5	386	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					71	75		10.1038/nature07593	http://dx.doi.org/10.1038/nature07593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122638				2022-12-24	WOS:000262104900032
J	Essers, MAG; Offner, S; Blanco-Bose, WE; Waibler, Z; Kalinke, U; Duchosal, MA; Trumpp, A				Essers, Marieke A. G.; Offner, Sandra; Blanco-Bose, William E.; Waibler, Zoe; Kalinke, Ulrich; Duchosal, Michel A.; Trumpp, Andreas			IFN alpha activates dormant haematopoietic stem cells in vivo	NATURE			English	Article							CHRONIC MYELOID-LEUKEMIA; SELF-RENEWAL; INTERFERONS; NICHES; EXPRESSION; THERAPY; DISEASE; MICE	Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly reestablish homeostasis(1). The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFN alpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFN alpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFN alpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFN alpha/beta receptor (IFNAR)(2), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFN alpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFN alpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil(1,5), HSCs pre-treated (primed) with IFN alpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFN alpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFN alpha pathway in HSCs impairs their function, acute IFN alpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFN alpha on leukaemic cells(6,7), and raise the possibility for new applications of type I interferons to target cancer stem cells(8).	[Essers, Marieke A. G.; Trumpp, Andreas] DKFZ ZMBH Alliance, Deutsch Krebsforschungszentrum, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Essers, Marieke A. G.; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Offner, Sandra; Blanco-Bose, William E.; Trumpp, Andreas] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Waibler, Zoe; Kalinke, Ulrich] Paul Ehrlich Inst, Div Immunol, D-63225 Langen, Germany; [Kalinke, Ulrich] TWINCORE Ctr Expt & Clin Infect Res, D-30625 Hannover, Germany; [Duchosal, Michel A.] Univ Lausanne Hosp, CHUV, Serv & Cent Lab Hematol, CH-1011 Lausanne, Switzerland	Helmholtz Association; German Cancer Research Center (DKFZ); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Paul Ehrlich Institute; Helmholtz Association; Helmholtz-Center for Infection Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Trumpp, A (corresponding author), DKFZ ZMBH Alliance, Deutsch Krebsforschungszentrum, Div Stem Cells & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.trumpp@dkfz-heidelberg.de	Essers, Marieke A.G./B-7758-2017; Trumpp, Andreas/Z-2141-2019	Essers, Marieke A.G./0000-0003-3117-1809; Trumpp, Andreas/0000-0002-6212-3466; Kalinke, Ulrich/0000-0003-0503-9564	Swiss National Science Foundation; Swiss Cancer League; EU; Deutsche Forschungsgemeinschaft [SFB432.B15]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to M. Aguet for discussions and advice throughout the project, and for providing mouse strains. We thank D. Tough for providing mouse recombinant IFN alpha 4, T. Pedrazzini, W. Stanford and M. Muller for mouse strains, K. Harshman and O. Hagenbuchle and the DAFL team for excellent service and help with the DNA microarrays. We thank C. Dubey and D. Aubry for animal husbandry, genetic screening and technical help, and J. Roberts for FACS sorting. We are grateful to A. Wilson for comments on the manuscript. M. A. G. E. is the recipient of an EMBO long-term fellowship. This work was supported by grants to A. T. from the Swiss National Science Foundation, the Swiss Cancer League, the EU-FP6 Program 'INTACT', the EU-FP7 Program 'EuroSyStem' and to UK from the Deutsche Forschungsgemeinschaft (SFB432.B15).	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Atallah E, 2007, CURR OPIN HEMATOL, V14, P138; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Heaney NCB, 2007, HEMATOL ONCOL, V25, P66, DOI 10.1002/hon.813; Hehlmann R, 2007, LANCET, V370, P342, DOI 10.1016/S0140-6736(07)61165-9; Hochhaus Andreas, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS1; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kujawski LA, 2007, CYTOKINE GROWTH F R, V18, P459, DOI 10.1016/j.cytogfr.2007.06.015; LERNER C, 1990, EXP HEMATOL, V18, P114; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200	30	930	951	3	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					904	U11		10.1038/nature07815	http://dx.doi.org/10.1038/nature07815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19212321				2022-12-24	WOS:000265182500046
J	Xiang, S; Cooper-Morgan, A; Jiao, XF; Kiledjian, M; Manley, JL; Tong, L				Xiang, Song; Cooper-Morgan, Amalene; Jiao, Xinfu; Kiledjian, Megerditch; Manley, James L.; Tong, Liang			Structure and function of the 5 '-> 3 ' exoribonuclease Rat1 and its activating partner Rai1	NATURE			English	Article							RNA-POLYMERASE-II; MESSENGER-RNA; TRANSCRIPTION TERMINATION; SACCHAROMYCES-CEREVISIAE; MACROMOLECULAR STRUCTURES; PIN DOMAINS; PROTEIN; EXONUCLEASE; TURNOVER; NUCLEAR	The 5'-> 3' exoribonucleases (XRNs) comprise a large family of conserved enzymes in eukaryotes with crucial functions in RNA metabolism and RNA interference(1-5). XRN2, or Rat1 in yeast(6), functions primarily in the nucleus and also has an important role in transcription termination by RNA polymerase II (refs 7-14). Rat1 exoribonuclease activity is stimulated by the protein Rai1 (refs 15, 16). Here we report the crystal structure at 2.2 angstrom resolution of Schizosaccharomyces pombe Rat1 in complex with Rai1, as well as the structures of Rai1 and its murine homologue Dom3Z alone at 2.0 angstrom resolution. The structures reveal the molecular mechanism for the activation of Rat1 by Rai1 and for the exclusive exoribonuclease activity of Rat1. Biochemical studies confirm these observations, and show that Rai1 allows Rat1 to degrade RNAs with stable secondary structure more effectively. There are large differences in the active site landscape of Rat1 compared to related and PIN (PilT N terminus) domain-containing nucleases(17-20). Unexpectedly, we identified a large pocket in Rai1 and Dom3Z that contains highly conserved residues, including three acidic side chains that coordinate a divalent cation. Mutagenesis and biochemical studies demonstrate that Rai1 possesses pyrophosphohydrolase activity towards 5' triphosphorylated RNA. Such an activity is important for messenger RNA degradation in bacteria(21), but this is, to our knowledge, the first demonstration of this activity in eukaryotes and suggests that Rai1/Dom3Z may have additional important functions in RNA metabolism.	[Xiang, Song; Cooper-Morgan, Amalene; Manley, James L.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Jiao, Xinfu; Kiledjian, Megerditch] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Columbia University; Rutgers State University New Brunswick	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Xiang, Song/AAF-6422-2019	Xiang, Song/0000-0001-9314-4684; Tong, Liang/0000-0002-0563-6468; Manley, James/0000-0002-8341-1459	NIH [GM077175, GM28983, GM67005]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067005, R01GM028983, R01GM077175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Abramowitz and J. Schwanof for setting up the X4A and X4C beamlines and H. Robinson for setting up the X29A beamline at the NSLS, and S. Jia for providing the S. pombe genome. This research is supported in part by grants from the NIH to L. T. (GM077175), J. L. M. (GM28983) and M. K. (GM67005).	AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; DeLano WL, 2002, PYMOL USERS MANUAL; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Jiao XF, 2006, MOL CELL, V24, P713, DOI 10.1016/j.molcel.2006.10.013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; LAMZIN VS, 2001, CRYSTALLOGRAPHY BIOL, VF, P720; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Luo WF, 2004, CELL, V119, P911, DOI 10.1016/j.cell.2004.11.041; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page AM, 1998, NUCLEIC ACIDS RES, V26, P3707, DOI 10.1093/nar/26.16.3707; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Piccirillo C, 2003, RNA, V9, P1138, DOI 10.1261/rna.5690503; Poole TL, 1997, BIOCHEM BIOPH RES CO, V235, P799, DOI 10.1006/bbrc.1997.6877; Shobuike T, 2001, NUCLEIC ACIDS RES, V29, P1326, DOI 10.1093/nar/29.6.1326; Solinger JA, 1999, MOL CELL BIOL, V19, P5930; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; West S, 2008, NUCLEIC ACIDS RES, V36, P905, DOI 10.1093/nar/gkm1112; Westmont K, 2004, URBAN AFF REV, V39, P522, DOI 10.1177/1078087404394009; Xue Y, 2000, MOL CELL BIOL, V20, P4006, DOI 10.1128/MCB.20.11.4006-4015.2000; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	42	143	147	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					784	U130		10.1038/nature07731	http://dx.doi.org/10.1038/nature07731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19194460	Green Accepted			2022-12-24	WOS:000265193600046
J	Park, CY; Hoover, PJ; Mullins, FM; Bachhawat, P; Covington, ED; Raunser, S; Walz, T; Garcia, KC; Dolmetsch, RE; Lewis, RS				Park, Chan Young; Hoover, Paul J.; Mullins, Franklin M.; Bachhawat, Priti; Covington, Elizabeth D.; Raunser, Stefan; Walz, Thomas; Garcia, K. Christopher; Dolmetsch, Ricardo E.; Lewis, Richard S.			STIM1 Clusters and Activates CRAC Channels via Direct Binding of a Cytosolic Domain to Orai1	CELL			English	Article							STROMAL INTERACTION MOLECULE-1; OPERATED CA2+ ENTRY; STORE DEPLETION; PORE SUBUNIT; I-CRAC; OLIGOMERIZATION; TERMINUS; RECEPTOR; SENSOR	Store-operated Ca2+ channels activated by the depletion of Ca2+ from the endoplasmic reticulum (ER) are a major Ca2+ entry pathway in nonexcitable cells and are essential for T cell activation and adaptive immunity. After store depletion, the ER Ca2+ sensor STIM1 and the CRAC channel protein Orai1 redistribute to ER-plasma membrane (PM) junctions, but the fundamental issue of how STIM1 activates the CRAC channel at these sites is unresolved. Here, we identify a minimal, highly conserved 107-aa CRAC activation domain (CAD) of STIM1 that binds directly to the N and C termini of Orai1 to open the CRAC channel. Purified CAD forms a tetramer that clusters CRAC channels, but analysis of STIM1 mutants reveals that channel clustering is not sufficient for channel activation. These studies establish a molecular mechanism for store-operated Ca2+ entry in which the direct binding of STIM1 to Orai1 drives the accumulation and the activation of CRAC channels at ER-PM junctions.	[Park, Chan Young; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Hoover, Paul J.; Mullins, Franklin M.; Bachhawat, Priti; Covington, Elizabeth D.; Garcia, K. Christopher; Lewis, Richard S.] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; [Mullins, Franklin M.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Bachhawat, Priti; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Raunser, Stefan; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu; rslewis@stanford.edu	Raunser, Stefan/AHE-1573-2022; Park, Chan Young/F-5696-2010	Park, Chan Young/0000-0002-5183-3665; Walz, Thomas/0000-0003-2606-2835; Raunser, Stefan/0000-0001-9373-3016; Lewis, Richard/0000-0002-6010-7403	National Science Foundation and Stanford University; NIH Medical Scientist Training Program; Korea Research Foundation [KRF-2005-214-C00222]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER	National Science Foundation and Stanford University(National Science Foundation (NSF)); NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank M. Wu for early Ca<SUP>2+</SUP> imaging experiments on CT- STIM1, D. Oh for helpful comments, and M. Cahalan, S. Feske, T. Meyer, S. Muallem, C. Romanin, and T. Xu for cDNA constructs. This work was supported by grants from the National Institutes of Health (NIH; R. E. D. and R. S. L.) and the Mathers Charitable Foundation (R. S. L.), graduate fellowships from the National Science Foundation and Stanford University (E.D.C.), an NIH Medical Scientist Training Program Grant (P.J.H.), and the Korea Research Foundation (KRF-2005-214-C00222) and the SPARK program (C.Y.P.). T. W. and K. C. G. are Investigators of the Howard Hughes Medical Institute.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bolotina VM, 2008, J PHYSIOL-LONDON, V586, P3035, DOI 10.1113/jphysiol.2008.154997; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; PRAKRIYA M, 2004, MOL CELLULAR INSIGHT, P121; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Thaminy Safia, 2004, Methods Mol Biol, V261, P297; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	38	712	737	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					876	890		10.1016/j.cell.2009.02.014	http://dx.doi.org/10.1016/j.cell.2009.02.014			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19249086	Green Accepted, Bronze			2022-12-24	WOS:000263930900011
J	Zhang, ZY; Lan, Y; Chai, Y; Jiang, RL				Zhang, Zunyi; Lan, Yu; Chai, Yang; Jiang, Rulang			Antagonistic Actions of Msx1 and Osr2 Pattern Mammalian Teeth into a Single Row	SCIENCE			English	Article							EARLY TOOTH DEVELOPMENT; MORPHOGENESIS; EXPRESSION; DIVERSITY; DENTITION; ECTODIN; SIGNALS; GENES; MODEL; CUSP	Mammals have single-rowed dentitions, whereas many nonmammalian vertebrates have teeth in multiple rows. Neither the molecular mechanism regulating iterative tooth initiation nor that restricting mammalian tooth development in one row is known. We found that mice lacking the transcription factor odd-skipped related-2 (Osr2) develop supernumerary teeth lingual to their molars because of expansion of the odontogenic field. Osr2 was expressed in a lingual-to-buccal gradient and restricted expression of bone morphogenetic protein 4 (Bmp4), an essential odontogenic signal, in the developing tooth mesenchyme. Expansion of odontogenic field in Osr2-deficient mice required Msx1, a feedback activator of Bmp4 expression. These findings suggest that the Bmp4-Msx1 pathway propagates mesenchymal activation for sequential tooth induction and that spatial modulation of this pathway provides a mechanism for patterning vertebrate dentition.	[Zhang, Zunyi; Lan, Yu; Jiang, Rulang] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Zhang, Zunyi; Lan, Yu; Jiang, Rulang] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Chai, Yang] Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of Rochester; University of Rochester; University of Southern California	Jiang, RL (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA.	Rulang_Jiang@urmc.rochester.edu		Jiang, Rulang/0000-0001-7842-4696	NIH [R01DE013681, T32DE007202]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH grants R01DE013681 (R.J.) and T32DE007202 (Z.Z.). We thank K. Maltby for technical assistance and K. Ackerman, C. E. Ovitt, and M. Dixon for comments.	Bei M, 1998, DEVELOPMENT, V125, P4325; Chen YP, 1996, DEVELOPMENT, V122, P3035; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Fraser GJ, 2006, J EXP ZOOL PART B, V306B, P183, DOI 10.1002/jez.b.21097; Fraser GJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-32; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Keranen SVE, 1998, DEV GENES EVOL, V208, P477, DOI 10.1007/s004270050206; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kulesa PM, 1996, J THEOR BIOL, V180, P287, DOI 10.1006/jtbi.1996.0103; Lan Y, 2001, MECH DEVELOP, V107, P175, DOI 10.1016/S0925-4773(01)00457-9; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Maas R, 1997, CRIT REV ORAL BIOL M, V8, P4, DOI 10.1177/10454411970080010101; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Peterkova R, 2006, J EXP ZOOL PART B, V306B, P234, DOI 10.1002/jez.b.21093; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Streelman JT, 2003, EVOL DEV, V5, P600, DOI 10.1046/j.1525-142X.2003.03065.x; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289	22	90	95	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1232	1234		10.1126/science.1167418	http://dx.doi.org/10.1126/science.1167418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251632	Green Accepted			2022-12-24	WOS:000263687600044
J	Nicklin, P; Bergman, P; Zhang, BL; Triantafellow, E; Wang, H; Nyfeler, B; Yang, HD; Hild, M; Kung, C; Wilson, C; Myer, VE; MacKeigan, JP; Porter, JA; Wang, YK; Cantley, LC; Finan, PM; Murphy, LO				Nicklin, Paul; Bergman, Philip; Zhang, Bailin; Triantafellow, Ellen; Wang, Henry; Nyfeler, Beat; Yang, Haidi; Hild, Marc; Kung, Charles; Wilson, Christopher; Myer, Vic E.; MacKeigan, Jeffrey P.; Porter, Jeffrey A.; Wang, Y. Karen; Cantley, Lewis C.; Finan, Peter M.; Murphy, Leon O.			Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy	CELL			English	Article							P70 S6 KINASE; FUNCTIONAL-CHARACTERIZATION; GLUTAMINE-METABOLISM; GENE-EXPRESSION; RAG GTPASES; CELL-SIZE; SYSTEM L; PROTEIN; RAPAMYCIN; MUSCLE	Amino acids are required for activation of the mammalian target of rapamycin ( mTOR) kinase which regulates protein translation, cell growth, and autophagy. Cell surface transporters that allow amino acids to enter the cell and signal to mTOR are unknown. We show that cellular uptake of L-glutamine and its subsequent rapid efflux in the presence of essential amino acids (EAA) is the rate-limiting step that activates mTOR. L-glutamine uptake is regulated by SLC1A5 and loss of SLC1A5 function inhibits cell growth and activates autophagy. The molecular basis for L-glutamine sensitivity is due to SLC7A5/SLC3A2, a bidirectional transporter that regulates the simultaneous efflux of L-glutamine out of cells and transport of L-leucine/EAA into cells. Certain tumor cell lines with high basal cellular levels of L-glutamine bypass the need for L-glutamine uptake and are primed for mTOR activation. Thus, L-glutamine flux regulates mTOR, translation and autophagy to coordinate cell growth and proliferation.	Novartis Inst BioMed Res, Dev & Mol Pathways, Cambridge, MA 02139 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Zhang, Bailin; Wang, Y. Karen] Novartis Inst BioMed Res, Analyt Sci, Cambridge, MA 02139 USA	Novartis; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Novartis	Murphy, LO (corresponding author), Novartis Inst BioMed Res, Dev & Mol Pathways, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	leon.murphy@novartis.com	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; MacKeigan, Jeffrey/0000-0002-0198-5679; Wilson, Christopher/0000-0002-9146-522X	Novartis Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER	Novartis Pharmaceuticals(Novartis); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Stephen Helliwell, Dan Garza, Dmitri Wiederschain, Greg Michaud, Alex Huang, Leslie Pond, and John Westwick for support, comments, and advice; and to Alan Abrams for help with graphics; and Akos Szilvasi for help with confocal imaging. All authors ( except L. C. C.) are employees of Novartis Pharmaceuticals.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arsham AM, 2006, CURR OPIN CELL BIOL, V18, P589, DOI 10.1016/j.ceb.2006.09.005; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Boado RJ, 1999, P NATL ACAD SCI USA, V96, P12079, DOI 10.1073/pnas.96.21.12079; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CHRISTA L, 1994, GASTROENTEROLOGY, V106, P1312, DOI 10.1016/0016-5085(94)90024-8; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DECHELOTTE P, 1991, AM J PHYSIOL, V260, pG677, DOI 10.1152/ajpgi.1991.260.5.G677; EAGLE H, 1956, J BIOL CHEM, V218, P607; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Esslinger CS, 2005, BIOORGAN MED CHEM, V13, P1111, DOI 10.1016/j.bmc.2004.11.028; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fuchs BC, 2006, J SURG RES, V131, P26, DOI 10.1016/j.jss.2005.07.013; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; GAUGITSCH HW, 1992, J BIOL CHEM, V267, P11267; GEBHARDT R, 1995, CARCINOGENESIS, V16, P1673; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Holecek M, 2002, NUTRITION, V18, P130, DOI 10.1016/S0899-9007(01)00767-5; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; KOVACEVIC Z, 1972, CANCER RES, V32, P326; Liu XM, 2004, FASEB J, V18, P768, DOI 10.1096/fj.03-0886fje; Martin JF, 2000, MECH DEVELOP, V92, P155, DOI 10.1016/S0925-4773(99)00338-X; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McGivan JD, 2007, FRONT BIOSCI, V12, P874, DOI 10.2741/2109; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V280, pE323, DOI 10.1152/ajpendo.2001.280.2.E323; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nii T, 2001, BIOCHEM J, V358, P693, DOI 10.1042/0264-6021:3580693; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Wolf DA, 1996, CANCER RES, V56, P5012; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4	59	1174	1234	9	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					521	534		10.1016/j.cell.2008.11.044	http://dx.doi.org/10.1016/j.cell.2008.11.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203585	Bronze, Green Accepted			2022-12-24	WOS:000263120600021
J	Wu, JI; Lessard, J; Crabtree, GR				Wu, Jiang I.; Lessard, Julie; Crabtree, Gerald R.			Understanding the Words of Chromatin Regulation	CELL			English	Article							REMODELING COMPLEX; POLYCOMB GROUP; HISTONE H3; BRG1; ISWI; EXPRESSION; SUBUNIT; DISRUPTION; PROTEINS; GENES	Recent studies indicate that chromatin regulatory complexes produce biological specificity in the way that letters produce meanings by combinations into words. Combinatorial assembly of chromatin regulatory complexes may be critical for maximizing the information content provided by arrays of histone modifications.	[Wu, Jiang I.; Lessard, Julie; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94062 USA; [Wu, Jiang I.; Lessard, Julie; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94062 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94062 USA.	crabtree@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI060037-02, R01 AI060037-03, R01 AI060037-01, R01 AI060037-05, R01 AI060037, R01 AI060037-04] Funding Source: Medline; NICHD NIH HHS [R01 HD055391] Funding Source: Medline; NINDS NIH HHS [R01 NS046789-04, R01 NS046789-06, R01 NS046789-05, R01 NS046789-03, R01 NS046789, R01 NS046789-01, R01 NS046789-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akasaka T, 1996, DEVELOPMENT, V122, P1513; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Carrera I, 2008, MOL CELL BIOL, V28, P5238, DOI 10.1128/MCB.00747-08; Chalkley GE, 2008, MOL CELL BIOL, V28, P2920, DOI 10.1128/MCB.02217-07; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; NEIGEBORN L, 1984, GENETICS, V108, P845; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wong AKC, 2000, CANCER RES, V60, P6171; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	58	271	277	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					200	206		10.1016/j.cell.2009.01.009	http://dx.doi.org/10.1016/j.cell.2009.01.009			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167321	Bronze, Green Accepted			2022-12-24	WOS:000262648800007
J	Dupont, S; Mamidi, A; Cordenonsi, M; Montagner, M; Zacchigna, L; Adorno, M; Martello, G; Stinchfield, MJ; Soligo, S; Morsut, L; Inui, M; Moro, S; Modena, N; Argenton, F; Newfeld, SJ; Piccolo, S				Dupont, Sirio; Mamidi, Anant; Cordenonsi, Michelangelo; Montagner, Marco; Zacchigna, Luca; Adorno, Maddalena; Martello, Graziano; Stinchfield, Michael J.; Soligo, Sandra; Morsut, Leonardo; Inui, Masafumi; Moro, Stefano; Modena, Nicola; Argenton, Francesco; Newfeld, Stuart J.; Piccolo, Stefano			FAM/USP9x, a Deubiquitinating Enzyme Essential for TGF beta Signaling, Controls Smad4 Monoubiquitination	CELL			English	Article							GROWTH-FACTOR-BETA; FAT-FACETS GENE; UBIQUITIN LIGASE; TUMOR-CELLS; INDUCTION; CANCER; PHOSPHORYLATION; PATHWAYS; RECEPTOR; P53	The assembly of the Smad complex is critical for TGF beta signaling, yet the mechanisms that inactivate or empower nuclear Smad complexes are less understood. By means of siRNA screen we identified FAM (USP9x), a deubiquitinase acting as essential and evolutionarily conserved component in TGFb and bone morphogenetic protein signaling. Smad4 is monoubiquitinated in lysine 519 in vivo, a modification that inhibits Smad4 by impeding association with phospho-Smad2. FAM reverts this negative modification, re-empowering Smad4 function. FAM opposes the activity of Ectodermin/Tif1 gamma (Ecto), a nuclear factor for which we now clarify a prominent role as Smad4 monoubiquitin ligase. Our study points to Smad4 monoubiquitination and deubiquitination as a way for cells to set their TGF beta responsiveness: loss of FAM disables Smad4-dependent responses in several model systems, with Ecto being epistatic to FAM. This defines a regulative ubiquitination step controlling Smads that is parallel to those impinging on R-Smad phosphorylation.	[Dupont, Sirio; Mamidi, Anant; Cordenonsi, Michelangelo; Montagner, Marco; Zacchigna, Luca; Adorno, Maddalena; Martello, Graziano; Soligo, Sandra; Morsut, Leonardo; Inui, Masafumi; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35131 Padua, Italy; [Stinchfield, Michael J.; Newfeld, Stuart J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Modena, Nicola; Argenton, Francesco] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Moro, Stefano] Univ Padua, Dept Pharmaceut Sci, Mol Modeling Sect, I-35131 Padua, Italy	University of Padua; Arizona State University; Arizona State University-Tempe; University of Padua; University of Padua	Piccolo, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35131 Padua, Italy.	piccolo@civ.bio.unipd.it	Montagner, Marco/AAY-3236-2020; Argenton, Francesco/AAS-8494-2021; Stinchfield, Michael/AAW-8983-2020; Inui, Masafumi/GWZ-2521-2022; Martello, Graziano/AAM-3325-2021; Cordenonsi, Michelangelo/K-7692-2016; Moro, Stefano/A-2979-2012; 高, 雨莉/HGU-8187-2022; Dupont, Sirio/AAP-8133-2021	Montagner, Marco/0000-0003-3080-2138; Argenton, Francesco/0000-0002-0803-8236; Inui, Masafumi/0000-0003-4720-007X; Cordenonsi, Michelangelo/0000-0002-8253-5724; Moro, Stefano/0000-0002-7514-3802; Mamidi, Anant/0000-0001-7953-7991; PICCOLO, STEFANO/0000-0002-2037-0004; Dupont, Sirio/0000-0002-6869-1966; Martello, Graziano/0000-0001-5520-085X	TELETHON-Italy [GGP07218]; Cariparo Foundation Excellence Grant, ASI; Swissbridge; AIRC; Marie Curie Epiplast Carcinoma RTN; NIH [CA095875]; SFAz [CAA0285-08]; EU [LSH-CT-2003-503496]; NATIONAL CANCER INSTITUTE [R01CA095875] Funding Source: NIH RePORTER	TELETHON-Italy(Fondazione Telethon); Cariparo Foundation Excellence Grant, ASI(Agenzia Spaziale Italiana (ASI)); Swissbridge; AIRC(Fondazione AIRC per la ricerca sul cancro); Marie Curie Epiplast Carcinoma RTN(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SFAz; EU(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to Caroline Hill for thoughtful discussions. We are grateful to S. Wood, K. Kaibuchi, F. Francis, A. Moustakas, P. Ten Dijke, C. Hill, M. Brattain, J. Massague, and C. Chang for gifts of reagents and Angela Bachi for comments. A special thanks to Anna Cabrelle for technical assistance with the FACS. Thanks to Oliver Wessely and Giorgio Bressan for reading the manuscript. We are also grateful to Chemical Computing Group and in particular to Dr. Andrea Bortolato for his assistance in molecular modeling. This work is supported by TELETHON-Italy (GGP07218), Cariparo Foundation Excellence Grant, ASI, and Swissbridge grants (to S. P.), and by an AIRC grant (to S. D.). A. M. is recipient of a Marie Curie Epiplast Carcinoma RTN network fellowship. S.J.N. is supported by the NIH (grant CA095875) and SFAz (grant CAA0285-08); F. A. is supported by EU grant LSH-CT-2003-503496.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; De Bosscher K, 2004, BIOCHEM J, V379, P209, DOI 10.1042/BJ20031886; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Heldin CH, 2006, DEV CELL, V10, P685, DOI 10.1016/j.devcel.2006.05.006; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hudson JB, 1998, DEVELOPMENT, V125, P1407; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; KONIKOFF EC, 2008, J MOL EVOL IN PRESS, DOI DOI 10.1007/S00239-008-9159-4; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Marquez RM, 2001, GENETICS, V157, P1639; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pinho S, 2007, DIFFERENTIATION, V75, P957, DOI 10.1111/j.1432-0436.2007.00185.x; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Wang J, 2004, J BIOL CHEM, V279, P40237, DOI 10.1074/jbc.M401665200; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Zhou SB, 1998, P NATL ACAD SCI USA, V95, P2412, DOI 10.1073/pnas.95.5.2412	36	387	398	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					123	135		10.1016/j.cell.2008.10.051	http://dx.doi.org/10.1016/j.cell.2008.10.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135894	Bronze			2022-12-24	WOS:000262318400020
J	Diehn, M; Cho, RW; Lobo, NA; Kalisky, T; Dorie, MJ; Kulp, AN; Qian, DL; Lam, JS; Ailles, LE; Wong, MZ; Joshua, B; Kaplan, MJ; Wapnir, I; Dirbas, FM; Somlo, G; Garberoglio, C; Paz, B; Shen, J; Lau, SK; Quake, SR; Brown, JM; Weissman, IL; Clarke, MF				Diehn, Maximilian; Cho, Robert W.; Lobo, Neethan A.; Kalisky, Tomer; Dorie, Mary Jo; Kulp, Angela N.; Qian, Dalong; Lam, Jessica S.; Ailles, Laurie E.; Wong, Manzhi; Joshua, Benzion; Kaplan, Michael J.; Wapnir, Irene; Dirbas, Frederick M.; Somlo, George; Garberoglio, Carlos; Paz, Benjamin; Shen, Jeannie; Lau, Sean K.; Quake, Stephen R.; Brown, J. Martin; Weissman, Irving L.; Clarke, Michael F.			Association of reactive oxygen species levels and radioresistance in cancer stem cells	NATURE			English	Article							OXIDATIVE STRESS; IONIZING-RADIATION; MAMMARY-GLAND; SELF-RENEWAL; PROGENITORS; DIFFERENTIATION; IDENTIFICATION; GLUTATHIONE; ENRICHMENT; BIOLOGY	The metabolism of oxygen, although central to life, produces reactive oxygen species (ROS) that have been implicated in processes as diverse as cancer, cardiovascular disease and ageing. It has recently been shown that central nervous system stem cells(1,2) and haematopoietic stem cells and early progenitors(3-6) contain lower levels of ROS than their more mature progeny, and that these differences are critical for maintaining stem cell function. We proposed that epithelial tissue stem cells and their cancer stem cell (CSC) counterparts may also share this property. Here we show that normal mammary epithelial stem cells contain lower concentrations of ROS than their more mature progeny cells. Notably, subsets of CSCs in some human and murine breast tumours contain lower ROS levels than corresponding non-tumorigenic cells (NTCs). Consistent with ROS being critical mediators of ionizing-radiation-induced cell killing(7,8), CSCs in these tumours develop less DNA damage and are preferentially spared after irradiation compared to NTCs. Lower ROS levels in CSCs are associated with increased expression of free radical scavenging systems. Pharmacological depletion of ROS scavengers in CSCs markedly decreases their clonogenicity and results in radiosensitization. These results indicate that, similar to normal tissue stem cells, subsets of CSCs in some tumours contain lower ROS levels and enhanced ROS defences compared to their non-tumorigenic progeny, which may contribute to tumour radioresistance.	[Diehn, Maximilian; Cho, Robert W.; Lobo, Neethan A.; Kulp, Angela N.; Qian, Dalong; Lam, Jessica S.; Ailles, Laurie E.; Wong, Manzhi; Weissman, Irving L.; Clarke, Michael F.] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Diehn, Maximilian; Dorie, Mary Jo; Brown, J. Martin] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Cho, Robert W.] Stanford Univ, Sch Med, Dept Pediat, Div Stem Cell Transplantat, Stanford, CA 94305 USA; [Joshua, Benzion; Kaplan, Michael J.] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Wapnir, Irene; Dirbas, Frederick M.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Clarke, Michael F.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Kalisky, Tomer; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kalisky, Tomer; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Somlo, George] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Garberoglio, Carlos; Paz, Benjamin; Shen, Jeannie] City Hope Natl Med Ctr, Dept Surg, Duarte, CA 91010 USA; [Lau, Sean K.] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; City of Hope; City of Hope; City of Hope	Clarke, MF (corresponding author), Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	mfclarke@stanford.edu		Bowman, Angela/0000-0003-0980-8586; Diehn, Maximilian/0000-0003-2032-0581	National Institutes of Health; Virginia and D. K. Ludwig Foundation; Breast Cancer Research Foundation; Machiah foundation; American Society for Therapeutic Radiology and Oncology; Radiological Society of North America; Leonard B. Holman Research Pathway fellowship; NATIONAL CANCER INSTITUTE [R01CA100225, U54CA126524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and D. K. Ludwig Foundation; Breast Cancer Research Foundation; Machiah foundation; American Society for Therapeutic Radiology and Oncology; Radiological Society of North America; Leonard B. Holman Research Pathway fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Spitz for helpful discussions and D. Menke, D. Rossi, and J. Seita for technical assistance. This work was supported by grants from the National Institutes of Health (M. F. C., G. S. and I. L. W.), the Virginia and D. K. Ludwig Foundation (M. F. C. and I. L. W.), the Breast Cancer Research Foundation (M. F. C.), the Machiah foundation (T. K.), the American Society for Therapeutic Radiology and Oncology (M. D.), and the Radiological Society of North America (M. D.). M. D. is a recipient of the Leonard B. Holman Research Pathway fellowship.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bailey HH, 1998, CHEM-BIOL INTERACT, V112, P239, DOI 10.1016/S0009-2797(97)00164-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Cohen-Jonathan E, 1999, CURR OPIN CHEM BIOL, V3, P77, DOI 10.1016/S1367-5931(99)80014-3; Dorie Mary Jo, 1999, Neoplasia (New York), V1, P461, DOI 10.1038/sj.neo.7900060; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; HAHN SM, 1994, CANCER RES, V54, pS2006; Hosokawa K, 2007, BIOCHEM BIOPH RES CO, V363, P578, DOI 10.1016/j.bbrc.2007.09.014; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; POWELL S, 1990, RADIOTHER ONCOL, V19, P95, DOI 10.1016/0167-8140(90)90123-E; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; WARD JF, 1985, RADIAT RES, V104, pS103, DOI 10.2307/3576637; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103	31	1760	1834	20	471	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					780	U123		10.1038/nature07733	http://dx.doi.org/10.1038/nature07733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19194462	Green Accepted			2022-12-24	WOS:000265193600045
J	Du, LQ; Ali, GS; Simons, KA; Hou, JG; Yang, TB; Reddy, ASN; Poovaiah, BW				Du, Liqun; Ali, Gul S.; Simons, Kayla A.; Hou, Jingguo; Yang, Tianbao; Reddy, A. S. N.; Poovaiah, B. W.			Ca2+/calmodulin regulates salicylic-acid-mediated plant immunity	NATURE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; CALMODULIN-BINDING PROTEIN; DISEASE-RESISTANCE; TRANSCRIPTIONAL REGULATION; HYPERSENSITIVE RESPONSE; ARABIDOPSIS-THALIANA; SIGNALING PATHWAYS; CELL-DEATH; DEFENSE; FAMILY	Intracellular calcium transients during plant-pathogen interactions are necessary early events leading to local and systemic acquired resistance(1). Salicylic acid, a critical messenger, is also required for both of these responses(2,3), but whether and how salicylic acid level is regulated by Ca2+ signalling during plant-pathogen interaction is unclear. Here we report a mechanism connecting Ca2+ signal to salicylic-acid-mediated immune response through calmodulin, AtSR1 (also known as CAMTA3), a Ca2+/calmodulin-binding transcription factor, and EDS1, an established regulator of salicylic acid level. Constitutive disease resistance and elevated levels of salicylic acid in loss-of-function alleles of Arabidopsis AtSR1 suggest that AtSR1 is a negative regulator of plant immunity. This was confirmed by epistasis analysis with mutants of compromised salicylic acid accumulation and disease resistance. We show that AtSR1 interacts with the promoter of EDS1 and represses its expression. Furthermore, Ca2+/calmodulin-binding to AtSR1 is required for suppression of plant defence, indicating a direct role for Ca2+/calmodulin in regulating the function of AtSR1. These results reveal a previously unknown regulatory mechanism linking Ca2+ signalling to salicylic acid level.	[Du, Liqun; Simons, Kayla A.; Yang, Tianbao; Poovaiah, B. W.] Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA; [Du, Liqun; Simons, Kayla A.; Yang, Tianbao; Poovaiah, B. W.] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Hou, Jingguo] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Ali, Gul S.; Reddy, A. S. N.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Ali, Gul S.; Reddy, A. S. N.] Colorado State Univ, Program Mol Plant Biol, Ft Collins, CO 80523 USA	Washington State University; Washington State University; Washington State University; Colorado State University; Colorado State University	Poovaiah, BW (corresponding author), Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA.	poovaiah@wsu.edu			United States Department of Agriculture [2002-00741, 2005-01107, 2008-01034]; National Science Foundation [MCB-0424898, MCB-0424895, DBI 0743097, IOS-0642146]; Colorado Sate University Academic Enrichment Program [180470]; Office of Naval Research [N0014-08-1-0470]; Washington State University Agricultural Research Center	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Colorado Sate University Academic Enrichment Program; Office of Naval Research(Office of Naval Research); Washington State University Agricultural Research Center	Constructs and transgenic lines produced in this research are available on request. This research was supported by United States Department of Agriculture grants 2002-00741, 2005-01107 and 2008-01034, National Science Foundation grants MCB-0424898, MCB-0424895, DBI 0743097 and IOS-0642146, Colorado Sate University Academic Enrichment Program grant 180470, Office of Naval Research N0014-08-1-0470 and the Washington State University Agricultural Research Center. We also thank I. Day for her comments on the manuscript and A. Mochel for her help in preparing the manuscript.	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Chen KG, 2003, PLANT MOL BIOL, V53, P61, DOI 10.1023/B:PLAN.0000009265.72567.58; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Du LQ, 2005, NATURE, V437, P741, DOI 10.1038/nature03973; Du LQ, 2004, PLANT MOL BIOL, V54, P549, DOI 10.1023/B:PLAN.0000038269.98972.bb; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Han JH, 2006, CELL, V127, P847, DOI 10.1016/j.cell.2006.09.030; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Hernandez JM, 2007, P NATL ACAD SCI USA, V104, P17222, DOI 10.1073/pnas.0705629104; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mauch F, 2001, PLANT J, V25, P67, DOI 10.1046/j.1365-313x.2001.00940.x; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Reddy ASN, 2000, BIOCHEM BIOPH RES CO, V279, P762, DOI 10.1006/bbrc.2000.4032; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; TIMMERMANS MCP, 1990, J BIOTECHNOL, V14, P333, DOI 10.1016/0168-1656(90)90117-T; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xing DH, 2006, PLANT SCI, V171, P251, DOI 10.1016/j.plantsci.2006.03.022; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Yang TB, 2000, J BIOL CHEM, V275, P38467, DOI 10.1074/jbc.M003566200; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819	40	365	414	11	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					1154	U116		10.1038/nature07612	http://dx.doi.org/10.1038/nature07612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19122675				2022-12-24	WOS:000263680100046
J	Bruix, J; Llovet, JM				Bruix, Jordi; Llovet, Josep M.			Major achievements in hepato cellular carcinoma	LANCET			English	Editorial Material							HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CLASSIFICATION; CIRRHOSIS; COHORT; NODULES; CANCER; RISK; HCC		[Bruix, Jordi; Llovet, Josep M.] Univ Barcelona, Barcelona Clin Liver Canc Grp, Liver Unit, Hosp Clin,IDIBAPS,CIBEREHD, E-08036 Barcelona, Spain; [Llovet, Josep M.] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, New York, NY USA; [Llovet, Josep M.] ICREA, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Icahn School of Medicine at Mount Sinai; ICREA	Bruix, J (corresponding author), Univ Barcelona, Barcelona Clin Liver Canc Grp, Liver Unit, Hosp Clin,IDIBAPS,CIBEREHD, E-08036 Barcelona, Spain.	jbruix@clinic.ub.es	Llovet, Josep M/D-4340-2014; Llovet, Josep M/ABB-6264-2021	Llovet, Josep M/0000-0003-0547-2667; Llovet, Josep M/0000-0003-0547-2667; Bruix, Jordi/0000-0002-9826-0753	ICREA Funding Source: Custom	ICREA(ICREA)		Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruno S, 2007, HEPATOLOGY, V46, P1350, DOI 10.1002/hep.21826; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243	20	247	264	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					614	616		10.1016/S0140-6736(09)60381-0	http://dx.doi.org/10.1016/S0140-6736(09)60381-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19231618				2022-12-24	WOS:000263563500009
J	Whitney, HM; Kolle, M; Andrew, P; Chittka, L; Steiner, U; Glover, BJ				Whitney, Heather M.; Kolle, Mathias; Andrew, Piers; Chittka, Lars; Steiner, Ullrich; Glover, Beverley J.			Floral Iridescence, Produced by Diffractive Optics, Acts As a Cue for Animal Pollinators	SCIENCE			English	Article							ULTRAVIOLET SIGNAL; COLIAS-EURYTHEME; FLOWER COLOR; CELL-SHAPE; BUMBLEBEES; LIGHT; FLUORESCENCE; PREFERENCES; ANTIRRHINUM; BUTTERFLIES	Iridescence, the change in hue of a surface with varying observation angles, is used by insects, birds, fish, and reptiles for species recognition and mate selection. We identified iridescence in flowers of Hibiscus trionum and Tulipa species and demonstrated that iridescence is generated through diffraction gratings that might be widespread among flowering plants. Although iridescence might be expected to increase attractiveness, it might also compromise target identification because the object's appearance will vary depending on the viewer's perspective. We found that bumblebees (Bombus terrestris) learn to disentangle flower iridescence from color and correctly identify iridescent flowers despite their continuously changing appearance. This ability is retained in the absence of cues from polarized light or ultraviolet reflectance associated with diffraction gratings.	[Kolle, Mathias; Steiner, Ullrich] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Whitney, Heather M.; Glover, Beverley J.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Kolle, Mathias; Andrew, Piers; Steiner, Ullrich] Univ Cambridge, Nanosci Ctr, Cambridge CB3 0HE, England; [Chittka, Lars] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of Cambridge; University of Cambridge; University of Cambridge; University of London; Queen Mary University London	Steiner, U (corresponding author), Univ Cambridge, Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England.	u.steiner@phy.cam.ac.uk; bjg26@cam.ac.uk	Andrew, Piers/F-8188-2013; Chittka, Lars/C-3110-2012; Steiner, Ullrich/K-4777-2013; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Kolle, Mathias/E-3313-2013	Andrew, Piers/0000-0001-5601-5322; Chittka, Lars/0000-0001-8153-1732; Steiner, Ullrich/0000-0001-5936-339X; Kolle, Mathias/0000-0001-7395-8824	Natural Environment Research Council [NE/C000552/1]; Engineering and Physical Sciences Research Council [EP/D040884/1]; European RTN-6 Network Patterns; Cambridge University Research Exchange; German Academic Exchange Service DAAD; EPSRC [EP/D040884/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European RTN-6 Network Patterns; Cambridge University Research Exchange(University of Cambridge); German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Rands, P. Rudall, R. Bateman, P. Cicuta, and J. Baumberg for discussions and Syngenta for bees. Funded by Natural Environment Research Council grant NE/C000552/1, Engineering and Physical Sciences Research Council grant EP/D040884/1, the European RTN-6 Network Patterns, the Cambridge University Research Exchange, and German Academic Exchange Service DAAD.	CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; DAUMER K, 1958, Z VERGL PHYSIOL, V41, P49; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Gandia-Herrero F, 2005, NATURE, V437, P334, DOI 10.1038/437334a; Gorton HL, 1996, PLANT PHYSIOL, V112, P879, DOI 10.1104/pp.112.3.879; GREEN PB, 1990, PROTOPLASMA, V158, P33, DOI 10.1007/BF01323271; HEBANT C, 1984, AM J BOT, V71, P216, DOI 10.2307/2443748; Heuschen B, 2005, PLANT SYST EVOL, V252, P121, DOI 10.1007/s00606-004-0249-5; JOKIEL PL, 1984, LIMNOL OCEANOGR, V29, P192, DOI 10.4319/lo.1984.29.1.0192; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; Kemp DJ, 2007, P R SOC B, V274, P1043, DOI 10.1098/rspb.2006.0043; KETTLER JE, 1991, AM J PHYS, V59, P367, DOI 10.1119/1.16553; Kevan P. G., 1998, COLOR VISION PERSPEC, P163; KEVAN PG, 1976, SCIENCE, V194, P341, DOI 10.1126/science.194.4262.341; KEVAN PG, 1985, P NATL ACAD SCI USA, V82, P4750, DOI 10.1073/pnas.82.14.4750; Kevan PG, 2001, J EXP BIOL, V204, P2571; Morehouse NI, 2007, P ROY SOC B-BIOL SCI, V274, P359, DOI 10.1098/rspb.2006.3730; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Palmer CA, 2005, DIFFRACTION GRATING; Parker AR, 2000, J OPT A-PURE APPL OP, V2, pR15, DOI 10.1088/1464-4258/2/6/201; Parker AR, 2003, J OPT A-PURE APPL OP, V5, pS111, DOI 10.1088/1464-4258/5/4/364; Prum RO, 2006, BIRD COLORATION, V1, P295; Rutowski RL, 2005, P ROY SOC B-BIOL SCI, V272, P2329, DOI 10.1098/rspb.2005.3216; Rutowski RL, 2007, BIOL J LINN SOC, V90, P349, DOI 10.1111/j.1095-8312.2007.00749.x; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Skorupski P, 2007, J COMP PHYSIOL A, V193, P485, DOI 10.1007/s00359-006-0206-6; Sweeney A, 2003, NATURE, V423, P31, DOI 10.1038/423031a; THORP RW, 1975, SCIENCE, V189, P476, DOI 10.1126/science.189.4201.476; VOGELMANN TC, 1993, ANNU REV PLANT PHYS, V44, P231, DOI 10.1146/annurev.pp.44.060193.001311; Whitney HM, 2008, NATURWISSENSCHAFTEN, V95, P845, DOI 10.1007/s00114-008-0393-9	30	263	277	12	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					130	133		10.1126/science.1166256	http://dx.doi.org/10.1126/science.1166256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119235				2022-12-24	WOS:000262104100058
J	Teixeiro, E; Daniels, MA; Hamilton, SE; Schrum, AG; Bragado, R; Jameson, SC; Palmer, E				Teixeiro, Emma; Daniels, Mark A.; Hamilton, Sara E.; Schrum, Adam G.; Bragado, Rafael; Jameson, Stephen C.; Palmer, Ed			Different T Cell Receptor Signals Determine CD8(+) Memory Versus Effector Development	SCIENCE			English	Article							TRANSCRIPTION; LYMPHOCYTE; GENERATION; RESPONSES; SELECTION; DIVISION	Following infection, naive CD8(+) T cells bearing pathogen- specific T cell receptors ( TCRs) differentiate into a mixed population of short- lived effector and long- lived memory T cells to mediate an adaptive immune response. How the TCR regulates memory T cell development has remained elusive. Using a mutant TCR transgenic model, we found that point mutations in the TCR beta transmembrane domain (beta TMD) impair the development and function of CD8(+) memory T cells without affecting primary effector T cell responses. Mutant T cells are deficient in polarizing the TCR and in organizing the nuclear factor kappa B signal at the immunological synapse. Thus, effector and memory states of CD8(+) T cells are separable fates, determined by differential TCR signaling.	[Teixeiro, Emma; Daniels, Mark A.; Schrum, Adam G.; Palmer, Ed] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Teixeiro, Emma; Daniels, Mark A.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Sch Med,Ctr Cellular & Mol Immunol, Columbia, MO 65212 USA; [Hamilton, Sara E.; Jameson, Stephen C.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55454 USA; [Hamilton, Sara E.; Jameson, Stephen C.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA; [Bragado, Rafael] Fdn Jimenez Diaz, Dept Immunol, E-28040 Madrid, Spain; [Schrum, Adam G.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA	University of Basel; University of Missouri System; University of Missouri Columbia; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Teixeiro, E (corresponding author), Univ Basel Hosp, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland.	teixeiropernase@missouri.edu; ed.palmer@unibas.ch	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Daniels, Mark/0000-0002-5175-9901; Schrum, Adam/0000-0001-9276-1859	Mission Enhancement Program, University of Missouri; Fundacion Ramon Areces, Spain; American Cancer Society; Cancer Research Institute; Spanish Ministry of Science and Education (MEC) [BFU 2005-02807]; Novartis; Roche; Sybilla (EUFP7); Swiss National Science Foundation	Mission Enhancement Program, University of Missouri; Fundacion Ramon Areces, Spain; American Cancer Society(American Cancer Society); Cancer Research Institute; Spanish Ministry of Science and Education (MEC)(Spanish Government); Novartis(Novartis); Roche(Roche Holding); Sybilla (EUFP7)(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank D. Roubaty, B. Hausmann, V. Jaggin, G. E. Fernandez, H. Karauzum, M. Schmaler, and Z. Rajacic for technical assistance; R. Landmann-Suter for technical advice; and C. Pernas Pernas for helpful discussion. This work was supported by Mission Enhancement Program, University of Missouri (E.T. and M.A.D.) fellowships from the Fundacion Ramon Areces, Spain (E.T.), the American Cancer Society (S.E.H.), the Cancer Research Institute (M.A.D.), the Spanish Ministry of Science and Education (MEC) (BFU 2005-02807) (R.B.), Novartis, Roche, Sybilla (EUFP7) and the Swiss National Science Foundation (E.P.).	Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Campbell K S, 1994, Semin Immunol, V6, P393, DOI 10.1006/smim.1994.1049; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hettmann T, 2003, IMMUNOL LETT, V85, P297, DOI 10.1016/S0165-2478(02)00260-2; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kersh EN, 2006, J IMMUNOL, V177, P3821, DOI 10.4049/jimmunol.177.6.3821; Krieg C, 2007, NAT IMMUNOL, V8, P162, DOI 10.1038/ni1418; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Teixeiro E, 1999, EUR J IMMUNOL, V29, P745, DOI 10.1002/(SICI)1521-4141(199903)29:03<745::AID-IMMU745>3.0.CO;2-0; Teixeiro E, 2004, IMMUNITY, V21, P515, DOI 10.1016/j.immuni.2004.08.014; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548	23	150	153	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					502	505		10.1126/science.1163612	http://dx.doi.org/10.1126/science.1163612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164748				2022-12-24	WOS:000262587900042
J	Chakravarti, A				Chakravarti, Aravinda			Kinship: Race relations	NATURE			English	Editorial Material									[Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Geriatr Med, Baltimore, MD 21205 USA	Johns Hopkins University	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Geriatr Med, Broadway Res Bldg,Room 579,733 N Broadway, Baltimore, MD 21205 USA.	aravinda@jhmi.edu							0	16	16	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					380	381		10.1038/457380a	http://dx.doi.org/10.1038/457380a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158772	Bronze			2022-12-24	WOS:000262519200019
J	Palmenberg, AC; Spiro, D; Kuzmickas, R; Wang, S; Djikeng, A; Rathe, JA; Fraser-Liggett, CM; Liggett, SB				Palmenberg, Ann C.; Spiro, David; Kuzmickas, Ryan; Wang, Shiliang; Djikeng, Appolinaire; Rathe, Jennifer A.; Fraser-Liggett, Claire M.; Liggett, Stephen B.			Sequencing and Analyses of All Known Human Rhinovirus Genomes Reveal Structure and Evolution	SCIENCE			English	Article							ASTHMA; RECOMBINATION; INFECTIONS; FEATURES; VIRUSES; TRACT	Infection by human rhinovirus (HRV) is a major cause of upper and lower respiratory tract disease worldwide and displays considerable phenotypic variation. We examined diversity by completing the genome sequences for all known serotypes (n = 99). Superimposition of capsid crystal structure and optimal-energy RNA configurations established alignments and phylogeny. These revealed conserved motifs; clade-specific diversity, including a potential newly identified species (HRV-D); mutations in field isolates; and recombination. In analogy with poliovirus, a hypervariable 5' untranslated region tract may affect virulence. A configuration consistent with nonscanning internal ribosome entry was found in all HRVs and may account for rapid translation. The data density from complete sequences of the reference HRVs provided high resolution for this degree of modeling and serves as a platform for full genome-based epidemiologic studies and antiviral or vaccine development.	[Rathe, Jennifer A.; Liggett, Stephen B.] Univ Maryland, Sch Med, Cardiopulm Genom Program, Baltimore, MD 21201 USA; [Palmenberg, Ann C.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Spiro, David; Kuzmickas, Ryan; Wang, Shiliang; Djikeng, Appolinaire] J Craig Venter Inst, Rockville, MD 20850 USA; [Fraser-Liggett, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University of Wisconsin System; University of Wisconsin Madison; J. Craig Venter Institute; University System of Maryland; University of Maryland Baltimore	Liggett, SB (corresponding author), Univ Maryland, Sch Med, Cardiopulm Genom Program, Baltimore, MD 21201 USA.	sligg001@umaryland.edu	liggett, stephen b/E-7453-2012	Fraser, Claire/0000-0003-1462-2428; Liggett, Stephen B./0000-0002-0128-3669; Djikeng, Appolinaire/0000-0001-9271-3419	University of Maryland School of Medicine; NIH [U19-AI070503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER	University of Maryland School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the University of Maryland School of Medicine internal funds and by NIH grant U19-AI070503. We thank A. Wolf and J.-Y. Sgro for implementation of the tree topology tests. The accession numbers for the hrv strains are FJ445111 to FJ445190 (see table S1).	ANDRIES K, 1990, J VIROL, V64, P1117, DOI 10.1128/JVI.64.3.1117-1123.1990; Barnard DL, 2006, CURR PHARM DESIGN, V12, P1379, DOI 10.2174/138161206776361129; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Dominguez SR, 2008, J CLIN VIROL, V43, P219, DOI 10.1016/j.jcv.2008.06.007; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Fleischer R, 2003, CLIN INFECT DIS, V37, P1722; GWALTNEY JM, 1966, NEW ENGL J MED, V275, P1261, DOI 10.1056/NEJM196612082752301; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; JACKSON RJ, 1996, TRANSLATIONAL CONTRO; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; KNOWLES N, COMMUNICATION; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin LR, 1996, J VIROL, V70, P2027, DOI 10.1128/JVI.70.3.2027-2031.1996; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Palmenberg AC, 1997, SEMIN VIROL, V8, P231, DOI 10.1006/smvy.1997.0126; PALMENBERG AC, 2001, MOL BIOL PICORNAVIRU; Savolainen C, 2002, VIRUS RES, V85, P41, DOI 10.1016/S0168-1702(02)00016-3; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vlasak M, 2005, J VIROL, V79, P7389, DOI 10.1128/JVI.79.12.7389-7395.2005; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262	26	328	348	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					55	59		10.1126/science.1165557	http://dx.doi.org/10.1126/science.1165557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19213880	Green Accepted			2022-12-24	WOS:000264802100029
J	Bokov, K; Steinberg, SV				Bokov, Konstantin; Steinberg, Sergey V.			A hierarchical model for evolution of 23S ribosomal RNA	NATURE			English	Article							PEPTIDYL TRANSFERASE CENTER; ANGSTROM RESOLUTION; BOND FORMATION; SUBUNIT; BASE; SITE; ORIGIN	The emergence of the ribosome constituted a pivotal step in the evolution of life. This event happened nearly four billion years ago, and any traces of early stages of ribosome evolution are generally thought to have completely eroded away. Surprisingly, a detailed analysis of the structure of the modern ribosome reveals a concerted and modular scheme of its early evolution.	[Bokov, Konstantin; Steinberg, Sergey V.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Steinberg, SV (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada.	serguei.chteinberg@umontreal.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank L. Brakier-Gingras, A. Mankin, S. Michnick and I. Ponomarenko for advice and comments. This work was supported by a grant from NSERC.	Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Kavran JM, 2007, J MOL BIOL, V371, P1047, DOI 10.1016/j.jmb.2007.05.091; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Polacek N, 2005, CRIT REV BIOCHEM MOL, V40, P285, DOI 10.1080/10409230500326334; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; STILLMAN B, 2001, RIBOSOME; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375	25	153	159	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					977	980		10.1038/nature07749	http://dx.doi.org/10.1038/nature07749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225518				2022-12-24	WOS:000263425400035
J	Jack, BW; Chetty, VK; Anthony, D; Greenwald, JL; Sanchez, GM; Johnson, AE; Forsythe, SR; O'Donnell, JK; Paasche-Orlow, MK; Manasseh, C; Martin, S; Culpepper, L				Jack, Brian W.; Chetty, Veerappa K.; Anthony, David; Greenwald, Jeffrey L.; Sanchez, Gail M.; Johnson, Anna E.; Forsythe, Shaula R.; O'Donnell, Julie K.; Paasche-Orlow, Michael K.; Manasseh, Christopher; Martin, Stephen; Culpepper, Larry			A Reengineered Hospital Discharge Program to Decrease Rehospitalization A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PATIENTS AFTER-DISCHARGE; ADVERSE EVENTS; HEALTH LITERACY; PATIENT SAFETY; FOLLOW-UP; CARE; INTERVENTION; CONTINUITY; INPATIENT; SEVERITY	Background: Emergency department visits and rehospitalization are common after hospital discharge. Objective: To test the effects of an intervention designed to minimize hospital utilization after discharge. Design: Randomized trial using block randomization of 6 and 8. Randomly arranged index cards were placed in opaque envelopes labeled consecutively with study numbers, and participants were assigned a study group by revealing the index card. Setting: General medical service at an urban, academic, safety-net hospital. Patients: 749 English-speaking hospitalized adults (mean age, 49.9 years). Intervention: A nurse discharge advocate worked with patients during their hospital stay to arrange follow-up appointments, confirm medication reconciliation, and conduct patient education with an individualized instruction booklet that was sent to their primary care provider. A clinical pharmacist called patients 2 to 4 days after discharge to reinforce the discharge plan and review medications. Participants and providers were not blinded to treatment assignment. Measurements: Primary outcomes were emergency department visits and hospitalizations within 30 days of discharge. Secondary outcomes were self-reported preparedness for discharge and frequency of primary care providers' follow-up within 30 days of discharge. Research staff doing follow-up were blinded to study group assignment. Results: Participants in the intervention group (n = 370) had a lower rate of hospital utilization than those receiving usual care (n = 368) (0.314 vs. 0.451 visit per person per month; incidence rate ratio, 0.695 [95% CI, 0.515 to 0.937]; P = 0.009). The intervention was most effective among participants with hospital utilization in the 6 months before index admission (P = 0.014). Adverse events were not assessed; these data were collected but are still being analyzed. Limitation: This was a single-center study in which not all potentially eligible patients could be enrolled, and outcome assessment sometimes relied on participant report. Conclusion: A package of discharge services reduced hospital utilization within 30 days of discharge.	[Jack, Brian W.] Boston Univ, Sch Med, Dept Family Med, Boston Med Ctr, Boston, MA 02118 USA; Brown Univ, Alpert Med Sch, Pawtucket, RI USA	Boston Medical Center; Boston University; Brown University	Jack, BW (corresponding author), Boston Univ, Sch Med, Dept Family Med, Boston Med Ctr, 1 BMC Pl,Dowling 5 S, Boston, MA 02118 USA.	brian.jack@bmc.org	Paasche-Orlow, Michael/ABF-7919-2020; Martin, Stephen A/L-9381-2013	Paasche-Orlow, Michael/0000-0002-9276-7190; Martin, Stephen A/0000-0002-0356-5440; Culpepper, Larry/0000-0002-7655-0477; Manasseh, Christopher/0000-0001-5736-6589; Chetty, Veerappa/0000-0002-2640-3874; Jack, Brian/0000-0002-6497-2437	Agency for Healthcare Research and Quality; National Heart, Lung, and Blood Institute; National Institutes of Health; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS015905, UC1HS014289] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081307] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Agency for Healthcare Research and Quality and National Heart, Lung, and Blood Institute, National Institutes of Health.	Al-Rashed SA, 2002, BRIT J CLIN PHARMACO, V54, P657, DOI 10.1046/j.1365-2125.2002.01707.x; Andersen HE, 2000, STROKE, V31, P1038, DOI 10.1161/01.STR.31.5.1038; Anderson Cheryl, 2005, Congest Heart Fail, V11, P315, DOI 10.1111/j.1527-5299.2005.04458.x; Anthony D., 2005, ADV PATIENT SAFETY R; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Balaban RB, 2008, J GEN INTERN MED, V23, P1228, DOI 10.1007/s11606-008-0618-9; Blue L, 2001, BRIT MED J, V323, P715, DOI 10.1136/bmj.323.7315.715; Bula CJ, 2001, ARCH INTERN MED, V161, P2609, DOI 10.1001/archinte.161.21.2609; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Davis T C, 1993, Fam Med, V25, P391; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; EVANS RL, 1993, MED CARE, V31, P358, DOI 10.1097/00005650-199304000-00007; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Greenwald JL., 2007, J PATIENT SAF, V3, P97, DOI 10.1097/01.jps.0000236916.94696.12; Holland R, 2005, BMJ-BRIT MED J, V330, P293, DOI 10.1136/bmj.38338.674583.AE; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P365, DOI 10.1016/0197-2456(88)90049-9; LEVIT K, 2005, HCUP FACTS FIGURES S; Makaryus AN, 2005, MAYO CLIN PROC, V80, P991, DOI 10.4065/80.8.991; MARQUIS KH, 1976, MED CARE, V14, P913, DOI 10.1097/00005650-197611000-00002; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Moore C, 2007, ARCH INTERN MED, V167, P1305, DOI 10.1001/archinte.167.12.1305; *NAT QUAL FOR, NAT QUAL FOR END CON; National Quality Forum (NQF), 2007, SAF PRACT BETT HEALT; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; Naylor M D, 1993, Image J Nurs Sch, V25, P73; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; PAASCHE O, 2007, MED MANAGEMENT VULNE, P101; Paasche-Orlow MK, 2006, J GEN INTERN MED, V21, P884, DOI 10.1111/j.1525-1497.2006.00544.x; Paasche-Orlow MK, 2005, AM J RESP CRIT CARE, V172, P980, DOI 10.1164/rccm.200409-1291OC; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4; Roberts RO, 1996, J CLIN EPIDEMIOL, V49, P989, DOI 10.1016/0895-4356(96)00143-6; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; Siu AL, 1996, ARCH INTERN MED, V156, P76, DOI 10.1001/archinte.156.1.76; Therneau TM, 2000, MODELING SURVIVAL DA; Tsilimingras D, 2008, JT COMM J QUAL PATIE, V34, P85, DOI 10.1016/S1553-7250(08)34011-2; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x; van Walraven C, 2002, J GEN INTERN MED, V17, P186, DOI 10.1046/j.1525-1497.2002.10741.x; Wachter RM, 2004, NEW ENGL J MED, V350, P1935, DOI 10.1056/NEJMp038201; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206	49	1069	1086	2	129	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2009	150	3					178	+		10.7326/0003-4819-150-3-200902030-00007	http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402RA	19189907	Green Accepted			2022-12-24	WOS:000263029600004
J	Reddy, KC; Andersen, EC; Kruglyak, L; Kim, DH				Reddy, Kirthi C.; Andersen, Erik C.; Kruglyak, Leonid; Kim, Dennis H.			A Polymorphism in npr-1 Is a Behavioral Determinant of Pathogen Susceptibility in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; INNATE IMMUNITY; NEURONS; EXPERIENCE; HOMOLOG; PATHWAY; OXYGEN	The nematode Caenorhabditis elegans responds to pathogenic bacteria with conserved innate immune responses and pathogen avoidance behaviors. We investigated natural variation in C. elegans resistance to pathogen infection. With the use of quantitative genetic analysis, we determined that the pathogen susceptibility difference between the laboratory wild-type strain N2 and the wild isolate CB4856 is caused by a polymorphism in the npr-1 gene, which encodes a homolog of the mammalian neuropeptide Y receptor. We show that the mechanism of NPR-1-mediated pathogen resistance is through oxygen-dependent behavioral avoidance rather than direct regulation of innate immunity. For C. elegans, bacteria represent food but also a potential source of infection. Our data underscore the importance of behavioral responses to oxygen levels in finding an optimal balance between these potentially conflicting cues.	[Andersen, Erik C.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Andersen, Erik C.; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Reddy, Kirthi C.; Kim, Dennis H.] MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; Massachusetts Institute of Technology (MIT)	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu; dhkim@mit.edu		Andersen, Erik/0000-0003-0229-9651	NIH [GM084477, HG004321, GM071508]; Burroughs Wellcome Fund; Jane Coffin Childs Fund for Medical Research; James S. McDonnell Foundation; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084477, P50GM071508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Jane Coffin Childs Fund for Medical Research; James S. McDonnell Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center, C. Bargmann, M. de Bono, and D. Omura for strains; S. Skrovanek for technical assistance; L. Dietrich for facilitating the oxygen assay; E. Alvarez-Saavedra, J. Shapiro, and members of our laboratories for advice; and C. Bargmann for comments on the manuscript. This work was supported by grants from NIH (GM084477 to D. H. K., HG004321 to L. K., and GM071508 to the Lewis-Sigler Institute), the Burroughs Wellcome Fund (to D. H. K.), the Jane Coffin Childs Fund for Medical Research (to K. C. R.), the James S. McDonnell Foundation (to L. K.), and the Howard Hughes Medical Institute (to L. K.).	AVERY L, 1993, GENETICS, V133, P897; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Darby C., 2005, WORMBOOK; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; PUJOL N, 2007, TOLL TOLL LIKE RECEP; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; TRENT C, 1983, GENETICS, V104, P619; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	22	162	178	4	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					382	384		10.1126/science.1166527	http://dx.doi.org/10.1126/science.1166527			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150845	Green Submitted, Green Accepted			2022-12-24	WOS:000262481400039
J	Benton, R; Vannice, KS; Gomez-Diaz, C; Vosshall, LB				Benton, Richard; Vannice, Kirsten S.; Gomez-Diaz, Carolina; Vosshall, Leslie B.			Variant Ionotropic Glutamate Receptors as Chemosensory Receptors in Drosophila	CELL			English	Article							LIGAND-BINDING CORE; OLFACTORY SENSE-ORGANS; CRYSTAL-STRUCTURES; ODORANT RECEPTORS; PRONEURAL GENE; ION CHANNELS; MEMBRANE TOPOLOGY; ANTENNAL LOBE; MECHANISMS; KAINATE	Ionotropic glutamate receptors (iGluRs) mediate neuronal communication at synapses throughout vertebrate and invertebrate nervous systems. We have characterized a family of iGluR-related genes in Drosophila, which we name ionotropic receptors (IRs). These receptors do not belong to the well-described kainate, AMPA, or NMDA classes of iGluRs, and they have divergent ligand-binding domains that lack their characteristic glutamate-interacting residues. IRs are expressed in a combinatorial fashion in sensory neurons that respond to many distinct odors but do not express either insect odorant receptors (ORs) or gustatory receptors (GRs). IR proteins accumulate in sensory dendrites and not at synapses. Misexpression of IRs in different olfactory neurons is sufficient to confer ectopic odor responsiveness. Together, these results lead us to propose that the IRs comprise a novel family of chemosensory receptors. Conservation of IR/iGlu-Rrelated proteins in bacteria, plants, and animals suggests that this receptor family represents an evolutionarily ancient mechanism for sensing both internal and external chemical cues.	[Benton, Richard; Vannice, Kirsten S.; Gomez-Diaz, Carolina; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Vosshall, Leslie B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Benton, Richard] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Lausanne	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie@mail.rockefeller.edu		Vosshall, Leslie/0000-0002-6060-8099; Benton, Richard/0000-0003-4305-8301; Gomez-Diaz, Carolina/0000-0003-2131-6074	European Molecular Biology Organization Long-Term Fellowship; Maclyn McCarty Fellow of the Helen Hay Whitney Foundation; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health [RO1 DC008600]; McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008600] Funding Source: NIH RePORTER	European Molecular Biology Organization Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Maclyn McCarty Fellow of the Helen Hay Whitney Foundation; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Andrew Jarman, Hugo Bellen, the Bloomington Drosophila Stock Center, and the Developmental Studies Hybridoma Bank for Drosophila strains and antibodies, and Raphael Rytz for identifying an additional IR pseudogene. Richard Axel, Kevin Lee, Sophie Martin, Charles Zuker, and members of the Vosshall Lab provided invaluable advice, discussion, and comments on the manuscript. R. B. was supported by a European Molecular Biology Organization Long-Term Fellowship and was the Maclyn McCarty Fellow of the Helen Hay Whitney Foundation. This work was funded in part by a grant to R. Axel and L. B. V. from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative and by grants to L. B. V. from the National Institutes of Health (RO1 DC008600) and the McKnight Endowment Fund for Neuroscience. R. B. designed and carried out all the experiments in the paper, with the exception of the in situ hybridization in Figures 3C-3F, which was carried out by K.S.V.C.G.-D. performed the gene-targeting screen for IR25a and the initial characterization of the IR25a antibodies. L.B.V. and R.B. together conceived and directed the project, interpreted the results, and wrote the paper.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2008, CURR OPIN NEUROBIOL, V18, P357, DOI 10.1016/j.conb.2008.08.012; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chiu J, 1999, MOL BIOL EVOL, V16, P826, DOI 10.1093/oxfordjournals.molbev.a026167; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Dubos C, 2003, PLANT J, V35, P800, DOI 10.1046/j.1365-313X.2003.01849.x; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Jhaveri D, 2000, MECH DEVELOP, V99, P101, DOI 10.1016/S0925-4773(00)00487-1; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lage PIZ, 2003, DEVELOPMENT, V130, P4683, DOI 10.1242/dev.00680; Lam HM, 1998, NATURE, V396, P125, DOI 10.1038/24066; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Naur P, 2007, P NATL ACAD SCI USA, V104, P14116, DOI 10.1073/pnas.0703718104; Qi Z, 2006, PLANT PHYSIOL, V142, P963, DOI 10.1104/pp.106.088989; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Warr CG, 2000, CELL, V102, P145; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	53	823	878	23	213	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					149	162		10.1016/j.cell.2008.12.001	http://dx.doi.org/10.1016/j.cell.2008.12.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135896	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000262318400022
J	Fronzes, R; Schafer, E; Wang, LC; Saibil, HR; Orlova, EV; Waksman, G				Fronzes, Remi; Schafer, Eva; Wang, Luchun; Saibil, Helen R.; Orlova, Elena V.; Waksman, Gabriel			Structure of a Type IV Secretion System Core Complex	SCIENCE			English	Article							AGROBACTERIUM-TUMEFACIENS; PROTEIN SUBASSEMBLIES; ESCHERICHIA-COLI; VIRB9; DNA; BIOGENESIS; MACHINERY; SUBSTRATE; MEMBRANES; COMPONENT	Type IV secretion systems (T4SSs) are important virulence factors used by Gram- negative bacterial pathogens to inject effectors into host cells or to spread plasmids harboring antibiotic resistance genes. We report the 15 angstrom resolution cryo- electron microscopy structure of the core complex of a T4SS. The core complex is composed of three proteins, each present in 14 copies and forming a similar to 1.1- megadalton two-chambered, double membrane- spanning channel. The structure is double- walled, with each component apparently spanning a large part of the channel. The complex is open on the cytoplasmic side and constricted on the extracellular side. Overall, the T4SS core complex structure is different in both architecture and composition from the other known double membrane- spanning secretion system that has been structurally characterized.	[Fronzes, Remi; Schafer, Eva; Wang, Luchun; Saibil, Helen R.; Orlova, Elena V.; Waksman, Gabriel] Univ London Birkbeck Coll, Inst Struct & Mol Biol, Sch Crystallog, London WC1E 7HX, England; [Waksman, Gabriel] UCL, Div Biosci, London WC1E 6BT, England	University of London; Birkbeck University London; University of London; University College London	Waksman, G (corresponding author), Univ London Birkbeck Coll, Inst Struct & Mol Biol, Sch Crystallog, Malet St, London WC1E 7HX, England.	g.waksman@ucl.ac.uk	Fronzes, Rémi/GLS-0406-2022; Fronzes, Remi/T-2578-2019; fronzes, Rémi/A-4311-2009; Orlova, Elena/CAF-8290-2022	Orlova, Elena/0000-0003-3371-415X; Fronzes, Remi/0000-0003-3031-9824	Wellcome Trust; UK Biotechnology and Biological Sciences Research Council; European Union Network of Excellence in Three-Dimensional Electron Microscopy (3DEM); Biotechnology and Biological Sciences Research Council [BB/C516144/1, BB/C516179/1, BB/F010281/1] Funding Source: researchfish; BBSRC [BB/C516179/1, BB/C516144/1, BB/F010281/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union Network of Excellence in Three-Dimensional Electron Microscopy (3DEM)(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by research grants from the Wellcome Trust to G.W. and UK Biotechnology and Biological Sciences Research Council to H.R.S. and by an equipment grant from the Wellcome Trust to H.R.S and E.V.O. Also, H.R.S. and E.V.O. thank the European Union Network of Excellence in Three-Dimensional Electron Microscopy (3DEM) for support. EM maps have been deposited to the EM data bank under the entry codes EMD-5031 to EMD5035 for cryo-EM wild-type, negative-stain EM wild-type, negative-stain EM D1, cryo-EM D2, and negative-stain DL2 complexes, respectively.	Baron C, 1997, J BACTERIOL, V179, P1211, DOI 10.1128/jb.179.4.1211-1218.1997; Bayliss R, 2007, P NATL ACAD SCI USA, V104, P1673, DOI 10.1073/pnas.0609535104; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Das A, 2000, J BACTERIOL, V182, P758, DOI 10.1128/JB.182.3.758-763.2000; Fernandez D, 1996, J BACTERIOL, V178, P3156, DOI 10.1128/jb.178.11.3156-3167.1996; Harris RL, 2001, MOL MICROBIOL, V42, P757, DOI 10.1046/j.1365-2958.2001.02667.x; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Liu ZY, 2003, J BACTERIOL, V185, P3259, DOI 10.1128/JB.185.11.3259-3269.2003; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	17	235	240	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					266	268		10.1126/science.1166101	http://dx.doi.org/10.1126/science.1166101			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131631	Green Accepted			2022-12-24	WOS:000262290600042
J	Wang, XN; Schwarz, TL				Wang, Xinnan; Schwarz, Thomas L.			The Mechanism of Ca2+-Dependent Regulation of Kinesin-Mediated Mitochondrial Motility	CELL			English	Article							FAST AXONAL-TRANSPORT; HEAVY-CHAIN; RHO GTPASES; DROSOPHILA; NEURONS; PROTEIN; SYNAPSES; BINDING; ACTIN; ORGANIZATION	Mitochondria are mobile organelles and cells regulate mitochondrial movement in order to meet the changing energy needs of each cellular region. Ca2+ signaling, which halts both anterograde and retrograde mitochondrial motion, serves as one regulatory input. Anterograde mitochondrial movement is generated by kinesin-1, which interacts with the mitochondrial protein Miro through an adaptor protein, milton. We show that kinesin is present on all axonal mitochondria, including those that are stationary or moving retrograde. We also show that the EF-hand motifs of Miro mediate Ca2+-dependent arrest of mitochondria and elucidate the regulatory mechanism. Rather than dissociating kinesin-1 from mitochondria, Ca2+-binding permits Miro to interact directly with the motor domain of kinesin-1, preventing motor/microtubule interactions. Thus, kinesin-1 switches from an active state in which it is bound to Miro only via milton, to an inactive state in which direct binding to Miro prevents its interaction with microtubules. Disrupting Ca2+-dependent regulation diminishes neuronal resistance to excitotoxicity.	[Schwarz, Thomas L.] Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Schwarz, TL (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu	Wang, Xinnan/B-2393-2013		NIH [RO1GM069808]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069808] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Rappley, Drs. F. Sun, Z. Wills, P. Aspenstrom, K. J. Verhey, A. M. Craig, T. Pawson, G. W. Hart, and F. A. Stephenson for reagents; S. Vasquez, Drs. Z. Wills, M. Greenberg, and Z. He for assistance with hippocampal cultures, Dr. L. Bu and the Developmental Disorders Research Center Imaging Core and E. Pogoda for technical assistance; Dr. Y. Chu for assistance with Matlab script and a Labview macro. This work was supported by NIH RO1GM069808.	Adio S, 2006, J MUSCLE RES CELL M, V27, P153, DOI 10.1007/s10974-005-9054-1; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Beck M, 2002, J BIOL CHEM, V277, P30079, DOI 10.1074/jbc.M200438200; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; BRADY ST, 1984, NATURE, V310, P56, DOI 10.1038/310056a0; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Cox RT, 2006, DEVELOPMENT, V133, P3371, DOI 10.1242/dev.02514; Deavours BE, 1998, CELL MOTIL CYTOSKEL, V40, P408, DOI 10.1002/(SICI)1097-0169(1998)40:4<408::AID-CM8>3.0.CO;2-6; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Hurd DD, 1996, GENETICS, V144, P1075; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; MURREY HE, 2008, CHEM REV IN PRESS; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Overly CC, 1996, J CELL SCI, V109, P971; Petrozzi L, 2007, BIOSCIENCE REP, V27, P87, DOI 10.1007/s10540-007-9038-z; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Smith MJ, 2006, J BIOL CHEM, V281, P27216, DOI 10.1074/jbc.M600522200; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vinogradova MV, 2004, J BIOL CHEM, V279, P23504, DOI 10.1074/jbc.M400741200; Yang ZK, 2000, J PHYSIOL-LONDON, V523, P29, DOI 10.1111/j.1469-7793.2000.00029.x; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038	44	601	615	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					163	174		10.1016/j.cell.2008.11.046	http://dx.doi.org/10.1016/j.cell.2008.11.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135897	Green Accepted, Bronze			2022-12-24	WOS:000262318400023
J	Liu, K; Victora, GD; Schwickert, TA; Guermonprez, P; Meredith, MM; Yao, KH; Chu, FF; Randolph, GJ; Rudensky, AY; Nussenzweig, M				Liu, Kang; Victora, Gabriel D.; Schwickert, Tanja A.; Guermonprez, Pierre; Meredith, Matthew M.; Yao, Kaihui; Chu, Fei-Fan; Randolph, Gwendalyn J.; Rudensky, Alexander Y.; Nussenzweig, Michel			In Vivo Analysis of Dendritic Cell Development and Homeostasis	SCIENCE			English	Article							BONE-MARROW; MONOCYTES; SUBSETS; DIFFERENTIATION; PROGENITORS; PRECURSORS; SUBTYPES; DISTINCT; TISSUE; MOUSE	Dendritic cells (DCs) in lymphoid tissue arise from precursors that also produce monocytes and plasmacytoid DCs (pDCs). Where DC and monocyte lineage commitment occurs and the nature of the DC precursor that migrates from the bone marrow to peripheral lymphoid organs are unknown. We show that DC development progresses from the macrophage and DC precursor to common DC precursors that give rise to pDCs and classical spleen DCs (cDCs), but not monocytes, and finally to committed precursors of cDCs (pre-cDCs). Pre-cDCs enter lymph nodes through and migrate along high endothelial venules and later disperse and integrate into the DC network. Further cDC development involves cell division, which is controlled in part by regulatory T cells and fms-like tyrosine kinase receptor-3.	[Liu, Kang; Victora, Gabriel D.; Schwickert, Tanja A.; Guermonprez, Pierre; Meredith, Matthew M.; Yao, Kaihui; Chu, Fei-Fan; Nussenzweig, Michel] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Randolph, Gwendalyn J.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Rudensky, Alexander Y.; Nussenzweig, Michel] Rockefeller Univ, HHMI, New York, NY 10021 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Rockefeller University	Liu, K (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	liuk@rockefeller.edu; nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Guermonprez, Pierre/ABE-7718-2020; Victora, Gabriel/C-5946-2011	Guermonprez, Pierre/0000-0001-5621-2262; Victora, Gabriel/0000-0001-8807-348X; Schwickert, Tanja/0000-0002-3371-2376	Rockefeller University; Schering Foundation; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051573] Funding Source: NIH RePORTER	Rockefeller University; Schering Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank S. Bhuvanendran for two-photon microscopy, K. Velinzon and T. Shengelia for cell sorting, and R. Steinman and A. Silva for discussions and critical reading of the manuscript. K.L. was supported by a C. H. Li Memorial Scholarship Award from the Rockefeller University. T.A.S. was supported by the Schering Foundation. This work was supported in part by grants from the NIH to M.C.N. M.C.N. is an HHMI investigator.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; DIPUCCHIO D, 2008, SCIENCE, V9, P551; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Tussiwand R, 2005, J IMMUNOL, V175, P3674, DOI 10.4049/jimmunol.175.6.3674; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615	25	961	979	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 17	2009	324	5925					392	397		10.1126/science.1170540	http://dx.doi.org/10.1126/science.1170540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19286519	Green Accepted			2022-12-24	WOS:000265221600044
J	Crisp, MD; Arroyo, MTK; Cook, LG; Gandolfo, MA; Jordan, GJ; McGlone, MS; Weston, PH; Westoby, M; Wilf, P; Linder, HP				Crisp, Michael D.; Arroyo, Mary T. K.; Cook, Lyn G.; Gandolfo, Maria A.; Jordan, Gregory J.; McGlone, Matt S.; Weston, Peter H.; Westoby, Mark; Wilf, Peter; Linder, H. Peter			Phylogenetic biome conservatism on a global scale	NATURE			English	Article							GENUS OREOMYRRHIS APIACEAE; LONG-DISTANCE DISPERSAL; MOLECULAR PHYLOGENY; NEW-ZEALAND; NICHE CONSERVATISM; SEQUENCE DATA; SENSU-LATO; EVOLUTION; BIOGEOGRAPHY; CHLOROPLAST	How and why organisms are distributed as they are has long intrigued evolutionary biologists(1-4). The tendency for species to retain their ancestral ecology has been demonstrated in distributions on local and regional scales(5-7), but the extent of ecological conservatism over tens of millions of years and across continents has not been assessed(8-13). Here we show that biome stasis at speciation has outweighed biome shifts by a ratio of more than 25:1, by inferring ancestral biomes for an ecologically diverse sample of more than 11,000 plant species from around the Southern Hemisphere. Stasis was also prevalent in transocean colonizations. Availability of a suitable biome could have substantially influenced which lineages establish on more than one landmass, in addition to the influence of the rarity of the dispersal events themselves. Conversely, the taxonomic composition of biomes has probably been strongly influenced by the rarity of species' transitions between biomes. This study has implications for the future because if clades have inherently limited capacity to shift biomes(13), then their evolutionary potential could be strongly compromised by biome contraction as climate changes.	[Crisp, Michael D.] Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; [Arroyo, Mary T. K.] Univ Chile, Inst Ecol & Biodivers, Santiago, Chile; [Cook, Lyn G.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; [Gandolfo, Maria A.] Cornell Univ, Dept Plant Biol, LH Bailey Hortorium, Ithaca, NY 14853 USA; [Jordan, Gregory J.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia; [McGlone, Matt S.] Landcare Res, Lincoln 7640, New Zealand; [Weston, Peter H.] Natl Herbarium New S Wales, Sydney, NSW 2000, Australia; [Westoby, Mark] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Linder, H. Peter] Univ Zurich, Inst Systemat Biol, CH-8008 Zurich, Switzerland	Australian National University; Universidad de Chile; University of Queensland; Cornell University; University of Tasmania; Landcare Research - New Zealand; Macquarie University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Zurich	Crisp, MD (corresponding author), Australian Natl Univ, Sch Bot & Zool, GPO Box 4, Canberra, ACT 0200, Australia.	mike.crisp@anu.edu.au	Crisp, Michael D/A-4888-2008; Linder, Hans Peter/F-5316-2010; Cook, Lyn/G-7336-2012; Jordan, Gregory/B-3932-2013	Crisp, Michael D/0000-0002-8255-6349; Cook, Lyn/0000-0002-3172-4920; Jordan, Gregory/0000-0002-6033-2766; Wilf, Peter/0000-0001-6813-1937; Westoby, Mark/0000-0001-7690-4530; Weston, Peter/0000-0001-8920-5376	Australian Research Council-New Zealand Research Network for Vegetation Function; US National Science Foundation	Australian Research Council-New Zealand Research Network for Vegetation Function(Australian Research Council); US National Science Foundation(National Science Foundation (NSF))	We thank the Australian Research Council-New Zealand Research Network for Vegetation Function for facilitating this collaboration. Participation by M. A. G. and P. W. was supported in part by a grant from the US National Science Foundation.	Aagesen L, 2005, PLANT SYST EVOL, V250, P197, DOI 10.1007/s00606-004-0204-5; Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; Barker NP, 2007, PLANT SYST EVOL, V264, P135, DOI 10.1007/s00606-006-0479-9; Barker NP, 2007, J BIOGEOGR, V34, P2012, DOI 10.1111/j.1365-2699.2007.01749.x; Barnes RW, 2001, AUST J BOT, V49, P301, DOI 10.1071/BT00036; Barreda V, 2007, BOT REV, V73, P31, DOI 10.1663/0006-8101(2007)73[31:PVTDTP]2.0.CO;2; Berry PE, 2004, AM J BOT, V91, P601, DOI 10.3732/ajb.91.4.601; Bogler DJ, 2004, BOT REV, V70, P260, DOI 10.1663/0006-8101(2004)070[0260:MSSICE]2.0.CO;2; Bradford JC, 2002, ANN MO BOT GARD, V89, P491, DOI 10.2307/3298592; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Briggs BG, 2000, MONOCOTS SYSTEMATICS, P661; Burgoyne PM, 2005, J AFR EARTH SCI, V43, P13, DOI 10.1016/j.jafrearsci.2005.07.015; Bytebier B, 2007, MOL PHYLOGENET EVOL, V43, P75, DOI 10.1016/j.ympev.2006.08.014; Case AL, 2008, INT J PLANT SCI, V169, P141, DOI 10.1086/523368; Chandler GT, 2007, AUST SYST BOT, V20, P390, DOI 10.1071/SB07004; Chung KF, 2005, AM J BOT, V92, P2054, DOI 10.3732/ajb.92.12.2054; Chung KF, 2007, SYST BOT, V32, P671, DOI 10.1600/036364407782250517; Clements Mark A., 2002, Lindleyana, V17, P135; Cook LG, 2005, P ROY SOC B-BIOL SCI, V272, P2535, DOI 10.1098/rspb.2005.3219; Cook LG, 2005, J BIOGEOGR, V32, P741, DOI 10.1111/j.1365-2699.2005.01261.x; Crayn DM, 2006, AM J BOT, V93, P1328, DOI 10.3732/ajb.93.9.1328; Crayn DM, 1998, AUST J BOT, V46, P187, DOI 10.1071/BT97019; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp MD, 2007, MOL PHYLOGENET EVOL, V43, P1106, DOI 10.1016/j.ympev.2007.02.030; Crisp M, 2006, J BIOGEOGR, V33, P1332, DOI 10.1111/j.1365-2699.2006.01551.x; DARWIN CR, 1855, GARDENERS CHRONICLE, V21, P356; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Ford KA, 2007, TAXON, V56, P783, DOI 10.2307/25065861; Gadek PA, 2000, AM J BOT, V87, P1044, DOI 10.2307/2657004; Goldblatt P, 2004, BOT J LINN SOC, V144, P41, DOI 10.1111/j.0024-4074.2004.00246.x; Goldblatt Peter, 2006, Aliso, V22, P399; Hallam A., 1994, OUTLINE PHANEROZOIC; Heenan PB, 1998, NEW ZEAL J BOT, V36, P53; Hershkovitz MA, 2006, PLANT SYST EVOL, V260, P1, DOI 10.1007/s00606-006-0428-7; Hershkovitz MA, 2006, MOL PHYLOGENET EVOL, V41, P594, DOI 10.1016/j.ympev.2006.05.003; Hill K.D., 1998, FLORA AUSTR, V48, P717; Hill KD, 2003, INT J PLANT SCI, V164, P933, DOI 10.1086/378538; Hill RS, 2004, PHILOS T R SOC B, V359, P1537, DOI 10.1098/rstb.2004.1526; Hopper SD, 1999, BOT J LINN SOC, V131, P285, DOI 10.1111/j.1095-8339.1999.tb00770.x; Howarth DG, 2003, AM J BOT, V90, P915, DOI 10.3732/ajb.90.6.915; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; Irwin H. S., 1982, The American Cassiinae: a synoptical revision of Leguminosae tribe Cassieae subtribe Cassiinae in the New World.; Jones D.L., 2002, AUSTR ORCHID REV, V4, P125; Jones DL., 2002, AUSTR ORCHID REV, V67, P3; Kadereit G, 2005, ORG DIVERS EVOL, V5, P59, DOI 10.1016/j.ode.2004.07.002; Kadereit G, 2006, TAXON, V55, P617, DOI 10.2307/25065639; Klak C, 2004, NATURE, V427, P63, DOI 10.1038/nature02243; Klak C, 2003, AM J BOT, V90, P1433, DOI 10.3732/ajb.90.10.1433; Knapp M, 2005, PLOS BIOL, V3, P38, DOI 10.1371/journal.pbio.0030014; Knapp M, 2007, SYST BIOL, V56, P862, DOI 10.1080/10635150701636412; Kores PJ, 2001, AM J BOT, V88, P1903, DOI 10.2307/3558366; Kron KA, 1999, PLANT SYST EVOL, V218, P55, DOI 10.1007/BF01087034; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Linder HP, 2005, NOVA ACT LC, V92, P29; Linder HP, 1995, CLADISTICS, V11, P5, DOI 10.1111/j.1096-0031.1995.tb00002.x; LINDER HP, 2000, GRASS SYSTEMATIC EVO, V2; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Manos PS, 1997, AM J BOT, V84, P1137, DOI 10.2307/2446156; Marazzi B, 2006, AM J BOT, V93, P288, DOI 10.3732/ajb.93.2.288; Mast AR, 2008, AM J BOT, V95, P843, DOI 10.3732/ajb.0700006; Mckenzie RJ, 2006, AM J BOT, V93, P1222, DOI 10.3732/ajb.93.8.1222; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Meudt HM, 2006, BIOL J LINN SOC, V87, P479, DOI 10.1111/j.1095-8312.2006.00584.x; Mitchell AD, 2000, NEW ZEAL J BOT, V38, P409; Orians GH, 2007, BIOL REV, V82, P393, DOI 10.1111/j.1469-185X.2007.00017.x; ORNLAND KE, 2008, BIOESSAYS, V30, P854; Orthia LA, 2005, AUST SYST BOT, V18, P133, DOI 10.1071/SB04028; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Perez F, 2006, AM J BOT, V93, P1029, DOI 10.3732/ajb.93.7.1029; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Plunkett GM, 2005, ANN MO BOT GARD, V92, P202; Plunkett GM, 2004, INT J PLANT SCI, V165, P861, DOI 10.1086/421855; Poole I, 1999, REV PALAEOBOT PALYNO, V107, P97, DOI 10.1016/S0034-6667(99)00013-5; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Pye MG, 2003, AUST SYST BOT, V16, P505, DOI 10.1071/SB02019; Qian H, 2004, J ECOL, V92, P253, DOI 10.1111/j.0022-0477.2004.00868.x; Quinn CJ, 2005, AUST SYST BOT, V18, P439, DOI 10.1071/SB05005; Quinn CJ, 2003, AUST SYST BOT, V16, P581, DOI 10.1071/SB03012; RAVEN PH, 1974, ANN MO BOT GARD, V61, P539, DOI 10.2307/2395021; Reeves G, 2001, AM J BOT, V88, P2074, DOI 10.2307/3558433; Renner SS, 2000, SYST BIOL, V49, P579, DOI 10.1080/10635159950127402; Richardson JE, 2000, AM J BOT, V87, P1309, DOI 10.2307/2656724; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Rivadavia F, 2003, AM J BOT, V90, P123, DOI 10.3732/ajb.90.1.123; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sauquet H, 2009, P NATL ACAD SCI USA, V106, P221, DOI 10.1073/pnas.0805607106; Schonenberger J, 2003, AM J BOT, V90, P293, DOI 10.3732/ajb.90.2.293; Schuettpelz E, 2004, AM J BOT, V91, P247, DOI 10.3732/ajb.91.2.247; Setoguchi H, 1998, AM J BOT, V85, P1507, DOI 10.2307/2446478; Silvertown J, 2006, P ROY SOC B-BIOL SCI, V273, P39, DOI 10.1098/rspb.2005.3288; SIMPSON MG, 1990, ANN MO BOT GARD, V77, P722, DOI 10.2307/2399670; Smissen RD, 2003, AUST SYST BOT, V16, P301, DOI 10.1071/SB01032; Smissen RD, 2002, BOT J LINN SOC, V140, P15, DOI 10.1046/j.1095-8339.2002.00081.x; Steane DA, 2003, MOL PHYLOGENET EVOL, V28, P47, DOI 10.1016/S1055-7903(03)00028-9; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Stockey RA., 2005, MONOGRAPH CUPRESSACE, P54; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Svenning JC, 2003, ECOL LETT, V6, P646, DOI 10.1046/j.1461-0248.2003.00477.x; Sweeney PW, 2004, ANN MO BOT GARD, V91, P266; SWENSON U, 1995, PLANT SYST EVOL, V197, P149, DOI 10.1007/BF00984638; Thompson Joy, 1993, Telopea, V5, P427; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Treutlein J, 2005, PLANT BIOLOGY, V7, P79, DOI 10.1055/s-2004-830478; Verboom GA, 2003, EVOLUTION, V57, P1008, DOI 10.1111/j.0014-3820.2003.tb00312.x; Vinnersten A, 2003, AM J BOT, V90, P1455, DOI 10.3732/ajb.90.10.1455; Wagstaff SJ, 2006, TAXON, V55, P95, DOI 10.2307/25065531; Wagstaff SJ, 1999, AM J BOT, V86, P1346, DOI 10.2307/2656781; Wagstaff SJ, 2000, SYST BOT, V25, P134, DOI 10.2307/2666679; Weston Peter H., 2006, Telopea, V11, P314; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wilson P.G., 1984, FLORA AUSTR, V4, P81; Wilson PG, 2005, PLANT SYST EVOL, V251, P3, DOI 10.1007/s00606-004-0162-y; Winkworth RC, 2002, MOL PHYLOGENET EVOL, V24, P180, DOI 10.1016/S1055-7903(02)00210-5; Wojciechowski MF, 2005, BRITTONIA, V57, P382, DOI 10.1663/0007-196X(2005)057[0382:AFAMPP]2.0.CO;2; Won H, 2006, SYST BIOL, V55, P610, DOI 10.1080/10635150600812619; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525; Yesson C, 2006, SYST BIOL, V55, P785, DOI 10.1080/1063515060081570; Yokoyama J, 2000, MOL PHYLOGENET EVOL, V14, P11, DOI 10.1006/mpev.1999.0672	127	496	505	5	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					754	U90		10.1038/nature07764	http://dx.doi.org/10.1038/nature07764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19219025				2022-12-24	WOS:000265193600039
J	Hornung, V; Ablasser, A; Charrel-Dennis, M; Bauernfeind, F; Horvath, G; Caffrey, DR; Latz, E; Fitzgerald, KA				Hornung, Veit; Ablasser, Andrea; Charrel-Dennis, Marie; Bauernfeind, Franz; Horvath, Gabor; Caffrey, Daniel. R.; Latz, Eicke; Fitzgerald, Katherine A.			AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC	NATURE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; CONTAINING APAF1-LIKE PROTEIN; REGULATES ACTIVATION; INDUCIBLE GENES; HIN-200 FAMILY; DNA; CASPASE-1; EXPRESSION; INFECTION	The innate immune system senses nucleic acids by germline-encoded pattern recognition receptors. RNA is sensed by Toll-like receptor members TLR3, TLR7 and TLR8, or by the RNA helicases RIG-I (also known as DDX58) and MDA-5 (IFIH1)(1). Little is known about sensors for cytoplasmic DNA that trigger antiviral and/or inflammatory responses(2-6). The best characterized of these responses involves activation of the TANK-binding kinase (TBK1)-interferon regulatory factor 3 (IRF3) signalling axis to trigger transcriptional induction of type I interferon genes(2,3). A second, less well-defined pathway leads to the activation of an 'inflammasome' that, via caspase-1, controls the catalytic cleavage of the pro-forms of the cytokines IL1 beta and IL18 (refs 6, 7). Using mouse and human cells, here we identify the PYHIN (pyrin and HIN domain-containing protein)(8) family member absent in melanoma 2 (AIM2) as a receptor for cytosolic DNA, which regulates caspase-1. The HIN200 domain of AIM2 binds to DNA, whereas the pyrin domain (but not that of the other PYHIN family members) associates with the adaptor molecule ASC (apoptosis-associated speck-like protein containing a caspase activation and recruitment domain) to activate both NF-kappa B and caspase-1. Knockdown of Aim2 abrogates caspase-1 activation in response to cytoplasmic double-stranded DNA and the double-stranded DNA vaccinia virus. Collectively, these observations identify AIM2 as a new receptor for cytoplasmic DNA, which forms an inflammasome with the ligand and ASC to activate caspase-1.	[Hornung, Veit; Ablasser, Andrea; Charrel-Dennis, Marie; Bauernfeind, Franz; Horvath, Gabor; Latz, Eicke; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Caffrey, Daniel. R.] Pfizer, Cambridge, MA 02139 USA; [Hornung, Veit; Ablasser, Andrea; Bauernfeind, Franz] Univ Klinikum Bonn, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany	University of Massachusetts System; University of Massachusetts Worcester; Pfizer; University of Bonn	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	veit.hornung@uni-bonn.de; kate.fitzgerald@umassmed.edu	Hornung, Veit/C-3565-2012; Bauernfeind, Franz-Georg/ABF-1148-2020; Latz, Eicke/H-3951-2014; Fitzgerald, Katherine/ABE-6317-2020; Horvath, Gabor L/J-3917-2014	Hornung, Veit/0000-0002-4150-194X; Latz, Eicke/0000-0003-1488-5666; Horvath, Gabor L/0000-0003-0309-595X; Fitzgerald, Kate/0000-0003-3175-609X	Deutsche Forschungsgemeinschaft [Ho2783/2-1]; National Institutes of Health [AI-065483, AI-067497]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067497, R37AI067497, R01AI067497, R01AI065483] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank A. Cerny for animal husbandry and genotyping and R. Johnstone for the anti-AIM2 antibody. V. H. is supported by a fellowship from the Deutsche Forschungsgemeinschaft (German Research Foundation; Ho2783/2-1), E. L. and K. A. F. are supported by grants from the National Institutes of Health (AI-065483 (to E. L.) and AI-067497 (to K. A. F.)).	Albrecht M, 2005, BIOCHEM BIOPH RES CO, V327, P679, DOI 10.1016/j.bbrc.2004.12.056; BURRUS GR, 1992, J CELL BIOCHEM, V48, P190, DOI 10.1002/jcb.240480210; Caffrey DR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-381; Cresswell KS, 2005, BIOCHEM BIOPH RES CO, V326, P417, DOI 10.1016/j.bbrc.2004.11.048; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Ding Y, 2004, ONCOGENE, V23, P4556, DOI 10.1038/sj.onc.1207592; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn R., 2003, CURR PROTOC BIOINFOR; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Landolfo S, 1998, BIOCHIMIE, V80, P721, DOI 10.1016/S0300-9084(99)80025-X; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; SCHACHMAN HK, 1960, J BIOL CHEM, V235, P3242; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun KH, 2000, IMMUNOLOGY, V99, P352, DOI 10.1046/j.1365-2567.2000.00970.x; Szentesi G, 2004, COMPUT METH PROG BIO, V75, P201, DOI 10.1016/j.cmpb.2004.02.004; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; TRAPANI JA, 1992, IMMUNOGENETICS, V36, P369; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	29	1685	1765	3	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					514	U6		10.1038/nature07725	http://dx.doi.org/10.1038/nature07725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19158675	Green Accepted, Green Submitted			2022-12-24	WOS:000264532400046
J	Han, JH; Kushner, SA; Yiu, AP; Hsiang, HL; Buch, T; Waisman, A; Bontempi, B; Neve, RL; Frankland, PW; Josselyn, SA				Han, Jin-Hee; Kushner, Steven A.; Yiu, Adelaide P.; Hsiang, Hwa-Lin (Liz); Buch, Thorsten; Waisman, Ari; Bontempi, Bruno; Neve, Rachael L.; Frankland, Paul W.; Josselyn, Sheena A.			Selective Erasure of a Fear Memory	SCIENCE			English	Article							BINDING PROTEIN OVEREXPRESSION; DIPHTHERIA-TOXIN; CONDITIONED FEAR; AMYGDALA; EXPRESSION; RECONSOLIDATION; HIPPOCAMPUS; RETRIEVAL; CIRCUITS; NEURONS	Memories are thought to be encoded by sparsely distributed groups of neurons. However, identifying the precise neurons supporting a given memory (the memory trace) has been a long-standing challenge. We have shown previously that lateral amygdala (LA) neurons with increased cyclic adenosine monophosphate response element-binding protein (CREB) are preferentially activated by fear memory expression, which suggests that they are selectively recruited into the memory trace. We used an inducible diphtheria-toxin strategy to specifically ablate these neurons. Selectively deleting neurons overexpressing CREB (but not a similar portion of random LA neurons) after learning blocked expression of that fear memory. The resulting memory loss was robust and persistent, which suggests that the memory was permanently erased. These results establish a causal link between a specific neuronal subpopulation and memory expression, thereby identifying critical neurons within the memory trace.	[Han, Jin-Hee; Kushner, Steven A.; Yiu, Adelaide P.; Hsiang, Hwa-Lin (Liz); Frankland, Paul W.; Josselyn, Sheena A.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Han, Jin-Hee; Yiu, Adelaide P.; Hsiang, Hwa-Lin (Liz); Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada; [Han, Jin-Hee; Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; [Kushner, Steven A.] Erasmus Univ, Med Ctr, Dept Psychiat, NL-3015 CE Rotterdam, Netherlands; [Buch, Thorsten] Univ Zurich, Dept Pathol, CH-8057 Zurich, Switzerland; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin 1, D-55131 Mainz, Germany; [Bontempi, Bruno] CNRS, UMR 5228, Ctr Neurosci Integrat & Cognit, F-33405 Talence, France; [Bontempi, Bruno] Univ Bordeaux 1, F-33405 Talence, France; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Erasmus University Rotterdam; Erasmus MC; University of Zurich; Johannes Gutenberg University of Mainz; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Massachusetts Institute of Technology (MIT)	Josselyn, SA (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sheena.josselyn@sickkids.ca	Buch, Thorsten/P-1659-2019; Han, Jin-Hee/C-2069-2011; Waisman, Ari/C-7383-2015	Buch, Thorsten/0000-0002-2236-9074; Waisman, Ari/0000-0003-4304-8234; Han, Jin-Hee/0000-0002-2139-5596; Kushner, Steven/0000-0002-9777-3338	Canadian Institutes of Health Research [MOP74650, MOP77561]; EJLB Foundation; National Alliance for Research on Schizophrenia and Depression [fellowship]; France-Canada Research Foundation [travel fellowship]; Agence Nationale de la Recherche (France) [06-NEURO-027-03]; Hospital for Sick Children [Restracomp Fellowships]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EJLB Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); France-Canada Research Foundation; Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Hospital for Sick Children(University of Toronto)	We thank T. Pekar, J. Park, and J. Guo for technical assistance. Supported by Canadian Institutes of Health Research (MOP74650, MOP77561) and EJLB Foundation grants to S.A.J. and P.W.F., National Alliance for Research on Schizophrenia and Depression fellowship to J.H.H., travel fellowship (France-Canada Research Foundation), Agence Nationale de la Recherche (France) grant (06-NEURO-027-03) to B.B., and Restracomp Fellowships from the Hospital for Sick Children to A.P.Y. and J.H.H.	BERGER TW, 1983, J NEUROPHYSIOL, V50, P1197, DOI 10.1152/jn.1983.50.5.1197; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; DORLAND RB, 1979, J BIOL CHEM, V254, P1337; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Han JH, 2008, LEARN MEMORY, V15, P443, DOI 10.1101/lm.993608; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Jasnow AM, 2005, BEHAV NEUROSCI, V119, P1125, DOI 10.1037/0735-7044.119.4.1125; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levine ES, 1997, ANN NY ACAD SCI, V835, P12, DOI 10.1111/j.1749-6632.1997.tb48614.x; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; NAGLICH JG, 1990, P NATL ACAD SCI USA, V87, P7250, DOI 10.1073/pnas.87.18.7250; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Roediger H.L., 2007, SCI MEMORY CONCEPTS, DOI [10.1093/acprof:oso/9780195310443.001.0001, DOI 10.1093/ACPROF:OSO/9780195310443.001.0001]; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Wallace TL, 2004, BIOL PSYCHIAT, V56, P151, DOI 10.1016/j.biopsych.2004.04.010	26	370	377	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1492	1496		10.1126/science.1164139	http://dx.doi.org/10.1126/science.1164139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286560				2022-12-24	WOS:000264101700045
J	Maher, CA; Kumar-Sinha, C; Cao, XH; Kalyana-Sundaram, S; Han, B; Jing, XJ; Sam, L; Barrette, T; Palanisamy, N; Chinnaiyan, AM				Maher, Christopher A.; Kumar-Sinha, Chandan; Cao, Xuhong; Kalyana-Sundaram, Shanker; Han, Bo; Jing, Xiaojun; Sam, Lee; Barrette, Terrence; Palanisamy, Nallasivam; Chinnaiyan, Arul M.			Transcriptome sequencing to detect gene fusions in cancer	NATURE			English	Article							SOMATIC MUTATIONS; HUMAN BREAST; LUNG-CANCER; IDENTIFICATION; ABERRATIONS; INHIBITOR; PATTERNS; EFFICACY; IMATINIB; PROTEIN	Recurrent gene fusions, typically associated with haematological malignancies and rare bone and soft-tissue tumours(1), have recently been described in common solid tumours(2-9). Here we use an integrative analysis of high-throughput long- and short-read transcriptome sequencing of cancer cells to discover novel gene fusions. As a proof of concept, we successfully used integrative transcriptome sequencing to 're-discover' the BCR-ABL1 (ref. 10) gene fusion in a chronic myelogenous leukaemia cell line and the TMPRSS2-ERG(2,3) gene fusion in a prostate cancer cell line and tissues. Additionally, we nominated, and experimentally validated, novel gene fusions resulting in chimaeric transcripts in cancer cell lines and tumours. Taken together, this study establishes a robust pipeline for the discovery of novel gene chimaeras using high-throughput sequencing, opening up an important class of cancer-related mutations for comprehensive characterization.	[Maher, Christopher A.; Kumar-Sinha, Chandan; Cao, Xuhong; Kalyana-Sundaram, Shanker; Han, Bo; Jing, Xiaojun; Sam, Lee; Barrette, Terrence; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Maher, Christopher A.; Kumar-Sinha, Chandan; Kalyana-Sundaram, Shanker; Han, Bo; Jing, Xiaojun; Sam, Lee; Barrette, Terrence; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Palanisamy, Nallasivam/ABC-8844-2020; Kalyana-Sundaram, Shanker/F-6860-2012	Palanisamy, Nallasivam/0000-0002-0633-9772; Kumar, Chandan/0000-0002-8696-3400; Kalyana-Sundaram, Shanker/0000-0002-7309-3848	National Institutes of Health; Department of Defense; Early Detection Research Network; NCIBI [U54 DA 021519]; American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research; Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [U01CA111275, R01CA132874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Early Detection Research Network; NCIBI; American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research(Amgen); Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Illumina and 454 for technical support, R. Mehra and J. Siddiqui for providing tissue samples, Y. Gong, S. Shankar, X. Wang and A. Menon for technical assistance, J. Yu for help with the Illumina Genome Analyzer, and R. J. Lonigro for discussions. C. A. M. was supported by a National Institutes of Health Ruth L. Kirschstein post-doctoral training grant, and currently derives support from the American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research, the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship. This work was supported in part by the National Institutes of Health ( to A. M. C.), the Department of Defense ( to A. M. C.), the Early Detection Research Network ( to A. M. C.), and NCIBI (grant number U54 DA 021519).	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Barber TD, 2004, NEW ENGL J MED, V351, P2883, DOI 10.1056/NEJM200412303512724; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Communi D, 2001, J BIOL CHEM, V276, P16561, DOI 10.1074/jbc.M009609200; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gleave M, 2006, PROSTATE, V66, P1674, DOI 10.1002/pros.20499; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han B, 2008, CANCER RES, V68, P7629, DOI 10.1158/0008-5472.CAN-08-2014; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Korenchuk S, 2001, IN VIVO, V15, P163; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Strausberg RL, 2000, TRENDS GENET, V16, P103, DOI 10.1016/S0168-9525(99)01937-X; Takahara T, 2005, MOL CELL, V18, P245, DOI 10.1016/j.molcel.2005.03.018; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	33	623	688	5	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					97	U9		10.1038/nature07638	http://dx.doi.org/10.1038/nature07638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19136943	Green Accepted			2022-12-24	WOS:000263836000040
J	Bezier, A; Annaheim, M; Herbiniere, J; Wetterwald, C; Gyapay, G; Bernard-Samain, S; Wincker, P; Roditi, I; Heller, M; Belghazi, M; Pfister-Wilhem, R; Periquet, G; Dupuy, C; Huguet, E; Volkoff, AN; Lanzrein, B; Drezen, JM				Bezier, Annie; Annaheim, Marc; Herbiniere, Juline; Wetterwald, Christoph; Gyapay, Gabor; Bernard-Samain, Sylvie; Wincker, Patrick; Roditi, Isabel; Heller, Manfred; Belghazi, Maya; Pfister-Wilhem, Rita; Periquet, Georges; Dupuy, Catherine; Huguet, Elisabeth; Volkoff, Anne-Nathalie; Lanzrein, Beatrice; Drezen, Jean-Michel			Polydnaviruses of Braconid Wasps Derive from an Ancestral Nudivirus	SCIENCE			English	Article							GENOME SEQUENCE; CHELONUS-INANITUS; VIRUS; DNA; EVOLUTION; REPLICATION; GENES; SYMBIOSIS; INSIGHTS; REVEALS	Many species of parasitoid wasps inject polydnavirus particles in order to manipulate host defenses and development. Because the DNA packaged in these particles encodes almost no viral structural proteins, their relation to viruses has been debated. Characterization of complementary DNAs derived from braconid wasp ovaries identified genes encoding subunits of a viral RNA polymerase and structural components of polydnavirus particles related most closely to those of nudiviruses- a sister group of baculoviruses. The conservation of this viral machinery in different braconid wasp lineages sharing polydnaviruses suggests that parasitoid wasps incorporated a nudivirus- related genome into their own genetic material. We found that the nudiviral genes themselves are no longer packaged but are actively transcribed and produce particles used to deliver genes essential for successful parasitism in lepidopteran hosts.	[Bezier, Annie; Herbiniere, Juline; Periquet, Georges; Dupuy, Catherine; Huguet, Elisabeth; Drezen, Jean-Michel] Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 6035, F-37200 Tours, France; [Annaheim, Marc; Wetterwald, Christoph; Roditi, Isabel; Pfister-Wilhem, Rita; Lanzrein, Beatrice] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Heller, Manfred] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Gyapay, Gabor; Bernard-Samain, Sylvie; Wincker, Patrick] Genoscope Ctr Natl Sequencage, CEA, F-91057 Evry, France; [Belghazi, Maya] Ctr Anal Proteom Marseille, Inst Federatif Rech J Roche IFR11, INSERM, Fac Med, F-13916 Marseille 20, France; [Volkoff, Anne-Nathalie] Univ Montpellier 2, INRA, UMR 1231, F-34095 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; University of Bern; University of Bern; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Universite de Montpellier	Drezen, JM (corresponding author), Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 6035, Parc Grandmont, F-37200 Tours, France.	drezen@univ-tours.fr	BEZIER, Annie/B-4429-2016; Dupuy, Catherine/AFK-5583-2022; Huguet, Elisabeth/D-3321-2009	BEZIER, Annie/0000-0002-2528-4260; Dupuy, Catherine/0000-0002-3947-3580; Huguet, Elisabeth/0000-0002-0096-0330; Heller, Manfred/0000-0002-6364-7325; Roditi, Isabel/0000-0003-2812-6513; Drezen, Jean-Michel/0000-0001-7578-635X	Agence Nationale de la Recherche (France); CNRS [GDR 2153, GDR 2157, IFR 136]; Swiss National Science Foundation [3100A0-103964, 3100A0-116067]	Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Investigations of C. congregata and H. didymator were performed as part of the project EVPARASITOID supported by the agencies Agence Nationale de la Recherche ( France) and CNRS (GDR 2153, GDR 2157, and IFR 136). C. inanitus study was supported by the Swiss National Science Foundation ( grants 3100A0- 103964 and 116067 to B. L.). We thank E. Herniou for helpful discussions and C. Menoret and C. Labrousse for insect- rearing. Sequences have been deposited in the EMBL Nucleotide Sequence Database, accession numbers FM201559- 80, FM201582- 97, and FM877774 for the viral cDNAs and FM212911- 15 for the chromosomally integrated form of nudivirus- related genes.	Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Annaheim M, 2007, J GEN VIROL, V88, P450, DOI 10.1099/vir.0.82396-0; Braunagel SC, 2007, CURR DRUG TARGETS, V8, P1084, DOI 10.2174/138945007782151315; Cheng CH, 2002, J VIROL, V76, P9024, DOI 10.1128/JVI.76.18.9024-9034.2002; Deng LQ, 2000, VIROLOGY, V269, P440, DOI 10.1006/viro.2000.0248; Desjardins CA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-61; Espagne E, 2005, J VIROL, V79, P9765, DOI 10.1128/JVI.79.15.9765-9776.2005; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Federici BA, 2003, J INSECT PHYSIOL, V49, P419, DOI 10.1016/S0022-1910(03)00059-3; GRANADOS RR, 1978, INTERVIROLOGY, V10, P309, DOI 10.1159/000148993; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; Pasquier-Barre F, 2002, J GEN VIROL, V83, P2035, DOI 10.1099/0022-1317-83-8-2035; Passarelli AL, 2007, CURR DRUG TARGETS, V8, P1103, DOI 10.2174/138945007782151324; Provost B, 2004, J VIROL, V78, P13090, DOI 10.1128/JVI.78.23.13090-13103.2004; Raina AK, 2000, J INVERTEBR PATHOL, V76, P6, DOI 10.1006/jipa.2000.4942; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; Vanarsdall AL, 2007, CURR DRUG TARGETS, V8, P1096, DOI 10.2174/138945007782151397; Wang YJ, 2008, J VIROL METHODS, V152, P106, DOI 10.1016/j.jviromet.2008.06.003; Wang YJ, 2007, J VIROL, V81, P5395, DOI 10.1128/JVI.02781-06; Webb BA, 2005, COMPREHENSIVE MOL IN, V6, P323, DOI DOI 10.1016/B0-44-451924-6/00086-7; Weber B, 2007, ARCH INSECT BIOCHEM, V66, P9, DOI 10.1002/arch.20190; Whitfield JB, 2002, P NATL ACAD SCI USA, V99, P7508, DOI 10.1073/pnas.112067199; Whitfield JB, 2003, J INSECT PHYSIOL, V49, P397, DOI 10.1016/S0022-1910(03)00057-X; Wyder S, 2003, J INSECT PHYSIOL, V49, P491, DOI 10.1016/S0022-1910(03)00056-8	29	223	234	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					926	930		10.1126/science.1166788	http://dx.doi.org/10.1126/science.1166788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213916	Green Published			2022-12-24	WOS:000263295400040
J	Schnabel, RB; Sullivan, LM; Levy, D; Pencina, M; Massaro, JM; D'Agostino, RB; Newton-Cheh, C; Yamamoto, JF; Magnani, JW; Tadros, TM; Kannel, WB; Wang, TJ; Ellinor, PT; Wolf, PA; Vasan, RS; Benjamin, EJ				Schnabel, Renate B.; Sullivan, Lisa M.; Levy, Daniel; Pencina, Michael; Massaro, Joseph M.; D'Agostino, Ralph B., Sr.; Newton-Cheh, Christopher; Yamamoto, Jennifer F.; Magnani, Jared W.; Tadros, Thomas M.; Kannel, William B.; Wang, Thomas J.; Ellinor, Patrick T.; Wolf, Philip A.; Vasan, Ramachandran S.; Benjamin, Emelia J.			Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study	LANCET			English	Article							PHYSICAL-ACTIVITY; PREVENTION; OBESITY; PREDICTION; MORTALITY; FAILURE; EVENTS; ADULTS; ONSET	Background Atrial fibrillation contributes to substantial increases in morbidity and mortality. We aimed to develop a risk score to predict individuals' absolute risk of developing the condition, and to provide a framework for researchers to assess new risk markers. Methods We assessed 4764 participants in the Framingham Heart Study from 8044 examinations (55% women, 45-95 years of age) undertaken between June, 1968, and September, 1987. Thereafter, participants were monitored for the first event of atrial fibrillation for a maximum of 10 years. Multivariable Cox regression identified clinical risk factors associated with development of atrial fibrillation in 10 years. Secondary analyses incorporated routine echocardiographic measurements (5152 participants, 7156 examinations) to reclassify the risk of atrial fibrillation and to assess whether these measurements improved risk prediction. Findings 457 (10%) of the 4764 participants developed atrial fibrillation. Age, sex, body-mass index, systolic blood pressure, treatment for hypertension, PR interval, clinically significant cardiac murmur, and heart failure were associated with atrial fibrillation and incorporated in a risk score (p<0.05, except body-mass index p=0.08), clinical model C statistic 0.78 (95% Cl 0.76-0.80). Risk of atrial fibrillation in 10 years varied with age: more than 15% risk was recorded in 53 (1%) participants younger than 65 years, compared with 783 (27%) older than 65 years. Additional incorporation of echocardiographic measurements to enhance the risk prediction model only slightly improved the C statistic from 0.78 (95% CI 0.75-0.80) to 0.79 (0.77-0.82), p=0.005. Echocardiographic measurements did not improve risk reclassification (p=0.18). Interpretation From clinical factors readily accessible in primary care, our risk score could help to identify risk of atrial fibrillation for individuals in the community; assess technologies or markers for improvement of risk prediction, and target high-risk individuals for preventive measures.	[Benjamin, Emelia J.] Boston Univ, Sch Med, Framingham Heart Study, Framingham, MA 01702 USA; [Sullivan, Lisa M.; Pencina, Michael; Massaro, Joseph M.; Yamamoto, Jennifer F.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Kannel, William B.; Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Evans Mem Dept Med, Boston, MA 02118 USA; [Levy, Daniel; Massaro, Joseph M.; Tadros, Thomas M.; Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Cardiol Sect, Evans Mem Dept Med, Boston, MA 02118 USA; [Levy, Daniel; Kannel, William B.; Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Prevent Med Sect, Evans Mem Dept Med, Boston, MA 02118 USA; [Wolf, Philip A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Wang, Thomas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Newton-Cheh, Christopher] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Schnabel, Renate B.] Johannes Gutenberg Univ Mainz, Dept Med 2, Mainz, Germany	Boston University; Framingham Heart Study; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johannes Gutenberg University of Mainz	Benjamin, EJ (corresponding author), Boston Univ, Sch Med, Framingham Heart Study, 73 Mt Wayte Ave, Framingham, MA 01702 USA.	emelia@bu.edu	Schnabel, Renate B/ABE-6668-2021; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Schnabel, Renate B/F-6527-2014; Ramachandran, Vasan/Y-2527-2019; Benjamin, Emelia/E-7103-2011	Schnabel, Renate B/0000-0001-7170-9509; Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Ellinor, Patrick/0000-0002-2067-0533; Pencina, Michael/0000-0001-5798-8855; Wolf, Philip/0000-0002-3628-301X; Sullivan, Lisa/0000-0003-0726-7149; Benjamin, Emelia/0000-0003-4076-2336; Massaro, Joseph/0000-0002-2682-4812; Wang, Thomas/0000-0003-4063-6508	US National Institutes of Health (NIH)/National Heart, Lung and Blood Institute [N01-HC-25195]; NIH [HL076784, AG028321, AG029451, HL092577, HL080124, HL077477, HL71039, HL093328, R01 NS 17950, 2K24 HL04334]; Deutsche Forschungsgemeinschaft (German Research Foundation) [SCHN 1149/1-1]; Doris Duke Charitable Foundation Clinical Scientist Development Award [HL080025]; Burroughs Wellcome Fund Career Award for Medical Scientists; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by US National Institutes of Health (NIH)/National Heart, Lung and Blood Institute contract N01-HC-25195 and NIH grants HL076784, AG028321. and AG029451 (E)B) HL092577 (EJB, PTE); HL080124, HL077477, HL71039, and HL093328 (RSV); R01 NS 17950 (PAW). NIH Research Career Award 2K24 HL04334 (RSV); Deutsche Forschungsgemeinschaft (German Research Foundation) Research Fellowship SCHN 1149/1-1 (RBS); HL080025, Doris Duke Charitable Foundation Clinical Scientist Development Award, and Burroughs Wellcome Fund Career Award for Medical Scientists (CN-C).	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; D'Agostino RB, 2004, HDB STAT, P1; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Darbar D, 2002, PACE, V25, P1447, DOI 10.1046/j.1460-9592.2002.01447.x; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Fauchier L, 2008, J AM COLL CARDIOL, V51, P828, DOI 10.1016/j.jacc.2007.09.063; Frost L, 2005, AM J MED, V118, P489, DOI 10.1016/j.amjmed.2005.01.031; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; KANNEL WB, 1998, AM J CARDIOL, V0082; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Miyasaka Y, 2007, AM J MED, V120, P357, DOI 10.1016/j.amjmed.2006.06.042; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mont L, 2008, EUROPACE, V10, P15, DOI 10.1093/europace/eum263; Mozaffarian D, 2008, CIRCULATION, V118, P800, DOI 10.1161/CIRCULATIONAHA.108.785626; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Psaty BM, 1997, CIRCULATION, V96, P2455; Quan SF, 1997, SLEEP, V20, P1077; Ringborg A, 2008, EUROPACE, V10, P403, DOI 10.1093/europace/eun048; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; Soliman EZ, 2008, J NATL MED ASSOC, V100, P447, DOI 10.1016/S0027-9684(15)31282-7; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Yamada T, 1999, EUR HEART J, V20, P211, DOI 10.1053/euhj.1998.1281	35	753	773	1	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					739	745		10.1016/S0140-6736(09)60443-8	http://dx.doi.org/10.1016/S0140-6736(09)60443-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19249635	Green Accepted			2022-12-24	WOS:000263725400033
J	Anstey, ML; Rogers, SM; Ott, SR; Burrows, M; Simpson, SJ				Anstey, Michael L.; Rogers, Stephen M.; Ott, Swidbert R.; Burrows, Malcolm; Simpson, Stephen J.			Serotonin Mediates Behavioral Gregarization Underlying Swarm Formation in Desert Locusts	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; PHASE-CHANGE; CRUSTACEANS; AGGRESSION; PHYSIOLOGY; RECEPTOR; FIGHT	Desert locusts, Schistocerca gregaria, show extreme phenotypic plasticity, transforming between a little- seen solitarious phase and the notorious swarming gregarious phase depending on population density. An essential tipping point in the process of swarm formation is the initial switch from strong mutual aversion in solitarious locusts to coherent group formation and greater activity in gregarious locusts. We show here that serotonin, an evolutionarily conserved mediator of neuronal plasticity, is responsible for this behavioral transformation, being both necessary if behavioral gregarization is to occur and sufficient to induce it. Our data demonstrate a neurochemical mechanism linking interactions between individuals to large- scale changes in population structure and the onset of mass migration.	[Anstey, Michael L.; Rogers, Stephen M.; Simpson, Stephen J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Rogers, Stephen M.; Ott, Swidbert R.; Burrows, Malcolm] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Simpson, Stephen J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Oxford; University of Cambridge; University of Sydney	Rogers, SM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	smr34@cam.ac.uk		Simpson, Stephen J./0000-0003-0256-7687; Ott, Swidbert/0000-0003-4278-2613	Biotechnology and Biological Sciences Research Council, UK; University Research Fellowship from the Royal Society, UK; Natural Sciences and Engineering Research Council of Canada; Hope Studentship in Entomology from Jesus College; University of Oxford, UK; Australian Research Council Federation Fellowship	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University Research Fellowship from the Royal Society, UK(Royal Society of London); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Hope Studentship in Entomology from Jesus College; University of Oxford, UK; Australian Research Council Federation Fellowship(Australian Research Council)	We thank J. Niven, G. Sutton, and G. Sword for reading and commenting upon the manuscript; C. de la Riva at the Babraham Institute (UK) for technical support with the HPLC and K. Kendrick for permission to use the facility; T. Dodgson and E. Miller for locust rearing and technical support; and M. Ungless for advice and support to M. A. This work is supported by grants from the Biotechnology and Biological Sciences Research Council, UK (to M.B, S.S., and S.O.), and a University Research Fellowship from the Royal Society, UK, to S.O.M.A. was supported by the Natural Sciences and Engineering Research Council of Canada, an Overseas Research Student Award, UK, and the Hope Studentship in Entomology from Jesus College and the University of Oxford, UK. S.S. is supported by an Australian Research Council Federation Fellowship.	Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Enserink M, 2004, SCIENCE, V306, P1880, DOI 10.1126/science.306.5703.1880; Gatellier L, 2004, J EXP BIOL, V207, P2487, DOI 10.1242/jeb.01035; Hoeffer CA, 2003, J NEUROSCI, V23, P6362; Hofmann HA, 2000, NATURE, V403, P613, DOI 10.1038/35001137; Huber R, 1997, P NATL ACAD SCI USA, V94, P5939, DOI 10.1073/pnas.94.11.5939; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Molaei G, 2003, J INSECT PHYSIOL, V49, P1073, DOI 10.1016/j.jinsphys.2003.08.004; OSBORNE NN, 1974, BRAIN RES, V74, P366, DOI 10.1016/0006-8993(74)90593-9; PARKER D, 1995, J NEUROPHYSIOL, V73, P923, DOI 10.1152/jn.1995.73.3.923; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; ROESSINGH P, 1993, P ROY SOC B-BIOL SCI, V252, P43, DOI 10.1098/rspb.1993.0044; Roessingh P, 1998, J INSECT PHYSIOL, V44, P883, DOI 10.1016/S0022-1910(98)00070-5; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; SLOLEY BD, 1988, J NEUROCHEM, V51, P535, DOI 10.1111/j.1471-4159.1988.tb01071.x; Spitzer N, 2008, J EXP BIOL, V211, P92, DOI 10.1242/jeb.012450; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; TYRER NM, 1984, J COMP NEUROL, V227, P313, DOI 10.1002/cne.902270303; Ureshi M, 2002, J COMP PHYSIOL A, V188, P767, DOI 10.1007/s00359-002-0364-0; Uvarov B., 1966, GRASSHOPPER LOCUSTS, V1; West-Eberhard Mary Jane, 2003, pi	30	251	259	2	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					627	630		10.1126/science.1165939	http://dx.doi.org/10.1126/science.1165939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179529				2022-12-24	WOS:000262862800041
J	Liti, G; Carter, DM; Moses, AM; Warringer, J; Parts, L; James, SA; Davey, RP; Roberts, IN; Burt, A; Koufopanou, V; Tsai, IJ; Bergman, CM; Bensasson, D; O'Kelly, MJT; van Oudenaarden, A; Barton, DBH; Bailes, E; Ba, ANN; Jones, M; Quail, MA; Goodhead, I; Sims, S; Smith, F; Blomberg, A; Durbin, R; Louis, EJ				Liti, Gianni; Carter, David M.; Moses, Alan M.; Warringer, Jonas; Parts, Leopold; James, Stephen A.; Davey, Robert P.; Roberts, Ian N.; Burt, Austin; Koufopanou, Vassiliki; Tsai, Isheng J.; Bergman, Casey M.; Bensasson, Douda; O'Kelly, Michael J. T.; van Oudenaarden, Alexander; Barton, David B. H.; Bailes, Elizabeth; Ba, Alex N. Nguyen; Jones, Matthew; Quail, Michael A.; Goodhead, Ian; Sims, Sarah; Smith, Frances; Blomberg, Anders; Durbin, Richard; Louis, Edward J.			Population genomics of domestic and wild yeasts	NATURE			English	Article							SENSU-STRICTO COMPLEX; SACCHAROMYCES-CEREVISIAE; DIVERSITY; EVOLUTION; PARADOXUS; KUDRIAVZEVII; GENES; LIFE; WINE	Since the completion of the genome sequence of Saccharomyces cerevisiae in 1996 (refs 1, 2), there has been a large increase in complete genome sequences, accompanied by great advances in our understanding of genome evolution. Although little is known about the natural and life histories of yeasts in the wild, there are an increasing number of studies looking at ecological and geographic distributions(3,4), population structure(5-8) and sexual versus asexual reproduction(9,10). Less well understood at the whole genome level are the evolutionary processes acting within populations and species that lead to adaptation to different environments, phenotypic differences and reproductive isolation. Here we present one- to fourfold or more coverage of the genome sequences of over seventy isolates of the baker's yeast S. cerevisiae and its closest relative, Saccharomyces paradoxus. We examine variation in gene content, single nucleotide polymorphisms, nucleotide insertions and deletions, copy numbers and transposable elements. We find that phenotypic variation broadly correlates with global genome-wide phylogenetic relationships. S. paradoxus populations are well delineated along geographic boundaries, whereas the variation among worldwide S. cerevisiae isolates shows less differentiation and is comparable to a single S. paradoxus population. Rather than one or two domestication events leading to the extant baker's yeasts, the population structure of S. cerevisiae consists of a few well-defined, geographically isolated lineages and many different mosaics of these lineages, supporting the idea that human influence provided the opportunity for cross-breeding and production of new combinations of pre-existing variations.	[Carter, David M.; Moses, Alan M.; Parts, Leopold; Jones, Matthew; Quail, Michael A.; Goodhead, Ian; Sims, Sarah; Smith, Frances; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Liti, Gianni; Barton, David B. H.; Bailes, Elizabeth; Louis, Edward J.] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England; [Moses, Alan M.; Ba, Alex N. Nguyen] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 2J4, Canada; [Warringer, Jonas; Blomberg, Anders] Univ Gothenburg, Lundberg Lab, Dept Cell & Mol Biol, S-41390 Gothenburg, Sweden; [James, Stephen A.; Davey, Robert P.; Roberts, Ian N.] Inst Food Res, Inst Food Res, Natl Collect Yeast Cultures, Norwich NR4 7UA, Norfolk, England; [Burt, Austin; Koufopanou, Vassiliki; Tsai, Isheng J.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Bergman, Casey M.; Bensasson, Douda] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [O'Kelly, Michael J. T.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA	Wellcome Trust Sanger Institute; University of Nottingham; University of Toronto; University of Gothenburg; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Imperial College London; University of Manchester; Massachusetts Institute of Technology (MIT)	Durbin, R (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1HH, England.	rd@sanger.ac.uk; ed.louis@nottingham.ac.uk	Warringer, Jonas/B-8520-2013; van Oudenaarden, Alexander/AAA-1705-2019; Bergman, Casey/F-7854-2010; Tsai, Isheng Jason/ABB-8273-2021; Quail, michael/ABE-6131-2020; Durbin, Richard/AAE-7178-2019; Roberts, Ian N/B-9743-2008; Louis, Edward/B-7920-2008; Liti, Gianni/I-9929-2014; Goodhead, Ian/ABC-9200-2020; Tsai, Isheng J/H-6606-2014	Warringer, Jonas/0000-0001-6144-2740; Bergman, Casey/0000-0002-5462-9854; Tsai, Isheng Jason/0000-0002-2123-5058; Durbin, Richard/0000-0002-9130-1006; Louis, Edward/0000-0003-1157-3608; Blomberg, Anders/0000-0002-1260-3920; Liti, Gianni/0000-0002-2318-0775; Burt, Austin/0000-0001-5146-9640; Bensasson, Douda/0000-0002-9015-2707; Davey, Robert/0000-0002-5589-7754; Goodhead, Ian/0000-0002-3110-9442; Parts, Leopold/0000-0002-2618-670X	The Wellcome Trust; Royal Society and the Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC; Swedish Research Council; Swedish Foundation for Strategic Research; National Environment Research Council (NERC); Wellcome Trust; NERC; Canada Foundation for Innovation; National Science Foundation; National Institutes of Health; Hertz fellowship; Biotechnology and Biological Sciences Research Council [BB/F015216/1, BBS/E/F/00042258] Funding Source: researchfish; Natural Environment Research Council [NE/D008824/1] Funding Source: researchfish; BBSRC [BB/F015216/1] Funding Source: UKRI; NERC [NE/D008824/1] Funding Source: UKRI	The Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society and the Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hertz fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank all the members of the Sanger sequencing production teams for generating the sequence data. We thank members of the Durbin and Louis laboratories and C. Nieduszynski for comments and suggestions, L. Kruglyak and J. Schacherer for sharing their unpublished manuscript and R. Ames and S. Lovell for sharing unpublished results. We also thank the British Council and Chinese Academy of Sciences for providing the opportunity to design and develop this project. Research at the Wellcome Trust Sanger Institute ( D. M. C., A. M. M., L. P, M. J., M. A. Q., I. G., S. S., F. S. and R. D.) is supported by The Wellcome Trust. G. L., D. B. H. B., E. B. and E. J. L. were supported by the Wellcome Trust, the Royal Society and the Biotechnology and Biological Sciences Research Council ( BBSRC). S. A. J., R. P. D. and I. N. R. were supported by the BBSRC. A. B. and J. W. were supported by the Swedish Research Council and the Swedish Foundation for Strategic Research. A. B. and V. K. were supported by the National Environment Research Council (NERC) and I. J. T. was supported by the Wellcome Trust. D. B. was supported by NERC. A. M. M. was supported by the Canada Foundation for Innovation. M. J. T. O. and A. v. O. were supported by the National Science Foundation, the National Institutes of Health and a Hertz fellowship.	Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; BULMER M, 1991, GENETICS, V129, P897; CARTER DM, 2005, SACCHAROMYCES GENOME; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000103; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Koufopanou V, 2006, PHILOS T R SOC B, V361, P1941, DOI 10.1098/rstb.2006.1922; Kuehne HA, 2007, CURR BIOL, V17, P407, DOI 10.1016/j.cub.2006.12.047; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Naumov GI, 2000, INT J SYST EVOL MICR, V50, P1931, DOI 10.1099/00207713-50-5-1931; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Pritchard JK, 2000, GENETICS, V155, P945; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; TAJIMA F, 1989, GENETICS, V123, P585; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wiens F, 2008, P NATL ACAD SCI USA, V105, P10426, DOI 10.1073/pnas.0801628105	29	1027	1042	3	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					337	341		10.1038/nature07743	http://dx.doi.org/10.1038/nature07743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19212322	Green Submitted, Green Accepted			2022-12-24	WOS:000264285600041
J	Hammell, CM; Lubin, I; Boag, PR; Blackwell, TK; Ambros, V				Hammell, Christopher M.; Lubin, Isabella; Boag, Peter R.; Blackwell, T. Keith; Ambros, Victor			nhl-2 Modulates MicroRNA Activity in Caenorhabditis elegans	CELL			English	Article							MEDIATED TRANSLATIONAL REPRESSION; PHYSIOLOGICAL GERMLINE APOPTOSIS; C-ELEGANS; RING FINGER; P-BODIES; RNA; GW182; PROTEIN; COMPLEX; DEADENYLASE	TRIM-NHL proteins represent a large class of metazoan proteins implicated in development and disease. We demonstrate that a C. elegans TRIM-NHL protein, NHL-2, functions as a cofactor for the microRNA-induced silencing complex (miRISC) and thereby enhances the posttranscriptional repression of several genetically verified microRNA targets, including hbl-1 and let-60/Ras (by the let-7 family of microRNAs) and cog-1 (by the lsy-6 microRNA). NHL-2 is localized to cytoplasmic P-bodies and physically associates with the P-body protein CGH-1 and the core miRISC components ALG-1/2 and AIN-1. nhl-2 and cgh-1 mutations compromise the repression of microRNA targets in vivo but do not affect microRNA biogenesis, indicating a role for an NHL-2: CGH-1 complex in the effector phase of miRISC activity. We propose that the NHL-2: CGH-1 complex functions in association with mature miRISC to modulate the efficacy of microRNA: target interactions in response to physiological and developmental signals, thereby ensuring the robustness of genetic regulatory pathways regulated by microRNAs.	[Hammell, Christopher M.; Lubin, Isabella; Ambros, Victor] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Boag, Peter R.; Blackwell, T. Keith] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Dept Pathol,Joslin Diabet Ctr, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Ambros, V (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	victor.ambros@umassmed.edu		Hammell, Christopher/0000-0002-5961-0976; Boag, Peter/0000-0002-0889-0859	NIH [F32 GM69186]; National Institutes of Health [GM30428, GM63826]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030428, F32GM069186, R01GM063826, R01GM034028] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to members of the Ambros laboratory and M. Hammell for thoughtful critiques of the data and the manuscript. We thank C. Mello and M. Han for antisera and worm strains and the Caenorhabditis Genetics Center for worm strains. C. M. H. was supported by an NIH postdoctoral fellowship (F32 GM69186). P. R. B. was supported by a fellowship from the M. R. Reinhard Family Foundation. V. A. and T. K. B. were supported by grants from the National Institutes of Health (GM30428 and GM63826, respectively).	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boag PR, 2008, J CELL BIOL, V182, P543, DOI 10.1083/jcb.200801183; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; BRENNER S, 1974, GENETICS, V77, P71; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Glasscock E, 2005, GENETICS, V170, P1677, DOI 10.1534/genetics.105.043174; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hammell CM, 2008, RNA BIOL, V5, P123, DOI 10.4161/rna.5.3.6570; HAN M, 1990, GENETICS, V126, P899; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Palmer RE, 2002, DEV BIOL, V252, P202, DOI 10.1006/dbio.2002.0850; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rajyaguru P, 2009, TRENDS CELL BIOL, V19, P24, DOI 10.1016/j.tcb.2008.11.001; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Sarin S, 2007, GENETICS, V176, P2109, DOI 10.1534/genetics.107.075648; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014	40	128	142	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					926	938		10.1016/j.cell.2009.01.053	http://dx.doi.org/10.1016/j.cell.2009.01.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269369	Green Accepted, Bronze			2022-12-24	WOS:000263930900015
J	Liu, D; Vader, G; Vromans, MJM; Lampson, MA; Lens, SMA				Liu, Dan; Vader, Gerben; Vromans, Martijn J. M.; Lampson, Michael A.; Lens, Susanne M. A.			Sensing Chromosome Bi-Orientation by Spatial Separation of Aurora B Kinase from Kinetochore Substrates	SCIENCE			English	Article							MICROTUBULE ATTACHMENT; CLEAVAGE FURROW; CELL-DIVISION; SPINDLE; ANAPHASE; COMPLEX; LOCALIZATION; CYTOKINESIS; MECHANISMS; CHECKPOINT	Successful cell division requires that chromosomes attach to opposite poles of the mitotic spindle (bi-orientation). Aurora B kinase regulates chromosome-spindle attachments by phosphorylating kinetochore substrates that bind microtubules. Centromere tension stabilizes bi-oriented attachments, but how physical forces are translated into signaling at individual centromeres is unknown. Using fluorescence resonance energy transfer-based biosensors to measure localized phosphorylation dynamics in living cells, we found that phosphorylation of an Aurora B substrate at the kinetochore depended on its distance from the kinase at the inner centromere. Furthermore, repositioning Aurora B closer to the kinetochore prevented stabilization of bi-oriented attachments and activated the spindle checkpoint. Thus, centromere tension can be sensed by increased spatial separation of Aurora B from kinetochore substrates, which reduces phosphorylation and stabilizes kinetochore microtubules.	[Liu, Dan; Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Vader, Gerben; Vromans, Martijn J. M.; Lens, Susanne M. A.] Univ Med Ctr, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands	University of Pennsylvania; Utrecht University; Utrecht University Medical Center	Lampson, MA (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	lampson@sas.upenn.edu	Liu, Dan/G-9006-2018	Liu, Dan/0000-0003-4017-3136; Vader, Gerben/0000-0001-5729-0991	American Cancer Society [IRG-78-002-30]; National Institutes of Health [GM083988]; Searle Scholars Program; Penn Genome Frontiers Institute; Netherlands Organization for Scientific Research [Vidi 917.66.332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083988] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Penn Genome Frontiers Institute; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. M. Kapoor (Rockefeller University) and R. H. Medema (University Medical Center, Utrecht) for their support during the initiation of these studies. We also thank B. E. Black, G. Kops, and R. H. Medema for critical reading of the manuscript and helpful comments and K. V. Le and T. Chiang for assistance with preparing reagents. This work was supported by grants from the American Cancer Society (IRG-78-002-30, M.A.L.), the National Institutes of Health (GM083988, M.A.L.), the Searle Scholars Program (M.A.L.), the Penn Genome Frontiers Institute (M.A.L.), and the Netherlands Organization for Scientific Research (Vidi 917.66.332, S.M.A.L.).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Eckley DM, 1997, J CELL BIOL, V136, P1169, DOI 10.1083/jcb.136.6.1169; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; PLUTA AF, 1992, J CELL BIOL, V116, P1081, DOI 10.1083/jcb.116.5.1081; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	21	408	412	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1350	1353		10.1126/science.1167000	http://dx.doi.org/10.1126/science.1167000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19150808	Green Accepted			2022-12-24	WOS:000263876700044
J	Hamdan, FF; Gauthier, J; Spiegelman, D; Noreau, A; Yang, Y; Pellerin, S; Dobrzeniecka, S; Cote, M; Perreault-Linck, E; Carmant, L; D'Anjou, G; Fombonne, E; Addington, AM; Rapoport, JL; Delisi, LE; Krebs, MO; Mouaffak, F; Joober, R; Mottron, L; Drapeau, P; Marineau, C; Lafreniere, RG; Lacaille, JC; Rouleau, GA; Michaud, JL				Hamdan, Fadi F.; Gauthier, Julie; Spiegelman, Dan; Noreau, Anne; Yang, Yan; Pellerin, Stephanie; Dobrzeniecka, Sylvia; Cote, Melanie; Perreault-Linck, Elizabeth; Carmant, Lionel; D'Anjou, Guy; Fombonne, Eric; Addington, Anjene M.; Rapoport, Judith L.; Delisi, Lynn E.; Krebs, Marie-Odile; Mouaffak, Faycal; Joober, Ridha; Mottron, Laurent; Drapeau, Pierre; Marineau, Claude; Lafreniere, Ronald G.; Lacaille, Jean Claude; Rouleau, Guy A.; Michaud, Jacques L.		Synapse Dis Grp	Mutations in SYNGAP1 in Autosomal nonsyndromic Mental Retardation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYNAPTIC PLASTICITY; NMDA RECEPTORS; PROTEIN; TRAFFICKING; COMPLEXES; GENETICS; DEFECT	Although autosomal forms of nonsyndromic mental retardation account for the majority of cases of mental retardation, the genes that are involved remain largely unknown. We sequenced the autosomal gene SYNGAP1, which encodes a ras GTPAse-activating protein that is critical for cognition and synapse function, in 94 patients with nonsyndromic mental retardation. We identified de novo truncating mutations (K138X, R579X, and L813RfsX22) in three of these patients. In contrast, we observed no de novo or truncating mutations in SYNGAP1 in samples from 142 subjects with autism spectrum disorders, 143 subjects with schizophrenia, and 190 control subjects. These results indicate that SYNGAP1 disruption is a cause of autosomal dominant nonsyndromic mental retardation.	[Hamdan, Fadi F.; Pellerin, Stephanie; Carmant, Lionel; D'Anjou, Guy; Michaud, Jacques L.] CHU St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Gauthier, Julie; Spiegelman, Dan; Noreau, Anne; Yang, Yan; Dobrzeniecka, Sylvia; Cote, Melanie; Marineau, Claude; Lafreniere, Ronald G.; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neurom, Ctr Hosp, Res Ctr, Montreal, PQ, Canada; [Gauthier, Julie; Spiegelman, Dan; Noreau, Anne; Yang, Yan; Dobrzeniecka, Sylvia; Cote, Melanie; Marineau, Claude; Lafreniere, Ronald G.; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neurom, Dept Med, Montreal, PQ, Canada; [Drapeau, Pierre] Univ Montreal, Ctr Excellence Neurom, Grp Rech Syst Nerveux Cent, Dept Pathol & Cell Biol, Montreal, PQ, Canada; [Lacaille, Jean Claude] Univ Montreal, Ctr Excellence Neurom, Dept Physiol, Montreal, PQ, Canada; [Perreault-Linck, Elizabeth; Mottron, Laurent] Univ Montreal, Ctr Excellence Neurom, Ctr Rech Fernand Seguin, Hop Riviere Prairies, Montreal, PQ, Canada; [Fombonne, Eric] Montreal Childrens Hosp, Dept Psychiat, Montreal, PQ H3H 1P3, Canada; [Joober, Ridha] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Addington, Anjene M.; Rapoport, Judith L.] NIMH, Child Psychiat Branch, Bethesda, MD 20892 USA; [Delisi, Lynn E.] Nathan S Kline Inst Psychiat Res, Ctr Adv Brain Imaging, Orangeburg, NY 10962 USA; [Krebs, Marie-Odile; Mouaffak, Faycal] Univ Paris 05, INSERM, Unite 894, Paris, France; [Krebs, Marie-Odile; Mouaffak, Faycal] Hop St Anne, F-75674 Paris, France	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Nathan Kline Institute for Psychiatric Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Michaud, JL (corresponding author), CHU St Justine, Res Ctr, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	michaud@recherche-ste-justine.qc.ca	Krebs, Marie-Odile/O-2104-2017; Fombonne, Eric/M-4893-2018	Krebs, Marie-Odile/0000-0002-4715-9890; Fombonne, Eric/0000-0002-8605-3538; spiegelman, dan/0000-0003-4971-8868; Mottron, Laurent/0000-0001-5668-5422; MOUAFFAK, Faycal/0000-0002-6277-5755; Addington, Anjene/0000-0001-7770-299X	Canadian Institute of Health Research; Fonds de la Recherche en Sant; Genome Canada; Genome Quebec; Universite de Montreal; Clinical Investigatorship Award; CIHR (Institute of Genetics); Fondation Pierre Deniker; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002581] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sant; Genome Canada(Genome Canada); Genome Quebec; Universite de Montreal; Clinical Investigatorship Award; CIHR (Institute of Genetics)(Canadian Institutes of Health Research (CIHR)); Fondation Pierre Deniker; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the Canadian Institute of Health Research (CIHR) (to Drs. Lacaille, Rouleau, and Michaud), from Fonds de la Recherche en Sant, (to Dr. Michaud), and from Genome Canada and Genome Quebec and cofunding by Universite de Montreal for the Synapse to Diseases project (to Drs. Drapeau and Rouleau). Dr. Michaud is the recipient of a Clinical Investigatorship Award of the CIHR (Institute of Genetics). The schizophrenia series was collected partly through the Collaborative Network for Family Study in Psychiatry, which is supported by the Fondation Pierre Deniker.; No potential conflict of interest relevant to this article was reported.; We thank the patients and their parents for participating in this study; the members of the Synapse to Disease Group, including Edouard Henrion and Ousmane Diallo of the bioinformatics division and Sandra Laurent, Frederic Kuku, Joannie Duguay, Laurie Destroismaisons, Karine Lachapelle, Philippe Jolivet, Pascale Thibodeau, and Annie Raymond of the genetic screening division; Annie Levert and Judith St.-Onge for performing DNA extraction and paternity testing, respectively; and Pierre Lepage, Sebastien Brunet, and Hao Fan Yam of McGill University and Genome Quebec Innovation Centre sequencing group and Louis Letourneau and Louis Dumond Joseph of the bioinformatics group.	Angehagen M, 2005, J NEUROCHEM, V94, P1124, DOI 10.1111/j.1471-4159.2005.03259.x; Basel-Vanagaite L, 2007, CLIN GENET, V72, P167, DOI 10.1111/j.1399-0004.2007.00881.x; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Du J, 2004, J NEUROSCI, V24, P6578, DOI 10.1523/JNEUROSCI.1258-04.2004; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Li WD, 2001, J BIOL CHEM, V276, P21417, DOI 10.1074/jbc.M010744200; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756	24	208	227	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					599	605		10.1056/NEJMoa0805392	http://dx.doi.org/10.1056/NEJMoa0805392			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402QS	19196676	Green Accepted			2022-12-24	WOS:000263028800006
J	Venteicher, AS; Abreu, EB; Meng, ZJ; McCann, KE; Terns, RM; Veenstra, TD; Terns, MP; Artandi, SE				Venteicher, Andrew S.; Abreu, Eladio B.; Meng, Zhaojing; McCann, Kelly E.; Terns, Rebecca M.; Veenstra, Timothy D.; Terns, Michael P.; Artandi, Steven E.			A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis	SCIENCE			English	Article							SMALL NUCLEOLAR RNPS; DYSKERATOSIS-CONGENITA; RNA; ACCUMULATION; HOMOLOG; BODIES; PURIFICATION; RECRUITMENT; BIOGENESIS; SHARE	Telomerase is a ribonucleoprotein ( RNP) complex that synthesizes telomere repeats in tissue progenitor cells and cancer cells. Active human telomerase consists of at least three principal subunits, including the telomerase reverse transcriptase, the telomerase RNA ( TERC), and dyskerin. Here, we identify a holoenzyme subunit, TCAB1 ( telomerase Cajal body protein 1), that is notably enriched in Cajal bodies, nuclear sites of RNP processing that are important for telomerase function. TCAB1 associates with active telomerase enzyme, established telomerase components, and small Cajal body RNAs that are involved in modifying splicing RNAs. Depletion of TCAB1 by using RNA interference prevents TERC from associating with Cajal bodies, disrupts telomerase- telomere association, and abrogates telomere synthesis by telomerase. Thus, TCAB1 controls telomerase trafficking and is required for telomere synthesis in human cancer cells.	[Venteicher, Andrew S.; McCann, Kelly E.; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Sch Med, Program Biophys, Stanford, CA 94305 USA; [Abreu, Eladio B.; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Abreu, Eladio B.; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Meng, Zhaojing; Veenstra, Timothy D.] NCI, Lab Proteom & Analyt Technol, Adv Technol Program, Sci Applicat Int Corp, Frederick, MD 21702 USA; [McCann, Kelly E.; Artandi, Steven E.] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Terns, Michael/N-6435-2016; Venteicher, Andrew/AAN-5666-2021	Venteicher, Andrew/0000-0003-0643-0493	Medical Scientist Training Program [GM07365]; NCI [CA104676, NO1-CO-12400, CA111691, CA125453]; Leukemia and Lymphoma Society Specialized Centers of Research [7007-09]; NATIONAL CANCER INSTITUTE [R01CA104676, R01CA111691, R01CA125453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER	Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society Specialized Centers of Research(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Medical Scientist Training Program grant GM07365 (A.S.V.) and NCI grant CA104676 (M.P.T. and R.M.T.), with a Supplement to Promote Diversity in Health- Related Research (E.B.A.). This project has been funded in part with federal funds from the NCI under contract NO1-CO-12400 (T.D.V.). This work was supported by NCI grants CA111691 and CA125453 (S.E.A.) and by Leukemia and Lymphoma Society Specialized Centers of Research grant 7007-09 (S.E.A.).	Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Dragon F, 2000, MOL CELL BIOL, V20, P3037, DOI 10.1128/MCB.20.9.3037-3048.2000; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Hoareau-Aveilla C, 2006, RNA, V12, P832, DOI 10.1261/rna.2344106; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; MEIER UT, 1994, J CELL BIOL, V127, P1505, DOI 10.1083/jcb.127.6.1505; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Reichenbach P, 2003, CURR BIOL, V13, P568, DOI 10.1016/S0960-9822(03)00173-8; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	23	375	397	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					644	648		10.1126/science.1165357	http://dx.doi.org/10.1126/science.1165357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179534	Green Accepted			2022-12-24	WOS:000262862800046
J	Battisti, DS; Naylor, RL				Battisti, David. S.; Naylor, Rosamond L.			Historical Warnings of Future Food Insecurity with Unprecedented Seasonal Heat	SCIENCE			English	Article							YIELDS	Higher growing season temperatures can have dramatic impacts on agricultural productivity, farm incomes, and food security. We used observational data and output from 23 global climate models to show a high probability (> 90%) that growing season temperatures in the tropics and subtropics by the end of the 21st century will exceed the most extreme seasonal temperatures recorded from 1900 to 2006. In temperate regions, the hottest seasons on record will represent the future norm in many locations. We used historical examples to illustrate the magnitude of damage to food systems caused by extreme seasonal heat and show that these short- run events could become long-term trends without sufficient investments in adaptation.	[Battisti, David. S.] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Naylor, Rosamond L.] Stanford Univ, Program Food Secur & Environm, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; Stanford University	Battisti, DS (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	battisti@washington.edu; roz@stanford.edu	Battisti, David S/A-3340-2013	Battisti, David S/0000-0003-4871-1293	NSF [SES 0433679]; Tamaki Foundation	NSF(National Science Foundation (NSF)); Tamaki Foundation	This work was made possible by grants from the NSF (grant SES 0433679) and the Tamaki Foundation. We thank M. Baker, M. Burke, W. Falcon, D. Kennedy, S.-H. Kim, D. Lobell, R. Nicholas, K. Niemer Johnson, K. Rennert, and D. Vimont for comments and/or assistance on the draft.	Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; DEBONO A, 2004, ENV ALERT B IMPACTS; Dronin Nikolai M., 2005, CLIMATE DEPENDENCE F; EASTERLING W, 2007, CLIMATE CHANGE 2007, P976; HATHAWAY DE, 1974, BROOKINGS PAPERS EC, V1, P63; *INT FIN STAT DAT, 2008, US GULF PORTS WHEAT; IPCC, 2007, 4 ASS REP SYNTH; JAYNE T, 2008, TRANSFORMATION AGRIF; KANDJI ST, 2006, CLIMATE CHANGE VARIA; LARSEN J, 2006, EARTH POLICY I; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; NAYLOR R, 2008, BOSTON REV, V33, P13; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; PIRARD A, 2005, EUROSURVEILLANCE, V10, P554; Schlenker W, 2006, REV AGR ECON, V28, P391, DOI 10.1111/j.1467-9353.2006.00304.x; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; *WORLD BANK, 2007, WORLD DEV REP 2008 A; World Bank, 2007, AFR DEV IND 2007	19	946	983	15	385	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					240	244		10.1126/science.1164363	http://dx.doi.org/10.1126/science.1164363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131626				2022-12-24	WOS:000262290600035
J	Wollert, T; Wunder, C; Lippincott-Schwartz, J; Hurley, JH				Wollert, Thomas; Wunder, Christian; Lippincott-Schwartz, Jennifer; Hurley, James H.			Membrane scission by the ESCRT-III complex	NATURE			English	Article							MULTIVESICULAR ENDOSOMES; STRUCTURAL BASIS; CELL-DIVISION; PROTEINS; VPS4; RECOGNITION; BIOGENESIS; MACHINERY; HIV-1; ALIX	The endosomal sorting complex required for transport (ESCRT) system is essential for multivesicular body biogenesis, in which cargo sorting is coupled to the invagination and scission of intralumenal vesicles. The ESCRTs are also needed for budding of enveloped viruses including human immunodeficiency virus 1, and for membrane abscission in cytokinesis. In Saccharomyces cerevisiae, ESCRT-III consists of Vps20, Snf7, Vps24 and Vps2 (also known as Did4), which assemble in that order and require the ATPase Vps4 for their disassembly. In this study, the ESCRT-III-dependent budding and scission of intralumenal vesicles into giant unilamellar vesicles was reconstituted and visualized by fluorescence microscopy. Here we show that three subunits of ESCRT-III, Vps20, Snf7 and Vps24, are sufficient to detach intralumenal vesicles. Vps2, the ESCRT-III subunit responsible for recruiting Vps4, and the ATPase activity of Vps4 were required for ESCRT-III recycling and supported additional rounds of budding. The minimum set of ESCRT-III and Vps4 proteins capable of multiple cycles of vesicle detachment corresponds to the ancient set of ESCRT proteins conserved from archaea to animals.	[Wollert, Thomas; Hurley, James H.] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA; [Wunder, Christian; Lippincott-Schwartz, Jennifer] NICHHD, Cell Biol & Metab Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hurley, JH (corresponding author), NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Wunder, Christian/K-8542-2017	Wunder, Christian/0000-0001-9091-0080; Wollert, Thomas/0000-0001-9732-4789	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609, ZICHD008874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036123, Z01DK036123, ZIADK036125] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK036123-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; EVANS WH, 1985, BIOCHEM J, V232, P33, DOI 10.1042/bj2320033; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	38	433	439	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					172	U2		10.1038/nature07836	http://dx.doi.org/10.1038/nature07836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19234443	Green Accepted			2022-12-24	WOS:000264059700036
J	Friedland, JC; Lee, MH; Boettiger, D				Friedland, Julie C.; Lee, Mark H.; Boettiger, David			Mechanically Activated Integrin Switch Controls alpha(5)beta(1) Function	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; MEDIATED ADHESION; CRYSTAL-STRUCTURE; CELL-ADHESION; LIVING CELLS; CATCH BONDS; FORCE; FIBRONECTIN; ALPHA-V-BETA-3	The cytoskeleton, integrin- mediated adhesion, and substrate stiffness control a common set of cell functions required for development and homeostasis that are often deranged in cancer. The connection between these mechanical elements and chemical signaling processes is not known. Here, we show that alpha 5 beta 1 integrin switches between relaxed and tensioned states in response to myosin II- generated cytoskeletal force. Force combines with extracellular matrix stiffness to generate tension that triggers the integrin switch. This switch directly controls the alpha(5)beta(1)- fibronectin bond strength through engaging the synergy site in fibronectin and is required to generate signals through phosphorylation of focal adhesion kinase. In the context of tissues, this integrin switch connects cytoskeleton and extracellular matrix mechanics to adhesion- dependent motility and signaling pathways.	[Friedland, Julie C.; Lee, Mark H.; Boettiger, David] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Friedland, Julie C.; Lee, Mark H.; Boettiger, David] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Boettiger, David] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Boettiger, D (corresponding author), Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.	boettige@upenn.edu			National Institutes of Health [GM57388]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM57388 from the National Institutes of Health to D. B. We thank S. Akiyama (NIH) for 13G12 antibody, H. Erickson (Duke) for mutant fibronectin constructs, and Qi Shi for technical assistance.	Boettiger D, 2007, METHOD ENZYMOL, V426, P1, DOI 10.1016/S0076-6879(07)26001-X; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; WANG YL, 2007, SCI STKE, pE10; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200	24	526	536	5	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 30	2009	323	5914					642	644		10.1126/science.1168441	http://dx.doi.org/10.1126/science.1168441			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179533				2022-12-24	WOS:000262862800045
J	Lichtenstein, P; Yip, BH; Bjork, C; Pawitan, Y; Cannon, TD; Sullivan, PF; Hultman, CM				Lichtenstein, Paul; Yip, Benjamin H.; Bjork, Camilla; Pawitan, Yudi; Cannon, Tyrone D.; Sullivan, Patrick F.; Hultman, Christina M.			Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study	LANCET			English	Article							GENOME SCAN METAANALYSIS; CANDIDATE GENES; BINARY TRAITS; RISK-FACTORS; I DISORDER; TWIN; SUSCEPTIBILITY; PSYCHOSIS; RELATIVES; REGISTER	Background Whether schizophrenia and bipolar disorder are the clinical outcomes of discrete or shared causative processes is much debated in psychiatry. We aimed to assess genetic and environmental contributions to liability for schizophrenia, bipolar disorder, and their comorbidity. Methods We linked the multi-generation register, which contains information about all children and their parents in Sweden, and the hospital discharge register, which includes all public psychiatric inpatient admissions in Sweden. We identified 9 009 202 unique individuals in more than 2 million nuclear families between 1973 and 2004. Risks for schizophrenia, bipolar disorder, and their comorbidity were assessed for biological and adoptive parents, offspring, full-siblings and half-siblings of probands with one of the diseases. We used a multivariate generalised linear mixed model for analysis of genetic and environmental contributions to liability for schizophrenia, bipolar disorder, and comorbidity. Findings First-degree relatives of probands with either schizophrenia (n=35 985) or bipolar disorder (n=40 487) were at increased risk of these disorders. Half-siblings had a significantly increased risk (schizophrenia: relative risk [RR] 3.6, 95% CI 2.3-5.5 for maternal half-siblings, and 2.7, 1. 9-3 . 8 for paternal half-siblings; bipolar disorder: 4.5, 2.7-7.4 for maternal half-siblings, and 2.4, 1.4-4-1 for paternal half-siblings), but substantially lower than that of the full-siblings (schizophrenia: 9.0, 8.5-11 .6; bipolar disorder: 7.9, 7.1-8.8). When relatives of probands with bipolar disorder were analysed, increased risks for schizophrenia existed for all relationships, including adopted children to biological parents with bipolar disorder. Heritability for schizophrenia and bipolar disorder was 64% and 59%, respectively. Shared environmental effects were small but substantial (schizophrenia: 4.5%, 4.4%-7.4%; bipolar disorder: 3.4%, 2.3%-6.2%) for both disorders. The comorbidity between disorders was mainly (63%) due to additive genetic effects common to both disorders. Interpretation Similar to molecular genetic studies, we showed evidence that schizophrenia and bipolar disorder partly share a common genetic cause. These results challenge the current nosological dichotomy between schizophrenia and bipolar disorder, and are consistent with a reappraisal of these disorders as distinct diagnostic entities. Funding Swedish Council for Working Life and Social Research, and the Swedish Research Council.	[Lichtenstein, Paul; Yip, Benjamin H.; Bjork, Camilla; Pawitan, Yudi; Sullivan, Patrick F.; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Hultman, Christina M.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Cannon, Tyrone D.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Cannon, Tyrone D.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90024 USA; [Cannon, Tyrone D.] Univ Calif Los Angeles, Dept Biobehav Sci, Los Angeles, CA 90024 USA	Karolinska Institutet; Uppsala University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lichtenstein, P (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	paul.lichtenstein@ki.se	YIP, Benjamin HK/I-2336-2013; Yip, Benjamin/AAC-7845-2019	Yip, Benjamin/0000-0002-4749-7611; lichtenstein, paul/0000-0003-3037-5287	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH077139] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1992, INT CLASS DIS; Arvidsson H, 2005, NORD J PSYCHIAT, V59, P186, DOI 10.1080/08039480510023061; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Berrettini W, 2003, AM J MED GENET C, V123C, P59, DOI 10.1002/ajmg.c.20014; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; Carter CJ, 2007, SCHIZOPHRENIA BULL, V33, P1343, DOI 10.1093/schbul/sbm007; Dalman C, 2002, SOC PSYCH PSYCH EPID, V37, P527, DOI 10.1007/s00127-002-0582-3; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; GENTZ A, 1992, J COMPUTATIONAL GRAP, V1, P141; Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P952; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; McIntosh AM, 2005, BIOL PSYCHIAT, V58, P254, DOI 10.1016/j.biopsych.2005.03.044; McQueen MB, 2005, AM J HUM GENET, V77, P582, DOI 10.1086/491603; Mortensen PB, 2003, ARCH GEN PSYCHIAT, V60, P1209, DOI 10.1001/archpsyc.60.12.1209; NEALE MC, 1994, BEHAV GENET, V24, P239, DOI 10.1007/BF01067191; Owen MJ, 2007, SCHIZOPHRENIA BULL, V33, P905, DOI 10.1093/schbul/sbm053; Pawitan Y, 2004, STAT MED, V23, P449, DOI 10.1002/sim.1603; Pawitan Y, 2001, ALL LIKELIHOOD STAT; Perlis RH, 2008, ARCH GEN PSYCHIAT, V65, P53, DOI 10.1001/archgenpsychiatry.2007.15; SAS Institute Inc, 2004, SAS STAT SOFTW VERS; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; *STAT SWED, 2006, MULT REG 2005 DESCR; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P1121, DOI 10.1016/j.biopsych.2006.11.010; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tsuang MT, 2004, J PSYCHIATR RES, V38, P3, DOI 10.1016/S0022-3956(03)00096-7; *WHO, 1978, INT CLASS DIS; World Health Organization, 1967, INT CLASS DIS; Yip BH, 2008, STAT MED, V27, P1086, DOI 10.1002/sim.2996	33	1397	1420	2	250	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					234	239		10.1016/S0140-6736(09)60072-6	http://dx.doi.org/10.1016/S0140-6736(09)60072-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150704	Green Accepted			2022-12-24	WOS:000262537500026
J	Schumacher, MA; Piro, KM; Xu, W; Hansen, S; Lewis, K; Brennan, RG				Schumacher, Maria A.; Piro, Kevin M.; Xu, Weijun; Hansen, Sonja; Lewis, Kim; Brennan, Richard G.			Molecular Mechanisms of HipA-Mediated Multidrug Tolerance and Its Neutralization by HipB	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; ELONGATION-FACTOR-TU; PERSISTER CELLS; AFFECTS LETHALITY; AFFECTS FREQUENCY; MUREIN SYNTHESIS; DNA-SYNTHESIS; INHIBITION; PEPTIDOGLYCAN; COMPLEX	Bacterial multidrug tolerance is largely responsible for the inability of antibiotics to eradicate infections and is caused by a small population of dormant bacteria called persisters. HipA is a critical Escherichia coli persistence factor that is normally neutralized by HipB, a transcription repressor, which also regulates hipBA expression. Here, we report multiple structures of HipA and a HipA-HipB-DNA complex. HipA has a eukaryotic serine/threonine kinase-like fold and can phosphorylate the translation factor EF-Tu, suggesting a persistence mechanism via cell stasis. The HipA-HipB-DNA structure reveals the HipB-operator binding mechanism, similar to 70 degrees DNA bending, and unexpected HipA-DNA contacts. Dimeric HipB interacts with two HipA molecules to inhibit its kinase activity through sequestration and conformational inactivation. Combined, these studies suggest mechanisms for HipA-mediated persistence and its neutralization by HipB.	[Schumacher, Maria A.; Piro, Kevin M.; Xu, Weijun; Brennan, Richard G.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, Houston, TX 77030 USA; [Hansen, Sonja; Lewis, Kim] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Hansen, Sonja; Lewis, Kim] Northeastern Univ, Antimicrobial Discovery Ctr, Boston, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Northeastern University; Northeastern University	Schumacher, MA (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, 1515 Holcombe Blvd, Houston, TX 77030 USA.	maschuma@mdanderson.org; rgbrenna@mdanderson.org		Brennan, Richard/0000-0001-7647-485X	Burroughs Wellcome [992863]; NIH [GM074815, GM061162, AI048593]; Robert A. Welch Foundation [G0040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815, R01GM061162] Funding Source: NIH RePORTER	Burroughs Wellcome(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. R. Knudsen for her generous gift of the GST-EF-Tu expression construct. Coordinates and structure factor amplitudes for the apoHipA, HipA-ATP, HipA-HipB-DNA, and HipA(ATP)-HipB-DNA complexes have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (www.rcsb.org/) under accession codes 3DNU, 3DNT, 3DNV, and 3DNW, respectively. We acknowledge support from Burroughs Wellcome Career Development Award 992863 and NIH grant GM074815 (to M. A. S.), NIH grant GM061162 (to K. L.), and the Robert A. Welch Foundation (grant G0040) and NIH grant AI048593 (to R. G. B.).	ALEXANDER C, 1995, J BIOL CHEM, V270, P14541, DOI 10.1074/jbc.270.24.14541; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; LIPPMANN C, 1993, J BIOL CHEM, V268, P601; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Nyborg J, 1998, FEBS LETT, V430, P95, DOI 10.1016/S0014-5793(98)00624-3; Papapanagiotou I, 2007, NUCLEIC ACIDS RES, V35, P2643, DOI 10.1093/nar/gkm129; SCHERRER R, 1988, J BACTERIOL, V170, P3321, DOI 10.1128/jb.170.8.3321-3326.1988; SHAH D, 2006, BMC MICROBIOL, V12, P6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514; WOLBERGER C, 1988, NATURE, V335, P789, DOI 10.1038/335789a0	30	242	252	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					396	401		10.1126/science.1163806	http://dx.doi.org/10.1126/science.1163806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150849	Green Accepted			2022-12-24	WOS:000262481400043
J	Lauren, J; Gimbel, DA; Nygaard, HB; Gilbert, JW; Strittmatter, SM				Lauren, Juha; Gimbel, David A.; Nygaard, Haakon B.; Gilbert, John W.; Strittmatter, Stephen M.			Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers	NATURE			English	Article							ALZHEIMERS-DISEASE; NATURAL OLIGOMERS; TRANSGENIC MICE; BINDING-SITES; PRP; RECEPTORS; MEMORY; IDENTIFICATION; TRANSMISSION; A-BETA(1-42)	A pathological hallmark of Alzheimer's disease is an accumulation of insoluble plaque containing the amyloid-beta peptide of 40-42 amino acid residues(1). Prefibrillar, soluble oligomers of amyloid-beta have been recognized to be early and key intermediates in Alzheimer's-disease-related synaptic dysfunction(2-9). At nanomolar concentrations, soluble amyloid-beta oligomers block hippocampal long-term potentiation(7), cause dendritic spine retraction from pyramidal cells(5,8) and impair rodent spatial memory(2). Soluble amyloid-beta oligomers have been prepared from chemical syntheses, transfected cell culture supernatants, transgenic mouse brain and human Alzheimer's disease brain(2,4,7,9). Together, these data imply a high-affinity cell-surface receptor for soluble amyloid-beta oligomers on neurons-one that is central to the pathophysiological process in Alzheimer's disease. Here we identify the cellular prion protein (PrPC) as an amyloid-beta-oligomer receptor by expression cloning. Amyloid-beta oligomers bind with nanomolar affinity to PrPC, but the interaction does not require the infectious PrPSc conformation. Synaptic responsiveness in hippocampal slices from young adult PrP null mice is normal, but the amyloid-beta oligomer blockade of long-term potentiation is absent. Anti-PrP antibodies prevent amyloid-beta-oligomer binding to PrPC and rescue synaptic plasticity in hippocampal slices from oligomeric amyloid-beta. Thus, PrPC is a mediator of amyloid-beta-oligomer-induced synaptic dysfunction, and PrPC-specific pharmaceuticals may have therapeutic potential for Alzheimer's disease.	[Lauren, Juha; Gimbel, David A.; Nygaard, Haakon B.; Gilbert, John W.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06536 USA	Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092	Brown-Coxe Postdoctoral Fellow; NIH [5T32GN07205]; Kavli Institute for Neuroscience at Yale University; Falk Medical Research Trust; NIDA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039962, R37NS033020, R01NS042304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	Brown-Coxe Postdoctoral Fellow; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Institute for Neuroscience at Yale University; Falk Medical Research Trust; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Tomita for cRNAs encoding GluR1-4 and stargazin (also known as CACNG2), B. Chesebro for providing us the Prnp null mice, M. Schachner for providing the PrP-Fc expression vector, E. Flechsig, C. Weismann and D. Harris for providing the PrP C deletion expression plasmids, D. Westaway for the Sprn expression plasmid and P. Seeburg for N-methyl-D-aspartate receptor subunit cDNAs. We thank S. Sodi for assistance with mouse husbandry. We thank E. Folta-Stogniew for SEC, and C. Rahner and M. Graham for electron microscopy. J.L. is a Brown-Coxe Postdoctoral Fellow, J.W.G. is supported by NIH Medical Scientist training Program grant 5T32GN07205, and S. M. S. is a member of the Kavli Institute for Neuroscience at Yale University. This work was supported by research grants from the Falk Medical Research Trust and the NIH to S. M. S. The SEC was supported by a NIDA-funded Neuroproteomic Center.	Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Curtis J, 2003, NEUROBIOL DIS, V13, P55, DOI 10.1016/S0969-9961(03)00017-2; Folta-Stogniew Ewa, 2006, V328, P97; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Papassotiropoulos A, 2005, HUM MOL GENET, V14, P2241, DOI 10.1093/hmg/ddi228; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Riemenschneider M, 2004, NEUROLOGY, V63, P364, DOI 10.1212/01.WNL.0000130198.72589.69; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yehiely F, 1997, NEUROBIOL DIS, V3, P339, DOI 10.1006/nbdi.1997.0130	37	1212	1268	3	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1128	U84		10.1038/nature07761	http://dx.doi.org/10.1038/nature07761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242475	Green Accepted			2022-12-24	WOS:000263680100040
J	Cruz, JA; Westhof, E				Cruz, Jose Almeida; Westhof, Eric			The Dynamic Landscapes of RNA Architecture	CELL			English	Article							GROUP-II INTRON; RIBOSOMAL-SUBUNIT; CRYSTAL-STRUCTURE; INDUCED FIT; TRANSCRIPTION; RIBOSWITCH; KINETICS; RIBOZYME; INTERMEDIATE; CATALYSIS	A wealth of information on RNA folding and ribonucleoprotein assembly has emerged from analyses of structures and from the use of innovative biophysical tools. Although integrating data obtained from static structures with dynamic measurements presents major challenges, such efforts are opening new vistas on the RNA folding landscape.	[Cruz, Jose Almeida; Westhof, Eric] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Westhof, E (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France.	e.westhof@ibmc.u-strasbg.fr		Almeida Cruz, Jose/0000-0003-1425-1444				Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Breaker RR, 2008, SCIENCE, V319, P1795, DOI 10.1126/science.1152621; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Chauhan S, 2008, J AM CHEM SOC, V130, P1296, DOI 10.1021/ja076166i; Geis M, 2008, J MOL BIOL, V379, P160, DOI 10.1016/j.jmb.2008.02.064; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Jackson SA, 2006, RNA, V12, P2149, DOI 10.1261/rna.184206; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Mahen EM, 2005, MOL CELL, V19, P27, DOI 10.1016/j.molcel.2005.05.025; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Pereira MJB, 2008, J MOL BIOL, V382, P496, DOI 10.1016/j.jmb.2008.07.020; Russell R, 2006, J MOL BIOL, V363, P531, DOI 10.1016/j.jmb.2006.08.024; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; STEINER M, 2008, NATL ACAD SCI US, V105, P13853; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Waldsich C, 2008, J MOL BIOL, V375, P572, DOI 10.1016/j.jmb.2007.10.052; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601	31	226	232	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					604	609		10.1016/j.cell.2009.02.003	http://dx.doi.org/10.1016/j.cell.2009.02.003			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239882	Bronze			2022-12-24	WOS:000263688200012
J	Sharp, PA				Sharp, Phillip A.			The Centrality of RNA	CELL			English	Article							GENE; TRANSCRIPTION; INTERFERENCE; ARGONAUTE; DNA	New roles for RNAs in biology continue to emerge, and a glance at the history of RNAs may prepare molecular biologists for future discoveries about these powerful molecules. A striking new role for RNAs is their widespread involvement in the regulation of numerous genes, suggesting that there is much yet to discover about these amazing cellular components.	[Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu						Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Lacadie SA, 2006, GENE DEV, V20, P2055, DOI 10.1101/gad.1434706; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	25	298	307	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					577	580		10.1016/j.cell.2009.02.007	http://dx.doi.org/10.1016/j.cell.2009.02.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239877	Bronze, Green Published			2022-12-24	WOS:000263688200007
J	Fejes-Toth, K; Sotirova, V; Sachidanandam, R; Assaf, G; Hannon, GJ; Kapranov, P; Foissac, S; Willingham, AT; Duttagupta, R; Dumais, E; Gingeras, TR				Fejes-Toth, Katalin; Sotirova, Vihra; Sachidanandam, Ravi; Assaf, Gordon; Hannon, Gregory J.; Kapranov, Philipp; Foissac, Sylvain; Willingham, Aarron T.; Duttagupta, Radha; Dumais, Erica; Gingeras, Thomas R.		Affymetrix Cold Spring Harbor Lab	Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs	NATURE			English	Article							GENE-EXPRESSION; HUMAN GENOME; CELLS; IDENTIFICATION; TRANSCRIPTION; REVEAL; MAPS	The transcriptomes of eukaryotic cells are incredibly complex. Individual non- coding RNAs dwarf the number of protein- coding genes, and include classes that are well understood as well as classes for which the nature, extent and functional roles are obscure(1). Deep sequencing of small RNAs (, 200 nucleotides) from human HeLa and HepG2 cells revealed a remarkable breadth of species. These arose both from within annotated genes and from unannotated intergenic regions. Overall, small RNAs tended to align with CAGE ( cap- analysis of gene expression) tags(2), which mark the 5 ' ends of capped, long RNA transcripts. Many small RNAs, including the previously described promoter- associated small RNAs3, appeared to possess cap structures. Members of an extensive class of both small RNAs and CAGE tags were distributed across internal exons of annotated protein coding and noncoding genes, sometimes crossing exon - exon junctions. Here we show that processing of mature mRNAs through an as yet unknown mechanism may generate complex populations of both long and short RNAs whose apparently capped 5 ' ends coincide. Supplying synthetic promoter- associated small RNAs corresponding to the c-MYC transcriptional start site reduced MYC messenger RNA abundance. The studies presented here expand the catalogue of cellular small RNAs and demonstrate a biological impact for at least one class of non- canonical small RNAs.	[Fejes-Toth, Katalin; Sotirova, Vihra; Sachidanandam, Ravi; Assaf, Gordon; Gingeras, Thomas R.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Fejes-Toth, Katalin; Sotirova, Vihra; Assaf, Gordon; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Kapranov, Philipp; Foissac, Sylvain; Willingham, Aarron T.; Duttagupta, Radha; Dumais, Erica; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA 95051 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Affymetrix	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu; gingeras@cshl.edu	Hannon, Gregory/AAB-3568-2019; sachidanandam, ravi/Q-6916-2019	sachidanandam, ravi/0000-0001-9844-4459; Gingeras, Thomas/0000-0001-9106-3573; Foissac, Sylvain/0000-0002-2631-5356	Schering Foundation; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004557] Funding Source: NIH RePORTER	Schering Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank L. Cardone, D. Rebolini, M. Kramer, and W. R. McCombie for Illumina sequencing. We wish to thank J. Brosius, J. Schmitz and T. Rozhdestvensky for their help with the small RNA cloning protocol and J. Dumais for technical assistance. K.F.-T. was in part supported by the Schering Foundation. This work was supported in part by grants from the NIH and was performed as part of the ENCODE consortium (G.J.H. and T.R.G.). G.J.H is an investigator of the Howard Hughes Medical Institute.	BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOCHNIG P, 1987, EUR J BIOCHEM, V168, P461, DOI 10.1111/j.1432-1033.1987.tb13439.x; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; EDDY S, 2006, UCSC GENOME BROWSER; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672	20	302	330	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1028	1032		10.1038/nature07759	http://dx.doi.org/10.1038/nature07759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19169241	Green Accepted, Green Published			2022-12-24	WOS:000263425400046
J	Visel, A; Blow, MJ; Li, ZR; Zhang, T; Akiyama, JA; Holt, A; Plajzer-Frick, I; Shoukry, M; Wright, C; Chen, F; Afzal, V; Ren, B; Rubin, EM; Pennacchio, LA				Visel, Axel; Blow, Matthew J.; Li, Zirong; Zhang, Tao; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Wright, Crystal; Chen, Feng; Afzal, Veena; Ren, Bing; Rubin, Edward M.; Pennacchio, Len A.			ChIP-seq accurately predicts tissue-specific activity of enhancers	NATURE			English	Article							GENOME; CHROMATIN; SEQUENCE; VERTEBRATE; CONSTRAINT; PROMOTERS; DATABASE; IDENTIFICATION; COACTIVATOR; RECRUITMENT	A major yet unresolved quest in decoding the human genome is the identification of the regulatory sequences that control the spatial and temporal expression of genes. Distant- acting transcriptional enhancers are particularly challenging to uncover because they are scattered among the vast non- coding portion of the genome. Evolutionary sequence constraint can facilitate the discovery of enhancers, but fails to predict when and where they are active in vivo. Here we present the results of chromatin immunoprecipitation with the enhancer- associated protein p300 followed by massively parallel sequencing, and map several thousand in vivo binding sites of p300 in mouse embryonic forebrain, midbrain and limb tissue. We tested 86 of these sequences in a transgenic mouse assay, which in nearly all cases demonstrated reproducible enhancer activity in the tissues that were predicted by p300 binding. Our results indicate that in vivo mapping of p300 binding is a highly accurate means for identifying enhancers and their associated activities, and suggest that such data sets will be useful to study the role of tissue- specific enhancers in human biology and disease on a genome- wide scale.	[Visel, Axel; Blow, Matthew J.; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Blow, Matthew J.; Zhang, Tao; Wright, Crystal; Chen, Feng; Rubin, Edward M.; Pennacchio, Len A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Li, Zirong; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Pennacchio, LA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, MS 84-171, Berkeley, CA 94720 USA.	LAPennacchio@lbl.gov	Ding, Cheng-Qiang/B-6287-2011; Visel, Axel/A-9398-2009; Blow, Matthew/G-6369-2012	Visel, Axel/0000-0002-4130-7784; Blow, Matthew/0000-0002-8844-9149; Pennacchio, Len/0000-0002-8748-3732	Berkeley-PGA; National Heart, Lung, & Blood Institute; National Human Genome Research Institute; American Heart Association; Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062859] Funding Source: NIH RePORTER	Berkeley-PGA; National Heart, Lung, & Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Heart Association(American Heart Association); Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank R. Hosseini and S. Phouanenavong for technical support, and J. Rubenstein, J. Long, J. Choi and Y. Zhu for help with microarray experiments. This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. L. A. P. and E. M. R. were supported by the Berkeley-PGA, under the Programs for Genomic Applications, funded by National Heart, Lung, & Blood Institute, and L. A. P. by the National Human Genome Research Institute. A. V. was supported by an American Heart Association postdoctoral fellowship. B. R. was supported by grants from the National Human Genome Research Institute and the Ludwig Institute for Cancer Research.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng Y, 2008, GENOME RES, V18, P1896, DOI 10.1101/gr.083089.108; Cooper GM, 2008, GENOME RES, V18, P201, DOI 10.1101/gr.7205808; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Krawchuk D, 2008, DEV DYNAM, V237, P1183, DOI 10.1002/dvdy.21514; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	53	1192	1232	4	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					854	858		10.1038/nature07730	http://dx.doi.org/10.1038/nature07730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212405	Green Submitted, Green Accepted			2022-12-24	WOS:000263266700039
J	Carnaval, AC; Hickerson, MJ; Haddad, CFB; Rodrigues, MT; Moritz, C				Carnaval, Ana Carolina; Hickerson, Michael J.; Haddad, Celio F. B.; Rodrigues, Miguel T.; Moritz, Craig			Stability Predicts Genetic Diversity in the Brazilian Atlantic Forest Hotspot	SCIENCE			English	Article							RAIN-FOREST; CLIMATE DYNAMICS; LATE QUATERNARY; PHYLOGEOGRAPHY; CONSERVATION; BIODIVERSITY; SELECTION; AMAZONIA; ENDEMISM; REPTILES	Biodiversity hotspots, representing regions with high species endemism and conservation threat, have been mapped globally. Yet, biodiversity distribution data from within hotspots are too sparse for effective conservation in the face of rapid environmental change. Using frogs as indicators, ecological niche models under paleoclimates, and simultaneous Bayesian analyses of multispecies molecular data, we compare alternative hypotheses of assemblage- scale response to late Quaternary climate change. This reveals a hotspot within the Brazilian Atlantic forest hotspot. We show that the southern Atlantic forest was climatically unstable relative to the central region, which served as a large climatic refugium for neotropical species in the late Pleistocene. This sets new priorities for conservation in Brazil and establishes a validated approach to biodiversity prediction in other understudied, species- rich regions.	[Carnaval, Ana Carolina; Moritz, Craig] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Hickerson, Michael J.] CUNY Queens Coll, Dept Biol, Flushing, NY 11367 USA; [Haddad, Celio F. B.] UNESP, Dept Zool, Inst Biociencias, BR-35264100 Rio Claro, SP, Brazil; [Rodrigues, Miguel T.] Univ Fed Sao Paulo, Dept Zool, Inst Biociencias, BR-05508090 Sao Paulo, SP, Brazil	University of California System; University of California Berkeley; City University of New York (CUNY) System; Queens College NY (CUNY); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Carnaval, AC (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	carnaval@berkeley.edu	Haddad, Célio F. B./C-4267-2012; Rodrigues, Miguel T./F-8174-2012; Moritz, Craig/A-7755-2012	Haddad, Célio F. B./0000-0002-7044-5764; Rodrigues, Miguel T./0000-0003-3958-9919; Moritz, Craig/0000-0001-5313-7279; Carnaval, Ana/0000-0002-4399-1313	NSF [DBI 0512013, DEB 0743648, DEB 416250, DEB 0817035]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	NSF(National Science Foundation (NSF)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank U. Caramaschi and H. Zaher for providing access to collections MNRJ and MZUSP; O. Peixoto, M. Gomes, A. Muri, R. Kautskyi, S. Lima, E. Santos, J. S. Filho, J. V. Filho, G. Barros, J. Queiroz, R. Araljo, L. Japp, H. Japp, J. Giovanelli, J. Alexandrino, L. Toledo, O. Araljo, G. Egito, J. Zina, D. Loebmann, D. Pavan, R. Amaro, V. Verdade, F. Curcio, M. Dixo, and J. Cassimiro for field work assistance; W. Monahan and R. Hijmans for discussions about the modeling work; L. Smith and D. Turong for DNA- sequencing assistance; R. Pereira, R. Damasceno, S. Rovito, J. Kolbe, S. Singhal, R. Puschendorf, and A. Pounds for discussions about earlier versions of the manuscript. Funding was provided by the NSF (awards DBI 0512013 to A.C.C., DEB 0743648 to M.J.H., DEB 416250 and DEB 0817035 to C.M.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grants to C.F.B.H. and M.T.R.). Sequences are deposited in GenBank (FJ502639-FJ502822). A.C.C. and C. M. designed the study; A.C.C., C.F.B.H., and M.T.R. collected the data; A.C.C., C.M. and M.J.H. analyzed the data; A.C.C. wrote the paper. All authors discussed the results and commented on earlier versions of the manuscript.	Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; BALLARD JWO, 1994, GENETICS, V138, P757; Behling H, 2002, PALAEOGEOGR PALAEOCL, V179, P227, DOI 10.1016/S0031-0182(01)00435-7; Behling H, 2001, QUATERNARY RES, V56, P383, DOI 10.1006/qres.2001.2264; Cabanne GS, 2008, MOL PHYLOGENET EVOL, V49, P760, DOI 10.1016/j.ympev.2008.09.013; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Fay JC, 2000, GENETICS, V155, P1405; FROST DR, 2008, AMPHIBIAN SPECIES WO; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Haddad C.F.B., 2008, ANFIBIOS MATA ATLANT; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hickerson MJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-322; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Ledru MP, 2007, DIVERS DISTRIB, V13, P761, DOI 10.1111/j.1472-4642.2007.00389.x; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Rodrigues MT, 2005, CONSERV BIOL, V19, P659, DOI 10.1111/j.1523-1739.2005.00690.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Tajima F, 1996, GENETICS, V143, P1457; TAMURA K, 1992, MOL BIOL EVOL, V9, P678	30	756	778	1	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					785	789		10.1126/science.1166955	http://dx.doi.org/10.1126/science.1166955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197066				2022-12-24	WOS:000263066800048
J	Steigemann, P; Wurzenberger, C; Schmitz, MHA; Held, M; Guizetti, J; Maar, S; Gerlich, DW				Steigemann, Patrick; Wurzenberger, Claudia; Schmitz, Michael H. A.; Held, Michael; Guizetti, Julien; Maar, Sandra; Gerlich, Daniel W.			Aurora B-Mediated Abscission Checkpoint Protects against Tetraploidization	CELL			English	Article							CHROMOSOME SEGREGATION; ANAPHASE BRIDGES; IN-VITRO; CYTOKINESIS; CELLS; CANCER; PHOSPHORYLATION; NONDISJUNCTION; LOCALIZATION; PROGRESSION	Genomic abnormalities are often seen in tumor cells, and tetraploidization, which results from failures during cytokinesis, is presumed to be an early step in cancer formation. Here, we report a cell division control mechanism that prevents tetraploidization in human cells with perturbed chromosome segregation. First, we found that Aurora B inactivation promotes completion of cytokinesis by abscission. Chromosome bridges sustained Aurora B activity to posttelophase stages and thereby delayed abscission at stabilized intercellular canals. This was essential to suppress tetraploidization by furrow regression in a pathway further involving the phosphorylation of mitotic kinesin-like protein 1 (Mklp1). We propose that Aurora B is part of a sensor that responds to unsegregated chromatin at the cleavage site. Our study provides evidence that in human cells abscission is coordinated with the completion of chromosome segregation to protect against tetraploidization by furrow regression.	[Steigemann, Patrick; Wurzenberger, Claudia; Schmitz, Michael H. A.; Held, Michael; Guizetti, Julien; Maar, Sandra; Gerlich, Daniel W.] Swiss Inst Technol Zurich ETHZ, Inst Biochem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gerlich, DW (corresponding author), Swiss Inst Technol Zurich ETHZ, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	daniel.gerlich@bc.biol.ethz.ch	Guizetti, Julien/AAF-3793-2020; Gerlich, Daniel Wolfram W/A-6991-2016	Guizetti, Julien/0000-0002-8762-4259; Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Guizetti, Julien/0000-0002-7735-4689				Acilan C, 2007, GENE CHROMOSOME CANC, V46, P522, DOI 10.1002/gcc.20425; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Cimini D, 2003, MOL BIOL CELL, V14, P3821, DOI 10.1091/mbc.E03-01-0860; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Jensen CG, 1996, CARCINOGENESIS, V17, P2013, DOI 10.1093/carcin/17.9.2013; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Keppler A, 2006, BIOTECHNIQUES, V41, P167, DOI 10.2144/000112216; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Muhlhausser P, 2007, J CELL BIOL, V178, P595, DOI 10.1083/jcb.200703002; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; PELIN K, 1992, TOXICOL IN VITRO, V6, P445, DOI 10.1016/0887-2333(92)90051-R; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Weaver BAA, 2006, NATURE, V442, pE9, DOI 10.1038/nature05139; Yan XM, 2005, GENES CELLS, V10, P617, DOI 10.1111/j.1365-2443.2005.00863.x; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	34	441	443	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					473	484		10.1016/j.cell.2008.12.020	http://dx.doi.org/10.1016/j.cell.2008.12.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203582	Bronze			2022-12-24	WOS:000263120600017
J	Ekiert, DC; Bhabha, G; Elsliger, MA; Friesen, RHE; Jongeneelen, M; Throsby, M; Goudsmit, J; Wilson, IA				Ekiert, Damian C.; Bhabha, Gira; Elsliger, Marc-Andre; Friesen, Robert H. E.; Jongeneelen, Mandy; Throsby, Mark; Goudsmit, Jaap; Wilson, Ian A.			Antibody Recognition of a Highly Conserved Influenza Virus Epitope	SCIENCE			English	Article							A VIRUSES; MEMBRANE-FUSION; HIV-1 NEUTRALIZATION; STRUCTURAL BASIS; AVIAN INFLUENZA; BINDING SITE; HEMAGGLUTININ; RECEPTOR; COMPLEX; PH	Influenza virus presents an important and persistent threat to public health worldwide, and current vaccines provide immunity to viral isolates similar to the vaccine strain. High-affinity antibodies against a conserved epitope could provide immunity to the diverse influenza subtypes and protection against future pandemic viruses. Cocrystal structures were determined at 2.2 and 2.7 angstrom resolutions for broadly neutralizing human antibody CR6261 Fab in complexes with the major surface antigen (hemagglutinin, HA) from viruses responsible for the 1918 H1N1 influenza pandemic and a recent lethal case of H5N1 avian influenza. In contrast to other structurally characterized influenza antibodies, CR6261 recognizes a highly conserved helical region in the membrane-proximal stem of HA1 and HA2. The antibody neutralizes the virus by blocking conformational rearrangements associated with membrane fusion. The CR6261 epitope identified here should accelerate the design and implementation of improved vaccines that can elicit CR6261-like antibodies, as well as antibody-based therapies for the treatment of influenza.	[Ekiert, Damian C.; Bhabha, Gira; Elsliger, Marc-Andre; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Friesen, Robert H. E.; Jongeneelen, Mandy; Throsby, Mark; Goudsmit, Jaap] Crucell Holland BV, NL-2301 CA Leiden, Netherlands; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Johnson & Johnson; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu		Ekiert, Damian/0000-0002-2570-0404; Elsliger, Marc Andre/0000-0002-1989-7626	NIH [AI-058113]; predoctoral fellowship from the Achievement Rewards for College Scientists Foundation; Skaggs Institute; NIH National Institute of General Medical Sciences (NIGMS) [U54 GM074898, Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074898] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); predoctoral fellowship from the Achievement Rewards for College Scientists Foundation; Skaggs Institute; NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)General Electric); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grant AI-058113 (I.A.W.) and a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation (D.C.E.) and the Skaggs Institute. The Joint Center for Structural Genomics (JCSG) is supported by NIH National Institute of General Medical Sciences (NIGMS) (U54 GM074898). The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the Advanced Photon Source (APS) was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the NIH. The authors thank H. Tien and D. Marciano of the Robotics Core at the JCSG for automated crystal screening; C. Ogata and the staff of the APS GM/CA CAT 23-ID-B for beamline support; X. Dai and R. Stanfield for excellent assistance with data collection and processing and analyses; R. Pejchal, M. Crispin, M. Wormald, and D. Wolan for valuable comments; and R. Lerner for insightful discussion. This is publication 19980 from the Scripps Research Institute. Coordinates and structure factors are deposited in the Protein Data Bank (PDB) (3GBN and 3GBM for CR6261-SC1918/H1 and CR6261-Viet04/H5, respectively).	Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; BEAN WJ, 1992, J VIROL, V66, P1129, DOI 10.1128/JVI.66.2.1129-1138.1992; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fleury D, 2000, PROTEINS, V40, P572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lerner RA, 2006, ANGEW CHEM INT EDIT, V45, P8106, DOI 10.1002/anie.200603381; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; Smirnov YA, 1999, ACTA VIROL, V43, P237; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zwick MB, 2007, CURR HIV RES, V5, P608, DOI 10.2174/157016207782418443; 2008, MMWR MORB MORTAL WKL, V57, P393	39	995	1123	2	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					246	251		10.1126/science.1171491	http://dx.doi.org/10.1126/science.1171491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19251591	Green Accepted			2022-12-24	WOS:000265024400045
J	Guttman, M; Amit, I; Garber, M; French, C; Lin, MF; Feldser, D; Huarte, M; Zuk, O; Carey, BW; Cassady, JP; Cabili, MN; Jaenisch, R; Mikkelsen, TS; Jacks, T; Hacohen, N; Bernstein, BE; Kellis, M; Regev, A; Rinn, JL; Lander, ES				Guttman, Mitchell; Amit, Ido; Garber, Manuel; French, Courtney; Lin, Michael F.; Feldser, David; Huarte, Maite; Zuk, Or; Carey, Bryce W.; Cassady, John P.; Cabili, Moran N.; Jaenisch, Rudolf; Mikkelsen, Tarjei S.; Jacks, Tyler; Hacohen, Nir; Bernstein, Bradley E.; Kellis, Manolis; Regev, Aviv; Rinn, John L.; Lander, Eric S.			Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals	NATURE			English	Article							X-INACTIVATION CENTER; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; MOUSE OOCYTES; STEM-CELLS; GENOME; CHROMOSOME; INTERFERENCE; SEQUENCES; NOISE	There is growing recognition that mammalian cells produce many thousands of large intergenic transcripts(1-4). However, the functional significance of these transcripts has been particularly controversial. Although there are some well-characterized examples, most (>95%) show little evidence of evolutionary conservation and have been suggested to represent transcriptional noise(5,6). Here we report a new approach to identifying large non-coding RNAs using chromatin-state maps to discover discrete transcriptional units intervening known protein-coding loci. Our approach identified similar to 1,600 large multi-exonic RNAs across four mouse cell types. In sharp contrast to previous collections, these large intervening non-coding RNAs (lincRNAs) show strong purifying selection in their genomic loci, exonic sequences and promoter regions, with greater than 95% showing clear evolutionary conservation. We also developed a functional genomics approach that assigns putative functions to each lincRNA, demonstrating a diverse range of roles for lincRNAs in processes from embryonic stem cell pluripotency to cell proliferation. We obtained independent functional validation for the predictions for over 100 lincRNAs, using cell-based assays. In particular, we demonstrate that specific lincRNAs are transcriptionally regulated by key transcription factors in these processes such as p53, NF kappa B, Sox2, Oct4 (also known as Pou5f1) and Nanog. Together, these results define a unique collection of functional lincRNAs that are highly conserved and implicated in diverse biological processes.	[Guttman, Mitchell; Amit, Ido; Garber, Manuel; French, Courtney; Lin, Michael F.; Huarte, Maite; Zuk, Or; Mikkelsen, Tarjei S.; Hacohen, Nir; Bernstein, Bradley E.; Kellis, Manolis; Regev, Aviv; Rinn, John L.; Lander, Eric S.] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Guttman, Mitchell; Carey, Bryce W.; Cassady, John P.; Jaenisch, Rudolf; Jacks, Tyler; Regev, Aviv; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Feldser, David; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Mikkelsen, Tarjei S.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Huarte, Maite; Rinn, John L.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Cabili, Moran N.; Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Carey, Bryce W.; Cassady, John P.; Jaenisch, Rudolf; Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Bernstein, Bradley E.; Rinn, John L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rinn, JL (corresponding author), MIT & Harvard, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	jrinn@broad.mit.edu	Kellis, Manolis/ABE-7385-2020; Huarte, Maite/J-6903-2014; Mikkelsen, Tarjei S/A-1306-2007	Kellis, Manolis/0000-0001-7113-9630; Huarte, Maite/0000-0003-3753-6493; Mikkelsen, Tarjei S/0000-0002-8133-3135; Rinn, John/0000-0002-7231-7539	Human Frontier Science Program Organization; Beth Israel Deaconess Medical Center; National Human Genome Research Institute; Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG004037] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	Human Frontier Science Program Organization(Human Frontier Science Program); Beth Israel Deaconess Medical Center; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank our colleagues at the Broad Institute, especially J. P. Mesirov for discussions and statistical insights, X. Xie for statistical help with conservation analyses, J. Robinson for visualization help, M. Ku, E. Mendenhall and X. Zhang for help generating ChIP samples, and N. Novershtern and A. Levy for providing transcription factor lists. M. Guttman is a Vertex scholar, I. A. acknowledges the support of the Human Frontier Science Program Organization. This work was funded by Beth Israel Deaconess Medical Center, National Human Genome Research Institute, and the Broad Institute of MIT and Harvard.	Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sotomaru Y, 2002, J BIOL CHEM, V277, P12474, DOI 10.1074/jbc.M109212200; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	30	3061	3288	12	393	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					223	227		10.1038/nature07672	http://dx.doi.org/10.1038/nature07672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19182780	Green Accepted, Green Submitted			2022-12-24	WOS:000264059700048
J	Cator, LJ; Arthur, BJ; Harrington, LC; Hoy, RR				Cator, Lauren J.; Arthur, Ben J.; Harrington, Laura C.; Hoy, Ronald R.			Harmonic Convergence in the Love Songs of the Dengue Vector Mosquito	SCIENCE			English	Article							STERILE INSECT TECHNIQUE; FEMALE AEDES-AEGYPTI; ATTRACTION; DIPTERA; FLIGHT; SOUND; ORGAN	The familiar buzz of flying mosquitoes is an important mating signal, with the fundamental frequency of the female's flight tone signaling her presence. In the yellow fever and dengue vector Aedes aegypti, both sexes interact acoustically by shifting their flight tones to match, resulting in a courtship duet. Matching is made not at the fundamental frequency of 400 hertz ( female) or 600 hertz ( male) but at a shared harmonic of 1200 hertz, which exceeds the previously known upper limit of hearing in mosquitoes. Physiological recordings from Johnston's organ ( the mosquito's "ear") reveal sensitivity up to 2000 hertz, consistent with our observed courtship behavior. These findings revise widely accepted limits of acoustic behavior in mosquitoes.	[Arthur, Ben J.; Hoy, Ronald R.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Cator, Lauren J.; Harrington, Laura C.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Hoy, RR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	rrh3@cornell.edu			Foundation for the National Institutes of Health; Grand Challenges in Global Health Initiative and Hatch Project [NTC-139432]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000103] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health; Grand Challenges in Global Health Initiative and Hatch Project; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Wyttenbach for the suggestion to look for sustained deflections in the neural response and are grateful to L. Ristroph and I. Cohen for high-speed video of males and females in free flight. Support was provided ( to L. C. H.) from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative and Hatch Project NYC-139432.	BELTON P, 1979, ENTOMOL EXP APPL, V26, P105, DOI 10.1111/j.1570-7458.1979.tb02904.x; BELTON P, 1989, CAN J ZOOL, V67, P2625, DOI 10.1139/z89-371; BELTON P, 1994, J AM MOSQUITO CONTR, V10, P297; Belton P., 1986, P60; BELTON P, 1974, P139; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BOO KS, 1975, J INSECT PHYSIOL, V21, P1129, DOI 10.1016/0022-1910(75)90126-2; Borkent A, 2006, CAN ENTOMOL, V138, P91; BUSHLAND RC, 1955, SCIENCE, V122, P287, DOI 10.1126/science.122.3163.287; CLEMENTS AN, 1999, BIOL MOSQUITOES SENS, P740; DOWNES JA, 1969, ANNU REV ENTOMOL, V14, P271, DOI 10.1146/annurev.en.14.010169.001415; Gibson G, 2006, CURR BIOL, V16, P1311, DOI 10.1016/j.cub.2006.05.053; Gopfert MC, 2001, P ROY SOC B-BIOL SCI, V268, P333, DOI 10.1098/rspb.2000.1376; Gopfert MC, 1999, J EXP BIOL, V202, P2727; Gopfert MC, 2000, P ROY SOC B-BIOL SCI, V267, P453, DOI 10.1098/rspb.2000.1021; Haskell P. T., 1974, PHYSL INSECTA, VII, P353; Johnston C., 1855, Q J MICROSC SCI, V3, P97; KAHN MC, 1949, AM J TROP MED, V29, P811; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Mayer AM, 1874, AM NAT, V8, P577; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; ROTH LM, 1948, AM MIDL NAT, V40, P265, DOI 10.2307/2421604; SCHWARTZKOFF J, 1974, PHYSIOL INSECT, V2, P273; Scott TW, 2008, ADV EXP MED BIOL, V627, P151, DOI 10.1007/978-0-387-78225-6_13; Vreysen M.J.B., 2007, AREA WIDE CONTROL IN, P792; WILLIAMS RW, 1980, MOSQ NEWS, V40, P597; WISHART G., 1959, CANADIAN ENT, V91, P181; YOUNG ADM, 1982, PHYSIOL ENTOMOL, V7, P467, DOI 10.1111/j.1365-3032.1982.tb00323.x	28	188	197	6	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1077	1079		10.1126/science.1166541	http://dx.doi.org/10.1126/science.1166541			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19131593	Green Accepted			2022-12-24	WOS:000263478400047
J	Eilken, HM; Nishikawa, SI; Schroeder, T				Eilken, Hanna M.; Nishikawa, Shin-Ichi; Schroeder, Timm			Continuous single-cell imaging of blood generation from haemogenic endothelium	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; DEFINITIVE HEMATOPOIESIS; MOUSE EMBRYO; EXPRESSION; ORIGIN; CD41; DIFFERENTIATION; VASCULOGENESIS; PROGENITORS; COMMITMENT	Despite decades of research, the identity of the cells generating the first haematopoietic cells in mammalian embryos is unknown(1). Indeed, whether blood cells arise from mesodermal cells, mesenchymal progenitors, bipotent endothelial - haematopoietic precursors or haemogenic endothelial cells remains controversial(2-9). Proximity of endothelial and blood cells at sites of embryonic haematopoiesis, as well as their similar gene expression, led to the hypothesis of the endothelium generating blood. However, owing to lacking technology(10) it has been impossible to observe blood cell emergence continuously at the single- cell level, and the postulated existence of haemogenic endothelial cells remains disputed(1). Here, using new imaging and cell- tracking methods, we show that embryonic endothelial cells can be haemogenic. By continuous long- term single- cell observation of mouse mesodermal cells generating endothelial cell and blood colonies, it was possible to detect haemogenic endothelial cells giving rise to blood cells. Living endothelial and haematopoietic cells were identified by simultaneous detection of morphology and multiple molecular and functional markers. Detachment of nascent blood cells from endothelium is not directly linked to asymmetric cell division, and haemogenic endothelial cells are specified from cells already expressing endothelial markers. These results improve our understanding of the developmental origin of mammalian blood and the potential generation of haematopoietic stem cells from embryonic stem cells.	[Eilken, Hanna M.; Schroeder, Timm] Helmholtz Ctr Munich, German Res Ctr Environm Hlth GmbH, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Nishikawa, Shin-Ichi] RIKEN, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; RIKEN	Schroeder, T (corresponding author), Helmholtz Ctr Munich, German Res Ctr Environm Hlth GmbH, Inst Stem Cell Res, D-85764 Neuherberg, Germany.	timm.schroeder@helmholtz-muenchen.de	Schroeder, Timm/F-8448-2010	Schroeder, Timm/0000-0001-9320-0252	Deutsche Forschungsgemeinschaft; Leading Project for the Realization of Regenerative Medicine	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leading Project for the Realization of Regenerative Medicine	We are grateful to S. Nishikawa, M. A. Rieger, A. Hermann and M. Yoder for technical advice and discussions, M. Ogawa and H. Niwa for the VEVC2 and EB3 ESC lines, respectively, B. Schauberger for programming contributions, and A. Roth and C. Raithel for technical support. We thank M. Goetz, A. Hermann, M. A. Rieger and A. IJpenberg for critical reading of the manuscript. Part of this study was financed by the Deutsche Forschungsgemeinschaft to T. S. and by the Leading Project for the Realization of Regenerative Medicine to S.-I.N.	Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Choi K, 1998, DEVELOPMENT, V125, P725; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fraser ST, 2002, EXP HEMATOL, V30, P1070, DOI 10.1016/S0301-472X(02)00887-1; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Guo RY, 2007, J CELL PHYSIOL, V211, P327, DOI 10.1002/jcp.20937; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Sugiyama D, 2003, BLOOD, V101, P4733, DOI 10.1182/blood-2002-09-2799; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	30	439	453	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					896	900		10.1038/nature07760	http://dx.doi.org/10.1038/nature07760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212410				2022-12-24	WOS:000263266700048
J	Hall, CB; Weinberg, GA; Iwane, MK; Blumkin, AK; Edwards, KM; Staat, MA; Auinger, P; Griffin, MR; Poehling, KA; Erdman, D; Grijalva, CG; Zhu, YW; Szilagyi, P				Hall, Caroline Breese; Weinberg, Geoffrey A.; Iwane, Marika K.; Blumkin, Aaron K.; Edwards, Kathryn M.; Staat, Mary A.; Auinger, Peggy; Griffin, Marie R.; Poehling, Katherine A.; Erdman, Dean; Grijalva, Carlos G.; Zhu, Yuwei; Szilagyi, Peter			The Burden of Respiratory Syncytial Virus Infection in Young Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; HUMAN METAPNEUMOVIRUS; TRACT INFECTIONS; 1ST YEAR; INFLUENZA; HOSPITALIZATION; INFANTS; DISEASE; RATES; RSV	Background The primary role of respiratory syncytial virus ( RSV) in causing infant hospitalizations is well recognized, but the total burden of RSV infection among young children remains poorly defined. Methods We conducted prospective, population- based surveillance of acute respiratory infections among children under 5 years of age in three U. S. counties. We enrolled hospitalized children from 2000 through 2004 and children presenting as outpatients in emergency departments and pediatric offices from 2002 through 2004. RSV was detected by culture and reverse- transcriptase polymerase chain reaction. Clinical information was obtained from parents and medical records. We calculated population- based rates of hospitalization associated with RSV infection and estimated the rates of RSV- associated outpatient visits. Results Among 5067 children enrolled in the study, 919 ( 18%) had RSV infections. Overall, RSV was associated with 20% of hospitalizations, 18% of emergency department visits, and 15% of office visits for acute respiratory infections from November through April. Average annual hospitalization rates were 17 per 1000 children under 6 months of age and 3 per 1000 children under 5 years of age. Most of the children had no coexisting illnesses. Only prematurity and a young age were independent risk factors for hospitalization. Estimated rates of RSV- associated office visits among children under 5 years of age were three times those in emergency departments. Outpatients had moderately severe RSV- associated illness, but few of the illnesses ( 3%) were diagnosed as being caused by RSV. Conclusions RSV infection is associated with substantial morbidity in U. S. children in both inpatient and outpatient settings. Most children with RSV infection were previously healthy, suggesting that control strategies targeting only high- risk children will have a limited effect on the total disease burden of RSV infection.	[Hall, Caroline Breese; Weinberg, Geoffrey A.; Blumkin, Aaron K.; Auinger, Peggy; Szilagyi, Peter] Univ Rochester, Sch Med & Dent, Div Infect Dis, Dept Pediat, Rochester, NY 14642 USA; [Hall, Caroline Breese] Univ Rochester, Sch Med & Dent, Div Infect Dis, Dept Med, Rochester, NY 14642 USA; [Iwane, Marika K.; Erdman, Dean] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Edwards, Kathryn M.; Poehling, Katherine A.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Griffin, Marie R.; Grijalva, Carlos G.] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37232 USA; [Zhu, Yuwei] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Staat, Mary A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	University of Rochester; University of Rochester; Centers for Disease Control & Prevention - USA; Vanderbilt University; Vanderbilt University; Vanderbilt University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hall, CB (corresponding author), Univ Rochester, Sch Med & Dent, Div Infect Dis, Dept Pediat, 601 Elmwood Ave,Box 689, Rochester, NY 14642 USA.	caroline_hall@urmc.rochester.edu	Weinberg, Geoffrey A./W-7510-2019	Weinberg, Geoffrey A./0000-0002-3900-379X; Grijalva, Carlos/0000-0002-2329-7797	MedImmune; Astellas; GlaxoSmithKline; Merck; Pfizer; Wyeth; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [K01IP000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI065805] Funding Source: NIH RePORTER	MedImmune(AstraZenecaMedimmune); Astellas(Astellas Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Wyeth(Wyeth); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported through cooperative agreements with the CDC.; Dr. Hall reports receiving grant support and consulting fees from MedImmune; Dr. Weinberg, research support from Astellas and MedImmune and consulting fees from MedImmune; Dr. Staat, consulting fees or fees for serving on paid advisory boards from GlaxoSmithKline, Merck, and MedImmune, lecture fees from Merck, and research support from MedImmune; Dr. Griffin, grant support from MedImmune and Pfizer; and Dr. Grijalva, lecture fees from Wyeth. No other potential conflict of interest relevant to this article was reported.; The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the CDC.; We thank the children and their parents who participated in this study; all the members of the New Vaccine Surveillance Network, including Geraldine Lofthus, Kenneth Schnabel, Andrea Marino, Lynne Shelley, Jennifer Carnahan, Linda Anderson, Gladys Lathan, Charlene Freundlich, Christina Albertin, and Rebecca Martinez at the University of Rochester; John Williams, Diane Kent, Ann Clay, Ayesha Khan, Yi Wei Tang, Haijing Li, Jennifer Doersam, Amondrea Blackman, Nayleen Whitehead, Erin Keckley, and Jody Peters at Vanderbilt University; Linda Jamison, David Witte, David Bernstein, Emilie Grube, Vanessa Florian, Pamela Groen, and Joel Mortensen at the Cincinnati Children's Medical Center; and Ranee Seither, Aaron Curns, Larry Anderson, Carolyn B. Bridges, Benjamin Schwartz, Frances Walker, John Copeland, Alicia Fry, Jennifer Reuer, and John Zhang at the CDC.	Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Bradley JP, 2005, PEDIATRICS, V115, pE7, DOI 10.1542/peds.2004-0059; Carbonell-Estrany Xavier, 2004, Pediatr Infect Dis J, V23, pS193, DOI 10.1097/01.inf.0000144664.31888.53; Casella G, 2002, STAT INFERENCE, P240; Collins Peter L, 2005, Proc Am Thorac Soc, V2, P166, DOI 10.1513/pats.200501-011AW; Comperat E, 2007, PROG UROL, V17, P5, DOI 10.1016/S1166-7087(07)92218-6; Englund J, 2005, J INFECT DIS, V191, P1036, DOI 10.1086/427998; Erdman DD, 2003, J CLIN MICROBIOL, V41, P4298, DOI 10.1128/JCM.41.9.4298-4303.2003; Griffin Marie R, 2004, Pediatr Infect Dis J, V23, pS188, DOI 10.1097/01.inf.0000144660.53024.64; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; HOLBERG CJ, 1991, AM J EPIDEMIOL, V133, P1135, DOI 10.1093/oxfordjournals.aje.a115826; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Law BJ, 2004, PEDIATR INFECT DIS J, V23, P806, DOI 10.1097/01.inf.0000137568.71589.bd; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; Meissner HC, 2004, PEDIATR INFECT DIS J, V23, P284, DOI 10.1097/01.inf.0000121203.33560.f9; Miller EK, 2008, PEDIATRICS, V121, P1, DOI 10.1542/peds.2007-1053; Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; *NAT I ALL INF DIS, 2002, JORD REP ACC DEV VAC; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Nielsen HE, 2003, ACTA PAEDIATR, V92, P1314, DOI 10.1080/08035250310006304; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Peck AJ, 2005, PEDIATR INFECT DIS J, V24, P342, DOI 10.1097/01.inf.0000157250.95880.91; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Reeve CA, 2006, J PAEDIATR CHILD H, V42, P248, DOI 10.1111/j.1440-1754.2006.00849.x; Romero JR, 2003, PEDIATR INFECT DIS J, V22, pS46, DOI 10.1097/00006454-200302001-00007; Rossi GA, 2007, EUR J PEDIATR, V166, P1267, DOI 10.1007/s00431-007-0418-y; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; StataCorp L, 2007, STAT DAT AN STAT SOF; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; von Linstow ML, 2008, EUR J PEDIATR, V167, P1125, DOI 10.1007/s00431-007-0643-4; Weinberg GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456; WEINBERG GA, J PEDIAT IN PRESS; WELLIVER RC, 2004, PAEDIATR RESPIR REV, pS127	38	1358	1413	1	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					588	598		10.1056/NEJMoa0804877	http://dx.doi.org/10.1056/NEJMoa0804877			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402QS	19196675	Green Accepted, Bronze			2022-12-24	WOS:000263028800005
J	Cook, PJ; Ju, BG; Telese, F; Wang, XT; Glass, CK; Rosenfeld, MG				Cook, Peter J.; Ju, Bong Gun; Telese, Francesca; Wang, Xiangting; Glass, Christopher K.; Rosenfeld, Michael G.			Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions	NATURE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HISTONE H2AX; EYES ABSENT; GENOMIC INSTABILITY; SIGNALING PATHWAYS; CELLULAR-RESPONSE; DROSOPHILA EYE; IN-VIVO; PROTEIN	Life and death fate decisions allow cells to avoid massive apoptotic death in response to genotoxic stress. Although the regulatory mechanisms and signalling pathways controlling DNA repair and apoptosis are well characterized, the precise molecular strategies that determine the ultimate choice of DNA repair and survival or apoptotic cell death remain incompletely understood. Here we report that a protein tyrosine phosphatase, EYA, is involved in promoting efficient DNA repair rather than apoptosis in response to genotoxic stress in mammalian embryonic kidney cells by executing a damage-signal-dependent dephosphorylation of an H2AX carboxy-terminal tyrosine phosphate (Y142). This post-translational modification determines the relative recruitment of either DNA repair or pro-apoptotic factors to the tail of serine phosphorylated histone H2AX (gamma-H2AX) and allows it to function as an active determinant of repair/survival versus apoptotic responses to DNA damage, revealing an additional phosphorylation-dependent mechanism that modulates survival/apoptotic decisions during mammalian organogenesis.	[Cook, Peter J.; Ju, Bong Gun; Telese, Francesca; Wang, Xiangting; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Cook, Peter J.] Univ Calif San Diego, Sch Med, Dept Biol Grad Program, La Jolla, CA 92093 USA; [Ju, Bong Gun] Sogang Univ, Dept Life Sci, Seoul 121742, South Korea; [Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Sogang University; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	mrosenfeld@ucsd.edu	Glass, Christopher/AAI-3933-2021; xiangting, wang/P-1010-2014	Glass, Christopher/0000-0003-4344-3592; xiangting, wang/0000-0003-2106-3425; Telese, Francesca/0000-0003-3877-0628	NIH; NCI; Sogang University Research Grant of 2008; USAMRAA; NATIONAL CANCER INSTITUTE [R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sogang University Research Grant of 2008; USAMRAA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Kastan for providing reagents/technical assistance for the I-PpoI system. We thank V. Lunyak, J. Dixon and R. Koladner for review and discussions. We thank the laboratory of R. S. Johnson for use of equipment and advice on hypoxia incubations, as well as H. Taylor for animal care assistance and C. Nelson for cell culture assistance. We thank A. Nussenzweig, Y. Xu and H. Song for H2ax 2/2 MEFs. We thank J. Hightower and M. Fisher for assistance with figure and manuscript preparation. We additionally thank X. Li and W. Liu. M. G. R. is an HHMI Investigator. This work was supported by grants from NIH and NCI to M. G. R. and C. K. G. This work also was supported by the Sogang University Research Grant of 2008 to B. G. J and PCF and USAMRAA grants to M. G. R.	Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Berkovich E, 2008, NAT PROTOC, V3, P915, DOI 10.1038/nprot.2008.54; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; DUILIO A, 1991, NUCLEIC ACIDS RES, V19, P5269, DOI 10.1093/nar/19.19.5269; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Karagiannis TC, 2007, LEUKEMIA, V21, P195, DOI 10.1038/sj.leu.2404478; Kim JE, 2006, MOL CARCINOGEN, V45, P403, DOI 10.1002/mc.20221; Kumar JP, 2001, NAT REV GENET, V2, P846, DOI 10.1038/35098564; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Minopoli G, 2007, J BIOL CHEM, V282, P831, DOI 10.1074/jbc.C600276200; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2005, BIOCHEMISTRY-US, V44, P751, DOI 10.1021/bi0481794; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sambrook J, 2001, MOL CLONING LAB MANU; Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722	35	388	414	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					591	U53		10.1038/nature07849	http://dx.doi.org/10.1038/nature07849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19234442	Green Accepted, Green Submitted			2022-12-24	WOS:000264796200032
J	Kamikouchi, A; Inagaki, HK; Effertz, T; Hendrich, O; Fiala, A; Gopfert, MC; Ito, K				Kamikouchi, Azusa; Inagaki, Hidehiko K.; Effertz, Thomas; Hendrich, Oliver; Fiala, Andre; Goepfert, Martin C.; Ito, Kei			The neural basis of Drosophila gravity-sensing and hearing	NATURE			English	Article							TRANSDUCTION CHANNEL; TRP CHANNELS; MELANOGASTER; EXPRESSION; MUTATIONS; PATHWAYS; CEREBELLUM; AUDITION; NEURONS; NUCLEI	The neural substrates that the fruitfly Drosophila uses to sense smell, taste and light share marked structural and functional similarities with ours, providing attractive models to dissect sensory stimulus processing. Here we focus on two of the remaining and less understood prime sensory modalities: graviception and hearing. We show that the fly has implemented both sensory modalities into a single system, Johnston's organ, which houses specialized clusters of mechanosensory neurons, each of which monitors specific movements of the antenna. Gravity- and sound-sensitive neurons differ in their response characteristics, and only the latter express the candidate mechanotransducer channel NompC. The two neural subsets also differ in their central projections, feeding into neural pathways that are reminiscent of the vestibular and auditory pathways in our brain. By establishing the Drosophila counterparts of these sensory systems, our findings provide the basis for a systematic functional and molecular dissection of how different mechanosensory stimuli are detected and processed.	[Kamikouchi, Azusa; Inagaki, Hidehiko K.; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kamikouchi, Azusa; Effertz, Thomas; Hendrich, Oliver; Goepfert, Martin C.] Univ Cologne, Inst Zool, Sensory Syst Lab, D-50923 Cologne, Germany; [Kamikouchi, Azusa] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan; [Effertz, Thomas; Hendrich, Oliver; Fiala, Andre; Goepfert, Martin C.] Univ Gottingen, Johann Friedrich Blumenbach Inst, D-37073 Gottingen, Germany; [Fiala, Andre] Univ Wurzburg, Dept Genet & Neurobiol, Theodor Boveri Inst, D-97074 Wurzburg, Germany	University of Tokyo; University of Cologne; Tokyo University of Pharmacy & Life Sciences; University of Gottingen; University of Wurzburg	Ito, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	mgoepfe@gwdg.de; itokei@iam.u-tokyo.ac.jp	Fiala, André/AAA-3852-2019; Effertz, Thomas/E-2930-2010	Fiala, André/0000-0002-9745-5145; Hendrich, Oliver/0000-0003-1185-520X; Inagaki, Hidehiko/0000-0003-4580-2763; Kamikouchi, Azusa/0000-0003-1552-6892; Gopfert, Martin/0000-0001-8201-5334	Japanese Cell Science Research Foundation; Alexander von Humboldt Foundation; Japan Society for the Promotion of Science; DFG Collaborative Research Centre 554; Volkswagen Foundation; BMBF Bernstein Network for Computational Neuroscience; DFG Research Centre Molecular Physiology of the Brain; Human Frontier Science Program Organisation; BIRD/Japan Science and Technology Agency	Japanese Cell Science Research Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); DFG Collaborative Research Centre 554(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); BMBF Bernstein Network for Computational Neuroscience(Federal Ministry of Education & Research (BMBF)); DFG Research Centre Molecular Physiology of the Brain(German Research Foundation (DFG)); Human Frontier Science Program Organisation(Human Frontier Science Program); BIRD/Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Japanese Cell Science Research Foundation, the Alexander von Humboldt Foundation, and the Japan Society for the Promotion of Science ( to A. K.), the DFG Collaborative Research Centre 554 ( to A. F.), the Volkswagen Foundation, the BMBF Bernstein Network for Computational Neuroscience, and the DFG Research Centre Molecular Physiology of the Brain ( to M. C. G.), and the Human Frontier Science Program Organisation, BIRD/Japan Science and Technology Agency, and the Japan Society for the Promotion of Science ( to K. I.).	Albert JT, 2007, CURR BIOL, V17, P1000, DOI 10.1016/j.cub.2007.05.004; ALBERT JT, 2006, NATURE PROTOCOLS, DOI DOI 10.1038/NPROT.2006.364; BACON JP, 1986, J COMP PHYSIOL A, V158, P529, DOI 10.1007/BF00603798; Baker DA, 2007, J COMP NEUROL, V501, P756, DOI 10.1002/cne.21257; Barmack NH, 2003, BRAIN RES BULL, V60, P511, DOI 10.1016/S0361-9230(03)00055-8; Beckingham KM, 2005, ADV GENET, V55, P105, DOI 10.1016/S0065-2660(05)55004-1; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buttner-Ennever JA, 1999, ANN NY ACAD SCI, V871, P51, DOI 10.1111/j.1749-6632.1999.tb09175.x; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; FIALA A, 2003, SCI STKE, pP16; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; GOLDBERG ME, 2000, PRINCIPLES NEURAL SC, P801; Gopfert MC, 2002, J EXP BIOL, V205, P1199; Gopfert MC, 2001, NATURE, V411, P908, DOI 10.1038/35082144; HORN E, 1978, J COMP PHYSIOL, V126, P137, DOI 10.1007/BF00666366; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kandel E. R., 2000, PRINCIPLES NEURAL SC, V4, P590; Keppel G., 2004, DESIGN ANAL RES HDB; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Nadrowski B, 2008, CURR BIOL, V18, P1365, DOI 10.1016/j.cub.2008.07.095; Newsome TP, 2000, DEVELOPMENT, V127, P851; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; Phelan P, 1996, J NEUROSCI, V16, P1101; Ricci AJ, 2005, J NEUROSCI, V25, P7831, DOI 10.1523/JNEUROSCI.1127-05.2005; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Smith HK, 1996, DEV GENES EVOL, V206, P14, DOI 10.1007/s004270050026; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tauber E, 2003, BEHAV PROCESS, V64, P197, DOI 10.1016/S0376-6357(03)00135-9; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Todi SV, 2004, MICROSC RES TECHNIQ, V63, P388, DOI 10.1002/jemt.20053; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	43	251	256	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					165	U1		10.1038/nature07810	http://dx.doi.org/10.1038/nature07810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279630				2022-12-24	WOS:000264059700035
J	Conley, DJ; Paerl, HW; Howarth, RW; Boesch, DF; Seitzinger, SP; Havens, KE; Lancelot, C; Likens, GE				Conley, Daniel J.; Paerl, Hans W.; Howarth, Robert W.; Boesch, Donald F.; Seitzinger, Sybil P.; Havens, Karl E.; Lancelot, Christiane; Likens, Gene E.			ECOLOGY Controlling Eutrophication: Nitrogen and Phosphorus	SCIENCE			English	Editorial Material							LIMITING NUTRIENT; MANAGEMENT; LAKES; ECOSYSTEM; HYPOXIA; SEA		[Conley, Daniel J.] Lund Univ, Dept Geol, GeoBiosphere Sci Ctr, SE-22362 Lund, Sweden; [Paerl, Hans W.] Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; [Howarth, Robert W.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14873 USA; [Boesch, Donald F.] Univ Maryland, Ctr Environm Sci, Cambridge, MD 21613 USA; [Havens, Karl E.] Royal Swedish Acad Sci, Int Geosphere Biosphere Programme, SE-10405 Stockholm, Sweden; [Havens, Karl E.] Univ Florida, Florida Sea Grant, Gainesville, FL 32611 USA; [Lancelot, Christiane] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Likens, Gene E.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA	Lund University; University of North Carolina; University of North Carolina Chapel Hill; Cornell University; University System of Maryland; University of Maryland Center for Environmental Science; Royal Swedish Academy of Sciences; State University System of Florida; University of Florida; Universite Libre de Bruxelles; Cary Institute of Ecosystem Studies	Conley, DJ (corresponding author), Lund Univ, Dept Geol, GeoBiosphere Sci Ctr, Solvegatan 12, SE-22362 Lund, Sweden.	daniel.conley@geol.lu.se; hpaerl@email.unc.edu; rwh2@cornell.edu; boesch@umces.edu; sybil.seitzinger@igpb.kva.se; khavens@ufl.edu; lancelot@ulb.ac.be; likensg@ecostudies.org		Boesch, Donald/0000-0002-8154-133X; Conley, Daniel Joseph/0000-0001-9668-9284; Howarth, Robert/0000-0001-9531-4288				Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Blomqvist S, 2004, LIMNOL OCEANOGR, V49, P2236, DOI 10.4319/lo.2004.49.6.2236; Conley DJ, 2002, ENVIRON SCI TECHNOL, V36, P5315, DOI 10.1021/es025763w; Conley DJ, 1999, HYDROBIOLOGIA, V410, P87, DOI 10.1023/A:1003784504005; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Havens KE, 2001, ENVIRON POLLUT, V111, P263, DOI 10.1016/S0269-7491(00)00074-9; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Howarth RW, 2005, MILLENNIUM ECOSYSTEM, P295; LIKENS GE, 1972, LIMNOLOGY OCEANOGRAP, V1, P328; Malone TC, 1996, ESTUARIES, V19, P371, DOI 10.2307/1352457; Marino R, 2006, MAR ECOL PROG SER, V309, P25, DOI 10.3354/meps309025; National Research Council, 2000, CLEAN COAST WAT UND; National Research Council, 1992, REST AQ EC; Paerl HW, 2006, ECOL STU AN, V189, P95, DOI 10.1007/978-3-540-32210-8_8; Paerl HW, 2004, ENVIRON SCI TECHNOL, V38, P3068, DOI 10.1021/es0352350; RYTHER JH, 1971, SCIENCE, V171, P1008, DOI 10.1126/science.171.3975.1008; Scavia D, 2007, ENVIRON SCI TECHNOL, V41, P8111, DOI 10.1021/es0714235; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; Skogen MD, 2004, J MARINE SYST, V46, P23, DOI 10.1016/j.jmarsys.2003.11.013; Sylvan JB, 2007, LIMNOL OCEANOGR, V52, P2679, DOI 10.4319/lo.2007.52.6.2679; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; van Beusekom JEE, 2005, HELGOLAND MAR RES, V59, P45, DOI 10.1007/s10152-004-0206-2; Visser PM., 2005, HARMFUL CYANOBACTERI, V3; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Wulff F, 2007, AMBIO, V36, P243, DOI 10.1579/0044-7447(2007)36[243:MOAEOA]2.0.CO;2	27	2363	2639	128	2444	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1014	1015		10.1126/science.1167755	http://dx.doi.org/10.1126/science.1167755			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229022				2022-12-24	WOS:000263478400024
J	Yan, H; Parsons, DW; Jin, GL; McLendon, R; Rasheed, BA; Yuan, WS; Kos, I; Batinic-Haberle, I; Jones, S; Riggins, GJ; Friedman, H; Friedman, A; Reardon, D; Herndon, J; Kinzler, KW; Velculescu, VE; Vogelstein, B; Bigner, DD				Yan, Hai; Parsons, D. Williams; Jin, Genglin; McLendon, Roger; Rasheed, B. Ahmed; Yuan, Weishi; Kos, Ivan; Batinic-Haberle, Ines; Jones, Sian; Riggins, Gregory J.; Friedman, Henry; Friedman, Allan; Reardon, David; Herndon, James; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert; Bigner, Darell D.			IDH1 and IDH2 Mutations in Gliomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPENDENT ISOCITRATE DEHYDROGENASE; COMPARATIVE GENOMIC HYBRIDIZATION; FACTOR RECEPTOR GENE; MALIGNANT GLIOMAS; GLIOBLASTOMA; PATHWAYS; AMPLIFICATION; EXPRESSION; MECHANISM; MAJORITY	Background A recent genomewide mutational analysis of glioblastomas ( World Health Organization [ WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene ( IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower- grade gliomas ( secondary glioblastomas). Methods We determined the sequence of the IDH1 gene and the related IDH2 gene in 445 central nervous system ( CNS) tumors and 494 non- CNS tumors. The enzymatic activity of the proteins that were produced from normal and mutant IDH1 and IDH2 genes was determined in cultured glioma cells that were transfected with these genes. Results We identified mutations that affected amino acid 132 of IDH1 in more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas and in glioblastomas that developed from these lower- grade lesions. Tumors without mutations in IDH1 often had mutations affecting the analogous amino acid ( R172) of the IDH2 gene. Tumors with IDH1 or IDH2 mutations had distinctive genetic and clinical characteristics, and patients with such tumors had a better outcome than those with wild- type IDH genes. Each of four tested IDH1 and IDH2 mutations reduced the enzymatic activity of the encoded protein. Conclusions Mutations of NADP(+)-dependent isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a majority of several types of malignant gliomas.	[Yan, Hai; Jin, Genglin; McLendon, Roger; Rasheed, B. Ahmed; Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Kos, Ivan; Batinic-Haberle, Ines] Duke Univ, Med Ctr, Dept Radiat Oncol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Friedman, Henry] Duke Univ, Med Ctr, Dept Neurooncol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Friedman, Allan; Reardon, David] Duke Univ, Med Ctr, Dept Surg, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Yan, Hai; Jin, Genglin; McLendon, Roger; Rasheed, B. Ahmed; Kos, Ivan; Batinic-Haberle, Ines; Friedman, Henry; Friedman, Allan; Reardon, David; Bigner, Darell D.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Herndon, James] Duke Univ, Med Ctr, Canc Stat Ctr, Durham, NC 27710 USA; [Parsons, D. Williams; Jones, Sian; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Parsons, D. Williams; Jones, Sian; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD USA; [Riggins, Gregory J.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Parsons, D. Williams] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Yuan, Weishi] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; US Food & Drug Administration (FDA)	Yan, H (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA.	yan00002@mc.duke.edu; dwparson@txccc.org	Velculescu, Victor/ABF-4846-2020; Jones, Sian/A-5050-2012; Jin, Genglin/F-6868-2011	Velculescu, Victor/0000-0003-1195-438X; Parsons, Donald/0000-0002-8775-3501	Pediatric Brain Tumor Foundation Institute; Damon Runyon Foundation Scholar Award; Southeastern Brain Tumor Foundation; Alex's Lemonade Stand Foundation; V Foundation for Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Pew Charitable Trusts; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins [R01CA118822, NS20023-21, R37CA11898-34, CA121113, CA43460, CA57345, 5P50-CA-108786, 5P50-NS-20023, 5R37CA-11898, 2P30-CA-14236]; Beckman Coulter; Accelerate Brain Cancer Cure Foundation; Johns Hopkins University; NATIONAL CANCER INSTITUTE [R01CA121113, R37CA011898, R37CA043460, P30CA014236, R01CA043460, R01CA140316, R37CA057345, R01CA057345, R01CA118822, P50CA062924, P50CA108786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020023] Funding Source: NIH RePORTER	Pediatric Brain Tumor Foundation Institute; Damon Runyon Foundation Scholar Award; Southeastern Brain Tumor Foundation; Alex's Lemonade Stand Foundation; V Foundation for Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Pew Charitable Trusts; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins; Beckman Coulter; Accelerate Brain Cancer Cure Foundation; Johns Hopkins University(Johns Hopkins University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a grant from the Pediatric Brain Tumor Foundation Institute, a Damon Runyon Foundation Scholar Award, a grant from the Southeastern Brain Tumor Foundation, Alex's Lemonade Stand Foundation, a grant from the V Foundation for Cancer Research, the Virginia and D. K. Ludwig Fund for Cancer Research, the Pew Charitable Trusts, the American Brain Tumor Association, the Brain Tumor Research Fund at Johns Hopkins, grants (R01CA118822, NS20023-21, R37CA11898-34, CA121113, CA43460, CA57345, 5P50-CA-108786, 5P50-NS-20023, 5R37CA-11898, and 2P30-CA-14236) from Beckman Coulter, and grants from the Accelerate Brain Cancer Cure Foundation.; Drs. Yan, Parsons, Jones, Kinzler, Velculescu, Vogelstein, and Bigner report being eligible for royalties received by Johns Hopkins University on sales of products related to research described in this article, under licensing agreements between the university and Beckman Coulter. No other potential conflict of interest relevant to this article was reported.; The views expressed in this article are those of the authors and do not necessarily represent the official views of the Food and Drug Administration.; We thank Melissa J. Ehinger, Diane L. Satterfield, Eric Lipp, Michael Leonard, Jennifer D. Funkhouser, and Patrick Killela for their assistance with the clinical information; P. Buckhaults, S. Powell, S. Kern, J. Eshleman, C. Civin, I.- M. Shih, and A. Gazdar for providing DNA from non-central nervous system cancers; and Dr. A. T. Campagnoni at the University of California, Los Angeles, for donating the human oligodendroglioma cell line.	Batinic-Haberle I, 2008, FREE RADICAL RES, V42, P618, DOI 10.1080/10715760802209639; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Burger PC, 2000, PATHOLOGY GENETICS T, P45; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Jennings GT, 1997, BIOCHEMISTRY-US, V36, P13743, DOI 10.1021/bi970916r; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; RIEFENBERGER J, 1994, AM J PATHOL, V145, P1175; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; The WHO, 2020, CLASSIFICATION TUMOU; Ueki K, 1996, CANCER RES, V56, P150; Wang TL, 2004, P NATL ACAD SCI USA, V101, P3089, DOI 10.1073/pnas.0308716101; Weber RG, 1996, ONCOGENE, V13, P983; Wen PY, 2008, NEW ENGL J MED, V359, P877; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200	24	3917	4092	12	299	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					765	773		10.1056/NEJMoa0808710	http://dx.doi.org/10.1056/NEJMoa0808710			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408CN	19228619	Green Accepted			2022-12-24	WOS:000263411300006
J	Wegrzyn, J; Potla, R; Chwae, YJ; Sepuri, NBV; Zhang, QF; Koeck, T; Derecka, M; Szczepanek, K; Szelag, M; Gornicka, A; Moh, A; Moghaddas, S; Chen, Q; Bobbili, S; Cichy, J; Dulak, J; Baker, DP; Wolfman, A; Stuehr, D; Hassan, MO; Fu, XY; Avadhani, N; Drake, JI; Fawcett, P; Lesnefsky, EJ; Larner, AC				Wegrzyn, Joanna; Potla, Ramesh; Chwae, Yong-Joon; Sepuri, Naresh B. V.; Zhang, Qifang; Koeck, Thomas; Derecka, Marta; Szczepanek, Karol; Szelag, Magdalena; Gornicka, Agnieszka; Moh, Akira; Moghaddas, Shadi; Chen, Qun; Bobbili, Santha; Cichy, Joanna; Dulak, Jozef; Baker, Darren P.; Wolfman, Alan; Stuehr, Dennis; Hassan, Medhat O.; Fu, Xin-Yuan; Avadhani, Narayan; Drake, Jennifer I.; Fawcett, Paul; Lesnefsky, Edward J.; Larner, Andrew C.			Function of Mitochondrial Stat3 in Cellular Respiration	SCIENCE			English	Article							REGULATORY GENE-PRODUCT; INTERFERON-BETA; COMPLEX-I; GRIM-19; SUBUNIT; PROTEIN; DOMAIN; NADH	Cytokines such as interleukin- 6 induce tyrosine and serine phosphorylation of Stat3 that results in activation of Stat3- responsive genes. We provide evidence that Stat3 is present in the mitochondria of cultured cells and primary tissues, including the liver and heart. In Stat3(-/-) cells, the activities of complexes I and II of the electron transport chain ( ETC) were significantly decreased. We identified Stat3 mutants that selectively restored the protein's function as a transcription factor or its functions within the ETC. In mice that do not express Stat3 in the heart, there were also selective defects in the activities of complexes I and II of the ETC. These data indicate that Stat3 is required for optimal function of the ETC, which may allow it to orchestrate responses to cellular homeostasis.	[Wegrzyn, Joanna; Chwae, Yong-Joon; Zhang, Qifang; Derecka, Marta; Szczepanek, Karol; Szelag, Magdalena; Gornicka, Agnieszka; Bobbili, Santha; Fawcett, Paul] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Wegrzyn, Joanna; Chwae, Yong-Joon; Zhang, Qifang; Derecka, Marta; Szczepanek, Karol; Szelag, Magdalena; Gornicka, Agnieszka; Bobbili, Santha; Fawcett, Paul] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Wegrzyn, Joanna; Szelag, Magdalena; Dulak, Jozef] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Potla, Ramesh; Stuehr, Dennis] Cleveland State Univ, Dept Biol, Cleveland, OH 44114 USA; [Sepuri, Naresh B. V.] Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India; [Koeck, Thomas; Stuehr, Dennis] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Derecka, Marta; Szczepanek, Karol; Cichy, Joanna] Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Gornicka, Agnieszka] Jagiellonian Univ, Dept Cell Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Moh, Akira; Fu, Xin-Yuan] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Moghaddas, Shadi; Chen, Qun; Lesnefsky, Edward J.] Case Western Reserve Univ, Div Cardiol, Dept Med, Cleveland, OH 44106 USA; [Baker, Darren P.] Biogenldec, Cambridge, MA 02142 USA; [Wolfman, Alan] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Hassan, Medhat O.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Pathol & Lab Med Serv, Cleveland, OH 44106 USA; [Avadhani, Narayan] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Drake, Jennifer I.; Fawcett, Paul] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Med Serv, Cleveland, OH 44106 USA	Virginia Commonwealth University; Virginia Commonwealth University; Jagiellonian University; University System of Ohio; Cleveland State University; University of Hyderabad; Cleveland Clinic Foundation; Jagiellonian University; Jagiellonian University; Indiana University System; Indiana University-Purdue University Indianapolis; Case Western Reserve University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Pennsylvania; Virginia Commonwealth University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Larner, AC (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	alarner@vcu.edu	zhang, qifang/H-5691-2013; Sepuri, Naresh/AAF-2704-2020; Chen, Qun/HGD-0868-2022; zhang, qifang/F-9857-2013	Derecka, Marta/0000-0001-6265-9781; Cichy, Joanna/0000-0002-0552-8344	NIH [CA098924, PO1AG15885]; Office of Research and Development; Medical Research Service Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA098924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development; Medical Research Service Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants CA098924 (A.C.L.) and PO1AG15885 and the Office of Research and Development, Medical Research Service Department of Veterans Affairs (E.J.L.). We thank I. Scheffler for his many suggestions. DHQ was a kind gift from C. Hoppel. This manuscript is dedicated to Joseph Larner in honor of 60 years of scientific achievement and enthusiasm.	Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Gamero AM, 2006, J BIOL CHEM, V281, P16238, DOI 10.1074/jbc.M509516200; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3	14	686	706	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					793	797		10.1126/science.1164551	http://dx.doi.org/10.1126/science.1164551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19131594	Green Accepted, Green Submitted			2022-12-24	WOS:000263066800050
J	Taylor, AF; Tinsley, MR; Wang, F; Huang, ZY; Showalter, K				Taylor, Annette F.; Tinsley, Mark R.; Wang, Fang; Huang, Zhaoyang; Showalter, Kenneth			Dynamical Quorum Sensing and Synchronization in Large Populations of Chemical Oscillators	SCIENCE			English	Article							EMERGING COHERENCE; FISCHERI; WAVES; CELLS	Populations of certain unicellular organisms, such as suspensions of yeast in nutrient solutions, undergo transitions to coordinated activity with increasing cell density. The collective behavior is believed to arise through communication by chemical signaling via the extracellular solution. We studied large, heterogeneous populations of discrete chemical oscillators (similar to 100,000) with well- defined kinetics to characterize two different types of density- dependent transitions to synchronized oscillatory behavior. For different chemical exchange rates between the oscillators and the surrounding solution, increasing oscillator density led to ( i) the gradual synchronization of oscillatory activity, or ( ii) the sudden "switching on" of synchronized oscillatory activity. We analyze the roles of oscillator density and exchange rate of signaling species in these transitions with a mathematical model of the interacting chemical oscillators.	[Tinsley, Mark R.; Wang, Fang; Huang, Zhaoyang; Showalter, Kenneth] W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA; [Taylor, Annette F.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	West Virginia University; University of Leeds	Showalter, K (corresponding author), W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA.	kshowalt@wvu.edu	Showalter, Kenneth/P-3460-2015; taylor, annette/Z-1062-2018	Showalter, Kenneth/0000-0003-3443-9911; taylor, annette/0000-0003-0071-8306	UK Engineering and Physical Sciences Research Council [GR/T11036/01]; NSF [CHE-0809058]; Engineering and Physical Sciences Research Council [GR/T11036/01] Funding Source: researchfish; Division Of Chemistry [0809058] Funding Source: National Science Foundation	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NSF(National Science Foundation (NSF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by UK Engineering and Physical Sciences Research Council grant GR/T11036/01 (A.F.T.) and by NSF grant CHE-0809058. We dedicate this paper to the memory of Anatol M. Zhabotinsky, a pioneer of modern research in oscillations and pattern formation in chemical systems.	ALDRIDGE J, 1976, NATURE, V259, P670, DOI 10.1038/259670a0; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; ENGEBRECHT J, 1983, CELL, V32, P773, DOI 10.1016/0092-8674(83)90063-6; ERMENTROUT GB, 1990, PHYSICA D, V41, P219, DOI 10.1016/0167-2789(90)90124-8; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; GERISCH G, 1974, P NATL ACAD SCI USA, V71, P2118, DOI 10.1073/pnas.71.5.2118; Greenberg EP, 1997, ASM NEWS, V63, P371; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; MASELKO J, 1989, J PHYS CHEM-US, V93, P2774, DOI 10.1021/j100344a016; MASELKO J, 1989, NATURE, V339, P609, DOI 10.1038/339609a0; Patriquin GM, 2008, J BACTERIOL, V190, P662, DOI 10.1128/JB.01473-07; SHINOMOTO S, 1986, PROG THEOR PHYS, V75, P1105, DOI 10.1143/PTP.75.1105; Toth R, 2006, J PHYS CHEM B, V110, P10170, DOI 10.1021/jp060732z; Winfree AT, 2002, SCIENCE, V298, P2336, DOI 10.1126/science.1072560; Yoshikawa K, 1998, J PHYS CHEM A, V102, P7649, DOI 10.1021/jp982136d; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0; ZHABOTINSKY AM, 1993, J PHYS CHEM-US, V97, P7578, DOI 10.1021/j100131a030	20	314	318	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					614	617		10.1126/science.1166253	http://dx.doi.org/10.1126/science.1166253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179525				2022-12-24	WOS:000262862800037
J	Sirotin, YB; Das, A				Sirotin, Yevgeniy B.; Das, Aniruddha			Anticipatory haemodynamic signals in sensory cortex not predicted by local neuronal activity	NATURE			English	Article							INTRINSIC SIGNAL; BOLD FMRI; SPECTROSCOPY; STIMULATION; SPIKES; MAPS; V1	Haemodynamic signals underlying functional brain imaging ( for example, functional magnetic resonance imaging ( fMRI)) are assumed to reflect metabolic demand generated by local neuronal activity, with equal increases in haemodynamic signal implying equal increases in the underlying neuronal activity(1-6). Few studies have compared neuronal and haemodynamic signals in alert animals(7,8) to test for this assumed correspondence. Here we present evidence that brings this assumption into question. Using a dual-wavelength optical imaging technique(9) that independently measures cerebral blood volume and oxygenation, continuously, in alert behaving monkeys, we find two distinct components to the haemodynamic signal in the alert animals' primary visual cortex (V1). One component is reliably predictable from neuronal responses generated by visual input. The other component - of almost comparable strength - is a hither to unknown signal that entrains to task structure independently of visual input or of standard neural predictors of haemodynamics. This latter component shows predictive timing, with increases of cerebral blood volume in anticipation of trial onsets even in darkness. This trial- locked haemodynamic signal could be due to an accompanying V1 arterial pumping mechanism, closely matched in time, with peaks of arterial dilation entrained to predicted trial onsets. These findings ( tested in two animals) challenge the current understanding of the link between brain haemodynamics and local neuronal activity. They also suggest the existence of a novel preparatory mechanism in the brain that brings additional arterial blood to cortex in anticipation of expected tasks.	[Sirotin, Yevgeniy B.; Das, Aniruddha] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, WM Keck Ctr Brain Plastic & Cognit, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, Mahoney Ctr Brain & Behav, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Das, Aniruddha] New York State Psychiat Inst & Hosp, Unit 87, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Das, A (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	ad2069@columbia.edu		Sirotin, Yevgeniy/0000-0001-7058-0424	Keck foundation; National Institutes of Health; Klingenstein Foundation; Gatsby Initiative in Brain Circuitry; Dana Foundation; National Research Service Award; NATIONAL EYE INSTITUTE [R01EY013759] Funding Source: NIH RePORTER	Keck foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); Gatsby Initiative in Brain Circuitry; Dana Foundation; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank: K. Korinek for designing and fabricating much of the dual- wavelength optical imaging hardware; P. P. Mitra for the suggestion of making continuous recordings and the use of the Chronux analysis software; E. M. C. Hillman for insights into brain haemodynamic mechanisms; C. Ma, G. Cantone, J. Ordinario, E. Glushenkova, W. Zhang, and M. Bucklin for help with recordings; E. Seidemann and R. Siegel for technical help during our initial setup; C. D. Gilbert and members of the Mahoney Center and the Center for Theoretical Neuroscience at Columbia University for comments on the manuscript. The work was supported by the Keck foundation, grants from the National Institutes of Health, the Klingenstein Foundation, the Gatsby Initiative in Brain Circuitry and the Dana Foundation to A. D. and a National Research Service Award to Y. B. S.	Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Berwick J, 2002, J CEREBR BLOOD F MET, V22, P670, DOI 10.1097/00004647-200206000-00005; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lucas B.D., 1981, P 7 INT JOINT C ARTI, P674, DOI DOI 10.5555/1623264.1623280; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; MATSUDA K, 2000, SOC NEUR ABSTR, V26; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; PRAHL S, 2007, TABULATED MOLAR EXTI; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; Ugurbil K, 2003, TRENDS NEUROSCI, V26, P108, DOI 10.1016/S0166-2236(02)00039-5; VANDERMOLEN MW, 1989, PSYCHOPHYSIOLOGY, V26, P70; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555	30	296	296	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					475	U6		10.1038/nature07664	http://dx.doi.org/10.1038/nature07664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158795	Green Accepted			2022-12-24	WOS:000262519200046
J	Woo, JS; Lim, JH; Shin, HC; Suh, MK; Ku, B; Lee, KH; Joo, K; Robinson, H; Lee, J; Park, SY; Ha, NC; Oh, BH				Woo, Jae-Sung; Lim, Jae-Hong; Shin, Ho-Chul; Suh, Min-Kang; Ku, Bonsu; Lee, Kwang-Hoon; Joo, Keehyoung; Robinson, Howard; Lee, Jooyoung; Park, Sam-Yong; Ha, Nam-Chul; Oh, Byung-Ha			Structural Studies of a Bacterial Condensin Complex Reveal ATP-Dependent Disruption of Intersubunit Interactions	CELL			English	Article							ESCHERICHIA-COLI; CHROMOSOME CONDENSATION; BACILLUS-SUBTILIS; SMC PROTEINS; CELL-CYCLE; MITOTIC CHROMOSOME; MUKB; DNA; LOCALIZATION; SEGREGATION	Condensins are key mediators of chromosome condensation across organisms. Like other condensins, the bacterial MukBEF condensin complex consists of an SMC family protein dimer containing two ATPase head domains, MukB, and two interacting subunits, MukE and MukF. We report complete structural views of the intersubunit interactions of this condensin along with ensuing studies that reveal a role for the ATPase activity of MukB. MukE and MukF together form an elongated dimeric frame, and MukF's C-terminal winged-helix domains (C-WHDs) bind MukB heads to constitute closed ring-like structures. Surprisingly, one of the two bound C-WHDs is forced to detach upon ATP-mediated engagement of MukB heads. This detachment reaction depends on the linker segment preceding the C-WHD, and mutations on the linker restrict cell growth. Thus ATP-dependent transient disruption of the MukB-MukF interaction, which creates openings in condensin ring structures, is likely to be a critical feature of the functional mechanism of condensins.	[Woo, Jae-Sung; Lim, Jae-Hong; Shin, Ho-Chul; Suh, Min-Kang; Ku, Bonsu; Lee, Kwang-Hoon; Oh, Byung-Ha] Pohang Univ Sci & Technol, Ctr Biomol Recognit, Pohang 790784, South Korea; [Woo, Jae-Sung; Lim, Jae-Hong; Shin, Ho-Chul; Suh, Min-Kang; Ku, Bonsu; Lee, Kwang-Hoon; Oh, Byung-Ha] Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang 790784, South Korea; [Joo, Keehyoung; Lee, Jooyoung] Korea Inst Adv Study, Sch Computat Sci, Seoul 130722, South Korea; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Park, Sam-Yong] Yokohama City Univ, Prot Design Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ha, Nam-Chul] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Korea Institute for Advanced Study (KIAS); United States Department of Energy (DOE); Brookhaven National Laboratory; Yokohama City University; Pusan National University	Oh, BH (corresponding author), Pohang Univ Sci & Technol, Ctr Biomol Recognit, Pohang 790784, South Korea.	bhoh@postech.ac.kr	Woo, Jae-Sung/T-2343-2019; Oh, Byung-Ha/C-2061-2011; Woo, Jae-Sung/J-4531-2017	Woo, Jae-Sung/0000-0001-9163-3433; Woo, Jae-Sung/0000-0001-9163-3433; Shin, Ho-chul/0000-0001-5500-3901; Ku, Bonsu/0000-0003-1784-8975	Creative Research Initiatives (Center for Biomolecular Interaction) of MOST/KOSEF; Core Research Program of POSTECH; Brain Korea 21 Project; NIH institute; National Center for Research Resources	Creative Research Initiatives (Center for Biomolecular Interaction) of MOST/KOSEF(Korea Science and Engineering Foundation); Core Research Program of POSTECH; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NIH institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Creative Research Initiatives (Center for Biomolecular Interaction) of MOST/KOSEF and partly by Core Research Program of POSTECH. J.-H.L., M.-K.S., H.-C.S., B.K. and K.-H.L. were supported by the Brain Korea 21 Project. This study made use of the beamline 4A at the Pohang Accelerator Laboratory in Korea, the beamline BL-5A at Photon Factory in Japan and the Brookhaven National Laboratory/Biology beamline X29 at the National Synchrotron Light Source in USA. The BNL Biology/PX Mail-in program is supported by the NIH institute, National Center for Research Resources.	Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; Cui YB, 2008, NAT STRUCT MOL BIOL, V15, P411, DOI 10.1038/nsmb.1410; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Fennell-Fezzie R, 2005, EMBO J, V24, P1921, DOI 10.1038/sj.emboj.7600680; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hudson DF, 2008, MOL BIOL CELL, V19, P3070, DOI 10.1091/mbc.E08-01-0057; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Mascarenhas J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-28; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; Matoba K, 2005, BIOCHEM BIOPH RES CO, V333, P694, DOI 10.1016/j.bbrc.2005.05.163; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Strunnikov AV, 2006, PLASMID, V55, P135, DOI 10.1016/j.plasmid.2005.08.004; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873	29	119	121	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					85	96		10.1016/j.cell.2008.10.050	http://dx.doi.org/10.1016/j.cell.2008.10.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135891	Green Submitted, Bronze			2022-12-24	WOS:000262318400017
